"Although it is still controversial whether leukotriene modifiers are more effective in patients with @Disease$ compared with other types of asthma, because LT plays an important role in the pathogenesis of AIA, @Chemical$ modifiers are the preferred medication for the long-term control of AIA."	0
The medical history of non-steroidal anti-inflammatory drugs (NSAIDs) or acetylsalicylic acid (@Chemical$) usage and the presence of coronary artery disease (@Disease$) were investigated in all patients with or without hemorrhage.	0
RESULTS: A significant association was detected between both AIU in general and the @Chemical$-intolerant acute urticaria (@Disease$) phenotype and the IL18 promoter polymorphism -607A/C.	0
Objective: Abnormalities of @Chemical$ profile were considered as risk factors of hemorrhage after ischemic @Disease$.	0
"Aspirin exacerbated @Disease$ (AERD) is a clinical condition characterized by severe decline in forced expiratory volume in one second (FEV1) following the ingestion of non-steroidal anti-inflammatory drugs (NSAIDs), including @Chemical$."	0
"At each visit, before the next dose of the drug, blood samples for determination of @Chemical$-induced @Disease$ were taken, physical examination, measurement of blood pressure (BP) and heart rate were recorded, adverse events were recorded."	1
CONCLUSION: Exhaled NO may indicate eosinophilic airway inflammation during @Chemical$ exposure in patients with ASA inducible @Disease$.	0
Most patients with @Disease$ can undergo @Chemical$ desensitization in an outpatient setting under the supervision of an allergist.	0
"The @Disease$, which can result from @Chemical$ administration, and which may occur with or without associated ulceration and bleeding, may lead patients to discontinue therapy, thus increasing their CVD risk."	1
"Aspirin-exacerbated @Disease$ (AERD) involves overexpression of proinflammatory mediators, including 5-lipoxygenase and leukotriene C4 synthase (LTC4S), resulting in constitutive overproduction of @Chemical$."	0
CONCLUSIONS: Patients on aspirin and clopidogrel &lt;5days before CABG who had preoperative ADP-induced @Disease$ &gt;=50% have bleeding risk similar to those receiving @Chemical$ monotherapy.	0
METHODS: We examined 246 @Disease$tic patients: 94 having @Chemical$ intolerance and 152 having aspirin tolerance.	0
AIM: To investigate the usefulness of anti-@Disease$ drugs for the prevention and treatment of low-dose @Chemical$-induced peptic ulcer.	0
AIM: The aim of the study was to assess the curcumin containing ethanolic extract (EtOH) obtained from Curcuma longa (Cl) against @Disease$ of wound healing by @Chemical$.	0
"Type 2 inflammation characterizes aspirin-exacerbated respiratory disease.Objectives: To determine whether high-dose @Chemical$ therapy changes biomarkers of type 2 inflammation in aspirin-exacerbated @Disease$.Methods: Forty-two subjects with aspirin-exacerbated respiratory disease underwent an aspirin desensitization and were placed on high-dose aspirin (1,300 mg daily)."	0
"CONCLUSIONS: This study showed an important proportion (18%) of dispatched aspirin users adults to digestive endoscopy, the 13.8% of them have a clear indication to use it, a substantial percent (13%) cannot inform any medical reason; the @Chemical$ usage for more than six months in doses lower than 500 mg per day increases the mucosal gastroduodenal injury prevalence (58%)and relative risk of suffering these @Disease$ are high."	1
The proportions of patients with an MLS of &gt;=1 and erosive @Disease$ were significantly lower in the rabeprazole group than in the @Chemical$ group at 12 weeks (gastric lesions 33.5 vs.	0
"Type 2 inflammation characterizes aspirin-exacerbated respiratory disease.Objectives: To determine whether high-dose aspirin therapy changes biomarkers of type 2 inflammation in aspirin-exacerbated respiratory disease.Methods: Forty-two subjects with @Chemical$-exacerbated @Disease$ underwent an aspirin desensitization and were placed on high-dose aspirin (1,300 mg daily)."	0
@Chemical$-sensitive @Disease$ (ASRD) is a condition characterized by persistent and often severe inflammation of the upper and lower respiratory tracts.	0
Bronchial mast cells are the dominating LTC4S-expressing cells in @Chemical$-tolerant @Disease$.	0
How should I treat subacute stent @Disease$ in the context of brain haemorrhage with @Chemical$?	0
"In haplotype analysis, the HLA-DRB1(*)1302-DQB1(*)0609-DPB1(*)0201 was significantly higher in the @Chemical$-induced @Disease$ (8.0%) than in the aspirin-intolerant asthma (0.7%, P=0.0014) and normal controls (2.0%, P=0.0006)."	1
Systematic review of prevalence of @Chemical$ induced @Disease$ and its implications for clinical practice.	1
"RESULTS: @Chemical$-exacerbated @Disease$ remains a complex, heterogeneous disease with manvaried clinical presentations."	1
"Data Sources: We searched PubMed, Embase, CENTRAL, and ClinicalTrials.gov from inception to May 28, 2018, with the terms novel oral anticoagulants, non-vitamin K antagonist oral anticoagulants, direct oral anticoagulants, dabigatran, rivaroxaban, @Chemical$, edoxaban, warfarin, Coumadin, vitamin K antagonist, aspirin, acetylsalicylic acid, or ASA, and major bleeding, fatal bleeding, or @Disease$."	0
"The aim of this study was to determine levels of MCP-3, RANTES, eotaxin, Il-5 and Il-3 in aspirin intolerant asthmatics (@Disease$) after nasal lysine-aspirin (Lys-@Chemical$) challenge."	0
"BACKGROUND: In patients with coronary or peripheral artery disease, the combination of rivaroxaban 2.5 mg twice daily and aspirin 100 mg once daily compared with @Chemical$ 100 mg once daily reduced major adverse cardiovascular events and mortality and increased @Disease$."	1
@Chemical$ @Disease$ affects 5-10% of asthmatics.	1
"OBJECTIVE: @Chemical$-induced @Disease$ is increasing, but whether the type of aspirin affects the gastrointestinal (GI) bleeding, especially small intestine, is unclear."	1
"Objectives: To investigate the association of @Chemical$ use with risk of all-cause, any cancer, gastrointestinal (GI) cancer, and colorectal @Disease$ (CRC) mortality among older adults and to perform an exploratory analysis of the association of aspirin use with mortality stratified by BMI."	0
Co-ingestion of @Chemical$ and acetaminophen promoting fulminant liver failure: A critical review of @Disease$ in the current perspective at the dawn of the 21st century.	0
"Two single nucleotide polymorphisms (SNP) of cyclooxygenase-1 (COX-1), A-842G and C50T, exhibited increased sensitivity to @Chemical$ and had lower prostaglandin synthesis capacity, lacking statistical significance in the association with bleeding peptic @Disease$."	0
"RESULTS: 9225 patients were enrolled (median 1.8years) post-MI: 52% with prior ST-elevation MI, median age 67years, 24% women, 67% Caucasian, 55% had &gt;=2 additional qualifying risk factors, 14% current smokers, 67% overweight/@Disease$, 34% with blood pressure &gt;=140/90mmHg. 81% underwent percutaneous coronary intervention (PCI; 66% with drug-eluting stents) for the index MI. 75% of patients had been discharged on dual antiplatelet therapy (DAPT; acetylsalicylic acid [ASA]+ADP receptor inhibitor [ADPri]), mainly @Chemical$ (75%). 63% had discontinued antiplatelet treatment (60% ADPri) around 1year, most commonly by physician recommendation (90%)."	0
"Between Day 7 and 35, @Disease$ were induced with @Chemical$ (25 mg/kg p.o. q8h)."	1
"The incidence of @Disease$ in the @Chemical$ group was higher than that in the Control group, although the difference was not significant (30 vs. 0%; p = 0.210)."	0
"In the @Disease$ group, subjects underwent @Chemical$ desensitization followed by a 1-month aspirin treatment."	0
BACKGROUND: Current knowledge about clinical and genetic risk factors for @Chemical$-induced @Disease$ is not sufficient to prevent these gastric mucosal lesions.	1
CONCLUSION: These data suggest that AR may be of special concern for diabetic patients with poor @Chemical$ control and @Disease$.	0
"CONCLUSION: Coupling of NO to ASA attenuates stress, ischemia-reperfusion, and ethanol-induced damage due to @Disease$ mediated by NO, which compensates for @Chemical$ deficiency induced by ASA."	0
"At 4 weeks, the mean scores of pain intensity and non@Disease$ symptoms were lower in the @Chemical$ group (5.61 +- 0.17 vs."	0
"@Disease$ will be evaluated with the ANKON magnetically controlled capsule endoscopy system (@Chemical$), a minimally invasive approach for detecting mucosal lesions in the stomach, duodenum and small intestine."	0
"The Fernand Widal syndrome is a set of associations between asthma, @Disease$ and @Chemical$ sensitivity."	0
"There are many potential gastroprotective drugs available in Japan, and studies are needed to assess the relative effectiveness of various strategies including PPI use for the prevention of @Chemical$-related @Disease$ and whether any of these other agents also provide protection against small bowel or colonic damage."	1
"Drainage amount, postoperative hemoglobin level, change in hemoglobin, calculated @Disease$, incidence and the amount of blood transfused, and the proportion of thromboembolic events were compared between patients who were and patients who were not on continued @Chemical$ mono-therapy."	0
"Aspirin-exacerbated @Disease$ (AERD) refers to the combination of asthma, chronic rhinosinusitis with nasal polyposis, and acute upper and lower respiratory tract reactions to the ingestion of @Chemical$ (acetylsalicylic acid, ASA) and other cyclooxygenase-1 inhibiting non-steroidal anti-inflammatory drugs."	0
In contrast @Chemical$ tended to decrease mortality among elderly @Disease$ patients with cardiovascular disease.	0
"@Chemical$-induced urticaria and @Disease$, but not bronchoconstriction, associated with cysteinyl leukotriene overproduction in 2 patients with asthma."	1
"Acetaminophen, @Chemical$ and progression of advanced @Disease$."	0
"Following @Chemical$, 38.7% of the participants developed @Disease$."	0
"This study estimates the @Disease$ risks associated with combinations of @Chemical$, thienopyridine derivatives, and warfarin in elderly patients."	1
"However, the risk of bleeding is further increased by combining other anti-platelet drugs (e.g. clopidogrel) with @Chemical$ in @Disease$ and coronary stent placement."	0
"Numerous vascular risk factors including white matter hyperintensity (WMH), duration of @Chemical$ treatment, age, hypertension or @Disease$ were investigated for a possible association with the presence of CMBs in the two groups."	0
"The use of @Chemical$ was associated with an increased prevalence of post-polypectomy @Disease$ (OR=6.72, 95% C.I."	1
"Univariate analysis showed that continuous @Chemical$ use was not significantly associated with bleeding complications (odds ratio, 0.933; 95% confidence interval, 0.283-3.074; P = .910 in the aspirin and control groups) and that discontinuous aspirin use was not significantly associated with @Disease$ complications (odds ratio, 0.963; 95% confidence interval, 0.230-4.025; P = .959 in the aspirin and control groups; odds ratio, 0.969; 95% confidence interval, 0.198-4.752; P = .969 in the aspirin and discontinuous groups)."	0
Low-dose @Chemical$ (&lt; 330 mg/d) is recommended for the prevention of @Disease$ or ischemic stroke.	0
"CONCLUSIONS Given the lack of guidelines regarding perioperative management of neurosurgical patients with antiplatelet therapy, these findings elucidate one issue, showing comparable @Disease$ rates in @Chemical$ users and nonusers undergoing VP shunt placement."	0
Fifty-four per cent recommended a proton pump inhibitor (PPI) for a patient with a recently healed @Disease$ who required ongoing @Chemical$.	0
"METHODS: 106 consecutive adults with confirmed, physician-diagnosed difficult @Disease$ and 100 patients with @Chemical$-induced asthma underwent psychiatric interview and assessment using M.I.N.I 5.0, Beck Depression Inventory (BDI) and Panic And Agoraphobia Scale (PAS)."	0
Oral aspirin challenge (OAC) reveals @Chemical$-exacerbated respiratory disease (AERD) in approximately 50% of unselected patients with @Disease$ with nasal polyposis (CRSwNP).	0
"In two separate series, platelet aggregation and @Chemical$ arthritis-induced inflammatory @Disease$ were measured in control, ASA and ASA-Tris-treated groups."	0
"The studies included are the Studies of @Disease$ (SOLVD) (N=6,797), the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) (N=6,090), the @Chemical$ and Thrombolysis Study (CATS) (N=296), and another study involving 317 subjects."	0
The goal of this study was to investigate a gene-gene interaction between IL-10 and TGF-beta1 polymorphisms in Korean @Disease$tics with @Chemical$ hypersensitivity.	0
"The association between aspirin use and the presence of DR or VTDR was assessed using multivariable logistic regression models including age, gender, ethnicity, socioeconomic status, HbA1c, systolic blood pressure, anti-hypertension medicine, total cholesterol, anti-@Chemical$ medicine, BMI, current smoking status, diabetes duration, history of cardiovascular disease (CVD) and @Disease$ (CKD.)."	0
Age when @Disease$ was developed (A+ASA groups)--45.5; the duration of asthma was 11 +/- 9 years. 58% of patients had polypectomy/ethmoidectomy (PP--45%; A--60%; @Chemical$--80%).	0
A new study suggests that co-prescription of low-dose @Chemical$ and PPIs increases the incidence of @Disease$.	1
"With skin testing and oral rechallenge with aspirin, but not rofecoxib, the allergist determined the cause of the reactions to be @Chemical$-induced @Disease$ and selective COX-2 inhibitor intolerance."	1
"It is very important to prevent @Chemical$-induced gastroduodenal @Disease$ complications including bleeding, and every effort should be exercised to prevent the bleeding complications."	0
"Also, women had less @Disease$ (aspirin, 2.4% versus 3.7%; @Chemical$, 1.4% versus 3.0%), more heart failure, and higher mean CHADS2 (congestive heart failure, hypertension, age of 75 years or older, diabetes [1 point each], stroke or transient ischemic attack [2 points]) scores (aspirin, 2.2 versus 2.0; apixaban, 2.1 versus 2.0)."	0
It may be that the risks associated with @Chemical$ cessation outweigh the risks of @Disease$.	1
Dual antiplatelet therapy (DAT) with aspirin and @Chemical$ is the standard regimen to achieve rapid platelet inhibition and prevent @Disease$ events.	0
"However, as discontinuation of @Chemical$, unlike NSAIDs, may precipitate cardiovascular and cerebrovascular events, treatment of aspirin-associated @Disease$s should re-start aspirin as soon as possible, using proton pump inhibitor (PPI)."	0
"BACKGROUND: The effect of aspirin on the release of key arachidonic acid metabolites in activated eosinophils from subjects with @Chemical$-intolerant @Disease$ (AIA) has not been investigated previously, despite the characteristic eosinophilia in AIA."	0
Effect of @Chemical$ on airway inflammation and pulmonary function in patients with persistent @Disease$.	1
@Disease$ associated with chronic low-dose @Chemical$ therapy.	0
BACKGROUND: Aspirin desensitization followed by maintenance therapy effectively improves symptom control in patients with @Chemical$ exacerbated @Disease$ (AERD).	0
@Disease$ complications of enoxaparin and @Chemical$ in patients with kidney transplants.	0
We therefore tested whether addition of the leukotriene receptor antagonist montelukast was of therapeutic benefit in a group of @Chemical$-intolerant patients with @Disease$ of whom 90% already were treated with moderate to high doses of glucocorticosteroids.	0
Safety and outcomes of @Chemical$ desensitization for aspirin-exacerbated @Disease$: A single-center study.	0
"CONCLUSION: In a large genetic epidemiology study of aspirin-intolerant asthma in a Korean population, genetic polymorphisms of NAT2 were found to be related to a risk of @Chemical$ @Disease$ among asthmatics."	1
Does continued @Chemical$ mono-therapy lead to a higher bleeding risk after total @Disease$?	0
Correlation between Helicobacter pylori infection and low-dose @Chemical$ use on damage of the @Disease$.	0
Comparison of incident @Disease$ between low-dose plain aspirin and enteric-coated @Chemical$.	0
Such large geographic differences in the net effect of H. pylori @Disease$ on gastric acid secretion could be at least partly responsible for the geographically distinct interaction between @Chemical$ use and H. pylori infection on adverse gastroduodenal lesions.	0
"OBJECTIVE: To determine whether celecoxib, a selective cyclooxygenase 2 (COX-2) inhibitor, cross-reacts in patients with @Chemical$-exacerbated @Disease$ (AERD) with asthma."	0
"Therefore, the abnormal regulation of @Chemical$ could contribute to the exacerbated processes observed in @Disease$."	0
"The most common reasons for recommending @Chemical$ discontinuation were concern about @Disease$ after polypectomy (62%), perceived minimal downside to stopping aspirin (38%), inertia to changing old policies (20%), and concern about medicolegal implications of postpolypectomy bleeding (15%)."	0
CONCLUSIONS: There is high mortality rate associated with @Chemical$ or clopidogrel or both in elderly patients who have head trauma resulting in @Disease$.	0
The Framingham Heart Study records of participants with @Disease$ (AF) during 1980 and 1994 were retrospectively reviewed to determine the prevalence of @Chemical$ and aspirin use in AF.	0
So we suspect that the pathogenic mechanism for aspirin @Disease$ differs from that for @Chemical$ asthma.	0
"OBJECTIVE: We sought to determine blood and urinary levels of @Chemical$,11beta-PGF(2), a major stable PGD(2) metabolite in 2 well-defined phenotypes of @Disease$, aspirin-induced asthma (AIA) and aspirin-tolerant asthma (ATA), and in healthy control subjects and to study the effects of aspirin on PGD(2) release."	0
"BACKGROUND: Aspirin (acetylsalicylic acid [@Chemical$]) hypersensitivity is frequent in patients with @Disease$ (NPs) and is called aspirin exacerbated respiratory disease, previously known as Samter's syndrome."	0
"In Japan, the preventive strategies upon the prescription of NSAIDs/@Chemical$ are expected to spread rapidly because the use of proton pump inhibitors for the prevention of recurrence of NSAID- or LDA-induced peptic ulcers and the use of COX-2 for the palliation of acute @Disease$ were recently approved under the national health insurance system."	0
"@Chemical$ sensitivity can cause acute @Disease$ in some individuals, aggravate pre-existing chronic urticaria in others or, rarely, act as a cofactor with food or exercise to provoke anaphylaxis."	1
"METHODS: This prospective, placebo-controlled trial was conducted in @Disease$ patients randomized (1:1) to receive either standard DAPT (aspirin and @Chemical$) vs TAPT with cilostazol for a minimum of 12 months after PCI with Endeavor zotarolimus-eluting stent (E-ZES)."	0
"Recent evidence showed that among patients with a history of @Chemical$-associated ulcer bleeding, the long-term incidence of recurrent @Disease$ with ASA use is low after eradication of H. pylori alone."	0
CONCLUSION: This article demonstrates the safety of reintroducing platelet-inhibitory doses of aspirin in patients in whom it is indicated and reporting @Chemical$-induced @Disease$ and/or angioedema with anti-inflammatory doses.	1
"SUMMARY: The HLA alleles DRB11302 and DQB10609, and the ALOX5 and FcepsilonRIalpha promoter polymorphisms, may contribute to the pathogenesis of @Chemical$-induced @Disease$/angioedema."	1
"Despite their different @Chemical$ compositions, FB and EF apple extracts assisted in protecting the @Disease$ following acute aspirin administration in rats."	0
"Thus, the lack of evidence of benefit with @Chemical$ in patients with heart failure and @Disease$, along with growing evidence that aspirin is directly harmful in patients with heart failure and that aspirin may negate the benefits of angiotensin-converting enzyme inhibitors suggest that, unless there is an opportunity to randomize the patient into a study of antithrombotic strategies, then aspirin should be withdrawn or possibly substituted with an anticoagulant or an antiplatelet agent that does not block cyclooxygenase."	0
[Prevention of @Chemical$-induced @Disease$ with an association of leukotriene inhibitors and antihistamines].	1
BACKGROUND: Aspirin (@Chemical$) is the drug of choice in patients with @Disease$ for primary and secondary prevention.	0
"The pathogenesis of aspirin (acetylsalicylic acid, ASA)-intolerant @Disease$ (AIU) is still poorly understood but it has recently been suggested that it is associated with the overproduction of @Chemical$ (LT)."	0
We assessed whether the association of aspirin and other NSAIDs with postmenopausal @Disease$ risk differs by estrogen and @Chemical$ receptor (ER and PR) status of the tumor.	0
Skin and colonic @Disease$ times are prolonged for 3 and 5 days after @Chemical$ and ticlopidine withdrawal respectively.	0
Identification of a high-risk group for low-dose @Chemical$-induced @Disease$ by measuring serum pepsinogen in H. pylori-infected subjects.	1
PURPOSE: To review current literature of the benefits that @Chemical$ provides for patients' cardiovascular health compared with the risk of @Disease$ worsening.	0
The effects of inhaled aspirin on fractional exhaled NO (FENO) in patients with aspirin-tolerant (@Chemical$) and aspirin-inducible (@Disease$) asthma compared with normal controls have been investigated.	0
@Chemical$ Does Not Increase Heart Failure Events in @Disease$ Patients: From the WARCEF Trial.	0
BACKGROUND: @Chemical$-intolerant asthma (AIA) refers to the development of bronchoconstriction in @Disease$tic individuals following the ingestion of aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs).	0
"While @Chemical$ reduces risk of ischemic events post-PCI, it also increases risk of @Disease$."	0
"Background: Aspirin-exacerbated respiratory disease (AERD), a syndrome that includes @Disease$, recurrent nasal polyps, and pathognomonic reactions to @Chemical$ and other nonselective cyclooxygenase inhibitors, is still not fully understood and lacks specific disease-modifying therapeutic options."	0
"CONCLUSION: Administration of low-dose @Chemical$, either plain or enteric-coated, induces endoscopic gastro-duodenal @Disease$ in a large majority of patients."	1
CONCLUSION: The prevalence of respiratory symptoms triggered by @Chemical$/NSAID use was found to be 10-11% in patients with asthma and 2.5% in non-@Disease$tics.	0
These estimates are valuable for benefit-risk assessments of low-dose @Chemical$ for cardiovascular and @Disease$ prevention.	0
INTRODUCTION: Preoperative discontinuation of @Chemical$ (acetylsalicylic acid) can reduce @Disease$ risk but may increase the risk of perioperative cardiovascular events.	0
Patients receiving apixaban plus aspirin had a similar @Disease$ risk compared with those receiving thienopyridine plus @Chemical$.	0
BACKGROUND: This multicenter retrospective study investigated the management and outcome of patients with peptic @Disease$/erosion-related aspirin and clopidogrel (A + @Chemical$) cotherapy.	0
"CONCLUSION: Although cysLT 1 expression predominates on inflammatory leukocytes in patients with aspirin-sensitive @Disease$, the effects of @Chemical$ on glands and epithelium may be mediated predominantly through cysLT 2."	0
Prediction of @Disease$ improved marginally after addition of variables not incorporated in the @Chemical$ score.	0
"CONCLUSIONS: In patients with @Disease$ taking low-dose aspirin, the use of celecoxib or @Chemical$ plus lansoprazole resulted in similar rates of gastroduodenal ulceration."	0
"In terms of gender differences, the OR for @Chemical$-induced @Disease$ in females was significantly increased at 2.55 (95% CI, 1.31-4.94; p = 0.006) but was not significantly increased in males at 0.70 (95% CI, 0.34-1.45; p = 0.334)."	1
"In this study, we compared the roles of CysLT receptor type 1 (CysLTR1) and leukotriene C4 synthase (LTC4S) gene polymorphisms in two major @Chemical$-related @Disease$, aspirin-intolerant asthma (AIA) and aspirin-induced chronic urticaria/angioedema (AICU)."	1
"Univariate analysis showed that continuous aspirin use was not significantly associated with bleeding complications (odds ratio, 0.933; 95% confidence interval, 0.283-3.074; P = .910 in the aspirin and control groups) and that discontinuous aspirin use was not significantly associated with @Disease$ complications (odds ratio, 0.963; 95% confidence interval, 0.230-4.025; P = .959 in the aspirin and control groups; odds ratio, 0.969; 95% confidence interval, 0.198-4.752; P = .969 in the @Chemical$ and discontinuous groups)."	0
"PATIENTS: Helicobacter pylori-negative patients taking daily low-dose ASA (75-325 mg), who fulfilled one or more of the following criteria: age &gt;=18 years with history of uncomplicated peptic @Disease$; age &gt;=60 years with either stable coronary artery disease, upper gastrointestinal symptoms and five or more gastric/duodenal erosions, or low-dose @Chemical$ treatment initiated within 1 month of randomisation; or age &gt;=65 years."	0
"According to APS standard of care, patients were treated with aspirin and/or low-molecular weight @Chemical$ (LMWH) at prophylactic (pure obstetric @Disease$) or therapeutic doses (history of thrombosis)."	0
@Chemical$ sensitivity and IgE antibodies to @Disease$ in nasal polyposis: studies on the relationship.	0
"CONCLUSIONS: In this study, we found higher concentrations of @Chemical$ and LTB4 in saliva from @Disease$ patients than in saliva from ATA patients, suggesting that the quantification of CysLT and LTB4 concentrations in saliva may be another diagnostic strategy for AIA."	0
"Data Sources: We searched PubMed, Embase, CENTRAL, and ClinicalTrials.gov from inception to May 28, 2018, with the terms novel oral anticoagulants, non-@Chemical$ antagonist oral anticoagulants, direct oral anticoagulants, dabigatran, rivaroxaban, apixaban, edoxaban, warfarin, Coumadin, vitamin K antagonist, aspirin, acetylsalicylic acid, or ASA, and major @Disease$, fatal bleeding, or intracranial hemorrhage."	0
"Adverse events considered possibly or probably related to treatment occurred in 5 (20.0%) @Chemical$ recipients (4 episodes of diarrhea, 1 episode of abdominal pain), 1 (14.3%) recipient of lansoprazole 30 mg (1 episode of pharyngitis), and 3 (13.6%) placebo recipients (1 episode each of @Disease$, palpitations, and dyspepsia)."	0
Dual antiplatelet therapy with ASA and clopidogrel increases the risk of @Disease$ in patients with acute coronary syndrome in whom concomitant treatment with a proton-pump inhibitor (PPI) was less effective owing to the interaction of @Chemical$ and PPI with the same hepatic cytochrome P-450.	0
"This review focuses on a description of patients with aspirin-exacerbated @Disease$, methods available to diagnose their condition, the unique ability of all nonsteroidal anti-inflammatory drugs that inhibit COX-1 to cross-react with @Chemical$, an update on pathogenesis, and current thoughts about treatment."	0
"In another study, 31 hemorrhagic peptic @Disease$ patients who had been receiving low-dose @Chemical$ were enrolled."	0
"METHODS AND RESULTS: Japanese patients (n=1,363) with @Disease$ undergoing percutaneous coronary intervention were randomized to either @Chemical$ (20/3.75 mg) or clopidogrel (300/75 mg), both in combination with aspirin (81-330 mg for the first dose and 81-100 mg/day thereafter), for 24-48 weeks."	0
"The majority of patients with a history of reactions to @Chemical$ have aspirin/nonsteroidal anti-inflammatory drug (NSAID)-induced @Disease$, easy bruisability, or other side effects."	0
Aspirin-intolerant chronic @Disease$ exacerbated by cutaneous application of a @Chemical$ poultice.	0
SIGNIFICANCE: IV DDAVP corrected prolongations in BMBT in dogs given aspirin and should be considered in dogs requiring prompt reversal of @Chemical$-induced coagulopathies to reduce the risk of @Disease$ complications.	0
"The important factors that increase the risk of low-dose aspirin-related ulcer complications include a history of bleeding peptic @Disease$, prior peptic ulcer, age &gt; 70 years, H pylori infection, and concomitant drug therapy with non-steroidal anti-inflammatory drugs, other antiplatelet agents (e.g., @Chemical$) or anticoagulants."	0
Efficacy of Lactobacillus casei treatment on @Disease$ in chronic low-dose @Chemical$ users: a pilot randomized controlled study.	0
"BACKGROUND: During a clinical trial, we obtained 16 biopsies of @Disease$ induced by aspirin in patients with chronic idiopathic urticaria (@Chemical$)."	0
"Pre-operative @Chemical$ ingestion did not significantly affect peri-operative @Disease$, or change in haemoglobin concentration or haematocrit."	0
AIM: To evaluate in symptomatic elderly chronic users of low-dose aspirin: (1) the association between H. pylori infection and the prevalence of @Disease$; and (2) the effect of H. pylori infection on the efficacy of proton pump inhibitors in the prevention of @Chemical$-related gastroduodenal lesions.	0
Proton pump inhibitors reduce the risk of gastrointestinal complications in @Chemical$ users with a history of @Disease$.	0
"Low-dose @Chemical$-induced @Disease$: past, present, and future."	1
"Although knowledge about endoscopic characteristics of L-ASA associated ulcers is limited, the @Disease$ have common distinctive feature that sudden gastrointestinal bleedings or latently advanced-anemia are often the earliest symptom because @Chemical$-induced ulcers often exist without symptoms of dyspepsia."	0
NSAID-intolerant asthmatics have higher basal levels of @Chemical$-LT than NSAID-tolerant @Disease$tics.	0
"CONCLUSIONS: In new patients presenting with colitis, there is a significantly high frequency of antecedent exposure to NSAIDs or @Chemical$, supporting the concept that these agents may be important in the pathogenesis of @Disease$."	0
Initial reaction to @Chemical$ involving @Disease$ and reacting to ASA within the past year increased the risk of having a reaction to desensitization.	0
"@Chemical$ or R-baclofen, GABA-B agonists, which suppressed sound-evoked AC neural firing rate and local field potentials, also suppressed the SS-induced enhancement of the AC field potential and the acoustic @Disease$ reflex."	0
"Prior known oral NSAIDs @Disease$ included aspirin (5), @Chemical$ (2), diclofenac (2), Synflex (2) and ibuprofen (1)."	0
Incomplete platelet inhibition is common around the time of acute @Disease$ events in patients prescribed @Chemical$.	0
We tested the hypothesis that combined pre-treatment with aspirin and @Chemical$ is a risk factor for thrombolysis-related symptomatic intracerebral hemorrhage (s@Disease$).	0
"Patients with diverticular @Disease$ had greater odds than controls of NSAID, LDA, and @Chemical$ use, OR 8.3 (95% CI, 3.8-18.3), OR 2.1 (95% CI, 1.15-3.67), and OR 2.6 (95% CI, 1.24-5.56), respectively."	0
"At the 12-month interval, analysis of @Disease$s and melena found significant associations for enteric-coated @Chemical$ users, with ASRs of 1.39 (1.13 - 1.73) and 20.83 (3.33 - 863.25), respectively."	0
"Nonsteroidal anti-inflammatory drugs (NSAIDs), including @Chemical$, have been associated with the @Disease$."	1
So we suspect that the pathogenic mechanism for @Chemical$ @Disease$ differs from that for aspirin asthma.	1
"DESIGN, SETTING, AND PARTICIPANTS: Prospective analysis of observational data from the EINSTEIN deep vein thrombosis and @Disease$ clinical trials comparing rivaroxaban with @Chemical$-VKA treatment, trials performed in hospitals and clinics in 8246 patients enrolled from 2007 to 2009."	0
The use of PPIs and histamine H(2) blockers may prevent @Chemical$-induced @Disease$ in such patients.	1
"Among the main confounding factors are the type of treatment, non aspirin NSAIDs or low-dose @Chemical$, the different strains of H. pylori, the variable host response and the type of @Disease$, gastric or duodenal."	0
"During the 12 months of follow up, 13 patients (43.3%) taking @Chemical$ and 19 (65.5%) taking the placebo experienced @Disease$ (P = 0.07)."	0
The Naranjo probability scale indicated that @Chemical$ was a highly probable cause and rofecoxib was a probable cause of this patient's @Disease$.	1
"One study showed increased major GI bleeding (but not non-GI @Disease$ endpoints) with aspirin versus @Chemical$ (RR=1.45; 95% CI, 1.00-2.10)."	0
"INTERPRETATION: Famotidine is effective in the prevention of gastric and duodenal @Disease$, and erosive oesophagitis in patients taking low-dose @Chemical$."	0
@Chemical$-exacerbated @Disease$ and current treatment modalities.	1
Non@Chemical$ NSAID use was not associated with incident cognitive impairment or mild @Disease$/dementia odds.	0
"Adverse reactions to @Chemical$ are frequent particularly among patients with asthma, chronic @Disease$."	1
"Although low-dose @Chemical$ (ASA) is recommended for prevention of cardiovascular events in at-risk patients, its long-term use can be associated with the risk of @Disease$ (GI) symptoms that may impact treatment compliance."	0
"OBJECTIVE: We investigated whether subjects with @Disease$ and/or nasal polyps (NP) and analgesic intolerance proven by oral ASA provocation test tolerated the selective COX-2 inhibitor, @Chemical$."	0
[@Chemical$-induced @Disease$].	1
"CONCLUSIONS: The data from this study show that @Chemical$ intolerance, HDM allergy, and asthma duration exceeding 10 years are major factors associated with severe @Disease$ in outpatients."	1
Safety of @Chemical$ desensitization in patients with reported aspirin allergy and @Disease$.	0
Nasal provocation test (NPT) with @Chemical$: a sensitive and safe method to diagnose aspirin-induced @Disease$ (AIA).	0
BACKGROUND: @Chemical$ causes bronchospasm in patients with aspirin exacerbated @Disease$ (AERD).	0
"RESULTS: Interaction analyses indicated that of all subgroups, only patients with serum @Chemical$ &gt; 1.3 mg/dl had a significantly greater reduction of cardiovascular events and @Disease$ (-13 and -7/1000 patient-years), while risk of bleeding was not significantly different between subgroups."	0
"Three major clinical phenotypes of NSAID-induced acute skin reactions manifesting with angioedema, urticaria, or both have been distinguished: NSAID-exacerbated cutaneous disease, nonsteroidal anti-inflammatory drug-induced @Disease$/angioedema (@Chemical$), and single NSAID-induced urticaria and angioedema."	0
"BACKGROUND: @Chemical$ (acetylsalicylic acid [ASA]) @Disease$ is frequent in patients with nasal polyps (NPs) and is called aspirin exacerbated respiratory disease, previously known as Samter's syndrome."	1
"The patients who received @Chemical$ therapy were divided according to the results of a @Disease$ test into ASA-resistant, ASA-semiresponsive, and ASA-sensitive groups."	0
"METHODS: Ninety-four aspirin-induced @Disease$ patients presenting urticaria/angioedema-induced by both ASA and NSAID (50 had underlying chronic urticaria) and showing positive responses on oral aspirin challenge test, 76 @Chemical$-intolerant asthmatics with positive responses on lysine-aspirin bronchoprovocation test, and 185 normal healthy controls were enrolled."	0
Outcomes after complete endoscopic sinus surgery and aspirin desensitization in @Chemical$-exacerbated @Disease$.	0
BACKGROUND: The objective of the study was to determine the frequency of cerebral microbleeds (CMBs) by using phasesensitive imaging in patients with previous transient ischemic attack (@Disease$) or stroke who were receiving @Chemical$ treatment.	0
A acute @Disease$ and a transient stroke happened in two patients wich @Chemical$ treatment was discontinued.	0
"@Chemical$-exacerbated respiratory disease (AERD) is characterized by the triad of asthma, eosinophilic nasal polyposis and a @Disease$ to all medications that inhibit the cyclo- oxygenase (COX) -1 enzyme."	0
"Long-term use of acetaminophen, @Chemical$, and other nonsteroidal anti-inflammatory drugs and risk of @Disease$: results from the prospective Vitamins and Lifestyle (VITAL) study."	0
"CONCLUSION: In addition to age, male gender, H. pylori @Disease$, and concomitant use of NSAIDs, COX-2 inhibitors, steroids, and @Chemical$, underlying co-morbidities including diabetes, CKD, cirrhosis, history of PUD are also important risk factors for first-time occurrence of non-variceal UGIB in aspirin users."	0
"@Chemical$-exacerbated respiratory disease (AERD) is characterized by the triad of asthma, @Disease$ and a hypersensitivity to all medications that inhibit the cyclo- oxygenase (COX) -1 enzyme."	0
Is there an association between @Chemical$ dosing and cardiac and @Disease$ events after treatment of acute coronary syndrome?	0
"CONCLUSION: Our results demonstrate that exercise and @Chemical$ augment clinical reactions in WDEIA by lowering the threshold and increase the severity of the @Disease$, whereas alcohol gives ambiguous results."	0
"METHODS: Ninety-four aspirin-induced urticaria patients presenting @Disease$/angioedema-induced by both ASA and NSAID (50 had underlying chronic urticaria) and showing positive responses on oral aspirin challenge test, 76 aspirin-intolerant asthmatics with positive responses on lysine-@Chemical$ bronchoprovocation test, and 185 normal healthy controls were enrolled."	0
"Genetic markers suggested for @Disease$ include HLA-DPBI*0301, leucotriene C4 synthase (LTC4S), ALOX5, CYSLT, @Chemical$, TBXA2R and TBX21."	0
"BACKGROUND: @Chemical$-exacerbated respiratory disease (AERD) is a distinct eosinophilic phenotype of severe @Disease$ with accompanying chronic rhinosinusitis, nasal polyposis, and hypersensitivity to aspirin."	0
Adjusted HRs for clopidogrel versus the combination of acetylsalicylic acid and @Chemical$ were 1.02 (95% confidence interval [CI]: 0.89-1.17) for ischemic @Disease$ and 1.06 (95% CI: 0.83-1.35) for bleeding.	0
"Data Sources: We searched PubMed, Embase, CENTRAL, and ClinicalTrials.gov from inception to May 28, 2018, with the terms novel oral anticoagulants, non-vitamin K antagonist oral anticoagulants, direct oral anticoagulants, dabigatran, rivaroxaban, apixaban, edoxaban, warfarin, Coumadin, @Chemical$ antagonist, aspirin, acetylsalicylic acid, or ASA, and major bleeding, fatal @Disease$, or intracranial hemorrhage."	0
"Compared with clopidogrel, aspirin increases the risk of GI bleeding but not other @Disease$; however, 883 patients (95% CI, 357-infinity) would need to be treated with @Chemical$ versus aspirin to prevent one major GI bleeding episode annually at a cost of over 1 million dollars."	0
"Evidence shows that concurrent use of a non-selective NSAID (such as @Chemical$) plus a PPI is as effective in preventing NSAID @Disease$ as celecoxib, and may be more cost-effective."	0
Tacrolimus reduces urinary excretion of leukotriene E(4) and inhibits @Chemical$-induced @Disease$ to threshold dose of aspirin.	1
"OBJECTIVE: To evaluate the efficiency of zafirlukast in patients with @Chemical$-induced-@Disease$ trough a measurement of VEF1, during the treatment and the symptoms daily reported."	0
The rates of both @Disease$ and bleeding increased with higher CHADS2 scores but apixaban compared with @Chemical$ was associated with a similar relative risk of bleeding (P interaction 0.21) and a reduced relative risk of stroke (P interaction 0.37) irrespective of CHADS2 category.	0
"Cyto@Disease$ was evaluated by cell viability, anti-oxidant enzyme activities, @Chemical$ (MDA) production and by the expression of MAPKs (Mitogen-Activated Protein Kinases) pathways."	0
"Both naproxen/aspirin and @Chemical$/aspirin groups demonstrated a higher incidence of @Disease$ and duodenal ulcers vs. placebo/aspirin (8%; RR: 3.7, 95% CI: 1.8-7.6 and RR: 2.6, 95% CI: 1.2-5.8, respectively)."	0
[The risk factors for @Chemical$ induced peptic @Disease$].	1
Prostaglandin E2 systemic production in patients with @Disease$ with and without @Chemical$ hypersensitivity.	0
Low-Dose @Chemical$-Associated Upper and @Disease$ and Gene Polymorphism.	1
[Safety and efficacy of long-term treatment with different @Chemical$ forms in patients with stable IHD and a high risk for development of @Disease$ by data from a cross-sectionals study].	0
@Disease$ and cerebrovascular events have been described after recent @Chemical$ withdrawal.	0
"An @Disease$, with systemic complaints consistent with a serum sickness-like reaction, attributed to @Chemical$ is described."	0
"METHODS: From 5555 patients undergoing upper gastrointestinal endoscopy from January 2005 to December 2006 at Teikyo University Hospital, Tokyo, Japan, 159 patients (76 males and 83 females, mean age: 69.3 +/- 11 years) fulfilling the following conditions were selected: (i) taking @Chemical$ (less than 100 mg/day) continuously; (ii) not taking acid suppressants; and (iii) no history of gastrointestinal tract surgery, malignancies, severe @Disease$, or liver cirrhosis."	0
BACKGROUND: @Chemical$ (ASA) is the drug of choice in patients with @Disease$ for primary and secondary prevention.	0
The presence of gastric acid plays a critical role in the mechanisms of NSAIDs/@Chemical$-associated gastric and @Disease$ and ulceration.	1
"Such information is unlikely to alter current recommendations for persons at high risk of @Disease$, but should help clarify the benefit-to-risk ratio of regular @Chemical$ use in the large majority of individuals at low-to-moderate risk."	0
"DATA SOURCES: Articles evaluating aspirin for primary prevention of CVD were gathered using a MEDLINE search with the keywords aspirin review, aspirin peripheral @Disease$, aspirin stroke, aspirin coronary artery disease, aspirin diabetes, aspirin primary prophylaxis, and @Chemical$ elderly."	0
"While @Chemical$ reduces risk of @Disease$ events post-PCI, it also increases risk of bleeding."	0
We compared @Disease$ and all-cause mortality after dual antiplatelet therapy (DAPT) for the combination of clopidogrel and aspirin (@Chemical$) versus ASA alone over 18 months follow-up in event-free patients at 12 months DAPT from the Health Insurance Review and Assessment (HIRA) dataset via the Korean Outcomes Registry Evaluating Antithrombotics (KOREA).	0
Recovery of platelet function after discontinuation of @Chemical$ or clopidogrel maintenance dosing in aspirin-treated patients with stable @Disease$: the recovery trial.	0
"PURPOSE OF REVIEW: To investigate the current approach to @Chemical$ challenge (drug provocation) and/or desensitization in patients with histories of hypersensitivity reactions to it, particularly in those with @Disease$."	0
Physiologic and pharmacologic studies support the hypothesis that @Chemical$-exacerbated @Disease$ (AERD) involves fundamental dysregulation in the production of and end-organ responsiveness to both antiinflammatory eicosanoids (prostaglandin E2) and proinflammatory effectors (cysteinyl leukotrienes).	1
"A convenience sample of patients taking @Chemical$, aspirin, clopidogrel or mixed therapy presenting to the ED with @Disease$ were included and followed-up over 3-18 months."	0
"QUESTION/PURPOSES: We sought to answer four questions: For the @Chemical$ and TKA cohorts, respectively, (1) was the incidence of readmission resulting from VTE and @Disease$ complications higher with LMWH than mobile compression plus ASA; and (2) was the incidence of wound bleeding complications higher with LMWH than mechanical compression plus ASA?"	0
CONCLUSIONS: Cross-reactive patients with NSAID-induced @Disease$ and angioedema exhibit an increased prevalence of sensitization to Dp and @Chemical$ and increased total serum IgE.	0
"Prior known oral NSAIDs @Disease$ included aspirin (5), mefenamic acid (2), diclofenac (2), Synflex (2) and @Chemical$ (1)."	0
CONCLUSION: @Chemical$ can prevent ASP-exacerbated allergic reactions in patients with @Disease$ resulting from inhibition of increases in allergen absorption.	0
BACKGROUND: Aspirin desensitization (@Disease$) treatment at doses of up to 1300 mg/day improves outcomes in @Chemical$-exacerbated respiratory disease (AERD).	0
METHODS: The Apixaban versus @Chemical$ to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin k Antagonist Treatment (AVERROES) trial randomized 5599 patients with @Disease$ and risk factors to receive either apixaban or aspirin.	0
METHODS: Twenty-nine patients with suspected aspirin-exacerbated @Disease$ were challenged with nasal ketorolac before oral challenge and desensitization with @Chemical$.	0
"OBJECTIVE: To evaluate the relationship between @Chemical$ ingestion and @Disease$ complications, and to test the hypothesis that there is a subset of patients who are aspirin hyperresponders with a proclivity toward platelet dysfunction."	0
"Although @Chemical$ is prescribed for a broad range of diseases, it can induce a wide array of clinically recognized hypersensitivity reactions, including aspirin-intolerant asthma (@Disease$) with rhinitis and aspirin-intolerant urticaria (AIU) with anaphylaxis."	1
"RESULTS: The in-hospital mortality rate was 72% for ICH patients treated with warfarin, 41.6% for @Disease$ patients treated with @Chemical$, and 35% for ICH patients treated with no drugs."	0
"Incidence and causes of new-onset @Disease$ in 3,719 patients treated with clopidogrel and @Chemical$ combination after coronary stenting."	0
Helicobacter pylori infection and the prevention of peptic @Disease$ with proton pump inhibitors in elderly subjects taking low-dose @Chemical$.	0
[Adaptive desensitization for @Chemical$ @Disease$: A success story?].	1
@Chemical$ plays a pivotal role in the management of patients with Coronary Artery Disease (CAD) with well-recognised benefits of reducing recurrent @Disease$ and minimising the risk of stent thrombosis for those undergoing Percutaneous Coronary Intervention (PCI).	0
"The odds ratio (OR) of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) was 0.85 (95%CI: 0.75-0.97, p=0.02), The ORs of follicular lymphoma (FL) and large @Disease$ (DLBCL) in individuals exposed to @Chemical$ were 1.12 (95%CI: 0.86-1.45, p=0.37) and 1.03 (95%CI: 0.9-1.19, p=0.6) respectively."	0
"The exact 1-sided 95% confidence interval for the underlying probability of 50 mg of @Chemical$ inducing respiratory @Disease$s in patients with AERD is 0 to 0.05, or 0% to 5%."	0
"Before, after 120, and 240 min of DDAVP administration the following parameters were measured: @Disease$ (PA) and ATP release induced by ADP, collagen, ristocetin and thrombin; @Chemical$-100 closure times (CT), factor VIII activity (FVIII:C), Von Willebrand factor antigen (VWF:Ag), collagen binding activity (VWF:CB) and blood count."	0
"Dual antiplatelet therapy (@Chemical$) with acetylsalicylic acid and a P2Y12 inhibitor (clopidogrel, ticagrelor, or prasugrel) reduces @Disease$ events in patients with acute coronary syndrome (ACS), but it is also associated with an increased risk of bleeding complications."	0
"HYPOTHESIS: @Chemical$ will cause less endoscopically detectable @Disease$ in dogs than aspirin, a nonselective nonsteroidal anti-inflammatory drug."	0
OBJECTIVE: To investigate the relationship between @Chemical$ resistance and clinical and neuroimaging measures of stroke severity in acute @Disease$ patients.	0
"Moreover, there was no association between @Chemical$ discontinuation regimens (&lt; 7 days and &gt;= 7 days) and @Disease$ events."	0
Time of @Disease$ occurred in early periods after starting of @Chemical$ and NSAIDs.	1
Physiologic and pharmacologic studies support the hypothesis that aspirin-exacerbated @Disease$ (AERD) involves fundamental dysregulation in the production of and end-organ responsiveness to both antiinflammatory eicosanoids (@Chemical$) and proinflammatory effectors (cysteinyl leukotrienes).	0
@Chemical$ @Disease$.	1
Clopidogrel alone administered to patients taking OAC after PCI was associated with a significantly lower rate of @Disease$ complications than clopidogrel plus @Chemical$.	0
"In total, it appears that when there is @Disease$ (mechanical from perctutaneous coronary intervention or a ruptured plaque), dual antiplatelet therapy with @Chemical$ and clopidogrel results in improved outcomes, albeit with a small but significant inherent risk of increased bleeding."	0
"CONCLUSIONS: Use of @Chemical$, low GCS score, opening to ventricle, older age, accompanying @Disease$, and/or hypertension were worse prognostic factors."	0
"INTRODUCTION: Antithrombotic drugs, such as low-dose aspirin (LDA) and @Chemical$, can cause @Disease$."	0
"Although @Chemical$ is prescribed for a broad range of diseases, it can induce a wide array of clinically recognized hypersensitivity reactions, including aspirin-intolerant asthma (AIA) with @Disease$ and aspirin-intolerant urticaria (AIU) with anaphylaxis."	0
"@Chemical$ has a role in the prevention of cardiovascular and cerebrovascular disease, @Disease$ and several cancers."	0
"Aspirin-exacerbated respiratory disease (AERD) refers to the combination of asthma, @Disease$ with nasal polyposis, and acute upper and lower respiratory tract reactions to the ingestion of aspirin (@Chemical$, ASA) and other cyclooxygenase-1 inhibiting non-steroidal anti-inflammatory drugs."	0
Associations of functional NLRP3 polymorphisms with susceptibility to food-induced anaphylaxis and @Chemical$-induced @Disease$.	1
"Recently, 7 patients hypersensitive to @Chemical$ have been desensitized in our department due to cardiologic and @Disease$."	0
Nasal provocation test (NPT) with aspirin: a sensitive and safe method to diagnose @Chemical$-induced asthma (@Disease$).	0
Altered metabolism of prostaglandin E2 in @Disease$ patients with @Chemical$ hypersensitivity.	0
"Furthermore, AERD patients under synthesize from arachidonic acid (AA) a peculiar product called @Chemical$, which opposes @Disease$ generated by leukotrienes."	0
A recent study by Chan et al. concluded that a combination of @Chemical$ and esomeprazole is superior to clopidogrel in the prevention of recurrent @Disease$ bleeding.	0
OBJECTIVE: We investigated whether omalizumab administration would be associated with attenuation of @Chemical$-provoked @Disease$ in patients with AERD undergoing aspirin desensitization.	1
"To minimize the induction of @Disease$, it would be better to take @Chemical$ 3 h after the evening meal, or after consuming diets that contain low amounts of insoluble DF and high amounts of soluble DF."	0
"The cells were isolated from 3 groups of subjects: non@Disease$tic patients (n = 10), patients with aspirin-tolerant asthma (ATA, n = 9), and patients with @Chemical$-intolerant asthma (AIA, n = 7)."	0
Reduction of @Disease$ in hemodialysis patients after reducing @Chemical$ use: A quality-assurance observational study.	0
"RESULTS: The in-hospital mortality rate was 72% for ICH patients treated with @Chemical$, 41.6% for @Disease$ patients treated with aspirin, and 35% for ICH patients treated with no drugs."	0
CONCLUSION: Data suggest that @Chemical$ causes significant @Disease$ even at the low doses used for cardiovascular protection.	1
"The aim of this study is to report the sinonasal outcomes of endoscopic sinus surgery (ESS) in treating NP in asthmatic patients, comparing aspirin-induced @Disease$tic (AIA) patients with @Chemical$-tolerant asthmatics (ATA)."	0
"All active therapies except @Chemical$ increased risk of composite @Disease$ by 2 to 4-fold compared to apixaban 2.5mg, with no difference found between the two apixaban doses."	0
"RECENT FINDINGS: The literature indicates that patients with coronary artery disease (CAD), including those with an acute @Disease$, may safely undergo low-dose @Chemical$ challenge and/or desensitization."	0
"DATA SOURCES: Articles evaluating aspirin for primary prevention of CVD were gathered using a MEDLINE search with the keywords aspirin review, aspirin peripheral artery disease, aspirin stroke, aspirin coronary @Disease$, @Chemical$ diabetes, aspirin primary prophylaxis, and aspirin elderly."	0
CONCLUSIONS: Desensitization may be safely performed in patients with reported ASA or NSAID @Disease$ and a cardiac indication for @Chemical$.	0
Dual antiplatelet therapy with @Chemical$ and clopidogrel increases the risk of gastrointestinal bleeding in patients with @Disease$ in whom concomitant treatment with a proton-pump inhibitor (PPI) was less effective owing to the interaction of clopidogrel and PPI with the same hepatic cytochrome P-450.	0
"We characterized the gastrointestinal risk profile of low-dose aspirin users in real clinical practice, and estimated the excess risk of @Disease$ attributable to @Chemical$ among patients with different gastrointestinal risk profiles."	0
OBJECTIVE: To address the hypothesis that expression of 1 or more EP receptors on nasal mucosal inflammatory cells is deficient in patients with aspirin-sensitive compared with non@Chemical$-sensitive polypoid @Disease$.	0
Nuclear factor-kappaB activity is down-regulated in nasal polyps from @Chemical$-sensitive @Disease$tics.	0
@Chemical$ desensitization for @Disease$.	0
"OBJECTIVE: @Chemical$-exacerbated respiratory disease (AERD) represents a severe form of chronic rhinosinusitis (@Disease$) characterized by nasal polyposis, bronchial asthma, and aspirin intolerance."	0
"CONCLUSION: HRW pretreatment alleviated the @Chemical$-induced @Disease$ by inhibiting the oxidative stress, inflammatory reaction and reducing the COX-2 in the gastric tissues."	1
A retrospective subgroup analysis of data from the CONSENSUS II study demonstrated that the 6-month mortality rate of patients with @Disease$ (MI) who received enalapril and aspirin was higher than the combined mortality rates of patients receiving enalapril or @Chemical$ alone.	0
"To investigate the relationship between @Chemical$ polymorphisms (SNPs) in the RAB1A gene and aspirin-exacerbated @Disease$ (AERD), asthmatics (n=1197) were categorized into AERD and aspirin-tolerant asthma (ATA)."	0
"BACKGROUND: The currently recommended duration of dual antiplatelet therapy (@Chemical$) in drug-eluting stent (DES) recipients is 12 months to reduce the risk of late stent thrombosis, particularly in those with @Disease$ (ACS)."	0
The Framingham Heart Study records of participants with atrial fibrillation (AF) during 1980 and 1994 were retrospectively reviewed to determine the prevalence of @Chemical$ and aspirin use in @Disease$.	0
"On day 1, peak final-extent inhibition of platelet aggregation (IPA) was observed 2-4 h post-dose with @Chemical$, whereas clopidogrel minimally inhibited @Disease$ (mean percentage IPA &lt; 20%, all time points)."	0
"Furthermore, @Disease$ patients under synthesize from arachidonic acid (AA) a peculiar product called @Chemical$, which opposes inflammation generated by leukotrienes."	0
[Clinical study on asthma and @Chemical$ @Disease$ affecting chronic rhinosinusitis].	1
"The study objective was to identify the prevalence of @Disease$, inhalant allergy and aspirin sensitivity in CRS patients referred to secondary care and establish any differences between @Chemical$ phenotypes."	0
CONCLUSION: The use of platelet reactivity assays to identify patients on @Chemical$ therapy at higher risk of @Disease$ is an unfounded strategy.	0
"METHODS: A comprehensive electronic database search was conducted for all RCTs that compared @Chemical$ versus placebo for the prevention of any type of disease, and where @Disease$ incidence or mortality was reported."	0
"In all patients, we measured the @Disease$, by multiplate electrode aggregometry, using two agonists [adenosine diphosphate with @Chemical$ (ADPHS) and arachidonic acid (ASPI)] two times: on the day of cessation of clopidogrel and 90 days after clopidogrel was stopped."	0
"BACKGROUND &amp; AIMS: With capsule endoscopy, the ulcerogenic effect of low-dose enteric-coated @Chemical$ on the small @Disease$ and the therapeutic effect of misoprostol on intestinal injury were evaluated."	0
"Platelet reactivity time (PRT) and whole @Disease$ (WBA) were measured in 160 healthy volunteers, before and after @Chemical$ and in 170 participants with established vascular disease or risk factors thereof treated with aspirin +- clopidogrel."	0
"BACKGROUND: The aim of this study was to evaluate whether an intraoperative bronchospasm is more frequent in sinus surgery than in non-sinus surgery, whether its appearance after application of a non-steroidal anti-inflammatory drug (NSAID) is an indicator of an @Chemical$ @Disease$, and whether its appearance can be interpreted as an aspirin provocation test."	1
@Chemical$ safety in glucose-6-phosphate dehydrogenase deficiency patients with @Disease$ undergoing percutaneous coronary intervention.	0
"Severe space-occupying @Disease$ needing operative re-exploration occurred in four (3.6%) patients under @Chemical$ and clopidogrel, seven (4.3%) under clopidogrel, and five (1.2%) under aspirin."	0
CONCLUSIONS: Dual antiplatelet therapy with combined aspirin and clopidogrel as well as @Chemical$ is associated with an increased incidence of perioperative wound @Disease$ compared to aspirin but on an acceptable low level of incidence.	0
"Only in subjects with @Chemical$-exacerbated @Disease$, exhaled nitric oxide (P &lt; 0.05), plasma tryptase (P &lt; 0.01), and blood eosinophil (P &lt; 0.01) and basophil (P &lt; 0.01) counts increased and plasma tryptase correlated with eosinophil counts (Pearson r = 0.514; P &lt; 0.01) on aspirin."	0
BACKGROUND: We previously reported that the ILVBL gene on chromosome 19p13.1 was associated with the risk for @Chemical$-exacerbated respiratory disease (@Disease$) and the percent decline of forced expired volume in one second (FEV1) after an oral aspirin challenge test.	0
Our aim was to assess the possible association of upper gastrointestinal tract @Disease$ with minidose @Chemical$ therapy.	0
"This article reviews chronic rhinosinusitis with and without nasal polyps, and the subgroup with @Chemical$-exacerbated respiratory disease, while focusing on the relationship with @Disease$."	0
"Search terms included @Chemical$, warfarin, secondary prevention, and @Disease$."	0
BACKGROUND AND PURPOSE: Recent studies have suggested that the use of low-dose @Chemical$ may reduce the risk of @Disease$ (aSAH).	0
@Chemical$ and non steroidal anti-inflammatory drugs @Disease$ review (2002-2004).	0
"METHODS: Ninety-four aspirin-induced urticaria patients presenting urticaria/angioedema-induced by both ASA and NSAID (50 had underlying chronic @Disease$) and showing positive responses on oral aspirin challenge test, 76 @Chemical$-intolerant asthmatics with positive responses on lysine-aspirin bronchoprovocation test, and 185 normal healthy controls were enrolled."	0
"However, @Chemical$ was an aggressive factor, and HP @Disease$ a protective factor."	0
It has been noticed that the incidence of LDA-induced @Disease$ has increased more than that of non-@Chemical$ non-steroidal anti-inflammatory drug (NSAID)-induced lesions.	0
This is the first reported case of @Chemical$ leading to an epidural @Disease$ following an interventional chronic pain procedure.	1
This study was designed to investigate the risks associated with aspirin (@Chemical$) therapy that is used in high doses for the treatment of ASA-exacerbated @Disease$ (AERD) and to review therapeutic strategies for the prevention of nonsteroidal anti-inflammatory drug (NSAID)-induced side effects.	0
"The 1-year predicted risks associated with acetylsalicylic acid, the combination of acetylsalicylic acid and dipyridamole, and @Chemical$ were 11.1 (95% CI: 10.2-12.2), 7.7 (95% CI: 7.3-8.3), and 8.0 (95% CI: 6.9-8.7) for ischemic stroke, respectively; while, the risks for @Disease$ were 3.4 (95% CI: 2.8-3.9), 2.4 (95% CI: 2.1-2.7), and 2.4 (95% CI: 1.9-2.9), respectively."	0
Risk of @Disease$ after endoscopic submucosal dissection for colorectal tumors in patients with continued use of low-dose @Chemical$.	0
This mechanism is also demonstrated to be present in platelets from @Chemical$-intolerant @Disease$tics (AIA).	0
"METHODS: Subjects 18 years or older with osteoarthritis, without gastroduodenal ulcer or erosive @Disease$ at baseline endoscopy, and a cardiovascular indication for prophylaxis low-dose (81 or 325 mg) aspirin were prescribed open-label aspirin and blindly randomized to celecoxib 200 mg/day or @Chemical$ 500 mg twice daily plus lansoprazole 30 mg once daily."	0
Failure of @Chemical$ to prevent aspirin-induced respiratory reactions in patients with aspirin-exacerbated @Disease$.	0
SUMMARY: Recent studies have improved our understanding of mechanisms operating in asthma and unvieled the role of @Chemical$ mediators in @Disease$.	0
"In fact, patients with blood dyscrasias have to be considered high-risk patients due to their increased propensity for uncontrolled @Disease$.The aim of this article was to present and discuss the management of a case of double consecutive retrobulbar hemorrhage in a high-risk patient in treatment with @Chemical$ and warfarin."	0
"The important factors that increase the risk of low-dose aspirin-related ulcer complications include a history of bleeding peptic ulcer, prior peptic ulcer, age &gt; 70 years, @Disease$, and concomitant drug therapy with non-steroidal anti-inflammatory drugs, other antiplatelet agents (e.g., @Chemical$) or anticoagulants."	0
Apixaban and @Chemical$ were the only therapies that did not increase composite @Disease$ risk significantly compared to placebo.	0
OBJECTIVE: Preoperative exposure to @Chemical$ and aspirin significantly increases @Disease$ in patients undergoing on-pump coronary artery bypass graft surgery.	0
"BACKGROUND: Previous studies have suggested a benefit of @Chemical$ in addition to standard dual-antiplatelet therapy (DAPT), reducing in-stent late luminal loss and @Disease$ after percutaneous coronary intervention (PCI) with bare-metal and drug-eluting stent (DES) implantation."	0
It has been proposed that @Chemical$ (ASA) and other non-steroidal anti-inflammatory drug (NSAID)-induced @Disease$ (UR)/angioedema (AE) are mediated through inhibition of cyclooxygenase-1 (COX-1) enzymes.	1
CONCLUSIONS: Increased rates of @Disease$ are observed in patients on long-term @Chemical$ therapy.	1
"In this study, we investigated whether the responsiveness of eosinophils and monocytes to @Chemical$ and EP4 receptor activation is altered in @Disease$ patients."	0
"OBJECTIVE: We evaluated hourly dose escalations in a subset of patients with chronic rhinosinusitis, nasal polyps, and @Disease$ who historically reacted to @Chemical$ within 1 hour or were avoiding aspirin with the goal of developing a safe and efficient desensitization protocol."	0
"What is really new is the observation that @Chemical$ and @Disease$ increase COX-2 expression on blood monocytes of AI asthmatics, a finding in contrast with the lack of an effect of the same stimuli on COX-2 expression on monocytes from healthy subjects."	0
The effect of intravenous @Chemical$ on the exocrine @Disease$ was investigated in a feline isolated pancreaticoduodenal preparation.	0
"We describe the case of a 64-year-old patient with glucose-6-phosphate dehydrogenase deficiency who was referred to our hospital because of an acute inferior myocardial infarction.Given the possible risk of @Disease$, @Chemical$ was not given in the acute phase, and the patient was successfully treated by balloon angioplasty of the right coronary artery.After functional and genetic testing showing the presence of the Mediterranean mutation, known to be a class II variant, the patient received oral daily aspirin (100 mg) under strict monitoring in order to promptly detect any sign of haemolysis."	0
"Among the 26 patients taking @Chemical$ continuously in group A, there were 5 @Disease$ complications (19.23%)."	0
"We describe the case of a 64-year-old patient with @Disease$ who was referred to our hospital because of an acute inferior myocardial infarction.Given the possible risk of acute haemolytic anaemia, @Chemical$ was not given in the acute phase, and the patient was successfully treated by balloon angioplasty of the right coronary artery.After functional and genetic testing showing the presence of the Mediterranean mutation, known to be a class II variant, the patient received oral daily aspirin (100 mg) under strict monitoring in order to promptly detect any sign of haemolysis."	0
The broken balance in @Chemical$ @Disease$.	1
"We evaluated changes in leukotriene and @Chemical$ metabolites for NIUA patients, using patients with NECD and single-NSAID-induced urticaria/@Disease$ or anaphylaxis (SNIUAA) for comparison."	0
"If @Disease$ risk is acceptable, dual APT (DAPT) should be continued perioperatively; otherwise P2Y12 inhibitor therapy should be discontinued for the minimum amount of time possible and @Chemical$ monotherapy continued."	0
@Chemical$ was significantly associated with HbA1c &gt; or = 8% (P=.002) and @Disease$ (BMI&gt; or = 30 kg/m(2); P=.01) and borderline associated with having &gt; or = 1 depressive symptom (P=.07).	1
The potential association of on-@Chemical$ platelet reactivity and @Disease$ is not established.	0
"Patients undergoing PCI benefit from dual anti-platelet therapy (including aspirin), and @Chemical$ desensitization in those with known @Disease$ may facilitate this."	0
"STUDY SELECTION: Randomized, controlled trials; cohort studies; and meta-analyses comparing @Chemical$ with placebo or no treatment to prevent CVD or @Disease$ in adults."	0
RESULTS: @Chemical$ metabolic changes in CM patients taking different dosage of analgesic during @Disease$-free periods and clear distinctions in several brain regions were observed.	0
"A case is reported of very late bare metal stents @Disease$ (33 months) in two different vessels after @Chemical$ discontinuation because of a prostatectomy in patient treated simultaneously with bare metal stents and paclitaxel eluting stents, found patent."	0
"Low-dose aspirin, one of non-steroidal anti-inflammatory drugs(NSAIDs), has been increasingly used to prevent cardiovascular and @Disease$ through its antiplatelet effect, mainly in the aged population, but @Chemical$ treatment has been associated with gastrointestinal injures, especially peptic ulcer bleedings."	0
"Delayed anti@Disease$ effects of @Chemical$ are compatible with the proposed mechanism, as continual microbleeding has a gradual cumulative effect on stored iron."	0
CONCLUSION: About two-thirds of uncoated @Chemical$ chronic users with @Disease$ have mucosal breaks in the small bowel.	0
OBJECTIVE: To investigate the functional variability of HNMT gene in relation to genetic polymorphisms in patients with @Chemical$ intolerant chronic @Disease$ (AICU).	0
"However, at multivariate analysis, an impaired metabolic status, with higher levels of glycosylated hemoglobin and low-density lipoprotein (LDL) cholesterol, but not diabetic status, emerged as independent predictors of HRPR with prasugrel [OR (95% CI)=2.1 (1.32-3.33), p=0.002 and OR (95% CI)=1.03 (1.01-1.05), p=0.003, respectively], with a stronger linear relationship between @Chemical$-mediated @Disease$ and glycosylated hemoglobin levels (r=0.24, p=0.002), than for LDL-cholesterol (r=0.13, p=0.09)."	0
OBJECTIVE: We sought to establish the effect of @Chemical$ on pulmonary @Disease$ and function in patients with persistent asthma.	0
"@Disease$ (MI), sham or normal male SD rats were injected intraperitoneally with high (300 mg/kg), low (5 mg/kg) @Chemical$ or saline (control) once a day for seven weeks."	0
Eosinophilic esophagitis as possible complication of @Chemical$ treatment in patient with aspirin-exacerbated @Disease$.	0
"BACKGROUND: Although many studies have investigated the possible association between analgesic use (@Chemical$ and aspirin) and the development of @Disease$ (CKD), the effect of analgesics on the progression of established CKD of any cause has not yet been investigated."	0
CONCLUSIONS: Rates of bleeding and @Disease$ events were not significantly different according to 6- versus 24-month DAPT after PCI with new-generation DES in good @Chemical$ responders.	0
"Also, women had less @Disease$ (aspirin, 2.4% versus 3.7%; apixaban, 1.4% versus 3.0%), more heart failure, and higher mean CHADS2 (congestive heart failure, hypertension, age of 75 years or older, diabetes [1 point each], stroke or transient ischemic attack [2 points]) scores (aspirin, 2.2 versus 2.0; @Chemical$, 2.1 versus 2.0)."	0
"SUMMARY: The full clinical picture of aspirin intolerance--the association of aspirin-induced bronchial asthma (with severe acute asthma attacks), @Chemical$ sensitivity and nasal @Disease$--is commonly summarized as the 'Samter triad'."	0
"RESULTS: Of 2389 baseline participants with follow-up data available, 257 individuals (10.8%) were regular @Chemical$ users and 63 of the 2389 developed neovascular @Disease$."	0
"BACKGROUND: Although it is well known that aspirin causes gastroduodenal mucosal injury and that aspirin-induced gastroduodenal mucosal injury is often asymptomatic, the prevalence and independent factors for @Disease$ have not been clarified in asymptomatic patients taking low-dose @Chemical$ and gastroprotective agents."	0
"RESULTS: For the THA cohort, there was no difference in the frequency of readmission for a @Disease$ complication (wound or systemic) between the two groups (2.6% for @Chemical$ versus 0.9% for mobile compression; p = 0.57; odds ratio [OR], 2.9)."	0
[To what extent does Trasylol decrease the need for blood and blood derivatives in postoperative @Chemical$ (ASA)-induced @Disease$ in CABG surgery?].	0
"The acute clinical symptoms that develop following the oral ingestion of @Chemical$, or any other inhibitor of cyclooxygenase-1, are well established in aspirin-exacerbated @Disease$: nasal congestion, rhinorrhea, and bronchospasm."	0
"Although @Chemical$ after ICH was not associated with lobar @Disease$ recurrence in univariate analyses, in multivariate analyses adjusting for baseline clinical predictors, it independently increased the risk of ICH recurrence (HR 3.95, 95% CI 1.6-8.3, p = 0.021)."	0
Further logistic analyses revealed that most polymorphisms of KIF3A were significantly associated with @Disease$ (P = 0.0004-0.02; P(corr) = 0.004-0.04) and the decline of forced expiratory volume at 1 s (FEV(1))% by @Chemical$ provocation (P = 0.004-0.04; P(corr) = 0.03).	0
Nuclear factor-kappaB activity is down-regulated in nasal @Disease$ from @Chemical$-sensitive asthmatics.	0
Use of ketoprofen oral challenges to detect cross-reactors among patients with a history of @Chemical$-induced @Disease$.	1
"Endoscopic characteristics of @Chemical$ associated @Disease$ seem to be required further investigation, including the impact of the severity of gastritis and corpus atrophy by Helicobacter pylori infection on the endoscopic characteristics."	1
"RESULTS: Prior @Chemical$ users (n = 17,839) were older (63 years vs. 59 years) and had more coronary risk factors and evidence of @Disease$ (MI, angina, prior intervention) than nonprior aspirin users (n = 48,604) (all p &lt; 0.0001)."	0
"BACKGROUND &amp; AIMS: With capsule endoscopy, the ulcerogenic effect of low-dose enteric-coated @Chemical$ on the small bowel and the therapeutic effect of misoprostol on @Disease$ were evaluated."	0
"AREAS COVERED IN THIS REVIEW: A number of risk factors can be used to determine which patients are more likely to develop @Chemical$-associated GI bleeding, mainly in the upper GI tract; these include a previous @Disease$, ulcer complications, dyspepsia, and concomitant drug therapy with non-steroidal anti-inflammatory drugs (NSAIDs) or clopidogrel."	0
Acetylsalicylic acid (@Chemical$) is mainly recognized as @Disease$ or anti-inflammatory drug.	0
"In addition, low dose @Chemical$ is employed as an anti-coagulant for those who have suffered or are at high risk of @Disease$ and cardiovascular disease."	0
The pathogenic mechanism of acetyl salicylic acid (ASA)-induced @Disease$ (@Chemical$) is not fully understood.	0
Ability of rabeprazole to prevent @Disease$ from clopidogrel and low doses of @Chemical$ depends on CYP2C19 genotype.	1
EVIDENCE SYNTHESIS: The prevalence of aspirin-exacerbated respiratory tract disease is approximately 10% and for @Chemical$-induced @Disease$ the prevalence varies from 0.07% to 0.2% of the general population.	1
"CONCLUSIONS: In nasal @Disease$ of @Chemical$-hypersensitive patients, up-regulation of the adhesion molecules ICAM-1 and VCAM-1 and the integrin VLA-4 may play an important role in the development of chronic eosinophilic inflammation."	1
"History of @Disease$ or non-complicated peptic ulcer, @Chemical$ intake, concomitant treatment with NSAID or calcic inhibitors are demonstrated risk factors of bleeding ulcer associated with low-dose aspirin."	0
"Although @Chemical$ alone is considered to be safe in neuraxial anaesthesia, the concurrent administration of other antithrombotic drugs significantly increases the risk of @Disease$ and the recommended safety times for each of these other drugs must be strictly followed."	0
Perfusion of the stomach with acidified @Chemical$ or ASA under histamine-stimulated acid secretion caused minimal @Disease$ in the stomach with few lesions.	0
The additional intake of @Chemical$ further increases the risk of @Disease$ (OR 7.4).	0
"Simultaneously, the influence of genetic factors in the clinical outcome of drug therapy cannot be ignored. 5-lipoxygenase activating (ALOX5AP) gene involved in the synthesis of @Chemical$, has been recognized as an important gene contributing towards susceptibility of @Disease$ risk."	0
"BACKGROUND/PURPOSE: We aimed to identify the risk factors of first-time occurrence of non-variceal @Disease$ (UGIB) among @Chemical$ users after adjusting for confounding factors like age, gender, underlying co-morbidities, and medications."	0
"Found low compliance of admission to long-term acetylsalicylic acid (ASA) in patients with @Disease$ (ACS): 74.9% of patients reported that the suspended or completely stopped taking the drug, and only 16.2% were fully committed to the long-term therapy with @Chemical$."	0
The relationship between @Disease$ and continuous therapy with low-dose aspirin (@Chemical$) remains controversial.	0
"For more than 30 years, @Chemical$ desensitization has proven to be of significant long-term benefit in carefully selected patients with @Disease$."	0
"Interaction between Helicobacter pylori @Disease$, nonsteroidal anti-inflammatory drugs and/or low-dose @Chemical$ use: old question new insights."	0
"Following endoscopic @Disease$ and discontinuation of dual APT, neoadjuvant chemotherapy with imatinib was started under continuation of 'single' APT with @Chemical$."	0
"Data Sources: We searched PubMed, Embase, CENTRAL, and ClinicalTrials.gov from inception to May 28, 2018, with the terms novel oral anticoagulants, non-vitamin K antagonist oral anticoagulants, direct oral anticoagulants, dabigatran, @Chemical$, apixaban, edoxaban, warfarin, Coumadin, vitamin K antagonist, aspirin, acetylsalicylic acid, or ASA, and major @Disease$, fatal bleeding, or intracranial hemorrhage."	0
"Since @Chemical$/NSAIDs cause @Disease$, serious side effects such as bleeding accompanied with their usage have been frequently reported."	1
CONCLUSIONS: These preliminary findings suggest a possible relationship between ZNRD1 and @Chemical$-induced @Disease$ in a Korean population and provide essential information on the etiology of AERD.	1
"Factors associated with an increased risk of upper GI complications during low-dose aspirin therapy include @Chemical$ dose, history of @Disease$ or upper GI bleeding, age &gt; 70 years, concomitant use of NSAIDs (including COX-2-selective NSAIDs), and Helicobacter pylori infection."	0
"CONCLUSIONS: In patients with AF, all combinations of warfarin, aspirin, and @Chemical$ are associated with increased risk of nonfatal and fatal @Disease$."	0
CONCLUSIONS: No evidence was found that PPI use is associated with increased risk of MACE or all-cause mortality in @Chemical$-treated @Disease$ patients.	0
"BACKGROUND: @Chemical$ therapy is widely accepted for patients with documented @Disease$, but there is a growing trend among healthy individuals to use aspirin as primary prevention for both cardiovascular disease and cancer."	0
@Chemical$ resistance may increase @Disease$ risk in some patients with heart disease.	1
We aimed to determine @Chemical$ levels in patients with AERD (n = 240) and aspirin-tolerant asthma (ATA) (n = 226) and to assess whether its addition to urinary leukotriene E4 (uLTE4) levels and @Disease$ can improve the prediction of AERD diagnosis.	0
We evaluated the association between @Chemical$ use and long-term rates of sepsis as well as @Disease$ outcomes.	0
"RESULTS: None of the 60 patients experienced any symptoms, changes in nasal examinations, or @Disease$ in forced expiratory volume in 1 second during the @Chemical$ challenges."	0
"Proton-pump inhibitor treatment resulted in an absolute risk reduction of peptic @Disease$ by 36.6% in acute and 34.6% in chronic non-steroidal anti-inflammatory drugs/aspirin users; indeed, the number needed to treat to avoid one peptic ulcer in elderly non-steroidal anti-inflammatory drugs/@Chemical$ users was three both in acute and chronic users."	0
"COX-1-derived PGs are responsible for gastroprotection, while @Chemical$ generated via COX-2 activity also play an important role in gastroprotection and @Disease$."	0
"METHODS: Subjects 18 years or older with osteoarthritis, without gastroduodenal @Disease$ or erosive esophagitis at baseline endoscopy, and a cardiovascular indication for prophylaxis low-dose (81 or 325 mg) aspirin were prescribed open-label @Chemical$ and blindly randomized to celecoxib 200 mg/day or naproxen 500 mg twice daily plus lansoprazole 30 mg once daily."	0
@Chemical$ use and development of @Disease$: confounding or causation?	0
"A second polymorphism study, conducted on histamine-related genes, did not find any significant associations with @Chemical$-induced urticaria/angioedema for the genes HNMT (encoding histamine N-methyltransferase), HRH1 or HRH2 (encoding histamine receptor types 1 and 2 respectively), or the gene encoding high-affinity IgE receptor Ibeta (@Disease$); however, the FcepsilonRIalpha gene promoter polymorphism was significantly associated with aspirin-induced urticaria/angioedema."	0
OBJECTIVE: To determine whether @Chemical$ nasal challenge has acceptable specificity and sensitivity for diagnosing aspirin-exacerbated @Disease$.	0
"INTRODUCTION: @Chemical$, aspirin, and the combination of these, have all proven to be efficacious in preventing future events after @Disease$."	0
"Bleeding complications associated with combinations of aspirin, @Chemical$ derivatives, and warfarin in elderly patients following acute @Disease$."	0
BACKGROUND: To improve understanding of aspirin @Disease$ this study focused on adenosine as a noncyclooxygenase target molecule of @Chemical$.	0
"More recently, @Chemical$ sulphide-releasing derivatives of NSAIDs and of other drugs, have been developed, based on the observed ability of H(2)S to reduce inflammation and @Disease$ in experimental models."	0
"Sodium cromoglycate (SCG) is used for the treatment of @Disease$ with food allergy, but the efficacy of SCG in @Chemical$-exacerbated food-allergy reactions is unclear."	0
These results suggest that @Chemical$ has a lower incidence of @Disease$ effects than other NSAIDs and should be useful in the management of patients with cardiovascular disease.	0
"The estimated average excess risk of @Disease$ attributable to @Chemical$ is around 5 extra cases per 1,000 aspirin users per year."	1
"The substantive risk for prophylactic aspirin is therefore @Disease$ which can be fatal or severely disabling, with an estimated risk of one death and one disabling stroke for every 1,000 people taking @Chemical$ for ten years."	0
Drug-induced hypersensitivity syndrome: @Disease$ with eosinophilia and systemic symptoms (DRESS) syndrome induced by @Chemical$ treatment of Kawasaki disease.	0
"However, there was a strong association of the ALOX5 Sp1 repeat polymorphism with airway hyperresponsiveness (AHR; PC20 @Chemical$); AIA patients carrying a mutant allele (n &gt; 5 or n &lt; 5 repeats) showed increased AHR compared to @Disease$ patients with wild-type genotype (P=0.003)."	0
AIM: To compare prospectively the incidence of endoscopic @Disease$s in healthy subjects receiving low-dose aspirin plus celecoxib or @Chemical$.	0
@Chemical$-related gene polymorphisms in patients with aspirin-intolerant @Disease$ and aspirin-intolerant asthma: differing contributions of ALOX5 polymorphism in Korean population.	0
Adhesion molecules and their ligands in nasal @Disease$ of @Chemical$-hypersensitive patients.	1
@Chemical$-exacerbated respiratory disease (AERD) is a syndrome of severe @Disease$ with nasal polyposis with exacerbations of baseline eosinophil-driven and mast cell-driven inflammation after nonsteroidal antiinflammatory drug ingestion.	0
We determined acute gastroduodenal erosion and ulceration following low-dose aspirin and aspirin-@Chemical$ complex (PL2200) in subjects at risk of aspirin @Disease$.	0
"BACKGROUND AND AIM: @Chemical$ (ASA [aspirin]) is a commonly used over-the-counter drug for the treatment of pain, @Disease$, or colds, but data on the safety of this use are very limited."	0
Risks of Bleeding Recurrence and Cardiovascular Events With Continued @Chemical$ Use After Lower @Disease$.	0
"The mean hospital stay was 1.94 days; 14 patients (15 %) required injection of @Chemical$ 1 : 10,000 to control @Disease$; and two patients died."	0
"In the MT analysis, there was more major @Disease$ in the first month after an ACS event with high-dose @Chemical$."	0
"CONCLUSIONS: Erosive oesophagitis is common in patients with @Disease$ taking low-dose @Chemical$ or antithrombotic agents, and could potentially be confused with the coexisting heart disease."	0
"RESULTS: Pretreatment with NO-@Chemical$ attenuated dose-dependently gastric erosions provoked by WRS, @Disease$-reperfusion, and ethanol."	0
"CONCLUSION: For patients with inguinal @Disease$s, laparoscopic TAPP repair is completely safe to be performed on those taking low-dose @Chemical$ when it was only ceased on the operation day, with intravenous salvianolate given after the operation instead."	0
"METHODS: Of 74 patients with CIU and a history of aspirin @Disease$ studied by us, two patients (probands) gave a family history of @Chemical$ intolerance."	0
Neither @Chemical$ nor nonaspirin NSAIDs are likely useful for prevention of @Disease$.	0
@Chemical$ for prophylactic use in the primary prevention of cardiovascular disease and @Disease$: a systematic review and overview of reviews.	0
Local mechanisms of GI protection are important as @Chemical$'s preassociation with surface-active phospholipids significantly reduced @Disease$.	0
Complications of @Disease$ may also be more frequent with @Chemical$ use.	0
"Here, we describe a patient who suffered from a split-thickness leg burn after applying a self-inflicted mixture consisting of white vinegar and @Chemical$ prepared for knee @Disease$."	0
Chronic rhinosinusitis with nasal polyps (CRSwNP) and asthma frequently coexist and are always present in patients with @Chemical$ exacerbated @Disease$ (AERD).	0
ADP (5 and 20 micromol)-induced @Disease$ was significantly decreased with clopidogrel (p &lt;0.001) but remained stable under additional treatment with atorvastatin or @Chemical$ in the 2 groups.	0
"Major @Disease$ in @Chemical$-anticoagulant-treated patients occurred with an event rate of 4.8 per 100 patient-years, compared to 2.2 per 100 patient-years during aspirin nonuse (HR, 1.50 [95% CI, 0.86-2.62])."	1
Nasal polyp tissues were obtained from 29 patients [including nine with @Chemical$ (ASA)-hypersensitivity and 12 with bronchial @Disease$] undergoing polypectomy for nasal obstruction.	0
"@Chemical$-exacerbated respiratory disease (AERD), formerly known as Samter's Triad, is a syndrome of @Disease$ characterized by rhinosinusitis with polyposis, asthma, and nonsteroidal anti-inflammatory drug (NSAID) intolerance."	0
CONCLUSION: Results of the pilot study indicate that implementation of a low @Chemical$ diet improves the nasal symptoms and nasal endoscopy findings of individuals with @Disease$.	0
Leukotriene modifiers to prevent @Chemical$-provoked respiratory reactions in @Disease$tics.	0
"In haplotype analysis, the HLA-DRB1(*)1302-DQB1(*)0609-DPB1(*)0201 was significantly higher in the aspirin-induced urticaria (8.0%) than in the @Chemical$-intolerant @Disease$ (0.7%, P=0.0014) and normal controls (2.0%, P=0.0006)."	0
KEY FINDINGS: Three dogs undergoing surgery for @Disease$ had marked prolongations in buccal mucosal bleeding time (@Chemical$) after aspirin administration.	0
"The triad of bronchial @Disease$, nasal polyposis, and intolerance to aspirin and @Chemical$-like chemicals are designated aspirin-induced asthma (AIA) or Samter's syndrome."	0
Catastrophic early drug eluting stents @Disease$ and @Chemical$ hypersensitivity.	0
We aimed to assess the presence of apoptotic cells in nasal polyps from aspirin-hypersensitive (AH) and @Chemical$-tolerant (AT) patients with @Disease$ as related to the characteristics of local inflammation.	0
"The main models included the following predictors: demographic characteristics (age, ethnicity, and socioeconomic deprivation), clinical measurements (systolic blood pressure and ratio of total-high-density lipoprotein cholesterol), family history of premature CVD, medical history (smoking, diabetes, @Disease$, peptic ulcer disease, cancer, chronic liver disease, chronic pancreatitis, or @Chemical$-related conditions), and medication use (nonsteroidal anti-inflammatory agents, corticosteroids, and selective serotonin reuptake inhibitors)."	0
We sought to examine associations between PPI use and MACE and all-cause mortality in @Chemical$-treated @Disease$ patients.	0
"CASE REPORT: A 58-year-old Caucasian male with a history of coronary heart disease and hypercholesterolemia, under treatment with acetyl-@Chemical$ for 6 years and simvastatin for 2 months, presented to the Emergency Department of our hospital with @Disease$ and vomiting of 24-hour duration."	0
"The association between aspirin use and the presence of DR or VTDR was assessed using multivariable logistic regression models including age, gender, ethnicity, socioeconomic status, HbA1c, systolic blood pressure, anti-hypertension medicine, total cholesterol, anti-@Chemical$ medicine, BMI, current smoking status, @Disease$ duration, history of cardiovascular disease (CVD) and chronic kidney disease (CKD.)."	0
"Aspirin (@Chemical$)-induced @Disease$ (AIA) consists of the clinical triad of asthma, chronic rhinosinusitis with nasal polyps, and precipitation of asthma and rhinitis attacks in response to aspirin and other NSAIDs."	1
CONCLUSIONS: Omeprazole was superior to famotidine with less gastrointestinal symptoms and recurrent @Disease$/erosions in patients using 24-week low-dose @Chemical$.	0
"METHODS: The patients enrolled in this study were the elderly requiring a single non-impacted tooth extraction. 300 elderly outpatients used lidocaine local infiltration anesthesia, 200 patients without using aspirin before tooth extraction served as control group I, 100 patients with prolong use of aspirin before tooth extraction as observation group I. 300 elderly outpatients used compound articaine local infiltration anesthesia, 200 patients without using @Chemical$ before tooth extraction served as control group II, 100 patients with prolong use of aspirin before tooth extraction as observation group II.Bleedings at 5, 10, 30 min, 24 h after tooth extraction were observed and the relationship between postoperative @Disease$ and intake of aspirin was analyzed."	0
"Over- production of cysteinyl-leukotrienes (CysLTs) and prostaglandin D2 (@Chemical$) correlate with the pathogenetic features of @Disease$, suggesting the possible involvement of mast cell activation with innate type 2 immune response."	0
"By comparison, there was no association with risk of incident @Disease$ for increasing use of @Chemical$, nonaspirin NSAIDs, or ibuprofen."	0
"RESULTS: Among the patients with asthma, polymorphism at -1082A/G was significantly associated with the phenotype of @Chemical$-intolerant asthma, @Disease$ (P = 0.007, P(c) = 0.021)."	0
"A 79-year-old man with atherosclerosis obliterans, taking cilostazol and @Chemical$, complained of @Disease$."	0
@Chemical$ is an important antiplatelet agent in the treatment of @Disease$.	1
"The risk of upper GI bleeding increased with a higher risk score, which for NSAID users included age, male gender, @Disease$ and concomitant use of @Chemical$ or anticoagulants."	0
"Patients undergoing TKA treated with @Chemical$ had higher rates of systemic @Disease$ or a complication secondary to LMWH administration (2.8% for LMWH versus 0% for mobile compression; p = 0.022; OR, 12.8)."	0
"@Disease$, peptic ulcer and @Chemical$: of good and evil."	0
"Significant differences in the number of erosions and @Disease$ were observed between the buffered and enteric-coated @Chemical$ groups (P=0.017 and P=0.037, respectively)."	0
We investigated the role of serum specific IgE to thyroid peroxidase (TPO) in patients with aspirin intolerant acute urticaria (AIAU) and @Chemical$ intolerant chronic @Disease$ (AICU).	0
"The use of this combination provides significant benefits compared with the use of @Chemical$ alone in patients with @Disease$, and in patients treated with percutaneous coronary intervention with stent placement (both bare metal and drug-eluting stents)."	0
"ASA-@Chemical$ did not cause bleeding, @Disease$, mucosal injury or an elevation in proinflammatory markers."	0
Lack of association of ALOX12 and ALOX15 polymorphisms with @Chemical$-exacerbated @Disease$ in Korean patients.	0
"METHODS: Of 271 patients suspected by history of having @Disease$, 96 were taking cys-LT receptor antagonists (@Chemical$-LTRAs) and 12 were taking zileuton at the time of oral ASA challenges."	0
"The aim of this study was to compare the @Disease$ risk of aspirin and VKA, as indicated by the aggregate body of clinical evidence including data from the recently published @Chemical$ trial."	0
@Chemical$ (ASA) or aspirin and nonsteroidal anti-inflammatory drug (NSAID) sensitivities encompass a diverse group of both pharmacological and @Disease$ reactions.	0
The incidence of @Disease$ for buffered aspirin and enteric-coated @Chemical$ was evaluated in patients receiving long-term low-dose aspirin (LDA) for cardiovascular (CV) diseases.	0
"These results show that in patients with mild to moderate @Disease$ resulting from MSC, @Chemical$ given in OTC doses for 6 days is as well tolerated as paracetamol and better tolerated than aspirin."	0
"Aspirin (ASA)-exacerbated respiratory disease (AERD) is characterized by upper airway congestion due to eosinophilic inflammation of the nasal and sinus membranes and @Disease$, associated with increased @Chemical$ production that is further accentuated by ASA or other nonsteroidal anti-inflammatory drug (NSAID) ingestion."	0
Clinical updates in @Chemical$-exacerbated @Disease$.	1
Pancreatitis as a novel complication of aspirin therapy in patients with @Chemical$-exacerbated @Disease$.	0
The effect of leukotriene-modifier drugs on @Chemical$-induced asthma and @Disease$.	1
"Previous trials have shown that up to 15-20 % of patients developed gastrointestinal symptoms with @Chemical$ monotherapy, and approximately 1 % of patients per year had a clinically significant @Disease$ event, including 1 in 1000 patients who suffered an intracranial or fatal bleed."	1
"RESULTS: In group of patients with @Chemical$ @Disease$ basic concentration of LTE4 was 416.6 +/- 374.4 pg/mL, and after provocation 496.6 +/- 485.3 pg/mL, in the group without sensitivity to aspirin appropriate 262.9 +/- 404.0 vs 261.2 +/- 259.66 pg/mL, and in the group disqualified to test 181.6 +/- 55.75 pg/mL."	1
CONCLUSIONS: GDF-15 at 1 month after an ACS is related to the risk of @Disease$ during @Chemical$ and provides additional information on the bleeding risk beyond baseline GDF-15 levels.	1
"CONCLUSION: Using simple serum measurement of H. pylori antibody and pepsinogen concentrations, an extremely high-risk group for @Chemical$-induced gastropathy could be extracted, and these patients should become a therapeutic target for prevention of LDA-induced @Disease$."	0
Pancreatitis as a novel complication of @Chemical$ therapy in patients with aspirin-exacerbated @Disease$.	0
"Edoxaban is an oral factor Xa (FXa) inhibitor in clinical development for @Disease$ prevention in patients with atrial fibrillation, an elderly population that frequently receives @Chemical$ (ASA) and/or nonsteroidal anti-inflammatory drugs for concurrent illnesses."	0
"Aspirin desensitization can usually be achieved for those in need of the antiplatelet effects of aspirin, with the exception of those with @Chemical$-induced urticaria and baseline chronic @Disease$."	1
@Chemical$-exacerbated respiratory disease (AERD) is a syndrome of severe asthma and rhinosinusitis with nasal polyposis with exacerbations of baseline eosinophil-driven and mast cell-driven @Disease$ after nonsteroidal antiinflammatory drug ingestion.	0
"In total, it appears that when there is vessel injury (mechanical from perctutaneous coronary intervention or a ruptured plaque), dual antiplatelet therapy with @Chemical$ and clopidogrel results in improved outcomes, albeit with a small but significant inherent risk of increased @Disease$."	0
"In this distinct clinical syndrome, @Chemical$ and most other nonsteroidal anti-inflammatory drugs that inhibit cyclooxygenase-1 precipitate rhinitis and @Disease$ attacks."	0
Treatment of @Chemical$ exacerbated @Disease$ with a low salicylate diet: a pilot crossover study.	0
OBJECT: In this paper the authors investigate whether shunt-treated patients with normal-pressure @Disease$ receiving @Chemical$ therapy are at increased risk of developing subdural hematoma (SDH).	0
"The drugs significantly associated with @Disease$ were loxoprofen (aOR 5.0), diclofenac (aOR 3.1), diclofenac suppository (aOR 8.0), etodolac (aOR 4.9), enteric-coated @Chemical$ (aOR 3.9), buffered aspirin (aOR 9.9), clopidogrel (aOR 2.5), and cilostazol (aOR 7.3)."	1
CONCLUSION: Aspirin desensitization following @Chemical$ appears to be a well-tolerated and effective adjunctive therapy for long-term control of nasal polyposis in patients with @Disease$.	0
"Previous laboratory studies have shown a possible drug-drug interaction of statins metabolized by cytochrome P450 3A4 and @Chemical$ (prodrug metabolized by cytochrome P450 3A4), resulting in an impaired inhibitory effect of clopidogrel on @Disease$."	0
CONCLUSION: The data suggest a possible role for @Chemical$(2) in mediating epithelial repair in @Disease$.	0
CONCLUSION: The incidence of postoperative definitive @Disease$ in Japanese patients receiving &lt;=100 mg enteric-coated @Chemical$ was 0.97%.	0
"RESULTS: Tacrolimus pretreatment failed to block respiratory reactions to provoking doses of @Chemical$ in 5 of 8 patients with @Disease$, and in the other 3 patients did not block higher doses of aspirin."	0
The effect of @Chemical$-modifier drugs on aspirin-induced asthma and @Disease$.	0
"@Chemical$-exacerbated respiratory disease is a clinical syndrome characterized by severe, persistent @Disease$, hyperplastic eosinophilic sinusitis with nasal polyps, and reactions to aspirin and other nonsteroidal antiinflammatory drugs that preferentially inhibit cyclooxygenase 1."	0
"OBJECTIVE: It was the aim of this study to investigate the prevalence of otologic manifestations in a cohort of Samter's syndrome patients (@Disease$ with chronic rhinosinusitis, @Chemical$ intolerance and asthma)."	0
"OBJECTIVE: We evaluated hourly dose escalations in a subset of patients with @Disease$, nasal polyps, and asthma who historically reacted to aspirin within 1 hour or were avoiding @Chemical$ with the goal of developing a safe and efficient desensitization protocol."	0
"Spirometry, skin-prick test and asthma control test were documented and intracellular cytokine expression in T lymphocytes and plasma lipoxin levels were measured in 23 @Disease$ patients, 17 @Chemical$-tolerant asthmatic (ATA) patients, and 16 healthy controls."	0
Functional @Chemical$ test and typing (FET) in acetylsalicylic acid intolerant patients with @Disease$.	0
Seventy-one per cent of @Chemical$ users had at least one risk factor (in addition to @Disease$) for the development of UGICs.	0
Safety of @Chemical$ in @Disease$tic patients with aspirin-exacerbated respiratory disease.	0
"BACKGROUND: In 5 to 10% of adult patients with asthma, @Chemical$ (acetylsalicylic acid [ASA]) and most other nonsteroidal anti-inflammatory drugs (NSAIDs) precipitate acute @Disease$tic attacks."	1
The study treatments were misoprostol 200 microg @Disease$ or @Chemical$ 15 or 30 mg OD.	0
CONCLU@Disease$ONS: Our results suggest no improved clinical outcomes associated with higher @Chemical$ maintenance doses in ACS patients receiving SI or MT.	0
The mechanism of mucosal injury included @Disease$ induced by aspirin and decreased synthesis of vascular endothelial growth factor (VEGF) by @Chemical$.	0
CE is useful to diagnose small bowel @Disease$ associated with @Chemical$.	1
PATIENTS AND METHODS: Adult patients with aspirin challenge-confirmed AERD underwent an oral @Disease$ followed by daily ingestion of @Chemical$ for at least 6 months.	0
"METHODS: We enrolled patients who received 100 mg of enteric-coated @Chemical$ daily for more than 3 months and were found to have more than 3 mucosal breaks (i.e., erosions or @Disease$) in the small intestine by capsule endoscopy."	0
"The magnitude of aspirin-associated increase, the prevalence and attributable risk of Helicobacter pylori @Disease$ on these events in @Chemical$ users was also assessed."	0
CONCLUSIONS: Helicobacter pylori @Disease$ may partially protect against low-dose @Chemical$-induced gastric erosions; damage to the stomach appears weakly dose-related; and older age does not increase the risk of erosions.	0
BACKGROUND: @Chemical$-intolerant asthma (AIA) is a subtype of asthma induced by non-steroidal anti-inflammatory drugs and characterized by an aggressive mucosal inflammation of the lower airway (@Disease$) and the upper airways (rhinitis and nasal polyp).	0
The effects of inhaled aspirin on fractional exhaled NO (FENO) in patients with aspirin-tolerant (@Chemical$) and aspirin-inducible (AIA) @Disease$ compared with normal controls have been investigated.	0
[HP eradication prevents recurrent @Disease$ caused by @Chemical$].	1
"METHODS: 430 consecutive subjects (70+/-14 years, 55% male, 41% with @Disease$) released from the hospital with a primary diagnosis of heart failure were classified into three groups based on the use of aspirin and ACE-I at discharge: ACE-I without @Chemical$ (group I, n=134), ACE-I with aspirin (group II, n=138) and no ACE-I (group III, n=158)."	0
BACKGROUND: Adaptive desensitization still remains the only causative therapy for @Chemical$ (ASA) @Disease$ and is carried out nearly worldwide.	1
"Letter by Feng et al regarding article, Ischemic @Disease$ and intracranial hemorrhage with aspirin, dabigatran, and @Chemical$: impact of quality of anticoagulation control."	0
"Compared with clopidogrel, aspirin increases the risk of GI bleeding but not other bleeding; however, 883 patients (95% CI, 357-infinity) would need to be treated with clopidogrel versus @Chemical$ to prevent one major GI @Disease$ episode annually at a cost of over 1 million dollars."	0
"Dual antiplatelet therapy (DAPT) with acetylsalicylic acid and a P2Y12 inhibitor (clopidogrel, ticagrelor, or @Chemical$) reduces @Disease$ events in patients with acute coronary syndrome (ACS), but it is also associated with an increased risk of bleeding complications."	0
The data are still lacking and further prospective studies are needed to identify the specific gene polymorphisms as risk or protective factors for @Disease$ associated with @Chemical$.	1
"This report describes a case of @Disease$ in the setting of @Chemical$-induced asthma also known as Samter-Beer triad combining nasal polyps, asthma, and aspirin allergy leading to vasospasm and myocardial infarction."	0
"RECENT FINDINGS: The incidence of @Chemical$ @Disease$ the general population ranges from 0.6-2.5%, but that in adult asthmatics ranges from 4.3-11%."	1
The trend towards increased @Disease$ with @Chemical$ appears to be explained by an excess of intracranial bleeding in warfarin patients.	1
"INTRODUCTION: Clinical features of aspirin-exacerbated respiratory disease (AERD) consist of moderate to severe asthma associated with chronic rhinosinusitis (@Disease$), which are derived from overproduction of @Chemical$ along with chronic type 2 mediated inflammation in the upper and lower airway mucosa."	0
"Risk factors for NSAID-related peptic ulcer include a previous history of peptic @Disease$, advanced age, high dose, concomitant use of corticosteroids, anticoagulants, other NSAIDs including low-dose @Chemical$."	0
"RESULTS: Among the patients with asthma, polymorphism at -1082A/G was significantly associated with the phenotype of @Chemical$-intolerant @Disease$, AIA (P = 0.007, P(c) = 0.021)."	0
"We investigated whether aspirin with @Chemical$ (ASA++) increases @Disease$ frequency compared with aspirin alone in migraine, tension-type headache (TTH), and migraine + TTH (MigTTH)."	0
The Naranjo probability scale indicated that aspirin was a highly probable cause and @Chemical$ was a probable cause of this patient's @Disease$.	0
During dose-reduced (2-3 times a week) @Chemical$ administration ADP-induced platelet aggregation was effectively inhibited and neither important @Disease$ nor stent thrombosis occurred.	0
"Differences between the @Disease$ and @Chemical$ phenotypes were associated with alterations in the 6p22, 22q13, and 1q23 chromosomal regions."	0
@Disease$ media with effusion in @Chemical$-exacerbated respiratory disease patients-A series of 22 cases.	0
"CONCLUSIONS: Adding clopidogrel to @Chemical$ beyond 4 weeks post PCI is not associated with a significant increase in the overall rate of major or minor bleeding, although it is associated with an increase in major gastrointestinal @Disease$ in the year after a PCI."	0
@Chemical$ and salicylate in @Disease$.	0
"BACKGROUND: @Chemical$ is one of the most used drugs around the @Disease$, it has wide therapeutic indications."	0
The objective of this study was to determine the risk of PUB associated with the interaction between H. pylori @Disease$ and current nonsteroidal anti-inflammatory drugs (NSAIDs) or low-dose @Chemical$ use.	0
"Dose-related increases in heart and ventricular weight, and @Disease$, were found more exacerbated in the aspirin-treated MI rat hearts than the @Chemical$-treated MI counterparts."	0
Immune @Chemical$-induced @Disease$ can occur in patients receiving clopidogrel and aspirin.	1
Aspirin desensitization as a treatment for @Chemical$-sensitive chronic spontaneous @Disease$.	0
"Average bleeding in @Chemical$ group 24 hours postoperatively was 1600 ml, Non ASA group had average @Disease$ 900 ml, while Trasylol group had average drainage of 700 ml after 24 hours."	0
"RESULTS: Seventeen patients with isolated @Disease$ were enrolled, twelve taking @Chemical$ and five not taking aspirin."	0
"CONCLUSION: After intravitreal injection of @Chemical$, no significant @Disease$ sign was observed other than a reversible cataract."	0
"In view of these animal studies and in the absence of controlled studies of @Chemical$ or NSAIDs in human myocarditis, we do not recommend indiscriminate treatment with NSAIDs or high-dose aspirin in patients with @Disease$ where there is no or minimal associated pericarditis."	0
"In the @Chemical$ group one patient developed a postoperative epidural hematoma needing revision surgery, while in the control group no postoperative epidural @Disease$s were seen (p = 0.40)."	0
RESULTS: Curcumin containing 5% and 10% ethanolic extract ointment have shown significant (P &lt; 0.01) wound healing activity against an @Chemical$ (administered 150 mg/kg body weight orally for 9 days) @Disease$ wound healing process.	0
"On epithelial and glandular cells, expression of cysLT 2 significantly exceeded that of cysLT 1 in both the patients with rhinosinusitis and the controls ( P &lt; or = .004), although there was no significant difference in the expression of either receptor in the patients with @Disease$ (aspirin-sensitive or @Chemical$-tolerant) and the controls."	0
Gastric @Disease$ evaluated by transnasal endoscopy and QOL assessments in ischemic heart disease patients receiving low-dose @Chemical$.	0
"However, in some patients, such treatment is associated with upper gastrointestinal (GI) adverse effects, e.g. dyspeptic symptoms, peptic ulceration, and @Disease$, that may interfere with adequate adherence to, and continuation of, low-dose @Chemical$ for CV protection."	0
Regular @Chemical$-use preceding the onset of primary @Disease$ is an independent predictor for death.	0
"The authors found no significant differences on quality of life, nasal symptoms, polyp size, and CT scan scores between patients with @Chemical$-tolerant and aspirin-sensitive @Disease$."	0
Overuse of @Chemical$ powders affects @Disease$ in chronic migraine patients.	0
"Cyclooxygenase-2 (COX-2) inhibitors (e.g. @Chemical$ 400 mg/day) were associated with a significant decrease in the recurrence of both @Disease$s (RR, 0.66 [95% CI, 0.59-0.72]) and advanced adenomas (RR, 0.45 [95% CI, 0.33-0.57]); however, this association did not persist and there was a trend of an increased risk of recurrent adenomas observed 2 years after the withdrawal."	0
OBJECTIVE: Patients who present with a spectrum of allergic and pseudo@Disease$ reactions to @Chemical$ pose a special challenge for the physician.	1
This meta-analysis found no statistically significant difference regarding the risk of operative mortality and @Disease$ between the 'continuing ASA' and 'stopping @Chemical$' strategies.	0
"In two separate series, platelet aggregation and carrageenan arthritis-induced inflammatory @Disease$ were measured in control, ASA and ASA-@Chemical$-treated groups."	0
We report the case of a patient who after a minor fall developed a subdural @Disease$ requiring craniotomy that likely was precipitated by concomitant use of high-dose omega-3 fatty acids 6 g/day with both @Chemical$ and warfarin.	0
"An adverse event secondary to @Chemical$ ingestion was defined as anaphylaxis or allergic reactions, such as @Disease$ or respiratory changes."	1
BACKGROUND: @Chemical$ has detrimental effects on the gastrointestinal tract mucosa and may play a role in the aetiology of @Disease$.	0
"We describe the most common clinical presentations of @Chemical$ hypersensitivity, i.e. aspirin-induced asthma, @Disease$ and aspirin-induced urticaria."	0
"The acute clinical symptoms that develop following the oral ingestion of aspirin, or any other inhibitor of cyclooxygenase-1, are well established in @Chemical$-exacerbated respiratory disease: nasal congestion, @Disease$, and bronchospasm."	0
"Any bridging AC (odds ratio [OR] 10.3, 1.8-60.8, P = 0.01), @Chemical$ (OR 10.0, 1.7-57.7, P = 0.01), and uninterrupted warfarin without bridging (OR 11.1, 1.7-74.3, P = 0.013) were independently associated with @Disease$ formation."	0
"The effects of pranlukast on changes in sputum LTC(4)-LTD(4), eosinophil cationic protein (ECP), eosinophil count, urinary LTE(4)/creatinine, 11-dehydrothromboxane B(2) (11-dhTXB(2))/@Chemical$, serum LTC(4)-LTD(4), ECP, and peripheral blood eosinophil count, during immediate @Disease$tic reaction (IAR) and late asthmatic reaction (LAR) in the HDM group and during IAR in the ASA group for each test, were compared in each group."	0
Cardioprotective @Chemical$ users and their excess risk of @Disease$.	1
CONCLUSION: The high use of @Chemical$ in patients at higher @Disease$ risk supports national recommendations.	0
The authors measured the presence and extent of asymptomatic microbleeds on gradient-recalled-echo MRI in 21 @Chemical$ users who developed @Disease$ and 21 aspirin users without history of intracerebral hemorrhage.	0
"@Disease$JECTIVE: To investigate the incidence, clinical characteristics and risk factors of upper gastrointestinal bleeding (UGIB) in patients with acute coronary syndrome (ACS) who were administrated with aspirin and @Chemical$ dual antiplatelet therapy after percutaneous coronary intervention (PCI)."	0
"The aim of this study is to report the sinonasal outcomes of endoscopic sinus surgery (@Chemical$) in treating NP in asthmatic patients, comparing aspirin-induced @Disease$tic (AIA) patients with aspirin-tolerant asthmatics (ATA)."	0
"METHODS: We compared aspirin and warfarin for HF events (hospitalization, @Disease$, or both) in the 2,305 patients enrolled in the WARCEF (@Chemical$ versus Aspirin in Reduced Cardiac Ejection Fraction) trial (98.6% on ACE inhibitor or ARB treatment), using conventional Cox models for time to first event (489 events)."	0
"Despite treatment with clopidogrel and @Chemical$, in the following days the patient experienced two new episodes of stent @Disease$, treated with thrombectomy and deployment of bioengineered stents."	0
"Two-thirds of the respondents felt that @Chemical$ was a risk factor for @Disease$ complications associated with spinal procedures, and more than half of the interviewees reported having personal experience of such problems."	1
"Although the disease is clinically well characterized, its physiopathology is incompletely understood and noninvasive procedures, allowing an effective distinction between @Chemical$-induced asthma (@Disease$) and aspirin-tolerant asthma (ATA) are missing."	0
"In the study, 100 patients with low on-treatment platelet aggregation and at high risk of bleeding and low risk of cardiovascular events, were switched to @Chemical$ (40 mg/d) and their platelet aggregation was measured again 7 days later.Their bleeding and @Disease$ were also recorded in following 3 months."	0
"Therefore, @Chemical$ are expected to become more important factor of peptic @Disease$ in the near future."	0
"To assess the effect of daily low-dose @Chemical$ therapy on perioperative @Disease$ of patients operated on for proximal femoral fracture, we did a prospective case-control study."	0
The authors present the case of a patient with acute coronary syndrome and @Chemical$ @Disease$ referred for urgent coronary angiography.	1
"This study was designed to investigate the degree of @Disease$, bleeding time (BT) and fluctuations in the serum levels of prostaglandin E2 (PGE2) and thromboxane A2 (TXA2) after oral administration of ASA (200 mg/kg) and @Chemical$ (50 mg/kg) either alone or in combination in rats in vivo."	0
"In iron depletion, less @Chemical$ may be available for carcinogenesis through free-radical mediated mechanisms and for promotion of @Disease$ growth."	0
"Our results indicate that apixaban, dabigatran, rivaroxaban, @Chemical$ and VKAs all reduced @Disease$ recurrence when compared to placebo."	0
"As patients with DM also derive greater @Disease$ benefit from drug-eluting stents, which requires prolonged @Chemical$, our findings suggest that the balance between benefit and risk of this therapeutic approach may be even more favorable in patients with DM than previously considered."	0
"Response to letter regarding article, Ischemic stroke and @Disease$ with aspirin, dabigatran, and @Chemical$: impact of quality of anticoagulation control."	0
"BACKGROUND: Aspirin-exacerbated @Disease$ is characterized by asthma, chronic rhinosinusitis, nasal polyposis, and sensitivity to @Chemical$ and other nonsteroidal anti-inflammatory drugs."	0
"@Chemical$ (acetylsalicylic acid)-induced asthma (AIA) consists of the clinical triad of asthma, @Disease$ with nasal polyps, and precipitation of asthma and rhinitis attacks in response to aspirin and other NSAIDs."	0
@Chemical$ plus indobufen in acute coronary syndrome patients with @Disease$ to aspirin undergoing percutaneous coronary intervention.	0
"Eight had a history of cutaneous sensitivity, 1 had rhinitis, 1 reported @Disease$ and rhinitis, while another patient showed a respiratory response in the form of an asthma attack after taking @Chemical$ in the past."	0
Aspirin-induced asthma (@Disease$) is associated with increased production of @Chemical$ (CysLT).	0
CONCLUSIONS: Desensitization may be safely performed in patients with reported @Chemical$ or NSAID @Disease$ and a cardiac indication for ASA.	0
"CONCLUSION: This study indicates that the causes of bleeding ulcers are changing, and the increasing use of low-dose @Chemical$ might become a major cause of @Disease$."	1
Risk of @Disease$ among users of @Chemical$ and other anti-inflammatory drugs.	0
Association of SLCO1B1 1b with peptic @Disease$ amongst Japanese patients taking low-dose @Chemical$.	0
CONCLUSIONS: Cross-reactive patients with NSAID-induced urticaria and @Disease$ exhibit an increased prevalence of sensitization to Dp and @Chemical$ and increased total serum IgE.	0
"The most common adverse events were abdominal pain (ten [20%] in the @Chemical$ group vs 13 [25%] in the placebo group), nausea or vomiting (nine [18%] vs seven [13%]), and @Disease$ (11 [22%] vs six [12%])."	0
"OBJECTIVE: Aspirin-exacerbated respiratory disease (AERD) represents a severe form of chronic rhinosinusitis (@Disease$) characterized by nasal polyposis, bronchial asthma, and @Chemical$ intolerance."	0
Population studies have associated @Chemical$ use with occult @Disease$ from the small or large bowel although the magnitude of this risk is difficult to estimate but certainly small.	0
"In saliva analysis among the three groups (AIA patients, @Chemical$-tolerant @Disease$ [ATA] patients, and healthy subjects), both the concentrations of CysLTs and LTB4 were significantly higher in AIA patients than in ATA patients and healthy subjects."	0
"The median intraoperative blood loss (600 ml versus 450 ml, P = 0.56), median postoperative blood loss (800 ml versus 790 ml, P = 0.60), blood transfusion requirements (25.1% versus 24.4%, P = 0.76) and composite outcome of in-hospital death, @Disease$ and reoperation for bleeding (2.8% versus 1.6%, P = 0.10) were similar in @Chemical$ and nonaspirin use group."	0
However those patients taking @Chemical$ pre-operatively had a significantly lower haemoglobin concentration and @Disease$ and were more likely to be anaemic at presentation than those who were not receiving aspirin.	0
"On the other hand, SA alone inhibited basal @Disease$ without any effect on mucosal PGE2 contents, and this agent, when given together with indomethacin, prevented gastric hypermotility and lesion formation in response to @Chemical$, without affecting the reduced PGE2 contents."	0
Clopidogrel plus indobufen in acute coronary syndrome patients with @Disease$ to @Chemical$ undergoing percutaneous coronary intervention.	1
"She had no symptom of urticaria and asthma, and had the both character of aspirin @Disease$ and asthma as to @Chemical$ challenge test."	0
@Chemical$-induced @Disease$ and the preventive effect of rebamipide.	1
The risk for developing a peptic @Disease$ during drug use was: 3.07 per 1000 person-years for acetylsalicylic acid and 4.31 for effervescent @Chemical$.	0
@Disease$: @Chemical$ Also Induces It.	1
"BACKGROUND: @Chemical$ triad disease (@Disease$) is a well-known clinical entity characterized by asthma, polyposis, and aspirin intolerance."	0
"Similar limited @Disease$ and protective actions were observed with a new class of hydrogen sulfide (H2S)-releasing NSAIDs, such as H2S-releasing naproxen (@Chemical$)."	0
"Further research is needed to assess the benefit-risk ratio of clopidogrel plus aspirin in specific subpopulations of patients at high risk for atherothrombotic events, and to determine the role of @Chemical$ plus aspirin in preventing cardioembolic @Disease$ or early recurrent stroke after symptomatic large-vessel atherostenosis."	0
"CONCLUSIONS: The patient's history and the intensity of eosinophilic inflammation are not similar in all nasal @Disease$ patients, that support the classification into PP, A and @Chemical$ groups."	0
Failure of montelukast to prevent @Chemical$-induced @Disease$.	1
Management of patients with nonaspirin-exacerbated respiratory disease @Chemical$ @Disease$ reactions.	1
"@Chemical$ @Disease$ is a hallmark of aspirin-exacerbated respiratory disease (AERD), a clinical syndrome characterized by the severe inflammation of the respiratory tract after ingestion of cyclooxygenase-1 inhibitors."	1
"Mucosal defects were found in 54 of 98 (60.7%) users of buffered @Chemical$ (BA), whereas 38 of 101 (37.6%) users of ECA had @Disease$."	0
"CONCLUSIONS: Our findings do not support that there is no difference in the risk of @Disease$ complications between enteric-coated @Chemical$ and buffered LDA, but rather may imply that the risk of GI complications associated with enteric-coated LDA is higher than that with buffered LDA."	0
AIM: To determine the preventive effect and safety of proton pump inhibitors (PPIs) in low-dose aspirin (@Chemical$)-associated gastrointestinal (GI) ulcers and @Disease$.	0
Effect of @Chemical$ and pravastatin on platelet inhibition by aspirin and clopidogrel treatment in patients with coronary stent @Disease$.	0
"The authors observed no associations between @Disease$ risk and duration of @Chemical$ use for current or past users (hazard rate ratio = 1.05, 95% confidence interval: 0.88, 1.25 and hazard rate ratio = 1.04, 95% confidence interval: 0.84, 1.27 for &gt; or =6 years of use, respectively) compared with nonusers."	0
CONCLUSIONS: @Chemical$ resistance is associated with increased clinical severity and stroke @Disease$ volume in acute stroke patients.	1
We examined five animal studies of NSAIDs (indomethacin and ibuprofen) and @Chemical$ in coxsackievirus B3- and B4-induced @Disease$.	0
"To prevent life-threatening reactions, patients with @Disease$ should avoid @Chemical$ and other analgesics that inhibit COX-1."	0
"The patients comprised three groups: LDA-interrupted group (13 patients with 13 @Disease$), @Chemical$-continued group (28 patients with 31 colorectal tumors), and no anticoagulant/antiplatelet group (541 patients with 565 colorectal tumors)."	0
METHODS: Arachidonic acid induced @Disease$(AA-Ag) was measured in 537 patients aged 80 or older treated with @Chemical$ (100 mg/d).	0
We have reported that @Disease$ is exacerbated by bile acids and that phosphatidylcholine (@Chemical$) can protect against this damage.	0
Use of the oral platelet inhibitors @Chemical$ and acetylsalicylic acid is associated with increased risk of @Disease$.	0
"@Chemical$-induced anaphylaxis was recorded in patients but may have been misdiagnosed, describing instead respiratory @Disease$ reactions."	0
@Chemical$ is associated with an increased risk of subdural @Disease$ in normal-pressure hydrocephalus patients following shunt implantation.	1
"RESULTS: Analysis of this patient group revealed that Patient 1 experienced nausea, emesis, anorexia, @Disease$ and significant clinical decline during treatment with @Chemical$."	0
"CONCLUSION: In addition to age, male gender, H. pylori infection, and concomitant use of NSAIDs, COX-2 inhibitors, steroids, and @Chemical$, underlying co-morbidities including diabetes, @Disease$, cirrhosis, history of PUD are also important risk factors for first-time occurrence of non-variceal UGIB in aspirin users."	0
"The other most common adverse event was @Disease$ (@Chemical$, n=2; placebo, n=4)."	0
The trend towards increased bleeding with warfarin appears to be explained by an excess of intracranial @Disease$ in @Chemical$ patients.	1
"The aim of the study was to assess the antiplatelet activity and safety of a combined antiplatelet treatment with indobufen and @Chemical$ in acute @Disease$ (ACS) patients with hypersensitivity to aspirin, undergoing coronary stenting."	0
"Allergic conditions include aspirin-exacerbated respiratory disease (@Disease$ or aspirin-induced asthma), @Chemical$-induced urticaria/angioedema (AIU), and anaphylaxis."	0
[New pathophysiological concepts on @Chemical$ hypersensitivity (@Disease$); diagnostic and therapeutic consequences].	0
"RESULTS: The allele frequencies of HLA-DRB1(*)1302 (18.1%) and HLA-DQB1(*)0609 (10.1%) in aspirin-induced urticaria were significantly higher than in @Chemical$-intolerant @Disease$ (5.3%, P=0.0004; 2.0%, P=0.0024) and in normal controls (8.1%, P=0.0005; 3.2%, P=0.0008), and they remained significant after correcting for multiple comparisons."	0
Logistic regression analysis showed that @Chemical$ intolerance was most closely associated with severe @Disease$ (beta = 5.79; P &lt; .001).	1
Microtrauma-induced recurrent @Disease$ and secondary  glaucoma associated with chronic @Chemical$ use.	0
CONCLUSION: This study indicates that 7.5 mg of @Chemical$ is a safe alternative treatment for ASA-@Disease$ asthma and/or NP patients with proven hypersensitivity via oral ASA challenges.	0
Meta-analysis of major @Disease$ events on @Chemical$ versus vitamin K antagonists in randomized trials.	0
"HYPOTHESES: The @Disease$ associated with prednisone and ultralow-dose aspirin administration will be similar to those caused by @Chemical$ alone, but both treatments will result in more severe lesions than placebo."	0
"Cotherapy with a PPI, misoprostol, or double dose H(2)RAs can reduce @Disease$ complications associated with high-dose @Chemical$ therapy."	0
"Wound @Disease$ occurred in 27 of 112 (24.1%) patients under combined aspirin and @Chemical$, 33 of 162 (20.4%) under clopidogrel, and 48 of 410 (11.7 %) under aspirin."	0
"However, there are a lack of data correlating @Chemical$ resistance and risk of @Disease$ events."	0
"@Chemical$, commonly known as aspirin, can induce some hypersensitive reactions with clinical symptoms such as urticaria, @Disease$, acute bronchospasm, and rarely anaphylactic shock."	1
AIM: To assess the risk of @Disease$ hospitalizations attributable to @Chemical$ in patients 50 years or older also using non-steroidal anti-inflammatory drugs.	0
"A meta-analysis study reported that data regarding the risk for @Disease$ of new direct oral anticoagulants (apixaban, dabigatran and @Chemical$) were inconclusive."	0
"In all patients, we measured the @Disease$, by multiplate electrode aggregometry, using two agonists [adenosine diphosphate with PGE1 (ADPHS) and arachidonic acid (@Chemical$)] two times: on the day of cessation of clopidogrel and 90 days after clopidogrel was stopped."	0
CONCLUSIONS: The continued use of @Chemical$ during AMI and @Disease$ was variable.	0
BACKGROUND/AIMS: Low-dose @Chemical$ is widely used for the prevention of cardiovascular and @Disease$.	0
"Of these, 38 (54.3%) had a history of @Chemical$-induced urticaria and/or angioedema, including three @Disease$ (7.9%)."	0
"Notwithstanding the consistent benefits demonstrated with @Chemical$ for both acute and chronic @Disease$, there are a number of toxicities associated with aspirin that have been showcased by recent long-term clinical trials that have included an aspirin monotherapy arm."	0
Aspirin has been the cornerstone of therapy for the secondary prevention treatment of patients with cardiovascular disease since landmark trials were completed in the late 1970s and early 1980s that demonstrated the efficacy of @Chemical$ for reducing the risk of @Disease$ events.	0
"Furthermore, Spearman's correlation coefficients suggest that VEGF expression levels and the extent of cell apoptosis in gastric mucosae shared a significant correlation with the severity of @Chemical$-induced @Disease$."	1
"For the TKA cohort specifically, (3) was the frequency of systemic @Disease$ events and complications related to chemical prophylaxis higher with @Chemical$ compared with mechanical compression plus ASA?"	0
"METHOD: We classified 1,041 gastroduodenal @Disease$ patients into three groups [patients taking @Chemical$ (group A), patients taking nonaspirin nonsteroidal anti-inflammatory drug (NSAID) (group N), and patients taking neither aspirin nor nonaspirin NSAID (group C)] and 241 bleeding gastroduodenal ulcer patients into three corresponding groups (groups a, n, and c)."	0
METHODS: Polyps were obtained from 11 @Chemical$-sensitive and 19 aspirin-tolerant patients with @Disease$.	0
CONCLUSION AND SIGNIFICANCE: @Disease$ water should be recommended douching solution in the early postoperative care of patients with @Chemical$-induced CRS.	0
"METHODS: We searched MEDLINE, EMBASE and the Cochrane Controlled Trials Register from inception to December 2013, and checked conference abstracts of randomized controlled trials (RCTs) on the effect of PPIs in reducing adverse GI events (@Disease$, ulcer, perforation, or obstruction) in patients taking @Chemical$."	0
"The strongest evidence was from a randomized controlled trial (RCT) specifically looking at elective abdominal surgery, which showed no statistically significant difference between @Chemical$ continuation and discontinuation in terms of @Disease$ or thrombotic events."	0
"Aspirin exacerbated @Disease$ is characterized by recalcitrant sinusitis/polyposis, asthma and precipitation of asthma after ingestion of @Chemical$ and most NSAIDs."	0
"@Disease$ risk associated with use of nonsteroidal anti-inflammatory drugs, @Chemical$, and acetaminophen and the effects of rheumatoid arthritis and osteoarthritis."	1
This meta-analysis found no statistically significant difference regarding the risk of operative mortality and @Disease$ between the 'continuing @Chemical$' and 'stopping ASA' strategies.	0
"AIM: To conduct a case-control analysis of new cases of @Disease$, with particular reference to the usage of NSAIDs and @Chemical$ prior to the development of the disease."	0
BACKGROUND: @Chemical$ has detrimental effects on the @Disease$ and may play a role in the aetiology of inflammatory bowel disease.	1
"Severe space-occupying @Disease$ needing operative re-exploration occurred in four (3.6%) patients under aspirin and clopidogrel, seven (4.3%) under @Chemical$, and five (1.2%) under aspirin."	0
"[Prostaglandin E2: metabolism, determination in body fluids and the role in @Chemical$ @Disease$."	1
"CONCLUSIONS: Although in patients undergoing pacemaker implantation dual antiplatelet therapy with aspirin and clopidogrel caused a significant increase of bleeding complications, the use of @Chemical$ alone was not associated with a significant increase in @Disease$ complications."	0
"METHODS: Ninety-four aspirin-induced urticaria patients presenting urticaria/@Disease$-induced by both @Chemical$ and NSAID (50 had underlying chronic urticaria) and showing positive responses on oral aspirin challenge test, 76 aspirin-intolerant asthmatics with positive responses on lysine-aspirin bronchoprovocation test, and 185 normal healthy controls were enrolled."	1
"We conclude that combined therapy with @Chemical$ and clopidogrel does not necessarily protect against clinical @Disease$, at least in patients with HIT antibodies that have strong platelet-activating characteristics."	0
BACKGROUND: The etiology of @Chemical$-exacerbated @Disease$ (AERD) has been attributed to the combination of environmental and genetic risk factors.	1
[Warm-needle moxibustion therapy may reduce @Chemical$-induced @Disease$ in rats].	1
Moderate @Disease$ was seen in 3 of 285 patients (1.1%) in the @Chemical$ group and in 13 of 932 patients (1.4%) in the control group (not significant).	0
"RESULTS: Four hundred eighty-nine (4.5%) of the 10,905 @Disease$ patients had used low-dose @Chemical$ during the 56-day case only period; 294 (2.7%) of the same patients had used low-dose aspirin during control only period."	0
"Based on the results of the MATCH trial, combination therapy with @Chemical$ plus clopidogrel is not recommended for patients with ischaemic @Disease$ or TIA due to the increased risk of haemorrhage."	0
"Thirteen dogs were assigned into @Chemical$, lyophilized aspirin/trehalose, and control groups, and the @Disease$ were assessed on gastroscopy with the modified Lanza scale."	0
"In the intensively treated patients of the Hypertension Optimal Treatment (HOT) Study, randomization to low-dose @Chemical$ (75 mg daily) versus placebo significantly reduced cardiovascular events (-15%) and @Disease$ (-36%), but increased major bleedings (+65%)."	0
"Despite more than a half-century of recognition, the triad characterised by severe @Disease$, nasal polyposis and @Chemical$ intolerance known as aspirin-induced asthma or Widal's triad remains markedly underdiagnosed and mistreated."	0
"@Chemical$ versus acetylsalicylic acid yielded HRs of 0.69 (95% CI: 0.59-0.81) and 0.72 (95% CI: 0.55-0.96) for stroke and @Disease$, respectively."	0
"Aspirin-exacerbated respiratory disease (AERD) refers to the combination of @Disease$, chronic rhinosinusitis with nasal polyposis, and acute upper and lower respiratory tract reactions to the ingestion of @Chemical$ (acetylsalicylic acid, ASA) and other cyclooxygenase-1 inhibiting non-steroidal anti-inflammatory drugs."	0
@Chemical$ and non-steroidal anti-inflammatory drug use and the risk of upper aerodigestive tract @Disease$.	0
METHODS: Patients with aspirin-related nonbleeding symptomatic @Disease$s were randomised to receive rabeprazole (20 mg/day) plus @Chemical$ (100 mg/day) or rabeprazole (20 mg/day) plus clopidogrel (75 mg/day) for 12 weeks.	0
"BACKGROUND: The incidence of @Disease$, which originates from the small bowel and is mainly associated with the use of @Chemical$ and non-steroidal anti-inflammatory drugs (NSAIDs), is rising."	1
"Also, we establish @Chemical$-induced @Disease$ model by the oral administration of aspirin (0.5 g/kg body weight) to verify the predicted targets from network pharmacology."	1
&lt;em&gt;Helicobacter pylori&lt;/em&gt; infection and the risk of @Disease$ in low dose @Chemical$ users: systematic review and meta-analysis.	0
"We compared 1- and 3-year outcomes for @Disease$ (CVA), transient ischemic attack (TIA), gastrointestinal (GI) bleeding, genitourinary (GU) bleeding, any bleeding, and AF recurrence among patients receiving: none, @Chemical$, or warfarin as long-term therapies."	0
Use of @Chemical$ combinations with caffeine and increasing @Disease$ frequency: a prospective population-based study.	1
OBJECTIVE: We examined the association of a TGFbeta1 genetic polymorphism with @Chemical$-intolerant chronic urticaria (AICU) and aspirin-tolerant chronic @Disease$ (ATCU) in a Korean population.	0
"BACKGROUND: Although there is increasing evidence of the importance of cysteinyl leukotrienes (LT) as mediators of aspirin-induced bronchoconstriction in @Chemical$-sensitive @Disease$, the cellular origin of the LT is not yet clear."	0
Increased risk of @Chemical$-induced @Disease$ in elderly Chinese men harboring SLCO1B1*1b/*1b while using aspirin and an ACEI or ARB concomitantly.	1
No @Disease$ or other possible cause for SSEH was found other than the aspirin and @Chemical$ medication.	0
"CONCLUSIONS: Compared with previous reports, a substantial proportion of these @Disease$ patients have been counseled about and use @Chemical$."	0
"In 2-23% of adults with @Disease$, and rarely in children with asthma, aspirin (@Chemical$) and non-steroidal anti-inflammatory drugs (NSAIDs) cause asthma exacerbations."	0
"Available evidence suggests that where aspirin and/or @Chemical$ are to be started or continued in patients with a recent history of UGI ulceration or @Disease$ (after ulcer healing and eradication of H. pylori infection), treatment with a PPI is a useful precaution."	0
"We collected data on the use of warfarin at implantation, INR prior to device implantation, use of dual-antiplatelet therapy (DAPT), such as concomitant @Chemical$ and clopidogrel and subsequent formation of @Disease$ in the peri-procedure period."	0
AIM: To evaluate in symptomatic elderly chronic users of low-dose aspirin: (1) the association between H. pylori infection and the prevalence of upper gastrointestinal lesions; and (2) the effect of H. pylori @Disease$ on the efficacy of proton pump inhibitors in the prevention of @Chemical$-related gastroduodenal lesions.	0
A recent study by Chan et al. concluded that a combination of aspirin and @Chemical$ is superior to clopidogrel in the prevention of recurrent gastrointestinal @Disease$.	0
We compared the levels of neutrophil activation and related cytokines in patients with ASA-intolerant acute @Disease$ (AIAU) and @Chemical$-intolerant chronic urticaria (AICU).	0
ZnPP reversed protective and @Disease$ effect of NaHS but @Chemical$ failed to affect CORM-2-induced gastroprotection.	0
"Risk factor profiles, drug usage, and prevalence of @Chemical$-associated @Disease$ among high-risk cardiovascular Japanese patients: the results from the MAGIC study."	1
"All of the 15 @Chemical$-@Disease$ patients (aged between 6.6 and 17.4 years), except for three, experienced an unequivocal angioedema of the lips as a positive reaction in SBPCPT."	0
CONCLUSION: Recognition of the association between Samter's syndrome and @Disease$ is important (26% of the cases) because it could also be responsive to systemic @Chemical$ which prevent progression to irreversible hearing loss or infectious otomastoiditis.	0
BACKGROUND: Patients with @Chemical$ sensitivity experience hyperplastic @Disease$ and nasal polyposis.	0
[Pathogenesis of @Chemical$-induced @Disease$].	1
Efficacy of hypertonic (2.3%) sea @Chemical$ in patients with aspirin-induced @Disease$ following endoscopic sinus surgery.	0
"Furthermore, we need to search for effective measures to detect and prevent mid and lower gastrointestinal injury caused by @Chemical$/NSAIDs which account for about 30% of all GI @Disease$s."	0
"BACKGROUND &amp; AIMS: With capsule endoscopy, the ulcerogenic effect of low-dose enteric-coated aspirin on the small @Disease$ and the therapeutic effect of @Chemical$ on intestinal injury were evaluated."	0
"CONCLUSION: In patients prescribed low-dose @Chemical$ for the secondary prevention of cardiovascular or cerebrovascular events, discontinuation of low-dose ASA was associated with a 40% increase in the risk of IS/@Disease$ compared with continuation of therapy."	0
"FINDINGS: The incidence of GI @Disease$ with low-dose aspirin was 0.48-3.64 cases per 1000 person-years, and the overall pooled estimate of the RR with low-dose @Chemical$ was 1.4 (95% confidence interval [CI]: 1.2-1.7)."	0
"A total of 221 biopsy specimens from 74 patients, including atrophic @Disease$ (AG) cases without aspirin use (control), AG cases with @Chemical$ use (AG group), and GC cases with aspirin use (GC group), were analyzed."	0
Diclofenac treatment was discontinued and occasional use of @Chemical$ for the @Disease$ was recommended.	0
Safety of @Chemical$ in patients with aspirin/non-steroidal anti-inflammatory drug-induced @Disease$ and angioedema.	0
Efficacy and safety of adjusted-dose @Chemical$ compared with clopidogrel in Japanese patients with @Disease$: the PRASFIT-ACS study.	0
@Chemical$ desensitization achieved after omalizumab treatment in a patient with aspirin-exacerbated @Disease$ and respiratory disease.	0
"BACKGROUND AND RATIONALE: Dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 inhibitor reduces @Disease$ events in patients undergoing percutaneous coronary intervention (PCI), but these benefits come at the expense of increased risk of bleeding when compared with @Chemical$ monotherapy."	0
Primary non-variceal @Disease$ in NSAID and low-dose @Chemical$ users: development and validation of risk scores for either medication in two large Dutch cohorts.	0
"AIM: The goal of the present study was to investigate whether a mucosal-protective agent, @Chemical$, could prevent @Disease$ induced by LDA with or without clopidogrel in healthy subjects."	0
This case-crossover study examined the transient effect of low-dose @Chemical$ use on major @Disease$ risks.	0
CONCLUSION: The prevalence of @Disease$ was very high in asymptomatic @Chemical$ users.	0
"We undertook a prospective, endoscopic study to evaluate gastro-duodenal @Disease$ produced by low-dose @Chemical$."	0
PPIs were superior to H2RA in prevention of @Chemical$-associated GI @Disease$s (OR = 0.12; 95%CI: 0.02-0.65) and bleeding (OR = 0.32; 95%CI: 0.13-0.79).	0
"Ischemic @Disease$ and intracranial hemorrhage with @Chemical$, dabigatran, and warfarin: impact of quality of anticoagulation control."	1
"@Chemical$ sensitivity can cause acute urticaria in some individuals, aggravate pre-existing chronic @Disease$ in others or, rarely, act as a cofactor with food or exercise to provoke anaphylaxis."	1
"RESULTS: @Disease$ was 221 ml in the @Chemical$ group and 140.16 ml in the control group, showing no statistical difference (p = 0.08)."	0
"Although it is still controversial whether leukotriene modifiers are more effective in patients with AIA compared with other types of @Disease$, because LT plays an important role in the pathogenesis of AIA, @Chemical$ modifiers are the preferred medication for the long-term control of AIA."	0
"DISCUSSION: Patients with aspirin-provoked FDEIA have been reported previously as taking ordinary doses of @Chemical$ for reducing pain, inflammation and @Disease$."	0
"DATA SOURCES: Literature retrieval was accessed through MEDLINE (1966-March 2007) using the terms acetaminophen, aspirin, antiinflammatory agents nonsteroidal, urticaria, angioedema, @Disease$, leukotriene antagonists, desensitization, and @Chemical$."	0
"Some studies have demonstrated that consumption of fish oil concentrate, @Chemical$ (n-3 PUFA), results in cardiovascular benefits that include reductions in mortality, sudden death, nonfatal myocardial infarction, and @Disease$, as well as improvement in graft patency."	0
"Evidence shows that concurrent use of a non-selective NSAID (such as naproxen) plus a PPI is as effective in preventing NSAID @Disease$ as @Chemical$, and may be more cost-effective."	0
"Conclusions and Relevance: A 15-mg to 20-mg dose of @Chemical$ once daily is associated with substantially increased risks of @Disease$, while smaller daily doses of rivaroxaban and apixaban were not, implying that risk increase is dose dependent."	0
The authors measured the presence and extent of asymptomatic microbleeds on gradient-recalled-echo MRI in 21 aspirin users who developed intracerebral hemorrhage and 21 @Chemical$ users without history of @Disease$.	0
Clinical impact of drug-drug interaction between @Chemical$ and prednisolone at a @Disease$ center.	0
"BACKGROUND: Aspirin-exacerbated @Disease$ (AERD) is a distinct eosinophilic phenotype of severe asthma with accompanying chronic rhinosinusitis, nasal polyposis, and hypersensitivity to @Chemical$."	0
We conclude that melatonin and its precursor @Chemical$ given orally significantly reduce @Disease$ induced by ASA possibly due to (a) direct gastroprotective action of exogenous melatonin or that generated from tryptophan and (b) gastrin released from the gastric mucosa by melatonin or tryptophan.	0
"The aim of this study is to report the sinonasal outcomes of endoscopic sinus surgery (ESS) in treating NP in asthmatic patients, comparing @Chemical$-induced asthmatic (@Disease$) patients with aspirin-tolerant asthmatics (ATA)."	0
The prevalence of @Disease$ and the risk factor profile including gastroprotective drug therapy needs to be clarified in Japanese patients taking daily @Chemical$ for cardioprotection.	0
"Low dose @Chemical$, &lt;em&gt;H. pylori&lt;/em&gt; @Disease$, and the risk of upper gastrointestinal bleeding."	0
There was also a significantly greater mean % PNIF response over 120 min after @Chemical$-aspirin challenge for PL (26+/-7) compared to either ML 10 mg (14+/-6) or @Disease$ 40 mg (17+/-6).	0
"Further research with a larger sample size and more outcome events are required to make definitive conclusions regarding the association between @Chemical$ use and complications, including hematoma and recurrent @Disease$."	0
It is unclear whether subclinical airway responses to @Chemical$ occur in subjects with nasal @Disease$ and/or asthma without overt sensitivity.	0
Safety of meloxicam in @Chemical$-hypersensitive patients with asthma and/or nasal @Disease$.	0
"The acute clinical symptoms that develop following the oral ingestion of aspirin, or any other inhibitor of cyclooxygenase-1, are well established in @Chemical$-exacerbated @Disease$: nasal congestion, rhinorrhea, and bronchospasm."	0
"CONCLUSIONS: Our findings do not support that there is no difference in the risk of GI complications between enteric-coated LDA and buffered LDA, but rather may imply that the risk of @Disease$ complications associated with enteric-coated LDA is higher than that with buffered @Chemical$."	0
Effect of genetic polymorphism of ALOX15 on @Chemical$-exacerbated @Disease$.	0
Aspirin (@Chemical$) is an important cause of asthma so that ASA induced @Disease$ (AIA) is considered a disease.	0
"We used sensitivity analyses to identify the incremental benefit of longer-duration @Chemical$ on either ST or the composite of cardiac death, @Disease$, and ischemic stroke (major adverse cardiovascular and cerebrovascular events [MACCEs]) required to outweigh the increased risk of bleeding associated with longer DAPT."	0
Patients with @Disease$ (GI) risk factors who require non-steroidal antiinflammatory drugs (NSAIDs) or @Chemical$ must receive gastropreventive therapies.	0
The authors measured the presence and extent of asymptomatic microbleeds on gradient-recalled-echo MRI in 21 @Chemical$ users who developed intracerebral hemorrhage and 21 aspirin users without history of @Disease$.	0
"OBJECTIVE: We sought to examine whether NLRP3 polymorphisms are associated with susceptibility to food allergy, food-induced @Disease$, and @Chemical$-induced asthma (AIA)."	0
"Reasons for not taking @Chemical$ included gastrointestinal intolerance (53.5%), @Disease$ (39.4%), non-gastrointestinal bleeding (5.5%) and others (1.6%)."	0
"METHODS: Therefore, nasal polypous tissue specimens of patients suffering from chronic nasal polypous sinusitis (NP), intrinsic asthma (ATA), aspirin-intolerance (AINA), and @Chemical$-triad (@Disease$) were investigated."	0
"METHODS: 300 consecutive @Disease$ patients were treated with recombinant tissue-type plasminogen activator (rt-PA) in a prospective open study (92 pretreated with @Chemical$, 202 ASA nonusers) with 3 months of follow-up."	0
"Women were classified as regular or non-regular users of @Chemical$, COX-2 inhibitors, ibuprofen and other NSAIDs, and acetaminophen (control) based on self-report at follow-up of ever using the medication for at least twice a week for &gt;=1 month prior to @Disease$ diagnosis."	0
"Further research is needed to assess the benefit-risk ratio of @Chemical$ plus aspirin in specific subpopulations of patients at high risk for atherothrombotic events, and to determine the role of clopidogrel plus aspirin in preventing cardioembolic @Disease$ or early recurrent stroke after symptomatic large-vessel atherostenosis."	0
"Results: Multiple new biologics are available for the treatment of severe @Disease$, several of which have been specifically studied and determined to be efficacious in the subset of patients with asthma who are also @Chemical$ sensitive."	0
We present the case of a patient taking @Chemical$ and etoricoxib who was admitted with upper digestive haemorrhage due to duodenal @Disease$.	0
@Chemical$ mediate various physiological aspects of mucosal defense and the suppression of prostaglandin synthesis in the stomach is a critical event in terms of the development of @Disease$ after NSAID administration.	0
@Chemical$-exacerbated respiratory disease (AERD) is a @Disease$             characterized by acute bronchial responses upon the administration of non-steroidal             anti-inflammatory drugs (NSAIDs) and the immune response by mast cells is regarded             as one of the noteworthy causes of AERD pathogenesis.	0
@Disease$ to @Chemical$ and urgent percutaneous coronary intervention: A therapeutic challenge.	1
"Twelve cases of @Disease$ are presented with different degrees of encephalopathy, hyperammonemia and hypoglycemia; associated to acetyl salicylic acid (@Chemical$) ingestion."	0
We have reported that @Disease$ is exacerbated by @Chemical$ and that phosphatidylcholine (PC) can protect against this damage.	0
"However, widespread under-prescribing of PPIs and potential noncompliance with their use means that substantial numbers of patients are at unnecessary risk of @Disease$ and-if @Chemical$ therapy is discontinued-CVD events."	0
"BACKGROUND: Aspirin-exacerbated respiratory disease (AERD) is a clinical syndrome characterized by chronic rhinitis, nasal polyps, asthma, and precipitation of @Disease$ and rhinitis attacks after ingestion of aspirin (@Chemical$) and most nonsteroidal anti-inflammatory drugs (NSAIDs)."	1
"METHODS: Using gas chromatography/mass spectrometry, we determined plasma and urinary concentrations of @Chemical$,11beta-PGF(2) at baseline in 131 stable @Disease$tic patients, 65 of whom had AIA and 66 of whom had ATA."	0
Platelet studies showed an @Chemical$-like defect resulting in a lack of arachidonate-induced @Disease$.	0
"METHODS: Fibroblasts were isolated from the NM of subjects without asthma who had septal deviation, turbinate @Disease$, or both (control subjects, n = 7); NPs of @Chemical$-tolerant nonasthmatic patients (n = 7); and NPs of patients with asthma who were intolerant of aspirin (n = 7)."	0
@Disease$: the case for a causal link with @Chemical$.	0
"METHODS: Subjects 18 years or older with osteoarthritis, without gastroduodenal @Disease$ or erosive esophagitis at baseline endoscopy, and a cardiovascular indication for prophylaxis low-dose (81 or 325 mg) aspirin were prescribed open-label aspirin and blindly randomized to celecoxib 200 mg/day or @Chemical$ 500 mg twice daily plus lansoprazole 30 mg once daily."	0
The aim of this study was to investigate prospectively the association between the regular use of @Chemical$ and non-aspirin analgesics and the incidence of @Disease$.	0
"Of these 52 cases, there were 22 nasal polyposis cases with aspirin sensitivity, 15 nasal polyposis cases without @Chemical$ sensitivity and 15 chronic @Disease$ cases without aspirin sensitivity."	0
RESULTS: A total of 144 patients who had @Disease$ on initial CT scan (@Chemical$ group: 72; No-ASA group: 72) were enrolled.	0
COX-1 has traditionally been regarded as a constitutively expressed enzyme that generates @Chemical$ for @Disease$ integrity.	0
"RESULTS: The prevalence of @Chemical$ induced @Disease$ was highest when determined by oral provocation testing (adults 21%, 95% confidence interval 14% to 29%; children 5%, 0% to 14%) than by verbal history (adults 3%, 2% to 4%; children 2%, 1% to 3%)."	1
"Diagnosis, prevention and treatment of @Chemical$-induced asthma and @Disease$."	1
"A 78-year-old woman visited a local clinic because of @Disease$, and was prescribed @Chemical$, carbocisteine, and cold medicine (salicylamide, acetaminophen, anhydrous caffeine, promethazine methylene disalicylate)."	0
RATIONALE: @Chemical$-induced asthma (AIA) is a distinct clinical syndrome that affects up to 10% of adults with @Disease$.	0
Desmopressin for the treatment of @Chemical$-induced @Disease$.	1
The rates of both stroke and bleeding increased with higher CHADS2 scores but apixaban compared with @Chemical$ was associated with a similar relative risk of bleeding (P interaction 0.21) and a reduced relative risk of @Disease$ (P interaction 0.37) irrespective of CHADS2 category.	0
The study confirms @Chemical$ desensitization is effective clinically in @Disease$ patients and suggests that IFN gamma and IL-10 expression in CD4(+) T lymphocytes may be related to the mechanism of action.	0
CONCLUSION: @Chemical$ and NSAIDs do not increase the risk of post-sphincterotomy @Disease$ and they can be safely used before the procedure.	0
"Fifty one percent of patients had extracapsular hip fractures, and these patients were comparable in terms of demographic characteristics, including @Chemical$ use, to the group with intracapsular @Disease$s."	0
"Treatment with KM dissociated @Chemical$-induced @Disease$ and revealed platelet counts with highest accuracy (no KM treatment, 1.3 x 10(4)/muL; KM treatment, 15.2 x 10(4)/muL)."	1
It has been noticed that the incidence of @Chemical$-induced @Disease$ has increased more than that of non-aspirin non-steroidal anti-inflammatory drug (NSAID)-induced lesions.	1
"BACKGROUND: Although the mechanism that underlies aspirin @Disease$ is not completely understood, an IgE-mediated response was reported for a patient with @Chemical$-intolerant chronic urticaria (AICU)."	0
Difficult endoscopic @Disease$--look beyond @Chemical$ and NSAIDs.	0
CONCLUSIONS: There was a clear impact of @Chemical$ treatment on CMBs associated with @Disease$ in Chinese patients.	1
BACKGROUND: @Chemical$ and other nonsteroidal anti-inflammatory drugs (NSAIDs) can precipitate adverse reactions in two apparently different clinical conditions: bronchial @Disease$ and chronic idiopathic urticaria (CIU).	0
"The aim of this blinded, randomised, multicentre study was to compare the tolerability of aspirin, paracetamol and @Chemical$ in common @Disease$ resulting from musculoskeletal conditions (MSC) in general practice with patients with other non-MSC pain conditions."	0
"In contrast, @Disease$ was seen in 50% of rats with a combination of ASA given before @Chemical$ only after 6 days of oral administration."	0
"Thus, the lack of evidence of benefit with @Chemical$ in patients with heart failure and coronary disease, along with growing evidence that aspirin is directly harmful in patients with @Disease$ and that aspirin may negate the benefits of angiotensin-converting enzyme inhibitors suggest that, unless there is an opportunity to randomize the patient into a study of antithrombotic strategies, then aspirin should be withdrawn or possibly substituted with an anticoagulant or an antiplatelet agent that does not block cyclooxygenase."	0
"CONCLUSIONS: The regular use of @Chemical$ and non-aspirin analgesics were both associated with an increased risk of developing @Disease$, independently of other risk factors."	1
"Aspirin (acetylsalicylic acid)-induced asthma (AIA) consists of the clinical triad of @Disease$, chronic rhinosinusitis with nasal polyps, and precipitation of asthma and rhinitis attacks in response to @Chemical$ and other NSAIDs."	0
Impact of @Disease$ in patients on low-dose @Chemical$ therapy: preliminary study.	0
"Events occurring after PCI-definite or probable stent @Disease$ (@Chemical$), myocardial infarction (MI) not related to ST, and clinically relevant bleeding (CB)-were classified as early (&lt;=30 days), late (31 to 365 days), or very late (&gt;365 days)."	0
"However, patients with low-risk @Disease$ and those who received coronary intervention were more likely to have @Chemical$ continued during PUD bleeding."	0
"Hence, surgeons should pay careful attention to postoperative @Disease$ and complications related to hemorrhage in patients who have been taking low-dose @Chemical$."	0
"Aspirin-exacerbated @Disease$ (AERD) is associated with severe asthma and @Chemical$ can cause asthma to worsen, often in the form of a severe and sudden attack."	0
"In the desensitized @Disease$ group, cytokine and lipoxin measurements were repeated after 1-month @Chemical$ treatment."	0
"The incidence of the disease has been decreased by prohibition of administration of @Chemical$ for children with high fever, especially caused by @Disease$ in western countries, also in Japan."	0
"AREAS COVERED IN THIS REVIEW: A number of risk factors can be used to determine which patients are more likely to develop aspirin-associated GI bleeding, mainly in the upper GI tract; these include a previous GI ulcer, @Disease$, dyspepsia, and concomitant drug therapy with non-steroidal anti-inflammatory drugs (NSAIDs) or @Chemical$."	0
Randomized controlled trials comparing PPIs and H2RAs for prevention of @Disease$ associated with low-dose aspirin (@Chemical$) were collected.	1
"@Chemical$-exacerbated respiratory disease (AERD) is defined as asthma, chronic rhinosinusitis with @Disease$, and hypersensitivity to cyclooxygenase-1 inhibitors."	0
"DISCUSSION: Patients with aspirin-provoked FDEIA have been reported previously as taking ordinary doses of @Chemical$ for reducing pain, @Disease$ and fever."	0
"Data Sources: We searched PubMed, Embase, CENTRAL, and ClinicalTrials.gov from inception to May 28, 2018, with the terms novel oral anticoagulants, non-vitamin K antagonist oral anticoagulants, direct oral anticoagulants, dabigatran, rivaroxaban, apixaban, edoxaban, warfarin, Coumadin, vitamin K antagonist, @Chemical$, acetylsalicylic acid, or ASA, and major bleeding, fatal bleeding, or @Disease$."	0
"Furthermore, it has been demonstrated that chronic use of low dose @Chemical$ results in a variety of lesions in the lower GI tract, including multiple petechiae, erosions, ulcers, diverticular bleeding and even circumferential @Disease$ with stricture."	1
@Chemical$ is well tolerated and effective in treating mild to moderate @Disease$ but there is growing concern about a possible risk of gastrointestinal toxicity and a possible link with asthma in children.	0
Does concomitant use of paracetamol potentiate the @Disease$ associated with @Chemical$?	1
"The authors prospectively examined the relation between frequency of aspirin, @Chemical$, and acetaminophen use and risk of @Disease$ among 62,261 women aged 31-48 years at baseline (1995) in Nurses' Health Study II."	0
BACKGROUND: We investigated the effect of individualised proton pump inhibitors (PPI) prescription on @Disease$ events in a cohort of patients who received combination antiplatelet therapy (@Chemical$ and clopidogrel) after percutaneous coronary intervention (PCI).	0
OBJECTIVE: We sought to evaluate whether titrated initiation of @Chemical$-dipyridamole in patients with stroke/transient ischemic attack (TIA) improves tolerance and to assess the appearance of headache in those with pre-existing history of @Disease$s.	0
"CASE REPORT: A 58-year-old Caucasian male with a history of coronary heart disease and hypercholesterolemia, under treatment with acetyl-salicylate for 6 years and @Chemical$ for 2 months, presented to the Emergency Department of our hospital with epigastric pain and @Disease$ of 24-hour duration."	0
The effect of @Chemical$ in primary cardiovascular (CV) prevention in people with @Disease$ is still a matter of debate.	0
"CONCLUSION: ASA pretreatment does not increase the risk of symptomatic @Disease$ after systemic thrombolysis with @Chemical$, even if thrombolysis is followed by anticoagulation."	0
BACKGROUND: This study evaluated the risk of @Disease$ (UGIB) associated with use of low-dose @Chemical$ (ASA) alone and in combination with other gastrotoxic medications.	1
"OBJECTIVE: Aspirin-exacerbated respiratory disease (AERD) represents a severe form of chronic rhinosinusitis (CRS) characterized by nasal polyposis, @Disease$, and @Chemical$ intolerance."	0
"RESULTS: In the placebo arm, oral @Chemical$ significantly decreased FEV 1 concomitant with significant increases in sputum @Disease$ protein and urinary leukotriene E(4) levels."	0
"Because low-dose @Chemical$ exerts a cardioprotective effect by irreversible inhibition of COX-1, @Disease$ patients who are at risk for coronary artery disease should be considered for aspirin desensitization."	0
Aspirin-angiotensin-converting enzyme inhibitor coadministration and mortality in patients with @Disease$: a dose-related adverse effect of @Chemical$.	0
"BACKGROUND: Aspirin-exacerbated respiratory disease (AERD) is a distinct eosinophilic phenotype of severe asthma with accompanying chronic @Disease$, nasal polyposis, and hypersensitivity to @Chemical$."	0
OBJECTIVES: Helicobacter pylori (H. pylori) infection and NSAID/low-dose @Chemical$ (ASA) use are associated with @Disease$.	1
"Aspirin prescription was associated with a nonsignificant risk reduction of @Disease$ of @Chemical$ (adjusted OR=0.9, 95% CI=0.8, 1.0), head and neck (HN; adjusted OR=0.9, 95% CI=0.7, 1.1) or the oesophagus (adjusted OR=0.8, 95% CI=0.7, 1.0)."	1
"@Chemical$, an anti-inflammatory agent, may play a role in attenuating the inflammatory response during @Disease$."	0
BACKGROUND: The use of low-dose aspirin (@Chemical$) has emerged as an important cause of @Disease$.	1
The risk of readmission resulting from bleeding and @Disease$ (VTE) has also not been determined for patients undergoing THA or TKA when treated with low-molecular-weight heparin (LMWH) alone compared with mechanical prophylaxis plus aspirin (@Chemical$).	0
"Eight had a history of cutaneous sensitivity, 1 had rhinitis, 1 reported urticaria and rhinitis, while another patient showed a respiratory response in the form of an @Disease$ attack after taking @Chemical$ in the past."	0
"To evaluate the extent of gastric mucosal injury and the protective effect of drugs, @Disease$ index, gastric mucosal blood flow, content of gastric mucosal hexosamine, prostaglandins (PG), @Chemical$(NO), tumor necrosis factor (TNF), and interleukin (IL) -1, 2, 8 were measured in each group, and histological changes were observed by gross as well as under microscope and electron microscope."	0
Some patients with imperative cardiologic indications for combination therapy with aspirin and clopidogrel (stent placement and/or acute coronary syndrome) have a history of @Disease$ to @Chemical$.	1
Safety of meloxicam in patients with @Chemical$/non-steroidal anti-inflammatory drug-induced urticaria and @Disease$.	0
"BACKGROUND: The combination of aspirin, clopidogrel, and @Chemical$ (combination therapy) is the standard treatment for acute coronary syndrome but is associated with @Disease$."	0
Safety of low-dose @Chemical$ in endovascular treatment for @Disease$.	0
Spontaneous @Disease$ of the knee associated with clopidogrel and @Chemical$ treatment.	0
Low-dose @Chemical$ or other nonsteroidal anti-inflammatory drug use and @Disease$ risk: a nationwide study.	0
RESULTS: Fifteen trials reporting the outcome of 2511 participants treated with VKA alone and 2471 treated with @Chemical$ alone were included; most common conditions evaluated were non-valvular atrial fibrillation (five trials) and @Disease$ (three trials).	0
"Aspirin was associated with increased @Disease$ risks when combined with non-steroidal anti-inflammatory drugs, @Chemical$ and selective serotonin reuptake inhibitors compared with monotherapy."	0
Hypersensitivity to @Chemical$: common eicosanoid alterations in @Disease$ and asthma.	0
"Adverse events considered possibly or probably related to treatment occurred in 5 (20.0%) @Chemical$ recipients (4 episodes of diarrhea, 1 episode of abdominal pain), 1 (14.3%) recipient of lansoprazole 30 mg (1 episode of pharyngitis), and 3 (13.6%) placebo recipients (1 episode each of abdominal pain, palpitations, and @Disease$)."	0
"We aimed to evaluate the association between several widely used analgesics, including aspirin, non-@Chemical$ NSAIDs, and acetaminophen (paracetamol), and risk of @Disease$ and psoriatic arthritis (PsA) in a large cohort of US women, the Nurses' Health Study II (1991-2005)."	0
Perioperative treatment with @Chemical$ or clonidine and risk of @Disease$.	0
Clinical course and urinary @Chemical$ in patients with aspirin-induced @Disease$ followed up for 4 years.	0
"METHODS: The effect of @Chemical$ or platelet agonists on LTC4 synthase activity was investigated in platelets obtained from healthy volunteers, aspirin-intolerant @Disease$tics or aspirin-tolerant asthmatics after in vivo treatment or in vitro pre-incubation with aspirin."	0
"The method for diagnosing @Disease$ is with aspirin challenge, and treatment includes aspirin desensitization followed by continued daily @Chemical$."	0
RECENT FINDINGS: @Chemical$ @Disease$ is reported in 1.5% of patients with cardiovascular disease.	1
"ULDA showed pro@Disease$ properties in the same model of induced thrombosis that were very similar to those described after aspirin withdrawal, but the effect was observed only 1 hour after @Chemical$ administration."	0
"Some @Disease$tics may react to @Chemical$ and other NSAIDs with acute bronchoconstriction, profuse rhinorrhea and skin flushing."	1
The Influence of Prolonged @Chemical$ Supplementation-Induced @Disease$ on the Neurochemistry of the Sympathetic Neurons Supplying Prepyloric Region of the Porcine Stomach.	1
A novel treatment adjunct for aspirin exacerbated @Disease$: the low-@Chemical$ diet: a multicenter randomized control crossover trial.	0
METHODS: We compared outpatients with difficult-to-treat asthma (@Chemical$; n = 486) in a tertiary hospital for allergic diseases in central Japan with those with controlled severe @Disease$ (n = 621) with respect to clinical factors including body mass index (BMI) and aspirin intolerance using multivariate logistic regression analysis stratified by gender and atopic phenotype.	0
Effect of @Chemical$ 75 mg versus 100 mg aspirin cardio on @Disease$ in 30 patients with high risk of cardiovascular events during 3 week treatment period was studied.	0
CONCLUSIONS: BNR to aspirin in AIAR indicates a more @Disease$ and more profound underlying @Chemical$ metabolism disturbances.	0
"The most common side effects are gastrointestinal and renal, but adverse respiratory effects are not uncommon, and approximately 10% of adult @Disease$tics are @Chemical$ intolerant."	0
"An adverse event secondary to @Chemical$ ingestion was defined as @Disease$ or allergic reactions, such as rash or respiratory changes."	1
"OBJECTIVE: Despite evidence that preoperative @Chemical$ improves outcomes in cardiac surgery, recommendations for aspirin use are inconsistent due to aspirin's anti-platelet effect and concern for @Disease$."	0
Safety of parecoxib in @Disease$tic patients with @Chemical$-exacerbated respiratory disease.	0
AIM: The author examined @Disease$ally a group of 106 patients with difficult asthma and 100 patients with @Chemical$-induced asthma.	0
"At admission, compared with aspirin sensitive patients (@Chemical$), patients with APR had more frequently @Disease$, anterior infarction and heart failure, while AHR patients had reduced values of creatine kinase, leukocytes, heart rate and systolic blood pressure."	0
Incidence of gastrointestinal bleeding in patients with @Disease$: buffered @Chemical$ versus enteric-coated aspirin.	0
"@Chemical$ exacerbated respiratory disease is characterized by recalcitrant @Disease$, asthma and precipitation of asthma after ingestion of aspirin and most NSAIDs."	0
"Although cyclooxygenase-2 and thromboxane A2 receptor polymorphisms were not associated with @Chemical$-induced @Disease$ phenotype, they may exert functional effects."	1
"All active therapies except aspirin increased risk of composite @Disease$ by 2 to 4-fold compared to @Chemical$ 2.5mg, with no difference found between the two apixaban doses."	0
OBJECTIVES: To study whether @Chemical$-Aspirin combined treatment for high risk transient ischaemic attack (TIA) or minor @Disease$ results in increased number of lesions associated with anti-thrombotic cerebral haemorrhage or cerebral micro-bleeds (CMB) than aspirin alone treatment.	0
CONCLUSION: Clopidogrel and the combination of acetylsalicylic acid and @Chemical$ were associated with similar risks for recurrent ischemic stroke and bleeding; whereas acetylsalicylic acid was associated with higher risks for both ischemic @Disease$ and bleeding.	0
"The average levels of IL-5,IL-17,IFN-gamma and TNF-alpha in the @Chemical$ @Disease$ group were significantly lower than those in the asthma group(P&lt;0.05)."	1
CONCLUSION: Our study did not find any significant reductions in @Disease$-related mortality or cancer incidence when compared @Chemical$ use with placebo or no aspirin.	0
"@Disease$ events occurred in 6 patients on ASA 81 mg+dipyridamole (26%; 0.42 events per patient year; mean INR at event, 2.2), 4 patients on ASA 81 mg (22%; 0.38 events per patient year; mean INR at event, 2.0), and in 38 patients on @Chemical$ 325 mg (54%; 1.4 events per patient year; mean INR at event, 2.2); P = 0.004."	0
OBJECTIVE: To report the probable association of @Disease$ with @Chemical$ therapy and the selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib.	0
@Chemical$ is an antiplatelet agent with low resistance rates but unknown efficacy and safety in @Disease$ patients.	0
"METHODS: Of 74 patients with @Chemical$ and a history of aspirin @Disease$ studied by us, two patients (probands) gave a family history of aspirin intolerance."	0
"Atopic patients aged 20-79 years with @Chemical$-exacerbated @Disease$ diagnosed by systemic aspirin challenge were randomized (1:1) to 3-month treatment with omalizumab or placebo, followed by >18-week washout period (cross-over design)."	0
"Regarding those with duration of @Chemical$ use, there was a tendency towards stronger risk reduction of @Disease$ for longer aspirin use (10% decreased risk for 4 years, 19% for 8 years and 28% for 12 years), and no duration threshold was observed."	0
"Age, male gender, Helicobacter pylori (H. pylori)infection, diabetes, chronic kidney disease (CKD), @Disease$, history of uncomplicated peptic ulcer disease (PUD), and use of NSAIDs, COX-2 inhibitors, steroids, and @Chemical$ were independent risk factors for UGIB among aspirin users."	0
"Ten out of 116 patients (8.6%) developed mild UR/AE, or only @Disease$ at a one-quarter or cumulative dose of 7.5 mg of @Chemical$."	0
The effect of @Chemical$ and aspirin on @Disease$ in hip fracture surgery.	0
"H. pylori @Disease$ could also be associated with the increased risk for adverse gastroduodenal events in low-dose @Chemical$ users, especially in patients with histories of peptic ulcers."	0
"Cross sensitivity to doses of over the counter non-steroidal anti-inflammatory drugs was present in most patients with @Chemical$ induced @Disease$: ibuprofen, 98%; naproxen, 100%; and diclofenac, 93%."	1
"In @Chemical$-induced @Disease$ dogs (n=5), prolonged BMBT (buccal mucosal bleeding time) was shortened significantly after DDAVP injection (2.2 +/- 1.2 min, P&lt;0.05)."	1
"BACKGROUND &@Chemical$; AIMS: With capsule endoscopy, the ulcerogenic effect of low-dose enteric-coated aspirin on the small @Disease$ and the therapeutic effect of misoprostol on intestinal injury were evaluated."	0
A 33-year-old woman had a severe @Disease$ attack with hypoxia and lost consciousness after oral provocation testing with 15 mg of aspirin and also with 50 mg of @Chemical$.	0
The objective of this review was to evaluate the effect of preoperative @Chemical$ on @Disease$ in patients undergoing elective bypass surgery.	0
These agents are highly effective in reducing the @Disease$ associated with @Chemical$ therapy and have been associated with increased aspirin adherence.	1
Does clopidogrel with @Chemical$ after acute minor @Disease$ or transient ischemic attack increase the risk of cerebral hemorrhage?	0
"CONCLUSIONS: The highly sensitive eicosanoid profiling in EBC makes it possible to detect alterations in @Disease$, especially in its distinct phenotype characterized by hypersensitivity to @Chemical$ and other nonsteroidal anti-inflammatory drugs."	0
@Chemical$-induced @Disease$: a tribute to John Vane as a source of inspiration.	1
"@Chemical$-exacerbated respiratory disease (AERD) is a distinct clinical condition characterized by chronic sinusitis with nasal polyps, asthma, and @Disease$ reactions to nonsteroidal anti-inflammatory drugs (NSAIDs)."	0
"METHODS: 430 consecutive subjects (70+/-14 years, 55% male, 41% with @Disease$) released from the hospital with a primary diagnosis of heart failure were classified into three groups based on the use of @Chemical$ and ACE-I at discharge: ACE-I without aspirin (group I, n=134), ACE-I with aspirin (group II, n=138) and no ACE-I (group III, n=158)."	0
"Compared with patients not associated with NSAIDs and @Chemical$ medication, they are older [(41.2 +- 1.9) years vs (59.4 +- 2.2) years, P &lt; 0.001], more commonly associated with hypertension (10.4% vs 39.2%, P &lt; 0.001), coronary heart disease (10.4% vs 17.6%, P &lt; 0.001), diabetes (4.2% vs 19.6%, P = 0.005); and had more severe @Disease$ (7.3% vs 23.5%, P = 0.008)."	0
"Multivariate analysis showed that a history of peptic @Disease$ or UGIB [risk ratio: 3.1, 95% CI: (1.5-6.5)] and @Chemical$ dose (per 100 mg/day) [1.8 (1.5-2.9)] was associated with higher risk of UGIB."	0
This study was performed to examine PBL cytokine expression in aspirin-sensitive patients who have @Disease$ before and after @Chemical$ desensitization.	0
"Preventive measure(s), such as COX-2 inhibitor, proton pump inhibitor or @Chemical$, should be done for patients requiring NSAID therapy who have high-risk factor(s) for peptic @Disease$."	0
BACKGROUND: Low-dose @Chemical$ (LDA) frequently causes @Disease$.	1
Much of our understanding of cross-reacting drugs and chemicals with @Chemical$ comes from studying asthmatics with aspirin-exacerbated @Disease$ (AERD).	0
Conclusion: We observed an increased risk of @Disease$ in children prenatally exposed to @Chemical$ and aspirin.	0
"@Chemical$-exacerbated respiratory disease is a clinical syndrome characterized by severe, persistent asthma, hyperplastic eosinophilic sinusitis with @Disease$, and reactions to aspirin and other nonsteroidal antiinflammatory drugs that preferentially inhibit cyclooxygenase 1."	0
"Following endoscopic @Disease$ and discontinuation of dual APT, neoadjuvant chemotherapy with @Chemical$ was started under continuation of 'single' APT with aspirin."	0
These results support the use of PPIs as a preventive measure against @Disease$ events for patients receiving clopidogrel and @Chemical$.	1
All effect studies found in Medline (January 1966-May 2002) on surgery and @Disease$ complications due to @Chemical$ were analysed.	1
"BACKGROUND: Leukotrienes (@Chemical$) are important in @Disease$, and LT modifiers modulate antigen-induced asthma."	0
"RESULTS: After stratification of the subjected patients by tertiles of @Chemical$-induced @Disease$, the events rates were 7.4%, 9.3% and 30.8% (P = 0.023)."	1
"For aspirin-anticoagulant concomitant treatment, clinically relevant @Disease$ occurred with an event rate of 36.6 per 100 patient-years, compared to 16.9 per 100 patient-years during @Chemical$ nonuse (HR, 1.70 [95% CI, 1.38-2.11])."	0
Prophylactic use of @Chemical$ does not induce @Disease$  among adults.	0
"Early initiation with high dose @Chemical$ (80 to &gt; 100 mg/kg per day), followed by low-dose therapy at the afebrile stage, has been often used to reduce morbidity and mortality in @Disease$."	0
The role of @Chemical$ as a primary prevention of @Disease$ is still controversial and may be more beneficial in certain cancers over others.	0
"The aim of the study was to assess the antiplatelet activity and safety of a combined antiplatelet treatment with @Chemical$ and clopidogrel in acute @Disease$ (ACS) patients with hypersensitivity to aspirin, undergoing coronary stenting."	0
"Desensitization protocols have been developed and are used for antibiotics, @Chemical$, non-steroidal antiinflammatory drugs, @Disease$, biologic agents, and many others."	0
"In urticaria or @Disease$ induced by multiple NSAIDs, patients without underlying disease develop urticaria or angioedema 30-90 minutes after ingestion of COX-1-inhibiting NSAIDs including @Chemical$."	1
"The main models included the following predictors: demographic characteristics (age, ethnicity, and socioeconomic deprivation), clinical measurements (systolic blood pressure and ratio of total-high-@Chemical$), family history of premature CVD, medical history (smoking, diabetes, bleeding, peptic @Disease$, cancer, chronic liver disease, chronic pancreatitis, or alcohol-related conditions), and medication use (nonsteroidal anti-inflammatory agents, corticosteroids, and selective serotonin reuptake inhibitors)."	0
"Age, male gender, Helicobacter pylori (H. pylori)@Disease$, diabetes, chronic kidney disease (CKD), cirrhosis, history of uncomplicated peptic ulcer disease (PUD), and use of NSAIDs, COX-2 inhibitors, @Chemical$, and thienopyridines were independent risk factors for UGIB among aspirin users."	0
BACKGROUND: @Chemical$-intolerant @Disease$ (AIA) is a subtype of asthma induced by non-steroidal anti-inflammatory drugs and characterized by an aggressive mucosal inflammation of the lower airway (asthma) and the upper airways (rhinitis and nasal polyp).	0
The proportions of patients with an @Disease$ of &gt;=1 and erosive esophagitis were significantly lower in the rabeprazole group than in the @Chemical$ group at 12 weeks (gastric lesions 33.5 vs.	0
The pathogenetic mechanisms underlying development of persistent @Disease$ in aspirin (@Chemical$) intolerance are not fully understood.	0
"BACKGROUND: @Chemical$-exacerbated respiratory disease (AERD) is a clinical syndrome associated with chronic @Disease$ in the airways coincident with chronic rhinitis, sinusitis, recurrent polyposis and asthma."	0
CONCLUSIONS: Preoperative treatment with low doses of @Chemical$ does not increase surgical @Disease$ and transfusion rate in total knee arthroplasty.	0
"The 21% of patients with histories compatible with @Chemical$ @Disease$ can be challenged and, if the results are positive, successfully desensitized."	1
The incidence of @Disease$ for buffered aspirin and enteric-coated aspirin was evaluated in patients receiving long-term low-dose @Chemical$ (LDA) for cardiovascular (CV) diseases.	0
CONCLUSION: This article demonstrates the safety of reintroducing platelet-inhibitory doses of aspirin in patients in whom it is indicated and reporting @Chemical$-induced urticaria and/or @Disease$ with anti-inflammatory doses.	1
"These patients were classified into three groups: Group A comprised patients with nasal polyps without asthma; Group B contained patients with nasal polyps and asthma; and Group C comprised patients with nasal polyps, @Disease$ and @Chemical$ sensitivity."	0
"The ulcerogenic and bleeding responses to ASA under these conditions were markedly aggravated by pretreatment with @Chemical$, which by itself provoked neither @Disease$ nor damage."	0
The effects of inhaled aspirin on fractional exhaled NO (FENO) in patients with @Chemical$-tolerant (ATA) and aspirin-inducible (@Disease$) asthma compared with normal controls have been investigated.	0
"@Disease$JECTIVE: To investigate the incidence, clinical characteristics and risk factors of upper gastrointestinal bleeding (UGIB) in patients with acute coronary syndrome (ACS) who were administrated with @Chemical$ and clopidogrel dual antiplatelet therapy after percutaneous coronary intervention (PCI)."	0
Effect of low-dose proton pump inhibitor on preventing upper gastrointestinal bleeding in chronic @Disease$ patients receiving @Chemical$.	0
"On day 1, peak final-extent inhibition of @Disease$ (IPA) was observed 2-4 h post-dose with @Chemical$, whereas clopidogrel minimally inhibited platelet aggregation (mean percentage IPA &lt; 20%, all time points)."	0
"METHODS: Sixty patients with @Disease$ underwent double-blinded, placebo-controlled oral challenges with @Chemical$ (100 mg, 200 mg, and 2 placebos) over 48 hours in our General Clinical Research Center."	0
Some patients with imperative cardiologic indications for combination therapy with aspirin and clopidogrel (stent placement and/or acute @Disease$) have a history of allergy to @Chemical$.	0
"RESULTS: Four hundred eighty-nine (4.5%) of the 10,905 @Disease$ patients had used low-dose aspirin during the 56-day case only period; 294 (2.7%) of the same patients had used low-dose @Chemical$ during control only period."	0
"SUMMARY: In summary, with rare exceptions, patients with a history of '@Chemical$/NSAID @Disease$' who need ASA for cardiovascular issues will be able to safely take aspirin either after a graded challenge or desensitization providing a central role of the allergist in the management of these patients."	0
"Furthermore, the use of @Chemical$ was associated with the risk of @Disease$ in the patients with advanced CKD without previous stroke."	1
"OBJECTIVE: It was the aim of this study to investigate the prevalence of otologic manifestations in a cohort of @Disease$ patients (nasal polyps with chronic rhinosinusitis, @Chemical$ intolerance and asthma)."	0
"BACKGROUND: The effect of aspirin on the release of key @Chemical$ metabolites in activated eosinophils from subjects with aspirin-intolerant @Disease$ (AIA) has not been investigated previously, despite the characteristic eosinophilia in AIA."	0
"The cells were isolated from 3 groups of subjects: nonasthmatic patients (n = 10), patients with aspirin-tolerant @Disease$ (ATA, n = 9), and patients with @Chemical$-intolerant asthma (AIA, n = 7)."	0
AIM: To evaluate in symptomatic elderly chronic users of low-dose @Chemical$: (1) the association between H. pylori infection and the prevalence of @Disease$; and (2) the effect of H. pylori infection on the efficacy of proton pump inhibitors in the prevention of aspirin-related gastroduodenal lesions.	0
"METHODS: Patients &gt;=50years with prior MI 1-3years ago and &gt;=1 risk factor (age &gt;=65years, diabetes, 2nd prior MI &gt;1yr ago, multivessel @Disease$, @Chemical$ clearance 15-&lt;60ml/min) were enrolled by 369 physicians (96% cardiologists) in 25 countries (2013-14) in the prospective TIGRIS study (NCT01866904)."	0
"RESULTS: In total, 133 @Disease$ patients were enrolled (@Chemical$ cohort = 65 patients) with 56.4% male and mean age of 60.8 years."	0
"RESULTS: In aspirin-induced @Disease$ patients (AIA, n=10), the basal concentration of urinary @Chemical$, but not the other metabolites, was significantly higher than that in aspirin-tolerant asthma patients (ATA, n=10)."	0
"Recent research suggests that the GI effects of aspirin may be dose-dependent; however, even low-dose @Chemical$ can cause significant @Disease$."	1
Preoperative @Chemical$ discontinuation management and @Disease$ outcome in elective coronary artery surgery.	0
"DATA SOURCES: Articles evaluating aspirin for primary prevention of CVD were gathered using a MEDLINE search with the keywords aspirin review, aspirin peripheral @Disease$, aspirin stroke, aspirin coronary artery disease, aspirin diabetes, @Chemical$ primary prophylaxis, and aspirin elderly."	0
"RESULTS: The final analysis included 1470 study participants: 221 controls, 553 CRS without nasal polyps (CRSsNPs), 651 CRS with @Disease$ (@Chemical$wNPs) and 45 allergic fungal rhinosinusitis (AFRS)."	0
"METHODS: House dust mite (HDM) inhalation provocation tests were performed in HDM-sensitive @Disease$tic inpatients without AIA (HDM group; n = 6), and @Chemical$ oral provocation tests were performed in AIA patients (ASA group; n = 7)."	0
Platelet Function Assay (@Chemical$)-100 is a coagulation device that can detect @Disease$ caused by aspirin and adenosine diphosphate inhibition.	0
"INTRODUCTION: Upper gastrointestinal (GI) bleeding in patients who undergo hip and knee arthroplasty tends to be associated with non-@Chemical$al anti-inflammatory drug use, steroid intake, pre-existing peptic @Disease$ and smoking."	0
Main Outcomes and Measures: Odds ratios (ORs) with 95% CI were used as a measure of the association of individual NOAC vs @Chemical$ with the risk of @Disease$.	0
Genetic mechanism of @Chemical$-induced @Disease$/angioedema.	1
"We evaluated the effects of @Chemical$ on genetic/epigenetic alterations in precancerous conditions, i.e., atrophic mucosa (AM) and @Disease$ (IM), in patients with chronic gastritis who had taken aspirin for more than 3 years."	0
"However, there is seldom patient of @Chemical$ intolerance who has the both symptoms, urticaria and @Disease$."	0
"The positive-predictive-value of FOBT for advanced @Disease$ was significantly higher in the control group (30.5%) when compared to those on low-dose aspirin (20.5%; p = 0.003), NSAIDs (19.7%; p = 0.003), clopidogrel (7.3%; p = 0.002), or @Chemical$ (20%; p = 0.05)."	0
"To estimate the baseline risk of @Disease$ according to major gastrointestinal risk factors and the excess risk attributable to @Chemical$ within levels of these factors, we used previously published meta-analyses on both absolute and relative risks of upper gastrointestinal complications."	0
Rapid desensitisation of patients with @Chemical$ allergy who undergo @Disease$.	0
"METHODS: Ninety-four aspirin-induced urticaria patients presenting urticaria/@Disease$-induced by both ASA and NSAID (50 had underlying chronic urticaria) and showing positive responses on oral aspirin challenge test, 76 @Chemical$-intolerant asthmatics with positive responses on lysine-aspirin bronchoprovocation test, and 185 normal healthy controls were enrolled."	0
"For @Chemical$ users, age, @Disease$, diabetes and concomitant use of other antiplatelet drugs or anticoagulants were included in the risk score."	0
"Currently, the frequency of @Disease$ among users of low-dose @Chemical$ is unknown."	0
The results indicated that lyophilized @Chemical$/trehalose induced less @Disease$ than aspirin despite maintaining therapeutic concentrations of plasma aspirin in both the groups.	0
A human gastric cell line (@Disease$) was exposed to physiologic concentrations (3 to 50 mM) of @Chemical$.	0
These adverse effects of @Chemical$ should be weighed against the reductions in @Disease$ and cancer.	0
"BACKGROUND: Although low-dose aprotinin administered after cardiopulmonary bypass has been reported to reduce mediastinal blood loss and blood product requirements in patients not taking @Chemical$, it is unknown whether low-dose postoperative aprotinin has any beneficial effects in patients undergoing coronary artery bypass operations who are at high risk of @Disease$ and increased transfusion requirements because of aspirin use until just before the operation."	0
In vitro studies into mechanistic processes of salicylate @Disease$ propose that there is a bi-directional link and potentiation with glutathione (GSH) depletion and @Chemical$ toxicity.	0
Rabeprazole was significantly more effective than @Chemical$ for the resolution and prevention of @Disease$ (resolution 53.6 vs.	0
[Diagnosis and therapy of @Disease$ due to low-dose @Chemical$].	1
"HPR was defined as on-clopidogrel P2Y12 platelet reaction units &gt;208 as measured by the VerifyNow assay; target vessel failure (@Chemical$) was defined as the composite of all-cause death, @Disease$, or ischemia-driven target vessel revascularization."	0
"At admission, compared with @Chemical$ sensitive patients (ASP), patients with APR had more frequently @Disease$, anterior infarction and heart failure, while AHR patients had reduced values of creatine kinase, leukocytes, heart rate and systolic blood pressure."	0
HYPOTHESIS: There is no difference for definite stent @Disease$ in patients taking low dose versus standard @Chemical$.	0
"Herein, we focus on the strategy to manage @Chemical$-induced peptic @Disease$ations and their complications, based on the scientific evidence."	0
"OBJECTIVES: To identify RCTs, systematic reviews and meta-analyses of RCTs of the prophylactic use of @Chemical$ in primary prevention of @Disease$ or cancer."	0
@Chemical$ analogues may prove to be useful for preventing mucosal injury and for modulating @Disease$.	0
Univariate analysis showed that postoperative administration of @Chemical$ derivatives was the only significant factor associated with postoperative @Disease$ (P = 0.01).	0
"We report a case of acute @Chemical$ intoxication resulting in a transitory hearing loss, @Disease$, and vertigo."	1
Low-dose @Chemical$ use and the risk of @Disease$: a meta-analysis of randomized clinical trials and observational studies.	0
"Identical questionnaires were sent to 210 neurosurgical facilities and proffered five main questions: (1) the adherence of any policy of stopping aspirin pre-operatively, (2) the personal risk assessment for patients with spinal surgery under low-dose @Chemical$ medication, (3) the preferred method of treatment for excessive @Disease$ in this context, (4) personal knowledge of hemorrhagic complications in this group of patients, and (5) the characteristics of the neurosurgical units concerned."	0
"Age, male gender, Helicobacter pylori (H. pylori)infection, @Disease$, chronic kidney disease (CKD), cirrhosis, history of uncomplicated peptic ulcer disease (PUD), and use of NSAIDs, COX-2 inhibitors, @Chemical$, and thienopyridines were independent risk factors for UGIB among aspirin users."	0
"We aimed to evaluate the association between several widely used analgesics, including aspirin, non-aspirin NSAIDs, and @Chemical$ (paracetamol), and risk of @Disease$ and psoriatic arthritis (PsA) in a large cohort of US women, the Nurses' Health Study II (1991-2005)."	0
"Many of these patients present with the so-called @Chemical$ triad of aspirin sensitivity, @Disease$ with associated nasal polyposis, and severe asthma."	0
"Compared with the patients treated with clopidogrel and @Chemical$ in the CURE study, we also found a three times greater risk of major @Disease$ in period 2."	0
"To evaluate the hemostatic effects of desmopressin (DDAVP) in dogs with @Chemical$-induced platelet dysfunction and hemostatic impairment in chronic @Disease$, 3 microg/kg DDAVP was administrated subcutaneously."	0
The @Disease$ has been related with this complication in some reports but its association with antiplatelet drugs and low molecular weight @Chemical$ could increase the risks in older patients.	0
"The aim of this study was to estimate the association of @Chemical$-induced mucosal injury, as well as H. pylori @Disease$, with gastric acid output."	0
BACKGROUND: @Chemical$ desensitization (AD) treatment at doses of up to 1300 mg/day improves outcomes in aspirin-exacerbated respiratory disease (@Disease$).	1
CONCLUSIONS: The use of local administration of tranexamic acid indicated the reduction of @Disease$ even in patients with preoperative @Chemical$ use.	0
"@Chemical$-exacerbated @Disease$ (AERD) is defined as asthma, chronic rhinosinusitis with nasal polyposis, and hypersensitivity to cyclooxygenase-1 inhibitors."	1
"Predictors of HS in patients taking @Chemical$ for secondary prevention included a history of HS (OR, 4.84; 95% CI, 1.48-15.88), a history of @Disease$ (OR, 4.03; 95% CI, 1.53-10.62), and hypnotic/anxiolytic drug use (OR, 2.67; 95% CI, 1.17-6.05)."	0
"Leukotriene C4 synthase has been established as a key genetic determinant of @Chemical$-induced @Disease$, but recent studies have demonstrated that several single nucleotide polymorphisms in the promoters of prostaglandin E2 receptor subtype 2, CYSLTR1 and CYSLTR2 and T-box expressed in T cells (TBX21) could increase risk for the condition."	1
CONCLUSION: Endoscopy reveals low-dose @Chemical$-induced @Disease$ in patients with cerebral infarction.	1
All of them concomitantly received 100 mg/day @Chemical$ because of previous @Disease$ and presented similar clinical features: sudden onset of abdominal pain during a severe cough episode due to bronchial infection.	0
"Conversely, @Chemical$ is well tolerated, has not been shown to contribute to gastrotoxicity when taken with aspirin, and has not been shown to interfere with the inhibition of @Disease$ produced by aspirin."	0
"METHODS: Forty otherwise healthy patients with a history of acute @Disease$ after the ingestion of @Chemical$ underwent single-blind, placebo-controlled oral challenges with ketoprofen."	0
"The Fernand @Disease$ is a set of associations between asthma, nasal polyposis and @Chemical$ sensitivity."	0
"RESULTS: The allele frequencies of HLA-DRB1(*)1302 (18.1%) and HLA-DQB1(*)0609 (10.1%) in aspirin-induced @Disease$ were significantly higher than in @Chemical$-intolerant asthma (5.3%, P=0.0004; 2.0%, P=0.0024) and in normal controls (8.1%, P=0.0005; 3.2%, P=0.0008), and they remained significant after correcting for multiple comparisons."	0
"A diagnosis of RA (RR = 1.75; 95% CI = 1.09-2.79), but not OA (RR = 1.06; 95% CI = 0.67-1.68), was associated with risk of NHL, but the positive association of use of @Chemical$ and other NSAIDs with NHL was independent of @Disease$ history."	0
"Irrespective of @Chemical$ use, @Disease$ was independently associated with an increased risk of major bleeding episodes (IRR, 1.36; 95% CI, 1.28-1.44)."	0
Two cases of patients with symptomatic @Disease$ requiring neurointervention who were successfully desensitized to their @Chemical$ hypersensitivity prior to treatment are described.	0
CONCLUSIONS: An intraoperative @Disease$ during sinus surgery is not a clear indicator of an @Chemical$ intolerance syndrome.	0
@Chemical$ and aspirin in combination with dexamethasone causes @Disease$ at high altitude.	0
"OBJECTIVE: We sought to determine blood and urinary levels of 9alpha,@Chemical$(2), a major stable PGD(2) metabolite in 2 well-defined phenotypes of asthma, aspirin-induced @Disease$ (AIA) and aspirin-tolerant asthma (ATA), and in healthy control subjects and to study the effects of aspirin on PGD(2) release."	0
"@Disease$ induced by low doses of celecoxib, aspirin, and @Chemical$."	0
"BACKGROUND: @Chemical$-exacerbated respiratory disease (AERD) is a clinical syndrome characterized by chronic rhinitis, nasal polyps, asthma, and precipitation of asthma and @Disease$ attacks after ingestion of aspirin (ASA) and most nonsteroidal anti-inflammatory drugs (NSAIDs)."	0
It is necessary for some conditions to occur at the same time so that @Chemical$ induced @Disease$ occurs.	1
"Multivariable analysis showed that @Chemical$ use was an independent predictor of rebleeding, but protected against cardiovascular events and @Disease$."	0
Topical and systemic effects of @Chemical$ in the @Disease$ are associated with mucosal damage in the upper and lower gastrointestinal tract.	0
"The prevalence of @Chemical$ in patients undergoing @Disease$ seems higher than in most of the studied populations, and this study has shown that the AR statuses of a significant number of patients undergoing HD change after an HD session."	0
Conclusions: @Chemical$ is effective in preventing @Disease$ in patients taking LDA.	0
INTRODUCTION: The Clopidogrel in Unstable @Disease$ to Prevent Recurrent Events (CURE) study showed that patients with unstable angina pectoris (UAP) and non-ST-elevation myocardial infarction (NSTEMI) benefit from combined therapy with acetylsalicylic acid (@Chemical$) and clopidogrel.	0
OBJECTIVE: To determine whether ketorolac nasal challenge has acceptable specificity and sensitivity for diagnosing @Chemical$-exacerbated @Disease$.	0
"These data closely match the frequency of dyspnea that was observed in the CAPRIE trial, suggesting that therapy with clopidogrel, and/or @Chemical$ holds very small (if any) risk for @Disease$."	0
BACKGROUND: A negative interaction has been shown to exist between @Chemical$ and angiotensin-converting enzyme inhibitors (ACE-I) in subjects with @Disease$.	0
OBJECTIVES: This study sought to characterize the average daily ischemic rates (ADIRs) and average daily @Disease$ rates (@Chemical$s) within the first year after primary PCI for STEMI.	0
"SA levels were significantly lower in the @Disease$ group (3.2 +- 0.2 g/dl vs 4.2 +- 0.4 g/dl, respectively, p <0.001) whereas mean @Chemical$ was significantly higher compared with the normal albumin group (548 +- 45 vs 444 +- 66 ARU, respectively, p <0.001)."	0
"METHOD: We classified 1,041 gastroduodenal ulcer patients into three groups [patients taking @Chemical$ (group A), patients taking nonaspirin nonsteroidal anti-inflammatory drug (NSAID) (group N), and patients taking neither aspirin nor nonaspirin NSAID (group C)] and 241 bleeding gastroduodenal @Disease$ patients into three corresponding groups (groups a, n, and c)."	0
"Use of aspirin, non-steroidal anti-inflammatory drugs, and @Chemical$ (paracetamol), and risk of psoriasis and @Disease$: a cohort study."	0
"However, recent studies have shown that continuation of @Chemical$ is beneficial because of a decrease of cardiovascular complications and only a relatively small increase of recurrent @Disease$ when combined with a proton pump inhibitor."	0
BACKGROUND: Historical aspirin- or nonsteroidal anti-inflammatory drug (NSAID)-induced reactions might provide predictive information about the severity of reactions in patients with aspirin-exacerbated @Disease$ (AERD) undergoing oral @Chemical$ challenge (OAC).	0
"Apixaban (2.5mg and 5mg), dabigatran, rivaroxaban, idraparinux and @Chemical$ antagonists (VKA) each significantly reduced the risk of @Disease$ recurrence compared to placebo, ranging from a 73% reduction with idraparinux to 86% with VKAs."	0
@Chemical$ and other NSAIDs were either associated with elevated or no @Disease$ risk.	0
"On the other hand, SA alone inhibited basal gastric motility without any effect on mucosal PGE2 contents, and this agent, when given together with @Chemical$, prevented @Disease$ and lesion formation in response to indomethacin, without affecting the reduced PGE2 contents."	0
Urticaria and @Disease$ (@Chemical$) represent a syndrome that is frequently encountered in children and adults.	0
"There is reasonable evidence to support the benefit of the addition of @Chemical$, an ingredient with antioxidant properties, to moderate the @Disease$ (GI) effects of aspirin."	0
BACKGROUND: @Chemical$ toxicity may lead to a levodopa-resistant @Disease$.	1
"Recently, vitamin C releasing @Chemical$ (ASA-VitC) has been shown to reduce @Disease$ of ASA in animal model of gastric injury."	0
"However, low-dose @Chemical$ may be associated with a slightly increased risk of @Disease$ (ICBs)."	1
"@Chemical$-exacerbated respiratory disease (AERD) is a distinct clinical condition characterized by chronic @Disease$ with nasal polyps, asthma, and hypersensitivity reactions to nonsteroidal anti-inflammatory drugs (NSAIDs)."	0
We suggest that pretreatment with @Chemical$ under controlled conditions is useful to confirm the diagnosis of @Disease$ when a challenge test with food alone or with food and exercise fails to induce positive reactions.	0
"AIM: We conducted a multicenter, randomized, double-blind, placebo-controlled trial to assess the efficacy of a high dose of rebamipide, a gastroprotective drug, for @Chemical$-induced moderate-to-severe @Disease$."	1
"The authors assessed the prevalence of @Disease$ following extended-release dipyridamole/aspirin combination (@Chemical$), and the efficacy of acetaminophen in the treatment of these headaches."	0
CONCLUSIONS: @Chemical$-precipitated @Disease$tic attacks are not associated with changes in the systemic production of prostaglandin E2.	0
"OBJECTIVE: Our objective was to measure the risks of @Disease$ (ACS) after dispensing of @Chemical$, versus paracetamol."	0
The impact of low-dose @Chemical$ on endoscopic gastric and duodenal @Disease$ rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor.	0
Conclusions: Elevated high-density lipoprotein @Chemical$ is independently associated with any bleeding and severe bleeding in the patients with acute minor @Disease$ or high-risk TIA on antiplatelet therapy.	0
[Efficacy and safety of various doses of @Chemical$ in prevention of complications of @Disease$].	0
"Furthermore, a recent study suggested that the administration of low-dose aspirin plus high-dose @Chemical$ (a potent PPI) was associated with fewer episodes of UGI bleeding than clopidogrel alone in patients with a history of recent UGI @Disease$."	0
Efficacy of hypertonic (2.3%) sea water in patients with @Chemical$-induced @Disease$ following endoscopic sinus surgery.	1
This review aims to describe the relationship between @Chemical$ and age-related macular degeneration (@Disease$) - a chronic disease that causes deterioration of visual acuity and is one of the most common ophthalmological diseases these days.	0
"CONCLUSIONS: The prevalence of asthma and @Disease$ in CRS varies by phenoytype, with @Chemical$wNPs and AFRS having a stronger association with both."	0
"We compared GI hospitalization rates among elderly patients taking @Chemical$, NS-NSAIDs, celecoxib and ASA or @Disease$ and ASA."	0
@Chemical$ in people with @Disease$: Time to clean up the prescription list?	0
"METHODS: Between 1981 and 2004, 678 patients with suspected @Disease$ were admitted for @Chemical$ challenge and desensitization."	0
"For those with OBRI score of &gt;=2, there was a trend for reduced @Disease$ with @Chemical$ compared to aspirin (HR 0.56, 95% CI 0.27 to 1.15, p = 0.12), but major bleeding was increased (HR 4.04, 95% CI 1.99 to 8.22, p &lt;0.001)."	1
CONCLUSIONS: Our results suggest that a history of peptic @Disease$ significantly increases the risk of @Chemical$-associated UGIB.	0
"Whether bleeding rates differ among patients with and without @Disease$, receiving long-term @Chemical$ is unknown."	0
An economic analysis of aspirin desensitization in @Chemical$-exacerbated @Disease$.	1
Thirty-one (45%) in the @Chemical$ group and 25 (42%) in the aspirin group had a minor @Disease$.	0
"CONCLUSIONS: In a randomized controlled trial of users of low-dose aspirin at risk for recurrent GI bleeding, a slightly lower proportion of patients receiving a PPI along with aspirin developed recurrent @Disease$ or ulcer than of patients receiving an H2RA with the @Chemical$, although this difference was not statistically significant."	0
"(3) The patients with @Disease$ (n = 7), but not those with @Chemical$-tolerant asthma (n = 6), showed significant increases in LTBG and LTE4 excretions after aspirin challenge."	0
"OBJECTIVE: To classify patients with a history of @Chemical$-induced @Disease$ as cross-reactors or single-drug reactors by oral challenges with another strong COX-1 inhibitor, namely, ketoprofen."	1
"We present a case of @Disease$ associated with concomitant ingestion of cilostazol, @Chemical$ and grapefruit juice."	0
"High-dose @Chemical$ (300-325 mg/day) did not statistically reduce the recurrent @Disease$s (RR, 0.90 [95% CI, 0.68-1.18])."	0
@Chemical$ exacerbated respiratory disease (AERD) is a clinical syndrome characterized by chronic @Disease$ with nasal polyposis and aspirin hypersensitivity.	0
"METHODS: In the first study, gastric mechanosensory thresholds (barostat technique) and gastric emptying ((13)C-octanoic breath test) were measured and endoscopy was performed at entry and after 5 days of treatment with @Chemical$ (500 mg 3 times daily) in 8 patients with functional @Disease$ (initially without symptoms) and 8 healthy controls."	0
"Despite relatively high incidence of these reactions, @Chemical$ @Disease$ remains underdiagnosed worldwide."	1
"CONCLUSIONS: Taken together, this study shows an increased release of the recently discovered lipid mediator EXC4, as well as the main indicator of 15-LO activity, 15-HETE, in activated eosinophils from severe and aspirin-intolerant @Disease$tics, and also elevated EXC4 and LTC4 formation in eosinophils from AIA patients after cellular activation in the presence of lysine-@Chemical$."	0
"QUESTION/PURPOSES: We sought to answer four questions: For the THA and TKA cohorts, respectively, (1) was the incidence of readmission resulting from VTE and bleeding complications higher with LMWH than mobile compression plus ASA; and (2) was the incidence of wound @Disease$ complications higher with LMWH than mechanical compression plus @Chemical$?"	0
"METHODS: We searched MEDLINE, EMBASE and the Cochrane Controlled Trials Register from inception to December 2013, and checked conference abstracts of randomized controlled trials (RCTs) on the effect of PPIs in reducing adverse GI events (hemorrhage, ulcer, perforation, or @Disease$) in patients taking @Chemical$."	0
Proton pump inhibitor use and risk of adverse cardiovascular events in @Chemical$ treated patients with first time @Disease$: nationwide propensity score matched study.	0
"@Chemical$ had no effect on platelet-leukocyte aggregates, platelet activation markers, or plasma cytokines in either group.Conclusions: High-dose aspirin therapy for 8 weeks paradoxically increases markers of type 2 inflammation in subjects with aspirin-exacerbated @Disease$, despite reducing nasal symptoms."	0
"BACKGROUND: @Chemical$-exacerbated respiratory disease (AERD) is a clinical syndrome associated with chronic inflammation in the airways coincident with chronic rhinitis, sinusitis, recurrent @Disease$."	0
BACKGROUND: The effect of low-dose @Chemical$ on endoscopic @Disease$ incidence in cyclo-oxygenase-2-selective inhibitor or non-selective non-steroidal anti-inflammatory drug users remains controversial.	0
PURPOSE OF REVIEW: The purpose of this review is to highlight recent advances in gene-expression profiling of nasal polyps in patients with chronic @Disease$ and @Chemical$-sensitive asthma.	0
Failure to maintain an aspirin-desensitized state in a patient with @Chemical$-exacerbated @Disease$.	0
"SA has a cytoprotective action against N@Chemical$ID-induced @Disease$, and this action is not mediated by endogenous AD but may be functionally associated with inhibition of the gastric motility response."	0
The association between obesity and @Chemical$ hypersensitivity in @Disease$ is unclear.	0
"To investigate the relationship between single-nucleotide polymorphisms (SNPs) in the RAB1A gene and aspirin-exacerbated @Disease$ (AERD), asthmatics (n=1197) were categorized into AERD and @Chemical$-tolerant asthma (ATA)."	0
Recent findings from several observational epidemiologic studies indicate that regular @Chemical$ use may also be associated with increased risks of some forms of age-related macular degeneration (@Disease$).	1
Benefits and risks of extended treatment of @Disease$ with rivaroxaban or with @Chemical$.	0
BACKGROUND: Low-dose @Chemical$ is used for secondary prevention of @Disease$ and ischemic cerebrovascular disease.	0
"The aim of the study was to assess the antiplatelet activity and safety of a combined antiplatelet treatment with @Chemical$ and clopidogrel in acute coronary syndrome (ACS) patients with @Disease$ to aspirin, undergoing coronary stenting."	0
Twenty patients with @Chemical$-induced asthma were included and 10 extrinsic @Disease$ patients as a group control.	0
Association of @Disease$ Risk With Non-Vitamin K Antagonist Oral Anticoagulant Use vs @Chemical$ Use: A Systematic Review and Meta-analysis.	0
"These include rhinitis and asthma induced by NSAIDs (also known as @Chemical$-exacerbated @Disease$), NSAID-exacerbated cutaneous disease (NECD), urticaria or angioedema induced by multiple NSAIDs, single NSAID-induced reactions, and delayed NSAID reactions."	1
The @Chemical$ induced writhing and hot plate tests were used as an in vivo @Disease$ models.	0
METHODS: Twenty-nine patients with suspected @Chemical$-exacerbated @Disease$ were challenged with nasal ketorolac before oral challenge and desensitization with aspirin.	0
"Data Sources: We searched PubMed, Embase, CENTRAL, and ClinicalTrials.gov from inception to May 28, 2018, with the terms novel oral anticoagulants, non-@Chemical$ antagonist oral anticoagulants, direct oral anticoagulants, dabigatran, rivaroxaban, apixaban, edoxaban, warfarin, Coumadin, vitamin K antagonist, aspirin, acetylsalicylic acid, or ASA, and major bleeding, fatal bleeding, or @Disease$."	0
"Because @Chemical$(2) exerts a range of inhibitory actions on inflammatory leukocytes via the EP(2) receptor, its reduced expression in aspirin-sensitive @Disease$ may be partly responsible for the increased inflammatory infiltrate and production of cysteinyl leukotrienes that characterize aspirin-sensitive disease."	0
"UNLABELLED: Aspirin (@Chemical$) and several other nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit cyclo-oxygenase (COX) enzyme both isoforms 1 and 2, and can precipitate asthmatic attacks in aspirin-induced @Disease$tics."	1
"Within 90 days after intervention, there were 4 patients (1.5%) with acute thrombosis, 5 patients (1.8%) with subacute thrombosis, 17 patients (6.2%) with stroke, and 2 death (0.7%) in low-dose @Chemical$ group, compared with no patient (0%) with acute thrombosis, 2 patient (2.1%) with subacute thrombosis, 6 patients (6.2%) with stroke, and 2 @Disease$ (2.1%) in high-dose aspirin group, and there were no significant difference in all study endpoints between two groups."	0
Important biochemical findings in many @Disease$ patients are increased basal @Chemical$ levels (at least in cell cultures) that excessively increase after intake of COX-1 inhibitors.	0
METHODS: Literature archives and main scientific sessions' abstracts were scanned for studies describing desensitization protocols for patients with @Chemical$ @Disease$.	1
"Thirteen of all 30 ICrHs (4 on ticagrelor and 9 on @Chemical$) were hemorrhagic @Disease$s, and 4 (2 in each group) were symptomatic hemorrhagic transformations of brain infarctions."	0
"CONCLUSION: Despite its common usage, the @Chemical$-100 is an unreliable tool to assist in the management of @Disease$ and CVA patients."	0
Aspirin as a cause of pancreatitis in patients with @Chemical$-exacerbated @Disease$.	0
In the present study was investigated the effects of @Chemical$ on upper gastrointestinal ulcer and potent risk factor for peptic @Disease$ associated with aspirin in a case-control study.	0
"In subgroup analysis, aspirin use was associated with renal failure in the patients with no history of stroke (HR, 1.41; 95% CI, 1.14-1.73), and there was a borderline interaction between previous @Disease$ and the use of @Chemical$ on renal failure (interaction p=0.0565)."	0
"OBJECTIVE: To investigate the incidence, clinical characteristics and risk factors of upper gastrointestinal bleeding (UGIB) in patients with @Disease$ (ACS) who were administrated with aspirin and @Chemical$ dual antiplatelet therapy after percutaneous coronary intervention (PCI)."	0
"METHODS: Ninety-four aspirin-induced @Disease$ patients presenting urticaria/angioedema-induced by both ASA and NSAID (50 had underlying chronic urticaria) and showing positive responses on oral aspirin challenge test, 76 aspirin-intolerant asthmatics with positive responses on @Chemical$-aspirin bronchoprovocation test, and 185 normal healthy controls were enrolled."	0
"Whereas aspirin administration is known to decrease the risk of @Disease$ problems, @Chemical$ withdrawal may temporarily increase the risk of thrombotic events."	0
Positive associations between non-@Chemical$ NSAID or aspirin and risk of @Disease$ tended to disappear when analyses were limited to drug use &gt;= 5 years before the disease diagnosis.	0
"CONCLUSIONS: Rapid aspirin desensitisation is an effective and safe procedure for patients with @Chemical$ allergy who are to undergo @Disease$ and stenting, allowing them to receive the optimum treatment."	0
IgE-mediated @Disease$ were evaluated by measuring changes in rectal temperature and Evans blue dye (@Chemical$) extravasation in the intestine and liver after oral challenge with OVA.	0
BACKGROUND: @Chemical$ desensitization (AD) has been the only available modifying treatment in aspirin-exacerbated @Disease$ (AERD).	0
We described @Disease$ with sensitivity to @Chemical$ and other nonsteroidal anti-inflammatory drugs (NSAID).	0
"Rebamipide prevented this damage, and may be a candidate drug for treating @Chemical$-induced @Disease$."	1
@Disease$ transformation of ischemic stroke associated with enoxaparin and @Chemical$ concomitant therapy.	0
Increased risk of minor bleeding and antiplatelet therapy cessation in patients with @Disease$ and low on-@Chemical$ platelet reactivity.	0
"CONCLUSIONS: As endoscopy frequently reveals gastroduodenal disorder among low-dose aspirin users, both administration of @Chemical$ and of enteric-coated aspirin warrant concern for gastroduodenal @Disease$."	0
"Also, our study did not show a statistically significant difference between @Disease$ onset, the length of mechanical ventilation, use of protamineand @Chemical$."	0
CONCLUSION: Exhaled NO may indicate eosinophilic airway @Disease$ during ASA exposure in patients with @Chemical$ inducible asthma.	0
"OBJECTIVE: The purpose of this study was to demonstrate that @Chemical$, a specific inhibitor of COX-2, does not cause @Disease$tic attacks in patients with ASA and/or other NSAID-induced asthma."	0
This pro@Disease$ effect of @Chemical$ is very similar to the effect observed after COX 2 selective inhibition with NS 398.	0
"QUESTION/PURPOSES: We sought to answer four questions: For the THA and TKA cohorts, respectively, (1) was the incidence of readmission resulting from VTE and @Disease$ complications higher with LMWH than mobile compression plus ASA; and (2) was the incidence of wound bleeding complications higher with LMWH than mechanical compression plus @Chemical$?"	0
"We sought to assess the performance of existing bleeding risk scores, such as the @Disease$, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly (HAS-BLED) score or the Outpatient Bleeding Risk Index (OBRI), in patients with heart failure with reduced ejection fraction (HFrEF) in sinus rhythm (SR) treated with warfarin or @Chemical$."	0
OBJECTIVE: The aim of this study was to determine the @Disease$ risks associated with single (@Chemical$) and dual (aspirin + clopidogrel) antiplatelet therapy (DAPT) versus placebo or no treatment in adults undergoing noncardiac surgery.	0
The logistic regression analysis results showed that @Chemical$ resistance plays a larger role in hospitalized @Disease$ than do other cardiovascular risk factors.	0
"Our study also highlights that the use of aspirin for primary prevention of cancer was found to cause higher rates of bleeding (any bleeding, major @Disease$, and GI bleeding) compared to placebo or no @Chemical$ at the longest follow-up period with no significant benefit in cancer primary prevention."	0
"Significant heterogeneity was present for the NSAIDs; e.g., @Chemical$ was associated with an increased overall @Disease$ risk (OR = 2.09, 95% CI 2.00-2.18 for &lt;20 DDD), while celecoxib was not (OR = 0.76, 95% CI 0.51-1.13 for &lt;20 DDD, 2P &lt; 0.01 for comparison)."	0
A 64 year old woman with previous history of coronary stenting five days before was admitted in our institution for intracranial @Disease$ while receiving aspirin and @Chemical$.	0
"INTERPRETATION: Compared with @Chemical$, extended anticoagulation with once daily rivaroxaban reduces recurrent @Disease$ with a favourable benefit-risk profile."	0
"Recently, flowcharts regarding challenge/desensitization procedures with @Chemical$ in patients with @Disease$ and histories of aspirin hypersensitivity reactions have become available."	0
Incidence of @Disease$ in new users of low-dose @Chemical$: a cohort study using The Health Improvement Network.	0
BACKGROUND: @Disease$ (@Chemical$) is a common disorder associated with other respiratory tract diseases such as asthma and inhalant allergy.	0
"RESULTS: A treatment with @Chemical$ in the human bronchial epithelial cells increased the mRNA expression level of KIF3A compared to that of the untreated control (P &lt;= 0.01), and nasal polyp epithelia from aspirin-intolerant asthma (@Disease$) patients also showed a higher expression of KIF3A protein than aspirin-tolerant asthma controls."	0
"History of bleeding or non-complicated peptic ulcer, alcohol intake, concomitant treatment with NSAID or calcic inhibitors are demonstrated risk factors of @Disease$ ulcer associated with low-dose @Chemical$."	0
"@Disease$ induced by low doses of @Chemical$, aspirin, and acetaminophen."	0
"METHODS: 300 consecutive @Disease$ patients were treated with recombinant tissue-type plasminogen activator (rt-PA) in a prospective open study (92 pretreated with ASA, 202 @Chemical$ nonusers) with 3 months of follow-up."	0
Con: Should @Chemical$ be continued after cardiac surgery in the setting of @Disease$?	0
"METHODS: The patients enrolled in this study were the elderly requiring a single non-impacted tooth extraction. 300 elderly outpatients used lidocaine local infiltration anesthesia, 200 patients without using aspirin before tooth extraction served as control group I, 100 patients with prolong use of aspirin before tooth extraction as observation group I. 300 elderly outpatients used compound articaine local infiltration anesthesia, 200 patients without using aspirin before tooth extraction served as control group II, 100 patients with prolong use of aspirin before tooth extraction as observation group II.Bleedings at 5, 10, 30 min, 24 h after tooth extraction were observed and the relationship between postoperative @Disease$ and intake of @Chemical$ was analyzed."	0
"ASA aggravates @Disease$ damage via enhancement of ROS and cytokine generation and suppression of SOD and GPx, and these effects are counteracted by NO released from NO-@Chemical$."	0
@Chemical$ resistance in the acute stages of acute @Disease$ is associated with the development of new ischemic lesions.	0
CONCLUSIONS: @Chemical$ intolerance in asthmatics explains the lesser association with @Disease$.	0
"BACKGROUND: Aspirin-exacerbated respiratory disease (AERD) is a clinical syndrome characterized by chronic @Disease$, nasal polyps, asthma, and precipitation of asthma and rhinitis attacks after ingestion of aspirin (@Chemical$) and most nonsteroidal anti-inflammatory drugs (NSAIDs)."	0
"Because of the potential interaction between proton pump inhibitors (PPI) and @Chemical$ that compromises the efficacy of clopidogrel on @Disease$, there has been a warning in the product information by health authorities in the US and in Europe who discourage the concomitant use of PPI and clopidogrel."	0
Association analysis of member RAS oncogene family gene polymorphisms with @Chemical$ intolerance in @Disease$tic patients.	0
Factors associated with asthma control in patients with @Chemical$-exacerbated @Disease$.	0
@Chemical$ in Alzheimer's disease: increased risk of @Disease$: cause for concern?	0
"We sought to assess the performance of existing bleeding risk scores, such as the Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly (HAS-BLED) score or the Outpatient Bleeding Risk Index (OBRI), in patients with @Disease$ with reduced ejection fraction (HFrEF) in sinus rhythm (SR) treated with warfarin or @Chemical$."	0
"In monocytes, we found no changes in basal or lipopolysaccharide (LPS)-stimulated @Chemical$ synthesis, but the response to EP4 receptor activation with respect to inhibition of LPS-induced tumor necrosis factor-alpha release was reduced in @Disease$ patients, especially in the presence of aspirin (acetylsalicylic acid)."	0
"To explore the neural mechanisms underlying @Chemical$ (SS)-induced hyperexcitability and increased central gain, we examined the effects of GABA receptor agonists and antagonists on SS-induced @Disease$ in the AC and startle reflex responses."	0
"RESULTS: In 674 @Disease$, we found that the odds ratio for the presence of erosive oesophagitis in @Chemical$ users was 2 (95% CI, 1-3; P = 0.03) and 3 (2-5; P = 0.0003) in patients taking other antithrombotic agents."	0
"INTRODUCTION: Antithrombotic drugs, such as low-dose @Chemical$ (LDA) and clopidogrel, can cause @Disease$."	1
"BACKGROUND: The aim of this study was to detect cysteinyl leukotriene (Cys-LT) receptors in aspirin-sensitive nasal polyposis patients, and compare them with nasal polyposis and chronic @Disease$ patients without @Chemical$ sensitivity."	0
CONCLUSION: The effect of H. pylori @Disease$ on the @Chemical$-induced gastropathy was biphasic depending on the individual gastric acid secretion level.	0
The pharmacological mechanisms of aspirin-sensitive @Disease$ are not fully understood but probably involve diversion of arachidonic acid metabolism from @Chemical$ to cysteinyl leukotriene formation leading to direct effects on blood vessels and delayed mast cell degranulation with release of histamine.	0
Platelet Function Assay (PFA)-100 is a coagulation device that can detect @Disease$ caused by aspirin and @Chemical$ inhibition.	0
"In asthmatics with symptoms of @Disease$ to non-steroidal anti-inflammatory drugs, which takes the course of clinically demonstrable @Chemical$-induced asthma, the risk of severe asthma is 30-fold higher."	0
"METHODS: Twenty-four aspirin-sensitive patients with @Disease$ and 18 aspirin-tolerant asthmatic patients were studied, and @Chemical$ released from PBLs were assessed by means of enzyme immunoassays."	0
Data on the chemopreventative role of these drugs on the risk of the upper aerodigestive tract cancer (@Chemical$) are insufficient and mostly refer to oesophageal @Disease$.	0
We investigated the relationship between @Chemical$-resistant platelet aggregation and @Disease$ in patients with stable coronary artery disease.	0
"METHODS: @Chemical$ from 115 adult @Disease$tic subjects (62 with aspirin intolerance) and 38 healthy control subjects were assessed quantitatively for 19 eicosanoids by using complementary HPLC, gas chromatography-mass spectrometry, or both."	0
High frequency of @Chemical$ resistance in patients with @Disease$.	0
DATA SYNTHESIS: The literature provides information regarding the safety of COX-2 inhibitors in asthma patients with @Chemical$-exacerbated @Disease$ (AERD).	0
Proton pump inhibitor use by @Chemical$-treated @Disease$ patients is not associated with increased risk of cardiovascular events.	0
There are reports of both tolerance and intolerance to selective COX-2 inhibitors in patients with documented @Disease$-like reactions to @Chemical$ and NSAIDs.	0
"In the intensively treated patients of the @Disease$ Optimal Treatment (HOT) Study, randomization to low-dose @Chemical$ (75 mg daily) versus placebo significantly reduced cardiovascular events (-15%) and myocardial infarction (-36%), but increased major bleedings (+65%)."	0
RESULTS: In both groups of asthmatic patients women were majority (74% with difficult asthma and 66% with @Chemical$-induced asthma) with a higher level of @Disease$ and depressive symptoms than men.	0
Expression of cyclooxygenase and lipoxygenase enzymes in nasal @Disease$ of @Chemical$-sensitive and aspirin-tolerant patients.	0
"Ischemic @Disease$ and intracranial hemorrhage with aspirin, @Chemical$, and warfarin: impact of quality of anticoagulation control."	0
"UNLABELLED: @Chemical$ (ASA) and several other nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit cyclo-oxygenase (COX) enzyme both isoforms 1 and 2, and can precipitate @Disease$tic attacks in aspirin-induced asthmatics."	0
"The risk of @Disease$ with @Chemical$ is increased with old age, male sex, ulcer history and concomitant medication with NSAIDs, cyclooxygenase 2 selective inhibitors, corticosteroids or other antithrombotic agents."	1
"METHODS: A total of 11 @Chemical$-sensitive patients with asthma, 10 aspirin-tolerant patients with @Disease$, and 10 controls without asthma were studied."	0
"Previous studies have suggested a role for the A-444C polymorphism on the leukotriene C4 synthase gene (LTC4S) in @Chemical$-induced @Disease$ (AIU), but the results are controversial."	1
"In the presence of sufficient amounts of gastric acid, H. pylori infection and aspirin could synergistically damage gastric mucosal integrity, while in the absence of sufficient amounts of gastric acid, the synergistic effect could be completely counteracted and the infection could even suppress the @Chemical$-induced @Disease$."	1
"OBJECTIVE: Aspirin exacerbated respiratory disease (@Disease$) is comprised of aspirin/@Chemical$ (ASA) sensitivity, bronchial asthma, and nasal polyposis."	0
"CONCLUSIONS: In nasal polyps of @Chemical$-@Disease$ patients, up-regulation of the adhesion molecules ICAM-1 and VCAM-1 and the integrin VLA-4 may play an important role in the development of chronic eosinophilic inflammation."	0
"Notably, 500 mg @Chemical$ caused complete inhibition of arachidonic acid-induced @Disease$ for 2 days in all volunteers."	0
GABAergic neural activity involved in @Chemical$-induced @Disease$ enhancement.	1
"In the desensitized @Disease$ group, cytokine and @Chemical$ measurements were repeated after 1-month aspirin treatment."	0
"Using a multiple regression analysis, the administration of non-@Chemical$ NSAIDs was identified as an independent factor for the decreased serum iron and the decreased @Disease$ levels."	0
"Data Sources: We searched PubMed, Embase, CENTRAL, and ClinicalTrials.gov from inception to May 28, 2018, with the terms novel oral anticoagulants, non-vitamin K antagonist oral anticoagulants, direct oral anticoagulants, dabigatran, rivaroxaban, apixaban, edoxaban, @Chemical$, Coumadin, vitamin K antagonist, aspirin, acetylsalicylic acid, or ASA, and major bleeding, fatal @Disease$, or intracranial hemorrhage."	0
"The eligible study population consisted of patients with a history of @Disease$/angioedema, naso-ocular symptoms, bronchospasm, and/or anaphylactoid reaction induced by @Chemical$ and/or NSAIDs."	1
"CONCLUSIONS: In patients with a principal discharge diagnosis of @Disease$, the use of @Chemical$, in combination with ACE-I, does not worsen long-term survival compared to the use of ACE-I without aspirin."	0
"CONCLUSION: In addition to age, male gender, H. pylori infection, and concomitant use of NSAIDs, COX-2 inhibitors, @Chemical$, and thienopyridines, underlying co-morbidities including @Disease$, CKD, cirrhosis, history of PUD are also important risk factors for first-time occurrence of non-variceal UGIB in aspirin users."	0
Enzyme up-regulation was monitored after in vitro stimulation with lipopolysaccharide (LPS) and/or aspirin in 19 aspirin-intolerant (AI) patients (8 @Chemical$-sensitive asthmatics and 11 @Disease$ patients) and 14 healthy controls.	0
"A 78-year-old woman visited a local clinic because of @Disease$, and was prescribed levofloxacin, carbocisteine, and cold medicine (salicylamide, acetaminophen, anhydrous @Chemical$, promethazine methylene disalicylate)."	0
BACKGROUND: There have been a number of reports of @Disease$ following exposure to non-steroidal anti-inflammatory drugs (NSAIDs) and @Chemical$.	0
"Patients with @Disease$ had significantly lower post-treatment values of ADP-induced aggregation (43+/-14% versus. 56+/-19%, p=0.002) and platelet reactivity index VASP (43+/-14% versus 54+/-23%; p=0.04) and a trend for lower values of @Chemical$-induced aggregation (2.4+/-5.4 versus 13+/-21; p=0.27)."	0
"When participants take low-dose @Chemical$ simultaneously, coxibs may not be useful for chemoprevention of @Disease$."	0
"The method for diagnosing @Disease$ is with aspirin challenge, and treatment includes @Chemical$ desensitization followed by continued daily aspirin."	0
"@Chemical$ and DAPT had similar rates of @Disease$, but TAPT had significantly higher rates of headache, palpitation, rash and gastrointestinal side-effects."	0
"RESULTS: Compared with the polyposis only group, hydrogen peroxide consumption, glutathione S-transferase, @Chemical$ and malondialdehyde were lower in the @Disease$ group."	0
"In our investigation of such adverse effects, we obtained 4 important findings considered useful for physicians, as follows; 1) even when aspirin was given at a dose, the incidence rate of gastrointestinal lesions was higher than with other non-steroidal anti-inflammatory drugs (NSAIDs), 2) the odds ratios for gastrointestinal lesions induced by aspirin with a histamine H2 receptor antagonist and proton pump inhibitor were 0.6 and 0.4, respectively, as compared with @Chemical$ alone, 3) it is difficult to administer aspirin, which exerts an antiplatelet effect, without inducing @Disease$, and 4) these gastrointestinal lesions appears early, especially within 2 years after administration."	0
@Chemical$ unmasking acquired haemophilia A in a patient with @Disease$.	0
"METHODS: Data from large clinical trials investigating the interaction between aspirin and ACE inhibitors were analyzed to determine the effect of @Chemical$ on the vasodilatory actions of ACE inhibitors in @Disease$ patients, and the results were analyzed on the basis of theoretical and laboratory findings."	0
"Combining aspirin 75-81 mg with @Chemical$ to maintain the international normalized ratio at 2.0-2.5 may provide added benefit, but should be considered only for patients at high risk for @Disease$ events."	0
"Use of NSAIDs, @Chemical$, APs, and ACs within 2 weeks prior to the endoscopy was compared between cases and controls, and effects on ulcer @Disease$ were calculated."	0
Risk of major @Disease$ in patients receiving @Chemical$ antagonists or low doses of aspirin.	1
OBJECTIVE: To examine whether @Chemical$ (oral prostaglandin E1 analogue) use during aspirin challenge and desensitization might decrease the severity of aspirin-induced symptoms and make desensitization safer for patients with @Disease$.	0
In vitro studies into mechanistic processes of salicylate @Disease$ propose that there is a bi-directional link and potentiation with @Chemical$ (GSH) depletion and salicylate toxicity.	0
"The causes of @Chemical$ resistance include inadequate doses of the drug, its low absorption, poor compliance with the treatment, polymorphism of ADP receptors, GP IIb/IIIa and cytochrome P450 genes, acute coronary syndrome and @Disease$, metabolic syndrome."	0
"Indications for which the benefit of @Chemical$ has been shown are women with a history of preeclampsia responsible for a premature birth before 34 weeks, those having at least two history of preeclampsia, those with an @Disease$ and those with lupus associated with positive antiphospholipid antibodies or renal failure."	0
Pro@Disease$ and hemorrhagic effects of @Chemical$.	1
"CONCLUSIONS: Our findings do not support the notion that entericcoated LDA products confer a lower risk for GI complications than buffered formulations, but may conversely imply that the risk of @Disease$ complications associated with buffered @Chemical$ is lower than that of enteric-coated LDA."	0
Lyophilized aspirin with @Chemical$ may decrease the incidence of @Disease$ in healthy dogs.	0
"Minor @Disease$, from a 1748-patient sample, was more common in @Chemical$ patients (OR 1.50; 95% CI 1.13-2.00)."	0
BACKGROUND: @Chemical$ and nonsteroidal anti-inflammatory drugs (NSAIDs) are anti-inflammatory but have been linked in some studies to @Disease$ (CD) and ulcerative colitis (UC).	1
The rates of both stroke and bleeding increased with higher CHADS2 scores but @Chemical$ compared with aspirin was associated with a similar relative risk of @Disease$ (P interaction 0.21) and a reduced relative risk of stroke (P interaction 0.37) irrespective of CHADS2 category.	0
@Chemical$ therapy was not an independent risk factor for @Disease$.	0
In the subpopulation of @Chemical$-sensitive @Disease$tics the number of polypectomies correlated also with the density of mast cells and eosinophils in the polyp tissue.	0
We determined acute gastroduodenal erosion and ulceration following low-dose aspirin and @Chemical$-phosphatidylcholine complex (PL2200) in subjects at risk of aspirin @Disease$.	0
@Chemical$ in the treatment of @Disease$ associated with dipyridamole-aspirin combination.	0
"The most common adverse events were abdominal pain (ten [20%] in the @Chemical$ group vs 13 [25%] in the placebo group), nausea or @Disease$ (nine [18%] vs seven [13%]), and diarrhoea (11 [22%] vs six [12%])."	0
"Aspirin exacerbated respiratory disease (AERD) is characterized as adult onset asthma, nasal polyps, @Disease$, and hypersensitivity to a cyclooxygenase-1 (COX-1) inhibitor, viz @Chemical$ or nonsteroidal antiinflammatory drugs (NSAIDs)."	0
"Low-dose @Chemical$, one of non-steroidal anti-inflammatory drugs(NSAIDs), has been increasingly used to prevent cardiovascular and @Disease$ through its antiplatelet effect, mainly in the aged population, but aspirin treatment has been associated with gastrointestinal injures, especially peptic ulcer bleedings."	0
"The prevalence of @Disease$ or erosion during chronic use of @Chemical$, LDA and the anti-platelet drug thienopyridine (clopidogrel or ticlopidine), and NSAIDs were 64.3%, 80.0%, and 75.0%, respectively."	0
BACKGROUND: Current acetylsalicylic acid (@Chemical$) dosing algorithms for the prevention of secondary thrombotic events in acute @Disease$ (ACS) patients are inconsistent and lack sufficient data support.	0
"Recently, vitamin C releasing aspirin (@Chemical$-VitC) has been shown to reduce @Disease$ of ASA in animal model of gastric injury."	0
[@Chemical$ @Disease$: a rare situation today].	1
"These data closely match the frequency of @Disease$ that was observed in the CAPRIE trial, suggesting that therapy with @Chemical$, and/or aspirin holds very small (if any) risk for dyspnea."	0
"In view of these animal studies and in the absence of controlled studies of aspirin or NSAIDs in human @Disease$, we do not recommend indiscriminate treatment with NSAIDs or high-dose @Chemical$ in patients with myocarditis where there is no or minimal associated pericarditis."	0
"BACKGROUND: Although it is well known that aspirin causes @Disease$ and that @Chemical$-induced gastroduodenal mucosal injury is often asymptomatic, the prevalence and independent factors for gastroduodenal mucosal injury have not been clarified in asymptomatic patients taking low-dose aspirin and gastroprotective agents."	0
We investigated the role of serum specific IgE to thyroid peroxidase (TPO) in patients with @Chemical$ intolerant acute @Disease$ (AIAU) and aspirin intolerant chronic urticaria (AICU).	0
This abnormality may explain the low production of @Chemical$ in nasal @Disease$ and may account for the increased susceptibility to the inhibitory effects of aspirin.	0
"METHOD: We classified 1,041 gastroduodenal @Disease$ patients into three groups [patients taking LDA (group A), patients taking nonaspirin nonsteroidal anti-inflammatory drug (NSAID) (group N), and patients taking neither @Chemical$ nor nonaspirin NSAID (group C)] and 241 bleeding gastroduodenal ulcer patients into three corresponding groups (groups a, n, and c)."	0
"The case-control study was performed in 141 with AICU, 153 with @Chemical$-tolerant chronic @Disease$ (ATCU) and 174 with normal controls (NCs)."	0
"@Disease$, immediate and accelerated reactions, atopy, older age and chronic/recurrent urticaria were risk factors for hypersensitivity and/or cross-reactivity between ASA, ibuprofen and @Chemical$."	0
Method: Eighty-six patients with CRS and asthma who were treated in the outpatient clinic during March 2015 to January 2018 were divided into asthma group(52 cases) and aspirin @Disease$ group(34 cases) according to asthma and @Chemical$ asthma.	0
Several @Chemical$ desensitization protocols exist and have been proven to successfully treat ASA @Disease$ and allow for ASA therapy to be safely initiated.	0
"However, it is still not clear, how @Chemical$ affects expression of major platelet receptors in chronic drug users with @Disease$, especially those recovering in the methadone clinic maintenance program."	0
"In @Disease$ patients treated with ASA 650 BID for at least a year, 115/172 (67%) improved in their clinical courses while decreasing systemic and topical cortico@Chemical$."	0
It has been recognized that a high proportion of @Disease$ patients experience symptom aggravation when exposed to @Chemical$ and NSAIDs.	0
Safety of aspirin desensitization in patients with reported @Chemical$ allergy and @Disease$.	0
It has been postulated that precipitation of @Disease$ attacks by @Chemical$ is linked to inhibition of COX activity and massive release of cysteinyl leukotriene into the airway.	0
"Drugs that have been tried for prevention of @Disease$ in patients taking NSAIDs including H2-receptor antagonists, proton pump inhibitors (PPIs), aluminum- or magnesium-containing antacids, the @Chemical$ (Cytotec, and others), and antibiotics to eradicate H. pylori."	0
Nasal @Disease$: 18.5 +/- 3% (PP-- 15.0 +/- 4; A-- 15.5 +/- 6; ASA-- 30.0 +/- 8% and PP/@Chemical$-- p = 0.01; A/ASA-- p = 0.02).	0
"The method for diagnosing @Disease$ is with @Chemical$ challenge, and treatment includes aspirin desensitization followed by continued daily aspirin."	0
Galectin-10 mRNA is overexpressed in peripheral blood of @Chemical$-induced @Disease$.	1
Failure of tacrolimus to prevent @Chemical$-induced respiratory reactions in patients with aspirin-exacerbated @Disease$.	0
One of them is @Chemical$-induced @Disease$.	1
BACKGROUND &@Chemical$; AIMS: We hypothesized that the development of @Disease$ during treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) would be linked to alterations in gastric mechanosensory function and gastric emptying.	0
SIGNIFICANCE: IV DDAVP corrected prolongations in BMBT in dogs given aspirin and should be considered in dogs requiring prompt reversal of @Chemical$-induced @Disease$ to reduce the risk of bleeding complications.	1
"INTRODUCTION: Clinical features of @Chemical$-exacerbated respiratory disease (AERD) consist of moderate to severe asthma associated with chronic rhinosinusitis (@Disease$), which are derived from overproduction of cysteinyl leukotrienes along with chronic type 2 mediated inflammation in the upper and lower airway mucosa."	0
"A 78-year-old woman visited a local clinic because of @Disease$, and was prescribed levofloxacin, carbocisteine, and cold medicine (@Chemical$, acetaminophen, anhydrous caffeine, promethazine methylene disalicylate)."	0
RESULTS: In both groups of asthmatic patients women were majority (74% with difficult asthma and 66% with @Chemical$-induced @Disease$) with a higher level of anxiety and depressive symptoms than men.	1
Four of 12 patients with warfarin and bridging AC (33%) and two of 13 patients with uninterrupted @Chemical$ (15%) developed a @Disease$.	0
"To evaluate the preventive effect of @Chemical$ on @Disease$ caused by LDA alone and by the combination of both LDA and loxoprofen, we conducted a clinical study using healthy volunteers."	0
"OBJECTIVE: We sought to determine blood and urinary levels of 9alpha,11beta-PGF(2), a major stable PGD(2) metabolite in 2 well-defined phenotypes of asthma, @Chemical$-induced @Disease$ (AIA) and aspirin-tolerant asthma (ATA), and in healthy control subjects and to study the effects of aspirin on PGD(2) release."	1
"Lab measurements along with clinical symptoms indicated that all three patients experienced @Disease$, having increases in serum @Chemical$ of 186%, 144% and 249%, respectively."	0
"Cardiovascular and gastrointestinal events of three antiplatelet therapies: clopidogrel, @Chemical$ plus proton-pump inhibitors, and aspirin plus proton-pump inhibitors in patients with previous @Disease$."	0
Rationale: Daily high-dose aspirin therapy benefits many patients with aspirin-exacerbated respiratory disease but provides no benefit for @Chemical$-tolerant patients with @Disease$.	0
"Data Sources: We searched PubMed, Embase, CENTRAL, and ClinicalTrials.gov from inception to May 28, 2018, with the terms novel oral anticoagulants, non-vitamin K antagonist oral anticoagulants, direct oral anticoagulants, dabigatran, rivaroxaban, apixaban, edoxaban, warfarin, @Chemical$, vitamin K antagonist, aspirin, acetylsalicylic acid, or ASA, and major bleeding, fatal @Disease$, or intracranial hemorrhage."	0
"Notwithstanding the consistent benefits demonstrated with aspirin for both acute and chronic cardiovascular disease, there are a number of @Disease$ associated with @Chemical$ that have been showcased by recent long-term clinical trials that have included an aspirin monotherapy arm."	1
"@Disease$ patients suffer from an active disease despite avoidance of aspirin, and it has been suggested that administration of @Chemical$ to these patients increases the generation of immediate oxygen products of arachidonic acid, 12-hydroperoxyeicosatetraenoic acid (12-HPETE), in their platelets."	0
"Nevertheless, a considerable number of patients interrupt receiving @Chemical$ therapy during the preoperative period to minimize @Disease$ complications despite the increased risk of experiencing major adverse cardiac events."	0
CONCLUSION: The low-@Chemical$ diet may offer a novel treatment adjunct to the current management of @Disease$.	0
"The objective of this study was to test the effects of aspirin (1, 2.5 and 5 mg/kg), and ibuprofen (4 and 15 mg/kg), diclofenac (2.5 mg/kg), flurbiprofen (2 mg/kg), celecoxib (7.5 mg/kg), and @Chemical$ (1 mg/kg), alone or combined on a rat model of arterial @Disease$."	0
Clopidogrel alone administered to patients taking OAC after PCI was associated with a significantly lower rate of @Disease$ complications than @Chemical$ plus aspirin.	0
"Background: Aspirin-exacerbated respiratory disease (@Disease$), a syndrome that includes asthma, recurrent nasal polyps, and pathognomonic reactions to @Chemical$ and other nonselective cyclooxygenase inhibitors, is still not fully understood and lacks specific disease-modifying therapeutic options."	0
The results indicated that lyophilized aspirin/trehalose induced less @Disease$ than aspirin despite maintaining therapeutic concentrations of plasma @Chemical$ in both the groups.	0
"Multiple electrode whole blood aggregometry, @Chemical$-100, and in vivo bleeding time for the point-of-care assessment of aspirin-induced @Disease$ in the preoperative setting."	0
APT was negative in 41 patients (77.4%) although three (7.3%) had a history of @Chemical$ @Disease$.	1
"Use of NSAIDs, LDA, @Chemical$, and ACs within 2 weeks prior to the endoscopy was compared between cases and controls, and effects on @Disease$ bleeding were calculated."	0
Changes in Hb after @Chemical$ and the emergence or worsening of pre-existing @Disease$ was determined.	0
"@Chemical$-exacerbated @Disease$ (AERD) is a unique syndrome of airway inflammation that frequently occurs in patients with nasal polyposis, chronic sinusitis, and asthma."	1
"However, recently, there has been growing interest among gastroenterologists on the adverse effects of @Chemical$ on the small bowel, especially as new endoscopic techniques, such as capsule endoscopy (CE) and balloon-assisted endoscopy, have become available for the evaluation of @Disease$ lesions."	0
"METHODS: A case series of three patients suffering severe nausea, vomiting, @Disease$, renal dysfunction and clinical decline during @Chemical$ therapy was examined."	0
"On the other hand, SA alone inhibited basal gastric motility without any effect on mucosal PGE2 contents, and this agent, when given together with indomethacin, prevented @Disease$ and lesion formation in response to indomethacin, without affecting the reduced @Chemical$ contents."	0
"Risk of @Disease$ with single, dual, or triple therapy with @Chemical$, aspirin, and clopidogrel in patients with atrial fibrillation."	0
Failure to maintain an @Chemical$-desensitized state in a patient with aspirin-exacerbated @Disease$.	0
Risk of major @Disease$ with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term @Chemical$ therapy.	0
"The presence of @Chemical$ in the blood or urine of @Disease$ patients has not been demonstrated, and no animal model of Reye's syndrome has been developed where aspirin causes the disease."	0
"CONCLUSION: In a healthy population taking aspirin (81 mg q.d.), coadministration of celecoxib resulted in fewer GDUs than naproxen, but significantly more @Disease$ than @Chemical$ alone."	0
All of them concomitantly received 100 mg/day @Chemical$ because of previous ischaemic heart disease and presented similar clinical features: sudden onset of abdominal pain during a severe @Disease$ episode due to bronchial infection.	0
@Chemical$ @Disease$ in perspective.	1
"Comparison between the warm needling group and @Chemical$ group showed that the UI, both serum and @Disease$ activity, and serum MDA level of the former group were evidently higher than those of the Omeprazole group (P&lt;0. 05), but gastric mucosal MDA level of the warm needling group was apparently lower than that of the Omeprazole group (P&lt;0.05)."	0
"Major @Disease$ occurred in only 9 patients, 2 of 285 (0.9%) in the @Chemical$ group and 7 of 932 (0.8%) in the control group (not significant)."	0
The two frequent clinical presentations of aspirin @Disease$ are: @Chemical$-induced bronchial asthma/rhinosinusitis (AIA/R) and aspirin-induced urticaria/angioedema (AIU).	0
"Results showed fewer upper GI symptoms, decreased size of @Disease$, and improved heartburn symptoms in subjects receiving @Chemical$ compared to EC-ASA."	0
RESULTS: The study observed a heterogeneous distributed @Chemical$ 100 mg/d AA-Ag (range: 0.42% to 28.78%)in the 537 very elderly patients.Aspirin 100 mg/d AA-Ag before the switch in aspirin 40 mg/d group was 5.00%+-2.32% and the rate of the patients with low on-treatment @Disease$ was 71.00%.	0
Local mechanisms of GI protection are important as aspirin's preassociation with surface-active @Chemical$ significantly reduced @Disease$.	0
"The authors assessed the prevalence of @Disease$ following extended-release @Chemical$/aspirin combination (DAC), and the efficacy of acetaminophen in the treatment of these headaches."	0
The present study evaluated the dose-response for montelukast (@Disease$) against nasal lysine-@Chemical$ challenge in patients with AIA.	0
"H. pylori @Disease$ and low-dose @Chemical$ (LDA) are not only independent causal factors of peptic ulcer and gastrointestinal bleeding, they also have synergistic and additive effects."	0
This is a distinct clinical syndrome called @Chemical$-induced asthma (@Disease$).	0
OBJECTIVE: The Japanese health insurance system approved the use of proton pump inhibitors (PPIs) for the prevention of peptic @Disease$ in patients using low-dose aspirin (@Chemical$) and/or non-steroidal anti-inflammatory drugs (NSAIDs).	0
Stroke recurrence in an elderly CADASIL patient on @Chemical$ discontinuation due to severe auto-immune @Disease$.	0
"History of @Disease$ or non-complicated peptic ulcer, alcohol intake, concomitant treatment with NSAID or calcic inhibitors are demonstrated risk factors of bleeding ulcer associated with low-dose @Chemical$."	0
"The effect of topical NSAID (tNSAID), especially @Chemical$ which are commonly present in topical medicated preparations, on @Disease$ control of this phenotype is studied."	0
"For those with OBRI score of &gt;=2, there was a trend for reduced @Disease$ with warfarin compared to @Chemical$ (HR 0.56, 95% CI 0.27 to 1.15, p = 0.12), but major bleeding was increased (HR 4.04, 95% CI 1.99 to 8.22, p &lt;0.001)."	0
"RESULTS: The pooled odd ratios showed that @Chemical$ use was associated with early @Disease$ (pooled odds ratio 1.43, 95% CI 1.09-1.88)."	0
"With exception of @Chemical$, all active therapies significantly reduced @Disease$ recurrence risk versus aspirin, ranging from a 73% reduction with either apixaban 2.5mg or rivaroxaban to 80% with VKAs."	0
Low-dose @Chemical$ is as effective as aspirin and paracetamol for the indications normally treated with over-the-counter (OTC) medications and is associated with the lowest risk of @Disease$ of any non-steroidal anti-inflammatory drug.	0
We conclude that melatonin and its precursor tryptophan given orally significantly reduce @Disease$ induced by ASA possibly due to (a) direct gastroprotective action of exogenous melatonin or that generated from tryptophan and (b) gastrin released from the gastric mucosa by melatonin or @Chemical$.	0
"CONCLUSIONS: We found that the prevalence of CMBs did not increase in the group of @Chemical$ use, and the presence of CMBs was not associated with the duration of aspirin use in asymptomatic elderly subjects without a history of @Disease$ or transient ischemic attack."	0
The effect of preceding @Chemical$-use on outcome after @Disease$ is poorly investigated.	0
Whole blood multiple electrode aggregometry is a reliable point-of-care test of @Chemical$-induced @Disease$.	1
"At 1 month after discharge, although patients with in-hospital @Disease$ remained significantly less likely to receive aspirin (odds ratio=0.68; 95% CI, 0.50 to 0.92), use of @Chemical$s in the 2 groups started to become similar."	0
"OBJECTIVE: To provide further insights on the risks of gastrointestinal (@Disease$) complications in individuals using low-dose aspirin (@Chemical$), we investigated the concomitant use of LDA and antisecretory drugs."	0
"In contrast, low-dose @Chemical$ is associated to increased risk of overall fractures and @Disease$s of the hip."	1
"CYP4F2 T allele significantly increased odds for @Disease$ in @Chemical$ users (OR: 8.270, 95% CI: 3.917-17.462; p &lt; 0.001)."	1
"Incidences of poor bleeding control during the procedure and @Disease$ after the procedure were 7.7% (1/13) and 15.4% (2/13) of patients, respectively, in the LDA-interrupted group, and 3.2% (1/31) and 16.1% (5/31) of patients, respectively, in the @Chemical$-continued group."	0
"Despite more than a half-century of recognition, the triad characterised by severe asthma, @Disease$ and acetylsalicylic acid intolerance known as @Chemical$-induced asthma or Widal's triad remains markedly underdiagnosed and mistreated."	0
"@Chemical$ is commonly used for many years as @Disease$ relief drug, anti-inflammatory and against temperature, as well as antiaggregatory agent in coronary disease therapy."	0
The relationship between historical aspirin-induced asthma and severity of @Disease$ induced during oral @Chemical$ challenges.	1
"Results: Multivariate binary regression analysis demonstrated that aspirin use and CYP4F2 T allele significantly increased odds for @Disease$ in @Chemical$ users (OR: 2.488, 95% CI: 1.452-4.265; p = 0.001 and OR: 1.573, 95% CI: 1.066-2.320; respectively; p = 0.022)."	1
"METHODS: The effect of arachidonic acid or platelet agonists on LTC4 synthase activity was investigated in platelets obtained from healthy volunteers, aspirin-intolerant asthmatics or aspirin-tolerant @Disease$tics after in vivo treatment or in vitro pre-incubation with @Chemical$."	0
@Chemical$-exacerbated @Disease$: characteristics and management strategies.	1
BACKGROUND: The blocking effect of controller medications for @Disease$ could have an effect on the outcome of @Chemical$ challenges in patients suspected of having aspirin-exacerbated respiratory disease (AERD).	0
"Forty two percent of patients were regular aspirin users, and were comparable to the non @Chemical$ group, apart from having a significantly greater prevalence of @Disease$."	0
"We investigated the risks of ischemic stroke and intracranial hemorrhage (@Disease$) in relation to warfarin at various TTRs in a real-world cohort of Chinese patients with atrial fibrillation receiving warfarin and compared with those on dabigatran, @Chemical$, and no therapy."	0
BACKGROUND: @Chemical$ (ASA) is used in the treatment of @Disease$ (AMI) but is also a risk factor for peptic ulcer disease (PUD) bleeding.	0
"Patients who are on chronic warfarin therapy and receive a coronary stent need to be treated with the triple therapy of aspirin, @Chemical$ and warfarin; however, the @Disease$ risk in these patients is unknown."	0
"Older age, @Chemical$ monotherapy and peptic @Disease$ were significant predictors of antithrombotic discontinuation, whereas dual antiplatelet use predicted antithrombotic maintenance."	0
"Prescription of other NSAIDs was associated with significantly reduced risk of @Disease$ of @Chemical$ (adjusted OR=0.8, 95% CI=0.7, 0.9), HN (adjusted OR=0.8, 95% CI=0.7, 0.9) and the oesophagus (adjusted OR=0.8, 95% CI=0.7, 0.9)."	1
These include @Disease$ from @Chemical$ and ischaemic colitis relating to serotonin antagonists.	1
"We examined 18 patients of aspirin @Disease$ at dermatology of Yodogawa Christian Hospital, especially as to oral @Chemical$ challenge test."	0
BACKGROUND: @Chemical$-exacerbated respiratory disease (@Disease$) is characterized by respiratory reactions on ingestion of COX-1 inhibitors and cysteinyl leukotriene overproduction.	0
"METHODS: Between June 1999 and December 2014, 1422 patients were treated for @Disease$ SAH in our institution, 144 (10.1%) with continuous @Chemical$ at the time of aneurysm rupture."	0
"CONCLUSIONS: This study showed an important proportion (18%) of dispatched @Chemical$ users adults to digestive endoscopy, the 13.8% of them have a clear indication to use it, a substantial percent (13%) cannot inform any medical reason; the aspirin usage for more than six months in doses lower than 500 mg per day increases the @Disease$ prevalence (58%)and relative risk of suffering these injuries are high."	0
"Alternatively, the most reliable evidence with which to evaluate the effects of regular @Chemical$ use in @Disease$ will derive from well-designed randomized trials of sufficient size and duration."	0
"For participants with OBRI scores of 0 to 1, @Chemical$ compared with aspirin reduced @Disease$ (hazard ratio [HR] 0.51, 95% CI 0.26 to 0.98, p = 0.042) without significantly increasing major bleeding (HR 1.24, 95% CI 0.66 to 2.30, p = 0.51)."	0
The intragastric administration of acidified @Chemical$ induced @Disease$ and hemorragic erosions in rat stomach.	1
"RRs (95% CI) for &gt;=1 year of low-dose @Chemical$ use were 0.90 (0.72-1.13) for ICH, 1.20 (0.91-1.57) for SDH, and 0.69 (0.50-0.94) for @Disease$."	0
RESULTS: The healing of @Chemical$ induced @Disease$s and the progenitor cells expressing CXCR4(+)VEGFR1(+) cell were significantly delayed in NSAID treated mice.	1
"RESULTS: During a median follow-up of 12 months, 9 of the 61 patients in the placebo group (14.8 percent), as compared with 1 of the 62 patients in the @Chemical$ group (1.6 percent), had a recurrence of @Disease$ complications (adjusted hazard ratio, 9.6; 95 percent confidence interval, 1.2 to 76.1)."	0
CONCLUSION: This study shows that the low expression of COX-2 mRNA in nasal @Disease$ from @Chemical$-sensitive patients is associated with a down-regulation of NF-kappaB activity.	0
METHODS: The Apixaban versus Acetylsalicylic Acid to Prevent @Disease$ in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for @Chemical$ Antagonist Treatment (AVERROES) trial randomized 5599 patients with atrial fibrillation and risk factors to receive either apixaban or aspirin.	0
Differential levels of these components in @Chemical$-exacerbated respiratory disease (AERD) and allergic rhinitis with @Disease$ (ARwA) may be related to a different inflammatory response in both asthma phenotypes.	0
"@Chemical$ has a cytoprotective action against NSAID-induced @Disease$, and this action is not mediated by endogenous AD but may be functionally associated with inhibition of the gastric motility response."	0
"One study showed increased major GI bleeding (but not non-GI @Disease$ endpoints) with @Chemical$ versus clopidogrel (RR=1.45; 95% CI, 1.00-2.10)."	0
@Chemical$-exacerbated @Disease$: update on pathogenesis and desensitization.	1
Oral @Chemical$ challenge (OAC) test was performed to identify aspirin @Disease$.	0
"CONCLUSION: The incidence of UGIB in patients with @Disease$ on long-term low-dose @Chemical$ is low, but is accompanied with significant morbidity."	0
Comparison of bleeding complications with omega-3 fatty acids + aspirin + clopidogrel--versus--@Chemical$ + clopidogrel in patients with @Disease$.	0
@Chemical$ and clopidogrel are well-known antiplatelet agents that are widely used across the spectrum of cardio- and @Disease$.	0
Spontaneous @Disease$ associated with high myopia and @Chemical$.	1
"Previous studies indicate that hypoacidity related to corpus atrophy, as well as taking PPIs and co-treatment with angiotensin type 1 receptor blockers (ARBs) and statins seem to reduce peptic @Disease$ among @Chemical$ users."	0
This analysis explores patterns of bleeding and defines bleeding risks based on @Disease$ risk with @Chemical$ and aspirin.	0
Single nucleotide polymorphism markers for low-dose @Chemical$-associated peptic ulcer and @Disease$ bleeding.	1
@Chemical$-sensitive respiratory disease (ASRD) is a condition characterized by persistent and often severe @Disease$ and lower respiratory tracts.	0
"In total, 9 fatal @Disease$ occurred on @Chemical$ and 4 on aspirin."	0
"Patients with in-hospital @Disease$ were less likely to be discharged on aspirin or @Chemical$ (adjusted odds ratio=0.45; 95% CI, 0.31 to 0.64; and odds ratio=0.62; 95% CI, 0.42 to 0.91, respectively)."	0
CONCLUSIONS: Rates of @Disease$ and thrombotic events were not significantly different according to 6- versus 24-month DAPT after PCI with new-generation DES in good @Chemical$ responders.	0
"There was no increase in headache frequency in participants with @Chemical$+ intake compared with aspirin (adjusted, all headache: -0.34 d/mo [95% confidence intervals: -2.50 to 1.82], migraine: -1.36 d/mo [-4.76 to 2.03], TTH: -0.57 d/mo [-4.97 to 3.84], MigTTH: 2.46 d/mo [-5.19 to 10.10]) or no analgesics (all @Disease$: -2.24 d/mo [-4.54 to 0.07], migraine: -3.77 d/mo [-9.22 to 1.68], TTH: -4.68 d/mo [-9.62 to 0.27]; MigTTH: -3.22 d/mo [-10.16 to 3.71])."	0
Combined @Chemical$-aspirin treatment for high risk @Disease$ or minor stroke does not increase cerebral microbleeds.	0
Lipoxin A4 levels in @Disease$: relation with disease severity and @Chemical$ sensitivity.	0
RESULTS: A total of 612 509 patients were included; 5118 (2.51%) out of 204 170 @Chemical$ users were diagnosed with CRC; and 2073 (1.02%) died of the @Disease$.	0
"Comparative tolerability of @Chemical$, aspirin and ibuprofen for short-term analgesia in patients with @Disease$: results in 4291 patients."	0
"The purpose of this study is to evaluate the peri- and @Disease$ and cardiovascular complication rates of patients undergoing non-instrumented, extradural, lumbar spine surgery with or without discontinuation of low-dose @Chemical$."	0
"Despite these insufficient @Chemical$ antiplatelet effects, @Disease$ events were rare and bleeding complications more frequent."	0
Dual antiplatelet therapy using @Chemical$ and a thienopyridine (e.g. clopidogrel) is known to be essential in patients in whom percutaneous coronary intervention with stent implantation has been performed in order to prevent stent @Disease$ and its fatal consequences.	0
We aimed to determine uBrTyr levels in patients with AERD (n = 240) and @Chemical$-tolerant @Disease$ (ATA) (n = 226) and to assess whether its addition to urinary leukotriene E4 (uLTE4) levels and blood eosinophilia can improve the prediction of AERD diagnosis.	0
"Data Sources: We searched PubMed, Embase, CENTRAL, and ClinicalTrials.gov from inception to May 28, 2018, with the terms novel oral anticoagulants, non-vitamin K antagonist oral anticoagulants, direct oral anticoagulants, dabigatran, rivaroxaban, apixaban, edoxaban, warfarin, Coumadin, @Chemical$ antagonist, aspirin, acetylsalicylic acid, or ASA, and major bleeding, fatal bleeding, or @Disease$."	0
"In contrast, low-dose @Chemical$ is associated to increased risk of overall @Disease$s and fractures of the hip."	1
Presented in the article are the results of studying antiaggregate activity of acetylsalicylic acid and @Chemical$ in a total of 36 patients suffering from various-severity chronic @Disease$ of lower limbs on the background of atherosclerosis obliterans.	0
"The full clinical picture reveals a classic triad of symptoms (Samters Triad): @Chemical$ induced bronchial asthma (with severe acute asthma attacks), aspirin-sensitivity and chronic rhinosinusitis with @Disease$."	0
"In those with established CVD, @Chemical$ use has been documented to decrease the risk of a first @Disease$ (MI)."	0
"CONCLUSION: In short-term @Disease$ induced by @Chemical$, damage was observed in the duodenum most frequently, and peak damage was at 24 hrs and 72 hrs."	1
"However, as discontinuation of aspirin, unlike NSAIDs, may precipitate @Disease$ and cerebrovascular events, treatment of aspirin-associated ulcers should re-start @Chemical$ as soon as possible, using proton pump inhibitor (PPI)."	0
"CONCLUSION: Upper @Disease$ and neoplasm were found in not only the stomach, but also the esophagus and duodenum in @Chemical$ taking subjects."	1
"PURPOSE: Self-@Disease$ occurs with over-the-counter (OTC) drugs, particularly @Chemical$ (acetaminophen)."	0
CONCLUSIONS: Patients on aspirin and @Chemical$ &lt;5days before CABG who had preoperative ADP-induced @Disease$ &gt;=50% have bleeding risk similar to those receiving aspirin monotherapy.	0
"The questions addressed different clinical scenarios regarding @Disease$ associated with traditional NSAIDs (tNSAIDs), @Chemical$ and Hp."	0
"METHODS: We searched PubMed, EMBase, @Disease$ and Cochrane Central Register of Controlled Trials (up to June, 2013) for randomized controlled trials evaluating the efficacy and safety of @Chemical$ plus aspirin versus aspirin alone in high vascular risk patients."	0
"A case-crossover study was used to retrieve data on 10,905 incident patients with major hemorrhagic complications (3,781 cerebral and 7,124 @Disease$) and prescribed low-dose @Chemical$ (&lt;=300 mg/day) from 2000-2008."	0
Chronic rhinosinusitis with nasal polyps (CRSwNP) and @Disease$ frequently coexist and are always present in patients with @Chemical$ exacerbated respiratory disease (AERD).	0
"Omeprazole appears to be very effective in reducing both acute gastroduodenal mucosal damage and upper GI bleeding in the high-risk patient taking low-dose aspirin, but data with other anti-@Disease$ agents are lacking (misoprostol) or inconsistent (@Chemical$) at present."	0
Approach to patients with @Chemical$ hypersensitivity and acute @Disease$.	1
"OBJECTIVES: To evaluate if @Chemical$ prevents recurrent peptic @Disease$ in adult patients with a history of peptic ulcer receiving low-dose acetylsalicylic acid (ASA, aspirin) for cardiovascular protection in East Asia."	0
The natural history and clinical characteristics of @Chemical$-exacerbated @Disease$.	1
The composite of ICrH or fatal @Disease$ included 15 patients on ticagrelor and 18 on @Chemical$.	0
We compared @Disease$ and all-cause mortality after dual antiplatelet therapy (DAPT) for the combination of clopidogrel and aspirin (ASA) versus ASA alone over 18 months follow-up in event-free patients at 12 months @Chemical$ from the Health Insurance Review and Assessment (HIRA) dataset via the Korean Outcomes Registry Evaluating Antithrombotics (KOREA).	0
"Non-steroidal anti-inflammatory drugs (NSAIDs), including @Chemical$, seem to have chemopreventive properties against several types of cancer, particularly colon @Disease$."	0
"Analyses of the genetic backgrounds of patients with AIA and @Chemical$ will promote the development of early diagnostic and therapeutic interventions, which may reduce the incidence of @Disease$ and AIU."	0
An evaluation of studies comparing various @Chemical$ preparations and the risk of @Disease$ was conducted.	0
Regular @Chemical$-use preceding the onset of @Disease$ associated significantly with hematoma enlargement during the first week after ICH (P=0.006).	0
@Chemical$-sensitive @Disease$ is the manifestation of aspirin intolerance in the upper respiratory tract.	1
"Type 2 inflammation characterizes @Chemical$-exacerbated respiratory disease.Objectives: To determine whether high-dose aspirin therapy changes biomarkers of type 2 @Disease$ in aspirin-exacerbated respiratory disease.Methods: Forty-two subjects with aspirin-exacerbated respiratory disease underwent an aspirin desensitization and were placed on high-dose aspirin (1,300 mg daily)."	0
BACKGROUND: @Chemical$ (ASP)-facilitated absorption of ingested allergens is considered an exacerbating factor in the development of @Disease$.	1
BACKGROUND: Low-dose aspirin (@Chemical$) frequently causes @Disease$.	1
Those who respond to systemic @Chemical$ or have intractable or recurrent nasal @Disease$ are particularly well-suited for this therapeutic intervention.	0
CONCLUSIONS: Daily @Chemical$ 20 mg is efficacious and well tolerated in reducing the recurrence of peptic ulcer in East-Asian patients with a history of @Disease$s who are taking low-dose ASA for cardiovascular protection.	0
"Aspirin results in prolonged inhibition of blood coagulation, and @Chemical$ can result in @Disease$ at normal dose and liver failure at higher dose."	1
Glutathione peroxidase (GPX) reduces semi-stable @Chemical$ to less reactive alcohols and removes H(2)O(2) involved in @Disease$.	0
"BACKGROUND: @Chemical$ in combination with aspirin, given before percutaneous coronary intervention, has become the standard for stent @Disease$ prevention."	0
CONCLUSIONS: Overusing @Chemical$ powders affects regional @Disease$ in CM.	1
Cerebral microbleeds in patients with @Disease$ taking aspirin or @Chemical$.	0
"The aim of our study was to evaluate the risk of @Disease$ associated with acute and chronic NSAID or @Chemical$ therapy in elderly subjects, and the influence of gastroprotective treatment on such a risk."	1
"To evaluate the @Disease$ risk in patients requiring chronic warfarin therapy and undergoing stent implantation, we compared 107 consecutive patients on chronic warfarin therapy who underwent coronary stenting and were discharged on aspirin, clopidogrel and warfarin to 107 contemporary patients who were treated with aspirin and @Chemical$."	0
METHODS: In this meta-analysis we included randomized controlled trials that compared @Chemical$ to VKA (1.4&lt;INR&lt;3.5) for the prevention of @Disease$ with a minimum of three month follow-up and of 50 patients per treatment arm.	0
Method: Eighty-six patients with CRS and asthma who were treated in the outpatient clinic during March 2015 to January 2018 were divided into @Disease$ group(52 cases) and aspirin asthma group(34 cases) according to asthma and @Chemical$ asthma.	0
"Any bridging @Chemical$ (odds ratio [OR] 10.3, 1.8-60.8, P = 0.01), clopidogrel (OR 10.0, 1.7-57.7, P = 0.01), and uninterrupted warfarin without bridging (OR 11.1, 1.7-74.3, P = 0.013) were independently associated with @Disease$ formation."	0
"@Chemical$ is widely used for its antiplatelet activity, but it harbors a risk of severe @Disease$, such as bleeding and perforation, especially in elderly people."	1
Altered eicosanoid metabolism is the generally accepted mechanism of aspirin intolerance; the overproduction of cysteinyl leucotrienes has been suggested to play a causative role in both @Disease$ and @Chemical$.	0
"It can be concluded that @Chemical$ and IBU administered either alone or in combination can cause @Disease$ in the rat stomach after 6 h and 18 h, but less severe after 6 days."	0
Our retrospective study reviewed the effectiveness of PFA-100 in detecting @Disease$ caused by @Chemical$ and clopidogrel and determined its clinical importance.	1
"@Chemical$ exacerbated @Disease$ (AERD) is an adult onset condition manifested as asthma, rhinosinusitis/nasal polyps, and sensitivity to aspirin and other cyclooxygenase-1 (Cox-1)-inhibitor nonsteroidal anti-inflammatory drugs (NSAIDs)."	1
"In patients with Hp-negative, NSAID-/aspirin-associated @Disease$, &gt; 80 % of respondents would initiate long-term proton pump inhibitor (PPI) therapy, whereas 20 % and 17.8 % would prescribe COX-2 selective inhibitors or opiates instead of non-selective NSAIDs and clopidogrel instead of @Chemical$."	0
"Although no causal link has been proven, data from case-control and historic cohort studies demonstrate an association between @Chemical$ use and @Disease$."	0
NSAID-induced inhibition of mucosal @Chemical$ synthesis is thought to be a major mechanism of @Disease$.	0
Nasal provocation test (NPT) with aspirin: a sensitive and safe method to diagnose @Chemical$-induced @Disease$ (AIA).	1
"Non@Chemical$ NSAID use was associated with a slightly increased OR for prostate cancer (1.13; 95 % CI 1.10-1.15); however, this association was confined to @Disease$ and did not vary materially with amount, duration, or consistency of nonaspirin NSAID use."	0
"However, inappropriately treated patients had significantly lower levels of blood pressure and total @Chemical$, and were more likely to be female, younger and @Disease$ than patients appropriately treated."	0
"Acute @Disease$ complications are not immediate and usually follow interruption of @Chemical$ or clopidogrel therapy after a mean delay of 8-25 days, a time lapse consistent with normal platelet turnover required to replace the platelet pool in circulation and suggestive of a rebound phenomenon."	0
"@Disease$ were found in 54 of 98 (60.7%) users of buffered @Chemical$ (BA), whereas 38 of 101 (37.6%) users of ECA had mucosal defects."	0
"Factors associated with an increased risk of upper GI complications during low-dose @Chemical$ therapy include aspirin dose, history of ulcer or upper GI bleeding, age &gt; 70 years, concomitant use of NSAIDs (including COX-2-selective NSAIDs), and @Disease$."	0
@Chemical$ is widely used as an antiinflammatory drug especially in children with @Disease$.	0
Bleeding during treatment with aspirin versus apixaban in patients with atrial fibrillation unsuitable for warfarin: the apixaban versus acetylsalicylic acid to prevent stroke in @Disease$ patients who have failed or are unsuitable for vitamin K antagonist treatment (@Chemical$) trial.	0
"@Disease$ patients suffer from an active disease despite avoidance of aspirin, and it has been suggested that administration of aspirin to these patients increases the generation of immediate @Chemical$ products of arachidonic acid, 12-hydroperoxyeicosatetraenoic acid (12-HPETE), in their platelets."	0
"The gene coding for LTC4 synthase exists in two common alleles, one of which appears to be associated with a severe, @Chemical$-dependent type of @Disease$."	0
CONCLUSIONS: SLCO1B1 1b haplotype may identify patients at increased risk for @Chemical$-induced peptic @Disease$.	0
"@Chemical$ (AA, 0.5 mg/mL) and adenosine diphosphate (ADP, 5 micromol/L) induced @Disease$ were measured via light transmission assay (LTA) to evaluate antiplatelet responses, referred as LTA-AA and LTA-ADP."	1
ADP (5 and 20 micromol)-induced @Disease$ was significantly decreased with @Chemical$ (p &lt;0.001) but remained stable under additional treatment with atorvastatin or pravastatin in the 2 groups.	0
"CONCLUSION: In a healthy population taking aspirin (81 mg q.d.), coadministration of celecoxib resulted in fewer GDUs than @Chemical$, but significantly more @Disease$ than aspirin alone."	0
"Subgaleal hematoma in a child with @Disease$: to prevent stroke-like episodes, is treatment with @Chemical$ advisable?"	0
"The multivariate odds ratio of @Chemical$-associated UGIB was 3.318 (95% confidence interval (CI) 1.650-6.671, p = 0.0008) for a history of peptic @Disease$, 0.086 (95% CI: 0.011-0.652, p = 0.0176) for the use of a proton pump inhibitor (PPI) with LDA, and 0.253 (95% CI: 0.113-0.569, p = 0.0009) for the use of a histamine type 2 receptor antagonist (H2RA) with LDA."	0
"Inducible nitric oxide synthase (iNOS) expression is upregulated in @Disease$ epithelium, implying a role for @Chemical$ (NO) in its formation."	0
"CONCLUSION: Most variants that have clinical significance in @Chemical$ response are related with drug efficacy or drug @Disease$ or ADR, indicating the urgency of variants screen in clinical practice.Significant population-specificity is detected in local 620 WES data in aspirin-response-related variants."	0
"Therefore, treatment with daily @Chemical$ is a significant therapeutic option for patients afflicted with @Disease$."	0
"Of the three ophthalmological studies highlighting the adverse affects of @Chemical$ association with AMD, all suggested an exacerbation of @Disease$ without statistical significance and broad confidence bands."	0
Nasal polyp tissues were obtained from 29 patients [including nine with @Chemical$ (ASA)-hypersensitivity and 12 with bronchial asthma] undergoing polypectomy for @Disease$.	0
@Chemical$ is a novel protease-activated receptor-1 (PAR-1) antagonist recently approved for the reduction of thrombotic cardiovascular events in patients with a history of myocardial infarction or with @Disease$.	0
"Aspirin-exacerbated respiratory disease (AERD) refers to the combination of asthma, chronic rhinosinusitis with @Disease$, and acute upper and lower respiratory tract reactions to the ingestion of @Chemical$ (acetylsalicylic acid, ASA) and other cyclooxygenase-1 inhibiting non-steroidal anti-inflammatory drugs."	0
"DISCUSSION: Our findings suggest that the KIF3A gene and/or its polymorphisms might have a susceptibility effect on @Disease$, providing a new step toward controlling @Chemical$ intolerance in asthmatics."	0
"QUESTION/PURPOSES: We sought to answer four questions: For the THA and TKA cohorts, respectively, (1) was the incidence of readmission resulting from VTE and @Disease$ complications higher with LMWH than mobile compression plus @Chemical$; and (2) was the incidence of wound bleeding complications higher with LMWH than mechanical compression plus ASA?"	0
"After 2 months of treatment with 10 mg/day of oral @Chemical$, 1600 mug/day of inhaled fluticasone propionate, montelukast as a leukotriene receptor antagonist (LTRA), and long-term beta-agonist, we again challenged her with a provocation test with up to 200 mg of celecoxib; this time there were neither @Disease$ symptoms nor decrease in forced expiratory volume in 1 second."	0
"Because of the potential interaction between proton pump inhibitors (PPI) and clopidogrel that compromises the efficacy of clopidogrel on @Disease$, there has been a warning in the product information by health authorities in the US and in Europe who discourage the concomitant use of PPI and @Chemical$."	0
"The most common reasons for recommending aspirin discontinuation were concern about bleeding after polypectomy (62%), perceived minimal downside to stopping @Chemical$ (38%), inertia to changing old policies (20%), and concern about medicolegal implications of postpolypectomy @Disease$ (15%)."	0
Mean @Disease$(20) was 163.4 +/- 39.9 mg @Chemical$ among patients who reacted with bronchospasm to ASA.	0
"In our study, @Chemical$+ intake did not increase @Disease$ frequency compared with aspirin or no analgesics."	0
"BACKGROUND: @Chemical$-exacerbated respiratory disease (AERD) is a disorder of nasal polyposis, @Disease$, and hypersensitivity respiratory reactions when on systemic cyclooxygenase 1 blockade."	0
Minimizing @Chemical$ use in hemodialysis patients with severe hypertension reduced intracerebral @Disease$ without a significant difference in cardiovascular mortality.	0
"In an effort to discover additional polymorphism(s), the variant(s) of which have been implicated in @Disease$ and @Chemical$ intolerance, we scrutinized genetic polymorphisms of the CYSLTR2 gene, and evaluated this locus as a potential candidate for asthma."	0
"METHODS: For 4 years, we followed up 22 patients with chronic idiopathic urticaria and aspirin @Disease$ who restrained from the use of @Chemical$ and other COX-1 inhibitors."	0
"CONCLUSIONS: In this subgroup analysis in patients at high risk for recurrence of gastric ulcer, use of cotherapy with misoprostol 200 microg QID or @Chemical$ 15 or 30 mg OD significantly lowered the risk for @Disease$ ulcer recurrence."	0
High serum triglycerides were associated only with @Chemical$-related peptic @Disease$.	0
"Omeprazole appears to be very effective in reducing both acute gastroduodenal mucosal damage and upper @Disease$ bleeding in the high-risk patient taking low-dose aspirin, but data with other anti-ulcer agents are lacking (@Chemical$) or inconsistent (ranitidine) at present."	0
Non-prior @Chemical$ users presented with higher rates of non-Q-wave @Disease$.	0
"By comparison, there was no association with risk of incident @Disease$ for increasing use of aspirin, non@Chemical$ NSAIDs, or ibuprofen."	0
"Low-dose aspirin, one of non-steroidal anti-inflammatory drugs(NSAIDs), has been increasingly used to prevent @Disease$ and cerebrovascular disease through its antiplatelet effect, mainly in the aged population, but @Chemical$ treatment has been associated with gastrointestinal injures, especially peptic ulcer bleedings."	0
"For subtypes of late AMD, regular @Chemical$ use 10 years prior to retinal examination was significantly associated with neovascular AMD (HR, 2.20 [95% CI, 1.20-4.15]; P = .01) but not pure geographic @Disease$ (HR, 0.66 [95% CI, 0.25-1.95]; P = .45)."	0
"Those receiving apixaban/aspirin had similar @Disease$ risk compared with those receiving @Chemical$/aspirin (HR 1.01, 95% CI 0.53-1.95)."	0
SBPCPTs with @Chemical$ revealed that 14 of 58 patients (24%) with CPU and one of 10 patients with CRU (10%) were aspirin @Disease$.	0
"As a result, @Chemical$'s incidence of peptic ulcer disease (PUD) and ulcer @Disease$ is lower than aspirin's."	0
"In 2-23% of adults with asthma, and rarely in children with asthma, @Chemical$ (acetylsalicylic acid) and non-steroidal anti-inflammatory drugs (NSAIDs) cause @Disease$ exacerbations."	0
"BACKGROUND: We describe three patients with Samter's triad (nasal polyps, @Chemical$ intolerance, and asthma) with skull base dehiscence in whom the @Disease$ extended into the extradural space and also resulted in hypertelorism and widening of the nasal bridge."	0
There was a strong signal for increased endoscopic erosions and @Disease$s in the combined group compared to either @Chemical$ or paracetamol alone.	0
"RESULTS: Compared to no use, neither dose of @Chemical$ was associated with a decreased risk of @Disease$: low dose (OR 1.03, 95 % CI 0.82-1.28) and high dose (OR 1.30, 95 % CI 0.96-1.75)."	0
@Disease$ in low-dose @Chemical$ users with obscure gastrointestinal bleeding.	0
OBJECTIVE: @Chemical$ is a commonly used medicine for primary and secondary prevention of @Disease$.	0
"BACKGROUND AND PURPOSE: @Chemical$ early after intravenous thrombolysis in acute @Disease$ increases the risk of symptomatic intracranial hemorrhage (SICH), without influencing functional outcome at 3 months."	0
"BACKGROUND: In 5 to 10% of adult patients with asthma, aspirin (@Chemical$ [ASA]) and most other nonsteroidal anti-inflammatory drugs (NSAIDs) precipitate acute @Disease$tic attacks."	1
"CASE REPORT: We present the case of a 56-year-old woman with a long history of headache and abuse of @Chemical$ and antiinflamatory drugs who was admitted for generalized seizures, @Disease$ and coma."	0
"In this study, use of ibuprofen or @Chemical$ (but not aspirin) 2 or more days per week was associated with an increased risk of @Disease$ in women."	0
"DATA SOURCES: Literature retrieval was accessed through MEDLINE (1966-March 2007) using the terms acetaminophen, aspirin, antiinflammatory agents nonsteroidal, urticaria, @Disease$, asthma, leukotriene antagonists, desensitization, and @Chemical$."	0
"METHODS: The study group consisted of twenty-three individuals with @Disease$ who underwent AD, followed by ingestion of 325 mg @Chemical$ twice daily."	0
[Acute @Disease$ in a patient in treatment with @Chemical$ and acetylsalicylic acid].	1
"Collectively, these results suggest that the sound-evoked behavioral and @Disease$ induced by SS may arise from a SS-induced suppression of @Chemical$ergic inhibition in the AC."	0
OBJECTIVE: To report the probable association of @Disease$ with aspirin therapy and the selective cyclooxygenase-2 (COX-2) inhibitor @Chemical$.	0
OBJECTIVE: To address the hypothesis that expression of 1 or more EP receptors on nasal mucosal inflammatory cells is deficient in patients with @Chemical$-sensitive compared with nonaspirin-sensitive polypoid @Disease$.	0
"@Chemical$-exacerbated @Disease$ (AERD), formerly known as Samter's Triad, is a syndrome of airway inflammation characterized by rhinosinusitis with polyposis, asthma, and nonsteroidal anti-inflammatory drug (NSAID) intolerance."	1
CONCLUSIONS: The elevated numbers of nasal inflammatory leukocytes expressing the CysLT1 receptor in aspirin-sensitive patients with chronic @Disease$ as compared with their non-aspirin-sensitive counterparts and the down-regulation of receptor expression after desensitization to aspirin are probably fundamental in the pathogenesis of @Chemical$ sensitivity and in the mechanism of aspirin desensitization.	0
"TAPT and DAPT had similar rates of @Disease$, but @Chemical$ had significantly higher rates of headache, palpitation, rash and gastrointestinal side-effects."	0
"Thirteen dogs were assigned into aspirin, lyophilized aspirin/@Chemical$, and control groups, and the @Disease$ were assessed on gastroscopy with the modified Lanza scale."	0
Severe nose bleeding after intake of @Chemical$: @Disease$ type 2A.	0
"@Chemical$ (ASA) is an effective antithrombotic agent, which prevents a variety of @Disease$."	0
"CONCLUSIONS: Taken together, this study shows an increased release of the recently discovered lipid mediator EXC4, as well as the main indicator of 15-LO activity, @Chemical$, in activated eosinophils from severe and aspirin-intolerant @Disease$tics, and also elevated EXC4 and LTC4 formation in eosinophils from AIA patients after cellular activation in the presence of lysine-aspirin."	0
"CONCLUSIONS: The highly sensitive eicosanoid profiling in @Chemical$ makes it possible to detect alterations in asthma, especially in its distinct phenotype characterized by @Disease$ to aspirin and other nonsteroidal anti-inflammatory drugs."	0
"Although acetylsalicylic acid is prescribed for a broad range of diseases, it can induce a wide array of clinically recognized hypersensitivity reactions, including aspirin-intolerant asthma (@Disease$) with rhinitis and aspirin-intolerant urticaria (@Chemical$) with anaphylaxis."	0
"@Chemical$ is cheap and effective and known to prevent cardiovascular and @Disease$, many cancers, and Alzheimer dementia."	0
"The authors assessed the prevalence of headaches following extended-release dipyridamole/aspirin combination (@Chemical$), and the efficacy of acetaminophen in the treatment of these @Disease$."	0
"OBJECTIVE: Low molecular weight (LMW) heparin, with or without @Chemical$ (acetylsalicylic acid [ASA]), is used to prevent complications in @Disease$ in pregnancy."	0
"Data Sources: We searched PubMed, Embase, CENTRAL, and ClinicalTrials.gov from inception to May 28, 2018, with the terms novel oral anticoagulants, non-vitamin K antagonist oral anticoagulants, direct oral anticoagulants, @Chemical$, rivaroxaban, apixaban, edoxaban, warfarin, Coumadin, vitamin K antagonist, aspirin, acetylsalicylic acid, or ASA, and major @Disease$, fatal bleeding, or intracranial hemorrhage."	0
An altered pattern of @Chemical$s also was found in patients suffering from gastroduodenal ulcer and in @Disease$.	0
This article updates data on the genetic mechanisms that govern @Disease$ and AIU and summarizes recent findings on the molecular genetic mechanism of @Chemical$ hypersensitivity.	0
"CONCLUSIONS: Patients who experience @Chemical$-sensitive @Disease$ should be cautious when taking aspirin and NSAIDs, despite treatment with leukotriene inhibitors."	0
@Chemical$-induced @Disease$ (AIAR) appear to be precipitated by the inhibition of cyclo-oxygenase (COX).	1
[@Chemical$ resistance in patients with stable @Disease$].	0
@Chemical$ in @Disease$: increased risk of intracerebral hemorrhage: cause for concern?	0
"Three weeks later, he had acute renal failure, which was initially thought to be secondary to @Disease$, but proved to be acute renal tubular necrosis as a delayed reaction to @Chemical$."	0
Thirty patients (4.3%; 95% CI: 2.8-5.8) of 703 @Disease$tics (5.4% of general population) reported symptoms attesting to hypersensitivity to @Chemical$.	0
"The results of the CHARISMA trial support this recommendation; despite previous data demonstrating a favourable benefit-risk profile of aspirin plus @Chemical$ in patients with @Disease$, this combination should not be used in patients at high risk for atherothrombosis and those with previous stroke or TIA."	0
BACKGROUND: Aspirin-exacerbated respiratory disease (@Disease$) is characterized by respiratory reactions on ingestion of COX-1 inhibitors and @Chemical$ overproduction.	0
Chronic @Chemical$ therapy is widespread in older individuals and decreases the risk of coronary artery occlusions and @Disease$.	0
The observation that fluctuations in eosinophils and neutrophils occur following OPT in @Disease$ patients only warrants further investigations and suggests a rapid pro-inflammatory role for @Chemical$.	0
@Chemical$ intolerance is the hallmark of aspirin-exacerbated respiratory disease (@Disease$).	0
RESULTS: In both groups of asthmatic patients women were majority (74% with difficult asthma and 66% with @Chemical$-induced asthma) with a higher level of anxiety and @Disease$ than men.	0
Bleeding complications in @Disease$ surgery are associated with @Chemical$ but not aspirin therapy.	0
It is widely recognized that increased cysteinyl leukotriene (@Chemical$) biosynthesis is associated with the development and progression of @Disease$.	0
BACKGROUND: Aspirin desensitization (@Chemical$) is an effective and safe therapeutic option for patients with nonsteroidal anti-inflammatory drugs (NSAIDs)-exacerbated respiratory disease (@Disease$).	0
"Besides, SUCRA values demonstrated that in the 7 drug therapies, aspirin plus @Chemical$ therapy was more effective than others (mortality: 80.67%; @Disease$: 76.6%; AE rate: 90.2%)."	0
"METHODS AND RESULTS: In total, 42 patients with no bleeding, 34 with nuisance bleeding, and 14 with alarming @Disease$ underwent platelet reactivity testing 1 month to 1 year after PCI with light transmission aggregometry (LTA 5 and 20 muM @Chemical$ [ADP]), vasodilator stimulated phosphoprotein phosphorylation (VASP) and VerifyNow P2Y12."	0
Several ASA desensitization protocols exist and have been proven to successfully treat ASA @Disease$ and allow for @Chemical$ therapy to be safely initiated.	0
Increased metabolism in the @Disease$ may be associated with recurrently overusing of @Chemical$ powders.	1
"Aspirin exacerbated respiratory disease (@Disease$) is a clinical condition characterized by severe decline in forced expiratory volume in one second (FEV1) following the ingestion of non-steroidal anti-inflammatory drugs (NSAIDs), including @Chemical$."	0
RESULTS: The rare allele frequency of the -344C&gt;T polymorphism was significantly higher in the patients with AICU compared with the other subjects (P= .008 for AICU vs @Chemical$-tolerant chronic @Disease$; P= .03 for AICU vs controls).	0
"The main models included the following predictors: demographic characteristics (age, ethnicity, and socioeconomic deprivation), clinical measurements (systolic blood pressure and ratio of total-high-density lipoprotein cholesterol), family history of premature CVD, medical history (smoking, diabetes, bleeding, peptic ulcer disease, @Disease$, chronic liver disease, chronic pancreatitis, or @Chemical$-related conditions), and medication use (nonsteroidal anti-inflammatory agents, corticosteroids, and selective serotonin reuptake inhibitors)."	0
"BACKGROUND: Clinical features of aspirin-exacerbated respiratory disease (AERD) are characterized by overproduction of @Chemical$ (LT) and eosinophil activation, in which epithelial cells contribute to eosinophilic airway @Disease$."	0
OBJECTIVES: The aim of this study was to determine whether @Chemical$ increases heart failure (HF) hospitalization or @Disease$ in patients with HF with reduced ejection fraction receiving an angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB).	0
"The presence of @Chemical$ in the blood or urine of Reye's syndrome patients has not been demonstrated, and no animal model of @Disease$ has been developed where aspirin causes the disease."	0
UNLABELLED: Prior meta-analysis and observational studies have suggested that the @Disease$ risks associated with anticoagulation using vitamin K antagonists (VKA) or @Chemical$ (ASA) are similar.	1
"Although the risk with low-dose @Chemical$ alone is less than that with NSAIDs, given its widespread use, aspirin-related @Disease$ has become a substantial health care issue."	0
"CASE REPORT: A 58-year-old Caucasian male with a history of coronary heart disease and @Disease$, under treatment with acetyl-salicylate for 6 years and @Chemical$ for 2 months, presented to the Emergency Department of our hospital with epigastric pain and vomiting of 24-hour duration."	0
Rapid @Chemical$ challenge/desensitization in the aspirin @Disease$ patient has been consistently shown to be both safe and successful in patients with acute coronary syndromes.	0
Oxidative stress parameters after combined @Chemical$ and acetylsalicylic acid therapy in @Disease$ patients.	0
"CONCLUSION: @Chemical$ @Disease$, which may cause a distinctive irreversible neurodegenerative disorder, can be seen frequently with Russian Cocktail abuse, a substance which can be accessed very easily and at a low cost."	1
H. pylori @Disease$ could have a synergistic or antagonistic interaction with @Chemical$ use in adverse gastroduodenal events depending on gastric acid secretion.	0
CONCLUSIONS: Fewer endoscopic @Disease$s were observed in patients treated with celecoxib/aspirin vs. @Chemical$/aspirin.	0
"In France, low-dose @Chemical$ or anti-thrombotic agents use has been found in 30% of upper @Disease$ and 40% of lower GI bleeding episodes."	0
These include @Disease$ from bisphosphonates and ischaemic colitis relating to @Chemical$ antagonists.	0
Excretion of LTE4 in patients with @Chemical$ induced @Disease$ raised after oral aspirin provocation and higher level was detected is til 24 hours after challenge.	1
"The improved pulmonary function in the group receiving @Chemical$ occurred at the same time as 27% less bronchodilator was used (p &lt; 0.05), and it was associated with fewer asthma symptoms than in the group given placebo, including 1.3 nights more of sleep per week and 54% fewer @Disease$ exacerbations (p &lt; 0.05)."	0
"CONCLUSION: Alterations in the COX pathway (ie, reduced production of @Chemical$(2) and lack of upregulation of COX-1, COX-2, and EP2 under conditions of @Disease$) are associated with NPs in patients with or without AIA."	0
"It is very important to prevent @Chemical$-induced gastroduodenal ulcer complications including @Disease$, and every effort should be exercised to prevent the bleeding complications."	0
"The aim of the study was to assess the antiplatelet activity and safety of a combined antiplatelet treatment with indobufen and clopidogrel in acute @Disease$ (ACS) patients with hypersensitivity to @Chemical$, undergoing coronary stenting."	0
"The H2RAs prevented less effectively @Chemical$-related GI bleeding (OR= 2.102, 95% CI: 1.008-4.385, p&lt;0.048) and @Disease$ formation (OR= 2.257, 95% CI: 1.277-3.989, p&lt;0.005) than PPIs."	0
Combined @Disease$ of @Chemical$ and aspirin therapy may elicit bilateral vestibulopathy.	1
"Our study was designed to determine the efficacy of @Chemical$, a cysteinyl leukotriene receptor antagonist, in nasal @Disease$."	0
Asthmatic patients have higher rates of @Chemical$ @Disease$.	1
"BACKGROUND: Full- or lower-dose anticoagulant therapy or @Chemical$ can be used for extended therapy in patients with venous thromboembolism (@Disease$), but information on their relative benefit-risk profiles is limited."	0
Is there an association between @Chemical$ dosing and cardiac and bleeding events after treatment of acute @Disease$?	0
OBJECTIVES: Whether clopidogrel should be added to @Chemical$ for @Disease$ prevention remained controversial for the risk of hemorrhagic complications.	0
Associations between @Chemical$ responsiveness and thrombosis rate and aspirin dose adjustment and @Disease$ rate were assessed with the use of multivariable logistic regression analysis.	0
@Chemical$ and the risk of intracranial complications following @Disease$.	0
We determined acute gastroduodenal erosion and ulceration following low-dose @Chemical$ and aspirin-phosphatidylcholine complex (PL2200) in subjects at risk of aspirin @Disease$.	0
"Questionnaires were sent to 210 neurosurgical facilities asking five main questions: (1) the adherence of any policy of stopping aspirin pre-operatively, (2) the personal risk assessment for patients with brain surgery under low-dose @Chemical$ medication, (3) the preferred method of treatment for excessive @Disease$ in this context, (4) personal knowledge of haemorrhagic complications in this group of patients, and (5) the characteristics of the neurosurgical units concerned."	0
"After multivariate adjustment for age, sex, current smoking, history of hypertension and diabetes, and aspirin dose (aspirin-treated patients only), the hazard ratio for @Disease$ in patients with an arterial versus a cardiac source was 0.74 (95% confidence interval, 0.30 to 1.82) for @Chemical$-treated patients and 4.34 (95% confidence interval, 0.35 to 54) for placebo-randomized patients."	0
METHODS: We compared outpatients with difficult-to-treat @Disease$ (DTA; n = 486) in a tertiary hospital for allergic diseases in central Japan with those with controlled severe asthma (n = 621) with respect to clinical factors including body mass index (BMI) and @Chemical$ intolerance using multivariate logistic regression analysis stratified by gender and atopic phenotype.	0
"Studies, review articles, and commentaries on @Chemical$-induced asthma and aspirin- or NSAID-induced @Disease$/angioedema were included in the review."	0
"In two separate series, @Disease$ and carrageenan arthritis-induced inflammatory pain were measured in control, @Chemical$ and ASA-Tris-treated groups."	0
Modification of outcomes with aspirin or @Chemical$ in relation to female and male sex in patients with @Disease$: a secondary analysis of the AVERROES study.	0
"For users of @Chemical$ and opioids, a non-significant trend towards more @Disease$s was present after adjustment."	0
Bleeding during treatment with aspirin versus apixaban in patients with @Disease$ unsuitable for warfarin: the @Chemical$ versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment (AVERROES) trial.	0
An economic analysis of @Chemical$ desensitization in aspirin-exacerbated @Disease$.	0
@Chemical$ use and post-operative @Disease$ from dental extractions.	0
"There is a well-recognized association of @Chemical$ sensitivity, aspirin-induced @Disease$, nasal polyposis or sinusitis, known as Samter's triad."	0
@Chemical$-resistant @Disease$ in a cohort of patients with coronary heart disease.	1
Systemic and local responses in @Chemical$-exacerbated @Disease$: same or different disease?	0
"BACKGROUND: In 5 to 10% of adult patients with @Disease$, aspirin (acetylsalicylic acid [@Chemical$]) and most other nonsteroidal anti-inflammatory drugs (NSAIDs) precipitate acute asthmatic attacks."	0
@Disease$ complications associated with @Chemical$: an underestimated hazard in clinical practice?	0
"BACKGROUND: The risk of postpolypectomy @Disease$ for patients taking @Chemical$ is low, and gastroenterology society guidelines state that aspirin is likely safe to continue; however, many practices recommend aspirin discontinuation."	0
"@Disease$, following low dose @Chemical$ administration in a mother and subsequent effect after delivery is being reported."	1
The diminishing effects of @Chemical$ on antioxidant enzymes and @Disease$ at high doses are well-known.	0
"[Coxib: a feasible therapeutic alternative in patients with intolerance or @Disease$ to acetilsallicilic acid, non-steroidal antiinflammatory drugs and @Chemical$]."	0
Patients with peripheral @Disease$ on long-term @Chemical$ therapy (&gt;=4 wk) were tested for aspirin responsiveness by means of the VerifyNow Aspirin Assay.	0
"RECENT FINDINGS: Numerous studies, including randomized, double-blind, placebo-controlled trials, have demonstrated the therapeutic effectiveness of aspirin desensitization with significant improvement in number of @Disease$ per year, olfactory scores, nasal symptom scores, asthma symptom scores, sinus operations, hospitalizations, emergency room visits, and oral @Chemical$ use."	0
"BACKGROUND AND AIM: Helicobacter pylori (H. pylori) and @Chemical$ are the major causes of @Disease$, and eradication of H. pylori can restore mucosal injury such as gastric ulcer."	1
"Although co-therapy with a PPI and the eradication of H. pylori substantially reduce the risk of recurrent @Disease$ bleeding with @Chemical$, the replacement of aspirin by clopidogrel cannot be recommended to patients with a high gastrointestinal risk."	0
Comparison of teprenone and @Chemical$ against @Disease$ in patients taking low-dose aspirin.	0
"Therefore, the present results indicated that DDAVP shortened the prolonged @Chemical$ in dogs with aspirin-induced platelet dysfunction and @Disease$."	0
@Chemical$ as a cause of pancreatitis in patients with aspirin-exacerbated @Disease$.	0
"However, desensitization to aspirin is a viable option for patients with @Chemical$-induced respiratory reactions, especially for those who require aspirin for @Disease$ prophylaxis."	0
We assessed whether the association of @Chemical$ and other NSAIDs with postmenopausal breast cancer risk differs by estrogen and progesterone receptor (ER and PR) status of the @Disease$.	0
"Patients without @Chemical$-detected gastrointestinal erosions, @Disease$ or bleeding after drug-eluting stent implantation are enrolled and treated with open-label aspirin (100 mg/d) plus clopidogrel (75 mg/d) for 6 months."	0
"CONCLUSION: @Chemical$ at a daily dose of &gt;=100 mg for prevention of preeclampsia that is initiated at &lt;=16 weeks of gestation, rather than &gt;16 weeks, may decrease the risk of placental abruption or antepartum @Disease$."	0
"To our knowledge, there have been no previous reports of @Chemical$-induced @Disease$ subsequent to Kawasaki disease."	1
Studies have confirmed that co-therapy with a proton pump inhibitor (PPI) or @Chemical$ decreases the risk for @Disease$ injury and complications.	0
RESULTS: In both groups of asthmatic patients women were majority (74% with difficult @Disease$ and 66% with @Chemical$-induced asthma) with a higher level of anxiety and depressive symptoms than men.	0
"Aspirin-exacerbated respiratory disease is a clinical syndrome characterized by severe, persistent asthma, hyperplastic eosinophilic sinusitis with @Disease$, and reactions to @Chemical$ and other nonsteroidal antiinflammatory drugs that preferentially inhibit cyclooxygenase 1."	0
"Aspirin exacerbated respiratory disease is characterized by recalcitrant @Disease$, asthma and precipitation of asthma after ingestion of @Chemical$ and most NSAIDs."	0
Prostaglandin (PG) E2 has been implicated in the pathogenesis of @Chemical$-exacerbated @Disease$ (AERD).	0
The prescription of @Chemical$ (acetylsalicylic acid (ASA)) to patients with a history of @Disease$ to this drug could prove harmful.	0
Areas covered: This review focuses on the direct and indirect complications of @Chemical$-exacerbated @Disease$.	1
"OBJECTIVE: This analysis compared the efficacy of misoprostol, lansoprazole, and placebo in reducing the risk of gastric or duodenal @Disease$ recurrence in patients taking NSAIDs and low-dose @Chemical$."	0
[Risk of @Disease$ after intake of @Chemical$ and acetylsalicylic acid].	0
"METHODS: Patients who reacted to 2 or more chemically unrelated NSAIDs with @Disease$ and angioedema, confirmed by a double-blinded provocation test with @Chemical$, were skin tested with inhalant allergens."	0
"MATERIALS AND METHODS: We report seven patients with a new form of chronic manganese @Disease$ due to long-term intravenous use of a solution consisting of @Chemical$, acetylsalicylic acid and potassium permanganate as a psycho-stimulant, popularly known as Russian Cocktail."	0
Modification of outcomes with @Chemical$ or apixaban in relation to female and male sex in patients with @Disease$: a secondary analysis of the AVERROES study.	0
"Regular use of non-@Chemical$ analgesic drugs was also associated with a higher risk of @Disease$ (hazard ratio=1.69; 95% confidence interval, 1.28-2.23)."	0
"Two cohorts (N = 170,336 each) aged 40-89 years from 2000 to 2009 and free of @Disease$ were identified: i) new-users of low-dose @Chemical$, ii) non-users of low-dose aspirin, at start of follow-up, matched by age, sex and previous primary care practitioner visits."	0
"OBJECTIVE: We evaluated the effects of tacrolimus in @Chemical$-induced @Disease$ by using a double-blind, crossover study design."	1
"However, concomitant use of thienopyridine such as @Chemical$ with LDA increased the proportion of @Disease$."	0
"METHODS: Forty otherwise healthy patients with a history of acute @Disease$ after the ingestion of aspirin underwent single-blind, placebo-controlled oral challenges with @Chemical$."	0
"RESULTS: Of 8754 Chinese patients with atrial fibrillation and CHA2DS2-VASc &gt;=1 (79.5+-9.2 years; CHA2DS2-VASc, 4.1+-1.5; and @Disease$, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile International Normalized Ratio, Elderly (&gt;65 years), Drugs/Alcohol Concomitantly [HAS-BLED], 2.2+-0.9), 16.3% received warfarin, 41.1% @Chemical$, 4.5% dabigatran, and 38.1% received no therapy."	0
"CONCLUSIONS: Our study indicates that long-term, consistent low-dose @Chemical$ use may provide modest protection against @Disease$."	0
OBJECTIVES: To study whether @Chemical$-Aspirin combined treatment for high risk transient ischaemic attack (@Disease$) or minor stroke results in increased number of lesions associated with anti-thrombotic cerebral haemorrhage or cerebral micro-bleeds (CMB) than aspirin alone treatment.	0
"In patients with Hp-negative, NSAID-/aspirin-associated @Disease$, &gt; 80 % of respondents would initiate long-term proton pump inhibitor (PPI) therapy, whereas 20 % and 17.8 % would prescribe COX-2 selective inhibitors or opiates instead of non-selective NSAIDs and @Chemical$ instead of aspirin."	0
"After adjusting for potential confounding factors (including treatment, cause of @Disease$, age, smoking, and diabetes mellitus), a time-dependent multivariate Cox proportional hazards regression analysis showed that the combination of high-dose @Chemical$ with an ACEI was independently associated with the risk of death (hazard ratio, 1.03; P =.01) and that the combination of low-dose aspirin with an ACEI was not (hazard ratio, 1.02; P =.18)."	0
"With the @Chemical$ regimen, @Disease$ occur in 7 patients (46.7%) (5, grade M; 2, grade A)."	0
Comparison of bleeding complications with omega-3 fatty acids + aspirin + @Chemical$--versus--aspirin + clopidogrel in patients with @Disease$.	0
The aim of this study was to clarify the prevalence and various clinical factors of @Disease$ associated with low-dose @Chemical$ treatment.	0
These agents are highly effective in reducing the @Disease$ associated with aspirin therapy and have been associated with increased @Chemical$ adherence.	0
@Chemical$ 300 mg/day is effective for treating aspirin-exacerbated @Disease$.	0
"Estimated excess major @Disease$ events were 1.39 (CI, 0.70 to 2.28) for GI bleeding and 0.32 (CI, -0.05 to 0.82) for hemorrhagic stroke per 1000 person-years of @Chemical$ exposure using baseline bleeding rates from a community-based observational sample."	0
"AIM: We conducted a multicenter, randomized, double-blind, placebo-controlled trial to assess the efficacy of a high dose of @Chemical$, a gastroprotective drug, for LDA-induced moderate-to-severe @Disease$."	0
"Aspirin-induced urticaria and @Disease$, but not bronchoconstriction, associated with @Chemical$ overproduction in 2 patients with asthma."	0
@Chemical$-associated iron loss as an anti@Disease$ mechanism.	0
"She had no symptom of urticaria and @Disease$, and had the both character of aspirin urticaria and asthma as to @Chemical$ challenge test."	0
CONCLUSION: Cross-reactivity between ASA and @Chemical$ does not occur in patients with @Disease$.	0
Airway responsiveness to inhaled @Chemical$ is influenced by @Disease$ in asthmatic patients.	0
"BACKGROUND: Aspirin-exacerbated respiratory disease (AERD) is a clinical syndrome characterized by chronic rhinitis, nasal polyps, asthma, and precipitation of @Disease$ and rhinitis attacks after ingestion of @Chemical$ (ASA) and most nonsteroidal anti-inflammatory drugs (NSAIDs)."	1
"Cardiovascular and gastrointestinal events of three antiplatelet therapies: clopidogrel, clopidogrel plus proton-pump inhibitors, and @Chemical$ plus proton-pump inhibitors in patients with previous @Disease$."	0
Aspirin @Disease$ is due to disturbances in the @Chemical$ metabolism implicating both the lipoxygenase and cyclooxygenase pathways.	0
Prednisolone was therefore seen to be effective for treating variant angina that manifested as a non-respiratory tract symptom of @Chemical$-exacerbated @Disease$.	0
"MATERIALS AND METHODS: We report seven patients with a new form of chronic @Chemical$ @Disease$ due to long-term intravenous use of a solution consisting of ephedrine, acetylsalicylic acid and potassium permanganate as a psycho-stimulant, popularly known as Russian Cocktail."	1
Risks versus benefits of NSAIDs including @Chemical$ in @Disease$: a review of the evidence from animal studies.	0
AIM: To compare the healing rate in aspirin-related dyspeptic @Disease$ patients who were given proton pump inhibitor (PPI) plus aspirin or PPI plus @Chemical$.	0
"INTRODUCTION: To study the effects of use of paracetamol, non-steroidal anti-inflammatory drugs (NSAID), @Chemical$ (ASA), and opioids on bone mineral density (BMD) and risk of @Disease$s."	0
"As an inhibitor of cyclooxygenase (COX), @Chemical$ @Disease$ protective mechanisms."	1
"@Chemical$, commonly known as aspirin, can induce some @Disease$ reactions with clinical symptoms such as urticaria, angioedema, acute bronchospasm, and rarely anaphylactic shock."	1
"INTRODUCTION: Although @Chemical$ is the cornerstone of medication in patients with @Disease$, a minority of these patients have aspirin sensitivity."	0
BACKGROUND: @Chemical$ (ASA)-exacerbated respiratory disease (@Disease$) is characterized by aggressive inflammation of the respiratory tract and often requires topical and/or systemic corticosteroids to maintain partial control of this disease.	0
Imbalance in the ratio of these @Chemical$ mediators likely leads to the increased @Disease$ and mast cell inflammatory responses in the respiratory tract.	0
CONCLUSION: The CHST2 2082 T allele as well as SLCO1B1*1b haplotype may identify patients at increased risk for @Chemical$-induced peptic ulcer or @Disease$ bleeding.	0
"Patients with clinical CHD and those with diabetes and without clinical CHD were 5.88 (P=0.008) and 7.54 (P=0.012) times more likely to utilize @Chemical$, respectively, than patients with only one @Disease$ risk factor of age."	0
Lyophilized @Chemical$/trehalose might be a solution to decrease aspirin-induced @Disease$.	0
CONCLUSIONS: Ecabet @Chemical$ had a preventive effect on low-dose aspirin-induced @Disease$ in the upper part of the small intestine.	0
"METHODS: Ninety-four aspirin-induced urticaria patients presenting urticaria/angioedema-induced by both ASA and NSAID (50 had underlying chronic urticaria) and showing positive responses on oral @Chemical$ challenge test, 76 aspirin-intolerant @Disease$tics with positive responses on lysine-aspirin bronchoprovocation test, and 185 normal healthy controls were enrolled."	0
"Aspirin-exacerbated respiratory disease (AERD) is an adult-onset condition that manifests as asthma, @Disease$, and sensitivity to @Chemical$ and other cyclooxygenase-1 (COX-1)-inhibitor nonsteroidal anti-inflammatory drugs (NSAIDs)."	0
"BACKGROUND: In aspirin-sensitive patients with asthma, @Disease$ induced by oral @Chemical$ may be associated with extrabronchial symptoms, suggesting the systemic character of the response."	1
OBJECTIVE: We present a case report of a patient who developed an epidural @Disease$ following an interlaminar epidural @Chemical$ injection with no risk factors aside from old age and aspirin use for secondary prevention.	0
BACKGROUND: @Chemical$ use as single antiplatelet therapy (SAPT) has never been evaluated in stable coronary artery disease (@Disease$) outpatients either as compared to placebo or aspirin.	0
"Fifteen @Disease$ patients, ten @Chemical$-tolerant asthmatics (ATA), and fifteen healthy controls (HC) were studied."	0
"However, there is cross-reactivity between the NSAIDs in patients with NSAID-exacerbated @Disease$ and NIUA, and thus only use of selective COX-2 inhibitors can replace the culprit drug if the chronic treatment is necessary, although @Chemical$ desensitization will allow for chronic treatment with NSAIDs in some patients with NIUA."	0
"This analysis suggests a potential mild excess @Disease$ risk, but no mortality benefit in Korean post-PCI patients treated with @Chemical$ for an additional 18 months beyond conventional 12 months DAPT."	0
This review will focus on these new developments on the prevention of @Disease$ and complications in @Chemical$ users.	0
"METHODS: Ten patients with rhinosinusitis, nasal polyps, and @Disease$ had a history of asthma attacks after ingesting @Chemical$ and nonsteroidal anti-inflammatory drugs."	0
"In our investigation of such adverse effects, we obtained 4 important findings considered useful for physicians, as follows; 1) even when @Chemical$ was given at a dose, the incidence rate of gastrointestinal lesions was higher than with other non-steroidal anti-inflammatory drugs (NSAIDs), 2) the odds ratios for gastrointestinal lesions induced by aspirin with a histamine H2 receptor antagonist and proton pump inhibitor were 0.6 and 0.4, respectively, as compared with aspirin alone, 3) it is difficult to administer aspirin, which exerts an antiplatelet effect, without inducing gastrointestinal lesions, and 4) these @Disease$ appears early, especially within 2 years after administration."	0
"In addition to a marked increase in cysteinyl-leukotriene production, aspirin challenge induced @Chemical$ production in @Disease$ patients."	0
"Identical questionnaires were sent to 210 neurosurgical facilities and proffered five main questions: (1) the adherence of any policy of stopping @Chemical$ pre-operatively, (2) the personal risk assessment for patients with spinal surgery under low-dose aspirin medication, (3) the preferred method of treatment for excessive bleeding in this context, (4) personal knowledge of @Disease$ complications in this group of patients, and (5) the characteristics of the neurosurgical units concerned."	0
"The patients comprised three groups: @Chemical$-interrupted group (13 patients with 13 colorectal tumors), LDA-continued group (28 patients with 31 colorectal tumors), and no anticoagulant/antiplatelet group (541 patients with 565 @Disease$)."	0
"However, celecoxib/aspirin was associated with a significantly higher incidence of gastric and duodenal @Disease$s than @Chemical$ alone."	0
A functional promoter polymorphism of the human IL18 gene is associated with @Chemical$-induced @Disease$.	1
"Regarding the pathogenesis of AI, modifications of eicosanoid metabolism are supposed to underlie AI, including aspirin-induced asthma and @Chemical$-induced @Disease$."	1
Aspirin and @Chemical$ are well-known antiplatelet agents that are widely used across the spectrum of cardio- and @Disease$.	0
This article reviews the different classifications of @Chemical$/NSAIDs @Disease$ to better guide the clinician in dealing with this patient population.	0
"The patients comprised three groups: LDA-interrupted group (13 patients with 13 colorectal tumors), @Chemical$-continued group (28 patients with 31 @Disease$), and no anticoagulant/antiplatelet group (541 patients with 565 colorectal tumors)."	0
"Aspirin, but not other NSAID use, was associated with about 20% lower risk of postmenopausal @Disease$ and did not vary by ER or PR status of the tumor, suggesting that the hypothesized protective effects of @Chemical$ may either be through cellular pathways independent of estrogen or progesterone signaling, or on tumor microenvironment."	0
"After adjusting for potential confounding factors (including treatment, cause of heart disease, age, smoking, and diabetes mellitus), a time-dependent multivariate Cox proportional hazards regression analysis showed that the combination of high-dose @Chemical$ with an ACEI was independently associated with the risk of @Disease$ (hazard ratio, 1.03; P =.01) and that the combination of low-dose aspirin with an ACEI was not (hazard ratio, 1.02; P =.18)."	1
CONCLUSION: We conclude that between the groups with and without pre-operative @Chemical$ the occurrence rate of lid @Disease$ was not significant in peribulbar block.	0
"METHODS: We screened a Korean asthma cohort (581 @Disease$tics including 81 aspirin-intolerant asthmatics and 231 @Chemical$-tolerant asthmatics, and 181 normal controls) for four single nucleotide polymorphisms (SNPs; -262 A&gt;T and -115 T&gt;C in the 5'-flanking region and +5467 T&gt;C [Pro450Pro] and+11860 A&gt;G [Thr776Thr] in the coding region) and one ins/del (+21288 CT) in the ACE gene."	0
"@Chemical$ therapy was not associated with a statistically significant increase in recurrent @Disease$ (2.6%; 95% CI, -1.1 to 8.6), but the results were inconclusive."	0
"In this study, we investigated the relationship between Prostaglandin E2 receptor (PTGER) gene family polymorphisms and AIA in 243 @Disease$ patients and 919 @Chemical$-tolerant asthma (ATA) controls of Korean ethnicity in two separate study cohorts."	0
"METHODS: A total of 11 aspirin-sensitive patients with asthma, 10 @Chemical$-tolerant patients with @Disease$, and 10 controls without asthma were studied."	0
"Among overweight and @Disease$ women, the inverse association with @Chemical$ was stronger for use 2-6 times/week (OR = 0.81, 95% CI 0.68-0.96) than for daily use (0.91, 0.80-1.03), possibly because a high proportion of daily users use low-dose formulations."	0
"Any bridging AC (odds ratio [OR] 10.3, 1.8-60.8, P = 0.01), clopidogrel (OR 10.0, 1.7-57.7, P = 0.01), and uninterrupted @Chemical$ without bridging (OR 11.1, 1.7-74.3, P = 0.013) were independently associated with @Disease$ formation."	0
"It has been postulated that mediators other than histamine, such as kinins, prostaglandin and @Chemical$, may be responsible for some of the symptoms in @Disease$ which are not controlled by antihistamines."	0
@Disease$ complications are increased by about 60% due to @Chemical$ use but are fatal only in a very small proportion of individuals younger than 70 years of age.	1
"METHODS: Using data from two large anonymized health insurance databases, we defined a development and validation cohort with NSAID and @Chemical$ users which were followed-up for the occurrence of a primary upper @Disease$."	0
"Although @Chemical$ is prescribed for a broad range of diseases, it can induce a wide array of clinically recognized @Disease$ reactions, including aspirin-intolerant asthma (AIA) with rhinitis and aspirin-intolerant urticaria (AIU) with anaphylaxis."	1
Use of low-dose @Chemical$ concurrently with use of a selective cyclo-oxygenase-2 inhibitor may provide some degree of protection against the potential cardiovascular toxicity of the latter but both laboratory and clinical studies suggest that the concomitant use of these two types of drugs results in @Disease$ comparable to what is seen with conventional non-steroidal anti-inflammatory drugs.	0
"CONCLUSIONS: In a randomized controlled trial of users of low-dose aspirin at risk for recurrent GI bleeding, a slightly lower proportion of patients receiving a PPI along with @Chemical$ developed recurrent bleeding or @Disease$ than of patients receiving an H2RA with the aspirin, although this difference was not statistically significant."	0
"Despite treatment with @Chemical$ and picotamide, in the following days the patient experienced two new episodes of stent @Disease$, treated with thrombectomy and deployment of bioengineered stents."	0
"We describe the most common clinical presentations of @Chemical$ hypersensitivity, i.e. aspirin-induced asthma, rhinosinusitis and aspirin-induced @Disease$."	0
Efficacy and Safety of Available Protocols for @Chemical$ @Disease$ Patients Undergoing Percutaneous Coronary Intervention: A Survey and Systematic Review.	1
The aim of this study was to determine the incidence of upper GI bleeding and whether the use of peri-operative oral @Chemical$ reduces the incidence of upper @Disease$ing when aspirin thromboprophylaxis is used for hip and knee arthroplasty.	0
"In addition, the haplotypes of CCC (-1031T &gt; C, -863C &gt; A, and -857C &gt; T) markedly reduced the risk of @Chemical$-induced UGIB in @Disease$ patients."	0
"Aspirin (@Chemical$) is used worldwide to treat various inflammatory conditions and prevent @Disease$, along with reducing the risk of cancer."	0
It has been postulated that precipitation of @Disease$ attacks by aspirin is linked to inhibition of COX activity and massive release of @Chemical$ into the airway.	0
METHODS: A whole-blood desktop platelet function analyzer (PFA-100) with an @Chemical$ agonist was used to assess AR among patients with @Disease$.	0
METHODS: An online questionnaire was completed by eligible US adult patients (aged &gt;=20 years) who had been recommended low-dose @Chemical$ by a healthcare professional for secondary CV prevention or high-risk primary CV prevention (defined as @Disease$ or three or more risk factors for CV disease) and had experience of upper GI problems.	0
"BACKGROUND: In patients with aspirin-exacerbated respiratory disease (AERD), pretreatment with asthma controller medications (leukotriene modifiers, inhaled or systemic corticosteroids, and salmeterol) partially modifies the severity of @Chemical$-induced @Disease$tic reactions."	1
"Concentrations of urinary leukotriene E4 (uLTE4) were measured by ELISA and plasma stable prostaglandin D2 metabolite, @Chemical$,11beta prostaglandin F(2) by GC/@Disease$."	0
CONCLUSION: Preoperative clopidogrel and @Chemical$ exposure even within 2 days of surgery does not increase perioperative @Disease$ and blood transfusion requirements in patients undergoing elective off-pump coronary artery bypass grafting.	0
"As PPIs reduce the risk of @Disease$ and dyspepsia, these risk factors were modelled together with PPI adverse effects for @Chemical$ users 60-69, 70-79 (base case) and 80 years and older."	0
"The main models included the following predictors: demographic characteristics (age, ethnicity, and socioeconomic deprivation), clinical measurements (systolic blood pressure and ratio of total-high-@Chemical$), family history of premature CVD, medical history (smoking, diabetes, @Disease$, peptic ulcer disease, cancer, chronic liver disease, chronic pancreatitis, or alcohol-related conditions), and medication use (nonsteroidal anti-inflammatory agents, corticosteroids, and selective serotonin reuptake inhibitors)."	0
CONCLUSION: This study indicates that 7.5 mg of meloxicam is a safe alternative treatment for ASA-hypersensitive asthma and/or NP patients with proven @Disease$ via oral @Chemical$ challenges.	0
Our results suggest that the combined administration of low-dose @Chemical$ and PPI is effective for the prevention of @Disease$ associated with low-dose aspirin.	0
AIM: The aim of the study was to assess the curcumin containing ethanolic extract (@Chemical$) obtained from Curcuma longa (Cl) against @Disease$ of wound healing by aspirin.	0
BACKGROUND: There are no country-based data focused on aspirin (@Chemical$)-exacerbated @Disease$ (AERD) in Turkey.	0
"At 3 years, 238 (5.9%) patients were on @Chemical$, 743 (18.6) on aspirin, and 3,013 (75.5%) on no therapy; with occurrences of @Disease$/TIA (1.4%, 3.0%, 3.9%, P &lt; 0.0001, respectively), GI bleeding (0.8%, 1.9%, 1.1%, P = 0.06, respectively), and GU bleeding (1.7%, 2.8%, 2.1%, P = 0.008, respectively) that increased with advancing CHA2 DS2 VASc score."	0
A retrospective study was carried out to evaluate whether the use of warfarin/low-dose @Chemical$ (LDA) is predictive of unfavorable outcomes in geriatric patients who sustain a fall-induced @Disease$.	0
OBJECTIVE: To review data concerning combined aspirin/warfarin versus @Chemical$ alone for secondary prevention after @Disease$ (MI).	0
"The risks of suffering ischemic stroke, @Disease$, or death with @Chemical$, aspirin, or no antithrombotic treatment during 2010 were related to CHA2DS2VASc scores, age, and complicating co-morbidities."	0
CONCLUSION: Our study appears to demonstrate that @Chemical$ is a suitable alternative to aspirin as antiplatelet agent to prevent @Disease$.	0
"CONCLUSION: Among elderly patients receiving cardiovascular protection with @Chemical$ and pain control with anti-inflammatory drugs, celecoxib may be safer with regards to @Disease$ than NS-NSAIDs."	0
[Asthma with @Disease$ to @Chemical$].	1
"The risk of upper gastrointestinal bleeding with @Chemical$ is increased with old age, male sex, @Disease$ history and concomitant medication with NSAIDs, cyclooxygenase 2 selective inhibitors, corticosteroids or other antithrombotic agents."	0
"Type 2 @Disease$ characterizes aspirin-exacerbated respiratory disease.Objectives: To determine whether high-dose aspirin therapy changes biomarkers of type 2 inflammation in aspirin-exacerbated respiratory disease.Methods: Forty-two subjects with aspirin-exacerbated respiratory disease underwent an @Chemical$ desensitization and were placed on high-dose aspirin (1,300 mg daily)."	0
"@Chemical$ prescription was associated with a nonsignificant risk reduction of @Disease$ of UADT (adjusted OR=0.9, 95% CI=0.8, 1.0), head and neck (HN; adjusted OR=0.9, 95% CI=0.7, 1.1) or the oesophagus (adjusted OR=0.8, 95% CI=0.7, 1.0)."	0
A case-control study of the association between polymorphisms of the endothelial nitric oxide synthase and glycoprotein IIIa genes and @Disease$ in users of low-dose @Chemical$.	0
"BACKGROUND: Aspirin (@Chemical$ [ASA]) hypersensitivity is frequent in patients with nasal polyps (NPs) and is called aspirin exacerbated @Disease$, previously known as Samter's syndrome."	0
"Aspirin-exacerbated @Disease$ is a clinical syndrome characterized by severe, persistent asthma, hyperplastic eosinophilic sinusitis with nasal polyps, and reactions to @Chemical$ and other nonsteroidal antiinflammatory drugs that preferentially inhibit cyclooxygenase 1."	0
"CONCLUSION: In our study, @Disease$ was found in all the patients with stable coronary artery disease, without any association of its presence and severity with @Chemical$ resistance."	0
Risks for stroke and bleeding with @Chemical$ or aspirin treatment in patients with @Disease$ at different CHA(2)DS(2)VASc scores: experience from the Stockholm region.	0
"Type 2 inflammation characterizes aspirin-exacerbated @Disease$.Objectives: To determine whether high-dose aspirin therapy changes biomarkers of type 2 inflammation in aspirin-exacerbated respiratory disease.Methods: Forty-two subjects with aspirin-exacerbated respiratory disease underwent an aspirin desensitization and were placed on high-dose @Chemical$ (1,300 mg daily)."	0
"This meta-analysis was aimed to assess the efficacy and safety of adding clopidogrel to @Chemical$ on @Disease$ prevention in high vascular risk patients, and to provide evidence for a suitable duration of dual antiplatelet therapy."	0
"BACKGROUND: Danhong injection (DHI) is quite often used in combination with low-dose aspirin (@Chemical$, 75-325mg daily) in clinic, particularly for the treatment of @Disease$."	0
"Cox proportional hazards analysis revealed that, HbA1c (p &lt;= 0.001), systolic pressure (p &lt;= 0.001), @Chemical$ free treatment (P = 0.0023) are independent predictor for cerebrovascular events in @Disease$ patients."	0
An adverse effect of @Chemical$ on the risk of @Disease$ cannot be completely ruled out.	0
OBJECTIVES: To study whether @Chemical$-Aspirin combined treatment for high risk transient ischaemic attack (TIA) or minor stroke results in increased number of lesions associated with anti-@Disease$ (CMB) than aspirin alone treatment.	0
"Thus, the lack of evidence of benefit with aspirin in patients with heart failure and coronary disease, along with growing evidence that @Chemical$ is directly harmful in patients with @Disease$ and that aspirin may negate the benefits of angiotensin-converting enzyme inhibitors suggest that, unless there is an opportunity to randomize the patient into a study of antithrombotic strategies, then aspirin should be withdrawn or possibly substituted with an anticoagulant or an antiplatelet agent that does not block cyclooxygenase."	0
"The risk of hospitalization for ED visits involving acute @Disease$s was not significantly different between DAT and @Chemical$ (risk ratio, 0.73; 95% CI, 0.38-1.08)."	0
CONCLUSION: Myocardial @Disease$ is a relatively common complication in CAD patients under @Chemical$ therapy presenting with upper gastrointestinal hemorrhage.	0
"The drugs significantly associated with @Disease$ were loxoprofen (aOR 5.0), diclofenac (aOR 3.1), diclofenac suppository (aOR 8.0), @Chemical$ (aOR 4.9), enteric-coated aspirin (aOR 3.9), buffered aspirin (aOR 9.9), clopidogrel (aOR 2.5), and cilostazol (aOR 7.3)."	0
"The most common reasons for recommending aspirin discontinuation were concern about bleeding after polypectomy (62%), perceived minimal downside to stopping @Chemical$ (38%), @Disease$ to changing old policies (20%), and concern about medicolegal implications of postpolypectomy bleeding (15%)."	0
"@Chemical$-Tris did not influence the cyclooxygenase-induced platelet aggregation significantly, but the inflammatory @Disease$ was reduced as effectively as in the case of equimolar ASA doses."	0
"CONCLUSIONS: Our findings do not support that there is no difference in the risk of GI complications between enteric-coated LDA and buffered @Chemical$, but rather may imply that the risk of @Disease$ complications associated with enteric-coated LDA is higher than that with buffered LDA."	0
"The drugs significantly associated with @Disease$ were loxoprofen (aOR 5.0), diclofenac (aOR 3.1), diclofenac suppository (aOR 8.0), etodolac (aOR 4.9), enteric-coated aspirin (aOR 3.9), buffered aspirin (aOR 9.9), clopidogrel (aOR 2.5), and @Chemical$ (aOR 7.3)."	0
"BACKGROUND: The safety of aspirin in @Disease$ (HF) has been called into question, particularly in those patients (1) without coronary disease, (2) with renal dysfunction, or (3) treated with low-dose angiotensin-converting enzyme (ACE) inhibitors and high-dose @Chemical$."	0
"DATA SOURCES: Articles evaluating aspirin for primary prevention of CVD were gathered using a MEDLINE search with the keywords aspirin review, aspirin peripheral artery disease, aspirin stroke, aspirin coronary @Disease$, aspirin diabetes, @Chemical$ primary prophylaxis, and aspirin elderly."	0
"Among women randomized to LDA, we observed a trend favoring fewer @Chemical$ due to spontaneous @Disease$ and preterm PPROMs, odds ratio (OR: 0.826 (0.620, 1.099)); the incidence of indicated PTBs appeared unchanged, OR: 0.999 (0.787, 1.268)."	0
The risk of @Disease$ resulting from stopping @Chemical$ may exceed the risk of perioperative bleeding and associated complications.	0
"BACKGROUND: Aspirin-exacerbated respiratory disease (AERD) is a clinical syndrome characterized by chronic @Disease$, nasal polyps, asthma, and precipitation of asthma and rhinitis attacks after ingestion of @Chemical$ (ASA) and most nonsteroidal anti-inflammatory drugs (NSAIDs)."	0
Risk factors for @Disease$ among @Chemical$ users: An old issue with new findings from a population-based cohort study.	1
Contemporary Reflections on the Safety of Long-Term @Chemical$ Treatment for the Secondary Prevention of @Disease$.	0
Perioperative treatment with aspirin or @Chemical$ and risk of @Disease$.	0
The induction of pSTAT6 was significantly higher in @Chemical$-sensitive patients with @Disease$ than in controls subjects.	0
"BACKGROUND: The risk of postpolypectomy @Disease$ for patients taking aspirin is low, and gastroenterology society guidelines state that aspirin is likely safe to continue; however, many practices recommend @Chemical$ discontinuation."	0
"Whether @Disease$ rates differ among patients with and without DM, receiving long-term @Chemical$ is unknown."	0
"RESULTS: @Chemical$ was well tolerated, without any signs of immediate or delayed @Disease$ aspirin- and nonsteroidal anti-inflammatory drug-induced asthmatic patients."	0
"Similarly, the use of non@Chemical$ nonsteroidal antiinflammatory drugs (NSAIDs), including cyclooxygenase (COX)-2 inhibitors, has also been shown to increase the risk of GI effects, and the concomitant use of aspirin and nonaspirin NSAIDs can significantly increase the risk of @Disease$."	0
"Concomitant therapy with @Chemical$ (APAP) and low-dose aspirin is often used in clinical settings; however, it is unclear whether this combination is involved in the progression of @Disease$ (CKD)."	0
DATA SYNTHESIS: @Chemical$ products are known to cause @Disease$.	1
"DATA SOURCES: Literature retrieval was accessed through MEDLINE (1966-March 2007) using the terms acetaminophen, @Chemical$, antiinflammatory agents nonsteroidal, urticaria, angioedema, @Disease$, leukotriene antagonists, desensitization, and tacrolimus."	0
"BACKGROUND: @Chemical$-exacerbated respiratory disease (AERD) is a clinical syndrome associated with chronic inflammation in the airways coincident with chronic rhinitis, @Disease$, recurrent polyposis and asthma."	0
"The results of the CHARISMA trial support this recommendation; despite previous data demonstrating a favourable benefit-risk profile of aspirin plus @Chemical$ in patients with acute coronary syndrome, this combination should not be used in patients at high risk for @Disease$ and those with previous stroke or TIA."	0
"SUMMARY: The HLA alleles DRB11302 and DQB10609, and the ALOX5 and FcepsilonRIalpha promoter polymorphisms, may contribute to the pathogenesis of @Chemical$-induced urticaria/@Disease$."	1
The prescription of aspirin (acetylsalicylic acid (@Chemical$)) to patients with a history of @Disease$ to this drug could prove harmful.	0
"(4) When the concentrations after aspirin challenge were analysed simultaneously, a significant linear correlation was observed between urinary @Chemical$ concentration and urinary LTE4 concentration in patients with @Disease$ (Spearman's rank correlation test, r = 0.817, P = 0.0003)."	0
"BACKGROUND: @Chemical$-exacerbated respiratory disease (AERD) is a clinical triad consisting of aspirin/acetylsalicylic acid (ASA) sensitivity, @Disease$, and nasal polyposis."	0
OBJECTIVE: To evaluate the expression of vascular cell adhesion molecule 1 (VCAM-1) and intercellular adhesion molecule I (ICAM-1) and their ligands (the integrins lymphocyte function-associated antigen 1 and very late-activation antigen 4 [VLA-4]) in nasal polyps of patients with aspirin @Disease$ compared with @Chemical$-tolerant individuals.	0
Taking @Chemical$ @Disease$ risk that is not always outweighed by the potential benefits for patients with low cardiovascular disease risk.	1
"Before, after 120, and 240 min of DDAVP administration the following parameters were measured: platelet aggregation (PA) and @Chemical$ release induced by ADP, collagen, ristocetin and thrombin; PFA-100 closure times (CT), factor VIII activity (FVIII:C), @Disease$ factor antigen (VWF:Ag), collagen binding activity (VWF:CB) and blood count."	0
There were 2 @Disease$s (1%) in the ketorolac group compared with 104 (10%) in the non@Chemical$ group (p &lt; 0.001).	0
BACKGROUND: @Chemical$ is widely used for the secondary prevention of ischemic stroke and @Disease$.	0
History of @Chemical$ @Disease$ and prolonged duration of NPs were associated with positive APT (p &lt; 0.05).	1
"To assess the incremental utility of variables not included in the @Chemical$ score, baseline high platelet reactivity was added to the @Disease$ model, and high platelet reactivity, baseline hemoglobin, and warfarin use 1 year after percutaneous coronary intervention were added to the bleeding model."	0
METHODS: This retrospective study evaluated @Chemical$ use in women aged &gt; or = 65 years based on cardiovascular and gastrointestinal @Disease$ risk using a medication therapy management database within a large mid-Atlantic managed care organization.	0
CASE REPORT: A 79-year-old man developed an epidural @Disease$ requiring surgical treatment following an uncomplicated interlaminar epidural @Chemical$ injection performed for neurogenic claudication.	0
This article discusses recent evidence regarding the @Disease$ risks associated with discontinuing @Chemical$ use in patients who take aspirin daily and presents a new recommendation for continuing low-dose aspirin during invasive dental procedures.	1
"BACKGROUND: Patients with diabetes mellitus (DM) experience higher rates of in-stent @Disease$ and greater benefit from drug-eluting stents implant at the time of percutaneous coronary intervention (PCI), necessitating prolonged dual anti-platelet therapy (@Chemical$)."	0
Correlation between serum triglycerides and gastro-duodenal @Disease$ associated with low-dose @Chemical$.	1
Gastric mucosal @Disease$ was inhibited equally among H pylori-positive subjects in the @Chemical$R group.	0
Large erosions or @Disease$ were observed in 12 (60%; 95% confidence interval 36%- 80%) @Chemical$ users.	0
"Despite their different polyphenol compositions, FB and EF apple extracts assisted in protecting the @Disease$ following acute @Chemical$ administration in rats."	0
We evaluated whether continuation of perioperative @Chemical$ alters @Disease$ complications in patients who undergo robotic partial nephrectomy (RPN).	0
A study on the effects of recent aspirin ingestion on platelet function in cardiac surgery showed a greater @Disease$ in patients treated with @Chemical$ &lt;2 days before the operation.	1
Immunomodulatory treatments for @Chemical$ exacerbated @Disease$.	0
"These data suggest that use of NSAIDs, either @Chemical$ or other non-aspirin NSAIDs, are associated positively with risk of @Disease$, and that this association is independent of RA history."	1
The risk of readmission resulting from @Disease$ and venous thromboembolism (VTE) has also not been determined for patients undergoing THA or TKA when treated with low-molecular-weight @Chemical$ (LMWH) alone compared with mechanical prophylaxis plus aspirin (ASA).	0
"This report describes a case of Kounis-Zavras syndrome in the setting of @Chemical$-induced @Disease$ also known as Samter-Beer triad combining nasal polyps, asthma, and aspirin allergy leading to vasospasm and myocardial infarction."	1
RECENT FINDINGS: @Chemical$ hypersensitivity is reported in 1.5% of patients with @Disease$.	0
"In patients with Hp-negative, NSAID-/@Chemical$-associated @Disease$, &gt; 80 % of respondents would initiate long-term proton pump inhibitor (PPI) therapy, whereas 20 % and 17.8 % would prescribe COX-2 selective inhibitors or opiates instead of non-selective NSAIDs and clopidogrel instead of aspirin."	1
@Chemical$ and @Disease$.	0
"These data suggest that use of NSAIDs, either @Chemical$ or other non-aspirin NSAIDs, are associated positively with risk of NHL, and that this association is independent of @Disease$ history."	0
Leukotriene C4 synthase promoter polymorphism in Japanese patients with @Chemical$-induced @Disease$.	1
"BACKGROUND: The frequency with which patients with aspirin-exacerbated respiratory disease (@Disease$) react to 325 mg of @Chemical$ during aspirin desensitization, or fail to react at all, is not fully known."	0
MATERIALS AND METHODS: Wound healing process was @Disease$ by administering the dose of 150 mg/kg body weight of @Chemical$ orally for 9 days to observe the effect of EtOH obtained from Cl using excision and incision wound model in rats.	0
"In this study, we compared the roles of CysLT receptor type 1 (CysLTR1) and leukotriene C4 synthase (LTC4S) gene polymorphisms in two major aspirin-related allergic diseases, aspirin-intolerant asthma (AIA) and @Chemical$-induced chronic @Disease$/angioedema (AICU)."	0
"Therefore, @Chemical$ desensitization is necessary in patients with CAD and histories of @Disease$ reactions to it."	0
"To evaluate the extent of @Disease$ and the protective effect of drugs, gastric mucosal lesion index, gastric mucosal blood flow, content of gastric mucosal hexosamine, @Chemical$ (PG), nitric oxide(NO), tumor necrosis factor (TNF), and interleukin (IL) -1, 2, 8 were measured in each group, and histological changes were observed by gross as well as under microscope and electron microscope."	0
"A total of 12 patients with a clear-cut history of AIA were randomised in double-blind cross-over fashion to receive single doses of @Disease$ 10 mg, ML 40 mg, or placebo (PL), with nasal lysine-@Chemical$ challenge performed 12 h after dosing."	0
"STUDY DESIGN: The OPT-BIRISK trial is a multicenter, double-blinded, placebo-controlled randomized study designed to test the superiority of extended antiplatelet therapy with clopidogrel monotherapy compared with aspirin and @Chemical$ for reduction of bleeding events in ACS patients with both high bleeding and high @Disease$ risks (bi-risk)."	0
[Exacerbation of @Chemical$-induced @Disease$ associated with RSV infection].	1
"Patients with @Disease$ had significantly lower post-treatment values of @Chemical$-induced aggregation (43+/-14% versus. 56+/-19%, p=0.002) and platelet reactivity index VASP (43+/-14% versus 54+/-23%; p=0.04) and a trend for lower values of arachidonic acid-induced aggregation (2.4+/-5.4 versus 13+/-21; p=0.27)."	0
@Disease$ due to antenatal low dose @Chemical$ intake.	1
"Blood investigations confirmed the diagnosis of acquired @Disease$ and he subsequently received treatment with factor VIII inhibitor bypassing activity, @Chemical$ and immunosuppresants."	0
The exact 1-sided confidence interval for the probability of @Chemical$ inducing cross-reactions in @Disease$ patients was calculated to be between 0% and 5%.	0
"In view of the above, it was decided to study both the effect of fluoxetine monotherapy and that of fluoxetine co-administered with acetylsalicylic acid on @Chemical$ peroxidation and antioxidative defense in patients with the first @Disease$ episode in their life."	0
"It has been postulated that mediators other than @Chemical$, such as kinins, prostaglandin and leukotrienes, may be responsible for some of the symptoms in @Disease$ which are not controlled by antihistamines."	0
Small-bowel mucosal injuries in low-dose @Chemical$ users with @Disease$.	0
"CONCLUSIONS: In patients with osteoarthritis taking low-dose aspirin, the use of @Chemical$ or naproxen plus lansoprazole resulted in similar rates of gastroduodenal @Disease$ation."	0
"BACKGROUND: Many patients requiring permanent pacemaker (PPM) or implantable cardiac defibrillator (@Disease$) placement are anticoagulated with warfarin, aspirin (ASA), and @Chemical$ for a number of thromboembolic risk indications."	0
"This review focuses on descriptions of these patients; methods available to diagnose ASA-exacerbated @Disease$; the unique ability of all NSAIDs that inhibit COX-1 to cross-react with @Chemical$; lack of cross-reactivity with selective COX-2 inhibitors; an update on pathogenesis; and current thoughts about treatment, including ASA desensitization and daily ingestion of ASA itself."	0
@Chemical$ and @Disease$: is the response appropriate?	0
Patients without @Disease$ or erosive oesophagitis on endoscopy at baseline were randomly assigned by computer-generated randomisation sequence to receive @Chemical$ 20 mg twice daily (n=204) or placebo twice daily (n=200).	0
"In all patients, we measured the @Disease$, by multiplate electrode aggregometry, using two agonists [adenosine diphosphate with PGE1 (ADPHS) and @Chemical$ (ASPI)] two times: on the day of cessation of clopidogrel and 90 days after clopidogrel was stopped."	0
The incidence of @Disease$ is also similar when @Chemical$ is used in doses &lt; 160 mg.	0
The aim of this meta-analysis was to evaluate the association between @Chemical$ use and the risk of @Disease$.	0
"CONCLUSIONS: Among aspirin users with a history of lower GI bleeding, continuation of @Chemical$ is associated with an increased risk of recurrent lower @Disease$, but reduced risk of serious cardiovascular events and death."	1
"When reviewing the existing literature on the effects of the coating on the incidence of gastrointestinal side effects we find that enteric-coated aspirin causes significantly less minor @Disease$ compared to plain @Chemical$ evaluated by endoscopy after short-term treatment, but there seems to be no effect of enteric-coating on the incidence of dyspepsia or gastrointestinal bleeding of clinical relevance."	0
"BACKGROUND: Using data from the Reduced-Dose Rivaroxaban in the Long-Term Prevention of Recurrent Symptomatic @Disease$ (EINSTEIN-CHOICE) trial, this study assessed cost impact of continued anticoagulation therapy with @Chemical$ vs aspirin."	0
"Further research is needed to assess the benefit-risk ratio of clopidogrel plus @Chemical$ in specific subpopulations of patients at high risk for atherothrombotic events, and to determine the role of clopidogrel plus aspirin in preventing cardioembolic stroke or early recurrent @Disease$ after symptomatic large-vessel atherostenosis."	0
@Chemical$ can help healthy women over age 56 prevent both @Disease$ and heart attacks.	0
"The cells were isolated from 3 groups of subjects: nonasthmatic patients (n = 10), patients with aspirin-tolerant asthma (ATA, n = 9), and patients with aspirin-intolerant @Disease$ (@Chemical$, n = 7)."	0
[Comparative assessment of antiaggregant efficacy of @Chemical$ and clopidogrel in peripheral @Disease$].	0
"Urinary @Chemical$, plasma tryptase and cytokine levels, platelet-leukocyte aggregates, and granulocyte transcripts were assessed.Measurements and Main Results: Eight weeks of high-dose aspirin decreased nasal symptoms and urinary prostaglandin E metabolite (P &lt; 0.05) and increased urinary leukotriene E4 (P &lt; 0.01) levels in subjects with aspirin-exacerbated @Disease$, but not in those with aspirin-tolerant asthma."	0
BACKGROUND: @Chemical$-induced @Disease$ is now increasingly being recognized although the pathogenesis of small intestinal damage induced by aspirin is not well understood and related risk factors have not been established.	1
"STUDY DESIGN: The OPT-BIRISK trial is a multicenter, double-blinded, placebo-controlled randomized study designed to test the superiority of extended antiplatelet therapy with clopidogrel monotherapy compared with @Chemical$ and clopidogrel for reduction of bleeding events in ACS patients with both high bleeding and high @Disease$ risks (bi-risk)."	0
"BACKGROUND: Danhong injection (DHI) is quite often used in combination with low-dose @Chemical$ (ASA, 75-325mg daily) in clinic, particularly for the treatment of @Disease$."	0
"Antisecretory drugs (H2 inhibitors, proton pump inhibitors), and @Chemical$ are associated with a decreased risk of bleeding @Disease$."	0
"CONCLUSION: In addition to age, male gender, H. pylori infection, and concomitant use of NSAIDs, COX-2 inhibitors, @Chemical$, and thienopyridines, underlying co-morbidities including diabetes, CKD, @Disease$, history of PUD are also important risk factors for first-time occurrence of non-variceal UGIB in aspirin users."	0
This study evaluated the risk of ischemic @Disease$ (IS) and TIA after low-dose @Chemical$ discontinuation in patients with cardiovascular disease or cerebrovascular disease.	0
BACKGROUND &@Chemical$; AIMS: There are few data on the incidence of upper and lower @Disease$ (UGIB and LGIB) from observational studies of low-dose aspirin users.	0
"In a Cochrane review the safety of non-steroidal anti-inflammatory drugs (NSAIDs), including @Chemical$ in people receiving methotrexate (MTX) for @Disease$ was evaluated."	0
"RESULTS: Pooled data suggested a significantly higher @Disease$ ratio in the LDA-continued group compared to both the @Chemical$-interrupted group (OR=2.05, 95% CI=1.05-3.99) and no-anticoagulant/APT group (OR=2.89, 95% CI=1.86-4.47)."	0
However @Chemical$-induced @Disease$ is one of its most common side effect which limits long-term use.	1
BACKGROUND: In this study we assessed patient outcomes after complete endoscopic sinus surgery (@Chemical$) and aspirin desensitization for patients with aspirin-exacerbated @Disease$ (AERD).	0
CONCLUSIONS: High-dose @Chemical$ is effective for the treatment of LDA-induced moderate-to-severe @Disease$.	0
"On a regimen of @Chemical$ 40 mg/d, AA-Ag increased to 11.21%+-4.95%(range: 2.12% to 28.84%) with 95.00%of the patients with AA-Ag&lt;20% and the rate of the patients with low on-treatment @Disease$ was 15.00%."	0
"CONCLUSIONS: Rapid aspirin desensitisation is an effective and safe procedure for patients with @Chemical$ @Disease$ who are to undergo coronary angioplasty and stenting, allowing them to receive the optimum treatment."	1
"Major @Disease$ events were increased with @Chemical$ though (RR 1.98, 95% CI 1.11 to 3.52, p = 0.02, I(2) 0%)."	0
We conclude that using @Chemical$ and Plavix  simultaneously has no considerable effect on the risk of @Disease$ in patients having conventional forceps extraction of a single tooth.	0
"METHODS: Of 271 patients suspected by history of having @Disease$, 96 were taking cys-LT receptor antagonists (cys-LTRAs) and 12 were taking zileuton at the time of oral @Chemical$ challenges."	0
"At 26 wk, @Chemical$-treated patients were more likely to experience resolution of heartburn, acid regurgitation, and @Disease$ (P &lt; 0.05)."	0
"Urinary @Chemical$, plasma tryptase and cytokine levels, platelet-leukocyte aggregates, and granulocyte transcripts were assessed.Measurements and Main Results: Eight weeks of high-dose aspirin decreased nasal symptoms and urinary prostaglandin E metabolite (P &lt; 0.05) and increased urinary leukotriene E4 (P &lt; 0.01) levels in subjects with aspirin-exacerbated respiratory disease, but not in those with aspirin-tolerant @Disease$."	0
@Chemical$ and cardiovascular primary prevention in non-endstage @Disease$: A meta-analysis.	0
"Overproduction of @Chemical$ (Cys-LTs) has been implicated as major mediators of @Disease$; however, the LT receptor antagonist montelukast is only partially effective in inhibiting aspirin responses."	0
"Before surgery, a standard oral placebo-controlled @Chemical$ challenge was performed to diagnose aspirin @Disease$."	0
"CONCLUSIONS: In this observational study, @Chemical$ use was not associated with an increase in mortality rates or HF readmission rates, and aspirin did not attenuate the benefits of ACE inhibitors, even in patients without coronary disease, patients with @Disease$, or patients treated with high-dose aspirin and low-dose ACE inhibitors."	0
"This report describes a case of Kounis-Zavras syndrome in the setting of @Chemical$-induced asthma also known as Samter-Beer triad combining nasal polyps, asthma, and aspirin allergy leading to @Disease$."	0
"We investigated the risks of ischemic stroke and @Disease$ (ICH) in relation to warfarin at various TTRs in a real-world cohort of Chinese patients with atrial fibrillation receiving warfarin and compared with those on @Chemical$, aspirin, and no therapy."	0
"Based on these findings, the patient was diagnosed with @Disease$/DRESS caused by @Chemical$."	1
"METHODS: Ancillary analysis of the @Chemical$ Versus Acetylsalicylic Acid [ASA] to Prevent @Disease$ in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment (AVERROES) trial, comparing aspirin and apixaban, focused on sex differences."	0
"Aspirin-exacerbated respiratory disease (AERD) refers to the combination of asthma, chronic rhinosinusitis with @Disease$, and acute upper and lower respiratory tract reactions to the ingestion of aspirin (acetylsalicylic acid, @Chemical$) and other cyclooxygenase-1 inhibiting non-steroidal anti-inflammatory drugs."	0
The presence of gastric acid plays a critical role in the mechanisms of NSAIDs/@Chemical$-associated gastric and duodenal mucosal injury and @Disease$ation.	1
"The studies report conflicting findings about the effect of H. pylori infection on NSAID-related ulcers, and proton-pump inhibitors (PPIs) seem to be superior to eradication only to prevent recurrent ulcer @Disease$ with @Chemical$."	1
BACKGROUND: We have previously demonstrated that @Chemical$ triggers specific generation of 15-hydroxyeicosateraenoic acid (15-HETE) from nasal polyp epithelial cells and peripheral blood leukocytes (PBL) from aspirin-sensitive (AS) but not aspirin-tolerant (AT) patients with @Disease$.	0
"A 70 year-old diabetic man receiving anti-coagulant therapy (@Chemical$) for pulmonary embolism secondary to factor V @Disease$, presented to the hospital for chest pain."	0
AIM: To compare prospectively the incidence of endoscopic @Disease$s in healthy subjects receiving low-dose aspirin plus @Chemical$ or naproxen.	0
It also detects an imbalance of the @Chemical$s in @Disease$.	0
We present a case of severe lower gastrointestinal bleeding due to @Disease$ associated with intake of enteric coated @Chemical$.	1
"The risk of @Disease$ development was significantly (log-rank test, P &lt; 0.001) lower in the lansoprazole group than in the @Chemical$ group, with the hazard ratio being 0.099 (95% confidence interval [CI] 0.042-0.230)."	0
BACKGROUND/AIMS: @Chemical$ significantly increases the risk of peptic @Disease$.	1
"CONCLUSIONS: Our findings provide important clues as to the underlying molecular mechanism behind @Disease$ resulting from exposure to @Chemical$ in elderly adults, and also suggest that interventions specifically targeting the pathways associated with angiogenesis and apoptosis may help facilitate the healing process."	1
BACKGROUND: Aspirin-intolerant @Disease$ (@Chemical$) refers to the development of bronchoconstriction in asthmatic individuals following the ingestion of aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs).	0
@Chemical$ sensitivity: implications for patients with @Disease$.	1
"CONCLUSIONS: For the treatment of high-risk TIA or minor @Disease$ patients, the clopidogrel-aspirin treatment did not increase the number of CMB than @Chemical$ alone."	0
"BACKGROUND: Aspirin triad is a subclass of chronic @Disease$ characterized by nasal polyposis, nonallergic induced asthma, and @Chemical$ sensitivity."	0
"Preventive effect of ecabet sodium on low-dose @Chemical$-induced @Disease$: a randomized, double-blind, pilot study."	1
"Antisecretory and nitrovasodilator drugs protect from UGIB, whereas previous peptic @Disease$ or UGIB and higher doses of @Chemical$ increase the risk."	0
"If aspirin and @Disease$ association are not formally documented in France, cautiousness must be kept in mind and all the @Chemical$ adverse effects notifications should be addressed to the public drugs survey network."	0
Patients on @Chemical$ have an increased risk of @Disease$ following trabeculectomy.	1
RESULTS: Curcumin containing 5% and 10% @Chemical$ ointment have shown significant (P &lt; 0.01) wound healing activity against an aspirin (administered 150 mg/kg body weight orally for 9 days) @Disease$ wound healing process.	0
"RESULTS: In 30 of 74 patients, the @Chemical$ challenge was positive, resulting in urticaria/@Disease$."	1
BACKGROUND: @Chemical$ desensitization is an effective treatment option for aspirin-exacerbated @Disease$.	0
Prevention by parenteral @Chemical$ of indomethacin-induced @Disease$ in rats: mediation by salicylic acid.	0
CONCLUSION: @Chemical$ is associated with increased @Disease$ and may be associated with a greater requirement for blood products.	1
Concomitant use of low-dose aspirin with any NSAID increases the risk of @Disease$ and diminishes the improved gastrointestinal safety profile of @Chemical$; whereas use of ibuprofen plus PPI regimens may negate aspirin's antiplatelet benefits.	0
RESULTS: Use of low-dose @Chemical$ was associated with an OR for @Disease$ of 0.94 (95 % CI 0.91-0.97).	0
"The evidence is not sufficient to justify advising long-term @Chemical$ therapy for patients with cardiovascular disease in general, and for those with @Disease$ in particular."	0
@Chemical$-Exacerbated Respiratory Disease (AERD) and Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) are both characterized by the presence of chronic sinonasal inflammation and @Disease$.	0
"There was no increase in @Disease$ frequency in participants with @Chemical$+ intake compared with aspirin (adjusted, all headache: -0.34 d/mo [95% confidence intervals: -2.50 to 1.82], migraine: -1.36 d/mo [-4.76 to 2.03], TTH: -0.57 d/mo [-4.97 to 3.84], MigTTH: 2.46 d/mo [-5.19 to 10.10]) or no analgesics (all headache: -2.24 d/mo [-4.54 to 0.07], migraine: -3.77 d/mo [-9.22 to 1.68], TTH: -4.68 d/mo [-9.62 to 0.27]; MigTTH: -3.22 d/mo [-10.16 to 3.71])."	0
"Helicobacter pylori-negative subjects in the @Chemical$R group with different CYP2C19 genotypes had significant differences in @Disease$, intragastric pH, and platelet function."	0
"We conclude that combined therapy with aspirin and @Chemical$ does not necessarily protect against clinical HIT, at least in patients with @Disease$ antibodies that have strong platelet-activating characteristics."	0
@Chemical$ was significantly associated with HbA1c &gt; or = 8% (P=.002) and obesity (BMI&gt; or = 30 kg/m(2); P=.01) and borderline associated with having &gt; or = 1 @Disease$ symptom (P=.07).	0
Enzyme up-regulation was monitored after in vitro stimulation with lipopolysaccharide (@Disease$) and/or @Chemical$ in 19 aspirin-intolerant (AI) patients (8 aspirin-sensitive asthmatics and 11 urticaria-angioedema patients) and 14 healthy controls.	0
@Chemical$'s ability to induce @Disease$ in rats is dependent on bile and can be reversed if pre-associated with phosphatidylcholine.	1
Hospitalization for @Disease$ associated with non-steroidal anti-inflammatory drugs among elderly patients using low-dose @Chemical$: a retrospective cohort study.	0
Ability of @Chemical$ to prevent @Disease$ from clopidogrel and low doses of aspirin depends on CYP2C19 genotype.	0
"A 42-year-old white woman with a history of severe @Disease$, nasal polyps, aspirin sensitivity, and chronic sinusitis was treated with @Chemical$ desensitization."	0
"DATA SYNTHESIS: @Chemical$ sensitivity is most often manifested as respiratory reactions (eg, @Disease$, profuse rhinorrhea, conjunctival injection) or urticaria/angioedema."	1
"The hemostasis was monitored by Simplate (bioMerieux, Inc, Durham, NC) @Disease$ time and capillary closure time (platelet function analyzer @Chemical$ 100; Sysmex UK Ltd, Milton Keynes, United Kingdom)."	0
Does @Chemical$ with aspirin after acute minor stroke or transient @Disease$ attack increase the risk of cerebral hemorrhage?	0
"Secondary prevention refers to the use of @Chemical$ to prevent cardiovascular events in patients with established CVD such as an MI, @Disease$, or angina."	0
"METHODS: Between 2009 and 2012, using a retrospective computer analysis, information was collected on all patients within a county-wide health care system presenting with @Disease$ and a prior history of @Chemical$ reactions."	0
"CONCLUSIONS: The multiple-dose regimen of @Chemical$ used for several days according to the OTC label is well-tolerated by otherwise healthy non-elderly subjects for short-term and symptomatic treatment of @Disease$, fever, and the common cold."	0
"Irrespective of @Chemical$ use, diabetes was independently associated with an increased risk of major @Disease$ episodes (IRR, 1.36; 95% CI, 1.28-1.44)."	0
Gastroduodenal @Disease$ of low-dose @Chemical$: a comparison with non-steroidal anti-inflammatory drugs.	0
"@Chemical$ results in prolonged inhibition of @Disease$, and acetaminophen can result in liver toxicity at normal dose and liver failure at higher dose."	1
"AIMS: Daily low-dose @Chemical$ is recommended for prevention of cardiovascular events in patients with coronary artery disease (CAD), and proton pump inhibitors (PPIs) are recommended to prevent or treat aspirin-associated @Disease$."	0
@Chemical$ exacerbated asthma (AEA) affects approximately 10% of the @Disease$tic population.	0
"The substantive risk for prophylactic @Chemical$ is therefore cerebral haemorrhage which can be fatal or severely disabling, with an estimated risk of one @Disease$ and one disabling stroke for every 1,000 people taking aspirin for ten years."	0
"More interestingly, regression analysis of the decline of forced expiratory volume in one second (FEV(1)) by aspirin provocation revealed that 10 SNPs (P = 0.003-0.04) and four relevant haplotypes (P = 0.002-0.02) were significantly associated with the fall rate of FEV(1) by @Chemical$ provocation, indicating that genetic polymorphisms of EMID2 could cause meaningful deficits in the upper and lower airways among @Disease$ patients."	0
The risk of readmission resulting from bleeding and @Disease$ (VTE) has also not been determined for patients undergoing THA or TKA when treated with low-molecular-weight heparin (@Chemical$) alone compared with mechanical prophylaxis plus aspirin (ASA).	0
"CONCLUSIONS: The highly sensitive eicosanoid profiling in @Chemical$ makes it possible to detect alterations in @Disease$, especially in its distinct phenotype characterized by hypersensitivity to aspirin and other nonsteroidal anti-inflammatory drugs."	0
Prevalence of @Chemical$-exacerbated respiratory disease in patients with @Disease$ in Turkey: a cross-sectional survey.	0
Concomitant use of low-dose aspirin with any NSAID increases the risk of @Disease$ and diminishes the improved gastrointestinal safety profile of celecoxib; whereas use of @Chemical$ plus PPI regimens may negate aspirin's antiplatelet benefits.	0
Clopidogrel is an ADP receptor antagonist and in combination with @Chemical$ widely used in patients with @Disease$ to reduce the incidence of ischemic events.	0
BACKGROUND: The role of @Chemical$ metabolites in NSAID-induced hypersensitivity has been studied in depth for NSAID-exacerbated respiratory disease (NERD) and NSAID-exacerbated @Disease$ (NECD).	0
"We encountered lower gastrointestinal bleeding in 16 patients taking a low dose of aspirin and examined the effect of low @Chemical$ dose on the stool occult blood test in 49 thrombotic patients (mean: 76.7 +/- 9.6 years old) including 39 with cerebral infarction, 8 with @Disease$ and 2 with atrial fibrillation."	0
"Induced sputum analyses were performed at baseline, one and six months after @Disease$ (differential cell count and levels of sputum supernatant @Chemical$, prostaglandin D2 and E2, and TSLP)."	0
INTRODUCTION: Helicobacter pylori (@Disease$ and use of nonsteroidal anti-inflammatory drugs (NSAIDs)/@Chemical$ (ASA) are risk factors for bleeding peptic ulcer.	0
A positive ASST was defined as an @Disease$ wheal with a diameter of &gt; 5 mm more than the @Chemical$-induced response.	0
"Regular @Chemical$ and non-aspirin analgesic use and the presence of other risk factors for @Disease$ were assessed by questionnaire at baseline, and the incidence of hypertension was assessed using biennial follow-up questionnaires."	0
"HYPOTHESES: The @Disease$ associated with prednisone and ultralow-dose @Chemical$ administration will be similar to those caused by prednisone alone, but both treatments will result in more severe lesions than placebo."	0
"CONCLUSIONS: Cyclooxygeneases transcripts expression is altered in HBEC derived from the asthmatic patients, and this phenomenon is pronounced in case of @Chemical$ @Disease$."	1
"We investigated the risks of ischemic stroke and intracranial hemorrhage (ICH) in relation to warfarin at various TTRs in a real-world cohort of Chinese patients with @Disease$ receiving @Chemical$ and compared with those on dabigatran, aspirin, and no therapy."	0
METHODS: The Apixaban versus @Chemical$ to Prevent @Disease$ in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin k Antagonist Treatment (AVERROES) trial randomized 5599 patients with atrial fibrillation and risk factors to receive either apixaban or aspirin.	0
BACKGROUND: We have previously demonstrated that aspirin triggers specific generation of 15-hydroxyeicosateraenoic acid (@Chemical$) from nasal polyp epithelial cells and peripheral blood leukocytes (PBL) from aspirin-sensitive (AS) but not aspirin-tolerant (AT) patients with @Disease$.	0
Proton pump inhibitors reduce the risk of @Disease$ in @Chemical$ users with a history of gastrointestinal complications.	1
"A meta-analysis study reported that data regarding the risk for @Disease$ of new direct oral anticoagulants (apixaban, @Chemical$ and rivaroxaban) were inconclusive."	0
"OBJECTIVE: Patients who present for coronary surgery often receive preoperative dual antiplatelet therapy with aspirin and a thienopyridine derivative (clopidogrel or @Chemical$), especially after a recent acute @Disease$."	0
"RESULTS: Among patients discharged after first-time ischemic @Disease$, 3043 patients were treated with acetylsalicylic acid, 12,295 with a combination of acetylsalicylic acid and dipyridamole, and 3885 with @Chemical$."	0
Our study suggests that even a low-dose @Chemical$ therapy can induce a gastroduodenal mucosal @Disease$.	1
This effect of @Chemical$ is unique to aspirin-exacerbated respiratory disease and not observed in subjects with aspirin-tolerant @Disease$.	0
In conclusion the underlying aetiopathogenesis of gastric @Disease$ (NASID/@Chemical$ vs.	0
"@Chemical$ or nonsteroidal antinflammatory drug sensitivity can be manifested as acute urticaria, angioedema, acute asthma, acetylsalicylic acid exacerbated @Disease$ and anaphylaxis."	1
"Based on data extracted from the validation process, recent recorded drug intake showed an increased frequency of anticoagulants with colonic diverticular and angiodysplasia bleeding, whereas NSAID and low-dose @Chemical$ use were more prevalent in @Disease$ and colonic diverticular bleeding respectively."	0
"In conclusion, spontaneous @Disease$ is a possible complication following @Chemical$-aspirin therapy and is recommended to be evaluated when appropriate clinical symptoms (e.g., intraarticular effusion) present."	0
"Questionnaires were sent to 210 neurosurgical facilities asking five main questions: (1) the adherence of any policy of stopping aspirin pre-operatively, (2) the personal risk assessment for patients with brain surgery under low-dose @Chemical$ medication, (3) the preferred method of treatment for excessive bleeding in this context, (4) personal knowledge of @Disease$ complications in this group of patients, and (5) the characteristics of the neurosurgical units concerned."	0
"SUMMARY: The full clinical picture of @Chemical$ intolerance--the association of aspirin-induced bronchial asthma (with severe acute @Disease$), aspirin sensitivity and nasal polyps--is commonly summarized as the 'Samter triad'."	0
"Prediagnostic exposure to @Chemical$ was associated with neither @Disease$-specific mortality (RR = 1.04, 95 % CI = 0.75-1.45, P = 0.80) nor all-cause mortality (RR = 1.04, 95 % CI = 0.61-1.78, P = 0.89)."	0
A multi-case report of @Disease$ in patients treated with @Chemical$.	1
"Also, women had less peripheral artery disease (@Chemical$, 2.4% versus 3.7%; apixaban, 1.4% versus 3.0%), more heart failure, and higher mean CHADS2 (congestive heart failure, hypertension, age of 75 years or older, diabetes [1 point each], @Disease$ or transient ischemic attack [2 points]) scores (aspirin, 2.2 versus 2.0; apixaban, 2.1 versus 2.0)."	0
"Of these 52 cases, there were 22 nasal polyposis cases with @Chemical$ sensitivity, 15 @Disease$ cases without aspirin sensitivity and 15 chronic rhinosinusitis cases without aspirin sensitivity."	0
"In clinical trials, PPI and @Chemical$ (40 mg/d) are proven to have the preventive effect to @Disease$ induced by low-dose aspirin use."	0
Aspirin (ASA) is an important cause of asthma so that @Chemical$ induced asthma (@Disease$) is considered a disease.	0
"STUDY DESIGN: Out of a large collective of patients with proven @Disease$ to @Chemical$, 194 patients with initiated desensitization treatment were observed for periods up to 5 years (average 32 months)."	1
The current state of the art management of @Disease$ will be addressed including the ongoing central role for @Chemical$ desensitization and high-dose aspirin therapy.	0
OBJECTIVE: Patients who present with a spectrum of @Disease$ and pseudoallergic reactions to @Chemical$ pose a special challenge for the physician.	1
Hypersensitivity to aspirin: common @Chemical$ alterations in urticaria and @Disease$.	0
"CONCLUSIONS: Early administration of a combined regimen of clopidogrel and @Chemical$ following off-pump CABG is safe and is associated with a relatively low incidence of major adverse cardiac events, @Disease$, PE, and DVT."	0
Evaluation of glomerular filtration rate in cats with @Disease$ and administered @Chemical$ and acetylsalicylic acid.	0
A short-term effect of low-dose @Chemical$ on major @Disease$ risks in primary prevention: a case-crossover design.	0
"Antileukotrienes are useful to treat @Disease$, in association with @Chemical$."	0
"Current diagnostic and treatment strategies for @Chemical$-exacerbated diseases remain limited, and continued research focusing on each of the unique @Disease$ reactions to aspirin is essential."	0
Polymorphisms of the CYP2C19 gene in Japanese patients with @Chemical$-exacerbated @Disease$.	0
"In about 10% of adult patients with asthma, @Chemical$ and other nonsteroidal anti-inflammatory drugs precipitate attacks of @Disease$."	0
"Famotidine for the prevention of peptic @Disease$ and oesophagitis in patients taking low-dose @Chemical$ (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial."	0
"Apixaban (2.5mg and 5mg), @Chemical$, rivaroxaban, idraparinux and vitamin K antagonists (VKA) each significantly reduced the risk of @Disease$ recurrence compared to placebo, ranging from a 73% reduction with idraparinux to 86% with VKAs."	0
"BACKGROUND: The management of patients with traumatic brain injury (TBI), primary intracerebral hemorrhage (@Chemical$) and primary @Disease$ (pSAH) remains a highly demanding challenge in critical care medicine."	0
"Continuous aspirin therapy for patients with gastrointestinal @Disease$ may increase the risk of recurrent bleeding but potentially reduces the mortality rates, as stopping @Chemical$ therapy is associated with higher mortality rates."	0
METHODS: The @Chemical$ versus Acetylsalicylic Acid to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin k Antagonist Treatment (AVERROES) trial randomized 5599 patients with @Disease$ and risk factors to receive either apixaban or aspirin.	0
"Recently, flowcharts regarding challenge/desensitization procedures with aspirin in patients with CAD and histories of @Chemical$ @Disease$ reactions have become available."	1
Is @Chemical$ a cause of @Disease$?	0
"Additionally, the increased rates of @Disease$ expansion in the @Chemical$ cohort may relate to its prolonged half-life."	0
"INTRODUCTION: Aspirin-exacerbated respiratory disease is defined by the clinical tetrad of @Chemical$ sensitivity, nasal polyps, @Disease$, and chronic rhinosinusitis."	0
Aspirin-exacerbated respiratory disease (AERD) is an acquired disease characterized by chronic @Disease$ with underlying dysregulation of @Chemical$ metabolism.	0
Risk factors for @Disease$ in coronary artery disease patients receiving both @Chemical$ and clopidogrel.	0
Such large geographic differences in the net effect of H. pylori infection on gastric acid secretion could be at least partly responsible for the geographically distinct interaction between @Chemical$ use and H. pylori @Disease$ on adverse gastroduodenal lesions.	0
"CONCLUSIONS: Gastroduodenal @Disease$s are found in one in 10 patients taking low-dose @Chemical$, and most are asymptomatic; this needs considering when discussing risks/benefits with patients."	0
An altered pattern of @Chemical$s also was found in patients suffering from @Disease$ and in intestinal malignancy.	0
"The origin of @Chemical$ @Disease$ remains unknown, but accumulating data from genetic studies strongly suggest that environmental factor, possibly a common viral infection, can trigger the disease in susceptible subjects."	1
"AIM: To assess endoscopically-proven @Disease$ and the amount of gastric microbleeding of four different buffered and plain @Chemical$ formulations, one containing paracetamol."	0
APT resulted positive in 12 patients (22.6%) of whom 3 (25%) had no history of @Chemical$ @Disease$.	1
Aspirin exacerbated respiratory disease (AERD) is a clinical syndrome characterized by chronic @Disease$ with nasal polyposis and @Chemical$ hypersensitivity.	0
BACKGROUND: Use of over-the-counter (OTC) high-dose acetylsalicylic acid (@Chemical$) is a risk factor for experiencing @Disease$.	1
"As a result, clopidogrel's incidence of peptic @Disease$ disease (PUD) and ulcer bleeding is lower than @Chemical$'s."	0
"The resumption of clopidogrel combined with @Chemical$ use (RR 26.71, 95%CI 7.09-100.53), and increased iatrogenic ulcer size (RR 1.52, 95%CI 1.14-2.02), were significantly associated with post-ESD @Disease$."	0
"Although @Chemical$ after @Disease$ was not associated with lobar ICH recurrence in univariate analyses, in multivariate analyses adjusting for baseline clinical predictors, it independently increased the risk of ICH recurrence (HR 3.95, 95% CI 1.6-8.3, p = 0.021)."	1
"Hazard ratio for major @Disease$ was 5.0 in patients receiving @Chemical$ therapy (95% confidence interval 1.4-17.8, p=0.012)."	0
"Thus, novel means for the treatment of @Chemical$-induced @Disease$ are urgently needed."	1
"Three major clinical phenotypes of NSAID-induced acute skin reactions manifesting with angioedema, urticaria, or both have been distinguished: NSAID-exacerbated cutaneous disease, nonsteroidal anti-inflammatory drug-induced urticaria/angioedema (@Chemical$), and single NSAID-induced @Disease$ and angioedema."	0
@Chemical$-treated patients more often had @Disease$ rebleeding (4.7% vs.	0
"The authors found no significant differences on quality of life, nasal symptoms, @Disease$ size, and CT scan scores between patients with aspirin-tolerant and @Chemical$-sensitive asthma."	0
"@Disease$ risk associated with use of nonsteroidal anti-inflammatory drugs, acetylsalicylic acid, and @Chemical$ and the effects of rheumatoid arthritis and osteoarthritis."	0
Patients on @Chemical$ suffered @Disease$ and trabeculectomy failure.	0
"There was no increase in headache frequency in participants with @Chemical$+ intake compared with aspirin (adjusted, all @Disease$: -0.34 d/mo [95% confidence intervals: -2.50 to 1.82], migraine: -1.36 d/mo [-4.76 to 2.03], TTH: -0.57 d/mo [-4.97 to 3.84], MigTTH: 2.46 d/mo [-5.19 to 10.10]) or no analgesics (all headache: -2.24 d/mo [-4.54 to 0.07], migraine: -3.77 d/mo [-9.22 to 1.68], TTH: -4.68 d/mo [-9.62 to 0.27]; MigTTH: -3.22 d/mo [-10.16 to 3.71])."	0
"@Chemical$ and aspirin are antiplatelet agents widely used in the treatment of peripheral vascular, cerebrovascular, and @Disease$."	0
"CONCLUSIONS AND CLINICAL IMPORTANCE: Administration of @Chemical$ to healthy dogs resulted in significantly lower @Disease$ scores, and fewer days of vomiting compared to aspirin, indicating that deracoxib is better tolerated than aspirin in some dogs."	1
The risk of readmission resulting from bleeding and @Disease$ (VTE) has also not been determined for patients undergoing THA or TKA when treated with low-molecular-weight @Chemical$ (LMWH) alone compared with mechanical prophylaxis plus aspirin (ASA).	0
@Chemical$ in the aetiology of Crohn's disease and @Disease$: a European prospective cohort study.	0
OBJECTIVE: To assess whether patients with CIU and aspirin sensitivity share common eicosanoid alterations with patients who have @Chemical$-sensitive @Disease$.	0
"For @Chemical$ users, age, anemia, @Disease$ and concomitant use of other antiplatelet drugs or anticoagulants were included in the risk score."	0
BACKGROUND: @Chemical$ is commonly prescribed for first-line symptomatic treatment in patients with @Disease$ and aspirin is often co-administered for cardiovascular prophylaxis.	0
"BACKGROUND: Previous studies have suggested a benefit of cilostazol in addition to standard dual-antiplatelet therapy (@Chemical$), reducing in-stent @Disease$ and restenosis after percutaneous coronary intervention (PCI) with bare-metal and drug-eluting stent (DES) implantation."	0
@Chemical$ exacerbated @Disease$ (AEA) affects approximately 10% of the asthmatic population.	1
We wanted to validate the risks of @Disease$ and thromboembolism with continued @Chemical$ mono-therapy in unilateral and simultaneous bilateral TKA.	0
OBJECTIVE: To identify genes whose expression is most characteristic of chronic rhino@Disease$ and @Chemical$-sensitive asthma through genome-wide transcriptional profiling of nasal polyp tissue.	0
Rationale: Daily high-dose aspirin therapy benefits many patients with @Chemical$-exacerbated @Disease$ but provides no benefit for aspirin-tolerant patients with asthma.	0
"RESULTS: In group of patients with aspirin @Disease$ basic concentration of LTE4 was 416.6 +/- 374.4 pg/mL, and after provocation 496.6 +/- 485.3 pg/mL, in the group without sensitivity to @Chemical$ appropriate 262.9 +/- 404.0 vs 261.2 +/- 259.66 pg/mL, and in the group disqualified to test 181.6 +/- 55.75 pg/mL."	0
"For patients who have inadequately controlled rhinosinusitis and/or @Disease$ despite treatment with topical corticosteroids and leukotriene-modifying drugs, @Chemical$ desensitization is an important therapeutic option."	0
Esomeprazole prevents @Chemical$-induced @Disease$.	1
One proposed mechanism of injury to the gastrointestinal mucosa by NSAIDs is @Chemical$-dependent @Disease$.	0
"Patients in the study group with &gt; or = 2 @Disease$, had lower @Chemical$ clearances than patients in the control group with &gt; or = 2 chronic diseases."	0
Exercise-induced @Disease$ in a cardiopathic patient on chronic @Chemical$ therapy.	0
"Compared with clopidogrel, aspirin increases the risk of GI bleeding but not other bleeding; however, 883 patients (95% CI, 357-infinity) would need to be treated with @Chemical$ versus aspirin to prevent one major GI @Disease$ episode annually at a cost of over 1 million dollars."	0
"In the @Chemical$ in @Disease$ (AD2000) trial, these proportions were, respectively, 2.6% (4/156; 95% CI, 0.7 to 6.4) and 0% (0/154; 95% CI, 0 to 2.4)."	0
@Disease$ induced by oral intake of @Chemical$: case report and literature review.	1
"BACKGROUND: In 5-10% of adult patients with @Disease$, @Chemical$ and most other nonsteroidal anti-inflammatory drugs (NSAIDs) precipitate acute asthmatic attacks."	0
The increased bronchial production of @Chemical$ (LTC4) in @Disease$ is assumed to derive from infiltrating eosinophils expressing LTC4-synthase (LTC4S).	0
Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (@Disease$ or Transient Ischemic Attack Treated With @Chemical$ or Ticagrelor and Patient Outcomes).	0
"To date, no case of spontaneous @Disease$ following clopidogrel-@Chemical$ therapy has been reported."	0
"Two independent authors searched databases using PICO questions (@Chemical$, H2RA, PPI, @Disease$ or ulcer), and reviewed abstracts and articles for comprehensive studies keeping adequate study quality."	0
"METHOD: We classified 1,041 gastroduodenal ulcer patients into three groups [patients taking LDA (group A), patients taking nonaspirin nonsteroidal anti-inflammatory drug (NSAID) (group N), and patients taking neither aspirin nor non@Chemical$ NSAID (group C)] and 241 @Disease$ gastroduodenal ulcer patients into three corresponding groups (groups a, n, and c)."	0
"Both @Chemical$ and clopidogrel were associated with @Disease$, but the association was more noteworthy for clopidogrel."	1
"Non@Chemical$ NSAID use was associated with a slightly increased OR for @Disease$ (1.13; 95 % CI 1.10-1.15); however, this association was confined to localized disease and did not vary materially with amount, duration, or consistency of nonaspirin NSAID use."	0
"CONCLUSIONS: The @Chemical$ ratio was found to be high in severe @Disease$ patients, especially haemodialysis patients, but not in mild and moderate CKD patients."	0
"BACKGROUND: @Chemical$-exacerbated respiratory disease (AERD) is a clinical syndrome characterized by chronic rhinitis, nasal polyps, @Disease$, and precipitation of asthma and rhinitis attacks after ingestion of aspirin (ASA) and most nonsteroidal anti-inflammatory drugs (NSAIDs)."	0
Nasal lysine-aspirin challenge appeared to be a reproducible and safe method in assessing patients with @Chemical$-induced @Disease$.	1
A previously healthy 60-year-old man receiving aspirin for primary prevention of @Disease$ presented with hemoptysis after 1 week of treatment for his back pain with @Chemical$.	0
It is generally accepted that in aspirin-induced asthma (AIA) the @Disease$ is provoked by inhibition of prostaglandin synthesis with overproduction of @Chemical$.	0
Gastrointestinal (@Disease$) complications are common side effects related to non-steroidal anti-inflammatory drugs (NSAID) and low-dose @Chemical$ (LDA) use.	1
OBJECTIVE: The aim of this study was to determine the @Disease$ risks associated with single (aspirin) and dual (aspirin + @Chemical$) antiplatelet therapy (DAPT) versus placebo or no treatment in adults undergoing noncardiac surgery.	0
"METHODS: We investigated intolerance and bleeding while on aspirin and aspirin discontinuation using 5337 post-acute @Disease$ patients considered appropriate for chronic antiplatelet therapy who were randomly assigned to @Chemical$ in SYMPHONY and 2nd SYMPHONY and followed for 94 (64,157) days."	0
"METHODS: Ancillary analysis of the Apixaban Versus @Chemical$ [ASA] to Prevent Stroke in @Disease$ Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment (AVERROES) trial, comparing aspirin and apixaban, focused on sex differences."	0
The role of @Chemical$ in post-polypectomy @Disease$--a retrospective survey.	0
"In patients presenting with peptic @Disease$ bleeding with low-dose aspirin, aspirin should be continued in association with PPI rather than replaced with @Chemical$."	0
"Intra-duodenal administration of @Chemical$ induced @Disease$ (observed histologically), an increase in vascular permeability and blood loss into the intestinal lumen, all of which could be attenuated if the NSAID was pre-associated with PC."	1
"CONCLUSIONS: Higher lifetime use of @Chemical$ and NSAIDs is not associated with renal function decline, but high acetaminophen use may increase the risk of @Disease$."	0
"RESULTS: Over 60% of @Chemical$ users are above 60 years of age, 4 to 6% have a recent history of peptic @Disease$s and over 13% use other non-steroidal anti-inflammatory drugs."	0
"Aspirin exacerbated respiratory disease (AERD) is characterized as adult onset asthma, @Disease$, chronic rhinosinusitis, and hypersensitivity to a cyclooxygenase-1 (COX-1) inhibitor, viz @Chemical$ or nonsteroidal antiinflammatory drugs (NSAIDs)."	0
"To evaluate the extent of @Disease$ and the protective effect of drugs, gastric mucosal lesion index, gastric mucosal blood flow, content of gastric mucosal @Chemical$, prostaglandins (PG), nitric oxide(NO), tumor necrosis factor (TNF), and interleukin (IL) -1, 2, 8 were measured in each group, and histological changes were observed by gross as well as under microscope and electron microscope."	0
"@Chemical$ can significantly reduce the incidence of @Disease$ events, recurrence and mortality, thereby improving the long-term prognosis of patients."	0
"We compared the antithrombotic effect of clopidogrel vs ticagrelor in an LVAD patient with @Chemical$ @Disease$ by using a modified protocol of the thrombin generation test, accounting selectively for the platelet contribution on thrombin generation."	1
"Subgaleal hematoma in a child with Sturge-Weber syndrome: to prevent @Disease$-like episodes, is treatment with @Chemical$ advisable?"	0
"Within 90 days after intervention, there were 4 patients (1.5%) with acute thrombosis, 5 patients (1.8%) with subacute thrombosis, 17 patients (6.2%) with stroke, and 2 death (0.7%) in low-dose aspirin group, compared with no patient (0%) with acute @Disease$, 2 patient (2.1%) with subacute thrombosis, 6 patients (6.2%) with stroke, and 2 death (2.1%) in high-dose @Chemical$ group, and there were no significant difference in all study endpoints between two groups."	0
"CONCLUSION: In patients prescribed low-dose ASA for the secondary prevention of cardiovascular or cerebrovascular events, discontinuation of low-dose @Chemical$ was associated with a 40% increase in the risk of IS/@Disease$ compared with continuation of therapy."	1
"BACKGROUND AND AIMS: Nitric oxide-releasing aspirin (NO-ASA) has been shown to inhibit cyclo-oxygenase and prostaglandin generation without causing mucosal damage, but the role of @Chemical$ (ROS) and cytokines in the action of ASA and NO-ASA against acute @Disease$ has been little studied."	0
Altered @Chemical$ production as well as differential EP receptor expression has been reported in both upper and lower airways of patients with @Disease$.	0
@Chemical$ reduces urinary excretion of leukotriene E(4) and inhibits aspirin-induced @Disease$ to threshold dose of aspirin.	0
The aspirin group without anti-@Disease$ drugs (A(-) group) comprised 47 patients and the non-@Chemical$ group without anti-ulcer drugs (NA(-) group) 31 patients.	0
"@Chemical$ pack size restriction: the impact on paracetamol @Disease$ and the over-the-counter supply of paracetamol, aspirin and ibuprofen."	0
"After the @Disease$s had healed and the H. pylori infection was eradicated, the patients were randomly assigned to treatment with 30 mg of @Chemical$ daily or placebo, in addition to 100 mg of aspirin daily, for 12 months."	0
"To evaluate the @Disease$ risk in patients requiring chronic warfarin therapy and undergoing stent implantation, we compared 107 consecutive patients on chronic warfarin therapy who underwent coronary stenting and were discharged on @Chemical$, clopidogrel and warfarin to 107 contemporary patients who were treated with aspirin and clopidogrel."	0
"@Disease$ (OR 3.07; 95 CI, 1.23-7.70; P 0.017), @Chemical$ consumption (OR 5.04; 95 CI, 1.86-13.70; P 0.001), and a history of peptic ulcer (OR 13.41; 95 CI, 3.78-47.64; P 0.001) were identified as risk factors for upper GI bleeding."	0
Obesity is not a risk factor in the development of @Disease$ in patients with @Chemical$.	0
"BACKGROUND: This study compares clinical outcomes in patients with @Disease$, taking preinjury antiplatelet drugs (@Chemical$, clopidogrel) and anticoagulants (warfarin)."	0
"INTERPRETATION: Famotidine is effective in the prevention of gastric and duodenal ulcers, and erosive @Disease$ in patients taking low-dose @Chemical$."	0
"RECENT FINDINGS: Numerous studies, including randomized, double-blind, placebo-controlled trials, have demonstrated the therapeutic effectiveness of @Chemical$ desensitization with significant improvement in number of @Disease$ per year, olfactory scores, nasal symptom scores, asthma symptom scores, sinus operations, hospitalizations, emergency room visits, and oral steroid use."	0
"BACKGROUND/AIMS: Many patients with aspirin-induced @Disease$ have severe methacholine airway hyperresponsiveness (AHR), suggesting a relationship between @Chemical$ and methacholine in airway response."	0
OBJECTIVE: To investigate the association between the prophylactic use of @Chemical$ and the prevalence of @Disease$ among adults.	0
Determinations were performed at baseline and following oral aspirin and @Chemical$ challenges in two well-defined @Disease$ phenotypes: aspirin-sensitive and aspirin-tolerant patients.	0
"Soon after the introduction of @Chemical$ for the treatment of pain, fever, and inflammation more than a century ago, clinicians were challenged by the frequent observation of ASAtriggered @Disease$ and pseudoallergic reactions occurring in the skin."	0
The study also documented that @Chemical$ users decreased the risk of fatal @Disease$ by 15%.	0
Overproduction of cysteinyl leukotriene in mast cells may be related with suppression of @Chemical$ in patients with aspirin @Disease$.	0
"Reye's syndrome is a serious, acute @Disease$ that has been linked with @Chemical$ (acetylsalicylic acid) use in children and teenagers &lt;18 years of age."	0
CONCLUSIONS: Patients treated with low-dose @Chemical$ therapy are more likely to have endoscopic evidence of @Disease$.	1
"We therefore investigated the efficacy of famotidine, a well-tolerated histamine H(2)-receptor antagonist, in the prevention of peptic ulcers and erosive @Disease$ in patients receiving low-dose @Chemical$ for vascular protection."	0
"Omeprazole appears to be very effective in reducing both acute @Disease$ and upper GI bleeding in the high-risk patient taking low-dose @Chemical$, but data with other anti-ulcer agents are lacking (misoprostol) or inconsistent (ranitidine) at present."	0
OBJECTIVE: We examined the association of a TGFbeta1 genetic polymorphism with aspirin-intolerant chronic urticaria (AICU) and @Chemical$-tolerant chronic @Disease$ (ATCU) in a Korean population.	0
Cases were patients with @Disease$ (CAD) and documented history of aspirin hypersensitivity who underwent rapid successful oral desensitization to @Chemical$.	0
This paper reviews recent clinical evidence that suggests that @Chemical$ prophylaxis against cardiac and cerebral vascular ischemia is associated with significant @Disease$.	1
We aimed to determine urinary metabolites of both histamine and leukotrienes (@Chemical$) in patients affected by chronic @Disease$ (CU).	0
"CONCLUSION: Advanced age, atherosclerosis, male gender and NSAID administration (particularly @Chemical$) are the major risk factors of upper GI @Disease$ in patients with gastric and/or duodenal ulcer."	1
@Chemical$ sensitivity and severity of asthma: evidence for irreversible @Disease$ in patients with severe or difficult-to-treat asthma.	0
"On epithelial and glandular cells, expression of cysLT 2 significantly exceeded that of cysLT 1 in both the patients with @Disease$ and the controls ( P &lt; or = .004), although there was no significant difference in the expression of either receptor in the patients with rhinosinusitis (@Chemical$-sensitive or aspirin-tolerant) and the controls."	0
"The present study, carried out on female rats, evaluates the effects of P. halepensis @Chemical$ (EOP) on aspirin (A)-induced @Disease$."	0
CONCLUSIONS: Our results point to a deficient @Chemical$(2) production under proinflammatory conditions in @Disease$tic airways.	0
This study evaluated the association of BMI and @Disease$ in patients with aspirin-tolerant asthma (ATA) and @Chemical$-intolerant asthma (AIA).	0
"In the gastric body, @Chemical$ was a non-significant, and HP @Disease$ a significant, aggressive factor."	0
We conclude that melatonin and its precursor tryptophan given orally significantly reduce @Disease$ induced by @Chemical$ possibly due to (a) direct gastroprotective action of exogenous melatonin or that generated from tryptophan and (b) gastrin released from the gastric mucosa by melatonin or tryptophan.	1
BACKGROUND: @Disease$ to @Chemical$ (ASA) constitutes a serious problem for subjects with coronary artery disease.	1
@Chemical$ desensitization in a patient with aspirin sensitivity and chronic @Disease$.	0
"Our study also highlights that the use of aspirin for primary prevention of cancer was found to cause higher rates of bleeding (any @Disease$, major bleeding, and GI bleeding) compared to placebo or no @Chemical$ at the longest follow-up period with no significant benefit in cancer primary prevention."	0
The two frequent clinical presentations of @Chemical$ hypersensitivity are: aspirin-induced bronchial asthma/rhinosinusitis (AIA/R) and aspirin-induced urticaria/@Disease$ (AIU).	0
"The big idea: the coxib crisis @Chemical$, aspirin and @Disease$ risk revisited."	0
@Chemical$-exacerbated respiratory disease (@Disease$) is a respiratory disease             characterized by acute bronchial responses upon the administration of non-steroidal             anti-inflammatory drugs (NSAIDs) and the immune response by mast cells is regarded             as one of the noteworthy causes of AERD pathogenesis.	0
"Although co-therapy with a PPI and the eradication of H. pylori substantially reduce the risk of recurrent @Disease$ bleeding with aspirin, the replacement of aspirin by @Chemical$ cannot be recommended to patients with a high gastrointestinal risk."	0
Aspirin desensitization in @Chemical$-exacerbated @Disease$: New insights into the molecular mechanisms.	1
"Data Sources: We searched PubMed, Embase, CENTRAL, and ClinicalTrials.gov from inception to May 28, 2018, with the terms novel oral anticoagulants, non-vitamin K antagonist oral anticoagulants, direct oral anticoagulants, dabigatran, rivaroxaban, apixaban, edoxaban, warfarin, Coumadin, vitamin K antagonist, aspirin, @Chemical$, or ASA, and major bleeding, fatal @Disease$, or intracranial hemorrhage."	0
"The values of @Disease$s of MPs in descending order were as follows: gefarnate, hydrotalcite &gt; teprenone &gt; sucralfate oral suspension &gt; @Chemical$ and sodium gualenate granules &gt; rebamipide &gt; sucralfate chewable tablets."	0
OBJECTIVE: To investigate the feasibility of periodontal mechanical therapy for chronic @Disease$ and coronary heart disease patients with low dose of @Chemical$.	0
The study included patients at high risk of @Disease$ who were regularly taking antiplatelet agents (e. g. thienopyridine derivatives and @Chemical$).	0
"METHODS: Subjects 18 years or older with osteoarthritis, without gastroduodenal ulcer or erosive @Disease$ at baseline endoscopy, and a cardiovascular indication for prophylaxis low-dose (81 or 325 mg) aspirin were prescribed open-label @Chemical$ and blindly randomized to celecoxib 200 mg/day or naproxen 500 mg twice daily plus lansoprazole 30 mg once daily."	0
"RESULTS: The age, BMI, hospital stay, @Chemical$ classification, morbidity of CHD and @Disease$, FIB value, and the time of resuming normal activities of patients taking acetylsalicylic acid were higher (p &lt; 0.05)."	0
We also did not observe an increased rate of @Disease$ in the case of a short interval between last @Chemical$ (less than 24 hours) or aspirin (less than five days) doses and delivery.	0
Further studies evaluating the gastrointestinal risk of immediate @Chemical$ use in AMI with acute @Disease$ are required.	0
"Considering the patient's previous history of GI disorders prior to initiation of treatment and Hp(+) serology, it appears that decreasing risk of symptomatic or complicated gastro-duodenal @Disease$ was higher in treatment with @Chemical$ in patients who did not have a previous history of ulcer, whatever their Hp status."	0
@Chemical$-induced @Disease$ of the tongue.	1
"Adjusted relative risk (RR) associated with different factors, and the interaction between NSAID/@Chemical$ and H. pylori @Disease$ was estimated by logistic regression analysis."	0
AIMS: Low-dose @Chemical$ (LDA) and non-steroidal-anti-inflammatory drugs (NSAIDs) both increase the risk of @Disease$ (UGIEs).	1
@Chemical$ therapy has been shown to reduce morbidity and mortality in patients with @Disease$.	0
"RESULTS: Among the patients with @Disease$, polymorphism at -1082A/G was significantly associated with the phenotype of @Chemical$-intolerant asthma, AIA (P = 0.007, P(c) = 0.021)."	0
"In conclusion, high-dose fish oil is safe in combination with aspirin and @Chemical$ and does not increase the risk of @Disease$ compared with that seen with aspirin and clopidogrel alone."	0
"METHODS: Using gas chromatography/mass spectrometry, we determined plasma and urinary concentrations of 9alpha,@Chemical$(2) at baseline in 131 stable @Disease$tic patients, 65 of whom had AIA and 66 of whom had ATA."	0
"Dual antiplatelet therapy consisting of low-dose @Chemical$ (LDA) and other antiplatelet medications is recommended in patients with coronary heart disease, but it may increase the risk of esophageal lesion and @Disease$."	0
Introduction: Risks of low-dose @Chemical$-associated upper and lower gastrointestinal bleeds (UGIB/LGIB) may vary by severity and presence of @Disease$ (CVD).	0
"In the presence of sufficient amounts of gastric acid, H. pylori infection and aspirin could synergistically damage gastric mucosal integrity, while in the absence of sufficient amounts of gastric acid, the synergistic effect could be completely counteracted and the @Disease$ could even suppress the @Chemical$-induced gastropathy."	0
"The incidence of @Disease$ was lowest in patients on dabigatran (0.32%/y) compared with those on @Chemical$ (0.90%/y), aspirin (0.80%/y), and no therapy (0.53%/y)."	0
"CONCLUSIONS: Based on this experience, we recommend the use of peri-operative gastric protection with ranitidine when @Chemical$ is used for thromboprophylaxis in hip and knee @Disease$."	0
Prominent role of IFN-gamma in patients with @Chemical$-exacerbated @Disease$.	0
"@Disease$ Following Percutaneous Computed Tomography-Guided Lung Biopsy: Retrospective Review of Risk Factors, Including @Chemical$ Usage."	0
Management of patients with non@Chemical$-exacerbated @Disease$ aspirin hypersensitivity reactions.	0
"In some @Disease$tic individuals, @Chemical$ and other nonsteroidal anti-inflammatory drugs (NSAIDs) that inhibit cyclooxygen-ase 1 (COX-1) exacerbate the condition."	0
The aim of this work was to determine the presence of galectin-10 in nasal lavage fluid (NLF) of patients with aspirin-sensitive @Disease$ (ASRD) before and after challenge with @Chemical$ (aspirin) by ELISA.	0
"A prior history of @Disease$ was predictive of @Chemical$-related UGS (OR: 17.60; CI 95%: 11.52-26.88) whereas neither, gender nor aspirin dosage (ranging from 75 and 325 mg) predicted the occurrence of UGS."	0
"CONCLUSIONS: NSAID, low-dose @Chemical$ use, and H. pylori infection are three independent risk factors for the development of PUB, but there were differences in the interaction effect between low-dose ASA (no interaction) or NSAID (addition) use and H. pylori @Disease$, which may have implications for clinical practice in prevention strategies."	0
"Furthermore, a recent study suggested that the administration of low-dose aspirin plus high-dose @Chemical$ (a potent PPI) was associated with fewer episodes of UGI @Disease$ than clopidogrel alone in patients with a history of recent UGI haemorrhage."	0
"There were significantly more patients who suffered GI adverse events, principally abdominal pain, dyspepsia, nausea and @Disease$, with aspirin (18.5%) than with ibuprofen (11.5%), but the difference between @Chemical$ and paracetamol (13.1%) was not significant."	0
"@Chemical$ desensitization, Leukotriene-modifying agents, biologic agents, management of asthma, chronic rhinosinusitis, and @Disease$ are recommended as treatment modalities."	0
"CONCLUSIONS: Low-dose @Chemical$ use could reduce the incidences of total cardiovascular events, stroke, nonfatal stroke and transient @Disease$ attack but increase the risk of bleeding, the incidence of nonfatal myocardial infarction, death from cardiovascular causes and death from any cause was not affected by low-dose aspirin use."	0
Heat shock protein 70 gene polymorphisms in Japanese patients with @Chemical$-exacerbated @Disease$.	0
"Of the three ophthalmological studies highlighting the adverse affects of @Chemical$ association with @Disease$, all suggested an exacerbation of AMD without statistical significance and broad confidence bands."	0
"Dual antiplatelet therapy (DAPT) with acetylsalicylic acid and a P2Y12 inhibitor (@Chemical$, ticagrelor, or prasugrel) reduces thrombotic events in patients with acute coronary syndrome (ACS), but it is also associated with an increased risk of @Disease$ complications."	0
"Data Sources: We searched PubMed, Embase, CENTRAL, and ClinicalTrials.gov from inception to May 28, 2018, with the terms novel oral anticoagulants, non-vitamin K antagonist oral anticoagulants, direct oral anticoagulants, dabigatran, rivaroxaban, apixaban, edoxaban, warfarin, Coumadin, vitamin K antagonist, aspirin, acetylsalicylic acid, or @Chemical$, and major bleeding, fatal @Disease$, or intracranial hemorrhage."	0
"METHODS: We retrospectively analyzed 300 outpatients with @Disease$ cerebrovascular disease: 150 had been receiving @Chemical$ treatment for &gt;1 year (patients), and 150 controls had not previously received aspirin."	0
"Patients with history of GI ulcer/@Disease$ were much more likely to be co-prescribed @Chemical$ than those who had no history of GI disorders (OR, 26.5)."	0
"Individuals with two single nucleotide polymorphisms (SNPs) of cyclooxygenase-1 (COX-1), A-842G and C50T, exhibit increased sensitivity to aspirin and lower @Chemical$ synthesis capacity but the polymorphism lacked statistical significance in relation to an association with bleeding peptic @Disease$."	0
"We concluded that in the absence of a suggestive clinical history, only a small proportion of patients with @Disease$ are likely to be sensitive to @Chemical$."	0
"The pathogenesis of aspirin-exacerbated respiratory disease (@Disease$) is thought to be based on, mainly, overproduction of eicosanoid @Chemical$ mediators and on defective anti-inflammatory regulators."	0
"The risk increased when ASA was combined with clopidogrel, compared with aspirin alone (OR, 1.86; 95% CI, 1.49-2.31), anticoagulants vs low doses of @Chemical$ alone (OR, 1.93; 95% CI, 1.42-2.61), or in studies that included patients with a history of GI @Disease$ or of longer duration."	0
"However, no information is available for NSAID-induced urticarial/angioedema (@Chemical$), despite it being the most frequent clinical entity induced by NSAID @Disease$."	0
"Unless @Chemical$ use is stopped, these @Disease$ remain incurable and dangerous."	0
"Despite reports in the literature, there does not appear to he cross-reactions between food coloring, hydrocortisone succinate and @Chemical$ in individuals with aspirin exacerbated @Disease$."	0
"We describe the most common clinical presentations of aspirin hypersensitivity, i.e. aspirin-induced asthma, @Disease$ and @Chemical$-induced urticaria."	0
"Ninety-four respondents (66.2%) considered that patients taking low-dose @Chemical$ were at increased risk for excessive peri-operative @Disease$ or were indetermined (8.6%), and 73 (51.4%) reported having personal experience of such problems."	1
Three @Chemical$ reactors reported the onset of spontaneous recurrent @Disease$ 1 to 3 years after the challenge tests.	0
There were more patients with @Disease$ on DAPT than @Chemical$ therapy and half of these patients with this complication needed pocket revision for evacuation.	0
"Factors associated with an increased risk of aspirin-related upper GI complications are still being elucidated but most importantly include a prior history of @Disease$ or GI bleeding, @Chemical$ dose, and concomitant use with an NSAID, anticoagulant, or additional antiplatelet drug."	0
PURPOSE: To evaluate the risk for serious bleeding with regular @Chemical$ use in @Disease$ (CVD) primary prevention.	0
BACKGROUND: We have previously demonstrated that aspirin triggers specific generation of 15-hydroxyeicosateraenoic acid (15-HETE) from nasal polyp epithelial cells and peripheral blood leukocytes (PBL) from @Chemical$-sensitive (AS) but not aspirin-tolerant (AT) patients with @Disease$.	0
Age when asthma was developed (A+ASA groups)--45.5; the duration of @Disease$ was 11 +/- 9 years. 58% of patients had polypectomy/ethmoidectomy (PP--45%; A--60%; @Chemical$--80%).	0
This study was undertaken to define the role that apoptosis may play in inducing cellular injury and @Disease$ in gastric mucosa exposed to @Chemical$.	0
"In addition, respiratory reactions sustained by 50 consecutive patients with @Disease$ during 2004 were recorded, analyzed, and compared with the @Chemical$/placebo-treated patients to determine whether there were any differences."	0
"@Chemical$, however, carries an increased risk for gastrointestinal (@Disease$) injury (e.g., ulceration) and its complications (e.g., hemorrhage), which may be caused by its antiplatelet and gastric mucosal effects."	1
"The ORs for bladder @Disease$ were 1.21 (95% CI: 0.87-1.68) for regular use of @Chemical$, 0.72 (95% CI: 0.54-0.97) for use of any CCBs, and 1.32 (95% CI: 0.87-1.99) for use of any statins."	0
This condition has been designated as @Chemical$-Exacerbated @Disease$ (AECD).	1
"HPR was defined as on-@Chemical$ P2Y12 platelet reaction units &gt;208 as measured by the VerifyNow assay; target vessel failure (TVF) was defined as the composite of all-cause death, myocardial infarction, or @Disease$-driven target vessel revascularization."	0
Patients treated with @Chemical$ preoperatively were significantly more likely to suffer @Disease$ events (5.7% vs.	0
"Safety of @Chemical$, a specific cyclooxygenase-2 inhibitor, in asthmatic patients with aspirin-exacerbated @Disease$."	0
@Disease$ after cutaneous surgery occurring in the setting of @Chemical$ therapy or thrombocytopenia: a presentation of six cases.	0
"The study objective was to identify the prevalence of @Disease$, inhalant allergy and @Chemical$ sensitivity in CRS patients referred to secondary care and establish any differences between CRS phenotypes."	0
This study investigated the association between serum albumin level and @Disease$ events in this population.Methods and Results:We enrolled 438 consecutive patients who were prescribed dual APT (@Chemical$; aspirin and thienopyridine) beyond 1 month after successful PCI without adverse events.	0
We sought to compare how a single pill of non-enteric coated aspirin (325-mg) affects human platelets in patients with @Disease$ dependent on @Chemical$ use.	0
"CONCLUSIONS: CIU with aspirin sensitivity is characterized by the eicosanoid alterations, which are similar to those present in @Chemical$-induced @Disease$."	1
"We examined whether mother's use of @Chemical$, aspirin or ibuprofen in pregnancy is associated with increased risk of @Disease$ (CP) in the child."	0
"Conventionally, @Disease$ include @Chemical$-exacerbated respiratory disease (AERD), ASA-induced urticaria, and anaphylaxis."	0
"Concomitant therapy with acetaminophen (@Chemical$) and low-dose aspirin is often used in clinical settings; however, it is unclear whether this combination is involved in the progression of @Disease$ (CKD)."	0
"The SNPs and haplotypes were not associated with risk of @Disease$ development, but were significantly associated with @Chemical$ intolerance."	0
"According to APS standard of care, patients were treated with aspirin and/or low-molecular weight heparin (@Chemical$) at prophylactic (pure obstetric @Disease$) or therapeutic doses (history of thrombosis)."	0
The features described here suggest the importance of the Eosinophils and CD 4 +/- Lymphocytes in @Disease$tic response of allergic asthmatic patients as well as in @Chemical$ sensitivity asthmatic patients.	0
"OBJECTIVES: Leukotriene receptor antagonists (LTRA), such as montelukast, have been used as a first-line treatment for patients with @Chemical$-intolerant asthma (@Disease$)."	0
Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of @Disease$ or Ulcers in High-Risk Users of Low-Dose @Chemical$.	0
[The characteristics and treatment in patients with @Disease$ relevant to long term oral use of @Chemical$].	0
"I've taken @Chemical$ for years to prevent heart attack, and now I've developed an @Disease$."	0
"Our aim was to investigate prophylaxis effects of famotidine, one of the representative histamine-2 receptor antagonists (H2RA), on @Disease$ induced by dual therapy with low-dose @Chemical$ and clopidogrel in relation to Helicobacter pylori (H. pylori) infection and CYP2C19 genotypes."	1
"OBJECTIVE: Aspirin exacerbated respiratory disease (AERD) is comprised of aspirin/acetylsalicylic acid (@Chemical$) sensitivity, @Disease$, and nasal polyposis."	0
"In patients requiring @Chemical$ therapy, the addition of dual antiplatelet therapy is associated with an approximately 7% major @Disease$ risk."	0
"SA has a cytoprotective action against N@Chemical$ID-induced gastric lesions, and this action is not mediated by endogenous AD but may be functionally associated with inhibition of the @Disease$ response."	0
"ASA aggravates @Disease$ damage via enhancement of @Chemical$ and cytokine generation and suppression of SOD and GPx, and these effects are counteracted by NO released from NO-ASA."	0
INTRODUCTION: The aim of this study was to assess the efficacy of @Chemical$- antagonists in aspirin-intolerant @Disease$ (AIA).	0
"The risk of bleeding, adjusted for age, gender, Helicobacter (H) pylori @Disease$, and gastroprotective drug use were 7.87 (CI 4.90-12.60) in acute users and 3.97 (95% CI 2.27-6.96) in chronic users of NSAIDs and/or @Chemical$."	0
Systemic corticosteroid therapy does not completely suppress lifelong @Chemical$-@Disease$.	0
"CONCLUSION: @Chemical$ at a daily dose of &gt;=100 mg for prevention of preeclampsia that is initiated at &lt;=16 weeks of gestation, rather than &gt;16 weeks, may decrease the risk of @Disease$ or antepartum hemorrhage."	0
BACKGROUND AND PURPOSE: Apixaban reduces @Disease$ with comparable bleeding risks when compared with @Chemical$ in patients with atrial fibrillation who are unsuitable for vitamin k antagonist therapy.	0
Importance: A decision to initiate @Chemical$ therapy for primary prevention of @Disease$ (CVD) requires consideration of both treatment benefits and harms.	0
Helicobacter pylori and low-dose @Chemical$ @Disease$ risk: A meta-analysis.	1
"We describe the case of a 64-year-old patient with glucose-6-phosphate dehydrogenase deficiency who was referred to our hospital because of an acute inferior myocardial infarction.Given the possible risk of acute haemolytic anaemia, aspirin was not given in the acute phase, and the patient was successfully treated by balloon angioplasty of the right coronary artery.After functional and genetic testing showing the presence of the Mediterranean mutation, known to be a class II variant, the patient received oral daily @Chemical$ (100 mg) under strict monitoring in order to promptly detect any sign of @Disease$."	0
"Mild @Disease$ occurred in 3 patients, and 2 of these occurred at higher starting doses of @Chemical$."	0
"Fifteen patients were off therapy; 10 (8%) patients stopped because of @Disease$ and/or gastrointestinal symptoms, whereas 4 patients were switched to other antiplatelet agents by their primary care physician as a matter of choice rather than @Chemical$-dipyridamole side effects."	0
"OBJECTIVES/HYPOTHESIS: To demonstrate that quality-of-life outcomes after endoscopic sinus surgery are not compromised in patients with Samter's triad (asthma, @Disease$, aspirin sensitivity) when compared to patients with eosinophilic chronic rhinosinusitis with nasal polyposis (eCRSwP) who are not @Chemical$ sensitive."	0
Randomized controlled trials comparing PPIs and H2RAs for prevention of @Disease$ associated with low-dose @Chemical$ (LDA) were collected.	1
"CONCLUSION: Using simple serum measurement of H. pylori antibody and pepsinogen concentrations, an extremely high-risk group for @Chemical$-induced @Disease$ could be extracted, and these patients should become a therapeutic target for prevention of LDA-induced gastropathy."	1
"Comparison between the warm needling group and Omeprazole group showed that the UI, both serum and @Disease$ activity, and serum MDA level of the former group were evidently higher than those of the @Chemical$ group (P&lt;0. 05), but gastric mucosal MDA level of the warm needling group was apparently lower than that of the Omeprazole group (P&lt;0.05)."	0
"Established risk factors for GI ulcer development include advanced age, history of ulcer or @Disease$ bleed, concomitant use of corticosteroids or anticoagulants, high-dose @Chemical$/NSAID therapy, and possibly concomitant Helicobacter pylori infection."	0
Lansoprazole for the prevention of recurrences of @Disease$ complications from long-term low-dose @Chemical$.	1
RATIONALE: @Chemical$-induced asthma (@Disease$) is a distinct clinical syndrome that affects up to 10% of adults with asthma.	0
In subjects with aspirin @Disease$ disruption of synthesis of prostaglandin E2 (@Chemical$) and overproduction of cysteinyl leukotrienes (Cys-LT) seem to be crucial in the pathogenesis of bronchial symptoms.	0
Reduced platelet reactivity to @Chemical$ can predict postoperative @Disease$ in CABG patients on dual antiplatelet therapy.	0
"Hypersensitivity to acetylsalicylic acid (@Chemical$) is characterized by the co-occurrence of symptoms so-called aspirin triad, which include @Disease$, chronic rhinitis and sinusitis and the nasal mucosa polyps."	0
Aspirin has been the cornerstone of therapy for the secondary prevention treatment of patients with @Disease$ since landmark trials were completed in the late 1970s and early 1980s that demonstrated the efficacy of @Chemical$ for reducing the risk of ischemic events.	0
"METHODS: Subjects 18 years or older with osteoarthritis, without gastroduodenal @Disease$ or erosive esophagitis at baseline endoscopy, and a cardiovascular indication for prophylaxis low-dose (81 or 325 mg) aspirin were prescribed open-label aspirin and blindly randomized to @Chemical$ 200 mg/day or naproxen 500 mg twice daily plus lansoprazole 30 mg once daily."	0
"TAPT and DAPT had similar rates of bleeding, but @Chemical$ had significantly higher rates of @Disease$, palpitation, rash and gastrointestinal side-effects."	1
"@Chemical$, a macrolide-derived immunosuppressant, is used for immunosuppression in organ transplantation and also for allergic diseases such as @Disease$."	0
"CONCLUSION: Among elderly patients receiving cardiovascular protection with ASA and pain control with anti-inflammatory drugs, @Chemical$ may be safer with regards to GI toxicity than @Disease$."	0
"There were no statistically significant differences between the @Chemical$ and control groups in severe haemorrhage (6 5 versus 5 6 per cent respectively; odds ratio (OR) 1 18, 95 per cent c.i. 0 38 to 3 62), intraoperative transfusion (23 4 versus 23 7 per cent; OR 0 98, 0 51 to 1 87), overall @Disease$ (10 2 versus 12 0 per cent; OR 0 83, 0 35 to 1 94), CCI score (24 versus 28; P = 0 520), major complications (23 1 versus 13 9 per cent; OR 1 82, 0 92 to 3 79) and 90-day mortality (5 6 versus 4 6 per cent; OR 1 21, 0 36 to 4 09)."	0
"STUDY DESIGN: The OPT-BIRISK trial is a multicenter, double-blinded, placebo-controlled randomized study designed to test the superiority of extended antiplatelet therapy with clopidogrel monotherapy compared with aspirin and @Chemical$ for reduction of bleeding events in ACS patients with both high @Disease$ and high ischemic risks (bi-risk)."	0
"OBJECTIVES: To evaluate if esomeprazole prevents recurrent peptic ulcer in adult patients with a history of peptic @Disease$ receiving low-dose acetylsalicylic acid (ASA, @Chemical$) for cardiovascular protection in East Asia."	0
"This theory, which is now generally accepted, states that @Disease$ attacks precipitated by @Chemical$ and other NSAIDs have no allergic background; instead, they occur due to the inhibition of cyclooxygenase-1 in sensitive patients."	1
"Although it is still controversial whether @Chemical$ modifiers are more effective in patients with AIA compared with other types of asthma, because LT plays an important role in the pathogenesis of @Disease$, leukotriene modifiers are the preferred medication for the long-term control of AIA."	0
"METHODS: Thirty genome-wide expression microarrays were used to compare nasal polyp tissue from patients with chronic rhinosinusitis alone (CRS, n = 10) or chronic rhino@Disease$ and a history of aspirin-sensitive asthma (@Chemical$, n = 10) to normal sinonasal mucosa from patients who underwent surgery for non-sinus related conditions (controls, n = 10)."	0
"Both @Chemical$/aspirin and celecoxib/aspirin groups demonstrated a higher incidence of gastric and duodenal @Disease$s vs. placebo/aspirin (8%; RR: 3.7, 95% CI: 1.8-7.6 and RR: 2.6, 95% CI: 1.2-5.8, respectively)."	1
@Disease$ to @Chemical$ is a common indication to desensitization in a daily practice.	1
"METHODS: Therefore, nasal polypous tissue specimens of patients suffering from chronic nasal polypous sinusitis (NP), intrinsic asthma (ATA), @Chemical$-intolerance (AINA), and aspirin-triad (@Disease$) were investigated."	0
"BACKGROUND: The aim of this study was to evaluate whether an intraoperative bronchospasm is more frequent in sinus surgery than in non-sinus surgery, whether its appearance after application of a non-steroidal anti-inflammatory drug (NSAID) is an indicator of an aspirin @Disease$, and whether its appearance can be interpreted as an @Chemical$ provocation test."	0
"Incidences of poor bleeding control during the procedure and @Disease$ after the procedure were 7.7% (1/13) and 15.4% (2/13) of patients, respectively, in the @Chemical$-interrupted group, and 3.2% (1/31) and 16.1% (5/31) of patients, respectively, in the LDA-continued group."	0
There were more patients with @Disease$ on @Chemical$ than warfarin therapy and half of these patients with this complication needed pocket revision for evacuation.	0
"BACKGROUND: @Chemical$-induced @Disease$ (CRS) is a severe progressive persistent disease, usually associated with nasal polyps (NPs)."	1
"Comparative tolerability of paracetamol, @Chemical$ and ibuprofen for short-term @Disease$ in patients with musculoskeletal conditions: results in 4291 patients."	0
"The studies report conflicting findings about the effect of H. pylori infection on NSAID-related @Disease$s, and proton-pump inhibitors (PPIs) seem to be superior to eradication only to prevent recurrent ulcer bleeding with @Chemical$."	0
@Chemical$ ingestion is associated with a lower small-intestinal @Disease$ than other NSAID.	0
"CONCLUSION: In @Disease$ patients treated with E-ZES, TAPT with @Chemical$ did not add any significant benefit in terms of NIH suppression or MACE reduction."	0
"However, treatment with steroids and an LTRAs may inhibit @Disease$ attacks induced by @Chemical$."	0
We evaluated the frequency of @Chemical$ resistance and its correlation with clinical and biochemical parameters among patients with @Disease$ (NS).	0
Aspirin's ability to induce @Disease$ in rats is dependent on bile and can be reversed if pre-associated with @Chemical$.	0
"RESULTS: The final analysis included 1470 study participants: 221 controls, 553 CRS without nasal polyps (CRSsNPs), 651 @Chemical$ with nasal polyps (CRSwNPs) and 45 @Disease$ (AFRS)."	0
Multivariable logistic regression models tested associations between baseline characteristics and @Chemical$ discontinuation and @Disease$.	0
"METHODS: We compared aspirin and warfarin for HF events (hospitalization, @Disease$, or both) in the 2,305 patients enrolled in the @Chemical$ (Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction) trial (98.6% on ACE inhibitor or ARB treatment), using conventional Cox models for time to first event (489 events)."	0
Low-dose @Chemical$-induced gastroduodenal mucosal injury in Japanese patients with @Disease$.	0
"Twelve cases of Reye's syndrome are presented with different degrees of encephalopathy, @Disease$ and hypoglycemia; associated to acetyl salicylic acid (@Chemical$) ingestion."	1
Nasal instillation or ingestion of @Chemical$ induces a nasal reaction in most aspirin-sensitive patients with @Disease$.	0
"The importance of @Chemical$, catheterization accuracy, and catheter design in external @Disease$-related hemorrhage: a multicenter study of 1002 procedures."	0
This article updates data on the genetic mechanisms that govern AERD and AIU and summarizes recent findings on the molecular genetic mechanism of @Chemical$ @Disease$.	1
"OBJECTIVE: The purpose of this study is to demonstrate that celecoxib, a specific inhibitor of COX-2, does not cause @Disease$tic attacks in patients with @Chemical$ and/or other nonsteroidal anti-inflammatory drug-induced asthma."	0
"BACKGROUND: Although it is well known that aspirin causes @Disease$ and that aspirin-induced gastroduodenal mucosal injury is often asymptomatic, the prevalence and independent factors for gastroduodenal mucosal injury have not been clarified in asymptomatic patients taking low-dose @Chemical$ and gastroprotective agents."	0
"Key Messages: This double-blind, placebo-controlled study found that LG may be useful in reducing @Chemical$-induced small bowel injuries and in mitigating @Disease$."	0
METHODS: Seventy-four patients with @Disease$ and a history of sensitivity to @Chemical$ and NSAIDs underwent placebo-controlled oral aspirin challenge tests.	0
"BACKGROUND: Aspirin therapy is widely accepted for patients with documented cardiovascular disease, but there is a growing trend among healthy individuals to use @Chemical$ as primary prevention for both @Disease$ and cancer."	0
"For average-risk individuals aged 50-65 years taking @Chemical$ for 10 years, there would be a relative reduction of between 7% (women) and 9% (men) in the number of cancer, myocardial infarction or @Disease$ events over a 15-year period and an overall 4% relative reduction in all deaths over a 20-year period."	0
"Age, male gender, Helicobacter pylori (H. pylori)infection, diabetes, @Disease$ (CKD), cirrhosis, history of uncomplicated peptic ulcer disease (PUD), and use of NSAIDs, COX-2 inhibitors, steroids, and @Chemical$ were independent risk factors for UGIB among aspirin users."	0
We report a rare case of a 79-year-old male treated with clopidogrel and @Chemical$ after coronary angioplasty and stenting to treat @Disease$.	0
Usefulness of anti-ulcer drugs for the prevention and treatment of peptic @Disease$s induced by low doses of @Chemical$.	1
Finally one recent retrospective cohort study revealed similar @Disease$ rates between ASA-treated and non-@Chemical$-treated patients but increased cardiac complication rates in the ASA group.	0
"BACKGROUND: The effect of aspirin on the release of key arachidonic acid metabolites in activated eosinophils from subjects with @Chemical$-intolerant asthma (AIA) has not been investigated previously, despite the characteristic @Disease$ in AIA."	0
"Drugs that can lead to @Disease$ include non-steroidal anti-inflammatory drugs (NSAIDs) like diclofenac and ibuprofen, platelet inhibitors such as acetylsalicylic acid (ASS), @Chemical$ and prasugrel, as well as anticoagulants like vitamin-K antagonists, heparin or direct oral anticoagulants (DOAKs)."	0
Early diagnosis and treatment with Intravenous immune globulin (IVIG) and aspirin (@Chemical$) can reduce the incidence of @Disease$ to 2%-5%.	0
@Disease$ with nasal polyps (CRSwNP) and asthma frequently coexist and are always present in patients with @Chemical$ exacerbated respiratory disease (AERD).	0
"BACKGROUND: Aspirin-exacerbated @Disease$ (AERD) is characterized by progressive sinusitis, nasal polyposis, and asthma that begins and continues in the absence of exposure to @Chemical$ and nonsteroidal anti-inflammatory drugs (NSAIDs)."	0
"In 2-23% of adults with asthma, and rarely in children with @Disease$, aspirin (@Chemical$) and non-steroidal anti-inflammatory drugs (NSAIDs) cause asthma exacerbations."	0
"AIMS: To investigate the impact of blood type, functional polymorphism (T-1676C) of the COX-1 gene promoter, and clinical factors on the development of peptic @Disease$ during cardiovascular prophylaxis with low-dose @Chemical$."	0
"We found no difference in microhemorrhage size for both young and aged mice dosed on aspirin, as compared to controls (@Disease$ diameter = 104 +/- 39 (97 +/- 38) mum in controls and 109 +/- 25 (101 +/- 28) mum in @Chemical$-treated young (aged) mice; mean +/- SD)."	0
"On the other hand, SA alone inhibited basal gastric motility without any effect on mucosal PGE2 contents, and this agent, when given together with indomethacin, prevented @Disease$ and lesion formation in response to @Chemical$, without affecting the reduced PGE2 contents."	0
"History of bleeding or non-complicated peptic ulcer, alcohol intake, concomitant treatment with NSAID or calcic inhibitors are demonstrated risk factors of bleeding @Disease$ associated with low-dose @Chemical$."	0
METHODS: @Chemical$ provocation tests were performed in 667 @Disease$tic patients and changes in FEV(1) were used to categorize patients as ATA or AIA.	0
Bleeding during treatment with aspirin versus apixaban in patients with @Disease$ unsuitable for @Chemical$: the apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment (AVERROES) trial.	0
"@Chemical$ use was not associated with the incidence of @Disease$ (multivariate-adjusted OR, 0.99; 95% CI, 0.59-1.65)."	0
OBJECTIVE: To evaluate the expression of cyclooxygenase (COX) and lipoxygenase (LO) enzymes in nasal polyp specimens from aspirin-sensitive (AS) and @Chemical$-tolerant (@Disease$) patients.	0
"With the increasing prevalence of @Disease$ and conflicting data regarding the effect of @Chemical$ in older adults, understanding the potential association of aspirin use with cancer mortality according to body mass index (BMI) and age is imperative."	0
"For non@Chemical$ NSAIDs, the relative risk was 2.6 (95% CI: 2.0, 3.5) for medium daily doses or lower and 4.9 (95% CI: 3.8, 6.5) for high daily doses; it was 5.6 (95% CI: 3.9, 8.2) for gastric and 3.1 (95% CI: 2.3, 4.2) for duodenal @Disease$s."	0
The development of NSAID formulations that offer effective @Disease$ control with fewer or less serious adverse effects due to interference with @Chemical$ would be a valuable medical advance.	0
The risk of readmission resulting from @Disease$ and venous thromboembolism (VTE) has also not been determined for patients undergoing THA or TKA when treated with low-molecular-weight heparin (@Chemical$) alone compared with mechanical prophylaxis plus aspirin (ASA).	0
The utility of biomarkers in diagnosis of @Chemical$ exacerbated @Disease$.	0
CONCLUSION: Adaptive desensitization therapy for hypersensitivity to @Chemical$ has been shown to be an effective causative therapy and chronic @Disease$ as well as bronchial asthma could be improved.	0
CONCLUSIONS: An intraoperative bronchospasm during sinus surgery is not a clear indicator of an @Chemical$ @Disease$.	1
Prevention by parenteral aspirin of @Chemical$-induced @Disease$ in rats: mediation by salicylic acid.	1
CONCLUSION: The current results suggest that continued use of anti-aggregant monotherapy does not increase the risk of overall @Disease$ or reintervention for patients undergoing transurethral resection of bladder neoplasms and that suspending @Chemical$ before such a procedure is therefore unnecessary.	0
Usefulness of anti-@Disease$ drugs for the prevention and treatment of peptic ulcers induced by low doses of @Chemical$.	0
"The results are less convincing when @Chemical$ is used for primary prevention even in high-risk patients (i.e., patients with @Disease$)."	0
"CONCLUSIONS: In patients who had @Disease$ complications related to the long-term use of low-dose @Chemical$, treatment with lansoprazole in addition to the eradication of H. pylori infection significantly reduced the rate of recurrence of ulcer complications."	0
"After adjustment for age, sex, smoking, history of cardiovascular disease, systolic blood pressure, and body mass index, persons who were regular @Chemical$ users had a higher risk of developing neovascular @Disease$ (odds ratio [OR], 2.46; 95% CI, 1.25-4.83)."	1
A new insight into @Chemical$-induced @Disease$.	1
"Factors associated with an increased risk of upper GI complications during low-dose aspirin therapy include @Chemical$ dose, history of ulcer or upper GI bleeding, age &gt; 70 years, concomitant use of NSAIDs (including COX-2-selective NSAIDs), and @Disease$."	0
"On the other hand, a very low dose of aspirin (10 mg daily) decreases the gastric mucosal @Chemical$ levels and causes significant @Disease$."	0
"In conclusion, high-dose fish oil is safe in combination with @Chemical$ and clopidogrel and does not increase the risk of @Disease$ compared with that seen with aspirin and clopidogrel alone."	0
"BACKGROUND: Although it is well known that @Chemical$ causes gastroduodenal mucosal injury and that aspirin-induced gastroduodenal mucosal injury is often asymptomatic, the prevalence and independent factors for @Disease$ have not been clarified in asymptomatic patients taking low-dose aspirin and gastroprotective agents."	0
"Available evidence suggests that where @Chemical$ and/or clopidogrel are to be started or continued in patients with a recent history of UGI ulceration or @Disease$ (after ulcer healing and eradication of H. pylori infection), treatment with a PPI is a useful precaution."	0
Understanding the effect of aspirin on @Disease$ can also alter the risk-benefit ratio in at-risk @Chemical$ users.	0
"The objective of this study was to test the effects of aspirin (1, 2.5 and 5 mg/kg), and @Chemical$ (4 and 15 mg/kg), diclofenac (2.5 mg/kg), flurbiprofen (2 mg/kg), celecoxib (7.5 mg/kg), and rofecoxib (1 mg/kg), alone or combined on a rat model of arterial @Disease$."	0
METHODS: Data from the EINSTEIN-CHOICE trial were used to compare the benefit-risk profiles of extended treatment with rivaroxaban (20 or 10 mg once daily) and @Chemical$ (100 mg once daily) in @Disease$ patients who had completed 6 to 12 months of anticoagulation therapy.	0
"STUDY DESIGN: The OPT-BIRISK trial is a multicenter, double-blinded, placebo-controlled randomized study designed to test the superiority of extended antiplatelet therapy with clopidogrel monotherapy compared with @Chemical$ and clopidogrel for reduction of @Disease$ events in ACS patients with both high bleeding and high ischemic risks (bi-risk)."	0
"RESULTS: The in-hospital mortality rate was 72% for @Disease$ patients treated with @Chemical$, 41.6% for ICH patients treated with aspirin, and 35% for ICH patients treated with no drugs."	0
"We describe the case of a 15-year-old female patient with adverse reaction to @Chemical$, chronic rhinosinusitis, and severe @Disease$."	0
@Chemical$ for prophylactic use in the primary prevention of @Disease$ and cancer: a systematic review and overview of reviews.	0
"CONCLUSIONS AND CLINICAL IMPORTANCE: Administration of deracoxib to healthy dogs resulted in significantly lower @Disease$ scores, and fewer days of vomiting compared to aspirin, indicating that deracoxib is better tolerated than @Chemical$ in some dogs."	0
In vitro studies into mechanistic processes of salicylate toxicity propose that there is a bi-directional link and potentiation with @Chemical$ (GSH) depletion and salicylate @Disease$.	0
"There was no increase in @Disease$ frequency in participants with ASA++ intake compared with @Chemical$ (adjusted, all headache: -0.34 d/mo [95% confidence intervals: -2.50 to 1.82], migraine: -1.36 d/mo [-4.76 to 2.03], TTH: -0.57 d/mo [-4.97 to 3.84], MigTTH: 2.46 d/mo [-5.19 to 10.10]) or no analgesics (all headache: -2.24 d/mo [-4.54 to 0.07], migraine: -3.77 d/mo [-9.22 to 1.68], TTH: -4.68 d/mo [-9.62 to 0.27]; MigTTH: -3.22 d/mo [-10.16 to 3.71])."	0
"Allergic conditions include aspirin-exacerbated @Disease$ (AERD or aspirin-induced asthma), @Chemical$-induced urticaria/angioedema (AIU), and anaphylaxis."	0
"In these patients, the CHARISMA trial demonstrated a lack of significant clinical efficacy and an increased risk of @Disease$ with @Chemical$ plus aspirin compared with aspirin alone."	1
OBJECTIVE: To investigate the correlation of tumor necrosis factor alpha (TNF-alpha) polymorphisms with upper gastrointestinal bleeding (UGIB) induced by enteric-coated @Chemical$ in coronary heart disease (@Disease$) patients.	0
"We evaluated the differences in ACS type, total mortality, and the composite end point of @Disease$, myocardial infarction (MI), recurrent ischemia, or stroke between prior @Chemical$ and nonprior aspirin users."	0
METHODS: We recruited 141 AERD and 995 @Chemical$-tolerant @Disease$tic (ATA) subjects.	0
RESULTS: Celecoxib and @Chemical$ significantly increased the severity of aspirin-induced @Disease$.	0
New highly specific COX-2 inhibitors appear to be a safe alternative for patients with @Chemical$-induced @Disease$.	1
Adverse reactions to @Chemical$ are reported in 1.5% of patients with @Disease$.	1
"Cyclooxygenase-2 (COX-2) inhibitors (e.g. @Chemical$ 400 mg/day) were associated with a significant decrease in the recurrence of both adenomas (RR, 0.66 [95% CI, 0.59-0.72]) and advanced @Disease$s (RR, 0.45 [95% CI, 0.33-0.57]); however, this association did not persist and there was a trend of an increased risk of recurrent adenomas observed 2 years after the withdrawal."	0
Mucosal breaks in @Chemical$ users were predominant in the first tertile of the @Disease$.	0
"CONCLUSIONS: The decreased risk of @Disease$ of the @Chemical$ associated with the use of non-COX-2 inhibitors, NSAIDs and long-term aspirin therapy warrants further exploration of the benefits vs risks of the use of these agents."	0
"METHODS: The effect of arachidonic acid or platelet agonists on LTC4 synthase activity was investigated in platelets obtained from healthy volunteers, @Chemical$-intolerant @Disease$tics or aspirin-tolerant asthmatics after in vivo treatment or in vitro pre-incubation with aspirin."	0
"The median @Disease$ in the @Chemical$ regimen was 3, while those in both aspirin + rabeprazole 10 mg and aspirin + rabeprazole 40 mg regimens were 0."	0
"However, a history of @Chemical$-induced urticaria and/or @Disease$ is usually a contraindication for further prescription of the drug."	1
Gene expression profiling of nasal polyps associated with chronic @Disease$ and @Chemical$-sensitive asthma.	0
"METHODS: Using gas chromatography/mass spectrometry, we determined plasma and urinary concentrations of @Chemical$,11beta-PGF(2) at baseline in 131 stable asthmatic patients, 65 of whom had @Disease$ and 66 of whom had ATA."	0
"METHOD: From July 2017 to @Disease$, 901 patients including 781 (86.7%) male and 120 (13.3%) female patients underwent laparoscopic inguinal hernia repair using trans-abdominal preperitoneal (TAPP) technique were recruited, among whom 152 (16.9%) had been taking low-dose (100 mg per day) @Chemical$ which was continued during hospitalization except the operation day."	0
The @Chemical$-induced bronchospasm is mediated by mast cell and @Disease$.	0
"Hypersensitivity to @Chemical$ and other non steroidal anti-inflammatory drugs (NSAIDs) manifesting in the airways (rhinosinusitis, polyps, asthma) or in the skin (urticaria, @Disease$) is the second most frequent untoward allergic reaction to drugs."	1
The risk of symptomatic @Disease$ for @Chemical$ and nonaspirin NSAIDs was elevated throughout treatment.	1
"The presence of salicylates in the blood or urine of Reye's syndrome patients has not been demonstrated, and no animal model of @Disease$ has been developed where @Chemical$ causes the disease."	0
"METHODS: Urine samples were taken from patients with confirmed NSAID-induced @Disease$ and healthy controls, at baseline and at various time intervals after @Chemical$ administration."	0
"OBJECTIVE: To provide further insights on the risks of gastrointestinal (@Disease$) complications in individuals using low-dose @Chemical$ (LDA), we investigated the concomitant use of LDA and antisecretory drugs."	0
OBJECTIVE: To evaluate frequency of @Disease$ and hemorrhagic events in patients treated with aspirin and @Chemical$ when associated with perioperative heparin bolus for unruptured aneurysms treated with intracranial stents.	0
Combined @Disease$ of penicillin and @Chemical$ therapy may elicit bilateral vestibulopathy.	0
"The risk of @Disease$ was significantly associated with acute but not chronic use of regular-dose @Chemical$ (OR 5.53, 95% CI 2.29-13.3), diclofenac (OR 4.44, 95% CI 2.21-8.93), ketorolac (OR 4.81, 95% CI 2.13-10.9), naproxen (OR 14.9, 95% CI 4.23-52.4) or nimesulide (OR 4.06, 95% CI 1.2-13.8)."	0
Much of our understanding of cross-reacting drugs and chemicals with aspirin comes from studying asthmatics with @Chemical$-exacerbated respiratory disease (@Disease$).	0
Taking @Chemical$ increases bleeding risk that is not always outweighed by the potential benefits for patients with @Disease$ risk.	0
"BACKGROUND: In patients with @Chemical$-exacerbated respiratory disease (AERD), pretreatment with asthma controller medications (leukotriene modifiers, inhaled or systemic corticosteroids, and salmeterol) partially modifies the severity of aspirin-induced @Disease$tic reactions."	0
[Gastro-@Disease$ caused by NSAIDs and low-dose @Chemical$].	1
"To investigate the associations between AERD and DCBLD2 polymorphisms, 12 common variants were genotyped in 163 AERD subjects and 429 @Chemical$ @Disease$ (ATA) controls."	1
All NSAIDS given alone also inhibited @Disease$ formation to approximately the same level as @Chemical$ 1 mg/kg/day.	0
"Despite its clinical benefits, @Chemical$ has been considered one of the predictors of worse outcomes in patients with unstable angina/non-ST-segment-elevation @Disease$."	1
"@Disease$ in patients receiving a combination of @Chemical$, clopidogrel, and enoxaparin in acute coronary syndrome."	0
"A worldwide use of @Chemical$ is now accepted due to its remarkable analgesic, antipyretic and anti-thrombotic prophylactics against myocardial infarct and coronary disorders despite the fact that the use of NSAIDs is associated with the risk of @Disease$, haemorrhagic lesions and ulcerations."	0
"This study compared proton pump inhibitors (PPIs) and histamine H2 receptor antagonists (H2RAs) for prevention of low-dose aspirin (@Chemical$)-related gastrointestinal (GI) erosion, @Disease$ and bleeding."	0
"Evidence suggests that @Chemical$ has antithrombotic effects; however, as with other NSAIDs, it poses a risk of @Disease$."	0
"EVIDENCE ACQUISITION: Published articles were identified through a search of MEDLINE and the Cochrane databases using the dates 1966 to June 2004 and the search terms aspirin allergy, @Disease$, @Chemical$ desensitization, and aspirin sensitivity."	0
"A total of 221 biopsy specimens from 74 patients, including atrophic @Disease$ (AG) cases without aspirin use (control), AG cases with aspirin use (AG group), and GC cases with @Chemical$ use (GC group), were analyzed."	0
"For patients who have inadequately controlled rhinosinusitis and/or @Disease$ despite treatment with topical corticosteroids and @Chemical$-modifying drugs, aspirin desensitization is an important therapeutic option."	0
Association of stem cell factor expression in nasal polyp epithelial cells with @Chemical$ sensitivity and @Disease$.	0
"HPR was defined as on-clopidogrel P2Y12 platelet reaction units &gt;208 as measured by the VerifyNow assay; target vessel failure (@Chemical$) was defined as the composite of all-cause @Disease$, myocardial infarction, or ischemia-driven target vessel revascularization."	0
METHODS: A total of 991 patients with coronary artery disease (@Disease$) on low-dose @Chemical$ were prospectively followed-up for two years for the occurrence and clinical features of first hospitalized episode of UGIB.	0
"METHODS: Ninety-four aspirin-induced urticaria patients presenting urticaria/angioedema-induced by both ASA and NSAID (50 had underlying chronic urticaria) and showing positive responses on oral aspirin challenge test, 76 aspirin-intolerant @Disease$tics with positive responses on lysine-@Chemical$ bronchoprovocation test, and 185 normal healthy controls were enrolled."	0
"Anti@Chemical$ are useful to treat @Disease$, in association with steroids."	0
"DATA SOURCES: Articles evaluating aspirin for primary prevention of CVD were gathered using a MEDLINE search with the keywords @Chemical$ review, aspirin peripheral artery disease, aspirin @Disease$, aspirin coronary artery disease, aspirin diabetes, aspirin primary prophylaxis, and aspirin elderly."	0
Chronic rhinosinusitis with nasal polyps (CRSwNP) and asthma frequently coexist and are always present in patients with @Chemical$ exacerbated respiratory disease (@Disease$).	0
Asthmatic reaction induced by @Chemical$ in a patient with aspirin-induced @Disease$.	0
"STUDY DESIGN: The OPT-BIRISK trial is a multicenter, double-blinded, placebo-controlled randomized study designed to test the superiority of extended antiplatelet therapy with @Chemical$ monotherapy compared with aspirin and clopidogrel for reduction of bleeding events in ACS patients with both high @Disease$ and high ischemic risks (bi-risk)."	0
@Disease$ syndrome developed related to @Chemical$ use.	1
"A 79-year-old man with @Disease$, taking cilostazol and @Chemical$, complained of purpura."	0
"On day 1, peak final-extent inhibition of platelet aggregation (IPA) was observed 2-4 h post-dose with AZD6140, whereas @Chemical$ minimally inhibited @Disease$ (mean percentage IPA &lt; 20%, all time points)."	0
"Short-term/low-dose @Chemical$-induced duodenal erosions are not dependent on Helicobacter pylori @Disease$, cyclooxygenase expression and prostaglandin E2 levels."	0
BACKGROUND: @Chemical$ has been shown to lower the incidence and the mortality of @Disease$ and cancer but its wider adoption appears to be seriously impeded by concerns about gastrointestinal (GI) bleeding.	0
CONCLUSION: Clopidogrel and the combination of @Chemical$ and dipyridamole were associated with similar risks for recurrent ischemic stroke and @Disease$; whereas acetylsalicylic acid was associated with higher risks for both ischemic stroke and bleeding.	1
"We sought to assess the performance of existing bleeding risk scores, such as the @Disease$, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly (HAS-BLED) score or the Outpatient Bleeding Risk Index (OBRI), in patients with heart failure with reduced ejection fraction (HFrEF) in sinus rhythm (SR) treated with @Chemical$ or aspirin."	0
We also review several pathogenic mechanisms that have been advanced by animal studies to explain the finding that a COX-2 selective inhibitor plus low-dose @Chemical$ leads to an @Disease$ rate near that of a dual COX-1/COX-2 inhibitor alone.	1
BACKGROUND: The objective of the study was to determine the frequency of cerebral microbleeds (@Chemical$) by using phasesensitive imaging in patients with previous transient @Disease$ attack (TIA) or stroke who were receiving aspirin treatment.	0
Regular use of @Chemical$ and other non-steroidal anti-inflammatory drugs and @Disease$ risk for women at familial or genetic risk: a cohort study.	0
The aim of this study was to evaluate the prevalence of @Chemical$ resistance (AR) in patients undergoing hemodialysis (@Disease$) and to assess the effect of HD on the results of the Multiplate test.	0
"We describe the case of a 64-year-old patient with glucose-6-phosphate dehydrogenase deficiency who was referred to our hospital because of an acute @Disease$.Given the possible risk of acute haemolytic anaemia, aspirin was not given in the acute phase, and the patient was successfully treated by balloon angioplasty of the right coronary artery.After functional and genetic testing showing the presence of the Mediterranean mutation, known to be a class II variant, the patient received oral daily @Chemical$ (100 mg) under strict monitoring in order to promptly detect any sign of haemolysis."	0
Aspirin-intolerant asthma (@Disease$) is a distinct clinical syndrome that refers to the development of bronchoconstriction in asthmatic individuals following the ingestion of @Chemical$ and other nonsteroidal anti-inflammatory drugs (NSAIDs).	0
We found that the activity of basophil activation of AICU was significantly higher in the patients with AICU compared to those with airway @Disease$ without @Chemical$ intolerance.	0
BACKGROUND: We have previously demonstrated that aspirin triggers specific generation of 15-hydroxyeicosateraenoic acid (15-HETE) from nasal polyp epithelial cells and peripheral blood leukocytes (@Chemical$) from aspirin-sensitive (AS) but not aspirin-tolerant (AT) patients with @Disease$.	0
"It is widely recognized that in some adult patients with @Disease$, @Chemical$ and other nonsteroidal anti-inflammatory drugs (NSAIDs) that inhibit cyclooxygenase (COX)-1 exacerbate the condition."	0
The diagnosis of @Disease$ was subsequently confirmed by an inadvertent @Chemical$ challenge which led to a serious adverse asthma outcome.	0
"CONCLUSIONS: As endoscopy frequently reveals @Disease$ among low-dose aspirin users, both administration of @Chemical$ and of enteric-coated aspirin warrant concern for gastroduodenal ulcer."	0
"Reye syndrome, characterized by acute @Disease$, selective liver damages, a fatty degeneration in visceral organs and miserable prognosis, is probably caused by various drugs, especially antipyretic such as @Chemical$."	1
"OBJECTIVE: Despite evidence that preoperative aspirin improves outcomes in cardiac surgery, recommendations for @Chemical$ use are inconsistent due to aspirin's anti-platelet effect and concern for @Disease$."	0
"Patients undergoing TKA treated with LMWH had higher readmission rates within 6 weeks of surgery because of a bleeding complication, a wound infection, or the development of a @Disease$ (6.8% for @Chemical$ versus 1.5% for mobile compression; p = 0.015; OR, 4.8)."	0
"BACKGROUND: @Chemical$-exacerbated respiratory disease (AERD) is a @Disease$, asthma, and hypersensitivity respiratory reactions when on systemic cyclooxygenase 1 blockade."	0
The authors conclude that @Chemical$ does not increase surgically relevant parenchymal or @Disease$ following moderate and minor head injury in patients older than 60 years of age.	0
"However, the introduction of new endoscopic techniques, such as capsule endoscopy and balloon-assisted endoscopy for the evaluation of @Disease$ have resulted in an increasing interest among gastroenterologists about the side effects of @Chemical$ on the large and small bowel."	0
"Type 2 inflammation characterizes @Chemical$-exacerbated respiratory disease.Objectives: To determine whether high-dose aspirin therapy changes biomarkers of type 2 inflammation in aspirin-exacerbated respiratory disease.Methods: Forty-two subjects with aspirin-exacerbated @Disease$ underwent an aspirin desensitization and were placed on high-dose aspirin (1,300 mg daily)."	0
INTERPRETATION: Use of @Chemical$ without aspirin was associated with a significant reduction in @Disease$ complications and no increase in the rate of thrombotic events.	0
Epidemiological studies have also shown that @Chemical$ donors and antisecretory drugs reduce the risk of upper gastrointestinal @Disease$ both in non-steroidal anti-inflammatory drug and low-dose aspirin users.	0
"@Chemical$, however, carries an increased risk for gastrointestinal (GI) injury (e.g., ulceration) and its complications (e.g., @Disease$), which may be caused by its antiplatelet and gastric mucosal effects."	0
"Both @Chemical$/aspirin and celecoxib/aspirin groups demonstrated a higher incidence of @Disease$ and duodenal ulcers vs. placebo/aspirin (8%; RR: 3.7, 95% CI: 1.8-7.6 and RR: 2.6, 95% CI: 1.2-5.8, respectively)."	1
"Also, women had less peripheral artery disease (aspirin, 2.4% versus 3.7%; @Chemical$, 1.4% versus 3.0%), more heart failure, and higher mean CHADS2 (congestive heart failure, hypertension, age of 75 years or older, diabetes [1 point each], @Disease$ or transient ischemic attack [2 points]) scores (aspirin, 2.2 versus 2.0; apixaban, 2.1 versus 2.0)."	0
"The authors assessed the prevalence of headaches following extended-release dipyridamole/@Chemical$ combination (DAC), and the efficacy of acetaminophen in the treatment of these @Disease$."	0
"In our investigation of such adverse effects, we obtained 4 important findings considered useful for physicians, as follows; 1) even when aspirin was given at a dose, the incidence rate of gastrointestinal lesions was higher than with other non-steroidal anti-inflammatory drugs (NSAIDs), 2) the odds ratios for @Disease$ induced by aspirin with a histamine H2 receptor antagonist and proton pump inhibitor were 0.6 and 0.4, respectively, as compared with aspirin alone, 3) it is difficult to administer @Chemical$, which exerts an antiplatelet effect, without inducing gastrointestinal lesions, and 4) these gastrointestinal lesions appears early, especially within 2 years after administration."	0
"In this study, we investigated the relationship between Prostaglandin E2 receptor (PTGER) gene family polymorphisms and @Disease$ in 243 AIA patients and 919 @Chemical$-tolerant asthma (ATA) controls of Korean ethnicity in two separate study cohorts."	0
The incidences of the combined outcome of recurrent VTE and major @Disease$ were 2.8% and 3.4% lower in the @Chemical$ 20-mg and 10-mg groups than in the aspirin group.	0
"CONCLUSIONS: Low-dose aspirin increases the risk of major @Disease$ by approximately 70%, but the absolute increase is modest: 769 patients (95% CI, 500-1250) need to be treated with @Chemical$ to cause one additional major bleeding episode annually."	0
"CONCLUSION: Despite its common usage, the @Chemical$-100 is an unreliable tool to assist in the management of TBI and @Disease$ patients."	0
METHODS: ASA-dipyridamole (25/200 mg) once daily together with ASA (81 mg) daily was started in 130 patients given the diagnosis of @Disease$/TIA with instructions to increase ASA-dipyridamole to twice daily after 7 days and discontinue @Chemical$ (81 mg).	0
"BACKGROUND AND AIMS: Although the administration of gastroprotective drugs may reduce the risk of gastrointestinal (GI) @Disease$ due to intake of non-steroidal anti-inflammatory drugs (NSAIDs) and @Chemical$ during chronic treatment, no consensus exists as to whether such co-therapy is effective in short-term prevention, particularly in old age."	0
"However, such GI risk increases dramatically in patients with a prior history of peptic @Disease$ disease, advanced age, and concomitant use of NSAIDs, corticosteroids, @Chemical$, or anticoagulants."	0
"@Chemical$-induced asthma is a distinct clinical syndrome consisting of inflammation, characterized by chronic @Disease$ with asthma and often nasal polyposis."	0
"CONCLUSIONS: In females, LDA increased the risk of @Disease$, suggesting that @Chemical$ may contribute to the pathogenesis of colonic ulceration or colitis."	0
Effect of aspirin desensitization on T-cell cytokines and plasma lipoxins in @Chemical$-exacerbated @Disease$.	0
"The eligible study population consisted of patients with a history of urticaria/@Disease$, naso-ocular symptoms, bronchospasm, and/or anaphylactoid reaction induced by @Chemical$ and/or NSAIDs."	1
A genetic effect of IL-5 receptor alpha polymorphism in patients with @Chemical$-exacerbated @Disease$.	0
"BACKGROUND: The management of patients with traumatic brain injury (TBI), primary intracerebral hemorrhage (pICH) and primary @Disease$ (@Chemical$) remains a highly demanding challenge in critical care medicine."	0
"RESULTS: We found significantly higher COX-2 expression levels after stimulation with @Disease$ and @Chemical$ (mean 78.8, range 44.9-92.3; p = 0.0002) in comparison to LPS alone (mean 65.9%, range 33.6-82.6) in AI patients."	0
The risk of readmission resulting from bleeding and @Disease$ (VTE) has also not been determined for patients undergoing THA or TKA when treated with low-molecular-weight heparin (LMWH) alone compared with mechanical prophylaxis plus @Chemical$ (ASA).	0
METHODS: Acute @Disease$ model was developed with intraperitoneal injection of @Chemical$ in Wistar rats.	0
"BACKGROUND: @Chemical$-exacerbated respiratory disease (AERD) is a distinct @Disease$ phenotype of severe asthma with accompanying chronic rhinosinusitis, nasal polyposis, and hypersensitivity to aspirin."	0
Some reports showed that the risk of @Disease$ (UGIB) was high in patients receiving @Chemical$ or clopidogrel.	0
Only one patient (1.1%) presented @Disease$l-type cutaneous reaction to @Chemical$ challenge.	0
"@Disease$ associated with chronic once-daily @Chemical$ exposure in males: A large, single-center, urban, US patient population cohort study from the Research on Adverse Drug events And Report (RADAR) project."	1
Exploring the role of curcumin containing ethanolic extract obtained from Curcuma longa (rhizomes) against @Disease$ of wound healing process by @Chemical$.	1
The eradication of H. pylori is equivalent to treatment with @Chemical$ in preventing recurrent @Disease$.	0
"Although no evidence establishes increased risk of hemorrhagic @Disease$ from daily low-dose @Chemical$, one gastrointestinal hemorrhage will occur for every 72 to 357 adults who take aspirin for longer than 10 years (SOR: A, systematic reviews and meta-analyses of multiple RCTs and cohort studies)."	0
"On the other hand, the mean volume of blood loss and packed red blood cell transfusion was higher in the 'continuing @Chemical$' group, but this finding did not translate into higher risk of reoperation for @Disease$."	0
"OBJECTIVE: We investigated the roles of PGE(2), COX-1 and COX-2, and @Chemical$(2) receptors in the development of NPs and @Disease$ by measuring their expression in fibroblasts derived from nasal mucosa (NM) and NPs."	0
This pilot study aimed to determine the prevalence of aspirin resistance in an Australian @Disease$ population and to correlate @Chemical$ resistance with an increased risk of ischaemic stroke.	0
"In monocytes, we found no changes in basal or @Chemical$ (LPS)-stimulated PGE2 synthesis, but the response to EP4 receptor activation with respect to inhibition of LPS-induced tumor necrosis factor-alpha release was reduced in @Disease$ patients, especially in the presence of aspirin (acetylsalicylic acid)."	0
Gastric acid secretion level modulates the association between Helicobacter pylori infection and low-dose @Chemical$-induced @Disease$.	1
"METHODS: Ancillary analysis of the @Chemical$ Versus Acetylsalicylic Acid [ASA] to Prevent Stroke in @Disease$ Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment (AVERROES) trial, comparing aspirin and apixaban, focused on sex differences."	0
"In the 1-month SI analysis, proportions of patients (95% CI) in the low- and high-dose @Chemical$ categories experiencing major @Disease$ were 2.1% (1.5-2.6) and 1.9% (0.0-3.8); proportions with myocardial infarction were 2.1% (1.3-2.8) and 1.8% (0.9-2.6); and proportions of all-cause death were 2.8% (2.2-3.4) and 2.4% (1.3-3.5), respectively."	0
We present a cohort of patients with @Disease$ undergoing @Chemical$ desensitization to evaluate its short- and long-term efficacy and safety and to reinforce data from previous studies.	0
"RESULTS: The mean perioperative @Disease$ was 899+-496 ml for patients not on clopidogrel, 1091+-654 ml for patients on clopidogrel (p=0.005) and 1312+-686 ml for those on combined clopidogrel and @Chemical$ (p=0.0003 vs. all others)."	0
Antral prostaglandin-E(2)-basal levels appear to be critical for development of @Chemical$-induced @Disease$ in subjects without H. pylori infection.	1
Comparison of @Disease$ complications with omega-3 fatty acids + aspirin + clopidogrel--versus--aspirin + @Chemical$ in patients with cardiovascular disease.	0
"CONCLUSIONS: Prasugrel 20/3.75 mg was associated with a low incidence of ischemic events, similar to the results of @Chemical$, and with a low risk of clinically serious @Disease$ in Japanese ACS patients."	0
Prior aspirin use in unstable @Disease$ predisposes to higher risk: the @Chemical$ paradox.	0
Does clopidogrel with @Chemical$ after acute minor stroke or transient @Disease$ attack increase the risk of cerebral hemorrhage?	0
Associations of functional NLRP3 polymorphisms with susceptibility to food-induced @Disease$ and @Chemical$-induced asthma.	0
"This review focuses on a description of patients with @Chemical$-exacerbated @Disease$, methods available to diagnose their condition, the unique ability of all nonsteroidal anti-inflammatory drugs that inhibit COX-1 to cross-react with aspirin, an update on pathogenesis, and current thoughts about treatment."	0
"METHODS: Between June 1999 and December 2014, 1422 patients were treated for aneurysmal @Disease$ in our institution, 144 (10.1%) with continuous @Chemical$ at the time of aneurysm rupture."	0
Aspirin resistance could be defined as @Disease$ and embolic cardiovascular events despite regular @Chemical$ therapy.	0
Objective: Abnormalities of @Chemical$ profile were considered as risk factors of hemorrhage after @Disease$ stroke.	0
Montelukast protects against nasal lysine-@Chemical$ challenge in patients with aspirin-induced @Disease$.	0
"All 129 patients with high risk TIA with microbleeds or minor @Disease$ within 24 hours after the onset (average age 65.9 +- 9.3, 48.7% were male patients) were divided randomly into two groups: (1) 67 patients were given combination therapy with clopidogrel and @Chemical$ (clopidogrel at an initial dose of 300 mg, then 75 mg per day for 90 days, plus aspirin at a dose of 75 mg per day for the first 21 days);(2) the rest patients were given aspirin treatment (75 mg per day for 90 days)."	0
"BACKGROUND: Anticoagulants and/or antiplatelet agents such as @Chemical$ (ASA) are important in prevention of cardiovascular (CV) events, but may be associated with @Disease$ (UGIB)."	1
The aim of this study was to evaluate the healing effect of @Chemical$ in patients with NSAIDs-induced @Disease$.	0
Genetic variation in the JAK/STAT/SOCS signaling pathway influences breast cancer-specific mortality through interaction with cigarette smoking and use of @Chemical$/NSAIDs: the @Disease$ Health Disparities Study.	0
"Further research is needed to assess the benefit-risk ratio of clopidogrel plus aspirin in specific subpopulations of patients at high risk for atherothrombotic events, and to determine the role of clopidogrel plus @Chemical$ in preventing cardioembolic stroke or early recurrent stroke after symptomatic large-vessel @Disease$."	0
"After 3 months, the patient is free from adverse events.Glucose-6-phosphate dehydrogenase deficiency is commonly considered a contraindication to aspirin intake; however, this case shows that @Chemical$ at low, antiplatelet dosage is well tolerated and should not be denied to patients with @Disease$ and complex coronary anatomy."	0
"Available evidence suggests that where aspirin and/or @Chemical$ are to be started or continued in patients with a recent history of UGI ulceration or bleeding (after @Disease$ and eradication of H. pylori infection), treatment with a PPI is a useful precaution."	0
"BACKGROUND: The frequency with which patients with aspirin-exacerbated respiratory disease (@Disease$) react to 325 mg of aspirin during @Chemical$ desensitization, or fail to react at all, is not fully known."	0
CONCLUSIONS: BNR to @Chemical$ in AIAR indicates a more @Disease$ and more profound underlying eicosanoid metabolism disturbances.	0
"CONCLUSIONS: Low-dose enteric-coated aspirin frequently damages the small intestine, and @Chemical$ is effective in the treatment of aspirin-induced @Disease$."	0
There is no consensus to stop @Chemical$ therapy before interventional chronic @Disease$ procedures.	0
"METHOD: We classified 1,041 gastroduodenal ulcer patients into three groups [patients taking LDA (group A), patients taking nonaspirin nonsteroidal anti-inflammatory drug (NSAID) (group N), and patients taking neither aspirin nor non@Chemical$ NSAID (group C)] and 241 bleeding gastroduodenal @Disease$ patients into three corresponding groups (groups a, n, and c)."	0
@Chemical$-exacerbated respiratory disease (AERD) is a respiratory disease             characterized by acute bronchial responses upon the administration of non-steroidal             anti-inflammatory drugs (NSAIDs) and the immune response by mast cells is regarded             as one of the noteworthy causes of @Disease$ pathogenesis.	0
"Also, women had less peripheral artery disease (aspirin, 2.4% versus 3.7%; apixaban, 1.4% versus 3.0%), more heart failure, and higher mean CHADS2 (congestive heart failure, hypertension, age of 75 years or older, diabetes [1 point each], @Disease$ or transient ischemic attack [2 points]) scores (@Chemical$, 2.2 versus 2.0; apixaban, 2.1 versus 2.0)."	0
"On the other hand, SA alone inhibited basal @Disease$ without any effect on mucosal PGE2 contents, and this agent, when given together with indomethacin, prevented gastric hypermotility and lesion formation in response to indomethacin, without affecting the reduced @Chemical$ contents."	0
"In addition, to reduce the incidence of @Disease$ in @Chemical$ users, it is important for clinicians to confirm the differences in the gastrointestinal toxicity between different types of aspirin formulations in clinical use."	1
"Variables included clinical coronary heart disease (@Disease$), number of CHD risk factors, diabetes diagnosis, number of chronic medications and presence of contraindications to @Chemical$."	0
@Chemical$/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin @Disease$.	0
"Aspirin-exacerbated @Disease$ (AERD) refers to the combination of asthma, chronic rhinosinusitis with nasal polyposis, and acute upper and lower respiratory tract reactions to the ingestion of aspirin (@Chemical$, ASA) and other cyclooxygenase-1 inhibiting non-steroidal anti-inflammatory drugs."	0
"RESULTS: Gastroduodenal @Disease$ and erosion were detected in 6.5, and 29.2% of the 1,454 patients receiving @Chemical$, respectively."	0
"Thus, intravitreal @Chemical$ injections may be an additional or alternative treatment option for several anterior or posterior segment @Disease$ in addition to their topical utilization."	0
CONCLUSION: Transient low-dose @Chemical$ use increases risk for major @Disease$ events in Han Chinese.	1
"@Chemical$ or nonsteroidal antinflammatory drug sensitivity can be manifested as acute @Disease$, angioedema, acute asthma, acetylsalicylic acid exacerbated respiratory disease and anaphylaxis."	1
"METHODS: @Disease$ patients (n=167), @Chemical$-intolerant chronic urticaria (AICU) patients (n=149), and healthy controls (NC) (n=265) were included."	0
"This association has also been confirmed in additional independent samples of asthma with @Disease$ (P = 0.008), regardless of @Chemical$ hypersensitivity."	0
Enzyme up-regulation was monitored after in vitro stimulation with @Chemical$ (@Disease$) and/or aspirin in 19 aspirin-intolerant (AI) patients (8 aspirin-sensitive asthmatics and 11 urticaria-angioedema patients) and 14 healthy controls.	0
"In @Disease$ or angioedema induced by multiple NSAIDs, patients without underlying disease develop urticaria or angioedema 30-90 minutes after ingestion of COX-1-inhibiting NSAIDs including @Chemical$."	1
The aim of this study was to assess a possible detrimental effect of @Chemical$ on survival in stable patients with @Disease$ who had congestive heart failure and had been treated with ACE-Is.	0
We sought to compare how a single pill of non-enteric coated @Chemical$ (325-mg) affects human platelets in patients with @Disease$ dependent on methadone use.	0
"The risk of @Disease$ development was significantly (log-rank test, P &lt; 0.001) lower in the @Chemical$ group than in the gefarnate group, with the hazard ratio being 0.099 (95% confidence interval [CI] 0.042-0.230)."	0
"RESULTS: @Chemical$ and aspirin was prescribed in 15/109 @Disease$ women without antiphospholipid antibodies (aPL), 5/14 with aPL, 11/13 with APS, 45/48 with primary APS."	0
"BACKGROUND: Many patients requiring permanent pacemaker (PPM) or implantable cardiac defibrillator (@Disease$) placement are anticoagulated with warfarin, aspirin (@Chemical$), and clopidogrel for a number of thromboembolic risk indications."	0
"@Chemical$ improved gastric mucus secretion, as well as decreased pepsin activity to maintain the integrity of @Disease$ barrier (P&lt;0.05)."	0
Objective:The aim of this study is to observe the effects of asthma and @Chemical$ asthma on chronic @Disease$ and to explore the corresponding clinical value.	0
"@Chemical$, but not other NSAID use, was associated with about 20% lower risk of postmenopausal @Disease$ and did not vary by ER or PR status of the tumor, suggesting that the hypothesized protective effects of aspirin may either be through cellular pathways independent of estrogen or progesterone signaling, or on tumor microenvironment."	0
"RESULTS: Compared with NM from control subjects, @Chemical$(2) concentrations were significantly lower in IL-1beta-stimulated fibroblasts from patients with NPs who were tolerant to aspirin and even lower in @Disease$ from patients with AIA."	0
"In view of these animal studies and in the absence of controlled studies of aspirin or NSAIDs in human myocarditis, we do not recommend indiscriminate treatment with NSAIDs or high-dose @Chemical$ in patients with myocarditis where there is no or minimal associated @Disease$."	0
"The incidence of the disease has been decreased by prohibition of administration of @Chemical$ for children with @Disease$, especially caused by influenza infection in western countries, also in Japan."	0
"Therefore, the present results indicated that DDAVP shortened the prolonged BMBT in dogs with @Chemical$-induced platelet dysfunction and @Disease$."	0
The aim of present study was to evaluate the safety and efficacy of @Chemical$ desensitization protocols in patients requiring dual antiplatelet therapy for @Disease$.	0
"In subgroup analysis, @Chemical$ use was associated with @Disease$ in the patients with no history of stroke (HR, 1.41; 95% CI, 1.14-1.73), and there was a borderline interaction between previous stroke and the use of aspirin on renal failure (interaction p=0.0565)."	1
"Aspirin-induced @Disease$ and angioedema, but not bronchoconstriction, associated with @Chemical$ overproduction in 2 patients with asthma."	0
CONCLUSION: Our study appears to demonstrate that @Chemical$ is a suitable NSAID for treatment of patients with ASA and/or other NSAID-induced @Disease$.	0
Interaction of angiotensin-converting enzyme inhibition and @Chemical$ in @Disease$: long controversy finally resolved?	0
"INTRODUCTION: Clinical features of @Chemical$-exacerbated respiratory disease (AERD) consist of moderate to severe asthma associated with chronic rhinosinusitis (CRS), which are derived from overproduction of cysteinyl leukotrienes along with chronic type 2 mediated @Disease$ in the upper and lower airway mucosa."	0
"Further research is needed to assess the benefit-risk ratio of @Chemical$ plus aspirin in specific subpopulations of patients at high risk for atherothrombotic events, and to determine the role of clopidogrel plus aspirin in preventing cardioembolic stroke or early recurrent @Disease$ after symptomatic large-vessel atherostenosis."	0
"@Chemical$ prevented this damage, and may be a candidate drug for treating aspirin-induced @Disease$."	0
"As patients with DM also derive greater ischemic benefit from drug-eluting stents, which requires prolonged @Chemical$, our findings suggest that the balance between benefit and risk of this therapeutic approach may be even more favorable in patients with @Disease$ than previously considered."	0
"PURPOSE OF REVIEW: To investigate the current approach to @Chemical$ challenge (drug provocation) and/or desensitization in patients with histories of @Disease$ reactions to it, particularly in those with cardiovascular diseases."	0
Oral aspirin challenge (OAC) test was performed to identify @Chemical$ @Disease$.	1
"RESULTS: The age, BMI, hospital stay, ASA classification, morbidity of CHD and @Disease$, FIB value, and the time of resuming normal activities of patients taking @Chemical$ were higher (p &lt; 0.05)."	1
"Aspirin desensitization, followed by daily @Chemical$ treatment, is a valuable therapeutic option in most patients with AIA, particularly those with recurrent @Disease$ or overdependence on systemic corticosteroids."	0
We describe a case of @Disease$ that was difficult to distinguish from malignancy in a patient with a history of ingesting @Chemical$ and prasugrel after implantation of a drug-eluting stent.	0
"CONCLUSION: Our results demonstrate that exercise and aspirin augment clinical reactions in WDEIA by lowering the threshold and increase the severity of the @Disease$, whereas @Chemical$ gives ambiguous results."	0
Recurrent epistaxis following peri-interventional antiplatelet therapy (after three elective percutaneous coronary interventions) and an episode of @Disease$ required aspirin withdrawal and less frequent @Chemical$ use.	0
"OBJECTIVES: To identify RCTs, systematic reviews and meta-analyses of RCTs of the prophylactic use of @Chemical$ in primary prevention of CVD or @Disease$."	0
The upper respiratory reaction is mediated by both histamine and @Chemical$ but the @Disease$ is mediated by LTs.	0
"In the @Chemical$-sensitive group, mast cell receptor intensity was significantly higher when compared to the @Disease$ and chronic rhinosinusitis group (p &lt; 0.0001 and p &lt; 0.0001, respectively)."	0
Predicting Bleeding Risk to Guide @Chemical$ Use for the Primary Prevention of @Disease$: A Cohort Study.	0
"The absolute annual increases attributable to @Chemical$ were major bleeding: 0.13% (95% CI, 0.08-0.20); major GI @Disease$: 0.12% (95% CI, 0.07-0.19), intracranial bleeding: 0.03% (95% CI, 0.01-0.08)."	1
The PBMCs were collected from a patient with @Chemical$-intolerant @Disease$ and one normal healthy control.	0
The present study evaluated the dose-response for @Chemical$ (ML) against nasal lysine-aspirin challenge in patients with @Disease$.	0
BACKGROUND: @Disease$ with tissue eosinophilia plays a key role in the pathogenesis of asthma and nasal polyps in patients with @Chemical$ hypersensitivity.	0
Current evidence shows that H. pylori infection increases the @Disease$ risk associated with NSAIDs or low-dose @Chemical$.	0
"However, the efficacy of eradication therapy on low-dose aspirin-related gastroduodenal lesions in unselected H. pylori-positive lowdose @Chemical$ users without histories of peptic @Disease$s remains to be clarified."	0
"Moreover, reoperation for @Disease$ was 10-fold higher in the @Chemical$ group (6.8% vs."	0
"BACKGROUND: During a clinical trial, we obtained 16 biopsies of skin eruptions induced by @Chemical$ in patients with chronic @Disease$ (CIU)."	0
We report the case of a patient who after a minor fall developed a subdural @Disease$ requiring craniotomy that likely was precipitated by concomitant use of high-dose @Chemical$ 6 g/day with both aspirin and warfarin.	0
OBJECTIVE: The purpose of this study is to estimate urinary LTB4 glucuronide (LTBG) concentration in the clinically stable condition in healthy subjects and asthmatic patients and to investigate changes in urinary @Chemical$ concentration in patients with @Disease$ after aspirin challenge.	0
The aim of this study was to evaluate the prevalence of @Chemical$ resistance (AR) in patients undergoing hemodialysis (HD) and to assess the effect of @Disease$ on the results of the Multiplate test.	0
"@Disease$ with ACH significantly decreased in both day 3 and 7 compared with @Chemical$, irrespective with H. pylori and CYP2C19 genotypes (P &lt; .05)."	0
"@Chemical$ was 1.64 (95% CI 0.71-3.78), and that for extracranial major @Disease$ was 1.03 (95% CI 0.61-1.75)."	0
"H. pylori infection, itself, did not show any significant effect on the @Chemical$-induced @Disease$ after adjusting for gastric acid secretion."	1
Effect of aspirin desensitization on T-cell cytokines and plasma @Chemical$s in aspirin-exacerbated @Disease$.	0
BACKGROUND: Clopidogrel use as single antiplatelet therapy (SAPT) has never been evaluated in stable coronary artery disease (@Disease$) outpatients either as compared to placebo or @Chemical$.	0
"Although acetylsalicylic acid is prescribed for a broad range of diseases, it can induce a wide array of clinically recognized @Disease$ reactions, including aspirin-intolerant asthma (AIA) with rhinitis and @Chemical$-intolerant urticaria (AIU) with anaphylaxis."	0
"METHODS: Ninety-four aspirin-induced @Disease$ patients presenting urticaria/angioedema-induced by both @Chemical$ and NSAID (50 had underlying chronic urticaria) and showing positive responses on oral aspirin challenge test, 76 aspirin-intolerant asthmatics with positive responses on lysine-aspirin bronchoprovocation test, and 185 normal healthy controls were enrolled."	0
[Prevention of @Disease$ in patients taking low-dose @Chemical$].	0
We sought to determine whether low on-@Chemical$ platelet reactivity (LAPR) is associated with @Disease$ events and antiplatelet therapy compliance in patients with ACSs receiving coronary stenting.	0
"Majority of peptic ulcers induced by @Chemical$ were shallow, and independent on H. pylori @Disease$."	0
@Chemical$ increases mortality in diabetic patients without @Disease$: a Swedish record linkage study.	0
The possible additive antiplatelet effects of aspirin and clopidogrel have been explored in the Clopidogrel in Unstable @Disease$ to Prevent Recurrent Events (CURE) and Management of Atherothrombosis with @Chemical$ in High Risk Patients (MATCH) studies.	0
"To evaluate the extent of gastric mucosal injury and the protective effect of drugs, @Disease$ index, gastric mucosal blood flow, content of gastric mucosal hexosamine, prostaglandins (@Chemical$), nitric oxide(NO), tumor necrosis factor (TNF), and interleukin (IL) -1, 2, 8 were measured in each group, and histological changes were observed by gross as well as under microscope and electron microscope."	0
"Further research is needed to determine the optimum dose and duration of use, to identify individuals at increased risk of @Disease$, and to test effectiveness of Helicobacter pylori screening-eradication before starting @Chemical$ prophylaxis."	0
"In patients with NSAIDs and @Chemical$ medication, re-bleeding was associated with previous @Disease$ history (P &lt; 0.05)."	0
"Two cohorts (N = 170,336 each) aged 40-89 years from 2000 to 2009 and free of @Disease$ were identified: i) new-users of low-dose aspirin, ii) non-users of low-dose @Chemical$, at start of follow-up, matched by age, sex and previous primary care practitioner visits."	0
"However, it is possible that the adaptive response is impaired in some @Chemical$ takers, who might be susceptible to severe @Disease$."	0
Patients with peripheral @Disease$ on long-term aspirin therapy (&gt;=4 wk) were tested for @Chemical$ responsiveness by means of the VerifyNow Aspirin Assay.	0
The data are still lacking and further prospective studies are needed to identify the specific risk or protective factors for upper GI @Disease$ and its complications associated with @Chemical$.	0
Association of PTGER gene family polymorphisms with @Chemical$ @Disease$ in Korean asthmatics.	1
"The substantive risk for prophylactic @Chemical$ is therefore cerebral haemorrhage which can be fatal or severely disabling, with an estimated risk of one death and one disabling @Disease$ for every 1,000 people taking aspirin for ten years."	0
BACKGROUND: We recently demonstrated in humans that the extent of low-dose aspirin (@Chemical$)-induced @Disease$ was directly related to the individual gastric acid secretion level.	1
"METHODS AND RESULTS: Japanese patients (n=1,363) with @Disease$ undergoing percutaneous coronary intervention were randomized to either prasugrel (20/3.75 mg) or clopidogrel (300/75 mg), both in combination with @Chemical$ (81-330 mg for the first dose and 81-100 mg/day thereafter), for 24-48 weeks."	0
"Omeprazole appears to be very effective in reducing both acute gastroduodenal mucosal damage and upper GI bleeding in the high-risk patient taking low-dose @Chemical$, but data with other anti-@Disease$ agents are lacking (misoprostol) or inconsistent (ranitidine) at present."	0
"Two drugs recently approved for health insurance reimbursement, celecoxib, a cyclooxygenase (COX)-2 specific inhibitor and low-dose lansoprazole for prevention of recurrent peptic ulcer due to @Chemical$/NSAIDs will be instrumental in mitigating the @Disease$."	0
"No statistically significant differences between the @Chemical$-resistant and aspirin-sensitive individuals were present in gender, major risk factors of @Disease$, number and localization of involved coronary vessels, serum lipid levels, and blood counts."	0
"Although acetylsalicylic acid is prescribed for a broad range of diseases, it can induce a wide array of clinically recognized @Disease$ reactions, including @Chemical$-intolerant asthma (AIA) with rhinitis and aspirin-intolerant urticaria (AIU) with anaphylaxis."	0
"CONCLUSIONS: The prevalence of asthma and @Disease$ in @Chemical$ varies by phenoytype, with CRSwNPs and AFRS having a stronger association with both."	1
"RESULTS: The @Chemical$-treated group was significantly older, with higher weight and poorer health state (higher incidence of @Disease$, cerebral ischemia and diabetes)."	0
Subdural @Disease$ after spinal anaesthesia in a patient taking @Chemical$.	0
"When other possible causes of stroke were excluded, the association of @Disease$ with the protracted vasoconstriction of ergotamine, able per se to damage the capillary endothelium, and an altered local hemostasis induced by @Chemical$ remained as the most probable mechanism of brain bleeding."	0
Early @Disease$ signs were present among 10.9% of @Chemical$ users and 4.9% of non-aspirin users (p&lt;0.001).	0
"No difference was noted in the rate of symptomatic @Disease$s between either group (for THA: 2.6% for the @Chemical$ group versus 1.9% for the mechanical compression group; p = 1; for TKA: 1.1% versus 0%, respectively; p = 0.22)."	0
"Moreover, besides the CV outcome, potential positive impact of @Chemical$ on @Disease$ is still under investigation."	0
"METHODS: Genotyping of LTC4S gene promoter was performed on 60 patients with @Disease$, 100 patients with @Chemical$-tolerant asthma (ATA), and 110 control subjects."	0
BACKGROUND: The blocking effect of controller medications for asthma could have an effect on the outcome of @Chemical$ challenges in patients suspected of having aspirin-exacerbated @Disease$ (AERD).	0
"Aspirin desensitization and continuous @Chemical$ therapy constitute an effective option in patients with nonsteroidal anti-inflammatory drug-exacerbated respiratory diseases (NERD) who have suboptimally controlled @Disease$, or require multiple revision polypectomies."	0
@Chemical$ resistance may increase death risk in some patients with @Disease$.	0
This analysis explores patterns of @Disease$ and defines bleeding risks based on stroke risk with @Chemical$ and aspirin.	0
"CONCLUSIONS: Omalizumab treatment inhibited urinary leukotriene E4 overproduction and upper/lower respiratory tract symptoms during oral aspirin challenge, resulting in @Chemical$ tolerance in 62.5% of aspirin-exacerbated @Disease$ patients."	0
"Dual antiplatelet therapy (@Chemical$) with acetylsalicylic acid and a P2Y12 inhibitor (clopidogrel, ticagrelor, or prasugrel) reduces thrombotic events in patients with @Disease$ (ACS), but it is also associated with an increased risk of bleeding complications."	0
"Although the pathogenic mechanisms of this condition are still unknown, @Disease$ may be due, at least in part, to an imbalance in eicosanoid metabolism (increased production of @Chemical$ (CysLTs) and reduced biosynthesis of prostaglandin (PG) E2), possibly increasing and perpetuating the process of inflammation."	0
"CONCLUSIONS: In this observational study, aspirin use was not associated with an increase in mortality rates or HF readmission rates, and aspirin did not attenuate the benefits of ACE inhibitors, even in patients without @Disease$, patients with renal dysfunction, or patients treated with high-dose @Chemical$ and low-dose ACE inhibitors."	0
"The risk increased when ASA was combined with @Chemical$, compared with aspirin alone (OR, 1.86; 95% CI, 1.49-2.31), anticoagulants vs low doses of ASA alone (OR, 1.93; 95% CI, 1.42-2.61), or in studies that included patients with a history of GI @Disease$ or of longer duration."	0
"To demonstrate an association between the beta 2 adrenergic receptor (ADRB2) polymorphism and the phenotype of AIAU, one hundred fourteen patients with AIAU, 110 patients with @Chemical$ intolerant chronic @Disease$ (AICU), and 498 normal healthy controls (NC) based on a Korean population were enrolled."	0
CONCLUSIONS: There was a clear impact of aspirin treatment on @Chemical$ associated with @Disease$ in Chinese patients.	1
"In the @Chemical$-sensitive group, mast cell receptor intensity was significantly higher when compared to the nasal polyposis and chronic @Disease$ group (p &lt; 0.0001 and p &lt; 0.0001, respectively)."	0
"TAPT and DAPT were associated with similar rates of death, non-fatal MI, @Disease$ and ST, but compared with @Chemical$, TAPT had lower rates of target lesion revascularization (TLR) (RR 0.67, 95 % CI 0.56-0.82, P &lt; 0.0001) and target vessel revascularization (TVR) (RR 0.65, 95 % CI 0.55-0.77, P &lt; 0.00001), as well as less late loss of minimal lumen diameter (mean difference -0.14, 95 % CI -0.17--0.11, P &lt; 0.00001), and less binary angiographic restenosis (RR 0.54, 95 % CI 0.45-0.65, P &lt; 0.00001)."	0
"OBJECTIVE: We evaluated the effects of @Chemical$ in aspirin-induced @Disease$ by using a double-blind, crossover study design."	0
"QUESTION/PURPOSES: We sought to answer four questions: For the THA and TKA cohorts, respectively, (1) was the incidence of readmission resulting from VTE and @Disease$ complications higher with LMWH than mobile compression plus ASA; and (2) was the incidence of wound bleeding complications higher with @Chemical$ than mechanical compression plus ASA?"	0
CONCLUSION: Our study appears to demonstrate that rofecoxib is a suitable NSAID for treatment of patients with @Chemical$ and/or other NSAID-induced @Disease$.	0
"However, studies evaluating the prevalence of @Chemical$ @Disease$  in patients with NPs using the oral aspirin provocation test (APT) are quite limited."	1
Dual antiplatelet therapy with ASA and @Chemical$ increases the risk of gastrointestinal bleeding in patients with @Disease$ in whom concomitant treatment with a proton-pump inhibitor (PPI) was less effective owing to the interaction of clopidogrel and PPI with the same hepatic cytochrome P-450.	0
"CONCLUSION: In a healthy population taking aspirin (81 mg q.d.), coadministration of @Chemical$ resulted in fewer GDUs than naproxen, but significantly more @Disease$ than aspirin alone."	0
METHODS: We performed a retrospective cohort study of 1677 patients undergoing coronary artery bypass surgery to determine the relationship of the preoperative use of @Chemical$ plus clopidogrel vs aspirin alone to the 30-day incidence of postoperative surgical site @Disease$ and bacteremia.	0
"In some patients, the cardiovascular benefits of low-dose @Chemical$ might be overcome by the risk of @Disease$, but withdrawal of aspirin therapy can precipitate a cardiovascular event."	0
"After adjusting for potential confounding factors (including treatment, cause of @Disease$, age, smoking, and diabetes mellitus), a time-dependent multivariate Cox proportional hazards regression analysis showed that the combination of high-dose aspirin with an ACEI was independently associated with the risk of death (hazard ratio, 1.03; P =.01) and that the combination of low-dose @Chemical$ with an ACEI was not (hazard ratio, 1.02; P =.18)."	0
The risk of readmission resulting from bleeding and @Disease$ (VTE) has also not been determined for patients undergoing @Chemical$ or TKA when treated with low-molecular-weight heparin (LMWH) alone compared with mechanical prophylaxis plus aspirin (ASA).	0
"OBJECTIVE: We investigated whether subjects with asthma and/or nasal @Disease$ (NP) and analgesic intolerance proven by oral ASA provocation test tolerated the selective COX-2 inhibitor, @Chemical$."	0
"However, @Chemical$, even at a low dose, can induce varying degrees of gastroduodenal mucosal injury (erosion, @Disease$, ulcer bleeding)."	1
"The incidence of @Chemical$ @Disease$ the general population ranges from 0.6 % to 2.5% and in adult asthmatics from 4,3 % to 11%."	1
"We compared 1- and 3-year outcomes for cerebrovascular accident (CVA), transient @Disease$ attack (TIA), gastrointestinal (GI) bleeding, genitourinary (GU) bleeding, any bleeding, and AF recurrence among patients receiving: none, @Chemical$, or warfarin as long-term therapies."	0
Patients on @Chemical$ had the lowest incidence of @Disease$ among all groups (2.24%/y).	0
"METHODS: To estimate the numbers and rates of emergency department (ED) visits for hemorrhage-related AEs (@Disease$ or evaluation for potential hemorrhage) from DAT in the United States and put them in the context of those from @Chemical$, we analyzed AEs from the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance project, 2006-2008, and outpatient prescribing from the National Ambulatory Medical Care Survey and the National Hospital Ambulatory Medical Care Survey, 2006-2007."	0
"MATERIAL AND METHODS: This prospective, randomized study included 30 patients with aspirin-induced @Disease$ undergoing @Chemical$."	0
@Chemical$ allergy desensitization in @Disease$.	0
Low-dose @Chemical$ prolongs @Disease$ after gastric biopsy in Japanese patients.	1
Immunoglobulin G4 @Disease$ in association with @Chemical$-exacerbated respiratory disease.	1
RESULTS: @Disease$ were found in 92 of 190 (48.4%) users of low-dose @Chemical$ and 6 of 46 (13.0%) nonusers.	0
"OBJECTIVES/HYPOTHESIS: @Chemical$-sensitivity, asthma, and @Disease$ (NP) comprise the clinical entity of Samter's triad."	0
The pharmacological mechanisms of aspirin-sensitive @Disease$ are not fully understood but probably involve diversion of arachidonic acid metabolism from prostaglandin to cysteinyl leukotriene formation leading to direct effects on blood vessels and delayed mast cell degranulation with release of @Chemical$.	0
"Moreover, cyclooxygenase-2 is markedly downregulated in polyps from @Chemical$-sensitive patients with @Disease$."	0
"A case of fibrous dysplasia, limited to the middle turbinate and associated with Widal triad (sinus-nasal polyposis, @Disease$, @Chemical$ intolerance), is described."	0
"Aspirin (acetylsalicylic acid)-induced asthma (AIA) consists of the clinical triad of asthma, chronic rhinosinusitis with nasal polyps, and precipitation of @Disease$ and rhinitis attacks in response to @Chemical$ and other NSAIDs."	0
Desensitization to @Chemical$ has classically been studied in patients with @Disease$.	0
OBJECTIVES: To identify prescribing patterns of antiulcer agents in patients on low-dose aspirin (@Chemical$) and to evaluate the number of gastrointestinal (@Disease$) risk factors of the patients.	0
The medical history of non-steroidal anti-inflammatory drugs (NSAIDs) or @Chemical$ (ASA) usage and the presence of @Disease$ (CAD) were investigated in all patients with or without hemorrhage.	0
"PATIENTS: Helicobacter pylori-negative patients taking daily low-dose @Chemical$ (75-325 mg), who fulfilled one or more of the following criteria: age &gt;=18 years with history of uncomplicated peptic @Disease$; age &gt;=60 years with either stable coronary artery disease, upper gastrointestinal symptoms and five or more gastric/duodenal erosions, or low-dose ASA treatment initiated within 1 month of randomisation; or age &gt;=65 years."	0
"RESULTS: Of 8754 Chinese patients with @Disease$ and CHA2DS2-VASc &gt;=1 (79.5+-9.2 years; CHA2DS2-VASc, 4.1+-1.5; and Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile International Normalized Ratio, Elderly (&gt;65 years), Drugs/Alcohol Concomitantly [HAS-BLED], 2.2+-0.9), 16.3% received @Chemical$, 41.1% aspirin, 4.5% dabigatran, and 38.1% received no therapy."	0
"CONCLUSIONS: Low-dose enteric-coated @Chemical$ frequently damages the small intestine, and misoprostol is effective in the treatment of aspirin-induced @Disease$."	0
BACKGROUND: Aspirin-intolerant asthma (AIA) refers to the development of bronchoconstriction in @Disease$tic individuals following the ingestion of @Chemical$ or other non-steroidal anti-inflammatory drugs (NSAIDs).	0
"We included participants with @Disease$ at t0, aspirin intake, @Chemical$+ or no analgesics at t0 and t2, and known headache frequency."	0
"Key search terms included cyclooxygenase inhibitors, @Chemical$, asthma, and @Disease$."	0
"BACKGROUND: Low-dose @Chemical$ is widely used for prevention of @Disease$, heart attacks, and death in patients with atherothrombotic disease, but its use is associated with serious gastrointestinal (GI) adverse effects."	0
"RESULTS: The @Chemical$-treated group was significantly older, with higher weight and poorer health state (higher incidence of ischemic heart disease, cerebral ischemia and @Disease$)."	0
"RESULTS: Prior aspirin users (n = 17,839) were older (63 years vs. 59 years) and had more coronary risk factors and evidence of @Disease$ (MI, angina, prior intervention) than nonprior @Chemical$ users (n = 48,604) (all p &lt; 0.0001)."	0
"METHODS: This retrospective cohort study assessed overt GI bleeding, decreased hemoglobin levels suspecting @Disease$, and CV death in patients taking LDA for more than 1 year (LDA group) and in patients not taking @Chemical$ (control group)."	0
The contribution of low-dose @Chemical$ to increased peri-operative risk of @Disease$ and blood loss is a contentious issue with conflicting published results from different surgical groups.	1
The aim was to analyze the prevalence of HLA class I phenotypes and HLA-DRB1* genotype in patients with @Chemical$ associated with ASA and NSAIDs @Disease$ (AICU).	0
"@Chemical$-induced @Disease$ is now increasingly being recognized and is presumably not uncommon, and the availability of new imaging techniques for the small intestine and noninvasive tests such as fecal calprotectin should allow rapid progress in this important area."	1
"Two weeks later, the patient took a 25-mg @Chemical$ tablet for a sore throat, and she developed @Disease$ 5(1/2) hours later."	0
Rabeprazole significantly inhibits acid secretion irrespective of CYP2C19 genotypes and decreases the incidence of @Chemical$-related @Disease$ and symptoms according to increasing pH value.	1
"[@Chemical$ induced @Disease$, urinary leukotriene E4 and zafirlukast]."	1
"@Chemical$-exacerbated respiratory disease is a chronic and treatment-resistant disease, characterized by the presence of eosinophilic rhinosinusitis, nasal polyposis, @Disease$, and nonsteroidal anti-inflammatory drugs hypersensitivity."	0
Neither aspirin nor non@Chemical$ NSAIDs are likely useful for prevention of @Disease$.	0
"BACKGROUND: Aspirin (acetylsalicylic acid [ASA]) hypersensitivity is frequent in patients with @Disease$ (NPs) and is called @Chemical$ exacerbated respiratory disease, previously known as Samter's syndrome."	0
Evaluation of desmopressin effect on primary haemostasis in pediatric patients with @Chemical$-like defect as @Disease$.	0
"@Disease$ patients suffer from an active disease despite avoidance of @Chemical$, and it has been suggested that administration of aspirin to these patients increases the generation of immediate oxygen products of arachidonic acid, 12-hydroperoxyeicosatetraenoic acid (12-HPETE), in their platelets."	0
"Factors associated with an increased risk of upper GI complications during low-dose @Chemical$ therapy include aspirin dose, history of @Disease$ or upper GI bleeding, age &gt; 70 years, concomitant use of NSAIDs (including COX-2-selective NSAIDs), and Helicobacter pylori infection."	0
"BACKGROUND: Aspirin-exacerbated @Disease$ (AERD) is a clinical triad consisting of @Chemical$/acetylsalicylic acid (ASA) sensitivity, bronchial asthma, and nasal polyposis."	0
AIM: The aim of this study was to examine the genotypes of RAS genes related to the risk of peptic ulcer and ulcer @Disease$ among patients taking low dose @Chemical$.	0
"CONCLUSION: This cross-sectional survey showed that AERD is highly prevalent among adult asthmatics and its prevalence seems to be affected by family history of @Chemical$ @Disease$, history of rhinosinusitis and presence of NP."	1
BACKGROUND: To improve understanding of aspirin @Disease$ this study focused on @Chemical$ as a noncyclooxygenase target molecule of aspirin.	0
"@Chemical$ and DAPT had similar rates of bleeding, but TAPT had significantly higher rates of headache, palpitation, @Disease$ and gastrointestinal side-effects."	0
"CONCLUSIONS: Adding @Chemical$ to aspirin beyond 4 weeks post PCI is not associated with a significant increase in the overall rate of major or minor @Disease$, although it is associated with an increase in major gastrointestinal bleeding in the year after a PCI."	0
"METHODS: The effect of arachidonic acid or platelet agonists on LTC4 synthase activity was investigated in platelets obtained from healthy volunteers, aspirin-intolerant @Disease$tics or aspirin-tolerant asthmatics after in vivo treatment or in vitro pre-incubation with @Chemical$."	0
"METHODS: Of 74 patients with CIU and a history of @Chemical$ @Disease$ studied by us, two patients (probands) gave a family history of aspirin intolerance."	1
CONCLUSIONS: Co-treatment of ARB reduces peptic ulcer and @Disease$ among patients taking low dose @Chemical$.	0
This would allow the use of an @Chemical$ for primary or secondary prevention in patients with @Disease$ despite a presumed history of NSAID hypersensitivity.	0
Acute reactions of @Chemical$ @Disease$ are elicited via cyclooxygenase inhibition by non-steroid anti-inflammatory drugs.	1
"BACKGROUND AND AIM: Owing to wide-spread use, low-dose @Chemical$ (LDA) produces a substantial amount of peptic @Disease$ disease."	1
"More interestingly, regression analysis of the decline of forced expiratory volume in one second (FEV(1)) by @Chemical$ provocation revealed that 10 SNPs (P = 0.003-0.04) and four relevant haplotypes (P = 0.002-0.02) were significantly associated with the fall rate of FEV(1) by aspirin provocation, indicating that genetic polymorphisms of EMID2 could cause meaningful deficits in the upper and lower airways among @Disease$ patients."	0
"METHODS: This retrospective cohort study assessed overt GI bleeding, decreased hemoglobin levels suspecting @Disease$, and CV death in patients taking LDA for more than 1 year (@Chemical$ group) and in patients not taking LDA (control group)."	0
"BACKGROUND: Aspirin-exacerbated respiratory disease (AERD) is a clinical syndrome characterized by chronic rhinitis, nasal polyps, asthma, and precipitation of asthma and @Disease$ attacks after ingestion of aspirin (@Chemical$) and most nonsteroidal anti-inflammatory drugs (NSAIDs)."	1
"There was no significant difference in COX-2 expression between LPS and aspirin stimulation (mean 61.8%, range 26.8-89.2; p = 0.09) and @Disease$ stimulation (mean 55.5%, range 28.1-74.3) nor between @Chemical$ stimulation alone (median 0.5%, range 0-8.6; p = 0.8) and baseline values (median 0.4%, range 0-5.4) in healthy control subjects."	0
"Based on the earlier work that aspirin and reduced platelet activity are associated with larger hemorrhage size and @Disease$ growth, we tested the hypothesis that @Chemical$ or reduced platelet activity would be associated with increased odds of craniotomy, likely through hemorrhage growth."	0
We present the case of a patient taking aspirin and @Chemical$ who was admitted with upper digestive haemorrhage due to duodenal @Disease$.	0
"CONCLUSIONS: CIU with @Chemical$ sensitivity is characterized by the eicosanoid alterations, which are similar to those present in aspirin-induced @Disease$."	0
"CONCLUSIONS: We present a patient with classic aspirin-exacerbated @Disease$, who despite undergoing a standard @Chemical$ desensitization protocol was unable to maintain his desensitized state."	0
"Yogurt Containing Lactobacillus gasseri Mitigates @Chemical$-Induced @Disease$: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial."	1
"BACKGROUND: @Chemical$-exacerbated @Disease$ (AERD) is a clinical syndrome characterized by chronic rhinitis, nasal polyps, asthma, and precipitation of asthma and rhinitis attacks after ingestion of aspirin (ASA) and most nonsteroidal anti-inflammatory drugs (NSAIDs)."	1
Accidental ingestion of aspirin and nonsteroidal anti-inflammatory drugs is common in patients with @Chemical$-exacerbated @Disease$.	0
Hypersensitivity to aspirin: common @Chemical$ alterations in @Disease$ and asthma.	0
"CONCLUSIONS: Physicians should consider additional risk factors for HS, such as a history of HS or @Disease$, and the use of @Chemical$, before prescribing ASA for the secondary prevention of cardiovascular events."	0
"@Chemical$ increased the risk of @Disease$ in both acute (OR 5.36, 95% CI 1.94-14.8) and chronic therapy (OR 5.53, 95% CI 1.23-24.9)."	0
"Based on the results of the MATCH trial, combination therapy with aspirin plus @Chemical$ is not recommended for patients with ischaemic @Disease$ or TIA due to the increased risk of haemorrhage."	0
Rapid oral aspirin desensitization for patients with @Chemical$ @Disease$ requiring dual antiplatelet therapy.	1
"Acetylsalicylic acid, commonly known as @Chemical$, can induce some @Disease$ reactions with clinical symptoms such as urticaria, angioedema, acute bronchospasm, and rarely anaphylactic shock."	1
The purpose of this work was to study the different cells involved in @Disease$tic inflammatory responses in allergic and aspirin sensitivity patients and compared with Extrinsic Allergic Alveolitis patients (@Chemical$) by BAL procedure.	0
"Therefore, @Chemical$ desensitization is necessary in patients with @Disease$ and histories of hypersensitivity reactions to it."	0
"Patients receiving treatment for &gt;5 years showed elevated risk of CMBs in the @Chemical$ (0.17; 0.09-0.36; P &lt; .001) and clopidogrel (0.15, 0.07-0.33; P &lt; .001) groups as well as higher odds of MB in the aspirin (0.34, 0.16-0.71; P = .004) and clopidogrel (0.37, 0.17-0.80; P = .010) groups.The WMHs and MB were associated with CMBs in patients taking aspirin or clopidogrel for &gt;1 year, and long-term use increased the risks of CMB and @Disease$."	0
All patients with aspirin exacerbated @Disease$ (AERD) can be desensitized to @Chemical$.	0
CONCLUSION: The findings of the present study do not support the notion that enteric-coated low-dose @Chemical$ reduces the risk of @Disease$ and is safer than buffered low-dose aspirin products.	0
"The 1-year predicted risks associated with acetylsalicylic acid, the combination of @Chemical$ and dipyridamole, and clopidogrel were 11.1 (95% CI: 10.2-12.2), 7.7 (95% CI: 7.3-8.3), and 8.0 (95% CI: 6.9-8.7) for ischemic @Disease$, respectively; while, the risks for bleeding were 3.4 (95% CI: 2.8-3.9), 2.4 (95% CI: 2.1-2.7), and 2.4 (95% CI: 1.9-2.9), respectively."	0
"OBJECTIVE: We evaluated hourly dose escalations in a subset of patients with @Disease$, nasal polyps, and asthma who historically reacted to @Chemical$ within 1 hour or were avoiding aspirin with the goal of developing a safe and efficient desensitization protocol."	0
"Nevertheless, further specifically designed studies with more sample size are needed to determine the best treatment for low dose @Chemical$ related @Disease$."	1
"Patients who are on chronic @Chemical$ therapy and receive a coronary stent need to be treated with the triple therapy of aspirin, clopidogrel and warfarin; however, the @Disease$ risk in these patients is unknown."	0
"Endoscopic @Disease$ rates in healthy subjects associated with use of @Chemical$ (81 mg q.d.) alone or coadministered with celecoxib or naproxen: a randomized, 1-week trial."	0
Multivariate analysis of the primary prevention group showed a trend towards @Disease$ (P = 0.054; HR 1.72; CI 0.99-2.97) with dual-antiplatelet therapy (aspirin plus @Chemical$).	0
"Exclusion criteria: cancer, sepsis or @Disease$, active inflammatory/rheumatic disease, recent major surgery, chronic liver failure, the administration of other antiplatelet drugs, nonadherence with @Chemical$ and thrombocytopenia."	0
"We describe the most common clinical presentations of aspirin @Disease$, i.e. aspirin-induced asthma, rhinosinusitis and @Chemical$-induced urticaria."	0
"OBJECTIVE: We investigated whether subjects with asthma and/or nasal @Disease$ (NP) and analgesic intolerance proven by oral @Chemical$ provocation test tolerated the selective COX-2 inhibitor, meloxicam."	0
RESULTS: Immunoreactive gliadins appeared in the sera of patients during the provocation test with both wheat-exercise and wheat-@Chemical$ challenges in parallel with @Disease$.	0
"Patients with AIA rarely experience @Disease$ attacks when taking @Chemical$, a specific inhibitor of cyclooxygenase (COX) 2."	0
This effect of aspirin is unique to aspirin-exacerbated respiratory disease and not observed in subjects with @Chemical$-tolerant @Disease$.	0
Low dose @Chemical$ administration has been generally accepted as prophylactic therapy for @Disease$ and cerebrovascular disease.	0
"All 129 patients with high risk @Disease$ with microbleeds or minor stroke within 24 hours after the onset (average age 65.9 +- 9.3, 48.7% were male patients) were divided randomly into two groups: (1) 67 patients were given combination therapy with clopidogrel and aspirin (clopidogrel at an initial dose of 300 mg, then 75 mg per day for 90 days, plus @Chemical$ at a dose of 75 mg per day for the first 21 days);(2) the rest patients were given aspirin treatment (75 mg per day for 90 days)."	0
"A total of 12 patients with a clear-cut history of AIA were randomised in double-blind cross-over fashion to receive single doses of ML 10 mg, @Disease$ 40 mg, or placebo (PL), with nasal lysine-@Chemical$ challenge performed 12 h after dosing."	0
Recognising the risk of aspirin-sensitive respiratory disease in a patient with @Disease$ who has previously tolerated @Chemical$.	0
"Post-ESD @Disease$ occurred in 4.1% (21/514) overall, and was more frequent in continuous @Chemical$ users (4/19 [21.1%]) than in those who never used aspirin (15/439 [3.4%]) (P=0.006) and those with interrupted aspirin use (2/56 [3.6%]) (P=0.033)."	0
Video capsule endoscopy of the @Disease$ and the Gastrointestinal Symptom Rating Scale (GSRS) questionnaire were performed before and after the administration of @Chemical$.	0
"Aspirin @Disease$ is a hallmark of @Chemical$-exacerbated respiratory disease (AERD), a clinical syndrome characterized by the severe inflammation of the respiratory tract after ingestion of cyclooxygenase-1 inhibitors."	0
"Secondary endpoints were: 1) the occurrence of @Disease$ symptoms during the protocol, 2) the rate of @Chemical$ discontinuation at follow-up; 3) recurrent cardiovascular ischemic events."	0
"MATERIALS AND METHODS: We report seven patients with a new form of chronic manganese @Disease$ due to long-term intravenous use of a solution consisting of ephedrine, @Chemical$ and potassium permanganate as a psycho-stimulant, popularly known as Russian Cocktail."	0
"BACKGROUND: Aspirin (acetylsalicylic acid [@Chemical$]) hypersensitivity is frequent in patients with nasal polyps (NPs) and is called aspirin exacerbated @Disease$, previously known as Samter's syndrome."	0
"Furthermore, @Disease$ patients under synthesize from @Chemical$ (AA) a peculiar product called lipoxins, which opposes inflammation generated by leukotrienes."	0
"The drugs significantly associated with @Disease$ were loxoprofen (aOR 5.0), @Chemical$ (aOR 3.1), diclofenac suppository (aOR 8.0), etodolac (aOR 4.9), enteric-coated aspirin (aOR 3.9), buffered aspirin (aOR 9.9), clopidogrel (aOR 2.5), and cilostazol (aOR 7.3)."	0
"We used sensitivity analyses to identify the incremental benefit of longer-duration DAPT on either ST or the composite of cardiac death, myocardial infarction, and ischemic stroke (major adverse cardiovascular and cerebrovascular events [MACCEs]) required to outweigh the increased risk of @Disease$ associated with longer @Chemical$."	0
Association of @Chemical$ and other non-steroidal anti-inflammatory drug use with incidence of @Disease$.	1
RATIONALE: @Chemical$-induced @Disease$ (AIA) is a distinct clinical syndrome that affects up to 10% of adults with asthma.	1
CONCLUSION: Symptom-based clusters in @Disease$ reveal a distinct grouping of symptom burden that may relate to @Chemical$ sensitivity and treatment outcomes.	0
"@Chemical$ perform a number of important functions in the @Disease$, particularly with respect to resistance of the mucosa to injury."	0
"RESULTS: We found significantly lower total symptom score (TSS) during the 7th (p = .009), 14th (p = .003), 21st (p &lt; .001) and the 28th day (p = .001), lower total endoscopic score (TES) on the 21st (p = .002) and 28th day (p = .001), lower nasal obstruction, facial pain/pressure, headache and trouble sleeping, and lower nasal mucosal edema, nasal secretion and nasal crusting in patients treated by @Disease$ sea @Chemical$."	0
"INTRODUCTION: Aspirin-intolerant @Disease$ (AIA), a major clinical presentation of @Chemical$ hypersensitivity, affects 10% of adult asthmatics."	0
"RESULTS: The gastric acid secretion level, with an odds ratio (OR) (95% confidence interval [CI]) of 10.5 (3.0-36.9) and @Chemical$ administration, with an OR (95% CI) of 7.4 (3.0-18.3) were independently associated with gastric mucosal injury, and the co-existence of both factors greatly elevated the risk of @Disease$, with an OR (95% CI) of 77.0 (13.5-440.0)."	0
BACKGROUND: This multicenter retrospective study investigated the management and outcome of patients with peptic @Disease$/erosion-related @@Chemical$hemical$ and clopidogrel (A + C) cotherapy.	0
The aim of this study was to determine the incidence of upper @Disease$ing and whether the use of peri-operative oral ranitidine reduces the incidence of upper GI bleeding when @Chemical$ thromboprophylaxis is used for hip and knee arthroplasty.	0
"OBJECTIVE: To classify patients with a history of aspirin-induced @Disease$ as cross-reactors or single-drug reactors by oral challenges with another strong COX-1 inhibitor, namely, @Chemical$."	0
"In multivariate logistic regression, after controlling for @Disease$ volume and location, any known @Chemical$ use (OR 3.4, 95% CI 1.1-10.4, P = 0.03), platelet activity &lt;=550 aspirin reaction units (OR 3.1, 95% CI 1.05-9.3, P = 0.04), or an elevated PFA-EPI closure time (OR 3.2, 95% CI 1.02-10.3, P = 0.04) were associated with increased odds of craniotomy."	0
"Within 90 days of surgery, there was 1 @Disease$ (1%) in the ketorolac group compared with 51 (5%) in the non@Chemical$ group (p = 0.01)."	0
Risk of @Disease$ with enteric- versus nonenteric-coated @Chemical$.	1
"We found no difference in microhemorrhage size for both young and aged mice dosed on @Chemical$, as compared to controls (@Disease$ diameter = 104 +/- 39 (97 +/- 38) mum in controls and 109 +/- 25 (101 +/- 28) mum in aspirin-treated young (aged) mice; mean +/- SD)."	0
It is not known if an interaction exists between @Chemical$ and paracetamol in regards to @Disease$.	0
"Recently, 7 patients @Disease$ to @Chemical$ have been desensitized in our department due to cardiologic and rheumatologic reasons."	1
"Adverse events considered possibly or probably related to treatment occurred in 5 (20.0%) misoprostol recipients (4 episodes of diarrhea, 1 episode of abdominal pain), 1 (14.3%) recipient of @Chemical$ 30 mg (1 episode of pharyngitis), and 3 (13.6%) placebo recipients (1 episode each of abdominal pain, palpitations, and @Disease$)."	0
"Letter by Feng et al regarding article, Ischemic @Disease$ and intracranial hemorrhage with aspirin, @Chemical$, and warfarin: impact of quality of anticoagulation control."	0
"At the 5-year follow-up, cardiovascular events were found to have developed in 11 patients (8 stroke and 3 myocardial infarction) who exhibited aspirin resistance (12.1%) and in 9 (4 stroke and 5 @Disease$) patients who did not exhibit @Chemical$ resistance (2.4%) (P &lt; .001)."	0
"Also, women had less peripheral artery disease (@Chemical$, 2.4% versus 3.7%; apixaban, 1.4% versus 3.0%), more heart failure, and higher mean CHADS2 (congestive heart failure, hypertension, age of 75 years or older, @Disease$ [1 point each], stroke or transient ischemic attack [2 points]) scores (aspirin, 2.2 versus 2.0; apixaban, 2.1 versus 2.0)."	0
BACKGROUND AND PURPOSE: Low doses of aspirin (acetylsalicylic acid; @Chemical$) and non-steroidal anti-inflammatory drugs (NSAIDs) increase the risk of @Disease$.	1
"For @Chemical$-anticoagulant concomitant treatment, clinically relevant @Disease$ occurred with an event rate of 36.6 per 100 patient-years, compared to 16.9 per 100 patient-years during aspirin nonuse (HR, 1.70 [95% CI, 1.38-2.11])."	0
Obesity in @Chemical$-tolerant and aspirin-intolerant @Disease$tics.	0
"CONCLUSION: Short-term, mostly single-dose exposure to @Chemical$ for the treatment of @Disease$, fever, or colds was associated with a small but significant increase in the risk of dyspepsia relative to placebo."	0
"@Chemical$ exacerbated respiratory disease (AERD) is characterized as adult onset asthma, nasal polyps, chronic rhinosinusitis, and @Disease$ cyclooxygenase-1 (COX-1) inhibitor, viz aspirin or nonsteroidal antiinflammatory drugs (NSAIDs)."	0
"Data Sources: We searched PubMed, Embase, CENTRAL, and ClinicalTrials.gov from inception to May 28, 2018, with the terms novel oral anticoagulants, non-@Chemical$ antagonist oral anticoagulants, direct oral anticoagulants, dabigatran, rivaroxaban, apixaban, edoxaban, warfarin, Coumadin, vitamin K antagonist, aspirin, acetylsalicylic acid, or ASA, and major bleeding, fatal @Disease$, or intracranial hemorrhage."	0
"Data Sources: We searched PubMed, Embase, CENTRAL, and ClinicalTrials.gov from inception to May 28, 2018, with the terms novel oral anticoagulants, non-vitamin K antagonist oral anticoagulants, direct oral anticoagulants, dabigatran, rivaroxaban, apixaban, edoxaban, warfarin, Coumadin, vitamin K antagonist, aspirin, @Chemical$, or ASA, and major @Disease$, fatal bleeding, or intracranial hemorrhage."	0
SIGNIFICANCE: IV DDAVP corrected prolongations in BMBT in dogs given @Chemical$ and should be considered in dogs requiring prompt reversal of aspirin-induced coagulopathies to reduce the risk of @Disease$ complications.	0
"The aim of this blinded, randomised, multicentre study was to compare the tolerability of aspirin, @Chemical$ and ibuprofen in common pain resulting from @Disease$ (MSC) in general practice with patients with other non-MSC pain conditions."	0
"METHODS: We investigated intolerance and bleeding while on @Chemical$ and aspirin discontinuation using 5337 post-acute @Disease$ patients considered appropriate for chronic antiplatelet therapy who were randomly assigned to aspirin in SYMPHONY and 2nd SYMPHONY and followed for 94 (64,157) days."	0
BACKGROUND &@Chemical$; AIMS: Effervescent calcium carbasalate is a calcium-salt of acetylsalicylic acid causing less local @Disease$ than acetylsalicylic acid at high doses in healthy controls.	0
"RESULTS: The frequency of @Chemical$ (60/150 (40%) vs 18/150 (12%); odds ratio 4.899, p &lt;0.0001) and intracerebral hemorrhage (@Disease$)(42/150 (28%) vs 2/150 (1%); odds ratio 28.778, p &lt;0.0001) were significantly higher in the patients than in the controls."	0
"The values of @Disease$s of MPs in descending order were as follows: @Chemical$, hydrotalcite &gt; teprenone &gt; sucralfate oral suspension &gt; L-glutamine and sodium gualenate granules &gt; rebamipide &gt; sucralfate chewable tablets."	0
We therefore analyzed the effect of @Chemical$ on mortality and serious bleeding in @Disease$ patients with and without cardiovascular disease.	0
The purpose of this work was to study the different cells involved in asthmatic inflammatory responses in @Disease$ and aspirin sensitivity patients and compared with Extrinsic Allergic Alveolitis patients (@Chemical$) by BAL procedure.	0
"Compared to women who did not use either aspirin or other non-aspirin NSAIDs, women using aspirin exclusively (RR = 1.71; 95% CI = 0.94-3.13), non-@Chemical$ NSAIDs exclusively (RR = 2.39; 95% CI = 1.18-4.83), or both types of drugs (RR = 1.97; 95% CI = 1.06-3.68) were at increased risk of @Disease$."	0
The aim of the study was to determine the rate of post polypectomy @Disease$ and to analyse the role of potential risk factors especially the role of @Chemical$.	0
"OBJECTIVE: Low molecular weight (LMW) @Chemical$, with or without aspirin (acetylsalicylic acid [ASA]), is used to prevent complications in @Disease$ in pregnancy."	0
"BACKGROUND: External @Disease$ (@Chemical$) is the commonest neurosurgical procedure performed in daily neurosurgical practice, but relatively few studies have investigated the incidence and risk factors of its related hemorrhagic complications."	0
"Dual antiplatelet therapy consisting of low-dose aspirin (@Chemical$) and other antiplatelet medications is recommended in patients with coronary heart disease, but it may increase the risk of @Disease$ and bleeding."	0
BACKGROUND: @Chemical$ desensitization (@Disease$) has been the only available modifying treatment in aspirin-exacerbated respiratory disease (AERD).	0
RESULTS: A total of 324 patients were admitted with @Disease$ of whom 94% were discharged on @Chemical$.	0
BACKGROUND: Clopidogrel use as single antiplatelet therapy (SAPT) has never been evaluated in stable @Disease$ (CAD) outpatients either as compared to placebo or @Chemical$.	0
"Major @Disease$ in aspirin-anticoagulant-treated patients occurred with an event rate of 4.8 per 100 patient-years, compared to 2.2 per 100 patient-years during @Chemical$ nonuse (HR, 1.50 [95% CI, 0.86-2.62])."	0
BACKGROUND: Acquired @Disease$ due to @Chemical$ ingestion may increase bleeding tendency during surgery.	1
RAS may play an important role in the development of @Disease$ induced by low dose @Chemical$.	1
Addition of a @Chemical$ receptor antagonist such as montelukast improves @Disease$ in aspirin-intolerant patients over and above what can be achieved by glucocorticosteroids.	0
"OBJECTIVE: Aspirin-exacerbated respiratory disease (AERD) represents a severe form of chronic rhinosinusitis (CRS) characterized by @Disease$, bronchial asthma, and @Chemical$ intolerance."	0
Comparison of @Disease$ complications with @Chemical$ + aspirin + clopidogrel--versus--aspirin + clopidogrel in patients with cardiovascular disease.	0
The main objective of this study was to evaluate the potential relationship between using @Chemical$ and development of @Disease$ with a meta-analysis.	0
Several genetic studies on @Chemical$ hypersensitivity have been performed to discover the genetic predisposition to aspirin @Disease$ and to gain insight into the phenotypic diversity.	0
"In these patients, the CHARISMA trial demonstrated a lack of significant clinical efficacy and an increased risk of @Disease$ with clopidogrel plus aspirin compared with @Chemical$ alone."	0
BACKGROUND: @Chemical$ hypersensitivity may represent a major problem in patients with @Disease$ coronary disease who need a stenting procedure.	0
"We investigated whether @Chemical$ with caffeine (ASA++) increases headache frequency compared with aspirin alone in @Disease$, tension-type headache (TTH), and migraine + TTH (MigTTH)."	0
"DISCUSSION: Patients with @Chemical$-provoked FDEIA have been reported previously as taking ordinary doses of aspirin for reducing @Disease$, inflammation and fever."	0
"The similarities in the reaction between the nose and airways in @Chemical$-sensitive patients provide compelling evidence for common pathogenic mechanisms for nasal polyps, @Disease$, and bronchial asthma."	0
@Disease$ always occurred before their admission and aspirin (n = 12) or @Chemical$ (n = 7) was prescribed.	0
This study examines current physician practices and the use of @Chemical$ therapy by individuals with @Disease$.	0
"In two separate series, @Disease$ and carrageenan arthritis-induced inflammatory pain were measured in control, ASA and ASA-@Chemical$-treated groups."	0
@Chemical$ continues to be underprescribed for @Disease$ and is considered to be very effective by many patients with AERD.	0
"Misoprostol, a synthetic analogue of prostaglandin E1 (@Chemical$) compensates prostagrandins of which synthesis is inhibited by aspirin and protect the @Disease$."	0
EVIDENCE SYNTHESIS: The prevalence of aspirin-exacerbated @Disease$ is approximately 10% and for @Chemical$-induced urticaria the prevalence varies from 0.07% to 0.2% of the general population.	0
OBJECTIVE: To estimate the bleeding risk of combined anticoagulant (rivaroxaban or @Chemical$-vitamin K antagonist [VKA]) and NSAID or aspirin therapy in patients with @Disease$.	0
The role of @Chemical$ as a primary prevention of cancer is still controversial and may be more beneficial in certain @Disease$s over others.	0
Aspirin (@Chemical$) is an important cause of @Disease$ so that ASA induced asthma (AIA) is considered a disease.	1
@Chemical$ derivatives as risk factors for @Disease$ following high risk endoscopic treatments: Safe Treatment on Antiplatelets (STRAP) study.	0
"In one RCT, no statistically significant differences for @Disease$ requiring admission to hospital (p = 0.14) or blood transfusion (p = 0.29) were observed between the group receiving concomitant famotidine and @Chemical$ and the group receiving concomitant placebo and ASA."	0
"Incidence and causes of new-onset @Disease$ in 3,719 patients treated with @Chemical$ and aspirin combination after coronary stenting."	0
"The studies report conflicting findings about the effect of H. pylori @Disease$ on NSAID-related ulcers, and proton-pump inhibitors (PPIs) seem to be superior to eradication only to prevent recurrent ulcer bleeding with @Chemical$."	0
@Chemical$ administration is associated with 2-fold increase in the GI risk in middle-aged users without prior history of peptic @Disease$ and without concomitant medications.	0
"According to APS standard of care, patients were treated with @Chemical$ and/or low-molecular weight heparin (LMWH) at prophylactic (pure obstetric @Disease$) or therapeutic doses (history of thrombosis)."	0
"@Chemical$ healed 64% of @Disease$, but despite follow-up maintenance with H2 receptor antagonists, all ulcers recurred rapidly, often in a new location."	0
"METHODS: By using specific antibodies, immunohistochemistry, and image analysis, we measured the expression of EP(1-4) in nasal biopsies from patients with aspirin-sensitive (n = 12) and non@Chemical$-sensitive (n = 10) polypoid @Disease$ and normal controls (n = 9)."	0
"Although the disease is clinically well characterized, its physiopathology is incompletely understood and noninvasive procedures, allowing an effective distinction between @Chemical$-induced asthma (AIA) and aspirin-tolerant @Disease$ (ATA) are missing."	0
Four of 12 patients with warfarin and bridging @Chemical$ (33%) and two of 13 patients with uninterrupted warfarin (15%) developed a @Disease$.	0
We examined five animal studies of NSAIDs (@Chemical$ and ibuprofen) and aspirin in coxsackievirus B3- and B4-induced @Disease$.	0
@Chemical$ @Disease$ in a patient with acute coronary syndrome represents one of the more urgent challenges an allergist may face.	1
"At about 4 years follow-up, no significant difference was observed among the @Chemical$ and nonaspirin use group in major adverse cardiac events free survival estimates (95.7% versus 91.5%, P = 0.23) and freedom from cardiogenic readmission (88.5% versus 85.3%, P = 0.77) whereas the @Disease$ recurrence free survival rates was 83.7% and 73.9% in the aspirin and nonaspirin use group respectively (P = 0.02), with odd ratio for preoperative aspirin estimated at 0.71 (95% confidence interval, 0.49-1.04, P = 0.08)."	0
"Among individuals with BMI 25 to 29.9, @Chemical$ use 3 or more times per week was associated with reduced risk of all-cause mortality (HR, 0.82; 95% CI, 0.79-0.85; P &lt; .001), any cancer mortality (HR, 0.86; 95% CI, 0.81-0.91; P &lt; .001), GI cancer mortality (HR, 0.72; 95% CI, 0.60-0.86; P &lt; .001), and @Disease$ mortality (HR, 0.66; 95% CI, 0.51-0.85; P = .001)."	0
"Recent evidence showed that among patients with a history of @Chemical$-associated @Disease$ bleeding, the long-term incidence of recurrent bleeding with ASA use is low after eradication of H. pylori alone."	1
"For the TKA cohort specifically, (3) was the frequency of systemic @Disease$ events and complications related to chemical prophylaxis higher with LMWH compared with mechanical compression plus @Chemical$?"	0
"Prolonged periods of dual antiplatelet therapy (@Chemical$), i.e., aspirin plus a thienopyridine, are currently recommended to prevent late drug-eluting stent (DES) @Disease$."	0
"Although knowledge about endoscopic characteristics of L-ASA associated ulcers is limited, the ulcers have common distinctive feature that sudden gastrointestinal bleedings or latently advanced-anemia are often the earliest symptom because @Chemical$-induced ulcers often exist without symptoms of @Disease$."	0
"However, since @Disease$ is now considered a CVD equivalent, it is imperative that clinicians include counseling about @Chemical$ therapy as a care priority for all their diabetic patients, as this simple intervention may prevent many cardiovascular events and deaths."	0
"In view of these animal studies and in the absence of controlled studies of @Chemical$ or NSAIDs in human myocarditis, we do not recommend indiscriminate treatment with NSAIDs or high-dose aspirin in patients with myocarditis where there is no or minimal associated @Disease$."	0
"CONCLUSIONS: Considering that human lung mast cells are capable of producing LTC4, @Chemical$, and histamine, our present results support the concept that mast cells, at least, may participate in the development of aspirin-induced @Disease$."	0
Aspirin and warfarin versus @Chemical$ monotherapy after @Disease$.	0
"Thus, the lack of evidence of benefit with aspirin in patients with @Disease$ and coronary disease, along with growing evidence that @Chemical$ is directly harmful in patients with heart failure and that aspirin may negate the benefits of angiotensin-converting enzyme inhibitors suggest that, unless there is an opportunity to randomize the patient into a study of antithrombotic strategies, then aspirin should be withdrawn or possibly substituted with an anticoagulant or an antiplatelet agent that does not block cyclooxygenase."	0
The relationship of @Chemical$ sensitivity to @Disease$ is complex.	0
"Aspirin (@Chemical$) is a well-known nonsteroidal anti-inflammatory drug that can potentiate some acute allergies and causes adverse immunological reactions collectively referred to as aspirin intolerance, a disorder that induces urticaria, @Disease$, and anaphylaxis in response to oral administration of the drug."	1
"In acute NSAID or @Chemical$ users, co-treatment with proton pump inhibitors, but not with H2-blockers, may reduce the risk of @Disease$ compared with non-users."	0
PURPOSE OF REVIEW: The use of aspirin in coronary artery disease and address the unmet need of aspirin therapy in patients with history of @Disease$ reactions to @Chemical$ (acetylsalicylic acid; ASA) or other nonsteroidal inflammatory drugs (NSAIDs).	1
"The risk of @Disease$ was also increased among patients who had non-end-stage chronic kidney disease or required renal-replacement therapy and was further increased with warfarin, @Chemical$, or both."	0
"CONCLUSIONS: In patients with stable @Disease$ and histories of nonsevere hypersensitivity reactions to @Chemical$/NSAIDs, an ASA challenge is advisable."	0
An update on the management of @Chemical$-exacerbated @Disease$.	1
AIM: The author examined psychiatrically a group of 106 patients with difficult @Disease$ and 100 patients with @Chemical$-induced asthma.	0
Our aim to assess the prevalence of upper gastrointestinal lesions and the effect of @Chemical$ on the @Disease$ in asymptomatic subjects taking minidose aspirin (100 to 325 mg per day) for more than 3 months.	0
"We investigated whether @Chemical$ with caffeine (ASA++) increases headache frequency compared with aspirin alone in migraine, tension-type @Disease$ (TTH), and migraine + TTH (MigTTH)."	0
"METHODS: The 267 patients who had survived a @Disease$ were randomly assigned in the Warfarin Aspirin Reinfarction Study to treatment with aspirin 160 mg/day, or warfarin (INR 2.8-4.2), or @Chemical$ 75 mg/day plus warfarin (INR 2.0-2.5)."	0
"We evaluated the differences in ACS type, total mortality, and the composite end point of death, myocardial infarction (MI), recurrent @Disease$, or stroke between prior aspirin and nonprior @Chemical$ users."	0
"RESULTS: In total, 421 cases of upper GI bleeding were identified in the initial cohort of 784,263 NSAID users (incidence rate 54.2 per 10,000 person-years), while 1,295 cases of upper @Disease$ were identified in 235,531 @Chemical$ users (incidence rate 37.9 per 10,000 person-years)."	0
"However, misoprostol 3 microg/ kg PO q8h was less effective in preventing @Chemical$-induced @Disease$ on days 14 and 28 than in previous studies."	1
"Although precipitation of @Disease$ attacks by ingestion of ASA and other NSAIDs is considered a hallmark of the syndrome, the respiratory mucosal inflammatory disease process begins and continues in the absence of ongoing or even intermittent exposure to @Chemical$ or NSAIDs."	0
CONCLUSIONS: @Chemical$ was superior to famotidine with less @Disease$ and recurrent ulcers/erosions in patients using 24-week low-dose aspirin.	0
"Regular @Chemical$ and non-aspirin analgesic use and the presence of other risk factors for hypertension were assessed by questionnaire at baseline, and the incidence of @Disease$ was assessed using biennial follow-up questionnaires."	0
"The association between aspirin use and the presence of DR or VTDR was assessed using multivariable logistic regression models including age, gender, ethnicity, socioeconomic status, HbA1c, systolic blood pressure, anti-hypertension medicine, total @Chemical$, anti-cholesterol medicine, BMI, current smoking status, @Disease$ duration, history of cardiovascular disease (CVD) and chronic kidney disease (CKD.)."	0
"Various strategies have been proposed to reduce the @Disease$ risk of @Chemical$, including gastroprotection with a proton pump inhibitor (PPI), eradication of Helicobacter pylori infection and replacing aspirin with other anti-platelet agents."	1
Presented in the article are the results of studying antiaggregate activity of @Chemical$ and clopidogrel in a total of 36 patients suffering from various-severity chronic @Disease$ of lower limbs on the background of atherosclerosis obliterans.	0
"CONCLUSIONS: The regular use of aspirin and non-@Chemical$ analgesics were both associated with an increased risk of developing @Disease$, independently of other risk factors."	0
"Therefore, we sought to determine whether @Chemical$ resistance in the acute stage was associated with early radiological events, including new @Disease$ (NILs)."	0
"In the present study, endoscopic examination was performed to investigate the frequency of @Disease$ associated with low-dose @Chemical$ in patients with cerebrovascular disease."	1
"We describe the most common clinical presentations of aspirin hypersensitivity, i.e. aspirin-induced @Disease$, rhinosinusitis and @Chemical$-induced urticaria."	0
"Conclusion Our findings support the safety of antithrombotic therapy with aspirin and/or @Chemical$ during pregnancy in high-risk women with @Disease$, and highlight the need for better treatments to improve pregnancy outcomes in APS."	0
"We searched MEDLINE for studies of @Chemical$ use and @Disease$ risk that were published in any language, from January 1, 1966, to July 1, 2011."	0
"RATIONALE: For the management of common disorders producing short-lasting @Disease$, there is very good evidence of the efficacy of @Chemical$."	0
PURPOSE OF REVIEW: @Chemical$-induced @Disease$/angioedema is a major aspirin-related hypersensitivity often associated with aspirin-intolerant asthma.	1
"@Chemical$ and DAPT had similar rates of bleeding, but TAPT had significantly higher rates of @Disease$, palpitation, rash and gastrointestinal side-effects."	0
We present a case of severe lower @Disease$ due to appendiceal ulcer associated with intake of enteric coated @Chemical$.	0
CONCLUSION: Asthmatic patients belonging to extrinsic or aspirin-induced @Disease$ groups irrespectively showed an improvement from @Chemical$ treatment on spirometric and clinic levels.	0
"RESULTS: At 4 weeks after randomization, 34 of the 73 patients assigned to @Chemical$ therapy (47%) as compared with 30 of the 70 patients given placebo (43%) reported complete @Disease$ symptom relief (P = 0.54)."	0
@Chemical$ resistance could be defined as thrombotic and @Disease$ despite regular aspirin therapy.	0
Safety of a cyclooxygenase-2 inhibitor in patients with @Chemical$-sensitive @Disease$.	0
"The role of gastric acid and its relationship to NSAIDs/@Chemical$ in @Disease$, ulcer and ulcer complications continues to be an important concern because of the increasing worldwide use of NSAIDs and aspirin."	0
Aspirin and the older nonsteroidal anti-inflammatory drugs (NSAIDs) that block cyclo-oxygenase-1 (COX-1) induce @Disease$ in patients with @Chemical$-exacerbated respiratory disease and urticaria in patients with chronic idiopathic urticaria.	0
"No statistically significant differences between the aspirin-resistant and @Chemical$-sensitive individuals were present in gender, major risk factors of @Disease$, number and localization of involved coronary vessels, serum lipid levels, and blood counts."	0
"However, in patients taking aspirin for the primary prevention of cardiovascular events, it seems reasonable to stop aspirin treatment, re-evaluate the indication and, if needed, reintroduce @Chemical$ after the risk of @Disease$ rebleeding decreases, usually after hospital discharge."	0
The present study was designed to investigate the antioxidant activities of citral and assess its possible protective effects against @Chemical$-induced @Disease$ in vitro.	1
"Risks of @Chemical$ outweigh benefits in people without @Disease$, shows analysis."	0
Randomised clinical trial: rabeprazole plus aspirin is not inferior to rabeprazole plus clopidogrel for the healing of @Chemical$-related peptic @Disease$.	0
"This article summarizes the current knowledge about the pathophysiology, focuses on modern diagnostic approaches of @Disease$ and discusses various @Chemical$ desensitization protocols with respect to efficacy as well as to undesirable side effects."	0
"A randomized, double-blind, placebo-controlled study of rebamipide for @Disease$ taking aspirin with or without @Chemical$."	0
"In this cohort of women, longer durations of NSAID and acetaminophen use were associated with slightly higher risks of @Disease$, but duration of @Chemical$ use was not."	0
"This study aimed to analyze @Chemical$ and white matter hyperintensities (WMHs) in patients taking aspirin or clopidogrel.This retrospective study included patients with @Disease$ administered 75 mg/day aspirin (n = 150) or clopidogrel (n = 150, matched for age and gender) for &gt;1 year (Affiliated Hospital of Inner Mongolia Medical University, China, from July, 2010 to July, 2015)."	0
"When reviewing the existing literature on the effects of the coating on the incidence of gastrointestinal side effects we find that enteric-coated aspirin causes significantly less minor gastrointestinal lesions compared to plain @Chemical$ evaluated by endoscopy after short-term treatment, but there seems to be no effect of enteric-coating on the incidence of @Disease$ of clinical relevance."	0
The most recent data show that eradication of H. pylori infection in patients with a previous peptic ulcer bleeding episode who continue to take aspirin reduces the recurrence rate of this complication to levels observed in patients without a history of ulcer bleeding history who take @Chemical$ for @Disease$.	0
CONCLUSION: @Chemical$ can prevent ASP-exacerbated @Disease$ in patients with food allergy resulting from inhibition of increases in allergen absorption.	0
Patients with @Disease$ were divided into the placebo and the @Chemical$ groups.	0
@Chemical$ use and counseling about aspirin among patients with @Disease$.	0
"CONCLUSIONS AND CLINICAL IMPORTANCE: Administration of deracoxib to healthy dogs resulted in significantly lower gastric lesion scores, and fewer days of @Disease$ compared to aspirin, indicating that @Chemical$ is better tolerated than aspirin in some dogs."	0
"Also, women had less peripheral artery disease (aspirin, 2.4% versus 3.7%; @Chemical$, 1.4% versus 3.0%), more @Disease$, and higher mean CHADS2 (congestive heart failure, hypertension, age of 75 years or older, diabetes [1 point each], stroke or transient ischemic attack [2 points]) scores (aspirin, 2.2 versus 2.0; apixaban, 2.1 versus 2.0)."	0
"RESULTS: Pooled data suggested a significantly higher @Disease$ ratio in the @Chemical$-continued group compared to both the LDA-interrupted group (OR=2.05, 95% CI=1.05-3.99) and no-anticoagulant/APT group (OR=2.89, 95% CI=1.86-4.47)."	0
The effects of inhaled aspirin on fractional exhaled NO (FENO) in patients with aspirin-tolerant (ATA) and @Chemical$-inducible (AIA) @Disease$ compared with normal controls have been investigated.	0
"We report an independent 88-year-old female, on @Chemical$ only for chronic atrial fibrillation, who presented with a 12-hour history of acute lumbar back pain, urinary incontinence and progressive bilateral lower @Disease$."	0
"The aim of this blinded, randomised, multicentre study was to compare the tolerability of @Chemical$, paracetamol and ibuprofen in common pain resulting from musculoskeletal conditions (MSC) in general practice with patients with other non-MSC @Disease$ conditions."	0
When patients with @Disease$ need aspirin for specific situations they should receive @Chemical$ desensitization therapy or treatment with selective cyclo-oxygenase 2 inhibitors.	0
"Available evidence suggests that where @Chemical$ and/or clopidogrel are to be started or continued in patients with a recent history of UGI ulceration or bleeding (after @Disease$ and eradication of H. pylori infection), treatment with a PPI is a useful precaution."	0
"CONCLUSIONS: CIU with aspirin sensitivity is characterized by the @Chemical$ alterations, which are similar to those present in aspirin-induced @Disease$."	0
"This report describes a case of Kounis-Zavras syndrome in the setting of aspirin-induced asthma also known as Samter-Beer triad combining nasal @Disease$, asthma, and @Chemical$ allergy leading to vasospasm and myocardial infarction."	0
Helicobacter pylori @Disease$ and the prevention of peptic ulcer with proton pump inhibitors in elderly subjects taking low-dose @Chemical$.	0
"Newer NSAIDs such as @Chemical$, an inhibitor of @Disease$ that acts by reversibly inhibiting the platelet cyclooxygenase enzyme, have proven to be as effective as the older NSAIDs and appear to have a better gastrointestinal tolerability profile."	0
"All of the 15 @Chemical$-hypersensitive patients (aged between 6.6 and 17.4 years), except for three, experienced an unequivocal @Disease$ of the lips as a positive reaction in SBPCPT."	0
Comparison of bleeding complications with omega-3 fatty acids + aspirin + clopidogrel--versus--aspirin + @Chemical$ in patients with @Disease$.	0
"Among patients with H. pylori infection and a history of ulcer @Disease$ who continue to use low-dose @Chemical$, 1 week of eradication therapy prevents recurrent ulcer bleeding."	0
"BACKGROUND: We have reported that in patients with chronic idiopathic @Disease$ (@Chemical$) who reacted adversely to aspirin, the frequency of the (-444)C allele of the leukotriene C(4) synthase gene (LTC4S) was higher than in patients who tolerated aspirin well."	0
Variance analysis of the correlation between HP @Disease$ and LDA by regional Lanza scores identified both HP infection and @Chemical$ use as factors that significantly influence the antral Lanza score.	0
"A 2-day, single-blind placebo-controlled APT was used to detect @Chemical$ @Disease$."	1
It is common practice to replace aspirin with clopidogrel in patients with @Disease$ intolerance to @Chemical$.	1
@Chemical$ and other inhibitors of cyclo-oxygenase precipitate acute @Disease$ in about 10% of adult asthmatics.	1
"DATA SYNTHESIS: Aspirin-sensitive asthmatics experience a wide variety of symptoms, ranging from rhinitis to life-threatening @Disease$, after the ingestion of @Chemical$ or nonsteroidal antiinflammatory drugs (NSAIDs)."	0
CONCLUSIONS: Nearly a quarter of children and adolescents with CSU were @Disease$ to @Chemical$.	1
"Identical questionnaires were sent to 210 neurosurgical facilities and proffered five main questions: (1) the adherence of any policy of stopping aspirin pre-operatively, (2) the personal risk assessment for patients with spinal surgery under low-dose @Chemical$ medication, (3) the preferred method of treatment for excessive bleeding in this context, (4) personal knowledge of @Disease$ complications in this group of patients, and (5) the characteristics of the neurosurgical units concerned."	0
"Inducible @Chemical$ synthase (iNOS) expression is upregulated in @Disease$ epithelium, implying a role for nitric oxide (NO) in its formation."	0
CONCLUSION: These data suggest that @Chemical$ may be of special concern for @Disease$ patients with poor glucose control and obesity.	0
The use of analgesic anti-inflammatory agents in patients with @Disease$ is clinically challenging because of the prevalence (10-20%) of @Chemical$ hypersensitivity.	0
CONCLUSIONS AND CLINICAL IMPORTANCE: Administration of the combination of zinc-L-carnosine and vitamin E at 1X or 2X dosing did not attenuate @Chemical$-induced @Disease$.	1
CONCLUSIONS: The odds of @Disease$ in patients taking low dose @Chemical$ is about twice as great in those infected with H. pylori.	0
"The patients with @Chemical$-sensitive @Disease$ require often prolonged oral, inhaled and nasal corticotherapy."	0
[One @Disease$ out of five not related to Helicobacter pylori or NSAID/@Chemical$].	0
BACKGROUND: Acquired platelet dysfunction due to @Chemical$ ingestion may increase @Disease$ during surgery.	0
"The independent risk factors for death were regular @Chemical$-use at the onset of ICH (relative risks [RR], 2.5; 95% CI, 1.3 to 4.6; P=0.004), warfarin-use at the onset of ICH (RR, 3.2; 95% CI, 1.6 to 6.1; P=0.001), and @Disease$ score higher than 2 on admission (RR, 13.8; 95% CI, 6.0 to 31.4; P&lt;0.001)."	0
"DATA SOURCES: Articles evaluating aspirin for primary prevention of CVD were gathered using a MEDLINE search with the keywords aspirin review, aspirin peripheral artery disease, @Chemical$ stroke, aspirin coronary artery disease, aspirin @Disease$, aspirin primary prophylaxis, and aspirin elderly."	0
The rate of complications related to @Disease$ was higher in the @Chemical$ group than in the control group.	0
"AIMS: Because of the widespread use of @Chemical$ for prevention of @Disease$, side-effects associated with thromboprophylactic doses are of interest."	0
"We sought to assess the performance of existing bleeding risk scores, such as the Hypertension, Abnormal Renal/Liver Function, @Disease$, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly (HAS-BLED) score or the Outpatient Bleeding Risk Index (OBRI), in patients with heart failure with reduced ejection fraction (HFrEF) in sinus rhythm (SR) treated with warfarin or @Chemical$."	0
"CONCLUSIONS: In addition to reducing the risk of @Disease$, statistically significant benefits with prophylactic @Chemical$ use on both pain and nonpain symptoms were evident at 4 weeks and sustained through 24 weeks."	0
"The aetiology of @Disease$ is complex and not fully understood, but most evidence points towards an abnormality of @Chemical$ (AA) metabolism."	0
The good clinical outcomes of @Disease$ in our study are supported by overall changes observed in the arachidonic acid metabolites (decreased @Chemical$ over a constant LTC4/PGE2).	0
Perfusion of the stomach with acidified ASA or ASA under @Chemical$-stimulated acid secretion caused minimal @Disease$ in the stomach with few lesions.	0
NSAIDs-including @Chemical$ (ASA)-that inhibit cyclooxygenase (COX)-1 induce nonallergic hypersensitivity reactions consisting of attacks of rhinitis and @Disease$.	0
"CONCLUSION: Pre-operative @Chemical$ increases post-operative @Disease$, but this may be avoided by the use of aspirin doses &lt;325 mg/day."	1
"Persistent eosinophilic rhinosinusitis precedes development of @Disease$, @Chemical$ hypersensitivity, and asthma."	0
"Significantly more dog-days of @Disease$ occurred in the prednisone and @Chemical$ group during treatment, compared with baseline."	0
INTRODUCTION: The Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) study showed that patients with unstable angina pectoris (UAP) and non-ST-elevation @Disease$ (NSTEMI) benefit from combined therapy with @Chemical$ (ASA) and clopidogrel.	0
"The inherited defect of cyclooxygenase-1, responsible for platelet @Chemical$ synthesis, did not protect the patient against coronary and extra-cardiac @Disease$."	0
Patients being treated for @Disease$ (N=48) who took @Chemical$ within the past 24 h constituted the study sample.	0
"OBJECTIVES/HYPOTHESIS: @Chemical$-sensitivity, @Disease$, and nasal polyposis (NP) comprise the clinical entity of Samter's triad."	0
"Similar limited @Disease$ and protective actions were observed with a new class of hydrogen sulfide (@Chemical$)-releasing NSAIDs, such as H2S-releasing naproxen (ATB-346)."	0
The patient was successfully managed with @Chemical$ therapy during the 16 months follow-up without recurrent thrombotic or @Disease$ events.	0
"OBJECTIVE: We sought to determine blood and urinary levels of 9alpha,11beta-PGF(2), a major stable PGD(2) metabolite in 2 well-defined phenotypes of asthma, aspirin-induced asthma (AIA) and @Chemical$-tolerant @Disease$ (ATA), and in healthy control subjects and to study the effects of aspirin on PGD(2) release."	0
"The prevalence of self-reported confirmed inhalant @Disease$ was 13.1, 20.3, 31.0 and 33.3% respectively; house dust mite allergy was significantly higher in @Chemical$wNPs (16%) compared to CRSsNPs (9%, p &lt; 0.001)."	0
Low-molecular-weight heparin and @Chemical$ use in relation to pregnancy outcome in women with systemic lupus erythematosus and @Disease$: A cohort study.	0
Low-dose @Chemical$ use was also significantly reduced the risk of @Disease$ in the elderly.	0
CONCLUSIONS: Fewer endoscopic @Disease$s were observed in patients treated with @Chemical$/aspirin vs. naproxen/aspirin.	0
No difference was observed in methacholine @Disease$(20)FEV(1) and baseline @Chemical$ between ATA and AIA patients.	0
The use of aspirin and @Chemical$ in combination has become part of the standard clinical care of patients with @Disease$.	0
"We evaluated the effects of @Chemical$ on genetic/epigenetic alterations in precancerous conditions, i.e., atrophic mucosa (AM) and intestinal metaplasia (IM), in patients with chronic @Disease$ who had taken aspirin for more than 3 years."	0
@Chemical$ desensitization and subsequent treatment has been shown to be highly effective for @Disease$.	0
Does continued @Chemical$ mono-therapy lead to a higher @Disease$ risk after total knee arthroplasty?	0
Low-dose @Chemical$ and @Disease$.	0
Method: Eighty-six patients with @Disease$ and asthma who were treated in the outpatient clinic during March 2015 to January 2018 were divided into asthma group(52 cases) and @Chemical$ asthma group(34 cases) according to asthma and aspirin asthma.	0
@Disease$: Effect of perioperative aspirin and @Chemical$ on AKI.	0
"Aspirin (acetylsalicylic acid)-induced @Disease$ (AIA) consists of the clinical triad of asthma, chronic rhinosinusitis with nasal polyps, and precipitation of asthma and rhinitis attacks in response to @Chemical$ and other NSAIDs."	0
"The triad of bronchial asthma, nasal polyposis, and intolerance to aspirin and aspirin-like chemicals are designated @Chemical$-induced @Disease$ (AIA) or Samter's syndrome."	1
"BACKGROUND: In patients with @Chemical$-exacerbated @Disease$ (AERD), pretreatment with asthma controller medications (leukotriene modifiers, inhaled or systemic corticosteroids, and salmeterol) partially modifies the severity of aspirin-induced asthmatic reactions."	0
The upper respiratory reaction is mediated by both @Chemical$ and LTs but the @Disease$ is mediated by LTs.	0
"The @Disease$ of salicylates such as @Chemical$ in this population is well known and documented, specifically in the form of Reye syndrome."	0
"Our study also highlights that the use of @Chemical$ for primary prevention of cancer was found to cause higher rates of bleeding (any bleeding, major bleeding, and GI bleeding) compared to placebo or no aspirin at the longest follow-up period with no significant benefit in @Disease$ primary prevention."	0
"Under double-blind conditions, 80 aspirin-intolerant patients with @Disease$ were randomized to receive 4 wk oral treatment of either 10 mg of @Chemical$ or placebo once daily at bedtime."	0
"Patients receiving treatment for &gt;5 years showed elevated risk of CMBs in the aspirin (0.17; 0.09-0.36; P &lt; .001) and clopidogrel (0.15, 0.07-0.33; P &lt; .001) groups as well as higher odds of MB in the aspirin (0.34, 0.16-0.71; P = .004) and clopidogrel (0.37, 0.17-0.80; P = .010) groups.The WMHs and MB were associated with CMBs in patients taking @Chemical$ or clopidogrel for &gt;1 year, and long-term use increased the risks of CMB and @Disease$."	0
"RESULTS: @Chemical$, 25 mg, was proven to be well tolerated in all 40 patients with ASA-induced and NSAID-induced @Disease$."	0
"BACKGROUND AND RATIONALE: Dual antiplatelet therapy (@Chemical$) with aspirin and a P2Y12 inhibitor reduces @Disease$ events in patients undergoing percutaneous coronary intervention (PCI), but these benefits come at the expense of increased risk of bleeding when compared with aspirin monotherapy."	0
CONCLUSIONS: Our study shows that a significant proportion of stable @Disease$ patients are treated with @Chemical$ as SAPT in modern practice.	0
"The H2RAs prevented less effectively @Chemical$-related @Disease$ (OR= 2.102, 95% CI: 1.008-4.385, p&lt;0.048) and ulcer formation (OR= 2.257, 95% CI: 1.277-3.989, p&lt;0.005) than PPIs."	1
METHODS: @Chemical$ induced @Disease$(AA-Ag) was measured in 537 patients aged 80 or older treated with aspirin (100 mg/d).	1
Chronic @Chemical$ therapy is widespread in older individuals and decreases the risk of @Disease$ and stroke.	0
Various @Disease$ reactions have been reported with @Chemical$ and nonsteroidal anti-inflammatory drugs.	0
"BACKGROUND: In patients with coronary or @Disease$, the combination of rivaroxaban 2.5 mg twice daily and @Chemical$ 100 mg once daily compared with aspirin 100 mg once daily reduced major adverse cardiovascular events and mortality and increased bleeding."	0
"CONCLUSIONS: In patients who had ulcer complications related to the long-term use of low-dose @Chemical$, treatment with lansoprazole in addition to the eradication of H. pylori infection significantly reduced the rate of recurrence of @Disease$ complications."	0
"BACKGROUND: @Chemical$-exacerbated respiratory disease (AERD) is a clinical syndrome characterized by chronic rhinitis, nasal polyps, asthma, and precipitation of @Disease$ and rhinitis attacks after ingestion of aspirin (ASA) and most nonsteroidal anti-inflammatory drugs (NSAIDs)."	0
"BACKGROUND: Many patients requiring permanent pacemaker (PPM) or implantable cardiac defibrillator (ICD) placement are anticoagulated with warfarin, aspirin (ASA), and @Chemical$ for a number of @Disease$ risk indications."	0
BACKGROUND AND OBJECTIVE: Non-steroidal anti-inflammatory drugs (NSAIDs) and @Chemical$ have antiaggregant properties and patients with @Disease$ commonly use these drugs.	0
Low or minimal doses of @Chemical$ are widely used for prevention of @Disease$.	0
"BACKGROUND: The aim of this study was to detect cysteinyl leukotriene (Cys-LT) receptors in @Chemical$-sensitive @Disease$ patients, and compare them with nasal polyposis and chronic rhinosinusitis patients without aspirin sensitivity."	0
CONCLUSION: Our study appears to demonstrate that triflusal is a suitable alternative to @Chemical$ as antiplatelet agent to prevent @Disease$.	0
"Patients being treated with @Chemical$, even at 81 mg/day for cardioprotection, should be assessed for factors that increase the risk for @Disease$ injury."	0
PURPOSE: To evaluate the risk for serious @Disease$ with regular @Chemical$ use in cardiovascular disease (CVD) primary prevention.	0
"BACKGROUND: In patients with @Chemical$-exacerbated respiratory disease (@Disease$), pretreatment with asthma controller medications (leukotriene modifiers, inhaled or systemic corticosteroids, and salmeterol) partially modifies the severity of aspirin-induced asthmatic reactions."	0
"Of the remaining 493 patients, 11 patients (2.2%) presented with post-polypectomy @Disease$ within 30 days of the investigation of which 8 were on @Chemical$."	0
The proportions of patients with an MLS of &gt;=1 and erosive esophagitis were significantly lower in the rabeprazole group than in the @Chemical$ group at 12 weeks (@Disease$ 33.5 vs.	0
"In some patients with chronic idiopathic @Disease$ (CIU), @Chemical$ and other nonsteroidal anti-inflammatory drugs (NSAIDs) that inhibit cyclooxygenase 1 (COX-1) precipitate wheals and swelling."	0
"It has been postulated that mediators other than histamine, such as kinins, prostaglandin and leukotrienes, may be responsible for some of the symptoms in @Disease$ which are not controlled by anti@Chemical$s."	0
[Secondary and primary prophylaxis of @Disease$ associated with nonsteroidal antiinflammatory drugs or low-dose-@Chemical$: a review based on four clinical scenarios].	1
CONCLUSIONS: High-dose rebamipide is effective for the treatment of @Chemical$-induced moderate-to-severe @Disease$.	0
"The values of @Disease$s of MPs in descending order were as follows: gefarnate, hydrotalcite &gt; teprenone &gt; sucralfate oral suspension &gt; L-glutamine and @Chemical$ granules &gt; rebamipide &gt; sucralfate chewable tablets."	0
Comparison of proton pump inhibitor and histamine-2 receptor antagonist in the prevention of recurrent peptic @Disease$/erosions in long-term low-dose @Chemical$ users: a retrospective cohort study.	0
Advances in @Chemical$-exacerbated respiratory disease (@Disease$).	0
"METHODS: Thirty genome-wide expression microarrays were used to compare nasal polyp tissue from patients with chronic rhinosinusitis alone (@Disease$, n = 10) or chronic rhinosinusitis and a history of @Chemical$-sensitive asthma (ASA, n = 10) to normal sinonasal mucosa from patients who underwent surgery for non-sinus related conditions (controls, n = 10)."	0
A randomized trial of @Chemical$ on the risk of embolic events in patients with @Disease$.	0
The administration of a single dose of @Chemical$ (30 mg/kg) immediately before cardiopulmonary bypass significantly reduced @Disease$ and inhibited fibrinolysis in these patients.	0
"Compared with @Chemical$ alone, the combination increased modified International Society on Thrombosis and Hemostasis major bleeding (288 of 9,152 [3.1%] vs. 170 of 9,126 [1.9%]), (HR: 1.70; 95% CI: 1.40 to 2.05; p &lt; 0.001), International Society on Thrombosis and Hemostasis major @Disease$ (206 of 9,152 [2.3%] vs. 116 of 9,126 [1.3%]), (HR: 1.78; 95% CI: 1.41 to 2.23; p &lt; 0.0001), and minor bleeding (838 of 9,152 [9.2%] vs. 503 of 9,126 [5.5%]), (HR: 1.70; 95% CI 1.52 to 1.90; p &lt; 0.0001); the combination also increased the need for any red cell transfusion (87 of 9,152 [1.0%] vs. 44 of 9,126 [0.5%]), (HR: 1.97; 95% CI 1.37 to 2.83, p = 0.0002)."	0
"If bleeding risk is prohibitive, both @Chemical$ and P2Y12 inhibitor therapy should be interrupted and bridging therapy may be considered in patients with high @Disease$ risk."	0
Post-PCI fatal bleeding in @Chemical$ and clopidogrel @Disease$ responder: shifting from antiplatelet resistance to bleeding risk assessment?	0
"Aspirin results in prolonged inhibition of @Disease$, and @Chemical$ can result in liver toxicity at normal dose and liver failure at higher dose."	0
Nasal polyp tissues were obtained from 29 patients [including nine with aspirin (@Chemical$)-hypersensitivity and 12 with bronchial @Disease$] undergoing polypectomy for nasal obstruction.	0
@Disease$ to aspirin: common @Chemical$ alterations in urticaria and asthma.	0
BACKGROUND &amp; AIMS: @Chemical$ is the first line therapy for cardiovascular and @Disease$ and is widely used.	0
@Chemical$ systemic production in patients with asthma with and without aspirin @Disease$.	0
"Results from this analysis showed that the combination of Cardiovascular (CV) death/Myocardial Infarction (MI) or @Disease$ was not significantly different between a low and high dose of @Chemical$ with OR: 1.08, 95 % CI: 0.98-1.18; P = 0.11."	0
"BACKGROUND: We examined whether a decreased activity of nuclear factor(NF)-kappaB), a transcriptional regulator of cyclooxygenase-2 (COX-2), could account for down-regulation of COX-2 in nasal @Disease$ of @Chemical$-sensitive asthmatics."	0
"In fact, patients with blood dyscrasias have to be considered high-risk patients due to their increased propensity for uncontrolled bleeding.The aim of this article was to present and discuss the management of a case of double consecutive retrobulbar @Disease$ in a high-risk patient in treatment with aspirin and @Chemical$."	0
A 71-year-old Japanese man who had been taking @Chemical$ tablets (81 mg) for a year presented with @Disease$ in the left flank region.	0
"The risk of bleeding was also increased among patients who had non-end-stage @Disease$ or required renal-replacement therapy and was further increased with warfarin, @Chemical$, or both."	0
"The ulcerogenic and @Disease$ responses to @Chemical$ under these conditions were markedly aggravated by pretreatment with clopidogrel, which by itself provoked neither bleeding nor damage."	0
"Urinary eicosanoids, plasma tryptase and cytokine levels, platelet-leukocyte aggregates, and granulocyte transcripts were assessed.Measurements and Main Results: Eight weeks of high-dose aspirin decreased nasal symptoms and urinary prostaglandin E metabolite (P &lt; 0.05) and increased urinary @Chemical$ (P &lt; 0.01) levels in subjects with aspirin-exacerbated respiratory disease, but not in those with aspirin-tolerant @Disease$."	0
@Chemical$ use in patients with @Disease$ and peptic ulcer bleeding.	0
"Although the pathogenic mechanisms of this condition are still unknown, AERD may be due, at least in part, to an imbalance in @Chemical$ metabolism (increased production of cysteinyl leukotrienes (CysLTs) and reduced biosynthesis of prostaglandin (PG) E2), possibly increasing and perpetuating the process of @Disease$."	0
@Chemical$-induced asthma is a special clinical syndrome existing in nearly 10 % of adult @Disease$tics.	0
"Type 2 inflammation characterizes aspirin-exacerbated respiratory disease.Objectives: To determine whether high-dose aspirin therapy changes biomarkers of type 2 inflammation in aspirin-exacerbated @Disease$.Methods: Forty-two subjects with aspirin-exacerbated respiratory disease underwent an aspirin desensitization and were placed on high-dose @Chemical$ (1,300 mg daily)."	0
BACKGROUND AND PURPOSE: Apixaban reduces stroke with comparable bleeding risks when compared with aspirin in patients with @Disease$ who are unsuitable for @Chemical$ antagonist therapy.	0
"BACKGROUND AND AIM: Helicobacter pylori (H. pylori) and @Chemical$ are the major causes of gastric injury, and eradication of H. pylori can restore mucosal injury such as @Disease$."	0
We assess the feasibility of performing robotic partial nephrectomy (@Disease$) in patients maintained on aspirin or dual antiplatelet therapy with aspirin and @Chemical$.	0
"Patients undergoing TKA treated with LMWH had higher rates of systemic @Disease$ or a complication secondary to @Chemical$ administration (2.8% for LMWH versus 0% for mobile compression; p = 0.022; OR, 12.8)."	0
"After 3 months, the patient is free from adverse events.@Disease$ is commonly considered a contraindication to @Chemical$ intake; however, this case shows that aspirin at low, antiplatelet dosage is well tolerated and should not be denied to patients with ischaemic heart disease and complex coronary anatomy."	0
Spinal epidural @Disease$ after spinal cord stimulator trial lead placement in a patient taking @Chemical$.	0
The aim of the present retrospective study was to describe our experience in selected patients with Reye's syndrome associated to the @Chemical$ ingestion and to underline the influence of @Disease$ on Reye's encephalopathy.	0
"CONCLUSION: @Disease$ were significantly milder in the LDA group than in the non-aspirin NSAID group, though reddened lesions were more frequent in the @Chemical$ group."	0
"We hypothesized that platelet transfusion would improve @Chemical$-induced, but not @Disease$-induced, platelet dysfunction."	0
The authors measured the presence and extent of asymptomatic microbleeds on gradient-recalled-echo MRI in 21 aspirin users who developed @Disease$ and 21 @Chemical$ users without history of intracerebral hemorrhage.	0
[Exacerbation of @Chemical$-induced asthma associated with @Disease$].	0
"For patients treated with dual anti-platelet therapy of LDA and clopidogrel, PPIs were able to prevent the @Chemical$-associated GI @Disease$ (OR = 0.36; 95%CI: 0.15-0.87) without increasing the risk of major adverse cardiovascular events (MACE) (OR = 1.00; 95%CI: 0.76-1.31)."	0
Rapid desensitisation of patients with @Chemical$ @Disease$ who undergo coronary angioplasty.	1
"In the 1-month @Disease$ analysis, proportions of patients (95% CI) in the low- and high-dose @Chemical$ categories experiencing major bleeding were 2.1% (1.5-2.6) and 1.9% (0.0-3.8); proportions with myocardial infarction were 2.1% (1.3-2.8) and 1.8% (0.9-2.6); and proportions of all-cause death were 2.8% (2.2-3.4) and 2.4% (1.3-3.5), respectively."	0
Analysis of the mechanism for the development of @Disease$ and the application for its treatment: @Chemical$ modulation of IgE-dependent mast cell activation: role of aspirin-induced exacerbation of immediate allergy.	0
CONCLUSIONS: Our data suggest that continued use of @Chemical$ increased the risk of @Disease$ after ESD for colorectal tumors compared with nonuse of anticoagulant/antiplatelets.	1
This analysis explores patterns of bleeding and defines @Disease$ risks based on stroke risk with @Chemical$ and aspirin.	0
CONCLUSION: We found no evidence of an overall increase in the risk of @Disease$ that could be associated with @Chemical$.	0
"In this study, we compared the roles of CysLT receptor type 1 (CysLTR1) and leukotriene C4 synthase (LTC4S) gene polymorphisms in two major aspirin-related allergic diseases, @Chemical$-intolerant asthma (AIA) and aspirin-induced chronic @Disease$/angioedema (AICU)."	0
"Conclusion Our findings support the safety of antithrombotic therapy with @Chemical$ and/or LMWH during pregnancy in high-risk women with APS, and highlight the need for better treatments to improve pregnancy outcomes in @Disease$."	0
Chronic @Chemical$ intake may cause recurrent @Disease$ and secondary glaucoma even after a microtrauma.	1
A 14C-@Chemical$ breath test was used for the detection of an H. pylori @Disease$.	0
BACKGROUND: @Chemical$ desensitization followed by high-dose aspirin therapy is routinely performed for patients with aspirin-exacerbated @Disease$ (AERD).	0
Most clinicians recognize @Chemical$ as an important treatment for patients with preexisting @Disease$.	0
"METHODS: Using an adult asthma cohort (COREA) from 11 university hospitals in Korea, we analyzed the prevalence of aspirin-intolerant asthma, defined as a positive response to the question: Have you ever experienced @Disease$ and cough after taking an @Chemical$ or any NSAID (cold medicine)?"	0
PATIENTS AND METHODS: Patients with a history of @Chemical$-induced @Disease$ and/or angioedema referred to our department between January 2000 and June 2008 for double-blind placebo-controlled reintroduction at platelet-inhibitory doses for a medical indication were enrolled in this study.	1
The identified genes present possible novel therapeutic targets for nasal polyps associated with chronic @Disease$ and @Chemical$-sensitive asthma.	0
"RESULTS: Compared with the @Disease$ only group, hydrogen peroxide consumption, glutathione S-transferase, @Chemical$ and malondialdehyde were lower in the asthma group."	0
"Aspirin plus dipyridamole has the highest surface under the cumulative ranking curves (@Chemical$) values in terms of mortality, intracranial hemorrhage, and adverse event rate among 7 drug therapies in the treatment of @Disease$."	0
"OBJECTIVE: Previous erosive @Disease$ studies have excluded patients with peptic ulcers or taking @Chemical$, and conflicting results have been reported concerning the influence of."	0
BACKGROUND: Aspirin desensitization followed by maintenance therapy effectively improves symptom control in patients with @Chemical$ exacerbated respiratory disease (@Disease$).	0
"Patients without AMCE-detected gastrointestinal erosions, @Disease$ or bleeding after drug-eluting stent implantation are enrolled and treated with open-label aspirin (100 mg/d) plus @Chemical$ (75 mg/d) for 6 months."	0
"@Chemical$-exacerbated respiratory disease (AERD) is a unique syndrome of airway inflammation that frequently occurs in patients with nasal polyposis, chronic @Disease$, and asthma."	0
"RESULTS: The rate of a @Disease$ event was 3.8%/year with aspirin and 4.5%/year with @Chemical$ (hazard ratio with apixaban, 1.18; 95% CI, 0.92-1.51; P=0.19)."	0
Peripheral blood lymphocyte (PBL) cytokine expression and its relation to aspirin desensitization in @Chemical$-sensitive patients with @Disease$ have not been studied.	0
The genetic mechanism of @Chemical$ intolerant acute @Disease$ (AIAU) is unknown.	0
CONCLUSIONS: Preoperative use of @Chemical$ plus clopidogrel is associated with an increased risk of @Disease$ after coronary artery bypass surgery.	1
UNLABELLED: Prior meta-analysis and observational studies have suggested that the @Disease$ risks associated with anticoagulation using vitamin K antagonists (VKA) or aspirin (@Chemical$) are similar.	1
Genetic variability of @Chemical$ receptor subtype EP4 gene in aspirin-intolerant chronic @Disease$.	0
"CASE REPORT: A 58-year-old Caucasian male with a history of @Disease$ and hypercholesterolemia, under treatment with acetyl-salicylate for 6 years and @Chemical$ for 2 months, presented to the Emergency Department of our hospital with epigastric pain and vomiting of 24-hour duration."	0
Adjusted HRs for @Chemical$ versus the combination of acetylsalicylic acid and dipyridamole were 1.02 (95% confidence interval [CI]: 0.89-1.17) for ischemic stroke and 1.06 (95% CI: 0.83-1.35) for @Disease$.	0
"Clinical and demographic characteristics of the 3 groups were generally similar, except that patients with alarming @Disease$ were less likely to be Caucasian; only 6 patients (6.7%) were taking @Chemical$."	0
"Strong data also support that chronic @Chemical$ users with a recent ulcer complication should be tested for H pylori infection and, if positive, receive H pylori eradication therapy after @Disease$ healing, while they appear to benefit from additional long-term therapy with a proton pump inhibitor (PPI)."	0
A 73-year old female developed severe @Disease$ following treatment with @Chemical$.	1
"In this distinct clinical syndrome, aspirin and most other non@Chemical$al anti-inflammatory drugs that inhibit cyclooxygenase-1 precipitate @Disease$ and asthma attacks."	0
"@Disease$ events occurred in 6 patients on @Chemical$ 81 mg+dipyridamole (26%; 0.42 events per patient year; mean INR at event, 2.2), 4 patients on ASA 81 mg (22%; 0.38 events per patient year; mean INR at event, 2.0), and in 38 patients on ASA 325 mg (54%; 1.4 events per patient year; mean INR at event, 2.2); P = 0.004."	0
"Results showed fewer upper GI symptoms, decreased size of @Disease$, and improved heartburn symptoms in subjects receiving PA32540 compared to @Chemical$."	0
RECENT FINDINGS: A recent study on HLA genotypes has suggested that the HLA alleles DRB11302 and DQB10609 may be genetic markers for @Chemical$-induced urticaria/@Disease$.	0
"Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with @Disease$: a double-blind comparison to clopidogrel with @Chemical$."	0
In this study we investigated the temporal association of gastric secretory parameters (acid and mucus) with @Chemical$-induced @Disease$.	1
"In a rather small study of 317 subjects with left @Disease$ (ejection fraction &lt;35%) who were followed up for a relatively longer period of time (5.7 years), the favorable long-term prognosis of patients receiving @Chemical$ was independent of receipt of an ACE inhibitor."	0
"In a second, double-blind, placebo-controlled, cross-over study, 6 new patients with functional @Disease$ and 6 controls were started with either placebo or @Chemical$ for 5 days."	0
"Whereas aspirin administration is known to decrease the risk of vascular ischemic problems, @Chemical$ withdrawal may temporarily increase the risk of @Disease$ events."	0
"Objectives: To investigate the association of @Chemical$ use with risk of all-cause, any @Disease$, gastrointestinal (GI) cancer, and colorectal cancer (CRC) mortality among older adults and to perform an exploratory analysis of the association of aspirin use with mortality stratified by BMI."	0
"In urticaria or angioedema induced by multiple NSAIDs, patients without underlying disease develop @Disease$ or angioedema 30-90 minutes after ingestion of COX-1-inhibiting NSAIDs including @Chemical$."	0
METHODS: Adults with CAD under @Chemical$ therapy (100 mg once daily) presenting to the emergency department with upper gastrointestinal hemorrhage were retrospectively recruited and divided into group A (@Disease$) and group B (non-ischemia).	0
AIM: The aim of this study was to examine the genotypes of RAS genes related to the risk of peptic @Disease$ and ulcer bleeding among patients taking low dose @Chemical$.	0
In the present study was investigated the effects of aspirin on upper gastrointestinal @Disease$ and potent risk factor for peptic ulcer associated with @Chemical$ in a case-control study.	0
"METHODS: Ten patients with rhinosinusitis, @Disease$, and asthma had a history of asthma attacks after ingesting @Chemical$ and nonsteroidal anti-inflammatory drugs."	0
Age when asthma was developed (A+@Chemical$ groups)--45.5; the duration of @Disease$ was 11 +/- 9 years. 58% of patients had polypectomy/ethmoidectomy (PP--45%; A--60%; ASA--80%).	0
CONCLUSIONS: Aspirin desensitization protocols represent a safe and effective option for the management of patients with a cardiovascular indication to @Chemical$ and history of @Disease$ to ASA.	0
"This study was designed to investigate the degree of @Disease$, bleeding time (BT) and fluctuations in the serum levels of prostaglandin E2 (PGE2) and @Chemical$ (TXA2) after oral administration of ASA (200 mg/kg) and IBU (50 mg/kg) either alone or in combination in rats in vivo."	0
"CONCLUSIONS: In patients with @Disease$, all combinations of @Chemical$, aspirin, and clopidogrel are associated with increased risk of nonfatal and fatal bleeding."	0
"Regarding the pathogenesis of AI, modifications of eicosanoid metabolism are supposed to underlie AI, including aspirin-induced @Disease$ and @Chemical$-induced urticaria."	0
"OBJECTIVE: We sought to assess a vast platform of eicosanoids in different @Disease$ phenotypes, including @Chemical$-intolerant asthma, by means of a recently developed analytic approach based on mass spectrometry."	0
"Aspirin (@Chemical$) is a well-known nonsteroidal anti-inflammatory drug that can potentiate some acute @Disease$ and causes adverse immunological reactions collectively referred to as aspirin intolerance, a disorder that induces urticaria, asthma, and anaphylaxis in response to oral administration of the drug."	0
"The most common cause is conditioned to a genetic predisposition towards atopy (atopic asthma), although other factors can also give rise to @Disease$, such as over-exposure to environmental irritants (occupational asthma), altered arachidonic acid metabolism (@Chemical$-induced asthma) and also exercise - in which different thermal and osmotic mechanisms are known to intervene."	0
"Age, male gender, Helicobacter pylori (H. pylori)infection, diabetes, chronic kidney disease (CKD), @Disease$, history of uncomplicated peptic ulcer disease (PUD), and use of NSAIDs, COX-2 inhibitors, steroids, and thienopyridines were independent risk factors for UGIB among @Chemical$ users."	0
BACKGROUND/AIMS: The aim of this study was to clarify the prevalence and various clinical factors of @Disease$ (UGIB) associated with low-dose aspirin (@Chemical$) treatment.	0
The CYP2C9 359Leu (CYP2C9*3) loss-of-function allele could be a risk factor for @Disease$ (AUGIB) related to the use of NSAIDs other than @Chemical$.	0
AIM/OBJECTIVE: To compare effect of @Disease$ (2.3% @Chemical$) sea water and isotonic 0.9% NaCl on symptoms and endoscopic findings in those patients in the period of 1 month after endoscopic sinus surgery (ESS).	0
"The aim of this study is to report the sinonasal outcomes of endoscopic sinus surgery (ESS) in treating NP in asthmatic patients, comparing @Chemical$-induced asthmatic (AIA) patients with aspirin-tolerant @Disease$tics (ATA)."	0
"BACKGROUND: @Chemical$-exacerbated @Disease$ is characterized by asthma, chronic rhinosinusitis, nasal polyposis, and sensitivity to aspirin and other nonsteroidal anti-inflammatory drugs."	1
"However, as discontinuation of aspirin, unlike NSAIDs, may precipitate cardiovascular and cerebrovascular events, treatment of aspirin-associated @Disease$s should re-start @Chemical$ as soon as possible, using proton pump inhibitor (PPI)."	0
"On multivariate analysis controlling for CCI and RENAL nephrometry score, @Chemical$ administration was not significantly associated with @Disease$ complications."	0
Oral aspirin challenge (@Chemical$) reveals aspirin-exacerbated respiratory disease (AERD) in approximately 50% of unselected patients with chronic rhinosinusitis with @Disease$ (CRSwNP).	0
"@Disease$ was 146.58 and 167.97 ml in the @Chemical$ and control groups, respectively, also without statistical difference (p = 0.76)."	0
The study was designed to determine the effect of aspirin desensitization on T-lymphocyte cytokine expression and on plasma @Chemical$ levels in @Disease$.	0
"We retrospectively reviewed the medical records for bleeding complications in 182 patients, most with @Disease$ (mean age 61 +/- 11 years, 82% men) and being treated with high-dose fish oil (mean dose 3 +/- 1.25 g), aspirin (mean dose 161 +/- 115 mg), and @Chemical$ (mean dose 75 mg), and in 182 age- and gender-matched controls treated with aspirin and clopidogrel alone."	0
Obesity and @Chemical$ intolerance are risk factors for difficult-to-treat @Disease$ in Japanese non-atopic women.	1
There has been particular attention looking at the role of cyclooxygenase enzymes and 2 and their role in @Chemical$ exacerbated @Disease$.	0
"OBJECTIVE: The purpose of this study is to demonstrate that @Chemical$, a specific inhibitor of COX-2, does not cause @Disease$tic attacks in patients with aspirin and/or other nonsteroidal anti-inflammatory drug-induced asthma."	0
"Estimates of absolute rates of harm from @Chemical$ use, per 100,000 patient-years of follow-up, were 99-178 for non-trivial @Disease$, 46-49 for major bleeds, 68-117 for GI bleeds and 8-10 for haemorrhagic stroke."	0
CONCLUSIONS: Low-dose @Chemical$ alone did not significantly increase @Disease$ incidence.	0
Management of patients with nonaspirin-exacerbated @Disease$ @Chemical$ hypersensitivity reactions.	0
Does withholding @Chemical$ for one week reduce the risk of post-@Disease$?	0
@Disease$ reactions to @Chemical$ and non-steroidal anti-inflammatory drugs constitute a major medical concern worldwide.	1
@Chemical$-exacerbated @Disease$ (AERD) is a syndrome of severe asthma and rhinosinusitis with nasal polyposis with exacerbations of baseline eosinophil-driven and mast cell-driven inflammation after nonsteroidal antiinflammatory drug ingestion.	1
"METHODS: We screened a Korean asthma cohort (581 @Disease$tics including 81 @Chemical$-intolerant asthmatics and 231 aspirin-tolerant asthmatics, and 181 normal controls) for four single nucleotide polymorphisms (SNPs; -262 A&gt;T and -115 T&gt;C in the 5'-flanking region and +5467 T&gt;C [Pro450Pro] and+11860 A&gt;G [Thr776Thr] in the coding region) and one ins/del (+21288 CT) in the ACE gene."	0
Gene-expression signatures of nasal @Disease$ associated with chronic rhinosinusitis and @Chemical$-sensitive asthma.	0
"@Chemical$ desensitization, followed by daily aspirin administration, can improve both upper and lower @Disease$ in up to 60% of individuals."	0
There was a correlation between the urinary LTE(4) concentration after @Chemical$ challenge and the intensity of @Disease$.	0
"Methods: Serum total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol and triglyceride were tested in a subgroup of 3 044 consecutive patients from @Chemical$ in High-risk patients with Acute @Disease$ (CHANCE) trial."	0
"METHOD: We classified 1,041 gastroduodenal @Disease$ patients into three groups [patients taking LDA (group A), patients taking nonaspirin nonsteroidal anti-inflammatory drug (NSAID) (group N), and patients taking neither aspirin nor non@Chemical$ NSAID (group C)] and 241 bleeding gastroduodenal ulcer patients into three corresponding groups (groups a, n, and c)."	0
Factors associated with @Disease$ control in patients with @Chemical$-exacerbated respiratory disease.	0
CONCLUSION: Compound bismuth and @Chemical$ granules and its herbal components may have significant protective effect on aspirin-induced @Disease$.	0
"In addition, low dose @Chemical$ is employed as an anti-coagulant for those who have suffered or are at high risk of ischemic stroke and @Disease$."	0
"Thus, the lack of evidence of benefit with aspirin in patients with heart failure and coronary disease, along with growing evidence that aspirin is directly harmful in patients with @Disease$ and that @Chemical$ may negate the benefits of angiotensin-converting enzyme inhibitors suggest that, unless there is an opportunity to randomize the patient into a study of antithrombotic strategies, then aspirin should be withdrawn or possibly substituted with an anticoagulant or an antiplatelet agent that does not block cyclooxygenase."	0
BACKGROUND: Current acetylsalicylic acid (@Chemical$) dosing algorithms for the prevention of secondary @Disease$ in acute coronary syndrome (ACS) patients are inconsistent and lack sufficient data support.	0
[Nonsteroidal Anti-inflammatory Drug and @Chemical$-induced @Disease$].	1
"The presence of a pathologic reaction of thrombocytes to exogenous melatonin, manifesting by changes in the 1st stage of aggregation, suggests the presence of pathology in thrombocyte membrane-receptor complex and the @Chemical$ homeostasis of the cell, which determines constant activation and the participation of thrombocytes in the development of @Disease$."	0
BACKGROUND: Little is known about the course of @Chemical$-induced @Disease$.	1
Anaesthesia in @Chemical$-induced @Disease$.	1
"RESULTS: The rate of a @Disease$ event was 3.8%/year with aspirin and 4.5%/year with apixaban (hazard ratio with @Chemical$, 1.18; 95% CI, 0.92-1.51; P=0.19)."	0
"Recent evidence showed that among patients with a history of ASA-associated @Disease$ bleeding, the long-term incidence of recurrent bleeding with @Chemical$ use is low after eradication of H. pylori alone."	0
"OBJECTIVES: To study the safety of etoricoxib, a specific cyclooxygenase-2 inhibitor, and to determine whether it cross-reacts with asthma in patients with @Chemical$-exacerbated @Disease$ (AERD)."	0
Three (4%) patients stopped @Chemical$ due to @Disease$.	0
Bleeding during treatment with aspirin versus apixaban in patients with @Disease$ unsuitable for warfarin: the apixaban versus @Chemical$ to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment (AVERROES) trial.	0
H pylori eradication is recommended for patients requiring long-term low-dose @Chemical$ therapy who have a prior history of peptic @Disease$ or GI bleeding.	0
"OBJECTIVES/HYPOTHESIS: To demonstrate that quality-of-life outcomes after endoscopic sinus surgery are not compromised in patients with Samter's triad (asthma, nasal polyps, @Chemical$ sensitivity) when compared to patients with eosinophilic chronic rhinosinusitis with @Disease$ (eCRSwP) who are not aspirin sensitive."	0
Study of Clinical and Genetic Risk Factors for @Chemical$-induced @Disease$.	1
"Five questions out of them were related to the clinical behavior, and three were the treatment of peptic @Disease$s in patients taking low-dose @Chemical$."	0
"OBJECTIVE: The objective of this study was to determine if @Chemical$ was associated with @Disease$ and to determine whether it was acetylsalicylic acid, dipyridamole or the combination that led to decline in renal function."	1
@Chemical$ could play a role in the development of a reliable and consistent model for the induction of @Disease$ under experimental settings.	0
These include pill oesophagitis from bisphosphonates and ischaemic @Disease$ relating to @Chemical$ antagonists.	0
This study evaluated the risk of ischemic stroke (IS) and @Disease$ after low-dose @Chemical$ discontinuation in patients with cardiovascular disease or cerebrovascular disease.	0
CONCLUSIONS: There was no statistically significant difference in the frequency or types of @Disease$tic intracranial hemorrhage between patients who had received @Chemical$ prophylaxis and those who had not.	0
The purpose of this capsule endoscopy study was to assess the incidence of @Disease$ in healthy volunteers treated with short-term low-dose @Chemical$.	0
"CONCLUSION: In addition to age, male gender, H. pylori @Disease$, and concomitant use of NSAIDs, COX-2 inhibitors, @Chemical$, and thienopyridines, underlying co-morbidities including diabetes, CKD, cirrhosis, history of PUD are also important risk factors for first-time occurrence of non-variceal UGIB in aspirin users."	0
"RESULTS: Twenty eight (60%) of 47 patients receiving @Chemical$ had @Disease$; stomach alone was the most frequent site (32%), followed by both stomach and duodenum (23%)."	1
"INTERPRETATION: @Chemical$ is effective in the prevention of gastric and duodenal ulcers, and erosive @Disease$ in patients taking low-dose aspirin."	0
It is suggested that the ASA- related increase in the @Chemical$ secretion of the pancreas should be regarded as an indication of aspirin induced @Disease$.	0
"Misoprostol might represent a pharmacological treatment option for lesions causing @Disease$ that is associated with @Chemical$ and NSAIDs, but its use should be balanced against the risk of side-effects."	1
"The association between @Chemical$ use and the presence of DR or VTDR was assessed using multivariable logistic regression models including age, gender, ethnicity, socioeconomic status, HbA1c, systolic blood pressure, anti-@Disease$ medicine, total cholesterol, anti-cholesterol medicine, BMI, current smoking status, diabetes duration, history of cardiovascular disease (CVD) and chronic kidney disease (CKD.)."	0
This mechanism can be of potential interest in @Chemical$-induced @Disease$.	1
During the last decade or so it has also become established that co-administering antagonists of the ADP receptor P2Y(12) with @Chemical$ further reduces the risk of acute @Disease$ events.	0
"At 12 weeks, comparing patients assigned to @Chemical$ with patients assigned to placebo, gastric @Disease$ had developed in seven (3.4%) of 204 patients compared with 30 (15.0%) of 200 patients (odds ratio [OR] 0.20, 95% CI 0.09-0.47; p=0.0002); duodenal ulcers had developed in one (0.5%) patient compared with 17 (8.5%; OR 0.05, 0.01-0.40; p=0.0045); and erosive oesophagitis in nine (4.4%) compared with 38 (19.0%; OR 0.20, 0.09-0.42; p&lt;0.0001), respectively."	0
"Regular @Chemical$ use 10 years prior to retinal examination was associated with late @Disease$ (hazard ratio [HR], 1.63 [95% CI, 1.01-2.63]; P = .05), with estimated incidence of 1.76% (95% CI, 1.17%-2.64%) in regular users and 1.03% (95% CI, 0.70%-1.51%) in nonusers."	1
Of the 23 @Disease$ patients 15 accepted to undergo @Chemical$ desensitization protocol and 14 of them were desensitized successfully.	0
[Prevention and treatment of @Disease$ in patients taking low-dose @Chemical$].	0
The risk of symptomatic @Disease$ for aspirin and non@Chemical$ NSAIDs was elevated throughout treatment.	0
"A nitrate-rich diet, as well as ingestion of reductive @Chemical$-bearing polyphenols, can collaborate in promoting NO generation in gastric juice, and they are protective in rodent models of @Disease$."	0
Bleeding during treatment with aspirin versus apixaban in patients with atrial fibrillation unsuitable for warfarin: the apixaban versus acetylsalicylic acid to prevent @Disease$ in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment (@Chemical$) trial.	0
Renin-angiotensin system associated with risk of @Disease$ induced by low dose @Chemical$: renin angiotensin system genes' polymorphism.	1
"METHOD: We classified 1,041 gastroduodenal ulcer patients into three groups [patients taking LDA (group A), patients taking non@Chemical$ nonsteroidal anti-inflammatory drug (NSAID) (group N), and patients taking neither aspirin nor nonaspirin NSAID (group C)] and 241 bleeding gastroduodenal @Disease$ patients into three corresponding groups (groups a, n, and c)."	0
"We investigated the risks of ischemic stroke and intracranial hemorrhage (ICH) in relation to warfarin at various TTRs in a real-world cohort of Chinese patients with @Disease$ receiving warfarin and compared with those on @Chemical$, aspirin, and no therapy."	0
"OBJECTIVE: To investigate the incidence, clinical characteristics and risk factors of @Disease$ (UGIB) in patients with acute coronary syndrome (ACS) who were administrated with @Chemical$ and clopidogrel dual antiplatelet therapy after percutaneous coronary intervention (PCI)."	0
"Background: @Chemical$-exacerbated @Disease$ (AERD), a syndrome that includes asthma, recurrent nasal polyps, and pathognomonic reactions to aspirin and other nonselective cyclooxygenase inhibitors, is still not fully understood and lacks specific disease-modifying therapeutic options."	1
"Patients without AMCE-detected gastrointestinal erosions, @Disease$ or bleeding after drug-eluting stent implantation are enrolled and treated with open-label @Chemical$ (100 mg/d) plus clopidogrel (75 mg/d) for 6 months."	0
RESULTS: @Disease$ were found in 62 of 101 (61.4%) low-dose aspirin users and three of 30 (10%) non@Chemical$ users.	0
"The role of gastric acid and its relationship to NSAIDs/aspirin in @Disease$, ulcer and ulcer complications continues to be an important concern because of the increasing worldwide use of NSAIDs and @Chemical$."	0
Analysis of basophil activation in patients with @Chemical$-exacerbated @Disease$.	0
The rate of polyp recurrence and morbidity from @Disease$ exacerbations are significant and warrant separating this group diagnostically from @Chemical$-tolerant peers.	0
"In Japan, the preventive strategies upon the prescription of NSAIDs/LDA are expected to spread rapidly because the use of proton pump inhibitors for the prevention of recurrence of NSAID- or @Chemical$-induced @Disease$ and the use of COX-2 for the palliation of acute pain were recently approved under the national health insurance system."	1
BACKGROUND: @Chemical$ desensitization (AD) treatment at doses of up to 1300 mg/day improves outcomes in aspirin-exacerbated @Disease$ (AERD).	0
"CONCLUSION: Warm-needle moxibustion can reduce the gastric lesion (ulcer) caused by @Chemical$ in the rat, which may be closed associated with its effects in up-regulating both serum and @Disease$ activity and down-regulating both serum and gastric mucosal MDA levels."	0
"BACKGROUND: In patients with coronary or peripheral artery disease, the combination of rivaroxaban 2.5 mg twice daily and @Chemical$ 100 mg once daily compared with aspirin 100 mg once daily reduced major adverse cardiovascular events and mortality and increased @Disease$."	0
@Chemical$ as antiplatelet agent in @Disease$: Cons.	1
"The 1-year predicted risks associated with acetylsalicylic acid, the combination of acetylsalicylic acid and @Chemical$, and clopidogrel were 11.1 (95% CI: 10.2-12.2), 7.7 (95% CI: 7.3-8.3), and 8.0 (95% CI: 6.9-8.7) for ischemic stroke, respectively; while, the risks for @Disease$ were 3.4 (95% CI: 2.8-3.9), 2.4 (95% CI: 2.1-2.7), and 2.4 (95% CI: 1.9-2.9), respectively."	0
"RESULTS: @Chemical$ pretreatment failed to block respiratory reactions to provoking doses of aspirin in 5 of 8 patients with @Disease$, and in the other 3 patients did not block higher doses of aspirin."	0
Aspirin-induced @Disease$ (AIA) and aspirin-induced urticaria/ angioedema (AIU) are two major @Chemical$-related allergies.	0
"BACKGROUND: Although a challenge test using non-steroidal anti-inflammatory drugs (NSAIDs) is crucial for diagnosis of @Chemical$-induced @Disease$ (AIA), it also has drawbacks in terms of possible side effects."	1
Extended antiplatelet therapy with clopidogrel alone versus @Chemical$ plus aspirin after completion of 9- to 12-month dual antiplatelet therapy for acute coronary syndrome patients with both high bleeding and @Disease$ risk.	0
Discontinuing @Chemical$ or warfarin optional before @Disease$ surgery.	0
"The most common cause is conditioned to a genetic predisposition towards atopy (atopic asthma), although other factors can also give rise to bronchial inflammation, such as over-exposure to environmental irritants (occupational @Disease$), altered @Chemical$ metabolism (aspirin-induced asthma) and also exercise - in which different thermal and osmotic mechanisms are known to intervene."	0
"@Chemical$ exacerbated @Disease$ (AERD) is a clinical condition characterized by severe decline in forced expiratory volume in one second (FEV1) following the ingestion of non-steroidal anti-inflammatory drugs (NSAIDs), including aspirin."	1
Low-dose @Chemical$ is a prominent cause of @Disease$ in patients who underwent emergency endoscopy.	1
"CONCLUSIONS: In a randomized controlled trial of users of low-dose aspirin at risk for recurrent GI bleeding, a slightly lower proportion of patients receiving a PPI along with aspirin developed recurrent bleeding or @Disease$ than of patients receiving an H2RA with the @Chemical$, although this difference was not statistically significant."	0
"METHODS: The patients enrolled in this study were the elderly requiring a single non-impacted tooth extraction. 300 elderly outpatients used lidocaine local infiltration anesthesia, 200 patients without using @Chemical$ before tooth extraction served as control group I, 100 patients with prolong use of aspirin before tooth extraction as observation group I. 300 elderly outpatients used compound articaine local infiltration anesthesia, 200 patients without using aspirin before tooth extraction served as control group II, 100 patients with prolong use of aspirin before tooth extraction as observation group II.Bleedings at 5, 10, 30 min, 24 h after tooth extraction were observed and the relationship between postoperative @Disease$ and intake of aspirin was analyzed."	0
INTRODUCTION: The @Chemical$ in Unstable @Disease$ to Prevent Recurrent Events (CURE) study showed that patients with unstable angina pectoris (UAP) and non-ST-elevation myocardial infarction (NSTEMI) benefit from combined therapy with acetylsalicylic acid (ASA) and clopidogrel.	0
Safety of COX-2 inhibitors in asthma patients with @Chemical$ @Disease$.	1
"CONCLUSIONS: For patients taking @Chemical$ for primary or secondary prophylaxis, the American Society of Regional Anesthesia and Pain Medicine antiplatelet and anticoagulation guidelines for spine and @Disease$ procedures recommend a shared assessment and risk stratification when deciding to hold the medication for intermediate-risk neuraxial procedures."	0
METHODS: The medical records of patients with @Disease$ prescribed @Chemical$ and prednisolone therapy between January 2007 and June 2011 were analyzed.	0
Rationale: Daily high-dose aspirin therapy benefits many patients with aspirin-exacerbated @Disease$ but provides no benefit for @Chemical$-tolerant patients with asthma.	0
"Similar limited @Disease$ and protective actions were observed with a new class of hydrogen sulfide (H2S)-releasing NSAIDs, such as @Chemical$-releasing naproxen (ATB-346)."	0
"@Chemical$, a nonsteroidal anti-inflammatory drug useful for severe @Disease$, is available in the United States in parenteral form."	0
"We describe the case of a 64-year-old patient with @Disease$ who was referred to our hospital because of an acute inferior myocardial infarction.Given the possible risk of acute haemolytic anaemia, aspirin was not given in the acute phase, and the patient was successfully treated by balloon angioplasty of the right coronary artery.After functional and genetic testing showing the presence of the Mediterranean mutation, known to be a class II variant, the patient received oral daily @Chemical$ (100 mg) under strict monitoring in order to promptly detect any sign of haemolysis."	0
"INTRODUCTION: Clinical features of aspirin-exacerbated respiratory disease (AERD) consist of moderate to severe asthma associated with chronic rhinosinusitis (CRS), which are derived from overproduction of @Chemical$ along with chronic type 2 mediated @Disease$ in the upper and lower airway mucosa."	0
We compared the levels of neutrophil activation and related cytokines in patients with @Chemical$-intolerant acute urticaria (@Disease$) and ASA-intolerant chronic urticaria (AICU).	0
"Also, women had less peripheral artery disease (aspirin, 2.4% versus 3.7%; apixaban, 1.4% versus 3.0%), more heart failure, and higher mean CHADS2 (congestive heart failure, hypertension, age of 75 years or older, diabetes [1 point each], stroke or transient @Disease$ attack [2 points]) scores (aspirin, 2.2 versus 2.0; @Chemical$, 2.1 versus 2.0)."	0
"BACKGROUND: The frequency with which patients with aspirin-exacerbated @Disease$ (AERD) react to 325 mg of aspirin during @Chemical$ desensitization, or fail to react at all, is not fully known."	0
Safety of parecoxib in asthmatic patients with @Chemical$-exacerbated @Disease$.	0
The medical history of non-steroidal anti-inflammatory drugs (NSAIDs) or @Chemical$ (ASA) usage and the presence of coronary artery disease (@Disease$) were investigated in all patients with or without hemorrhage.	0
"IMPORTANCE: Combined anticoagulant and @Chemical$ therapy is associated with increased bleeding risk in patients with @Disease$, but the bleeding risk of combined use of anticoagulant and nonsteroidal anti-inflammatory drugs (NSAIDs) is poorly documented."	0
BACKGROUND: Warfarin and aspirin (@Chemical$ [ASA]) are the most commonly used anticoagulant and antiplatelet drugs in the treatment of @Disease$.	0
"She had no symptom of urticaria and asthma, and had the both character of @Chemical$ @Disease$ and asthma as to aspirin challenge test."	1
"Aspirin-exacerbated diseases are important examples of drug hypersensitivities and include @Chemical$-exacerbated @Disease$ (AERD), aspirin- or non-steroidal anti-inflammatory drug (NSAID)-induced urticaria/angioedema, and aspirin- or NSAID-induced anaphylaxis."	1
"CONCLUSIONS: In this population of stable patients with @Disease$, our retrospective analysis did not demonstrate any interaction between the use of @Chemical$ and survival in patients receiving ACE-Is."	0
Low-dose @Chemical$ and risk of upper/lower @Disease$ by bleed severity: a cohort study with nested case-control analysis using primary care electronic health records from the United Kingdom.	1
"METHODS: Subjects 18 years or older with @Disease$, without gastroduodenal ulcer or erosive esophagitis at baseline endoscopy, and a cardiovascular indication for prophylaxis low-dose (81 or 325 mg) aspirin were prescribed open-label aspirin and blindly randomized to celecoxib 200 mg/day or naproxen 500 mg twice daily plus @Chemical$ 30 mg once daily."	0
BACKGROUND: Clinical role of low-dose @Chemical$ (LDA) in pathogenesis of @Disease$ is by far controversial.	0
"A total of 221 biopsy specimens from 74 patients, including atrophic @Disease$ (AG) cases without @Chemical$ use (control), AG cases with aspirin use (AG group), and GC cases with aspirin use (GC group), were analyzed."	0
"We investigated the risks of ischemic stroke and @Disease$ (ICH) in relation to warfarin at various TTRs in a real-world cohort of Chinese patients with atrial fibrillation receiving warfarin and compared with those on dabigatran, @Chemical$, and no therapy."	0
"CONCLUSIONS: These results highlight the importance of @Chemical$ therapy compliance and give an estimate of the risk associated with the discontinuation of aspirin therapy in patients at risk for IS, particularly those with @Disease$."	0
"Less is known regarding the use of @Chemical$ following CABG, although it is now recommended as postoperative antiplatelet therapy in patients with recent acute @Disease$."	0
CONCLUSIONS: @Chemical$ is useful for the primary prevention of @Disease$ induced by LDA alone or by LDA plus clopidogrel in healthy subjects.	0
"RESULTS: Both groups of @Disease$tics (AERD, n = 240; ATA, n = 226) had significantly higher @Chemical$, uLTE4 levels, and blood eosinophils than healthy controls (HC) (n = 71) (p &lt; 0.05)."	0
"BACKGROUND: It remains unclear to what extent asthma in adults is linked to allergic rhinitis (AR), @Disease$ (GERD), and @Chemical$ exacerbated respiratory disease (AERD), and how these comorbidities may affect asthma outcomes in the general population."	0
We describe a case of @Disease$ that was difficult to distinguish from malignancy in a patient with a history of ingesting LDA and @Chemical$ after implantation of a drug-eluting stent.	0
It has been proposed that aspirin (@Chemical$) and other non-steroidal anti-inflammatory drug (NSAID)-induced @Disease$ (UR)/angioedema (AE) are mediated through inhibition of cyclooxygenase-1 (COX-1) enzymes.	1
"Notwithstanding the consistent benefits demonstrated with @Chemical$ for both acute and chronic cardiovascular disease, there are a number of @Disease$ associated with aspirin that have been showcased by recent long-term clinical trials that have included an aspirin monotherapy arm."	0
CONCLUSIONS: These results show the molecules involved in @Disease$ to aspirin and may lead to a better understanding of adverse responses to @Chemical$.	0
@Disease$ patients can take up to 650 mg of @Chemical$ for analgesic or antipyretic relief.	0
Complications and Safety of Preconception Low-Dose @Chemical$ Among Women With @Disease$.	0
"RESULTS: The frequency of @Chemical$ (60/150 (40%) vs 18/150 (12%); odds ratio 4.899, p &lt;0.0001) and @Disease$ (ICH)(42/150 (28%) vs 2/150 (1%); odds ratio 28.778, p &lt;0.0001) were significantly higher in the patients than in the controls."	0
"Attempts to control massive @Disease$ by resuscitation, blood products and haemostatics (desmopressin, @Chemical$) failed."	0
"In the study, 100 patients with low on-treatment @Disease$ and at high risk of bleeding and low risk of cardiovascular events, were switched to @Chemical$ (40 mg/d) and their platelet aggregation was measured again 7 days later.Their bleeding and upper gastrointestinal symptoms were also recorded in following 3 months."	0
"METHODS: Twenty-four aspirin-sensitive patients with @Disease$ and 18 @Chemical$-tolerant asthmatic patients were studied, and eicosanoids released from PBLs were assessed by means of enzyme immunoassays."	0
Spontaneous @Disease$ in a patient treated with @Chemical$ and aspirin.	1
"The @Disease$ and symptoms precede clinical reactions to @Chemical$ or other NSAIDs, but ultimately affected subjects experience worsening of symptoms with ingestion of ASA/NSAIDs."	0
"Our previous studies demonstrated that @Chemical$ blocks trafficking of STAT6 into the nucleus and thereby prevents IL-4-mediated induction of these transcripts, thereby suggesting a modality by which aspirin desensitization could provide therapeutic benefit for @Disease$ patients."	0
These results suggest that TMG is effective for the treatment of @Chemical$-induced @Disease$.	1
"Dual antiplatelet therapy (DAPT) with @Chemical$ and a P2Y12 inhibitor (clopidogrel, ticagrelor, or prasugrel) reduces thrombotic events in patients with acute coronary syndrome (ACS), but it is also associated with an increased risk of @Disease$ complications."	0
Association of @Chemical$ resistance with increased @Disease$ severity and infarct size.	0
OBJECTIVE: To assess whether cardiovascular events are increased after cessation of dual antiplatelet therapy (DAPT) following acute @Disease$ (ACS) and to explore predictors for recurrent events after @Chemical$ cessation during long-term follow-up.	0
"In addition, to reduce the incidence of @Disease$ in LDA users, it is important for clinicians to confirm the differences in the gastrointestinal toxicity between different types of @Chemical$ formulations in clinical use."	0
"Several days before hospitalization, he had @Disease$ and began to use @Chemical$ of 100 mg per day."	0
OBJECTIVE: To describe the clinical course of a man with @Chemical$-exacerbated @Disease$ who was unable to be desensitized to oral aspirin.	0
"The median @Disease$ in the aspirin regimen was 3, while those in both @Chemical$ + rabeprazole 10 mg and aspirin + rabeprazole 40 mg regimens were 0."	0
@Chemical$ intolerance in boy with primary ciliary @Disease$.	0
"@Chemical$ desensitization treatment, the mainstay of controlling asthma and rhinitis in @Disease$ patients, however, is the least understood aspect of the disease."	0
We report a case of a large spontaneous latissimus dorsi @Disease$ in a patient receiving clopidogrel and @Chemical$ therapy.	0
"RESULTS: Compared with the polyposis only group, hydrogen peroxide consumption, @Chemical$ S-transferase, vitamin E and malondialdehyde were lower in the @Disease$ group."	0
"CONCLUSIONS: In this subgroup analysis in patients at high risk for recurrence of gastric ulcer, use of cotherapy with @Chemical$ 200 microg QID or lansoprazole 15 or 30 mg OD significantly lowered the risk for @Disease$ ulcer recurrence."	0
"We evaluated the differences in ACS type, total mortality, and the composite end point of @Disease$, myocardial infarction (MI), recurrent ischemia, or stroke between prior aspirin and nonprior @Chemical$ users."	0
In the present study was investigated the effects of aspirin on upper gastrointestinal ulcer and potent risk factor for peptic @Disease$ associated with @Chemical$ in a case-control study.	1
Ulcers associated with @Disease$ were seen only in those given @Chemical$.	0
@Chemical$-Exacerbated Respiratory Disease (@Disease$) and Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) are both characterized by the presence of chronic sinonasal inflammation and nasal polyps.	0
We aimed to assess the presence of apoptotic cells in nasal polyps from aspirin-hypersensitive (@Disease$) and @Chemical$-tolerant (AT) patients with rhinosinusitis as related to the characteristics of local inflammation.	0
"The annual incidence rates of major GI @Disease$ were estimated at 0.25% for outpatients taking aspirin and 0.5% for outpatients taking aspirin/@Chemical$, respectively."	0
METHODS: The @Chemical$ versus Acetylsalicylic Acid to Prevent Stroke in @Disease$ Patients Who Have Failed or Are Unsuitable for Vitamin k Antagonist Treatment (AVERROES) trial randomized 5599 patients with atrial fibrillation and risk factors to receive either apixaban or aspirin.	0
"Pooling the results from the fixed-effects model showed that a dose of 15 to 20 mg of @Chemical$ once daily was associated with an increased risk of @Disease$ (2 trials; OR, 3.31 [95% CI, 1.42 to 7.72]) compared with aspirin, while a 10-mg dose of rivaroxaban once daily or a 5-mg dose twice daily (3 trials; OR, 1.43 [95% CI, 0.93 to 2.21]) and a 5-mg dose of apixaban twice daily (1 trial; OR, 0.84 [95% CI, 0.38 to 1.88]) were not."	0
"At admission, compared with aspirin sensitive patients (@Chemical$), patients with APR had more frequently diabetes, anterior infarction and @Disease$, while AHR patients had reduced values of creatine kinase, leukocytes, heart rate and systolic blood pressure."	0
"KIF3A, a cilia structural gene on chromosome 5q31, and its polymorphisms show an association with @Chemical$ @Disease$ asthma."	1
"Aspirin-exacerbated @Disease$ (AERD), or @Chemical$-induced asthma, is characterized by asthma and rhinitis triggered by the ingestion of aspirin and non-steroidal anti-inflammatory drugs."	0
"However, @Chemical$ 3 microg/ kg PO q8h was less effective in preventing aspirin-induced @Disease$ on days 14 and 28 than in previous studies."	0
"Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist @Chemical$ with aspirin in patients with @Disease$: a double-blind comparison to clopidogrel with aspirin."	0
OBJECTIVE: Transnasal endoscopy was conducted to examine gastric mucosal damage in Japanese patients with ischemic heart disease who were receiving low-dose @Chemical$ for preventing the onset or recurrence of @Disease$.	0
"@Chemical$ interruption yielded an odds ratio for IS/transient @Disease$ attack of 3.4 (95% confidence interval, 1.08-10.63; P &lt; .005) after adjustment in a multivariable model."	0
H. pylori @Disease$ was determined by CagA/VacA serology and @Chemical$-urea breath test in all cases and controls.	0
"If you take daily @Chemical$, make sure you know why and understand the small but real @Disease$ risk."	0
"RESULTS: The mean perioperative @Disease$ was 899+-496 ml for patients not on clopidogrel, 1091+-654 ml for patients on clopidogrel (p=0.005) and 1312+-686 ml for those on combined @Chemical$ and aspirin (p=0.0003 vs. all others)."	0
"The majority of patients with a history of reactions to aspirin have @Chemical$/nonsteroidal anti-inflammatory drug (NSAID)-induced @Disease$, easy bruisability, or other side effects."	1
"METHODS: This prospective, placebo-controlled trial was conducted in @Disease$ patients randomized (1:1) to receive either standard DAPT (aspirin and clopidogrel) vs TAPT with @Chemical$ for a minimum of 12 months after PCI with Endeavor zotarolimus-eluting stent (E-ZES)."	0
The study included patients at high risk of @Disease$ who were regularly taking antiplatelet agents (e. g. @Chemical$ derivatives and aspirin).	0
CONCLUSION: It is proposed that the higher platelet @Chemical$ concentration observed in @Disease$ patients contributed to the higher platelet GPX activity seen in these patients.	0
"RESULTS: Pretreatment with NO-@Chemical$ attenuated dose-dependently gastric erosions provoked by @Disease$, ischemia-reperfusion, and ethanol."	0
@Chemical$ is recommended during anaphylaxis but is controversial in @Disease$ as it may worsen coronary spasm.	0
"METHODS: We screened a Korean asthma cohort (581 asthmatics including 81 @Chemical$-intolerant @Disease$tics and 231 aspirin-tolerant asthmatics, and 181 normal controls) for four single nucleotide polymorphisms (SNPs; -262 A&gt;T and -115 T&gt;C in the 5'-flanking region and +5467 T&gt;C [Pro450Pro] and+11860 A&gt;G [Thr776Thr] in the coding region) and one ins/del (+21288 CT) in the ACE gene."	0
"Aspirin-exacerbated diseases are important examples of drug hypersensitivities and include @Chemical$-exacerbated respiratory disease (AERD), aspirin- or non-steroidal anti-inflammatory drug (NSAID)-induced @Disease$/angioedema, and aspirin- or NSAID-induced anaphylaxis."	0
"CONCLUSIONS: In this subgroup analysis in patients at high risk for recurrence of gastric ulcer, use of cotherapy with @Chemical$ 200 microg @Disease$ or lansoprazole 15 or 30 mg OD significantly lowered the risk for gastric ulcer recurrence."	0
@Chemical$-intolerant asthma (@Disease$) is a distinct clinical syndrome that refers to the development of bronchoconstriction in asthmatic individuals following the ingestion of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs).	0
"Spirometry, skin-prick test and asthma control test were documented and intracellular cytokine expression in T lymphocytes and plasma @Chemical$ levels were measured in 23 AERD patients, 17 aspirin-tolerant @Disease$tic (ATA) patients, and 16 healthy controls."	0
"RESULTS: Interaction analyses indicated that of all subgroups, only patients with serum @Chemical$ &gt; 1.3 mg/dl had a significantly greater reduction of cardiovascular events and myocardial infarction (-13 and -7/1000 patient-years), while risk of @Disease$ was not significantly different between subgroups."	0
Excretion of @Chemical$ in patients with aspirin induced @Disease$ raised after oral aspirin provocation and higher level was detected is til 24 hours after challenge.	0
"CONCLUSIONS: After catheter ablation, low risk patients do not benefit from long-term aspirin therapy, but are at risk for higher rates of @Disease$ when compared to no therapy or @Chemical$."	0
"In particular, the risk of @Disease$ associated to the use of antiplatelet drugs, especially low-dose acetylsalicylic acid (@Chemical$) should deserve much attention."	1
"This study--the first one from a population outside North America--adds relevant information on the absence of a consistent association between @Chemical$ use and @Disease$ risk, even in high-risk overweight and obese women."	0
The proportions of patients with an MLS of &gt;=1 and erosive @Disease$ were significantly lower in the @Chemical$ group than in the gefarnate group at 12 weeks (gastric lesions 33.5 vs.	0
INTRODUCTION: The role of Helicobacter pylori @Disease$ on the risk of low-dose aspirin-related gastroduodenal damage and on the efficacy of the prevention therapy in elderly chronic users of low-dose @Chemical$ is still controversial.	0
"However, the small intestinal @Disease$ of @Chemical$ remains unclear."	1
Do @Chemical$ and non-steroidal anti-inflammatory drugs increase the risk of post-sphincterotomy @Disease$--a case-control study.	1
The @Disease$ after surgery was 864.4 cc in the @Chemical$ group but only 458.4 cc in the control group (p&lt;.001).	0
@Disease$ caused by NSAIDs/@Chemical$: finding new from old.	1
"Since @Chemical$ is a weak inhibitor of the COX-1 enzyme, patients with aspirin-induced @Disease$ should not take more than 1000 mg of acetaminophen in a single dose."	0
"Conclusions and Relevance: In this cohort study, @Chemical$ use 3 or more times per week was associated with a reduction in all-cause, cancer, GI cancer and @Disease$ mortality in older adults."	0
"In addition, the effects of treatment with warfarin, @Chemical$, or both in patients with @Disease$ were compared with the effects in patients with no renal disease."	0
It is generally accepted that in aspirin-induced asthma (@Disease$) the bronchospasm is provoked by inhibition of @Chemical$ synthesis with overproduction of cysteinyl leukotrienes.	0
"Patients receiving aspirin with @Chemical$ were demonstrated to have more comorbidities, lower time in therapeutic range levels, and higher @Disease$ rates."	0
"@Chemical$ has a role in the prevention of cardiovascular and @Disease$, Alzheimer's dementia and several cancers."	0
CONCLUSION: Ethanolic extract of Cl ointment (EtOHCl) containing 10% curcumin displayed remarkable healing process against wound @Disease$ by @Chemical$.	1
CONCLUSION: Risk factors for primary upper @Disease$ are to a large extent similar for NSAID and @Chemical$ users.	0
This increased @Chemical$ ratio in severe CKD patients may affect the prognosis in patients who already have an increased risk for @Disease$.	0
A 57-year-old man with @Chemical$ @Disease$ underwent successful percutaneous revascularization of a chronic total occlusion of the left anterior descending artery (LAD).	1
"Patients were administered a 100 mg enteric-coated @Chemical$ tablet once daily: before a meal (30 min before a meal), during a meal, after a meal (30 min after a meal), or before sleep, and all patients were followed up for 6-9 months to observe for @Disease$ and other side effects."	0
"BACKGROUND: Chronic urticaria/@Disease$ is a common phenotype in patients with @Chemical$ sensitivity; however, its genetic mechanism is not understood."	0
[Prevention of aspirin-induced @Disease$ with an association of @Chemical$ inhibitors and antihistamines].	0
"We report a patient, having used @Chemical$ for secondary stroke prevention, who had an acute @Disease$ after taking nattokinase 400 mg daily for 7 consecutive days."	0
"We sought to assess the performance of existing bleeding risk scores, such as the @Disease$, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/@Chemical$ Concomitantly (HAS-BLED) score or the Outpatient Bleeding Risk Index (OBRI), in patients with heart failure with reduced ejection fraction (HFrEF) in sinus rhythm (SR) treated with warfarin or aspirin."	0
A consensus view has emerged favoring an anti@Disease$ effect of long-term @Chemical$ use.	0
Diagnostic Accuracy of Urinary LTE4 Measurement to Predict @Chemical$-Exacerbated Respiratory Disease in Patients with @Disease$.	0
"RESULTS: When compared with @Disease$ patients who received no controller medications, the combined use of LTMDs, inhaled corticosteroids, and long-acting beta2-agonists led to a statistically significant change in @Chemical$ challenge outcomes (P = .009), mainly shifting the reaction from a classic upper and lower respiratory tract reaction to naso-ocular reactions only."	0
"Co-therapy with non-steroidal anti-inflammatory drugs, clopidogrel or @Chemical$ increases the risk of @Disease$, while co-therapy with proton pump inhibitors reduces it."	0
Bleeding risk of patients with acute @Disease$ taking nonsteroidal anti-inflammatory drugs or @Chemical$.	1
"We reviewed all previous cases of @Disease$ patients with ACS, in addition to a review of the available literature, to better understand the safety of @Chemical$ use in this population."	0
"Chronic users of NSAIDs or aspirin co-treated with proton pump inhibitors had a lower risk of @Disease$ (OR 1.12, 95% CI 0.21-6.07) than those treated with @Chemical$ (OR 1.91, 95% CI 0.33-10.9) or H2 blockers (OR 2.26, 95% CI 0.81-6.36)."	0
"Acetylsalicylic acid, commonly known as @Chemical$, can induce some hypersensitive reactions with clinical symptoms such as urticaria, @Disease$, acute bronchospasm, and rarely anaphylactic shock."	1
"DATA SOURCES: Literature retrieval was accessed through MEDLINE (1966-March 2007) using the terms acetaminophen, aspirin, antiinflammatory agents nonsteroidal, @Disease$, angioedema, asthma, leukotriene antagonists, desensitization, and @Chemical$."	0
@Chemical$ @Disease$ desensitization in cerebrovascular disease.	1
"Patients receiving @Chemical$ with warfarin were demonstrated to have more comorbidities, lower time in therapeutic range levels, and higher @Disease$ rates."	0
"OBJECTIVE: Aspirin exacerbated respiratory disease (AERD) is comprised of @Chemical$/acetylsalicylic acid (ASA) sensitivity, @Disease$, and nasal polyposis."	0
"@Chemical$ and other nonsteroidal anti-inflammatory drugs (NSAIDs) exacerbate @Disease$, resulting in violent attacks."	1
"Among patients with H. pylori @Disease$ and a history of ulcer bleeding who continue to use low-dose @Chemical$, 1 week of eradication therapy prevents recurrent ulcer bleeding."	0
"The most common reasons for recommending @Chemical$ discontinuation were concern about bleeding after polypectomy (62%), perceived minimal downside to stopping aspirin (38%), @Disease$ to changing old policies (20%), and concern about medicolegal implications of postpolypectomy bleeding (15%)."	0
PATIENTS AND METHODS: All patients who underwent RARP with @Chemical$ @Disease$ at our institution since 2007 were included in this analysis.	1
"Although acetylsalicylic acid is prescribed for a broad range of diseases, it can induce a wide array of clinically recognized hypersensitivity reactions, including aspirin-intolerant asthma (AIA) with @Disease$ and @Chemical$-intolerant urticaria (AIU) with anaphylaxis."	0
Serum Specific IgE to Thyroid Peroxidase Activates Basophils in @Chemical$ @Disease$.	1
"METHODS: Asthma control status was monitored for 1 year with maintenance medications of inhaled corticosteroid and oral LTRA, and @Disease$ patients were classified into three groups according to the mean montelukast dose required per month to maintain asthma control for 1 year: group I (&gt; or = 200 mg @Chemical$/month; n = 37), group II (5-150 mg/month; n = 25) and group III (&lt; 5 mg/month; n = 27)."	0
CONCLUSIONS: There was no significant benefit in preventing ischemic @Disease$ in the patients with advanced CKD who received @Chemical$ therapy.	0
BACKGROUND AND PURPOSE: Apixaban reduces stroke with comparable @Disease$ risks when compared with aspirin in patients with atrial fibrillation who are unsuitable for @Chemical$ antagonist therapy.	0
"PATIENTS: Helicobacter pylori-negative patients taking daily low-dose ASA (75-325 mg), who fulfilled one or more of the following criteria: age &gt;=18 years with history of uncomplicated peptic ulcer; age &gt;=60 years with either stable @Disease$, upper gastrointestinal symptoms and five or more gastric/duodenal erosions, or low-dose @Chemical$ treatment initiated within 1 month of randomisation; or age &gt;=65 years."	0
"Polyphenol content of the apple extracts varied, with the EF extract having 20% w/w @Chemical$s and a high proportion of @Disease$ as epicatechin and procyanidin, whereas the FB extract comprised 12% w/w polyphenols, which were mostly flavonols as quercetin glycosides."	0
"Regular @Chemical$ intake was positively associated with the risk of developing @Disease$ (OR=6.14, 95% CI=1.76-21.35)."	1
"In addition, @Chemical$ may have an adverse effect on outcome in patients with @Disease$ that is independent of any interaction with angiotensin-converting enzyme inhibitors, possibly by blocking endogenous vasodilator prostaglandin production and enhancing the vasoconstrictor potential of endothelin."	0
"@Chemical$-exacerbated @Disease$ (AERD), or aspirin-induced asthma, is characterized by asthma and rhinitis triggered by the ingestion of aspirin and non-steroidal anti-inflammatory drugs."	1
Aspirin and @Chemical$ versus aspirin monotherapy after @Disease$.	0
"Although aspirin-@Chemical$ combination is more useful for @Disease$ (ACS), the renal safety of this combination had not been established."	0
There is now strong evidence that aspirin desensitization and daily @Chemical$ therapy is effective for treatment of the chronic @Disease$ of the upper airway and lower airways in AERD.	0
METHODS: The 24-week clinical outcomes of the patients using low-dose aspirin for cardiovascular protection with a history of @Disease$/erosions and cotherapy of omeprazole or @Chemical$ were retrospectively reviewed.	0
"@Chemical$ exacerbated @Disease$ is characterized by recalcitrant sinusitis/polyposis, asthma and precipitation of asthma after ingestion of aspirin and most NSAIDs."	1
"SUMMARY: The full clinical picture of aspirin intolerance--the association of @Chemical$-induced bronchial asthma (with severe acute @Disease$), aspirin sensitivity and nasal polyps--is commonly summarized as the 'Samter triad'."	0
The risk of @Disease$ should be communicated properly to elderly taking @Chemical$.	0
CONCLUSION: @Chemical$ is safe and may prevent peptic @Disease$s &gt;= 5 mm in diameter or those with pigmented spots in patients receiving dual antiplatelets for 1 year (NCT02166008).	0
"Objectives: To investigate the association of aspirin use with risk of all-cause, any cancer, gastrointestinal (GI) @Disease$, and colorectal cancer (CRC) mortality among older adults and to perform an exploratory analysis of the association of @Chemical$ use with mortality stratified by BMI."	0
"Pooling the results from the fixed-effects model showed that a dose of 15 to 20 mg of rivaroxaban once daily was associated with an increased risk of @Disease$ (2 trials; OR, 3.31 [95% CI, 1.42 to 7.72]) compared with aspirin, while a 10-mg dose of rivaroxaban once daily or a 5-mg dose twice daily (3 trials; OR, 1.43 [95% CI, 0.93 to 2.21]) and a 5-mg dose of @Chemical$ twice daily (1 trial; OR, 0.84 [95% CI, 0.38 to 1.88]) were not."	0
Logistic regression analysis revealed that @Disease$ and cerebral vascular disease were associated with @Chemical$ use.	1
Measurement of shear-activated platelet aggregate formation in non-anticoagulated blood: utility in detection of @Chemical$-aspirin-induced @Disease$.	0
"METHOD: From July 2017 to @Disease$, 901 patients including 781 (86.7%) male and 120 (13.3%) female patients underwent laparoscopic inguinal hernia repair using trans-abdominal preperitoneal (@Chemical$) technique were recruited, among whom 152 (16.9%) had been taking low-dose (100 mg per day) acetylsalicylic acid which was continued during hospitalization except the operation day."	0
"@Chemical$-exacerbated respiratory disease (AERD) is a clinical syndrome characterized by severe persistent @Disease$, hyperplastic eosinophilic sinusitis with nasal polyps, and an intolerance to aspirin and other NSAIDs that preferentially inhibit COX-1."	0
CONCLUSIONS: Patients on aspirin and clopidogrel &lt;5days before CABG who had preoperative ADP-induced platelet aggregation &gt;=50% have @Disease$ risk similar to those receiving @Chemical$ monotherapy.	0
[The effectiveness of leukotriene antagonists in the treatment of @Chemical$-intolerant @Disease$tic patients].	0
CONCLUSIONS: There was no statistically significant difference in the frequency or types of traumatic @Disease$ between patients who had received @Chemical$ prophylaxis and those who had not.	0
Interactions between @Chemical$ and COX-2 inhibitors or NSAIDs in a rat @Disease$ model.	0
@Chemical$ use and @Disease$ risk after endoscopic submucosal dissection in patients with gastric neoplasms.	0
The meta-analysis showed that PPIs decreased the risk of @Chemical$-associated upper GI ulcers (OR = 0.16; 95%CI: 0.12-0.23) and @Disease$ (OR = 0.27; 95%CI: 0.16-0.43) compared with control.	1
"In this study, we compared the roles of CysLT receptor type 1 (CysLTR1) and leukotriene C4 synthase (LTC4S) gene polymorphisms in two major aspirin-related @Disease$, aspirin-intolerant asthma (AIA) and @Chemical$-induced chronic urticaria/angioedema (AICU)."	0
We report a case of a 76-year-old-man who developed spontaneous @Disease$ of his right knee following clopidogrel-@Chemical$ treatment.	0
"Fifteen patients were off therapy; 10 (8%) patients stopped because of headache and/or @Disease$, whereas 4 patients were switched to other antiplatelet agents by their primary care physician as a matter of choice rather than ASA-@Chemical$ side effects."	0
We therefore tested whether addition of the leukotriene receptor antagonist montelukast was of therapeutic benefit in a group of aspirin-intolerant patients with @Disease$ of whom 90% already were treated with moderate to high doses of @Chemical$.	0
CONCLUSIONS: Low-dose aspirin should be recommended to well-treated @Disease$ patients with even moderate increase in serum @Chemical$.	0
"BACKGROUND: @Chemical$-exacerbated respiratory disease (AERD) is a clinical syndrome associated with chronic inflammation in the airways coincident with chronic @Disease$, sinusitis, recurrent polyposis and asthma."	0
Positive associations between non-aspirin NSAID or @Chemical$ and risk of @Disease$ tended to disappear when analyses were limited to drug use &gt;= 5 years before the disease diagnosis.	0
"With exception of idraparinux, all active therapies significantly reduced @Disease$ recurrence risk versus aspirin, ranging from a 73% reduction with either @Chemical$ 2.5mg or rivaroxaban to 80% with VKAs."	0
"We retrospectively reviewed the medical records for @Disease$ complications in 182 patients, most with coronary artery disease (mean age 61 +/- 11 years, 82% men) and being treated with high-dose fish oil (mean dose 3 +/- 1.25 g), @Chemical$ (mean dose 161 +/- 115 mg), and clopidogrel (mean dose 75 mg), and in 182 age- and gender-matched controls treated with aspirin and clopidogrel alone."	0
"Within 90 days after intervention, there were 4 patients (1.5%) with acute thrombosis, 5 patients (1.8%) with subacute thrombosis, 17 patients (6.2%) with stroke, and 2 death (0.7%) in low-dose aspirin group, compared with no patient (0%) with acute thrombosis, 2 patient (2.1%) with subacute thrombosis, 6 patients (6.2%) with stroke, and 2 @Disease$ (2.1%) in high-dose @Chemical$ group, and there were no significant difference in all study endpoints between two groups."	0
"Treatment of @Disease$ consisted of washing of the nasal cavities, steroid spray, and oral @Chemical$ administration."	0
"@Chemical$ (SCG) is used for the treatment of atopic dermatitis with @Disease$, but the efficacy of SCG in ASP-exacerbated food-allergy reactions is unclear."	0
Could discontinuation of @Chemical$ therapy be a trigger for @Disease$?	0
AIM/OBJECTIVE: To compare effect of @Disease$ (2.3% NaCl) sea @Chemical$ and isotonic 0.9% NaCl on symptoms and endoscopic findings in those patients in the period of 1 month after endoscopic sinus surgery (ESS).	0
"The substantive risk for prophylactic @Chemical$ is therefore @Disease$ which can be fatal or severely disabling, with an estimated risk of one death and one disabling stroke for every 1,000 people taking aspirin for ten years."	1
Neither @Chemical$ nor aspirin alone nor combined therapy increased the risk of @Disease$.	0
"CONCLUSIONS: In a randomized controlled trial of users of low-dose aspirin at risk for recurrent GI @Disease$, a slightly lower proportion of patients receiving a PPI along with aspirin developed recurrent bleeding or ulcer than of patients receiving an H2RA with the @Chemical$, although this difference was not statistically significant."	0
@Chemical$-induced asthma was diagnosed in 11 patients (14.7%) with clinical manifestations of @Disease$ responses.	1
"STUDY OBJECTIVES: To characterize the safety of concomitant aspirin, @Chemical$, and warfarin therapy after percutaneous coronary intervention (PCI), and to identify patient characteristics that increase the risk of @Disease$."	0
"@Chemical$-Tris did not cause @Disease$, microcirculatory dysfunction, mucosal injury or an elevation in proinflammatory markers."	0
Twenty @Disease$ and 10 @Chemical$ tolerant controls (ATC) were challenged with saline or 14.4mg of Lys-ASA.	0
"Conversely, acetaminophen is well tolerated, has not been shown to contribute to gastrotoxicity when taken with aspirin, and has not been shown to interfere with the inhibition of @Disease$ produced by @Chemical$."	0
"All 129 patients with high risk TIA with microbleeds or minor @Disease$ within 24 hours after the onset (average age 65.9 +- 9.3, 48.7% were male patients) were divided randomly into two groups: (1) 67 patients were given combination therapy with clopidogrel and aspirin (clopidogrel at an initial dose of 300 mg, then 75 mg per day for 90 days, plus aspirin at a dose of 75 mg per day for the first 21 days);(2) the rest patients were given @Chemical$ treatment (75 mg per day for 90 days)."	0
"To evaluate the extent of @Disease$ and the protective effect of drugs, gastric mucosal lesion index, gastric mucosal blood flow, content of gastric mucosal hexosamine, prostaglandins (PG), @Chemical$(NO), tumor necrosis factor (TNF), and interleukin (IL) -1, 2, 8 were measured in each group, and histological changes were observed by gross as well as under microscope and electron microscope."	0
CONCLUSIONS: Nasal ketorolac administration is a reasonably accurate and safe method for diagnosing @Chemical$-exacerbated @Disease$.	0
BACKGROUND: In vitro experiments and limited animal studies suggest that @Chemical$ and nonsteroidal anti-inflammatory drugs may inhibit @Disease$.	0
CONCLUSION: 1 Patients with @Chemical$ @Disease$ have higher concentration of LTE4.	1
BACKGROUND: Historical aspirin- or nonsteroidal anti-inflammatory drug (NSAID)-induced reactions might provide predictive information about the severity of reactions in patients with aspirin-exacerbated @Disease$ (AERD) undergoing oral aspirin challenge (@Chemical$).	0
Adjusted HRs for acetylsalicylic acid versus the combination of @Chemical$ and dipyridamole were 1.48 (95% CI: 1.31-1.67) for @Disease$ and 1.47 (95% CI: 1.18-1.82) for bleeding.	0
"OBJECTIVE: This analysis compared the efficacy of misoprostol, @Chemical$, and placebo in reducing the risk of @Disease$ or duodenal ulcer recurrence in patients taking NSAIDs and low-dose aspirin."	0
"BACKGROUND &@Chemical$; AIMS: We performed a meta-analysis of data from randomized trials to estimate the risk of all-cause mortality and bleeding (and especially gastrointestinal [GI] @Disease$) in patients treated with low doses of acetylsalicylic acid (ASA) (75-325 mg/d), alone or in combination with other medications."	0
"@Chemical$-exacerbated @Disease$ (AERD) is associated with severe asthma and aspirin can cause asthma to worsen, often in the form of a severe and sudden attack."	1
SBPCPTs with aspirin revealed that 14 of 58 patients (24%) with CPU and one of 10 patients with CRU (10%) were @Chemical$ @Disease$.	1
Low-dose @Chemical$-induced @Disease$ are becoming an important problem in clinical practice.	1
CONCLUSIONS: These results show the molecules involved in @Disease$ to @Chemical$ and may lead to a better understanding of adverse responses to aspirin.	1
OBJECTIVES: To identify prescribing patterns of antiulcer agents in patients on low-dose @Chemical$ (LDA) and to evaluate the number of gastrointestinal (@Disease$) risk factors of the patients.	0
@Chemical$-induced asthma (AIA) is a distinct clinical entity characterised by hypersensitivity to aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) typically occurring in the form of asthma and severe @Disease$.	0
"BACKGROUND AND AIMS: Nitric oxide-releasing aspirin (NO-ASA) has been shown to inhibit cyclo-oxygenase and prostaglandin generation without causing mucosal damage, but the role of reactive oxygen species (@Chemical$) and cytokines in the action of ASA and NO-ASA against acute @Disease$ has been little studied."	0
"Dual antiplatelet therapy (DAPT) with acetylsalicylic acid and a P2Y12 inhibitor (@Chemical$, ticagrelor, or prasugrel) reduces thrombotic events in patients with @Disease$ (ACS), but it is also associated with an increased risk of bleeding complications."	0
OBJECTIVE: To estimate the @Disease$ risk of combined anticoagulant (@Chemical$ or enoxaparin-vitamin K antagonist [VKA]) and NSAID or aspirin therapy in patients with venous thromboembolism.	0
Factors driving the @Chemical$ exacerbated @Disease$ phenotype.	1
Acetaminophen in the treatment of @Disease$ associated with dipyridamole-@Chemical$ combination.	0
Patients with a normal PFA-100 indicating no @Disease$ but with documented aspirin and/or @Chemical$ use were selected.	0
@Disease$ are increased in early pregnancy in women taking low-dose @Chemical$.	1
"INTRODUCTION: @Chemical$-intolerant @Disease$ (AIA), a major clinical presentation of aspirin hypersensitivity, affects 10% of adult asthmatics."	0
"Many of these patients present with the so-called aspirin triad of @Chemical$ sensitivity, chronic rhinosinusitis with associated @Disease$, and severe asthma."	0
Our case is the second one in which hemorrhage from a @Disease$ may have been induced by @Chemical$ prophylaxis.	1
@Chemical$-exacerbated @Disease$.	1
@Chemical$-induced @Disease$.	1
Protective role of @Chemical$-rich water on aspirin-induced @Disease$ in rats.	0
BACKGROUND: Data on @Chemical$ for primary prevention of @Disease$ (CVD) are conflicting and changing as new trials are published on the subject.	0
"STUDY DESIGN: The OPT-BIRISK trial is a multicenter, double-blinded, placebo-controlled randomized study designed to test the superiority of extended antiplatelet therapy with @Chemical$ monotherapy compared with aspirin and clopidogrel for reduction of @Disease$ events in ACS patients with both high bleeding and high ischemic risks (bi-risk)."	0
"While no single genetic factor has been identified in either CRSwNP or @Disease$ to date, differences in the metabolism of @Chemical$ as well as innate immune cell activation may uniquely contribute to AERD pathogenesis."	0
"For upper and lower GI @Disease$, the RRs with low-dose @Chemical$ were 2.3 (2.0-2.6) and 1.8 (1.1-3.0), respectively."	0
This study evaluated the association of BMI and @Disease$ in patients with @Chemical$-tolerant asthma (ATA) and aspirin-intolerant asthma (AIA).	0
BACKGROUND: We aimed to investigate how high-dose ecabet @Chemical$ affects low-dose aspirin-induced @Disease$ in healthy volunteers.	0
"Within 90 days after intervention, there were 4 patients (1.5%) with acute thrombosis, 5 patients (1.8%) with subacute thrombosis, 17 patients (6.2%) with stroke, and 2 death (0.7%) in low-dose @Chemical$ group, compared with no patient (0%) with acute thrombosis, 2 patient (2.1%) with subacute @Disease$, 6 patients (6.2%) with stroke, and 2 death (2.1%) in high-dose aspirin group, and there were no significant difference in all study endpoints between two groups."	0
"For the THA cohort, there was higher wound @Disease$ complication frequency with LMWH (9.2% for @Chemical$ versus 0.9% for mechanical compression; p = 0.009; OR, 10.9)."	0
[Tolerability of Asacard--controlled-release @Chemical$ and aspirin-induced @Disease$].	0
The aim of the investigation was to study melatonin production in thrombocytes and their functional activity in correlation with 6-sulfatoximelatonin (6-SOM) urinary excretion in patients with aspirin-induced @Disease$ (@Chemical$).	0
"METHODS: Fibroblasts were isolated from the NM of subjects without @Disease$ who had septal deviation, turbinate hypertrophy, or both (control subjects, n = 7); NPs of aspirin-tolerant nonasthmatic patients (n = 7); and NPs of patients with asthma who were intolerant of @Chemical$ (n = 7)."	0
"Any (major or minor) bleeding occurred in 71 (8.1%) and 77 (8.9%), major bleeding in 34 (3.9%) and 49 (5.6%), and minor @Disease$ in 37 (4.2%) and 29 (3.3%) of placebo- and @Chemical$-treated patients, respectively; these differences were not significant."	0
It is generally accepted that in @Chemical$-induced @Disease$ (AIA) the bronchospasm is provoked by inhibition of prostaglandin synthesis with overproduction of cysteinyl leukotrienes.	1
"RESULTS: In @Chemical$-induced asthma patients (AIA, n=10), the basal concentration of urinary LTE4, but not the other metabolites, was significantly higher than that in aspirin-tolerant @Disease$ patients (ATA, n=10)."	0
"ULTE4 levels and blood eosinophils were significantly higher in AERD as compared to ATA (p = 0.004, p &lt; 0.0001, respectively). whereas @Chemical$ levels were not significantly different between both @Disease$ phenotypes (p = 0.34)."	0
"CONCLUSIONS: NSAIDs, LDA, and @Chemical$ were associated with ALGIB and diverticular @Disease$."	0
"Aspirin desensitization, @Chemical$-modifying agents, biologic agents, management of asthma, @Disease$, and nasal polyposis are recommended as treatment modalities."	0
CONCLUSION: The use of PPI treatment is advisable in order to prevent the discontinuation of @Chemical$ or NSAIDs due to the development of gastrointestinal disorders in elderly patients with @Disease$.	0
"@Chemical$ fitness grade, cardiovascular disease, previous history of @Disease$, angioplasty, diabetes, use of vitamin K antagonists, cirrhosis and type of hepatectomy were significantly different between the groups."	0
"However, many of those labeled as @Disease$ to aspirin had experienced side-effects and could be safely treated with @Chemical$."	0
"Of these 52 cases, there were 22 nasal polyposis cases with @Chemical$ sensitivity, 15 nasal polyposis cases without aspirin sensitivity and 15 chronic @Disease$ cases without aspirin sensitivity."	0
"Compared with clopidogrel, @Chemical$ increases the risk of GI bleeding but not other bleeding; however, 883 patients (95% CI, 357-infinity) would need to be treated with clopidogrel versus aspirin to prevent one major GI @Disease$ episode annually at a cost of over 1 million dollars."	0
Safety of aspirin desensitization in patients with reported @Chemical$ @Disease$ and cardiovascular disease.	1
"UNLABELLED: @Chemical$ (ASA) and several other nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit cyclo-oxygenase (COX) enzyme both isoforms 1 and 2, and can precipitate asthmatic attacks in aspirin-induced @Disease$tics."	0
The mechanism of @Disease$ included free radical injury induced by aspirin and decreased synthesis of vascular endothelial growth factor (VEGF) by @Chemical$.	0
"BACKGROUND: Low-dose @Chemical$ (LDA, 75 mg/day to 325 mg/day) is recommended for primary and secondary prevention of cardiovascular events, but has been linked to an increased risk of @Disease$ (UGIB)."	1
The authors present the case of a patient with @Disease$ and @Chemical$ hypersensitivity referred for urgent coronary angiography.	0
Risk of @Disease$ should be minimized by using the lowest effective dose among short-term and long-term @Chemical$ users.	0
"After propensity score matching (PSM) for identified confounders, the relationship between preoperative @Chemical$ use and 30-day all-cause mortality, postoperative renal failure, major @Disease$ (MACE), blood transfusion, reoperation for bleeding, and postoperative infection were estimated with separate logistic regression models."	0
"METHODS: Ninety-four @Chemical$-induced @Disease$ patients presenting urticaria/angioedema-induced by both ASA and NSAID (50 had underlying chronic urticaria) and showing positive responses on oral aspirin challenge test, 76 aspirin-intolerant asthmatics with positive responses on lysine-aspirin bronchoprovocation test, and 185 normal healthy controls were enrolled."	1
[Endoscopic findings of low-dose @Chemical$ associated @Disease$].	1
"OBJECTIVE: The use of low-dose aspirin (acetylsalicylic acid [@Chemical$]) has been suggested to attenuate growth of @Disease$ (AAAs), yet solid clinical evidence of this hypothesis is still missing."	0
@Chemical$-Exacerbated Respiratory Disease: The Hunt for the Rosetta Stone of @Disease$.	0
Does @Chemical$ attenuate the effect of angiotensin-converting enzyme inhibitors in @Disease$ or heart failure?	0
The risk of post-operative @Disease$ was significantly higher in patients on @Chemical$ therapy (relative risk=2.46; 95% confidence interval: 1.45-4.81) but bleeding time was not significantly different between the two groups (standardised mean difference=0.63; 95% CI: - 0.04 to 1.31).	1
"CONCLUSIONS: In females, LDA increased the risk of colonic mucosal lesions, suggesting that @Chemical$ may contribute to the pathogenesis of colonic ulceration or @Disease$."	1
"In incomplete responders on admission, @Disease$ with adenosine diphosphate (@Chemical$) was significantly higher compared with responders (p&lt;0.05) but there were no significant differences in collagen aggregation, platelet fibrinogen binding or P-selectin expression, plasma von Willebrand factor, fibrinogen, high-sensitivity C-reactive protein, or the urinary metabolite, 11-dehydro-TxB2."	0
[@Disease$ and @Chemical$ intolerance].	0
"OBJECTIVE: We sought to determine blood and urinary levels of 9alpha,11beta-PGF(2), a major stable PGD(2) metabolite in 2 well-defined phenotypes of asthma, aspirin-induced @Disease$ (AIA) and aspirin-tolerant asthma (ATA), and in healthy control subjects and to study the effects of @Chemical$ on PGD(2) release."	0
METHODS: Adults with @Disease$ under @Chemical$ therapy (100 mg once daily) presenting to the emergency department with upper gastrointestinal hemorrhage were retrospectively recruited and divided into group A (ischemia) and group B (non-ischemia).	0
"We found no evidence that @Chemical$ or non-aspirin NSAID use conferred risk reductions for @Disease$, regardless of the control series."	0
"METHODS: Subjects 18 years or older with osteoarthritis, without gastroduodenal ulcer or erosive @Disease$ at baseline endoscopy, and a cardiovascular indication for prophylaxis low-dose (81 or 325 mg) @Chemical$ were prescribed open-label aspirin and blindly randomized to celecoxib 200 mg/day or naproxen 500 mg twice daily plus lansoprazole 30 mg once daily."	0
There is now strong evidence that @Chemical$ desensitization and daily aspirin therapy is effective for treatment of the chronic inflammatory disease of the upper airway and lower airways in @Disease$.	0
"Addition of a cyclooxygenase-2 (COX-2) selective inhibitor to low-dose @Chemical$ increased @Disease$ incidence, to a rate not significantly less than a nonselective nonsteroidal anti-inflammatory drug (NSAID) alone."	0
"However, preoperative @Chemical$ use, compared with nonuse, was not associated with risks of MACE, 30-day mortality, postoperative renal failure, blood transfusion, or @Disease$ in the entire cohort, in patients undergoing valve operations only, and in patients undergoing CABG only after PSM."	0
Patients receiving @Chemical$ plus aspirin had a similar @Disease$ risk compared with those receiving thienopyridine plus aspirin.	0
"Provocation tests therefore, remain to be the only relevant method used for the diagnosis of both AIAR (@Chemical$-intolerant @Disease$) and ASA intolerance of organs other than respiratory tract."	0
CONCLUSIONS: Daily @Chemical$ 20 mg is efficacious and well tolerated in reducing the recurrence of peptic @Disease$ in East-Asian patients with a history of ulcers who are taking low-dose ASA for cardiovascular protection.	0
"CONCLUSIONS: Among STEMI patients treated with a fibrinolytic agent and @Chemical$, use of NSAIDs in the week preceding the incident event was associated with a higher incidence of MI, the composite of death and MI as well as the composite of death, MI, severe heart failure and @Disease$ at 30 days."	0
These results suggest that @Chemical$ is effective for the treatment of aspirin-induced @Disease$.	0
"Because I am @Disease$ to @Chemical$, it has been suggested that I take Plavix."	1
@Chemical$ and @Disease$: discovery of aspirin and paracetamol.	0
Different doses of @Chemical$ have been shown to be safe in a broad population subjected to neuraxial anaesthesia or @Disease$.	0
"BACKGROUND: Although the mechanism that underlies @Chemical$ hypersensitivity is not completely understood, an IgE-mediated response was reported for a patient with aspirin-intolerant chronic @Disease$ (AICU)."	0
This condition has been designated as @Chemical$-Exacerbated Cutaneous Disease (@Disease$).	0
Bleeding during treatment with aspirin versus apixaban in patients with atrial fibrillation unsuitable for warfarin: the apixaban versus acetylsalicylic acid to prevent @Disease$ in atrial fibrillation patients who have failed or are unsuitable for @Chemical$ antagonist treatment (AVERROES) trial.	0
This report describes a patient with @Disease$ and serves as a reminder for health professionals to continue to discourage the use of @Chemical$ for the treatment of viral infections.	0
"CONCLUSIONS: In A@Chemical$-DES, the DAPT score was predictive of @Disease$ events between 1 and 2 years after drug-eluting stents."	0
"A meta-analysis study reported that data regarding the risk for @Disease$ of new direct oral anticoagulants (@Chemical$, dabigatran and rivaroxaban) were inconclusive."	0
"Paradoxically, infrequent @Chemical$ users reported more @Disease$ and heavy menses than frequent users (21% vs."	0
Acetylsalicylic acid (ASA) or @Chemical$ and nonsteroidal anti-inflammatory drug (NSAID) sensitivities encompass a diverse group of both pharmacological and @Disease$ reactions.	0
"@Chemical$ (ASA) causes @Disease$ (GI) tract, and previous results have suggested that combination therapy with 2-amino-2-(hydroxymethyl)-1,3-propanediol (Tris) could provide protection in this scenario."	1
"We report the case of a 59-year-old female with hypertension, admitted to the coronary care unit for acute @Disease$ and treated with tissue-type plasminogen activator 100 mg in 90 min, intravenous @Chemical$ 25,000 U, aspirin 100 mg, and metoprolol 50 mg orally once daily."	0
"In all patients, we measured the @Disease$, by multiplate electrode aggregometry, using two agonists [adenosine diphosphate with PGE1 (@Chemical$) and arachidonic acid (ASPI)] two times: on the day of cessation of clopidogrel and 90 days after clopidogrel was stopped."	0
"The use of low-dose aspirin (@Chemical$) is well known to be associated with an increased risk of serious @Disease$, such as peptic ulceration and bleeding."	1
"BACKGROUND: @Chemical$-exacerbated respiratory disease (AERD) is a clinical syndrome characterized by chronic @Disease$, nasal polyps, asthma, and precipitation of asthma and rhinitis attacks after ingestion of aspirin (ASA) and most nonsteroidal anti-inflammatory drugs (NSAIDs)."	0
BACKGROUND: A complex relationship between arachidonic acid metabolites and @Chemical$ (NO) synthesis has been reported in @Disease$.	0
Previous @Chemical$ use in acute @Disease$: more than a marker?	0
BACKGROUND: @Chemical$ has been shown to lower the incidence and the mortality of vascular disease and cancer but its wider adoption appears to be seriously impeded by concerns about gastrointestinal (GI) @Disease$.	0
"Patients undergoing TKA treated with @Chemical$ had higher readmission rates within 6 weeks of surgery because of a @Disease$ complication, a wound infection, or the development of a VTE (6.8% for LMWH versus 1.5% for mobile compression; p = 0.015; OR, 4.8)."	0
"A 42-year-old white woman with a history of severe @Disease$, nasal polyps, @Chemical$ sensitivity, and chronic sinusitis was treated with aspirin desensitization."	0
"We encountered lower gastrointestinal bleeding in 16 patients taking a low dose of aspirin and examined the effect of low @Chemical$ dose on the stool occult blood test in 49 thrombotic patients (mean: 76.7 +/- 9.6 years old) including 39 with @Disease$, 8 with ischemic heart disease and 2 with atrial fibrillation."	0
"We evaluated the effects of aspirin on genetic/epigenetic alterations in precancerous conditions, i.e., @Disease$ (AM) and intestinal metaplasia (IM), in patients with chronic gastritis who had taken @Chemical$ for more than 3 years."	0
Nasal @Disease$: 18.5 +/- 3% (PP-- 15.0 +/- 4; A-- 15.5 +/- 6; @Chemical$-- 30.0 +/- 8% and PP/ASA-- p = 0.01; A/ASA-- p = 0.02).	0
The dose and the time of oral aspirin challenge test for these 18 patients were more spent than those for reported patients of @Chemical$ @Disease$.	1
Subanalysis of @Disease$ (23 lesions in 19 patients) confirmed that the administration of @Chemical$ derivatives (P = 0.01) and that of multiple agents (P = 0.02) were the significant factors.	0
"This study aimed to analyze CMBs and white matter hyperintensities (WMHs) in patients taking aspirin or clopidogrel.This retrospective study included patients with @Disease$ administered 75 mg/day aspirin (n = 150) or @Chemical$ (n = 150, matched for age and gender) for &gt;1 year (Affiliated Hospital of Inner Mongolia Medical University, China, from July, 2010 to July, 2015)."	0
"Although the latter is conventionally used in nasal lysine-aspirin challenge, use of the former in @Chemical$-induced @Disease$ (AIA) has never been evaluated."	1
CONCLUSION: Exhaled NO may indicate eosinophilic airway @Disease$ during @Chemical$ exposure in patients with ASA inducible asthma.	0
"Sodium cromoglycate (SCG) is used for the treatment of @Disease$ with food allergy, but the efficacy of @Chemical$ in ASP-exacerbated food-allergy reactions is unclear."	0
Aspirin-associated @Chemical$ loss as an anti@Disease$ mechanism.	0
"Non-steroidal anti-inflammatory drugs, @Chemical$ and newly diagnosed @Disease$: a case-control study."	0
INTRODUCTION: Helicobacter pylori (@Disease$ and use of nonsteroidal anti-inflammatory drugs (NSAIDs)/acetyl salicylic acid (@Chemical$) are risk factors for bleeding peptic ulcer.	0
It is necessary to be aware of not only gastro-duodenal @Disease$ but also lower intestinal lesions with long-term use of low-dose @Chemical$.	0
Gastric @Disease$ induced by aspirin were significantly inhibited by treatment with @Chemical$.	0
"Conversely, @Chemical$ is well tolerated, has not been shown to contribute to @Disease$ when taken with aspirin, and has not been shown to interfere with the inhibition of platelet aggregation produced by aspirin."	0
"RESULTS: Compared with the blank group, the gastric UI, @Chemical$ levels of both serum and gastric mucosa in the model group were increased obviously (P&lt;0. 01), while serum and @Disease$ activity in the model group were decreased considerably (P&lt;0."	0
METHODS: We retrospectively analysed the medical records of 66 patients admitted to our institution from June 2003 to July 2008 who suffered a primary @Disease$ while receiving antiplatelet (acetylsalicylic acid and/or @Chemical$) therapy.	0
"BACKGROUND: In patients with aspirin-exacerbated @Disease$ (AERD), pretreatment with asthma controller medications (leukotriene modifiers, inhaled or systemic corticosteroids, and @Chemical$) partially modifies the severity of aspirin-induced asthmatic reactions."	0
The rates of both stroke and bleeding increased with higher CHADS2 scores but apixaban compared with @Chemical$ was associated with a similar relative risk of @Disease$ (P interaction 0.21) and a reduced relative risk of stroke (P interaction 0.37) irrespective of CHADS2 category.	0
"A second polymorphism study, conducted on histamine-related genes, did not find any significant associations with @Chemical$-induced urticaria/angioedema for the genes HNMT (encoding histamine N-methyltransferase), HRH1 or HRH2 (encoding histamine receptor types 1 and 2 respectively), or the gene encoding high-affinity IgE receptor Ibeta (FcepsilonRIbeta); however, the FcepsilonRIalpha gene promoter polymorphism was significantly associated with aspirin-induced @Disease$/angioedema."	0
"We investigated the risks of ischemic @Disease$ and intracranial hemorrhage (ICH) in relation to warfarin at various TTRs in a real-world cohort of Chinese patients with atrial fibrillation receiving warfarin and compared with those on dabigatran, @Chemical$, and no therapy."	0
"Risk of bleeding with single, dual, or triple therapy with warfarin, @Chemical$, and clopidogrel in patients with @Disease$."	0
The primary endpoint was to evaluate @Disease$ in healthy subjects before and after taking low-dose @Chemical$ for 4 wk.	0
"To investigate the relationship between @Chemical$ polymorphisms (SNPs) in the RAB1A gene and aspirin-exacerbated respiratory disease (AERD), asthmatics (n=1197) were categorized into AERD and aspirin-tolerant @Disease$ (ATA)."	0
BACKGROUND: The benefit-risk profile of low-dose @Chemical$ in primary prevention of @Disease$ is unclear.	0
CONCLUSIONS: This meta-analysis demonstrates that short-term combination of clopidogrel and @Chemical$ is effective and safe for @Disease$ prevention in high vascular risk patients.	0
"Famotidine group had more @Disease$ episodes than @Chemical$ group (46.9% versus 23.6%, P=0.01)."	0
"Based on the earlier work that aspirin and reduced platelet activity are associated with larger hemorrhage size and hemorrhage growth, we tested the hypothesis that @Chemical$ or reduced platelet activity would be associated with increased odds of craniotomy, likely through @Disease$ growth."	0
"Among patients with H. pylori infection and a history of ulcer bleeding who continue to use low-dose @Chemical$, 1 week of eradication therapy prevents recurrent @Disease$ bleeding."	0
"We performed a randomized, placebo-controlled study to determine the efficacy of @Chemical$ for primary prevention of @Disease$ in patients taking LDA for vascular protection."	0
"Fifteen patients were off therapy; 10 (8%) patients stopped because of @Disease$ and/or gastrointestinal symptoms, whereas 4 patients were switched to other antiplatelet agents by their primary care physician as a matter of choice rather than ASA-@Chemical$ side effects."	0
"Moreover, @Disease$ patients are characterized by the presence of elements of an inflammatory process, which is one of the sources of @Chemical$ (ROS)."	0
BACKGROUND &amp; AIMS: It is not clear whether H2-receptor antagonists (H2RAs) reduce the risk of gastrointestinal (GI) @Disease$ in @Chemical$ users at high risk.	1
Safety and outcomes of aspirin desensitization for @Chemical$-exacerbated @Disease$: A single-center study.	1
The aim of the present study was to evaluate the association between HAPR and albumin levels in patients with stable @Disease$ (CAD) treated with @Chemical$.	0
Sinonasal outcomes after endoscopic sinus surgery in asthmatic patients with nasal polyps: a difference between @Chemical$-tolerant and aspirin-induced @Disease$?	0
BACKGROUND: We previously reported that the ILVBL gene on chromosome 19p13.1 was associated with the risk for aspirin-exacerbated @Disease$ (AERD) and the percent decline of forced expired volume in one second (FEV1) after an oral @Chemical$ challenge test.	0
Effects of @Chemical$ on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant @Disease$tic patients.	0
METHODS: Aspirin-treated patients with @Disease$ were randomly assigned to either prasugrel 10 mg or @Chemical$ 75 mg daily for 7 days.	0
"The triad of bronchial asthma, @Disease$, and intolerance to aspirin and aspirin-like chemicals are designated @Chemical$-induced asthma (AIA) or Samter's syndrome."	0
"The independent risk factors for @Disease$ were regular aspirin-use at the onset of ICH (relative risks [RR], 2.5; 95% CI, 1.3 to 4.6; P=0.004), @Chemical$-use at the onset of ICH (RR, 3.2; 95% CI, 1.6 to 6.1; P=0.001), and ICH score higher than 2 on admission (RR, 13.8; 95% CI, 6.0 to 31.4; P&lt;0.001)."	0
"Of the 46 patients previously hospitalized for @Chemical$/NSAID-induced @Disease$ attacks, 9 (20%) had a 20% to 29% decrease and 6 (13%) had a 30% or greater decrease in FEV(1) during OAC."	1
"An adverse event secondary to @Chemical$ ingestion was defined as anaphylaxis or @Disease$, such as rash or respiratory changes."	1
"METHODS: Using an adult asthma cohort (COREA) from 11 university hospitals in Korea, we analyzed the prevalence of aspirin-intolerant asthma, defined as a positive response to the question: Have you ever experienced dyspnea and @Disease$ after taking an @Chemical$ or any NSAID (cold medicine)?"	0
AIM: The aim of this study was to examine the genotypes of RAS genes related to the risk of peptic ulcer and @Disease$ bleeding among patients taking low dose @Chemical$.	0
"RESULTS: The groups were found to be matched for the confounding variables and no significant differences were found between post-@Chemical$ bleeding (p=0.37), RBCs and blood product usage (p=0.90) or incidences of re-operation for control of @Disease$ (p=1.00) between the two groups."	0
"These studies indicated a deleterious effect of NSAIDs and @Chemical$ in this setting, demonstrating a 2- to 3-fold increase in @Disease$, myocytes necrosis and even mortality when compared with placebo."	0
BACKGROUND: The A to C transversion in the promoter region of the gene encoding leukotriene C4 synthase (LTC4S) is proposed to be associated with the development of @Chemical$-induced asthma (@Disease$).	0
"CONCLUSIONS: In the population of adults in Poland, the frequency of @Chemical$-induced @Disease$ amounted to 0.1%."	1
Such an enhanced antioxidant defence system might represent an adaptive response to protect against increasing @Chemical$ production by inflammatory cells in @Disease$ and help decelerate ongoing respiratory hypersensitivity.	0
"@Chemical$ therapy was associated with a statistically significant increase in total @Disease$ formation (3.3%; 95% CI, 0.4-9.0), but the results were inconclusive."	1
Five randomised controlled trials of healthy volunteers undergoing endoscopy after a period of either enteric-coated aspirin or plain @Chemical$ administration all demonstrated a clear reduction of @Disease$.	0
PPI vs. @Chemical$ in preventing recurrence of @Disease$ during low-dose aspirin.	0
"To prevent attacks of @Disease$, sensitive patients should avoid the use of @Chemical$/NSAIDs or use selective cyclo-oxygenase 2 inhibitors when required."	0
"METHODS: We screened a Korean asthma cohort (581 asthmatics including 81 @Chemical$-intolerant asthmatics and 231 aspirin-tolerant @Disease$tics, and 181 normal controls) for four single nucleotide polymorphisms (SNPs; -262 A&gt;T and -115 T&gt;C in the 5'-flanking region and +5467 T&gt;C [Pro450Pro] and+11860 A&gt;G [Thr776Thr] in the coding region) and one ins/del (+21288 CT) in the ACE gene."	0
"Type 2 inflammation characterizes aspirin-exacerbated respiratory disease.Objectives: To determine whether high-dose @Chemical$ therapy changes biomarkers of type 2 @Disease$ in aspirin-exacerbated respiratory disease.Methods: Forty-two subjects with aspirin-exacerbated respiratory disease underwent an aspirin desensitization and were placed on high-dose aspirin (1,300 mg daily)."	0
Aspirin desensitization achieved after @Chemical$ treatment in a patient with aspirin-exacerbated @Disease$ and respiratory disease.	0
Association between TNF-alpha polymorphisms and the risk of @Disease$ induced by @Chemical$ in patients with coronary heart disease.	1
"Age, male gender, Helicobacter pylori (H. pylori)infection, diabetes, chronic kidney disease (CKD), cirrhosis, history of uncomplicated @Disease$ (PUD), and use of NSAIDs, COX-2 inhibitors, @Chemical$, and thienopyridines were independent risk factors for UGIB among aspirin users."	0
CONCLUSIONS: The presence of the SLCO1B1*1b/*1b diplotype may be a risk factor for aspirin-induced @Disease$ in elderly Chinese men taking @Chemical$ and an ACEI or ARB concomitantly.	0
"Recent interest in @Disease$ has been stirred by the finding of alterations in arachidonate metabolic pathways, leading to @Chemical$ overproduction."	0
STUDY DESIGN: We reviewed the literature for published studies that reported exposure to @Chemical$ during the first trimester of pregnancy and @Disease$.	0
@Chemical$ systemic production in patients with @Disease$ with and without aspirin hypersensitivity.	0
"The prevalence of self-reported confirmed inhalant allergy was 13.1, 20.3, 31.0 and 33.3% respectively; house dust mite @Disease$ was significantly higher in CRSwNPs (16%) compared to @Chemical$sNPs (9%, p &lt; 0.001)."	0
"Employing two molecular biological methods, we demonstrate that galectin-10 mRNA is overexpressed in @Disease$, suggesting a novel candidate gene and a potentially innovative pathway for mucosal inflammation in @Chemical$ intolerance."	0
We investigated whether injury was correlated with platelet function and gastric juice pH in 45 patients with @Disease$ administered @Chemical$ daily (study 2).	0
"DISCUSSION: Patients with @Chemical$-provoked FDEIA have been reported previously as taking ordinary doses of aspirin for reducing pain, inflammation and @Disease$."	0
@Chemical$ use and @Disease$ of the upper aerodigestive tract.	0
"OBJECTIVE: To determine the risk of @Disease$ (UGIB) associated with the use of coxibs, traditional NSAIDs, @Chemical$ or combinations of these drugs in clinical practice."	0
All of them concomitantly received 100 mg/day @Chemical$ because of previous ischaemic heart disease and presented similar clinical features: sudden onset of @Disease$ during a severe cough episode due to bronchial infection.	0
"CONCLUSIONS: In a meta-analysis, low doses of @Chemical$ increased the risk for GI @Disease$; risk increased with accompanying use of clopidogrel and anticoagulant therapies, but decreased in patients who took PPIs."	1
HYPOTHESIS: Desensitization to ASA may be carried out safely and effectively in patients with reported ASA or nonsteroidal anti-inflammatory drug (NSAID) @Disease$ needing @Chemical$ for cardiac indications.	0
"@Chemical$ also potentiates some acute allergies such as food-dependent exercise-induced anaphylaxis (FDEIA), a food @Disease$ induced by physical exercise."	0
Method: Eighty-six patients with CRS and @Disease$ who were treated in the outpatient clinic during March 2015 to January 2018 were divided into asthma group(52 cases) and @Chemical$ asthma group(34 cases) according to asthma and aspirin asthma.	0
CONCLUSION: The effective analgesic and anti-inflammatory doses of 1:10 aspirin complex with @Chemical$ are twice less compared to pure aspirin and safer for the @Disease$.	0
Aspirin-induced @Disease$ (AIA) is associated with increased production of @Chemical$ (CysLT).	0
OBJECTIVE: Difference in the risk of gastrointestinal (@Disease$) complications between users of enteric-coated and buffered low-dose aspirin (@Chemical$) is unclear.	0
"BACKGROUND: Aspirin triad is a subclass of chronic sinusitis characterized by nasal polyposis, nonallergic induced @Disease$, and @Chemical$ sensitivity."	0
"These results show that in patients with mild to moderate @Disease$ resulting from MSC, ibuprofen given in OTC doses for 6 days is as well tolerated as paracetamol and better tolerated than @Chemical$."	0
@Chemical$ is a very useful medication for the prevention of cardiovascular @Disease$ events in patients with or those at risk for cardiovascular disease (CVD).	0
Rapid oral @Chemical$ desensitization for patients with aspirin @Disease$ requiring dual antiplatelet therapy.	0
"CONCLUSIONS: Low-dose @Chemical$ increases the risk of major bleeding by approximately 70%, but the absolute increase is modest: 769 patients (95% CI, 500-1250) need to be treated with aspirin to cause one additional major @Disease$ episode annually."	0
CONCLUSION: 1 Patients with aspirin @Disease$ have higher concentration of @Chemical$.	0
"The ICrHs were spontaneous in 6 and 13, @Disease$ in 3 and 3, and procedural in 3 and 2 patients on ticagrelor and @Chemical$, respectively."	0
"The acute clinical symptoms that develop following the oral ingestion of @Chemical$, or any other inhibitor of cyclooxygenase-1, are well established in aspirin-exacerbated respiratory disease: nasal congestion, rhinorrhea, and @Disease$."	0
METHODS: Patients taking 100mg of enteric-coated @Chemical$ for @Disease$ who also participated in endoscopic surveillance were studied.	0
"@Chemical$-induced urticaria and angioedema, but not bronchoconstriction, associated with cysteinyl leukotriene overproduction in 2 patients with @Disease$."	0
"CONCLUSIONS: When combined with ACEI or ARB, @Chemical$ had no demonstrable adverse effect on intermediate-term postdischarge outcomes for patients with @Disease$ or nonischemic HF."	0
Early effects of @Chemical$ desensitization treatment in @Disease$tic patients with aspirin-exacerbated respiratory disease.	0
The grade of gastric mucosal injury was assessed endoscopically according to the modified Lanza score; intensive @Chemical$-induced @Disease$ was defined as a modified Lanza score of &gt;=4.	1
"CONCLUSIONS: We found that the prevalence of CMBs did not increase in the group of @Chemical$ use, and the presence of CMBs was not associated with the duration of aspirin use in asymptomatic elderly subjects without a history of stroke or transient @Disease$ attack."	0
"METHODS: Patients &gt;=50years with prior MI 1-3years ago and &gt;=1 risk factor (age &gt;=65years, @Disease$, 2nd prior MI &gt;1yr ago, multivessel CAD, @Chemical$ clearance 15-&lt;60ml/min) were enrolled by 369 physicians (96% cardiologists) in 25 countries (2013-14) in the prospective TIGRIS study (NCT01866904)."	0
Low-dose @Chemical$ medication for one week does not affect either cyclooxygenase expression or duodenal PGE(2) levels and therefore is likely to induce duodenal damage mainly through topical @Disease$.	1
"The resumption of @Chemical$ combined with aspirin use (RR 26.71, 95%CI 7.09-100.53), and increased @Disease$ size (RR 1.52, 95%CI 1.14-2.02), were significantly associated with post-ESD bleeding."	0
"METHODS: To define the reduction in @Disease$ events required to outweigh increased bleeding with longer-duration DAPT, we developed a decision-analytic Markov model comparing @Chemical$ durations of 6, 12, and 30 months after DES."	0
"To investigate the relationship between single-nucleotide polymorphisms (SNPs) in the RAB1A gene and @Chemical$-exacerbated @Disease$ (AERD), asthmatics (n=1197) were categorized into AERD and aspirin-tolerant asthma (ATA)."	0
METHODS: Patients with aspirin-related non@Disease$ symptomatic ulcers were randomised to receive rabeprazole (20 mg/day) plus aspirin (100 mg/day) or @Chemical$ (20 mg/day) plus clopidogrel (75 mg/day) for 12 weeks.	0
"Allergic conditions include aspirin-exacerbated respiratory disease (AERD or @Chemical$-induced asthma), aspirin-induced @Disease$/angioedema (AIU), and anaphylaxis."	0
"Response to letter regarding article, Ischemic stroke and @Disease$ with aspirin, @Chemical$, and warfarin: impact of quality of anticoagulation control."	0
"CONCLUSIONS: Low-dose aspirin induced a surprisingly high incidence of acute gastroduodenal @Disease$ in at risk subjects, highlighting that @Chemical$'s upper GI risk begins early and may require gastroprotection."	0
"BACKGROUND/AIMS: Many patients with @Chemical$-induced @Disease$ have severe methacholine airway hyperresponsiveness (AHR), suggesting a relationship between aspirin and methacholine in airway response."	1
"Calotropis gigantea, Carica papaya, Jatropha curcas, Oxystelma esculentum, Tabernaemontana divaricata, and Vallaris solanacea LPFs and papain from C. papaya latex significantly reduced @Disease$ on a topical application in normal and @Chemical$ administered mice."	0
"@Chemical$ exacerbated respiratory disease (AERD) is characterized as adult onset asthma, nasal polyps, @Disease$, and hypersensitivity to a cyclooxygenase-1 (COX-1) inhibitor, viz aspirin or nonsteroidal antiinflammatory drugs (NSAIDs)."	1
"She had no symptom of urticaria and asthma, and had the both character of @Chemical$ urticaria and @Disease$ as to aspirin challenge test."	0
"Type 2 inflammation characterizes aspirin-exacerbated respiratory disease.Objectives: To determine whether high-dose aspirin therapy changes biomarkers of type 2 inflammation in @Chemical$-exacerbated respiratory disease.Methods: Forty-two subjects with aspirin-exacerbated @Disease$ underwent an aspirin desensitization and were placed on high-dose aspirin (1,300 mg daily)."	0
"OBJECTIVES AND METHODS: The cysteinyl leukotriene receptor 2 (CYSLTR2) gene on chromosome 13q14.12-q21.1 encodes a receptor for CYSLTs, potent biological mediators in the pathogenesis of @Disease$, particularly that associated with aspirin intolerance (@Chemical$)."	0
"METHODS: To assess response to medical therapy in patients taking aspirin prior to admission with an acute @Disease$, we reviewed outcomes data from the Efficacy and Safety of Subcutaneous @Chemical$ in Non-Q-wave Coronary Events (ESSENCE) and Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) studies."	0
"However, treatment with @Chemical$ and an LTRAs may inhibit @Disease$ attacks induced by celecoxib."	0
"BACKGROUND: Clinical features of @Chemical$-exacerbated @Disease$ (AERD) are characterized by overproduction of cysteinyl leukotrienes (LT) and eosinophil activation, in which epithelial cells contribute to eosinophilic airway inflammation."	1
"We conclude that in patients with an @Disease$ and OAC based regimen, addition of @Chemical$ because of a stent placement results in a significant increase in NSH but no increase in SH."	0
Adjusted HRs for acetylsalicylic acid versus the combination of @Chemical$ and dipyridamole were 1.48 (95% CI: 1.31-1.67) for stroke and 1.47 (95% CI: 1.18-1.82) for @Disease$.	0
"In the Evaluation of Vascular Care in Alzheimer's Disease (EVA) trial (conducted in our center), 4.6% of patients in the group receiving a multicomponent treatment that included @Chemical$ had an @Disease$ (3/65; 95% confidence interval [CI], 1.0 to 12.9) versus 0% in the control group (0/58; 95% CI, 0 to 6.2)."	0
"Nonetheless, @Chemical$'s effectiveness in such disease prevention is limited by the risk of upper and lower gastrointestinal (GI) complications such as ulceration, @Disease$ and perforation."	0
It is generally accepted that in aspirin-induced asthma (AIA) the @Disease$ is provoked by inhibition of @Chemical$ synthesis with overproduction of cysteinyl leukotrienes.	0
BACKGROUND: Aspirin desensitization (AD) treatment at doses of up to 1300 mg/day improves outcomes in @Chemical$-exacerbated @Disease$ (AERD).	1
@Chemical$ desensitization in a patient with NSAID-induced delayed @Disease$.	0
"Some of the evidence points to illness severity being dose related although it seems that in the presence of a @Disease$, no dose of @Chemical$ can be considered safe."	0
The effects of inhaled @Chemical$ on fractional exhaled NO (FENO) in patients with aspirin-tolerant (ATA) and aspirin-inducible (@Disease$) asthma compared with normal controls have been investigated.	0
"The aim of this blinded, randomised, multicentre study was to compare the tolerability of aspirin, @Chemical$ and ibuprofen in common @Disease$ resulting from musculoskeletal conditions (MSC) in general practice with patients with other non-MSC pain conditions."	0
Prescription and event sequence symmetry analysis was used to identify the risk of @Chemical$-induced @Disease$ complications over the period from January 2005 to July 2011.	1
"Some asthmatics may react to @Chemical$ and other NSAIDs with acute bronchoconstriction, profuse @Disease$ and skin flushing."	0
"The improved pulmonary function in the group receiving @Chemical$ occurred at the same time as 27% less bronchodilator was used (p &lt; 0.05), and it was associated with fewer @Disease$ symptoms than in the group given placebo, including 1.3 nights more of sleep per week and 54% fewer asthma exacerbations (p &lt; 0.05)."	0
Meta-analysis on the effect of @Chemical$ use for prevention of preeclampsia on placental abruption and antepartum @Disease$.	0
CONCLUSION: Recognition of the association between Samter's syndrome and otological disease is important (26% of the cases) because it could also be responsive to systemic @Chemical$ which prevent progression to irreversible hearing loss or @Disease$.	0
"METHODS: Genotyping of LTC4S gene promoter was performed on 60 patients with AIA, 100 patients with @Chemical$-tolerant @Disease$ (ATA), and 110 control subjects."	0
"RESULTS: Among patients discharged after first-time ischemic @Disease$, 3043 patients were treated with acetylsalicylic acid, 12,295 with a combination of @Chemical$ and dipyridamole, and 3885 with clopidogrel."	0
We address the strength of evidence between low-dose @Chemical$ use and @Disease$ and also discuss the risks and benefits of aspirin use in primary versus secondary prevention of cardiovascular diseases in these cases.	0
"CONCLUSIONS: As endoscopy frequently reveals gastroduodenal disorder among low-dose aspirin users, both administration of BA and of enteric-coated @Chemical$ warrant concern for gastroduodenal @Disease$."	0
"PATIENTS AND METHODS: Using data from the Women's Health Initiative, we estimated hazard ratios for CRC in association with @Chemical$ use, with stratifications by @Disease$ (CVD) risk status, family history of CRC, and history of colorectal polypectomy."	0
In subjects with aspirin @Disease$ disruption of synthesis of prostaglandin E2 (PGE2) and overproduction of @Chemical$ (Cys-LT) seem to be crucial in the pathogenesis of bronchial symptoms.	0
"METHODS: We investigated intolerance and @Disease$ while on aspirin and aspirin discontinuation using 5337 post-acute coronary syndrome patients considered appropriate for chronic antiplatelet therapy who were randomly assigned to @Chemical$ in SYMPHONY and 2nd SYMPHONY and followed for 94 (64,157) days."	0
"Even at the top TTR quartile, warfarin was associated with a higher @Disease$ and ICH risk than @Chemical$."	0
"METHODS: By using specific antibodies, immunohistochemistry, and image analysis, we measured the expression of EP(1-4) in nasal biopsies from patients with @Chemical$-sensitive (n = 12) and nonaspirin-sensitive (n = 10) polypoid @Disease$ and normal controls (n = 9)."	0
"We encountered lower gastrointestinal bleeding in 16 patients taking a low dose of aspirin and examined the effect of low @Chemical$ dose on the stool occult blood test in 49 thrombotic patients (mean: 76.7 +/- 9.6 years old) including 39 with cerebral infarction, 8 with ischemic heart disease and 2 with @Disease$."	0
"Also, women had less peripheral artery disease (aspirin, 2.4% versus 3.7%; apixaban, 1.4% versus 3.0%), more heart failure, and higher mean CHADS2 (congestive heart failure, @Disease$, age of 75 years or older, diabetes [1 point each], stroke or transient ischemic attack [2 points]) scores (aspirin, 2.2 versus 2.0; @Chemical$, 2.1 versus 2.0)."	0
"Methods: Serum total @Chemical$, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol and triglyceride were tested in a subgroup of 3 044 consecutive patients from Clopidogrel in High-risk patients with Acute @Disease$ (CHANCE) trial."	0
RESULTS: The use of low-dose @Chemical$ without gastroprotective agents was found to be associated with the risk of peptic @Disease$.	1
Rapid @Chemical$ challenge/desensitization in the aspirin allergic patient has been consistently shown to be both safe and successful in patients with @Disease$s.	0
Clopidogrel and @Chemical$ in @Disease$.	0
RESULTS: Two randomized controlled trials on @Chemical$ for @Disease$ were found.	0
"CONCLUSIONS: The highly sensitive @Chemical$ profiling in EBC makes it possible to detect alterations in asthma, especially in its distinct phenotype characterized by @Disease$ to aspirin and other nonsteroidal anti-inflammatory drugs."	0
"Variables included clinical coronary heart disease (CHD), number of @Disease$ risk factors, diabetes diagnosis, number of chronic medications and presence of contraindications to @Chemical$."	0
"In the @Chemical$ group one patient developed a postoperative epidural @Disease$ needing revision surgery, while in the control group no postoperative epidural hematomas were seen (p = 0.40)."	0
METHODS: The Apixaban versus Acetylsalicylic Acid to Prevent @Disease$ in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin k Antagonist Treatment (AVERROES) trial randomized 5599 patients with atrial fibrillation and risk factors to receive either @Chemical$ or aspirin.	0
Aggrenox (@Chemical$)-induced @Disease$.	1
"Hypersensitivity to acetylsalicylic acid (@Chemical$) is characterized by the co-occurrence of symptoms so-called aspirin triad, which include bronchial asthma, chronic @Disease$ and sinusitis and the nasal mucosa polyps."	0
"Aspirin (@Chemical$)-induced asthma (AIA) consists of the clinical triad of @Disease$, chronic rhinosinusitis with nasal polyps, and precipitation of asthma and rhinitis attacks in response to aspirin and other NSAIDs."	0
CONCLUSIONS: Provided patients are carefully chosen and monitored @Chemical$ challenge is suitable for ENT day case practice where respiratory physician help with @Disease$ is available and should reduce the under-diagnosis of this condition.	0
"CASE SUMMARY: A 44-year-old white woman, previously tolerant to @Chemical$ and other nonsteroidal antiinflammatory drugs (NSAIDs), developed @Disease$ of the lips after ingesting two 325-mg aspirin tablets during one day."	0
BACKGROUND: Patients with aspirin-exacerbated respiratory disease (AERD) are distinguished from patients with aspirin-tolerant @Disease$ (ATA) by significantly higher baseline concentrations of urinary @Chemical$ (uLTE4).	0
@Chemical$(2) significantly enhanced anti-IgE induced histamine and PGD(2) release from mast cells of normal subjects but not those of ATA and @Disease$ patients.	0
OBJECTIVE: Low-dose aspirin (@Chemical$) is widely used because it reduces the risk of vascular events in patients with @Disease$.	0
"To evaluate the @Disease$ risk in patients requiring chronic warfarin therapy and undergoing stent implantation, we compared 107 consecutive patients on chronic warfarin therapy who underwent coronary stenting and were discharged on aspirin, clopidogrel and warfarin to 107 contemporary patients who were treated with @Chemical$ and clopidogrel."	0
"In details, DHI decreased @Disease$ @Chemical$ level, increased CAT, GSH-Px and SOD activity, and reduced MDA concentration (P&lt;0.05)."	0
PURPOSE: To determine if patient @Chemical$ exposure and timing affect @Disease$ risk after renal allograft biopsy.	0
"CONCLUSIONS: @Chemical$ intake overall was not associated with early @Disease$ in this sample of Asian Indians, but in those with a history of cardiovascular disease the association between aspirin intake and early AMD might warrant further investigation."	0
Aspirin Does Not Increase @Disease$ Events in Heart Failure Patients: From the @Chemical$ Trial.	0
"Conventionally, hypersensitivities include @Chemical$-exacerbated respiratory disease (AERD), ASA-induced @Disease$, and anaphylaxis."	0
"Acetylsalicylic acid or nonsteroidal antinflammatory drug sensitivity can be manifested as acute urticaria, angioedema, acute asthma, @Chemical$ exacerbated @Disease$ and anaphylaxis."	0
"Further, oral administration of @Chemical$ could prevent @Disease$ induced by ingestion of 100g wheat, but sodium cromoglycate partially reduced the reactions."	0
"METHODS: Ancillary analysis of the Apixaban Versus Acetylsalicylic Acid [ASA] to Prevent @Disease$ in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment (AVERROES) trial, comparing @Chemical$ and apixaban, focused on sex differences."	0
Is @Chemical$ a cause of @Disease$?	0
Main causes of GI bleeding with low-dose @Chemical$ are gastroduodenal peptic @Disease$ and colonic diverticulosis.	0
"Lack of aspirin responsiveness on initial testing was a significant risk factor for @Disease$ (P &lt; .001) independent of age, weight, diagnosis, and initial @Chemical$ dose."	0
It is generally accepted that in aspirin-induced asthma (@Disease$) the bronchospasm is provoked by inhibition of prostaglandin synthesis with overproduction of @Chemical$.	0
"On the other hand, a very low dose of @Chemical$ (10 mg daily) decreases the gastric mucosal prostaglandin levels and causes significant @Disease$."	0
"This was significantly different in a high-risk stroke setting (incidence 5%) where the required relative risk reduction with @Chemical$ use for physicians was 20% versus patients 40% (P &lt;0.001); and for @Disease$, physicians 20% versus patients 36% (P=0.051)."	0
We compared @Disease$ and all-cause mortality after dual antiplatelet therapy (DAPT) for the combination of @Chemical$ and aspirin (ASA) versus ASA alone over 18 months follow-up in event-free patients at 12 months DAPT from the Health Insurance Review and Assessment (HIRA) dataset via the Korean Outcomes Registry Evaluating Antithrombotics (KOREA).	0
"Also, women had less peripheral artery disease (aspirin, 2.4% versus 3.7%; apixaban, 1.4% versus 3.0%), more heart failure, and higher mean CHADS2 (congestive @Disease$, hypertension, age of 75 years or older, diabetes [1 point each], stroke or transient ischemic attack [2 points]) scores (aspirin, 2.2 versus 2.0; @Chemical$, 2.1 versus 2.0)."	0
"Our institutional @Disease$ registry was used to identify patients 65 years old or older after a GLF while taking warfarin, @Chemical$, or aspirin over a 2-year period."	0
CONCLUSION: The DDAVP-induced improvement of primary @Disease$ in patients with @Chemical$-like defect is mainly due to the marked increase of the VWF.	0
"We investigated the risks of ischemic stroke and @Disease$ (ICH) in relation to warfarin at various TTRs in a real-world cohort of Chinese patients with atrial fibrillation receiving @Chemical$ and compared with those on dabigatran, aspirin, and no therapy."	0
BACKGROUND/AIMS: The differences in the severity of @Disease$ induced by aspirin and non-@Chemical$ non-steroidal anti-inflammatory drugs (NSAIDs) remain unclear.	0
RESULTS: The authors identified 37 patients with @Chemical$-related @Disease$ but otherwise intact upper gastrointestinal tracts.	1
"CONCLUSIONS: In this observational study, @Chemical$ use was not associated with an increase in mortality rates or HF readmission rates, and aspirin did not attenuate the benefits of ACE inhibitors, even in patients without @Disease$, patients with renal dysfunction, or patients treated with high-dose aspirin and low-dose ACE inhibitors."	0
"CONCLUSION: @Disease$ were significantly milder in the LDA group than in the non-@Chemical$ NSAID group, though reddened lesions were more frequent in the LDA group."	0
"If @Chemical$ and @Disease$ association are not formally documented in France, cautiousness must be kept in mind and all the aspirin adverse effects notifications should be addressed to the public drugs survey network."	0
"Compared with @Chemical$ alone, the combination increased modified International Society on Thrombosis and Hemostasis major bleeding (288 of 9,152 [3.1%] vs. 170 of 9,126 [1.9%]), (HR: 1.70; 95% CI: 1.40 to 2.05; p &lt; 0.001), International Society on @Disease$ and Hemostasis major bleeding (206 of 9,152 [2.3%] vs. 116 of 9,126 [1.3%]), (HR: 1.78; 95% CI: 1.41 to 2.23; p &lt; 0.0001), and minor bleeding (838 of 9,152 [9.2%] vs. 503 of 9,126 [5.5%]), (HR: 1.70; 95% CI 1.52 to 1.90; p &lt; 0.0001); the combination also increased the need for any red cell transfusion (87 of 9,152 [1.0%] vs. 44 of 9,126 [0.5%]), (HR: 1.97; 95% CI 1.37 to 2.83, p = 0.0002)."	0
"In addition, in vitro experiments were performed in which @Disease$ cell line (MKN-45 cells) was incubated with ASA or ASA-@Chemical$ alone or in combination with H.pylori."	0
CONCLUSION: CYSLTR2 polymorphisms are associated with @Chemical$ intolerance in @Disease$tics.	0
BACKGROUND: A complex relationship between @Chemical$ metabolites and nitric oxide (NO) synthesis has been reported in @Disease$.	0
"CONCLUSION: After intravitreal injection of @Chemical$, no significant toxicity sign was observed other than a reversible @Disease$."	0
Glutathione peroxidase activity in blood cells from @Chemical$-induced @Disease$ patients.	1
"All 129 patients with high risk @Disease$ with microbleeds or minor stroke within 24 hours after the onset (average age 65.9 +- 9.3, 48.7% were male patients) were divided randomly into two groups: (1) 67 patients were given combination therapy with clopidogrel and aspirin (@Chemical$ at an initial dose of 300 mg, then 75 mg per day for 90 days, plus aspirin at a dose of 75 mg per day for the first 21 days);(2) the rest patients were given aspirin treatment (75 mg per day for 90 days)."	0
"@Chemical$ at a dose of &lt;100 mg per day had no impact on the risk of @Disease$ or antepartum hemorrhage, irrespective of whether it was initiated at &lt;=16 weeks of gestation (relative risk, 1.11; 95% confidence interval, 0.52-2.36) or at &gt;16 weeks of gestation (relative risk, 1.32; 95% confidence interval, 0.73-2.39)."	0
The pathogenic mechanism of @Chemical$ (ASA)-induced @Disease$ (AIU) is not fully understood.	0
"Aspirin-exacerbated respiratory disease (@Disease$) severity and its clinical phenotypes are characterized by genetic variation within pathways for @Chemical$ metabolism, inflammation, and immune responses."	0
"BACKGROUND: @Chemical$-exacerbated respiratory disease (@Disease$) is explained in part by overexpression of 5-lipoxygenase and leukotriene C4 synthase (LTC4S), resulting in constitutive overproduction of cysteinyl leukotrienes (CysLTs) and driving the surge in CysLT production that occurs with aspirin ingestion."	0
"@Chemical$-exacerbated @Disease$ is a clinical entity comprising chronic rhinosinusitis with nasal polyposis, asthma and intolerance to COX-1 inhibiting drugs."	1
Leukotriene-related gene polymorphisms in patients with @Chemical$-intolerant @Disease$ and aspirin-intolerant asthma: differing contributions of ALOX5 polymorphism in Korean population.	0
CONCLUSIONS: @Chemical$ induced @Disease$ in adults is more prevalent than previously suggested.	1
"We recruited 139 AERD patients, 171 @Chemical$-tolerant @Disease$ patients and 160 normal controls."	0
"OBJECTIVE: The aim of this systematic review was to provide the odds ratios (ORs) of major bleeding, intracranial @Disease$ or major extra-cranial bleeding of anticoagulation with VKA compared to low doses of @Chemical$."	0
"BACKGROUND: @Chemical$ (ie, aspirin) administration inhibits @Disease$ in dogs and is associated with increased perioperative blood loss and transfusion requirements in people."	0
"OBJECTIVE: The aim of this study was to determine whether concomitant treatment with LTMDs was associated with a reduction of ASA-provoked lower respiratory tract reactions in patients with @Chemical$-exacerbated respiratory disease (@Disease$), when compared to AERD patients who were not treated with LTMDs."	0
"@Chemical$, aspirin, and @Disease$."	0
Nasal polyp tissues were obtained from 29 patients [including nine with @Chemical$ (ASA)-@Disease$ and 12 with bronchial asthma] undergoing polypectomy for nasal obstruction.	0
Obesity in aspirin-tolerant and @Chemical$-intolerant @Disease$tics.	0
"In about 10% of adult patients with @Disease$, @Chemical$ and other nonsteroidal anti-inflammatory drugs precipitate attacks of dyspnoea."	0
"The effect of pre-operative @Chemical$ on bleeding, transfusion, @Disease$, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies."	0
@Chemical$-induced @Disease$ without aspirin intolerance.	1
"Estimates of absolute rates of harm from @Chemical$ use, per 100,000 patient-years of follow-up, were 99-178 for non-trivial bleeds, 46-49 for major bleeds, 68-117 for GI @Disease$ and 8-10 for haemorrhagic stroke."	0
This study compared the preventive effect of histamine-2 receptor antagonists (H2RAs) and proton-pump inhibitors (PPIs) against chronic low-dose aspirin (@Chemical$)-related @Disease$ and ulcer formation.	1
"The @Chemical$ TTR &gt;=55% episodes were associated with a 77% lower risk of stroke/SE (relative risk=0.23 [0.18 to 0.28]) compared to never on therapy; and the warfarin TTR &lt;55% and on-aspirin episodes were associated with a 20% lower and with a 26% lower risk of @Disease$/SE compared to never on therapy, respectively."	0
OBJECTIVE: To investigate the feasibility of periodontal mechanical therapy for chronic periodontitis and @Disease$ patients with low dose of @Chemical$.	0
"Participants completed a detailed questionnaire at baseline assessing @Chemical$ use, @Disease$ status, and AMD risk factors."	0
"@Chemical$-exacerbated respiratory disease (AERD) is a unique syndrome of airway inflammation that frequently occurs in patients with nasal polyposis, chronic sinusitis, and @Disease$."	0
"A second polymorphism study, conducted on histamine-related genes, did not find any significant associations with aspirin-induced urticaria/@Disease$ for the genes HNMT (encoding histamine N-methyltransferase), HRH1 or HRH2 (encoding histamine receptor types 1 and 2 respectively), or the gene encoding high-affinity IgE receptor Ibeta (FcepsilonRIbeta); however, the FcepsilonRIalpha gene promoter polymorphism was significantly associated with @Chemical$-induced urticaria/angioedema."	0
"Although treatment and prevention for low-dose @Chemical$ (LDA) induced @Disease$ is important problem, significance of H. pylori eradication has not been clarified."	1
OBJECTIVE: To characterize the clinical presentation of a cohort of patients with @Disease$ (CAD) and @Chemical$ reactions.	0
"RECENT FINDINGS: Numerous studies, including randomized, double-blind, placebo-controlled trials, have demonstrated the therapeutic effectiveness of aspirin desensitization with significant improvement in number of sinus infections per year, olfactory scores, nasal symptom scores, @Disease$ symptom scores, sinus operations, hospitalizations, emergency room visits, and oral @Chemical$ use."	0
"RESULTS: A 77-yo, HIV-negative female under longterm treatment over three years with @Chemical$ 50 mg/d for varicositas, prescribed by her general practitioner, experienced @Disease$ with radiation towards both knees after getting up in the morning."	0
"Despite more than a half-century of recognition, the triad characterised by severe asthma, @Disease$ and @Chemical$ intolerance known as aspirin-induced asthma or Widal's triad remains markedly underdiagnosed and mistreated."	0
"@Chemical$ desensitization, followed by daily aspirin treatment, is a valuable therapeutic option in most patients with AIA, particularly those with recurrent @Disease$ or overdependence on systemic corticosteroids."	0
BACKGROUND: This study evaluated the risk of @Disease$ (UGIB) associated with use of low-dose acetylsalicylic acid (@Chemical$) alone and in combination with other gastrotoxic medications.	1
@Chemical$ sensitivity and desensitization for asthma and @Disease$.	1
"CASE REPORT: A 58-year-old Caucasian male with a history of @Disease$ and hypercholesterolemia, under treatment with acetyl-@Chemical$ for 6 years and simvastatin for 2 months, presented to the Emergency Department of our hospital with epigastric pain and vomiting of 24-hour duration."	0
"Sodium cromoglycate (SCG) is used for the treatment of atopic dermatitis with food allergy, but the efficacy of SCG in @Chemical$-exacerbated @Disease$ reactions is unclear."	0
"In view of the above, it was decided to study both the effect of @Chemical$ monotherapy and that of fluoxetine co-administered with acetylsalicylic acid on lipid peroxidation and antioxidative defense in patients with the first @Disease$ episode in their life."	0
Effect of @Chemical$ and other NSAIDs on postmenopausal @Disease$ incidence by hormone receptor status: results from a prospective cohort study.	0
"Combination therapy with @Chemical$, clopidogrel and warfarin following coronary stenting is associated with a significant risk of @Disease$."	0
"CONCLUSION: Although cysLT 1 expression predominates on inflammatory leukocytes in patients with @Chemical$-sensitive @Disease$, the effects of cysteinyl leukotrienes on glands and epithelium may be mediated predominantly through cysLT 2."	0
One clinically relevant phenotype is that of @Chemical$-sensitive @Disease$ (ASRD) which is more frequently seen in patients with difficult asthma.	0
"Several types of diet, @Disease$ (DRY, DF: 2.8 %), canned food (CAN, DF: 0.4 %), and diets with added @Chemical$ or pectin were provided twice daily."	0
"Hypersensitivity to @Chemical$ and other non steroidal anti-inflammatory drugs (NSAIDs) manifesting in the airways (rhinosinusitis, polyps, asthma) or in the skin (@Disease$, angioedema) is the second most frequent untoward allergic reaction to drugs."	1
Association of @Chemical$ resistance with increased stroke severity and @Disease$ size.	0
PPI versus Histamine H2 Receptor Antagonists for Prevention of Upper @Disease$ Associated with Low-Dose @Chemical$: Systematic Review and Meta-analysis.	1
We also aimed to assess the effects of @Chemical$ pretreatment and to ascertain the value of platelet function studies as predictors of postoperative @Disease$.	0
"This multicentre, randomized, investigator-blinded, parallel-group study compared the gastrointestinal (GI) tolerability of ibuprofen, @Chemical$ and aspirin at over-the-counter doses for common @Disease$ indications."	0
"BACKGROUND AND AIMS: Nitric oxide-releasing aspirin (NO-ASA) has been shown to inhibit cyclo-oxygenase and @Chemical$ generation without causing @Disease$, but the role of reactive oxygen species (ROS) and cytokines in the action of ASA and NO-ASA against acute gastric damage has been little studied."	0
"BACKGROUND: In 5 to 10% of adult patients with @Disease$, @Chemical$ (acetylsalicylic acid [ASA]) and most other nonsteroidal anti-inflammatory drugs (NSAIDs) precipitate acute asthmatic attacks."	0
"These include @Disease$ and asthma induced by NSAIDs (also known as @Chemical$-exacerbated respiratory disease), NSAID-exacerbated cutaneous disease (NECD), urticaria or angioedema induced by multiple NSAIDs, single NSAID-induced reactions, and delayed NSAID reactions."	0
Intranasal @Chemical$ challenge for the diagnosis of aspirin-exacerbated @Disease$.	0
This study evaluated the risk of ischemic stroke (IS) and TIA after low-dose @Chemical$ discontinuation in patients with @Disease$ or cerebrovascular disease.	0
@Chemical$ sensitivity syndrome (Samter's Triad): an unrecognized disorder in children with @Disease$.	0
"Also in patients with @Disease$, @Chemical$ should be withdrawn prior to the operation."	0
"Thirteen of all 30 ICrHs (4 on ticagrelor and 9 on @Chemical$) were hemorrhagic strokes, and 4 (2 in each group) were symptomatic hemorrhagic transformations of @Disease$."	0
The serum @Chemical$ level and transferrin saturation (@Disease$) were significantly lower in group C patients than those in group A.	0
The aim of the investigation was to study melatonin production in thrombocytes and their functional activity in correlation with 6-sulfatoximelatonin (@Chemical$) urinary excretion in patients with aspirin-induced @Disease$ (AIBA).	0
Aspirin and @Disease$: discovery of @Chemical$ and paracetamol.	0
"Fifteen famotidine group patients and 5 @Chemical$ group patients had recurrent @Disease$/erosions (30.6% versus 9.1%, P=0.005)."	0
"@Chemical$-Tris did not influence the cyclooxygenase-induced @Disease$ significantly, but the inflammatory pain was reduced as effectively as in the case of equimolar ASA doses."	0
"We sought to assess the performance of existing bleeding risk scores, such as the Hypertension, @Disease$, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/@Chemical$ Concomitantly (HAS-BLED) score or the Outpatient Bleeding Risk Index (OBRI), in patients with heart failure with reduced ejection fraction (HFrEF) in sinus rhythm (SR) treated with warfarin or aspirin."	0
CONCLUSIONS: Omeprazole was superior to @Chemical$ with less gastrointestinal symptoms and recurrent @Disease$/erosions in patients using 24-week low-dose aspirin.	0
"Higher CHADS2 scores are associated with increasing rates of @Disease$ and stroke, but the balance between risks and benefits of apixaban compared with @Chemical$ is favorable irrespective of baseline stroke risk."	0
Prostaglandins mediate various physiological aspects of mucosal defense and the suppression of @Chemical$ synthesis in the stomach is a critical event in terms of the development of @Disease$ after NSAID administration.	0
"The use of low-dose @Chemical$ (LDA) is well known to be associated with an increased risk of serious @Disease$, such as peptic ulceration and bleeding."	1
"BACKGROUND: @Chemical$-exacerbated respiratory disease (AERD) is characterized by progressive @Disease$, nasal polyposis, and asthma that begins and continues in the absence of exposure to aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs)."	0
"Many of these patients present with the so-called aspirin triad of @Chemical$ sensitivity, @Disease$ with associated nasal polyposis, and severe asthma."	0
Twenty @Disease$ and 10 aspirin tolerant controls (ATC) were challenged with @Chemical$ or 14.4mg of Lys-ASA.	0
We hypothesized that lyophilized aspirin/trehalose could decrease the severity of @Chemical$-induced @Disease$.	1
"On epithelial and glandular cells, expression of cysLT 2 significantly exceeded that of cysLT 1 in both the patients with @Disease$ and the controls ( P &lt; or = .004), although there was no significant difference in the expression of either receptor in the patients with rhinosinusitis (aspirin-sensitive or @Chemical$-tolerant) and the controls."	0
"Gastrointestinal bleeding in patients receiving a combination of aspirin, @Chemical$, and enoxaparin in acute @Disease$."	0
"Recent advances in endoscopic techniques such as capsule endoscopy have revealed that @Chemical$ and other nonsteroidal antiinflammatory drugs (NSAIDs) often cause mucosal lesions not only in the @Disease$, but also in the small intestine in humans."	0
"Platelet reactivity time (PRT) and whole blood aggregation (WBA) were measured in 160 healthy volunteers, before and after aspirin and in 170 participants with established @Disease$ or risk factors thereof treated with aspirin +- @Chemical$."	0
"The multivariate odds ratio of LDA-associated UGIB was 3.318 (95% confidence interval (CI) 1.650-6.671, p = 0.0008) for a history of peptic @Disease$, 0.086 (95% CI: 0.011-0.652, p = 0.0176) for the use of a proton pump inhibitor (PPI) with LDA, and 0.253 (95% CI: 0.113-0.569, p = 0.0009) for the use of a histamine type 2 receptor antagonist (H2RA) with @Chemical$."	0
Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With @Chemical$ After Transient Ischemic Attack or Acute @Disease$ in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes).	0
"Thus, our study examined the protective effect of wheat germ oil on @Chemical$-induced @Disease$ in the stomach and liver tissues of Swiss albino mice."	1
RESULTS: @Disease$ were found in 62 of 101 (61.4%) low-dose @Chemical$ users and three of 30 (10%) nonaspirin users.	1
"As for bleeding complications related to the gastrointestinal system, e.g., @Disease$, the statistical metrics suggested a stronger association for aspirin than @Chemical$."	0
[@Disease$ to @Chemical$].	1
BACKGROUND AND PURPOSE: Apixaban reduces stroke with comparable bleeding risks when compared with @Chemical$ in patients with @Disease$ who are unsuitable for vitamin k antagonist therapy.	0
METHODS: ASA-dipyridamole (25/200 mg) once daily together with ASA (81 mg) daily was started in 130 patients given the diagnosis of @Disease$/TIA with instructions to increase ASA-@Chemical$ to twice daily after 7 days and discontinue ASA (81 mg).	0
BACKGROUND: The role of @Chemical$ metabolites in NSAID-induced hypersensitivity has been studied in depth for NSAID-exacerbated @Disease$ (NERD) and NSAID-exacerbated cutaneous disease (NECD).	0
"Ischemic stroke and @Disease$ with aspirin, dabigatran, and @Chemical$: impact of quality of anticoagulation control."	0
CONCLUSIONS: The elevated numbers of nasal inflammatory leukocytes expressing the CysLT1 receptor in aspirin-sensitive patients with chronic @Disease$ as compared with their non-aspirin-sensitive counterparts and the down-regulation of receptor expression after desensitization to aspirin are probably fundamental in the pathogenesis of aspirin sensitivity and in the mechanism of @Chemical$ desensitization.	0
"Within 90 days of surgery, there was 1 @Disease$ (1%) in the @Chemical$ group compared with 51 (5%) in the nonketorolac group (p = 0.01)."	0
"According to the high prevalence of @Disease$, many people are affected by @Chemical$ resistance, which may play a role in adverse cardiovascular events."	0
"The pooled odds ratios with 95% confidence intervals (CI) for the risk of @Chemical$ @Disease$s in H. pylori-positive versus H. pylori-negative individuals were 1.68 (95%CI 1.40-2.02) and 1.65 (95%CI 1.29-2.08) under fixed-effects and random-effects models, respectively."	1
The aim of this study was to evaluate the prevalence of aspirin resistance (@Chemical$) in patients undergoing hemodialysis (HD) and to assess the effect of @Disease$ on the results of the Multiplate test.	0
The medical history of non-steroidal anti-inflammatory drugs (NSAIDs) or acetylsalicylic acid (@Chemical$) usage and the presence of coronary artery disease (CAD) were investigated in all patients with or without @Disease$.	0
"BACKGROUND: Aspirin-exacerbated respiratory disease (AERD) is a distinct eosinophilic phenotype of severe asthma with accompanying chronic rhinosinusitis, nasal polyposis, and @Disease$ to @Chemical$."	1
Addition of high platelet reactivity and 2 other @Disease$ covariates to the @Chemical$ score marginally improved discrimination.	0
Prostaglandin (PG) E2 has been implicated in the pathogenesis of @Chemical$-exacerbated respiratory disease (@Disease$).	0
Aspirin-exacerbated @Disease$ (AERD) is an acquired disease characterized by chronic eosinophilic airway inflammation with underlying dysregulation of @Chemical$ metabolism.	0
"@Chemical$, non-steroidal anti-inflammatory drugs (NSAIDs) and paracetamol are the most frequent drugs used worldwide for the management of pain, inflammation and @Disease$ associated with many acute and chronic conditions."	0
"A diagnosis of RA (RR = 1.75; 95% CI = 1.09-2.79), but not OA (RR = 1.06; 95% CI = 0.67-1.68), was associated with risk of NHL, but the positive association of use of @Chemical$ and other NSAIDs with @Disease$ was independent of RA history."	0
Patients on @Chemical$ for the prevention of @Disease$ received concurrent antisecretory therapy (AST).	0
Approach to patients with @Chemical$ @Disease$ and acute cardiovascular emergencies.	1
"The possible toxic synergism with aspirin and @Chemical$, however, is not previously described; though case reports suggest such co-@Disease$ with low levels of aspirin and other compounds can exist."	0
"In other patients, symptoms of aspirin @Disease$ may develop in the days after stenting, at which time discontinuation of @Chemical$ carries a risk of catastrophic stent thrombosis."	0
"Concentrations of urinary leukotriene E4 (uLTE4) were measured by ELISA and plasma stable @Chemical$ metabolite, 9alpha,11beta prostaglandin F(2) by GC/@Disease$."	0
"@Chemical$-exacerbated diseases are important examples of drug hypersensitivities and include aspirin-exacerbated @Disease$ (AERD), aspirin- or non-steroidal anti-inflammatory drug (NSAID)-induced urticaria/angioedema, and aspirin- or NSAID-induced anaphylaxis."	0
Patients intolerant of alternative drugs and those with therapy-resistant asthma or @Disease$ benefit from @Chemical$ desensitization.	0
"BACKGROUND/AIMS: Many patients with aspirin-induced @Disease$ have severe @Chemical$ airway hyperresponsiveness (AHR), suggesting a relationship between aspirin and methacholine in airway response."	0
"RESULTS: A lower incidence of gastric and duodenal @Disease$s was seen in celecoxib/@Chemical$-treated subjects (19%) vs. naproxen/aspirin (27%; RR: 0.63, 95% CI: 0.44-0.92)."	0
"CONCLUSIONS: Considering that human lung mast cells are capable of producing LTC4, prostaglandin D2, and @Chemical$, our present results support the concept that mast cells, at least, may participate in the development of aspirin-induced @Disease$."	0
OBJECTIVE: We sought to evaluate whether titrated initiation of @Chemical$-dipyridamole in patients with @Disease$/transient ischemic attack (TIA) improves tolerance and to assess the appearance of headache in those with pre-existing history of headaches.	0
"Furthermore, it has been demonstrated that chronic use of low dose @Chemical$ results in a variety of lesions in the lower GI tract, including multiple petechiae, erosions, ulcers, diverticular @Disease$ and even circumferential ulcers with stricture."	1
@Disease$ after @Chemical$.	1
Aspirin 300 mg/day is effective for treating @Chemical$-exacerbated @Disease$.	0
"There was no difference in progression on RHCT (25% in @Chemical$ versus 16.6% in no-ASA), change in management as a result of RHCT (1.4% versus 1.4%), RHCT as a result of neurological decline (0 versus 1.4%), discharge @Disease$ Scale (15 [14-15] versus 15 [14-15]), and mortality (0 versus 1.4%) between the two groups."	0
"A nitrate-rich diet, as well as ingestion of reductive catechol-bearing @Chemical$, can collaborate in promoting NO generation in gastric juice, and they are protective in rodent models of @Disease$."	0
CONCLUSION: This study did not find more @Disease$ than in previous neurointerventional reports using DAPT with @Chemical$ + ticagrelor or aspirin + clopidogrel.	0
Conclusion: Prognostic @Disease$ risk models were developed that can be used to estimate the absolute bleeding harms of @Chemical$ among persons in whom aspirin is being considered for the primary prevention of CVD.	0
"OBJECTIVE: Previous erosive oesophagitis studies have excluded patients with @Disease$ or taking @Chemical$, and conflicting results have been reported concerning the influence of."	0
Uncoupled regulation of @Chemical$ C4 synthase in platelets from aspirin-intolerant @Disease$tics and healthy volunteers after aspirin treatment.	0
"Considering the available evidence, the majority of national scientific societies agree that the isolated use of @Chemical$ does not increase the risk of @Disease$ and does not represent a contraindication to neuraxial blocks."	0
"Aspirin exacerbated respiratory disease (@Disease$) is characterized as adult onset asthma, nasal polyps, chronic rhinosinusitis, and hypersensitivity to a cyclooxygenase-1 (COX-1) inhibitor, viz @Chemical$ or nonsteroidal antiinflammatory drugs (NSAIDs)."	0
"CONCLUSIONS: As endoscopy frequently reveals @Disease$ among low-dose aspirin users, both administration of BA and of enteric-coated @Chemical$ warrant concern for gastroduodenal ulcer."	0
"According to APS standard of care, patients were treated with aspirin and/or low-molecular weight heparin (@Chemical$) at prophylactic (pure obstetric APS) or therapeutic doses (history of @Disease$)."	0
[The study of 18 cases of aspirin urticaria at dermatology of Yodogawa Christian Hospital--on the difference between @Chemical$ asthma and aspirin @Disease$].	0
"RESULTS: Overall, 386 patients were enrolled; 57% used NSAIDs (51% @Chemical$ only) and 43% were non-users. 57% of the whole cohort was H. pylori-positive (including 66% with duodenal ulcers and 47% with gastric @Disease$)."	0
"The objective of this study was to investigate the association between the intake of corticosteroids, @Chemical$ or aspirin and @Disease$."	0
The aim of this study was to determine the incidence of upper GI bleeding and whether the use of peri-operative oral ranitidine reduces the incidence of upper GI bleeding when @Chemical$ thromboprophylaxis is used for hip and knee @Disease$.	0
"BACKGROUND: @Chemical$ is often used in patients with @Disease$, but it can also cause gastrointestinal complications."	0
"Despite more than a half-century of recognition, the triad characterised by severe @Disease$, nasal polyposis and acetylsalicylic acid intolerance known as @Chemical$-induced asthma or Widal's triad remains markedly underdiagnosed and mistreated."	0
"Numerous vascular risk factors including white matter hyperintensity (WMH), duration of aspirin treatment, age, hypertension or @Disease$ were investigated for a possible association with the presence of @Chemical$ in the two groups."	0
"Examined parameters included Helicobacter pylori @Disease$, cyclooxygenase (COX)-1 and COX-2 activity, and current nonsteroidal anti-inflammatory drug (NSAID) usage including @Chemical$."	0
"METHODS: Ninety-four aspirin-induced urticaria patients presenting @Disease$/angioedema-induced by both ASA and NSAID (50 had underlying chronic urticaria) and showing positive responses on oral aspirin challenge test, 76 @Chemical$-intolerant asthmatics with positive responses on lysine-aspirin bronchoprovocation test, and 185 normal healthy controls were enrolled."	0
Preliminary CE studies conducted in healthy subjects have shown that short-term administration of @Chemical$ can induce mild mucosal inflammation of the @Disease$.	1
This study suggests that @Chemical$ 3 microg/kg PO q12h is as effective as misoprostol 3 microg/kg PO q8h in preventing aspirin-induced @Disease$ in this model.	0
"@Chemical$ therapy can also lead to an increased risk of gastrointestinal ulcers, @Disease$ and other haemorrhagic complications."	1
"There is evidence that aspirin and non-@Chemical$ non-steroidal anti-inflammatory drug (NSAID) have anti-carcinogenic properties, but their effect on @Disease$, in particular in never-smokers, is unclear."	0
"CONCLUSIONS: In patients with osteoarthritis taking low-dose aspirin, the use of celecoxib or naproxen plus @Chemical$ resulted in similar rates of gastroduodenal @Disease$ation."	0
"@Chemical$ @Disease$ poses a significant clinical dilemma, as the safety and efficacy of oral antiplatelet combinations that exclude aspirin have not been validated."	1
"A relatively frequent problem with the use of NSAIDs and/or aspirin, and less frequently with @Chemical$, is the development of intolerance and @Disease$ reactions, a situation for which diverse alternatives have been proposed."	0
The study treatments were @Chemical$ 200 microg @Disease$ or lansoprazole 15 or 30 mg OD.	0
Minidose @Chemical$ (ASA) administration is a significant risk factor for changes in the stomach and duodenal mucosa also in persons whose anamnesis does not indicate any previous symptoms of @Disease$ or any other risk factor.	0
"METHODS: In 19 patients with a history of @Chemical$-induced @Disease$, placebo-controlled bronchial challenges with lysine-aspirin were performed."	1
"Ten patients (group C) presented urticaria and/or the appearance of @Disease$ during or 24 h after challenge, with reactions to @Chemical$ (five patients) or food additives (five patients)."	0
[Significance of the stool occult blood test in patients with @Disease$ under treatment with low dose @Chemical$].	0
"@Chemical$-exacerbated respiratory disease (AERD) is a unique syndrome of @Disease$ that frequently occurs in patients with nasal polyposis, chronic sinusitis, and asthma."	0
"Aspirin-exacerbated respiratory disease (AERD) refers to the combination of asthma, @Disease$ with nasal polyposis, and acute upper and lower respiratory tract reactions to the ingestion of aspirin (acetylsalicylic acid, @Chemical$) and other cyclooxygenase-1 inhibiting non-steroidal anti-inflammatory drugs."	0
METHODS: The Apixaban versus Acetylsalicylic Acid to Prevent @Disease$ in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin k Antagonist Treatment (@Chemical$) trial randomized 5599 patients with atrial fibrillation and risk factors to receive either apixaban or aspirin.	0
@Chemical$ is commonly used as an anti-inflammatory therapy for @Disease$.	0
"With an increasing prevalence of @Disease$ in an aging population, @Chemical$ continues to play a significant role in cardiac prophylaxis in a large patient population."	0
CONCLUSIONS: GDF-15 at 1 month after an ACS is related to the risk of bleeding during @Chemical$ and provides additional information on the @Disease$ risk beyond baseline GDF-15 levels.	0
Main causes of @Disease$ bleeding with low-dose @Chemical$ are gastroduodenal peptic ulcer and colonic diverticulosis.	0
"Nonsteroidal antiinflammatory drugs (N@Chemical$IDs) produce @Disease$ in experimental animals, irrespective of the route of administration."	0
Randomised clinical trial: rabeprazole plus aspirin is not inferior to @Chemical$ plus clopidogrel for the healing of aspirin-related peptic @Disease$.	0
@Chemical$ use and long-term rates of @Disease$: A population-based cohort study.	0
"Compared to women who did not use either aspirin or other non-aspirin NSAIDs, women using @Chemical$ exclusively (RR = 1.71; 95% CI = 0.94-3.13), non-aspirin NSAIDs exclusively (RR = 2.39; 95% CI = 1.18-4.83), or both types of drugs (RR = 1.97; 95% CI = 1.06-3.68) were at increased risk of @Disease$."	0
[Evaluation of drug information service available for physicians regarding low-dose @Chemical$-induced @Disease$].	1
"@Chemical$ hypersensitivity is a hallmark of aspirin-exacerbated respiratory disease (AERD), a clinical syndrome characterized by the severe @Disease$ after ingestion of cyclooxygenase-1 inhibitors."	0
In this brief note caution is raised about use of @Chemical$ and COX inhibitors generally in inflammatory states and specifically in @Disease$.	0
"The aim of our study was to verify the hypothesis if @Chemical$, as a form of aspirin, which theoretically does not block prostacycline synthesis in systematic circulation, would be well tolerated by patients with @Disease$."	0
"These include rhinitis and asthma induced by NSAIDs (also known as @Chemical$-exacerbated respiratory disease), NSAID-exacerbated cutaneous disease (NECD), @Disease$ or angioedema induced by multiple NSAIDs, single NSAID-induced reactions, and delayed NSAID reactions."	0
"In the non@Disease$tic patient group the mean PGE(2) production was 32 +/- 33 ng/mL (35-fold of the basic production), in the ATA group it was 16 +/- 18 ng/mL (16-fold), and in the @Chemical$ group it was only 5.3 +/- 3.6 ng/mL (4-fold)."	0
"There were significantly more patients who suffered GI adverse events, principally abdominal pain, dyspepsia, @Disease$ and diarrhoea, with aspirin (18.5%) than with ibuprofen (11.5%), but the difference between ibuprofen and @Chemical$ (13.1%) was not significant."	0
Recognising the risk of aspirin-sensitive @Disease$ in a patient with asthma who has previously tolerated @Chemical$.	0
"Pre-operative @Chemical$ ingestion did not significantly affect peri-operative blood loss, or change in haemoglobin concentration or @Disease$."	0
Proton-pump inhibitor and @Chemical$ antagonist were effective for prevention of upper @Disease$ in patients receiving low-dose aspirin.	0
"Background: Aspirin-exacerbated @Disease$ (AERD), a syndrome that includes asthma, recurrent nasal polyps, and pathognomonic reactions to @Chemical$ and other nonselective cyclooxygenase inhibitors, is still not fully understood and lacks specific disease-modifying therapeutic options."	0
"METHODS: Seventy-six out-patients with @Disease$ (qi deficiency and blood stasis syndrom) pectoris intolerable to @Chemical$ were randomized into two groups, 40 in the treated group and 36 in the control group."	0
"CONCLUSIONS: Medications such as aspirin that interfere with the @Chemical$ pathway, taken during pregnancy, may influence the risk of @Disease$ in the offspring."	0
"The authors assessed the prevalence of @Disease$ following extended-release dipyridamole/@Chemical$ combination (DAC), and the efficacy of acetaminophen in the treatment of these headaches."	0
The aspirin @Disease$tic patients (b) (n: 8) (5 male and 3 female) demonstrated by progressive challenge with @Chemical$ and fall of FEV 1 (3) 20%.	0
"Among @Disease$ hospitalizations, @Chemical$ use was not associated with organ dysfunction or hospital death."	0
Intranasal ketorolac challenge for the diagnosis of @Chemical$-exacerbated @Disease$.	0
The use of @Chemical$ and clopidogrel in combination has become part of the standard clinical care of patients with @Disease$.	0
"Although knowledge about endoscopic characteristics of @Chemical$ associated ulcers is limited, the ulcers have common distinctive feature that sudden @Disease$ bleedings or latently advanced-anemia are often the earliest symptom because aspirin-induced ulcers often exist without symptoms of dyspepsia."	0
"INTRODUCTION: Aspirin-exacerbated respiratory disease is defined by the clinical tetrad of @Chemical$ sensitivity, nasal polyps, asthma, and @Disease$."	0
"METHODS: EBC from 115 adult @Disease$tic subjects (62 with aspirin intolerance) and 38 healthy control subjects were assessed quantitatively for 19 @Chemical$s by using complementary HPLC, gas chromatography-mass spectrometry, or both."	0
"Patients undergoing TKA treated with LMWH had higher rates of systemic @Disease$ or a complication secondary to LMWH administration (2.8% for @Chemical$ versus 0% for mobile compression; p = 0.022; OR, 12.8)."	0
"Meta-analysis results showed that: (1) Compared with placebo, the incidences of total cardiovascular events (RR = 0.85, 95% CI: 0.80-0.92), stroke (RR = 0.87, 95% CI: 0.77-0.98), nonfatal stroke (RR = 0.81, 95% CI: 0.70-0.95) and transient @Disease$ attack (RR = 0.76, 95% CI: 0.64-0.90) were significantly lower in low-dose @Chemical$ group than those in placebo control group (all P &lt; 0.05)."	0
[Investigation into the effect of gastric secretion inhibitor for the prevention of @Disease$ associated with low-dose @Chemical$].	1
CONCLUSIONS: The findings support the hypothesis that @Chemical$ is associated with a greater likelihood of @Disease$.	1
"We refer to these patients as having @Chemical$-exacerbated respiratory disease, a disease process that produces devastating @Disease$ of both the upper and lower respiratory tracts."	0
"In this context, we sought to investigate whether @Chemical$ use is associated with CMBs in subjects without previous history of @Disease$."	0
[Does combination therapy of @Chemical$ plus antiplatelet therapy increase the risk of @Disease$?].	0
PURPOSE OF REVIEW: The use of aspirin in coronary artery disease and address the unmet need of aspirin therapy in patients with history of @Disease$ reactions to aspirin (@Chemical$; ASA) or other nonsteroidal inflammatory drugs (NSAIDs).	0
The most recent data show that eradication of H. pylori infection in patients with a previous peptic ulcer bleeding episode who continue to take @Chemical$ reduces the recurrence rate of this complication to levels observed in patients without a history of @Disease$ history who take aspirin for cardiovascular disease.	0
The two frequent clinical presentations of aspirin hypersensitivity are: aspirin-induced @Disease$ (AIA/R) and @Chemical$-induced urticaria/angioedema (AIU).	0
A case of acute @Disease$ possibly associated with combined @Chemical$ and simvastatin treatment.	0
"A worldwide use of @Chemical$ is now accepted due to its remarkable analgesic, antipyretic and anti-thrombotic prophylactics against myocardial infarct and coronary disorders despite the fact that the use of NSAIDs is associated with the risk of gastrointestinal bleedings, @Disease$ and ulcerations."	0
"AIMS: Daily low-dose aspirin is recommended for prevention of cardiovascular events in patients with @Disease$ (CAD), and proton pump inhibitors (PPIs) are recommended to prevent or treat @Chemical$-associated gastrointestinal injury."	0
We previously compared expression of cysLT 1 on mucosal leukocytes in patients with @Chemical$-sensitive and aspirin-tolerant @Disease$.	0
"Type 2 @Disease$ characterizes @Chemical$-exacerbated respiratory disease.Objectives: To determine whether high-dose aspirin therapy changes biomarkers of type 2 inflammation in aspirin-exacerbated respiratory disease.Methods: Forty-two subjects with aspirin-exacerbated respiratory disease underwent an aspirin desensitization and were placed on high-dose aspirin (1,300 mg daily)."	0
"In the @Chemical$ group, no @Disease$ events were noted after 350 biopsies [upper confidence limit (UCL) for probability of bleeding=0.0085]."	0
BACKGROUND: @Chemical$ desensitization is a useful therapy in patients with aspirin-exacerbated @Disease$.	0
"Short-term acetylsalicylic acid (@Chemical$) use for @Disease$, fever, or colds - gastrointestinal adverse effects: a meta-analysis of randomized clinical trials."	1
"The risk of @Disease$, adjusted for age, gender, Helicobacter (H) pylori infection, and gastroprotective drug use were 7.87 (CI 4.90-12.60) in acute users and 3.97 (95% CI 2.27-6.96) in chronic users of NSAIDs and/or @Chemical$."	0
@Chemical$ unresponsiveness is associated with increased risk of @Disease$ after specific pediatric cardiac surgical procedures.	1
"They were compared with twenty-seven control patients with sensitivity to @Chemical$ or non-steroidal anti-inflammatories, manifesting as asthma, @Disease$ or rhino-conjunctivitis."	1
CONCLUSIONS: Daily esomeprazole 20 mg is efficacious and well tolerated in reducing the recurrence of peptic @Disease$ in East-Asian patients with a history of ulcers who are taking low-dose @Chemical$ for cardiovascular protection.	0
"Among the @Chemical$-treated patients with CHA2DS2VASc scores &gt;=2, half had possible contraindications and high risks for ischemic stroke (5.2 %), @Disease$ (5.0 %), and death (19.3 %)."	0
@Chemical$ and aspirin were the only therapies that did not increase composite @Disease$ risk significantly compared to placebo.	0
OBJECTIVE: To evaluate the use of @Chemical$ modifiers in preventing aspirin-provoked respiratory reactions in @Disease$tics.	0
"CONCLUSIONS: In the REGARDS cohort, baseline @Chemical$ use was not associated with long-term rates of @Disease$."	0
CONCLUSIONS: The elevated numbers of nasal inflammatory leukocytes expressing the CysLT1 receptor in aspirin-sensitive patients with chronic @Disease$ as compared with their non-@Chemical$-sensitive counterparts and the down-regulation of receptor expression after desensitization to aspirin are probably fundamental in the pathogenesis of aspirin sensitivity and in the mechanism of aspirin desensitization.	0
RESULTS: A 57-year-old woman with a perimesencephalic pattern of hemorrhage and negative CT angiography was treated with carbasalate calcium and intravenous @Chemical$ because of an acute @Disease$.	0
"METHODS: To define the reduction in ischemic events required to outweigh increased @Disease$ with longer-duration @Chemical$, we developed a decision-analytic Markov model comparing DAPT durations of 6, 12, and 30 months after DES."	0
The incidence of @Chemical$-induced @Disease$ and bleeding has increased.	1
"CONCLUSIONS:   @Chemical$ had aggressive effects in all gastric lesions; on the other hand, HP @Disease$ had protective effects in the antrum and fundus in the stomach, and aggressive effects in the body in the stomach."	0
"@Chemical$-exacerbated respiratory disease (AERD) is characterized by chronic @Disease$ with nasal polyps, asthma, and reactions to cyclooxygenase-1-inhibiting drugs."	0
"With the increasing prevalence of obesity and conflicting data regarding the effect of @Chemical$ in older adults, understanding the potential association of aspirin use with @Disease$ mortality according to body mass index (BMI) and age is imperative."	0
"CONCLUSIONS AND CLINICAL IMPORTANCE: Administration of @Chemical$ to healthy dogs resulted in significantly lower gastric lesion scores, and fewer days of @Disease$ compared to aspirin, indicating that deracoxib is better tolerated than aspirin in some dogs."	0
Finally one recent retrospective cohort study revealed similar @Disease$ rates between ASA-treated and non-ASA-treated patients but increased cardiac complication rates in the @Chemical$ group.	0
"To date, there are no reported cases of @Disease$ following @Chemical$ use in this patient group and no guideline is established to date."	0
Meta-analysis of randomized controlled studies and case-control studies showed that the risk of low-dose @Chemical$ for @Disease$ was 1.6-8.2.	1
The aim of the study was to assess the tolerability of triflusal in patients with @Chemical$-exacerbated @Disease$ (AERD).	0
"Patients undergoing TKA treated with @Chemical$ had a higher frequency of wound bleeding complications or @Disease$ (3.9% for LMWH versus 0.5% for mobile compression; p = 0.028; OR, 8.2)."	0
"In fact, patients with blood dyscrasias have to be considered high-risk patients due to their increased propensity for uncontrolled @Disease$.The aim of this article was to present and discuss the management of a case of double consecutive retrobulbar hemorrhage in a high-risk patient in treatment with aspirin and @Chemical$."	0
CONCLUSION: This article demonstrates the safety of reintroducing platelet-inhibitory doses of @Chemical$ in patients in whom it is indicated and reporting aspirin-induced urticaria and/or @Disease$ with anti-inflammatory doses.	0
"No significant differences in mean perioperative @Disease$ were seen between the aspirin-continuing group (mean=553.9 milliliters, 95% CI=468.0; 639.9; I2=83.4%; 170 patients) and the @Chemical$-discontinuing group (mean=538.7 milliliters, 95% CI=427.6; 649.8; I2=985.5%; 200 patients); (P-interaction=0.96)."	0
Altered metabolism of prostaglandin E2 in asthma patients with @Chemical$ @Disease$.	1
@Chemical$s included non-coronary artery bypass graft-related @Disease$ major and minor bleeding.	0
"Patients receiving treatment for &gt;5 years showed elevated risk of CMBs in the aspirin (0.17; 0.09-0.36; P &lt; .001) and clopidogrel (0.15, 0.07-0.33; P &lt; .001) groups as well as higher odds of MB in the aspirin (0.34, 0.16-0.71; P = .004) and @Chemical$ (0.37, 0.17-0.80; P = .010) groups.The WMHs and MB were associated with CMBs in patients taking aspirin or clopidogrel for &gt;1 year, and long-term use increased the risks of CMB and @Disease$."	0
"RESULTS: There were 2392 cases of @Chemical$ @Disease$ diagnosed between 1996 and 2010 and 7165 age-, gender- and medical practice-matched controls from 131 general medical practices."	0
"CONCLUSION: During @Chemical$ desensitization for @Disease$, provoking reactions at the 325-mg dose are rare (1%) and mild."	0
"Preoperative @Chemical$ was not associated with an increase in chest tube drainage, re-operation for @Disease$ complications, or transfusion of FFP or platelets."	0
@Chemical$ safety in @Disease$ patients with acute coronary syndrome undergoing percutaneous coronary intervention.	0
"BACKGROUND: Low-dose @Chemical$ is widely used for prevention of stroke, heart attacks, and death in patients with atherothrombotic disease, but its use is associated with serious @Disease$ (GI) adverse effects."	1
A pooled estimate derived from the 2904 patients enrolled indicated a trend towards an increase in major @Disease$ risk in those randomized to @Chemical$ (OR 1.27; 95% CI 0.83-1.94).	0
"BACKGROUND: @Chemical$ (LTs) are important in asthma, and LT modifiers modulate antigen-induced @Disease$."	0
OBJECTIVE: To investigate the correlation of tumor necrosis factor alpha (TNF-alpha) polymorphisms with @Disease$ (UGIB) induced by enteric-coated @Chemical$ in coronary heart disease (CHD) patients.	0
CONCLUSIONS: @Chemical$ hypersensitivity manifesting as urticaria/@Disease$ remains present after 4 years in about two thirds of patients.	1
Patients therefore should be advised to use eASA first for @Disease$ attacks and use a @Chemical$ in case of no response.	0
Possible involvement of mast-cell activation in @Chemical$ provocation of aspirin-induced @Disease$.	0
"CONCLUSIONS: The high transcript haplotype ht1 [CG] of the IL18 gene may contribute to the development of acute cutaneous @Disease$ sensitive to @Chemical$, leading to the clinical presentation of AIAU."	0
Aspirin-sensitive @Disease$ is associated with reduced @Chemical$ 2 receptor expression on nasal mucosal inflammatory cells.	0
Celecoxib 400 mg was well tolerated by all patients except for one with @Chemical$-induced @Disease$.	1
Spontaneous spinal epidural @Disease$ in a geriatric patient on @Chemical$.	0
CONCLUSION: This study did not find more @Disease$ than in previous neurointerventional reports using DAPT with aspirin + ticagrelor or @Chemical$ + clopidogrel.	0
"INTRODUCTION: Aspirin-exacerbated respiratory disease is defined by the clinical tetrad of @Chemical$ sensitivity, @Disease$, asthma, and chronic rhinosinusitis."	0
"CONCLUSION: In addition to age, male gender, H. pylori infection, and concomitant use of NSAIDs, COX-2 inhibitors, steroids, and thienopyridines, underlying co-morbidities including diabetes, CKD, @Disease$, history of PUD are also important risk factors for first-time occurrence of non-variceal UGIB in @Chemical$ users."	0
"Conversely, acetaminophen is well tolerated, has not been shown to contribute to @Disease$ when taken with @Chemical$, and has not been shown to interfere with the inhibition of platelet aggregation produced by aspirin."	0
"In the recent past, clinical research was mainly focused on @Chemical$-related @Disease$."	1
"RESULTS: @Chemical$ increased the risk of major bleeding (RR=1.71; 95% confidence interval [CI], 1.41-2.08), major gastrointestinal (GI) bleeding (RR=2.07; 95% CI, 1.61-2.66), and intracranial @Disease$ (RR=1.65; 95% CI, 1.06-5.99) versus placebo."	1
"LXA4 dose dependently (0.25-2.5 microg/kg, intraperitoneally) reduced the severity of aspirin-induced @Disease$ and suppressed @Chemical$-induced leukocyte adherence, whereas an LXA4 antagonist had the opposite effects."	0
Cysteinyl leukotriene receptor expression in @Chemical$-sensitive @Disease$ patients.	0
@Chemical$ ameliorated these ASP-facilitated absorptions and @Disease$ in a dose-dependent manner.	0
"When subjects were stratified accordingly to blood platelet glycoprotein IIb/IIIa genotype, in the @Chemical$ group PlA2 carriers had greater @Disease$ than PlA1 homozygotes (1858 +/- 932 mL vs 1216 +/- 525 mL, P &lt; .05)."	0
Overall number of @Disease$ was lower when a lower dose of @Chemical$ was administered.	0
"After 2 months of treatment with 10 mg/day of oral prednisolone, 1600 mug/day of inhaled fluticasone propionate, montelukast as a leukotriene receptor antagonist (LTRA), and long-term beta-agonist, we again challenged her with a provocation test with up to 200 mg of @Chemical$; this time there were neither @Disease$ symptoms nor decrease in forced expiratory volume in 1 second."	0
"The new class of NO-releasing NSAIDs, including NO-aspirin or @Chemical$, represent a very promising approach to reducing the @Disease$ of their parent NSAIDs."	0
OBJECTIVES: The association of low-dose @Chemical$ use and @Disease$ is well described.	0
METHODS: We recruited 141 @Disease$ and 995 @Chemical$-tolerant asthmatic (ATA) subjects.	0
"Whereas @Chemical$ administration is known to decrease the risk of @Disease$ problems, aspirin withdrawal may temporarily increase the risk of thrombotic events."	0
H. pylori infection combined with PG I at &gt;123 ng/mL had an OR (95% CI) of 15.8 (2.4 +- 104.5) for the prediction of @Chemical$-induced @Disease$.	1
The annual incidence of major GI @Disease$ due to low-dose @Chemical$ was estimated for outpatients.	1
"OBJECTIVE: Patients who present for coronary surgery often receive preoperative dual antiplatelet therapy with @Chemical$ and a thienopyridine derivative (clopidogrel or prasugrel), especially after a recent acute @Disease$."	0
"METHODS: Seventy-six out-patients with stable angina (@Disease$) pectoris intolerable to @Chemical$ were randomized into two groups, 40 in the treated group and 36 in the control group."	0
"Taken together, these studies point to a possible deleterious effect of @Chemical$ and NSAIDs in human @Disease$."	0
@Chemical$ for the prevention of low-dose aspirin-induced @Disease$ in Helicobacter pylori-negative patients.	0
"BACKGROUND: Although it is well known that aspirin causes gastroduodenal mucosal injury and that aspirin-induced @Disease$ is often asymptomatic, the prevalence and independent factors for gastroduodenal mucosal injury have not been clarified in asymptomatic patients taking low-dose @Chemical$ and gastroprotective agents."	0
PURPOSE OF REVIEW: The use of @Chemical$ in coronary artery disease and address the unmet need of aspirin therapy in patients with history of @Disease$ reactions to aspirin (acetylsalicylic acid; ASA) or other nonsteroidal inflammatory drugs (NSAIDs).	0
"Helicobacter pylori infection increases the risk for upper GI bleeding with low-dose @Chemical$, but infection should be searched and treated only in patients with peptic @Disease$."	0
"The objectives of this study were to determine the HP prevalence and NSAID/@Chemical$ use in patients with bleeding @Disease$ in a low-prevalence HP area, to determine the proportion of idiopathic ulcers and to estimate the proportion of initially false negative HP tests."	0
"@Chemical$ desensitization in an aspirin-sensitive patient with @Disease$ resulted in an increase in IFN-gamma expression by CD4(+) lymphocytes and a decrease in IFN-gamma expression by CD8(+) lymphocytes, the significance of which needs additional investigation."	0
"After multivariate adjustment for age, sex, current smoking, history of hypertension and @Disease$, and aspirin dose (@Chemical$-treated patients only), the hazard ratio for ICH in patients with an arterial versus a cardiac source was 0.74 (95% confidence interval, 0.30 to 1.82) for aspirin-treated patients and 4.34 (95% confidence interval, 0.35 to 54) for placebo-randomized patients."	0
"The proportions of patients who were free of gastric @Disease$s at the end of 12 weeks were 96% in the misoprostol group, 93% in the @Chemical$ 15-mg group, 100% in the lansoprazole 30-mg group, and 35% in the placebo group (P &lt;or= 0.008, each active treatment vs placebo)."	0
Patients with atrial fibrillation and a further risk factor for @Disease$ (CHA2DS2-VASc &gt;0) should therefore either receive @Chemical$ or a novel oral agent.	0
Thirty-day mortality after peptic @Disease$ in hospitalized patients receiving low-dose @Chemical$ at time of admission.	0
"Efficacy and safety of 1,000 mg effervescent @Chemical$: individual patient data meta-analysis of three trials in migraine @Disease$ and migraine accompanying symptoms."	1
"In patients who stopped clopidogrel for up to 5 days before surgery, the @Chemical$ test failed to exhibit prognostic utility for predicting @Disease$ risk."	0
Very late multivessel @Disease$ of bare metal stents with concomitant patent drug-eluting stents after withdrawal of @Chemical$.	0
METHODS: A retrospective chart review was conducted evaluating @Chemical$ desensitization in patients with reported ASA or NSAID @Disease$ and a cardiac indication for ASA.	0
"After 3 months, the patient is free from adverse events.Glucose-6-phosphate dehydrogenase deficiency is commonly considered a contraindication to @Chemical$ intake; however, this case shows that aspirin at low, antiplatelet dosage is well tolerated and should not be denied to patients with @Disease$ and complex coronary anatomy."	0
Our practice at Thomas Jefferson University has been to continue @Chemical$ therapy throughout the perioperative period in patients undergoing elective @Disease$ surgery.	0
"In multivariate logistic regression, after controlling for @Disease$ volume and location, any known aspirin use (OR 3.4, 95% CI 1.1-10.4, P = 0.03), platelet activity &lt;=550 @Chemical$ reaction units (OR 3.1, 95% CI 1.05-9.3, P = 0.04), or an elevated PFA-EPI closure time (OR 3.2, 95% CI 1.02-10.3, P = 0.04) were associated with increased odds of craniotomy."	0
METHODS: We included patients without significant @Disease$ on coronary angiography (CAG) and with positive results on intracoronary @Chemical$ provocation test between January 2003 and December 2014.	0
"However, patients taking @Chemical$ may demonstrate highly variable responses to in vitro tests for @Disease$ and may experience breakthrough thromboembolic events."	0
METHODS: The Apixaban versus Acetylsalicylic Acid to Prevent Stroke in @Disease$ Patients Who Have Failed or Are Unsuitable for Vitamin k Antagonist Treatment (@Chemical$) trial randomized 5599 patients with atrial fibrillation and risk factors to receive either apixaban or aspirin.	0
@Disease$ associated with combined @Chemical$ and aspirin therapy.	0
How should I treat subacute stent thrombosis in the context of @Disease$ with @Chemical$?	1
"Improvement of aspirin-intolerant @Disease$ by @Chemical$, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial."	1
Patients with aspirin @Disease$ can be safely challenged with @Chemical$.	0
"There were, however, significantly more subjects with one or more lesions (erosion or @Disease$) per subject in the @Chemical$ and aspirin (16/20, 80%) treated subjects as compared to the aspirin (8/19, 42%, P &lt; 0.001) or the paracetamol (3/21, 14%, P &lt; 0.01) exposed subjects."	0
"METHODS: This retrospective cohort study assessed overt @Disease$, decreased hemoglobin levels suspecting small bowel blood loss, and CV death in patients taking LDA for more than 1 year (@Chemical$ group) and in patients not taking LDA (control group)."	0
"INTRODUCTION: Aspirin-intolerant asthma (AIA), a major clinical presentation of @Chemical$ hypersensitivity, affects 10% of adult @Disease$tics."	0
CLINICAL IMPLICATIONS: The common factor in these cases is that @Chemical$ was the only possible cause of the @Disease$.	1
"OBJECTIVE: We sought to determine blood and urinary levels of @Chemical$,11beta-PGF(2), a major stable PGD(2) metabolite in 2 well-defined phenotypes of asthma, aspirin-induced asthma (@Disease$) and aspirin-tolerant asthma (ATA), and in healthy control subjects and to study the effects of aspirin on PGD(2) release."	0
"Comparison between the warm needling group and Omeprazole group showed that the UI, both serum and @Disease$ activity, and serum MDA level of the former group were evidently higher than those of the Omeprazole group (P&lt;0. 05), but gastric mucosal MDA level of the warm needling group was apparently lower than that of the @Chemical$ group (P&lt;0.05)."	0
A 33-year-old woman had a severe asthma attack with @Disease$ and lost consciousness after oral provocation testing with 15 mg of @Chemical$ and also with 50 mg of celecoxib.	0
"In monocytes, we found no changes in basal or lipopolysaccharide (LPS)-stimulated PGE2 synthesis, but the response to EP4 receptor activation with respect to inhibition of LPS-induced tumor necrosis factor-alpha release was reduced in @Disease$ patients, especially in the presence of aspirin (@Chemical$)."	0
@Disease$ to @Chemical$ (ASA) limits treatment options.	1
"Aspirin use was not significantly associated with increased risk of @Disease$ complication except for use of 325 mg of @Chemical$ within 3 days of biopsy (any complication OR 3.87 [1.12, 13.4], P = .032; major complication OR 6.30 [1.27, 31.3], P = .024)."	0
The incidences of the combined outcome of recurrent @Disease$ and major bleeding were 2.8% and 3.4% lower in the @Chemical$ 20-mg and 10-mg groups than in the aspirin group.	0
The meta-analysis showed that PPIs decreased the risk of @Chemical$-associated upper GI @Disease$s (OR = 0.16; 95%CI: 0.12-0.23) and bleeding (OR = 0.27; 95%CI: 0.16-0.43) compared with control.	1
"Spirometry, skin-prick test and asthma control test were documented and intracellular cytokine expression in T lymphocytes and plasma lipoxin levels were measured in 23 AERD patients, 17 @Chemical$-tolerant @Disease$tic (ATA) patients, and 16 healthy controls."	0
"The use of low-dose @Chemical$ (LDA) is well known to be associated with an increased risk of serious upper gastrointestinal complications, such as peptic ulceration and @Disease$."	1
"METHODS: Ten patients with @Disease$, nasal polyps, and asthma had a history of asthma attacks after ingesting @Chemical$ and nonsteroidal anti-inflammatory drugs."	0
"BACKGROUND: Many patients requiring permanent pacemaker (PPM) or implantable cardiac defibrillator (ICD) placement are anticoagulated with warfarin, aspirin (@Chemical$), and clopidogrel for a number of @Disease$ risk indications."	0
"OBJECTIVE: To evaluate the relationship between @Chemical$ ingestion and postoperative bleeding complications, and to test the hypothesis that there is a subset of patients who are aspirin hyperresponders with a proclivity toward @Disease$."	0
Extended antiplatelet therapy with clopidogrel alone versus @Chemical$ plus aspirin after completion of 9- to 12-month dual antiplatelet therapy for @Disease$ patients with both high bleeding and ischemic risk.	0
"Based on the earlier work that aspirin and reduced platelet activity are associated with larger @Disease$ size and hemorrhage growth, we tested the hypothesis that @Chemical$ or reduced platelet activity would be associated with increased odds of craniotomy, likely through hemorrhage growth."	0
"CONCLUSION: Coupling of NO to @Chemical$ attenuates stress, @Disease$-reperfusion, and ethanol-induced damage due to mucosal hyperemia mediated by NO, which compensates for prostaglandin deficiency induced by ASA."	0
"Patients receiving treatment for &gt;5 years showed elevated risk of CMBs in the aspirin (0.17; 0.09-0.36; P &lt; .001) and clopidogrel (0.15, 0.07-0.33; P &lt; .001) groups as well as higher odds of MB in the aspirin (0.34, 0.16-0.71; P = .004) and clopidogrel (0.37, 0.17-0.80; P = .010) groups.The WMHs and MB were associated with @Chemical$ in patients taking aspirin or clopidogrel for &gt;1 year, and long-term use increased the risks of CMB and @Disease$."	0
"Allergic conditions include aspirin-exacerbated respiratory disease (AERD or @Chemical$-induced @Disease$), aspirin-induced urticaria/angioedema (AIU), and anaphylaxis."	1
"@Chemical$-exacerbated diseases are important examples of drug hypersensitivities and include aspirin-exacerbated respiratory disease (AERD), aspirin- or non-steroidal anti-inflammatory drug (NSAID)-induced urticaria/@Disease$, and aspirin- or NSAID-induced anaphylaxis."	0
The effect of dosing interval on the efficacy of @Chemical$ in the prevention of aspirin-induced @Disease$.	0
OBJECTIVES: Helicobacter pylori (H. pylori) @Disease$ and NSAID/low-dose @Chemical$ (ASA) use are associated with peptic ulcer disease.	0
"Treating GPBAR1(+/+) mice with two GPBAR1 agonists, ciprofloxacin and betulinic acid, rescued mice from @Disease$ caused by @Chemical$ and NSAIDs."	1
"The authors found no significant differences on quality of life, nasal symptoms, @Disease$ size, and CT scan scores between patients with @Chemical$-tolerant and aspirin-sensitive asthma."	0
"METHODS: Collection and analysis of data on @Chemical$ challenges and desensitizations from 10 @Disease$ centers, as well as consensus among the related physicians and an expert panel."	0
"METHODS: 430 consecutive subjects (70+/-14 years, 55% male, 41% with coronary artery disease) released from the hospital with a primary diagnosis of @Disease$ were classified into three groups based on the use of @Chemical$ and ACE-I at discharge: ACE-I without aspirin (group I, n=134), ACE-I with aspirin (group II, n=138) and no ACE-I (group III, n=158)."	0
"Many of these patients present with the so-called @Chemical$ triad of aspirin sensitivity, chronic rhinosinusitis with associated @Disease$, and severe asthma."	0
"In this study, use of ibuprofen or acetaminophen (but not @Chemical$) 2 or more days per week was associated with an increased risk of @Disease$ in women."	0
We report three patients aged 75-80 years observed in the Emergency Room with severe @Disease$ (requiring transfusion) due to a large abdominal wall haematoma while receiving standard prophylaxis against venous thromboembolism (40 mg/day @Chemical$ for 6 days on average).	0
"@Chemical$ also potentiates some acute @Disease$ such as food-dependent exercise-induced anaphylaxis (FDEIA), a food allergy induced by physical exercise."	0
BACKGROUND: Historical @Chemical$- or nonsteroidal anti-inflammatory drug (NSAID)-induced reactions might provide predictive information about the severity of reactions in patients with aspirin-exacerbated @Disease$ (AERD) undergoing oral aspirin challenge (OAC).	0
"We describe the case of a 15-year-old female patient with adverse reaction to @Chemical$, chronic @Disease$, and severe asthma."	0
National estimates of emergency department visits for @Disease$-related adverse events from clopidogrel plus @Chemical$ and from warfarin.	0
This study investigates whether @Chemical$ induces @Disease$ and whether a proton-pump inhibitor can prevent such injury in relation to CYP2C19 genotypes.	0
"RESULTS: At baseline, patients with @Disease$ had significantly higher plasma levels of @Chemical$,11beta-PGF(2) than either patients with ATA or healthy subjects."	0
"This study--the first one from a population outside North America--adds relevant information on the absence of a consistent association between @Chemical$ use and endometrial cancer risk, even in high-risk overweight and @Disease$ women."	0
"However, there is seldom patient of @Chemical$ intolerance who has the both symptoms, @Disease$ and asthma."	0
Safety and efficacy of @Chemical$ for primary prevention of @Disease$: a meta-analysis of randomized controlled trials.	0
NSAIDs-including @Chemical$ (ASA)-that inhibit cyclooxygenase (COX)-1 induce nonallergic @Disease$ reactions consisting of attacks of rhinitis and asthma.	0
"CONCLUSIONS: In a real-world PCI registry, patients with @Disease$ experienced lower risk of bleeding risk on @Chemical$."	0
NSAIDs including @Chemical$ and H. pylori @Disease$ are independent causal factors for gastroduodenal ulcer.	0
"CONCLUSION: This cross-sectional survey showed that @Disease$ is highly prevalent among adult asthmatics and its prevalence seems to be affected by family history of @Chemical$ hypersensitivity, history of rhinosinusitis and presence of NP."	0
Acetaminophen-induced @Disease$ without @Chemical$ intolerance.	0
"CONCLUSIONS: Despite trends indicating increased rebleeding rates and a lower incidence of permanent disability due to delayed ischemic neurological deficits, there was no significant effect of previous @Chemical$ use on overall outcome following @Disease$ SAH."	0
"Regular use of non-@Chemical$ NSAID, paracetamol, steroid creams and steroid pills was uncommon and no association with @Disease$ was detected."	0
EVIDENCE SYNTHESIS: The prevalence of @Chemical$-exacerbated @Disease$ is approximately 10% and for aspirin-induced urticaria the prevalence varies from 0.07% to 0.2% of the general population.	0
"Dual antiplatelet therapy (DAPT) with acetylsalicylic acid and a P2Y12 inhibitor (clopidogrel, @Chemical$, or prasugrel) reduces thrombotic events in patients with @Disease$ (ACS), but it is also associated with an increased risk of bleeding complications."	0
"@Chemical$ desensitization, Leukotriene-modifying agents, biologic agents, management of asthma, @Disease$, and nasal polyposis are recommended as treatment modalities."	0
"Our aim was to investigate prophylaxis effects of @Chemical$, one of the representative histamine-2 receptor antagonists (H2RA), on @Disease$ induced by dual therapy with low-dose aspirin and clopidogrel in relation to Helicobacter pylori (H. pylori) infection and CYP2C19 genotypes."	0
"@Chemical$ is widely accepted as a treatment option for @Disease$ pain relief and could provide an alternative not only for treatment of moderate migraine attacks, but also for severe migraine attacks."	0
"CONCLUSIONS: Although in patients undergoing pacemaker implantation dual antiplatelet therapy with aspirin and @Chemical$ caused a significant increase of bleeding complications, the use of aspirin alone was not associated with a significant increase in @Disease$ complications."	0
The risk of readmission resulting from @Disease$ and venous thromboembolism (VTE) has also not been determined for patients undergoing @Chemical$ or TKA when treated with low-molecular-weight heparin (LMWH) alone compared with mechanical prophylaxis plus aspirin (ASA).	0
The frequency of @Disease$ is similar between @Chemical$ users and ECA users.	0
Only 1 @Chemical$ group patient had @Disease$.	0
@Chemical$ use may attenuate the potential adverse effect of trans fat intake on @Disease$.	1
"In the Coumadin and @Chemical$ studies 100% of the randomized patients had an unprovoked VTE, while in the DOAC studies between 73.5% and 93.2% of the @Disease$ events were unprovoked."	0
METHODS: The Apixaban versus Acetylsalicylic Acid to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin k Antagonist Treatment (AVERROES) trial randomized 5599 patients with @Disease$ and risk factors to receive either apixaban or @Chemical$.	0
@Chemical$ is an ADP receptor antagonist and in combination with aspirin widely used in patients with @Disease$ to reduce the incidence of ischemic events.	0
"In our investigation of such adverse effects, we obtained 4 important findings considered useful for physicians, as follows; 1) even when aspirin was given at a dose, the incidence rate of gastrointestinal lesions was higher than with other non-steroidal anti-inflammatory drugs (NSAIDs), 2) the odds ratios for @Disease$ induced by @Chemical$ with a histamine H2 receptor antagonist and proton pump inhibitor were 0.6 and 0.4, respectively, as compared with aspirin alone, 3) it is difficult to administer aspirin, which exerts an antiplatelet effect, without inducing gastrointestinal lesions, and 4) these gastrointestinal lesions appears early, especially within 2 years after administration."	1
"OBJECTIVE: We performed a long-term observation on clinical course, @Chemical$ sensitivity, and urinary eicosanoids in patients with aspirin-induced @Disease$."	0
"Long-term oral anticoagulant (@Chemical$) and dual-antiplatelet therapy are commonly needed in patients with @Disease$ and in patients undergoing percutaneous coronary intervention (PCI), respectively."	0
@Disease$ in @Chemical$ users were predominant in the first tertile of the small bowel.	1
OBJECTIVE: To evaluate frequency of @Disease$ and hemorrhagic events in patients treated with @Chemical$ and ticagrelor when associated with perioperative heparin bolus for unruptured aneurysms treated with intracranial stents.	0
"@Chemical$-exacerbated @Disease$ (AERD) refers to the combination of asthma, chronic rhinosinusitis with nasal polyposis, and acute upper and lower respiratory tract reactions to the ingestion of aspirin (acetylsalicylic acid, ASA) and other cyclooxygenase-1 inhibiting non-steroidal anti-inflammatory drugs."	1
During dose-reduced (2-3 times a week) clopidogrel administration @Chemical$-induced platelet aggregation was effectively inhibited and neither important bleeding nor stent @Disease$ occurred.	0
"BACKGROUND: Although it is well known that aspirin causes gastroduodenal mucosal injury and that @Chemical$-induced gastroduodenal mucosal injury is often asymptomatic, the prevalence and independent factors for @Disease$ have not been clarified in asymptomatic patients taking low-dose aspirin and gastroprotective agents."	0
"This study aimed to evaluate the relationship between SLCO1B1 polymorphisms, which can affect ACEI and ARB transport, and @Disease$ in elderly male Chinese patients with cardiovascular disease who use @Chemical$."	0
Different factors may increase the gastro-intestinal (GI) @Disease$ associated with @Chemical$.	1
"EVIDENCE ACQUISITION: Published articles were identified through a search of MEDLINE and the Cochrane databases using the dates 1966 to June 2004 and the search terms aspirin allergy, @Disease$, aspirin desensitization, and @Chemical$ sensitivity."	0
[Bleeding complications after treatment with clopidogrel and @Chemical$ after acute @Disease$].	0
Genetic variability of prostaglandin E2 receptor subtype EP4 gene in @Chemical$-intolerant chronic @Disease$.	0
"Within 48 hours (h) of onset, blood and urine samples were collected to assess @Disease$, activation and @Chemical$ response by a range of methods."	0
DATA SYNTHESIS: The literature provides information regarding the safety of COX-2 inhibitors in @Disease$ patients with @Chemical$-exacerbated respiratory disease (AERD).	0
"CONCLUSIONS: The data from this study show that @Chemical$ intolerance, @Disease$ allergy, and asthma duration exceeding 10 years are major factors associated with severe asthma in outpatients."	0
"In addition to a marked increase in cysteinyl-leukotriene production, @Chemical$ challenge induced LTB4 production in @Disease$ patients."	0
RESULTS: No association between @Chemical$ use and prevalence of @Disease$ was observed.	0
"Multivariate predictors of @Disease$ included older age, prior MI, and discharge @Chemical$ which were associated with greater risk; and US region and intervention to the LAD which were associated with lower risk."	0
"BACKGROUND: @Chemical$-exacerbated @Disease$ (AERD) is nonatopic asthma, and the role of heat shock protein (HSP) 70 in AERD remains unknown."	1
"@Chemical$ also increased the risk of serious bleeding by 46% (95%CI, 22-75) in @Disease$ patients without cardiovascular disease but decreased the risk among those with cardiovascular disease."	0
"BACKGROUND: Although there is evidence about the beneficial effects of probiotics, their effects on @Chemical$-induced @Disease$ have not been well examined."	1
Approach to @Chemical$ @Disease$ in cardiovascular patients.	1
Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and @Disease$ With Reduced Ejection Fraction Treated With Warfarin or @Chemical$.	0
Our retrospective study reviewed the effectiveness of PFA-100 in detecting @Disease$ caused by aspirin and @Chemical$ and determined its clinical importance.	0
BACKGROUND: Evidence about the risk of @Disease$ and thromboembolism because of @Chemical$ mono-therapy in total knee arthroplasty (TKA) is scant.	1
"RESULTS: 9225 patients were enrolled (median 1.8years) post-MI: 52% with prior ST-elevation MI, median age 67years, 24% women, 67% Caucasian, 55% had &gt;=2 additional qualifying risk factors, 14% current smokers, 67% overweight/@Disease$, 34% with blood pressure &gt;=140/90mmHg. 81% underwent percutaneous coronary intervention (PCI; 66% with drug-eluting stents) for the index MI. 75% of patients had been discharged on dual antiplatelet therapy (DAPT; acetylsalicylic acid [@Chemical$]+ADP receptor inhibitor [ADPri]), mainly clopidogrel (75%). 63% had discontinued antiplatelet treatment (60% ADPri) around 1year, most commonly by physician recommendation (90%)."	0
@Chemical$ and the older nonsteroidal anti-inflammatory drugs (NSAIDs) that block cyclo-oxygenase-1 (COX-1) induce asthma attacks in patients with aspirin-exacerbated respiratory disease and urticaria in patients with chronic idiopathic @Disease$.	0
Urinary metabolites of histamine and @Chemical$ before and after placebo-controlled challenge with ASA and food additives in chronic @Disease$ patients.	0
"The association between aspirin use and the presence of DR or VTDR was assessed using multivariable logistic regression models including age, gender, ethnicity, socioeconomic status, HbA1c, systolic blood pressure, anti-hypertension medicine, total cholesterol, anti-@Chemical$ medicine, BMI, current smoking status, diabetes duration, history of @Disease$ (CVD) and chronic kidney disease (CKD.)."	0
BACKGROUND CONTEXT: Low-dose @Chemical$ for the prevention of @Disease$ is recommended to be discontinued at least 7 days before spinal surgery.	0
"A relatively frequent problem with the use of NSAIDs and/or @Chemical$, and less frequently with paracetamol, is the development of intolerance and @Disease$ reactions, a situation for which diverse alternatives have been proposed."	0
"Thirteen dogs were assigned into aspirin, lyophilized @Chemical$/trehalose, and control groups, and the @Disease$ were assessed on gastroscopy with the modified Lanza scale."	0
"We hypothesized that platelet transfusion would improve @Chemical$-induced, but not trauma-induced, platelet @Disease$."	1
Use of 325 mg of @Chemical$ within 3 days of renal allograft biopsy was associated with increased @Disease$ complications.	1
"INTRODUCTION: The gastro-intestinal (GI) @Disease$ associated with high dose @Chemical$ has been fully demonstrated, but remains poorly elucidated at low doses i.e., less than 500 mg/day."	0
BACKGROUND &amp; AIMS: Patients requiring low-dose @Chemical$ along with nonsteroidal anti-inflammatory drugs are at increased risk for @Disease$.	1
Recent cohort studies have shown that the relative risk of @Disease$ bleeding with low-dose @Chemical$ was comprised between 2 and 4 and the absolute risk comprised between 1 per 100 and 1 per 1000 aspirin users per year.	0
An extremely unusual case presentation of @Chemical$-exacerbated @Disease$ (AERD).	1
The aim of the study was to assess the tolerability of @Chemical$ in patients with aspirin-exacerbated @Disease$ (AERD).	0
"OBJECTIVE: Although the pathogenesis of @Chemical$-induced @Disease$ (AIU) is not fully understood, mast cell activation has been noted in patients with AIU."	1
"BACKGROUND: @Chemical$-exacerbated respiratory disease (AERD) is a clinical triad consisting of aspirin/acetylsalicylic acid (ASA) sensitivity, bronchial asthma, and @Disease$."	0
"METHODS AND RESULTS: Twenty-two consecutive patients with OHCA of cardiac origin were prospectively included after therapeutic hypothermia and randomized to receive @Chemical$ 100mg per day, either intravenously (n=13) or orally via a @Disease$ (n=9)."	0
Tranexamic acid reduces @Disease$ in coronary artery bypass grafting patients treated with @Chemical$ until the day before surgery.	0
"After the @Chemical$ challenge, C3 decreased in both patients with AIA and those with ATA, but the C3a concentration increased in the @Disease$ patient group (p = 0.019)."	0
"A 70 year-old diabetic man receiving anti-coagulant therapy (@Chemical$) for pulmonary embolism secondary to factor V Leiden deficiency, presented to the hospital for @Disease$."	0
"In addition, aspirin may have an adverse effect on outcome in patients with @Disease$ that is independent of any interaction with angiotensin-converting enzyme inhibitors, possibly by blocking endogenous vasodilator @Chemical$ production and enhancing the vasoconstrictor potential of endothelin."	0
"Furthermore, the use of @Chemical$ was associated with the risk of renal failure in the patients with advanced @Disease$ without previous stroke."	0
"This possible deleterious effect was more predominant when NSAIDs or aspirin were administered during the acute and subacute phases of @Disease$; however, it was still noted when NSAIDs were administered during the late phase of the disease (the effect of @Chemical$ was not evaluated in late phase studies)."	0
OBJECTIVE: To examine whether misoprostol (oral prostaglandin E1 analogue) use during @Chemical$ challenge and desensitization might decrease the severity of aspirin-induced symptoms and make desensitization safer for patients with @Disease$.	0
@Disease$ with low-dose aspirin and its prevention by @Chemical$.	0
"Omeprazole appears to be very effective in reducing both acute @Disease$ and upper GI bleeding in the high-risk patient taking low-dose aspirin, but data with other anti-ulcer agents are lacking (misoprostol) or inconsistent (@Chemical$) at present."	0
@Chemical$ does not adversely affect survival in patients with stable @Disease$ treated with Angiotensin-converting enzyme inhibitors.	0
"During 873,376 person-years of follow-up (1990-2012), longer durations of NSAID use (for &gt;6 years of use compared with &lt;1 year, multivariable-adjusted relative risk = 1.10, 95% confidence interval: 1.06, 1.15; P for trend &lt; 0.001) and @Chemical$ use (for &gt;6 years of use compared with &lt;1 year, multivariable-adjusted relative risk = 1.09, 95% confidence interval: 1.04, 1.14; P for trend &lt; 0.001) were associated with higher risks of @Disease$."	0
Comparable safety of 2 @Chemical$ desensitization protocols for aspirin exacerbated @Disease$.	0
We conclude that wheat germ oil has a potential protective effect against @Chemical$ induced gastro- and hepato-@Disease$ because of its free radical scavenging ability.	1
@Chemical$ appears to be associated with fewer UGI side effects and @Disease$ compared with aspirin.	0
Nasal provocation test (NPT) with @Chemical$: a sensitive and safe method to diagnose aspirin-induced asthma (@Disease$).	0
"OBJECTIVE: The purpose of this study is to demonstrate that @Chemical$, a specific inhibitor of COX-2, does not cause asthmatic attacks in patients with aspirin and/or other nonsteroidal anti-inflammatory drug-induced @Disease$."	0
"Aspirin-exacerbated respiratory disease (AERD) severity and its clinical phenotypes are characterized by genetic variation within pathways for @Chemical$ metabolism, @Disease$, and immune responses."	0
"CONCLUSIONS: In this subgroup analysis in patients at high risk for recurrence of @Disease$ ulcer, use of cotherapy with misoprostol 200 microg QID or @Chemical$ 15 or 30 mg OD significantly lowered the risk for gastric ulcer recurrence."	0
"The @Disease$ of selective and nonselective cyclooxygenase inhibitors: comparisons, contrasts, and @Chemical$ confounding."	0
"The role of gastric acid and its relationship to NSAIDs/aspirin in mucosal damage, ulcer and @Disease$ complications continues to be an important concern because of the increasing worldwide use of NSAIDs and @Chemical$."	0
"In family 2, @Disease$ following @Chemical$ ingestion was present only with variant LTC4S genotype."	1
"Recently, @Disease$ was found at autopsy in 46% of 26 @Chemical$-intoxicated adults."	1
Moreover some patients with imperative cardiologic indications for combination therapy with aspirin and clopidogrel (stent placement and/or acute @Disease$) have a history of allergy to @Chemical$.	0
"CONCLUSION: Longer-term, low-dose @Chemical$ administration induced @Disease$."	1
"RECENT FINDINGS: Numerous studies, including randomized, double-blind, placebo-controlled trials, have demonstrated the therapeutic effectiveness of @Chemical$ desensitization with significant improvement in number of sinus infections per year, olfactory scores, nasal symptom scores, @Disease$ symptom scores, sinus operations, hospitalizations, emergency room visits, and oral steroid use."	0
"Thirteen of all 30 ICrHs (4 on @Chemical$ and 9 on aspirin) were hemorrhagic @Disease$s, and 4 (2 in each group) were symptomatic hemorrhagic transformations of brain infarctions."	0
"Patients on ASA 325 mg had a higher adjusted hazard ratio of 2.9 (95% confidence interval, 1.2-7.0 versus ASA 81 mg+dipyridamole; P = 0.02) and 3.4 (95% confidence interval, 1.2-9.5 versus @Chemical$ 81 mg; P = 0.02) for @Disease$ events."	0
"In @Chemical$-induced platelet dysfunction dogs (n=5), prolonged BMBT (buccal @Disease$ time) was shortened significantly after DDAVP injection (2.2 +/- 1.2 min, P&lt;0.05)."	0
BACKGROUND: Aspirin-exacerbated respiratory disease (@Disease$) refers to the development of bronchoconstriction in asthmatics following the ingestion of @Chemical$.	0
Conclusion: Prognostic @Disease$ risk models were developed that can be used to estimate the absolute bleeding harms of aspirin among persons in whom @Chemical$ is being considered for the primary prevention of CVD.	0
"The RR of @Disease$ requiring reintervention was not significantly higher for any agent compared to control [RR 0.96 (0.76-1.22, P = 0.76) for @Chemical$, 1.84 (0.87-3.87, P = 0.11) for clopidogrel, and 1.51 (0.92-2.49, P = 0.1) for DAPT]."	0
BACKGROUND: @Chemical$ (ASA) and warfarin are used to prevent @Disease$.	0
"RESULTS: Adjusted survival curves showed that the usage of @Chemical$ was not associated with ischemic stroke, hospitalization for bleeding events, cardiovascular mortality or all-cause mortality, however, it was significantly associated with @Disease$."	1
"The aim of this blinded, randomised, multicentre study was to compare the tolerability of aspirin, @Chemical$ and ibuprofen in common pain resulting from musculoskeletal conditions (MSC) in general practice with patients with other non-MSC @Disease$ conditions."	0
Several genetic studies on aspirin hypersensitivity have been performed to discover the genetic predisposition to @Chemical$ @Disease$ and to gain insight into the phenotypic diversity.	1
National estimates of emergency department visits for @Disease$-related adverse events from @Chemical$ plus aspirin and from warfarin.	0
"METHODS: Two hundred thirty-nine patients with AIU consisting of 120 patients with @Chemical$ intolerant chronic urticaria (AICU) and 119 with aspirin-intolerant acute @Disease$ (AIAU), and 524 normal controls were enrolled."	0
"Patients undergoing PCI benefit from dual anti-platelet therapy (including @Chemical$), and aspirin desensitization in those with known @Disease$ may facilitate this."	0
"Also, women had less peripheral artery disease (aspirin, 2.4% versus 3.7%; @Chemical$, 1.4% versus 3.0%), more heart failure, and higher mean CHADS2 (congestive heart failure, @Disease$, age of 75 years or older, diabetes [1 point each], stroke or transient ischemic attack [2 points]) scores (aspirin, 2.2 versus 2.0; apixaban, 2.1 versus 2.0)."	0
Data on the association between aspirin and statin use and @Disease$ (@Chemical$) risk are conflicting.	0
@Chemical$ @Disease$ is due to disturbances in the arachidonic acid metabolism implicating both the lipoxygenase and cyclooxygenase pathways.	1
Rapid desensitization to @Chemical$ in acute @Disease$ patients with NSAID intolerance.	0
Nasal @Chemical$-aspirin challenge appeared to be a reproducible and safe method in assessing patients with aspirin-induced @Disease$.	0
Frequency-risk and duration-risk relationships between @Chemical$ use and @Disease$: a systematic review and meta-analysis.	0
Bleeding during treatment with aspirin versus apixaban in patients with atrial fibrillation unsuitable for warfarin: the @Chemical$ versus acetylsalicylic acid to prevent stroke in @Disease$ patients who have failed or are unsuitable for vitamin K antagonist treatment (AVERROES) trial.	0
"Age, male gender, Helicobacter pylori (H. pylori)infection, diabetes, chronic kidney disease (@Disease$), cirrhosis, history of uncomplicated peptic ulcer disease (PUD), and use of NSAIDs, COX-2 inhibitors, @Chemical$, and thienopyridines were independent risk factors for UGIB among aspirin users."	0
Neutrophil activation in patients with @Chemical$-induced @Disease$.	1
The Framingham Heart Study records of participants with atrial fibrillation (@Disease$) during 1980 and 1994 were retrospectively reviewed to determine the prevalence of @Chemical$ and aspirin use in AF.	0
"Low-dose @Chemical$ use is also associated with an increased risk of upper gastrointestinal @Disease$, but the increase is about 3 times lower than that found with common non-steroidal anti-inflammatory drugs."	1
Reproducibility of response to nasal lysine-@Chemical$ challenge in patients with aspirin-induced @Disease$.	0
"Based on the earlier work that @Chemical$ and reduced platelet activity are associated with larger @Disease$ size and hemorrhage growth, we tested the hypothesis that aspirin or reduced platelet activity would be associated with increased odds of craniotomy, likely through hemorrhage growth."	0
"This article reviews chronic @Disease$ with and without nasal polyps, and the subgroup with @Chemical$-exacerbated respiratory disease, while focusing on the relationship with asthma."	0
"OBJECTIVE: @Chemical$-exacerbated respiratory disease (AERD) represents a severe form of chronic rhinosinusitis (CRS) characterized by nasal polyposis, @Disease$, and aspirin intolerance."	0
Continuous @Chemical$ Treatment Does Not Influence Bleeding Pattern or Outcome of @Disease$: A Matched-Pair Analysis.	0
"The important factors that increase the risk of low-dose @Chemical$-related ulcer complications include a history of bleeding peptic ulcer, prior peptic @Disease$, age &gt; 70 years, H pylori infection, and concomitant drug therapy with non-steroidal anti-inflammatory drugs, other antiplatelet agents (e.g., clopidogrel) or anticoagulants."	0
"These recent results suggest that care must be exercised in the use of selective cyclo-oxygenase-2 inhibitors by individuals who are at increased risk of @Disease$ and stroke, and the use of low-dose @Chemical$ by these patients may place them at increased risk of gastrointestinal complications."	0
"CONCLUSIONS: Low-dose @Chemical$ induced a surprisingly high incidence of acute gastroduodenal @Disease$ in at risk subjects, highlighting that aspirin's upper GI risk begins early and may require gastroprotection."	1
@Chemical$ challenge/desensitisation before coronary stenting in subjects with history of @Disease$.	0
"The drugs significantly associated with @Disease$ were loxoprofen (aOR 5.0), diclofenac (aOR 3.1), diclofenac suppository (aOR 8.0), etodolac (aOR 4.9), enteric-coated aspirin (aOR 3.9), buffered @Chemical$ (aOR 9.9), clopidogrel (aOR 2.5), and cilostazol (aOR 7.3)."	1
Preoperative @Chemical$ use tended to decrease the hazard of mid-term @Disease$ recurrence.	0
"Although others may disagree, it is my belief that any objective analysis of published material in the last 20 years must conclude that there is a close link between the devastating @Disease$ Reye's syndrome and ingestion of @Chemical$ during the febrile prodrome."	0
"Persistent eosinophilic rhinosinusitis precedes development of nasal polyposis, @Chemical$ @Disease$ and asthma."	1
"In addition, it also suggested that the gastric acid secretion level modulates the association between H. pylori @Disease$ and @Chemical$-induced gastropathy."	0
BACKGROUND: Few studies have evaluated the effects of rabeprazole on low-dose aspirin (@Chemical$)-induced @Disease$.	1
RESULTS: The rate of patients with continuous @Chemical$ treatment while @Disease$ is rising significantly (P &lt; 0.01).	0
"After multivariate adjustment for age, sex, current smoking, history of hypertension and diabetes, and aspirin dose (@Chemical$-treated patients only), the hazard ratio for @Disease$ in patients with an arterial versus a cardiac source was 0.74 (95% confidence interval, 0.30 to 1.82) for aspirin-treated patients and 4.34 (95% confidence interval, 0.35 to 54) for placebo-randomized patients."	0
Continuation of low-dose @Chemical$ during perioperative period of laparoscopic inguinal @Disease$ repair is safe: results of a prospective clinical trial.	0
"@Chemical$A4 dose dependently (0.25-2.5 microg/kg, intraperitoneally) reduced the severity of aspirin-induced @Disease$ and suppressed aspirin-induced leukocyte adherence, whereas an LXA4 antagonist had the opposite effects."	0
PURPOSE OF REVIEW: Aspirin-induced urticaria/angioedema is a major aspirin-related @Disease$ often associated with @Chemical$-intolerant asthma.	0
"In the @Chemical$ in Alzheimer's Disease (@Disease$2000) trial, these proportions were, respectively, 2.6% (4/156; 95% CI, 0.7 to 6.4) and 0% (0/154; 95% CI, 0 to 2.4)."	0
"In patients who stopped @Chemical$ for up to 5 days before surgery, the ADP test failed to exhibit prognostic utility for predicting @Disease$ risk."	0
"However, recently, there has been growing interest among gastroenterologists on the adverse effects of @Chemical$ on the @Disease$, especially as new endoscopic techniques, such as capsule endoscopy (CE) and balloon-assisted endoscopy, have become available for the evaluation of small bowel lesions."	1
The endoscopic findings and clinical features of gastroduodenal @Disease$ have not been thoroughly investigated in patients taking @Chemical$.	0
"By ROC analysis the VerifyNow  @Chemical$ assay was able to distinguish between patients with and without minor bleeding (area under the curve [AUC] 0.66, 95 % confidence interval [CI] 0.62-0.70, P &lt; 0.0001) whereas major @Disease$ could not be predicted by the assay (AUC 0.54, 95 % CI 0.49-0.58, P = 0.473)."	0
[The association of @Chemical$ profile and bleeding in patients with minor stroke or transient @Disease$ attack on antiplatelet therapy: subgroup analysis of CHANCE].	0
"In the @Disease$ group, subjects underwent aspirin desensitization followed by a 1-month @Chemical$ treatment."	0
"OBJECTIVE: Aspirin-induced @Disease$ is increasing, but whether the type of @Chemical$ affects the gastrointestinal (GI) bleeding, especially small intestine, is unclear."	0
"We describe the case of a 64-year-old patient with glucose-6-phosphate dehydrogenase deficiency who was referred to our hospital because of an acute inferior myocardial infarction.Given the possible risk of acute haemolytic anaemia, @Chemical$ was not given in the acute phase, and the patient was successfully treated by balloon angioplasty of the right coronary artery.After functional and genetic testing showing the presence of the Mediterranean mutation, known to be a class II variant, the patient received oral daily aspirin (100 mg) under strict monitoring in order to promptly detect any sign of @Disease$."	0
"Older age, prior @Disease$ events, chronic renal failure, use of other injurious medicine such as NSAIDs, antithrombotic medicine, especially thienopyridine, and corticosteroids seem to be factors associated with an increased risk for upper GI ulcer and bleeding among the patients taking low dose @Chemical$."	0
"CONCLUSION: In addition to age, male gender, H. pylori @Disease$, and concomitant use of NSAIDs, COX-2 inhibitors, steroids, and thienopyridines, underlying co-morbidities including diabetes, CKD, cirrhosis, history of PUD are also important risk factors for first-time occurrence of non-variceal UGIB in @Chemical$ users."	0
Subjects with @Chemical$-intolerant @Disease$ were distinguished by a sharp increase in the level of prostaglandin D(2) and E(2) metabolites; their 5- and 15-hydroxyeicosateraenoic acid levels were also higher than in aspirin-tolerant subjects.	0
"METHODS: 40 subjects with @Disease$ (NP) were classified as aspirin-sensitive (n=13, ASNP) or aspirin-tolerant (n=27, ATNP) based on a bronchial @Chemical$ challenge test."	0
@Chemical$ plays a pivotal role in the management of patients with @Disease$ (CAD) with well-recognised benefits of reducing recurrent myocardial infarction and minimising the risk of stent thrombosis for those undergoing Percutaneous Coronary Intervention (PCI).	0
"TAPT and DAPT were associated with similar rates of death, non-fatal MI, @Disease$ and ST, but compared with DAPT, @Chemical$ had lower rates of target lesion revascularization (TLR) (RR 0.67, 95 % CI 0.56-0.82, P &lt; 0.0001) and target vessel revascularization (TVR) (RR 0.65, 95 % CI 0.55-0.77, P &lt; 0.00001), as well as less late loss of minimal lumen diameter (mean difference -0.14, 95 % CI -0.17--0.11, P &lt; 0.00001), and less binary angiographic restenosis (RR 0.54, 95 % CI 0.45-0.65, P &lt; 0.00001)."	0
CONCLUSION: @Chemical$ and the combination of acetylsalicylic acid and dipyridamole were associated with similar risks for recurrent ischemic @Disease$ and bleeding; whereas acetylsalicylic acid was associated with higher risks for both ischemic stroke and bleeding.	0
It could be concluded that the treatment with P. halepensis @Chemical$ inhibited aspirin-induced @Disease$.	0
"CONCLUSIONS: The type of @Chemical$ does not affect the incidence of overt @Disease$ and decreased hemoglobin, but enteric-coated aspirin may be associated with an increased incidence of decreased hemoglobin."	0
"Our study also highlights that the use of aspirin for primary prevention of cancer was found to cause higher rates of @Disease$ (any bleeding, major bleeding, and GI bleeding) compared to placebo or no @Chemical$ at the longest follow-up period with no significant benefit in cancer primary prevention."	0
"Urinary eicosanoids, plasma tryptase and cytokine levels, platelet-leukocyte aggregates, and granulocyte transcripts were assessed.Measurements and Main Results: Eight weeks of high-dose aspirin decreased nasal symptoms and urinary @Chemical$ metabolite (P &lt; 0.05) and increased urinary leukotriene E4 (P &lt; 0.01) levels in subjects with aspirin-exacerbated respiratory disease, but not in those with aspirin-tolerant @Disease$."	0
The association between @Disease$ and @Chemical$ hypersensitivity in asthma is unclear.	0
"Significant heterogeneity was present for the NSAIDs; e.g., ibuprofen was associated with an increased overall fracture risk (OR = 2.09, 95% CI 2.00-2.18 for &lt;20 DDD), while @Chemical$ was not (OR = 0.76, 95% CI 0.51-1.13 for &lt;20 @Disease$, 2P &lt; 0.01 for comparison)."	0
"After stratification by quartiles based on post-treatment @Chemical$-induced @Disease$, we identified patients in the first quartile as hyper-responders with very low post-treatment platelet reactivity, below &lt;40%."	1
We report three patients aged 75-80 years observed in the Emergency Room with severe anaemia (requiring transfusion) due to a large abdominal wall haematoma while receiving standard prophylaxis against @Disease$ (40 mg/day @Chemical$ for 6 days on average).	0
"After propensity score matching (PSM) for identified confounders, the relationship between preoperative @Chemical$ use and 30-day all-cause mortality, @Disease$, major adverse cardiocerebral events (MACE), blood transfusion, reoperation for bleeding, and postoperative infection were estimated with separate logistic regression models."	0
PURPOSE OF REVIEW: The use of aspirin in @Disease$ and address the unmet need of aspirin therapy in patients with history of hypersensitivity reactions to aspirin (acetylsalicylic acid; @Chemical$) or other nonsteroidal inflammatory drugs (NSAIDs).	0
Postprocedural Thrombolysis in @Disease$ flow grade 3 was less often demonstrated in the prior @Chemical$ users (odds ratio: 1.512; P = 0.059).	0
"METHODS: The frequencies of all and GI adverse events (AEs) and adverse drug reactions (ADRs) were calculated from the pooled individual patient data of nine similar randomized, double-blind, placebo controlled clinical trials of single-doses of @Chemical$ 1000 mg in the treatment of acute migraine attacks, episodic tension-type headache and dental @Disease$."	0
We report a case of a large spontaneous latissimus dorsi @Disease$ in a patient receiving @Chemical$ and aspirin therapy.	1
All of them concomitantly received 100 mg/day @Chemical$ because of previous ischaemic heart disease and presented similar clinical features: sudden onset of abdominal pain during a severe cough episode due to @Disease$.	0
"We included participants with headache at t0, @Chemical$ intake, ASA++ or no analgesics at t0 and t2, and known @Disease$ frequency."	0
No association was retrieved with @Chemical$ intake and peptic @Disease$ history.	0
"These associations were stronger after more than 10 years of use (@Chemical$: odds ratio (OR) = 1.8, 95% confidence interval (CI): 1.3, 2.6; aspirin: OR = 1.6, 95% CI: 1.1, 2.2) and were present for indications of @Disease$, menstrual pain, and other pain/injury."	0
The slightly increased risk of only localized @Disease$ with non@Chemical$ NSAID use suggests a noncausal explanation of the observed association.	0
"@Chemical$ at a dose of &lt;100 mg per day had no impact on the risk of placental abruption or antepartum @Disease$, irrespective of whether it was initiated at &lt;=16 weeks of gestation (relative risk, 1.11; 95% confidence interval, 0.52-2.36) or at &gt;16 weeks of gestation (relative risk, 1.32; 95% confidence interval, 0.73-2.39)."	0
Aspirin desensitization achieved after @Chemical$ treatment in a patient with aspirin-exacerbated urticaria and @Disease$.	0
"OBJECTIVES: To study the pattern of aspirin-induced @Disease$ (AIU) in two families, with special interest on the polymorphisms of LTC4S (AA, AC, CC) and the @Chemical$ S-transferase M1 and P1 genes (GSTM1 and GSTP1)."	0
Acetylsalicylic acid in combination with @Chemical$ shows significantly fewer @Disease$ and the lowest increase in gastric microbleeding compared with the other tested formulations.	0
Intravenous administration of desmopressin acetate to reverse @Chemical$-induced @Disease$ in three dogs.	1
OBJECTIVE: Difference in the risk of gastrointestinal (@Disease$) complications between users of enteric-coated and buffered low-dose @Chemical$ (LDA) is unclear.	0
We aimed to determine the relationship between @Chemical$ levels and bleeding in minor @Disease$ or transient ischemic attack (TIA) patients receiving antiplatelet therapy.	0
BACKGROUND: The use of low-dose @Chemical$ (LDA) has emerged as an important cause of @Disease$.	1
PURPOSE: To determine the effect of stopping low-dose @Chemical$ at least 7 days before surgery on the level of the perioperative blood loss or complications related to @Disease$.	0
"RESULTS: Subjects in groups A, C, and @Chemical$ had significantly higher levels of @Disease$ on days 3 and 7, compared with baseline."	0
The five patients with ST segment elevation @Disease$ were treated with @Chemical$ until desensitization was complete.	0
"BACKGROUND: Many patients requiring permanent pacemaker (PPM) or implantable @Disease$ (ICD) placement are anticoagulated with @Chemical$, aspirin (ASA), and clopidogrel for a number of thromboembolic risk indications."	0
"There is evidence that aspirin and non-aspirin non-@Chemical$al anti-inflammatory drug (NSAID) have anti-@Disease$ properties, but their effect on lung cancer, in particular in never-smokers, is unclear."	0
Dietary modifications toward a diet that is high in omega-3 fatty acids and low in omega-6 fatty acids can reduce the production of the inflammatory @Chemical$ and prostaglandin D2 lipids and help improve symptoms for patients with @Disease$.	0
"METHODS: The 267 patients who had survived a @Disease$ were randomly assigned in the Warfarin Aspirin Reinfarction Study to treatment with @Chemical$ 160 mg/day, or warfarin (INR 2.8-4.2), or aspirin 75 mg/day plus warfarin (INR 2.0-2.5)."	0
METHODS: Patients taking @Chemical$ and an ACEI or ARB concomitantly who had undergone endoscopic screening for @Disease$ were analyzed for SLCO1B1 polymorphisms by a TaqMan assay.	0
"The cells were isolated from 3 groups of subjects: non@Disease$tic patients (n = 10), patients with @Chemical$-tolerant asthma (ATA, n = 9), and patients with aspirin-intolerant asthma (AIA, n = 7)."	0
"TAPT and @Chemical$ were associated with similar rates of @Disease$, non-fatal MI, ischemic stroke and ST, but compared with DAPT, TAPT had lower rates of target lesion revascularization (TLR) (RR 0.67, 95 % CI 0.56-0.82, P &lt; 0.0001) and target vessel revascularization (TVR) (RR 0.65, 95 % CI 0.55-0.77, P &lt; 0.00001), as well as less late loss of minimal lumen diameter (mean difference -0.14, 95 % CI -0.17--0.11, P &lt; 0.00001), and less binary angiographic restenosis (RR 0.54, 95 % CI 0.45-0.65, P &lt; 0.00001)."	1
"These complications are mainly attributable to NSAIDs and @Chemical$, which can injure the mucosa anywhere along the @Disease$."	0
CONCLUSIONS: This study has demonstrated that @Chemical$-induced @Disease$ is directly associated with gastric acid secretion.	1
"@Disease$ is a serious, acute encephalopathy that has been linked with @Chemical$ (acetylsalicylic acid) use in children and teenagers &lt;18 years of age."	1
"RESULTS: In the stable condition, expression of all surface markers on platelets, the percentage of platelet-adherent eosinophils, and the plasma levels of @Chemical$ and sCD40L were significantly higher in patients with @Disease$ compared with those in patients with ATA."	0
"We evaluated changes in leukotriene and prostaglandin metabolites for @Chemical$ patients, using patients with NECD and single-NSAID-induced urticaria/@Disease$ or anaphylaxis (SNIUAA) for comparison."	0
"Platelet transfusion improves @Chemical$-induced, but not @Disease$-induced, platelet dysfunction."	0
"As for @Disease$ complications related to the gastrointestinal system, e.g., melaena and haematochezia, the statistical metrics suggested a stronger association for @Chemical$ than clopidogrel."	0
@Chemical$-exacerbated @Disease$ (AECD) is a distinct subphenotype of chronic spontaneous urticaria.	1
"@Chemical$, non-steroidal anti-inflammatory drugs (NSAIDs) and paracetamol are the most frequent drugs used worldwide for the management of pain, @Disease$ and fever associated with many acute and chronic conditions."	0
Method: Eighty-six patients with CRS and asthma who were treated in the outpatient clinic during March 2015 to January 2018 were divided into asthma group(52 cases) and @Chemical$ asthma group(34 cases) according to @Disease$ and aspirin asthma.	0
Nonmajor @Disease$ were more common on @Chemical$.	0
"BACKGROUND: After coronary stent placement, whether dual antiplatelet therapy (@Chemical$) duration should be extended to prevent late stent @Disease$ (ST) or adverse cardiovascular events is uncertain."	0
Drug-induced hypersensitivity syndrome: drug reaction with @Disease$ and systemic symptoms (DRESS) syndrome induced by @Chemical$ treatment of Kawasaki disease.	0
"RESULTS: Of 8754 Chinese patients with atrial fibrillation and CHA2DS2-VASc &gt;=1 (79.5+-9.2 years; CHA2DS2-VASc, 4.1+-1.5; and Hypertension, Abnormal Renal/Liver Function, @Disease$, Bleeding History or Predisposition, Labile International Normalized Ratio, Elderly (&gt;65 years), Drugs/Alcohol Concomitantly [HAS-BLED], 2.2+-0.9), 16.3% received @Chemical$, 41.1% aspirin, 4.5% dabigatran, and 38.1% received no therapy."	0
Aspirin-induced asthma (AIA) is a distinct clinical entity characterised by @Disease$ to @Chemical$ and other non-steroidal anti-inflammatory drugs (NSAIDs) typically occurring in the form of asthma and severe rhinosinusitis.	1
"Platelet transfusion is often used to limit progression of @Disease$ in patients on @Chemical$, but has not been shown to improve platelet function or outcomes."	0
The risk of @Disease$ with LDA may increase with simultaneous use of @Chemical$.	0
@Chemical$ dose increase in unresponsive patients is associated with reduced risk of @Disease$.	0
"Also, women had less peripheral artery disease (aspirin, 2.4% versus 3.7%; apixaban, 1.4% versus 3.0%), more @Disease$, and higher mean CHADS2 (congestive heart failure, hypertension, age of 75 years or older, diabetes [1 point each], stroke or transient ischemic attack [2 points]) scores (aspirin, 2.2 versus 2.0; @Chemical$, 2.1 versus 2.0)."	0
"Patients with history of @Disease$/bleeding were much more likely to be co-prescribed @Chemical$ than those who had no history of GI disorders (OR, 26.5)."	0
"MAIN OUTCOMES AND MEASURES: Days of NSAID or @Chemical$ use and nonuse, clinically relevant @Disease$ event and major bleeding event rates by patient-years, and hazard ratios."	0
"We collected data on the use of warfarin at implantation, INR prior to device implantation, use of dual-antiplatelet therapy (@Chemical$), such as concomitant aspirin and clopidogrel and subsequent formation of @Disease$ in the peri-procedure period."	0
"Risk of @Disease$ associated with selective cyclo-oxygenase-2 inhibitors, traditional non-@Chemical$ non-steroidal anti-inflammatory drugs, aspirin and combinations."	0
"Of all antiplatelet therapies approved for the secondary prevention of stroke, @Chemical$ is the most well-established and is recommended for all patients with a history of @Disease$."	0
"METHODS: We compared aspirin and warfarin for HF events (hospitalization, @Disease$, or both) in the 2,305 patients enrolled in the WARCEF (Warfarin versus @Chemical$ in Reduced Cardiac Ejection Fraction) trial (98.6% on ACE inhibitor or ARB treatment), using conventional Cox models for time to first event (489 events)."	0
"It is still controversial whether @Chemical$ use during pregnancy increases the risk of certain congenital abnormalities (in particular, @Disease$, gastroschisis, and cleft lip +/- palate)."	0
"OBJECTIVE: The use of low-dose @Chemical$ (acetylsalicylic acid [ASA]) has been suggested to attenuate growth of @Disease$ (AAAs), yet solid clinical evidence of this hypothesis is still missing."	0
"@Disease$ associated with the use of nonsteroidal anti-inflammatory drugs, low-dose @Chemical$, antiplatelet drugs, and dual therapy."	1
CONCLUSIONS: Early administration (1 hour after surgery) of @Chemical$ did not appear to increase the risk of post-operative @Disease$ in patients undergoing CABG.	0
@Chemical$ inhibited @Disease$ formation in a dose-dependent manner.	1
"The @Disease$s were negatively correlated with the 24-h intragastric pH (P = -0.711, &lt; 0.001), whereas @Chemical$ had no effect on the intragastric pH."	0
Prospective cohort study of @Disease$ and vascular diseases in patients taking @Chemical$: rationale and design of the MAGIC Study.	0
BACKGROUND: Prophylactic @Chemical$ has been considered to be beneficial in reducing the risks of @Disease$ and cancer.	0
"Adverse events considered possibly or probably related to treatment occurred in 5 (20.0%) misoprostol recipients (4 episodes of diarrhea, 1 episode of abdominal pain), 1 (14.3%) recipient of @Chemical$ 30 mg (1 episode of pharyngitis), and 3 (13.6%) placebo recipients (1 episode each of @Disease$, palpitations, and dyspepsia)."	0
"For the @Chemical$ cohort, there was higher wound @Disease$ complication frequency with LMWH (9.2% for LMWH versus 0.9% for mechanical compression; p = 0.009; OR, 10.9)."	0
"OBJECTIVE: We sought to determine blood and urinary levels of @Chemical$,11beta-PGF(2), a major stable PGD(2) metabolite in 2 well-defined phenotypes of asthma, aspirin-induced asthma (AIA) and aspirin-tolerant @Disease$ (ATA), and in healthy control subjects and to study the effects of aspirin on PGD(2) release."	0
OBJECTIVE: To assess the association between @Chemical$ and NSAID use and incident @Disease$ and UC.	0
"Our study also highlights that the use of aspirin for primary prevention of cancer was found to cause higher rates of bleeding (any bleeding, major bleeding, and GI @Disease$) compared to placebo or no @Chemical$ at the longest follow-up period with no significant benefit in cancer primary prevention."	0
"Our approach to aspirin @Disease$ in patients needing coronary stenting, based on a severity stratification, allowed to achieve an effective tolerance to @Chemical$ in the majority of subject in a reasonable short time."	0
Extended antiplatelet therapy with clopidogrel alone versus clopidogrel plus @Chemical$ after completion of 9- to 12-month dual antiplatelet therapy for @Disease$ patients with both high bleeding and ischemic risk.	0
We address the strength of evidence between low-dose @Chemical$ use and AMD and also discuss the risks and benefits of aspirin use in primary versus secondary prevention of @Disease$ in these cases.	0
@Chemical$ desensitization is a safe and simple way to manage ASA @Disease$.	0
BACKGROUND AND PURPOSE: Cerebral microbleeds (@Chemical$) may predict future risk for intracerebral hemorrhage (@Disease$).	0
"DATA SYNTHESIS: @Chemical$ resistance has been reported in patients with cardiovascular, cerebrovascular, and peripheral @Disease$."	0
Excretion of LTE4 in patients with aspirin induced @Disease$ raised after oral @Chemical$ provocation and higher level was detected is til 24 hours after challenge.	0
"Compared with patients not associated with NSAIDs and @Chemical$ medication, they are older [(41.2 +- 1.9) years vs (59.4 +- 2.2) years, P &lt; 0.001], more commonly associated with @Disease$ (10.4% vs 39.2%, P &lt; 0.001), coronary heart disease (10.4% vs 17.6%, P &lt; 0.001), diabetes (4.2% vs 19.6%, P = 0.005); and had more severe anemia (7.3% vs 23.5%, P = 0.008)."	0
"We evaluated the differences in ACS type, total mortality, and the composite end point of death, myocardial infarction (MI), recurrent @Disease$, or stroke between prior @Chemical$ and nonprior aspirin users."	0
"CONCLUSIONS: Low-dose aspirin use could reduce the incidences of total cardiovascular events, stroke, nonfatal stroke and transient ischemic attack but increase the risk of bleeding, the incidence of nonfatal myocardial infarction, @Disease$ from cardiovascular causes and death from any cause was not affected by low-dose @Chemical$ use."	0
"It is, therefore, currently not clear whether the @Disease$ severity or the presence of AERD has a primary role in the disturbed @Chemical$ metabolism."	0
"Dual antiplatelet therapy (DAPT) with acetylsalicylic acid and a P2Y12 inhibitor (clopidogrel, ticagrelor, or @Chemical$) reduces thrombotic events in patients with @Disease$ (ACS), but it is also associated with an increased risk of bleeding complications."	0
"@Chemical$, @Disease$, Kawasaki disease, and allergies; a reconsideration of the links."	1
"METHOD: We classified 1,041 gastroduodenal ulcer patients into three groups [patients taking LDA (group A), patients taking non@Chemical$ nonsteroidal anti-inflammatory drug (NSAID) (group N), and patients taking neither aspirin nor nonaspirin NSAID (group C)] and 241 @Disease$ gastroduodenal ulcer patients into three corresponding groups (groups a, n, and c)."	0
"Aspirin @Disease$ was diagnosed in 180 (13.6%) asthmatic patients, with a reliable history in 145 (80.5%), and oral @Chemical$ provocation test in 35 (19.5%) patients."	0
"@Disease$ patients suffer from an active disease despite avoidance of aspirin, and it has been suggested that administration of aspirin to these patients increases the generation of immediate oxygen products of @Chemical$, 12-hydroperoxyeicosatetraenoic acid (12-HPETE), in their platelets."	0
We also did not observe an increased rate of @Disease$ in the case of a short interval between last LMWH (less than 24 hours) or @Chemical$ (less than five days) doses and delivery.	0
"RESULTS: Although wheat with exercise did not induce any symptoms, addition of @Chemical$ induced @Disease$ and elevation of blood gliadin levels in both cases."	1
"METHODS: We screened a Korean @Disease$ cohort (581 asthmatics including 81 aspirin-intolerant asthmatics and 231 @Chemical$-tolerant asthmatics, and 181 normal controls) for four single nucleotide polymorphisms (SNPs; -262 A&gt;T and -115 T&gt;C in the 5'-flanking region and +5467 T&gt;C [Pro450Pro] and+11860 A&gt;G [Thr776Thr] in the coding region) and one ins/del (+21288 CT) in the ACE gene."	0
"Aspirin results in prolonged inhibition of blood coagulation, and @Chemical$ can result in liver toxicity at normal dose and @Disease$ at higher dose."	0
CONCLUSION: Gastroduodenal @Disease$ and erosion are common in Japanese patients taking low dose @Chemical$ for cardioprotection.	0
AIM: To investigate the role of the hydrogen-rich @Chemical$ (HRW) in the prevention of aspirin-induced @Disease$ in rats.	0
The trend towards increased @Disease$ with warfarin appears to be explained by an excess of intracranial bleeding in @Chemical$ patients.	0
"Impact of blood type, functional polymorphism (T-1676C) of the COX-1 gene promoter and clinical factors on the development of peptic @Disease$ during cardiovascular prophylaxis with low-dose @Chemical$."	0
"BACKGROUND/AIMS: Many patients with aspirin-induced asthma have severe methacholine @Disease$ (AHR), suggesting a relationship between @Chemical$ and methacholine in airway response."	0
Effects of zinc-L-carnosine and @Chemical$ on aspirin-induced @Disease$ in dogs.	0
The most comorbid disease was @Disease$ and the two most frequent NSAIDs inducing UR/AE were @Chemical$ (19. 6%) and ASA (19%).	0
"OBJECTIVE: The purpose of this study was to determine, on the basis of published reports, whether @Chemical$ use during the first trimester of pregnancy is associated with an increased risk of @Disease$."	0
"A worldwide use of @Chemical$ is now accepted due to its remarkable analgesic, antipyretic and anti-thrombotic prophylactics against @Disease$ and coronary disorders despite the fact that the use of NSAIDs is associated with the risk of gastrointestinal bleedings, haemorrhagic lesions and ulcerations."	0
"BACKGROUND &@Chemical$; AIMS: We performed a meta-analysis of data from randomized trials to estimate the risk of all-cause mortality and @Disease$ (and especially gastrointestinal [GI] bleeding) in patients treated with low doses of acetylsalicylic acid (ASA) (75-325 mg/d), alone or in combination with other medications."	0
Five patients discontinued @Chemical$ maintenance therapy due to @Disease$ and respiratory side effects.	0
Severe nose @Disease$ after intake of @Chemical$: von Willebrand disease type 2A.	1
"RESULTS: Patients taking @Chemical$ had a significantly higher cumulative incidence of haematuria and rectal bleeding, but not of @Disease$."	0
The risk of readmission resulting from bleeding and venous thromboembolism (@Disease$) has also not been determined for patients undergoing @Chemical$ or TKA when treated with low-molecular-weight heparin (LMWH) alone compared with mechanical prophylaxis plus aspirin (ASA).	0
Dietary modifications toward a diet that is high in @Chemical$ and low in omega-6 fatty acids can reduce the production of the inflammatory leukotriene and prostaglandin D2 lipids and help improve symptoms for patients with @Disease$.	0
The MAGIC Study and the gastrointestinal effects of low-dose @Chemical$ : editorial to: Prospective cohort study of @Disease$ and vascular diseases in patients taking aspirin: rationale and design of the MAGIC Study by H.	0
A study on the effects of recent aspirin ingestion on platelet function in cardiac surgery showed a greater @Disease$ in patients treated with aspirin &@Chemical$;2 days before the operation.	0
@Chemical$ (ASA) is widely used in the prevention of @Disease$.	0
We describe the case of a 58-year old man with late onset asthma who was suspected to have @Disease$ on the basis of associated clinical features despite having taken @Chemical$ safely in the past.	0
"CONCLUSIONS: Preoperatively continued @Chemical$ use was not associated with increased risk of intra- and post-operative blood loss, blood transfusion requirements and composite outcome of in-hospital death, @Disease$ and reoperation for bleeding in off-pump CABG."	0
OBJECTIVE: To characterize the clinical presentation of a cohort of patients with coronary artery disease (@Disease$) and @Chemical$ reactions.	0
"CONCLUSION: On the basis of the present studies, it cannot be unequivocally said whether @Chemical$ influences @Disease$ and if people endangered with AMD progression or who are diagnosed with AMD should use this drug."	0
Valproic acid @Disease$ associated with low dose of @Chemical$ and low total valproic acid levels: a case report.	1
[Clinical study on @Disease$ and @Chemical$ asthma affecting chronic rhinosinusitis].	0
Recognising the risk of @Chemical$-sensitive respiratory disease in a patient with @Disease$ who has previously tolerated aspirin.	0
BACKGROUND: @Chemical$ use is with an increased risk of @Disease$ (UGICs).	1
METHODS: We performed a prospective study of 84 @Chemical$ users with @Disease$ who required continued aspirin therapy in Hong Kong and Japan.	0
"BACKGROUND AND AIM: Acetylsalicylic acid (ASA [@Chemical$]) is a commonly used over-the-counter drug for the treatment of @Disease$, fever, or colds, but data on the safety of this use are very limited."	0
"SUMMARY: The full clinical picture of @Chemical$ intolerance--the association of aspirin-induced bronchial asthma (with severe acute asthma attacks), aspirin sensitivity and nasal @Disease$--is commonly summarized as the 'Samter triad'."	0
CONCLUSION: The findings of the present study do not support the notion that enteric-coated low-dose aspirin reduces the risk of @Disease$ and is safer than buffered low-dose @Chemical$ products.	0
OBJECTIVE: The aim of this study was to investigate the associations between proton pump inhibitor (PPI) usage patterns and risk of severe @Disease$ in patients treated with low-dose @Chemical$ (LDA).	0
"After @Chemical$, gastric blood flow (GBF) was determined by H2 gas clearance technique and @Disease$ were assessed by planimetry and histology."	0
"Forty-nine reported no significant side effects, and 9 reported either allergic reaction or minimal to significant @Disease$ on @Chemical$."	0
"BACKGROUND: In patients with ischemic stroke of non-cardioembolic origin, acetylsalicylic acid, clopidogrel, or a combination of acetylsalicylic acid and @Chemical$ are recommended for the prevention of a recurrent @Disease$."	0
"@Chemical$ hypersensitivity is a hallmark of aspirin-exacerbated @Disease$ (AERD), a clinical syndrome characterized by the severe inflammation of the respiratory tract after ingestion of cyclooxygenase-1 inhibitors."	0
"Background: @Chemical$-exacerbated respiratory disease (@Disease$), a syndrome that includes asthma, recurrent nasal polyps, and pathognomonic reactions to aspirin and other nonselective cyclooxygenase inhibitors, is still not fully understood and lacks specific disease-modifying therapeutic options."	0
RESULTS: The study observed a heterogeneous distributed aspirin 100 mg/d AA-Ag (range: 0.42% to 28.78%)in the 537 very elderly patients.@Chemical$ 100 mg/d AA-Ag before the switch in aspirin 40 mg/d group was 5.00%+-2.32% and the rate of the patients with low on-treatment @Disease$ was 71.00%.	0
"Use of paracetamol, ibuprofen or @Chemical$ in pregnancy and risk of @Disease$ in the child."	0
BACKGROUND: Patients with @Chemical$-exacerbated respiratory disease (AERD) are distinguished from patients with aspirin-tolerant @Disease$ (ATA) by significantly higher baseline concentrations of urinary leukotriene E4 (uLTE4).	0
Hemorrhagic transformation of @Disease$ associated with enoxaparin and @Chemical$ concomitant therapy.	0
"The possible toxic synergism with @Chemical$ and acetaminophen, however, is not previously described; though case reports suggest such co-@Disease$ with low levels of aspirin and other compounds can exist."	0
Method: Eighty-six patients with CRS and @Disease$ who were treated in the outpatient clinic during March 2015 to January 2018 were divided into asthma group(52 cases) and aspirin asthma group(34 cases) according to asthma and @Chemical$ asthma.	0
"Considering the patient's previous history of GI disorders prior to initiation of treatment and Hp(+) serology, it appears that decreasing risk of symptomatic or complicated gastro-duodenal ulcer was higher in treatment with @Chemical$ in patients who did not have a previous history of @Disease$, whatever their Hp status."	0
Microtrauma-induced recurrent hyphema and secondary  @Disease$ associated with chronic @Chemical$ use.	0
The features described here suggest the importance of the Eosinophils and CD 4 +/- Lymphocytes in asthmatic response of @Disease$ asthmatic patients as well as in @Chemical$ sensitivity asthmatic patients.	0
"Although acetylsalicylic acid is prescribed for a broad range of diseases, it can induce a wide array of clinically recognized hypersensitivity reactions, including @Chemical$-intolerant asthma (AIA) with @Disease$ and aspirin-intolerant urticaria (AIU) with anaphylaxis."	0
Low-dose @Chemical$ and @Disease$.	0
"OBJECTIVE: We investigated whether subjects with @Disease$ and/or nasal polyps (NP) and analgesic intolerance proven by oral @Chemical$ provocation test tolerated the selective COX-2 inhibitor, meloxicam."	0
Different impact of @Chemical$ on renal progression in patients with predialysis advanced @Disease$ with or without previous stroke.	0
"CONCLUSIONS: Among CRS subjects requiring FESS, as many as 33.3% may have @Disease$ and respond to a small provocative dose of @Chemical$ with bronchoconstriction and/or mucosal and skin edema."	0
"Cox proportional hazards models were used to identify predictors of recurrence stratified by @Disease$ location, with @Chemical$ and warfarin exposures as time-dependent variables adjusting for potential confounders."	0
@Disease$ was induced by intragastric administration of @Chemical$ and 0.15 N HCl in male Sprague-Dawley rats.	1
"Also, women had less peripheral artery disease (aspirin, 2.4% versus 3.7%; apixaban, 1.4% versus 3.0%), more @Disease$, and higher mean CHADS2 (congestive heart failure, hypertension, age of 75 years or older, diabetes [1 point each], stroke or transient ischemic attack [2 points]) scores (@Chemical$, 2.2 versus 2.0; apixaban, 2.1 versus 2.0)."	0
"CONCLUSIONS: Considering that human lung mast cells are capable of producing LTC4, prostaglandin D2, and histamine, our present results support the concept that mast cells, at least, may participate in the development of @Chemical$-induced @Disease$."	1
The use of low-dose @Chemical$ in pregnancy should remain a highly targeted indication since its long-term safety has not been established and should be restricted to women at high risk of @Disease$.	0
CONCLUSION: Clopidogrel and the combination of @Chemical$ and dipyridamole were associated with similar risks for recurrent ischemic stroke and bleeding; whereas acetylsalicylic acid was associated with higher risks for both ischemic @Disease$ and bleeding.	0
"These patients were classified into three groups: Group A comprised patients with nasal polyps without asthma; Group B contained patients with nasal polyps and @Disease$; and Group C comprised patients with nasal polyps, asthma and @Chemical$ sensitivity."	0
"CONCLUSIONS AND RELEVANCE: Among patients with venous thromboembolism receiving anticoagulant therapy, concomitant use of an NSAID or @Chemical$ is associated with an increased risk of clinically relevant and major @Disease$."	1
"It is suggested that, by understanding the age-related changes in @Disease$ physiology and the mechanisms by which @Chemical$ leads to the risk reductions associated with its use, it may be possible to direct interventions to improve tolerability in older subjects."	0
The question addressed was whether enteric-coated aspirin results in a lower incidence of @Disease$ compared to normal @Chemical$ in CABG surgery.	0
"To explore the neural mechanisms underlying salicylate (SS)-induced hyperexcitability and increased central gain, we examined the effects of @Chemical$ receptor agonists and antagonists on SS-induced @Disease$ in the AC and startle reflex responses."	0
Low-dose ibuprofen is as effective as aspirin and @Chemical$ for the indications normally treated with over-the-counter (OTC) medications and is associated with the lowest risk of @Disease$ of any non-steroidal anti-inflammatory drug.	0
"Three major clinical phenotypes of NSAID-induced acute skin reactions manifesting with angioedema, urticaria, or both have been distinguished: NSAID-exacerbated cutaneous disease, nonsteroidal anti-inflammatory drug-induced urticaria/angioedema (@Chemical$), and single NSAID-induced urticaria and @Disease$."	0
The aim of our study was to determine the risk and predictors of @Disease$ and compliance associated with such prolongation of @Chemical$.	0
We aimed to determine urinary metabolites of both @Chemical$ and leukotrienes (LTs) in patients affected by chronic @Disease$ (CU).	0
It is clear from epidemiological data that the incidence of @Disease$ was decreasing well before warning labels were placed on @Chemical$ products.	0
"After adjustment for age, sex, smoking, history of @Disease$, systolic blood pressure, and body mass index, persons who were regular @Chemical$ users had a higher risk of developing neovascular AMD (odds ratio [OR], 2.46; 95% CI, 1.25-4.83)."	0
"BACKGROUND: Many patients requiring permanent pacemaker (PPM) or implantable @Disease$ (ICD) placement are anticoagulated with warfarin, aspirin (@Chemical$), and clopidogrel for a number of thromboembolic risk indications."	0
"@Chemical$-induced @Disease$ occurred preferentially in the antrum among H. pylori-positive non-hyposecretors, while it affected the fundus among H. pylori-positive hyposecretors."	1
The risk of readmission resulting from bleeding and venous thromboembolism (@Disease$) has also not been determined for patients undergoing THA or TKA when treated with low-molecular-weight heparin (LMWH) alone compared with mechanical prophylaxis plus aspirin (@Chemical$).	0
"Subgroup analysis suggested that @Disease$ was increased with @Chemical$ doses &gt; or =325 mg/day, but not with lower doses."	1
Cross-reactivity amongst all nonsteroidal drugs is common in @Chemical$-aggravated chronic @Disease$ but appears not to occur with selective cyclo-oxygenase 2 inhibitors.	0
"To explore the neural mechanisms underlying @Chemical$ (SS)-induced @Disease$ and increased central gain, we examined the effects of GABA receptor agonists and antagonists on SS-induced hyperexcitability in the AC and startle reflex responses."	0
Incidence of gastrointestinal bleeding in patients with @Disease$: buffered aspirin versus enteric-coated @Chemical$.	0
"In Reye's syndrome, @Disease$ and perhaps the increase of @Chemical$ are the leading factors in the mechanism of brain damage and encephalopathy."	0
@Chemical$-sensitive @Disease$.	0
"CONCLUSIONS: In patients with osteoarthritis taking low-dose @Chemical$, the use of celecoxib or naproxen plus lansoprazole resulted in similar rates of gastroduodenal @Disease$ation."	0
"In two separate series, @Disease$ and carrageenan arthritis-induced inflammatory pain were measured in control, ASA and @Chemical$-Tris-treated groups."	0
"Misoprostol, a synthetic analogue of @Chemical$ (PGE1) compensates prostagrandins of which synthesis is inhibited by aspirin and protect the @Disease$."	0
Tighter @Chemical$ control urged for patients with @Disease$.	0
"Anaphylaxis, immediate and accelerated reactions, atopy, older age and chronic/recurrent urticaria were risk factors for @Disease$ and/or cross-reactivity between ASA, ibuprofen and @Chemical$."	0
METHODS: ASA-@Chemical$ (25/200 mg) once daily together with ASA (81 mg) daily was started in 130 patients given the diagnosis of @Disease$/TIA with instructions to increase ASA-dipyridamole to twice daily after 7 days and discontinue ASA (81 mg).	0
Single-dose tranexamic acid reduces @Disease$ after coronary surgery in patients treated with @Chemical$ until surgery.	0
"Clopidogrel is the most widely used, and in combination with @Chemical$ it is the standard of care for @Disease$ and percutaneous coronary interventions."	0
"CASE REPORT: A 58-year-old Caucasian male with a history of coronary heart disease and hypercholesterolemia, under treatment with acetyl-salicylate for 6 years and @Chemical$ for 2 months, presented to the Emergency Department of our hospital with @Disease$ and vomiting of 24-hour duration."	0
"BACKGROUND: Aspirin-exacerbated respiratory disease (AERD) is characterized by progressive @Disease$, nasal polyposis, and asthma that begins and continues in the absence of exposure to @Chemical$ and nonsteroidal anti-inflammatory drugs (NSAIDs)."	0
"Omeprazole appears to be very effective in reducing both acute gastroduodenal mucosal damage and upper @Disease$ bleeding in the high-risk patient taking low-dose @Chemical$, but data with other anti-ulcer agents are lacking (misoprostol) or inconsistent (ranitidine) at present."	0
PURPOSE OF REVIEW: To summarize recent findings related to the pathogenic mechanisms of @Chemical$-induced @Disease$ with emphasis on molecular genetic mechanisms.	1
"CONCLUSIONS: When combined with ACEI or ARB, @Chemical$ had no demonstrable adverse effect on intermediate-term postdischarge outcomes for patients with ischemic or non@Disease$ HF."	0
A recent study by Chan et al. concluded that a combination of aspirin and esomeprazole is superior to @Chemical$ in the prevention of recurrent @Disease$ bleeding.	0
CONCLUSIONS: Rebamipide is useful for the primary prevention of @Disease$ induced by LDA alone or by LDA plus @Chemical$ in healthy subjects.	0
@Chemical$-exacerbated respiratory disease (@Disease$) is an acquired disease characterized by chronic eosinophilic airway inflammation with underlying dysregulation of arachidonic acid metabolism.	0
"The proportions of patients who were free of @Disease$ ulcers at the end of 12 weeks were 96% in the misoprostol group, 93% in the lansoprazole 15-mg group, 100% in the @Chemical$ 30-mg group, and 35% in the placebo group (P &lt;or= 0.008, each active treatment vs placebo)."	0
"Other risk factors identified were a previous @Disease$ history (OR, 15.2; 95% CI, 3.8-60.1), @Chemical$ use (OR, 4.2; 95% CI, 1.7-10.4) and use of calcium channel blockers (OR, 2.54; 95% CI, 1.25-5.14)."	0
"The median intraoperative blood loss (600 ml versus 450 ml, P = 0.56), median postoperative @Disease$ (800 ml versus 790 ml, P = 0.60), blood transfusion requirements (25.1% versus 24.4%, P = 0.76) and composite outcome of in-hospital death, stroke and reoperation for bleeding (2.8% versus 1.6%, P = 0.10) were similar in @Chemical$ and nonaspirin use group."	0
CD55 polymorphisms and risk of @Chemical$-exacerbated @Disease$.	1
We examined whether the use of non-steroidal anti-inflammatory drugs (NSAIDs) can affect the @Disease$ and @Chemical$ status of hemodialysis patients.	0
RECENT FINDINGS: The overproduction of @Chemical$ with the increased expression of cysteinyl leukotriene receptor 1 (CYSLTR1) is a consistent finding in aspirin-induced @Disease$ patients.	0
"Aspirin-exacerbated diseases are important examples of drug @Disease$ and include aspirin-exacerbated respiratory disease (AERD), @Chemical$- or non-steroidal anti-inflammatory drug (NSAID)-induced urticaria/angioedema, and aspirin- or NSAID-induced anaphylaxis."	0
"Events occurring after PCI-definite or probable stent thrombosis (ST), myocardial infarction (MI) not related to @Chemical$, and clinically relevant @Disease$ (CB)-were classified as early (&lt;=30 days), late (31 to 365 days), or very late (&gt;365 days)."	0
"Various strategies have been proposed to reduce the @Disease$ risk of aspirin, including gastroprotection with a proton pump inhibitor (PPI), eradication of Helicobacter pylori infection and replacing @Chemical$ with other anti-platelet agents."	0
Low-dose @Chemical$ is widely used because it reduces the risk of vascular events in patients with coronary and @Disease$.	0
"Since it remains to be determined whether gastroprotective agents should be used routinely in patients without risk factors who are taking aspirin, more risk factors for @Chemical$-related peptic @Disease$ should be detected."	0
Platelet activation markers overexpressed specifically in patients with @Chemical$-exacerbated @Disease$.	0
"A 42-year-old white woman with a history of severe asthma, @Disease$, aspirin sensitivity, and chronic sinusitis was treated with @Chemical$ desensitization."	0
The later recent genome-wide analysis of SNPs indicated the association of several SNPs with @Disease$ in Japanese patients taking @Chemical$.	0
"We encountered lower @Disease$ in 16 patients taking a low dose of @Chemical$ and examined the effect of low aspirin dose on the stool occult blood test in 49 thrombotic patients (mean: 76.7 +/- 9.6 years old) including 39 with cerebral infarction, 8 with ischemic heart disease and 2 with atrial fibrillation."	0
"Patients with higher @Chemical$ scores (&gt;=2 versus &lt;2) had higher rates of @Disease$ or stent thrombosis (1.9% versus 1.1%; P=0.01) and similar rates of bleeding (2.2% versus 2.4%, respectively; P=0.79)."	0
INTRODUCTION: The Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) study showed that patients with unstable angina pectoris (UAP) and non-ST-elevation @Disease$ (NSTEMI) benefit from combined therapy with acetylsalicylic acid (ASA) and @Chemical$.	0
"METHODS: Between June 1999 and December 2014, 1422 patients were treated for aneurysmal SAH in our institution, 144 (10.1%) with continuous @Chemical$ at the time of @Disease$."	0
@Chemical$ modifiers to prevent aspirin-provoked respiratory reactions in @Disease$tics.	0
CONCLUSIONS: There is high mortality rate associated with @Chemical$ or clopidogrel or both in elderly patients who have head @Disease$ resulting in ICH.	0
"The present study, carried out on female rats, evaluates the effects of P. halepensis L. essential oil (@Chemical$) on aspirin (A)-induced @Disease$."	0
"The frequencies of rare alleles on c.-819T&gt;G, c.2078C&gt;T, and c.2534A&gt;G were higher in subjects with AIA than in subjects with @Chemical$-tolerant @Disease$ (P=0.013-0.031)."	0
"The lowest stroke/SE rates and major bleed rates were observed in warfarin time in therapeutic range (TTR) &gt;=55% episodes (@Disease$/SE: 0.87 [0.71 to 1.04]; major bleed: 4.91 [4.53 to 5.28] per 100 person-years), which was similar to the bleed rate in @Chemical$ episodes (4.95 [4.58 to 5.32] per 100 person-years)."	0
Addition of a leukotriene receptor antagonist such as montelukast improves @Disease$ in aspirin-intolerant patients over and above what can be achieved by @Chemical$.	0
"The mean concentration of PGD(2) for non@Disease$tic patients, patients with ATA, and patients with @Chemical$ was 0.18 +/- 0.16 ng/mL (4.7-fold of the basic production), 0.18 +/- 0.14 ng/mL (4.2-fold), and 0.235 +/- 0.19 ng/mL (1.9-fold), respectively."	0
"The importance of @Chemical$, catheterization accuracy, and catheter design in external ventricular drainage-related @Disease$: a multicenter study of 1002 procedures."	0
"@Chemical$ plus dipyridamole has the highest surface under the cumulative ranking curves (SUCRA) values in terms of mortality, intracranial hemorrhage, and adverse event rate among 7 drug therapies in the treatment of @Disease$."	0
"BACKGROUND: Multiple NSAID-induced urticaria/angioedema (MNSAID-UA) is an entity well differentiated from @Chemical$-exacerbated @Disease$ (AERD), although no detailed phenotype analysis has yet been performed."	1
"Because @Disease$ was evident in the smear, we re-examined the patient for hematology using tubes that contained @Chemical$, showing also low platelet count (2.3 x 10(4)/muL)."	0
"METHOD: We classified 1,041 gastroduodenal @Disease$ patients into three groups [patients taking LDA (group A), patients taking non@Chemical$ nonsteroidal anti-inflammatory drug (NSAID) (group N), and patients taking neither aspirin nor nonaspirin NSAID (group C)] and 241 bleeding gastroduodenal ulcer patients into three corresponding groups (groups a, n, and c)."	0
"For subtypes of late AMD, regular @Chemical$ use 10 years prior to retinal examination was significantly associated with neovascular @Disease$ (HR, 2.20 [95% CI, 1.20-4.15]; P = .01) but not pure geographic atrophy (HR, 0.66 [95% CI, 0.25-1.95]; P = .45)."	1
"Exclusion criteria: cancer, @Disease$ or acute infection, active inflammatory/rheumatic disease, recent major surgery, chronic liver failure, the administration of other antiplatelet drugs, nonadherence with @Chemical$ and thrombocytopenia."	0
There are a few studies of the association between genetic polymorphisms and the risks of acetylsalicylic acid (@Chemical$)-induced @Disease$ or its complications.	1
"In humans, treatment with @Chemical$-VitC induced significantly less @Disease$ lesions than plain ASA."	0
Minimizing @Chemical$ use in hemodialysis patients with severe @Disease$ reduced intracerebral bleeding without a significant difference in cardiovascular mortality.	0
"METHODS: A total of 11 aspirin-sensitive patients with @Disease$, 10 @Chemical$-tolerant patients with asthma, and 10 controls without asthma were studied."	0
MAIN OUTCOME MEASURES: Odds of having been exposed to prior non-aspirin NSAID or @Chemical$ use by participants with @Disease$ and by their controls in each case-control set.	0
Safety of @Chemical$ in aspirin-hypersensitive patients with asthma and/or nasal @Disease$.	1
"BACKGROUND: Although low-dose aprotinin administered after cardiopulmonary bypass has been reported to reduce mediastinal @Disease$ and blood product requirements in patients not taking aspirin, it is unknown whether low-dose postoperative aprotinin has any beneficial effects in patients undergoing coronary artery bypass operations who are at high risk of excessive postoperative bleeding and increased transfusion requirements because of @Chemical$ use until just before the operation."	0
"@Chemical$ use 3 or more times per week was associated with decreased risk of mortality of all causes (HR, 0.81; 95% CI, 0.80-0.83; P &lt; .001), any cancer (HR, 0.85; 95% CI, 0.81-0.88; P &lt; .001), GI @Disease$ (HR, 0.75; 95% CI, 0.66-0.84; P &lt; .001), and CRC (HR, 0.71; 95% CI, 0.61-0.84; P &lt; .001)."	0
"In two separate series, platelet aggregation and @Chemical$ @Disease$-induced inflammatory pain were measured in control, ASA and ASA-Tris-treated groups."	1
"@Chemical$, also known as fish oil, have been used for hyperlipidemia, coronary heart disease, @Disease$, and other conditions."	0
Central features of AERD pathogenesis are overproduction of proinflammatory and @Disease$ and prostaglandin (PG) D2 and inhibition of bronchoprotective and antiinflammatory @Chemical$.	0
"Stratification to evaluate the heterogeneity found that both @Chemical$ (summary RR = 2.24, 95 % CI 1.63-3.09; 5 studies) and aspirin (summary RR = 1.73; 95 % CI 1.31-2.30; 3 studies) were associated with the risk of @Disease$."	0
Low-dose @Chemical$ and @Disease$ risks with ventriculoperitoneal shunt placement.	0
"BACKGROUND: The management of patients with traumatic brain injury (TBI), @Disease$ (@Chemical$) and primary subarachnoid hemorrhage (pSAH) remains a highly demanding challenge in critical care medicine."	0
"The patients were classified into two groups based on the type of low-dose @Chemical$ that they had been prescribed (enteric-coated aspirin group or buffered aspirin group), and evaluated the numbers of @Disease$ and the Lewis score."	0
"This benefit-versus-risk balance may, however, be influenced by evidence that @Chemical$ reduces @Disease$ risk."	0
"AIM: To investigate if the regular use of @Chemical$ is associated with the development of Crohn's disease (CD) and @Disease$ (UC) using, for the first time, a prospective cohort study design."	0
"Results: Multivariate binary regression analysis demonstrated that @Chemical$ use and CYP4F2 T allele significantly increased odds for @Disease$ in clopidogrel users (OR: 2.488, 95% CI: 1.452-4.265; p = 0.001 and OR: 1.573, 95% CI: 1.066-2.320; respectively; p = 0.022)."	1
"CONCLUSION: According to the results of this analysis, a high dose of @Chemical$ following PCI was not associated with any significantly higher rate of CV death/MI/@Disease$, mortality or MI."	0
"@Chemical$ fitness grade, cardiovascular disease, previous history of angina pectoris, angioplasty, @Disease$, use of vitamin K antagonists, cirrhosis and type of hepatectomy were significantly different between the groups."	0
@Chemical$ has been the cornerstone of therapy for the secondary prevention treatment of patients with @Disease$ since landmark trials were completed in the late 1970s and early 1980s that demonstrated the efficacy of aspirin for reducing the risk of ischemic events.	0
"METHODS: Ninety-four aspirin-induced urticaria patients presenting urticaria/angioedema-induced by both ASA and NSAID (50 had underlying chronic @Disease$) and showing positive responses on oral aspirin challenge test, 76 aspirin-intolerant asthmatics with positive responses on lysine-@Chemical$ bronchoprovocation test, and 185 normal healthy controls were enrolled."	0
"Older age, @Chemical$ monotherapy and peptic ulcer disease were significant predictors of anti@Disease$ discontinuation, whereas dual antiplatelet use predicted antithrombotic maintenance."	0
INTRODUCTION: The Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) study showed that patients with @Disease$ (UAP) and non-ST-elevation myocardial infarction (NSTEMI) benefit from combined therapy with acetylsalicylic acid (ASA) and @Chemical$.	0
"DATA SYNTHESIS: @Chemical$-sensitive asthmatics experience a wide variety of symptoms, ranging from rhinitis to life-threatening @Disease$, after the ingestion of aspirin or nonsteroidal antiinflammatory drugs (NSAIDs)."	0
"CONCLUSION: These results suggest that the polymorphism of TBXA2R+795T&gt;C may increase bronchoconstrictive response to @Chemical$, which could contribute to the development of the @Disease$ phenotype."	0
OBJECTIVES: Whether @Chemical$ should be added to aspirin for @Disease$ prevention remained controversial for the risk of hemorrhagic complications.	0
"@Chemical$ also increased the risk of serious @Disease$ by 46% (95%CI, 22-75) in diabetic patients without cardiovascular disease but decreased the risk among those with cardiovascular disease."	1
"Older age, prior GI events, chronic renal failure, use of other injurious medicine such as NSAIDs, antithrombotic medicine, especially @Chemical$, and corticosteroids seem to be factors associated with an increased risk for upper GI @Disease$ and bleeding among the patients taking low dose aspirin."	0
The two frequent clinical presentations of aspirin hypersensitivity are: aspirin-induced bronchial asthma/rhinosinusitis (AIA/R) and @Chemical$-induced @Disease$/angioedema (AIU).	1
Key Messages: Serum PG I and H. pylori @Disease$ could be used to identify potential high-risk @Chemical$-induced gastroduodenal injury patients.	0
"We found 95 cases (9.44% of the study group) of @Chemical$ intolerance, including 23 of the 75 patients with severe @Disease$ (30.67%; OR = 5.44)."	0
"Randomized placebo-controlled trials (RCTs) assessing the efficacy of H2 blockers in reducing gastrointestinal harms (@Disease$, ulcers) among adults taking @Chemical$ for 2 weeks or longer were included."	0
"In a pooled analysis, major/life-threatening @Disease$ on A+C occurred in 9/241 aspirin-naive patients (90-day risk = 4.8%, 1.6-8.0) versus 1/204 prior-@Chemical$ patients (p = 0.009)."	0
"The triad of bronchial @Disease$, nasal polyposis, and intolerance to aspirin and aspirin-like chemicals are designated @Chemical$-induced asthma (AIA) or Samter's syndrome."	0
METHODS: We measured @Chemical$ concentrations and GPX activities in platelets and plasma from 13 patients with @Disease$.	0
Patients without ulcers or erosive @Disease$ on endoscopy at baseline were randomly assigned by computer-generated randomisation sequence to receive @Chemical$ 20 mg twice daily (n=204) or placebo twice daily (n=200).	0
BACKGROUND: The objective of the study was to determine the frequency of cerebral microbleeds (@Chemical$) by using phasesensitive imaging in patients with previous transient ischemic attack (@Disease$) or stroke who were receiving aspirin treatment.	0
Biphasic effects of H. pylori @Disease$ on low-dose @Chemical$-induced gastropathy depending on the gastric acid secretion level.	0
"A @Chemical$-rich diet, as well as ingestion of reductive catechol-bearing polyphenols, can collaborate in promoting NO generation in gastric juice, and they are protective in rodent models of @Disease$."	0
"Despite the excellent benefits, @Disease$ due to gastric/duodenal ulcers or injury is a major complication in @Chemical$ users."	0
HYPOTHESIS: Desensitization to ASA may be carried out safely and effectively in patients with reported @Chemical$ or nonsteroidal anti-inflammatory drug (NSAID) @Disease$ needing ASA for cardiac indications.	0
A defined daily dose (@Disease$) methodology was applied to each @Chemical$.	0
@Chemical$ efficacy against aspirin-exacerbated @Disease$ has not been investigated in a randomized manner.	0
The aspirin group without anti-ulcer drugs (A(-) group) comprised 47 patients and the non-@Chemical$ group without anti-@Disease$ drugs (NA(-) group) 31 patients.	0
The premature suspension of the Alzheimer Disease Anti-inflammatory Prevention (ADAPT) and the @Disease$ Prevention with @Chemical$ (APC) trials prompted intense review of the cardiovascular safety profile of selective and nonselective cyclooxygenase (COX) inhibitors.	0
"Newer NSAIDs such as @Chemical$, an inhibitor of platelet aggregation that acts by reversibly inhibiting the platelet cyclooxygenase enzyme, have proven to be as effective as the older NSAIDs and appear to have a better @Disease$ tolerability profile."	0
"Effective strategies to prevent @Disease$ complications include initiation of a proton pump inhibitor (PPI), misoprostol, or double dose H(2)-receptor antagonists (H(2)RAs) at the start of @Chemical$ therapy."	0
Dual antiplatelet therapy with ASA and @Chemical$ increases the risk of @Disease$ in patients with acute coronary syndrome in whom concomitant treatment with a proton-pump inhibitor (PPI) was less effective owing to the interaction of clopidogrel and PPI with the same hepatic cytochrome P-450.	0
BACKGROUND: @Chemical$ causes bronchospasm in patients with aspirin exacerbated respiratory disease (@Disease$).	0
"CONCLUSION: In Asian patients taking @Chemical$ derivatives with aspirin, cautious postoperative care is necessary for those undergoing endoscopic procedures that are associated with a high risk of @Disease$, especially gastric ESD."	0
"A conserved linkage group on chromosome 6, the 8.1 ancestral haplotype, is a predisposing factor of chronic rhinosinusitis associated with @Disease$ in @Chemical$-sensitive Hungarians."	0
"A total of 12 patients with a clear-cut history of AIA were randomised in double-blind cross-over fashion to receive single doses of ML 10 mg, @Disease$ 40 mg, or placebo (PL), with nasal @Chemical$-aspirin challenge performed 12 h after dosing."	0
"OBJECTIVE: The objective of this study was to determine if Aggrenox was associated with @Disease$ and to determine whether it was @Chemical$, dipyridamole or the combination that led to decline in renal function."	0
"A case of fibrous dysplasia, limited to the middle turbinate and associated with Widal triad (@Disease$, asthma, @Chemical$ intolerance), is described."	0
The aim of the present retrospective study was to describe our experience in selected patients with Reye's syndrome associated to the @Chemical$ ingestion and to underline the influence of hyperammonemia on Reye's @Disease$.	0
Re: transrectal ultrasound-guided biopsy of the prostate: @Chemical$ increases the incidence of minor @Disease$.	1
Screening and eradication of H. pylori infection could substantially lower @Chemical$-related @Disease$ harms.	1
"OBJECTIVES/HYPOTHESIS: To demonstrate that quality-of-life outcomes after endoscopic sinus surgery are not compromised in patients with Samter's triad (asthma, @Disease$, @Chemical$ sensitivity) when compared to patients with eosinophilic chronic rhinosinusitis with nasal polyposis (eCRSwP) who are not aspirin sensitive."	0
The two frequent clinical presentations of aspirin hypersensitivity are: @Chemical$-induced bronchial asthma/rhinosinusitis (@Disease$/R) and aspirin-induced urticaria/angioedema (AIU).	1
We made a comparison between treatments Aspirin-Clopidogrel combined group and the @Chemical$ alone group in the numbers of CMB and subsequent @Disease$.	0
"The patients who received ASA therapy were divided according to the results of a @Disease$ test into ASA-resistant, @Chemical$-semiresponsive, and ASA-sensitive groups."	0
"In 73 patients, 23 with previous coronary stent thrombosis (ST) (ST group) and 50 without coronary ST (control group), @Disease$ was measured 3 times in monthly intervals using light transmission aggregometry (adenosine diphosphate [ADP] and @Chemical$ induction)."	0
BACKGROUND: Dual antiplatelet therapy with @Chemical$ and a P2Y12 inhibitor is the cornerstone for prevention @Disease$ events in patients with acute coronary syndromes (ACS) and undergoing percutaneous coronary intervention.	0
@Chemical$ is relatively contraindicated in those with a history of @Disease$ and an absolute contraindication in pregnancy.	0
However those patients taking aspirin pre-operatively had a significantly lower haemoglobin concentration and @Disease$ and were more likely to be anaemic at presentation than those who were not receiving @Chemical$.	0
"In this patient, acute @Disease$ developed only two weeks after the initiation of @Chemical$."	1
"We examined 18 patients of @Chemical$ @Disease$ at dermatology of Yodogawa Christian Hospital, especially as to oral aspirin challenge test."	1
"METHODS: Of 271 patients suspected by history of having @Disease$, 96 were taking @Chemical$-LT receptor antagonists (cys-LTRAs) and 12 were taking zileuton at the time of oral ASA challenges."	0
"Given observations of substantial increases in @Disease$ rates from many prior long-term clinical trials that have evaluated @Chemical$ together with other oral platelet inhibitors or oral anticoagulants, the focus of contemporary research has pivoted towards tailored antithrombotic regimens that attempt to either shorten the duration of exposure to aspirin or replace aspirin with an alternative antithrombotic agent."	1
"There was an increased risk of @Disease$ in men who had 1-2 years of regular non-@Chemical$ NSAID use (odds ratio 1.35 (1.07 to 1.70)), a finding that remained significant after matching for confounder scores as well (odds ratio 1.35 (1.05 to 1.75))."	0
"RESULTS: In patients treated with cys-LTRAs, there were significant reductions in numbers of patients with @Chemical$-induced @Disease$ and a concomitant increase in upper respiratory reactors."	1
The risk of @Disease$ (UGIC) due to low-dose @Chemical$ (LDA) can be further increased by the concurrent exposure to other antithrombotic agents.	1
@Chemical$-exacerbated @Disease$ (AERD) has attracted a great deal of attention because of its association with increased asthma severity.	1
"In the remaining 5, it provoked @Disease$, a fall in FEV1 &gt; or = 20% and other extrabronchial symptoms of @Chemical$ intolerance."	0
It has been proposed that @Chemical$ (ASA) and other non-steroidal anti-inflammatory drug (NSAID)-induced urticaria (UR)/@Disease$ (AE) are mediated through inhibition of cyclooxygenase-1 (COX-1) enzymes.	1
"CONCLUSIONS: Aspirin and enoxaparin conferred similar bleeding risks, and both exhibited less @Disease$ than patients who received @Chemical$."	0
"METHODS: Adult patients (aged &gt;/=18 years) from the cardiovascular, cerebrovascular, and @Disease$ clinics at Crosshouse Hospital, Kilmarnock, UK, were eligible for enrolment in this phase III, randomised, double-blind, placebo-controlled trial if they were taking @Chemical$ 75-325 mg per day with or without other cardioprotective drugs."	0
Spontaneous spinal epidural @Disease$ associated with @Chemical$ intake.	1
"METHODS: We screened a Korean asthma cohort (581 asthmatics including 81 aspirin-intolerant asthmatics and 231 @Chemical$-tolerant @Disease$tics, and 181 normal controls) for four single nucleotide polymorphisms (SNPs; -262 A&gt;T and -115 T&gt;C in the 5'-flanking region and +5467 T&gt;C [Pro450Pro] and+11860 A&gt;G [Thr776Thr] in the coding region) and one ins/del (+21288 CT) in the ACE gene."	0
"BACKGROUND: Using data from the Reduced-Dose Rivaroxaban in the Long-Term Prevention of Recurrent Symptomatic @Disease$ (EINSTEIN-CHOICE) trial, this study assessed cost impact of continued anticoagulation therapy with rivaroxaban vs @Chemical$."	0
"But, an increment of @Chemical$ prescription has become an object of public concern for @Disease$ events through its antiplatelet action and cyclooxygenase inhibitory action."	0
"The warning regarding @Chemical$ sensitivity was present on 4.3%, @Disease$ was 2.9%, and interactions with anticoagulants/blood thinners was 4.3%."	0
"To investigate the relationship between @Chemical$ polymorphisms (SNPs) in the RAB1A gene and aspirin-exacerbated respiratory disease (AERD), @Disease$tics (n=1197) were categorized into AERD and aspirin-tolerant asthma (ATA)."	0
"DATA SOURCES: Articles evaluating aspirin for primary prevention of CVD were gathered using a MEDLINE search with the keywords @Chemical$ review, aspirin peripheral @Disease$, aspirin stroke, aspirin coronary artery disease, aspirin diabetes, aspirin primary prophylaxis, and aspirin elderly."	0
"Although the risk with low-dose aspirin alone is less than that with NSAIDs, given its widespread use, @Chemical$-related @Disease$ has become a substantial health care issue."	1
"@Chemical$-exacerbated respiratory disease (@Disease$), formerly known as Samter's Triad, is a syndrome of airway inflammation characterized by rhinosinusitis with polyposis, asthma, and nonsteroidal anti-inflammatory drug (NSAID) intolerance."	0
"The current report describes a Japanese boy who underwent @Chemical$ treatment for @Disease$, and who subsequently presented with the manifestations of DIHS/DRESS syndrome."	0
"As PPIs reduce the risk of UGI bleeding and @Disease$, these risk factors were modelled together with PPI adverse effects for @Chemical$ users 60-69, 70-79 (base case) and 80 years and older."	0
"INTRODUCTION: In routine medical practice, the diagnosis of @Chemical$ hypersensitivity (@Disease$) remains difficult."	0
"We encountered lower gastrointestinal bleeding in 16 patients taking a low dose of @Chemical$ and examined the effect of low aspirin dose on the stool occult blood test in 49 thrombotic patients (mean: 76.7 +/- 9.6 years old) including 39 with cerebral infarction, 8 with ischemic heart disease and 2 with @Disease$."	0
"CONCLUSIONS: This study showed an important proportion (18%) of dispatched aspirin users adults to digestive endoscopy, the 13.8% of them have a clear indication to use it, a substantial percent (13%) cannot inform any medical reason; the @Chemical$ usage for more than six months in doses lower than 500 mg per day increases the @Disease$ prevalence (58%)and relative risk of suffering these injuries are high."	1
"Results were adjusted for age, sex, ethnicity, study site, anti-@Disease$ medication use, education, income, health insurance status, diabetes, smoking, exercise, body mass index, blood pressure, serum lipids, inflammatory markers, fasting @Chemical$, statin medication use, and a simple diet score."	0
"However, since diabetes is now considered a CVD equivalent, it is imperative that clinicians include counseling about @Chemical$ therapy as a care priority for all their @Disease$ patients, as this simple intervention may prevent many cardiovascular events and deaths."	0
"METHODS: The study groups consisted of 22 subjects with AERD, 22 subjects with ATA and 10 volunteers without @Disease$ and @Chemical$ sensitivity."	0
"CONCLUSIONS: Our findings do not support the notion that entericcoated LDA products confer a lower risk for @Disease$ complications than buffered formulations, but may conversely imply that the risk of GI complications associated with buffered LDA is lower than that of enteric-coated @Chemical$."	0
"H. pylori infection and low-dose @Chemical$ (LDA) are not only independent causal factors of peptic @Disease$ and gastrointestinal bleeding, they also have synergistic and additive effects."	1
AIM: To investigate the clinical differences between small intestinal injuries in low-dose aspirin (@Chemical$) users and in non-steroidal anti-inflammatory drug (NSAID) users who were examined by capsule endoscopy (CE) for @Disease$ (OGIB).	0
Association of TNF-alpha promoter polymorphisms with @Chemical$-induced @Disease$.	1
Low-dose @Chemical$ and other antiplatelet agents are widely used for the management of @Disease$.	0
"Helicobacter pylori infection (OR 3.07; 95 CI, 1.23-7.70; P 0.017), @Chemical$ consumption (OR 5.04; 95 CI, 1.86-13.70; P 0.001), and a history of peptic ulcer (OR 13.41; 95 CI, 3.78-47.64; P 0.001) were identified as risk factors for @Disease$."	0
"Preventive effect of ecabet @Chemical$ on low-dose aspirin-induced @Disease$: a randomized, double-blind, pilot study."	0
"In addition, to reduce the incidence of gastrointestinal lesions in LDA users, it is important for clinicians to confirm the differences in the @Disease$ between different types of @Chemical$ formulations in clinical use."	0
Physiologic and pharmacologic studies support the hypothesis that aspirin-exacerbated respiratory disease (@Disease$) involves fundamental dysregulation in the production of and end-organ responsiveness to both antiinflammatory @Chemical$ (prostaglandin E2) and proinflammatory effectors (cysteinyl leukotrienes).	0
AIM: To investigate the role of the hydrogen-rich water (HRW) in the prevention of @Chemical$-induced @Disease$ in rats.	1
"Following in-hospital @Chemical$ administration, there was a significant decrease in @Disease$ (p=0.001) suggesting poor adherence to therapy prior to admission."	0
"The origin of @Chemical$ hypersensitivity remains unknown, but accumulating data from genetic studies strongly suggest that environmental factor, possibly a common @Disease$, can trigger the disease in susceptible subjects."	0
"METHODS: 40 subjects with @Disease$ (NP) were classified as aspirin-sensitive (n=13, ASNP) or @Chemical$-tolerant (n=27, ATNP) based on a bronchial aspirin challenge test."	0
Dual antiplatelet therapy using aspirin and a @Chemical$ (e.g. clopidogrel) is known to be essential in patients in whom percutaneous coronary intervention with stent implantation has been performed in order to prevent stent @Disease$ and its fatal consequences.	0
OBJECT: In this paper the authors investigate whether shunt-treated patients with normal-pressure hydrocephalus receiving @Chemical$ therapy are at increased risk of developing subdural @Disease$ (SDH).	0
"Type 2 inflammation characterizes aspirin-exacerbated respiratory disease.Objectives: To determine whether high-dose aspirin therapy changes biomarkers of type 2 inflammation in aspirin-exacerbated @Disease$.Methods: Forty-two subjects with aspirin-exacerbated respiratory disease underwent an @Chemical$ desensitization and were placed on high-dose aspirin (1,300 mg daily)."	0
"The aim of this study was to determine levels of MCP-3, RANTES, eotaxin, Il-5 and Il-3 in @Chemical$ intolerant asthmatics (@Disease$) after nasal lysine-aspirin (Lys-ASA) challenge."	0
We aimed to determine urinary metabolites of both histamine and leukotrienes (LTs) in patients affected by chronic @Disease$ (@Chemical$).	0
Enzyme up-regulation was monitored after in vitro stimulation with lipopolysaccharide (LPS) and/or @Chemical$ in 19 aspirin-intolerant (AI) patients (8 aspirin-sensitive asthmatics and 11 @Disease$ patients) and 14 healthy controls.	0
"Moreover, no significant associations were found between the genotype of each SNP in @Disease$ patients with the clinical characteristics, including a forced expiratory volume in one second (FEV1) %, a provocation concentration of @Chemical$ to induce more than 20% decrease of FEV1 (PC20) to methacholine, and serum total IgE levels (p &gt; 0.05)."	0
"Aspirin had no effect on platelet-leukocyte aggregates, platelet activation markers, or plasma cytokines in either group.Conclusions: High-dose @Chemical$ therapy for 8 weeks paradoxically increases markers of type 2 inflammation in subjects with aspirin-exacerbated @Disease$, despite reducing nasal symptoms."	0
Adhesion molecules and their ligands in nasal polyps of @Chemical$-@Disease$ patients.	1
A rigorous analysis shows a weak but statistically significant association between @Chemical$ use and the risk of @Disease$; a result which is different to that previously reported.	0
"We report the case of a 59-year-old female with @Disease$, admitted to the coronary care unit for acute inferior myocardial infarction and treated with tissue-type plasminogen activator 100 mg in 90 min, intravenous @Chemical$ 25,000 U, aspirin 100 mg, and metoprolol 50 mg orally once daily."	0
[@Chemical$ @Disease$: characteristics and diagnostic approach].	1
"METHODS: A case series of three patients suffering severe nausea, @Disease$, diarrhea, renal dysfunction and clinical decline during @Chemical$ therapy was examined."	0
PURPOSE OF REVIEW: The use of aspirin in @Disease$ and address the unmet need of @Chemical$ therapy in patients with history of hypersensitivity reactions to aspirin (acetylsalicylic acid; ASA) or other nonsteroidal inflammatory drugs (NSAIDs).	0
A previously healthy 60-year-old man receiving @Chemical$ for primary prevention of @Disease$ presented with hemoptysis after 1 week of treatment for his back pain with diclofenac.	0
"The main models included the following predictors: demographic characteristics (age, ethnicity, and socioeconomic deprivation), clinical measurements (systolic blood pressure and ratio of total-high-density lipoprotein cholesterol), family history of premature CVD, medical history (smoking, @Disease$, bleeding, peptic ulcer disease, cancer, chronic liver disease, chronic pancreatitis, or @Chemical$-related conditions), and medication use (nonsteroidal anti-inflammatory agents, corticosteroids, and selective serotonin reuptake inhibitors)."	0
"This study was designed to investigate the degree of @Disease$, bleeding time (BT) and fluctuations in the serum levels of prostaglandin E2 (PGE2) and thromboxane A2 (TXA2) after oral administration of @Chemical$ (200 mg/kg) and IBU (50 mg/kg) either alone or in combination in rats in vivo."	0
"Use of NSAIDs, @Chemical$, APs, and ACs within 2 weeks prior to the endoscopy was compared between cases and controls, and effects on @Disease$ bleeding were calculated."	0
OBJECTIVE: The purpose of this study is to estimate urinary LTB4 glucuronide (LTBG) concentration in the clinically stable condition in healthy subjects and asthmatic patients and to investigate changes in urinary LTBG concentration in patients with @Disease$ after @Chemical$ challenge.	1
"METHODS: Endoscopic oesophageal and gastro-duodenal lesions were graded in 287 patients with reflux @Disease$, median age 57 years, including 168 with oesophageal erosions, 131 infected with, 45 patients taking aspirin 75 mg daily, and 65 patients taking simple analgesics containing paracetamol/@Chemical$."	0
We explored the effect of combined ACE-I and @Chemical$ therapy compared to ACE-I without aspirin on clinical outcomes in patients with @Disease$.	0
"The presence of @Chemical$ could cause the onset of the mitochondrial permeability transition and the mitochondrial swelling in the astrocyte, leading to @Disease$."	1
Genetic variation in the JAK/STAT/SOCS signaling pathway influences @Disease$-specific mortality through interaction with cigarette smoking and use of @Chemical$/NSAIDs: the Breast Cancer Health Disparities Study.	1
"RESULTS: Global mucosal expression of EP(1) and EP(2), but not EP(3) or EP(4), immunoreactivity was significantly elevated in aspirin-sensitive and non@Chemical$-sensitive @Disease$ compared with controls (P &lt; .03)."	0
CONCLUSIONS: @Chemical$ and low doses of aspirin cause a similar degree of @Disease$.	0
BACKGROUND &amp; AIMS: Effervescent calcium carbasalate is a @Chemical$ of acetylsalicylic acid causing less local @Disease$ than acetylsalicylic acid at high doses in healthy controls.	0
"Moreover, no significant associations were found between the genotype of each SNP in @Disease$ patients with the clinical characteristics, including a forced expiratory volume in one second (FEV1) %, a provocation concentration of methacholine to induce more than 20% decrease of FEV1 (PC20) to @Chemical$, and serum total IgE levels (p &gt; 0.05)."	0
"INTRODUCTION: To study the effects of use of @Chemical$, non-steroidal anti-inflammatory drugs (NSAID), acetylsalicylic acid (ASA), and opioids on bone mineral density (BMD) and risk of @Disease$s."	0
"In stratified analysis, @Chemical$ use was significantly associated with early @Disease$ in participants with (adjusted OR 2.64, 95% CI 1.31 to 5.36) but not without (OR 0.73; 95% CI 0.36 to 1.51) a history of cardiovascular disease (interaction term, p=0.011)."	1
"RESULTS: In 30 of 74 patients, the @Chemical$ challenge was positive, resulting in @Disease$/angioedema."	1
"@Disease$ with @Chemical$H significantly decreased in both day 3 and 7 compared with AC, irrespective with H. pylori and CYP2C19 genotypes (P &lt; .05)."	1
"RESULTS: @Chemical$-exacerbated @Disease$ remains a complex, heterogenous disease with varied clinical presentations."	1
"However, there was a strong association of the ALOX5 Sp1 repeat polymorphism with @Disease$ (AHR; PC20 @Chemical$); AIA patients carrying a mutant allele (n &gt; 5 or n &lt; 5 repeats) showed increased AHR compared to AIA patients with wild-type genotype (P=0.003)."	0
Epidemiological studies have also shown that nitric oxide donors and antisecretory drugs reduce the risk of upper gastrointestinal @Disease$ both in non-steroidal anti-inflammatory drug and low-dose @Chemical$ users.	0
[Intraoperative bronchospasm during paranasal sinus surgery -- indicator of @Chemical$ @Disease$?].	1
Various medicamentous methods of counteracting @Chemical$-induced platelet dysfunction and excessive @Disease$ in this context are discussed and evaluated.	1
"They were compared with twenty-seven control patients with sensitivity to @Chemical$ or non-steroidal anti-inflammatories, manifesting as @Disease$, urticaria or rhino-conjunctivitis."	1
@Chemical$ was significantly more effective than gefarnate for the resolution and prevention of @Disease$ (resolution 53.6 vs.	0
Original studies reporting prevalence or incidence of uncomplicated @Disease$s in @Chemical$ users were included.	0
"Moreover, recent data suggest that @Chemical$ and NSAIDs may counteract part of the efficacy of ACE inhibitors and be deleterious in chronic @Disease$."	1
"Presence of asthma was associated with age, female gender, NP duration,  and @Chemical$ @Disease$ history (p &lt; 0.05), but not with smoking, atopy, NP extension, and positive APT."	1
"However, it appears that continuing @Chemical$ isn't associated with excessive @Disease$."	0
This study compared the preventive effect of histamine-2 receptor antagonists (H2RAs) and proton-pump inhibitors (PPIs) against chronic low-dose aspirin (@Chemical$)-related GI bleeding and @Disease$ formation.	1
"Comparative tolerability of paracetamol, aspirin and @Chemical$ for short-term @Disease$ in patients with musculoskeletal conditions: results in 4291 patients."	0
Upper @Disease$ is a common adverse effect of chronic @Chemical$ treatment.	1
"Multiple electrode whole blood aggregometry, PFA-100, and in vivo bleeding time for the point-of-care assessment of @Chemical$-induced @Disease$ in the preoperative setting."	1
"Associations of several HLA alleles with subtypes of AI, such as @Chemical$-induced urticaria and aspirin-induced @Disease$, and single nucleotide polymorphisms in genes encoding enzymes involved in arachidonic acid metabolism have been shown."	0
"Similarly, the use of nonaspirin nonsteroidal antiinflammatory drugs (NSAIDs), including cyclooxygenase (COX)-2 inhibitors, has also been shown to increase the risk of GI effects, and the concomitant use of aspirin and non@Chemical$ NSAIDs can significantly increase the risk of @Disease$."	0
"In addition, a combination of LDA and NSAIDs or @Chemical$ and APs contributed more profoundly to the @Disease$ (OR 3.59 and 95 % CI 1.19-10.81 for LDA/NSAIDs; OR 6.70 and 95 % CI 1.83-24.50 for LDA/APs)."	1
"BACKGROUND AND AIM: Acetylsalicylic acid (@Chemical$ [aspirin]) is a commonly used over-the-counter drug for the treatment of pain, @Disease$, or colds, but data on the safety of this use are very limited."	0
"Also, our study did not show a statistically significant difference between @Disease$ onset, the length of mechanical ventilation, use of @Chemical$ tranexamic acid."	0
"Wound @Disease$ occurred in 27 of 112 (24.1%) patients under combined aspirin and clopidogrel, 33 of 162 (20.4%) under @Chemical$, and 48 of 410 (11.7 %) under aspirin."	0
"Omeprazole appears to be very effective in reducing both acute @Disease$ and upper GI bleeding in the high-risk patient taking low-dose aspirin, but data with other anti-ulcer agents are lacking (@Chemical$) or inconsistent (ranitidine) at present."	0
"BACKGROUND: Aspirin-exacerbated respiratory disease (AERD) is a distinct eosinophilic phenotype of severe asthma with accompanying chronic rhinosinusitis, @Disease$, and hypersensitivity to @Chemical$."	0
"S-baclofen or @Chemical$, GABA-B agonists, which suppressed sound-evoked AC neural firing rate and local field potentials, also suppressed the SS-induced enhancement of the AC field potential and the acoustic @Disease$ reflex."	0
"METHODS: We searched MEDLINE, EMBASE and the Cochrane Controlled Trials Register from inception to December 2013, and checked conference abstracts of randomized controlled trials (RCTs) on the effect of PPIs in reducing adverse GI events (hemorrhage, @Disease$, perforation, or obstruction) in patients taking @Chemical$."	0
"With exception of idraparinux, all active therapies significantly reduced @Disease$ recurrence risk versus aspirin, ranging from a 73% reduction with either apixaban 2.5mg or @Chemical$ to 80% with VKAs."	0
"@Disease$ patients suffer from an active disease despite avoidance of aspirin, and it has been suggested that administration of aspirin to these patients increases the generation of immediate oxygen products of arachidonic acid, 12-hydroperoxyeicosatetraenoic acid (@Chemical$), in their platelets."	0
Evaluation of glomerular filtration rate in cats with @Disease$ and administered meloxicam and @Chemical$.	0
A recent study by Chan et al. concluded that a combination of @Chemical$ and esomeprazole is superior to clopidogrel in the prevention of recurrent gastrointestinal @Disease$.	0
Aspirin exacerbated respiratory disease (AERD) is a clinical syndrome characterized by chronic rhinosinusitis with @Disease$ and @Chemical$ hypersensitivity.	0
"RESULTS: Of 8754 Chinese patients with atrial fibrillation and CHA2DS2-VASc &gt;=1 (79.5+-9.2 years; CHA2DS2-VASc, 4.1+-1.5; and Hypertension, Abnormal Renal/Liver Function, @Disease$, Bleeding History or Predisposition, Labile International Normalized Ratio, Elderly (&gt;65 years), Drugs/Alcohol Concomitantly [HAS-BLED], 2.2+-0.9), 16.3% received warfarin, 41.1% aspirin, 4.5% @Chemical$, and 38.1% received no therapy."	0
CONTEXT: The benefit of @Chemical$ for the primary prevention of cardiovascular events is relatively small for individuals with and without @Disease$.	0
"Our results indicate that a marked over-representation of LTC4 synthase in @Disease$ is closely linked to @Chemical$ intolerance in the nasal airway, as in the bronchial airways."	1
"CONCLUSION: Alterations in the COX pathway (ie, reduced production of @Chemical$(2) and lack of upregulation of COX-1, COX-2, and EP2 under conditions of inflammation) are associated with NPs in patients with or without @Disease$."	0
"RESULTS: A lower incidence of @Disease$ and duodenal ulcers was seen in celecoxib/aspirin-treated subjects (19%) vs. naproxen/@Chemical$ (27%; RR: 0.63, 95% CI: 0.44-0.92)."	0
Pretreatment with @Chemical$ or tryptophan remarkably reduced ASA induced @Disease$ and microbleeding.	0
"To assess the effect of daily low-dose @Chemical$ therapy on perioperative bleeding of patients operated on for proximal femoral @Disease$, we did a prospective case-control study."	0
"OBJECTIVE: We sought to determine blood and urinary levels of 9alpha,11beta-PGF(2), a major stable PGD(2) metabolite in 2 well-defined phenotypes of asthma, aspirin-induced @Disease$ (AIA) and @Chemical$-tolerant asthma (ATA), and in healthy control subjects and to study the effects of aspirin on PGD(2) release."	0
"RESULTS: A treatment with @Chemical$ in the human bronchial epithelial cells increased the mRNA expression level of KIF3A compared to that of the untreated control (P &lt;= 0.01), and @Disease$ from aspirin-intolerant asthma (AIA) patients also showed a higher expression of KIF3A protein than aspirin-tolerant asthma controls."	0
"Compared to @Chemical$ never users, women who regularly consumed aspirin had a lower risk of @Disease$ (RR = 0.80; 95% CI: 0.71-0.90), and there was evidence for lower risk with increasing frequency of use (RR = 0.71 for aspirin use 6 or more times/week vs. never use; P trend = 0.00001)."	0
There appears to be an association between minidose @Chemical$ treatment and hospitalization for upper gastrointestinal tract @Disease$.	1
"RESULTS: Any @Chemical$ use (OR: 0.66; 95% CI, 0.49-0.89), daily use of &gt;= 1 tablet (OR: 0.68; 95% CI, 0.50-0.90), and use for &gt;= 3 years (OR: 0.61; 95% CI, 0.44-0.85) was associated with lower @Disease$ risk only among men, even after adjustment for covariates including body mass index and global genetic ancestry."	0
METHODS: We analysed results of the Severity of @Disease$ Assessment questionnaires collected in the @Chemical$ and the Optimization of Gastrointestinal Events Trial.	0
@Chemical$ is well tolerated and effective in treating mild to moderate pain but there is growing concern about a possible risk of @Disease$ and a possible link with asthma in children.	0
"Risk of @Disease$ with single, dual, or triple therapy with warfarin, @Chemical$, and clopidogrel in patients with atrial fibrillation."	1
We conclude that using aspirin and @Chemical$  simultaneously has no considerable effect on the risk of @Disease$ in patients having conventional forceps extraction of a single tooth.	0
METHODS: Nasal polyps were obtained from 16 aspirin-tolerant patients with asthma/rhinitis (ATAR) and 18 @Chemical$-intolerant patients with @Disease$/rhinitis (AIAR) undergoing nasal polypectomy.	0
"METHODS: Thirty genome-wide expression microarrays were used to compare nasal polyp tissue from patients with chronic rhino@Disease$ alone (CRS, n = 10) or chronic rhinosinusitis and a history of aspirin-sensitive asthma (@Chemical$, n = 10) to normal sinonasal mucosa from patients who underwent surgery for non-sinus related conditions (controls, n = 10)."	0
CONCLUSION: Adaptive desensitization therapy for @Disease$ to @Chemical$ has been shown to be an effective causative therapy and chronic hyperplastic sinusitis as well as bronchial asthma could be improved.	1
"CONCLUSION: Warm-needle moxibustion can reduce the gastric lesion (@Disease$) caused by aspirin in the rat, which may be closed associated with its effects in up-regulating both serum and gastric mucosal SOD activity and down-regulating both serum and gastric mucosal @Chemical$ levels."	0
"For @Chemical$ users, no excess risk of @Disease$s was present."	0
"Hypersensitivity to acetylsalicylic acid (ASA) is characterized by the co-occurrence of symptoms so-called @Chemical$ triad, which include bronchial asthma, chronic rhinitis and @Disease$."	1
"During surgery, the estimated @Disease$ was 855.3 cc in the @Chemical$ group and 840.8 cc in the control group with no significant difference (p=.84)."	0
Association of beta 2-adrenergic receptor polymorphism with the phenotype of @Chemical$-intolerant acute @Disease$.	0
"In this study, we compared the roles of CysLT receptor type 1 (CysLTR1) and leukotriene C4 synthase (LTC4S) gene polymorphisms in two major aspirin-related allergic diseases, aspirin-intolerant asthma (@Disease$) and @Chemical$-induced chronic urticaria/angioedema (AICU)."	0
Antral prostaglandin-E(2)-basal levels appear to be critical for development of @Chemical$-induced gastric damage in subjects without H. pylori @Disease$.	0
Moreover some patients with imperative cardiologic indications for combination therapy with aspirin and clopidogrel (stent placement and/or acute coronary syndrome) have a history of @Disease$ to @Chemical$.	1
"The ideal treatment for @Disease$ in low dose ASA users would be withdrawal of @Chemical$, however, this withdrawal could increase the risk of CV/cerebrovascular morbidity and mortality in high percentage of patients."	0
"Aspirin-induced @Disease$ and bleeding in the rat is dependent on the presence of luminal bile, which is likely attributable to it's constituent @Chemical$."	0
BACKGROUND: We recently demonstrated in humans that the extent of low-dose @Chemical$ (LDA)-induced @Disease$ was directly related to the individual gastric acid secretion level.	0
Oral @Chemical$ challenge (OAC) reveals aspirin-exacerbated @Disease$ (AERD) in approximately 50% of unselected patients with chronic rhinosinusitis with nasal polyposis (CRSwNP).	0
Influence of low-dose @Chemical$ (81 mg) on the incidence of definite stent @Disease$ in patients receiving bare-metal and drug-eluting stents.	0
"Low-dose @Chemical$ dose, infection by Helicobacter pylori, NSAID intake, and absence of enteric coating, are possible risk factors for non-complicated peptic @Disease$."	1
Physiologic and pharmacologic studies support the hypothesis that aspirin-exacerbated @Disease$ (AERD) involves fundamental dysregulation in the production of and end-organ responsiveness to both antiinflammatory @Chemical$ (prostaglandin E2) and proinflammatory effectors (cysteinyl leukotrienes).	0
"BACKGROUND: Comparing a patient's bleeding symptoms with those of healthy individuals is an important component of the diagnosis of @Disease$, but little is known about whether bleeding symptoms in healthy individuals vary by sex, race, ethnicity, age, or @Chemical$ use."	0
"METHODS: Using an adult asthma cohort (COREA) from 11 university hospitals in Korea, we analyzed the prevalence of @Chemical$-intolerant asthma, defined as a positive response to the question: Have you ever experienced @Disease$ and cough after taking an aspirin or any NSAID (cold medicine)?"	0
"This is the first study to utilize a disease-specific, validated outcomes instrument in comparing Samter's triad patients with @Chemical$-tolerant patients who have @Disease$ and tissue eosinophilia."	0
"[Asthma, @Disease$ and @Chemical$ intolerance--a triad to remember]."	0
"Drugs that can lead to @Disease$ include non-steroidal anti-inflammatory drugs (NSAIDs) like diclofenac and ibuprofen, platelet inhibitors such as acetylsalicylic acid (ASS), clopidogrel and prasugrel, as well as anticoagulants like vitamin-K antagonists, @Chemical$ or direct oral anticoagulants (DOAKs)."	0
"Patients undergoing TKA treated with @Chemical$ had higher readmission rates within 6 weeks of surgery because of a bleeding complication, a wound @Disease$, or the development of a VTE (6.8% for LMWH versus 1.5% for mobile compression; p = 0.015; OR, 4.8)."	0
@Chemical$-Exacerbated Respiratory Disease (AERD) and Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) are both characterized by the presence of chronic @Disease$ and nasal polyps.	0
Clopidogrel plus indobufen in acute @Disease$ patients with hypersensitivity to @Chemical$ undergoing percutaneous coronary intervention.	0
Aspirin (@Chemical$) is an important cause of asthma so that ASA induced asthma (@Disease$) is considered a disease.	0
"OBJECTIVES: To evaluate if esomeprazole prevents recurrent peptic ulcer in adult patients with a history of peptic @Disease$ receiving low-dose @Chemical$ (ASA, aspirin) for cardiovascular protection in East Asia."	0
"CONCLUSION: @Chemical$ toxicity, which may cause a distinctive irreversible @Disease$, can be seen frequently with Russian Cocktail abuse, a substance which can be accessed very easily and at a low cost."	0
"Sixty-three subjects without known aspirin sensitivity (13 controls, 17 nasal polyps alone, 15 nasal @Disease$ and asthma and 18 asthma alone) inhaled increasing concentrations of nebulized lysine @Chemical$."	0
"In the @Chemical$ induced @Disease$ group, there were 66 women (66%) and 34 men (34%)."	1
"The reported cases of @Disease$ were due to the ingestion of contaminated fresh fruit, juices, or @Chemical$."	1
INTRODUCTION: The Clopidogrel in Unstable @Disease$ to Prevent Recurrent Events (CURE) study showed that patients with unstable angina pectoris (UAP) and non-ST-elevation myocardial infarction (NSTEMI) benefit from combined therapy with acetylsalicylic acid (ASA) and @Chemical$.	0
Underutilization of gastroprotective strategies in @Chemical$ users at increased risk of @Disease$.	1
METHODS: A total of 136 patients aged 60 to 80 years with @Chemical$-induced (100 mg/d for at least 1 month) @Disease$ and 48 age-matched healthy subjects were enrolled in this study.	0
"METHODS: Of 1306 patients admitted to our Coronary Care Unit between February 2011 and February 2013, 24 (1.8%) had a history of @Chemical$ @Disease$."	1
PGE(2) significantly enhanced anti-IgE induced histamine and @Chemical$(2) release from mast cells of normal subjects but not those of ATA and @Disease$ patients.	0
@Chemical$ resistance associated with HbA1c and @Disease$ in diabetic patients.	1
"Aspirin had no effect on platelet-leukocyte aggregates, platelet activation markers, or plasma cytokines in either group.Conclusions: High-dose aspirin therapy for 8 weeks paradoxically increases markers of type 2 inflammation in subjects with @Chemical$-exacerbated @Disease$, despite reducing nasal symptoms."	0
"CONCLUSION: Short-term, mostly single-dose exposure to @Chemical$ for the treatment of pain, fever, or colds was associated with a small but significant increase in the risk of @Disease$ relative to placebo."	0
"Antisecretory drugs (H2 inhibitors, proton pump inhibitors), and @Chemical$ are associated with a decreased risk of @Disease$ ulcer."	0
"OBJECTIVE: Although @Chemical$ has been widely prescribed for the prevention of cardiovascular events, its risk of @Disease$ is of great concern."	0
"Hypersensitivity to @Chemical$ (ASA) is characterized by the co-occurrence of symptoms so-called aspirin triad, which include @Disease$, chronic rhinitis and sinusitis and the nasal mucosa polyps."	0
"We describe the most common clinical presentations of aspirin hypersensitivity, i.e. @Chemical$-induced asthma, @Disease$ and aspirin-induced urticaria."	1
@Chemical$-related hemorrhage was defined as new intracranial @Disease$ immediately adjacent or within the ventricular catheter trajectory.	0
@Chemical$ is widely used for the prevention of @Disease$.	0
"In subgroup analysis, aspirin use was associated with renal failure in the patients with no history of @Disease$ (HR, 1.41; 95% CI, 1.14-1.73), and there was a borderline interaction between previous stroke and the use of @Chemical$ on renal failure (interaction p=0.0565)."	0
"There were, however, significantly more subjects with one or more lesions (erosion or @Disease$) per subject in the paracetamol and aspirin (16/20, 80%) treated subjects as compared to the aspirin (8/19, 42%, P &lt; 0.001) or the @Chemical$ (3/21, 14%, P &lt; 0.01) exposed subjects."	0
"After the ulcers had healed and the H. pylori @Disease$ was eradicated, the patients were randomly assigned to treatment with 30 mg of @Chemical$ daily or placebo, in addition to 100 mg of aspirin daily, for 12 months."	0
Lyophilized aspirin/@Chemical$ might be a solution to decrease aspirin-induced @Disease$.	0
"The multivariate odds ratio of LDA-associated UGIB was 3.318 (95% confidence interval (CI) 1.650-6.671, p = 0.0008) for a history of peptic @Disease$, 0.086 (95% CI: 0.011-0.652, p = 0.0176) for the use of a proton pump inhibitor (PPI) with @Chemical$, and 0.253 (95% CI: 0.113-0.569, p = 0.0009) for the use of a histamine type 2 receptor antagonist (H2RA) with LDA."	0
"OBJECTIVE: We sought to examine whether NLRP3 polymorphisms are associated with susceptibility to food allergy, food-induced anaphylaxis, and @Chemical$-induced asthma (@Disease$)."	0
"Although hypersensitivity reactions to @Chemical$, especially in asthmatic patients or those with @Disease$, are well reported, our patients did not exhibit any underlying history of atopy."	0
[@Chemical$ and its danger: @Disease$ in young adult].	1
Previous studies have revealed that @Chemical$ desensitization and subsequent treatment with ASA is associated with clinical improvement in @Disease$.	0
@Chemical$ and the older nonsteroidal anti-inflammatory drugs (NSAIDs) that block cyclo-oxygenase-1 (COX-1) induce asthma attacks in patients with aspirin-exacerbated respiratory disease and @Disease$ in patients with chronic idiopathic urticaria.	0
"Drugs that can lead to @Disease$ include non-steroidal anti-inflammatory drugs (NSAIDs) like diclofenac and ibuprofen, platelet inhibitors such as acetylsalicylic acid (ASS), clopidogrel and prasugrel, as well as anticoagulants like @Chemical$ antagonists, heparin or direct oral anticoagulants (DOAKs)."	0
"Individuals with two single nucleotide polymorphisms (SNPs) of cyclooxygenase-1 (COX-1), A-842G and C50T, exhibit increased sensitivity to @Chemical$ and lower prostaglandin synthesis capacity but the polymorphism lacked statistical significance in relation to an association with bleeding peptic @Disease$."	0
"BACKGROUND AND AIMS: Nitric oxide-releasing aspirin (NO-ASA) has been shown to inhibit cyclo-oxygenase and @Chemical$ generation without causing mucosal damage, but the role of reactive oxygen species (ROS) and cytokines in the action of ASA and NO-ASA against acute @Disease$ has been little studied."	0
"The estimated average excess risk of @Disease$ attributable to aspirin is around 5 extra cases per 1,000 @Chemical$ users per year."	0
"In humans, treatment with ASA-VitC induced significantly less @Disease$ lesions than plain @Chemical$."	0
"Recently, vitamin C releasing aspirin (ASA-@Chemical$) has been shown to reduce @Disease$ of ASA in animal model of gastric injury."	0
"Compared with the use of @Chemical$ alone, combined use of coxib and aspirin for 3 years increased the risk of a colorectal neoplasm by 80% in the fifth year (RR = 1.80, 95% CI 1.22-2.66; P = 0.003) but decreased by 79% and 30%, respectively, the risks of cardiovascular thromboembolic events (RR = 1.79, 95% CI 1.33-2.41; P = 0.0001) and @Disease$ (RR = 1.30, 95% CI 1.09-1.54; P = 0.003) caused by coxib use alone."	0
@Chemical$-@Disease$ (AIA) is characterized by severe asthmatic attack after ingestion of aspirin and/or non-steroidal anti-inflammatory drugs.	0
"CONCLUSIONS: Our findings do not support the notion that entericcoated LDA products confer a lower risk for GI complications than buffered formulations, but may conversely imply that the risk of @Disease$ complications associated with buffered LDA is lower than that of enteric-coated @Chemical$."	0
"@Chemical$ @Disease$ was diagnosed in 180 (13.6%) asthmatic patients, with a reliable history in 145 (80.5%), and oral ASA provocation test in 35 (19.5%) patients."	1
"METHODS: Ninety-four aspirin-induced @Disease$ patients presenting urticaria/angioedema-induced by both ASA and NSAID (50 had underlying chronic urticaria) and showing positive responses on oral @Chemical$ challenge test, 76 aspirin-intolerant asthmatics with positive responses on lysine-aspirin bronchoprovocation test, and 185 normal healthy controls were enrolled."	0
Thirty-five patients were admitted to this hospital in 2011 because of acute @Disease$ of upper digestive tract induced by low-dose @Chemical$.	1
"RESULTS: Seventeen patients with isolated @Disease$ were enrolled, twelve taking aspirin and five not taking @Chemical$."	0
Are Prior @Chemical$ Users With ST-Elevation @Disease$ at Increased Risk of Adverse Events and Worse Angiographic Features?	0
@Chemical$-exacerbated @Disease$ (AERD)].	1
"In monocytes, we found no changes in basal or lipopolysaccharide (LPS)-stimulated @Chemical$ synthesis, but the response to EP4 receptor activation with respect to inhibition of LPS-induced @Disease$ factor-alpha release was reduced in AERD patients, especially in the presence of aspirin (acetylsalicylic acid)."	0
"Age, male gender, Helicobacter pylori (H. pylori)infection, @Disease$, chronic kidney disease (CKD), cirrhosis, history of uncomplicated peptic ulcer disease (PUD), and use of NSAIDs, COX-2 inhibitors, steroids, and @Chemical$ were independent risk factors for UGIB among aspirin users."	0
The effects of inhaled aspirin on fractional exhaled NO (FENO) in patients with aspirin-tolerant (ATA) and @Chemical$-inducible (@Disease$) asthma compared with normal controls have been investigated.	0
BACKGROUND: Current knowledge about clinical and genetic risk factors for @Chemical$-induced gastric mucosal injury is not sufficient to prevent these @Disease$.	0
"METHODS: Stable patients with AERD (n = 30), @Chemical$-tolerant asthma (ATA; n = 21), or @Disease$ (n = 10) were enrolled."	0
"These associations were stronger after more than 10 years of use (acetaminophen: odds ratio (OR) = 1.8, 95% confidence interval (CI): 1.3, 2.6; @Chemical$: OR = 1.6, 95% CI: 1.1, 2.2) and were present for indications of headache, @Disease$, and other pain/injury."	0
"The dyspeptic symptoms, which can result from @Chemical$ administration, and which may occur with or without associated @Disease$ and bleeding, may lead patients to discontinue therapy, thus increasing their CVD risk."	0
We now refer to their underlying inflammatory disease of the entire respiratory tract as @Chemical$-exacerbated @Disease$.	1
"RESULTS: @Chemical$ users were significantly older (P &lt; 0.001), with a higher proportion of males (P &lt; 0.001) and higher frequencies of hypertension (P  = 0.004) and @Disease$ (P &lt; 0.001)."	0
"In this context, we sought to investigate whether aspirin use is associated with @Chemical$ in subjects without previous history of @Disease$."	0
@Chemical$-100 detected @Disease$ as the result of pre-injury use of antiplatelet agents in TBI and CVA patients with a sensitivity of only 48.6% and a specificity of 74.8%.	0
"In saliva analysis among the three groups (@Disease$ patients, aspirin-tolerant asthma [ATA] patients, and healthy subjects), both the concentrations of @Chemical$ and LTB4 were significantly higher in AIA patients than in ATA patients and healthy subjects."	0
"CONCLUSIONS: Rapid @Chemical$ desensitisation is an effective and safe procedure for patients with aspirin @Disease$ who are to undergo coronary angioplasty and stenting, allowing them to receive the optimum treatment."	0
CONCLUSION: Consideration of the safety of primary prevention with @Chemical$ requires an individualized assessment of aspirin's effects on @Disease$ risks and expected benefits because absolute bleeding risk may vary considerably by patient.	0
"RESULTS: A treatment with aspirin in the human bronchial epithelial cells increased the mRNA expression level of KIF3A compared to that of the untreated control (P &lt;= 0.01), and @Disease$ from @Chemical$-intolerant asthma (AIA) patients also showed a higher expression of KIF3A protein than aspirin-tolerant asthma controls."	1
"METHODS: Using data from the Maryland @Disease$ (NSCLC) Case-Control Study (1,220 cases [404 AA and 816 EA] and 1,634 controls [1,004 EA and 630 AA]), we estimated the adjusted odds ratios (OR) and hazard ratios (HR) with 95% confidence intervals (CI) of the associations between @Chemical$ use and NSCLC risk and survival, respectively."	0
"Additionally, eosinophils, mast cells, and their products, prostaglandins and @Chemical$, have been identified in the pathogenesis of @Disease$."	0
The authors analyzed the effects of prior @Chemical$ use on clinical course and outcomes following @Disease$ SAH.	0
@Chemical$ reduced the damage of low-dose aspirin-induced @Disease$ complications.	0
"Eosinophilia as well as a variety of other biologic markers, for example, Th2 cytokines, peripheral blood periostin, and @Chemical$ enzymes and receptors, are associated with @Disease$ both in the blood and in respiratory mucosa."	0
"The incidence of cross-sensitivity to @Chemical$ in @Disease$ patients is low and, when a reaction does occur, the symptoms experienced are shorter and milder than if the reactions were evoked by an NSAID."	0
"@Chemical$ also increased the risk of serious bleeding by 46% (95%CI, 22-75) in diabetic patients without @Disease$ but decreased the risk among those with cardiovascular disease."	0
"There were significantly more patients who suffered GI adverse events, principally abdominal @Disease$, dyspepsia, nausea and diarrhoea, with @Chemical$ (18.5%) than with ibuprofen (11.5%), but the difference between ibuprofen and paracetamol (13.1%) was not significant."	0
"CONCLUSIONS: Prasugrel 20/3.75 mg was associated with a low incidence of @Disease$ events, similar to the results of @Chemical$, and with a low risk of clinically serious bleeding in Japanese ACS patients."	0
"Aspirin, non-steroidal anti-inflammatory drugs (NSAIDs) and @Chemical$ are the most frequent drugs used worldwide for the management of pain, inflammation and @Disease$ associated with many acute and chronic conditions."	0
"Paracetamol pack size restriction: the impact on paracetamol @Disease$ and the over-the-counter supply of paracetamol, @Chemical$ and ibuprofen."	0
BACKGROUND: Accumulating evidence supports an effect of @Chemical$ in reducing overall @Disease$ incidence and mortality in the general population.	0
"The effect of admission blood pressure on the prognosis of patients with @Disease$ that occurred during treatment with aspirin, @Chemical$, or no drugs."	0
"Significantly more dog-days of @Disease$ occurred in the @Chemical$ and aspirin group during treatment, compared with baseline."	0
"BACKGROUND: Danhong injection (@Chemical$) is quite often used in combination with low-dose aspirin (ASA, 75-325mg daily) in clinic, particularly for the treatment of @Disease$."	0
We aimed to determine uBrTyr levels in patients with AERD (n = 240) and aspirin-tolerant asthma (ATA) (n = 226) and to assess whether its addition to urinary @Chemical$ (uLTE4) levels and @Disease$ can improve the prediction of AERD diagnosis.	0
CONCLUSIONS: Continuation or discontinuation of @Chemical$ did not show a statistically significant difference in the risk of relevant perioperative @Disease$ complications in our study.	0
"PURPOSE OF REVIEW: @Chemical$-exacerbated respiratory disease (AERD) is a progressive inflammatory disease of the upper and lower airways characterized by marked eosinophilic nasal polyposis, @Disease$, and respiratory reactions to medications that inhibit the cyclooxygenase pathway."	0
Poor awareness of preventing @Chemical$-induced @Disease$ with combined protective medications.	1
[@Chemical$-induced asthma (@Disease$)].	0
The experiments results indicated that @Chemical$ group has visible @Disease$ and lesions while aspirin + PNS group have not.	0
"BACKGROUND AND AIMS: Nitric oxide-releasing aspirin (NO-ASA) has been shown to inhibit cyclo-oxygenase and prostaglandin generation without causing mucosal damage, but the role of reactive oxygen species (ROS) and cytokines in the action of @Chemical$ and NO-ASA against acute @Disease$ has been little studied."	0
"In addition, we experienced one patient of @Chemical$ intolerance which caused hyperemia and @Disease$ of the bulbar conjunctiva."	1
"There was no increase in headache frequency in participants with @Chemical$+ intake compared with aspirin (adjusted, all headache: -0.34 d/mo [95% confidence intervals: -2.50 to 1.82], migraine: -1.36 d/mo [-4.76 to 2.03], TTH: -0.57 d/mo [-4.97 to 3.84], MigTTH: 2.46 d/mo [-5.19 to 10.10]) or no analgesics (all headache: -2.24 d/mo [-4.54 to 0.07], @Disease$: -3.77 d/mo [-9.22 to 1.68], TTH: -4.68 d/mo [-9.62 to 0.27]; MigTTH: -3.22 d/mo [-10.16 to 3.71])."	0
"In the 1-month SI analysis, proportions of patients (95% CI) in the low- and high-dose @Chemical$ categories experiencing major bleeding were 2.1% (1.5-2.6) and 1.9% (0.0-3.8); proportions with @Disease$ were 2.1% (1.3-2.8) and 1.8% (0.9-2.6); and proportions of all-cause death were 2.8% (2.2-3.4) and 2.4% (1.3-3.5), respectively."	0
"BACKGROUND: During a clinical trial, we obtained 16 biopsies of @Disease$ induced by @Chemical$ in patients with chronic idiopathic urticaria (CIU)."	1
"WHAT THE READER WILL GAIN: Aspirin-induced @Disease$ can be reduced, and a number of strategies can be implemented to shift the risk-benefit ratio in favour of @Chemical$."	0
"However, celecoxib/@Chemical$ was associated with a significantly higher incidence of gastric and duodenal @Disease$s than aspirin alone."	1
"We report the case of a 59-year-old female with @Disease$, admitted to the coronary care unit for acute inferior myocardial infarction and treated with tissue-type plasminogen activator 100 mg in 90 min, intravenous heparin 25,000 U, @Chemical$ 100 mg, and metoprolol 50 mg orally once daily."	0
SIGNIFICANCE: IV DDAVP corrected prolongations in @Chemical$ in dogs given aspirin and should be considered in dogs requiring prompt reversal of aspirin-induced @Disease$ to reduce the risk of bleeding complications.	0
CONCLUSIONS: Low-dose @Chemical$ should be recommended to well-treated @Disease$ patients with even moderate increase in serum creatinine.	0
"BACKGROUND: Multiple NSAID-induced urticaria/@Disease$ (MNSAID-UA) is an entity well differentiated from @Chemical$-exacerbated respiratory disease (AERD), although no detailed phenotype analysis has yet been performed."	0
"METHODS: The effect of arachidonic acid or platelet agonists on LTC4 synthase activity was investigated in platelets obtained from healthy volunteers, aspirin-intolerant asthmatics or @Chemical$-tolerant @Disease$tics after in vivo treatment or in vitro pre-incubation with aspirin."	0
OBJECTIVES: To investigate the genetic contribution of @Chemical$ A3 receptor gene (ADORA3) polymorphisms in the pathogenesis of aspirin-induced @Disease$ (AIU) in a case-control association study in a Korean population.	0
"PURPOSE: This study evaluated the benefits of and possible contraindications to @Chemical$ treatment in patients with atrial fibrillation (@Disease$) prior to the introduction of new oral anticoagulants using health registry data from inpatient care, specialist ambulatory care, and primary care."	0
"METHODS: Preoperative computed tomography (CT), pre- and postoperative endoscopy, and two validated disease specific QOL instruments, the Rhinosinusitis Disability Index (RSDI) and @Disease$ (@Chemical$), were collected."	0
"OBJECTIVE: This analysis compared the efficacy of misoprostol, @Chemical$, and placebo in reducing the risk of gastric or duodenal @Disease$ recurrence in patients taking NSAIDs and low-dose aspirin."	0
"BACKGROUND: We have reported that in patients with chronic idiopathic @Disease$ (CIU) who reacted adversely to aspirin, the frequency of the (-444)C allele of the leukotriene C(4) synthase gene (LTC4S) was higher than in patients who tolerated @Chemical$ well."	0
"Recently, @Chemical$ releasing aspirin (ASA-VitC) has been shown to reduce @Disease$ of ASA in animal model of gastric injury."	0
"Patients who are on chronic warfarin therapy and receive a coronary stent need to be treated with the triple therapy of aspirin, clopidogrel and @Chemical$; however, the @Disease$ risk in these patients is unknown."	0
Use of low-dose @Chemical$ concurrently with use of a selective cyclo-oxygenase-2 inhibitor may provide some degree of protection against the potential cardiovascular @Disease$ of the latter but both laboratory and clinical studies suggest that the concomitant use of these two types of drugs results in gastrointestinal ulceration comparable to what is seen with conventional non-steroidal anti-inflammatory drugs.	0
"Regarding the pathogenesis of AI, modifications of @Chemical$ metabolism are supposed to underlie AI, including aspirin-induced @Disease$ and aspirin-induced urticaria."	0
@Disease$ transformation of ischemic stroke associated with @Chemical$ and aspirin concomitant therapy.	0
"CONCLUSION: Among elderly patients receiving cardiovascular protection with ASA and pain control with anti-inflammatory drugs, @Chemical$ may be safer with regards to @Disease$ than NS-NSAIDs."	0
"METHODS AND MATERIALS: We compared the effect of NO-ASA and ASA on @Disease$ provoked by water-immersion and restraint stress (WRS), ischemia-reperfusion, and 100% @Chemical$."	0
"RESULTS: Overall, 386 patients were enrolled; 57% used NSAIDs (51% @Chemical$ only) and 43% were non-users. 57% of the whole cohort was H. pylori-positive (including 66% with duodenal @Disease$ and 47% with gastric ulcers)."	0
"In our investigation of such adverse effects, we obtained 4 important findings considered useful for physicians, as follows; 1) even when @Chemical$ was given at a dose, the incidence rate of @Disease$ was higher than with other non-steroidal anti-inflammatory drugs (NSAIDs), 2) the odds ratios for gastrointestinal lesions induced by aspirin with a histamine H2 receptor antagonist and proton pump inhibitor were 0.6 and 0.4, respectively, as compared with aspirin alone, 3) it is difficult to administer aspirin, which exerts an antiplatelet effect, without inducing gastrointestinal lesions, and 4) these gastrointestinal lesions appears early, especially within 2 years after administration."	1
"RESULTS: For the @Chemical$ cohort, there was no difference in the frequency of readmission for a @Disease$ complication (wound or systemic) between the two groups (2.6% for LMWH versus 0.9% for mobile compression; p = 0.57; odds ratio [OR], 2.9)."	0
CONCLUSION: There is an extremely high ratio of @Disease$ in the LDA-continued group compared to both the @Chemical$-interrupted group and no-anticoagulant/APT group.	0
@Chemical$: a dominant mediator of aspirin-exacerbated @Disease$.	0
CONCLUSION: The results may help in minimizing concerns about the development of @Disease$ among patients on @Chemical$.	0
"PLATO major @Disease$ occurred in 31 patients (0.5%) on ticagrelor and 38 patients (0.6%) on @Chemical$ (hazard ratio, 0.83; 95% confidence interval, 0.52-1.34)."	0
This study evaluated the association of BMI and asthma in patients with @Chemical$-tolerant @Disease$ (ATA) and aspirin-intolerant asthma (AIA).	0
"CONCLUSIONS: A high proportion of patients taking @Chemical$ underwent neuroimaging, but @Disease$ and admission rates were comparable between groups."	0
BACKGROUND: Patients with aspirin-exacerbated respiratory disease (AERD) are distinguished from patients with @Chemical$-tolerant @Disease$ (ATA) by significantly higher baseline concentrations of urinary leukotriene E4 (uLTE4).	0
To report a case of microtrauma-induced recurrent @Disease$ and secondary glaucoma associated with voluntary chronic acetylsalicylic acid (@Chemical$) use.	0
"OBJECTIVE: The aim of this study was to determine whether concomitant treatment with LTMDs was associated with a reduction of ASA-provoked lower respiratory tract reactions in patients with @Chemical$-exacerbated @Disease$ (AERD), when compared to AERD patients who were not treated with LTMDs."	0
"AREAS COVERED IN THIS REVIEW: A number of risk factors can be used to determine which patients are more likely to develop aspirin-associated @Disease$, mainly in the upper GI tract; these include a previous GI ulcer, ulcer complications, dyspepsia, and concomitant drug therapy with non-steroidal anti-inflammatory drugs (NSAIDs) or @Chemical$."	0
The two frequent clinical presentations of @Chemical$ hypersensitivity are: aspirin-induced bronchial asthma/rhinosinusitis (AIA/R) and aspirin-induced @Disease$/angioedema (AIU).	0
"DATA SOURCES: Articles evaluating @Chemical$ for primary prevention of CVD were gathered using a MEDLINE search with the keywords aspirin review, aspirin peripheral artery disease, aspirin stroke, aspirin coronary artery disease, aspirin @Disease$, aspirin primary prophylaxis, and aspirin elderly."	0
"BACKGROUND: The frequency with which patients with @Chemical$-exacerbated respiratory disease (@Disease$) react to 325 mg of aspirin during aspirin desensitization, or fail to react at all, is not fully known."	0
"SUMMARY: The full clinical picture of aspirin intolerance--the association of aspirin-induced @Disease$ (with severe acute asthma attacks), @Chemical$ sensitivity and nasal polyps--is commonly summarized as the 'Samter triad'."	0
"RESULTS: In addition to a recent history of @Disease$, all patients had at least 1 other risk factor and 112 (45.3%) had 3 or more risk factors; 78.9% were taking low-dose @Chemical$ and the remainder non-aspirin NSAIDs."	0
"In the 1-month SI analysis, proportions of patients (95% CI) in the low- and high-dose @Chemical$ categories experiencing major bleeding were 2.1% (1.5-2.6) and 1.9% (0.0-3.8); proportions with myocardial infarction were 2.1% (1.3-2.8) and 1.8% (0.9-2.6); and proportions of all-cause @Disease$ were 2.8% (2.2-3.4) and 2.4% (1.3-3.5), respectively."	0
"CONCLUSIONS: @Chemical$ 20/3.75 mg was associated with a low incidence of @Disease$ events, similar to the results of TRITON-TIMI 38, and with a low risk of clinically serious bleeding in Japanese ACS patients."	0
"Compared with clopidogrel, @Chemical$ increases the risk of GI @Disease$ but not other bleeding; however, 883 patients (95% CI, 357-infinity) would need to be treated with clopidogrel versus aspirin to prevent one major GI bleeding episode annually at a cost of over 1 million dollars."	1
AIMS: To investigate through endoscopic examination the frequency of @Disease$ associated with buffered and enteric-coated aspirin (@Chemical$).	0
"Type 2 inflammation characterizes aspirin-exacerbated respiratory disease.Objectives: To determine whether high-dose aspirin therapy changes biomarkers of type 2 @Disease$ in aspirin-exacerbated respiratory disease.Methods: Forty-two subjects with aspirin-exacerbated respiratory disease underwent an @Chemical$ desensitization and were placed on high-dose aspirin (1,300 mg daily)."	0
@Chemical$ desensitization is an option for those with refractory @Disease$ or who require aspirin for other medical conditions.	0
"RESULTS: The allele frequencies of HLA-DRB1(*)1302 (18.1%) and HLA-DQB1(*)0609 (10.1%) in @Chemical$-induced urticaria were significantly higher than in aspirin-intolerant @Disease$ (5.3%, P=0.0004; 2.0%, P=0.0024) and in normal controls (8.1%, P=0.0005; 3.2%, P=0.0008), and they remained significant after correcting for multiple comparisons."	0
@Chemical$ CysLT1-receptor antagonism and nasal lysine-aspirin provocation in aspirin-induced @Disease$.	0
"Since acetaminophen is a weak inhibitor of the COX-1 enzyme, patients with aspirin-induced @Disease$ should not take more than 1000 mg of @Chemical$ in a single dose."	0
The most recent data show that eradication of H. pylori @Disease$ in patients with a previous peptic ulcer bleeding episode who continue to take aspirin reduces the recurrence rate of this complication to levels observed in patients without a history of ulcer bleeding history who take @Chemical$ for cardiovascular disease.	0
"Examined parameters included Helicobacter pylori @Disease$, cyclooxygenase (COX)-1 and COX-2 activity, and current non@Chemical$al anti-inflammatory drug (NSAID) usage including aspirin."	0
@Disease$ to @Chemical$ and other nonsteroidal anti-inflammatory drugs (NSAIDs).	1
CONCLUSION: Our case describes the recurrence of spontaneous hemorrhages (perirenal and intramuscular @Disease$) as a result of an underlying platelet aggregation defect worsened by administration of @Chemical$.	0
"Also, women had less peripheral artery disease (@Chemical$, 2.4% versus 3.7%; apixaban, 1.4% versus 3.0%), more @Disease$, and higher mean CHADS2 (congestive heart failure, hypertension, age of 75 years or older, diabetes [1 point each], stroke or transient ischemic attack [2 points]) scores (aspirin, 2.2 versus 2.0; apixaban, 2.1 versus 2.0)."	0
"Dual antiplatelet therapy (DAPT) with @Chemical$ and a P2Y12 inhibitor (clopidogrel, ticagrelor, or prasugrel) reduces @Disease$ events in patients with acute coronary syndrome (ACS), but it is also associated with an increased risk of bleeding complications."	0
Much of our understanding of cross-reacting drugs and chemicals with @Chemical$ comes from studying asthmatics with aspirin-exacerbated respiratory disease (@Disease$).	0
The authors conclude that @Chemical$ does not increase surgically relevant parenchymal or meningeal bleeding following moderate and minor @Disease$ in patients older than 60 years of age.	0
"CONCLUSIONS: Our study revealed that nasal @Disease$ of aspirin-sensitive patients were infiltrated with eosinophils and mast cells, Cys-LT(1) receptor proportions in these inflammatory cells were found to be higher and @Chemical$-LT(1) receptor immunoreactivity in eosinophils and mast cells was increased."	0
"@Chemical$-intolerant asthma is associated with lower age, higher prevalence of rhinosinusitis and @Disease$, and more frequent exacerbations."	0
@Chemical$-intolerant chronic @Disease$ exacerbated by cutaneous application of a ketoprofen poultice.	0
"The PAIN (Paracetamol, @Chemical$, Ibuprofen New tolerability) study was a blinded randomised comparison of the tolerability of OTC analgesics in the treatment of common types of acute @Disease$ encountered in the community."	0
One patient had @Disease$ on day 14 after restarting coumadin in addition to their @Chemical$.	0
Failure of tacrolimus to prevent aspirin-induced respiratory reactions in patients with @Chemical$-exacerbated @Disease$.	0
Nasal and bronchial tolerability of Rofecoxib in patients with @Chemical$ induced @Disease$.	1
Sinonasal outcomes after endoscopic sinus surgery in @Disease$tic patients with nasal polyps: a difference between @Chemical$-tolerant and aspirin-induced asthma?	0
"The use of aspirin, @Chemical$ plus extended-release dipyridamole, or clopidogrel is recommended as initial therapy in patients with noncardioembolic ischaemic stroke or TIA to reduce the risk of recurrent @Disease$ and other cardiovascular events."	0
"In a review of the literature describes the risks and benefits of surgical interventions, in particular, coronary artery bypass grafting in patients with @Disease$ receiving antiplatelet therapy with no cancellation or late withdrawal of acetylsalicylic acid (@Chemical$)."	0
"The hypothesis presented herein is that @Chemical$ contributed to the incidence and severity of viral pathology, @Disease$, and death, because physicians of the day were unaware that the regimens (8.0-31.2 g per day) produce levels associated with hyperventilation and pulmonary edema in 33% and 3% of recipients, respectively."	0
The most recent data show that eradication of H. pylori infection in patients with a previous peptic @Disease$ episode who continue to take @Chemical$ reduces the recurrence rate of this complication to levels observed in patients without a history of ulcer bleeding history who take aspirin for cardiovascular disease.	0
"The prevalence of AR in patients undergoing HD seems higher than in most of the studied populations, and this study has shown that the @Chemical$ statuses of a significant number of patients undergoing @Disease$ change after an HD session."	0
"Similarly, LTC4 synthase activity in platelets from @Disease$ and @Chemical$-tolerant asthmatics (ATA) was reduced by approximately 50% after pre-treatment with arachidonic acid in vitro."	0
The role of food for the formation and prevention of @Disease$ induced by @Chemical$ in cats.	1
Mean @Disease$(20) was 163.4 +/- 39.9 mg ASA among patients who reacted with bronchospasm to @Chemical$.	0
"BACKGROUND AND AIM: Acetylsalicylic acid (@Chemical$ [aspirin]) is a commonly used over-the-counter drug for the treatment of @Disease$, fever, or colds, but data on the safety of this use are very limited."	0
BACKGROUND: Aspirin causes bronchospasm in patients with @Chemical$ exacerbated @Disease$ (AERD).	0
BACKGROUND: There are no country-based data focused on aspirin (@Chemical$)-exacerbated respiratory disease (@Disease$) in Turkey.	0
"On the @Chemical$-induced @Disease$, age range was between 28-82 years old patients with an average of 55. 17 female and three male and group control with demographic similar features."	1
"METHODS: Ninety-four aspirin-induced urticaria patients presenting urticaria/angioedema-induced by both ASA and NSAID (50 had underlying chronic urticaria) and showing positive responses on oral aspirin challenge test, 76 @Chemical$-intolerant @Disease$tics with positive responses on lysine-aspirin bronchoprovocation test, and 185 normal healthy controls were enrolled."	0
@Chemical$ increases the risk of @Disease$ in surgical patients.	1
"Type 2 @Disease$ characterizes aspirin-exacerbated respiratory disease.Objectives: To determine whether high-dose @Chemical$ therapy changes biomarkers of type 2 inflammation in aspirin-exacerbated respiratory disease.Methods: Forty-two subjects with aspirin-exacerbated respiratory disease underwent an aspirin desensitization and were placed on high-dose aspirin (1,300 mg daily)."	0
"Hypersensitivity to @Chemical$ and other non steroidal anti-inflammatory drugs (NSAIDs) manifesting in the airways (rhinosinusitis, polyps, @Disease$) or in the skin (urticaria, angioedema) is the second most frequent untoward allergic reaction to drugs."	1
This study aimed to evaluate the clinical course of patients receiving antithrombotic monotherapy with @Chemical$ (ASA) 100 mg who underwent transurethral resection of @Disease$.	0
"RESULTS: The final analysis included 1470 study participants: 221 controls, 553 CRS without @Disease$ (CRSsNPs), 651 @Chemical$ with nasal polyps (CRSwNPs) and 45 allergic fungal rhinosinusitis (AFRS)."	0
@Chemical$ therapy in aspirin-exacerbated @Disease$: a risk-benefit analysis for the practicing allergist.	0
"OUTCOMES: @Disease$ in random urine (albumin-@Chemical$ ratio &gt;or= 30 mg/g; n = 1,088) and reduced estimated glomerular filtration rate (eGFR; &lt;60 mL/min/1.73 m(2), n = 852) using the Modification of Diet in Renal Disease Study equation and the composite of either."	0
Association of @Chemical$ with @Disease$ in peripheral blood.	1
Continuous low-dose @Chemical$ therapy in robotic-assisted laparoscopic radical prostatectomy does not increase risk of surgical @Disease$.	0
"RESULTS: The mean perioperative @Disease$ was 899+-496 ml for patients not on clopidogrel, 1091+-654 ml for patients on @Chemical$ (p=0.005) and 1312+-686 ml for those on combined clopidogrel and aspirin (p=0.0003 vs. all others)."	0
"This study aimed to analyze CMBs and white matter hyperintensities (WMHs) in patients taking aspirin or clopidogrel.This retrospective study included patients with @Disease$ administered 75 mg/day @Chemical$ (n = 150) or clopidogrel (n = 150, matched for age and gender) for &gt;1 year (Affiliated Hospital of Inner Mongolia Medical University, China, from July, 2010 to July, 2015)."	0
"BACKGROUND: @Chemical$-exacerbated respiratory disease (AERD) is characterized by progressive sinusitis, nasal polyposis, and @Disease$ that begins and continues in the absence of exposure to aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs)."	0
"The use of aspirin, aspirin plus extended-release dipyridamole, or @Chemical$ is recommended as initial therapy in patients with noncardioembolic ischaemic stroke or @Disease$ to reduce the risk of recurrent stroke and other cardiovascular events."	0
The mean number of reddened lesions was significantly higher and the mean number of erosions/@Disease$ and CE scores significantly lower in the LDA group than in the other non-@Chemical$ NSAID group.	0
BACKGROUND: We have previously demonstrated that aspirin triggers specific generation of @Chemical$ (15-HETE) from nasal polyp epithelial cells and peripheral blood leukocytes (PBL) from aspirin-sensitive (AS) but not aspirin-tolerant (AT) patients with @Disease$.	0
The risk of readmission resulting from bleeding and venous thromboembolism (@Disease$) has also not been determined for patients undergoing THA or TKA when treated with low-molecular-weight heparin (LMWH) alone compared with mechanical prophylaxis plus @Chemical$ (ASA).	0
"OBJECTIVES: Leukotriene receptor antagonists (LTRA), such as @Chemical$, have been used as a first-line treatment for patients with aspirin-intolerant asthma (@Disease$)."	0
Gene-expression signatures of nasal polyps associated with chronic @Disease$ and @Chemical$-sensitive asthma.	0
"We conclude that combined therapy with @Chemical$ and clopidogrel does not necessarily protect against clinical HIT, at least in patients with @Disease$ antibodies that have strong platelet-activating characteristics."	0
"ASA fitness grade, cardiovascular disease, previous history of angina pectoris, angioplasty, diabetes, use of @Chemical$ antagonists, @Disease$ and type of hepatectomy were significantly different between the groups."	0
"We investigated whether aspirin with caffeine (ASA++) increases headache frequency compared with @Chemical$ alone in migraine, tension-type @Disease$ (TTH), and migraine + TTH (MigTTH)."	0
COX-2: Where are we in 2003? - Specific cyclooxygenase-2 inhibitors and @Chemical$-exacerbated @Disease$.	1
"Arachidonic acid (AA, 0.5 mg/mL) and adenosine diphosphate (@Chemical$, 5 micromol/L) induced @Disease$ were measured via light transmission assay (LTA) to evaluate antiplatelet responses, referred as LTA-AA and LTA-ADP."	0
@Chemical$-exacerbated @Disease$: not always adult-onset.	1
"The prevalence of @Disease$ or erosion during chronic use of LDA, LDA and the anti-platelet drug @Chemical$ (clopidogrel or ticlopidine), and NSAIDs were 64.3%, 80.0%, and 75.0%, respectively."	0
"BACKGROUND: Aspirin-exacerbated respiratory disease (AERD) is a clinical syndrome characterized by chronic rhinitis, @Disease$, asthma, and precipitation of asthma and rhinitis attacks after ingestion of aspirin (@Chemical$) and most nonsteroidal anti-inflammatory drugs (NSAIDs)."	0
"Significant heterogeneity was present for the NSAIDs; e.g., @Chemical$ was associated with an increased overall fracture risk (OR = 2.09, 95% CI 2.00-2.18 for &lt;20 DDD), while celecoxib was not (OR = 0.76, 95% CI 0.51-1.13 for &lt;20 @Disease$, 2P &lt; 0.01 for comparison)."	0
Low-dose @Chemical$ (LDA) has been increasingly used worldwide to prevent @Disease$ events.	0
&lt;em&gt;Helicobacter pylori&lt;/em&gt; @Disease$ and the risk of upper gastrointestinal bleeding in low dose @Chemical$ users: systematic review and meta-analysis.	0
AIM: To determine the preventive effect and safety of proton pump inhibitors (PPIs) in low-dose @Chemical$ (LDA)-associated gastrointestinal (GI) ulcers and @Disease$.	0
"BACKGROUND: Aspirin (acetylsalicylic acid [ASA]) hypersensitivity is frequent in patients with nasal polyps (NPs) and is called @Chemical$ exacerbated @Disease$, previously known as Samter's syndrome."	1
"RESULTS: The age, BMI, hospital stay, @Chemical$ classification, morbidity of @Disease$ and hypertension, FIB value, and the time of resuming normal activities of patients taking acetylsalicylic acid were higher (p &lt; 0.05)."	0
"RESULTS: The mean +/- SD values of the semiquantitatively evaluated immunoexpression of ICAM-1, VCAM-1, and VLA-4 were significantly increased in patients with @Chemical$ @Disease$ compared with aspirin-tolerant patients (1.7 +/- 0.8 vs 0.9 +/- 0.8, P &lt; .003; 1.8 +/- 0.8 vs 0.8 +/- 0.8, P &lt; .001; and 2.2 +/- 0.7 vs 1.3 +/- 0.7, P &lt; .001, respectively), whereas the mean +/- SD values of the expression of lymphocyte function-associated antigen 1 did not differ significantly (2.4 +/- 0.5 vs 2.2 +/- 0.9; P = .57)."	1
MATERIALS AND METHODS: We retrospectively assessed the impact of preoperative continuation versus discontinuation of @Chemical$ compared with a control group in a cohort of 739 consecutive patients undergoing total hip (THA) (n = 396) or knee @Disease$ (TKA) (n = 343) at a tertiary hospital.	0
"The median intraoperative blood loss (600 ml versus 450 ml, P = 0.56), median postoperative blood loss (800 ml versus 790 ml, P = 0.60), blood transfusion requirements (25.1% versus 24.4%, P = 0.76) and composite outcome of in-hospital death, @Disease$ and reoperation for bleeding (2.8% versus 1.6%, P = 0.10) were similar in aspirin and non@Chemical$ use group."	0
"The prevalence of @Chemical$ in patients undergoing HD seems higher than in most of the studied populations, and this study has shown that the AR statuses of a significant number of patients undergoing @Disease$ change after an HD session."	0
This study aimed to determine the effects of @Chemical$ and clopidogrel therapy on perioperative @Disease$ and blood transfusion requirements in off-pump coronary artery bypass grafting.	0
BACKGROUND: @Chemical$ desensitization followed by maintenance therapy effectively improves symptom control in patients with aspirin exacerbated respiratory disease (@Disease$).	0
@Chemical$ desensitization has been proven to be efficacious and safe and was able to reduce the need for other medications in @Disease$ patients.	0
Combined @Chemical$-aspirin treatment for high risk TIA or minor @Disease$ does not increase cerebral microbleeds.	0
"At 12 weeks, comparing patients assigned to @Chemical$ with patients assigned to placebo, gastric ulcers had developed in seven (3.4%) of 204 patients compared with 30 (15.0%) of 200 patients (odds ratio [OR] 0.20, 95% CI 0.09-0.47; p=0.0002); duodenal @Disease$ had developed in one (0.5%) patient compared with 17 (8.5%; OR 0.05, 0.01-0.40; p=0.0045); and erosive oesophagitis in nine (4.4%) compared with 38 (19.0%; OR 0.20, 0.09-0.42; p&lt;0.0001), respectively."	0
The aim of the investigation was to study @Chemical$ production in thrombocytes and their functional activity in correlation with 6-sulfatoximelatonin (6-SOM) urinary excretion in patients with aspirin-induced @Disease$ (AIBA).	0
"The independent risk factors for death were regular @Chemical$-use at the onset of ICH (relative risks [RR], 2.5; 95% CI, 1.3 to 4.6; P=0.004), warfarin-use at the onset of @Disease$ (RR, 3.2; 95% CI, 1.6 to 6.1; P=0.001), and ICH score higher than 2 on admission (RR, 13.8; 95% CI, 6.0 to 31.4; P&lt;0.001)."	0
"Platelet adenosine diphosphate (ADP) receptors may play a role in potentiating platelet activation induced by IgG from patients with immune heparin-induced thrombocytopenia (@Disease$), as shown by previous studies using the ADP receptor antagonists AR-C66096 and @Chemical$."	0
Catastrophic early drug eluting stents thrombosis and @Chemical$ @Disease$.	1
"BACKGROUND: @Chemical$-exacerbated respiratory disease (AERD) is a distinct eosinophilic phenotype of severe asthma with accompanying chronic rhinosinusitis, @Disease$, and hypersensitivity to aspirin."	0
"MATERIAL AND METHODS: The study included 504 patients that were administered the primary (n=345) or secondary thromboprophylaxis after @Disease$ (n=159), by applying @Chemical$ antagonists, or the combination of vitamin K antagonists and low-dose aspirin."	0
"Compared with no use, @Chemical$ use 1 to 3 times per month was associated with reduced risk of all-cause mortality (HR, 0.84; 95% CI, 0.80-0.88; P &lt; .001) and @Disease$ mortality (HR, 0.87; 95% CI, 0.81-0.94; P &lt; .001)."	1
"@Chemical$ desensitization can usually be achieved for those in need of the antiplatelet effects of aspirin, with the exception of those with aspirin-induced @Disease$ and baseline chronic urticaria."	0
"Soon after the introduction of @Chemical$ for the treatment of pain, fever, and inflammation more than a century ago, clinicians were challenged by the frequent observation of ASAtriggered allergic and pseudo@Disease$ reactions occurring in the skin."	0
"Effects of @Chemical$, non-steroidal anti-inflammatory drugs, acetylsalicylic acid, and opioids on bone mineral density and risk of @Disease$: results of the Danish Osteoporosis Prevention Study (DOPS)."	0
"BACKGROUND: @Chemical$ therapy is widely accepted for patients with documented cardiovascular disease, but there is a growing trend among healthy individuals to use aspirin as primary prevention for both cardiovascular disease and @Disease$."	0
Post-PCI fatal bleeding in aspirin and @Chemical$ hyper responder: shifting from antiplatelet resistance to @Disease$ risk assessment?	0
"RESULTS: Etoricoxib was well tolerated, without any signs of immediate or delayed hypersensitivity in @Chemical$- and nonsteroidal anti-inflammatory drug-induced @Disease$tic patients."	0
"In the study, 100 patients with low on-treatment platelet aggregation and at high risk of bleeding and low risk of cardiovascular events, were switched to @Chemical$ (40 mg/d) and their platelet aggregation was measured again 7 days later.Their @Disease$ and upper gastrointestinal symptoms were also recorded in following 3 months."	0
"A second polymorphism study, conducted on histamine-related genes, did not find any significant associations with @Chemical$-induced urticaria/@Disease$ for the genes HNMT (encoding histamine N-methyltransferase), HRH1 or HRH2 (encoding histamine receptor types 1 and 2 respectively), or the gene encoding high-affinity IgE receptor Ibeta (FcepsilonRIbeta); however, the FcepsilonRIalpha gene promoter polymorphism was significantly associated with aspirin-induced urticaria/angioedema."	0
@Chemical$-induced loss of stored iron from chronic @Disease$ is proposed as a mechanism underlying this beneficial effect.	0
"RECENT FINDINGS: As the American population ages, it is anticipated that there will be an increased incidence of upper and lower GIB related to age-specific disease, higher burden of comorbidity and increased use of anticoagulants, antiplatelets and @Chemical$ to treat @Disease$."	0
@Disease$ as a complication of aspirin desensitization for @Chemical$-exacerbated respiratory disease.	0
"CONCLUSIONS AND CLINICAL IMPORTANCE: Administration of deracoxib to healthy dogs resulted in significantly lower @Disease$ scores, and fewer days of vomiting compared to aspirin, indicating that @Chemical$ is better tolerated than aspirin in some dogs."	0
"BACKGROUND: The aim of this study was to detect cysteinyl leukotriene (@Chemical$-LT) receptors in aspirin-sensitive nasal polyposis patients, and compare them with @Disease$ and chronic rhinosinusitis patients without aspirin sensitivity."	0
BACKGROUND: Historical aspirin- or nonsteroidal anti-inflammatory drug (NSAID)-induced reactions might provide predictive information about the severity of reactions in patients with @Chemical$-exacerbated @Disease$ (AERD) undergoing oral aspirin challenge (OAC).	0
"Using an in vivo model of laser-induced thrombosis, @Chemical$ injected in 1 single dose of 100 mg/kg body weight has also shown a pro@Disease$ activity in the rat 8 to 10 days after injection in the normal rat."	0
"INTRODUCTION: @Chemical$-exacerbated respiratory disease is defined by the clinical tetrad of aspirin sensitivity, @Disease$, asthma, and chronic rhinosinusitis."	0
@Disease$ and @Chemical$ are independent risk factors for hemorrhage in patients with gastric or duodenal ulcer.	0
"The association between aspirin counseling, @Chemical$ use, and reported @Disease$ (CVD) and classical CVD risk factors were examined using logistic regression."	0
"BACKGROUND: Clinical features of @Chemical$-exacerbated respiratory disease (AERD) are characterized by overproduction of cysteinyl leukotrienes (LT) and eosinophil activation, in which epithelial cells contribute to eosinophilic airway @Disease$."	0
"At 1 month after discharge, although patients with in-hospital @Disease$ remained significantly less likely to receive @Chemical$ (odds ratio=0.68; 95% CI, 0.50 to 0.92), use of thienopyridines in the 2 groups started to become similar."	0
Discontinuing chronic @Chemical$ therapy: another risk factor for @Disease$?	0
"OBJECTIVE: @Chemical$-exacerbated respiratory disease (AERD) represents a severe form of @Disease$ (CRS) characterized by nasal polyposis, bronchial asthma, and aspirin intolerance."	0
Rapid desensitization procedure for patients with @Chemical$ @Disease$ undergoing coronary stenting.	1
RESULTS: Seventy patients with @Chemical$ @Disease$ as well as a medical indication for this therapy were referred to our department.	1
"Dual antiplatelet therapy (DAPT) with acetylsalicylic acid and a P2Y12 inhibitor (clopidogrel, @Chemical$, or prasugrel) reduces thrombotic events in patients with acute coronary syndrome (ACS), but it is also associated with an increased risk of @Disease$ complications."	0
"In this article, we summarize the results of those studies that explore the role of @Chemical$, @Disease$ medication and statins."	1
"On the other hand, @Chemical$ alone inhibited basal @Disease$ without any effect on mucosal PGE2 contents, and this agent, when given together with indomethacin, prevented gastric hypermotility and lesion formation in response to indomethacin, without affecting the reduced PGE2 contents."	0
Proton-pump inhibitor and eradication of Helicobacter pylori are not efficient in primary prevention of @Disease$ complications related to low-dose @Chemical$ use.	0
"Apixaban (2.5mg and 5mg), dabigatran, rivaroxaban, @Chemical$ and vitamin K antagonists (VKA) each significantly reduced the risk of @Disease$ recurrence compared to placebo, ranging from a 73% reduction with idraparinux to 86% with VKAs."	0
We assess the feasibility of performing robotic partial nephrectomy (@Disease$) in patients maintained on @Chemical$ or dual antiplatelet therapy with aspirin and clopidogrel.	0
"METHODS AND MATERIALS: We compared the effect of NO-ASA and ASA on gastric lesions provoked by water-immersion and restraint stress (WRS), @Disease$-reperfusion, and 100% @Chemical$."	0
AIM: To compare prospectively the incidence of endoscopic @Disease$s in healthy subjects receiving low-dose @Chemical$ plus celecoxib or naproxen.	0
The authors analyzed the effects of prior @Chemical$ use on clinical course and outcomes following aneurysmal @Disease$.	0
METHODS: Patients taking 100 mg of enteric-coated @Chemical$ for cardiovascular diseases and with a peptic @Disease$ or ulcer bleeding and patients who also participated in endoscopic surveillance were studied.	0
Risk of major @Disease$ in patients receiving vitamin K antagonists or low doses of @Chemical$.	0
AIM: The aim of this study was to evaluate the effects of chronic use of acetylsalicylic acid (ASA) and @Chemical$ antagonists (VKA) on the incidence of age related macular degeneration (@Disease$).	0
"Regarding the pathogenesis of AI, modifications of @Chemical$ metabolism are supposed to underlie AI, including aspirin-induced asthma and aspirin-induced @Disease$."	0
"CONCLUSIONS: The data from this study show that @Chemical$ intolerance, HDM @Disease$, and asthma duration exceeding 10 years are major factors associated with severe asthma in outpatients."	0
BACKGROUND: A special regulatory role for prostaglandin E2 has been postulated in @Chemical$-induced @Disease$.	1
"In the few case reports of @Disease$ involving @Chemical$ therapy, additional complicating factors were present."	0
"The objectives of this study were to determine the HP prevalence and NSAID/@Chemical$ use in patients with bleeding ulcer in a low-prevalence HP area, to determine the proportion of idiopathic @Disease$s and to estimate the proportion of initially false negative HP tests."	0
"The hypothesis presented herein is that @Chemical$ contributed to the incidence and severity of viral pathology, bacterial infection, and @Disease$, because physicians of the day were unaware that the regimens (8.0-31.2 g per day) produce levels associated with hyperventilation and pulmonary edema in 33% and 3% of recipients, respectively."	0
[Clinical study on asthma and @Chemical$ asthma affecting chronic @Disease$].	0
The risk is increased by the old age and by cardiovascular and @Disease$ of the patients receiving low-dose @Chemical$.	1
The human leucocyte antigen-DRB1*1302-DQB1*0609-DPB1*0201 haplotype may be a strong genetic marker for @Chemical$-induced @Disease$.	1
"In Reye's syndrome, hyperammonemia and perhaps the increase of @Chemical$ are the leading factors in the mechanism of brain damage and @Disease$."	0
Comparison of @Disease$ complications with omega-3 fatty acids + @Chemical$ + clopidogrel--versus--aspirin + clopidogrel in patients with cardiovascular disease.	0
BACKGROUND AND PURPOSE: Cerebral microbleeds (@Chemical$) may predict future risk for @Disease$ (ICH).	0
"During 764,247 person-years of follow-up, @Chemical$ use and acetaminophen use were independently associated with increased risk of @Disease$, but aspirin use was not."	0
"We investigated the risks of ischemic stroke and intracranial hemorrhage (@Disease$) in relation to warfarin at various TTRs in a real-world cohort of Chinese patients with atrial fibrillation receiving @Chemical$ and compared with those on dabigatran, aspirin, and no therapy."	0
Period of 6.6 years of rhinitis had preceded the diagnosis of nasal @Disease$ (PP--7.3; A--7.1; @Chemical$--4.5).	0
"BACKGROUND: Aspirin (@Chemical$ [ASA]) hypersensitivity is frequent in patients with nasal polyps (NPs) and is called aspirin exacerbated respiratory disease, previously known as @Disease$."	0
"CONCLUSIONS: Aspirin intake overall was not associated with early AMD in this sample of Asian Indians, but in those with a history of cardiovascular disease the association between @Chemical$ intake and early @Disease$ might warrant further investigation."	0
Association of @Disease$ Risk With Non-@Chemical$ Antagonist Oral Anticoagulant Use vs Aspirin Use: A Systematic Review and Meta-analysis.	0
Prevalence of erosive @Disease$ among Japanese patients taking low-dose @Chemical$.	0
"Although @Chemical$ has a toxic effect in vitro, enteral or parenteral administration in vivo, in animal models, did not result to @Disease$."	0
BACKGROUND: We previously found differences in the minor allele frequency (MAF) of single-nucleotide polymorphisms (SNPs) in transmembrane protein 196 (TMEM196) between 995 patients with @Chemical$-tolerant asthma (ATA) and 141 @Disease$tic patients with NSAID-exacerbated respiratory disease (NERD).	0
"Exclusion criteria: cancer, sepsis or acute infection, active inflammatory/rheumatic disease, recent major surgery, @Disease$, the administration of other antiplatelet drugs, nonadherence with @Chemical$ and thrombocytopenia."	0
"METHODS: A retrospective review identified @Disease$ patients, age 50 or greater, who had computed tomography (CT) evidence of ICH and were taking ASA, @Chemical$, or a combination of both."	0
"However, at multivariate analysis, an impaired metabolic status, with higher levels of glycosylated hemoglobin and low-density lipoprotein (LDL) cholesterol, but not @Disease$ status, emerged as independent predictors of HRPR with @Chemical$ [OR (95% CI)=2.1 (1.32-3.33), p=0.002 and OR (95% CI)=1.03 (1.01-1.05), p=0.003, respectively], with a stronger linear relationship between ADP-mediated platelet aggregation and glycosylated hemoglobin levels (r=0.24, p=0.002), than for LDL-cholesterol (r=0.13, p=0.09)."	0
"BACKGROUND: @Chemical$ (acetylsalicylic acid [ASA]) hypersensitivity is frequent in patients with nasal polyps (NPs) and is called aspirin exacerbated @Disease$, previously known as Samter's syndrome."	0
"Aspirin-exacerbated diseases are important examples of drug hypersensitivities and include aspirin-exacerbated @Disease$ (AERD), aspirin- or non-steroidal anti-inflammatory drug (NSAID)-induced urticaria/angioedema, and @Chemical$- or NSAID-induced anaphylaxis."	0
@Chemical$ @Disease$ can pose a challenge to achieving optimum medical management prior to and after neurointerventional treatment.	1
@Chemical$ desensitization in patients with @Disease$: A comprehensive overview of currently available protocols.	0
The American Heart Association guidelines recommend @Chemical$ use in women &gt; or = 65 years of age if blood pressure is controlled and the benefits of cardiovascular risk reduction likely outweigh the risk of @Disease$.	0
@Disease$ induced by both @Chemical$ and clopidogrel in the same patient.	1
Low-dose @Chemical$-induced @Disease$ in Japanese patients with arteriosclerotic disease.	1
"In some patients with chronic idiopathic @Disease$ (@Chemical$), aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) that inhibit cyclooxygenase 1 (COX-1) precipitate wheals and swelling."	0
Bleeding during treatment with aspirin versus @Chemical$ in patients with atrial fibrillation unsuitable for warfarin: the apixaban versus acetylsalicylic acid to prevent stroke in @Disease$ patients who have failed or are unsuitable for vitamin K antagonist treatment (AVERROES) trial.	0
[Clinical evaluation of influence of @Chemical$ on post-operative @Disease$ after tooth extraction in the elderly].	0
METHODS: We enrolled 123 patients who had @Disease$ complications after using low-dose @Chemical$ continuously for more than one month and who had H. pylori infection.	0
"CONCLUSIONS: Although in patients undergoing pacemaker implantation dual antiplatelet therapy with aspirin and @Chemical$ caused a significant increase of @Disease$ complications, the use of aspirin alone was not associated with a significant increase in bleeding complications."	0
"The meta-analysis showed that PPIs were superior to H2RAs for prevention of @Chemical$-associated GI erosion/@Disease$ [odds ratio (OR=0.28, 95% confidence interval (CI): 0.16-0.50] and bleeding (OR=0.28, 95% CI: 0.14-0.59)."	0
@Chemical$ and other nonsteroidal anti-inflammatory drugs and risk of @Disease$.	0
"We evaluated the effects of aspirin on genetic/epigenetic alterations in precancerous conditions, i.e., atrophic mucosa (AM) and intestinal metaplasia (IM), in patients with chronic @Disease$ who had taken @Chemical$ for more than 3 years."	0
The CT scans revealed evidence of traumatic @Disease$ in 27 (24.5%) patients in the @Chemical$-treated group and in 31 patients (25.6%) in the control group.	0
"Low-dose aspirin, one of non-steroidal anti-inflammatory drugs(NSAIDs), has been increasingly used to prevent cardiovascular and cerebrovascular disease through its antiplatelet effect, mainly in the aged population, but @Chemical$ treatment has been associated with @Disease$, especially peptic ulcer bleedings."	1
"This review focuses on descriptions of these patients; methods available to diagnose ASA-exacerbated @Disease$; the unique ability of all NSAIDs that inhibit COX-1 to cross-react with ASA; lack of cross-reactivity with selective COX-2 inhibitors; an update on pathogenesis; and current thoughts about treatment, including @Chemical$ desensitization and daily ingestion of ASA itself."	0
"BACKGROUND: Multiple NSAID-induced @Disease$/angioedema (MNSAID-UA) is an entity well differentiated from @Chemical$-exacerbated respiratory disease (AERD), although no detailed phenotype analysis has yet been performed."	0
"In patients with long-term @Chemical$ use, the changes of molecular events in AM but not IM may be an important factor in the reduction of @Disease$ incidence."	0
"Exclusion criteria: cancer, sepsis or acute infection, active inflammatory/rheumatic disease, recent major surgery, chronic liver failure, the administration of other antiplatelet drugs, nonadherence with @Chemical$ and @Disease$."	0
"In total, 9 fatal @Disease$ occurred on ticagrelor and 4 on @Chemical$."	0
The protective effect of COX-2 inhibitors on the risk of @Disease$ ulcer is suppressed by concomitant treatment with low-dose @Chemical$.	0
We present a case of catastrophic early drug eluting stents @Disease$ in a 79-year-old Italian woman with @Chemical$ hypersensitivity.	0
@Disease$: Effect of perioperative @Chemical$ and clonidine on AKI.	1
Presented in the article are the results of studying antiaggregate activity of acetylsalicylic acid and @Chemical$ in a total of 36 patients suffering from various-severity chronic arterial insufficiency of lower limbs on the background of @Disease$ obliterans.	0
The aim of the study was to assess the tolerability of triflusal in patients with @Chemical$-exacerbated respiratory disease (@Disease$).	0
"A case of @Disease$, limited to the middle turbinate and associated with Widal triad (sinus-nasal polyposis, asthma, @Chemical$ intolerance), is described."	0
There was a non-significant trend for a lower intracranial @Disease$ risk on @Chemical$ versus VKA (relative risk=0.65; 95% CI: 0.40-1.06; p=0.09).	0
"The use of @Chemical$, aspirin plus extended-release dipyridamole, or clopidogrel is recommended as initial therapy in patients with noncardioembolic ischaemic stroke or TIA to reduce the risk of recurrent @Disease$ and other cardiovascular events."	0
There was also a suggestion that men who regularly used @Chemical$ had an increased risk of @Disease$.	1
The possible additive antiplatelet effects of aspirin and clopidogrel have been explored in the @Chemical$ in Unstable Angina to Prevent Recurrent Events (CURE) and Management of @Disease$ with Clopidogrel in High Risk Patients (MATCH) studies.	0
The aim of this study was to investigate the association between @Chemical$-induced @Disease$ and the expression of vascular endothelial growth factor (VEGF) and cell apoptosis in elderly Chinese patients.	1
All patients with aspirin exacerbated respiratory disease (@Disease$) can be desensitized to @Chemical$.	0
"The results of the CHARISMA trial support this recommendation; despite previous data demonstrating a favourable benefit-risk profile of aspirin plus @Chemical$ in patients with acute coronary syndrome, this combination should not be used in patients at high risk for atherothrombosis and those with previous stroke or @Disease$."	0
A 57-year-old man who had hypertension and had been on dual antiplatelet therapy with aspirin and @Chemical$ for primary prevention presented with the sudden onset of @Disease$ and monoplegia of the left lower extremity.	0
Low-dose ibuprofen is as effective as @Chemical$ and paracetamol for the indications normally treated with over-the-counter (OTC) medications and is associated with the lowest risk of @Disease$ of any non-steroidal anti-inflammatory drug.	0
"Regular aspirin and non-@Chemical$ analgesic use and the presence of other risk factors for hypertension were assessed by questionnaire at baseline, and the incidence of @Disease$ was assessed using biennial follow-up questionnaires."	0
@Chemical$s included non-coronary artery bypass graft-related Thrombolysis In Myocardial Infarction major and minor @Disease$.	0
"No significant differences in mean perioperative @Disease$ were seen between the @Chemical$-continuing group (mean=553.9 milliliters, 95% CI=468.0; 639.9; I2=83.4%; 170 patients) and the aspirin-discontinuing group (mean=538.7 milliliters, 95% CI=427.6; 649.8; I2=985.5%; 200 patients); (P-interaction=0.96)."	0
"However, regular @Chemical$ use 10 years prior was associated with a small but statistically significant increase in the risk of incident late and neovascular @Disease$."	1
"BACKGROUND: This study compares clinical outcomes in patients with @Disease$, taking preinjury antiplatelet drugs (aspirin, @Chemical$) and anticoagulants (warfarin)."	0
"The pooled HR for an @Disease$ in AD patients using @Chemical$ is 7.63 (95% CI, 0.72 to 81.00; P=0.09)."	0
@Disease$: Does @Chemical$ increase the risk of major bleeds?	0
CONCLUSION: This study did not find more @Disease$ than in previous neurointerventional reports using @Chemical$ with aspirin + ticagrelor or aspirin + clopidogrel.	0
"Although knowledge about endoscopic characteristics of @Chemical$ associated ulcers is limited, the ulcers have common distinctive feature that sudden gastrointestinal bleedings or latently advanced-anemia are often the earliest symptom because aspirin-induced @Disease$ often exist without symptoms of dyspepsia."	0
"The risk of major GI @Disease$ increased with low doses of @Chemical$ alone (OR, 1.55; 95% CI, 1.27-1.90), compared with inert control reagents."	0
"Type 2 inflammation characterizes aspirin-exacerbated @Disease$.Objectives: To determine whether high-dose aspirin therapy changes biomarkers of type 2 inflammation in @Chemical$-exacerbated respiratory disease.Methods: Forty-two subjects with aspirin-exacerbated respiratory disease underwent an aspirin desensitization and were placed on high-dose aspirin (1,300 mg daily)."	0
Gastric @Disease$ induced by @Chemical$ were significantly inhibited by treatment with rolipram.	1
[Acute @Disease$ in a patient treated with @Chemical$ who took aspirin as self-medication].	0
It should be used for @Disease$ patients who do not respond to topical cortico@Chemical$ and leukotriene modifier drugs.	0
@Chemical$ reversed protective and @Disease$ effect of NaHS but PAG failed to affect CORM-2-induced gastroprotection.	0
"METHODOLOGY: This review is based on a detailed review of randomized studies, case-control and cohort studies which aim to study the GI @Disease$ of low-dose @Chemical$."	0
"ASA fitness grade, @Disease$, previous history of angina pectoris, angioplasty, diabetes, use of @Chemical$ antagonists, cirrhosis and type of hepatectomy were significantly different between the groups."	0
"The pathogenesis of @Chemical$-induced @Disease$ (AIU) is not fully understood, but appears to involve mast cell activation and neutrophil infiltration."	1
"AZD6140 (100 and 200 mg bid, 400 mg qd) rapidly and nearly completely inhibited @Chemical$-induced @Disease$ after initial dosing (day 1) and at day 28."	1
MEASUREMENTS: Incident @Disease$ and UC between 1990 and 2008 (outcome) and NSAID and @Chemical$ use (exposure).	0
Co-ingestion of @Chemical$ and acetaminophen promoting fulminant @Disease$: A critical review of Reye syndrome in the current perspective at the dawn of the 21st century.	0
"A randomized, double-blind, placebo-controlled study of rebamipide for @Disease$ taking @Chemical$ with or without clopidogrel."	0
"CONCLUSIONS: In patients with @Disease$ taking low-dose aspirin, the use of @Chemical$ or naproxen plus lansoprazole resulted in similar rates of gastroduodenal ulceration."	0
"Long-term introduction of the complex at doses of 250 and 500 mg/kg was safe for @Disease$, while @Chemical$ at the dose of 50 mg/kg showed a strong gastric mucosal damage."	0
BACKGROUND: Aspirin (@Chemical$)-exacerbated respiratory disease (AERD) is characterized by aggressive @Disease$ of the respiratory tract and often requires topical and/or systemic corticosteroids to maintain partial control of this disease.	0
"METHODS AND MATERIALS: We compared the effect of NO-@Chemical$ and ASA on gastric lesions provoked by water-immersion and restraint stress (@Disease$), ischemia-reperfusion, and 100% ethanol."	0
We conclude that melatonin and its precursor tryptophan given orally significantly reduce @Disease$ induced by ASA possibly due to (a) direct gastroprotective action of exogenous melatonin or that generated from tryptophan and (b) gastrin released from the gastric mucosa by @Chemical$ or tryptophan.	0
"Nonetheless, @Chemical$'s effectiveness in such disease prevention is limited by the risk of upper and lower gastrointestinal (GI) complications such as @Disease$ation, hemorrhage and perforation."	0
"BACKGROUND: Recent data from Western countries indicate that the aetiology of @Disease$ (PUD) is changing as the prevalence of Helicobacter pylori is decreasing while the use of low-dose @Chemical$ (LDA, &lt;=325 mg/day) is increasing."	0
@Chemical$ was safe for treating @Disease$ in patients with AERD.	0
"PATIENTS AND METHODS: Patients with @Disease$ (n = 13), patients with ASA-tolerant asthma (@Chemical$) (n = 12) and healthy volunteers as controls (n = 13) were included to the study."	0
"The resumption of clopidogrel combined with @Chemical$ use (RR 26.71, 95%CI 7.09-100.53), and increased @Disease$ size (RR 1.52, 95%CI 1.14-2.02), were significantly associated with post-ESD bleeding."	0
"INTRODUCTION: @Chemical$ ingestion may cause serious gastrointestinal toxicity, in @Disease$ or perforated peptic ulcer."	1
@Disease$ as possible complication of aspirin treatment in patient with @Chemical$-exacerbated respiratory disease.	0
"No patients on interrupted AC without bridging (n = 26, 13 with warfarin, 13 with DO@Chemical$) developed a @Disease$."	0
Functional variability of the adenosine A3 receptor (ADORA3) gene polymorphism in @Chemical$-induced @Disease$.	1
"The prevalence of @Disease$ or erosion during chronic use of LDA, LDA and the anti-platelet drug thienopyridine (@Chemical$ or ticlopidine), and NSAIDs were 64.3%, 80.0%, and 75.0%, respectively."	0
@Chemical$-induced asthma (AIA) and aspirin-induced @Disease$/ angioedema (AIU) are two major aspirin-related allergies.	0
"The possible toxic synergism with aspirin and acetaminophen, however, is not previously described; though case reports suggest such co-@Disease$ with low levels of @Chemical$ and other compounds can exist."	0
Does enteric-coated @Chemical$ result in a lower incidence of @Disease$ compared to normal aspirin?	0
BACKGROUND: Chronic rhinosinusitis (@Chemical$) is a common disorder associated with other respiratory tract diseases such as asthma and inhalant @Disease$.	0
Effect of atorvastatin and pravastatin on platelet inhibition by @Chemical$ and clopidogrel treatment in patients with coronary stent @Disease$.	0
This article summarizes the current knowledge in the field of clinical presentation and diagnosis of @Chemical$-exacerbated respiratory disease (@Disease$).	0
We aimed to determine urinary metabolites of both histamine and @Chemical$ (LTs) in patients affected by chronic @Disease$ (CU).	0
"OBJECTIVES: Many elderly patients are prescribed both low-dose @Chemical$ (ASA), for cardiovascular protection and non-steroidal anti-inflammatory drugs (NSAIDs) for @Disease$ control."	0
"Key Messages: This double-blind, placebo-controlled study found that LG may be useful in reducing @Chemical$-induced @Disease$ and in mitigating gastrointestinal symptoms."	1
METHODS: Patients taking 100 mg of enteric-coated @Chemical$ for cardiovascular diseases and with a peptic ulcer or @Disease$ bleeding and patients who also participated in endoscopic surveillance were studied.	0
"In the study, 100 patients with low on-treatment platelet aggregation and at high risk of @Disease$ and low risk of cardiovascular events, were switched to @Chemical$ (40 mg/d) and their platelet aggregation was measured again 7 days later.Their bleeding and upper gastrointestinal symptoms were also recorded in following 3 months."	0
"BACKGROUND AND PURPOSE: @Chemical$ early after intravenous thrombolysis in acute ischemic stroke increases the risk of symptomatic @Disease$ (SICH), without influencing functional outcome at 3 months."	1
"In this setting, @Chemical$ triggers @Disease$ through a well-established non-immunological mechanism involving the inhibition of cyclooxygenase type I."	0
"CONCLUSIONS: @Chemical$ has not only the healing effect for NSAIDs-induced @Disease$ compared with placebo, but the improvement of nutritional condition."	0
OBJECTIVES: The aim of this study was to determine whether @Chemical$ @Disease$ (HF) hospitalization or death in patients with HF with reduced ejection fraction receiving an angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB).	1
"METHODS: Gastric ulcers were induced by the serosal application of 100% @Chemical$, and the areas of the @Disease$s were measured thereafter."	0
"Use of paracetamol, @Chemical$ or aspirin in pregnancy and risk of @Disease$ in the child."	0
"DATA SOURCES: Articles evaluating aspirin for primary prevention of CVD were gathered using a MEDLINE search with the keywords aspirin review, aspirin peripheral artery disease, aspirin stroke, aspirin coronary artery disease, aspirin @Disease$, @Chemical$ primary prophylaxis, and aspirin elderly."	0
"In haplotype analysis, the HLA-DRB1(*)1302-DQB1(*)0609-DPB1(*)0201 was significantly higher in the aspirin-induced @Disease$ (8.0%) than in the @Chemical$-intolerant asthma (0.7%, P=0.0014) and normal controls (2.0%, P=0.0006)."	0
"The odds ratio (OR) of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) was 0.85 (95%CI: 0.75-0.97, p=0.02), The ORs of @Disease$ (FL) and large B-cell lymphoma (DLBCL) in individuals exposed to @Chemical$ were 1.12 (95%CI: 0.86-1.45, p=0.37) and 1.03 (95%CI: 0.9-1.19, p=0.6) respectively."	0
"In the Coumadin and @Chemical$ studies 100% of the randomized patients had an unprovoked @Disease$, while in the DOAC studies between 73.5% and 93.2% of the VTE events were unprovoked."	0
"To determine the prevalence of use of preventive strategies to reduce @Disease$ complications in NSAID and/or @Chemical$ users in primary care in Spain, we performed an observational, cross-sectional, multicentre study in which primary care physicians from Spain participated."	0
"METHODS: Twenty-four @Chemical$-sensitive patients with @Disease$ and 18 aspirin-tolerant asthmatic patients were studied, and eicosanoids released from PBLs were assessed by means of enzyme immunoassays."	0
"The factors associated with an increased risk of upper gastrointestinal (GI) complications in subjects taking @Chemical$ are aspirin dose, history of ulcer or upper GI @Disease$, age &gt; 70 years, concomitant use of non-aspirin NSAIDs including COX-2-selective NSAIDs, and Helicobacter pylori (H. pylori) infection."	0
Subjects with aspirin-intolerant @Disease$ were distinguished by a sharp increase in the level of prostaglandin D(2) and E(2) metabolites; their 5- and 15-hydroxyeicosateraenoic acid levels were also higher than in @Chemical$-tolerant subjects.	0
The blocking effect of essential controller medications during aspirin challenges in patients with @Chemical$-exacerbated @Disease$.	0
We report a rare case of a 79-year-old male treated with @Chemical$ and acetylsalicylic acid after coronary angioplasty and stenting to treat @Disease$.	0
Post-PCI fatal @Disease$ in @Chemical$ and clopidogrel hyper responder: shifting from antiplatelet resistance to bleeding risk assessment?	1
Our findings provide further evidence that polymorphisms in PTGER3 might play a significant role in @Chemical$ @Disease$ among Korean asthmatics.	1
"Despite more than a half-century of recognition, the triad characterised by severe asthma, nasal polyposis and @Chemical$ intolerance known as aspirin-induced @Disease$ or Widal's triad remains markedly underdiagnosed and mistreated."	0
These results support the opinion that @Chemical$ @Disease$ has the different pathogenic mechanism from aspirin asthma.	1
"METHODS: AIAU patients (n=167), @Chemical$-intolerant chronic @Disease$ (AICU) patients (n=149), and healthy controls (NC) (n=265) were included."	0
"METHODS: Ninety-four aspirin-induced urticaria patients presenting urticaria/@Disease$-induced by both ASA and NSAID (50 had underlying chronic urticaria) and showing positive responses on oral aspirin challenge test, 76 aspirin-intolerant asthmatics with positive responses on lysine-@Chemical$ bronchoprovocation test, and 185 normal healthy controls were enrolled."	0
Patients were excluded if they were treated with multiple agents or experienced @Disease$ before the initiation of @Chemical$.	0
"Because of the potential interaction between proton pump inhibitors (PPI) and clopidogrel that compromises the efficacy of @Chemical$ on @Disease$, there has been a warning in the product information by health authorities in the US and in Europe who discourage the concomitant use of PPI and clopidogrel."	0
Moreover some patients with imperative cardiologic indications for combination therapy with aspirin and @Chemical$ (stent placement and/or acute coronary syndrome) have a history of @Disease$ to aspirin.	0
"Of 509 participants (56.0% women, 42.0 +- 11.8 years [mean +- SD]), 45.2% reported @Chemical$ intake (41.3 +- 10.9 years, 59.6% women, @Disease$ days at t0: 2.8 +- 3.1 d/mo, t2: 3.6 +- 4.1 d/mo), 11.8% ASA++ intake (46.0 +- 9.8 years, 73.3%, t0: 4.8 +- 6.1 d/mo, t2: 5.3 +- 5.1 d/mo), and 43.0% no analgesics (41.6 +- 13.1 years, 47.5%, t0: 3.8 +- 6.2 d/mo, t2: 5.3 +- 6.6 d/mo)."	0
"In addition, TIMI defined minor bleeding was significantly higher with a high dose of @Chemical$ whereas the results for the major @Disease$ outcomes were not statistically significant."	0
Clinical approach on challenge and desensitization procedures with @Chemical$ in patients with ischemic heart disease and nonsteroidal anti-inflammatory drug @Disease$.	0
OBJECTIVE: Spontaneous spinal epidural @Disease$ (SEH) has not been reported under anti-thrombotic therapy with @Chemical$ (ASA) in a dosage of 50 mg/d.	0
BACKGROUND: Dual antiplatelet therapy (@Chemical$) associating aspirin + clopidogrel is commonly utilized in @Disease$ interventions despite unpredictable clopidogrel efficacy with 4% to 50% of patients considered nonresponders.	0
The safety and efficacy of @Chemical$ and clopidogrel as a combination treatment in patients with @Disease$.	0
We hypothesized that lyophilized @Chemical$/trehalose could decrease the severity of aspirin-induced @Disease$.	0
"METHODS: Thirty genome-wide expression microarrays were used to compare nasal polyp tissue from patients with chronic rhinosinusitis alone (@Disease$, n = 10) or chronic rhinosinusitis and a history of aspirin-sensitive asthma (@Chemical$, n = 10) to normal sinonasal mucosa from patients who underwent surgery for non-sinus related conditions (controls, n = 10)."	0
"Co-therapy with non-steroidal anti-inflammatory drugs, @Chemical$ or warfarin increases the risk of @Disease$, while co-therapy with proton pump inhibitors reduces it."	0
"A polymorphism study that examined nine single-nucleotide polymorphisms of five leukotriene-related genes [ALOX5 (encoding 5-lipoxygenase), ALOX5AP (5-lipoxygenase-activating protein), PTGS2 (cyclooxygenase 2), LTC4S (leukotriene C4 synthase), and CYSLTR1 (cysteinyl leukotriene receptor 1)] found that promoter polymorphisms of ALOX5 (-1708A&gt;G) and CYSLTR1 (-634C&gt;T) were significantly different between aspirin-intolerant asthma and @Chemical$-induced @Disease$/angioedema, suggesting different contributions to the lipoxygenase pathway."	1
@Disease$ caused by chewing @Chemical$.	1
@Chemical$ is an ADP receptor antagonist and in combination with aspirin widely used in patients with atherosclerotic vascular disease to reduce the incidence of @Disease$ events.	0
"Use of aspirin, non-steroidal anti-inflammatory drugs, and acetaminophen (@Chemical$), and risk of psoriasis and @Disease$: a cohort study."	0
"Sixty-three subjects without known @Chemical$ sensitivity (13 controls, 17 nasal @Disease$ alone, 15 nasal polyps and asthma and 18 asthma alone) inhaled increasing concentrations of nebulized lysine aspirin."	0
Effect of misoprostol on patients with @Chemical$-exacerbated @Disease$ undergoing aspirin challenge and desensitization.	0
"Today, the presence of H. pylori @Disease$ associated with low dose @Chemical$ and/or NSAID use in the same patient is becoming more frequent and therefore the potential interaction between these factors and the consequences of it has important implications."	1
"@Chemical$ is commonly used for many years as pain relief drug, anti-inflammatory and against temperature, as well as antiaggregatory agent in @Disease$ therapy."	0
"Regular aspirin and non-@Chemical$ analgesic use and the presence of other risk factors for @Disease$ were assessed by questionnaire at baseline, and the incidence of hypertension was assessed using biennial follow-up questionnaires."	0
"In other patients, symptoms of @Chemical$ hypersensitivity may develop in the days after stenting, at which time discontinuation of aspirin carries a risk of catastrophic stent @Disease$."	0
"However, at multivariate analysis, an impaired metabolic status, with higher levels of glycosylated hemoglobin and low-density lipoprotein (LDL) cholesterol, but not diabetic status, emerged as independent predictors of HRPR with @Chemical$ [OR (95% CI)=2.1 (1.32-3.33), p=0.002 and OR (95% CI)=1.03 (1.01-1.05), p=0.003, respectively], with a stronger linear relationship between ADP-mediated @Disease$ and glycosylated hemoglobin levels (r=0.24, p=0.002), than for LDL-cholesterol (r=0.13, p=0.09)."	0
OBJECTIVE: This study aimed to assess sinonasal outcomes in patients with aspirin exacerbated respiratory disease (@Disease$) undergoing @Chemical$ desensitization following endoscopic sinus surgery (ESS).	0
CONCLUSIONS: Anatomic sites and predictors of @Disease$ are similar for @Chemical$ and aspirin in these patients.	0
"Factors associated with an increased risk of upper GI complications during low-dose @Chemical$ therapy include aspirin dose, history of ulcer or upper GI @Disease$, age &gt; 70 years, concomitant use of NSAIDs (including COX-2-selective NSAIDs), and Helicobacter pylori infection."	0
"CONCLUSIONS: In a randomized controlled trial of users of low-dose @Chemical$ at risk for recurrent GI bleeding, a slightly lower proportion of patients receiving a PPI along with aspirin developed recurrent @Disease$ or ulcer than of patients receiving an H2RA with the aspirin, although this difference was not statistically significant."	0
"Aspirin use (odds ratio, 2.14; 95% confidence interval [CI], 1.02-4.73; P = .04) and a long duration (&gt;=10 years) of @Chemical$ use (odds ratio, 3.75; 95% CI, 1.31-10.86; P = .01) were significantly associated with deep or infratentorial microbleeds in the crude analysis, but this became nonsignificant after adjustment for @Disease$ and other confounding factors."	0
Aspirin and the older nonsteroidal anti-inflammatory drugs (NSAIDs) that block cyclo-oxygenase-1 (COX-1) induce asthma attacks in patients with @Chemical$-exacerbated respiratory disease and @Disease$ in patients with chronic idiopathic urticaria.	0
"Aspirin-exacerbated diseases are important examples of drug hypersensitivities and include aspirin-exacerbated respiratory disease (AERD), aspirin- or non-steroidal anti-inflammatory drug (NSAID)-induced urticaria/@Disease$, and @Chemical$- or NSAID-induced anaphylaxis."	0
@Chemical$ was restarted 1 month later; there was no recurrence of @Disease$.	0
"EVIDENCE ACQUISITION: Published articles were identified through a search of MEDLINE and the Cochrane databases using the dates 1966 to June 2004 and the search terms @Chemical$ allergy, @Disease$, aspirin desensitization, and aspirin sensitivity."	0
"BACKGROUND: @Chemical$-exacerbated @Disease$ (AERD) is a disorder of nasal polyposis, asthma, and hypersensitivity respiratory reactions when on systemic cyclooxygenase 1 blockade."	1
This study shows that @Chemical$ resistance is prevalent within the Australian ischaemic @Disease$ population.	0
Helicobacter pylori @Disease$ and the risk of gastro-duodenal damage in symptomatic elderly chronic low-dose @Chemical$ users: effect of antisecretory drugs.	0
Enzyme up-regulation was monitored after in vitro stimulation with @Chemical$ (LPS) and/or aspirin in 19 aspirin-intolerant (AI) patients (8 aspirin-sensitive asthmatics and 11 @Disease$ patients) and 14 healthy controls.	0
Blood @Disease$: 5.6 +/- 0.4% (PP-- 4.6 +/- 0.5; A-- 6.2 +/- 0.9; @Chemical$-- 7.2 +/- 0.9% and PP/ASA-- p = 0.019; PP/A+ASA-- p = 0.03).	0
Mechanisms of @Chemical$-intolerant asthma: identifying inflammatory pathways in the pathogenesis of @Disease$.	0
CONCLUSIONS: Continued @Chemical$ therapy in patients undergoing dental osteotomies has no effect on the incidence of @Disease$ and should not be interrupted.	0
"We measured GPX activity in platelets, peripheral blood lymphocytes (PBL), red blood cells (RBC) and plasma from 13 patients with @Chemical$-induced @Disease$ (AIA)."	1
"Patients with in-hospital @Disease$ were less likely to be discharged on @Chemical$ or thienopyridine (adjusted odds ratio=0.45; 95% CI, 0.31 to 0.64; and odds ratio=0.62; 95% CI, 0.42 to 0.91, respectively)."	0
CONCLUSION AND SIGNIFICANCE: Hypertonic sea @Chemical$ should be recommended douching solution in the early postoperative care of patients with aspirin-induced @Disease$.	0
"PATIENTS: Helicobacter pylori-negative patients taking daily low-dose ASA (75-325 mg), who fulfilled one or more of the following criteria: age &gt;=18 years with history of uncomplicated peptic ulcer; age &gt;=60 years with either stable coronary artery disease, @Disease$ and five or more gastric/duodenal erosions, or low-dose @Chemical$ treatment initiated within 1 month of randomisation; or age &gt;=65 years."	0
DISCUSSION: @Chemical$-induced @Disease$ is a challenging issue.	1
@Chemical$-exacerbated @Disease$: burden of disease.	1
"Factors associated with an increased risk of @Chemical$-related upper GI complications are still being elucidated but most importantly include a prior history of ulcer or GI @Disease$, aspirin dose, and concomitant use with an NSAID, anticoagulant, or additional antiplatelet drug."	0
"@Chemical$ is the most widely used, and in combination with acetylsalicylic acid it is the standard of care for @Disease$ and percutaneous coronary interventions."	0
"The investigated compounds provide equivalent @Disease$ to ligand structures for @Chemical$, glycine, NMDA and nicotinic receptors."	0
Measurement of shear-activated platelet aggregate formation in non-anticoagulated blood: utility in detection of clopidogrel-@Chemical$-induced @Disease$.	1
"It is very important to prevent @Chemical$-induced gastroduodenal ulcer complications including bleeding, and every effort should be exercised to prevent the @Disease$ complications."	0
"By multivariable analysis, the only significant independent risk factor for @Disease$ was failure to increase @Chemical$ dose after initial unresponsiveness (P &lt; .001)."	0
"Medical management of @Disease$, @Chemical$ sensitivity, gastroesophageal reflux, immune deficiencies."	0
"We compared GI hospitalization rates among elderly patients taking celecoxib, NS-NSAIDs, celecoxib and @Chemical$ or @Disease$ and ASA."	0
"Logistic regression indicated that the frequency of the rare alleles of -262 A&gt;T and -115 T&gt;C was higher in subjects with @Chemical$ than in subjects with aspirin-tolerant @Disease$ (ATA) (P=0.003-0.01, P( corr)=0.015-0.05)."	0
The risk of @Disease$ with @Chemical$ may increase with simultaneous use of APs.	1
"Conclusion Our findings support the safety of antithrombotic therapy with aspirin and/or @Chemical$ during pregnancy in high-risk women with APS, and highlight the need for better treatments to improve pregnancy outcomes in @Disease$."	0
"We investigated whether aspirin with @Chemical$ (ASA++) increases headache frequency compared with aspirin alone in migraine, tension-type @Disease$ (TTH), and migraine + TTH (MigTTH)."	0
"METHODS: TBXA2R gene polymorphisms (TBXA2R+795T&gt;C, TBXA2R+924T&gt;C) were determined using a single-base extension method in 93 @Disease$ patients compared with 172 patients with @Chemical$-tolerant asthma (ATA) and 118 normal controls (NCs) recruited from the Korean population."	0
METHODS: ASA-dipyridamole (25/200 mg) once daily together with ASA (81 mg) daily was started in 130 patients given the diagnosis of @Disease$/TIA with instructions to increase @Chemical$-dipyridamole to twice daily after 7 days and discontinue ASA (81 mg).	0
"A worldwide use of @Chemical$ is now accepted due to its remarkable analgesic, antipyretic and anti-thrombotic prophylactics against myocardial infarct and coronary disorders despite the fact that the use of NSAIDs is associated with the risk of gastrointestinal bleedings, haemorrhagic lesions and @Disease$."	0
"However, celecoxib/aspirin was associated with a significantly higher incidence of @Disease$ and duodenal ulcers than @Chemical$ alone."	0
Lipoxins and @Chemical$ are important mediators of mucosal defence in the stomach (and elsewhere in the gastrointestinal tract) and represent attractive therapeutic targets for reducing the incidence of @Disease$.	0
"OBJECTIVES: Aspirin may be involved in microscopic @Disease$ (MC) development, but there are no data on colon histology in asymptomatic @Chemical$ users."	0
"Significant heterogeneity was present for the NSAIDs; e.g., @Chemical$ was associated with an increased overall fracture risk (OR = 2.09, 95% CI 2.00-2.18 for &lt;20 @Disease$), while celecoxib was not (OR = 0.76, 95% CI 0.51-1.13 for &lt;20 DDD, 2P &lt; 0.01 for comparison)."	0
Perioperative @Disease$ and combined clopidogrel and @Chemical$ therapy.	0
Combination of low-dose @Chemical$ and thienopyridine exacerbates small @Disease$.	1
This is a case of a 60-year-old gentleman who presented with an extensive cutaneous vasculitic rash (leukocytoclastic) with @Disease$ following a small dose of @Chemical$ (81 mg).	0
AIM: This study aimed to identify prognostic factors of @Chemical$-exacerbated @Disease$ by comparing clinical and genetic data with the clinical course.	0
"The primary outcome measure was @Disease$ events in @Chemical$ users versus nonusers, whereas secondary outcome measures were postoperative cardiovascular events, hematological findings, morbidity, and mortality."	0
"Although leukotriene @Chemical$1-receptor antagonists improve lower airway outcomes in @Disease$, their effects and dose-response in the upper airway is less well documented."	0
Safety risks for patients with @Chemical$-exacerbated @Disease$ after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2 inhibitors: Meta-analysis of controlled clinical trials.	0
The Framingham Heart Study records of participants with atrial fibrillation (AF) during 1980 and 1994 were retrospectively reviewed to determine the prevalence of warfarin and @Chemical$ use in @Disease$.	0
"Dual antiplatelet therapy (DAPT) with acetylsalicylic acid and a P2Y12 inhibitor (@Chemical$, ticagrelor, or prasugrel) reduces @Disease$ events in patients with acute coronary syndrome (ACS), but it is also associated with an increased risk of bleeding complications."	0
CONCLUSIONS: Anatomic sites and predictors of @Disease$ are similar for apixaban and @Chemical$ in these patients.	1
Poor control of @Disease$ with interleukin-5 inhibitors in four patients with @Chemical$-exacerbated respiratory disease.	0
"Recent evidence showed that among patients with a history of ASA-associated ulcer bleeding, the long-term incidence of recurrent @Disease$ with @Chemical$ use is low after eradication of H. pylori alone."	1
Low @Disease$ risk patients (CHADS2 VASc 0-2) are often treated long-term with @Chemical$ after catheter ablation.	0
"BACKGROUND AND AIMS: We investigated the incidence of @Disease$ in the esophagus, stomach and duodenum in patients on low-dose aspirin (@Chemical$) therapy."	0
Here we describe a patient presenting with stupor and @Disease$ after @Chemical$ intake at 35 weeks of gestation.	1
"RESULTS: Area of @Disease$ in animals with @Chemical$ dose of 100 mg/kg/day showed a 36.5% increase compared with controls, although it failed to achieve statistical significance (p = 0.812)."	0
"Further research is needed to assess the benefit-risk ratio of clopidogrel plus aspirin in specific subpopulations of patients at high risk for atherothrombotic events, and to determine the role of clopidogrel plus @Chemical$ in preventing cardioembolic stroke or early recurrent @Disease$ after symptomatic large-vessel atherostenosis."	0
"Studies, review articles, and commentaries on aspirin-induced asthma and @Chemical$- or NSAID-induced urticaria/@Disease$ were included in the review."	1
BACKGROUND: Concomitant @Chemical$ use is a risk factor for nonsteroidal anti-inflammatory drug (NSAID)-associated @Disease$.	1
"CONCLUSION: In Japanese patients taking @Chemical$, EE was not as common as peptic @Disease$."	0
AIM: To assess the impact of prophylactic @Chemical$ with background dual anti-platelet therapy on patient-reported symptoms of @Disease$ compared to placebo.	0
Racial and Ethnic Differences in the Relationship between @Chemical$ Use and @Disease$ Risk and Survival.	0
AIM: To assess the incidence of @Chemical$ resistance and its association with cardiovascular risk factors (@Disease$) and renal graft function after renal transplantation.	0
High levels of nitric oxide synthase activity are associated with @Disease$ tissue from @Chemical$-sensitive asthmatics.	0
Almost every day I read how important it is for people with @Disease$ to take an @Chemical$.	0
"We evaluated the differences in ACS type, total mortality, and the composite end point of death, @Disease$ (MI), recurrent ischemia, or stroke between prior @Chemical$ and nonprior aspirin users."	0
"We used conditional logistic regression to estimate odds ratios (ORs), with 95 % confidence intervals (CIs), for @Disease$ associated with low-dose @Chemical$ (75-150 mg) or nonaspirin NSAID use, adjusted for potential confounders."	0
AIM: To clarify the gender differences about the clinical features and risk factors of low-dose @Chemical$ (LDA) (81-100 mg daily)-associated peptic @Disease$ in Japanese patients.	0
"RESULTS: Of 9,565 patients with @Disease$, a prior history of @Chemical$ reactions was recorded in 142 patients."	0
"UNLABELLED: Aspirin (@Chemical$) and several other nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit cyclo-oxygenase (COX) enzyme both isoforms 1 and 2, and can precipitate @Disease$tic attacks in aspirin-induced asthmatics."	0
OBJECTIVE: To estimate the @Disease$ risk of combined anticoagulant (rivaroxaban or @Chemical$-vitamin K antagonist [VKA]) and NSAID or aspirin therapy in patients with venous thromboembolism.	0
"METHODS: Genotyping for the 2 polymorphisms was performed in patients hospitalized for @Disease$ associated with the use of low-dose @Chemical$ between September 1998 and October 2000, and race-, age-, and sex-matched controls who were taking low-dose aspirin but had no history of upper GI bleeding."	0
"Presence of @Disease$ was associated with age, female gender, NP duration,  and @Chemical$ hypersensitivity history (p &lt; 0.05), but not with smoking, atopy, NP extension, and positive APT."	0
This study summarizes the relative risk (RR) for serious @Disease$ (UGIC) associated with @Chemical$ exposure in general and with specific aspirin doses and formulations in particular.	0
"Aspirin desensitization, followed by daily @Chemical$ administration, can improve both upper and lower @Disease$ in up to 60% of individuals."	0
"METHOD: From July 2017 to January 2019, 901 patients including 781 (86.7%) male and 120 (13.3%) female patients underwent laparoscopic inguinal @Disease$ repair using trans-abdominal preperitoneal (TAPP) technique were recruited, among whom 152 (16.9%) had been taking low-dose (100 mg per day) @Chemical$ which was continued during hospitalization except the operation day."	0
"In two separate series, platelet aggregation and carrageenan @Disease$-induced inflammatory pain were measured in control, @Chemical$ and ASA-Tris-treated groups."	0
"Overall, the use of VKA was associated with an increased risk of major @Disease$ (OR 1.76 (95% CI 1.33-2.33) when compared to @Chemical$."	0
"Also, women had less @Disease$ (aspirin, 2.4% versus 3.7%; apixaban, 1.4% versus 3.0%), more heart failure, and higher mean CHADS2 (congestive heart failure, hypertension, age of 75 years or older, diabetes [1 point each], stroke or transient ischemic attack [2 points]) scores (@Chemical$, 2.2 versus 2.0; apixaban, 2.1 versus 2.0)."	0
"Clinical presentations of @Chemical$ @Disease$ were respiratory in 76% (n=137), respiratory/cutaneous in 15% (n=27), and systemic in 9% (n=16) of the patients."	1
"Our results indicate that apixaban, dabigatran, @Chemical$, idraparinux and VKAs all reduced @Disease$ recurrence when compared to placebo."	0
The prescription of aspirin (@Chemical$ (ASA)) to patients with a history of @Disease$ to this drug could prove harmful.	0
@Chemical$-exacerbated cutaneous disease (AECD) is a distinct subphenotype of chronic spontaneous @Disease$.	0
"@Chemical$ has a potent inhibitory effect on the activation of cells derived from the site of @Disease$, regardless of sensitivity to aspirin."	0
"BACKGROUND/AIMS: Many patients with aspirin-induced asthma have severe @Chemical$ @Disease$ (AHR), suggesting a relationship between aspirin and methacholine in airway response."	1
METHODS: A retrospective chart review was conducted evaluating ASA desensitization in patients with reported ASA or NSAID @Disease$ and a cardiac indication for @Chemical$.	0
"Patients on prehospital low-dose (81 mg) @Chemical$ therapy were matched with patients exclusive of antiplatelet and anticoagulation therapy using propensity score matching in a 1:1 ratio for age, @Disease$ Scale, head Abbreviated Injury Scale score, Injury Severity Score, and neurological examination."	0
"A @Disease$ was also more likely with the use of @Chemical$ (n = 4/10 vs 10/190, 40% vs 5.3%, P &lt; 0.0001) in combination with aspirin in 12/14 patients."	0
"CONCLUSIONS: Our findings do not support the notion that entericcoated @Chemical$ products confer a lower risk for GI complications than buffered formulations, but may conversely imply that the risk of @Disease$ complications associated with buffered LDA is lower than that of enteric-coated LDA."	0
"Drugs that can lead to @Disease$ include non-steroidal anti-inflammatory drugs (NSAIDs) like diclofenac and @Chemical$, platelet inhibitors such as acetylsalicylic acid (ASS), clopidogrel and prasugrel, as well as anticoagulants like vitamin-K antagonists, heparin or direct oral anticoagulants (DOAKs)."	0
"LDA was more frequently associated with CAS and ischemic symptoms, as well as severe and multivessel @Disease$, suggesting the patients who have received @Chemical$ would require more intensive medical therapies and close follow up."	0
The frequency of @Disease$ was not associated with the duration of @Chemical$ treatment.	0
Upper @Disease$ is a serious complication of @Chemical$ and clopidogrel (dual) anti-platelet therapy with a high morbidity and mortality.	1
"Patients with @Disease$ were more likely than controls to use @Chemical$, OR 2.3 (95% CI, 1.14-4.45)."	0
CONCLUSION: The meta-analysis showed that H2RAs were less effective in the prevention of @Chemical$-related GI bleeding and @Disease$ formation suggesting the preferable usage of PPIs in case of tolerance.	0
[@Chemical$ for @Disease$ in pregnancy.	0
"BACKGROUND AND AIMS: Nitric oxide-releasing aspirin (NO-@Chemical$) has been shown to inhibit cyclo-oxygenase and prostaglandin generation without causing @Disease$, but the role of reactive oxygen species (ROS) and cytokines in the action of ASA and NO-ASA against acute gastric damage has been little studied."	0
"Anticoagulant use increased significantly in the 393 men and women (mean ages 72.5 and 79.0 years, respectively) who developed @Disease$ over the observation period: @Chemical$ use increased from 14% to 39% in men and from 19% to 33% in women, and warfarin use increased from 10% to 39% in men and from 17% to 38% in women."	0
"CONCLUSION: This life-threatening and potentially disabling complication must stress to physicians about the risks of @Chemical$ plus aspirin abuse, drawing their efforts to prevent, to recognize and to control the propensity to self medication of some patients with daily @Disease$s."	0
"Two drugs recently approved for health insurance reimbursement, celecoxib, a cyclooxygenase (COX)-2 specific inhibitor and low-dose @Chemical$ for prevention of recurrent peptic @Disease$ due to LDA/NSAIDs will be instrumental in mitigating the gastrointestinal injuries."	0
BACKGROUND: Xuesaitong dispersible tablet (@Chemical$) product has been clinically proven to be effective for treating @Disease$.	0
Topical and systemic effects of @Chemical$ in the gastrointestinal mucosa are associated with mucosal damage in the upper and lower @Disease$.	0
The potential risk to patients is sufficient to mandate detailed monitoring of @Disease$ risk in ongoing trials and stratify results by whether patients were @Chemical$-naive.	0
Failure of @Chemical$ to prevent aspirin-induced @Disease$.	0
"The most common cause is conditioned to a genetic predisposition towards atopy (atopic @Disease$), although other factors can also give rise to bronchial inflammation, such as over-exposure to environmental irritants (occupational asthma), altered arachidonic acid metabolism (@Chemical$-induced asthma) and also exercise - in which different thermal and osmotic mechanisms are known to intervene."	0
Cases were patients with @Disease$ (CAD) and documented history of @Chemical$ hypersensitivity who underwent rapid successful oral desensitization to aspirin.	0
"RESULTS: In 29 patients with preoperative @Chemical$-induced aggregation &gt;=50%, compared with 23 subjects with aggregation &lt;50%, lower @Disease$ volumes (after 6h, p=0.002; and 12h, p=0.001) and fewer rethoracotomies were observed (p=0.03)."	0
"Since it remains to be determined whether gastroprotective agents should be used routinely in patients without risk factors who are taking @Chemical$, more risk factors for aspirin-related peptic @Disease$ should be detected."	0
AIM/OBJECTIVE: To compare effect of @Disease$ (2.3% NaCl) sea water and isotonic 0.9% @Chemical$ on symptoms and endoscopic findings in those patients in the period of 1 month after endoscopic sinus surgery (ESS).	0
"We sought to assess the performance of existing bleeding risk scores, such as the Hypertension, Abnormal Renal/Liver Function, @Disease$, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/@Chemical$ Concomitantly (HAS-BLED) score or the Outpatient Bleeding Risk Index (OBRI), in patients with heart failure with reduced ejection fraction (HFrEF) in sinus rhythm (SR) treated with warfarin or aspirin."	0
@Chemical$ pretreatment revealed no beneficial effects and resulted in increased postoperative bleeding and requirement for blood product transfusions after coronary artery bypass grafting in patients with @Disease$.	0
"Both naproxen/@Chemical$ and celecoxib/aspirin groups demonstrated a higher incidence of @Disease$ and duodenal ulcers vs. placebo/aspirin (8%; RR: 3.7, 95% CI: 1.8-7.6 and RR: 2.6, 95% CI: 1.2-5.8, respectively)."	1
"CONCLUSION: Among elderly patients receiving cardiovascular protection with @Chemical$ and pain control with anti-inflammatory drugs, celecoxib may be safer with regards to GI toxicity than @Disease$."	0
"Higher CHADS2 scores are associated with increasing rates of bleeding and stroke, but the balance between risks and benefits of apixaban compared with @Chemical$ is favorable irrespective of baseline @Disease$ risk."	0
"Even at the top TTR quartile, @Chemical$ was associated with a higher @Disease$ and ICH risk than dabigatran."	0
@Chemical$ and the risk of @Disease$ following head injury.	0
Effects of DDAVP administrated subcutaneously in dogs with @Chemical$-induced platelet dysfunction and hemostatic impairment due to chronic @Disease$.	0
"Higher CHADS2 scores are associated with increasing rates of @Disease$ and stroke, but the balance between risks and benefits of @Chemical$ compared with aspirin is favorable irrespective of baseline stroke risk."	0
"High-density lipoprotein @Chemical$ (adjusted HR=2.16; 95%CI 1.17-4.00, P=0.014) and age (adjusted HR=1.04; 95%CI 1.01-1.06, P=0.006) were significantly associated with any @Disease$."	0
"METHODS: We compared @Chemical$ and warfarin for HF events (hospitalization, @Disease$, or both) in the 2,305 patients enrolled in the WARCEF (Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction) trial (98.6% on ACE inhibitor or ARB treatment), using conventional Cox models for time to first event (489 events)."	0
"Pooling the results from the fixed-effects model showed that a dose of 15 to 20 mg of rivaroxaban once daily was associated with an increased risk of @Disease$ (2 trials; OR, 3.31 [95% CI, 1.42 to 7.72]) compared with aspirin, while a 10-mg dose of @Chemical$ once daily or a 5-mg dose twice daily (3 trials; OR, 1.43 [95% CI, 0.93 to 2.21]) and a 5-mg dose of apixaban twice daily (1 trial; OR, 0.84 [95% CI, 0.38 to 1.88]) were not."	0
"In the paediatric population, there is some evidence of possible interaction, synergism, and co-@Disease$ of @Chemical$ and acetaminophen."	1
@Chemical$ in combination with ascorbic acid shows significantly fewer @Disease$ and the lowest increase in gastric microbleeding compared with the other tested formulations.	0
A 33-year-old woman had a severe asthma attack with @Disease$ and lost consciousness after oral provocation testing with 15 mg of aspirin and also with 50 mg of @Chemical$.	0
"@Chemical$ exacerbated respiratory disease (@Disease$) is a clinical condition characterized by severe decline in forced expiratory volume in one second (FEV1) following the ingestion of non-steroidal anti-inflammatory drugs (NSAIDs), including aspirin."	0
"In other patients, symptoms of @Chemical$ @Disease$ may develop in the days after stenting, at which time discontinuation of aspirin carries a risk of catastrophic stent thrombosis."	1
A hypothesis has been suggested in which ASA is considered as @Disease$ caused by dysfunction of @Chemical$-producing cells.	0
"AREAS COVERED IN THIS REVIEW: A number of risk factors can be used to determine which patients are more likely to develop @Chemical$-associated GI bleeding, mainly in the upper GI tract; these include a previous GI ulcer, @Disease$, dyspepsia, and concomitant drug therapy with non-steroidal anti-inflammatory drugs (NSAIDs) or clopidogrel."	0
"BACKGROUND: Chronic @Disease$/angioedema is a common phenotype in patients with @Chemical$ sensitivity; however, its genetic mechanism is not understood."	0
"HPR was defined as on-@Chemical$ P2Y12 platelet reaction units &gt;208 as measured by the VerifyNow assay; target vessel failure (TVF) was defined as the composite of all-cause @Disease$, myocardial infarction, or ischemia-driven target vessel revascularization."	0
"Urinary eicosanoids, plasma tryptase and cytokine levels, platelet-leukocyte aggregates, and granulocyte transcripts were assessed.Measurements and Main Results: Eight weeks of high-dose aspirin decreased nasal symptoms and urinary prostaglandin E metabolite (P &lt; 0.05) and increased urinary leukotriene E4 (P &lt; 0.01) levels in subjects with aspirin-exacerbated respiratory disease, but not in those with @Chemical$-tolerant @Disease$."	0
"BACKGROUND: We have reported that in patients with chronic idiopathic @Disease$ (CIU) who reacted adversely to @Chemical$, the frequency of the (-444)C allele of the leukotriene C(4) synthase gene (LTC4S) was higher than in patients who tolerated aspirin well."	1
Risk analysis for @Chemical$ and postoperative intracranial @Disease$--report of 3 cases.	0
"In this distinct clinical syndrome, aspirin and most other non@Chemical$al anti-inflammatory drugs that inhibit cyclooxygenase-1 precipitate rhinitis and @Disease$ attacks."	0
After a @Disease$ that was eventually treated with @Chemical$ Reye's syndrome has to be discussed after exclusion of common causes of hepatic failure.	0
Rebound @Disease$ and the risk of ischemic stroke after discontinuation of @Chemical$ therapy.	0
"In addition, TIMI defined minor @Disease$ was significantly higher with a high dose of @Chemical$ whereas the results for the major bleeding outcomes were not statistically significant."	0
"Data from neurosurgical spine patients is sparse, but @Chemical$ has been identified as an important risk factor in the development of post-operative @Disease$ following intracranial surgery."	1
To report a case of @Disease$-induced recurrent hyphema and secondary glaucoma associated with voluntary chronic acetylsalicylic acid (@Chemical$) use.	0
BACKGROUND &@Chemical$; AIMS: Patients requiring low-dose aspirin along with nonsteroidal anti-inflammatory drugs are at increased risk for @Disease$.	0
Safety of meloxicam in @Chemical$-@Disease$ patients with asthma and/or nasal polyps.	0
OBJECTIVE: The mechanisms of interaction between Helicobacter pylori @Disease$ and low-dose @Chemical$ in the induction of duodenal erosions are not fully understood.	0
"DATA SYNTHESIS: Aspirin-sensitive asthmatics experience a wide variety of symptoms, ranging from @Disease$ to life-threatening bronchospasms, after the ingestion of @Chemical$ or nonsteroidal antiinflammatory drugs (NSAIDs)."	0
"Initial ART indicated @Disease$ in 54 (64%) patients, including 42% of patients without a documented history of @Chemical$ use."	0
BACKGROUND: We previously found differences in the minor allele frequency (MAF) of single-nucleotide polymorphisms (SNPs) in transmembrane protein 196 (TMEM196) between 995 patients with @Chemical$-tolerant asthma (ATA) and 141 asthmatic patients with NSAID-exacerbated @Disease$ (NERD).	0
"CONCLUSIONS: Among STEMI patients treated with a fibrinolytic agent and @Chemical$, use of NSAIDs in the week preceding the incident event was associated with a higher incidence of MI, the composite of @Disease$ and MI as well as the composite of death, MI, severe heart failure and shock at 30 days."	0
Increased total and mite-specific immunoglobulin E in patients with @Chemical$-induced @Disease$ and angioedema.	1
"ASA-Tris did not influence the cyclooxygenase-induced @Disease$ significantly, but the inflammatory pain was reduced as effectively as in the case of equimolar @Chemical$ doses."	0
"BACKGROUND: Aspirin-exacerbated @Disease$ (AERD) is a clinical syndrome characterized by chronic rhinitis, nasal polyps, asthma, and precipitation of asthma and rhinitis attacks after ingestion of @Chemical$ (ASA) and most nonsteroidal anti-inflammatory drugs (NSAIDs)."	0
"However, knowledge on leukotriene B4 (@Chemical$) generation in patients with @Disease$ is insufficient."	0
"BACKGROUND: Many patients requiring permanent pacemaker (PPM) or implantable cardiac defibrillator (ICD) placement are anticoagulated with warfarin, @Chemical$ (ASA), and clopidogrel for a number of @Disease$ risk indications."	0
"However, studies evaluating the prevalence of ASA @Disease$  in patients with NPs using the oral @Chemical$ provocation test (APT) are quite limited."	0
RESULTS: The rare C allele frequency of TBXA2R+795T&gt;C was significantly higher in AIA than in ATA (P=0.03) and the TBXA2R+795T&gt;C polymorphism was also associated with extent of percent fall in forced expiratory volume in 1 s (FEV1) after the inhalation of lysine-@Chemical$ in @Disease$ patients (P=0.009); AIA patients homozygous for the +795 C allele had a greater percent fall of FEV1 compared with individuals with TBXA2R+795 CT or TT genotypes.	0
METHODS: We retrospectively analysed the medical records of 66 patients admitted to our institution from June 2003 to July 2008 who suffered a primary @Disease$ while receiving antiplatelet (@Chemical$ and/or clopidogrel) therapy.	0
"In monocytes, we found no changes in basal or lipopolysaccharide (LPS)-stimulated PGE2 synthesis, but the response to EP4 receptor activation with respect to inhibition of LPS-induced tumor necrosis factor-alpha release was reduced in @Disease$ patients, especially in the presence of @Chemical$ (acetylsalicylic acid)."	0
Acute @Disease$ in an elderly woman taking aspirin and @Chemical$.	0
"The sinus CT results showed that compared with the @Chemical$ @Disease$ group, the asthmatic group had irregular turbinates and a large turbinate,as shown in Figure 1."	1
"BACKGROUND AND AIMS: Nitric oxide-releasing @Chemical$ (NO-ASA) has been shown to inhibit cyclo-oxygenase and prostaglandin generation without causing @Disease$, but the role of reactive oxygen species (ROS) and cytokines in the action of ASA and NO-ASA against acute gastric damage has been little studied."	0
"In aspirin-induced platelet dysfunction dogs (n=5), prolonged @Chemical$ (buccal @Disease$ time) was shortened significantly after DDAVP injection (2.2 +/- 1.2 min, P&lt;0.05)."	0
[The relationship between @Chemical$ resistance and @Disease$ in patients with stable coronary artery disease].	0
RESULTS: Secondary @Chemical$ prophylaxis is effective in reducing the risk of ischaemic events in patients with @Disease$.	0
"BACKGROUND: Aspirin-exacerbated respiratory disease (AERD) is a distinct @Disease$ phenotype of severe asthma with accompanying chronic rhinosinusitis, nasal polyposis, and hypersensitivity to @Chemical$."	0
"Thus, mucosal mast cells, and not eosinophils, were the dominating LTC4S-containing cells in both untreated and treated @Chemical$-tolerant @Disease$."	0
Dual antiplatelet therapy with @Chemical$ and clopidogrel increases the risk of @Disease$ in patients with acute coronary syndrome in whom concomitant treatment with a proton-pump inhibitor (PPI) was less effective owing to the interaction of clopidogrel and PPI with the same hepatic cytochrome P-450.	1
"Over- production of @Chemical$ (CysLTs) and prostaglandin D2 (PGD2) correlate with the pathogenetic features of @Disease$, suggesting the possible involvement of mast cell activation with innate type 2 immune response."	0
@Chemical$ for the prevention of recurrences of @Disease$ complications from long-term low-dose aspirin.	0
Helicobacter pylori-(@Chemical$-) induced ulcers were diagnosed when non-homogeneous @Disease$ material containing granulocytes and cell debris was noted.	0
"Aspirin desensitization in an @Chemical$-sensitive patient with @Disease$ resulted in an increase in IFN-gamma expression by CD4(+) lymphocytes and a decrease in IFN-gamma expression by CD8(+) lymphocytes, the significance of which needs additional investigation."	0
"CONCLUSION: Regular @Chemical$ use is associated with increased risk of incident neovascular AMD, independent of a history of @Disease$ and smoking."	0
"Nonsteroidal anti-inflammatory drugs, @Chemical$, and @Disease$ prophylaxis: an ounce of prevention."	0
"CONCLUSIONS: Patients who experience aspirin-sensitive @Disease$ should be cautious when taking aspirin and NSAIDs, despite treatment with @Chemical$ inhibitors."	0
"BACKGROUND: @Chemical$-exacerbated respiratory disease is characterized by asthma, @Disease$, nasal polyposis, and sensitivity to aspirin and other nonsteroidal anti-inflammatory drugs."	0
[A genetic background of @Disease$ induced by NSAID/@Chemical$].	1
RESULTS: Twenty-one patients with AERD were compared with 19 patients with @Chemical$-tolerant @Disease$ (ATA).	0
Our aim to assess the prevalence of @Disease$ and the effect of @Chemical$ on the gastrointestinal mucosa in asymptomatic subjects taking minidose aspirin (100 to 325 mg per day) for more than 3 months.	0
"Compared with clopidogrel, aspirin increases the risk of GI @Disease$ but not other bleeding; however, 883 patients (95% CI, 357-infinity) would need to be treated with clopidogrel versus @Chemical$ to prevent one major GI bleeding episode annually at a cost of over 1 million dollars."	0
Twenty-seven patients (5.4%) in the placebo group developed a gastric or duodenal @Disease$ during 26 weeks' treatment compared with eight patients (1.6%) in the @Chemical$ group (life-table estimates: 6.2%vs 1.8%; P= 0.0007).	0
"It has been shown that the ratios of @Disease$s located in the body, fundus and cardia are significantly higher in bleeding patients than the ratio of gastroduodenal ulcers in patients taking @Chemical$."	0
"Patients with clinical @Disease$ and those with diabetes and without clinical CHD were 5.88 (P=0.008) and 7.54 (P=0.012) times more likely to utilize @Chemical$, respectively, than patients with only one CHD risk factor of age."	0
"Further research is needed to assess the benefit-risk ratio of @Chemical$ plus aspirin in specific subpopulations of patients at high risk for @Disease$, and to determine the role of clopidogrel plus aspirin in preventing cardioembolic stroke or early recurrent stroke after symptomatic large-vessel atherostenosis."	0
"Both apple @Chemical$ extracts significantly reduced the @Disease$ area, ulcer lesion index and gastric injury score."	0
We evaluated the efficacy of omeprazole and @Chemical$ in preventing recurrent @Disease$/erosions in low-dose aspirin users.	0
"CONCLUSIONS: @Chemical$ and enoxaparin conferred similar @Disease$ risks, and both exhibited less bleeding than patients who received rivaroxaban."	1
Aspirin and @Disease$: discovery of aspirin and @Chemical$.	0
The most recent data show that eradication of H. pylori infection in patients with a previous peptic ulcer bleeding episode who continue to take aspirin reduces the recurrence rate of this complication to levels observed in patients without a history of @Disease$ history who take @Chemical$ for cardiovascular disease.	0
METHODS: The Apixaban versus Acetylsalicylic Acid to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for @Chemical$ Antagonist Treatment (AVERROES) trial randomized 5599 patients with @Disease$ and risk factors to receive either apixaban or aspirin.	0
"CONCLUSIONS: For the treatment of high-risk TIA or minor @Disease$ patients, the clopidogrel-@Chemical$ treatment did not increase the number of CMB than Aspirin alone."	0
"We found no evidence that aspirin or non-@Chemical$ NSAID use conferred risk reductions for @Disease$, regardless of the control series."	0
"CONCLUSIONS: In patients with @Disease$, all combinations of warfarin, @Chemical$, and clopidogrel are associated with increased risk of nonfatal and fatal bleeding."	0
CONCLUSIONS: The elevated numbers of nasal inflammatory leukocytes expressing the CysLT1 receptor in aspirin-sensitive patients with chronic @Disease$ as compared with their non-aspirin-sensitive counterparts and the down-regulation of receptor expression after desensitization to @Chemical$ are probably fundamental in the pathogenesis of aspirin sensitivity and in the mechanism of aspirin desensitization.	0
"Platelet adenosine diphosphate (ADP) receptors may play a role in potentiating platelet activation induced by IgG from patients with immune @Chemical$-induced @Disease$ (HIT), as shown by previous studies using the ADP receptor antagonists AR-C66096 and ticlopidine."	1
OBJECTIVE: To evaluate the expression of vascular cell adhesion molecule 1 (VCAM-1) and intercellular adhesion molecule I (ICAM-1) and their ligands (the integrins lymphocyte function-associated antigen 1 and very late-activation antigen 4 [VLA-4]) in nasal @Disease$ of patients with @Chemical$ hypersensitivity compared with aspirin-tolerant individuals.	0
The use of proton-pump inhibitors (PPIs) decreases the rate of UGI @Disease$ in patients receiving @Chemical$ or clopidogrel.	1
We aimed to determine the relationship between @Chemical$ levels and @Disease$ in minor stroke or transient ischemic attack (TIA) patients receiving antiplatelet therapy.	0
The possible additive antiplatelet effects of @Chemical$ and clopidogrel have been explored in the Clopidogrel in Unstable @Disease$ to Prevent Recurrent Events (CURE) and Management of Atherothrombosis with Clopidogrel in High Risk Patients (MATCH) studies.	0
"BACKGROUND AND AIMS: Nitric oxide-releasing @Chemical$ (NO-ASA) has been shown to inhibit cyclo-oxygenase and prostaglandin generation without causing mucosal damage, but the role of reactive oxygen species (ROS) and cytokines in the action of ASA and NO-ASA against acute @Disease$ has been little studied."	0
@Chemical$ is used mainly to prevent arterial events in patients with @Disease$.	0
Implications of reactive oxygen species and cytokines in gastroprotection against stress-induced @Disease$ by @Chemical$ releasing aspirin.	1
"Major advances in the molecular biology of eicosanoids, exemplified by the cloning of cysteinyl-leukotriene receptors and discovery of a whole family of cyclooxygenase enzymes, offer new insights into mechanisms operating in @Chemical$-induced @Disease$."	1
"A previous history of @Disease$ or GI bleeding are identified risk factors for GI bleeding, but few studies have been conducted on patients treated with low-dose @Chemical$ to confirm this."	0
"METHODS: Using data from the Maryland Non-Small Cell Lung Cancer (@Disease$) Case-Control Study (1,220 cases [404 AA and 816 EA] and 1,634 controls [1,004 EA and 630 AA]), we estimated the adjusted odds ratios (OR) and hazard ratios (HR) with 95% confidence intervals (CI) of the associations between @Chemical$ use and NSCLC risk and survival, respectively."	0
"Hypersensitivity to @Chemical$ and other non steroidal anti-inflammatory drugs (NSAIDs) manifesting in the airways (@Disease$, polyps, asthma) or in the skin (urticaria, angioedema) is the second most frequent untoward allergic reaction to drugs."	1
"In these patients, the CHARISMA trial demonstrated a lack of significant clinical efficacy and an increased risk of @Disease$ with clopidogrel plus @Chemical$ compared with aspirin alone."	0
"CONCLUSIONS: Low-dose @Chemical$ use could reduce the incidences of total cardiovascular events, stroke, nonfatal stroke and transient ischemic attack but increase the risk of @Disease$, the incidence of nonfatal myocardial infarction, death from cardiovascular causes and death from any cause was not affected by low-dose aspirin use."	1
"In patients with @Disease$, as opposed to healthy subjects, @Chemical$ challenge invariably precipitated a clinical reaction, accompanied in most patients by a further rise in plasma levels of PGD(2) metabolite and tryptase."	0
"The authors assessed the prevalence of headaches following extended-release dipyridamole/aspirin combination (DAC), and the efficacy of @Chemical$ in the treatment of these @Disease$."	0
"Type 2 inflammation characterizes aspirin-exacerbated respiratory disease.Objectives: To determine whether high-dose aspirin therapy changes biomarkers of type 2 inflammation in aspirin-exacerbated @Disease$.Methods: Forty-two subjects with @Chemical$-exacerbated respiratory disease underwent an aspirin desensitization and were placed on high-dose aspirin (1,300 mg daily)."	0
"While the expression of the EP4 receptor in eosinophils was unaltered in AERD patients, inhibition of eosinophil chemotaxis by @Chemical$ or the EP4 agonist CAY10598 was less pronounced in @Disease$ patients as compared to healthy control subjects."	0
If such findings are consistent in other work then @Chemical$ may affect the development of @Disease$ in a middle-aged to elderly population.	1
"Gastrointestinal bleeding in patients receiving a combination of aspirin, clopidogrel, and @Chemical$ in acute @Disease$."	0
@Chemical$-resistant platelet aggregation in a cohort of patients with @Disease$.	0
@Disease$ always occurred before their admission and @Chemical$ (n = 12) or acetaminophen (n = 7) was prescribed.	0
"In conclusion, new derivatives of NSAIDs releasing vasoactive gaseous mediators NO or @Chemical$ are associated with fewer @Disease$ effects, suggesting that, in the future, they may be used as a safer alternative in everyday clinical practice and antithrombotic therapy."	0
Linear IgA bullous @Disease$ in a two-year-old child: possible association with @Chemical$.	0
There is evidence that selenium (@Chemical$) nutrition can influence @Disease$ but Se status in AIA patients has not received much attention.	0
"RESULTS: A treatment with aspirin in the human bronchial epithelial cells increased the mRNA expression level of KIF3A compared to that of the untreated control (P &lt;= 0.01), and nasal polyp epithelia from aspirin-intolerant asthma (@Disease$) patients also showed a higher expression of KIF3A protein than @Chemical$-tolerant asthma controls."	0
"DATA SOURCES: Articles evaluating aspirin for primary prevention of CVD were gathered using a MEDLINE search with the keywords aspirin review, aspirin peripheral @Disease$, aspirin stroke, @Chemical$ coronary artery disease, aspirin diabetes, aspirin primary prophylaxis, and aspirin elderly."	0
"For patients treated with dual anti-platelet therapy of @Chemical$ and clopidogrel, PPIs were able to prevent the LDA-associated GI @Disease$ (OR = 0.36; 95%CI: 0.15-0.87) without increasing the risk of major adverse cardiovascular events (MACE) (OR = 1.00; 95%CI: 0.76-1.31)."	0
"The evidence is not sufficient to justify advising long-term @Chemical$ therapy for patients with @Disease$ in general, and for those with heart failure in particular."	0
"INTRODUCTION: Clinical features of @Chemical$-exacerbated respiratory disease (@Disease$) consist of moderate to severe asthma associated with chronic rhinosinusitis (CRS), which are derived from overproduction of cysteinyl leukotrienes along with chronic type 2 mediated inflammation in the upper and lower airway mucosa."	0
"The cumulative incidences of recurrent @Disease$ in the rivaroxaban 20-mg, @Chemical$ 10-mg and aspirin groups were 1.9%, 1.6%, and 5.0%, respectively, whereas the cumulative incidences of major bleeding were 0.7%, 0.4% and 0.5%, respectively."	0
"However, this finding did not impact angiographic late-lumen loss (0.60 +- 0.46 mm @Chemical$ group vs 0.64 +- 0.48 mm control group; P=.30) and binary @Disease$ (9.8% vs 6.8%; P=.99)."	0
Metabolic profile of plasma @Chemical$ in patients with aspirin-intolerant @Disease$.	0
"Analysis of bronchial biopsies and bronchial epithelial cells in culture conducted so far gave conflicting results of expression pattern of these enzymes in healthy subjects and asthmatics patients, with and without @Chemical$ @Disease$."	1
The risk for @Disease$ events with @Chemical$ is at least additive to the risk for these events in those who also are receiving therapy with a nonsteroidal anti-inflammatory drug.	0
BACKGROUND: Few studies have evaluated the effects of @Chemical$ on low-dose aspirin (LDA)-induced @Disease$.	0
"H. pylori infection and low-dose aspirin (@Chemical$) are not only independent causal factors of peptic ulcer and @Disease$, they also have synergistic and additive effects."	1
@Chemical$ desensitization is an option for those with refractory @Disease$ or who require aspirin for other medical conditions.	0
CONCLUSION: Our study confirmed a significantly increased risk of lower gastrointestinal @Disease$ following polypectomy in patients taking @Chemical$.	1
"BACKGROUND: The aim of this study was to detect cysteinyl leukotriene (Cys-LT) receptors in @Chemical$-sensitive nasal polyposis patients, and compare them with @Disease$ and chronic rhinosinusitis patients without aspirin sensitivity."	0
"In comparison to the control, the @Chemical$-sensitive @Disease$ group had a significant increase of VIP-like immunoreactivity in mucosal nerve fibres."	0
"The incidence of @Disease$ was lowest in patients on @Chemical$ (0.32%/y) compared with those on warfarin (0.90%/y), aspirin (0.80%/y), and no therapy (0.53%/y)."	0
"METHODS: House dust mite (HDM) inhalation provocation tests were performed in HDM-sensitive @Disease$tic inpatients without AIA (HDM group; n = 6), and aspirin oral provocation tests were performed in AIA patients (@Chemical$ group; n = 7)."	0
Association analysis of formyl peptide receptor 2 (FPR2) polymorphisms and @Chemical$ exacerbated @Disease$.	0
"After multivariate adjustment for age, sex, current smoking, history of hypertension and @Disease$, and aspirin dose (aspirin-treated patients only), the hazard ratio for ICH in patients with an arterial versus a cardiac source was 0.74 (95% confidence interval, 0.30 to 1.82) for @Chemical$-treated patients and 4.34 (95% confidence interval, 0.35 to 54) for placebo-randomized patients."	0
"However, an increase in @Disease$ due to @Chemical$ is preventing many patients from adhering to this daily regimen."	1
"@Chemical$, also known as fish oil, have been used for @Disease$, coronary heart disease, hypertension, and other conditions."	0
"A second polymorphism study, conducted on histamine-related genes, did not find any significant associations with @Chemical$-induced urticaria/angioedema for the genes HNMT (encoding histamine N-methyltransferase), HRH1 or HRH2 (encoding histamine receptor types 1 and 2 respectively), or the gene encoding high-affinity IgE receptor Ibeta (FcepsilonRIbeta); however, the FcepsilonRIalpha gene promoter polymorphism was significantly associated with aspirin-induced urticaria/@Disease$."	0
"Studies, review articles, and commentaries on aspirin-induced @Disease$ and @Chemical$- or NSAID-induced urticaria/angioedema were included in the review."	0
Acetaminophen in the treatment of @Disease$ associated with @Chemical$-aspirin combination.	1
MAIN OUTCOMES AND MEASURES: Acute @Disease$ was primarily defined as an increase in serum @Chemical$ concentration from the preoperative concentration by either an increase of 0.3 mg/dL or greater (&gt;=26.5 mumol/L) within 48 hours of surgery or an increase of 50% or greater within 7 days of surgery.	0
@Chemical$ use in @Disease$: side effects and clinical outcomes.	0
"In the @Chemical$ and aspirin studies 100% of the randomized patients had an unprovoked @Disease$, while in the DOAC studies between 73.5% and 93.2% of the VTE events were unprovoked."	0
METHODS: We compared the frequency of @Chemical$ therapy discontinuation during the 4 weeks before an @Disease$ cerebral event in patients and the 4 weeks before interview in controls.	0
He had been treated with a single high dose of intravenous immunoglobulin and @Chemical$ orally for @Disease$.	0
"METHODS: This prospective, placebo-controlled trial was conducted in @Disease$ patients randomized (1:1) to receive either standard DAPT (@Chemical$ and clopidogrel) vs TAPT with cilostazol for a minimum of 12 months after PCI with Endeavor zotarolimus-eluting stent (E-ZES)."	0
@Chemical$ and acenocoumadin were significantly associated with total @Disease$ (OR = 3.81 and 4.85 with p = 0.005 and 0.001 respectively).	1
"METHODS: Ancillary analysis of the Apixaban Versus Acetylsalicylic Acid [@Chemical$] to Prevent Stroke in @Disease$ Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment (AVERROES) trial, comparing aspirin and apixaban, focused on sex differences."	0
"Although @Chemical$-clopidogrel combination is more useful for @Disease$ (ACS), the renal safety of this combination had not been established."	0
"As for bleeding complications related to the @Disease$, e.g., melaena and haematochezia, the statistical metrics suggested a stronger association for aspirin than @Chemical$."	0
Bleeding during treatment with @Chemical$ versus apixaban in patients with @Disease$ unsuitable for warfarin: the apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment (AVERROES) trial.	0
"CONCLUSIONS: As endoscopy frequently reveals @Disease$ among low-dose @Chemical$ users, both administration of BA and of enteric-coated aspirin warrant concern for gastroduodenal ulcer."	0
BACKGROUND: @Chemical$ production seems to be dysregulated in patients with @Disease$ to aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs).	0
There were fewer adverse events in the @Chemical$ group than in the placebo group (nine vs 15); four patients in the placebo group were admitted to hospital with @Disease$.	0
"In details, DHI decreased @Disease$ ROS level, increased CAT, @Chemical$-Px and SOD activity, and reduced MDA concentration (P&lt;0.05)."	0
"As patients with @Disease$ also derive greater ischemic benefit from drug-eluting stents, which requires prolonged @Chemical$, our findings suggest that the balance between benefit and risk of this therapeutic approach may be even more favorable in patients with DM than previously considered."	0
"@Chemical$ was more frequently associated with CAS and ischemic symptoms, as well as severe and multivessel @Disease$, suggesting the patients who have received LDA would require more intensive medical therapies and close follow up."	1
The most recent data show that eradication of H. pylori infection in patients with a previous peptic ulcer bleeding episode who continue to take @Chemical$ reduces the recurrence rate of this complication to levels observed in patients without a history of ulcer bleeding history who take aspirin for @Disease$.	0
"METHODS: Two hundred thirty-nine patients with AIU consisting of 120 patients with aspirin intolerant chronic urticaria (AICU) and 119 with @Chemical$-intolerant acute @Disease$ (AIAU), and 524 normal controls were enrolled."	0
During dose-reduced (2-3 times a week) clopidogrel administration @Chemical$-induced @Disease$ was effectively inhibited and neither important bleeding nor stent thrombosis occurred.	1
"MEASUREMENTS AND RESULTS: @Disease$ were seen in 4/198 control patients and 6/198 @Chemical$-only patients [2 vs. 3 %, p = 0.5, OR = 1.52 (0.42-5.46)]."	0
"None of 77 study patients experienced any symptoms or developed @Disease$, change in nasal examination, significant variation in peak expiratory flow rate greater than 20%, or decline in forced expiratory volume in 1 second greater than 15% during @Chemical$ challenge."	0
"INTRODUCTION: Aspirin-exacerbated @Disease$ is defined by the clinical tetrad of @Chemical$ sensitivity, nasal polyps, asthma, and chronic rhinosinusitis."	0
"The estimated @Disease$ was similar between the two groups, aspirin versus no @Chemical$ (median 400 mL vs 400 mL, P = .661), as was the rate of blood transfusion anytime during the index admission (29% vs 26%, P = 0.37) and the postoperative duration of hospital stay (median 7 days vs 6 days, P = .103)."	0
"@Chemical$ alone caused a marked rise of @Disease$ and gastric blood loss, mainly at day 3rd and 7th, but they were significantly reduced at 11th day."	1
"After multivariate adjustment for age, sex, current smoking, history of hypertension and @Disease$, and @Chemical$ dose (aspirin-treated patients only), the hazard ratio for ICH in patients with an arterial versus a cardiac source was 0.74 (95% confidence interval, 0.30 to 1.82) for aspirin-treated patients and 4.34 (95% confidence interval, 0.35 to 54) for placebo-randomized patients."	0
"At the same time showed a significant reduction in the risk of perioperative @Disease$ and improve survival after intervention, which did not occur before the removal of the drug @Chemical$."	0
We report three patients aged 75-80 years observed in the Emergency Room with severe anaemia (requiring transfusion) due to a large @Disease$ while receiving standard prophylaxis against venous thromboembolism (40 mg/day @Chemical$ for 6 days on average).	0
"In conclusion, spontaneous hemarthrosis is a possible complication following @Chemical$-aspirin therapy and is recommended to be evaluated when appropriate clinical symptoms (e.g., @Disease$) present."	0
"In order to minimize the risk for thrombotic complications, since 2007 robotic-assisted laparoscopic radical prostatectomy (RARP) has taken place under continuous @Disease$ with @Chemical$ at our institution."	1
"CONCLUSIONS: The high transcript haplotype ht1 [CG] of the IL18 gene may contribute to the development of acute cutaneous inflammation sensitive to @Chemical$, leading to the clinical presentation of @Disease$."	1
"METHODS: Subjects 18 years or older with osteoarthritis, without gastroduodenal ulcer or erosive @Disease$ at baseline endoscopy, and a cardiovascular indication for prophylaxis low-dose (81 or 325 mg) aspirin were prescribed open-label aspirin and blindly randomized to celecoxib 200 mg/day or naproxen 500 mg twice daily plus @Chemical$ 30 mg once daily."	0
"In prevention of @Chemical$ induced @Disease$ recurrence, H. pylori eradication plus PPI treatment are necessary."	1
A previously healthy 60-year-old man receiving aspirin for primary prevention of cardiovascular disease presented with hemoptysis after 1 week of treatment for his @Disease$ with @Chemical$.	1
"BACKGROUND: Aspirin-exacerbated respiratory disease (AERD) is a clinical triad consisting of @Chemical$/acetylsalicylic acid (ASA) sensitivity, bronchial asthma, and @Disease$."	0
Physiologic and pharmacologic studies support the hypothesis that @Chemical$-exacerbated respiratory disease (@Disease$) involves fundamental dysregulation in the production of and end-organ responsiveness to both antiinflammatory eicosanoids (prostaglandin E2) and proinflammatory effectors (cysteinyl leukotrienes).	0
"Based on this event, the chronic use of @Chemical$ in young patients with SWS, as suggested to prevent @Disease$-like episodes, is disputable."	0
"Acetylsalicylic acid (@Chemical$) is an effective antithrombotic agent, which prevents a variety of @Disease$."	0
"Aspirin (@Chemical$)-exacerbated @Disease$ (AERD) is characterized by upper airway congestion due to eosinophilic inflammation of the nasal and sinus membranes and nasal polyposis, associated with increased leukotriene production that is further accentuated by ASA or other nonsteroidal anti-inflammatory drug (NSAID) ingestion."	1
"We examined whether mother's use of paracetamol, @Chemical$ or ibuprofen in pregnancy is associated with increased risk of @Disease$ (CP) in the child."	0
This syndrome seems to be more frequent among the patients with @Chemical$-induced @Disease$.	1
"To do this, RNAs from 24 subjects with AERD and 18 subjects with @Chemical$-tolerant @Disease$ (ATA) were subjected to microarray analysis of ~34,560 genes."	0
"METHODS: We searched PubMed, EMBase, @Disease$ and Cochrane Central Register of Controlled Trials (up to June, 2013) for randomized controlled trials evaluating the efficacy and safety of clopidogrel plus @Chemical$ versus aspirin alone in high vascular risk patients."	0
"RESULTS: Of 8754 Chinese patients with atrial fibrillation and CHA2DS2-VASc &gt;=1 (79.5+-9.2 years; CHA2DS2-VASc, 4.1+-1.5; and @Disease$, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile International Normalized Ratio, Elderly (&gt;65 years), Drugs/Alcohol Concomitantly [HAS-BLED], 2.2+-0.9), 16.3% received warfarin, 41.1% aspirin, 4.5% @Chemical$, and 38.1% received no therapy."	0
Alcohol and @Chemical$ in combination with dexamethasone causes @Disease$ at high altitude.	1
"@Chemical$-exacerbated respiratory disease (AERD) is defined as @Disease$, chronic rhinosinusitis with nasal polyposis, and hypersensitivity to cyclooxygenase-1 inhibitors."	0
"Desensitization to @Chemical$ is well described in the @Disease$ and cardiovascular literature, but there are no similar discussions specific to neurointervention."	0
@Disease$ as a novel complication of aspirin therapy in patients with @Chemical$-exacerbated respiratory disease.	0
"Dual antiplatelet therapy (DAPT) with acetylsalicylic acid and a P2Y12 inhibitor (clopidogrel, @Chemical$, or prasugrel) reduces @Disease$ events in patients with acute coronary syndrome (ACS), but it is also associated with an increased risk of bleeding complications."	0
CONCLUSION: Clopidogrel and the combination of acetylsalicylic acid and @Chemical$ were associated with similar risks for recurrent ischemic stroke and bleeding; whereas acetylsalicylic acid was associated with higher risks for both ischemic stroke and @Disease$.	0
Twenty patients with @Chemical$-induced @Disease$ were included and 10 extrinsic asthma patients as a group control.	1
"COX-1-derived @Chemical$ are responsible for gastroprotection, while PGs generated via COX-2 activity also play an important role in gastroprotection and @Disease$."	0
We have previously shown that hypoacidity related with @Disease$ as well as taking PPI and co-treatment of angiotensin type 1 receptor blocker seem to reduce peptic ulcer among @Chemical$ users.	0
"BACKGROUND: In patients with @Chemical$-exacerbated respiratory disease (AERD), pretreatment with @Disease$ controller medications (leukotriene modifiers, inhaled or systemic corticosteroids, and salmeterol) partially modifies the severity of aspirin-induced asthmatic reactions."	0
"She had no symptom of urticaria and asthma, and had the both character of aspirin urticaria and @Disease$ as to @Chemical$ challenge test."	0
"The management of @Disease$ in patients with @Chemical$-sensitive asthma often needs to be considered as a separate issue, and requires a team approach."	0
"CONCLUSION: Among elderly patients receiving cardiovascular protection with @Chemical$ and @Disease$ control with anti-inflammatory drugs, celecoxib may be safer with regards to GI toxicity than NS-NSAIDs."	0
Pooling the results of all studies showed a significant increase in @Disease$ and transfusion of red blood cells and fresh frozen plasma in the @Chemical$ group (p &lt; 0.05).	0
@Chemical$ or Nonsteroidal Anti-inflammatory Drug-Exacerbated @Disease$.	1
@Disease$ caused by low-dose @Chemical$ therapy in consecutive Japanese patients: a prospective study.	1
"BACKGROUND: Previous studies have suggested a benefit of @Chemical$ in addition to standard dual-antiplatelet therapy (DAPT), reducing in-stent @Disease$ and restenosis after percutaneous coronary intervention (PCI) with bare-metal and drug-eluting stent (DES) implantation."	0
"Based on the results of the MATCH trial, combination therapy with @Chemical$ plus clopidogrel is not recommended for patients with ischaemic stroke or TIA due to the increased risk of @Disease$."	1
We found that @Chemical$ was not associated with a significant reduction of @Disease$-related mortality compared with placebo (RR 0.99; 95% CI: 0.87-1.12; P = 0.85: I2 = 41%).	0
Combined aspirin and @Chemical$ in @Disease$ surgical patients: a new risk factor for ocular haemorrhage?	0
OBJECTIVE: To assess whether patients with @Disease$ and @Chemical$ sensitivity share common eicosanoid alterations with patients who have aspirin-sensitive asthma.	0
Safety of @Chemical$ desensitization in patients with reported aspirin @Disease$ and cardiovascular disease.	0
"Therefore, the present results indicated that DDAVP shortened the prolonged @Chemical$ in dogs with aspirin-induced @Disease$ and chronic liver disease."	0
"Low dose aspirin (@Chemical$), commonly defined as the cardiovascular (CV) dose of 75 to 325 mg daily, is one of the most widely prescribed drugs in the world and the cornerstone of therapy and prophylaxis for @Disease$."	0
OBJECTIVE: The Japanese health insurance system approved the use of proton pump inhibitors (PPIs) for the prevention of peptic @Disease$ in patients using low-dose @Chemical$ (LDA) and/or non-steroidal anti-inflammatory drugs (NSAIDs).	0
CONCLUSION: A large proportion of users of high-dose @Chemical$ have risk factors for experiencing @Disease$.	1
"Conversely, concomitant treatment with H2-blockers was associated with a significantly higher risk of peptic @Disease$ both in acute (OR = 10.9, 95% CI: 3.87-30.9) and chronic (OR = 6.26, 95% CI: 2.56-15.3) non-steroidal anti-inflammatory drugs/@Chemical$ users than non-users."	0
CONCLUSIONS: This meta-analysis demonstrates that short-term combination of @Chemical$ and aspirin is effective and safe for @Disease$ prevention in high vascular risk patients.	0
OBJECTIVE: The present study was performed to investigate the prevalence of @Disease$ in asymptomatic @Chemical$ users.	0
"RESULTS: A lower incidence of gastric and duodenal @Disease$s was seen in celecoxib/aspirin-treated subjects (19%) vs. naproxen/@Chemical$ (27%; RR: 0.63, 95% CI: 0.44-0.92)."	0
"Previous studies indicate that hypoacidity related to @Disease$, as well as taking PPIs and co-treatment with angiotensin type 1 receptor blockers (ARBs) and statins seem to reduce peptic ulcer among @Chemical$ users."	0
High serum @Chemical$ were associated only with aspirin-related peptic @Disease$.	0
"The pathogenesis of aspirin-exacerbated @Disease$ (AERD) is thought to be based on, mainly, overproduction of @Chemical$ lipid mediators and on defective anti-inflammatory regulators."	0
The mean number of reddened lesions was significantly higher and the mean number of erosions/@Disease$ and CE scores significantly lower in the @Chemical$ group than in the other non-aspirin NSAID group.	0
"A total of 12 patients with a clear-cut history of AIA were randomised in double-blind cross-over fashion to receive single doses of @Disease$ 10 mg, ML 40 mg, or placebo (PL), with nasal @Chemical$-aspirin challenge performed 12 h after dosing."	0
"RESULTS: We found that treatment with @Chemical$ is associated with increased overall fracture risk, but not to the risk of osteoporotic @Disease$s."	0
One available option for preventing @Chemical$-induced @Disease$ is the simultaneous use of the agents that inhibit acid secretion such as H(2)-receptor antagonists and proton pump inhibitors.	1
CONCLUSION AND SIGNIFICANCE: @Disease$ @Chemical$ should be recommended douching solution in the early postoperative care of patients with aspirin-induced CRS.	0
"The cumulative incidences of recurrent VTE in the rivaroxaban 20-mg, @Chemical$ 10-mg and aspirin groups were 1.9%, 1.6%, and 5.0%, respectively, whereas the cumulative incidences of major @Disease$ were 0.7%, 0.4% and 0.5%, respectively."	0
"In addition, in vitro experiments were performed in which @Disease$ cell line (MKN-45 cells) was incubated with ASA or @Chemical$-VitC alone or in combination with H.pylori."	0
Potential for drug-drug interactions in patients taking analgesics for mild-to-moderate @Disease$ and low-dose @Chemical$ for cardioprotection.	0
@Disease$ with @Chemical$ is associated with decreased mortality after isolated coronary artery bypass graft surgery in patients already receiving aspirin: a propensity-matched study.	1
We describe the case of a 19-year-old male diagnosed with @Disease$ within the context of viral pericarditis and @Chemical$ ingestion.	0
"AIMS: Daily low-dose aspirin is recommended for prevention of cardiovascular events in patients with coronary artery disease (CAD), and proton pump inhibitors (PPIs) are recommended to prevent or treat @Chemical$-associated @Disease$."	1
An association was found between CYP2C19 681A allele carriage and the increased extent of @Disease$ induced by @Chemical$.	1
"METHODS: From 5555 patients undergoing upper gastrointestinal endoscopy from January 2005 to December 2006 at Teikyo University Hospital, Tokyo, Japan, 159 patients (76 males and 83 females, mean age: 69.3 +/- 11 years) fulfilling the following conditions were selected: (i) taking @Chemical$ (less than 100 mg/day) continuously; (ii) not taking acid suppressants; and (iii) no history of gastrointestinal tract surgery, @Disease$, severe cardiac failure, or liver cirrhosis."	0
"The substantive risk for prophylactic aspirin is therefore cerebral haemorrhage which can be fatal or severely disabling, with an estimated risk of one death and one disabling @Disease$ for every 1,000 people taking @Chemical$ for ten years."	0
This is a distinct clinical syndrome called @Chemical$-induced @Disease$ (AIA).	1
"CONCLUSIONS: There is a small but statistically significant association between @Chemical$ use and early @Disease$, which may warrant further investigation."	1
"A second polymorphism study, conducted on histamine-related genes, did not find any significant associations with aspirin-induced urticaria/angioedema for the genes HNMT (encoding histamine N-methyltransferase), HRH1 or HRH2 (encoding histamine receptor types 1 and 2 respectively), or the gene encoding high-affinity IgE receptor Ibeta (FcepsilonRIbeta); however, the FcepsilonRIalpha gene promoter polymorphism was significantly associated with @Chemical$-induced @Disease$/angioedema."	1
"Compared to women who did not use either aspirin or other non-@Chemical$ NSAIDs, women using aspirin exclusively (RR = 1.71; 95% CI = 0.94-3.13), non-aspirin NSAIDs exclusively (RR = 2.39; 95% CI = 1.18-4.83), or both types of drugs (RR = 1.97; 95% CI = 1.06-3.68) were at increased risk of @Disease$."	0
"In our investigation of such adverse effects, we obtained 4 important findings considered useful for physicians, as follows; 1) even when @Chemical$ was given at a dose, the incidence rate of gastrointestinal lesions was higher than with other non-steroidal anti-inflammatory drugs (NSAIDs), 2) the odds ratios for gastrointestinal lesions induced by aspirin with a histamine H2 receptor antagonist and proton pump inhibitor were 0.6 and 0.4, respectively, as compared with aspirin alone, 3) it is difficult to administer aspirin, which exerts an antiplatelet effect, without inducing @Disease$, and 4) these gastrointestinal lesions appears early, especially within 2 years after administration."	0
"Data Sources: We searched PubMed, Embase, CENTRAL, and ClinicalTrials.gov from inception to May 28, 2018, with the terms novel oral anticoagulants, non-vitamin K antagonist oral anticoagulants, direct oral anticoagulants, dabigatran, rivaroxaban, apixaban, edoxaban, warfarin, @Chemical$, vitamin K antagonist, aspirin, acetylsalicylic acid, or ASA, and major @Disease$, fatal bleeding, or intracranial hemorrhage."	0
"The study objective was to identify the prevalence of asthma, inhalant @Disease$ and @Chemical$ sensitivity in CRS patients referred to secondary care and establish any differences between CRS phenotypes."	0
"@Chemical$ is widely accepted as a treatment option for migraine pain relief and could provide an alternative not only for treatment of moderate @Disease$ attacks, but also for severe migraine attacks."	0
Relationship between human leucocyte antigen class I and class II and chronic idiopathic urticaria associated with @Chemical$ and/or NSAIDs @Disease$.	0
"Aspirin-exacerbated diseases are important examples of drug hypersensitivities and include aspirin-exacerbated respiratory disease (@Disease$), @Chemical$- or non-steroidal anti-inflammatory drug (NSAID)-induced urticaria/angioedema, and aspirin- or NSAID-induced anaphylaxis."	0
[Protective effect of compound bismuth and @Chemical$ granules on aspirin-induced @Disease$ in rats].	0
"The objective of this study was to test the effects of aspirin (1, 2.5 and 5 mg/kg), and ibuprofen (4 and 15 mg/kg), @Chemical$ (2.5 mg/kg), flurbiprofen (2 mg/kg), celecoxib (7.5 mg/kg), and rofecoxib (1 mg/kg), alone or combined on a rat model of arterial @Disease$."	0
"Aspirin exacerbated @Disease$ (AERD) is characterized as adult onset asthma, nasal polyps, chronic rhinosinusitis, and hypersensitivity to a cyclooxygenase-1 (COX-1) inhibitor, viz @Chemical$ or nonsteroidal antiinflammatory drugs (NSAIDs)."	0
Aspirin-induced asthma (@Disease$) is associated with increased production of cysteinyl leukotrienes (@Chemical$).	0
"BACKGROUND: Aspirin-exacerbated @Disease$ (AERD) is a clinical syndrome characterized by chronic rhinitis, nasal polyps, asthma, and precipitation of asthma and rhinitis attacks after ingestion of aspirin (@Chemical$) and most nonsteroidal anti-inflammatory drugs (NSAIDs)."	0
Method: Eighty-six patients with CRS and asthma who were treated in the outpatient clinic during March 2015 to January 2018 were divided into asthma group(52 cases) and @Chemical$ @Disease$ group(34 cases) according to asthma and aspirin asthma.	1
"A convenience sample of patients taking warfarin, @Chemical$, clopidogrel or mixed therapy presenting to the ED with @Disease$ were included and followed-up over 3-18 months."	0
"Before surgery, a standard oral placebo-controlled aspirin challenge was performed to diagnose @Chemical$ @Disease$."	1
@Chemical$ and warfarin versus aspirin monotherapy after @Disease$.	0
Differential contribution of the CysLTR1 gene in patients with @Chemical$ @Disease$.	1
"AIM: The goal of the present study was to investigate whether a mucosal-protective agent, rebamipide, could prevent @Disease$ induced by LDA with or without @Chemical$ in healthy subjects."	0
"CONCLUSION: Warm-needle moxibustion can reduce the gastric lesion (ulcer) caused by aspirin in the rat, which may be closed associated with its effects in up-regulating both serum and @Disease$ activity and down-regulating both serum and gastric mucosal @Chemical$ levels."	0
"@Chemical$-exacerbated @Disease$ (AERD) severity and its clinical phenotypes are characterized by genetic variation within pathways for arachidonic acid metabolism, inflammation, and immune responses."	1
Chronic @Chemical$ via dose-dependent and selective inhibition of cardiac proteasome possibly contributed a potential risk to the @Disease$ heart.	0
"Three-quarter of the respondents felt that @Chemical$ was a risk factor for @Disease$ complications associated with intracranial procedures, and more than half of the interviewees reported having personal experience of such problems."	1
"RESULTS: In 6 cases (26%), otological manifestations with ear pressure and conductive @Disease$ occurred during an advanced stage of Samter's syndrome (&gt;5 years after onset of the first nasal symptoms) partially responsive to systemic @Chemical$."	0
"Aspirin (acetylsalicylic acid) is a well-known nonsteroidal anti-inflammatory drug that can potentiate some acute @Disease$ and causes adverse immunological reactions collectively referred to as @Chemical$ intolerance, a disorder that induces urticaria, asthma, and anaphylaxis in response to oral administration of the drug."	0
"CONCLUSIONS: As endoscopy frequently reveals gastroduodenal disorder among low-dose @Chemical$ users, both administration of BA and of enteric-coated aspirin warrant concern for gastroduodenal @Disease$."	0
[Do antiplatelet agents (@Chemical$ and other antiplatelets such as clopidogrel) increase the risk of @Disease$ after endoscopic polypectomy or endoscopic sphincterotomy and should these drugs therefore be withdrawn 7-10 days before these procedures are performed?].	0
"Acetylsalicylic acid, commonly known as @Chemical$, can induce some hypersensitive reactions with clinical symptoms such as urticaria, angioedema, @Disease$, and rarely anaphylactic shock."	1
Incidence of and risk factors for @Disease$ in patients taking low-dose @Chemical$ in Japan.	0
METHODS: A whole-blood desktop platelet function analyzer (PFA-100) with an epinephrine agonist was used to assess @Chemical$ among patients with @Disease$.	0
Low-dose @Chemical$ and @Disease$.	0
Use of a composite symptom score during challenge in patients with suspected @Chemical$-exacerbated @Disease$.	0
"The finding in that syndrome of hyperreactive basophils suggests that the NSAID @Disease$ is due to the associated effect of several factors: 1) Localized inflammatory processes causing a non specific cellular hyperreactivity; 2) An abnormal pharmacogenetic reaction to NSAIDs resulting in a hyperproduction of @Chemical$ and other mediators by activated mast cells, basophils and eosinophils."	0
"In contrast, @Chemical$ aggravated significantly @Disease$-induced lesions, and this was accompanied by a fall in the GBF, suppression of prostaglandin E(2) generation, and significant rise in ROS chemiluminescence and in plasma TNFalpha and IL-1beta levels."	0
"RESULTS: Patients with @Disease$ had significantly higher median platelet @Chemical$ concentration (102 ng/mg platelet protein) when compared with controls (49 ng/mg platelet protein, P = 0.003)."	0
"Forty-nine reported no significant side effects, and 9 reported either @Disease$ or minimal to significant bleeding on @Chemical$."	0
"BACKGROUND: The combination of aspirin, @Chemical$, and enoxaparin (combination therapy) is the standard treatment for acute coronary syndrome but is associated with @Disease$."	0
CONCLUSION: Frequent use of NSAIDs but not @Chemical$ seemed to be associated with increased absolute incidence of @Disease$ and UC.	0
RESULTS: Rebamipide significantly inhibited @Disease$ induced by LDA alone or by LDA plus @Chemical$ when compared with placebo in healthy subjects.	0
"Overall, acetaminophen and @Chemical$ were associated with weakly increased risks of @Disease$."	0
"The aim of this blinded, randomised, multicentre study was to compare the tolerability of aspirin, paracetamol and @Chemical$ in common pain resulting from @Disease$ (MSC) in general practice with patients with other non-MSC pain conditions."	0
Significantly more of those patients with a history of @Disease$ (n = 371) developed GI adverse events than did those with no such history; the incidence of GI adverse events in both groups was lowest with @Chemical$.	0
"The @Disease$ (Paracetamol, @Chemical$, Ibuprofen New tolerability) study was a blinded randomised comparison of the tolerability of OTC analgesics in the treatment of common types of acute pain encountered in the community."	0
"BACKGROUND: In patients with ischemic @Disease$ of non-cardioembolic origin, @Chemical$, clopidogrel, or a combination of acetylsalicylic acid and dipyridamole are recommended for the prevention of a recurrent stroke."	0
"After propensity score matching (PSM) for identified confounders, the relationship between preoperative @Chemical$ use and 30-day all-cause mortality, postoperative renal failure, major adverse cardiocerebral events (MACE), blood transfusion, reoperation for @Disease$, and postoperative infection were estimated with separate logistic regression models."	0
"There were significantly more patients who suffered GI adverse events, principally abdominal pain, dyspepsia, @Disease$ and diarrhoea, with @Chemical$ (18.5%) than with ibuprofen (11.5%), but the difference between ibuprofen and paracetamol (13.1%) was not significant."	0
"The SCF/beta-actin mRNA ratios were significantly higher in ASA-@Disease$ (AH) asthmatics (median 0.97, range: 0.8-1.5) when compared with @Chemical$-tolerant (AT) patients (median 0.5, range: 0.1-0.7; P &lt; 0.001)."	0
Four studies involving 10292 individuals examining the association between @Chemical$ and @Disease$ met the inclusion criteria.	0
The identified genes present possible novel therapeutic targets for nasal @Disease$ associated with chronic rhinosinusitis and @Chemical$-sensitive asthma.	0
AIM: The aim of this study was to evaluate the effects of chronic use of acetylsalicylic acid (@Chemical$) and vitamin K antagonists (VKA) on the incidence of age related macular degeneration (@Disease$).	0
Lower doses of @Chemical$ are associated with a reduced risk of @Disease$ and are equally effective in reducing cardiovascular risk.	0
Risk factors for upper gastrointestinal bleeding in @Disease$ patients receiving both aspirin and @Chemical$.	0
"With skin testing and oral rechallenge with @Chemical$, but not rofecoxib, the allergist determined the cause of the reactions to be aspirin-induced @Disease$ and selective COX-2 inhibitor intolerance."	0
"Aspirin plus @Chemical$ has the highest surface under the cumulative ranking curves (SUCRA) values in terms of mortality, @Disease$, and adverse event rate among 7 drug therapies in the treatment of cerebral infarction."	0
"Aspirin (ASA)-exacerbated respiratory disease (AERD) is characterized by upper airway congestion due to @Disease$ of the nasal and sinus membranes and nasal polyposis, associated with increased @Chemical$ production that is further accentuated by ASA or other nonsteroidal anti-inflammatory drug (NSAID) ingestion."	0
Aspirin desensitization achieved after omalizumab treatment in a patient with @Chemical$-exacerbated @Disease$ and respiratory disease.	0
"Among the risk factors of @Chemical$-associated ulcer bleeding, @Disease$ is one of the few that is treatable."	0
CONCLUSION: Aspirin desensitization following @Chemical$ appears to be a well-tolerated and effective adjunctive therapy for long-term control of @Disease$ in patients with AERD.	0
Long-term low-dose @Chemical$ intake leads to a 2 - 4-fold risk of risk for @Disease$.	1
"OBJECTIVE: Aspirin-exacerbated @Disease$ (AERD) represents a severe form of chronic rhinosinusitis (CRS) characterized by nasal polyposis, bronchial asthma, and @Chemical$ intolerance."	0
"Similarly, IL-1beta exposure induced the expression of COX-1 and COX-2 in fibroblasts from NM of control subjects, had only moderate effects on fibroblasts from NPs of @Chemical$-tolerant non@Disease$tic patients, and almost no effect on fibroblasts from NPs of patients with AIA."	0
It is safe to do surgery for a proximal femoral @Disease$ in patients who are taking @Chemical$.	0
"CONCLUSIONS: Preoperatively continued @Chemical$ use was not associated with increased risk of intra- and post-operative blood loss, blood transfusion requirements and composite outcome of in-hospital death, stroke and reoperation for @Disease$ in off-pump CABG."	0
"DATA SOURCES: Articles evaluating @Chemical$ for primary prevention of CVD were gathered using a MEDLINE search with the keywords aspirin review, aspirin peripheral @Disease$, aspirin stroke, aspirin coronary artery disease, aspirin diabetes, aspirin primary prophylaxis, and aspirin elderly."	0
"OBJECTIVES: To evaluate if @Chemical$ prevents recurrent peptic ulcer in adult patients with a history of peptic @Disease$ receiving low-dose acetylsalicylic acid (ASA, aspirin) for cardiovascular protection in East Asia."	0
BACKGROUND/AIMS: To examine the relationship between @Chemical$ intake and early age-related macular degeneration (@Disease$) among an Asian population.	0
To report a case of microtrauma-induced recurrent hyphema and secondary @Disease$ associated with voluntary chronic @Chemical$ (ASA) use.	0
"In addition, a combination of LDA and NSAIDs or LDA and APs contributed more profoundly to the @Disease$ (OR 3.59 and 95 % CI 1.19-10.81 for LDA/NSAIDs; OR 6.70 and 95 % CI 1.83-24.50 for LDA/@Chemical$)."	0
[The association of @Chemical$ profile and @Disease$ in patients with minor stroke or transient ischemic attack on antiplatelet therapy: subgroup analysis of CHANCE].	0
"Methods: Serum total cholesterol, low-density lipoprotein @Chemical$, high-density lipoprotein cholesterol and triglyceride were tested in a subgroup of 3 044 consecutive patients from Clopidogrel in High-risk patients with Acute @Disease$ (CHANCE) trial."	0
"It is still controversial whether @Chemical$ use during pregnancy increases the risk of certain @Disease$ (in particular, neural tube defects, gastroschisis, and cleft lip +/- palate)."	0
"Recently, @Chemical$ releasing aspirin (ASA-VitC) has been shown to reduce gastric toxicity of ASA in animal model of @Disease$."	0
BACKGROUND: Aspirin-induced @Disease$ (AIAR) is characterized by the altered metabolism of @Chemical$ and proinflammatory prostaglandins.	0
EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of @Chemical$ @Disease$.	1
"BACKGROUND: In patients with aspirin-exacerbated respiratory disease (AERD), pretreatment with asthma controller medications (@Chemical$ modifiers, inhaled or systemic corticosteroids, and salmeterol) partially modifies the severity of aspirin-induced @Disease$tic reactions."	0
"This review focuses on descriptions of these patients; methods available to diagnose @Chemical$-exacerbated @Disease$; the unique ability of all NSAIDs that inhibit COX-1 to cross-react with ASA; lack of cross-reactivity with selective COX-2 inhibitors; an update on pathogenesis; and current thoughts about treatment, including ASA desensitization and daily ingestion of ASA itself."	0
"Acetylsalicylic acid, commonly known as @Chemical$, can induce some hypersensitive reactions with clinical symptoms such as @Disease$, angioedema, acute bronchospasm, and rarely anaphylactic shock."	1
"METHODS: In this multicenter, hospital-based, case-control study, 400 patients underwent upper and lower endoscopy, 80 had acute overt @Chemical$ and 320 had no @Disease$ and were matched for age and sex as controls (1:4)."	0
"These studies demonstrated a non-significant increase in esophageal, gastric and duodenal @Disease$ during treatment with low-dose @Chemical$ (Odds Ratio = 1.22, P = 0.08), but a significant increase in bleeding ulcers (Odds Ratio = 1.77, P = 0.04)."	0
"Secondary endpoints were: 1) the occurrence of hypersensitivity symptoms during the protocol, 2) the rate of @Chemical$ discontinuation at follow-up; 3) recurrent @Disease$ events."	0
"The pooled RR of 10 included studies between the use of @Chemical$ and risk of @Disease$ was 1.09 (95% CI, 0.96-1.24)."	0
"Response to letter regarding article, Ischemic stroke and @Disease$ with @Chemical$, dabigatran, and warfarin: impact of quality of anticoagulation control."	1
"There were significantly more patients who suffered GI adverse events, principally abdominal pain, dyspepsia, nausea and @Disease$, with aspirin (18.5%) than with @Chemical$ (11.5%), but the difference between ibuprofen and paracetamol (13.1%) was not significant."	0
"Provocation tests therefore, remain to be the only relevant method used for the diagnosis of both AIAR (aspirin-intolerant @Disease$) and @Chemical$ intolerance of organs other than respiratory tract."	0
Low-molecular-weight @Chemical$ and aspirin use in relation to pregnancy outcome in women with systemic lupus erythematosus and @Disease$: A cohort study.	0
We report a 56-year-old patient who had been taking antihypertensive medication in combination with prophylactic @Chemical$ for 19 years who was diagnosed with @Disease$ with significant coronary artery stenosis on angiography.	0
"CONCLUSIONS: Low-dose @Chemical$ use could reduce the incidences of total cardiovascular events, stroke, nonfatal stroke and transient ischemic attack but increase the risk of bleeding, the incidence of nonfatal myocardial infarction, death from cardiovascular causes and @Disease$ from any cause was not affected by low-dose aspirin use."	1
"Gastritis is a common ailment that can be caused by poor dietary habits, intake of @Chemical$ or other gastric irritants, bacterial @Disease$, or by the widespread use of non-steroidal anti-inflammatory drugs (NSAIDs)."	0
A study was undertaken to investigate the effects of aspirin on the systemic production of @Chemical$ and cysteinyl leucotrienes in patients with @Disease$.	0
"OBJECTIVES: To identify the reasons of using @Chemical$, endoscopic findings on gastropathy caused by ASA and the relative risk of developing @Disease$."	0
"CONCLUSION: This life-threatening and potentially disabling complication must stress to physicians about the risks of ergotamine plus @Chemical$ abuse, drawing their efforts to prevent, to recognize and to control the propensity to self medication of some patients with daily @Disease$s."	0
PURPOSE OF REVIEW: The use of aspirin in coronary artery disease and address the unmet need of @Chemical$ therapy in patients with history of @Disease$ reactions to aspirin (acetylsalicylic acid; ASA) or other nonsteroidal inflammatory drugs (NSAIDs).	0
CONCLUSION AND SIGNIFICANCE: Hypertonic sea water should be recommended douching solution in the early postoperative care of patients with @Chemical$-induced @Disease$.	1
"METHODS: Systematic searches of Medline and Embase were conducted to identify observational studies published between 1946 and 4 March 2015 that reported the risks of gastrointestinal (GI) bleeding or intracranial hemorrhage (@Disease$) with long-term, low-dose @Chemical$ (75-325 mg/day)."	0
OBJECTIVES: To investigate the genetic contribution of adenosine A3 receptor gene (ADORA3) polymorphisms in the pathogenesis of @Chemical$-induced @Disease$ (AIU) in a case-control association study in a Korean population.	1
"Aspirin exacerbated respiratory disease is characterized by recalcitrant sinusitis/polyposis, asthma and precipitation of @Disease$ after ingestion of @Chemical$ and most NSAIDs."	1
"Although co-therapy with a PPI and the eradication of H. pylori substantially reduce the risk of recurrent ulcer @Disease$ with aspirin, the replacement of @Chemical$ by clopidogrel cannot be recommended to patients with a high gastrointestinal risk."	0
"The association between @Chemical$ use and the presence of DR or VTDR was assessed using multivariable logistic regression models including age, gender, ethnicity, socioeconomic status, HbA1c, systolic blood pressure, anti-hypertension medicine, total cholesterol, anti-cholesterol medicine, BMI, current smoking status, diabetes duration, history of cardiovascular disease (CVD) and @Disease$ (CKD.)."	0
"Short-term acetylsalicylic acid (@Chemical$) use for pain, @Disease$, or colds - gastrointestinal adverse effects: a meta-analysis of randomized clinical trials."	1
We investigated whether @Disease$ was correlated with platelet function and gastric juice pH in 45 patients with cardiovascular disease administered @Chemical$ daily (study 2).	0
"@Chemical$ also increased the risk of serious bleeding by 46% (95%CI, 22-75) in diabetic patients without cardiovascular disease but decreased the risk among those with @Disease$."	0
@Chemical$ further activates the 5-lipoxygenase of leukotriene B4-producing inflammatory macrophages precipitating an acute @Disease$tic attack.	0
"@Chemical$, commonly known as aspirin, can induce some hypersensitive reactions with clinical symptoms such as urticaria, angioedema, @Disease$, and rarely anaphylactic shock."	1
Our findings suggest that @Chemical$ at cardioprophylactic doses as well as paracetamol at analgesic doses is associated with a reduced risk of @Disease$.	0
"RESULTS: The in-hospital mortality rate was 72% for ICH patients treated with warfarin, 41.6% for ICH patients treated with @Chemical$, and 35% for @Disease$ patients treated with no drugs."	0
Exclusive and Combined Use of Statins and @Chemical$ and the Risk of @Disease$: a Case-Control Study.	0
"Notwithstanding the consistent benefits demonstrated with aspirin for both acute and chronic cardiovascular disease, there are a number of @Disease$ associated with aspirin that have been showcased by recent long-term clinical trials that have included an @Chemical$ monotherapy arm."	0
"RESULTS: Mortality was not increased (hazard ratio [95% CI]) when @Chemical$ was used in conjunction with ACEI (0.51 [0.29-0.87]) or ARB (0.29 [0.09-0.96]) in patients with @Disease$ or nonischemic (ACEI 0.71 [0.42-1.21], ARB 1.42 [0.74-2.74]) HF."	0
"In severe cases, a single therapeutic dose of @Chemical$/NSAIDs can provoke violent bronchospasm, @Disease$, and respiratory arrest."	1
"The triad of bronchial asthma, @Disease$, and intolerance to @Chemical$ and aspirin-like chemicals are designated aspirin-induced asthma (AIA) or Samter's syndrome."	0
OBJECTIVE: To evaluate frequency of ischemic and hemorrhagic events in patients treated with aspirin and ticagrelor when associated with perioperative @Chemical$ bolus for @Disease$ treated with intracranial stents.	0
The association persisted even after excluding those with conventional risks for @Chemical$-@Disease$ such as ulcer histories.	0
"The new class of NO-releasing NSAIDs, including NO-@Chemical$ or NO-naproxen, represent a very promising approach to reducing the @Disease$ of their parent NSAIDs."	0
This study suggests that the combined antiplatelet treatment with clopidogrel and indobufen could be a good option in ACS patients with @Disease$ to @Chemical$ undergoing coronary stenting.	1
@Chemical$-sensitive chronic @Disease$ patients may also react adversely to some food additives.	0
"Patients receiving treatment for &gt;5 years showed elevated risk of CMBs in the aspirin (0.17; 0.09-0.36; P &lt; .001) and clopidogrel (0.15, 0.07-0.33; P &lt; .001) groups as well as higher odds of MB in the @Chemical$ (0.34, 0.16-0.71; P = .004) and clopidogrel (0.37, 0.17-0.80; P = .010) groups.The WMHs and MB were associated with CMBs in patients taking aspirin or clopidogrel for &gt;1 year, and long-term use increased the risks of CMB and @Disease$."	0
AIM: To compare the healing rate in aspirin-related dyspeptic @Disease$ patients who were given proton pump inhibitor (PPI) plus @Chemical$ or PPI plus clopidogrel.	0
"RESULTS: One-year risks for ischemic @Disease$ were 1.0-1.2 % with aspirin, 0-0.3 % with @Chemical$, and 0.1-0.2 % without treatment at CHA2DS2VASc scores 0-1."	0
"Patients undergoing TKA treated with @Chemical$ had a higher frequency of wound @Disease$ complications or infection (3.9% for LMWH versus 0.5% for mobile compression; p = 0.028; OR, 8.2)."	0
"In our investigation of such adverse effects, we obtained 4 important findings considered useful for physicians, as follows; 1) even when aspirin was given at a dose, the incidence rate of @Disease$ was higher than with other non-steroidal anti-inflammatory drugs (NSAIDs), 2) the odds ratios for gastrointestinal lesions induced by aspirin with a histamine H2 receptor antagonist and proton pump inhibitor were 0.6 and 0.4, respectively, as compared with aspirin alone, 3) it is difficult to administer @Chemical$, which exerts an antiplatelet effect, without inducing gastrointestinal lesions, and 4) these gastrointestinal lesions appears early, especially within 2 years after administration."	0
"METHODS AND MATERIALS: We compared the effect of NO-ASA and ASA on gastric lesions provoked by water-immersion and restraint stress (@Disease$), ischemia-reperfusion, and 100% @Chemical$."	0
Incidence of @Disease$ and compliance on prolonged dual antiplatelet therapy (@Chemical$ + thienopyridine) following drug-eluting stent implantation.	0
"BACKGROUND: Patients with @Disease$ are frequently on @Chemical$, which may place them at risk for bleeding during surgical procedures."	0
CONCLUSIONS: From this study it appears that platelet transfusion within 36 hours post injury for patients with @Disease$ who were treated with @Chemical$ prior to the head injury does not reduce the rate or extent of hemorrhagic expansion.	0
"Multivariate analysis showed that only chronic @Disease$ was the independent risk factor for IBC (P &lt; 0.001, odds ratio = 12.355), but preoperative continuation of APT or multiple APT use did not affect @Chemical$."	0
Comparison of bleeding complications with omega-3 fatty acids + @Chemical$ + clopidogrel--versus--aspirin + clopidogrel in patients with @Disease$.	0
"At about 4 years follow-up, no significant difference was observed among the aspirin and nonaspirin use group in major adverse cardiac events free survival estimates (95.7% versus 91.5%, P = 0.23) and freedom from cardiogenic readmission (88.5% versus 85.3%, P = 0.77) whereas the @Disease$ recurrence free survival rates was 83.7% and 73.9% in the aspirin and nonaspirin use group respectively (P = 0.02), with odd ratio for preoperative @Chemical$ estimated at 0.71 (95% confidence interval, 0.49-1.04, P = 0.08)."	0
Clinical course and urinary eicosanoids in patients with @Chemical$-induced @Disease$ followed up for 4 years.	1
"Conclusions and Relevance: In this cohort study, @Chemical$ use 3 or more times per week was associated with a reduction in all-cause, @Disease$, GI cancer and CRC mortality in older adults."	0
AIM/OBJECTIVE: To compare effect of @Disease$ (2.3% NaCl) sea water and isotonic 0.9% NaCl on symptoms and endoscopic findings in those patients in the period of 1 month after endoscopic sinus surgery (@Chemical$).	0
METHODS: We compared outpatients with difficult-to-treat asthma (DTA; n = 486) in a tertiary hospital for allergic diseases in central Japan with those with controlled severe @Disease$ (n = 621) with respect to clinical factors including body mass index (BMI) and @Chemical$ intolerance using multivariate logistic regression analysis stratified by gender and atopic phenotype.	0
CONCLUSIONS: Patients on @Chemical$ and clopidogrel &lt;5days before CABG who had preoperative ADP-induced platelet aggregation &gt;=50% have @Disease$ risk similar to those receiving aspirin monotherapy.	0
"Aspirin (@Chemical$)-induced asthma (AIA) consists of the clinical triad of asthma, @Disease$ with nasal polyps, and precipitation of asthma and rhinitis attacks in response to aspirin and other NSAIDs."	0
"We encountered lower gastrointestinal bleeding in 16 patients taking a low dose of @Chemical$ and examined the effect of low aspirin dose on the stool occult blood test in 49 thrombotic patients (mean: 76.7 +/- 9.6 years old) including 39 with @Disease$, 8 with ischemic heart disease and 2 with atrial fibrillation."	0
"This report describes a case of Kounis-Zavras syndrome in the setting of aspirin-induced asthma also known as Samter-Beer triad combining nasal polyps, asthma, and @Chemical$ @Disease$ leading to vasospasm and myocardial infarction."	1
MATERIALS AND METHODS: Wound healing process was @Disease$ by administering the dose of 150 mg/kg body weight of aspirin orally for 9 days to observe the effect of @Chemical$ obtained from Cl using excision and incision wound model in rats.	0
Pathogenesis of @Chemical$-exacerbated @Disease$ and reactions.	1
"Diagnosis, prevention and treatment of @Chemical$-induced @Disease$ and rhinitis."	1
BACKGROUND: Aspirin-exacerbated @Disease$ is under-diagnosed and therefore effective and inexpensive therapy with @Chemical$ desensitization is rarely performed.	0
"BACKGROUND &amp; AIMS: We performed a meta-analysis of data from randomized trials to estimate the risk of all-cause mortality and @Disease$ (and especially gastrointestinal [GI] bleeding) in patients treated with low doses of acetylsalicylic acid (@Chemical$) (75-325 mg/d), alone or in combination with other medications."	0
"@Chemical$-induced @Disease$: clinical aspects, pathogenesis and management."	1
Bleeding during treatment with aspirin versus apixaban in patients with @Disease$ unsuitable for warfarin: the apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for @Chemical$ antagonist treatment (AVERROES) trial.	0
This study evaluated the association of BMI and @Disease$ in patients with aspirin-tolerant asthma (ATA) and aspirin-intolerant asthma (@Chemical$).	0
"Periorbital @Disease$, a relatively uncommonly reported side effect of @Chemical$ and its derivates, can occur even after previous long-term medication use."	1
The effect of increasing @Chemical$ use on risk of @Disease$ (MI) and cardiovascular mortality was demonstrated by simulation.	1
"BACKGROUND AND PURPOSE: @Chemical$ early after intravenous thrombolysis in acute ischemic stroke increases the risk of symptomatic intracranial hemorrhage (@Disease$), without influencing functional outcome at 3 months."	0
"This permits us to discriminate asthmatic subjects from healthy subjects, as well as to distinguish the 2 asthma phenotypes based on the presence or absence of @Chemical$ @Disease$."	1
"METHODS AND RESULTS: Using electronic medical record and healthcare claims data, we conducted a retrospective population-based cohort study to examine patients 40 years or older with a diagnosis of @Disease$ and documented @Chemical$ use."	0
"In addition, in vitro experiments were performed in which @Disease$ cell line (@Chemical$ cells) was incubated with ASA or ASA-VitC alone or in combination with H.pylori."	0
"Allergic conditions include @Chemical$-exacerbated respiratory disease (AERD or aspirin-induced @Disease$), aspirin-induced urticaria/angioedema (AIU), and anaphylaxis."	0
@Chemical$ intolerance is the hallmark of aspirin-exacerbated @Disease$ (AERD).	0
Differential levels of these components in @Chemical$-exacerbated respiratory disease (AERD) and @Disease$ with asthma (ARwA) may be related to a different inflammatory response in both asthma phenotypes.	0
We describe the case of a 19-year-old male diagnosed with Reye syndrome within the context of @Disease$ and @Chemical$ ingestion.	0
"BACKGROUND: Patients with diabetes mellitus (@Disease$) experience higher rates of in-stent restenosis and greater benefit from drug-eluting stents implant at the time of percutaneous coronary intervention (PCI), necessitating prolonged dual anti-platelet therapy (@Chemical$)."	0
CONCLUSION: There is a significant increase in the risk of wound discharge when aspirin or @Chemical$ is used in @Disease$ patients.	0
"Despite these in vitro and ex vivo findings, we observed two patients develop acute @Disease$ while receiving both clopidogrel and aspirin: both patients' sera tested strongly positive in a @Chemical$-dependent washed platelet activation assay (100% serotonin release) and PF4/heparin-enzyme-immunoassay (2.594 and 2.190 absorbance units)."	0
Risk factors for @Disease$ common to @Chemical$ and aspirin were use of nonstudy aspirin&gt;50% of the time and a history of daily/occasional nosebleeds.	0
"Drainage amount, postoperative hemoglobin level, change in hemoglobin, calculated blood loss, incidence and the amount of blood transfused, and the proportion of @Disease$ events were compared between patients who were and patients who were not on continued @Chemical$ mono-therapy."	0
We report a near fatal @Disease$ in a patient with shunt and on aspirin and @Chemical$.	0
Use of electronic personal health records to identify patients at risk for @Chemical$-induced @Disease$.	1
Low-dose @Chemical$ prophylaxis and risk of @Disease$ in patients older than 60 years of age with mild or moderate head injury: a prospective study.	0
Proton-pump inhibitor and histamine 2-recetor antagonist were effective for prevention of upper @Disease$ in patients receiving low-dose @Chemical$.	1
"Drugs that can lead to @Disease$ include non-steroidal anti-inflammatory drugs (NSAIDs) like diclofenac and ibuprofen, platelet inhibitors such as acetylsalicylic acid (ASS), clopidogrel and @Chemical$, as well as anticoagulants like vitamin-K antagonists, heparin or direct oral anticoagulants (DOAKs)."	0
Evaluation of desmopressin effect on primary @Disease$ in pediatric patients with @Chemical$-like defect as hereditary thrombocytopathy.	0
"RESULTS: The GI @Disease$ of low-dose @Chemical$ appears to be dose-dependent, apparently starting with 10 mg/day, but this observation has not been confirmed by all studies."	1
"CONCLUSIONS: Our findings do not support that there is no difference in the risk of GI complications between enteric-coated LDA and buffered LDA, but rather may imply that the risk of @Disease$ complications associated with enteric-coated @Chemical$ is higher than that with buffered LDA."	0
"The results of the CHARISMA trial support this recommendation; despite previous data demonstrating a favourable benefit-risk profile of aspirin plus @Chemical$ in patients with acute coronary syndrome, this combination should not be used in patients at high risk for atherothrombosis and those with previous @Disease$ or TIA."	0
ASA desensitization is a safe and simple way to manage @Chemical$ @Disease$.	1
It is common practice to replace aspirin with @Chemical$ in patients with @Disease$ intolerance to aspirin.	0
The proportions of patients with an @Disease$ of &gt;=1 and erosive esophagitis were significantly lower in the @Chemical$ group than in the gefarnate group at 12 weeks (gastric lesions 33.5 vs.	0
"In @Chemical$ depletion, less iron may be available for @Disease$ through free-radical mediated mechanisms and for promotion of tumor growth."	0
BACKGROUND: Aspirin causes @Disease$ in patients with @Chemical$ exacerbated respiratory disease (AERD).	0
@Chemical$ intolerance and @Disease$ to house dust mites: important factors associated with development of severe asthma.	0
"The @Disease$ of @Chemical$s such as aspirin in this population is well known and documented, specifically in the form of Reye syndrome."	1
"We examined whether mother's use of paracetamol, aspirin or @Chemical$ in pregnancy is associated with increased risk of @Disease$ (CP) in the child."	0
"In patients on @Chemical$, the incidence rate (30 days to 18 months) of any @Disease$ event was 2.57 per 100 person-years (95% CI 1.85 to 3.48) and major bleeding was 1.10 per 100 person-years (95% CI 0.65 to 1.74)."	0
"Transfusion rates were also higher among patients who were receiving dual antiplatelet therapy than among patients who were receiving @Chemical$ monotherapy (68.4% vs 60.4%, P = .04), but transfusion played a modest role in mediating the risk of @Disease$ (adjusted HR, 1.37; 95% CI, 0.96-1.93])."	0
The aim of our study was to describe @Disease$ in patients on prehospital aspirin (@Chemical$) therapy undergoing emergent cholecystectomy.	0
"In the presence of sufficient amounts of gastric acid, H. pylori @Disease$ and aspirin could synergistically damage gastric mucosal integrity, while in the absence of sufficient amounts of gastric acid, the synergistic effect could be completely counteracted and the infection could even suppress the @Chemical$-induced gastropathy."	0
METHODS: Aspirin provocation tests were performed in 667 @Disease$tic patients and changes in FEV(1) were used to categorize patients as ATA or @Chemical$.	0
Risk factors for upper gastrointestinal bleeding in @Disease$ patients receiving both @Chemical$ and clopidogrel.	0
CONCLUSION: The current results suggest that continued use of anti-aggregant monotherapy does not increase the risk of overall bleeding or reintervention for patients undergoing transurethral resection of @Disease$ and that suspending @Chemical$ before such a procedure is therefore unnecessary.	0
"After network establishment and analysis, 27 potential targets hit by PNS, @Chemical$ and 6 kind of @Disease$ were found."	0
@Chemical$ (ASA) is an important cause of asthma so that ASA induced asthma (@Disease$) is considered a disease.	0
BACKGROUND: Patients with aspirin-exacerbated respiratory disease (AERD) also recently known as nonsteroidal anti-inflammatory drug (NSAID) exacerbated @Disease$ (NERD) must avoid @Chemical$ and all other oral NSAIDs.	0
METHODS: We enrolled 123 patients who had ulcer complications after using low-dose @Chemical$ continuously for more than one month and who had H. pylori @Disease$.	0
"METHODS: Using data from the Maryland Non-Small Cell Lung Cancer (NSCLC) Case-Control Study (1,220 cases [404 AA and 816 EA] and 1,634 controls [1,004 EA and 630 AA]), we estimated the adjusted odds ratios (OR) and hazard ratios (HR) with 95% confidence intervals (CI) of the associations between @Chemical$ use and @Disease$ risk and survival, respectively."	0
"BACKGROUND: @Chemical$ plus clopidogrel (A+C) may be more effective than aspirin only (AO) acutely after TIA and minor @Disease$, but the risk of bleeding in the acute phase is uncertain."	0
"The studies report conflicting findings about the effect of H. pylori infection on NSAID-related ulcers, and proton-pump inhibitors (PPIs) seem to be superior to eradication only to prevent recurrent @Disease$ bleeding with @Chemical$."	0
"Older age, prior GI events, chronic renal failure, use of other injurious medicine such as NSAIDs, antithrombotic medicine, especially thienopyridine, and corticosteroids seem to be factors associated with an increased risk for upper @Disease$ ulcer and bleeding among the patients taking low dose @Chemical$."	0
@Disease$ with Samter-Beer triad treated with intracoronary @Chemical$.	0
"Aspirin desensitization, @Chemical$-modifying agents, biologic agents, management of @Disease$, chronic rhinosinusitis, and nasal polyposis are recommended as treatment modalities."	0
"OBJECTIVE: Aspirin exacerbated @Disease$ (AERD) is comprised of @Chemical$/acetylsalicylic acid (ASA) sensitivity, bronchial asthma, and nasal polyposis."	0
BACKGROUND: Dual antiplatelet therapy (DAPT) associating aspirin + clopidogrel is commonly utilized in @Disease$ interventions despite unpredictable @Chemical$ efficacy with 4% to 50% of patients considered nonresponders.	0
"In this study, we compared the roles of CysLT receptor type 1 (CysLTR1) and leukotriene C4 synthase (LTC4S) gene polymorphisms in two major aspirin-related @Disease$, @Chemical$-intolerant asthma (AIA) and aspirin-induced chronic urticaria/angioedema (AICU)."	0
BACKGROUND: Prior @Chemical$ treatment is considered a risk factor for adverse outcomes in @Disease$ (ACS) patients.	1
"OBJECTIVE: @Chemical$ exacerbated respiratory disease (AERD) is comprised of aspirin/acetylsalicylic acid (ASA) sensitivity, @Disease$, and nasal polyposis."	1
AIMS: To analyse the incidence and factors influencing the occurrence of UGIB in patients taking low-dose @Chemical$ for the prevention of @Disease$ outside clinical trials.	0
"HYPOTHESIS: Deracoxib will cause less endoscopically detectable @Disease$ in dogs than @Chemical$, a nonselective nonsteroidal anti-inflammatory drug."	0
A 47-year-old woman with @Chemical$-exacerbated respiratory disease visited our hospital complaining of persistent @Disease$ that manifested in the evenings and early mornings.	0
"@Chemical$ alone caused a marked rise of gastric damage and gastric @Disease$, mainly at day 3rd and 7th, but they were significantly reduced at 11th day."	1
"Compared with the use of @Chemical$ alone, combined use of coxib and aspirin for 3 years increased the risk of a @Disease$ by 80% in the fifth year (RR = 1.80, 95% CI 1.22-2.66; P = 0.003) but decreased by 79% and 30%, respectively, the risks of cardiovascular thromboembolic events (RR = 1.79, 95% CI 1.33-2.41; P = 0.0001) and renal impairment/hypertension (RR = 1.30, 95% CI 1.09-1.54; P = 0.003) caused by coxib use alone."	1
METHODS: We studied a group of 20 AIA patients compared to a control group with 40 @Chemical$-tolerant patients (confirmed by oral provocation test): 10 @Disease$tic patients and 30 healthy subjects.	0
"In this study, we compared the roles of CysLT receptor type 1 (CysLTR1) and leukotriene C4 synthase (LTC4S) gene polymorphisms in two major @Chemical$-related allergic diseases, aspirin-intolerant asthma (@Disease$) and aspirin-induced chronic urticaria/angioedema (AICU)."	0
"In contrast, ASA aggravated significantly @Disease$-induced lesions, and this was accompanied by a fall in the GBF, suppression of @Chemical$ E(2) generation, and significant rise in ROS chemiluminescence and in plasma TNFalpha and IL-1beta levels."	0
BACKGROUND/AIMS: The differences in the severity of @Disease$ induced by @Chemical$ and non-aspirin non-steroidal anti-inflammatory drugs (NSAIDs) remain unclear.	1
"A randomized, double-blinded, placebo-controlled, multicenter trial, healing effect of @Chemical$ in patients with low-dose aspirin and/or non-steroidal anti-inflammatory drug induced @Disease$."	0
The effect of leukotriene-modifier drugs on @Chemical$-induced @Disease$ and rhinitis reactions.	1
"CONCLUSIONS: Preoperative @Chemical$ use in all patients undergoing cardiac operations was not associated with risks of major cardiac, cerebral, or @Disease$ and death; however, the risk of reoperation for bleeding was elevated among preoperative aspirin users compared with nonusers in a subpopulation of patients undergoing valve operations only."	0
"METHODS: 106 consecutive adults with confirmed, physician-diagnosed difficult asthma and 100 patients with @Chemical$-induced asthma underwent psychiatric interview and assessment using M.I.N.I 5.0, @Disease$ Inventory (BDI) and Panic And Agoraphobia Scale (PAS)."	0
Leukotriene CysLT1-receptor antagonism and nasal lysine-aspirin provocation in @Chemical$-induced @Disease$.	1
High on-@Chemical$ platelet reactivity predicts cardiac death in acute @Disease$ patients undergoing PCI.	0
This study was intended to compare the therapeutic effects of an H2RA and a GP against @Disease$ in patients taking @Chemical$.	1
"The management of Hp-positive @Disease$, especially in cases with additional use of aspirin or NSAIDs, was very heterogenous, including Hp-eradication only, eradication +  long-term PPI, eradication +  @Chemical$ or COX-2-inhibitors/opiates."	0
"The 1-year predicted risks associated with acetylsalicylic acid, the combination of acetylsalicylic acid and dipyridamole, and @Chemical$ were 11.1 (95% CI: 10.2-12.2), 7.7 (95% CI: 7.3-8.3), and 8.0 (95% CI: 6.9-8.7) for ischemic @Disease$, respectively; while, the risks for bleeding were 3.4 (95% CI: 2.8-3.9), 2.4 (95% CI: 2.1-2.7), and 2.4 (95% CI: 1.9-2.9), respectively."	0
"@Chemical$ for the prevention of peptic @Disease$ and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial."	0
Association of thromboxane A2 receptor (TBXA2R) gene polymorphism in patients with @Chemical$-intolerant acute @Disease$.	0
"Estimated excess major bleeding events were 1.39 (CI, 0.70 to 2.28) for GI bleeding and 0.32 (CI, -0.05 to 0.82) for @Disease$ per 1000 person-years of @Chemical$ exposure using baseline bleeding rates from a community-based observational sample."	1
Does @Chemical$ prevent @Disease$ in patients taking aspirin and clopidogrel?	0
"Lafutidine prevents low-dose aspirin and @Chemical$ induced @Disease$: a randomized, double-blinded, placebo controlled study."	1
@Chemical$ is a novel protease-activated receptor-1 (PAR-1) antagonist recently approved for the reduction of @Disease$ in patients with a history of myocardial infarction or with peripheral arterial disease.	0
"Although it is still controversial whether @Chemical$ modifiers are more effective in patients with @Disease$ compared with other types of asthma, because LT plays an important role in the pathogenesis of AIA, leukotriene modifiers are the preferred medication for the long-term control of AIA."	0
We have previously shown that @Disease$ related with corpus atrophy as well as taking PPI and co-treatment of angiotensin type 1 receptor blocker seem to reduce peptic ulcer among @Chemical$ users.	0
"Subjects with @Disease$ had significantly lower mean postbronchodilator percent predicted FEV(1) compared with subjects with non-@Chemical$-sensitive asthma (75.3% vs 79.9%, P &lt; .001)."	0
"Although the pathogenic mechanisms of this condition are still unknown, AERD may be due, at least in part, to an imbalance in eicosanoid metabolism (increased production of @Chemical$ (CysLTs) and reduced biosynthesis of prostaglandin (PG) E2), possibly increasing and perpetuating the process of @Disease$."	0
"In contrast to NSAID-induced gastrointestinal ulcers, a well-tolerated histamine H2-receptor antagonist is reportedly effective in prevention of @Chemical$-induced gastrointestinal @Disease$s."	0
A retrospective subgroup analysis of data from the CONSENSUS II study demonstrated that the 6-month mortality rate of patients with @Disease$ (MI) who received enalapril and aspirin was higher than the combined mortality rates of patients receiving @Chemical$ or aspirin alone.	0
"@Chemical$ has been studied as a primary prevention method for multiple diseases, mainly @Disease$ and various forms of cancer."	0
Data on the chemopreventative role of these drugs on the risk of the upper aerodigestive tract cancer (@Chemical$) are @Disease$ and mostly refer to oesophageal cancer.	0
"Failure of eradication and concomitant use of NSAIDs, however, account for most cases of recurrent @Disease$ with low-dose @Chemical$."	0
"BACKGROUND: Aspirin-exacerbated respiratory disease (@Disease$) is explained in part by overexpression of 5-lipoxygenase and leukotriene C4 synthase (LTC4S), resulting in constitutive overproduction of @Chemical$ (CysLTs) and driving the surge in CysLT production that occurs with aspirin ingestion."	0
"BACKGROUND: @Chemical$-exacerbated respiratory disease (AERD) is characterized by progressive sinusitis, @Disease$, and asthma that begins and continues in the absence of exposure to aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs)."	0
"At the 5-year follow-up, cardiovascular events were found to have developed in 11 patients (8 stroke and 3 myocardial infarction) who exhibited @Chemical$ resistance (12.1%) and in 9 (4 @Disease$ and 5 myocardial infarction) patients who did not exhibit aspirin resistance (2.4%) (P &lt; .001)."	0
"@Chemical$ exacerbated respiratory disease (AERD) is characterized as adult onset asthma, @Disease$, chronic rhinosinusitis, and hypersensitivity to a cyclooxygenase-1 (COX-1) inhibitor, viz aspirin or nonsteroidal antiinflammatory drugs (NSAIDs)."	1
"These patients were classified into three groups: Group A comprised patients with nasal polyps without asthma; Group B contained patients with nasal polyps and asthma; and Group C comprised patients with @Disease$s, asthma and @Chemical$ sensitivity."	0
Those who received aspirin or enoxaparin were less likely to experience any @Disease$ compared to those patients who received @Chemical$ ( P &lt; .05).	0
"PURPOSE OF REVIEW: @Chemical$-exacerbated @Disease$ (AERD) is a progressive inflammatory disease of the upper and lower airways characterized by marked eosinophilic nasal polyposis, asthma, and respiratory reactions to medications that inhibit the cyclooxygenase pathway."	1
We explored the effect of combined ACE-I and aspirin therapy compared to ACE-I without @Chemical$ on clinical outcomes in patients with @Disease$.	0
"At 6 months following @Chemical$, 63.4% of @Disease$ patients vs. 56% of ATA patients had symptomatic improvement."	0
BACKGROUND: @Disease$ to acetylsalicylic acid (@Chemical$) constitutes a serious problem for subjects with coronary artery disease.	1
"OBJECTIVE: We performed a long-term observation on clinical course, aspirin sensitivity, and urinary @Chemical$ in patients with aspirin-induced @Disease$."	0
"After multivariate adjustment for age, sex, current smoking, history of @Disease$ and diabetes, and @Chemical$ dose (aspirin-treated patients only), the hazard ratio for ICH in patients with an arterial versus a cardiac source was 0.74 (95% confidence interval, 0.30 to 1.82) for aspirin-treated patients and 4.34 (95% confidence interval, 0.35 to 54) for placebo-randomized patients."	0
The most probable cause of his @Disease$ is an increase in the blood level of @Chemical$ because of the inhibition of cilostazol metabolism by components of grapefruit juice.	0
We present the case of a patient taking @Chemical$ and etoricoxib who was admitted with upper digestive @Disease$ due to duodenal ulcer.	0
"@Chemical$ (acetylsalicylic acid) is a well-known nonsteroidal anti-inflammatory drug that can potentiate some acute @Disease$ and causes adverse immunological reactions collectively referred to as aspirin intolerance, a disorder that induces urticaria, asthma, and anaphylaxis in response to oral administration of the drug."	0
"@Chemical$ is an oral factor Xa (FXa) inhibitor in clinical development for @Disease$ prevention in patients with atrial fibrillation, an elderly population that frequently receives aspirin (ASA) and/or nonsteroidal anti-inflammatory drugs for concurrent illnesses."	0
"Acute @Disease$ complications are not immediate and usually follow interruption of aspirin or @Chemical$ therapy after a mean delay of 8-25 days, a time lapse consistent with normal platelet turnover required to replace the platelet pool in circulation and suggestive of a rebound phenomenon."	0
The duration of nasal @Disease$ was 10 +/- 10 years (range 0.5-30 years): PP-- 10 +/- 9; A-- 14 +/- 11; @Chemical$-- 7 +/- 7 (A/ASA-- p = 0.045).	0
"CONCLUSION: This cross-sectional survey showed that AERD is highly prevalent among adult @Disease$tics and its prevalence seems to be affected by family history of @Chemical$ hypersensitivity, history of rhinosinusitis and presence of NP."	0
"The cumulative incidences of recurrent @Disease$ in the @Chemical$ 20-mg, rivaroxaban 10-mg and aspirin groups were 1.9%, 1.6%, and 5.0%, respectively, whereas the cumulative incidences of major bleeding were 0.7%, 0.4% and 0.5%, respectively."	0
"The risk of bleeding was also increased among patients who had non-end-stage @Disease$ or required renal-replacement therapy and was further increased with @Chemical$, aspirin, or both."	0
"CONCLUSIONS: We found that the prevalence of CMBs did not increase in the group of aspirin use, and the presence of CMBs was not associated with the duration of @Chemical$ use in asymptomatic elderly subjects without a history of stroke or transient @Disease$ attack."	0
"RESULTS: The in-hospital mortality rate was 72% for ICH patients treated with @Chemical$, 41.6% for ICH patients treated with aspirin, and 35% for @Disease$ patients treated with no drugs."	0
"We compared 1- and 3-year outcomes for cerebrovascular accident (CVA), transient ischemic attack (TIA), gastrointestinal (GI) bleeding, genitourinary (GU) bleeding, any bleeding, and @Disease$ recurrence among patients receiving: none, @Chemical$, or warfarin as long-term therapies."	0
"In 2-23% of adults with @Disease$, and rarely in children with asthma, @Chemical$ (acetylsalicylic acid) and non-steroidal anti-inflammatory drugs (NSAIDs) cause asthma exacerbations."	0
"Background: @Chemical$-exacerbated respiratory disease (AERD), a syndrome that includes asthma, recurrent @Disease$, and pathognomonic reactions to aspirin and other nonselective cyclooxygenase inhibitors, is still not fully understood and lacks specific disease-modifying therapeutic options."	0
SUMMARY: The identification of genetic markers for @Chemical$-induced @Disease$ susceptibility along with in-vitro functional studies would help to elucidate the pathogenesis of the condition.	1
"Also, women had less peripheral artery disease (@Chemical$, 2.4% versus 3.7%; apixaban, 1.4% versus 3.0%), more heart failure, and higher mean CHADS2 (congestive heart failure, hypertension, age of 75 years or older, diabetes [1 point each], stroke or transient @Disease$ attack [2 points]) scores (aspirin, 2.2 versus 2.0; apixaban, 2.1 versus 2.0)."	0
"BACKGROUND: Aspirin (acetylsalicylic acid [ASA]) hypersensitivity is frequent in patients with nasal polyps (NPs) and is called @Chemical$ exacerbated respiratory disease, previously known as @Disease$."	0
Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and @Chemical$-intolerant @Disease$tic patients.	0
"The risks of suffering ischemic stroke, bleeding, or @Disease$ with warfarin, @Chemical$, or no antithrombotic treatment during 2010 were related to CHA2DS2VASc scores, age, and complicating co-morbidities."	0
"BACKGROUND: In 5-10% of adult patients with asthma, @Chemical$ and most other nonsteroidal anti-inflammatory drugs (NSAIDs) precipitate acute @Disease$tic attacks."	1
The disease represents a @Disease$ against @Chemical$ or related nonsteroidal anti-inflammatory drugs.	0
Histamine N-methyltransferase 939A&gt;G polymorphism affects mRNA stability in patients with @Chemical$-intolerant chronic @Disease$.	0
"The warfarin TTR &gt;=55% episodes were associated with a 77% lower risk of stroke/SE (relative risk=0.23 [0.18 to 0.28]) compared to never on therapy; and the warfarin TTR &lt;55% and on-@Chemical$ episodes were associated with a 20% lower and with a 26% lower risk of @Disease$/SE compared to never on therapy, respectively."	0
Significant differences in dog-days of @Disease$ were found between the aspirin and deracoxib groups whereas no significant differences were found between the @Chemical$ and placebo groups.	0
Fifty patients (39 women and 11 men) with a history of @Disease$ reaction to @Chemical$ were included in the study.	1
"There were significantly more patients who suffered GI adverse events, principally abdominal @Disease$, dyspepsia, nausea and diarrhoea, with aspirin (18.5%) than with ibuprofen (11.5%), but the difference between @Chemical$ and paracetamol (13.1%) was not significant."	0
"OBJECTIVE: We sought to determine blood and urinary levels of 9alpha,11beta-PGF(2), a major stable PGD(2) metabolite in 2 well-defined phenotypes of asthma, @Chemical$-induced asthma (@Disease$) and aspirin-tolerant asthma (ATA), and in healthy control subjects and to study the effects of aspirin on PGD(2) release."	0
There was also a significantly greater mean % PNIF response over 120 min after lysine-@Chemical$ challenge for PL (26+/-7) compared to either @Disease$ 10 mg (14+/-6) or ML 40 mg (17+/-6).	0
"Compared with @Chemical$, aspirin increases the risk of GI bleeding but not other bleeding; however, 883 patients (95% CI, 357-infinity) would need to be treated with clopidogrel versus aspirin to prevent one major GI @Disease$ episode annually at a cost of over 1 million dollars."	0
"Despite the excellent benefits, GI bleeding due to gastric/duodenal @Disease$ is a major complication in @Chemical$ users."	0
PATIENTS AND METHODS: Patients with a history of @Chemical$-induced urticaria and/or @Disease$ referred to our department between January 2000 and June 2008 for double-blind placebo-controlled reintroduction at platelet-inhibitory doses for a medical indication were enrolled in this study.	0
"METHODS: We did a prospective population-based cohort study in patients with a first transient ischaemic attack, @Disease$, or myocardial infarction treated with antiplatelet drugs (mainly @Chemical$ based, without routine PPI use) after the event in the Oxford Vascular Study from 2002 to 2012, with follow-up until 2013."	0
Four patients with the Fernand Widal syndrome developed @Disease$ after taking the usually recommended daily dose of @Chemical$ while all the control patients tolerated it.	0
"INTERPRETATION: Compared with aspirin, extended anticoagulation with once daily @Chemical$ reduces recurrent @Disease$ with a favourable benefit-risk profile."	0
"Age, male gender, Helicobacter pylori (H. pylori)infection, diabetes, chronic kidney disease (@Disease$), cirrhosis, history of uncomplicated peptic ulcer disease (PUD), and use of NSAIDs, COX-2 inhibitors, steroids, and @Chemical$ were independent risk factors for UGIB among aspirin users."	0
"RESULTS: @Chemical$ was well tolerated, without any signs of immediate or delayed hypersensitivity in aspirin- and nonsteroidal anti-inflammatory drug-induced @Disease$tic patients."	0
"DATA SOURCES: Articles evaluating aspirin for primary prevention of CVD were gathered using a MEDLINE search with the keywords aspirin review, aspirin peripheral artery disease, aspirin stroke, @Chemical$ coronary @Disease$, aspirin diabetes, aspirin primary prophylaxis, and aspirin elderly."	0
Method: Eighty-six patients with @Disease$ and asthma who were treated in the outpatient clinic during March 2015 to January 2018 were divided into asthma group(52 cases) and aspirin asthma group(34 cases) according to asthma and @Chemical$ asthma.	0
"CONCLUSIONS: In Chinese patients with atrial fibrillation, the benefits of @Chemical$ therapy for stroke prevention and @Disease$ risk are closely dependent on the quality of anticoagulation, as reflected by TTR."	0
Peripheral blood lymphocyte (PBL) cytokine expression and its relation to @Chemical$ desensitization in aspirin-sensitive patients with @Disease$ have not been studied.	0
"Before, after 120, and 240 min of DDAVP administration the following parameters were measured: @Disease$ (PA) and ATP release induced by ADP, collagen, @Chemical$ and thrombin; PFA-100 closure times (CT), factor VIII activity (FVIII:C), Von Willebrand factor antigen (VWF:Ag), collagen binding activity (VWF:CB) and blood count."	0
Combined @Chemical$ and clopidogrel in cataract surgical patients: a new risk factor for @Disease$?	0
"METHODS: Ninety-four aspirin-induced urticaria patients presenting urticaria/angioedema-induced by both @Chemical$ and NSAID (50 had underlying chronic @Disease$) and showing positive responses on oral aspirin challenge test, 76 aspirin-intolerant asthmatics with positive responses on lysine-aspirin bronchoprovocation test, and 185 normal healthy controls were enrolled."	0
Significant differences in dog-days of @Disease$ were found between the aspirin and @Chemical$ groups whereas no significant differences were found between the deracoxib and placebo groups.	0
"The patient experienced an increase in peripheral blood eosinophils during the clinical course and received @Chemical$ for the same, which resulted in the resolution of her @Disease$."	0
"Similarly, LTC4 synthase activity in platelets from AIA and @Chemical$-tolerant @Disease$tics (ATA) was reduced by approximately 50% after pre-treatment with arachidonic acid in vitro."	0
We divided the study into two phases: phase one (125 patients) where @Chemical$ was used without restrictions and phase two (110 patients) where aspirin was avoided in severe @Disease$ and primary prevention.	0
"Factors associated with an increased risk of upper GI complications during low-dose aspirin therapy include @Chemical$ dose, history of ulcer or upper GI @Disease$, age &gt; 70 years, concomitant use of NSAIDs (including COX-2-selective NSAIDs), and Helicobacter pylori infection."	0
"There was an overall 29% reduced risk of @Disease$ corresponding to @Chemical$ use (RR  = 0.71, 95% CI 0.60-0.82)."	0
"RESULTS AND DISCUSSION: Our results indicate the low incidence of @Disease$ (0.01 patient per a year), with a lower incidence in the vitamin K antagonists group than in the group with the combination of vitamin K antagonists and @Chemical$ (0.008 patient per a year versus 0.01 patient per a year)."	0
"The most significant harm associated with @Chemical$ is major bleeding, yet there is a paucity of data on @Disease$ risk in suitable community populations."	0
Spontaneous @Disease$ of the knee associated with @Chemical$ and aspirin treatment.	0
"Acetylsalicylic acid or nonsteroidal antinflammatory drug sensitivity can be manifested as acute urticaria, @Disease$, acute asthma, @Chemical$ exacerbated respiratory disease and anaphylaxis."	0
BACKGROUND: @Chemical$ @Disease$ may lead to a levodopa-resistant akinetic-rigid syndrome.	1
Patients with @Chemical$ @Disease$ can be safely challenged with aspirin.	1
"The authors prospectively examined the relation between frequency of aspirin, ibuprofen, and @Chemical$ use and risk of @Disease$ among 62,261 women aged 31-48 years at baseline (1995) in Nurses' Health Study II."	0
"Among the @Chemical$-treated patients with CHA2DS2VASc scores &gt;=2, half had possible contraindications and high risks for ischemic stroke (5.2 %), bleeding (5.0 %), and @Disease$ (19.3 %)."	0
Low-molecular-weight @Chemical$ and aspirin use in relation to pregnancy outcome in women with @Disease$ and antiphospholipid syndrome: A cohort study.	0
"AIM: To conduct a randomised, double-blind, triple-dummy, active-controlled, multicentre trial, named the PLANETARIUM study, to assess the efficacy, dose-response relationship and safety of rabeprazole for peptic @Disease$ recurrence in Japanese patients on long-term @Chemical$ therapy."	0
"We compared GI hospitalization rates among elderly patients taking @Chemical$, @Disease$, celecoxib and ASA or NS-NSAIDs and ASA."	0
RESULTS: Rebamipide significantly inhibited @Disease$ induced by LDA alone or by @Chemical$ plus clopidogrel when compared with placebo in healthy subjects.	1
"Overall, @Chemical$ and aspirin were associated with weakly increased risks of @Disease$."	0
"These associations were stronger after more than 10 years of use (@Chemical$: odds ratio (OR) = 1.8, 95% confidence interval (CI): 1.3, 2.6; aspirin: OR = 1.6, 95% CI: 1.1, 2.2) and were present for indications of headache, @Disease$, and other pain/injury."	0
"On the other hand, SA alone inhibited basal gastric motility without any effect on mucosal @Chemical$ contents, and this agent, when given together with indomethacin, prevented @Disease$ and lesion formation in response to indomethacin, without affecting the reduced PGE2 contents."	0
"Our institutional @Disease$ registry was used to identify patients 65 years old or older after a GLF while taking warfarin, clopidogrel, or @Chemical$ over a 2-year period."	0
"@Chemical$-induced @Disease$ is a distinct clinical syndrome consisting of inflammation, characterized by chronic eosinophilic rhinosinusitis with asthma and often nasal polyposis."	1
"@Disease$ (TIMI) defined minor bleeding was also significantly higher with a high dose @Chemical$ with OR: 1.22, 95 % CI: 1.02-1.47; P = 0.03."	0
Much of our understanding of cross-reacting drugs and chemicals with aspirin comes from studying @Disease$tics with @Chemical$-exacerbated respiratory disease (AERD).	0
Functional variability of the @Chemical$ A3 receptor (ADORA3) gene polymorphism in aspirin-induced @Disease$.	0
@Chemical$ for the prevention of recurrences of @Disease$ complications from long-term low-dose aspirin use.	0
"Because PGE(2) exerts a range of inhibitory actions on inflammatory leukocytes via the EP(2) receptor, its reduced expression in @Chemical$-sensitive @Disease$ may be partly responsible for the increased inflammatory infiltrate and production of cysteinyl leukotrienes that characterize aspirin-sensitive disease."	0
"Use of @Chemical$, non-steroidal anti-inflammatory drugs, and acetaminophen (paracetamol), and risk of psoriasis and @Disease$: a cohort study."	0
"Meta-analysis results showed that: (1) Compared with placebo, the incidences of total cardiovascular events (RR = 0.85, 95% CI: 0.80-0.92), stroke (RR = 0.87, 95% CI: 0.77-0.98), nonfatal @Disease$ (RR = 0.81, 95% CI: 0.70-0.95) and transient ischemic attack (RR = 0.76, 95% CI: 0.64-0.90) were significantly lower in low-dose @Chemical$ group than those in placebo control group (all P &lt; 0.05)."	0
"METHODS: Electronic databases of Pubmed, Embase and Cochrane Central Register of Controlled Trials were searched for human observations (randomised controlled trials and observational studies) comparing the long term effects of PPIs and H2RAs treatment in the prevention of @Disease$ or ulcer formation in patients on chronic @Chemical$ treatment listed up till September 30, 2016."	0
"BACKGROUND: We describe three patients with Samter's triad (nasal @Disease$, @Chemical$ intolerance, and asthma) with skull base dehiscence in whom the polyps extended into the extradural space and also resulted in hypertelorism and widening of the nasal bridge."	0
"In @Chemical$ users who suffered from upper gastrointestinal bleeding, the frequency of the TT genotype of rs2238631 and TT genotype of rs2243100 was higher than in those without @Disease$."	0
"To estimate the baseline risk of upper gastrointestinal complications according to major gastrointestinal risk factors and the excess risk attributable to @Chemical$ within levels of these factors, we used previously published meta-analyses on both absolute and relative risks of @Disease$."	0
The objective of this study was to assess whether polymorphisms in UGT1A6 and CYP2C9 genes are related to the prevalence of @Disease$ symptoms in cardiovascular patients using @Chemical$ for secondary prevention of ischaemic heart disease.	0
"We sought to compare the risk of @Disease$ due to the low (&lt;100 mg), moderate (100 to 200 mg), and high (&gt;200 mg) doses of @Chemical$ (acetylsalicylic acid [ASA]) in 192,036 patients enrolled in 31 clinical trials."	0
BACKGROUND: There are no country-based data focused on @Chemical$ (ASA)-exacerbated @Disease$ (AERD) in Turkey.	0
"BACKGROUND: Aspirin plus @Chemical$ (A+C) may be more effective than aspirin only (AO) acutely after TIA and minor @Disease$, but the risk of bleeding in the acute phase is uncertain."	0
"Among asthma phenotypes, a promoter -1993T--&gt;C SNP, which is in linkage disequilibrium with a synonymous coding 390A--&gt;G SNP in exon 1, is significantly associated with a risk of @Chemical$-induced asthma (@Disease$; P = 0.004, P(c) = 0.016)."	0
"The antithrombotic treatment actually ongoing at major @Disease$ was @Chemical$ in 44%, DT in 50%, and DAPT in 6% of cases."	0
An overproduction of leukotrienes was observed in patients with aspirin @Disease$ at baseline and following @Chemical$ challenge.	0
"BACKGROUND AND AIM: In our previous study, the SLCO1B1 521TT genotype and the SLCO1B1*1b haplotype were significantly associated with the risk of peptic @Disease$ in patients taking low-dose @Chemical$ (LDA)."	0
"The SCF/beta-actin mRNA ratios were significantly higher in ASA-hypersensitive (AH) @Disease$tics (median 0.97, range: 0.8-1.5) when compared with @Chemical$-tolerant (AT) patients (median 0.5, range: 0.1-0.7; P &lt; 0.001)."	0
This study was performed to determine whether methacholine AHR affects the response of @Disease$tics to inhaled @Chemical$.	0
Cytokine expression in peripheral blood lymphocytes before and after @Chemical$ desensitization in aspirin-exacerbated @Disease$.	0
"In case 2, premedication of misoprostol suppressed the @Disease$ and elevation of blood gliadin levels which were induced by wheat and @Chemical$ intake."	0
"OBJECTIVE: We evaluated hourly dose escalations in a subset of patients with chronic rhinosinusitis, nasal polyps, and @Disease$ who historically reacted to aspirin within 1 hour or were avoiding @Chemical$ with the goal of developing a safe and efficient desensitization protocol."	0
"OBJECTIVE: It was the aim of this study to investigate the prevalence of otologic manifestations in a cohort of Samter's syndrome patients (nasal polyps with @Disease$, @Chemical$ intolerance and asthma)."	0
"The information might be important not only to @Disease$ surgeons who take care of injured elderly, but also to geriatric physicians who prescribe warfarin/@Chemical$ to them."	0
"OBJECTIVE: We sought to determine blood and urinary levels of 9alpha,11beta-PGF(2), a major stable PGD(2) metabolite in 2 well-defined phenotypes of @Disease$, @Chemical$-induced asthma (AIA) and aspirin-tolerant asthma (ATA), and in healthy control subjects and to study the effects of aspirin on PGD(2) release."	0
OBJECTIVE: To determine the association of RGS7BP gene polymorphisms with the development of @Chemical$-exacerbated @Disease$ (AERD).	0
"The risk of upper @Disease$ increased with a higher risk score, which for NSAID users included age, male gender, anemia and concomitant use of @Chemical$ or anticoagulants."	0
"A convenience sample of patients taking warfarin, aspirin, @Chemical$ or mixed therapy presenting to the ED with @Disease$ were included and followed-up over 3-18 months."	0
Early @Chemical$ desensitization in unstable patients with @Disease$: Short and long-term efficacy and safety.	0
"ASA fitness grade, cardiovascular disease, previous history of @Disease$, angioplasty, diabetes, use of @Chemical$ antagonists, cirrhosis and type of hepatectomy were significantly different between the groups."	0
"In patients on @Chemical$, the incidence rate (30 days to 18 months) of any bleeding event was 2.57 per 100 person-years (95% CI 1.85 to 3.48) and major @Disease$ was 1.10 per 100 person-years (95% CI 0.65 to 1.74)."	0
Increased risk of @Disease$ after discontinuation of @Chemical$: a UK primary care study.	1
The median @Disease$ for the @Chemical$ group was similar to that of the A group.	0
"RESULTS: Of 147 patients who reported seeking acute medical care for their historical @Chemical$/NSAID-induced @Disease$ attacks, 101 (69%) were treated in an emergency department and released, and 46 (31%) required hospitalization."	1
"METHODS: We investigated intolerance and @Disease$ while on aspirin and @Chemical$ discontinuation using 5337 post-acute coronary syndrome patients considered appropriate for chronic antiplatelet therapy who were randomly assigned to aspirin in SYMPHONY and 2nd SYMPHONY and followed for 94 (64,157) days."	0
High levels of @Chemical$ synthase activity are associated with nasal polyp tissue from aspirin-sensitive @Disease$tics.	0
"Objectives: To investigate the association of @Chemical$ use with risk of all-cause, any cancer, gastrointestinal (GI) @Disease$, and colorectal cancer (CRC) mortality among older adults and to perform an exploratory analysis of the association of aspirin use with mortality stratified by BMI."	0
"BACKGROUND &amp; AIMS: We performed a meta-analysis of data from randomized trials to estimate the risk of all-cause mortality and bleeding (and especially gastrointestinal [GI] @Disease$) in patients treated with low doses of @Chemical$ (ASA) (75-325 mg/d), alone or in combination with other medications."	0
"CONCLUSIONS: The type of aspirin does not affect the incidence of overt @Disease$ and decreased hemoglobin, but enteric-coated @Chemical$ may be associated with an increased incidence of decreased hemoglobin."	0
"Ten polymorphic sites (ST+4, ST+7, T1, T2, T+1, V-3, V-2, V-1, V4, V5) were genotyped in 102 AIA patients, 282 @Chemical$-tolerant @Disease$ (ATA) patients and 120 control (CTR) subjects by direct sequencing."	0
@Chemical$-intolerant asthma (@Disease$) is characterized by severe asthmatic attack after ingestion of aspirin and/or non-steroidal anti-inflammatory drugs.	0
RESULTS: @Chemical$ 200 mg was proven to be well tolerated in all 30 three aspirin- and NSAID-induced @Disease$ patients.	0
"Factors independently associated with @Chemical$ use were prior aortic or peripheral intervention, drug-eluting stent implantation, @Disease$, carotid endarterectomy and time since CAD diagnosis."	0
CONCLUSIONS: A history of @Disease$ may be a useful indicator of potential @Chemical$ and allow preventative methods to be introduced.	0
"Fifteen @Chemical$ group patients and 5 omeprazole group patients had recurrent @Disease$/erosions (30.6% versus 9.1%, P=0.005)."	0
"Since @Chemical$/NSAIDs cause gastrointestinal injury, serious side effects such as @Disease$ accompanied with their usage have been frequently reported."	1
DESIGN: Prospective single-center survey of acute ischemic @Disease$ patients receiving @Chemical$ therapy.	0
"CONCLUSIONS: The decreased risk of @Disease$ of the UADT associated with the use of non-COX-2 inhibitors, NSAIDs and long-term @Chemical$ therapy warrants further exploration of the benefits vs risks of the use of these agents."	0
"The objective of this study was to investigate the association between the intake of corticosteroids, indometacin or @Chemical$ and @Disease$."	0
@Chemical$ was therefore seen to be effective for treating @Disease$ that manifested as a non-respiratory tract symptom of aspirin-exacerbated respiratory disease.	0
The mechanisms of @Chemical$-intolerant @Disease$ and its management.	1
"While the expression of the EP4 receptor in eosinophils was unaltered in @Disease$ patients, inhibition of eosinophil chemotaxis by PGE2 or the EP4 agonist @Chemical$ was less pronounced in AERD patients as compared to healthy control subjects."	0
"COX-2 selective NSAIDs, especially in patients with @Chemical$-induced @Disease$, have not been found to cross-react."	1
"Response to letter regarding article, Ischemic @Disease$ and intracranial hemorrhage with aspirin, dabigatran, and @Chemical$: impact of quality of anticoagulation control."	0
Carrying the CYP2C9 variants is reported a significantly increased risk of non-@Chemical$ NSAID-related @Disease$.	0
"Fifty-six percent of them managed aspirin @Disease$ changing the therapeutic regimen (eg, clopidogrel monotherapy and @Chemical$)."	0
Effect of inhalation aspirin challenge on exhaled @Chemical$ in patients with aspirin-inducible @Disease$.	0
"TAPT and DAPT had similar rates of bleeding, but @Chemical$ had significantly higher rates of headache, palpitation, @Disease$ and gastrointestinal side-effects."	1
"OBJECTIVE: We sought to determine blood and urinary levels of 9alpha,@Chemical$(2), a major stable PGD(2) metabolite in 2 well-defined phenotypes of asthma, aspirin-induced asthma (@Disease$) and aspirin-tolerant asthma (ATA), and in healthy control subjects and to study the effects of aspirin on PGD(2) release."	0
"Conclusion: In our study, we could not demonstrate less postoperative @Disease$ and use of blood and blood products in a group of patients who were preoperatively treated with @Chemical$ compared to patients with dual antiplatelet therapy in the elective isolated CABG surgery."	0
"In an effort to discover additional polymorphism(s), the variant(s) of which have been implicated in asthma and @Chemical$ intolerance, we scrutinized genetic polymorphisms of the CYSLTR2 gene, and evaluated this locus as a potential candidate for @Disease$."	0
"The effect of pre-operative @Chemical$ on @Disease$, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies."	0
"Low-dose @Chemical$, one of non-steroidal anti-inflammatory drugs(NSAIDs), has been increasingly used to prevent @Disease$ and cerebrovascular disease through its antiplatelet effect, mainly in the aged population, but aspirin treatment has been associated with gastrointestinal injures, especially peptic ulcer bleedings."	0
"Aspirin (@Chemical$) is a well-known nonsteroidal anti-inflammatory drug that can potentiate some acute allergies and causes adverse immunological reactions collectively referred to as aspirin intolerance, a disorder that induces @Disease$, asthma, and anaphylaxis in response to oral administration of the drug."	1
Use of @Chemical$ in conjunction with angiotensin-converting enzyme inhibitors does not worsen long-term survival in @Disease$.	0
"A 42-year-old white woman with a history of severe asthma, nasal polyps, aspirin sensitivity, and chronic @Disease$ was treated with @Chemical$ desensitization."	0
"To evaluate the @Disease$ risk in patients requiring chronic warfarin therapy and undergoing stent implantation, we compared 107 consecutive patients on chronic warfarin therapy who underwent coronary stenting and were discharged on aspirin, clopidogrel and @Chemical$ to 107 contemporary patients who were treated with aspirin and clopidogrel."	0
"Furthermore, @Disease$ patients under synthesize from arachidonic acid (AA) a peculiar product called lipoxins, which opposes inflammation generated by @Chemical$."	0
"In addition, the effects of treatment with @Chemical$, aspirin, or both in patients with @Disease$ were compared with the effects in patients with no renal disease."	0
"The important factors that increase the risk of low-dose aspirin-related ulcer complications include a history of bleeding peptic ulcer, prior peptic @Disease$, age &gt; 70 years, H pylori infection, and concomitant drug therapy with non-steroidal anti-inflammatory drugs, other antiplatelet agents (e.g., @Chemical$) or anticoagulants."	0
RESULTS: A 57-year-old woman with a perimesencephalic pattern of @Disease$ and negative CT angiography was treated with carbasalate calcium and intravenous @Chemical$ because of an acute coronary syndrome.	0
"OBJECTIVES: To evaluate if esomeprazole prevents recurrent peptic @Disease$ in adult patients with a history of peptic ulcer receiving low-dose @Chemical$ (ASA, aspirin) for cardiovascular protection in East Asia."	0
"CONCLUSION: TNF-alpha -863A and -1031C increased the risk of UGIB induction by enteric-coated @Chemical$ in @Disease$ patients, whereas TNF-alpha -857C &gt; T was not correlated with the UGIB risk."	0
"This study evaluated associations between the clinical requirement for LTRA and genetic polymorphisms of the ALOX5, LTC4S, COX-2, CysLTR1 and TBXA2R genes in the @Chemical$ cascade in the long-term management of 89 @Disease$ patients from a Korean population."	0
An overproduction of leukotrienes was observed in patients with @Chemical$ @Disease$ at baseline and following aspirin challenge.	1
"Indeed, @Chemical$ withdrawal has been associated with an increased risk of @Disease$ both in clinical and fundamental research studies."	0
@Chemical$ induces IL-4 production: augmented IL-4 production in aspirin-exacerbated @Disease$.	0
"It can be concluded that ASA and @Chemical$ administered either alone or in combination can cause @Disease$ in the rat stomach after 6 h and 18 h, but less severe after 6 days."	0
"The new class of NO releasing NSAIDs, including NO-@Chemical$, represent a very promising approach to reducing the @Disease$ of anti-inflammatory drugs."	0
CONCLUSIONS: The use of local administration of @Chemical$ indicated the reduction of @Disease$ even in patients with preoperative aspirin use.	0
"These recent results suggest that care must be exercised in the use of selective cyclo-oxygenase-2 inhibitors by individuals who are at increased risk of myocardial infarction and @Disease$, and the use of low-dose @Chemical$ by these patients may place them at increased risk of gastrointestinal complications."	0
"Currently, @Disease$ randomised control trial data exists to recommend universal use or avoidance of @Chemical$ for primary prevention of cardiovascular events in CKD."	0
"The patients were classified into two groups based on the type of low-dose aspirin that they had been prescribed (enteric-coated @Chemical$ group or buffered aspirin group), and evaluated the numbers of @Disease$ and the Lewis score."	0
Clopidogrel appears to be associated with fewer UGI side effects and @Disease$ compared with @Chemical$.	0
BACKGROUND: In this study we assessed patient outcomes after complete endoscopic sinus surgery (ESS) and aspirin desensitization for patients with @Chemical$-exacerbated @Disease$ (AERD).	0
"We report the case of a 60 year old woman, suffering for 8 years from @Chemical$-induced asthma, having an airway @Disease$."	0
Oral @Chemical$ challenge (OAC) reveals aspirin-exacerbated respiratory disease (AERD) in approximately 50% of unselected patients with chronic rhinosinusitis with @Disease$ (CRSwNP).	0
"Data Sources: We searched PubMed, Embase, CENTRAL, and ClinicalTrials.gov from inception to May 28, 2018, with the terms novel oral anticoagulants, non-vitamin K antagonist oral anticoagulants, direct oral anticoagulants, dabigatran, rivaroxaban, apixaban, edoxaban, warfarin, Coumadin, vitamin K antagonist, aspirin, @Chemical$, or ASA, and major bleeding, fatal bleeding, or @Disease$."	0
"AIM: To assess endoscopically-proven @Disease$ and the amount of gastric microbleeding of four different buffered and plain acetylsalicylic acid formulations, one containing @Chemical$."	0
Stopping @Chemical$ before coronary artery surgery: between the devil and the @Disease$.	0
"METHODS: To assess response to medical therapy in patients taking @Chemical$ prior to admission with an acute @Disease$, we reviewed outcomes data from the Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-wave Coronary Events (ESSENCE) and Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) studies."	0
"RESULTS: The final analysis included 1470 study participants: 221 controls, 553 CRS without nasal polyps (CRSsNPs), 651 CRS with nasal polyps (@Chemical$wNPs) and 45 @Disease$ (AFRS)."	0
"Compared with @Chemical$ alone, the combination increased modified International Society on Thrombosis and Hemostasis major @Disease$ (288 of 9,152 [3.1%] vs. 170 of 9,126 [1.9%]), (HR: 1.70; 95% CI: 1.40 to 2.05; p &lt; 0.001), International Society on Thrombosis and Hemostasis major bleeding (206 of 9,152 [2.3%] vs. 116 of 9,126 [1.3%]), (HR: 1.78; 95% CI: 1.41 to 2.23; p &lt; 0.0001), and minor bleeding (838 of 9,152 [9.2%] vs. 503 of 9,126 [5.5%]), (HR: 1.70; 95% CI 1.52 to 1.90; p &lt; 0.0001); the combination also increased the need for any red cell transfusion (87 of 9,152 [1.0%] vs. 44 of 9,126 [0.5%]), (HR: 1.97; 95% CI 1.37 to 2.83, p = 0.0002)."	0
BACKGROUND: @Chemical$ is used in the secondary prevention of @Disease$.	0
"In univariate analysis, only combined pre-treatment with @Chemical$ and clopidogrel treatment were associated with the occurrence of s@Disease$."	1
"Results 3366 of 19,925 (16.9%) @Chemical$ treated patients experienced recurrent myocardial infarction, @Disease$, or cardiovascular death."	0
AIM: To determine @Disease$ prevalence and incidence in a population representative of those given @Chemical$ therapy and evaluate risk predictors.	0
"Type 2 inflammation characterizes aspirin-exacerbated respiratory disease.Objectives: To determine whether high-dose aspirin therapy changes biomarkers of type 2 @Disease$ in @Chemical$-exacerbated respiratory disease.Methods: Forty-two subjects with aspirin-exacerbated respiratory disease underwent an aspirin desensitization and were placed on high-dose aspirin (1,300 mg daily)."	1
"However, @Chemical$/aspirin was associated with a significantly higher incidence of gastric and duodenal @Disease$s than aspirin alone."	0
"Before, after 120, and 240 min of DDAVP administration the following parameters were measured: platelet aggregation (PA) and ATP release induced by ADP, collagen, ristocetin and thrombin; @Chemical$-100 closure times (CT), factor VIII activity (FVIII:C), @Disease$ factor antigen (VWF:Ag), collagen binding activity (VWF:CB) and blood count."	0
"CONCLUSIONS: Low-dose @Chemical$ increases the risk of major @Disease$ by approximately 70%, but the absolute increase is modest: 769 patients (95% CI, 500-1250) need to be treated with aspirin to cause one additional major bleeding episode annually."	1
@Chemical$ usage was more common than NSAID in patients with ulcer @Disease$ (NSAID usage n=35 (40%); ASA usage n=51 (60%); p=0.035).	0
Our aim to assess the prevalence of upper gastrointestinal lesions and the effect of aspirin on the @Disease$ in asymptomatic subjects taking minidose @Chemical$ (100 to 325 mg per day) for more than 3 months.	0
CONCLUSIONS AND CLINICAL RELEVANCE: @Chemical$ administration resulted in @Disease$ in healthy dogs as indicated by an increase in MA and plasma fibrinogen concentration and a decrease in antithrombin activity.	0
"Concentrations of urinary @Chemical$ (uLTE4) were measured by ELISA and plasma stable prostaglandin D2 metabolite, 9alpha,11beta prostaglandin F(2) by GC/@Disease$."	0
CONCLUSIONS: There is high mortality rate associated with ASA or @Chemical$ or both in elderly patients who have head trauma resulting in @Disease$.	0
"CONCLUSIONS: Low-dose aspirin use could reduce the incidences of total cardiovascular events, @Disease$, nonfatal stroke and transient ischemic attack but increase the risk of bleeding, the incidence of nonfatal myocardial infarction, death from cardiovascular causes and death from any cause was not affected by low-dose @Chemical$ use."	0
"Meta-analyses of randomized, placebo-controlled trials of low-dose @Chemical$ indicate that aspirin approximately doubles the risk of major @Disease$ compared with placebo."	0
These findings have implications for clinical benefits of aspirin desensitization in @Chemical$-sensitive patients with @Disease$.	0
"OBJECTIVE: To determine whether @Chemical$, a selective cyclooxygenase 2 (COX-2) inhibitor, cross-reacts in patients with aspirin-exacerbated respiratory disease (AERD) with @Disease$."	0
"When other possible causes of @Disease$ were excluded, the association of migraine with the protracted vasoconstriction of ergotamine, able per se to damage the capillary endothelium, and an altered local hemostasis induced by @Chemical$ remained as the most probable mechanism of brain bleeding."	0
"Although alterations in @Chemical$ metabolites play a role in @Disease$, other immune or inflammatory mechanisms may be involved."	0
"Arachidonic acid (AA, 0.5 mg/mL) and @Chemical$ (ADP, 5 micromol/L) induced @Disease$ were measured via light transmission assay (LTA) to evaluate antiplatelet responses, referred as LTA-AA and LTA-ADP."	0
"CONCLUSIONS: The combination of rivaroxaban and @Chemical$ compared with aspirin alone increased major @Disease$, mainly from the GI tract."	1
"The full clinical picture reveals a classic triad of symptoms (Samters Triad): aspirin induced bronchial asthma (with severe acute asthma attacks), @Chemical$-sensitivity and chronic @Disease$ with nasal polyps."	0
"OBJECTIVE: To determine whether @Chemical$, a selective cyclooxygenase 2 (COX-2) inhibitor, cross-reacts in patients with aspirin-exacerbated respiratory disease (@Disease$) with asthma."	0
"To evaluate the @Disease$ risk in patients requiring chronic @Chemical$ therapy and undergoing stent implantation, we compared 107 consecutive patients on chronic warfarin therapy who underwent coronary stenting and were discharged on aspirin, clopidogrel and warfarin to 107 contemporary patients who were treated with aspirin and clopidogrel."	0
"Established risk factors for GI ulcer development include advanced age, history of @Disease$ or GI bleed, concomitant use of corticosteroids or anticoagulants, high-dose @Chemical$/NSAID therapy, and possibly concomitant Helicobacter pylori infection."	0
We studied the incidence of @Disease$ in high-risk patients taking long-term low-dose aspirin or non-@Chemical$-NSAIDs combined with omeprazole in a real-life clinical setting.	0
METHODS: Adults with CAD under @Chemical$ therapy (100 mg once daily) presenting to the emergency department with upper gastrointestinal hemorrhage were retrospectively recruited and divided into group A (ischemia) and group B (non-@Disease$).	0
Aspirin-induced asthma (AIA) and @Chemical$-induced urticaria/ angioedema (AIU) are two major aspirin-related @Disease$.	0
"Following @Chemical$ administration, we noted an improvement in the QOL and @Disease$ subjective parameters, and an objective improvement in spirometrical measurements and in the doses of oral corticosteroids."	0
"RESULTS: Of 8754 Chinese patients with @Disease$ and CHA2DS2-VASc &gt;=1 (79.5+-9.2 years; CHA2DS2-VASc, 4.1+-1.5; and Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile International Normalized Ratio, Elderly (&gt;65 years), Drugs/Alcohol Concomitantly [HAS-BLED], 2.2+-0.9), 16.3% received warfarin, 41.1% @Chemical$, 4.5% dabigatran, and 38.1% received no therapy."	0
"AREAS COVERED IN THIS REVIEW: A number of risk factors can be used to determine which patients are more likely to develop @Chemical$-associated @Disease$, mainly in the upper GI tract; these include a previous GI ulcer, ulcer complications, dyspepsia, and concomitant drug therapy with non-steroidal anti-inflammatory drugs (NSAIDs) or clopidogrel."	1
The results indicated that lyophilized aspirin/trehalose induced less @Disease$ than @Chemical$ despite maintaining therapeutic concentrations of plasma aspirin in both the groups.	0
"The effects of pranlukast on changes in sputum LTC(4)-LTD(4), eosinophil cationic protein (ECP), eosinophil count, urinary LTE(4)/creatinine, 11-dehydrothromboxane B(2) (@Chemical$(2))/creatinine, serum LTC(4)-LTD(4), ECP, and peripheral blood eosinophil count, during immediate asthmatic reaction (IAR) and late @Disease$tic reaction (LAR) in the HDM group and during IAR in the ASA group for each test, were compared in each group."	0
"BACKGROUND: Leukotrienes (@Chemical$) are important in asthma, and LT modifiers modulate antigen-induced @Disease$."	0
OBJECTIVE: To estimate the bleeding risk of combined anticoagulant (rivaroxaban or enoxaparin-vitamin K antagonist [VKA]) and NSAID or @Chemical$ therapy in patients with @Disease$.	0
"CONCLUSIONS: In DES-treated patients on prolonged DAPT, major @Disease$ occurring at 1 year and up to 4 years following DES implantation in patients on prolonged @Chemical$ is associated with poor long-term prognosis."	0
"OBJECTIVE: It was the aim of this study to investigate the prevalence of otologic manifestations in a cohort of Samter's syndrome patients (nasal polyps with chronic rhinosinusitis, @Chemical$ intolerance and @Disease$)."	0
"Although acetylsalicylic acid is prescribed for a broad range of diseases, it can induce a wide array of clinically recognized hypersensitivity reactions, including @Chemical$-intolerant asthma (@Disease$) with rhinitis and aspirin-intolerant urticaria (AIU) with anaphylaxis."	0
"CONCLUSIONS: @Chemical$ and enoxaparin conferred similar bleeding risks, and both exhibited less @Disease$ than patients who received rivaroxaban."	0
"We report the case of a 59-year-old female with hypertension, admitted to the coronary care unit for acute @Disease$ and treated with tissue-type plasminogen activator 100 mg in 90 min, intravenous heparin 25,000 U, aspirin 100 mg, and @Chemical$ 50 mg orally once daily."	0
"(3) The patients with @Disease$ (n = 7), but not those with aspirin-tolerant asthma (n = 6), showed significant increases in LTBG and LTE4 excretions after @Chemical$ challenge."	0
Risk factors for @Disease$ in @Chemical$ users: review of clinical and experimental data.	1
"Proton-pump inhibitor treatment resulted in an absolute risk reduction of peptic @Disease$ by 36.6% in acute and 34.6% in chronic non-steroidal anti-inflammatory drugs/@Chemical$ users; indeed, the number needed to treat to avoid one peptic ulcer in elderly non-steroidal anti-inflammatory drugs/aspirin users was three both in acute and chronic users."	0
"To reduce @Disease$ events by informing best evidence for physicians prescribing @Chemical$, guidelines were published some years ago."	0
METHODS: Thirty-five patients who took low-dose enteric-coated @Chemical$ 100 mg daily (for more than 3 months) plus omeprazole 20 mg daily and were diagnosed as having @Disease$ participated in this prospective randomized controlled trial.	0
"Although knowledge about endoscopic characteristics of @Chemical$ associated ulcers is limited, the ulcers have common distinctive feature that sudden gastrointestinal bleedings or latently advanced-anemia are often the earliest symptom because aspirin-induced ulcers often exist without symptoms of @Disease$."	0
PPI vs. teprenone in preventing recurrence of @Disease$ during low-dose @Chemical$ - authors' reply.	1
A recent study by Chan et al. concluded that a combination of aspirin and @Chemical$ is superior to clopidogrel in the prevention of recurrent @Disease$ bleeding.	0
"@Chemical$-exacerbated respiratory disease (AERD) is an adult-onset condition that manifests as asthma, @Disease$, and sensitivity to aspirin and other cyclooxygenase-1 (COX-1)-inhibitor nonsteroidal anti-inflammatory drugs (NSAIDs)."	0
Testing for @Chemical$ @Disease$.	1
Low-dose @Chemical$ (ASA) has emerged as one of the most important causes of peptic ulcer @Disease$ in developed countries.	1
"Univariate analysis showed that continuous aspirin use was not significantly associated with @Disease$ complications (odds ratio, 0.933; 95% confidence interval, 0.283-3.074; P = .910 in the aspirin and control groups) and that discontinuous aspirin use was not significantly associated with bleeding complications (odds ratio, 0.963; 95% confidence interval, 0.230-4.025; P = .959 in the @Chemical$ and control groups; odds ratio, 0.969; 95% confidence interval, 0.198-4.752; P = .969 in the aspirin and discontinuous groups)."	0
"Primary end points were pre-discharge hematuria necessitating the restoration of bladder irrigation or the cessation of aspirin treatment and late @Disease$ treated in an urgent care setting, requiring hospital admission or compelling the cessation of @Chemical$ treatment."	0
Whether the prostacyclin-inhibiting effects of @Chemical$ attenuate some of the beneficial effects of ACE inhibitors mediated by prostacyclin stimulation in @Disease$ patients is currently unknown.	0
A pilot study of resistance to @Chemical$ in @Disease$ patients.	0
"METHODS: A total of 11 @Chemical$-sensitive patients with asthma, 10 aspirin-tolerant patients with asthma, and 10 controls without @Disease$ were studied."	0
"Dual antiplatelet therapy consisting of low-dose aspirin (@Chemical$) and other antiplatelet medications is recommended in patients with @Disease$, but it may increase the risk of esophageal lesion and bleeding."	0
"The aim of this study was to estimate the association of @Chemical$-induced @Disease$, as well as H. pylori infection, with gastric acid output."	1
Early effects of aspirin desensitization treatment in asthmatic patients with @Chemical$-exacerbated @Disease$.	0
"An increased excretion of LTE4 and 9alpha,@Chemical$ has been detected in a patient who suffered an @Disease$ attack after percutaneous administration of nonsteroidal anti-inflammatory drugs."	0
This study investigated the association between serum albumin level and @Disease$ events in this population.Methods and Results:We enrolled 438 consecutive patients who were prescribed dual APT (DAPT; @Chemical$ and thienopyridine) beyond 1 month after successful PCI without adverse events.	0
"However, the prevalence of @Disease$ was not different between the @Chemical$ group and the control group."	0
"RESULTS: The final analysis included 1470 study participants: 221 controls, 553 CRS without nasal polyps (CRSsNPs), 651 @Chemical$ with @Disease$ (CRSwNPs) and 45 allergic fungal rhinosinusitis (AFRS)."	1
"Data Sources: We searched PubMed, Embase, CENTRAL, and ClinicalTrials.gov from inception to May 28, 2018, with the terms novel oral anticoagulants, non-vitamin K antagonist oral anticoagulants, direct oral anticoagulants, dabigatran, rivaroxaban, apixaban, @Chemical$, warfarin, Coumadin, vitamin K antagonist, aspirin, acetylsalicylic acid, or ASA, and major @Disease$, fatal bleeding, or intracranial hemorrhage."	0
"BACKGROUND: The safety of @Chemical$ in @Disease$ (HF) has been called into question, particularly in those patients (1) without coronary disease, (2) with renal dysfunction, or (3) treated with low-dose angiotensin-converting enzyme (ACE) inhibitors and high-dose aspirin."	0
"The results showed that patients who used @Chemical$ after diagnosis had a RR of 0.73 (95 % CI = 0.54-0.98, P = 0.04) for @Disease$-specific mortality compared to those who did not use aspirin."	0
"PATIENTS/METHODS: Ovid MEDLINE, Embase and the Cochrane Library, up to September 2011, were searched for RCTs comparing @Disease$ rates in adult patients randomized to warfarin, target International Normalized Ratio (INR) 2.0-3.5, and @Chemical$, 50-650 mg daily, with at least 3 months of follow-up."	0
IL-1beta also induced expression of EP2 in fibroblasts from control NM but not in fibroblasts from NPs of @Chemical$-tolerant nonasthmatic patients or those with @Disease$.	0
[Acute @Disease$ in a patient in treatment with apixaban and @Chemical$].	0
"OBJECTIVE: To determine whether celecoxib, a selective cyclooxygenase 2 (COX-2) inhibitor, cross-reacts in patients with @Chemical$-exacerbated respiratory disease (@Disease$) with asthma."	0
"Although treatment and prevention for low-dose aspirin (@Chemical$) induced @Disease$ is important problem, significance of H. pylori eradication has not been clarified."	1
AIM: To compare the healing rate in @Chemical$-related dyspeptic @Disease$ patients who were given proton pump inhibitor (PPI) plus aspirin or PPI plus clopidogrel.	0
"@Chemical$-exacerbated @Disease$ is a chronic and treatment-resistant disease, characterized by the presence of eosinophilic rhinosinusitis, nasal polyposis, bronchial asthma, and nonsteroidal anti-inflammatory drugs hypersensitivity."	1
[Iatrogenic dementia and @Disease$: rare adverse effect of @Chemical$-aspirin combination].	0
"Compared with current users of low-dose @Chemical$, those who discontinued treatment 31-180 days before the index date had a significantly increased overall risk of IS/@Disease$ (RR 1.40; 95% CI 1.03-1.92)."	0
"Found low compliance of admission to long-term acetylsalicylic acid (@Chemical$) in patients with @Disease$ (ACS): 74.9% of patients reported that the suspended or completely stopped taking the drug, and only 16.2% were fully committed to the long-term therapy with ASA."	0
"In Japan, the preventive strategies upon the prescription of NSAIDs/@Chemical$ are expected to spread rapidly because the use of proton pump inhibitors for the prevention of recurrence of NSAID- or LDA-induced @Disease$ and the use of COX-2 for the palliation of acute pain were recently approved under the national health insurance system."	0
Large-scale trials are warranted to determine the safety and efficacy of @Chemical$ desensitization therapy in patients with concomitant @Disease$ because data are currently limited to small case series.	0
Subgroup analysis revealed that there was a higher rate of @Disease$ expansion in the clopidogrel cohort (p=0.034) than in the cohort of patients receiving @Chemical$ alone.	0
"We sought to assess the performance of existing bleeding risk scores, such as the Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/@Chemical$ Concomitantly (HAS-BLED) score or the Outpatient Bleeding Risk Index (OBRI), in patients with @Disease$ with reduced ejection fraction (HFrEF) in sinus rhythm (SR) treated with warfarin or aspirin."	0
"We investigated the risks of ischemic @Disease$ and intracranial hemorrhage (ICH) in relation to warfarin at various TTRs in a real-world cohort of Chinese patients with atrial fibrillation receiving @Chemical$ and compared with those on dabigatran, aspirin, and no therapy."	0
"Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and @Chemical$ in patients with @Disease$."	0
"Although co-therapy with a PPI and the eradication of H. pylori substantially reduce the risk of recurrent ulcer @Disease$ with aspirin, the replacement of aspirin by @Chemical$ cannot be recommended to patients with a high gastrointestinal risk."	0
We investigated the role of serum specific IgE to thyroid peroxidase (TPO) in patients with aspirin intolerant acute urticaria (AIAU) and @Chemical$ intolerant chronic urticaria (@Disease$).	0
"Conclusion: In sum, our study provides the valuable information for the impact of @Chemical$, NSAID, statin, and COX-2 inhibitor on the risk of prostate, kidney, and @Disease$ development and its survival outcomes."	0
"At 3 years, 238 (5.9%) patients were on warfarin, 743 (18.6) on @Chemical$, and 3,013 (75.5%) on no therapy; with occurrences of CVA/TIA (1.4%, 3.0%, 3.9%, P &lt; 0.0001, respectively), GI @Disease$ (0.8%, 1.9%, 1.1%, P = 0.06, respectively), and GU bleeding (1.7%, 2.8%, 2.1%, P = 0.008, respectively) that increased with advancing CHA2 DS2 VASc score."	0
"Although it is difficult to solely attribute intratumoral @Disease$ to @Chemical$, we have to be careful when prescribing aspirin for patients who have asymptomatic meningioma."	1
Comparison of @Disease$ according to use of @Chemical$ in lumbar fusion patients.	0
BACKGROUND: @Chemical$-intolerant @Disease$ (AIA) refers to the development of bronchoconstriction in asthmatic individuals following the ingestion of aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs).	0
AIM: To investigate the role of the @Chemical$-rich water (HRW) in the prevention of aspirin-induced @Disease$ in rats.	0
No @Disease$ was seen among @Chemical$ users.	0
"Response to letter regarding article, Ischemic @Disease$ and intracranial hemorrhage with @Chemical$, dabigatran, and warfarin: impact of quality of anticoagulation control."	0
"BACKGROUND: If percutaneous coronary intervention (PCI) is required in patients taking oral anticoagulants, antiplatelet therapy with @Chemical$ and clopidogrel is indicated, but such triple therapy increases the risk of serious @Disease$."	0
AIMS: Low-dose aspirin (@Chemical$) and non-steroidal-anti-inflammatory drugs (NSAIDs) both increase the risk of @Disease$ (UGIEs).	1
"There is a well-recognized association of aspirin sensitivity, @Chemical$-induced @Disease$, nasal polyposis or sinusitis, known as Samter's triad."	1
Double consecutive retrobulbar @Disease$ in a high-risk patient in treatment with aspirin and @Chemical$.	0
"@Chemical$ intolerance, house dust mite (@Disease$) allergy, male sex, age older than 65 years, and duration of asthma exceeding 10 years were investigated as factors potentially related to the severity of asthma."	0
"Upper gastrointestinal @Disease$ is a serious complication, but had low case fatality in trials of @Chemical$ and is not generally thought to cause long-term disability."	0
Low dose @Chemical$ administration has been generally accepted as prophylactic therapy for myocardial infarction and @Disease$.	0
"These patients were classified into three groups: Group A comprised patients with nasal polyps without asthma; Group B contained patients with @Disease$s and asthma; and Group C comprised patients with nasal polyps, asthma and @Chemical$ sensitivity."	0
CONCLUSION: Low-dose @Chemical$ delayed the early phase of the healing process in the @Disease$ after H. pylori eradication.	0
Sinonasal outcomes after endoscopic sinus surgery in asthmatic patients with nasal polyps: a difference between aspirin-tolerant and @Chemical$-induced @Disease$?	1
"@Chemical$ showed pro@Disease$ properties in the same model of induced thrombosis that were very similar to those described after aspirin withdrawal, but the effect was observed only 1 hour after aspirin administration."	0
"Owing to the complexity of drug combination, the protective mechanism of PNS on @Chemical$-induced @Disease$ remains unclear."	1
"RESULTS: The in-hospital mortality rate was 72% for @Disease$ patients treated with warfarin, 41.6% for ICH patients treated with @Chemical$, and 35% for ICH patients treated with no drugs."	0
"OBJECTIVE: To investigate the incidence, clinical characteristics and risk factors of upper gastrointestinal bleeding (UGIB) in patients with @Disease$ (ACS) who were administrated with @Chemical$ and clopidogrel dual antiplatelet therapy after percutaneous coronary intervention (PCI)."	0
Proton pump inhibitors in prevention of low-dose @Chemical$-associated @Disease$.	1
Diminished PGE2 regulation in @Chemical$-exacerbated respiratory disease (@Disease$) leads to respiratory reactions on cyclooxygenase 1 inhibition.	0
[Role of proton pump inhibitor in the management of low dose @Chemical$ related @Disease$ations].	1
Gastric @Disease$ model was established by intragastric infusion of @Chemical$ (420 mg/kg).	0
BACKGROUND: Chronic inflammation with tissue eosinophilia plays a key role in the pathogenesis of @Disease$ and nasal polyps in patients with @Chemical$ hypersensitivity.	0
"It has been proposed that overproduction of cys-LTs, together with removal by aspirin/NSAIDs of the 'brake' imposed by the bronchodilator @Chemical$, may cause an asthma attack in patients with @Disease$."	0
Drug-eluting stents in a patient with @Disease$: is the @Chemical$ administration safe?	0
"We compared 1- and 3-year outcomes for cerebrovascular accident (CVA), transient ischemic attack (TIA), gastrointestinal (GI) bleeding, genitourinary (GU) bleeding, any @Disease$, and AF recurrence among patients receiving: none, aspirin, or @Chemical$ as long-term therapies."	0
"The haplotype of block 3 may play a protective role against @Chemical$ @Disease$ asthma, perhaps by altering the responsiveness of muscarinic receptors."	1
Previous @Disease$ history was identified as a risk factor for peptic ulcer and upper gastrointestinal bleeding during low-dose @Chemical$ therapy.	0
"CONCLUSIONS: Both @Chemical$ and NSAIDs are risk factors for upper GI @Disease$ in patients with gastroduodenal ulcer, while ACs are unrelated to the increased risk."	1
"To investigate the relationship between single-nucleotide polymorphisms (SNPs) in the RAB1A gene and aspirin-exacerbated respiratory disease (AERD), @Disease$tics (n=1197) were categorized into AERD and @Chemical$-tolerant asthma (ATA)."	0
"However, patients in the @Chemical$ group had less @Disease$ than did patients in the aspirin group (1.5% vs 4.9%, P=0.035)."	0
We evaluated the efficacy of @Chemical$ and famotidine in preventing recurrent @Disease$/erosions in low-dose aspirin users.	0
"@Chemical$-sensitive asthma is often accompanied by severe @Disease$ and recurrent nasal polyposis, causing significant impairment of patients' quality of life."	0
METHODS: Patients with aspirin-related nonbleeding symptomatic @Disease$s were randomised to receive rabeprazole (20 mg/day) plus aspirin (100 mg/day) or rabeprazole (20 mg/day) plus @Chemical$ (75 mg/day) for 12 weeks.	0
Is the cause of @Disease$ due only to @Chemical$ use?	0
"RESULTS: Among the patients using @Chemical$, the prevalence of open @Disease$ was significantly lower in the patients using PPIs than in those using mucosal protective agent only and those not receiving antiulcer treatment (p&lt;0.001)."	0
"Two single nucleotide polymorphisms (SNP) of cyclooxygenase-1 (COX-1), A-842G and C50T, exhibited increased sensitivity to aspirin and had lower @Chemical$ synthesis capacity, lacking statistical significance in the association with bleeding peptic @Disease$."	0
OBJECTIVE: The purpose of this study is to estimate urinary LTB4 glucuronide (@Chemical$) concentration in the clinically stable condition in healthy subjects and asthmatic patients and to investigate changes in urinary LTBG concentration in patients with @Disease$ after aspirin challenge.	0
"Aspirin, but not other NSAID use, was associated with about 20% lower risk of postmenopausal breast cancer and did not vary by ER or PR status of the tumor, suggesting that the hypothesized protective effects of @Chemical$ may either be through cellular pathways independent of estrogen or progesterone signaling, or on @Disease$ microenvironment."	0
Recently we found it necessary to use packing for persistent brisk @Disease$ during 'vaginal hysterectomy' in a patient on @Chemical$ therapy for heart disease.	0
"Conventionally, hypersensitivities include @Chemical$-exacerbated @Disease$ (AERD), ASA-induced urticaria, and anaphylaxis."	1
Aspirin and @Chemical$ in @Disease$.	0
This study evaluated the association between genetic TBXA2R variants and the development of acetyl salicylic acid (@Chemical$)-intolerant acute @Disease$ (AIAU).	0
"@Chemical$, also known as fish oil, have been used for hyperlipidemia, @Disease$, hypertension, and other conditions."	0
Perfusion of the stomach with acidified ASA or @Chemical$ under histamine-stimulated acid secretion caused minimal @Disease$ in the stomach with few lesions.	0
Antral @Chemical$(2)-basal levels appear to be critical for development of aspirin-induced @Disease$ in subjects without H. pylori infection.	0
@Disease$ patients are treated with antiplatelet drugs like aspirin and @Chemical$ to prevent a secondary stroke.	0
"Within 90 days after intervention, there were 4 patients (1.5%) with acute thrombosis, 5 patients (1.8%) with subacute thrombosis, 17 patients (6.2%) with stroke, and 2 @Disease$ (0.7%) in low-dose aspirin group, compared with no patient (0%) with acute thrombosis, 2 patient (2.1%) with subacute thrombosis, 6 patients (6.2%) with stroke, and 2 death (2.1%) in high-dose @Chemical$ group, and there were no significant difference in all study endpoints between two groups."	0
"CONCLUSIONS: Despite trends indicating increased rebleeding rates and a lower incidence of permanent disability due to delayed @Disease$, there was no significant effect of previous @Chemical$ use on overall outcome following aneurysmal SAH."	0
"OBJECTIVE: Aspirin exacerbated respiratory disease (AERD) is comprised of aspirin/@Chemical$ (ASA) sensitivity, bronchial asthma, and @Disease$."	0
A disease marker for @Chemical$-induced @Disease$.	1
"CONCLUSIONS: Low-dose @Chemical$ use could reduce the incidences of total cardiovascular events, stroke, nonfatal stroke and transient ischemic attack but increase the risk of bleeding, the incidence of @Disease$, death from cardiovascular causes and death from any cause was not affected by low-dose aspirin use."	1
"METHODS: In total, 154 @Disease$ patients taking enteric-coated @Chemical$ were enrolled in this study."	0
"CONCLUSIONS: For the treatment of high-risk @Disease$ or minor stroke patients, the clopidogrel-aspirin treatment did not increase the number of CMB than @Chemical$ alone."	0
"QUESTION/PURPOSES: We sought to answer four questions: For the THA and TKA cohorts, respectively, (1) was the incidence of readmission resulting from @Disease$ and bleeding complications higher with LMWH than mobile compression plus ASA; and (2) was the incidence of wound bleeding complications higher with @Chemical$ than mechanical compression plus ASA?"	0
Risk of uncomplicated peptic @Disease$ among users of @Chemical$ and nonaspirin nonsteroidal antiinflammatory drugs.	0
"The pathogenesis of aspirin-exacerbated respiratory disease (@Disease$) is thought to be based on, mainly, overproduction of @Chemical$ lipid mediators and on defective anti-inflammatory regulators."	0
"We retrospectively reviewed the medical records for bleeding complications in 182 patients, most with @Disease$ (mean age 61 +/- 11 years, 82% men) and being treated with high-dose fish oil (mean dose 3 +/- 1.25 g), @Chemical$ (mean dose 161 +/- 115 mg), and clopidogrel (mean dose 75 mg), and in 182 age- and gender-matched controls treated with aspirin and clopidogrel alone."	0
Recent cohort studies have shown that the relative risk of @Disease$ bleeding with low-dose aspirin was comprised between 2 and 4 and the absolute risk comprised between 1 per 100 and 1 per 1000 @Chemical$ users per year.	0
The possible additive antiplatelet effects of aspirin and clopidogrel have been explored in the Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) and Management of @Disease$ with @Chemical$ in High Risk Patients (MATCH) studies.	1
Sputum biomarkers during @Chemical$ desensitization in nonsteroidal anti-inflammatory drugs exacerbated @Disease$.	0
BACKGROUND: We aimed to investigate how high-dose ecabet sodium affects low-dose @Chemical$-induced @Disease$ in healthy volunteers.	1
"CONCLUSION: The chronic @Disease$ and coronary heart disease patients with long-term oral administration of low dose of @Chemical$ can be safely treated with periodontal mechanical treatment, and the effect of local hemostasis is positive without stopping the drug."	0
NSAIDs-including aspirin (@Chemical$)-that inhibit cyclooxygenase (COX)-1 induce nonallergic hypersensitivity reactions consisting of attacks of rhinitis and @Disease$.	0
"OBJECTIVES: To identify the reasons of using @Chemical$, endoscopic findings on @Disease$ caused by ASA and the relative risk of developing mucosal lesions."	0
"CONCLUSIONS: In new patients presenting with @Disease$, there is a significantly high frequency of antecedent exposure to NSAIDs or @Chemical$, supporting the concept that these agents may be important in the pathogenesis of colitis."	0
"QUESTION/PURPOSES: We sought to answer four questions: For the THA and TKA cohorts, respectively, (1) was the incidence of readmission resulting from VTE and @Disease$ complications higher with @Chemical$ than mobile compression plus ASA; and (2) was the incidence of wound bleeding complications higher with LMWH than mechanical compression plus ASA?"	0
"Of these 52 cases, there were 22 nasal polyposis cases with aspirin sensitivity, 15 nasal polyposis cases without aspirin sensitivity and 15 chronic @Disease$ cases without @Chemical$ sensitivity."	0
Relapsed spontaneous spinal epidural @Disease$ associated with @Chemical$ and clopidogrel.	1
The authors comprehensively discuss provocation tests with @Chemical$ as the most reliable method to confirm the diagnosis of @Disease$.	0
"After adjusting for potential confounders, including age, smoking and previous cataract surgery, @Chemical$ use was associated with early @Disease$ (OR 1.50; 95% CI: 1.01 to 2.22)."	1
"From time to time, several cases have been reported in which statins or @Chemical$s have been associated with the development of acute @Disease$."	0
"Aspirin (acetylsalicylic acid)-induced asthma (@Disease$) consists of the clinical triad of asthma, chronic rhinosinusitis with nasal polyps, and precipitation of asthma and rhinitis attacks in response to @Chemical$ and other NSAIDs."	0
"Reyes's syndrome, @Disease$, hyperammonemia and @Chemical$ ingestion in a city hospital of Buenos Aires, Argentina."	0
AIMS: To review the current knowledge of the benefits and risks of long-term @Chemical$ therapy for the prevention of @Disease$.	0
"CONCLUSIONS: We found that the prevalence of CMBs did not increase in the group of aspirin use, and the presence of @Chemical$ was not associated with the duration of aspirin use in asymptomatic elderly subjects without a history of @Disease$ or transient ischemic attack."	0
"@Disease$ to inhaled allergens, hypersensitivity to @Chemical$ are factors significantly worsening the course of CRSwNP."	0
Daily low-dose @Chemical$ (ASA) is prescribed to patients with @Disease$ frequently to prevent vascular complications.	0
"Factors associated with an increased risk of aspirin-related upper GI complications are still being elucidated but most importantly include a prior history of ulcer or GI @Disease$, @Chemical$ dose, and concomitant use with an NSAID, anticoagulant, or additional antiplatelet drug."	0
"Conclusions and Relevance: A 15-mg to 20-mg dose of rivaroxaban once daily is associated with substantially increased risks of @Disease$, while smaller daily doses of rivaroxaban and @Chemical$ were not, implying that risk increase is dose dependent."	0
"CONCLUSIONS: The majority of the adverse events caused by aspirin are GI @Disease$, and there appears to be no valid evidence that the overall frequency of fatal GI bleeds is increased by @Chemical$."	0
Conclusions and Relevance: These results suggest that @Chemical$ therapy can be maintained prior to thyroid surgery without increased intraoperative @Disease$.	0
OBJECTIVE: Low-dose @Chemical$ (LDA) is widely used because it reduces the risk of vascular events in patients with @Disease$.	0
"Also, the pharmacists should be especially careful for @Disease$ development within two years after administration of low-dose @Chemical$, regardless of combined whether H2RA or PPI."	0
OBJECTIVE: Patients using acetylsalicylic acid (@Chemical$) have an increased risk of @Disease$ discomfort.	1
"Management of NSAID/@Chemical$-induced small intestinal damage by GI-sparing NSAIDs, anti-@Disease$ drugs and food constituents."	0
Randomized controlled trials reporting @Disease$ rates in adult patients randomized to a VKA (INR 2-3) or to @Chemical$ alone (&lt;325mg daily).	0
Association of angiotensin I-converting enzyme gene polymorphisms with @Chemical$ intolerance in @Disease$tics.	0
Eradication of H. pylori infection before @Chemical$ use could reduce the incidence of upper @Disease$ complications by 25-30%.	0
"BACKGROUND/AIMS: To determine the association between @Chemical$ use and @Disease$ (DR) among persons with diabetes, in a population-based, cross-sectional study."	0
"According to @Disease$ standard of care, patients were treated with aspirin and/or low-molecular weight heparin (@Chemical$) at prophylactic (pure obstetric APS) or therapeutic doses (history of thrombosis)."	0
"Conclusion Our findings support the safety of antithrombotic therapy with @Chemical$ and/or LMWH during pregnancy in high-risk women with @Disease$, and highlight the need for better treatments to improve pregnancy outcomes in APS."	0
OBJECTIVE: To quantify the risk of @Disease$ (ICBs) associated with new use of prophylactic low-dose @Chemical$ using a population-based primary care database in the United Kingdom.	0
"Although knowledge about endoscopic characteristics of L-ASA associated ulcers is limited, the ulcers have common distinctive feature that sudden gastrointestinal bleedings or latently advanced-anemia are often the earliest symptom because @Chemical$-induced @Disease$ often exist without symptoms of dyspepsia."	1
"CONCLUSIONS: Among @Chemical$ users with a history of lower GI bleeding, continuation of aspirin is associated with an increased risk of recurrent lower @Disease$, but reduced risk of serious cardiovascular events and death."	0
"CONCLUSIONS: The majority of the adverse events caused by aspirin are GI bleeds, and there appears to be no valid evidence that the overall frequency of fatal GI @Disease$ is increased by @Chemical$."	0
"METHODS: Ninety-four aspirin-induced urticaria patients presenting urticaria/angioedema-induced by both @Chemical$ and NSAID (50 had underlying chronic urticaria) and showing positive responses on oral aspirin challenge test, 76 aspirin-intolerant @Disease$tics with positive responses on lysine-aspirin bronchoprovocation test, and 185 normal healthy controls were enrolled."	0
Coated (56%) and plain (63.6%) @Chemical$ induced @Disease$ with similar frequency.	1
Risk of @Disease$ with low-dose @Chemical$ alone and in combination with clopidogrel and other medications.	1
"OBJECTIVES AND SCOPE: To review the clinical evidence for, and the pharmacodynamic basis of, ASA-induced gastroduodenal @Disease$ in comparison with NSAIDs, and address the question of whether low-dose @Chemical$ is 'safe' from a gastroduodenal perspective."	0
"@Disease$ events occurred in 6 patients on ASA 81 mg+@Chemical$ (26%; 0.42 events per patient year; mean INR at event, 2.2), 4 patients on ASA 81 mg (22%; 0.38 events per patient year; mean INR at event, 2.0), and in 38 patients on ASA 325 mg (54%; 1.4 events per patient year; mean INR at event, 2.2); P = 0.004."	0
"Further, male gender, old age, @Chemical$-lowering drugs, baseline @Disease$, and myocardial bridge were independent predictors of CAS."	0
"Furthermore, it has been demonstrated that chronic use of low dose @Chemical$ results in a variety of lesions in the lower GI tract, including multiple petechiae, erosions, @Disease$, diverticular bleeding and even circumferential ulcers with stricture."	1
METHODS: The clinical records of 207 @Disease$tic patients who underwent inhalation challenges with both aspirin and @Chemical$ were reviewed retrospectively.	0
"@Disease$ formed in a total of seven patients (3.5%), five of whom were on DAPT consisting of ASA and @Chemical$ (P &lt; 0.0001) while only two of them were on warfarin (P = 0.67)."	1
BACKGROUND: @Chemical$-exacerbated respiratory disease (@Disease$) refers to the development of bronchoconstriction in asthmatics following the ingestion of aspirin.	0
One patient had @Disease$ on day 14 after restarting @Chemical$ in addition to their aspirin.	1
Clopidogrel plus @Chemical$ in acute coronary syndrome patients with @Disease$ to aspirin undergoing percutaneous coronary intervention.	0
Cytokine expression in peripheral blood lymphocytes before and after aspirin desensitization in @Chemical$-exacerbated @Disease$.	0
@Chemical$-Tris conjugation is an effective approach through which the @Disease$ side-effects of ASA are controlled by decreasing the cytokine-mediated progression of pro-inflammatory events.	0
We compared @Disease$ and all-cause mortality after dual antiplatelet therapy (@Chemical$) for the combination of clopidogrel and aspirin (ASA) versus ASA alone over 18 months follow-up in event-free patients at 12 months DAPT from the Health Insurance Review and Assessment (HIRA) dataset via the Korean Outcomes Registry Evaluating Antithrombotics (KOREA).	0
"Compared with those who held or never took aspirin, patients continuing @Chemical$ had similar rates of overall @Disease$ complications (27% vs 15% vs 14%, p = 0.13), hemoglobin drop &gt;3 g/dL (24% vs 15% vs 14%, p = 0.24), and postoperative blood transfusion (4% vs 3% vs 2%, p = 0.43)."	0
AIM: To assess primary care physician perceptions of non-steroidal anti-inflammatory drug (NSAID) and @Chemical$-associated @Disease$.	1
"OBJECTIVE: To compare expression of cysLT 1 and cysLT 2 on leukocytes, mucus glands, and epithelium in 32 patients with chronic polypoid @Disease$ (21 @Chemical$-sensitive, 11 aspirin-tolerant) and 9 normal controls."	0
Objective:The aim of this study is to observe the effects of asthma and @Chemical$ @Disease$ on chronic rhinosinusitis and to explore the corresponding clinical value.	1
"In conclusion, we found a significant association between @Chemical$ use and deep or infratentorial microbleeds, but this association may reflect the presence of @Disease$ as a confounding factor."	0
"Type 2 inflammation characterizes aspirin-exacerbated @Disease$.Objectives: To determine whether high-dose aspirin therapy changes biomarkers of type 2 inflammation in aspirin-exacerbated respiratory disease.Methods: Forty-two subjects with aspirin-exacerbated respiratory disease underwent an @Chemical$ desensitization and were placed on high-dose aspirin (1,300 mg daily)."	0
@Chemical$ sensitivity and desensitization for @Disease$ and sinusitis.	1
Adjusted HRs for clopidogrel versus the combination of acetylsalicylic acid and @Chemical$ were 1.02 (95% confidence interval [CI]: 0.89-1.17) for ischemic stroke and 1.06 (95% CI: 0.83-1.35) for @Disease$.	0
ASA-@Chemical$ conjugation is an effective approach through which the @Disease$ side-effects of ASA are controlled by decreasing the cytokine-mediated progression of pro-inflammatory events.	0
Dietary modifications toward a diet that is high in omega-3 fatty acids and low in omega-6 fatty acids can reduce the production of the inflammatory leukotriene and @Chemical$ and help improve symptoms for patients with @Disease$.	0
"PURPOSE OF REVIEW: This review summarizes the latest information on the appropriate identification, evaluation, and treatment of patients with nonsteroidal anti-inflammatory drug (NSAID)-exacerbated @Disease$ (NSAID-ERD), also known as @Chemical$-exacerbated respiratory disease (AERD)."	0
"Recent evidence showed that among patients with a history of @Chemical$-associated ulcer @Disease$, the long-term incidence of recurrent bleeding with ASA use is low after eradication of H. pylori alone."	0
"@Disease$ to acetylsalicylic acid (@Chemical$) is characterized by the co-occurrence of symptoms so-called aspirin triad, which include bronchial asthma, chronic rhinitis and sinusitis and the nasal mucosa polyps."	1
Combined clopidogrel-@Chemical$ treatment for high risk TIA or minor @Disease$ does not increase cerebral microbleeds.	0
"Although major or minor @Disease$ was common (12.6%), only 1.0% of @Chemical$-treated patients were reported to discontinue due to bleeding."	0
BACKGROUND: @Chemical$ and other nonsteroidal anti-inflammatory drugs (NSAIDs) can precipitate adverse reactions in two apparently different clinical conditions: bronchial asthma and chronic idiopathic urticaria (@Disease$).	0
Risk factors for @Disease$ common to apixaban and @Chemical$ were use of nonstudy aspirin&gt;50% of the time and a history of daily/occasional nosebleeds.	1
There is also considerable evidence that @Chemical$ may entirely neutralize the clinical benefits of angiotensin-converting enzyme inhibitors in patients with @Disease$.	0
"Although low-dose acetylsalicylic acid (@Chemical$) is recommended for prevention of cardiovascular events in at-risk patients, its long-term use can be associated with the risk of @Disease$ (GI) symptoms that may impact treatment compliance."	1
Prevalence and independent factors for gastroduodenal @Disease$/erosions in asymptomatic patients taking low-dose aspirin and gastroprotective agents: the @Chemical$ study.	0
"Patients who are on chronic warfarin therapy and receive a coronary stent need to be treated with the triple therapy of @Chemical$, clopidogrel and warfarin; however, the @Disease$ risk in these patients is unknown."	0
CE is useful to diagnose @Disease$ enteropathy associated with @Chemical$.	1
"CONCLUSION: Using simple serum measurement of H. pylori antibody and pepsinogen concentrations, an extremely high-risk group for LDA-induced @Disease$ could be extracted, and these patients should become a therapeutic target for prevention of @Chemical$-induced gastropathy."	0
"Majority of peptic @Disease$s induced by @Chemical$ were shallow, and independent on H. pylori infection."	1
"Low-dose @Chemical$ use increase the risk of developing a major @Disease$ 1.33-fold (95% CI = 1.13-1.55, P&lt;0.0001)."	1
A meta-analyses was then performed to estimate the risk of fatal gastrointestinal @Disease$ attributable to low-dose @Chemical$.	0
"Within 90 days after intervention, there were 4 patients (1.5%) with acute thrombosis, 5 patients (1.8%) with subacute thrombosis, 17 patients (6.2%) with @Disease$, and 2 death (0.7%) in low-dose aspirin group, compared with no patient (0%) with acute thrombosis, 2 patient (2.1%) with subacute thrombosis, 6 patients (6.2%) with stroke, and 2 death (2.1%) in high-dose @Chemical$ group, and there were no significant difference in all study endpoints between two groups."	0
"BACKGROUND: It is debated whether in patients with chronic @Disease$ (CHF), @Chemical$ may contrast the clinical benefits of angiotensin-converting enzyme inhibitors (ACEIs)."	0
"Type 2 inflammation characterizes aspirin-exacerbated respiratory disease.Objectives: To determine whether high-dose aspirin therapy changes biomarkers of type 2 @Disease$ in aspirin-exacerbated respiratory disease.Methods: Forty-two subjects with aspirin-exacerbated respiratory disease underwent an aspirin desensitization and were placed on high-dose @Chemical$ (1,300 mg daily)."	0
BACKGROUND: The role of @Chemical$ metabolites in NSAID-induced @Disease$ has been studied in depth for NSAID-exacerbated respiratory disease (NERD) and NSAID-exacerbated cutaneous disease (NECD).	0
@Chemical$ could reduce cardiovascular complications and yet might increase risk of @Disease$.	1
"The aim of this study is to report the sinonasal outcomes of endoscopic sinus surgery (ESS) in treating NP in @Disease$tic patients, comparing aspirin-induced asthmatic (AIA) patients with @Chemical$-tolerant asthmatics (ATA)."	0
Patients receiving apixaban plus @Chemical$ had a similar @Disease$ risk compared with those receiving thienopyridine plus aspirin.	1
"METHOD: We classified 1,041 gastroduodenal ulcer patients into three groups [patients taking LDA (group A), patients taking nonaspirin nonsteroidal anti-inflammatory drug (NSAID) (group N), and patients taking neither @Chemical$ nor nonaspirin NSAID (group C)] and 241 bleeding gastroduodenal @Disease$ patients into three corresponding groups (groups a, n, and c)."	0
"@Chemical$ appears to be very effective in reducing both acute @Disease$ and upper GI bleeding in the high-risk patient taking low-dose aspirin, but data with other anti-ulcer agents are lacking (misoprostol) or inconsistent (ranitidine) at present."	0
Bleeding complications in @Disease$ surgery are associated with warfarin but not @Chemical$ therapy.	0
"CONCLUSIONS: @Chemical$ intake overall was not associated with early AMD in this sample of Asian Indians, but in those with a history of cardiovascular disease the association between aspirin intake and early @Disease$ might warrant further investigation."	0
"CONCLUSION: Coupling of NO to @Chemical$ attenuates stress, ischemia-reperfusion, and ethanol-induced damage due to mucosal hyperemia mediated by NO, which compensates for prostaglandin @Disease$ induced by ASA."	0
"The pathogenesis of aspirin-exacerbated @Disease$ (AERD) is thought to be based on, mainly, overproduction of eicosanoid @Chemical$ mediators and on defective anti-inflammatory regulators."	0
"A 78-year-old woman visited a local clinic because of @Disease$, and was prescribed levofloxacin, carbocisteine, and cold medicine (salicylamide, acetaminophen, anhydrous caffeine, @Chemical$)."	0
"@Disease$ events occurred in 6 patients on ASA 81 mg+dipyridamole (26%; 0.42 events per patient year; mean INR at event, 2.2), 4 patients on @Chemical$ 81 mg (22%; 0.38 events per patient year; mean INR at event, 2.0), and in 38 patients on ASA 325 mg (54%; 1.4 events per patient year; mean INR at event, 2.2); P = 0.004."	0
"RESULTS: After 2 weeks of treatment, the percentages of subjects with small @Disease$ were 80% in the @Chemical$ group compared with 20% in the Control group (p = 0.023)."	0
"Low-dose aspirin also reduces the recurrence of advanced @Disease$s (RR, 0.66 [95% CI, 0.44-0.99]); however, @Chemical$ indicated lack of firm evidence for a beneficial effect."	0
"TAPT and @Chemical$ had similar rates of bleeding, but TAPT had significantly higher rates of @Disease$, palpitation, rash and gastrointestinal side-effects."	0
@Chemical$-induced asthma (AIA) is a distinct clinical entity characterised by hypersensitivity to aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) typically occurring in the form of @Disease$ and severe rhinosinusitis.	0
"RESULTS: LMWH and @Chemical$ was prescribed in 15/109 @Disease$ women without antiphospholipid antibodies (aPL), 5/14 with aPL, 11/13 with APS, 45/48 with primary APS."	0
Antiplatelet efficacy of @Chemical$ was assessed by its effect on spontaneous and ADP- induced @Disease$.	0
"@Chemical$-exacerbated respiratory disease (AERD) is characterized by chronic rhinosinusitis with nasal polyps, @Disease$, and reactions to cyclooxygenase-1-inhibiting drugs."	0
"The use of aspirin, aspirin plus extended-release dipyridamole, or @Chemical$ is recommended as initial therapy in patients with noncardioembolic ischaemic stroke or TIA to reduce the risk of recurrent @Disease$ and other cardiovascular events."	0
"CASE REPORT: We present the case of a 56-year-old woman with a long history of @Disease$ and abuse of @Chemical$ and antiinflamatory drugs who was admitted for generalized seizures, right hemiparesis and coma."	1
CONCLUSION: Endoscopy frequently reveals low-dose @Chemical$-induced gastroduodenal injuries in patients with @Disease$.	0
[Comparative assessment of antiaggregant efficacy of acetylsalicylic acid and @Chemical$ in peripheral @Disease$].	0
METHODS: Two hundred consecutive subjects suffering from stable @Disease$ and under daily @Chemical$ therapy were enrolled in our study.	0
The study was designed to determine the effect of @Chemical$ desensitization on T-lymphocyte cytokine expression and on plasma lipoxin levels in @Disease$.	0
The risk of readmission resulting from @Disease$ and venous thromboembolism (VTE) has also not been determined for patients undergoing THA or TKA when treated with low-molecular-weight heparin (LMWH) alone compared with mechanical prophylaxis plus aspirin (@Chemical$).	0
"Use of non-@Chemical$ nonsteroidal anti-inflammatory drugs for more than 1 year was not associated with a reduced risk of @Disease$ (OR=1.00 (95% CI: 0.84, 1.17), and the corresponding estimate among users with at least 2 years duration was similar."	0
The combination of @Chemical$ plus clopidogrel increases the risk of UGI @Disease$.	1
"The triad of bronchial @Disease$, nasal polyposis, and intolerance to @Chemical$ and aspirin-like chemicals are designated aspirin-induced asthma (AIA) or Samter's syndrome."	0
CONCLUSION: @Chemical$ resistance is associated with higher lipid levels and inflammatory and @Disease$ risk factors and lower GFRs in renal transplant recipients.	1
BACKGROUND CONTEXT: @Chemical$ is typically discontinued in spinal surgery because of increased risk of @Disease$.	1
AIM: To determine the rate of endoscopic gastric/duodenal @Disease$s (GDUs) associated with use of aspirin (81 mg q.d.) alone or coadministered with @Chemical$ or naproxen.	0
"[@Chemical$-induced @Disease$: clinical presentation, pathogenesis and treatment]."	1
"Aspirin (@Chemical$)-exacerbated respiratory disease (AERD) is characterized by upper airway congestion due to @Disease$ of the nasal and sinus membranes and nasal polyposis, associated with increased leukotriene production that is further accentuated by ASA or other nonsteroidal anti-inflammatory drug (NSAID) ingestion."	0
CONCLUSIONS: @Chemical$ resistance is associated with increased clinical severity and @Disease$ infarct volume in acute stroke patients.	0
"We compared GI hospitalization rates among elderly patients taking celecoxib, NS-NSAIDs, @Chemical$ and ASA or @Disease$ and ASA."	0
[The study of 18 cases of aspirin @Disease$ at dermatology of Yodogawa Christian Hospital--on the difference between @Chemical$ asthma and aspirin urticaria].	0
CONCLUSION: Baseline FEV1 and lower lung function after treatment were clinical factors indicating a poor prognosis of @Chemical$-exacerbated @Disease$.	0
Risk of uncomplicated peptic @Disease$ among users of aspirin and non@Chemical$ nonsteroidal antiinflammatory drugs.	0
"In conclusion, any form of @Chemical$, even controlled-release, should not be prescribed for patients with @Disease$, because it may provoke symptoms of intolerance to this drug."	1
Most patients with @Chemical$ sensitivity are able to undergo desensitization therapy safely and successfully except in cases of chronic idiopathic @Disease$.	0
Omalizumab for @Chemical$-@Disease$ and Leukotriene Overproduction in Aspirin-Exacerbated Respiratory Disease: A Randomized Trial.	1
The lesions of redness or small erosions in the @Chemical$ and the combined groups tended to exist in the proximal part of @Disease$.	0
Classifying the type of NSAID hypersensitivity is important because many patients with a prior history of @Disease$ or angioedema induced by multiple NSAIDs will often tolerate @Chemical$ test dose.	0
"The full clinical picture reveals a classic triad of symptoms (Samters Triad): aspirin induced bronchial asthma (with severe acute asthma attacks), @Chemical$-sensitivity and chronic rhinosinusitis with @Disease$."	0
Combined toxicity of penicillin and @Chemical$ therapy may elicit @Disease$.	1
It is common practice to replace @Chemical$ with clopidogrel in patients with @Disease$ intolerance to aspirin.	0
"Ischemic stroke and @Disease$ with aspirin, @Chemical$, and warfarin: impact of quality of anticoagulation control."	0
We aimed to assess the presence of apoptotic cells in nasal @Disease$ from aspirin-hypersensitive (AH) and @Chemical$-tolerant (AT) patients with rhinosinusitis as related to the characteristics of local inflammation.	0
[@Chemical$-intolerance (@Disease$): an important differential diagnosis for chronic airway diseases].	0
[Oral @Chemical$ caused @Disease$ in a child].	1
Conclusion: Prognostic bleeding risk models were developed that can be used to estimate the absolute @Disease$ harms of aspirin among persons in whom @Chemical$ is being considered for the primary prevention of CVD.	0
UNLABELLED: Prior meta-analysis and observational studies have suggested that the @Disease$ risks associated with anticoagulation using @Chemical$ antagonists (VKA) or aspirin (ASA) are similar.	0
"We therefore investigated the efficacy of @Chemical$, a well-tolerated histamine H(2)-receptor antagonist, in the prevention of peptic @Disease$ and erosive oesophagitis in patients receiving low-dose aspirin for vascular protection."	0
We found there are nonlinear frequency-risk and linear duration-risk relations between @Chemical$ use and @Disease$.	1
Variance analysis of the correlation between HP infection and LDA by regional Lanza scores identified both HP @Disease$ and @Chemical$ use as factors that significantly influence the antral Lanza score.	0
@Chemical$ (ASA) is an important cause of asthma so that ASA induced @Disease$ (AIA) is considered a disease.	0
"Considering the patient's previous history of @Disease$ disorders prior to initiation of treatment and Hp(+) serology, it appears that decreasing risk of symptomatic or complicated gastro-duodenal ulcer was higher in treatment with @Chemical$ in patients who did not have a previous history of ulcer, whatever their Hp status."	0
BACKGROUND: Aspirin-exacerbated @Disease$ (AERD) is characterized by the development of airway obstruction in asthmatic individuals following the ingestion of @Chemical$ or other nonsteroidal anti-inflammatory drugs.	0
Despite of a rapid decline of @Chemical$ serum levels further @Disease$ occurred.	1
"METHODS AND MATERIALS: We compared the effect of NO-ASA and ASA on gastric lesions provoked by @Chemical$-immersion and restraint stress (WRS), @Disease$-reperfusion, and 100% ethanol."	0
"The risk of perioperative @Disease$ is high in patients who take aspirin and @Chemical$ after a percutaneous coronary intervention, and whether to stop the drugs is a matter of concern for dentists."	0
"CONCLUSIONS: In addition to reducing the risk of gastrointestinal bleeding, statistically significant benefits with prophylactic @Chemical$ use on both @Disease$ and nonpain symptoms were evident at 4 weeks and sustained through 24 weeks."	0
"@Chemical$-exacerbated respiratory disease (@Disease$) is a clinical syndrome characterized by severe persistent asthma, hyperplastic eosinophilic sinusitis with nasal polyps, and an intolerance to aspirin and other NSAIDs that preferentially inhibit COX-1."	0
"METHODS: Ninety-four @Chemical$-induced urticaria patients presenting urticaria/angioedema-induced by both ASA and NSAID (50 had underlying chronic urticaria) and showing positive responses on oral aspirin challenge test, 76 aspirin-intolerant @Disease$tics with positive responses on lysine-aspirin bronchoprovocation test, and 185 normal healthy controls were enrolled."	0
"In the present study, endoscopic examination was performed to investigate the frequency of gastroduodenal injuries associated with low-dose @Chemical$ in patients with @Disease$."	0
Clinical features of @Disease$ associated with long-term low-dose @Chemical$ therapy.	1
Other NSAIDs and @Chemical$ were not associated with @Disease$ risk in either cohort.	0
BACKGROUND: We previously reported that the ILVBL gene on chromosome 19p13.1 was associated with the risk for aspirin-exacerbated respiratory disease (@Disease$) and the percent decline of forced expired volume in one second (FEV1) after an oral @Chemical$ challenge test.	0
OBJECTIVE: To investigate the relationship between @Chemical$ resistance and clinical and neuroimaging measures of @Disease$ severity in acute stroke patients.	0
"Atopic patients aged 20-79 years with aspirin-exacerbated @Disease$ diagnosed by systemic @Chemical$ challenge were randomized (1:1) to 3-month treatment with omalizumab or placebo, followed by >18-week washout period (cross-over design)."	0
BACKGROUND: The A to C transversion in the promoter region of the gene encoding leukotriene C4 synthase (LTC4S) is proposed to be associated with the development of @Chemical$-induced @Disease$ (AIA).	1
"Among patients with H. pylori infection and a history of @Disease$ bleeding who continue to use low-dose @Chemical$, 1 week of eradication therapy prevents recurrent ulcer bleeding."	0
"Aspirin exacerbated respiratory disease is characterized by recalcitrant sinusitis/polyposis, @Disease$ and precipitation of asthma after ingestion of @Chemical$ and most NSAIDs."	0
[Bleeding complications after treatment with @Chemical$ and acetylsalicylic acid after acute @Disease$].	0
Potential benefits from using low-dose @Chemical$ with a PPI in patients previously experiencing @Disease$ ulcers while taking NSAIDs remains to be proven.	0
BACKGROUND: Patients with aspirin-exacerbated @Disease$ (AERD) also recently known as nonsteroidal anti-inflammatory drug (NSAID) exacerbated respiratory disease (NERD) must avoid @Chemical$ and all other oral NSAIDs.	0
"Answer to the Letter to the Editor of Liang Ding et al. concerning Comparison of @Disease$ according to use of @Chemical$ in lumbar fusion patients (by Park HJ, Kwon KY, Woo JH (2014) Eur Spine J. doi:10.1007/s00586-014-3294-y)."	0
METHODS: The single-nucleotide polymorphisms in HSPA1B-179C&gt;T and 1267A&gt;G gene were examined in patients with AERD and those with @Chemical$-tolerant @Disease$ (ATA).	0
@Chemical$ is considered a first-line therapy for patients with mild-to-moderate joint @Disease$.	0
Frequency of @Chemical$-induced asthma with clinical symptoms amounted to 1.9% of @Disease$tics.	0
The possible additive antiplatelet effects of @Chemical$ and clopidogrel have been explored in the Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) and Management of @Disease$ with Clopidogrel in High Risk Patients (MATCH) studies.	0
"Associations of several HLA alleles with subtypes of AI, such as aspirin-induced @Disease$ and aspirin-induced asthma, and single nucleotide polymorphisms in genes encoding enzymes involved in @Chemical$ metabolism have been shown."	0
BACKGROUND: The effects of @Chemical$ in subjects without @Disease$ are controversial.	0
"The median intraoperative @Disease$ (600 ml versus 450 ml, P = 0.56), median postoperative blood loss (800 ml versus 790 ml, P = 0.60), blood transfusion requirements (25.1% versus 24.4%, P = 0.76) and composite outcome of in-hospital death, stroke and reoperation for bleeding (2.8% versus 1.6%, P = 0.10) were similar in @Chemical$ and nonaspirin use group."	0
[Protective effect of compound @Chemical$ and magnesium granules on aspirin-induced @Disease$ in rats].	0
CONCLUSION: @Chemical$ desensitization following ESS appears to be a well-tolerated and effective adjunctive therapy for long-term control of nasal polyposis in patients with @Disease$.	0
@Disease$ associated with low-dose @Chemical$ use: relevance and management in clinical practice.	0
"BACKGROUND: The use of @Chemical$ and other non-steroidal anti-inflammatory drugs (NSAIDs) has been associated with reduced @Disease$ risk, but it is not known if this association extends to women at familial or genetic risk."	0
"CONCLUSIONS: Taken together, this study shows an increased release of the recently discovered lipid mediator EXC4, as well as the main indicator of 15-LO activity, 15-HETE, in activated eosinophils from severe and aspirin-intolerant @Disease$tics, and also elevated EXC4 and LTC4 formation in eosinophils from AIA patients after cellular activation in the presence of @Chemical$-aspirin."	0
"Aspirin-exacerbated diseases are important examples of drug hypersensitivities and include aspirin-exacerbated @Disease$ (AERD), @Chemical$- or non-steroidal anti-inflammatory drug (NSAID)-induced urticaria/angioedema, and aspirin- or NSAID-induced anaphylaxis."	0
@Chemical$ for prevention and resolution of @Disease$ in patients treated with low-dose acetylsalicylic acid for cardiovascular protection: the OBERON trial.	0
OBJECTIVE: To determine whether the risk of @Disease$ in patients taking low dose @Chemical$ (&lt;= 325 mg/day) is increased in people with Helicobacter pylori infections.	0
"OBJECTIVE: The objective of this study was to determine if Aggrenox was associated with @Disease$ and to determine whether it was acetylsalicylic acid, @Chemical$ or the combination that led to decline in renal function."	0
"@Chemical$ (100 and 200 mg bid, 400 mg qd) rapidly and nearly completely inhibited ADP-induced @Disease$ after initial dosing (day 1) and at day 28."	1
"In 73 patients, 23 with previous coronary stent @Disease$ (ST) (ST group) and 50 without coronary ST (control group), platelet aggregation was measured 3 times in monthly intervals using light transmission aggregometry (@Chemical$ [ADP] and arachidonic acid induction)."	0
"CONCLUSION: Patients with @Chemical$ abuse have atypical, often multiple, intractable @Disease$ with many complications."	1
"Thus, test-and-treat H. pylori is a potentially useful strategy for @Chemical$ users with high @Disease$ risk."	0
"Within 90 days after intervention, there were 4 patients (1.5%) with acute thrombosis, 5 patients (1.8%) with subacute thrombosis, 17 patients (6.2%) with stroke, and 2 death (0.7%) in low-dose @Chemical$ group, compared with no patient (0%) with acute @Disease$, 2 patient (2.1%) with subacute thrombosis, 6 patients (6.2%) with stroke, and 2 death (2.1%) in high-dose aspirin group, and there were no significant difference in all study endpoints between two groups."	0
"Although it is still controversial whether @Chemical$ modifiers are more effective in patients with AIA compared with other types of @Disease$, because LT plays an important role in the pathogenesis of AIA, leukotriene modifiers are the preferred medication for the long-term control of AIA."	0
CONCLUSION: @Chemical$ and the combination of acetylsalicylic acid and dipyridamole were associated with similar risks for recurrent ischemic stroke and bleeding; whereas acetylsalicylic acid was associated with higher risks for both ischemic stroke and @Disease$.	0
We assessed the long-term risks of recurrent lower GI bleeding and serious cardiovascular outcomes after @Chemical$-associated lower @Disease$.	1
"CONCLUSIONS: In a meta-analysis, low doses of ASA increased the risk for GI @Disease$; risk increased with accompanying use of @Chemical$ and anticoagulant therapies, but decreased in patients who took PPIs."	0
"However, in patients taking @Chemical$ for the primary prevention of cardiovascular events, it seems reasonable to stop aspirin treatment, re-evaluate the indication and, if needed, reintroduce aspirin after the risk of @Disease$ rebleeding decreases, usually after hospital discharge."	0
"The authors suggest that in order to avoid possible risks of @Disease$ development, people who frequently take @Chemical$ should have their vision checked regularly."	1
"Compared to women who did not use either @Chemical$ or other non-aspirin NSAIDs, women using aspirin exclusively (RR = 1.71; 95% CI = 0.94-3.13), non-aspirin NSAIDs exclusively (RR = 2.39; 95% CI = 1.18-4.83), or both types of drugs (RR = 1.97; 95% CI = 1.06-3.68) were at increased risk of @Disease$."	0
Incidence of @Disease$ induced by low-dose @Chemical$: a crossover study using capsule endoscopy in healthy volunteers.	1
"Medical management of rhinosinusitis comorbidities-asthma, @Chemical$ sensitivity, @Disease$, immune deficiencies."	0
"A randomized, double-blind, placebo-controlled study of @Chemical$ for @Disease$ taking aspirin with or without clopidogrel."	0
CONCLUSION: Transnasal endoscopy was possible to perform during the oral intake of low-dose @Chemical$ without causing any @Disease$.	0
Diminished @Chemical$ regulation in aspirin-exacerbated respiratory disease (@Disease$) leads to respiratory reactions on cyclooxygenase 1 inhibition.	0
BACKGROUND: @Chemical$-intolerant asthma (AIA) is a subtype of asthma induced by non-steroidal anti-inflammatory drugs and characterized by an aggressive mucosal inflammation of the lower airway (asthma) and the upper airways (@Disease$ and nasal polyp).	0
Protective role of hydrogen-rich water on @Chemical$-induced @Disease$ in rats.	1
CONCLUSIONS: @Chemical$ was superior to famotidine with less gastrointestinal symptoms and recurrent @Disease$/erosions in patients using 24-week low-dose aspirin.	0
Association of four-locus gene interaction with @Chemical$-intolerant asthma in Korean @Disease$tics.	0
"The use of @Chemical$ was associated with a greater risk of major @Disease$ in most of the subgroups investigated but not in individuals with diabetes (IRR, 1.09; 95% CI, 0.97-1.22)."	1
Studies have shown that patients on @Chemical$ and clopidogrel are at increased risk for perioperative @Disease$ and related events.	1
"Here, we summarize randomized controlled trials (RCTs) on the preventive effects of antisecretory drugs for NSAID- or @Chemical$-induced @Disease$."	1
"In our investigation of such adverse effects, we obtained 4 important findings considered useful for physicians, as follows; 1) even when aspirin was given at a dose, the incidence rate of @Disease$ was higher than with other non-steroidal anti-inflammatory drugs (NSAIDs), 2) the odds ratios for gastrointestinal lesions induced by @Chemical$ with a histamine H2 receptor antagonist and proton pump inhibitor were 0.6 and 0.4, respectively, as compared with aspirin alone, 3) it is difficult to administer aspirin, which exerts an antiplatelet effect, without inducing gastrointestinal lesions, and 4) these gastrointestinal lesions appears early, especially within 2 years after administration."	0
"RESULTS: In aspirin-induced asthma patients (AIA, n=10), the basal concentration of urinary @Chemical$, but not the other metabolites, was significantly higher than that in aspirin-tolerant @Disease$ patients (ATA, n=10)."	0
"BACKGROUND: The effect of @Chemical$ on the release of key arachidonic acid metabolites in activated eosinophils from subjects with aspirin-intolerant @Disease$ (AIA) has not been investigated previously, despite the characteristic eosinophilia in AIA."	0
AIM: To determine the preventive effect and safety of proton pump inhibitors (PPIs) in low-dose @Chemical$ (LDA)-associated gastrointestinal (GI) @Disease$s and bleeding.	0
Associations between aspirin responsiveness and @Disease$ rate and @Chemical$ dose adjustment and thrombosis rate were assessed with the use of multivariable logistic regression analysis.	0
"We investigated whether aspirin with caffeine (@Chemical$+) increases headache frequency compared with aspirin alone in migraine, tension-type @Disease$ (TTH), and migraine + TTH (MigTTH)."	0
"@Chemical$-exacerbated respiratory disease (AERD), or aspirin-induced asthma, is characterized by asthma and @Disease$ triggered by the ingestion of aspirin and non-steroidal anti-inflammatory drugs."	0
"Allergic conditions include aspirin-exacerbated respiratory disease (AERD or aspirin-induced asthma), @Chemical$-induced urticaria/@Disease$ (AIU), and anaphylaxis."	1
"CONCLUSION: This survey depicts individual discrepancies in the clinical management of patients receiving NSAIDs and/or @Chemical$, regarding the prophylaxis of gastroduodenal @Disease$."	0
"Survivors were followed prospectively for recurrent @Disease$ and intercurrent @Chemical$ and warfarin use, including duration of exposure."	0
"BACKGROUND: Anticoagulants and antiplatelet drugs (e.g., warfarin, clopidogrel and @Chemical$) are key therapeutic agents in the treatment of @Disease$."	0
CONCLUSION: This study did not find more @Disease$ than in previous neurointerventional reports using DAPT with aspirin + ticagrelor or aspirin + @Chemical$.	0
"Persistent eosinophilic rhinosinusitis precedes development of nasal polyposis, @Chemical$ hypersensitivity, and @Disease$."	0
"CONCLUSIONS:   @Chemical$ had aggressive effects in all @Disease$; on the other hand, HP infection had protective effects in the antrum and fundus in the stomach, and aggressive effects in the body in the stomach."	1
"METHODS: We retrospectively compared the records of 78 and 40 @Disease$ patients receiving low-dose aspirin (@Chemical$) and non-aspirin NSAIDs, respectively."	0
"@Chemical$ is an oral factor Xa (FXa) inhibitor in clinical development for stroke prevention in patients with @Disease$, an elderly population that frequently receives aspirin (ASA) and/or nonsteroidal anti-inflammatory drugs for concurrent illnesses."	0
The present study was designed to investigate the antioxidant activities of @Chemical$ and assess its possible protective effects against aspirin-induced @Disease$ in vitro.	0
"@Disease$ patients suffer from an active disease despite avoidance of aspirin, and it has been suggested that administration of aspirin to these patients increases the generation of immediate oxygen products of arachidonic acid, @Chemical$ (12-HPETE), in their platelets."	0
"In asthmatics with symptoms of hypersensitivity to non-steroidal anti-inflammatory drugs, which takes the course of clinically demonstrable @Chemical$-induced @Disease$, the risk of severe asthma is 30-fold higher."	1
"Aspirin, non-@Chemical$ analgesics and the risk of @Disease$ in the SUN cohort."	0
METHODS: The @Chemical$ versus Acetylsalicylic Acid to Prevent @Disease$ in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin k Antagonist Treatment (AVERROES) trial randomized 5599 patients with atrial fibrillation and risk factors to receive either apixaban or aspirin.	0
"Furthermore, a recent study suggested that the administration of low-dose @Chemical$ plus high-dose esomeprazole (a potent PPI) was associated with fewer episodes of UGI @Disease$ than clopidogrel alone in patients with a history of recent UGI haemorrhage."	0
"The causes of @Chemical$ resistance include inadequate doses of the drug, its low absorption, poor compliance with the treatment, polymorphism of ADP receptors, GP IIb/IIIa and cytochrome P450 genes, acute coronary syndrome and stroke, @Disease$."	1
"RESULTS: Altogether, 310 subjects were assessed; 217 had histories of urticaria/angioedema, 50 of anaphylaxis, 26 of nonimmediate cutaneous eruptions, and 17 of @Disease$ related to @Chemical$/nonsteroidal anti-inflammatory drugs (NSAID) intake."	1
This effect of aspirin is unique to aspirin-exacerbated @Disease$ and not observed in subjects with @Chemical$-tolerant asthma.	0
@Chemical$ use should be stopped in patients with a low risk for thromboembolic disease to minimize @Disease$ complications.	0
INTRODUCTION: The @Chemical$ in Unstable Angina to Prevent Recurrent Events (CURE) study showed that patients with @Disease$ (UAP) and non-ST-elevation myocardial infarction (NSTEMI) benefit from combined therapy with acetylsalicylic acid (ASA) and clopidogrel.	0
When patients with @Disease$ need @Chemical$ for specific situations they should receive aspirin desensitization therapy or treatment with selective cyclo-oxygenase 2 inhibitors.	0
"In the @Chemical$ and aspirin studies 100% of the randomized patients had an unprovoked VTE, while in the DOAC studies between 73.5% and 93.2% of the @Disease$ events were unprovoked."	0
Previous ulcer history was identified as a risk factor for peptic @Disease$ and upper gastrointestinal bleeding during low-dose @Chemical$ therapy.	0
@Chemical$ and non-aspirin non-steroidal anti-inflammatory drug use and risk of @Disease$.	0
"@Chemical$-exacerbated @Disease$ (AERD) is an adult-onset condition that manifests as asthma, rhinosinusitis/nasal polyps, and sensitivity to aspirin and other cyclooxygenase-1 (COX-1)-inhibitor nonsteroidal anti-inflammatory drugs (NSAIDs)."	1
Those who received aspirin or @Chemical$ were less likely to experience any @Disease$ compared to those patients who received rivaroxaban ( P &lt; .05).	0
"Also, women had less peripheral artery disease (@Chemical$, 2.4% versus 3.7%; apixaban, 1.4% versus 3.0%), more heart failure, and higher mean CHADS2 (congestive heart failure, @Disease$, age of 75 years or older, diabetes [1 point each], stroke or transient ischemic attack [2 points]) scores (aspirin, 2.2 versus 2.0; apixaban, 2.1 versus 2.0)."	0
"Compared with clopidogrel, aspirin increases the risk of GI @Disease$ but not other bleeding; however, 883 patients (95% CI, 357-infinity) would need to be treated with @Chemical$ versus aspirin to prevent one major GI bleeding episode annually at a cost of over 1 million dollars."	0
"Fifty patients treated with @Chemical$ for 2 years were tested for aspirin resistance using the Ultegra Rapid Platelet Function Assay (Accumetrics, San Diego, CA, USA) on admission to Royal Melbourne Hospital for ischaemic @Disease$."	0
"Concomitant therapy with acetaminophen (APAP) and low-dose @Chemical$ is often used in clinical settings; however, it is unclear whether this combination is involved in the progression of @Disease$ (CKD)."	0
"CONCLUSION: Advanced age, atherosclerosis, male gender and NSAID administration (particularly @Chemical$) are the major risk factors of upper GI hemorrhage in patients with gastric and/or duodenal @Disease$."	0
"BACKGROUND: The anti-inflammatory actions of acetylsalicylic acid (ASA)/non-steroidal anti-inflammatory drugs (NSAIDs) are thought to be due to inhibition of COX-2, whereas the side effects such as gastric damage and @Chemical$-induced @Disease$ are mediated through inhibition of COX-1."	1
[@Chemical$-induced asthma in patients with @Disease$].	0
An online international survey was performed to critically analyze rates of @Chemical$ @Disease$ and its medical and interventional management.	1
This study was aimed to evaluate whether genetic variants of TBXA2R may be related with development of @Chemical$ (ASA)-intolerant asthma (@Disease$).	0
"METHODS: The frequencies of all and GI adverse events (AEs) and adverse drug reactions (ADRs) were calculated from the pooled individual patient data of nine similar randomized, double-blind, placebo controlled clinical trials of single-doses of @Chemical$ 1000 mg in the treatment of acute @Disease$, episodic tension-type headache and dental pain."	0
CONCLUSIONS: There was no significant benefit in preventing ischemic stroke in the patients with advanced @Disease$ who received @Chemical$ therapy.	1
"METHODS: Two hundred thirty-nine patients with AIU consisting of 120 patients with aspirin intolerant chronic urticaria (AICU) and 119 with @Chemical$-intolerant acute urticaria (@Disease$), and 524 normal controls were enrolled."	0
"@Chemical$-exacerbated @Disease$ (AERD) is characterized by chronic rhinosinusitis with nasal polyps, asthma, and reactions to cyclooxygenase-1-inhibiting drugs."	1
"In two separate series, platelet aggregation and carrageenan arthritis-induced inflammatory @Disease$ were measured in control, @Chemical$ and ASA-Tris-treated groups."	0
"BACKGROUND: Aspirin-exacerbated @Disease$ (AERD) is a clinical triad consisting of aspirin/acetylsalicylic acid (@Chemical$) sensitivity, bronchial asthma, and nasal polyposis."	0
"OBJECTIVE: Buffered and enteric-coated formulations of low-dose @Chemical$ therapy are although expected to avoid @Disease$, there are reports that these modified products are associated with such complications."	1
"CONCLUSION: This cross-sectional survey showed that AERD is highly prevalent among adult asthmatics and its prevalence seems to be affected by family history of @Chemical$ hypersensitivity, history of @Disease$ and presence of NP."	0
"Some studies have demonstrated that consumption of fish oil concentrate, @Chemical$ (n-3 PUFA), results in cardiovascular benefits that include reductions in mortality, sudden death, @Disease$, and thrombotic stoke, as well as improvement in graft patency."	0
"@Chemical$ (acetyl salicylic acid) is used worldwide to treat various inflammatory conditions and prevent cardiovascular disease, along with reducing the risk of @Disease$."	0
The relationship between historical aspirin-induced @Disease$ and severity of asthma induced during oral @Chemical$ challenges.	0
"Any (major or minor) bleeding occurred in 71 (8.1%) and 77 (8.9%), major @Disease$ in 34 (3.9%) and 49 (5.6%), and minor bleeding in 37 (4.2%) and 29 (3.3%) of placebo- and @Chemical$-treated patients, respectively; these differences were not significant."	0
The objective of this review is to compile a documented inventory of @Disease$ induced by low-dose @Chemical$.	1
"In this study, we investigated possible synergistic or negative interactions between HP infection and @Chemical$ in @Disease$, according to lesion site."	0
"METHODS: We performed a cohort study using nationwide registries to identify all Danish patients surviving first-time hospitalization for @Disease$ between January 1, 1997, and December 31, 2006, and their posthospital therapy of @Chemical$, aspirin, clopidogrel, and combinations of these drugs."	0
"Together, the results show that @Disease$ correlated well with the inhibition of serum @Chemical$ and TXA2 levels."	0
"Univariate analysis showed that continuous aspirin use was not significantly associated with bleeding complications (odds ratio, 0.933; 95% confidence interval, 0.283-3.074; P = .910 in the aspirin and control groups) and that discontinuous @Chemical$ use was not significantly associated with @Disease$ complications (odds ratio, 0.963; 95% confidence interval, 0.230-4.025; P = .959 in the aspirin and control groups; odds ratio, 0.969; 95% confidence interval, 0.198-4.752; P = .969 in the aspirin and discontinuous groups)."	0
[@Chemical$-induced @Disease$ (AIA)].	1
"Overproduction of cysteinyl-leukotrienes (Cys-LTs) has been implicated as major mediators of @Disease$; however, the LT receptor antagonist @Chemical$ is only partially effective in inhibiting aspirin responses."	0
Prednisolone was therefore seen to be effective for treating @Disease$ that manifested as a non-respiratory tract symptom of @Chemical$-exacerbated respiratory disease.	1
"CONCLUSIONS: In this observational study, aspirin use was not associated with an increase in mortality rates or HF readmission rates, and @Chemical$ did not attenuate the benefits of ACE inhibitors, even in patients without @Disease$, patients with renal dysfunction, or patients treated with high-dose aspirin and low-dose ACE inhibitors."	0
"Although major or minor bleeding was common (12.6%), only 1.0% of @Chemical$-treated patients were reported to discontinue due to @Disease$."	1
@Chemical$ (ASA) is the mainstay of treatment in @Disease$.	0
Data regarding alternative antiplatelet therapy in patients with @Disease$ or intolerance to @Chemical$ are lacking.	0
"RESULTS: Of 8754 Chinese patients with atrial fibrillation and CHA2DS2-VASc &gt;=1 (79.5+-9.2 years; CHA2DS2-VASc, 4.1+-1.5; and Hypertension, Abnormal Renal/Liver Function, @Disease$, Bleeding History or Predisposition, Labile International Normalized Ratio, Elderly (&gt;65 years), Drugs/Alcohol Concomitantly [HAS-BLED], 2.2+-0.9), 16.3% received warfarin, 41.1% @Chemical$, 4.5% dabigatran, and 38.1% received no therapy."	0
"@Chemical$ exacerbated respiratory disease (AERD) is an adult onset condition manifested as asthma, @Disease$, and sensitivity to aspirin and other cyclooxygenase-1 (Cox-1)-inhibitor nonsteroidal anti-inflammatory drugs (NSAIDs)."	0
"Clopidogrel versus @Chemical$ yielded HRs of 0.69 (95% CI: 0.59-0.81) and 0.72 (95% CI: 0.55-0.96) for @Disease$ and bleeding, respectively."	0
CONCLUSION: SCG can prevent @Chemical$-exacerbated allergic reactions in patients with @Disease$ resulting from inhibition of increases in allergen absorption.	0
"Pre-association of @Chemical$ with PC provides a novel therapeutic approach to significantly reduce aspirin-induced small @Disease$ and bleeding, as may occur with enteric-coated aspirin."	0
"CONCLUSIONS: Peptic @Disease$ history, dual anti-platelet medication, H. pylori current infection, and male gender were possible clinical risk factors for @Chemical$-induced gastric mucosal injury."	0
The discoveries that cyclooxygenase (COX)-2 is an inducible form of COX that is involved in @Disease$ and that COX-1 is the major isoform responsible for the production of @Chemical$ have provided a reasonable basis for the development of specific COX-2 inhibitors as a new class of anti-inflammatory agents.	0
All patients were treated with @Chemical$ as an anticoagulant. 267 patients (26.7%) developed a total of 331 bleeding events. 100 patients had @Disease$ during the first 30 days of therapy.	0
Lyophilized aspirin/trehalose might be a solution to decrease @Chemical$-induced @Disease$.	1
BACKGROUND: We previously found differences in the minor allele frequency (MAF) of single-nucleotide polymorphisms (SNPs) in transmembrane protein 196 (TMEM196) between 995 patients with @Chemical$-tolerant @Disease$ (ATA) and 141 asthmatic patients with NSAID-exacerbated respiratory disease (NERD).	0
"This was significantly different in a high-risk @Disease$ setting (incidence 5%) where the required relative risk reduction with @Chemical$ use for physicians was 20% versus patients 40% (P &lt;0.001); and for myocardial infarction, physicians 20% versus patients 36% (P=0.051)."	0
Whether the PFA-100 or any other practical measure of @Chemical$ can be used in clinical practice to identify added @Disease$ risk and to inform platelet inhibition therapy needs further study.	0
OBJECTIVE: We examined the association of a TGFbeta1 genetic polymorphism with @Chemical$-intolerant chronic @Disease$ (AICU) and aspirin-tolerant chronic urticaria (ATCU) in a Korean population.	0
"Urinary eicosanoids, plasma tryptase and cytokine levels, platelet-leukocyte aggregates, and granulocyte transcripts were assessed.Measurements and Main Results: Eight weeks of high-dose @Chemical$ decreased nasal symptoms and urinary prostaglandin E metabolite (P &lt; 0.05) and increased urinary leukotriene E4 (P &lt; 0.01) levels in subjects with aspirin-exacerbated respiratory disease, but not in those with aspirin-tolerant @Disease$."	0
"Mucosal defects were found in 54 of 98 (60.7%) users of buffered aspirin (@Chemical$), whereas 38 of 101 (37.6%) users of ECA had @Disease$."	0
Several genetic studies on @Chemical$ @Disease$ have been performed to discover the genetic predisposition to aspirin hypersensitivity and to gain insight into the phenotypic diversity.	1
"When other possible causes of stroke were excluded, the association of @Disease$ with the protracted vasoconstriction of @Chemical$, able per se to damage the capillary endothelium, and an altered local hemostasis induced by aspirin remained as the most probable mechanism of brain bleeding."	0
"Although, genuine hypersensitivity to @Chemical$ is encountered infrequently, it can be challenging when managing patients with concomitant @Disease$ given the paucity of safe and effective alternatives."	1
@Chemical$ desensitization in patients with @Disease$.	0
"Response to @Chemical$ provocation was @Disease$ + bronchospasm in 13, and extrabronchial reactions in 8 (isolated rhinitis in 3) patients."	0
"BACKGROUND: The aim of this study was to detect cysteinyl leukotriene (@Chemical$-LT) receptors in aspirin-sensitive @Disease$ patients, and compare them with nasal polyposis and chronic rhinosinusitis patients without aspirin sensitivity."	0
This is the first reported case of @Chemical$ leading to an epidural hematoma following an interventional chronic @Disease$ procedure.	1
"CONCLUSIONS: The incidence of UGIB is 0.61% in ACS patients on dual antiplatelet therapy (aspirin and @Chemical$) for 1 year after PCI and falls year by year.Administration of PPI after PCI protects patients from UGIB, especially in those with precious history of peptic ulcer and @Disease$."	0
"Although oral challenge has been the mainstay in the United States, lysyl-@Chemical$ has been validated as a diagnostic tool for aspirin-sensitive @Disease$ and will be discussed further in this article."	0
"Polyphenol content of the apple extracts varied, with the EF extract having 20% w/w polyphenols and a high proportion of @Disease$ as epicatechin and procyanidin, whereas the FB extract comprised 12% w/w @Chemical$s, which were mostly flavonols as quercetin glycosides."	0
@Chemical$ attenuates aspirin-induced @Disease$: role of inducible nitric oxide synthase.	0
"PATIENTS AND METHODS: Patients with AIA (n = 13), patients with @Chemical$-tolerant @Disease$ (ATA) (n = 12) and healthy volunteers as controls (n = 13) were included to the study."	0
BACKGROUND: The current risk stratification systems in @Disease$ do not correct for the intake of low-dose @Chemical$ and other antithrombotic drugs.	1
"The use of aspirin, @Chemical$ plus extended-release dipyridamole, or clopidogrel is recommended as initial therapy in patients with noncardioembolic ischaemic @Disease$ or TIA to reduce the risk of recurrent stroke and other cardiovascular events."	0
CONCLUSION: Our case describes the recurrence of spontaneous @Disease$s (perirenal and intramuscular hematoma) as a result of an underlying platelet aggregation defect worsened by administration of @Chemical$.	1
Previous ulcer history was identified as a risk factor for peptic ulcer and upper gastrointestinal @Disease$ during low-dose @Chemical$ therapy.	0
BACKGROUND: Platelets are involved in the pathogenesis of @Chemical$-induced asthma (@Disease$).	0
"Polyphenol content of the apple extracts varied, with the EF extract having 20% w/w polyphenols and a high proportion of @Disease$ as epicatechin and procyanidin, whereas the FB extract comprised 12% w/w polyphenols, which were mostly flavonols as @Chemical$."	0
Effects of preoperative @Chemical$ and clopidogrel therapy on perioperative @Disease$ and blood transfusion requirements in patients undergoing off-pump coronary artery bypass graft surgery.	0
Does enteric-coated aspirin result in a lower incidence of @Disease$ compared to normal @Chemical$?	0
Primary prevention of @Disease$ in patients taking @Chemical$ or NSAIDs.	1
"There is a well-recognized association of aspirin sensitivity, @Chemical$-induced asthma, @Disease$ or sinusitis, known as Samter's triad."	0
"@Chemical$ (acetylsalicylic acid) is a well-known nonsteroidal anti-inflammatory drug that can potentiate some acute allergies and causes adverse immunological reactions collectively referred to as aspirin intolerance, a disorder that induces @Disease$, asthma, and anaphylaxis in response to oral administration of the drug."	1
"Our study also highlights that the use of @Chemical$ for primary prevention of @Disease$ was found to cause higher rates of bleeding (any bleeding, major bleeding, and GI bleeding) compared to placebo or no aspirin at the longest follow-up period with no significant benefit in cancer primary prevention."	0
"However, in patients taking @Chemical$ for the primary prevention of cardiovascular events, it seems reasonable to stop aspirin treatment, re-evaluate the indication and, if needed, reintroduce aspirin after the risk of ulcer re@Disease$ decreases, usually after hospital discharge."	0
"Data Sources: We searched PubMed, Embase, CENTRAL, and ClinicalTrials.gov from inception to May 28, 2018, with the terms novel oral anticoagulants, non-vitamin K antagonist oral anticoagulants, direct oral anticoagulants, dabigatran, rivaroxaban, apixaban, edoxaban, warfarin, Coumadin, vitamin K antagonist, @Chemical$, acetylsalicylic acid, or ASA, and major bleeding, fatal @Disease$, or intracranial hemorrhage."	0
These findings are important because of the wide availability of @Chemical$ and the propensity for use of complementary and alternative medicine in patients with @Disease$ who are already taking antiplatelet and/or anticoagulant agents.	0
"Our approach to @Chemical$ @Disease$ in patients needing coronary stenting, based on a severity stratification, allowed to achieve an effective tolerance to aspirin in the majority of subject in a reasonable short time."	1
"CONCLUSION: Short-term, mostly single-dose exposure to @Chemical$ for the treatment of pain, @Disease$, or colds was associated with a small but significant increase in the risk of dyspepsia relative to placebo."	0
"We report an independent 88-year-old female, on @Chemical$ only for chronic atrial fibrillation, who presented with a 12-hour history of acute lumbar back pain, urinary @Disease$ and progressive bilateral lower limb paresis."	0
"OBJECTIVE: To determine whether @Chemical$, a selective cyclooxygenase 2 (COX-2) inhibitor, cross-reacts in patients with aspirin-exacerbated @Disease$ (AERD) with asthma."	0
CONCLUSIONS: @Chemical$ @Disease$ manifesting as urticaria/angioedema remains present after 4 years in about two thirds of patients.	1
"CONCLUSION: In addition to age, male gender, H. pylori infection, and concomitant use of NSAIDs, COX-2 inhibitors, steroids, and thienopyridines, underlying co-morbidities including diabetes, @Disease$, cirrhosis, history of PUD are also important risk factors for first-time occurrence of non-variceal UGIB in @Chemical$ users."	0
METHODS: @Disease$ were obtained from 11 @Chemical$-sensitive and 19 aspirin-tolerant patients with chronic rhinosinusitis.	0
We assess the feasibility of performing robotic partial nephrectomy (@Disease$) in patients maintained on aspirin or dual antiplatelet therapy with @Chemical$ and clopidogrel.	0
@Chemical$ and @Disease$ after neuraxial anaesthesia: Myth or reality?	1
"In this study, we investigated the effect of histamin H2 receptor antagonist (H2RA) or proton pump inhibitor (PPI) for the prevention of @Disease$ associated with low-dose @Chemical$."	1
"Comparative tolerability of @Chemical$, aspirin and ibuprofen for short-term @Disease$ in patients with musculoskeletal conditions: results in 4291 patients."	0
"Upper gastrointestinal bleeding is a serious complication, but had low case fatality in trials of @Chemical$ and is not generally thought to cause long-term @Disease$."	0
"Conventionally, hypersensitivities include aspirin-exacerbated respiratory disease (AERD), @Chemical$-induced @Disease$, and anaphylaxis."	1
"Recent evidence showed that among patients with a history of ASA-associated ulcer @Disease$, the long-term incidence of recurrent bleeding with @Chemical$ use is low after eradication of H. pylori alone."	0
"Some asthmatics may react to @Chemical$ and other NSAIDs with acute bronchoconstriction, profuse rhinorrhea and @Disease$."	0
"Pooled estimates of the relative risk (RR) for @Disease$ events with @Chemical$ versus non-use were calculated using random-effects models, based on reported estimates of RR (including odds ratios, hazard ratios, incidence rate ratios and standardized incidence ratios) in 39 articles."	0
@Chemical$ mediator profiles in different phenotypes of nonsteroidal anti-inflammatory drug-induced @Disease$.	0
The @Chemical$ group without anti-ulcer drugs (A(-) group) comprised 47 patients and the non-aspirin group without anti-@Disease$ drugs (NA(-) group) 31 patients.	0
"In 1918, the US Surgeon General, the US Navy, and the Journal of the American Medical Association recommended use of @Chemical$ just before the October @Disease$ spike."	0
"We determined the number and area of @Disease$, gastric blood flow (GBF), plasma concentration of proinflammatory cytokines IL-1beta and TNFalpha, expression of superoxide dismutase (SOD) and glutathione peroxidase (GPx), ROS generation, and the malondialdehyde (MDA) concentration as an index of @Chemical$ peroxidation."	0
"Data Sources: We searched PubMed, Embase, CENTRAL, and ClinicalTrials.gov from inception to May 28, 2018, with the terms novel oral anticoagulants, non-vitamin K antagonist oral anticoagulants, direct oral anticoagulants, dabigatran, @Chemical$, apixaban, edoxaban, warfarin, Coumadin, vitamin K antagonist, aspirin, acetylsalicylic acid, or ASA, and major bleeding, fatal @Disease$, or intracranial hemorrhage."	0
Chronic @Chemical$ @Disease$ due to substance abuse in Turkish patients.	1
Tolerance of daily low-dose @Chemical$ does not preclude aspirin-exacerbated @Disease$.	0
CONCLUSION: The meta-analysis showed that H2RAs were less effective in the prevention of @Chemical$-related @Disease$ and ulcer formation suggesting the preferable usage of PPIs in case of tolerance.	1
"@Chemical$-Exacerbated Diseases: Advances in Asthma with Nasal Polyposis, Urticaria, @Disease$, and Anaphylaxis."	1
CONCLUSION: @Chemical$ use in @Disease$ patients without cardiovascular disease remains controversial and current guidelines should be revised until results from ongoing large randomized controlled trials become available.	0
"METHODS: 106 consecutive adults with confirmed, physician-diagnosed difficult asthma and 100 patients with @Chemical$-induced asthma underwent psychiatric interview and assessment using M.I.N.I 5.0, Beck Depression Inventory (BDI) and @Disease$ Scale (PAS)."	0
"However, the risk of bleeding is further increased by combining other anti-platelet drugs (e.g. @Chemical$) with ASA in @Disease$ and coronary stent placement."	0
"To evaluate the hemostatic effects of desmopressin (DDAVP) in dogs with @Chemical$-induced platelet dysfunction and @Disease$ in chronic liver diseases, 3 microg/kg DDAVP was administrated subcutaneously."	0
"METHODS: We performed a cohort study using nationwide registries to identify all Danish patients surviving first-time hospitalization for @Disease$ between January 1, 1997, and December 31, 2006, and their posthospital therapy of warfarin, aspirin, @Chemical$, and combinations of these drugs."	0
This is a distinct clinical syndrome called @Chemical$-induced @Disease$ (AIA).	1
"In this study, we compared the roles of CysLT receptor type 1 (CysLTR1) and leukotriene C4 synthase (LTC4S) gene polymorphisms in two major aspirin-related allergic diseases, aspirin-intolerant asthma (AIA) and @Chemical$-induced chronic urticaria/@Disease$ (AICU)."	0
Prevalence and independent factors for gastroduodenal @Disease$/erosions in asymptomatic patients taking low-dose @Chemical$ and gastroprotective agents: the OITA-GF study.	0
"Although co-therapy with a PPI and the eradication of H. pylori substantially reduce the risk of recurrent ulcer bleeding with aspirin, the replacement of aspirin by @Chemical$ cannot be recommended to patients with a high @Disease$ risk."	0
This mechanism is also demonstrated to be present in platelets from @Chemical$-intolerant asthmatics (@Disease$).	0
"Type 2 @Disease$ characterizes aspirin-exacerbated respiratory disease.Objectives: To determine whether high-dose aspirin therapy changes biomarkers of type 2 inflammation in aspirin-exacerbated respiratory disease.Methods: Forty-two subjects with @Chemical$-exacerbated respiratory disease underwent an aspirin desensitization and were placed on high-dose aspirin (1,300 mg daily)."	0
"Reasons for not taking @Chemical$ included @Disease$ (53.5%), allergy (39.4%), non-gastrointestinal bleeding (5.5%) and others (1.6%)."	1
Addition of a leukotriene receptor antagonist such as @Chemical$ improves @Disease$ in aspirin-intolerant patients over and above what can be achieved by glucocorticosteroids.	0
"INTRODUCTION: Clinical features of aspirin-exacerbated respiratory disease (AERD) consist of moderate to severe asthma associated with @Disease$ (CRS), which are derived from overproduction of @Chemical$ along with chronic type 2 mediated inflammation in the upper and lower airway mucosa."	0
METHODS: Patients with aspirin-related nonbleeding symptomatic @Disease$s were randomised to receive @Chemical$ (20 mg/day) plus aspirin (100 mg/day) or rabeprazole (20 mg/day) plus clopidogrel (75 mg/day) for 12 weeks.	0
"We compared GI hospitalization rates among elderly patients taking celecoxib, @Disease$, celecoxib and @Chemical$ or NS-NSAIDs and ASA."	0
"When other possible causes of @Disease$ were excluded, the association of migraine with the protracted vasoconstriction of @Chemical$, able per se to damage the capillary endothelium, and an altered local hemostasis induced by aspirin remained as the most probable mechanism of brain bleeding."	0
The rates of both @Disease$ and bleeding increased with higher CHADS2 scores but @Chemical$ compared with aspirin was associated with a similar relative risk of bleeding (P interaction 0.21) and a reduced relative risk of stroke (P interaction 0.37) irrespective of CHADS2 category.	0
Endoscopic @Disease$ with low-dose @Chemical$ and reality testing.	0
"Blood type O, advanced age, history of peptic ulcer, and concomitant use of NSAID are of independent significance in predicting peptic @Disease$ development during treatment with low-dose @Chemical$."	0
This article discusses recent evidence regarding the @Disease$ risks associated with discontinuing aspirin use in patients who take aspirin daily and presents a new recommendation for continuing low-dose @Chemical$ during invasive dental procedures.	0
"@Chemical$-induced asthma is a distinct clinical syndrome consisting of @Disease$, characterized by chronic eosinophilic rhinosinusitis with asthma and often nasal polyposis."	0
"We compared 1- and 3-year outcomes for @Disease$ (CVA), transient ischemic attack (TIA), gastrointestinal (GI) bleeding, genitourinary (GU) bleeding, any bleeding, and AF recurrence among patients receiving: none, aspirin, or @Chemical$ as long-term therapies."	0
"The cumulative incidences of recurrent VTE in the @Chemical$ 20-mg, rivaroxaban 10-mg and aspirin groups were 1.9%, 1.6%, and 5.0%, respectively, whereas the cumulative incidences of major @Disease$ were 0.7%, 0.4% and 0.5%, respectively."	0
We conclude that melatonin and its precursor tryptophan given orally significantly reduce @Disease$ induced by ASA possibly due to (a) direct gastroprotective action of exogenous @Chemical$ or that generated from tryptophan and (b) gastrin released from the gastric mucosa by melatonin or tryptophan.	0
"CONCLUSION: A high MABP at admission was found to be an independent predictor of poor prognosis for @Disease$ patients treated with @Chemical$ or with no drugs, but not for ICH patients treated with warfarin."	0
"Both naproxen/aspirin and celecoxib/@Chemical$ groups demonstrated a higher incidence of @Disease$ and duodenal ulcers vs. placebo/aspirin (8%; RR: 3.7, 95% CI: 1.8-7.6 and RR: 2.6, 95% CI: 1.2-5.8, respectively)."	1
Aim of this study was to evaluate small @Disease$ using video capsule endoscopy (VCE) in obscure gastrointestinal bleeding (OGIB) patients taking low-dose @Chemical$ including other antithrombotics.	0
Extended antiplatelet therapy with clopidogrel alone versus clopidogrel plus @Chemical$ after completion of 9- to 12-month dual antiplatelet therapy for acute coronary syndrome patients with both high bleeding and @Disease$ risk.	1
Low-dose @Chemical$ has additional effects in the @Disease$.	0
"Furthermore, life-threatening @Disease$ complications have been related temporally to perioperative discontinuation of both aspirin and @Chemical$."	0
PATIENTS: Ninety acute @Disease$ patients who previously received @Chemical$ therapy were enrolled.	0
All @Disease$ complications (postoperative day 11.2 +- 3.5) occurred after resuming @Chemical$ derivative therapy postoperatively (postoperative day 2.3 +- 2.4).	0
@Chemical$ N-methyltransferase 939A&gt;G polymorphism affects mRNA stability in patients with acetylsalicylic acid-intolerant chronic @Disease$.	0
"On multivariate regression analysis, significant predictors of continued @Chemical$ use included lowrisk @Disease$ on endoscopy (OR 3.7; 95% CI 1.4 to 10.2; P=0.01) and AMI requiring coronary intervention (OR 8.2; 95% CI 2.1 to 32.1; P=0.002)."	0
"@Chemical$ (acetylsalicylic acid)-induced asthma (AIA) consists of the clinical triad of asthma, chronic rhinosinusitis with nasal polyps, and precipitation of @Disease$ and rhinitis attacks in response to aspirin and other NSAIDs."	0
Aspirin exacerbated asthma (@Chemical$) affects approximately 10% of the @Disease$tic population.	0
Physiologic and pharmacologic studies support the hypothesis that aspirin-exacerbated respiratory disease (@Disease$) involves fundamental dysregulation in the production of and end-organ responsiveness to both antiinflammatory eicosanoids (@Chemical$) and proinflammatory effectors (cysteinyl leukotrienes).	0
"This report describes a case of Kounis-Zavras syndrome in the setting of @Chemical$-induced asthma also known as Samter-Beer triad combining nasal polyps, @Disease$, and aspirin allergy leading to vasospasm and myocardial infarction."	0
"(3) The patients with @Disease$ (n = 7), but not those with aspirin-tolerant asthma (n = 6), showed significant increases in @Chemical$ and LTE4 excretions after aspirin challenge."	0
"We evaluated changes in @Chemical$ and prostaglandin metabolites for NIUA patients, using patients with NECD and single-NSAID-induced @Disease$/angioedema or anaphylaxis (SNIUAA) for comparison."	0
Adherence to the preventive strategies for nonsteroidal anti-inflammatory drug- or low-dose @Chemical$-induced @Disease$.	1
BACKGROUND: Patients with @Chemical$ sensitivity experience hyperplastic sinusitis and @Disease$.	0
"Twelve cases of Reye's syndrome are presented with different degrees of @Disease$, hyperammonemia and hypoglycemia; associated to @Chemical$ (ASA) ingestion."	1
"DATA SOURCES: Literature retrieval was accessed through MEDLINE (1966-March 2007) using the terms acetaminophen, @Chemical$, antiinflammatory agents nonsteroidal, urticaria, @Disease$, asthma, leukotriene antagonists, desensitization, and tacrolimus."	0
"The cumulative incidences of recurrent @Disease$ in the rivaroxaban 20-mg, rivaroxaban 10-mg and @Chemical$ groups were 1.9%, 1.6%, and 5.0%, respectively, whereas the cumulative incidences of major bleeding were 0.7%, 0.4% and 0.5%, respectively."	0
Spontaneous @Disease$ in a patient treated with clopidogrel and @Chemical$.	0
"CONCLUSIONS: @Chemical$ treatment inhibited urinary leukotriene E4 overproduction and upper/lower respiratory tract symptoms during oral aspirin challenge, resulting in aspirin tolerance in 62.5% of aspirin-exacerbated @Disease$ patients."	0
"A worldwide use of @Chemical$ is now accepted due to its remarkable analgesic, antipyretic and anti-thrombotic prophylactics against myocardial infarct and @Disease$ despite the fact that the use of NSAIDs is associated with the risk of gastrointestinal bleedings, haemorrhagic lesions and ulcerations."	0
Short Communication: Evaluation of nephrotoxicity by aspirin-@Chemical$ combination therapy in patients with @Disease$.	0
"The effects of @Chemical$ on changes in sputum LTC(4)-LTD(4), eosinophil cationic protein (ECP), eosinophil count, urinary LTE(4)/creatinine, 11-dehydrothromboxane B(2) (11-dhTXB(2))/creatinine, serum LTC(4)-LTD(4), ECP, and peripheral blood eosinophil count, during immediate asthmatic reaction (IAR) and late @Disease$tic reaction (LAR) in the HDM group and during IAR in the ASA group for each test, were compared in each group."	0
CONCLUSIONS: Dual antiplatelet therapy with combined aspirin and @Chemical$ as well as clopidogrel is associated with an increased incidence of perioperative wound @Disease$ compared to aspirin but on an acceptable low level of incidence.	0
"The association between aspirin use and the presence of DR or VTDR was assessed using multivariable logistic regression models including age, gender, ethnicity, socioeconomic status, HbA1c, systolic blood pressure, anti-@Disease$ medicine, total @Chemical$, anti-cholesterol medicine, BMI, current smoking status, diabetes duration, history of cardiovascular disease (CVD) and chronic kidney disease (CKD.)."	0
"Regular @Chemical$ use (twice a week or more, for a month or more) was associated with a reduced risk of @Disease$ (adjusted odds ratio [OR] 0.50, 95% confidence intervals [95%CI] 0.31-0.81 in non-smokers; OR 0.38, 95%CI 0.16-0.93 in smokers)."	0
"RESULTS: Adjusted survival curves showed that the usage of @Chemical$ was not associated with ischemic stroke, hospitalization for @Disease$ events, cardiovascular mortality or all-cause mortality, however, it was significantly associated with renal failure."	0
DISCUSSION: These results suggest that a multilocus SNP acts in combination to influence the susceptibility to @Chemical$ intolerance in @Disease$tics and could be a useful genetic marker for the diagnosis of AIA.	0
AIM: To evaluate in symptomatic elderly chronic users of low-dose @Chemical$: (1) the association between H. pylori @Disease$ and the prevalence of upper gastrointestinal lesions; and (2) the effect of H. pylori infection on the efficacy of proton pump inhibitors in the prevention of aspirin-related gastroduodenal lesions.	0
BACKGROUND: Patients with @Disease$ who have aspirin sensitivity have greater cysteinyl leukotriene production and greater airway hyperresponsiveness to the effects of inhaled @Chemical$s than their aspirin-tolerant counterparts.	0
CONCLUSION: There is an extremely high ratio of @Disease$ in the @Chemical$-continued group compared to both the LDA-interrupted group and no-anticoagulant/APT group.	1
Acute attack of @Disease$ precipitated by concomitant use of @Chemical$ and diuretic in a rheumatic mitral stenosis patient.	1
@Chemical$-exacerbated @Disease$: an update.	1
"Recent observational epidemiological evidence has raised the concern that @Chemical$ withdrawal for treatment noncompliance, surgery, or side effects can carry an increased @Disease$ risk."	1
Correlation between serum @Chemical$ and gastro-duodenal @Disease$ associated with low-dose aspirin.	0
METHODS: Patients with @Chemical$-related non@Disease$ symptomatic ulcers were randomised to receive rabeprazole (20 mg/day) plus aspirin (100 mg/day) or rabeprazole (20 mg/day) plus clopidogrel (75 mg/day) for 12 weeks.	0
BACKGROUND: Use of cyclo-oxygenase-2 specific nonsteroidal anti-inflammatory drugs such as @Chemical$ has been advocated because of their anti-inflammatory actions and apparently low incidence of @Disease$ effects.	0
"@Chemical$-exacerbated respiratory disease is a chronic and treatment-resistant disease, characterized by the presence of eosinophilic rhinosinusitis, @Disease$, bronchial asthma, and nonsteroidal anti-inflammatory drugs hypersensitivity."	0
CONCLUSION: Our study appears to demonstrate that @Chemical$ is a suitable NSAID in aspirin-induced and/or nonsteroidal anti-inflammatory drug-induced @Disease$ patients.	0
@Chemical$-exacerbated @Disease$: Mediators and mechanisms of a clinical disease.	1
"Among several options to provide cardiovascular protection with @Chemical$ while reducing @Disease$ risk, PPI co-therapy is considered to be preferred approach for wider populations according to recent cost-effectiveness analyses based on increasing awareness of importance on adherence of LDA together with declining cost of PPI."	0
"In other patients, symptoms of aspirin hypersensitivity may develop in the days after stenting, at which time discontinuation of @Chemical$ carries a risk of catastrophic stent @Disease$."	0
"Conclusions and Relevance: A 15-mg to 20-mg dose of rivaroxaban once daily is associated with substantially increased risks of @Disease$, while smaller daily doses of @Chemical$ and apixaban were not, implying that risk increase is dose dependent."	0
"Both naproxen/aspirin and @Chemical$/aspirin groups demonstrated a higher incidence of gastric and duodenal @Disease$s vs. placebo/aspirin (8%; RR: 3.7, 95% CI: 1.8-7.6 and RR: 2.6, 95% CI: 1.2-5.8, respectively)."	0
EAACI/GA2LEN guideline: @Chemical$ provocation tests for diagnosis of aspirin @Disease$.	0
"Daily @Chemical$ reduces risk of developing and dying from @Disease$, researchers find."	0
Selective cyclooxygenase-2 inhibitor cross-reactivity in @Chemical$-exacerbated @Disease$.	0
OBJECTIVE: To evaluate the expression of vascular cell adhesion molecule 1 (VCAM-1) and intercellular adhesion molecule I (ICAM-1) and their ligands (the integrins lymphocyte function-associated antigen 1 and very late-activation antigen 4 [VLA-4]) in nasal polyps of patients with @Chemical$ @Disease$ compared with aspirin-tolerant individuals.	1
"No significant differences occurred in diffusing capacity, exhaled @Chemical$, @Disease$, or exhaled breath condensate pH."	0
"(4) The risk of @Disease$ was higher in low @Chemical$ group compared to placebo group (RR = 1.15, 95% CI: 1.12-1.18, P &lt; 0.01)."	0
"However, concomitant use of @Chemical$ such as clopidogrel with LDA increased the proportion of @Disease$."	0
"We fit Cox proportional hazards models assessing the association between @Chemical$ use and rates of @Disease$, adjusted for participant demographics, health behaviors, chronic medical conditions, medication adherence, and biomarkers."	0
@Chemical$ and nitric oxide are important mediators of mucosal defence in the stomach (and elsewhere in the gastrointestinal tract) and represent attractive therapeutic targets for reducing the incidence of @Disease$.	0
"Ischemic @Disease$ and intracranial hemorrhage with aspirin, dabigatran, and @Chemical$: impact of quality of anticoagulation control."	0
"In study 2, the severity of @Chemical$-induced @Disease$ was associated with gastric juice pH, but not with antiplatelet effects of LDA."	1
"The important factors that increase the risk of low-dose aspirin-related @Disease$ complications include a history of bleeding peptic ulcer, prior peptic ulcer, age &gt; 70 years, H pylori infection, and concomitant drug therapy with non-steroidal anti-inflammatory drugs, other antiplatelet agents (e.g., @Chemical$) or anticoagulants."	0
Prostaglandin E2 systemic production in patients with asthma with and without @Chemical$ @Disease$.	1
@Chemical$ administration is associated with 2-fold increase in GI risk in middle-aged users without prior history of peptic @Disease$ and without concomitant medications.	0
"CONCLUSIONS: During short-term use, @Chemical$ is associated with a higher frequency of gastrointestinal complaints than other medications commonly used for treatment of pain, colds, and @Disease$."	0
BACKGROUND: Regulation of @Chemical$ synthesis and the activation of human airway fibroblasts associated with the remodeling of the bronchi play an important role in @Disease$.	0
"CONCLUSION: Switching @Chemical$ dosage from 100 mg/d to 40 mg/d reduces the bleeding events and improves @Disease$, thus inhibiting platelet aggregation effectively in very elderly patients."	0
Most studies reported an increase in clinically non-relevant @Disease$ induced by @Chemical$.	1
"CONCLUSION: Overall, the number, size, and quality of the cardiovascular studies recommending @Chemical$ use are far superior to the fewer, smaller and conflicting studies suggesting a possible adverse effect of aspirin use in relation to @Disease$."	0
"METHODS: @Chemical$ were obtained from 43 AS patients with @Disease$, 35 AT asthmatics and 17 healthy control (HC) subjects."	0
"The 1-year predicted risks associated with acetylsalicylic acid, the combination of @Chemical$ and dipyridamole, and clopidogrel were 11.1 (95% CI: 10.2-12.2), 7.7 (95% CI: 7.3-8.3), and 8.0 (95% CI: 6.9-8.7) for ischemic stroke, respectively; while, the risks for @Disease$ were 3.4 (95% CI: 2.8-3.9), 2.4 (95% CI: 2.1-2.7), and 2.4 (95% CI: 1.9-2.9), respectively."	0
"Letter by Feng et al regarding article, Ischemic stroke and @Disease$ with aspirin, dabigatran, and @Chemical$: impact of quality of anticoagulation control."	0
Risks for stroke and @Disease$ with @Chemical$ or aspirin treatment in patients with atrial fibrillation at different CHA(2)DS(2)VASc scores: experience from the Stockholm region.	1
Concurrent Use of Low-Dose Aspirin and @Chemical$ and Risk of @Disease$: A Cohort Study with Nested Case-Control Analysis.	0
"RESULTS: @Chemical$ users were significantly older (P &lt; 0.001), with a higher proportion of males (P &lt; 0.001) and higher frequencies of @Disease$ (P  = 0.004) and diabetes mellitus (P &lt; 0.001)."	0
"Although co-therapy with a PPI and the eradication of H. pylori substantially reduce the risk of recurrent ulcer bleeding with @Chemical$, the replacement of aspirin by clopidogrel cannot be recommended to patients with a high @Disease$ risk."	0
"[Aspirin induced @Disease$, urinary @Chemical$ and zafirlukast]."	0
CONCLUSIONS: The present study results suggest that hypertriglycerides might be one of the risk factors for peptic @Disease$ caused by @Chemical$.	1
"@Chemical$, however, carries an increased risk for gastrointestinal (GI) injury (e.g., ulceration) and its complications (e.g., hemorrhage), which may be caused by its antiplatelet and @Disease$ effects."	0
"Although no evidence establishes increased risk of hemorrhagic @Disease$ from daily low-dose aspirin, one gastrointestinal hemorrhage will occur for every 72 to 357 adults who take @Chemical$ for longer than 10 years (SOR: A, systematic reviews and meta-analyses of multiple RCTs and cohort studies)."	0
"@Chemical$ desensitization and continuous aspirin therapy constitute an effective option in patients with nonsteroidal anti-inflammatory drug-exacerbated respiratory diseases (NERD) who have suboptimally controlled @Disease$, or require multiple revision polypectomies."	0
"CONCLUSION: Coupling of NO to ASA attenuates stress, @Disease$-reperfusion, and ethanol-induced damage due to mucosal hyperemia mediated by NO, which compensates for prostaglandin deficiency induced by @Chemical$."	0
"OBJECTIVE: We sought to determine blood and urinary levels of 9alpha,@Chemical$(2), a major stable PGD(2) metabolite in 2 well-defined phenotypes of asthma, aspirin-induced asthma (AIA) and aspirin-tolerant @Disease$ (ATA), and in healthy control subjects and to study the effects of aspirin on PGD(2) release."	0
"Older age, prior @Disease$ events, chronic renal failure, use of other injurious medicine such as NSAIDs, antithrombotic medicine, especially @Chemical$, and corticosteroids seem to be factors associated with an increased risk for upper GI ulcer and bleeding among the patients taking low dose aspirin."	0
"After adjusting for potential confounding factors (including treatment, cause of heart disease, age, smoking, and @Disease$), a time-dependent multivariate Cox proportional hazards regression analysis showed that the combination of high-dose @Chemical$ with an ACEI was independently associated with the risk of death (hazard ratio, 1.03; P =.01) and that the combination of low-dose aspirin with an ACEI was not (hazard ratio, 1.02; P =.18)."	0
"The RR of PUB for concomitant NSAID use and H. pylori @Disease$ suggested an additive effect (RR: 8.0; 95% CI: 5.0-12.8), whereas no interaction was observed with @Chemical$ use (RR: 3.5; 95% CI: 2.0-6.1)."	0
In this review article are discussed the important characteristics and treatment of @Chemical$-exacerbated @Disease$.	0
"BACKGROUND &@Chemical$; AIMS: With capsule endoscopy, the ulcerogenic effect of low-dose enteric-coated aspirin on the small bowel and the therapeutic effect of misoprostol on @Disease$ were evaluated."	0
"Further research is needed to assess the benefit-risk ratio of clopidogrel plus aspirin in specific subpopulations of patients at high risk for @Disease$, and to determine the role of clopidogrel plus @Chemical$ in preventing cardioembolic stroke or early recurrent stroke after symptomatic large-vessel atherostenosis."	0
"The resumption of @Chemical$ combined with aspirin use (RR 26.71, 95%CI 7.09-100.53), and increased iatrogenic ulcer size (RR 1.52, 95%CI 1.14-2.02), were significantly associated with post-ESD @Disease$."	0
Subjects with aspirin-intolerant @Disease$ were distinguished by a sharp increase in the level of prostaglandin D(2) and E(2) metabolites; their 5- and 15-@Chemical$ levels were also higher than in aspirin-tolerant subjects.	0
@Chemical$ use is associated with @Disease$ and increased risk of upper gastrointestinal (GI) bleeding.	1
"Additionally, eosinophils, mast cells, and their products, @Chemical$ and leukotrienes, have been identified in the pathogenesis of @Disease$."	0
"CONCLUSIONS: Although the number of cases in both trials is small, our findings suggest that @Chemical$ use in @Disease$ might pose an increased risk of ICH, whereas it has no effect on cognition."	0
"Our study also highlights that the use of @Chemical$ for primary prevention of cancer was found to cause higher rates of bleeding (any @Disease$, major bleeding, and GI bleeding) compared to placebo or no aspirin at the longest follow-up period with no significant benefit in cancer primary prevention."	1
@Disease$ to @Chemical$ and other NSAIDs: Diagnostic Approach in Patients with Chronic Rhinosinusitis.	1
The aim of this study was to determine the incidence of upper @Disease$ing and whether the use of peri-operative oral @Chemical$ reduces the incidence of upper GI bleeding when aspirin thromboprophylaxis is used for hip and knee arthroplasty.	0
@Chemical$-sensitive @Disease$.	1
"METHODS: 430 consecutive subjects (70+/-14 years, 55% male, 41% with @Disease$) released from the hospital with a primary diagnosis of heart failure were classified into three groups based on the use of aspirin and ACE-I at discharge: ACE-I without aspirin (group I, n=134), ACE-I with @Chemical$ (group II, n=138) and no ACE-I (group III, n=158)."	0
"CLINICAL RELEVANCE: With the wide use of this drug and other NSAIDs for the relief of @Disease$ and inflammatory dental and facial conditions, such localized manifestation of @Chemical$ intolerance may present to the general dental practitioner and other dental specialties."	0
"Among 725 matched patients undergoing coronary artery bypass grafting (CABG), preoperative @Chemical$ therapy was not associated with a statistically significant higher risk of reoperation for @Disease$."	0
This would allow the use of an @Chemical$ for primary or secondary prevention in patients with coronary artery disease despite a presumed history of NSAID @Disease$.	0
"METHODS: Systematic searches of Medline and Embase were conducted to identify observational studies published between 1946 and 4 March 2015 that reported the risks of gastrointestinal (GI) @Disease$ or intracranial hemorrhage (ICH) with long-term, low-dose @Chemical$ (75-325 mg/day)."	0
"At 3 years, 238 (5.9%) patients were on warfarin, 743 (18.6) on @Chemical$, and 3,013 (75.5%) on no therapy; with occurrences of @Disease$/TIA (1.4%, 3.0%, 3.9%, P &lt; 0.0001, respectively), GI bleeding (0.8%, 1.9%, 1.1%, P = 0.06, respectively), and GU bleeding (1.7%, 2.8%, 2.1%, P = 0.008, respectively) that increased with advancing CHA2 DS2 VASc score."	0
"RESULTS: The allele frequencies of HLA-DRB1(*)1302 (18.1%) and HLA-DQB1(*)0609 (10.1%) in @Chemical$-induced @Disease$ were significantly higher than in aspirin-intolerant asthma (5.3%, P=0.0004; 2.0%, P=0.0024) and in normal controls (8.1%, P=0.0005; 3.2%, P=0.0008), and they remained significant after correcting for multiple comparisons."	1
There is a theoretical concern that treatment prior to the @Disease$ with @Chemical$ may expand the size of TICH.	1
"In contrast, testing for H pylori or PPI therapy is not recommended for chronic NSAID/@Chemical$ users with no @Disease$ complications or those at a low risk of complications."	0
"@Chemical$-exacerbated @Disease$: Prevalence, diagnosis, treatment, and considerations for the future."	1
"Edoxaban is an oral factor Xa (FXa) inhibitor in clinical development for @Disease$ prevention in patients with atrial fibrillation, an elderly population that frequently receives aspirin (@Chemical$) and/or nonsteroidal anti-inflammatory drugs for concurrent illnesses."	0
"Data Sources: We searched PubMed, Embase, CENTRAL, and ClinicalTrials.gov from inception to May 28, 2018, with the terms novel oral anticoagulants, non-vitamin K antagonist oral anticoagulants, direct oral anticoagulants, dabigatran, rivaroxaban, apixaban, edoxaban, warfarin, Coumadin, @Chemical$ antagonist, aspirin, acetylsalicylic acid, or ASA, and major @Disease$, fatal bleeding, or intracranial hemorrhage."	0
Variance analysis of the correlation between HP @Disease$ and @Chemical$ by regional Lanza scores identified both HP infection and LDA use as factors that significantly influence the antral Lanza score.	0
"BACKGROUND: Low-dose @Chemical$ is widely used for prevention of stroke, heart attacks, and death in patients with @Disease$, but its use is associated with serious gastrointestinal (GI) adverse effects."	0
"Questionnaires were sent to 210 neurosurgical facilities asking five main questions: (1) the adherence of any policy of stopping @Chemical$ pre-operatively, (2) the personal risk assessment for patients with brain surgery under low-dose aspirin medication, (3) the preferred method of treatment for excessive @Disease$ in this context, (4) personal knowledge of haemorrhagic complications in this group of patients, and (5) the characteristics of the neurosurgical units concerned."	0
"Endoscopic characteristics of @Chemical$ associated ulcers seem to be required further investigation, including the impact of the severity of gastritis and corpus atrophy by Helicobacter pylori @Disease$ on the endoscopic characteristics."	0
"Aspirin, but not other NSAID use, was associated with about 20% lower risk of postmenopausal breast cancer and did not vary by ER or PR status of the tumor, suggesting that the hypothesized protective effects of aspirin may either be through cellular pathways independent of estrogen or @Chemical$ signaling, or on @Disease$ microenvironment."	0
"In view of these animal studies and in the absence of controlled studies of @Chemical$ or NSAIDs in human @Disease$, we do not recommend indiscriminate treatment with NSAIDs or high-dose aspirin in patients with myocarditis where there is no or minimal associated pericarditis."	0
"RESULTS: A lower incidence of gastric and duodenal @Disease$s was seen in celecoxib/aspirin-treated subjects (19%) vs. @Chemical$/aspirin (27%; RR: 0.63, 95% CI: 0.44-0.92)."	0
"RESULTS: Fifty-four @Disease$s occurred in 16 625 patient-years in the @Chemical$-treated patients, and 7 ICHs occurred in 4317 patient-years in those on placebo."	0
"METHODS: Ninety-four aspirin-induced urticaria patients presenting @Disease$/angioedema-induced by both ASA and NSAID (50 had underlying chronic urticaria) and showing positive responses on oral aspirin challenge test, 76 aspirin-intolerant asthmatics with positive responses on @Chemical$-aspirin bronchoprovocation test, and 185 normal healthy controls were enrolled."	0
"Patients undergoing TKA treated with LMWH had a higher frequency of wound bleeding complications or @Disease$ (3.9% for @Chemical$ versus 0.5% for mobile compression; p = 0.028; OR, 8.2)."	0
"Low-dose aspirin, one of non-steroidal anti-inflammatory drugs(NSAIDs), has been increasingly used to prevent cardiovascular and cerebrovascular disease through its antiplatelet effect, mainly in the aged population, but @Chemical$ treatment has been associated with gastrointestinal injures, especially peptic @Disease$ bleedings."	1
"Among patients included in the FAERS database, the concurrent use of aspirin and @Chemical$ with PPIs reduced the adjusted ROR of @Disease$ events."	0
Recovery of platelet function after discontinuation of prasugrel or @Chemical$ maintenance dosing in aspirin-treated patients with stable @Disease$: the recovery trial.	0
The two frequent clinical presentations of @Chemical$ @Disease$ are: aspirin-induced bronchial asthma/rhinosinusitis (AIA/R) and aspirin-induced urticaria/angioedema (AIU).	1
"In all patients, we measured the @Disease$, by multiplate electrode aggregometry, using two agonists [adenosine diphosphate with PGE1 (ADPHS) and arachidonic acid (ASPI)] two times: on the day of cessation of clopidogrel and 90 days after @Chemical$ was stopped."	0
"In humans, treatment with ASA-@Chemical$ induced significantly less @Disease$ lesions than plain ASA."	0
"In order to minimize the risk for @Disease$, since 2007 robotic-assisted laparoscopic radical prostatectomy (RARP) has taken place under continuous OAT with @Chemical$ at our institution."	0
Comparison of @Disease$ complications with omega-3 fatty acids + aspirin + clopidogrel--versus--@Chemical$ + clopidogrel in patients with cardiovascular disease.	0
CONCLUSION: Our study demonstrates an increased risk of major @Disease$ in unselected patients receiving combination therapy with ASA and @Chemical$ after UAP or NSTEMI.	1
"The key words used to search for articles about exposure to @Chemical$ were salicylic acid, pregnancy, and pregnancy complications; key words used to search for outcome were @Disease$."	0
RESULTS: The study observed a heterogeneous distributed aspirin 100 mg/d AA-Ag (range: 0.42% to 28.78%)in the 537 very elderly patients.Aspirin 100 mg/d AA-Ag before the switch in @Chemical$ 40 mg/d group was 5.00%+-2.32% and the rate of the patients with low on-treatment @Disease$ was 71.00%.	0
"The independent risk factors for death were regular aspirin-use at the onset of ICH (relative risks [RR], 2.5; 95% CI, 1.3 to 4.6; P=0.004), @Chemical$-use at the onset of @Disease$ (RR, 3.2; 95% CI, 1.6 to 6.1; P=0.001), and ICH score higher than 2 on admission (RR, 13.8; 95% CI, 6.0 to 31.4; P&lt;0.001)."	0
"The substantive risk for prophylactic aspirin is therefore cerebral haemorrhage which can be fatal or severely disabling, with an estimated risk of one @Disease$ and one disabling stroke for every 1,000 people taking @Chemical$ for ten years."	0
"CONCLUSIONS: The incidence of UGIB is 0.61% in ACS patients on dual antiplatelet therapy (aspirin and @Chemical$) for 1 year after PCI and falls year by year.Administration of PPI after PCI protects patients from UGIB, especially in those with precious history of peptic @Disease$ and renal impairment."	0
Gastroduodenal @Disease$ in elderly patients on low dose @Chemical$ therapy.	0
"The effects of pranlukast on changes in sputum LTC(4)-LTD(4), eosinophil cationic protein (ECP), eosinophil count, urinary LTE(4)/creatinine, 11-dehydrothromboxane B(2) (11-dhTXB(2))/@Chemical$, serum LTC(4)-LTD(4), ECP, and peripheral blood eosinophil count, during immediate asthmatic reaction (IAR) and late @Disease$tic reaction (LAR) in the HDM group and during IAR in the ASA group for each test, were compared in each group."	0
"Low-dose @Chemical$ and @Disease$ in primary versus secondary cardiovascular prevention: a population-based, nested case-control study."	0
The composite of ICrH or fatal @Disease$ included 15 patients on @Chemical$ and 18 on aspirin.	0
"Adverse reactions to @Chemical$ are frequent particularly among patients with @Disease$, chronic rhinosinusitis and nasal polyps."	1
"METHODS: This retrospective cohort study assessed overt GI bleeding, decreased hemoglobin levels suspecting small bowel blood loss, and @Disease$ in patients taking LDA for more than 1 year (@Chemical$ group) and in patients not taking LDA (control group)."	0
BACKGROUND AND AIMS: Small intestinal @Disease$ of low-dose @Chemical$ remains unclear.	0
"The association between aspirin use and the presence of DR or VTDR was assessed using multivariable logistic regression models including age, gender, ethnicity, socioeconomic status, HbA1c, systolic blood pressure, anti-hypertension medicine, total @Chemical$, anti-cholesterol medicine, BMI, current smoking status, diabetes duration, history of cardiovascular disease (CVD) and @Disease$ (CKD.)."	0
"Based on a convincing clinical history or positive responses in challenges with the drug(s), @Disease$ to one or several drug(s) was diagnosed in 49.4% of the children (60, 76.5 and 23.2% of the children reporting reactions to @Chemical$, ibuprofen and paracetamol respectively)."	1
"In total, it appears that when there is @Disease$ (mechanical from perctutaneous coronary intervention or a ruptured plaque), dual antiplatelet therapy with aspirin and @Chemical$ results in improved outcomes, albeit with a small but significant inherent risk of increased bleeding."	0
"CONCLUSIONS: In a randomized controlled trial of users of low-dose @Chemical$ at risk for recurrent GI bleeding, a slightly lower proportion of patients receiving a PPI along with aspirin developed recurrent bleeding or @Disease$ than of patients receiving an H2RA with the aspirin, although this difference was not statistically significant."	0
"The warfarin TTR &gt;=55% episodes were associated with a 77% lower risk of stroke/SE (relative risk=0.23 [0.18 to 0.28]) compared to never on therapy; and the @Chemical$ TTR &lt;55% and on-aspirin episodes were associated with a 20% lower and with a 26% lower risk of @Disease$/SE compared to never on therapy, respectively."	0
"More recently, @Chemical$ sulphide-releasing derivatives of NSAIDs and of other drugs, have been developed, based on the observed ability of H(2)S to reduce @Disease$ and pain in experimental models."	0
"BACKGROUND: The anti-inflammatory actions of @Chemical$ (ASA)/non-steroidal anti-inflammatory drugs (NSAIDs) are thought to be due to inhibition of COX-2, whereas the side effects such as gastric damage and aspirin-induced @Disease$ are mediated through inhibition of COX-1."	0
"(3) The patients with @Disease$ (n = 7), but not those with aspirin-tolerant asthma (n = 6), showed significant increases in LTBG and @Chemical$ excretions after aspirin challenge."	0
The aim of this work was to determine the presence of galectin-10 in nasal lavage fluid (NLF) of patients with aspirin-sensitive respiratory disease (@Disease$) before and after challenge with @Chemical$ (aspirin) by ELISA.	0
"This paper provides a review of recent investigations into the pathogenesis of this process, which have furthered our understanding of the mechanisms and management of @Chemical$-induced @Disease$."	1
This analysis explores patterns of bleeding and defines bleeding risks based on @Disease$ risk with apixaban and @Chemical$.	0
"Data Sources: We searched PubMed, Embase, CENTRAL, and ClinicalTrials.gov from inception to May 28, 2018, with the terms novel oral anticoagulants, non-vitamin K antagonist oral anticoagulants, direct oral anticoagulants, dabigatran, rivaroxaban, apixaban, edoxaban, warfarin, Coumadin, vitamin K antagonist, aspirin, acetylsalicylic acid, or @Chemical$, and major @Disease$, fatal bleeding, or intracranial hemorrhage."	0
@Chemical$ and @Disease$ after coronary artery bypass grafting.	1
CONCLUSION: Clopidogrel and the combination of @Chemical$ and dipyridamole were associated with similar risks for recurrent ischemic stroke and bleeding; whereas acetylsalicylic acid was associated with higher risks for both ischemic stroke and @Disease$.	0
"CONCLUSIONS: In patients with stable @Disease$ and histories of nonsevere hypersensitivity reactions to ASA/NSAIDs, an @Chemical$ challenge is advisable."	0
Increases in risk for clinically relevant and major @Disease$ were similar for rivaroxaban and @Chemical$-VKA anticoagulation regimens.	0
The purpose of the current study was to evaluate the effect of platelet transfusion on the extent of @Disease$ expansion among patients treated with @Chemical$.	0
We evaluated whether continuation of perioperative @Chemical$ alters bleeding complications in patients who undergo robotic partial nephrectomy (@Disease$).	0
"The most common cause is conditioned to a genetic predisposition towards atopy (atopic asthma), although other factors can also give rise to @Disease$, such as over-exposure to environmental irritants (occupational asthma), altered @Chemical$ metabolism (aspirin-induced asthma) and also exercise - in which different thermal and osmotic mechanisms are known to intervene."	0
Risks for stroke and bleeding with warfarin or @Chemical$ treatment in patients with @Disease$ at different CHA(2)DS(2)VASc scores: experience from the Stockholm region.	0
"Aspirin (acetylsalicylic acid) is a well-known nonsteroidal anti-inflammatory drug that can potentiate some acute allergies and causes adverse immunological reactions collectively referred to as @Chemical$ intolerance, a disorder that induces @Disease$, asthma, and anaphylaxis in response to oral administration of the drug."	0
"RESULTS AND DISCUSSION: Our results indicate the low incidence of @Disease$ (0.01 patient per a year), with a lower incidence in the @Chemical$ antagonists group than in the group with the combination of vitamin K antagonists and aspirin (0.008 patient per a year versus 0.01 patient per a year)."	0
CONCLUSIONS: From this study it appears that platelet transfusion within 36 hours post injury for patients with TICH who were treated with @Chemical$ prior to the @Disease$ does not reduce the rate or extent of hemorrhagic expansion.	0
"AIM: In this study, transnasal endoscopy was used to observe the time-course changes of @Disease$ with low-dose @Chemical$ (ASA), and the preventive effect of rebamipide was compared with placebo."	0
"Further research is needed to assess the benefit-risk ratio of @Chemical$ plus aspirin in specific subpopulations of patients at high risk for atherothrombotic events, and to determine the role of clopidogrel plus aspirin in preventing cardioembolic stroke or early recurrent stroke after symptomatic large-vessel @Disease$."	0
"We evaluated the effects of aspirin on genetic/epigenetic alterations in pre@Disease$ous conditions, i.e., atrophic mucosa (AM) and intestinal metaplasia (IM), in patients with chronic gastritis who had taken @Chemical$ for more than 3 years."	0
"The pathogenesis of @Chemical$-exacerbated respiratory disease (@Disease$) is thought to be based on, mainly, overproduction of eicosanoid lipid mediators and on defective anti-inflammatory regulators."	0
Low-molecular-weight heparin and @Chemical$ use in relation to pregnancy outcome in women with @Disease$ and antiphospholipid syndrome: A cohort study.	0
"Based on current references four clinical scenarios were discussed and different management strategies were compared for secondary and primary prophylaxis of ulcer or peptic @Disease$ bleeding under continuous therapy with non-steroidal antiinflammatory drugs (NSAID) or low-dose-@Chemical$, for H.pylori-positive and H.pylori-negative patients."	0
"The prevalence of pre-@Chemical$ @Disease$ was 9.1% (11 cases), and 45.9% post-treatment (56 cases)."	1
OBJECTIVES: To study whether Clopidogrel-Aspirin combined treatment for high risk transient ischaemic attack (@Disease$) or minor stroke results in increased number of lesions associated with anti-thrombotic cerebral haemorrhage or cerebral micro-bleeds (CMB) than @Chemical$ alone treatment.	0
"Two independent authors searched databases using PICO questions (@Chemical$, H2RA, PPI, GI bleeding or @Disease$), and reviewed abstracts and articles for comprehensive studies keeping adequate study quality."	0
"A case of a patient with unstable @Disease$, insulin-dependent diabetes mellitus and @Chemical$ hypersensitivity is presented."	1
"We report an independent 88-year-old female, on @Chemical$ only for chronic @Disease$, who presented with a 12-hour history of acute lumbar back pain, urinary incontinence and progressive bilateral lower limb paresis."	0
"Amongst cases with @Disease$, 17.6% were on NSAIDs and 14.9% on aspirin; 27.4% of controls took NSAIDs, and 9.8% @Chemical$ (P&gt;0.05)."	0
CysLTR1 promoter polymorphism and requirement for leukotriene receptor antagonist in @Chemical$-intolerant @Disease$ patients.	0
"RESULTS: In group of patients with aspirin @Disease$ basic concentration of @Chemical$ was 416.6 +/- 374.4 pg/mL, and after provocation 496.6 +/- 485.3 pg/mL, in the group without sensitivity to aspirin appropriate 262.9 +/- 404.0 vs 261.2 +/- 259.66 pg/mL, and in the group disqualified to test 181.6 +/- 55.75 pg/mL."	0
"Acetylsalicylic acid or nonsteroidal antinflammatory drug sensitivity can be manifested as acute @Disease$, angioedema, acute asthma, @Chemical$ exacerbated respiratory disease and anaphylaxis."	0
"METHODS: Fibroblasts were isolated from the NM of subjects without asthma who had septal deviation, turbinate hypertrophy, or both (control subjects, n = 7); NPs of @Chemical$-tolerant nonasthmatic patients (n = 7); and NPs of patients with @Disease$ who were intolerant of aspirin (n = 7)."	0
"@Chemical$ desensitization, Leukotriene-modifying agents, biologic agents, management of @Disease$, chronic rhinosinusitis, and nasal polyposis are recommended as treatment modalities."	0
"METHODS: The 18 790 @Disease$ patients (@Chemical$ 9399, placebo 9391; average treatment duration 3.8 years) were stratified for global cardiovascular risk and for individual risk factors."	0
The effect of twice-daily administration of misoprostol on @Chemical$-induced @Disease$ was evaluated.	1
Increased risk of aspirin-induced @Disease$ in elderly Chinese men harboring SLCO1B1*1b/*1b while using @Chemical$ and an ACEI or ARB concomitantly.	1
"Additionally, @Disease$ Inventory (BDI) and Sinonasal Outcome Test 22 (SNOT 22) were applied. 31 patients were tested before and 7 months after @Chemical$ and aspirin desensitization in case of diagnosed AERD."	0
BACKGROUND: The blocking effect of controller medications for asthma could have an effect on the outcome of @Chemical$ challenges in patients suspected of having aspirin-exacerbated respiratory disease (@Disease$).	0
Bleeding during treatment with aspirin versus apixaban in patients with atrial fibrillation unsuitable for warfarin: the apixaban versus acetylsalicylic acid to prevent stroke in @Disease$ patients who have failed or are unsuitable for @Chemical$ antagonist treatment (AVERROES) trial.	0
"METHODS: This retrospective cohort study assessed overt @Disease$, decreased hemoglobin levels suspecting small bowel blood loss, and CV death in patients taking LDA for more than 1 year (LDA group) and in patients not taking @Chemical$ (control group)."	0
"Adverse events considered possibly or probably related to treatment occurred in 5 (20.0%) @Chemical$ recipients (4 episodes of @Disease$, 1 episode of abdominal pain), 1 (14.3%) recipient of lansoprazole 30 mg (1 episode of pharyngitis), and 3 (13.6%) placebo recipients (1 episode each of abdominal pain, palpitations, and dyspepsia)."	1
"Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and @Chemical$ in elderly patients following acute @Disease$."	0
"We report a case of acute @Chemical$ intoxication resulting in a transitory @Disease$, tinnitus, and vertigo."	1
CONCLUSION: The prescribing pattern of low-dose @Chemical$ revealed a poor awareness of preventing @Disease$ with combined protective medications.	0
"Aspirin-exacerbated respiratory disease (AERD) is associated with severe @Disease$ and @Chemical$ can cause asthma to worsen, often in the form of a severe and sudden attack."	0
The risk for developing a peptic @Disease$ during drug use was: 3.07 per 1000 person-years for @Chemical$ and 4.31 for effervescent calcium carbasalate.	0
OBJECTIVES: The purpose of this study was to determine whether patients taking @Chemical$ before an acute @Disease$ (ACS) are at higher risk of recurrent events or mortality.	0
"The patients comprised three groups: @Chemical$-interrupted group (13 patients with 13 colorectal tumors), LDA-continued group (28 patients with 31 @Disease$), and no anticoagulant/antiplatelet group (541 patients with 565 colorectal tumors)."	0
OBJECTIVE: We present a case report of a patient who developed an epidural @Disease$ following an interlaminar epidural steroid injection with no risk factors aside from old age and @Chemical$ use for secondary prevention.	0
Low-dose @Chemical$ (ASA) has emerged as one of the most important causes of peptic @Disease$ bleeding in developed countries.	0
METHODS: The Apixaban versus Acetylsalicylic Acid to Prevent Stroke in @Disease$ Patients Who Have Failed or Are Unsuitable for Vitamin k Antagonist Treatment (AVERROES) trial randomized 5599 patients with atrial fibrillation and risk factors to receive either apixaban or @Chemical$.	0
Mean PD(20) was 163.4 +/- 39.9 mg ASA among patients who reacted with @Disease$ to @Chemical$.	1
OBJECTIVE: This study evaluated whether there was an association between 2 polymorphisms--the platelet glycoprotein (GP) IIIa PlA1/A2 polymorphism and the 27-bp VNTR (variable number of tandem repeats) polymorphism in intron 4 of the endothelial nitric oxide synthase (eNOS) gene--and a risk for nonvariceal @Disease$ in Spanish patients taking low-dose @Chemical$ for secondary prophylaxis of vascular occlusive diseases.	1
"METHODS: Thirty genome-wide expression microarrays were used to compare nasal polyp tissue from patients with chronic rhino@Disease$ alone (CRS, n = 10) or chronic rhinosinusitis and a history of @Chemical$-sensitive asthma (ASA, n = 10) to normal sinonasal mucosa from patients who underwent surgery for non-sinus related conditions (controls, n = 10)."	0
"RESULTS: Nine patients (5.8%) presented symptomatic @Disease$ poststenting (3 ischemic, 6 hemorrhagic): 8 patients received 70 U/kg of @Chemical$ (11.1%) and 1 patient received 50 U/kg (1.2%; P &lt; .009)."	0
@Chemical$ pretreatment revealed no beneficial effects and resulted in increased postoperative @Disease$ and requirement for blood product transfusions after coronary artery bypass grafting in patients with stable angina.	1
"BACKGROUND: @Chemical$ is often used in patients with cardiovascular disease, but it can also cause @Disease$."	1
STUDY DESIGN: A systematic search for all publications since 1989 (when H. pylori was named) using search term equivalents for upper @Disease$ and @Chemical$.	0
"Currently, little information is available regarding alternative antiplatelet therapy in patients with an @Disease$ or intolerance to @Chemical$."	0
BACKGROUND: @Chemical$ desensitization (AD) is an effective and safe therapeutic option for patients with nonsteroidal anti-inflammatory drugs (NSAIDs)-exacerbated @Disease$ (N-ERD).	0
"OBJECTIVE: Demographic changes are leading to an aging society with a growing number of patients with @Disease$, relying on antiplatelet drugs like acetylsalicylic acid (@Chemical$)."	0
"Our study is novel in that it shows that @Disease$l damage caused by @Chemical$, a commonly used NSAID, facilitates T. cruzi infection by the oral route."	1
"OBJECTIVES: To compare @Disease$ changes among dogs administered @Chemical$, prednisone, and combination treatment."	0
"The association between @Chemical$ use and the presence of DR or VTDR was assessed using multivariable logistic regression models including age, gender, ethnicity, socioeconomic status, HbA1c, systolic blood pressure, anti-hypertension medicine, total cholesterol, anti-cholesterol medicine, BMI, current smoking status, diabetes duration, history of @Disease$ (CVD) and chronic kidney disease (CKD.)."	0
"The authors assessed the prevalence of @Disease$ following extended-release dipyridamole/aspirin combination (DAC), and the efficacy of @Chemical$ in the treatment of these headaches."	0
OBJECTIVE: We sought to evaluate whether titrated initiation of @Chemical$-dipyridamole in patients with stroke/transient ischemic attack (TIA) improves tolerance and to assess the appearance of @Disease$ in those with pre-existing history of headaches.	0
"BACKGROUND: Non-steroidal anti-inflammatory drugs (NSAIDs) and low-dose @Chemical$ (ASA) have several @Disease$ (GI) effects, including upper GI bleeding."	1
"The present study, carried out on female rats, evaluates the effects of P. halepensis L. essential oil (EOP) on @Chemical$ (A)-induced @Disease$."	1
"In two separate series, platelet aggregation and carrageenan arthritis-induced inflammatory @Disease$ were measured in control, ASA and @Chemical$-Tris-treated groups."	0
"Clopidogrel versus @Chemical$ yielded HRs of 0.69 (95% CI: 0.59-0.81) and 0.72 (95% CI: 0.55-0.96) for stroke and @Disease$, respectively."	0
"Four days after clopidogrel withdrawal and transfusion of 12 platelet concentrate units, @Chemical$ aggregation transiently normalized and bilateral trepanation with @Disease$ evacuation was performed."	1
"After @Chemical$ desensitization, patients can take daily ASA in order to treat their underlying @Disease$."	0
"A case of a patient with unstable coronary artery disease, @Disease$ and @Chemical$ hypersensitivity is presented."	1
Symptom-Based Clustering in @Disease$ Relates to History of @Chemical$ Sensitivity and Postsurgical Outcomes.	0
CONCLUSIONS: High IFN-gamma levels distinguish AERD from aspirin-tolerant @Disease$ and underlie the robust constitutive and @Chemical$-induced secretion of CysLTs that characterize this disorder.	0
CONCLUSION: @Chemical$ and the combination of acetylsalicylic acid and dipyridamole were associated with similar risks for recurrent ischemic stroke and @Disease$; whereas acetylsalicylic acid was associated with higher risks for both ischemic stroke and bleeding.	0
"BACKGROUND: @Chemical$-exacerbated @Disease$ (AERD) is characterized by progressive sinusitis, nasal polyposis, and asthma that begins and continues in the absence of exposure to aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs)."	1
"However, desensitization to @Chemical$ is a viable option for patients with aspirin-induced respiratory reactions, especially for those who require aspirin for @Disease$ prophylaxis."	0
"At about 4 years follow-up, no significant difference was observed among the aspirin and nonaspirin use group in major adverse cardiac events free survival estimates (95.7% versus 91.5%, P = 0.23) and freedom from cardiogenic readmission (88.5% versus 85.3%, P = 0.77) whereas the @Disease$ recurrence free survival rates was 83.7% and 73.9% in the @Chemical$ and nonaspirin use group respectively (P = 0.02), with odd ratio for preoperative aspirin estimated at 0.71 (95% confidence interval, 0.49-1.04, P = 0.08)."	0
"This study estimates the @Disease$ risks associated with combinations of aspirin, thienopyridine derivatives, and @Chemical$ in elderly patients."	0
"METHODS: Ninety-four @Chemical$-induced urticaria patients presenting urticaria/angioedema-induced by both ASA and NSAID (50 had underlying chronic @Disease$) and showing positive responses on oral aspirin challenge test, 76 aspirin-intolerant asthmatics with positive responses on lysine-aspirin bronchoprovocation test, and 185 normal healthy controls were enrolled."	0
"Recently, vitamin C releasing aspirin (ASA-@Chemical$) has been shown to reduce gastric toxicity of ASA in animal model of @Disease$."	0
"The study was conducted between 1992 and 2006 in three Italian areas, on 442 cases with histologically confirmed @Disease$ and 676 control women admitted to the same hospitals as cases for a wide spectrum of acute, non-neoplastic, non-gynaecological, non-hormone-related conditions, providing information on @Chemical$ use."	0
The aim of this work was to determine the presence of galectin-10 in nasal lavage fluid (NLF) of patients with aspirin-sensitive @Disease$ (ASRD) before and after challenge with L-ASA (@Chemical$) by ELISA.	0
"RESULTS: A lower incidence of @Disease$ and duodenal ulcers was seen in celecoxib/aspirin-treated subjects (19%) vs. @Chemical$/aspirin (27%; RR: 0.63, 95% CI: 0.44-0.92)."	0
@Chemical$ and nitric oxide are important mediators of mucosal defence in the stomach (and elsewhere in the @Disease$) and represent attractive therapeutic targets for reducing the incidence of gastric ulceration.	0
Association analysis of cysteinyl-leukotriene receptor 2 (CYSLTR2) polymorphisms with @Chemical$ intolerance in @Disease$tics.	0
"ASA-@Chemical$ did not cause bleeding, microcirculatory dysfunction, @Disease$ or an elevation in proinflammatory markers."	0
"RESULTS: Nine patients (5.8%) presented symptomatic neurological complications poststenting (3 @Disease$, 6 hemorrhagic): 8 patients received 70 U/kg of @Chemical$ (11.1%) and 1 patient received 50 U/kg (1.2%; P &lt; .009)."	0
"CONCLUSIONS: Continued perioperative OAT with @Chemical$ in RARP is safe, feasible, and not associated with increased @Disease$."	0
"For subtypes of late @Disease$, regular @Chemical$ use 10 years prior to retinal examination was significantly associated with neovascular AMD (HR, 2.20 [95% CI, 1.20-4.15]; P = .01) but not pure geographic atrophy (HR, 0.66 [95% CI, 0.25-1.95]; P = .45)."	0
OBJECTIVE: Low-dose enteric-coated @Chemical$ is increasingly being used for prevention of @Disease$.	0
"CONCLUSION: These results support the possibility that in some patients with @Disease$ who are taking an ACEI, a dose-related effect of @Chemical$ may adversely affect survival."	1
We aimed to determine the relationship between @Chemical$ levels and bleeding in minor stroke or transient ischemic attack (@Disease$) patients receiving antiplatelet therapy.	0
@Chemical$-related @Disease$ was defined as new intracranial hemorrhage immediately adjacent or within the ventricular catheter trajectory.	1
"[@Chemical$: metabolism, determination in body fluids and the role in aspirin @Disease$."	0
"RESULTS: Increasing frequency of @Chemical$ use during pregnancy was associated with an increased risk of @Disease$ experiences (adjusted OR 1.44, 95% CI 1.08-1.92)."	1
It is suggested that the ASA- related increase in the calcium secretion of the pancreas should be regarded as an indication of @Chemical$ induced @Disease$.	1
BACKGROUND: Patients with @Disease$ who have aspirin sensitivity have greater @Chemical$ production and greater airway hyperresponsiveness to the effects of inhaled cysteinyl leukotrienes than their aspirin-tolerant counterparts.	0
"@Chemical$ group had more @Disease$ episodes than omeprazole group (46.9% versus 23.6%, P=0.01)."	0
Poor control of asthma symptoms with interleukin-5 inhibitors in four patients with @Chemical$-exacerbated @Disease$.	0
Exploring the role of curcumin containing @Chemical$ obtained from Curcuma longa (rhizomes) against @Disease$ of wound healing process by aspirin.	0
"BACKGROUND: Acetylsalicylic acid (ie, @Chemical$) administration inhibits @Disease$ in dogs and is associated with increased perioperative blood loss and transfusion requirements in people."	0
CONCLUSIONS: This is the first pilot study using capsule endoscopy to report on the relation between @Disease$ and low-dose @Chemical$.	0
Much of our understanding of cross-reacting drugs and chemicals with @Chemical$ comes from studying @Disease$tics with aspirin-exacerbated respiratory disease (AERD).	0
Immune heparin-induced @Disease$ can occur in patients receiving @Chemical$ and aspirin.	1
Aspirin intolerance is the hallmark of @Chemical$-exacerbated @Disease$ (AERD).	1
"LXA4 dose dependently (0.25-2.5 microg/kg, intraperitoneally) reduced the severity of @Chemical$-induced @Disease$ and suppressed aspirin-induced leukocyte adherence, whereas an LXA4 antagonist had the opposite effects."	1
@Chemical$-Exacerbated Respiratory Disease (AERD) and @Disease$ with Nasal Polyps (CRSwNP) are both characterized by the presence of chronic sinonasal inflammation and nasal polyps.	0
"METHODS: The label of each willow supplement and willow-containing product was assessed for the presence or absence of 3 warnings: (1) @Chemical$ allergy/sensitivity, (2) use of anticoagulants or blood thinners, and (3) children with flu-like symptoms or @Disease$."	0
"CONCLUSIONS: In nasal polyps of @Chemical$-hypersensitive patients, up-regulation of the adhesion molecules ICAM-1 and VCAM-1 and the integrin VLA-4 may play an important role in the development of @Disease$."	0
"Major advances in the molecular biology of @Chemical$s, exemplified by the cloning of cysteinyl-leukotriene receptors and discovery of a whole family of cyclooxygenase enzymes, offer new insights into mechanisms operating in aspirin-induced @Disease$."	0
"METHODS AND RESULTS: In total, 42 patients with no bleeding, 34 with nuisance @Disease$, and 14 with alarming bleeding underwent platelet reactivity testing 1 month to 1 year after PCI with light transmission aggregometry (LTA 5 and 20 muM adenosine disphosphate [@Chemical$]), vasodilator stimulated phosphoprotein phosphorylation (VASP) and VerifyNow P2Y12."	0
"METHODS: Asthma control status was monitored for 1 year with maintenance medications of inhaled corticosteroid and oral LTRA, and AIA patients were classified into three groups according to the mean @Chemical$ dose required per month to maintain @Disease$ control for 1 year: group I (&gt; or = 200 mg montelukast/month; n = 37), group II (5-150 mg/month; n = 25) and group III (&lt; 5 mg/month; n = 27)."	0
"RESULTS: Altogether, 310 subjects were assessed; 217 had histories of @Disease$/angioedema, 50 of anaphylaxis, 26 of nonimmediate cutaneous eruptions, and 17 of bronchospasm related to @Chemical$/nonsteroidal anti-inflammatory drugs (NSAID) intake."	0
"A case-crossover study was used to retrieve data on 10,905 incident patients with major @Disease$ complications (3,781 cerebral and 7,124 gastrointestinal) and prescribed low-dose @Chemical$ (&lt;=300 mg/day) from 2000-2008."	0
"@Chemical$ (acetylsalicylic acid)-induced asthma (AIA) consists of the clinical triad of asthma, chronic rhinosinusitis with @Disease$, and precipitation of asthma and rhinitis attacks in response to aspirin and other NSAIDs."	0
"Data Sources: We searched PubMed, Embase, CENTRAL, and ClinicalTrials.gov from inception to May 28, 2018, with the terms novel oral anticoagulants, non-vitamin K antagonist oral anticoagulants, direct oral anticoagulants, @Chemical$, rivaroxaban, apixaban, edoxaban, warfarin, Coumadin, vitamin K antagonist, aspirin, acetylsalicylic acid, or ASA, and major bleeding, fatal @Disease$, or intracranial hemorrhage."	0
"Established risk factors for @Disease$ ulcer development include advanced age, history of ulcer or GI bleed, concomitant use of corticosteroids or anticoagulants, high-dose @Chemical$/NSAID therapy, and possibly concomitant Helicobacter pylori infection."	0
"We calculated mortality ratios (MRs) according to the use of low-dose @Chemical$, adjusted for age, sex, comorbidity, @Disease$, and use of other PUB-associated or antiulcer drugs."	0
"Safety of @Chemical$, a specific cyclooxygenase-2 inhibitor, in @Disease$tic patients with aspirin-exacerbated respiratory disease."	0
"METHODS AND RESULTS: Pubmed, Google Scholar, and Cochrane were systematically searched for papers describing protocols about @Chemical$ @Disease$ in the percutaneous coronary intervention setting."	1
"METHODS: The patients enrolled in this study were the elderly requiring a single non-impacted tooth extraction. 300 elderly outpatients used lidocaine local infiltration anesthesia, 200 patients without using aspirin before tooth extraction served as control group I, 100 patients with prolong use of aspirin before tooth extraction as observation group I. 300 elderly outpatients used compound articaine local infiltration anesthesia, 200 patients without using aspirin before tooth extraction served as control group II, 100 patients with prolong use of @Chemical$ before tooth extraction as observation group II.Bleedings at 5, 10, 30 min, 24 h after tooth extraction were observed and the relationship between postoperative @Disease$ and intake of aspirin was analyzed."	0
"CONCLUSIONS: NSAID, low-dose @Chemical$ use, and H. pylori @Disease$ are three independent risk factors for the development of PUB, but there were differences in the interaction effect between low-dose ASA (no interaction) or NSAID (addition) use and H. pylori infection, which may have implications for clinical practice in prevention strategies."	0
METHODS: The clinical records of 207 @Disease$tic patients who underwent inhalation challenges with both @Chemical$ and methacholine were reviewed retrospectively.	0
Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment: aspirin modulation of IgE-dependent mast cell activation: role of @Chemical$-induced exacerbation of immediate @Disease$.	1
"Because serum pepsinogens (PGs) and gastrin-17 (G17) can reflect gastric acid secretion, this study intended to elucidate whether serum PGs, serum G17, and H. pylori @Disease$ are associated with @Chemical$-induced gastrointestinal injury."	1
"This study compared proton pump inhibitors (PPIs) and histamine H2 receptor antagonists (H2RAs) for prevention of low-dose @Chemical$ (LDA)-related gastrointestinal (GI) erosion, @Disease$ and bleeding."	0
OBJECTIVE: To find potential factors associated with asthma control in patients with @Chemical$-exacerbated @Disease$ (AERD).	0
Triflusal in Patients With @Chemical$ @Disease$ Treated With Coronary Stent Implantation.	1
OBJECTIVE: Spontaneous spinal epidural @Disease$ (SEH) has not been reported under anti-thrombotic therapy with acetyl-salicylic acid (@Chemical$) in a dosage of 50 mg/d.	0
"PA32540, a combination pill with @Chemical$ and omeprazole, is a newly emerging intervention that has the potential to reinforce patient compliance with the aspirin regimen due to fewer @Disease$ effects."	0
"CONCLUSIONS: Although in patients undergoing pacemaker implantation dual antiplatelet therapy with @Chemical$ and clopidogrel caused a significant increase of @Disease$ complications, the use of aspirin alone was not associated with a significant increase in bleeding complications."	0
OBJECTIVES: @Chemical$ is recommended for primary prevention in patients with @Disease$ (MetS).	0
@Disease$ was induced by intragastric administration of aspirin and 0.15 N @Chemical$ in male Sprague-Dawley rats.	0
"METHODS: Fibroblasts were isolated from the NM of subjects without @Disease$ who had septal deviation, turbinate hypertrophy, or both (control subjects, n = 7); NPs of @Chemical$-tolerant nonasthmatic patients (n = 7); and NPs of patients with asthma who were intolerant of aspirin (n = 7)."	0
BACKGROUND: Dual antiplatelet therapy with @Chemical$ and a P2Y12 inhibitor is the cornerstone for prevention ischemic events in patients with @Disease$s (ACS) and undergoing percutaneous coronary intervention.	0
"In our investigation of such adverse effects, we obtained 4 important findings considered useful for physicians, as follows; 1) even when aspirin was given at a dose, the incidence rate of @Disease$ was higher than with other non-steroidal anti-inflammatory drugs (NSAIDs), 2) the odds ratios for gastrointestinal lesions induced by aspirin with a histamine H2 receptor antagonist and proton pump inhibitor were 0.6 and 0.4, respectively, as compared with @Chemical$ alone, 3) it is difficult to administer aspirin, which exerts an antiplatelet effect, without inducing gastrointestinal lesions, and 4) these gastrointestinal lesions appears early, especially within 2 years after administration."	0
"In iron depletion, less @Chemical$ may be available for @Disease$ through free-radical mediated mechanisms and for promotion of tumor growth."	0
The A-444C polymorphism in the leukotriene C4 synthase gene is associated with @Chemical$-induced @Disease$.	1
"Soon after the introduction of @Chemical$ for the treatment of pain, @Disease$, and inflammation more than a century ago, clinicians were challenged by the frequent observation of ASAtriggered allergic and pseudoallergic reactions occurring in the skin."	0
The most recent data show that eradication of H. pylori @Disease$ in patients with a previous peptic ulcer bleeding episode who continue to take @Chemical$ reduces the recurrence rate of this complication to levels observed in patients without a history of ulcer bleeding history who take aspirin for cardiovascular disease.	0
"In contrast to native NSAIDs, their NO-releasing derivatives such as NO-@Chemical$ were found to exhibit lower @Disease$ despite inhibiting both COX-1 and COX-2 activity in the gastric mucosa."	0
@Chemical$ @Disease$ often directs the physician away from this potentially life-saving modality.	1
"Aspirin (ASA)-exacerbated @Disease$ (AERD) is characterized by upper airway congestion due to eosinophilic inflammation of the nasal and sinus membranes and nasal polyposis, associated with increased @Chemical$ production that is further accentuated by ASA or other nonsteroidal anti-inflammatory drug (NSAID) ingestion."	0
OBJECTIVE: To evaluate the expression of vascular cell adhesion molecule 1 (VCAM-1) and intercellular adhesion molecule I (ICAM-1) and their ligands (the integrins lymphocyte function-associated antigen 1 and very late-activation antigen 4 [VLA-4]) in nasal @Disease$ of patients with aspirin hypersensitivity compared with @Chemical$-tolerant individuals.	0
OBJECTIVE: To estimate the bleeding risk of combined anticoagulant (@Chemical$ or enoxaparin-vitamin K antagonist [VKA]) and NSAID or aspirin therapy in patients with @Disease$.	0
A study on the effects of recent @Chemical$ ingestion on platelet function in cardiac surgery showed a greater @Disease$ in patients treated with aspirin &lt;2 days before the operation.	1
"CONCLUSIONS: Preoperative aspirin use in all patients undergoing cardiac operations was not associated with risks of major cardiac, cerebral, or renal complications and infections and death; however, the risk of reoperation for @Disease$ was elevated among preoperative @Chemical$ users compared with nonusers in a subpopulation of patients undergoing valve operations only."	1
"CONCLUSIONS: Our findings suggest that although the use of @Chemical$ plus PPIs provides GI benefits, with this treatment, there is an increased CV risk among patients with a history of @Disease$."	0
"However, @Chemical$ treatment was associated with significantly increased risks of any @Disease$ (RR 1.63; 95% CI: 1.31-2.03; P &lt; 0.01), major bleeding (RR 1.41; 95% CI: 1.26-1.57; P &lt; 0.01), and GI bleeding (RR 1.85; 95% CI: 1.38-2.48; P &lt; 0.01) compared with placebo."	1
"There were, however, significantly more subjects with one or more lesions (erosion or @Disease$) per subject in the paracetamol and aspirin (16/20, 80%) treated subjects as compared to the @Chemical$ (8/19, 42%, P &lt; 0.001) or the paracetamol (3/21, 14%, P &lt; 0.01) exposed subjects."	0
CONCLUSIONS: A considerable number of @Disease$tic patients with no history of aspirin intolerance responded to the inhalation @Chemical$ challenge.	0
"CONCLUSION: On the basis of the present studies, it cannot be unequivocally said whether @Chemical$ influences people's vision and if people endangered with @Disease$ progression or who are diagnosed with AMD should use this drug."	0
"RESULTS: The mean perioperative @Disease$ was 899+-496 ml for patients not on @Chemical$, 1091+-654 ml for patients on clopidogrel (p=0.005) and 1312+-686 ml for those on combined clopidogrel and aspirin (p=0.0003 vs. all others)."	0
The effect of twice-daily administration of @Chemical$ on aspirin-induced @Disease$ was evaluated.	0
"BACKGROUND: Aspirin-exacerbated respiratory disease (@Disease$) is a clinical triad consisting of @Chemical$/acetylsalicylic acid (ASA) sensitivity, bronchial asthma, and nasal polyposis."	0
"Nested case-control analyses were used to assess risk factors for IS/@Disease$, including low-dose @Chemical$ discontinuation."	0
"There were four independent factors for bleeding: age 67 years or older (odds ratio (OR) 4.7 (95 per cent confidence interval 1.8 to 12.2); P = 0.002), @Chemical$ therapy (OR 2.9 (1.4 to 6.3); P = 0.006), surgery on or around the ear (OR 2.6 (1.2 to 5.7); P = 0.012) and closure with a @Disease$ or graft (OR 2.7 (1.4 to 5.3); P = 0.004)."	0
It was designed to test whether low dose @Chemical$ as an antithrombotic agent is as safe as aspirin in patients with @Disease$ (ACS).	0
@Disease$ disappeared from countries where aspirin was not used in children as well as from countries which continued to use @Chemical$ in children.	0
Provision of @Chemical$ and an immediate-release PPI as a coordinated-delivery combination tablet has been shown to both reduce the risk of @Disease$ formation and improve patient compliance.	0
BACKGROUND: The blocking effect of controller medications for @Disease$ could have an effect on the outcome of aspirin challenges in patients suspected of having @Chemical$-exacerbated respiratory disease (AERD).	0
"Despite these in vitro and ex vivo findings, we observed two patients develop acute @Disease$ while receiving both @Chemical$ and aspirin: both patients' sera tested strongly positive in a heparin-dependent washed platelet activation assay (100% serotonin release) and PF4/heparin-enzyme-immunoassay (2.594 and 2.190 absorbance units)."	1
"OBJECTIVE: In order to uncover the genetic mechanism, we studied the associations of the human leucocyte antigen (HLA) genotypes in patients with aspirin-induced @Disease$ compared with @Chemical$-intolerant asthma and normal control in a Korean population."	0
CONCLUSIONS: @Chemical$ desensitization is effective and safe in unstable patients with @Disease$ in both the short and long term.	0
"BACKGROUND: Previous studies have suggested a benefit of cilostazol in addition to standard dual-antiplatelet therapy (@Chemical$), reducing in-stent late luminal loss and @Disease$ after percutaneous coronary intervention (PCI) with bare-metal and drug-eluting stent (DES) implantation."	0
"Age, male gender, Helicobacter pylori (H. pylori)@Disease$, diabetes, chronic kidney disease (CKD), cirrhosis, history of uncomplicated peptic ulcer disease (PUD), and use of NSAIDs, COX-2 inhibitors, steroids, and thienopyridines were independent risk factors for UGIB among @Chemical$ users."	0
Objective:The aim of this study is to observe the effects of @Disease$ and @Chemical$ asthma on chronic rhinosinusitis and to explore the corresponding clinical value.	0
RESULTS: A total of 144 patients who had @Disease$ on initial CT scan (ASA group: 72; No-@Chemical$ group: 72) were enrolled.	0
"Both apple @Chemical$ extracts significantly reduced the ulcer area, @Disease$ lesion index and gastric injury score."	0
"The patients were classified into two groups based on the type of low-dose aspirin that they had been prescribed (enteric-coated aspirin group or buffered @Chemical$ group), and evaluated the numbers of @Disease$ and the Lewis score."	0
The @Chemical$ @Disease$tic patients (b) (n: 8) (5 male and 3 female) demonstrated by progressive challenge with aspirin and fall of FEV 1 (3) 20%.	1
"Significant heterogeneity among included studies may be due to a single study, after removing which the significant association between postdiagnosis aspirin use and @Disease$-specific mortality disappeared; however, prediagnosis @Chemical$ use achieved a borderline significant association with risk of all-cause mortality (RR = 0.81, 95 % CI = 0.68-0.97, P = 0.03)."	0
We sought to quantify @Disease$ (UGIB) risk associated with low-dose @Chemical$ in secondary versus primary prevention patients.	0
The new highly selective cyclooxygenase 2 inhibitors are well tolerated in AERD @Disease$tics who have not been desensitized to @Chemical$.	0
"@Chemical$, non-steroidal anti-inflammatory drugs (NSAIDs) and paracetamol are the most frequent drugs used worldwide for the management of @Disease$, inflammation and fever associated with many acute and chronic conditions."	0
Two cases of patients with symptomatic cerebrovascular disease requiring neurointervention who were successfully desensitized to their @Chemical$ @Disease$ prior to treatment are described.	1
METHODS: Polyps were obtained from 11 aspirin-sensitive and 19 @Chemical$-tolerant patients with @Disease$.	0
"The hypothesis presented herein is that @Chemical$ contributed to the incidence and severity of viral pathology, bacterial infection, and death, because physicians of the day were unaware that the regimens (8.0-31.2 g per day) produce levels associated with hyperventilation and @Disease$ in 33% and 3% of recipients, respectively."	1
Studies have shown that patients on aspirin and @Chemical$ are at increased risk for perioperative @Disease$ and related events.	0
It is concluded that CAST-ELISA might be of value as an additional test for the detection of @Chemical$ nonallergic @Disease$ in suspected individuals.	0
"While some drugs have been reported to be effective in treating @Chemical$-induced @Disease$, most studies did not exclude patients with mild damage thought to be clinically insignificant."	1
"CONCLUSIONS: We present a case series demonstrating that in carefully selected patients, @Disease$ on aspirin and @Chemical$ is feasible and safe."	0
"In the guideline, eight clinical questions were chosen for peptic @Disease$s associated with use of low-dose @Chemical$."	0
"For patients who have inadequately controlled @Disease$ and/or asthma despite treatment with topical corticosteroids and @Chemical$-modifying drugs, aspirin desensitization is an important therapeutic option."	0
"CONCLUSIONS: Omalizumab treatment inhibited urinary leukotriene E4 overproduction and upper/lower respiratory tract symptoms during oral @Chemical$ challenge, resulting in aspirin tolerance in 62.5% of aspirin-exacerbated @Disease$ patients."	0
"Hypersensitivity to @Chemical$ (ASA) is characterized by the co-occurrence of symptoms so-called aspirin triad, which include bronchial asthma, chronic rhinitis and @Disease$."	0
"OBJECTIVE: To provide a diagnostic strategy for evaluating and treating patients with @Chemical$ sensitivity, with additional consideration for issues specific to patients with coronary artery disease (@Disease$)."	0
"RESULTS: Based on 384 cases, there were an estimated 7654 (95% confidence interval [CI], 3325-11 983) ED visits annually for @Disease$-related AEs from DAT compared with 2926 cases and an estimated 60 575 (36 117-85 033) ED visits from @Chemical$."	0
@Chemical$ was associated with a significantly higher risk of @Disease$ (P=0.0015) but this was not found to significantly affect IOP control at 2 years.	1
CONCLUSION: High use of @Chemical$ was associated with an almost two-fold increased risk of incident @Disease$ other than CLL/SLL.	0
"CONCLUSIONS AND CLINICAL IMPORTANCE: Administration of deracoxib to healthy dogs resulted in significantly lower @Disease$ scores, and fewer days of vomiting compared to @Chemical$, indicating that deracoxib is better tolerated than aspirin in some dogs."	0
"Randomized placebo-controlled trials (RCTs) assessing the efficacy of H2 blockers in reducing gastrointestinal harms (bleeding, @Disease$) among adults taking @Chemical$ for 2 weeks or longer were included."	0
BACKGROUND: Exposure to acetylsalicylic acid (@Chemical$) may exacerbate respiratory or @Disease$ or induce anaphylactoid reactions in apparently healthy individuals.	1
The effects of inhaled @Chemical$ on fractional exhaled NO (FENO) in patients with aspirin-tolerant (ATA) and aspirin-inducible (AIA) @Disease$ compared with normal controls have been investigated.	0
"This report describes a case of Kounis-Zavras syndrome in the setting of @Chemical$-induced asthma also known as Samter-Beer triad combining nasal polyps, asthma, and aspirin @Disease$ leading to vasospasm and myocardial infarction."	0
Aspirin plus @Chemical$ and risk of @Disease$ after coronary artery bypass surgery.	0
"In the subanalysis of 25 aspirin-takers without severe @Disease$, gastric mucus secretion was increased and the acid/mucus ratio was decreased compared with controls, but there was no such association in the remaining 17 @Chemical$-takers with severe gastropathy."	0
"Data Sources: We searched PubMed, Embase, CENTRAL, and ClinicalTrials.gov from inception to May 28, 2018, with the terms novel oral anticoagulants, non-vitamin K antagonist oral anticoagulants, direct oral anticoagulants, dabigatran, rivaroxaban, apixaban, edoxaban, @Chemical$, Coumadin, vitamin K antagonist, aspirin, acetylsalicylic acid, or ASA, and major @Disease$, fatal bleeding, or intracranial hemorrhage."	0
Hemorrhagic transformation of @Disease$ associated with @Chemical$ and aspirin concomitant therapy.	1
RESULTS: Adult subjects (&gt;/=18 years) with @Disease$ (n = 459) were compared with subjects with non-@Chemical$-sensitive asthma (n = 2848).	0
"We investigated whether aspirin with @Chemical$ (ASA++) increases headache frequency compared with aspirin alone in @Disease$, tension-type headache (TTH), and migraine + TTH (MigTTH)."	0
This study evaluated the association of BMI and asthma in patients with aspirin-tolerant asthma (ATA) and aspirin-intolerant @Disease$ (@Chemical$).	0
@Chemical$ (ASA) is an important cause of @Disease$ so that ASA induced asthma (AIA) is considered a disease.	1
"The aim of this study was to investigate the relation between bladder cancer risk and the use of selected drugs for @Disease$ (CVD) prevention, such as @Chemical$, statins, and calcium channel blockers (CCBs)."	0
Significant differences in dog-days of @Disease$ were found between the @Chemical$ and deracoxib groups whereas no significant differences were found between the deracoxib and placebo groups.	0
"BACKGROUND: In patients with aspirin-exacerbated respiratory disease (@Disease$), pretreatment with asthma controller medications (leukotriene modifiers, inhaled or systemic corticosteroids, and @Chemical$) partially modifies the severity of aspirin-induced asthmatic reactions."	0
"Among the risk factors of @Chemical$-associated @Disease$ bleeding, Helicobacter pylori infection is one of the few that is treatable."	1
A few reports have shown that @Chemical$ did not increase the risk of @Disease$ and may be beneficial to be continued until the time of surgery.	0
This experiment was designed to establish the localization and neurochemical phenotyping of sympathetic neurons supplying prepyloric area of the porcine stomach in a physiological state and during acetylsalicylic acid (@Chemical$) induced @Disease$.	1
"This anti-inflammatory effect of @Chemical$ seems to be related to impairment of lipid peroxidation, neutrophil function and cytokine production in @Disease$."	0
Primary PCI with endothelial progenitor cell-capture stent in patient with skull base @Disease$ and @Chemical$ allergy.	0
"CONCLUSIONS: In patients who had ulcer complications related to the long-term use of low-dose aspirin, treatment with @Chemical$ in addition to the eradication of H. pylori infection significantly reduced the rate of recurrence of @Disease$ complications."	0
Sustained maintenance of the intragastric pH at an elevated value is necessary to prevent @Disease$l damage induced by @Chemical$.	0
"BACKGROUND AND AIM: Low-dose @Chemical$ (LDA), and Helicobacter pylori (HP) @Disease$ are considered the two primary causes of peptic ulceration."	0
The aim of the present retrospective study was to describe our experience in selected patients with @Disease$ associated to the @Chemical$ ingestion and to underline the influence of hyperammonemia on Reye's encephalopathy.	1
"Reduced risk was observed among @Chemical$ users who began regular use within the previous 5 years (OR = 0.6, 95% CI: 0.4, 1.0) or used this drug for prevention of @Disease$ (OR = 0.7, 95% CI: 0.5, 1.0)."	0
"The most common cause is conditioned to a genetic predisposition towards atopy (atopic asthma), although other factors can also give rise to bronchial inflammation, such as over-exposure to environmental irritants (occupational asthma), altered @Chemical$ metabolism (aspirin-induced @Disease$) and also exercise - in which different thermal and osmotic mechanisms are known to intervene."	0
@Chemical$ induced @Disease$ accompanied with allergic bronchopulmonary aspergillosis: a case report.	1
Such an enhanced antioxidant defence system might represent an adaptive response to protect against increasing @Chemical$ production by inflammatory cells in AIA and help decelerate ongoing respiratory @Disease$.	0
"BACKGROUND AND AIM: Low-dose aspirin (@Chemical$), and Helicobacter pylori (HP) @Disease$ are considered the two primary causes of peptic ulceration."	0
"In fact, patients with @Disease$ have to be considered high-risk patients due to their increased propensity for uncontrolled bleeding.The aim of this article was to present and discuss the management of a case of double consecutive retrobulbar hemorrhage in a high-risk patient in treatment with @Chemical$ and warfarin."	0
A protective effect of induced @Chemical$ reduction against @Disease$ mortality has been confirmed in a recent trial (FeAST) with subjects randomized to iron reduction or observation.	0
"Compared with clopidogrel, aspirin increases the risk of GI bleeding but not other @Disease$; however, 883 patients (95% CI, 357-infinity) would need to be treated with clopidogrel versus @Chemical$ to prevent one major GI bleeding episode annually at a cost of over 1 million dollars."	0
"The aging is one of the most important risk factors of upper @Disease$ induced by @Chemical$, such as gastric ulcer."	1
"The values of @Disease$s of @Chemical$s in descending order were as follows: gefarnate, hydrotalcite &gt; teprenone &gt; sucralfate oral suspension &gt; L-glutamine and sodium gualenate granules &gt; rebamipide &gt; sucralfate chewable tablets."	0
"@Disease$ to acetylsalicylic acid (ASA) is characterized by the co-occurrence of symptoms so-called @Chemical$ triad, which include bronchial asthma, chronic rhinitis and sinusitis and the nasal mucosa polyps."	0
INTRODUCTION: The aim of this study was to assess the efficacy of leucotrien- antagonists in @Chemical$-intolerant @Disease$ (AIA).	0
AIMS: To report our experience on surgical resection of @Disease$ for patients with a history of chronic anticoagulation (ACT) or @Chemical$ use.	0
"Independent significant predictors for EVD-related @Disease$ were the preoperative prescription of @Chemical$ (adjusted OR 1.94; 95% CI 1.10-3.44), catheter malposition (aOR 1.99; 95% CI 1.22-3.23), and use of the 2.8-mm Medtronic  catheter (aOR 4.22; 95% CI 2.39-7.41)."	0
The effect of clopidogrel and @Chemical$ on @Disease$ in hip fracture surgery.	0
It was calculated OR and 95% CI of peptic @Disease$ for serum @Chemical$.	0
"Four subjects (one @Disease$ alone, one asthma alone, two with both) had a positive response to lysine @Chemical$ predefined as symptoms plus a &gt;10% fall in FEV1 from baseline."	0
"Among them, the three main risk factors are prior history of peptic ulcer, the single most important risk factor, age, the most common, and concomitant @Chemical$ use, due to their @Disease$ and cardiovascular implications."	1
"Risk of @Disease$ associated to NSAIDs, low-dose @Chemical$ and their combinations: Results of a pharmacovigilance reporting system."	0
"SA levels were significantly lower in the @Disease$ group (3.2 +- 0.2 g/dl vs 4.2 +- 0.4 g/dl, respectively, p <0.001) whereas mean ARU was significantly higher compared with the normal albumin group (548 +- 45 vs 444 +- 66 @Chemical$, respectively, p <0.001)."	0
"BACKGROUND: In patients with ischemic stroke of non-cardioembolic origin, acetylsalicylic acid, clopidogrel, or a combination of @Chemical$ and dipyridamole are recommended for the prevention of a recurrent @Disease$."	0
"Overproduction of cysteinyl-leukotrienes (Cys-LTs) has been implicated as major mediators of @Disease$; however, the LT receptor antagonist montelukast is only partially effective in inhibiting @Chemical$ responses."	0
It could be concluded that the treatment with P. halepensis L. essential oil inhibited @Chemical$-induced @Disease$.	1
Galectin-10 is released in the nasal lavage fluid of patients with @Chemical$-sensitive @Disease$.	0
OBJECTIVE: To investigate the protective effect of compound @Chemical$ and magnesium granules on aspirin-induced @Disease$ in rats and its possible mechanism.	0
"We therefore investigated the efficacy of @Chemical$, a well-tolerated histamine H(2)-receptor antagonist, in the prevention of peptic ulcers and erosive @Disease$ in patients receiving low-dose aspirin for vascular protection."	0
Differential levels of these components in @Chemical$-exacerbated respiratory disease (@Disease$) and allergic rhinitis with asthma (ARwA) may be related to a different inflammatory response in both asthma phenotypes.	0
HYPOTHESIS: The combination of zinc-L-carnosine and @Chemical$ attenuates aspirin-induced @Disease$.	0
This clinical picture is known as @Chemical$-exacerbated @Disease$.	1
[@Chemical$-intolerance (Samter's syndrome): an important differential diagnosis for chronic @Disease$].	0
Efficacy of @Disease$ (2.3%) sea water in patients with @Chemical$-induced chronic rhinosinusitis following endoscopic sinus surgery.	0
Recognising the risk of @Chemical$-sensitive @Disease$ in a patient with asthma who has previously tolerated aspirin.	0
"The group receiving @Chemical$ showed a remarkable improvement of their @Disease$, whereas the group given placebo showed no change."	1
"CONCLUSIONS: In this observational study, aspirin use was not associated with an increase in mortality rates or HF readmission rates, and aspirin did not attenuate the benefits of ACE inhibitors, even in patients without coronary disease, patients with @Disease$, or patients treated with high-dose @Chemical$ and low-dose ACE inhibitors."	0
"The role of @Chemical$ on the risk of @Disease$ of the upper aerodigestive tract was investigated in the combined data of three Italian case-control studies, including 965 cases and 1779 hospital controls."	0
"In a Cochrane review the safety of non-steroidal anti-inflammatory drugs (NSAIDs), including aspirin in people receiving methotrexate (@Chemical$) for @Disease$ was evaluated."	0
"Furthermore, a recent study suggested that the administration of low-dose @Chemical$ plus high-dose esomeprazole (a potent PPI) was associated with fewer episodes of UGI bleeding than clopidogrel alone in patients with a history of recent UGI @Disease$."	0
"Similarly, the use of nonaspirin nonsteroidal antiinflammatory drugs (NSAIDs), including cyclooxygenase (COX)-2 inhibitors, has also been shown to increase the risk of GI effects, and the concomitant use of @Chemical$ and nonaspirin NSAIDs can significantly increase the risk of @Disease$."	1
The most probable cause of his @Disease$ is an increase in the blood level of cilostazol because of the inhibition of @Chemical$ metabolism by components of grapefruit juice.	0
Chronic rhinosinusitis with @Disease$ (CRSwNP) and asthma frequently coexist and are always present in patients with @Chemical$ exacerbated respiratory disease (AERD).	0
"The magnitude of @Chemical$-associated increase, the prevalence and attributable risk of Helicobacter pylori @Disease$ on these events in aspirin users was also assessed."	0
This article discusses recent evidence regarding the @Disease$ risks associated with discontinuing aspirin use in patients who take @Chemical$ daily and presents a new recommendation for continuing low-dose aspirin during invasive dental procedures.	0
[Case of acute @Disease$ caused by @Chemical$].	1
PURPOSE OF REVIEW: The use of aspirin in @Disease$ and address the unmet need of aspirin therapy in patients with history of hypersensitivity reactions to @Chemical$ (acetylsalicylic acid; ASA) or other nonsteroidal inflammatory drugs (NSAIDs).	0
BACKGROUND: @Chemical$ is the most widely prescribed agent used in prevention of @Disease$.	0
Moreover some patients with imperative cardiologic indications for combination therapy with @Chemical$ and clopidogrel (stent placement and/or acute @Disease$) have a history of allergy to aspirin.	0
"With regard to the metabolism of @Chemical$ (AA) in NSAID-intolerant @Disease$tic patients, the following changes have been observed: 1) A low production of prostaglandin E2, seemingly due to deficient Cox-2 regulation; 2) an increased expression of leukotriene-C4 synthase; and 3) a reduced production of metabolites (lipoxins) released through the transcellular metabolism of AA."	0
"Aspirin hypersensitivity was diagnosed in 180 (13.6%) @Disease$tic patients, with a reliable history in 145 (80.5%), and oral @Chemical$ provocation test in 35 (19.5%) patients."	0
BACKGROUND: Evidence about the risk of bleeding and thromboembolism because of @Chemical$ mono-therapy in total @Disease$ (TKA) is scant.	0
"The use of @Chemical$ was associated with a greater risk of major bleeding in most of the subgroups investigated but not in individuals with @Disease$ (IRR, 1.09; 95% CI, 0.97-1.22)."	0
OBJECTIVE: We sought to evaluate whether titrated initiation of @Chemical$-dipyridamole in patients with stroke/transient @Disease$ attack (TIA) improves tolerance and to assess the appearance of headache in those with pre-existing history of headaches.	0
"In our investigation of such adverse effects, we obtained 4 important findings considered useful for physicians, as follows; 1) even when aspirin was given at a dose, the incidence rate of gastrointestinal lesions was higher than with other non-steroidal anti-inflammatory drugs (NSAIDs), 2) the odds ratios for gastrointestinal lesions induced by aspirin with a histamine H2 receptor antagonist and proton pump inhibitor were 0.6 and 0.4, respectively, as compared with aspirin alone, 3) it is difficult to administer @Chemical$, which exerts an antiplatelet effect, without inducing gastrointestinal lesions, and 4) these @Disease$ appears early, especially within 2 years after administration."	0
PURPOSE: The present study aimed to assess the cost effectiveness of concomitant proton pump inhibitor (PPI) treatment in low-dose @Chemical$ (LDASA) users at risk of @Disease$ (UGI) adverse effects as compared with no PPI co-medication with attention to the age-dependent influence of PPI-induced adverse effects.	0
"We investigated the risks of ischemic stroke and intracranial hemorrhage (@Disease$) in relation to @Chemical$ at various TTRs in a real-world cohort of Chinese patients with atrial fibrillation receiving warfarin and compared with those on dabigatran, aspirin, and no therapy."	0
"@Chemical$ (SCG) is used for the treatment of @Disease$ with food allergy, but the efficacy of SCG in ASP-exacerbated food-allergy reactions is unclear."	0
"The authors assessed the prevalence of headaches following extended-release @Chemical$/aspirin combination (DAC), and the efficacy of acetaminophen in the treatment of these @Disease$."	0
"Aside from patients with known aspirin-sensitive @Disease$, physicians have avoided the use of @Chemical$ in asthmatic patients in general because it was believed that this agent might precipitate worsening of their condition."	0
"The cells were isolated from 3 groups of subjects: non@Disease$tic patients (n = 10), patients with aspirin-tolerant asthma (ATA, n = 9), and patients with aspirin-intolerant asthma (@Chemical$, n = 7)."	0
@Chemical$ Prevents Exacerbation of IgE-Mediated Food-Allergic Reaction Induced by Aspirin in a Rat Model of Egg @Disease$.	0
"Our aim was to investigate prophylaxis effects of famotidine, one of the representative histamine-2 receptor antagonists (H2RA), on gastric mucosal injury induced by dual therapy with low-dose aspirin and @Chemical$ in relation to Helicobacter pylori (H. pylori) @Disease$ and CYP2C19 genotypes."	0
"Aspirin- and @Chemical$-associated @Disease$ complications: data mining of the public version of the FDA adverse event reporting system, AERS."	1
A case of acute @Disease$ possibly associated with combined salicylate and @Chemical$ treatment.	0
No difference was observed in methacholine @Disease$(20)FEV(1) and baseline FENO between @Chemical$ and AIA patients.	0
"Aspirin (acetylsalicylic acid) is a well-known nonsteroidal anti-inflammatory drug that can potentiate some acute allergies and causes adverse immunological reactions collectively referred to as @Chemical$ intolerance, a disorder that induces urticaria, @Disease$, and anaphylaxis in response to oral administration of the drug."	0
"OBJECTIVE: We sought to determine blood and urinary levels of 9alpha,11beta-PGF(2), a major stable PGD(2) metabolite in 2 well-defined phenotypes of asthma, aspirin-induced asthma (@Disease$) and @Chemical$-tolerant asthma (ATA), and in healthy control subjects and to study the effects of aspirin on PGD(2) release."	0
OBJECTIVES: To provide a pooled estimate of the @Disease$ risk from randomized controlled trials (RCTs) comparing @Chemical$ and ASA at the dose ranges recommended in evidence-based guidelines.	0
"CONCLUSIONS: We conclude that the risk of severe bleeding after transbronchial lung biopsy is small (ie, &lt; 1%) and that the use of @Chemical$ is not associated with any increased risk of @Disease$."	0
"CONCLUSIONS: In patients with stable CIHD and histories of nonsevere @Disease$ reactions to @Chemical$/NSAIDs, an ASA challenge is advisable."	1
CONCLUSIONS: Preoperative treatment with low doses of @Chemical$ does not increase surgical bleeding and transfusion rate in total knee @Disease$.	0
"When compared with the cardiac surgical patients they treat, physicians required a smaller thrombotic risk reduction with @Chemical$ whilst accepting its known increased risk of @Disease$."	1
"Therefore, it is essential that prescribing physicians be aware of the risk of @Chemical$-induced @Disease$."	1
The question addressed was whether enteric-coated @Chemical$ results in a lower incidence of @Disease$ compared to normal aspirin in CABG surgery.	0
Aspirin-induced asthma (AIA) is a distinct clinical entity characterised by hypersensitivity to @Chemical$ and other non-steroidal anti-inflammatory drugs (NSAIDs) typically occurring in the form of asthma and severe @Disease$.	0
"A previous history of ulcer or GI bleeding are identified risk factors for GI @Disease$, but few studies have been conducted on patients treated with low-dose @Chemical$ to confirm this."	0
"Prior known oral NSAIDs @Disease$ included aspirin (5), mefenamic acid (2), diclofenac (2), @Chemical$ (2) and ibuprofen (1)."	0
Rebamipide reduced the damage of low-dose @Chemical$-induced @Disease$ complications.	1
There is good evidence that co-therapy with a proton-pump inhibitor (PPI) reduces upper gastrointestinal @Disease$ with @Chemical$ alone or dual anti-platelet therapy.	1
"The preventive effects of PPIs were compared with the control group [taking placebo, a cytoprotective agent, or an H2 receptor antagonist (H2RA)] in @Chemical$-associated @Disease$."	1
CONCLUSIONS: Over-the-counter analgesic powders containing high doses of @Chemical$ including BC Powder and Goody's Powder may contribute to @Disease$ in patients with no or minimal risk factors.	1
"RESULTS: A total of 82,854 of 118,606 patients (69.9%) surviving @Disease$ hospitalization had at least 1 prescription filled for warfarin, @Chemical$, or clopidogrel after discharge."	0
"She had no symptom of urticaria and @Disease$, and had the both character of @Chemical$ urticaria and asthma as to aspirin challenge test."	0
"METHODS AND RESULTS: Patients (n = 200) with @Disease$ were randomized to receive @Chemical$ 50, 100, or 200 mg twice daily (bid) or 400 mg daily (qd) or clopidogrel 75 mg qd for 28 days."	0
"OBJECTIVE: We sought to determine blood and urinary levels of 9alpha,11beta-PGF(2), a major stable PGD(2) metabolite in 2 well-defined phenotypes of @Disease$, aspirin-induced asthma (AIA) and @Chemical$-tolerant asthma (ATA), and in healthy control subjects and to study the effects of aspirin on PGD(2) release."	0
Aspirin-induced @Disease$ (AIA) is associated with increased production of cysteinyl leukotrienes (@Chemical$).	0
CONCLUSION: Our study did not find any significant reductions in cancer-related mortality or @Disease$ incidence when compared @Chemical$ use with placebo or no aspirin.	0
"Patients with clinical CHD and those with diabetes and without clinical @Disease$ were 5.88 (P=0.008) and 7.54 (P=0.012) times more likely to utilize @Chemical$, respectively, than patients with only one CHD risk factor of age."	0
"Of all antiplatelet therapies approved for the secondary prevention of @Disease$, @Chemical$ is the most well-established and is recommended for all patients with a history of cerebrovascular disease."	0
"RESULTS: In aspirin-induced asthma patients (@Chemical$, n=10), the basal concentration of urinary LTE4, but not the other metabolites, was significantly higher than that in aspirin-tolerant @Disease$ patients (ATA, n=10)."	0
The intragastric administration of @Chemical$ induced multiple @Disease$ in rat gastric mucosa.	1
"OBJECTIVE: The use of low-dose aspirin (@Chemical$ [ASA]) has been suggested to attenuate growth of @Disease$ (AAAs), yet solid clinical evidence of this hypothesis is still missing."	0
"Furthermore, life-threatening @Disease$ complications have been related temporally to perioperative discontinuation of both @Chemical$ and warfarin."	1
"CONCLUSION: In addition to age, male gender, H. pylori infection, and concomitant use of NSAIDs, COX-2 inhibitors, @Chemical$, and thienopyridines, underlying co-morbidities including diabetes, @Disease$, cirrhosis, history of PUD are also important risk factors for first-time occurrence of non-variceal UGIB in aspirin users."	0
Cardiovascular prophylaxis and @Chemical$ @Disease$.	1
Interaction between endogenous carbon monoxide and hydrogen sulfide in the mechanism of gastroprotection against acute @Chemical$-induced @Disease$.	1
"A polymorphism study that examined nine single-nucleotide polymorphisms of five leukotriene-related genes [ALOX5 (encoding 5-lipoxygenase), ALOX5AP (5-lipoxygenase-activating protein), PTGS2 (cyclooxygenase 2), LTC4S (leukotriene C4 synthase), and CYSLTR1 (cysteinyl leukotriene receptor 1)] found that promoter polymorphisms of ALOX5 (-1708A&gt;G) and CYSLTR1 (-634C&gt;T) were significantly different between @Chemical$-intolerant asthma and aspirin-induced @Disease$/angioedema, suggesting different contributions to the lipoxygenase pathway."	0
Multivariate analysis showed that use of @Chemical$ by itself was associated with post-ESD @Disease$ (relative risk [RR] 4.49; 95% confidence interval [95%CI] 1.09-18.38).	0
"METHODS: We investigated intolerance and bleeding while on aspirin and @Chemical$ discontinuation using 5337 post-acute @Disease$ patients considered appropriate for chronic antiplatelet therapy who were randomly assigned to aspirin in SYMPHONY and 2nd SYMPHONY and followed for 94 (64,157) days."	0
"RESULTS: When 19 confounding factors (diseases and interventions) were assessed, @Chemical$ significantly increased mortality in diabetic patients without @Disease$ from 17% (95% confidence interval; 95%CI, 1-36) at age 50 years to 29% (16-43) at age 85 years."	0
"Patients were divided into four groups according to the presence or absence of degenerative changes at the bottom of an eye: group D - 80 patients with drusen (23 men and 57 women), 27,4% of studied population, group @Chemical$ - 25 patients with geographic atrophy (10 men, 15 women), 8,56% of studied population, group CNV - 52 patients with neovascular form of @Disease$ (28 men, 24 women), 17,81% of studied population, group Z - 135 healthy people (44 men, 91 women), 46,23% of studied population."	0
RESULTS: The median @Disease$s were 0 in the baseline and the @Chemical$ 10 mg regimen.	0
"Association of @Chemical$ Use With Mortality Risk Among Older Adult Participants in the Prostate, Lung, @Disease$ Screening Trial."	0
Univariate analysis was performed to examine the association between @Chemical$ and @Disease$ complications.	0
"After adjustment for other explanatory variables, the association between @Chemical$ and END@Disease$ remained significant."	1
Perioperative treatment with aspirin or @Chemical$ and risk of @Disease$--reply.	0
"In this article, we discuss the mechanism of these reactions, and the characteristic course of @Chemical$-induced @Disease$ and its management."	1
Primary PCI with endothelial progenitor cell-capture stent in patient with skull base fracture and @Chemical$ @Disease$.	1
TT genotype of rs2238631 and TT genotype of rs2243100 may be risk factors for @Disease$ in @Chemical$ users.	1
In subjects with aspirin @Disease$ disruption of synthesis of @Chemical$ (PGE2) and overproduction of cysteinyl leukotrienes (Cys-LT) seem to be crucial in the pathogenesis of bronchial symptoms.	1
"EVIDENCE ACQUISITION: Published articles were identified through a search of MEDLINE and the Cochrane databases using the dates 1966 to June 2004 and the search terms aspirin @Disease$, coronary artery disease, @Chemical$ desensitization, and aspirin sensitivity."	0
The objective of this study was to assess whether polymorphisms in UGT1A6 and CYP2C9 genes are related to the prevalence of upper gastrointestinal symptoms in cardiovascular patients using @Chemical$ for secondary prevention of @Disease$.	0
"Intervention studies are required to determine the clinical relevance of measured platelet response to @Chemical$ in terms of outcome, and the effectiveness of improved pharmacotherapy for @Disease$ prevention."	0
"Previous trials have shown that up to 15-20 % of patients developed @Disease$ with @Chemical$ monotherapy, and approximately 1 % of patients per year had a clinically significant bleeding event, including 1 in 1000 patients who suffered an intracranial or fatal bleed."	1
"It is particularly important to know the risk of side effects when @Chemical$ is used as primary prevention--that is when used by people as yet free of, but at risk of developing, @Disease$ (CVD) or cancer."	0
"RESULTS: Of 8754 Chinese patients with @Disease$ and CHA2DS2-VASc &gt;=1 (79.5+-9.2 years; CHA2DS2-VASc, 4.1+-1.5; and Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile International Normalized Ratio, Elderly (&gt;65 years), Drugs/Alcohol Concomitantly [HAS-BLED], 2.2+-0.9), 16.3% received warfarin, 41.1% aspirin, 4.5% @Chemical$, and 38.1% received no therapy."	0
"The most common reasons for recommending @Chemical$ discontinuation were concern about bleeding after polypectomy (62%), perceived minimal downside to stopping aspirin (38%), inertia to changing old policies (20%), and concern about medicolegal implications of postpolypectomy @Disease$ (15%)."	0
Decreased vascular endothelial growth factor expression is associated with cell apoptosis in low-dose @Chemical$-induced @Disease$.	1
"A total of 12 patients with a clear-cut history of @Disease$ were randomised in double-blind cross-over fashion to receive single doses of ML 10 mg, ML 40 mg, or placebo (PL), with nasal @Chemical$-aspirin challenge performed 12 h after dosing."	0
"Also, women had less peripheral artery disease (aspirin, 2.4% versus 3.7%; apixaban, 1.4% versus 3.0%), more heart failure, and higher mean CHADS2 (congestive heart failure, @Disease$, age of 75 years or older, diabetes [1 point each], stroke or transient ischemic attack [2 points]) scores (@Chemical$, 2.2 versus 2.0; apixaban, 2.1 versus 2.0)."	0
"In conclusion, early point-of-care on-@Chemical$ platelet reactivity testing in ACS may identify patients with increased risk of minor @Disease$ events and subsequent discontinuation of antiplatelet therapy."	0
"BACKGROUND: The aim of this study was to detect cysteinyl leukotriene (@Chemical$-LT) receptors in aspirin-sensitive nasal polyposis patients, and compare them with nasal polyposis and chronic @Disease$ patients without aspirin sensitivity."	0
"Although the ability to interpret the meaning of the individual gene in these signatures remains a challenge, integrated analysis of a large number of these signatures with other genome-scale data sets and more traditional targeted approaches has a potential to revolutionarize understanding and treatment of chronic @Disease$ and @Chemical$-sensitive asthma."	0
Aspirin as a cause of @Disease$ in patients with @Chemical$-exacerbated respiratory disease.	0
"DATA SOURCES: Articles evaluating aspirin for primary prevention of CVD were gathered using a MEDLINE search with the keywords aspirin review, @Chemical$ peripheral artery disease, aspirin @Disease$, aspirin coronary artery disease, aspirin diabetes, aspirin primary prophylaxis, and aspirin elderly."	0
@Disease$-induced recurrent hyphema and secondary  glaucoma associated with chronic @Chemical$ use.	1
"Improvement of @Chemical$-intolerant @Disease$ by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial."	0
At present there is no reliable detection method available for the diagnosis of @Chemical$-@Disease$ and its relation to clinical symptoms.	0
@Chemical$ increased the risk of major @Disease$.	1
"AIM: To evaluate the effects of low-dose @Chemical$ on @Disease$, mucosal prostaglandin-E(2) levels and cyclooxygenase-enzyme expression in relation to the H. pylori status."	0
"METHODS: Two hundred thirty-nine patients with AIU consisting of 120 patients with @Chemical$ intolerant chronic urticaria (AICU) and 119 with aspirin-intolerant acute urticaria (@Disease$), and 524 normal controls were enrolled."	0
OBJECTIVES: Endothelial dysfunction may enhance @Disease$ despite regular @Chemical$ therapy.	0
"METHODS: Ninety-four aspirin-induced urticaria patients presenting urticaria/angioedema-induced by both ASA and NSAID (50 had underlying chronic @Disease$) and showing positive responses on oral aspirin challenge test, 76 aspirin-intolerant asthmatics with positive responses on @Chemical$-aspirin bronchoprovocation test, and 185 normal healthy controls were enrolled."	0
Aspirin desensitization is an option for those with refractory @Disease$ or who require @Chemical$ for other medical conditions.	0
Comparable safety of 2 aspirin desensitization protocols for @Chemical$ exacerbated @Disease$.	0
"@Chemical$-exacerbated respiratory disease (AERD) is associated with severe asthma and aspirin can cause @Disease$ to worsen, often in the form of a severe and sudden attack."	0
"METHODS: Ninety-four aspirin-induced urticaria patients presenting @Disease$/angioedema-induced by both ASA and NSAID (50 had underlying chronic urticaria) and showing positive responses on oral @Chemical$ challenge test, 76 aspirin-intolerant asthmatics with positive responses on lysine-aspirin bronchoprovocation test, and 185 normal healthy controls were enrolled."	0
"The results of the CHARISMA trial support this recommendation; despite previous data demonstrating a favourable benefit-risk profile of @Chemical$ plus clopidogrel in patients with acute coronary syndrome, this combination should not be used in patients at high risk for atherothrombosis and those with previous stroke or @Disease$."	0
"RESULTS: Seventy-five patients were studied; and 24 (32.0%) and 16 (21.3%) of them concurrently received antithrombotic drugs other than @Chemical$ and anti@Disease$ drugs, respectively."	0
We conclude that melatonin and its precursor tryptophan given orally significantly reduce @Disease$ induced by ASA possibly due to (a) direct gastroprotective action of exogenous melatonin or that generated from @Chemical$ and (b) gastrin released from the gastric mucosa by melatonin or tryptophan.	0
"There was no significant difference in COX-2 expression between @Disease$ and @Chemical$ stimulation (mean 61.8%, range 26.8-89.2; p = 0.09) and LPS stimulation (mean 55.5%, range 28.1-74.3) nor between aspirin stimulation alone (median 0.5%, range 0-8.6; p = 0.8) and baseline values (median 0.4%, range 0-5.4) in healthy control subjects."	0
"Type 2 inflammation characterizes aspirin-exacerbated respiratory disease.Objectives: To determine whether high-dose aspirin therapy changes biomarkers of type 2 inflammation in @Chemical$-exacerbated @Disease$.Methods: Forty-two subjects with aspirin-exacerbated respiratory disease underwent an aspirin desensitization and were placed on high-dose aspirin (1,300 mg daily)."	0
"The role of Helicobacter pylori is controversial in NSAID users, but there is now wide agreement that H. pylori infection increases mucosal damage and the risk of upper @Disease$ bleeding in low-dose @Chemical$ users."	0
"In total, it appears that when there is vessel injury (mechanical from perctutaneous coronary intervention or a ruptured plaque), dual antiplatelet therapy with aspirin and @Chemical$ results in improved outcomes, albeit with a small but significant inherent risk of increased @Disease$."	0
Outcomes after complete endoscopic sinus surgery and @Chemical$ desensitization in aspirin-exacerbated @Disease$.	0
"For the prediction of @Disease$ or stent thrombosis, bleeding and death, @Chemical$ score &gt;=2 had sensitivities of 57%, 41%, and 56%, respectively; specificities of 58%, 57%, and 58%, respectively; positive predictive values of 1.9%, 2.2%, and 2.1%, respectively; and negative predictive values of 99%, 98%, and 99%, respectively."	0
PGE(2) significantly enhanced anti-IgE induced @Chemical$ and PGD(2) release from mast cells of normal subjects but not those of ATA and @Disease$ patients.	0
Co-ingestion of aspirin and @Chemical$ promoting fulminant liver failure: A critical review of @Disease$ in the current perspective at the dawn of the 21st century.	0
"The patients who received ASA therapy were divided according to the results of a @Disease$ test into ASA-resistant, ASA-semiresponsive, and @Chemical$-sensitive groups."	0
"Risk factors for upper gastrointestinal (GI) ulcer or bleeding among @Chemical$ users include a history of prior @Disease$ events, older age, chronic renal failure, combined antithrombotic therapy and nonsteroidal anti-inflammatory drugs (NSAIDs)."	0
Prospective studies are needed to identify specific risk factors for upper @Disease$ in Japanese patients taking low-dose @Chemical$.	0
"DATA SOURCES: Literature retrieval was accessed through MEDLINE (1966-March 2007) using the terms @Chemical$, aspirin, antiinflammatory agents nonsteroidal, urticaria, angioedema, @Disease$, leukotriene antagonists, desensitization, and tacrolimus."	0
In the present study endoscopic examination was performed to investigate the frequency of gastroduodenal injuries associated with low-dose @Chemical$ in patients with ischemic heart disease (@Disease$).	0
@Disease$ was markedly decreased when @Chemical$ was administered 3 h after the evening meal.	0
"In incomplete responders on admission, platelet aggregation with @Chemical$ (ADP) was significantly higher compared with responders (p&lt;0.05) but there were no significant differences in collagen aggregation, platelet fibrinogen binding or P-selectin expression, plasma @Disease$ factor, fibrinogen, high-sensitivity C-reactive protein, or the urinary metabolite, 11-dehydro-TxB2."	0
"Although @Chemical$ metabolites appear to play an important role in @Disease$, the exact pathogenic mechanism for the syndrome remains obscure."	0
"METHODS: Therefore, nasal polypous tissue specimens of patients suffering from chronic nasal polypous sinusitis (NP), intrinsic @Disease$ (ATA), aspirin-intolerance (AINA), and @Chemical$-triad (TRIAD) were investigated."	0
"Acetaminophen, @Chemical$, and @Disease$."	0
Sinonasal outcomes after endoscopic sinus surgery in asthmatic patients with @Disease$: a difference between aspirin-tolerant and @Chemical$-induced asthma?	0
Gastroduodenal @Disease$ were observed in 17.6% of @Chemical$-treated compared with 5.1% of subjects treated with PL2200 (P=0.0069).	0
"METHODS: Ten patients with rhinosinusitis, nasal polyps, and asthma had a history of @Disease$ attacks after ingesting @Chemical$ and nonsteroidal anti-inflammatory drugs."	0
BACKGROUND: Some clinical studies have demonstrated that the proton pump inhibitor (PPI) could decrease @Chemical$ platelet response and increase major @Disease$ (MACE) in white or black subjects.	0
"RESULTS: Mortality was not increased (hazard ratio [95% CI]) when @Chemical$ was used in conjunction with ACEI (0.51 [0.29-0.87]) or ARB (0.29 [0.09-0.96]) in patients with ischemic or non@Disease$ (ACEI 0.71 [0.42-1.21], ARB 1.42 [0.74-2.74]) HF."	0
"Although three retrospective studies suggested that @Chemical$ does not increase the risk of polypectomy-induced @Disease$, the power of these studies is limited."	0
"Established risk factors for GI ulcer development include advanced age, history of ulcer or GI bleed, concomitant use of corticosteroids or anticoagulants, high-dose @Chemical$/NSAID therapy, and possibly concomitant Helicobacter pylori @Disease$."	0
Implications of reactive oxygen species and cytokines in gastroprotection against stress-induced @Disease$ by nitric oxide releasing @Chemical$.	0
Method: Eighty-six patients with CRS and asthma who were treated in the outpatient clinic during March 2015 to January 2018 were divided into @Disease$ group(52 cases) and @Chemical$ asthma group(34 cases) according to asthma and aspirin asthma.	0
The safety of celecoxib in patients with @Chemical$-sensitive @Disease$.	0
Do changes in visceral sensory function determine the development of @Disease$ during treatment with @Chemical$?	1
@Chemical$ should be held for at least 5 days before CABG to avoid perioperative @Disease$ complications.	0
"No patients on interrupted @Chemical$ without bridging (n = 26, 13 with warfarin, 13 with DOAC) developed a @Disease$."	0
"OBJECTIVE: This analysis compared the efficacy of @Chemical$, lansoprazole, and placebo in reducing the risk of @Disease$ or duodenal ulcer recurrence in patients taking NSAIDs and low-dose aspirin."	0
Aspirin exacerbated @Disease$ (AERD) is a clinical syndrome characterized by chronic rhinosinusitis with nasal polyposis and @Chemical$ hypersensitivity.	0
Altered eicosanoid metabolism is the generally accepted mechanism of @Chemical$ intolerance; the overproduction of cysteinyl leucotrienes has been suggested to play a causative role in both @Disease$ and AIU.	0
"However, no information is available for NSAID-induced @Disease$l/angioedema (@Chemical$), despite it being the most frequent clinical entity induced by NSAID hypersensitivity."	0
The aim of the investigation was to study melatonin production in thrombocytes and their functional activity in correlation with 6-sulfatoximelatonin (6-SOM) urinary excretion in patients with @Chemical$-induced @Disease$ (AIBA).	1
@Chemical$ or VKA intake was found not to be an independent risk factor for @Disease$.	0
Primary care physician perceptions of non-steroidal anti-inflammatory drug and @Chemical$-associated @Disease$: results of a national survey.	1
"@Chemical$-exacerbated respiratory disease (AERD), or aspirin-induced @Disease$, is characterized by asthma and rhinitis triggered by the ingestion of aspirin and non-steroidal anti-inflammatory drugs."	0
Gastroprotective effects of @Chemical$ and thymoquinone against acetylsalicylic acid-induced @Disease$ in rats.	0
CONCLUSIONS: Rates of @Disease$ and thrombotic events were not significantly different according to 6- versus 24-month @Chemical$ after PCI with new-generation DES in good aspirin responders.	0
"Importance: @Chemical$ use has been associated with reduced risk of @Disease$ mortality, particularly of the colorectum."	0
"BACKGROUND: In 5 to 10% of adult patients with asthma, aspirin (acetylsalicylic acid [@Chemical$]) and most other nonsteroidal anti-inflammatory drugs (NSAIDs) precipitate acute @Disease$tic attacks."	1
In vitro studies into mechanistic processes of @Chemical$ @Disease$ propose that there is a bi-directional link and potentiation with glutathione (GSH) depletion and salicylate toxicity.	1
In the present study endoscopic examination was performed to investigate the frequency of gastroduodenal injuries associated with low-dose @Chemical$ in patients with @Disease$ (IHD).	0
"In contrast, no elevated OR of peptic @Disease$ was shown in cases without @Chemical$."	0
OBJECTIVE: To investigate the correlation of tumor necrosis factor alpha (TNF-alpha) polymorphisms with upper gastrointestinal bleeding (UGIB) induced by enteric-coated @Chemical$ in @Disease$ (CHD) patients.	0
"BACKGROUND: @Chemical$ triad disease (ATD) is a well-known clinical entity characterized by asthma, @Disease$, and aspirin intolerance."	0
"Edoxaban is an oral factor Xa (FXa) inhibitor in clinical development for stroke prevention in patients with @Disease$, an elderly population that frequently receives @Chemical$ (ASA) and/or nonsteroidal anti-inflammatory drugs for concurrent illnesses."	0
Effect of atorvastatin and @Chemical$ on platelet inhibition by aspirin and clopidogrel treatment in patients with coronary stent @Disease$.	0
"The main models included the following predictors: demographic characteristics (age, ethnicity, and socioeconomic deprivation), clinical measurements (systolic blood pressure and ratio of total-high-density lipoprotein cholesterol), family history of premature CVD, medical history (smoking, diabetes, bleeding, peptic ulcer disease, cancer, chronic liver disease, @Disease$, or @Chemical$-related conditions), and medication use (nonsteroidal anti-inflammatory agents, corticosteroids, and selective serotonin reuptake inhibitors)."	0
"The prevalence of @Disease$ or erosion during chronic use of LDA, @Chemical$ and the anti-platelet drug thienopyridine (clopidogrel or ticlopidine), and NSAIDs were 64.3%, 80.0%, and 75.0%, respectively."	0
"Data Sources: We searched PubMed, Embase, CENTRAL, and ClinicalTrials.gov from inception to May 28, 2018, with the terms novel oral anticoagulants, non-vitamin K antagonist oral anticoagulants, direct oral anticoagulants, dabigatran, rivaroxaban, apixaban, @Chemical$, warfarin, Coumadin, vitamin K antagonist, aspirin, acetylsalicylic acid, or ASA, and major bleeding, fatal @Disease$, or intracranial hemorrhage."	0
CONCLUSION: These findings suggest that the HLA-DRB1(*)1302-DQB1(*)0609-DPB1(*)0201 may be a strong genetic marker to determine the @Chemical$-induced @Disease$ phenotype.	1
"Compared with @Chemical$ alone, the combination increased modified International Society on @Disease$ and Hemostasis major bleeding (288 of 9,152 [3.1%] vs. 170 of 9,126 [1.9%]), (HR: 1.70; 95% CI: 1.40 to 2.05; p &lt; 0.001), International Society on Thrombosis and Hemostasis major bleeding (206 of 9,152 [2.3%] vs. 116 of 9,126 [1.3%]), (HR: 1.78; 95% CI: 1.41 to 2.23; p &lt; 0.0001), and minor bleeding (838 of 9,152 [9.2%] vs. 503 of 9,126 [5.5%]), (HR: 1.70; 95% CI 1.52 to 1.90; p &lt; 0.0001); the combination also increased the need for any red cell transfusion (87 of 9,152 [1.0%] vs. 44 of 9,126 [0.5%]), (HR: 1.97; 95% CI 1.37 to 2.83, p = 0.0002)."	0
"@Chemical$-Exacerbated Diseases: Advances in Asthma with Nasal Polyposis, Urticaria, Angioedema, and @Disease$."	1
"In a nationwide case-control study, using Danish high-quality registry data, we evaluated the association between the use of low-dose @Chemical$ or other nonsteroidal anti-inflammatory drugs (NSAIDs) and the risk of @Disease$."	0
"Of these 52 cases, there were 22 @Disease$ cases with aspirin sensitivity, 15 nasal polyposis cases without @Chemical$ sensitivity and 15 chronic rhinosinusitis cases without aspirin sensitivity."	0
CONCLUSIONS: These results suggest that postoperative administration of low-dose aprotinin in patients taking @Chemical$ until just before primary coronary artery operations with cardiopulmonary bypass not only reduces the rate and total amount of postoperative mediastinal @Disease$ but also lowers postoperative blood product use.	0
"Sixteen failed to improve, 24 stopped ASA because of intractable side effects (@Disease$ or hives) and 17 patients discontinued @Chemical$ treatment in the first year of study for unrelated reasons."	0
BACKGROUND: The objective of the study was to determine the frequency of cerebral microbleeds (@Chemical$) by using phasesensitive imaging in patients with previous transient ischemic attack (TIA) or @Disease$ who were receiving aspirin treatment.	0
The effects of ASP and @Chemical$ on such absorption and @Disease$ were also evaluated kinetically.	0
The protective effect of COX-2 inhibitors on the risk of bleeding @Disease$ is suppressed by concomitant treatment with low-dose @Chemical$.	0
Conclusions: Elevated high-density lipoprotein @Chemical$ is independently associated with any @Disease$ and severe bleeding in the patients with acute minor stroke or high-risk TIA on antiplatelet therapy.	0
"CONCLUSION: Coupling of NO to ASA attenuates stress, ischemia-reperfusion, and ethanol-induced damage due to @Disease$ mediated by NO, which compensates for prostaglandin deficiency induced by @Chemical$."	0
"Prevalence of asthma, @Chemical$ sensitivity and allergy in chronic rhinosinusitis: data from the UK National @Disease$ Epidemiology Study."	0
"SUMMARY BACKGROUND DATA: Despite numerous retrospective and prospective analyses, it is still controversial as to whether @Chemical$ ingestion before coronary artery bypass grafting (CABG) is associated with significant @Disease$."	0
NSAIDs-including aspirin (@Chemical$)-that inhibit cyclooxygenase (COX)-1 induce nonallergic @Disease$ reactions consisting of attacks of rhinitis and asthma.	0
"We describe the case of a 64-year-old patient with glucose-6-phosphate dehydrogenase deficiency who was referred to our hospital because of an acute @Disease$.Given the possible risk of acute haemolytic anaemia, @Chemical$ was not given in the acute phase, and the patient was successfully treated by balloon angioplasty of the right coronary artery.After functional and genetic testing showing the presence of the Mediterranean mutation, known to be a class II variant, the patient received oral daily aspirin (100 mg) under strict monitoring in order to promptly detect any sign of haemolysis."	0
"After adjustment for possible confounding factors, a possible association between @Chemical$ use and incident @Disease$ (Relative Risk(RR): 1.60; 95%Confidence Interval (CI): 1.19-2.15) did not replicate in the HNR cohort (RR: 1.06; 95%CI: 0.87-1.28)."	0
"The results of oral aspirin challenges in the control population of 50 patients were compared with either the baseline or postchallenge data from the @Chemical$-pretreated or placebo-pretreated patients with @Disease$, and there were no significant differences."	0
"CONCLUSION: A high MABP at admission was found to be an independent predictor of poor prognosis for ICH patients treated with @Chemical$ or with no drugs, but not for @Disease$ patients treated with warfarin."	0
"RESULTS: In aspirin-induced asthma patients (AIA, n=10), the basal concentration of urinary LTE4, but not the other metabolites, was significantly higher than that in aspirin-tolerant @Disease$ patients (@Chemical$, n=10)."	0
"Inverse associations for regular @Chemical$ use were observed for ER+ (RR = 0.77; 95% CI 0.67-0.89), ER- (RR = 0.78; 95% CI 0.56-1.08), PR+ (RR = 0.79; 95% CI 0.68-0.92), and PR- (RR = 0.73; 95% CI 0.56-0.95) @Disease$s."	0
"@Chemical$ also appears to be a key mediator of gastrointestinal mucosal defence, and this has been exploited in the development of a novel class of anti-inflammatory drugs, called NO-NSAIDs, which exhibit little if any @Disease$."	0
"Events occurring after PCI-definite or probable stent thrombosis (@Chemical$), @Disease$ (MI) not related to ST, and clinically relevant bleeding (CB)-were classified as early (&lt;=30 days), late (31 to 365 days), or very late (&gt;365 days)."	0
"Prevalence of asthma, @Chemical$ sensitivity and allergy in @Disease$: data from the UK National Chronic Rhinosinusitis Epidemiology Study."	0
"We sought to compare the risk of @Disease$ due to the low (&lt;100 mg), moderate (100 to 200 mg), and high (&gt;200 mg) doses of aspirin (@Chemical$ [ASA]) in 192,036 patients enrolled in 31 clinical trials."	0
"Type 2 inflammation characterizes aspirin-exacerbated respiratory disease.Objectives: To determine whether high-dose @Chemical$ therapy changes biomarkers of type 2 inflammation in aspirin-exacerbated respiratory disease.Methods: Forty-two subjects with aspirin-exacerbated @Disease$ underwent an aspirin desensitization and were placed on high-dose aspirin (1,300 mg daily)."	0
"@Chemical$-exacerbated respiratory disease (AERD) refers to the combination of asthma, @Disease$ with nasal polyposis, and acute upper and lower respiratory tract reactions to the ingestion of aspirin (acetylsalicylic acid, ASA) and other cyclooxygenase-1 inhibiting non-steroidal anti-inflammatory drugs."	0
"There was no increase in headache frequency in participants with ASA++ intake compared with @Chemical$ (adjusted, all headache: -0.34 d/mo [95% confidence intervals: -2.50 to 1.82], migraine: -1.36 d/mo [-4.76 to 2.03], TTH: -0.57 d/mo [-4.97 to 3.84], MigTTH: 2.46 d/mo [-5.19 to 10.10]) or no analgesics (all headache: -2.24 d/mo [-4.54 to 0.07], @Disease$: -3.77 d/mo [-9.22 to 1.68], TTH: -4.68 d/mo [-9.62 to 0.27]; MigTTH: -3.22 d/mo [-10.16 to 3.71])."	0
"@Chemical$ dose, age, sex, body mass index, history of hypertension, diabetes mellitus, intraprocedural glycoprotein IIb-IIIa or anticoagulant type, and postprocedural anticoagulant use did not have a significant effect on the risk of major @Disease$."	0
"In @Chemical$ depletion, less iron may be available for carcinogenesis through free-radical mediated mechanisms and for promotion of @Disease$ growth."	0
"However, several patients are excluded from the benefits of @Chemical$ for @Disease$ problems, and controversies still exist on their management."	0
Double consecutive retrobulbar @Disease$ in a high-risk patient in treatment with @Chemical$ and warfarin.	0
"At &gt;=100 mg per day, @Chemical$ was not associated with a significant change on the risk of @Disease$ or antepartum hemorrhage, whether the treatment was initiated at &lt;=16 weeks of gestation (relative risk, 0.62, 95% confidence interval, 0.31-1.26), or at &gt;16 weeks of gestation (relative risk, 2.08; 95% confidence interval, 0.86-5.06), but the difference between the subgroups was significant (P=.04)."	0
"Patients on @Chemical$ 325 mg had a higher adjusted hazard ratio of 2.9 (95% confidence interval, 1.2-7.0 versus ASA 81 mg+dipyridamole; P = 0.02) and 3.4 (95% confidence interval, 1.2-9.5 versus ASA 81 mg; P = 0.02) for @Disease$ events."	1
"@Chemical$- and clopidogrel-associated @Disease$ complications: data mining of the public version of the FDA adverse event reporting system, AERS."	1
"The impaired cardiac proteasome, enhanced by chronic aspirin treatment, attenuated the removal of oxidative and ubiquitinated proteins, and chronic @Chemical$ treatment via selective and dose-dependent inhibition of cardiac proteasome possibly constituted a potential risk to @Disease$ heart."	0
"RESULTS: Logistic regression analysis showed no relationship of @Disease$ within the first 48 h to @Chemical$ pretreatment (p = 0.15), or heparin application (p = 0.38), but dependency on stroke severity (NIHSS) at baseline (p = 0.01)."	0
"We compared the antithrombotic effect of @Chemical$ vs ticagrelor in an @Disease$ patient with aspirin allergy by using a modified protocol of the thrombin generation test, accounting selectively for the platelet contribution on thrombin generation."	0
"Effects of paracetamol, non-steroidal anti-inflammatory drugs, @Chemical$, and opioids on bone mineral density and risk of @Disease$: results of the Danish Osteoporosis Prevention Study (DOPS)."	0
@Disease$ to @Chemical$ was confirmed by skin patch test and by lymphocyte stimulation test.	1
[The study of 18 cases of aspirin urticaria at dermatology of Yodogawa Christian Hospital--on the difference between aspirin asthma and @Chemical$ @Disease$].	1
"Soon after the introduction of @Chemical$ for the treatment of @Disease$, fever, and inflammation more than a century ago, clinicians were challenged by the frequent observation of ASAtriggered allergic and pseudoallergic reactions occurring in the skin."	0
"It is sufficient to use eradication of H.pylori alone as secondary prophylaxis in preventing recurrent peptic @Disease$ or recurrent ulcer bleeding for H.pylori-positive patients, who continue to take low-dose-@Chemical$."	0
"Nowadays, low-dose @Chemical$ is widely administered at low dose as an antithrombotic drug for the prevention of cerebrovascular and @Disease$."	0
"@Chemical$ (2.5mg and 5mg), dabigatran, rivaroxaban, idraparinux and vitamin K antagonists (VKA) each significantly reduced the risk of @Disease$ recurrence compared to placebo, ranging from a 73% reduction with idraparinux to 86% with VKAs."	0
"Questionnaires were sent to 210 neurosurgical facilities asking five main questions: (1) the adherence of any policy of stopping @Chemical$ pre-operatively, (2) the personal risk assessment for patients with brain surgery under low-dose aspirin medication, (3) the preferred method of treatment for excessive bleeding in this context, (4) personal knowledge of @Disease$ complications in this group of patients, and (5) the characteristics of the neurosurgical units concerned."	0
"DATA SOURCES: Articles evaluating aspirin for primary prevention of CVD were gathered using a MEDLINE search with the keywords aspirin review, aspirin peripheral artery disease, aspirin stroke, aspirin coronary artery disease, @Chemical$ @Disease$, aspirin primary prophylaxis, and aspirin elderly."	1
The aim of this study was to assess a possible detrimental effect of @Chemical$ on survival in stable patients with left ventricular systolic dysfunction who had @Disease$ and had been treated with ACE-Is.	0
The two frequent clinical presentations of @Chemical$ hypersensitivity are: aspirin-induced bronchial asthma/rhinosinusitis (@Disease$/R) and aspirin-induced urticaria/angioedema (AIU).	0
"A case of a patient with unstable coronary artery disease, insulin-dependent diabetes mellitus and @Chemical$ @Disease$ is presented."	1
"CONCLUSIONS: NSAIDs, @Chemical$, and warfarin were associated with ALGIB and diverticular @Disease$."	1
"Based on this event, the chronic use of @Chemical$ in young patients with @Disease$, as suggested to prevent stroke-like episodes, is disputable."	0
There were significantly more @Disease$ among low-dose @Chemical$ users than among the non-users (P&lt;0.0001).	0
"OBJECTIVE: Aspirin-exacerbated respiratory disease (AERD) represents a severe form of @Disease$ (CRS) characterized by nasal polyposis, bronchial asthma, and @Chemical$ intolerance."	0
"To evaluate the extent of gastric mucosal injury and the protective effect of drugs, @Disease$ index, gastric mucosal blood flow, content of gastric mucosal @Chemical$, prostaglandins (PG), nitric oxide(NO), tumor necrosis factor (TNF), and interleukin (IL) -1, 2, 8 were measured in each group, and histological changes were observed by gross as well as under microscope and electron microscope."	0
"The @Disease$ index, contents of TNF, and IL-1, 2, 8 were significantly lower in all the protection groups than in the injury group (all P&lt;0.01), and contents of IL-2 and IL-8 in the compound bismuth and @Chemical$ granules group were significantly lower than those in the sucralfate group ((328.17+-6.56) vs(340.23+-8.05)pg/ml, P&lt;0.01; (170.82+-7.31) vs(179.31+-7.80)pg/ml, P&lt;0.05)."	0
@Chemical$ for Aspirin-@Disease$ and Leukotriene Overproduction in Aspirin-Exacerbated Respiratory Disease: A Randomized Trial.	0
CONCLUSIONS: Ecabet sodium had a preventive effect on low-dose @Chemical$-induced @Disease$ in the upper part of the small intestine.	1
"The aim of this study is to report the sinonasal outcomes of endoscopic sinus surgery (ESS) in treating NP in @Disease$tic patients, comparing @Chemical$-induced asthmatic (AIA) patients with aspirin-tolerant asthmatics (ATA)."	0
"METHODS: Among patients who underwent PCI and were maintained on @Chemical$ for 1 year in a multicenter US registry, we assessed patient-reported @Disease$ over one year following PCI in patients with and without DM."	0
[@Chemical$-induced @Disease$ in patients with osteoarthritis].	1
Adjusted HRs for acetylsalicylic acid versus the combination of acetylsalicylic acid and @Chemical$ were 1.48 (95% CI: 1.31-1.67) for @Disease$ and 1.47 (95% CI: 1.18-1.82) for bleeding.	0
"DESIGN, SETTING, AND PARTICIPANTS: Prospective analysis of observational data from the EINSTEIN deep vein thrombosis and @Disease$ clinical trials comparing @Chemical$ with enoxaparin-VKA treatment, trials performed in hospitals and clinics in 8246 patients enrolled from 2007 to 2009."	0
"@Chemical$ has a cytoprotective action against NSAID-induced gastric lesions, and this action is not mediated by endogenous AD but may be functionally associated with inhibition of the @Disease$ response."	0
BACKGROUND: Use of over-the-counter (OTC) high-dose @Chemical$ (ASA) is a risk factor for experiencing @Disease$.	1
"AIMS: Daily low-dose aspirin is recommended for prevention of cardiovascular events in patients with coronary artery disease (@Disease$), and proton pump inhibitors (PPIs) are recommended to prevent or treat @Chemical$-associated gastrointestinal injury."	0
AIM: To investigate whether or not co-administered @Chemical$ with paracetamol results in an increased rate of endoscopic @Disease$ as compared to either agent alone.	0
We conclude that @Chemical$ and its precursor tryptophan given orally significantly reduce @Disease$ induced by ASA possibly due to (a) direct gastroprotective action of exogenous melatonin or that generated from tryptophan and (b) gastrin released from the gastric mucosa by melatonin or tryptophan.	0
"Response to letter regarding article, Ischemic @Disease$ and intracranial hemorrhage with aspirin, @Chemical$, and warfarin: impact of quality of anticoagulation control."	0
"Prolonged periods of dual antiplatelet therapy (DAT), i.e., aspirin plus a @Chemical$, are currently recommended to prevent late drug-eluting stent (DES) @Disease$."	0
"Methods: Serum total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein @Chemical$ and triglyceride were tested in a subgroup of 3 044 consecutive patients from Clopidogrel in High-risk patients with Acute @Disease$ (CHANCE) trial."	0
We aimed to develop a simple risk score to identify high risk NSAID and @Chemical$ users for primary upper @Disease$.	0
"Because PGE(2) exerts a range of inhibitory actions on inflammatory leukocytes via the EP(2) receptor, its reduced expression in aspirin-sensitive @Disease$ may be partly responsible for the increased inflammatory infiltrate and production of @Chemical$s that characterize aspirin-sensitive disease."	0
"All 129 patients with high risk @Disease$ with microbleeds or minor stroke within 24 hours after the onset (average age 65.9 +- 9.3, 48.7% were male patients) were divided randomly into two groups: (1) 67 patients were given combination therapy with @Chemical$ and aspirin (clopidogrel at an initial dose of 300 mg, then 75 mg per day for 90 days, plus aspirin at a dose of 75 mg per day for the first 21 days);(2) the rest patients were given aspirin treatment (75 mg per day for 90 days)."	0
"These results show that in patients with mild to moderate @Disease$ resulting from MSC, ibuprofen given in OTC doses for 6 days is as well tolerated as @Chemical$ and better tolerated than aspirin."	0
The specific PDE IV inhibitor rolipram is known to be a potent inhibitor of @Disease$ by increasing intracellular @Chemical$ in leukocytes.	1
"In contrast to NSAID-induced gastrointestinal @Disease$s, a well-tolerated histamine H2-receptor antagonist is reportedly effective in prevention of @Chemical$-induced gastrointestinal ulcers."	0
"The similarities in the reaction between the nose and airways in @Chemical$-sensitive patients provide compelling evidence for common pathogenic mechanisms for nasal polyps, chronic rhinosinusitis, and bronchial @Disease$."	0
"Widal disease is characterized by symptomatic triad of @Chemical$ intolerance, @Disease$."	0
"However, current evidence suggests that the @Disease$ and other bleeding risks of @Chemical$ probably outweigh its potential benefits in primary prevention."	0
@Chemical$ @Disease$ in patients presenting with acute cerebrovascular ischaemia.	1
"OBJECTIVE: To compare expression of cysLT 1 and cysLT 2 on leukocytes, mucus glands, and epithelium in 32 patients with chronic polypoid @Disease$ (21 aspirin-sensitive, 11 @Chemical$-tolerant) and 9 normal controls."	0
"The risk of perioperative @Disease$ is high in patients who take @Chemical$ and clopidogrel after a percutaneous coronary intervention, and whether to stop the drugs is a matter of concern for dentists."	1
A retrospective study was carried out to evaluate whether the use of @Chemical$/low-dose aspirin (LDA) is predictive of unfavorable outcomes in geriatric patients who sustain a fall-induced @Disease$.	0
"Drugs that can lead to @Disease$ include non-steroidal anti-inflammatory drugs (NSAIDs) like @Chemical$ and ibuprofen, platelet inhibitors such as acetylsalicylic acid (ASS), clopidogrel and prasugrel, as well as anticoagulants like vitamin-K antagonists, heparin or direct oral anticoagulants (DOAKs)."	0
"The results of oral @Chemical$ challenges in the control population of 50 patients were compared with either the baseline or postchallenge data from the tacrolimus-pretreated or placebo-pretreated patients with @Disease$, and there were no significant differences."	0
"We investigated whether aspirin with caffeine (ASA++) increases headache frequency compared with @Chemical$ alone in @Disease$, tension-type headache (TTH), and migraine + TTH (MigTTH)."	0
"BACKGROUND: The management of patients with traumatic @Disease$ (TBI), primary intracerebral hemorrhage (pICH) and primary subarachnoid hemorrhage (@Chemical$) remains a highly demanding challenge in critical care medicine."	0
"BACKGROUND AND AIM: The risk for erosive @Disease$ (EE) with low-dose @Chemical$ (ASA) remains unknown, especially among Japanese patients."	0
KEY FINDINGS: Three dogs undergoing surgery for intervertebral disc disease had marked prolongations in buccal mucosal @Disease$ time (BMBT) after @Chemical$ administration.	1
"Patients in @Chemical$ group had more @Disease$ (90.6% patient-years vs 8.29% patient-years, p&lt;0.01) due to an increase in NSH (90.6% patient-years vs 5.52% patient-years, p&lt;0.01), without changes in SH."	0
"OBJECTIVE: The purpose of this study is to demonstrate that celecoxib, a specific inhibitor of COX-2, does not cause asthmatic attacks in patients with @Chemical$ and/or other nonsteroidal anti-inflammatory drug-induced @Disease$."	0
"H. pylori infection and low-dose aspirin (@Chemical$) are not only independent causal factors of peptic @Disease$ and gastrointestinal bleeding, they also have synergistic and additive effects."	1
"In addition, to reduce the incidence of gastrointestinal lesions in @Chemical$ users, it is important for clinicians to confirm the differences in the @Disease$ between different types of aspirin formulations in clinical use."	0
"CONCLUSIONS: Early administration of a combined regimen of @Chemical$ and aspirin following off-pump CABG is safe and is associated with a relatively low incidence of major adverse cardiac events, @Disease$, PE, and DVT."	0
CONCLUSIONS: Omeprazole was superior to famotidine with less @Disease$ and recurrent ulcers/erosions in patients using 24-week low-dose @Chemical$.	0
METHODS: Thirty-five patients who took low-dose enteric-coated aspirin 100 mg daily (for more than 3 months) plus @Chemical$ 20 mg daily and were diagnosed as having @Disease$ participated in this prospective randomized controlled trial.	0
"METHODS: The effect of arachidonic acid or platelet agonists on LTC4 synthase activity was investigated in platelets obtained from healthy volunteers, aspirin-intolerant @Disease$tics or @Chemical$-tolerant asthmatics after in vivo treatment or in vitro pre-incubation with aspirin."	0
The combination of aspirin plus @Chemical$ increases the risk of UGI @Disease$.	0
BACKGROUND: Both @Chemical$ therapy and @Disease$ impair platelet function.	0
"In case 1, premedication of @Chemical$ suppressed the @Disease$ and elevation of blood gliadin levels which were induced by exercise, wheat and aspirin intake."	0
"@Chemical$-intolerant asthma is associated with lower age, higher prevalence of @Disease$ and atopic dermatitis, and more frequent exacerbations."	0
"Moreover, @Chemical$- induced @Disease$ resulted in increased expression of NPY (76.59 +- 3.02%) and GAL (26.45 +- 2.75%) as well as the novo-synthesis of nNOS (6.13 +- 1.11%) and LENK (4.77 +- 0.42%) in traced CCMG neurons."	1
"CONCLUSION: In our study, endothelial dysfunction was found in all the patients with stable @Disease$, without any association of its presence and severity with @Chemical$ resistance."	0
"We aimed to evaluate the association between several widely used analgesics, including @Chemical$, non-aspirin NSAIDs, and acetaminophen (paracetamol), and risk of psoriasis and @Disease$ (PsA) in a large cohort of US women, the Nurses' Health Study II (1991-2005)."	0
A 57-year-old man who had @Disease$ and had been on dual antiplatelet therapy with aspirin and @Chemical$ for primary prevention presented with the sudden onset of mid back pain and monoplegia of the left lower extremity.	0
"As for bleeding complications related to the gastrointestinal system, e.g., @Disease$, the statistical metrics suggested a stronger association for @Chemical$ than clopidogrel."	0
"AIMS: Daily low-dose @Chemical$ is recommended for prevention of cardiovascular events in patients with coronary artery disease (@Disease$), and proton pump inhibitors (PPIs) are recommended to prevent or treat aspirin-associated gastrointestinal injury."	0
"In view of the above, it was decided to study both the effect of fluoxetine monotherapy and that of fluoxetine co-administered with @Chemical$ on lipid peroxidation and antioxidative defense in patients with the first @Disease$ episode in their life."	0
INTERPRETATION: Use of clopiogrel without @Chemical$ was associated with a significant reduction in @Disease$ complications and no increase in the rate of thrombotic events.	0
OBJECTIVES: To study whether Clopidogrel-@Chemical$ combined treatment for high risk transient ischaemic attack (@Disease$) or minor stroke results in increased number of lesions associated with anti-thrombotic cerebral haemorrhage or cerebral micro-bleeds (CMB) than aspirin alone treatment.	0
"All active therapies except aspirin increased risk of composite @Disease$ by 2 to 4-fold compared to apixaban 2.5mg, with no difference found between the two @Chemical$ doses."	0
"The pooled RR for the @Chemical$ use on the risk of @Disease$ was 1 137 (95% CI, 1 003-1 289; I(2) , 68 4%)."	0
Chronic @Chemical$ intake may cause recurrent hyphema and secondary glaucoma even after a @Disease$.	1
"BACKGROUND: It remains unclear to what extent asthma in adults is linked to @Disease$ (AR), gastroesophageal reflux disease (GERD), and @Chemical$ exacerbated respiratory disease (AERD), and how these comorbidities may affect asthma outcomes in the general population."	0
"Dual antiplatelet therapy consisting of low-dose @Chemical$ (LDA) and other antiplatelet medications is recommended in patients with @Disease$, but it may increase the risk of esophageal lesion and bleeding."	0
BACKGROUND: Dual therapy (aspirin and @Chemical$) increases the risk of @Disease$ (UGIB).	0
"Patients with clinical CHD and those with @Disease$ and without clinical CHD were 5.88 (P=0.008) and 7.54 (P=0.012) times more likely to utilize @Chemical$, respectively, than patients with only one CHD risk factor of age."	0
Aspirin intolerance is the hallmark of @Chemical$-exacerbated respiratory disease (@Disease$).	0
"Fifty-six percent of them managed aspirin @Disease$ changing the therapeutic regimen (eg, @Chemical$ monotherapy and indobufen)."	0
Leukotriene CysLT1-receptor antagonism and nasal lysine-@Chemical$ provocation in aspirin-induced @Disease$.	0
CONCLUSION: The carriage of the cytochrome P450 CYP2C19 681A allele rather than platelet receptor gene polymorphisms determines a risk for @Chemical$ resistance in patients with @Disease$.	0
"CONTEXT: Although acetylsalicylic acid (@Chemical$) is commonly used for patients with @Disease$, a minority of patients have a sensitivity to acetylsalicylic acid and other nonsteroidal anti-inflammatory drugs."	0
@Chemical$ use and bleeding risk after endoscopic submucosal dissection in patients with @Disease$.	0
"Although co-therapy with a PPI and the eradication of H. pylori substantially reduce the risk of recurrent @Disease$ bleeding with aspirin, the replacement of @Chemical$ by clopidogrel cannot be recommended to patients with a high gastrointestinal risk."	0
Combinations of analgesics with @Chemical$ have been discussed as bearing a risk for @Disease$ chronicity.	1
Atherosclerosis and @Chemical$ are independent risk factors for @Disease$ in patients with gastric or duodenal ulcer.	1
Atypical and @Disease$ associated with @Chemical$ abuse.	1
CONCLUSION: Consideration of the safety of primary prevention with aspirin requires an individualized assessment of @Chemical$'s effects on @Disease$ risks and expected benefits because absolute bleeding risk may vary considerably by patient.	0
"A total of 16 patients with @Chemical$-exacerbated respiratory diseases (@Disease$, 81.3% were female) with median age of 29 +- 4.3 years were included in this study."	0
CASE REPORT: A 79-year-old man developed an epidural hematoma requiring surgical treatment following an uncomplicated interlaminar epidural @Chemical$ injection performed for @Disease$.	0
"In saliva analysis among the three groups (@Disease$ patients, @Chemical$-tolerant asthma [ATA] patients, and healthy subjects), both the concentrations of CysLTs and LTB4 were significantly higher in AIA patients than in ATA patients and healthy subjects."	0
Long-term sinonasal outcomes of aspirin desensitization in @Chemical$ exacerbated @Disease$.	0
"RESULTS: Of 8754 Chinese patients with atrial fibrillation and CHA2DS2-VASc &gt;=1 (79.5+-9.2 years; CHA2DS2-VASc, 4.1+-1.5; and Hypertension, @Disease$, Stroke, Bleeding History or Predisposition, Labile International Normalized Ratio, Elderly (&gt;65 years), Drugs/Alcohol Concomitantly [HAS-BLED], 2.2+-0.9), 16.3% received warfarin, 41.1% aspirin, 4.5% @Chemical$, and 38.1% received no therapy."	0
"[Aspirin (@Chemical$)-induced @Disease$, an unknown adverse effect]."	1
CONCLUSION: Clopidogrel and the combination of acetylsalicylic acid and dipyridamole were associated with similar risks for recurrent ischemic stroke and bleeding; whereas @Chemical$ was associated with higher risks for both ischemic stroke and @Disease$.	1
CONCLUSIONS: Patients on aspirin and clopidogrel &lt;5days before CABG who had preoperative @Chemical$-induced platelet aggregation &gt;=50% have @Disease$ risk similar to those receiving aspirin monotherapy.	0
Our perioperative management of patients with high @Disease$ risks included preoperative continuation of single @Chemical$ therapy and early postoperative reinstitution.	0
"Within 90 days after intervention, there were 4 patients (1.5%) with acute thrombosis, 5 patients (1.8%) with subacute thrombosis, 17 patients (6.2%) with stroke, and 2 death (0.7%) in low-dose @Chemical$ group, compared with no patient (0%) with acute thrombosis, 2 patient (2.1%) with subacute thrombosis, 6 patients (6.2%) with @Disease$, and 2 death (2.1%) in high-dose aspirin group, and there were no significant difference in all study endpoints between two groups."	0
"Apixaban (2.5mg and 5mg), dabigatran, rivaroxaban, idraparinux and vitamin K antagonists (VKA) each significantly reduced the risk of @Disease$ recurrence compared to placebo, ranging from a 73% reduction with @Chemical$ to 86% with VKAs."	0
Projected excess @Disease$ events with @Chemical$ depend on baseline assumptions.	0
"Key search terms included @Chemical$, resistance, resistant, @Disease$, tolerance, and nonresponder."	0
@Chemical$-100 detected platelet dysfunction as the result of pre-injury use of antiplatelet agents in @Disease$ and CVA patients with a sensitivity of only 48.6% and a specificity of 74.8%.	0
"Because of its definitive inhibitory effect on platelet aggregation, @Chemical$ (more than other non-steroidal anti-inflammatory drugs exerting unselective inhibition of cyclooxygenase) is a strong factor in triggering or sustaining the @Disease$ disorders in these patients."	1
"MATERIALS AND METHODS: An open, cross-sectional study compared three groups of patients consisting of 200 patients each who had stable IHD and a high risk of @Disease$ and who received a long-term antiaggregant monotherapy with one of @Chemical$ drugs (group 1, Aspirin Cardio; group 2, Thrombo ASS; group 3, Cardiomagnyl)."	0
"RESULTS: In aspirin-induced @Disease$ patients (@Chemical$, n=10), the basal concentration of urinary LTE4, but not the other metabolites, was significantly higher than that in aspirin-tolerant asthma patients (ATA, n=10)."	0
[When the cardiac patient with @Disease$ needs @Chemical$ and NSAID: how to protect the stomach?].	0
Enzyme up-regulation was monitored after in vitro stimulation with lipopolysaccharide (@Disease$) and/or aspirin in 19 aspirin-intolerant (AI) patients (8 @Chemical$-sensitive asthmatics and 11 urticaria-angioedema patients) and 14 healthy controls.	0
"Patients with diverticular @Disease$ had greater odds than controls of NSAID, @Chemical$, and warfarin use, OR 8.3 (95% CI, 3.8-18.3), OR 2.1 (95% CI, 1.15-3.67), and OR 2.6 (95% CI, 1.24-5.56), respectively."	0
"Paracetamol pack size restriction: the impact on paracetamol @Disease$ and the over-the-counter supply of paracetamol, aspirin and @Chemical$."	0
We compared the levels of neutrophil activation and related cytokines in patients with @Chemical$-intolerant acute @Disease$ (AIAU) and ASA-intolerant chronic urticaria (AICU).	0
OBJECTIVES: We aimed to identify proteins that were differentially expressed in between @Disease$ and @Chemical$-tolerant asthma (ATA) plasma.	0
"[Coxib: a feasible therapeutic alternative in patients with intolerance or @Disease$ to @Chemical$, non-steroidal antiinflammatory drugs and paracetamol]."	1
"Although knowledge about endoscopic characteristics of @Chemical$ associated ulcers is limited, the @Disease$ have common distinctive feature that sudden gastrointestinal bleedings or latently advanced-anemia are often the earliest symptom because aspirin-induced ulcers often exist without symptoms of dyspepsia."	0
"This study compared proton pump inhibitors (PPIs) and histamine H2 receptor antagonists (H2RAs) for prevention of low-dose aspirin (@Chemical$)-related gastrointestinal (GI) erosion, ulcer and @Disease$."	0
Low-dose aspirin medication for one week does not affect either cyclooxygenase expression or duodenal @Chemical$(2) levels and therefore is likely to induce duodenal damage mainly through topical @Disease$.	1
This commentary on the review by Christen and Chew discusses the controversy surrounding @Chemical$ use and its association with age-related macular degeneration (@Disease$).	0
Significant association of FcepsilonRIalpha promoter polymorphisms with @Chemical$-intolerant chronic @Disease$.	1
"BACKGROUND: @Chemical$ triad disease (ATD) is a well-known clinical entity characterized by @Disease$, polyposis, and aspirin intolerance."	0
The results of our study show that a high percentage of the NSAID/@Chemical$-induced @Disease$ of the stomach can indeed be correctly diagnosed at histology.	1
Relapsed spontaneous spinal epidural @Disease$ associated with aspirin and @Chemical$.	0
These estimates are valuable for benefit-risk assessments of low-dose @Chemical$ for @Disease$ and colorectal cancer prevention.	0
@Chemical$-sensitive @Disease$-associated changes in upper airway innervation.	0
"Ulcers, perforation, and serious @Disease$ were not seen after use of @Chemical$ or any of the other interventions."	0
"Pooling the results from the fixed-effects model showed that a dose of 15 to 20 mg of rivaroxaban once daily was associated with an increased risk of @Disease$ (2 trials; OR, 3.31 [95% CI, 1.42 to 7.72]) compared with @Chemical$, while a 10-mg dose of rivaroxaban once daily or a 5-mg dose twice daily (3 trials; OR, 1.43 [95% CI, 0.93 to 2.21]) and a 5-mg dose of apixaban twice daily (1 trial; OR, 0.84 [95% CI, 0.38 to 1.88]) were not."	0
BACKGROUND: Hypersensitivity to acetylsalicylic acid (@Chemical$) constitutes a serious problem for subjects with @Disease$.	0
RESULTS: Fifteen trials reporting the outcome of 2511 participants treated with VKA alone and 2471 treated with @Chemical$ alone were included; most common conditions evaluated were non-valvular @Disease$ (five trials) and heart failure (three trials).	0
"We compared 1- and 3-year outcomes for cerebrovascular accident (CVA), transient ischemic attack (TIA), gastrointestinal (GI) @Disease$, genitourinary (GU) bleeding, any bleeding, and AF recurrence among patients receiving: none, @Chemical$, or warfarin as long-term therapies."	0
"BACKGROUND: @Chemical$ (acetylsalicylic acid [ASA]) hypersensitivity is frequent in patients with @Disease$ (NPs) and is called aspirin exacerbated respiratory disease, previously known as Samter's syndrome."	0
The black box warning for the use of maintenance @Chemical$ doses &gt;100 mg with ticagrelor is inappropriate for patients with @Disease$ and not evidence based.	0
"Here, we evaluate the literature on the risk of ICH as a complication in patients with @Disease$ treated with @Chemical$."	1
There is evidence that selenium (@Chemical$) nutrition can influence asthma but Se status in @Disease$ patients has not received much attention.	0
"ULDA showed prothrombotic properties in the same model of induced @Disease$ that were very similar to those described after @Chemical$ withdrawal, but the effect was observed only 1 hour after aspirin administration."	1
"The association between @Chemical$ counseling, aspirin use, and reported @Disease$ (CVD) and classical CVD risk factors were examined using logistic regression."	0
Acute reactions of aspirin @Disease$ are elicited via cyclooxygenase inhibition by non-@Chemical$ anti-inflammatory drugs.	0
METHODS: Patients with aspirin-related non@Disease$ symptomatic ulcers were randomised to receive rabeprazole (20 mg/day) plus @Chemical$ (100 mg/day) or rabeprazole (20 mg/day) plus clopidogrel (75 mg/day) for 12 weeks.	0
The primary risk of using @Chemical$ therapy is the development of @Disease$ complications.	1
@Chemical$ and VKA intake was found not to be an independent risk factor for @Disease$.	0
"METHODS: We used a challenge-desensitisation protocol in 11 patients (6 men, mean age 56 +- 9.6 years) who reported @Disease$ to @Chemical$ and were to undergo percutaneous coronary intervention with stent implantation."	1
@Chemical$-exacerbated @Disease$ (AERD) is a respiratory disease             characterized by acute bronchial responses upon the administration of non-steroidal             anti-inflammatory drugs (NSAIDs) and the immune response by mast cells is regarded             as one of the noteworthy causes of AERD pathogenesis.	1
"METHODS: A total of 11 @Chemical$-sensitive patients with @Disease$, 10 aspirin-tolerant patients with asthma, and 10 controls without asthma were studied."	0
"RESULTS: When 19 confounding factors (diseases and interventions) were assessed, @Chemical$ significantly increased mortality in @Disease$ patients without cardiovascular disease from 17% (95% confidence interval; 95%CI, 1-36) at age 50 years to 29% (16-43) at age 85 years."	0
"Here, we aimed to understand the influence of @Chemical$ usage on the size of @Disease$ and explored the impact of age."	0
"There were significantly more patients who suffered GI adverse events, principally abdominal @Disease$, dyspepsia, nausea and diarrhoea, with aspirin (18.5%) than with ibuprofen (11.5%), but the difference between ibuprofen and @Chemical$ (13.1%) was not significant."	0
BACKGROUND: Aspirin-intolerant @Disease$ (AIA) refers to the development of bronchoconstriction in asthmatic individuals following the ingestion of @Chemical$ or other non-steroidal anti-inflammatory drugs (NSAIDs).	0
There was a trend towards an increased risk of @Disease$ in patients who discontinued @Chemical$ (6.5 vs.	1
ZnPP reversed protective and @Disease$ effect of @Chemical$ but PAG failed to affect CORM-2-induced gastroprotection.	0
"Myocardial infarction after @Chemical$ treatment, and @Disease$."	1
Uncoupled regulation of leukotriene C4 synthase in platelets from aspirin-intolerant @Disease$tics and healthy volunteers after @Chemical$ treatment.	0
"I suggest that @Chemical$-resistant should be considered as a description for those individuals in whom aspirin fails to inhibit thromboxane A2 production, irrespective of the results of unspecific tests of platelet function, such as the bleeding time, @Disease$, or the PFA-100 system."	0
"@Chemical$ aggravates @Disease$ damage via enhancement of ROS and cytokine generation and suppression of SOD and GPx, and these effects are counteracted by NO released from NO-ASA."	1
"Platelet adenosine diphosphate (ADP) receptors may play a role in potentiating platelet activation induced by IgG from patients with immune heparin-induced @Disease$ (HIT), as shown by previous studies using the ADP receptor antagonists AR-C66096 and @Chemical$."	0
"Allergic conditions include aspirin-exacerbated respiratory disease (AERD or aspirin-induced @Disease$), @Chemical$-induced urticaria/angioedema (AIU), and anaphylaxis."	0
"A bespoke web-based trial management system developed for the trial (and housed within the secure NHS Data Network) communicates directly with the HEAT Toolkit software downloaded at participating practices, which issues queries searching entry criteria (&gt;= 60 years, on chronic @Chemical$ &lt;= 325 mg daily, not on anti-@Disease$ therapy or non-steroidal anti-inflammatory drugs) for GP review of eligibility."	0
METHODS: A retrospective chart review was conducted evaluating ASA desensitization in patients with reported @Chemical$ or NSAID @Disease$ and a cardiac indication for ASA.	0
"RESULTS: In aspirin-induced asthma patients (AIA, n=10), the basal concentration of urinary LTE4, but not the other metabolites, was significantly higher than that in @Chemical$-tolerant @Disease$ patients (ATA, n=10)."	0
"BACKGROUND: The risk of postpolypectomy @Disease$ for patients taking aspirin is low, and gastroenterology society guidelines state that @Chemical$ is likely safe to continue; however, many practices recommend aspirin discontinuation."	0
"Aspirin-induced @Disease$ and @Chemical$-induced urticaria, in a substantial part of the patients, are driven by a release of mediators from activated mast cells."	0
METHODS: Nasal polyps were obtained from 16 aspirin-tolerant patients with @Disease$/rhinitis (ATAR) and 18 @Chemical$-intolerant patients with asthma/rhinitis (AIAR) undergoing nasal polypectomy.	0
"As a result, @Chemical$'s incidence of peptic ulcer disease (PUD) and @Disease$ bleeding is lower than aspirin's."	0
"Because PGE(2) exerts a range of inhibitory actions on inflammatory leukocytes via the EP(2) receptor, its reduced expression in aspirin-sensitive @Disease$ may be partly responsible for the increased inflammatory infiltrate and production of cysteinyl leukotrienes that characterize @Chemical$-sensitive disease."	0
Patients in the @Chemical$ group were significantly less likely to have a recurrence of @Disease$ complications than patients in the placebo group (P=0.008).	0
Acetylsalicylic acid (@Chemical$) is widely used in the prevention of @Disease$.	0
"Found low compliance of admission to long-term @Chemical$ (ASA) in patients with @Disease$ (ACS): 74.9% of patients reported that the suspended or completely stopped taking the drug, and only 16.2% were fully committed to the long-term therapy with ASA."	0
"METHODS: AIAU patients (n=167), @Chemical$-intolerant chronic urticaria (@Disease$) patients (n=149), and healthy controls (NC) (n=265) were included."	0
"CONCLUSIONS: The incidence of UGIB is 0.61% in ACS patients on dual antiplatelet therapy (@Chemical$ and clopidogrel) for 1 year after PCI and falls year by year.Administration of PPI after PCI protects patients from UGIB, especially in those with precious history of peptic ulcer and @Disease$."	0
"OBJECTIVE: The purpose of this study was to demonstrate that rofecoxib, a specific inhibitor of COX-2, does not cause @Disease$tic attacks in patients with @Chemical$ and/or other NSAID-induced asthma."	0
A risk score to predict silent @Disease$ in patients with coronary artery disease under @Chemical$ therapy presenting with upper gastrointestinal hemorrhage.	0
"CONCLUSIONS: After catheter ablation, low risk patients do not benefit from long-term @Chemical$ therapy, but are at risk for higher rates of @Disease$ when compared to no therapy or warfarin."	1
CONCLUSION: This study indicates that 7.5 mg of meloxicam is a safe alternative treatment for @Chemical$-hypersensitive @Disease$ and/or NP patients with proven hypersensitivity via oral ASA challenges.	0
Nonsteroidal anti-inflammatory-induced inhibition of signal transducer and activator of transcription 6 (STAT-6) phosphorylation in @Chemical$-exacerbated @Disease$.	0
@Disease$ patients are treated with antiplatelet drugs like @Chemical$ and clopidogrel to prevent a secondary stroke.	0
"Patients with higher @Chemical$ scores (&gt;=2 versus &lt;2) had higher rates of myocardial infarction or stent @Disease$ (1.9% versus 1.1%; P=0.01) and similar rates of bleeding (2.2% versus 2.4%, respectively; P=0.79)."	0
There are few data on cardiovascular outcomes in patients with peripheral @Disease$ who manifest @Chemical$ resistance.	1
"As a result, clopidogrel's incidence of peptic ulcer disease (PUD) and ulcer @Disease$ is lower than @Chemical$'s."	0
"BACKGROUND: Nonsteroidal anti-inflammatory drugs (NSAIDs) cause bronchospasm in susceptible patients with asthma, often termed @Chemical$-exacerbated respiratory disease (@Disease$), with the risk being greatest after acute exposure."	0
This paper describes how the discoveries of John Vane inspired the authors of the cyclooxygenase theory and led to further insight into the biology of @Chemical$ metabolism in this relatively common type of @Disease$.	0
The lesions of @Disease$ or small erosions in the @Chemical$ and the combined groups tended to exist in the proximal part of small bowel.	0
"The event sequence symmetry analysis of ulcer, @Disease$, and melena found significant associations with entericcoated @Chemical$ use, with adjusted sequence ratios (ASRs) of 1.58 (1.23 - 2.06), 1.30 (1.03 - 1.65), and 14.38 (2.19 - 607.95), respectively, at the 6-month interval."	0
There was also a significantly greater mean % PNIF response over 120 min after @Chemical$-aspirin challenge for PL (26+/-7) compared to either @Disease$ 10 mg (14+/-6) or ML 40 mg (17+/-6).	0
"Additionally, @Disease$ Inventory (BDI) and Sinonasal Outcome Test 22 (SNOT 22) were applied. 31 patients were tested before and 7 months after OAC and @Chemical$ desensitization in case of diagnosed AERD."	0
Spontaneous rectus sheath @Disease$ associated with low dose of @Chemical$.	1
SUMMARY: Recent studies have improved our understanding of mechanisms operating in @Disease$ and unvieled the role of @Chemical$ mediators in pulmonary disease.	0
"INTRODUCTION: In routine medical practice, the diagnosis of @Chemical$ @Disease$ (AH) remains difficult."	1
"At 3 years, 238 (5.9%) patients were on @Chemical$, 743 (18.6) on aspirin, and 3,013 (75.5%) on no therapy; with occurrences of CVA/TIA (1.4%, 3.0%, 3.9%, P &lt; 0.0001, respectively), GI bleeding (0.8%, 1.9%, 1.1%, P = 0.06, respectively), and GU @Disease$ (1.7%, 2.8%, 2.1%, P = 0.008, respectively) that increased with advancing CHA2 DS2 VASc score."	0
"@Chemical$ results in prolonged inhibition of blood coagulation, and acetaminophen can result in liver toxicity at normal dose and @Disease$ at higher dose."	1
Decreased apoptosis and distinct profile of infiltrating cells in the nasal polyps of patients with @Chemical$ @Disease$.	1
"An association between @Disease$ and the ingestion of aspirin (@Chemical$) was claimed, although no proof of causation was ever established."	1
"Compared with @Chemical$, aspirin increases the risk of GI @Disease$ but not other bleeding; however, 883 patients (95% CI, 357-infinity) would need to be treated with clopidogrel versus aspirin to prevent one major GI bleeding episode annually at a cost of over 1 million dollars."	0
"CONCLUSIONS: We conclude, that decreased apoptosis of inflammatory cells in nasal polyps from @Chemical$-hypersensitive patients, reflects a distinct mechanisms of local @Disease$ and may be related to persistence and severity of the disease in these patients."	0
Clopidogrel is a platelet aggregation inhibitor that increases the risk of @Disease$ complications when combined with @Chemical$.	0
In subjects with aspirin @Disease$ disruption of synthesis of prostaglandin E2 (PGE2) and overproduction of cysteinyl leukotrienes (@Chemical$-LT) seem to be crucial in the pathogenesis of bronchial symptoms.	0
To report a case of microtrauma-induced recurrent @Disease$ and secondary glaucoma associated with voluntary chronic @Chemical$ (ASA) use.	0
Perioperative treatment with @Chemical$ or clonidine and risk of @Disease$--reply.	0
"Despite these in vitro and ex vivo findings, we observed two patients develop acute @Disease$ while receiving both clopidogrel and aspirin: both patients' sera tested strongly positive in a heparin-dependent washed platelet activation assay (100% @Chemical$ release) and PF4/heparin-enzyme-immunoassay (2.594 and 2.190 absorbance units)."	0
Clinical impact of drug-drug interaction between aspirin and @Chemical$ at a @Disease$ center.	0
"Endoscopic @Disease$ rates in healthy subjects associated with use of aspirin (81 mg q.d.) alone or coadministered with celecoxib or @Chemical$: a randomized, 1-week trial."	0
"Both apple @Chemical$ extracts significantly reduced the ulcer area, ulcer lesion index and @Disease$ score."	0
"The SCF/beta-actin mRNA ratios were significantly higher in @Chemical$-hypersensitive (AH) asthmatics (median 0.97, range: 0.8-1.5) when compared with ASA-tolerant (@Disease$) patients (median 0.5, range: 0.1-0.7; P &lt; 0.001)."	0
AIM: To evaluate in symptomatic elderly chronic users of low-dose aspirin: (1) the association between H. pylori @Disease$ and the prevalence of upper gastrointestinal lesions; and (2) the effect of H. pylori infection on the efficacy of proton pump inhibitors in the prevention of @Chemical$-related gastroduodenal lesions.	0
"DATA SOURCES: Articles evaluating aspirin for primary prevention of CVD were gathered using a MEDLINE search with the keywords aspirin review, aspirin peripheral artery disease, aspirin @Disease$, @Chemical$ coronary artery disease, aspirin diabetes, aspirin primary prophylaxis, and aspirin elderly."	0
"We investigated the risks of ischemic @Disease$ and intracranial hemorrhage (ICH) in relation to warfarin at various TTRs in a real-world cohort of Chinese patients with atrial fibrillation receiving warfarin and compared with those on @Chemical$, aspirin, and no therapy."	0
BACKGROUND: Acetylsalicylic acid (ASA) and @Chemical$ are used to prevent @Disease$.	0
The aim of the present study was to evaluate the association between HAPR and albumin levels in patients with stable coronary artery disease (@Disease$) treated with @Chemical$.	0
"We characterized the gastrointestinal risk profile of low-dose @Chemical$ users in real clinical practice, and estimated the excess risk of @Disease$ attributable to aspirin among patients with different gastrointestinal risk profiles."	0
"METHODS: 430 consecutive subjects (70+/-14 years, 55% male, 41% with coronary artery disease) released from the hospital with a primary diagnosis of @Disease$ were classified into three groups based on the use of aspirin and ACE-I at discharge: ACE-I without @Chemical$ (group I, n=134), ACE-I with aspirin (group II, n=138) and no ACE-I (group III, n=158)."	0
"In the setting of @Chemical$ use and @Disease$, strategies to reverse the drug effects have improved outcomes."	0
CONCLUSION: Recognition of the association between @Disease$ and otological disease is important (26% of the cases) because it could also be responsive to systemic @Chemical$ which prevent progression to irreversible hearing loss or infectious otomastoiditis.	0
"Comparison between the warm needling group and Omeprazole group showed that the UI, both serum and @Disease$ activity, and serum MDA level of the former group were evidently higher than those of the Omeprazole group (P&lt;0. 05), but gastric mucosal @Chemical$ level of the warm needling group was apparently lower than that of the Omeprazole group (P&lt;0.05)."	0
"I suggest that aspirin-resistant should be considered as a description for those individuals in whom @Chemical$ fails to inhibit thromboxane A2 production, irrespective of the results of unspecific tests of platelet function, such as the bleeding time, @Disease$, or the PFA-100 system."	0
"An even larger number of respondents stopped @Chemical$ therapy before surgery if the patient was taking aspirin due to an @Disease$ or due to peripheral arterial disease with infrainguinal stenting (59-63% and 59-65%, respectively)."	0
"We investigated whether aspirin with caffeine (@Chemical$+) increases @Disease$ frequency compared with aspirin alone in migraine, tension-type headache (TTH), and migraine + TTH (MigTTH)."	0
RESULT: Thirty-eight @Chemical$-response-related variants that had clinical significance had been detected in the 620 WES data.Ten (26%) of them were related with drug efficacy while 28 (74%) were related with toxicity or @Disease$ (ADR).	0
"It is particularly important to know the risk of side effects when @Chemical$ is used as primary prevention--that is when used by people as yet free of, but at risk of developing, cardiovascular disease (CVD) or @Disease$."	0
"Older age, @Chemical$ monotherapy and peptic ulcer disease were significant predictors of antithrombotic discontinuation, whereas dual antiplatelet use predicted anti@Disease$ maintenance."	0
"Despite the demonstrated benefits of aspirin, many patients develop secondary @Disease$ or other vascular events, an observation that has led to the concept of @Chemical$ resistance."	0
Differential levels of these components in @Chemical$-exacerbated respiratory disease (AERD) and allergic rhinitis with asthma (ARwA) may be related to a different inflammatory response in both @Disease$ phenotypes.	0
PURPOSE: The present study aimed to assess the cost effectiveness of concomitant proton pump inhibitor (PPI) treatment in low-dose acetylsalicylic acid (@Chemical$) users at risk of @Disease$ (UGI) adverse effects as compared with no PPI co-medication with attention to the age-dependent influence of PPI-induced adverse effects.	0
Severe @Disease$ and a significant decrease in serosal red blood cell velocity developed in the @Chemical$-treated group and an ~2-fold elevation in proinflammatory mediator levels evolved.	0
The case of a patient is presented whose clinical picture of classic dengue @Disease$ was worsened by self-treatment with @Chemical$.	1
"@Chemical$-exacerbated respiratory disease (AERD) is defined as asthma, chronic rhinosinusitis with nasal polyposis, and @Disease$ to cyclooxygenase-1 inhibitors."	0
CONCLUSION: Exhaled NO may indicate eosinophilic airway inflammation during ASA exposure in patients with @Chemical$ inducible @Disease$.	0
"At the biochemical level, @Disease$ is characterized by a chronic overproduction of @Chemical$."	1
We investigated the relationship between @Chemical$-resistant @Disease$ and endothelial dysfunction in patients with stable coronary artery disease.	0
"RRs (95% CI) for &gt;=1 year of low-dose @Chemical$ use were 0.90 (0.72-1.13) for @Disease$, 1.20 (0.91-1.57) for SDH, and 0.69 (0.50-0.94) for SAH."	0
"BACKGROUND: In aspirin-sensitive patients with @Disease$, bronchial obstruction induced by oral @Chemical$ may be associated with extrabronchial symptoms, suggesting the systemic character of the response."	1
PURPOSE OF REVIEW: Aspirin-induced urticaria/@Disease$ is a major @Chemical$-related hypersensitivity often associated with aspirin-intolerant asthma.	0
"BACKGROUND: Aspirin (acetylsalicylic acid [ASA]) @Disease$ is frequent in patients with nasal polyps (NPs) and is called @Chemical$ exacerbated respiratory disease, previously known as Samter's syndrome."	0
"OBJECTIVE: We evaluated hourly dose escalations in a subset of patients with chronic rhinosinusitis, @Disease$, and asthma who historically reacted to @Chemical$ within 1 hour or were avoiding aspirin with the goal of developing a safe and efficient desensitization protocol."	0
"BACKGROUND: The combination of aspirin, @Chemical$, and enoxaparin (combination therapy) is the standard treatment for acute @Disease$ but is associated with gastrointestinal bleeding."	0
This study was designed to investigate the risks associated with aspirin (ASA) therapy that is used in high doses for the treatment of @Chemical$-exacerbated @Disease$ (AERD) and to review therapeutic strategies for the prevention of nonsteroidal anti-inflammatory drug (NSAID)-induced side effects.	0
Incidence and predictors of @Disease$ in patients receiving low-dose @Chemical$ for secondary prevention of cardiovascular events in patients with coronary artery disease.	0
"ASA-@Chemical$ did not cause @Disease$, microcirculatory dysfunction, mucosal injury or an elevation in proinflammatory markers."	0
OBJECTIVES: Surgical bleeding. transfusion rate and cardiovascular complications were analized in patients undergoing chronic treatment with low-doses @Chemical$ and scheduled to unilateral primary knee @Disease$.	0
"Numerous vascular risk factors including white matter hyperintensity (WMH), duration of @Chemical$ treatment, age, @Disease$ or diabetes mellitus were investigated for a possible association with the presence of CMBs in the two groups."	0
"@Chemical$-exacerbated diseases are important examples of drug hypersensitivities and include aspirin-exacerbated respiratory disease (@Disease$), aspirin- or non-steroidal anti-inflammatory drug (NSAID)-induced urticaria/angioedema, and aspirin- or NSAID-induced anaphylaxis."	0
"If @Disease$ risk is prohibitive, both @Chemical$ and P2Y12 inhibitor therapy should be interrupted and bridging therapy may be considered in patients with high thrombotic risk."	0
"The independent risk factors for death were regular aspirin-use at the onset of @Disease$ (relative risks [RR], 2.5; 95% CI, 1.3 to 4.6; P=0.004), @Chemical$-use at the onset of ICH (RR, 3.2; 95% CI, 1.6 to 6.1; P=0.001), and ICH score higher than 2 on admission (RR, 13.8; 95% CI, 6.0 to 31.4; P&lt;0.001)."	0
"CONCLUSION: This study indicates that the causes of @Disease$ are changing, and the increasing use of low-dose @Chemical$ might become a major cause of bleeding ulcers."	0
"In our investigation of such adverse effects, we obtained 4 important findings considered useful for physicians, as follows; 1) even when @Chemical$ was given at a dose, the incidence rate of gastrointestinal lesions was higher than with other non-steroidal anti-inflammatory drugs (NSAIDs), 2) the odds ratios for @Disease$ induced by aspirin with a histamine H2 receptor antagonist and proton pump inhibitor were 0.6 and 0.4, respectively, as compared with aspirin alone, 3) it is difficult to administer aspirin, which exerts an antiplatelet effect, without inducing gastrointestinal lesions, and 4) these gastrointestinal lesions appears early, especially within 2 years after administration."	0
"These include rhinitis and @Disease$ induced by NSAIDs (also known as @Chemical$-exacerbated respiratory disease), NSAID-exacerbated cutaneous disease (NECD), urticaria or angioedema induced by multiple NSAIDs, single NSAID-induced reactions, and delayed NSAID reactions."	0
The most comorbid disease was @Disease$ and the two most frequent NSAIDs inducing UR/AE were paracetamol (19. 6%) and @Chemical$ (19%).	0
"Finally, various medicamentous methods of counteracting @Chemical$-induced platelet dysfunction and excessive @Disease$ in this context are elicited, discussed and evaluated."	0
@Chemical$ is likely to increase the risk of major @Disease$ events.	1
"In a pooled analysis of all studies, @Chemical$ use was associated with reduced risk for @Disease$ (odds ratio [OR] = 0.86, 95% confidence interval [CI] = 0.81, 0.92)."	0
Early diagnosis and treatment with Intravenous immune globulin (IVIG) and @Chemical$ (ASA) can reduce the incidence of @Disease$ to 2%-5%.	0
"In fact, patients with @Disease$ have to be considered high-risk patients due to their increased propensity for uncontrolled bleeding.The aim of this article was to present and discuss the management of a case of double consecutive retrobulbar hemorrhage in a high-risk patient in treatment with aspirin and @Chemical$."	0
SUMMARY: The use of @Chemical$ has proven to reduce morbidity and mortality associated with @Disease$.	0
"@Chemical$ plus dipyridamole has the highest surface under the cumulative ranking curves (SUCRA) values in terms of mortality, @Disease$, and adverse event rate among 7 drug therapies in the treatment of cerebral infarction."	0
Tacrolimus significantly inhibited bronchoconstriction and abrogated @Chemical$-induced increase in both sputum @Disease$ protein and urinary leukotriene E(4) levels.	1
This study evaluated the association between genetic TBXA2R variants and the development of @Chemical$ (ASA)-intolerant acute @Disease$ (AIAU).	0
"BACKGROUND: In patients with ischemic @Disease$ of non-cardioembolic origin, acetylsalicylic acid, clopidogrel, or a combination of @Chemical$ and dipyridamole are recommended for the prevention of a recurrent stroke."	0
"Average @Disease$ in @Chemical$ group 24 hours postoperatively was 1600 ml, Non ASA group had average bleeding 900 ml, while Trasylol group had average drainage of 700 ml after 24 hours."	1
Age when @Disease$ was developed (A+@Chemical$ groups)--45.5; the duration of asthma was 11 +/- 9 years. 58% of patients had polypectomy/ethmoidectomy (PP--45%; A--60%; ASA--80%).	0
RECENT FINDINGS: The overproduction of cysteinyl leukotrienes with the increased expression of cysteinyl leukotriene receptor 1 (CYSLTR1) is a consistent finding in @Chemical$-induced @Disease$ patients.	1
Uncoupled regulation of leukotriene C4 synthase in platelets from @Chemical$-intolerant @Disease$tics and healthy volunteers after aspirin treatment.	0
"At 4 weeks, the mean scores of @Disease$ intensity and nonpain symptoms were lower in the @Chemical$ group (5.61 +- 0.17 vs."	0
"BACKGROUND: @Chemical$ triad is a subclass of chronic @Disease$ characterized by nasal polyposis, nonallergic induced asthma, and aspirin sensitivity."	0
@Chemical$-induced asthma (AIA) is a distinct clinical entity characterised by @Disease$ to aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) typically occurring in the form of asthma and severe rhinosinusitis.	0
Nasal @Disease$: 18.5 +/- 3% (PP-- 15.0 +/- 4; A-- 15.5 +/- 6; ASA-- 30.0 +/- 8% and PP/ASA-- p = 0.01; A/@Chemical$-- p = 0.02).	0
"Among asthma phenotypes, a promoter -1993T--&gt;C SNP, which is in linkage disequilibrium with a synonymous coding 390A--&gt;G SNP in exon 1, is significantly associated with a risk of @Chemical$-induced @Disease$ (AIA; P = 0.004, P(c) = 0.016)."	1
"Antenatal intake of low dose @Chemical$ is advised for prevention of pregnancy induced @Disease$, intrauterine growth retardation and pre-term labour."	0
"Furthermore, a recent study suggested that the administration of low-dose aspirin plus high-dose esomeprazole (a potent PPI) was associated with fewer episodes of UGI bleeding than @Chemical$ alone in patients with a history of recent UGI @Disease$."	0
"METHODS: The effect of @Chemical$ or platelet agonists on LTC4 synthase activity was investigated in platelets obtained from healthy volunteers, aspirin-intolerant asthmatics or aspirin-tolerant @Disease$tics after in vivo treatment or in vitro pre-incubation with aspirin."	0
Safety of @Chemical$ in aspirin-hypersensitive patients with @Disease$ and/or nasal polyps.	0
Bleeding during treatment with aspirin versus @Chemical$ in patients with atrial fibrillation unsuitable for warfarin: the apixaban versus acetylsalicylic acid to prevent @Disease$ in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment (AVERROES) trial.	0
"Also, women had less peripheral artery disease (aspirin, 2.4% versus 3.7%; apixaban, 1.4% versus 3.0%), more heart failure, and higher mean CHADS2 (congestive heart failure, hypertension, age of 75 years or older, @Disease$ [1 point each], stroke or transient ischemic attack [2 points]) scores (aspirin, 2.2 versus 2.0; @Chemical$, 2.1 versus 2.0)."	0
Standard-dose lafutidine significantly prevents @Disease$ induced by @Chemical$ alone or LDA plus loxoprofen in H. pylori-negative volunteers.	1
"The triad of bronchial asthma, @Disease$, and intolerance to aspirin and @Chemical$-like chemicals are designated aspirin-induced asthma (AIA) or Samter's syndrome."	0
SUMMARY: Background Low-dose @Chemical$ protects against both ischemic cardiovascular (CV) events and @Disease$ (CRC).	0
ADP (5 and 20 micromol)-induced @Disease$ was significantly decreased with clopidogrel (p &lt;0.001) but remained stable under additional treatment with @Chemical$ or pravastatin in the 2 groups.	0
"CONCLUSIONS: Aspirin intake overall was not associated with early AMD in this sample of Asian Indians, but in those with a history of @Disease$ the association between @Chemical$ intake and early AMD might warrant further investigation."	0
"RESULTS: The mean numbers of reddened lesions in the @Chemical$ group and non-aspirin NSAID group were 2.49 +- 3.15 and 1.65 +- 3.04; the mean numbers of erosions/@Disease$ 1.56 +- 3.75 and 6.08 +- 10.4, and the mean CE scores 154 +- 294 and 520 +- 758, respectively."	0
"OBJECTIVE: To evaluate the relationship between aspirin ingestion and postoperative bleeding complications, and to test the hypothesis that there is a subset of patients who are @Chemical$ hyperresponders with a proclivity toward @Disease$."	0
"Analyses of the genetic backgrounds of patients with AIA and AIU will promote the development of early diagnostic and therapeutic interventions, which may reduce the incidence of @Disease$ and @Chemical$."	0
"METHODS: We compared aspirin and @Chemical$ for HF events (hospitalization, @Disease$, or both) in the 2,305 patients enrolled in the WARCEF (Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction) trial (98.6% on ACE inhibitor or ARB treatment), using conventional Cox models for time to first event (489 events)."	0
"In addition, a combination of LDA and NSAIDs or LDA and APs contributed more profoundly to the @Disease$ (OR 3.59 and 95 % CI 1.19-10.81 for LDA/NSAIDs; OR 6.70 and 95 % CI 1.83-24.50 for @Chemical$/APs)."	0
"Three weeks later, he had @Disease$, which was initially thought to be secondary to systemic vasculitis, but proved to be acute renal tubular necrosis as a delayed reaction to @Chemical$."	1
"Sixteen failed to improve, 24 stopped @Chemical$ because of intractable side effects (@Disease$ or hives) and 17 patients discontinued ASA treatment in the first year of study for unrelated reasons."	1
"RESULTS: Of 8754 Chinese patients with atrial fibrillation and CHA2DS2-VASc &gt;=1 (79.5+-9.2 years; CHA2DS2-VASc, 4.1+-1.5; and Hypertension, @Disease$, Stroke, Bleeding History or Predisposition, Labile International Normalized Ratio, Elderly (&gt;65 years), Drugs/Alcohol Concomitantly [HAS-BLED], 2.2+-0.9), 16.3% received warfarin, 41.1% @Chemical$, 4.5% dabigatran, and 38.1% received no therapy."	0
"BACKGROUND: The effect of aspirin on the release of key @Chemical$ metabolites in activated eosinophils from subjects with aspirin-intolerant asthma (AIA) has not been investigated previously, despite the characteristic @Disease$ in AIA."	0
OBJECTIVES: The aim of this prospective study was to evaluate the @Disease$ risk of split-thickness skin transplantation repair to chronic wounds in patients on @Chemical$ therapy.	0
"With prolonged use of aspirin, UGIB continues to be a problem for those with risk factors and especially in patients with a history of peptic @Disease$, in which UGIB tends to occur early after @Chemical$ therapy."	0
"In all patients, we measured the @Disease$, by multiplate electrode aggregometry, using two agonists [adenosine diphosphate with PGE1 (ADPHS) and arachidonic acid (ASPI)] two times: on the day of cessation of @Chemical$ and 90 days after clopidogrel was stopped."	0
We tested the hypothesis that combined pre-treatment with @Chemical$ and clopidogrel is a risk factor for thrombolysis-related symptomatic @Disease$ (sICH).	1
"Even if TIMI defined major @Disease$ favored a low dose of @Chemical$, with OR: 1.42, 95 % CI: 0.95-2.13; P = 0.09, or even if major bleeding was insignificantly higher with a high dose aspirin, with OR: 1.78, 95 % CI: 1.01-3.13; P = 0.05; I(2) = 94 %, higher levels of heterogeneity observed in these subgroups could not be considered significant to any extent."	0
"Acetylsalicylic acid (ASA) causes adverse haemorrhagic reactions in the upper gastrointestinal (@Disease$) tract, and previous results have suggested that combination therapy with 2-amino-2-(hydroxymethyl)-1,3-propanediol (@Chemical$) could provide protection in this scenario."	0
"The ideal treatment for @Disease$ injury in patients taking LDA would be withdrawal of aspirin, however, @Chemical$ is used as an antiplatelet agent in the majority of patients, and its withdrawal could increase the risk of cardiovascular/cerebrovascular morbidity and mortality."	0
"Risk of @Disease$ with single, dual, or triple therapy with warfarin, aspirin, and @Chemical$ in patients with atrial fibrillation."	0
The aim of this study was to investigate the efficacy of @Chemical$ 300 mg/day in the treatment of patients with @Disease$.	0
The genetic mechanism of @Chemical$ intolerant acute urticaria (@Disease$) is unknown.	0
"In conclusions, the assessment for genotype of COX-1 gene promoter polymorphism, especially rs1330344, may be useful for detecting the high risk group of developing NSAID/@Chemical$-induced @Disease$."	1
His past medical history included an @Disease$ treated with @Chemical$ daily.	1
We tested the hypothesis that combined pre-treatment with @Chemical$ and clopidogrel is a risk factor for thrombolysis-related symptomatic intracerebral hemorrhage (s@Disease$).	1
"In conclusion, the CysLTR1 polymorphism may contribute to develop to the @Disease$ phenotype and be used as a genetic marker for differentiating two major @Chemical$ hypersensitivity phenotypes."	0
BACKGROUND: @Chemical$-exacerbated @Disease$ (AERD) is characterized by respiratory reactions on ingestion of COX-1 inhibitors and cysteinyl leukotriene overproduction.	1
"BACKGROUND: The effect of @Chemical$ on the release of key arachidonic acid metabolites in activated eosinophils from subjects with aspirin-intolerant asthma (AIA) has not been investigated previously, despite the characteristic @Disease$ in AIA."	0
"Proton-pump inhibitor treatment resulted in an absolute risk reduction of peptic ulcer by 36.6% in acute and 34.6% in chronic non-steroidal anti-inflammatory drugs/aspirin users; indeed, the number needed to treat to avoid one peptic @Disease$ in elderly non-steroidal anti-inflammatory drugs/@Chemical$ users was three both in acute and chronic users."	0
"@Chemical$-induced @Disease$ and bleeding in the rat is dependent on the presence of luminal bile, which is likely attributable to it's constituent bile acids."	1
This study determined the efficacy of using a low-dose proton pump inhibitor (PPI) to reduce the risk of non-variceal UGIB in @Disease$ patients receiving @Chemical$.	0
"CONCLUSIONS: Despite trends indicating increased rebleeding rates and a lower incidence of permanent disability due to delayed ischemic neurological deficits, there was no significant effect of previous @Chemical$ use on overall outcome following aneurysmal @Disease$."	0
Aspirin (ASA) is an important cause of asthma so that @Chemical$ induced @Disease$ (AIA) is considered a disease.	1
BACKGROUND/AIMS: The aim of this study was to clarify the prevalence and various clinical factors of @Disease$ (UGIB) associated with low-dose @Chemical$ (LDA) treatment.	0
OBJECTIVE: This study aimed to assess sinonasal outcomes in patients with @Chemical$ exacerbated respiratory disease (@Disease$) undergoing aspirin desensitization following endoscopic sinus surgery (ESS).	0
The woman who heard music: high @Chemical$ levels and @Disease$.	1
METHODS: Eleven patients who developed @Disease$ while undergoing low-dose enteric-coated @Chemical$ therapy were enrolled.	1
Aspirin exacerbated @Disease$ (@Chemical$) affects approximately 10% of the asthmatic population.	0
CONCLUSION: The concurrent use of @Chemical$ and ultralow-dose aspirin did not increase the severity of @Disease$ compared with prednisone or placebo.	0
"Effects of @Chemical$, Nonsteroidal Anti-inflammatory Drugs, Statin, and COX2 Inhibitor on the Developments of @Disease$: A Population-Based Study with 10-Year Follow-up Data in Korea."	0
"BACKGROUND: Aspirin-exacerbated respiratory disease (AERD) is a clinical syndrome characterized by chronic rhinitis, nasal polyps, asthma, and precipitation of asthma and @Disease$ attacks after ingestion of @Chemical$ (ASA) and most nonsteroidal anti-inflammatory drugs (NSAIDs)."	1
Multivariate analysis was used to determine predictors of the primary outcome of continued @Chemical$ use during @Disease$.	0
CONCLUSION: The CHST2 2082 T allele as well as SLCO1B1*1b haplotype may identify patients at increased risk for @Chemical$-induced peptic @Disease$ or ulcer bleeding.	1
METHODS: We compared outpatients with difficult-to-treat asthma (DTA; n = 486) in a tertiary hospital for @Disease$ in central Japan with those with controlled severe asthma (n = 621) with respect to clinical factors including body mass index (BMI) and @Chemical$ intolerance using multivariate logistic regression analysis stratified by gender and atopic phenotype.	0
"Aspirin had no effect on platelet-leukocyte aggregates, platelet activation markers, or plasma cytokines in either group.Conclusions: High-dose aspirin therapy for 8 weeks paradoxically increases markers of type 2 @Disease$ in subjects with @Chemical$-exacerbated respiratory disease, despite reducing nasal symptoms."	0
"Edoxaban is an oral factor Xa (FXa) inhibitor in clinical development for stroke prevention in patients with @Disease$, an elderly population that frequently receives aspirin (@Chemical$) and/or nonsteroidal anti-inflammatory drugs for concurrent illnesses."	0
Efficacy of @Disease$ (2.3%) sea @Chemical$ in patients with aspirin-induced chronic rhinosinusitis following endoscopic sinus surgery.	0
"Although precipitation of asthma attacks by ingestion of @Chemical$ and other NSAIDs is considered a @Disease$, the respiratory mucosal inflammatory disease process begins and continues in the absence of ongoing or even intermittent exposure to ASA or NSAIDs."	1
"INTRODUCTION: Antithrombotic drugs, such as low-dose aspirin (@Chemical$) and clopidogrel, can cause @Disease$."	1
Concomitant use of low-dose aspirin with any NSAID increases the risk of @Disease$ and diminishes the improved gastrointestinal safety profile of celecoxib; whereas use of ibuprofen plus PPI regimens may negate @Chemical$'s antiplatelet benefits.	0
"CONCLUSIONS: In patients with @Disease$ taking low-dose @Chemical$, the use of celecoxib or naproxen plus lansoprazole resulted in similar rates of gastroduodenal ulceration."	0
"Although H. pylori @Disease$ may be a risk factor of @Chemical$-induced ulcer bleeding, the role of its eradication in the prevention of this outcome requires further investigation."	0
"EVIDENCE ACQUISITION: Published articles were identified through a search of MEDLINE and the Cochrane databases using the dates 1966 to June 2004 and the search terms @Chemical$ @Disease$, coronary artery disease, aspirin desensitization, and aspirin sensitivity."	1
CONCLUSIONS: Daily esomeprazole 20 mg is efficacious and well tolerated in reducing the recurrence of peptic ulcer in East-Asian patients with a history of @Disease$s who are taking low-dose @Chemical$ for cardiovascular protection.	0
"@Chemical$-exacerbated diseases are important examples of drug @Disease$ and include aspirin-exacerbated respiratory disease (AERD), aspirin- or non-steroidal anti-inflammatory drug (NSAID)-induced urticaria/angioedema, and aspirin- or NSAID-induced anaphylaxis."	0
BACKGROUND: @Chemical$ use as single antiplatelet therapy (SAPT) has never been evaluated in stable @Disease$ (CAD) outpatients either as compared to placebo or aspirin.	0
CONCLUSION: Recognition of the association between Samter's syndrome and otological disease is important (26% of the cases) because it could also be responsive to systemic @Chemical$ which prevent progression to irreversible @Disease$ or infectious otomastoiditis.	0
@Disease$ to @Chemical$: common eicosanoid alterations in urticaria and asthma.	1
"METHODS: We examined the incidence, severity, and predictors of @Disease$ associated with 1 year of dual antiplatelet therapy after PCI among 1,816 patients in the @Chemical$ for the Reduction of Event During Observation (CREDO) trial."	0
"Hypersensitivity to @Chemical$ and other non steroidal anti-inflammatory drugs (NSAIDs) manifesting in the airways (rhinosinusitis, @Disease$, asthma) or in the skin (urticaria, angioedema) is the second most frequent untoward allergic reaction to drugs."	1
Minor @Disease$ occurred in 5 of 285 patients (1.8%) taking @Chemical$ and in 27 of 932 control patients (2.9%; not significant).	1
"Polyphenol content of the apple extracts varied, with the EF extract having 20% w/w polyphenols and a high proportion of @Disease$ as epicatechin and @Chemical$, whereas the FB extract comprised 12% w/w polyphenols, which were mostly flavonols as quercetin glycosides."	0
"Mice lacking GPBAR1 were more sensitive to gastric and @Disease$ caused by @Chemical$ and NSAIDs and exhibited a markedly reduced expression of cystathionine-gamma-liase (CSE), cystathionine-beta-synthase (CBS) and endothelial NOS enzymes required for generation of H(2)S and NO, in the stomach."	1
"History of bleeding or non-complicated peptic @Disease$, alcohol intake, concomitant treatment with NSAID or calcic inhibitors are demonstrated risk factors of bleeding ulcer associated with low-dose @Chemical$."	0
"To explore the neural mechanisms underlying salicylate (SS)-induced @Disease$ and increased central gain, we examined the effects of @Chemical$ receptor agonists and antagonists on SS-induced hyperexcitability in the AC and startle reflex responses."	0
"Anaphylaxis, immediate and accelerated reactions, atopy, older age and chronic/recurrent @Disease$ were risk factors for hypersensitivity and/or cross-reactivity between ASA, ibuprofen and @Chemical$."	0
"Within 90 days after intervention, there were 4 patients (1.5%) with acute thrombosis, 5 patients (1.8%) with subacute thrombosis, 17 patients (6.2%) with @Disease$, and 2 death (0.7%) in low-dose @Chemical$ group, compared with no patient (0%) with acute thrombosis, 2 patient (2.1%) with subacute thrombosis, 6 patients (6.2%) with stroke, and 2 death (2.1%) in high-dose aspirin group, and there were no significant difference in all study endpoints between two groups."	0
"METHODS: Asthma control status was monitored for 1 year with maintenance medications of inhaled corticosteroid and oral LTRA, and @Disease$ patients were classified into three groups according to the mean @Chemical$ dose required per month to maintain asthma control for 1 year: group I (&gt; or = 200 mg montelukast/month; n = 37), group II (5-150 mg/month; n = 25) and group III (&lt; 5 mg/month; n = 27)."	0
This review aims to describe the relationship between @Chemical$ and age-related macular degeneration (AMD) - a chronic disease that causes @Disease$ and is one of the most common ophthalmological diseases these days.	0
This study should alert clinicians to the risk of discontinuing chronic @Chemical$ therapy in patients with severe @Disease$.	0
"CONCLUSIONS: Preoperative aspirin use in all patients undergoing cardiac operations was not associated with risks of major cardiac, cerebral, or @Disease$ and death; however, the risk of reoperation for bleeding was elevated among preoperative @Chemical$ users compared with nonusers in a subpopulation of patients undergoing valve operations only."	0
"@Chemical$ prevents low-dose aspirin and loxoprofen induced @Disease$: a randomized, double-blinded, placebo controlled study."	0
Tacrolimus reduces urinary excretion of @Chemical$(4) and inhibits aspirin-induced @Disease$ to threshold dose of aspirin.	0
"Furthermore, we should be cautious when we prescribe @Chemical$ in addition to aspirin because it could cause @Disease$ complications like SSEH."	0
"Only in subjects with aspirin-exacerbated @Disease$, exhaled nitric oxide (P &lt; 0.05), plasma tryptase (P &lt; 0.01), and blood eosinophil (P &lt; 0.01) and basophil (P &lt; 0.01) counts increased and plasma tryptase correlated with eosinophil counts (Pearson r = 0.514; P &lt; 0.01) on @Chemical$."	0
"METHODS: The effect of arachidonic acid or platelet agonists on LTC4 synthase activity was investigated in platelets obtained from healthy volunteers, @Chemical$-intolerant asthmatics or aspirin-tolerant @Disease$tics after in vivo treatment or in vitro pre-incubation with aspirin."	0
"RESULTS: The @Chemical$-Cardio treatment reduced the mean score of GI symptom severity from the questionnaire (1.4-1.6 times, r=0.001), requirement for proton pump inhibitors (r=0.002) and endoscopy during the ASA treatment the mean score of GI symptom questionnaire &gt;3 predicted non-compliance or @Disease$ compliance with a diagnostic sensitivity of 58.9 % and specificity of 56.3 % (r=0.002), which makes this value a threshold for considering a modification of the treatment."	0
CONCLUSIONS: Nasal @Chemical$ administration is a reasonably accurate and safe method for diagnosing aspirin-exacerbated @Disease$.	0
PURPOSE OF REVIEW: The use of aspirin in @Disease$ and address the unmet need of aspirin therapy in patients with history of hypersensitivity reactions to aspirin (@Chemical$; ASA) or other nonsteroidal inflammatory drugs (NSAIDs).	0
"BACKGROUND: Non-steroidal anti-inflammatory drugs (NSAIDs) and low-dose @Chemical$ (ASA) have several adverse gastrointestinal (GI) effects, including upper @Disease$."	1
"CONCLUSIONS: The incidence of UGIB is 0.61% in ACS patients on dual antiplatelet therapy (@Chemical$ and clopidogrel) for 1 year after PCI and falls year by year.Administration of PPI after PCI protects patients from UGIB, especially in those with precious history of peptic @Disease$ and renal impairment."	0
Does @Chemical$ with aspirin after acute minor stroke or transient ischemic attack increase the risk of @Disease$?	0
"Thus, we investigated the effect of antioxidant enzyme cofactors-zinc and selenium-supplementation on superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), and @Chemical$ (MDA) levels (erythrocyte and liver) and @Disease$ during aspirin treatment at therapeutic doses."	0
Only 5 (12.5%) centers had a local policy for aspirin desensitization although 25 (64.1%) units had a clinical strategy for dealing with @Chemical$ @Disease$; the majority (72%) giving higher doses of thienopyridine class drugs.	1
We hypothesized that lyophilized aspirin/@Chemical$ could decrease the severity of aspirin-induced @Disease$.	0
"METHODS: Of 271 patients suspected by history of having @Disease$, 96 were taking cys-LT receptor antagonists (cys-LTRAs) and 12 were taking @Chemical$ at the time of oral ASA challenges."	0
"BACKGROUND: The aim of this study was to detect cysteinyl leukotriene (Cys-LT) receptors in aspirin-sensitive @Disease$ patients, and compare them with nasal polyposis and chronic rhinosinusitis patients without @Chemical$ sensitivity."	0
Overproduction of @Chemical$ in mast cells may be related with suppression of PGE2 in patients with aspirin @Disease$.	0
"Leukotriene C4 synthase has been established as a key genetic determinant of aspirin-induced @Disease$, but recent studies have demonstrated that several single nucleotide polymorphisms in the promoters of @Chemical$ receptor subtype 2, CYSLTR1 and CYSLTR2 and T-box expressed in T cells (TBX21) could increase risk for the condition."	0
"METHODS: To assess response to medical therapy in patients taking aspirin prior to admission with an acute coronary syndrome, we reviewed outcomes data from the Efficacy and Safety of Subcutaneous @Chemical$ in Non-Q-wave Coronary Events (ESSENCE) and Platelet Receptor Inhibition in @Disease$ Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) studies."	0
BACKGROUND: Patients with @Chemical$-exacerbated @Disease$ (AERD) also recently known as nonsteroidal anti-inflammatory drug (NSAID) exacerbated respiratory disease (NERD) must avoid aspirin and all other oral NSAIDs.	1
"A short cut review was carried out to establish whether pre-injury @Chemical$ increases the risk of intracranial complications following @Disease$. 124 papers were found using the reported searches, of which three presented the best evidence to answer the clinical question."	0
We aimed to assess the presence of apoptotic cells in nasal @Disease$ from @Chemical$-hypersensitive (AH) and aspirin-tolerant (AT) patients with rhinosinusitis as related to the characteristics of local inflammation.	1
"For non@Chemical$ NSAIDs, the relative risk was 2.6 (95% CI: 2.0, 3.5) for medium daily doses or lower and 4.9 (95% CI: 3.8, 6.5) for high daily doses; it was 5.6 (95% CI: 3.9, 8.2) for @Disease$ and 3.1 (95% CI: 2.3, 4.2) for duodenal ulcers."	0
CONCLUSIONS: We have found that there is a fine balance between benefits and risks from regular @Chemical$ use in primary prevention of @Disease$.	0
"METHODS: This prospective, placebo-controlled trial was conducted in @Disease$ patients randomized (1:1) to receive either standard DAPT (aspirin and clopidogrel) vs TAPT with cilostazol for a minimum of 12 months after PCI with Endeavor @Chemical$-eluting stent (E-ZES)."	0
"At admission, compared with @Chemical$ sensitive patients (ASP), patients with APR had more frequently diabetes, anterior @Disease$ and heart failure, while AHR patients had reduced values of creatine kinase, leukocytes, heart rate and systolic blood pressure."	0
"METHODS: Ninety-four aspirin-induced urticaria patients presenting urticaria/angioedema-induced by both ASA and NSAID (50 had underlying chronic @Disease$) and showing positive responses on oral @Chemical$ challenge test, 76 aspirin-intolerant asthmatics with positive responses on lysine-aspirin bronchoprovocation test, and 185 normal healthy controls were enrolled."	0
The current state of the art management of @Disease$ will be addressed including the ongoing central role for aspirin desensitization and high-dose @Chemical$ therapy.	0
BACKGROUND: A special regulatory role for @Chemical$ has been postulated in aspirin-induced @Disease$.	0
"In the intensively treated patients of the Hypertension Optimal Treatment (HOT) Study, randomization to low-dose @Chemical$ (75 mg daily) versus placebo significantly reduced cardiovascular events (-15%) and myocardial infarction (-36%), but increased major @Disease$s (+65%)."	0
"Among patients included in the FAERS database, the concurrent use of @Chemical$ and clopidogrel with PPIs reduced the adjusted ROR of @Disease$ events."	0
"Dual antiplatelet therapy (DAPT) with @Chemical$ and a P2Y12 inhibitor (clopidogrel, ticagrelor, or prasugrel) reduces thrombotic events in patients with @Disease$ (ACS), but it is also associated with an increased risk of bleeding complications."	0
"@Chemical$, aspirin, and @Disease$."	0
"We evaluated the differences in ACS type, total mortality, and the composite end point of death, @Disease$ (MI), recurrent ischemia, or stroke between prior aspirin and nonprior @Chemical$ users."	0
Metabolic profile of plasma free fatty acids in patients with @Chemical$-intolerant @Disease$.	0
"PLATO major @Disease$ occurred in 31 patients (0.5%) on @Chemical$ and 38 patients (0.6%) on aspirin (hazard ratio, 0.83; 95% confidence interval, 0.52-1.34)."	0
"In 73 patients, 23 with previous coronary stent thrombosis (ST) (ST group) and 50 without coronary ST (control group), @Disease$ was measured 3 times in monthly intervals using light transmission aggregometry (adenosine diphosphate [@Chemical$] and arachidonic acid induction)."	0
[Risk and prevention of @Disease$ due to low-dose @Chemical$ and other antiplatelet agents].	1
"(4) When the concentrations after @Chemical$ challenge were analysed simultaneously, a significant linear correlation was observed between urinary LTBG concentration and urinary LTE4 concentration in patients with @Disease$ (Spearman's rank correlation test, r = 0.817, P = 0.0003)."	0
"In the patient showing aspirin-induced @Disease$ responses, 31 genes were up-regulated and 6 were down-regulated after @Chemical$ treatment."	0
CONCLUSION: The severity of the historical aspirin/NSAID-induced asthma attack was not predictive of @Disease$ severity during @Chemical$.	1
"BACKGROUND: Aspirin triad disease (ATD) is a well-known clinical entity characterized by @Disease$, polyposis, and @Chemical$ intolerance."	0
"CONCLUSION: H2RA therapy was effective for both the prevention and treatment of low-dose @Chemical$-induced peptic ulcer, similar to the effects of PPIs, while cytoprotective anti-ulcer drugs were ineffective in preventing @Disease$ation."	0
"When stratified by BMI (calculated as weight in kilograms divided by height in meters squared), @Chemical$ use 3 or more times per week among individuals with BMI 20 to 24.9 was associated with reduced risk of all-cause mortality (HR, 0.82; 95% CI, 0.78-0.85; P &lt; .001) and any @Disease$ mortality (HR, 0.86; 95% CI, 0.79-0.82; P &lt; .001)."	0
[Acute @Disease$ in a patient treated with rofecoxib who took @Chemical$ as self-medication].	1
Conclusions: Elevated high-density lipoprotein @Chemical$ is independently associated with any bleeding and severe @Disease$ in the patients with acute minor stroke or high-risk TIA on antiplatelet therapy.	0
"In addition to a marked increase in @Chemical$ production, aspirin challenge induced LTB4 production in @Disease$ patients."	0
"CONCLUSION: In our retrospective study, only pre-treatment with aspirin and @Chemical$ was associated with thrombolysis-related @Disease$."	1
"Aspirin exacerbated respiratory disease (AERD) is characterized as adult onset asthma, nasal polyps, chronic rhinosinusitis, and @Disease$ cyclooxygenase-1 (COX-1) inhibitor, viz @Chemical$ or nonsteroidal antiinflammatory drugs (NSAIDs)."	0
"METHOD: We classified 1,041 gastroduodenal ulcer patients into three groups [patients taking @Chemical$ (group A), patients taking nonaspirin nonsteroidal anti-inflammatory drug (NSAID) (group N), and patients taking neither aspirin nor nonaspirin NSAID (group C)] and 241 @Disease$ gastroduodenal ulcer patients into three corresponding groups (groups a, n, and c)."	0
Risks for @Disease$ and bleeding with warfarin or @Chemical$ treatment in patients with atrial fibrillation at different CHA(2)DS(2)VASc scores: experience from the Stockholm region.	1
Aspirin-induced asthma (AIA) and @Chemical$-induced @Disease$/ angioedema (AIU) are two major aspirin-related allergies.	1
"PURPOSE: Lower urinary tract operations are being increasingly performed in elderly patients, in whom @Chemical$ intake is common for preventing @Disease$."	0
"The study demonstrated that combined therapy with fluoxetine and ASA is characterized by the same efficacy and clinical safety as @Chemical$ monotherapy, resulting additionally in improvement of oxidative stress parameters in the patients treated for @Disease$."	0
BACKGROUND: @Chemical$-intolerant asthma (AIA) is a subtype of asthma induced by non-steroidal anti-inflammatory drugs and characterized by an @Disease$ of the lower airway (asthma) and the upper airways (rhinitis and nasal polyp).	0
"METHODS: The frequencies of all and GI adverse events (AEs) and adverse drug reactions (ADRs) were calculated from the pooled individual patient data of nine similar randomized, double-blind, placebo controlled clinical trials of single-doses of @Chemical$ 1000 mg in the treatment of acute migraine attacks, @Disease$ and dental pain."	0
[The study of 18 cases of aspirin urticaria at dermatology of Yodogawa Christian Hospital--on the difference between aspirin @Disease$ and @Chemical$ urticaria].	0
We asked the patient to stop @Chemical$ intake and the @Disease$ cleared considerably on the third day after discontinuation of the drug.	1
"We investigated the risks of ischemic stroke and intracranial hemorrhage (ICH) in relation to warfarin at various TTRs in a real-world cohort of Chinese patients with @Disease$ receiving warfarin and compared with those on dabigatran, @Chemical$, and no therapy."	0
Urinary metabolites of @Chemical$ and leukotrienes before and after placebo-controlled challenge with ASA and food additives in chronic @Disease$ patients.	0
"METHODS: Ancillary analysis of the Apixaban Versus @Chemical$ [ASA] to Prevent @Disease$ in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment (AVERROES) trial, comparing aspirin and apixaban, focused on sex differences."	0
"Age, male gender, Helicobacter pylori (H. pylori)infection, diabetes, chronic kidney disease (CKD), cirrhosis, history of uncomplicated @Disease$ (PUD), and use of NSAIDs, COX-2 inhibitors, steroids, and @Chemical$ were independent risk factors for UGIB among aspirin users."	0
"The values of @Disease$s of MPs in descending order were as follows: gefarnate, @Chemical$ &gt; teprenone &gt; sucralfate oral suspension &gt; L-glutamine and sodium gualenate granules &gt; rebamipide &gt; sucralfate chewable tablets."	0
"The risk of gastroduodenal toxicity is particularly high among 'at-risk' low-dose @Chemical$ patients (aged &gt;70 years, previous ulcer or @Disease$ and users of antiplatelets or NSAIDs)."	0
"Two years later, 15 days after @Chemical$ discontinuation, he experienced an anterior ST-segment elevation @Disease$ and underwent rescue percutaneous LAD thrombectomy after unsuccessful fibrinolysis."	0
Persistent eosinophil activation in both the upper and lower airway mucosa is a central feature of @Chemical$-exacerbated respiratory disease (@Disease$).	0
"Two drugs recently approved for health insurance reimbursement, celecoxib, a cyclooxygenase (COX)-2 specific inhibitor and low-dose @Chemical$ for prevention of recurrent peptic ulcer due to LDA/NSAIDs will be instrumental in mitigating the @Disease$."	0
"There were significantly more patients who suffered GI adverse events, principally abdominal pain, @Disease$, nausea and diarrhoea, with @Chemical$ (18.5%) than with ibuprofen (11.5%), but the difference between ibuprofen and paracetamol (13.1%) was not significant."	1
"BACKGROUND: It remains unclear to what extent asthma in adults is linked to allergic rhinitis (AR), gastroesophageal reflux disease (GERD), and @Chemical$ exacerbated @Disease$ (AERD), and how these comorbidities may affect asthma outcomes in the general population."	0
Upregulation of CD11b on eosinophils in @Chemical$ induced @Disease$.	1
"CONCLUSIONS: @Disease$ with @Chemical$ sensitivity is characterized by the eicosanoid alterations, which are similar to those present in aspirin-induced asthma."	1
"The association between @Chemical$ use and the presence of DR or VTDR was assessed using multivariable logistic regression models including age, gender, ethnicity, socioeconomic status, HbA1c, systolic blood pressure, anti-hypertension medicine, total cholesterol, anti-cholesterol medicine, BMI, current smoking status, @Disease$ duration, history of cardiovascular disease (CVD) and chronic kidney disease (CKD.)."	0
A previously healthy 60-year-old man receiving @Chemical$ for primary prevention of cardiovascular disease presented with hemoptysis after 1 week of treatment for his @Disease$ with diclofenac.	0
"Low dose @Chemical$ also increases the risk of peptic @Disease$, so preventive measure(s) should be done for high-risk patients."	1
@Chemical$ and the older nonsteroidal anti-inflammatory drugs (NSAIDs) that block cyclo-oxygenase-1 (COX-1) induce asthma attacks in patients with aspirin-exacerbated @Disease$ and urticaria in patients with chronic idiopathic urticaria.	0
This different response might indicate COX-1-dependent @Chemical$ control of inflammatory cells in aspirin-induced @Disease$.	0
Randomised clinical trial: rabeprazole plus aspirin is not inferior to rabeprazole plus @Chemical$ for the healing of aspirin-related peptic @Disease$.	0
Risk factors for @Disease$ in coronary artery disease patients receiving both aspirin and @Chemical$.	0
H. pylori @Disease$ and @Chemical$ interact synergic and negative synergic with reference to gastric mucosal injury.	0
"For @Chemical$, a small increase in overall @Disease$ risk was observed with use within the last year (odds ratio [OR] = 1.45, 95% confidence interval [CI] 1.41-1.49)."	0
"CONCLUSIONS: This meta-analysis failed to find a statistically significant difference in major @Disease$ between warfarin, target INR 2.0-3.5, and @Chemical$, 50-650 mg daily."	0
"CONCLUSIONS: We found that the prevalence of @Chemical$ did not increase in the group of aspirin use, and the presence of CMBs was not associated with the duration of aspirin use in asymptomatic elderly subjects without a history of @Disease$ or transient ischemic attack."	0
This report describes a patient with Reye's syndrome and serves as a reminder for health professionals to continue to discourage the use of @Chemical$ for the treatment of @Disease$.	0
Conclusion: @Chemical$ use and CYP4F2 T allele were significantly associated with @Disease$ during dual antiplatelet therapy.	1
"Only in subjects with aspirin-exacerbated @Disease$, exhaled @Chemical$ (P &lt; 0.05), plasma tryptase (P &lt; 0.01), and blood eosinophil (P &lt; 0.01) and basophil (P &lt; 0.01) counts increased and plasma tryptase correlated with eosinophil counts (Pearson r = 0.514; P &lt; 0.01) on aspirin."	0
BACKGROUND: Dual antiplatelet therapy (DAPT) associating @Chemical$ + clopidogrel is commonly utilized in @Disease$ interventions despite unpredictable clopidogrel efficacy with 4% to 50% of patients considered nonresponders.	0
"There were significantly more patients who suffered GI adverse events, principally abdominal @Disease$, dyspepsia, nausea and diarrhoea, with aspirin (18.5%) than with @Chemical$ (11.5%), but the difference between ibuprofen and paracetamol (13.1%) was not significant."	0
"In more recent studies, small @Disease$ and enteropathy associated with low-dose @Chemical$ are increasingly being recognized."	1
Prospective cohort study of gastrointestinal complications and @Disease$ in patients taking @Chemical$: rationale and design of the MAGIC Study.	1
"CONCLUSIONS: Among @Chemical$ users with a history of lower @Disease$, continuation of aspirin is associated with an increased risk of recurrent lower GI bleeding, but reduced risk of serious cardiovascular events and death."	0
The end point was the occurrence of upper @Disease$ during combination therapy or within 7 days of stopping @Chemical$.	0
"These associations were stronger after more than 10 years of use (@Chemical$: odds ratio (OR) = 1.8, 95% confidence interval (CI): 1.3, 2.6; aspirin: OR = 1.6, 95% CI: 1.1, 2.2) and were present for indications of headache, menstrual pain, and other @Disease$."	0
"When determining whether low-dose @Chemical$ is appropriate for an individual patient, the cardiovascular benefit must be weighed against the potential for clinical events such as @Disease$."	0
OBJECTIVE: To find potential factors associated with @Disease$ control in patients with @Chemical$-exacerbated respiratory disease (AERD).	0
BACKGROUND: Patients with @Chemical$-exacerbated @Disease$ (AERD) are distinguished from patients with aspirin-tolerant asthma (ATA) by significantly higher baseline concentrations of urinary leukotriene E4 (uLTE4).	0
"Survivors were followed prospectively for recurrent @Disease$ and intercurrent aspirin and @Chemical$ use, including duration of exposure."	0
"BACKGROUND: Aspirin plus @Chemical$ (A+C) may be more effective than aspirin only (AO) acutely after TIA and minor stroke, but the risk of @Disease$ in the acute phase is uncertain."	0
INTRODUCTION: The role of Helicobacter pylori @Disease$ on the risk of low-dose @Chemical$-related gastroduodenal damage and on the efficacy of the prevention therapy in elderly chronic users of low-dose aspirin is still controversial.	0
"Concentrations of urinary leukotriene E4 (uLTE4) were measured by ELISA and plasma stable prostaglandin D2 metabolite, 9alpha,@Chemical$(2) by GC/@Disease$."	0
Aspirin Does Not Increase Heart Failure Events in @Disease$ Patients: From the @Chemical$ Trial.	0
LTMDs alone or in combination with other controllers blocked lower respiratory tract reactions during @Chemical$ challenge in some patients with @Disease$ but did not change the overall rate of positive aspirin challenge results and did not lead to false-negative challenges.	0
"METHODS: Ninety-four aspirin-induced urticaria patients presenting urticaria/@Disease$-induced by both ASA and NSAID (50 had underlying chronic urticaria) and showing positive responses on oral aspirin challenge test, 76 aspirin-intolerant asthmatics with positive responses on @Chemical$-aspirin bronchoprovocation test, and 185 normal healthy controls were enrolled."	0
"@Disease$ induced by anti-coagulant agents, especially low-dose aspirin (@Chemical$) increased."	1
BACKGROUND: The association of Helicobacter pylori @Disease$ with @Chemical$-induced gastropathy is controversial.	0
Aspirin and the older nonsteroidal anti-inflammatory drugs (NSAIDs) that block cyclo-oxygenase-1 (COX-1) induce asthma attacks in patients with @Chemical$-exacerbated @Disease$ and urticaria in patients with chronic idiopathic urticaria.	0
The significance of previous @Chemical$ use in patients with @Disease$ is unknown.	0
"@Chemical$-exacerbated respiratory disease (@Disease$) is a distinct clinical condition characterized by chronic sinusitis with nasal polyps, asthma, and hypersensitivity reactions to nonsteroidal anti-inflammatory drugs (NSAIDs)."	0
"BACKGROUND: @Chemical$ therapy is widely accepted for patients with documented cardiovascular disease, but there is a growing trend among healthy individuals to use aspirin as primary prevention for both @Disease$ and cancer."	0
@Chemical$ are involved in the physiological mechanism of atherosclerotic events and @Disease$.	0
CONCLUSIONS: Clopidogrel in combination with @Chemical$ before CABG is associated with higher postoperative @Disease$ and morbidity.	0
"Platelet adenosine diphosphate (ADP) receptors may play a role in potentiating platelet activation induced by IgG from patients with immune heparin-induced thrombocytopenia (@Disease$), as shown by previous studies using the ADP receptor antagonists @Chemical$ and ticlopidine."	0
@Chemical$ @Disease$ Patients Undergoing Percutaneous Coronary Intervention.	1
"Aspirin hypersensitivity is a hallmark of @Chemical$-exacerbated respiratory disease (AERD), a clinical syndrome characterized by the severe @Disease$ after ingestion of cyclooxygenase-1 inhibitors."	0
"Adverse events considered possibly or probably related to treatment occurred in 5 (20.0%) misoprostol recipients (4 episodes of @Disease$, 1 episode of abdominal pain), 1 (14.3%) recipient of @Chemical$ 30 mg (1 episode of pharyngitis), and 3 (13.6%) placebo recipients (1 episode each of abdominal pain, palpitations, and dyspepsia)."	0
"INTRODUCTION: Clinical features of aspirin-exacerbated respiratory disease (AERD) consist of moderate to severe @Disease$ associated with chronic rhinosinusitis (CRS), which are derived from overproduction of @Chemical$ along with chronic type 2 mediated inflammation in the upper and lower airway mucosa."	0
Minidose acetylsalicylic acid (@Chemical$) administration is a significant risk factor for changes in the stomach and duodenal mucosa also in persons whose anamnesis does not indicate any previous symptoms of @Disease$ or any other risk factor.	0
"METHODS: Among patients who underwent PCI and were maintained on @Chemical$ for 1 year in a multicenter US registry, we assessed patient-reported bleeding over one year following PCI in patients with and without @Disease$."	0
Sodium Cromoglycate Prevents Exacerbation of IgE-Mediated Food-Allergic Reaction Induced by @Chemical$ in a Rat Model of Egg @Disease$.	0
"RESULTS: Within 5 years, lower @Disease$ recurred in 18.9% of @Chemical$ users (95% confidence interval [CI], 13.3%-25.3%) vs 6.9% of nonusers (95% CI, 3.2%-12.5%; P = .007)."	0
"The absolute annual increases attributable to @Chemical$ were major @Disease$: 0.13% (95% CI, 0.08-0.20); major GI bleeding: 0.12% (95% CI, 0.07-0.19), intracranial bleeding: 0.03% (95% CI, 0.01-0.08)."	1
Our results suggest that @Chemical$ consumption may reduce lung cancer risk in Asian women and are consistent with current understanding of the role of cyclooxygenase in @Disease$.	0
"MATERIALS AND METHODS: An open, cross-sectional study compared three groups of patients consisting of 200 patients each who had stable IHD and a high risk of @Disease$ and who received a long-term antiaggregant monotherapy with one of ASA drugs (group 1, @Chemical$ Cardio; group 2, Thrombo ASS; group 3, Cardiomagnyl)."	0
"In aspirin-induced @Disease$ dogs (n=5), prolonged @Chemical$ (buccal mucosal bleeding time) was shortened significantly after DDAVP injection (2.2 +/- 1.2 min, P&lt;0.05)."	0
"The effects of pranlukast on changes in sputum LTC(4)-LTD(4), eosinophil cationic protein (ECP), eosinophil count, urinary LTE(4)/@Chemical$, 11-dehydrothromboxane B(2) (11-dhTXB(2))/creatinine, serum LTC(4)-LTD(4), ECP, and peripheral blood eosinophil count, during immediate @Disease$tic reaction (IAR) and late asthmatic reaction (LAR) in the HDM group and during IAR in the ASA group for each test, were compared in each group."	0
"@Chemical$-induced asthma is a distinct clinical syndrome consisting of inflammation, characterized by chronic eosinophilic rhinosinusitis with @Disease$ and often nasal polyposis."	0
OBJECTIVE: To examine whether misoprostol (oral @Chemical$ analogue) use during aspirin challenge and desensitization might decrease the severity of aspirin-induced symptoms and make desensitization safer for patients with @Disease$.	0
Drug-induced hypersensitivity syndrome: drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome induced by @Chemical$ treatment of @Disease$.	0
"Of these 52 cases, there were 22 nasal polyposis cases with aspirin sensitivity, 15 @Disease$ cases without aspirin sensitivity and 15 chronic rhinosinusitis cases without @Chemical$ sensitivity."	0
"Cyto@Disease$ was evaluated by cell viability, anti-oxidant enzyme activities, malondialdehyde (@Chemical$) production and by the expression of MAPKs (Mitogen-Activated Protein Kinases) pathways."	0
"Mucosal defects were found in 54 of 98 (60.7%) users of buffered aspirin (BA), whereas 38 of 101 (37.6%) users of @Chemical$ had @Disease$."	1
"Although @Chemical$ after ICH was not associated with lobar ICH recurrence in univariate analyses, in multivariate analyses adjusting for baseline clinical predictors, it independently increased the risk of @Disease$ recurrence (HR 3.95, 95% CI 1.6-8.3, p = 0.021)."	0
"Patients receiving treatment for &gt;5 years showed elevated risk of CMBs in the aspirin (0.17; 0.09-0.36; P &lt; .001) and @Chemical$ (0.15, 0.07-0.33; P &lt; .001) groups as well as higher odds of MB in the aspirin (0.34, 0.16-0.71; P = .004) and clopidogrel (0.37, 0.17-0.80; P = .010) groups.The WMHs and MB were associated with CMBs in patients taking aspirin or clopidogrel for &gt;1 year, and long-term use increased the risks of CMB and @Disease$."	0
"@Disease$ to @Chemical$ is a difficult diagnostic problem, so the increased knowledge on this subject is a very important for the physicians of many specialties."	1
PURPOSE: To determine the impact of preoperative @Chemical$ on @Disease$ and other complications in patients undergoing robot-assisted radical prostatectomy and nephrectomy.	0
"Data Sources: We searched PubMed, Embase, CENTRAL, and ClinicalTrials.gov from inception to May 28, 2018, with the terms novel oral anticoagulants, non-vitamin K antagonist oral anticoagulants, direct oral anticoagulants, dabigatran, rivaroxaban, @Chemical$, edoxaban, warfarin, Coumadin, vitamin K antagonist, aspirin, acetylsalicylic acid, or ASA, and major @Disease$, fatal bleeding, or intracranial hemorrhage."	0
"@Chemical$ (ASA)-exacerbated respiratory disease (@Disease$) is characterized by upper airway congestion due to eosinophilic inflammation of the nasal and sinus membranes and nasal polyposis, associated with increased leukotriene production that is further accentuated by ASA or other nonsteroidal anti-inflammatory drug (NSAID) ingestion."	0
The patient was successfully managed with @Chemical$ therapy during the 16 months follow-up without recurrent @Disease$ or hemorrhagic events.	0
"METHODS: Genotyping for the 2 polymorphisms was performed in patients hospitalized for @Disease$ associated with the use of low-dose aspirin between September 1998 and October 2000, and race-, age-, and sex-matched controls who were taking low-dose @Chemical$ but had no history of upper GI bleeding."	0
"The proportions of patients who were free of @Disease$ ulcers at the end of 12 weeks were 96% in the misoprostol group, 93% in the @Chemical$ 15-mg group, 100% in the lansoprazole 30-mg group, and 35% in the placebo group (P &lt;or= 0.008, each active treatment vs placebo)."	0
CONCLUSION: The ART should be used to better target and guide platelet transfusions in @Disease$ patients with known or suspected @Chemical$ use history.	0
"Maternal complications were evenly distributed by treatment arm with the exception of @Disease$, which was more commonly reported in the low-dose @Chemical$ arm (22% compared with 17%, P=.02)."	0
Does @Chemical$ with aspirin after acute minor @Disease$ or transient ischemic attack increase the risk of cerebral hemorrhage?	0
"BACKGROUND: @Chemical$-exacerbated respiratory disease (AERD) is a distinct eosinophilic phenotype of severe asthma with accompanying chronic @Disease$, nasal polyposis, and hypersensitivity to aspirin."	0
The aim of this study was to determine the incidence of upper GI bleeding and whether the use of peri-operative oral @Chemical$ reduces the incidence of upper GI bleeding when aspirin thromboprophylaxis is used for hip and knee @Disease$.	0
"@Chemical$-exacerbated respiratory disease (AERD) is characterized by the triad of @Disease$, eosinophilic nasal polyposis and a hypersensitivity to all medications that inhibit the cyclo- oxygenase (COX) -1 enzyme."	0
Associations between aspirin responsiveness and thrombosis rate and @Chemical$ dose adjustment and @Disease$ rate were assessed with the use of multivariable logistic regression analysis.	1
Another class of inflammatory mediators that contribute to @Disease$ are the @Chemical$.	0
"To our knowledge, there have been no previous reports of @Chemical$-induced hypersensitivity syndrome subsequent to @Disease$."	1
"METHODS: Ancillary analysis of the Apixaban Versus Acetylsalicylic Acid [ASA] to Prevent @Disease$ in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment (AVERROES) trial, comparing aspirin and @Chemical$, focused on sex differences."	0
METHODS: We performed a retrospective cohort study of 1677 patients undergoing coronary artery bypass surgery to determine the relationship of the preoperative use of aspirin plus @Chemical$ vs aspirin alone to the 30-day incidence of postoperative surgical site @Disease$ and bacteremia.	0
"After oral provocation aspirin challenge in 5 subjects' @Chemical$ induced @Disease$ was confirmed, 3 persons were not qualified to test."	1
@Disease$ and the changing use of COX-2 non-steroidal anti-inflammatory drugs and low-dose @Chemical$.	0
"In saliva analysis among the three groups (AIA patients, @Chemical$-tolerant asthma [ATA] patients, and healthy subjects), both the concentrations of CysLTs and LTB4 were significantly higher in @Disease$ patients than in ATA patients and healthy subjects."	0
"OBJECTIVES: Leukotriene receptor antagonists (LTRA), such as montelukast, have been used as a first-line treatment for patients with @Chemical$-intolerant @Disease$ (AIA)."	0
"There are important differences in the mechanism of @Chemical$-induced gastroduodenal @Disease$, relative to NSAIDs."	1
"Based on the AIA-specific gene expression profile of nasal polyp, candidate genes for AIA susceptibility were selected and screened by a case-control design of 219 AIA patients, 374 non-@Disease$tic control (CTR), and 282 @Chemical$-tolerant asthmatic (ATA) subjects."	0
"RESULTS: Post-@Chemical$ VCE detected 10 cases (50%) with @Disease$ not apparent in baseline studies (6 cases had petechiae, 3 had erosions, and 1 had bleeding stigmata in 2 ulcers)."	0
"The majority of patients with a history of reactions to @Chemical$ have aspirin/nonsteroidal anti-inflammatory drug (NSAID)-induced gastritis, @Disease$, or other side effects."	0
OBJECTIVE: We sought to evaluate whether titrated initiation of ASA-@Chemical$ in patients with @Disease$/transient ischemic attack (TIA) improves tolerance and to assess the appearance of headache in those with pre-existing history of headaches.	0
"BACKGROUND: We describe three patients with Samter's triad (nasal polyps, @Chemical$ intolerance, and asthma) with skull base dehiscence in whom the polyps extended into the extradural space and also resulted in @Disease$ and widening of the nasal bridge."	1
"To assess the incremental utility of variables not included in the @Chemical$ score, baseline high platelet reactivity was added to the ischemia model, and high platelet reactivity, baseline hemoglobin, and warfarin use 1 year after percutaneous coronary intervention were added to the @Disease$ model."	0
@Disease$ provoked by combined use of nattokinase and @Chemical$ in a patient with cerebral microbleeds.	1
CONCLUSIONS: Fewer endoscopic @Disease$s were observed in patients treated with celecoxib/@Chemical$ vs. naproxen/aspirin.	0
"BACKGROUND: The combination of @Chemical$, clopidogrel, and enoxaparin (combination therapy) is the standard treatment for acute @Disease$ but is associated with gastrointestinal bleeding."	0
[Antiplatelet therapy with @Chemical$: approaches to reducing the frequency of @Disease$].	0
This is the first documented case of spontaneous perirenal @Disease$ secondary to low-dose @Chemical$ treatment.	0
"We evaluated the effects of aspirin on genetic/epigenetic alterations in precancerous conditions, i.e., atrophic mucosa (AM) and @Disease$ (IM), in patients with chronic gastritis who had taken @Chemical$ for more than 3 years."	0
"The lowest @Disease$/SE rates and major bleed rates were observed in warfarin time in therapeutic range (TTR) &gt;=55% episodes (stroke/SE: 0.87 [0.71 to 1.04]; major bleed: 4.91 [4.53 to 5.28] per 100 person-years), which was similar to the bleed rate in @Chemical$ episodes (4.95 [4.58 to 5.32] per 100 person-years)."	0
"Recently, vitamin C releasing aspirin (ASA-VitC) has been shown to reduce @Disease$ of @Chemical$ in animal model of gastric injury."	1
"Urinary eicosanoids, plasma tryptase and cytokine levels, platelet-leukocyte aggregates, and granulocyte transcripts were assessed.Measurements and Main Results: Eight weeks of high-dose aspirin decreased nasal symptoms and urinary @Chemical$ metabolite (P &lt; 0.05) and increased urinary leukotriene E4 (P &lt; 0.01) levels in subjects with aspirin-exacerbated @Disease$, but not in those with aspirin-tolerant asthma."	0
Enzyme up-regulation was monitored after in vitro stimulation with lipopolysaccharide (@Disease$) and/or aspirin in 19 @Chemical$-intolerant (AI) patients (8 aspirin-sensitive asthmatics and 11 urticaria-angioedema patients) and 14 healthy controls.	0
CONCLUSION: These data suggest that @Chemical$ may be of special concern for diabetic patients with poor glucose control and @Disease$.	1
"The median intraoperative blood loss (600 ml versus 450 ml, P = 0.56), median postoperative @Disease$ (800 ml versus 790 ml, P = 0.60), blood transfusion requirements (25.1% versus 24.4%, P = 0.76) and composite outcome of in-hospital death, stroke and reoperation for bleeding (2.8% versus 1.6%, P = 0.10) were similar in aspirin and non@Chemical$ use group."	0
"CONCLUSION: Switching @Chemical$ dosage from 100 mg/d to 40 mg/d reduces the @Disease$ events and improves upper gastrointestinal symptoms, thus inhibiting platelet aggregation effectively in very elderly patients."	0
H. pylori @Disease$ was determined by CagA/VacA serology and 13C-@Chemical$ breath test in all cases and controls.	0
Unusual @Disease$ due to application of white vinegar and @Chemical$ mixture.	1
"CONCLUSIONS: In this observational study, aspirin use was not associated with an increase in mortality rates or HF readmission rates, and @Chemical$ did not attenuate the benefits of ACE inhibitors, even in patients without coronary disease, patients with @Disease$, or patients treated with high-dose aspirin and low-dose ACE inhibitors."	0
"@Chemical$-exacerbated @Disease$ (AERD) involves overexpression of proinflammatory mediators, including 5-lipoxygenase and leukotriene C4 synthase (LTC4S), resulting in constitutive overproduction of cysteinyl leukotrienes."	1
We report the use of intracoronary @Chemical$ in successfully reversing @Disease$ in this hemodynamically unstable patient.	0
"Cytokines, staphylococcus super antigens, and eosinophil activation are proposed to play important roles in @Chemical$-exacerbated @Disease$ (AERD)."	0
"@Chemical$ expanded the mean diameter of the microvessels of the @Disease$, which, in turn, was negatively correlated with the intragastric pH."	0
"Aspirin-exacerbated respiratory disease (AERD), or @Chemical$-induced asthma, is characterized by @Disease$ and rhinitis triggered by the ingestion of aspirin and non-steroidal anti-inflammatory drugs."	0
The incidences of the combined outcome of recurrent @Disease$ and major bleeding were 2.8% and 3.4% lower in the rivaroxaban 20-mg and 10-mg groups than in the @Chemical$ group.	0
CONCLUSIONS: There is high mortality rate associated with ASA or @Chemical$ or both in elderly patients who have head @Disease$ resulting in ICH.	0
"INTRODUCTION: Clinical features of @Chemical$-exacerbated respiratory disease (AERD) consist of moderate to severe @Disease$ associated with chronic rhinosinusitis (CRS), which are derived from overproduction of cysteinyl leukotrienes along with chronic type 2 mediated inflammation in the upper and lower airway mucosa."	0
"Based on current, although limited, data, we propose that these patients should undergo early endoscopic therapy to control @Disease$ followed by a high-dose intravenous PPI, with early reintroduction of @Chemical$ treatment within a 5-day window after the last dose."	1
Objective: To develop prognostic bleeding risk models among persons in whom @Chemical$ might be considered for the primary prevention of @Disease$ (CVD).	0
"Allergic conditions include aspirin-exacerbated @Disease$ (AERD or @Chemical$-induced asthma), aspirin-induced urticaria/angioedema (AIU), and anaphylaxis."	0
"Our results indicate that @Chemical$, dabigatran, rivaroxaban, idraparinux and VKAs all reduced @Disease$ recurrence when compared to placebo."	0
OBJECTIVE: Histological analysis of 16 biopsies of @Disease$ induced by oral @Chemical$ challenge in patients with CIU.	1
After a viral infection that was eventually treated with @Chemical$ @Disease$ has to be discussed after exclusion of common causes of hepatic failure.	1
"OBJECTIVE: To evaluate the relationship between aspirin ingestion and @Disease$ complications, and to test the hypothesis that there is a subset of patients who are @Chemical$ hyperresponders with a proclivity toward platelet dysfunction."	0
Systemic responses after bronchial @Chemical$ challenge in sensitive patients with @Disease$.	0
CONCLUSION: The severity of the historical @Chemical$/NSAID-induced asthma attack was not predictive of @Disease$ severity during OAC.	0
Anti-platelet drug-induced @Disease$ was alleviated by @Chemical$ without attenuation of anti-platelet functions irrespective of H. pylori and CYP2C19 genotypes.	0
"Within 90 days after intervention, there were 4 patients (1.5%) with acute @Disease$, 5 patients (1.8%) with subacute thrombosis, 17 patients (6.2%) with stroke, and 2 death (0.7%) in low-dose @Chemical$ group, compared with no patient (0%) with acute thrombosis, 2 patient (2.1%) with subacute thrombosis, 6 patients (6.2%) with stroke, and 2 death (2.1%) in high-dose aspirin group, and there were no significant difference in all study endpoints between two groups."	0
"OBJECTIVE: We sought to determine blood and urinary levels of 9alpha,11beta-PGF(2), a major stable PGD(2) metabolite in 2 well-defined phenotypes of @Disease$, aspirin-induced asthma (AIA) and aspirin-tolerant asthma (ATA), and in healthy control subjects and to study the effects of @Chemical$ on PGD(2) release."	0
"BACKGROUND: In patients with aspirin-exacerbated @Disease$ (AERD), pretreatment with asthma controller medications (leukotriene modifiers, inhaled or systemic corticosteroids, and salmeterol) partially modifies the severity of @Chemical$-induced asthmatic reactions."	0
"OBJECTIVE: Patients who present for coronary surgery often receive preoperative dual antiplatelet therapy with aspirin and a @Chemical$ derivative (clopidogrel or prasugrel), especially after a recent acute @Disease$."	0
"INTRODUCTION: @Chemical$-intolerant asthma (AIA), a major clinical presentation of aspirin hypersensitivity, affects 10% of adult @Disease$tics."	0
"CONCLUSION: Regular @Chemical$ use is associated with increased risk of incident neovascular @Disease$, independent of a history of cardiovascular disease and smoking."	1
"Comparison of @Disease$ Patients Receiving @Chemical$, Enoxaparin, or Aspirin for Thromboprophylaxis."	0
BACKGROUND: Intranasal administration of @Chemical$-lysine has been used in Europe for the diagnosis of aspirin-exacerbated @Disease$.	0
"However, desensitization to @Chemical$ is a viable option for patients with aspirin-induced @Disease$, especially for those who require aspirin for thromboembolic prophylaxis."	0
"AIM: This study was designed to determine the effect of admission BP on the early prognosis of @Disease$ patients by dividing them into three groups (warfarin, @Chemical$, and no drugs)."	0
The incidence of @Disease$ for buffered @Chemical$ and enteric-coated aspirin was evaluated in patients receiving long-term low-dose aspirin (LDA) for cardiovascular (CV) diseases.	0
"When conducted in accordance with current guidelines, @Chemical$ desensitization is a safe procedure that allows patients with @Disease$ who have an indication for aspirin or other NSAIDs to safely ingest these medications."	0
Aspirin induces IL-4 production: augmented IL-4 production in @Chemical$-exacerbated @Disease$.	0
"RESULTS: Buffered @Chemical$ plus ascorbic acid yielded the lowest Lanza score, the lowest increase in the number of @Disease$ and the lowest increase in the amount of gastric microbleeding."	0
@Disease$ in a patient taking low-dose @Chemical$.	1
This pilot study aimed to determine the prevalence of aspirin resistance in an Australian stroke population and to correlate @Chemical$ resistance with an increased risk of ischaemic @Disease$.	0
Fatal @Disease$ of a Flow Diverter due to @Chemical$-related Antagonization of Acetylsalicylic Acid.	1
"Platelet adenosine diphosphate (ADP) receptors may play a role in potentiating platelet activation induced by IgG from patients with immune @Chemical$-induced thrombocytopenia (@Disease$), as shown by previous studies using the ADP receptor antagonists AR-C66096 and ticlopidine."	0
CONCLUSIONS: @Chemical$ in combination with aspirin before CABG is associated with higher postoperative @Disease$ and morbidity.	0
The blocking effect of essential controller medications during @Chemical$ challenges in patients with aspirin-exacerbated @Disease$.	0
"The antithrombotic treatment actually ongoing at major @Disease$ was TT in 44%, @Chemical$ in 50%, and DAPT in 6% of cases."	0
The Framingham Heart Study records of participants with atrial fibrillation (@Disease$) during 1980 and 1994 were retrospectively reviewed to determine the prevalence of warfarin and @Chemical$ use in AF.	0
In this paper the current opinion on nasal @Disease$ management in @Chemical$ triad patients was presented.	0
We investigated the role of serum specific IgE to thyroid peroxidase (TPO) in patients with @Chemical$ intolerant acute urticaria (@Disease$) and aspirin intolerant chronic urticaria (AICU).	0
CONCLUSIONS: Rates of bleeding and @Disease$ events were not significantly different according to 6- versus 24-month @Chemical$ after PCI with new-generation DES in good aspirin responders.	0
"In this study, we compared the roles of CysLT receptor type 1 (CysLTR1) and leukotriene C4 synthase (LTC4S) gene polymorphisms in two major @Chemical$-related allergic diseases, aspirin-intolerant asthma (AIA) and aspirin-induced chronic @Disease$/angioedema (AICU)."	0
CONCLUSIONS: The use of @Chemical$ was not associated with the risk of @Disease$.	0
These findings indicate that gastroprotective therapy should be considered for preventing peptic ulcer associated with low-dose @Chemical$ in patients with @Disease$.	0
"The aim of the study was to assess the antiplatelet activity and safety of a combined antiplatelet treatment with indobufen and @Chemical$ in acute coronary syndrome (ACS) patients with @Disease$ to aspirin, undergoing coronary stenting."	0
"METHODS AND RESULTS: Patients (n = 200) with @Disease$ were randomized to receive AZD6140 50, 100, or 200 mg twice daily (bid) or 400 mg daily (qd) or @Chemical$ 75 mg qd for 28 days."	0
"DATA SOURCES: Articles evaluating aspirin for primary prevention of CVD were gathered using a MEDLINE search with the keywords aspirin review, @Chemical$ peripheral artery disease, aspirin stroke, aspirin coronary artery disease, aspirin @Disease$, aspirin primary prophylaxis, and aspirin elderly."	0
"METHODS: 106 consecutive adults with confirmed, physician-diagnosed difficult asthma and 100 patients with @Chemical$-induced asthma underwent @Disease$ interview and assessment using M.I.N.I 5.0, Beck Depression Inventory (BDI) and Panic And Agoraphobia Scale (PAS)."	0
Aspirin use and counseling about @Chemical$ among patients with @Disease$.	0
"According to our recent report, a PG I value &gt;= 50 ng/mL was defined as estimated hyperchlorhydria in H. pylori-negative subjects, while a @Chemical$ &gt;= 3.3 was defined as estimated @Disease$ in H. pylori-positive subjects."	0
"Safety of etoricoxib, a specific cyclooxygenase-2 inhibitor, in @Disease$tic patients with @Chemical$-exacerbated respiratory disease."	0
"Type 2 inflammation characterizes aspirin-exacerbated respiratory disease.Objectives: To determine whether high-dose aspirin therapy changes biomarkers of type 2 inflammation in aspirin-exacerbated respiratory disease.Methods: Forty-two subjects with aspirin-exacerbated @Disease$ underwent an @Chemical$ desensitization and were placed on high-dose aspirin (1,300 mg daily)."	0
@Chemical$ therapy and bleeding during proximal femoral @Disease$ surgery.	0
"@Chemical$-exacerbated @Disease$ (AERD) is a clinical syndrome characterized by severe persistent asthma, hyperplastic eosinophilic sinusitis with nasal polyps, and an intolerance to aspirin and other NSAIDs that preferentially inhibit COX-1."	1
"BACKGROUND: In patients with coronary or @Disease$, the combination of rivaroxaban 2.5 mg twice daily and aspirin 100 mg once daily compared with @Chemical$ 100 mg once daily reduced major adverse cardiovascular events and mortality and increased bleeding."	0
"Our aim was to investigate prophylaxis effects of @Chemical$, one of the representative histamine-2 receptor antagonists (H2RA), on gastric mucosal injury induced by dual therapy with low-dose aspirin and clopidogrel in relation to Helicobacter pylori (H. pylori) @Disease$ and CYP2C19 genotypes."	0
"The current report describes a Japanese boy who underwent @Chemical$ treatment for Kawasaki disease, and who subsequently presented with the manifestations of DIHS/@Disease$."	1
"We encountered lower @Disease$ in 16 patients taking a low dose of aspirin and examined the effect of low @Chemical$ dose on the stool occult blood test in 49 thrombotic patients (mean: 76.7 +/- 9.6 years old) including 39 with cerebral infarction, 8 with ischemic heart disease and 2 with atrial fibrillation."	0
"In addition, the interaction between H. pylori @Disease$ and low-dose @Chemical$ remains even more controversial."	0
"METHODS: Endoscopic oesophageal and gastro-duodenal lesions were graded in 287 patients with reflux @Disease$, median age 57 years, including 168 with oesophageal erosions, 131 infected with, 45 patients taking aspirin 75 mg daily, and 65 patients taking simple analgesics containing @Chemical$/codeine."	0
Only 5 (12.5%) centers had a local policy for @Chemical$ desensitization although 25 (64.1%) units had a clinical strategy for dealing with aspirin @Disease$; the majority (72%) giving higher doses of thienopyridine class drugs.	0
"In the periprocedural period, he continued @Chemical$ for secondary prophylaxis following a @Disease$."	0
"CONCLUSIONS: In patients who had @Disease$ complications related to the long-term use of low-dose aspirin, treatment with @Chemical$ in addition to the eradication of H. pylori infection significantly reduced the rate of recurrence of ulcer complications."	0
"OBJECTIVES: This study sought to explore the effects of the combination of @Chemical$ and aspirin compared with aspirin on sites, timing, severity, and management of @Disease$ in the COMPASS (Cardiovascular Outcomes for People Using Anticoagulation Strategies) study."	0
@Chemical$ use in children for @Disease$ or viral syndromes.	0
CASE REPORT: A 53-year-old female with a history of atrial fibrillation and @Disease$ on anticoagulants and @Chemical$ presented with abdominal pain of a few days duration which had worsened prior to presentation.	0
"We evaluated changes in leukotriene and prostaglandin metabolites for NIUA patients, using patients with NECD and single-NSAID-induced @Disease$/angioedema or anaphylaxis (S@Chemical$A) for comparison."	0
"DISCUSSION: Patients with aspirin-provoked FDEIA have been reported previously as taking ordinary doses of @Chemical$ for reducing @Disease$, inflammation and fever."	0
PURPOSE: To determine the effect of stopping low-dose @Chemical$ at least 7 days before surgery on the level of the perioperative @Disease$ or complications related to hemorrhage.	0
"Anaphylaxis, immediate and accelerated reactions, atopy, older age and chronic/recurrent urticaria were risk factors for @Disease$ and/or cross-reactivity between @Chemical$, ibuprofen and paracetamol."	0
The association between obesity and @Chemical$ @Disease$ in asthma is unclear.	1
This finding does not correlate simply with disease severity or with the occurrence of @Disease$ and could indicate another important facet of @Chemical$-induced airways disease.	0
"Older age, prior GI events, chronic renal failure, use of other injurious medicine such as NSAIDs, antithrombotic medicine, especially @Chemical$, and corticosteroids seem to be factors associated with an increased risk for upper GI ulcer and @Disease$ among the patients taking low dose aspirin."	0
This study compared the preventive effect of histamine-2 receptor antagonists (H2RAs) and proton-pump inhibitors (PPIs) against chronic low-dose @Chemical$ (LDA)-related GI bleeding and @Disease$ formation.	1
"For the prediction of myocardial infarction or stent thrombosis, @Disease$ and death, @Chemical$ score &gt;=2 had sensitivities of 57%, 41%, and 56%, respectively; specificities of 58%, 57%, and 58%, respectively; positive predictive values of 1.9%, 2.2%, and 2.1%, respectively; and negative predictive values of 99%, 98%, and 99%, respectively."	0
"The study demonstrated that combined therapy with fluoxetine and @Chemical$ is characterized by the same efficacy and clinical safety as fluoxetine monotherapy, resulting additionally in improvement of oxidative stress parameters in the patients treated for @Disease$."	0
Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and @Disease$ With Reduced Ejection Fraction Treated With @Chemical$ or Aspirin.	0
The estimated RR for @Disease$ with low-dose @Chemical$ was 1.4 (1.2-1.7) overall.	0
"Drugs that have been tried for prevention of @Disease$ in patients taking NSAIDs including H2-receptor antagonists, proton pump inhibitors (PPIs), aluminum- or @Chemical$-containing antacids, the prostaglandin misoprostol (Cytotec, and others), and antibiotics to eradicate H. pylori."	0
"METHODS: Fibroblasts were isolated from the NM of subjects without asthma who had septal deviation, turbinate @Disease$, or both (control subjects, n = 7); NPs of aspirin-tolerant nonasthmatic patients (n = 7); and NPs of patients with asthma who were intolerant of @Chemical$ (n = 7)."	0
Safety of high-dose rofecoxib in patients with @Chemical$-exacerbated @Disease$.	0
"TAPT and @Chemical$ had similar rates of @Disease$, but TAPT had significantly higher rates of headache, palpitation, rash and gastrointestinal side-effects."	0
"BACKGROUND: Although previous meta-analyses have suggested an association between @Chemical$ use and risk of @Disease$, current evidence is inconsistent."	1
The effects of inhaled aspirin on fractional exhaled NO (@Chemical$) in patients with aspirin-tolerant (ATA) and aspirin-inducible (@Disease$) asthma compared with normal controls have been investigated.	0
"S-baclofen or R-baclofen, @Chemical$-B agonists, which suppressed sound-evoked AC neural firing rate and local field potentials, also suppressed the SS-induced enhancement of the AC field potential and the acoustic @Disease$ reflex."	0
"The annual incidence rates of major GI @Disease$ were estimated at 0.25% for outpatients taking @Chemical$ and 0.5% for outpatients taking aspirin/warfarin, respectively."	0
"Risk factors for the development of @Disease$ in patients taking low-dose @Chemical$ are not well defined, although patients with a previous history of peptic ulcer, concomitant NSAID use and serious diseases should receive gastroprotection."	0
No @Disease$ and some erosions were mainly observed in the duodenum; erosions amounted to 5 at 3 days and 3 at 7 days in the @Chemical$ group.	0
"Variables included clinical coronary heart disease (CHD), number of CHD risk factors, @Disease$ diagnosis, number of chronic medications and presence of contraindications to @Chemical$."	0
"CONCLUSIONS: There is an increased risk of posttonsillectomy @Disease$ with the use of @Chemical$ after tonsillectomy; however, there appears to be no significant increased risk of bleeding for nonaspirin NSAIDs in this meta-analysis."	1
"There was a significantly increased risk for both @Disease$/TIA with @Chemical$ therapy, when compared to no therapy or warfarin therapy in general, and across all CHA2 DS2 VASc scores."	1
All the patients underwent a test for @Disease$ induced by @Chemical$ (2.5 and 5.0 microm) and epinephrine (0.2 microm).	1
"RESULTS: We found significantly lower total symptom score (TSS) during the 7th (p = .009), 14th (p = .003), 21st (p &lt; .001) and the 28th day (p = .001), lower total endoscopic score (TES) on the 21st (p = .002) and 28th day (p = .001), lower nasal obstruction, facial pain/pressure, headache and trouble sleeping, and lower @Disease$, nasal secretion and nasal crusting in patients treated by hypertonic sea @Chemical$."	0
"Four subjects (one @Disease$ alone, one asthma alone, two with both) had a positive response to lysine aspirin predefined as symptoms plus @Chemical$;10% fall in FEV1 from baseline."	0
Both patients also developed HIT-associated clinical sequelae (acute systemic reaction postintravenous @Chemical$ bolus; @Disease$) in association with their episode of HIT.	0
"INTRODUCTION: Upper gastrointestinal (GI) bleeding in patients who undergo hip and knee @Disease$ tends to be associated with non-@Chemical$al anti-inflammatory drug use, steroid intake, pre-existing peptic ulcers and smoking."	0
"OBJECTIVE: Low molecular weight (LMW) heparin, with or without aspirin (acetylsalicylic acid [@Chemical$]), is used to prevent complications in @Disease$ in pregnancy."	0
Esomeprazole for prevention and resolution of @Disease$ in patients treated with low-dose @Chemical$ for cardiovascular protection: the OBERON trial.	0
METHODS: One hundred and five consecutive new cases of @Disease$ presenting to a single gastroenterologist were questioned about their recent usage of NSAIDs and @Chemical$.	0
CONCLUSION: Our study demonstrates an increased risk of major @Disease$ in unselected patients receiving combination therapy with @Chemical$ and clopidogrel after UAP or NSTEMI.	1
"METHODS: The 267 patients who had survived a @Disease$ were randomly assigned in the Warfarin Aspirin Reinfarction Study to treatment with aspirin 160 mg/day, or warfarin (INR 2.8-4.2), or aspirin 75 mg/day plus @Chemical$ (INR 2.0-2.5)."	0
"Within 90 days after intervention, there were 4 patients (1.5%) with acute thrombosis, 5 patients (1.8%) with subacute thrombosis, 17 patients (6.2%) with stroke, and 2 death (0.7%) in low-dose aspirin group, compared with no patient (0%) with acute thrombosis, 2 patient (2.1%) with subacute @Disease$, 6 patients (6.2%) with stroke, and 2 death (2.1%) in high-dose @Chemical$ group, and there were no significant difference in all study endpoints between two groups."	0
"CONCLUSION: Our findings provide strong evidence that COX-2 and ITGA2 @Disease$ might increase the risk of having @Chemical$ insensitivity, especially for aspirin semi-resistance and in Chinese populations."	1
"We describe the case of a 64-year-old patient with glucose-6-phosphate dehydrogenase deficiency who was referred to our hospital because of an acute inferior myocardial infarction.Given the possible risk of @Disease$, aspirin was not given in the acute phase, and the patient was successfully treated by balloon angioplasty of the right coronary artery.After functional and genetic testing showing the presence of the Mediterranean mutation, known to be a class II variant, the patient received oral daily @Chemical$ (100 mg) under strict monitoring in order to promptly detect any sign of haemolysis."	0
"OBJECTIVE: To provide a diagnostic strategy for evaluating and treating patients with @Chemical$ sensitivity, with additional consideration for issues specific to patients with @Disease$ (CAD)."	0
"Cross sensitivity to doses of over the counter non-steroidal anti-inflammatory drugs was present in most patients with aspirin induced @Disease$: @Chemical$, 98%; naproxen, 100%; and diclofenac, 93%."	0
This article summarizes the current knowledge in the field of clinical presentation and diagnosis of @Chemical$-exacerbated @Disease$ (AERD).	0
"OBJECTIVES: To identify the reasons of using aspirin, endoscopic findings on @Disease$ caused by @Chemical$ and the relative risk of developing mucosal lesions."	1
"The aim of this study is to report the sinonasal outcomes of endoscopic sinus surgery (@Chemical$) in treating NP in @Disease$tic patients, comparing aspirin-induced asthmatic (AIA) patients with aspirin-tolerant asthmatics (ATA)."	0
"BACKGROUND: The Fernand-Widal triad (FWT) is the association of @Disease$, nasal polyposis and sensitivity to @Chemical$."	0
H pylori eradication is recommended for patients requiring long-term low-dose @Chemical$ therapy who have a prior history of peptic ulcer or @Disease$.	0
CONCLUSIONS: High-dose @Chemical$ in Heart Mate II patients treated concomitantly with warfarin is associated with an increased hazard of bleeding but does not reduce @Disease$ events.	1
"Compared to aspirin never users, women who regularly consumed aspirin had a lower risk of @Disease$ (RR = 0.80; 95% CI: 0.71-0.90), and there was evidence for lower risk with increasing frequency of use (RR = 0.71 for @Chemical$ use 6 or more times/week vs. never use; P trend = 0.00001)."	0
"This study aimed to analyze CMBs and white matter hyperintensities (WMHs) in patients taking @Chemical$ or clopidogrel.This retrospective study included patients with @Disease$ administered 75 mg/day aspirin (n = 150) or clopidogrel (n = 150, matched for age and gender) for &gt;1 year (Affiliated Hospital of Inner Mongolia Medical University, China, from July, 2010 to July, 2015)."	0
"We used sensitivity analyses to identify the incremental benefit of longer-duration @Chemical$ on either ST or the composite of @Disease$, myocardial infarction, and ischemic stroke (major adverse cardiovascular and cerebrovascular events [MACCEs]) required to outweigh the increased risk of bleeding associated with longer DAPT."	0
"Low-dose @Chemical$, one of non-steroidal anti-inflammatory drugs(NSAIDs), has been increasingly used to prevent cardiovascular and cerebrovascular disease through its antiplatelet effect, mainly in the aged population, but aspirin treatment has been associated with @Disease$, especially peptic ulcer bleedings."	0
[Digestive and @Disease$ complications of low-dose @Chemical$].	1
"We used sensitivity analyses to identify the incremental benefit of longer-duration DAPT on either ST or the composite of cardiac death, myocardial infarction, and @Disease$ stroke (major adverse cardiovascular and cerebrovascular events [MACCEs]) required to outweigh the increased risk of bleeding associated with longer @Chemical$."	0
"Misoprostol, a synthetic analogue of prostaglandin E1 (PGE1) compensates prostagrandins of which synthesis is inhibited by @Chemical$ and protect the @Disease$."	0
"Cox proportional hazards models were used to identify predictors of recurrence stratified by @Disease$ location, with aspirin and @Chemical$ exposures as time-dependent variables adjusting for potential confounders."	0
"QUESTION/PURPOSES: We sought to answer four questions: For the THA and TKA cohorts, respectively, (1) was the incidence of readmission resulting from VTE and bleeding complications higher with @Chemical$ than mobile compression plus ASA; and (2) was the incidence of wound @Disease$ complications higher with LMWH than mechanical compression plus ASA?"	0
"METHODS: This retrospective cohort study assessed overt GI bleeding, decreased hemoglobin levels suspecting @Disease$, and CV death in patients taking @Chemical$ for more than 1 year (LDA group) and in patients not taking LDA (control group)."	0
"The association between aspirin use and the presence of DR or VTDR was assessed using multivariable logistic regression models including age, gender, ethnicity, socioeconomic status, HbA1c, systolic blood pressure, anti-hypertension medicine, total @Chemical$, anti-cholesterol medicine, BMI, current smoking status, diabetes duration, history of @Disease$ (CVD) and chronic kidney disease (CKD.)."	0
Incidence of @Disease$ in patients with cardiovascular disease: buffered @Chemical$ versus enteric-coated aspirin.	0
The effects of inhaled aspirin on fractional exhaled NO (FENO) in patients with @Chemical$-tolerant (ATA) and aspirin-inducible (AIA) @Disease$ compared with normal controls have been investigated.	0
Gastric mucosal damage evaluated by transnasal endoscopy and QOL assessments in @Disease$ patients receiving low-dose @Chemical$.	0
"Our aim was to investigate prophylaxis effects of famotidine, one of the representative histamine-2 receptor antagonists (H2RA), on gastric mucosal injury induced by dual therapy with low-dose @Chemical$ and clopidogrel in relation to Helicobacter pylori (H. pylori) @Disease$ and CYP2C19 genotypes."	0
"We investigated whether aspirin with caffeine (ASA++) increases headache frequency compared with @Chemical$ alone in migraine, tension-type headache (TTH), and @Disease$ + TTH (MigTTH)."	0
"METHODS: Genotyping for the 2 polymorphisms was performed in patients hospitalized for upper GI bleeding associated with the use of low-dose aspirin between September 1998 and October 2000, and race-, age-, and sex-matched controls who were taking low-dose @Chemical$ but had no history of @Disease$."	0
A 33-year-old woman had a severe @Disease$ attack with hypoxia and lost consciousness after oral provocation testing with 15 mg of @Chemical$ and also with 50 mg of celecoxib.	0
"Of the patients on @Chemical$, 20 (56%) had @Disease$, compared with 83 (59%) of those not taking aspirin (difference 3%, 95% confidence interval, CI, -15 to 21)."	1
BACKGROUND: Clinical role of low-dose aspirin (@Chemical$) in pathogenesis of @Disease$ is by far controversial.	1
"This study was designed to investigate the degree of @Disease$, bleeding time (BT) and fluctuations in the serum levels of prostaglandin E2 (@Chemical$) and thromboxane A2 (TXA2) after oral administration of ASA (200 mg/kg) and IBU (50 mg/kg) either alone or in combination in rats in vivo."	0
"@Chemical$-exacerbated respiratory disease (AERD) is a clinical syndrome characterized by severe persistent asthma, hyperplastic eosinophilic sinusitis with @Disease$, and an intolerance to aspirin and other NSAIDs that preferentially inhibit COX-1."	0
These results support the opinion that @Chemical$ urticaria has the different pathogenic mechanism from aspirin @Disease$.	0
"Within 90 days after intervention, there were 4 patients (1.5%) with acute thrombosis, 5 patients (1.8%) with subacute thrombosis, 17 patients (6.2%) with stroke, and 2 @Disease$ (0.7%) in low-dose @Chemical$ group, compared with no patient (0%) with acute thrombosis, 2 patient (2.1%) with subacute thrombosis, 6 patients (6.2%) with stroke, and 2 death (2.1%) in high-dose aspirin group, and there were no significant difference in all study endpoints between two groups."	0
@Chemical$ and the older nonsteroidal anti-inflammatory drugs (NSAIDs) that block cyclo-oxygenase-1 (COX-1) induce @Disease$ in patients with aspirin-exacerbated respiratory disease and urticaria in patients with chronic idiopathic urticaria.	0
"Although @Disease$ reactions to @Chemical$, especially in asthmatic patients or those with nasal polyps, are well reported, our patients did not exhibit any underlying history of atopy."	1
Moreover some patients with imperative cardiologic indications for combination therapy with aspirin and @Chemical$ (stent placement and/or acute @Disease$) have a history of allergy to aspirin.	0
"CONCLUSIONS: Low-dose @Chemical$ use could reduce the incidences of total cardiovascular events, @Disease$, nonfatal stroke and transient ischemic attack but increase the risk of bleeding, the incidence of nonfatal myocardial infarction, death from cardiovascular causes and death from any cause was not affected by low-dose aspirin use."	0
"Univariate analysis showed that continuous aspirin use was not significantly associated with bleeding complications (odds ratio, 0.933; 95% confidence interval, 0.283-3.074; P = .910 in the @Chemical$ and control groups) and that discontinuous aspirin use was not significantly associated with @Disease$ complications (odds ratio, 0.963; 95% confidence interval, 0.230-4.025; P = .959 in the aspirin and control groups; odds ratio, 0.969; 95% confidence interval, 0.198-4.752; P = .969 in the aspirin and discontinuous groups)."	0
"Acetylsalicylic acid or nonsteroidal antinflammatory drug sensitivity can be manifested as acute urticaria, angioedema, acute @Disease$, @Chemical$ exacerbated respiratory disease and anaphylaxis."	0
"BACKGROUND: @Chemical$-exacerbated @Disease$ (AERD) is a clinical triad consisting of aspirin/acetylsalicylic acid (ASA) sensitivity, bronchial asthma, and nasal polyposis."	1
Safety of COX-2 inhibitors in @Disease$ patients with @Chemical$ hypersensitivity.	0
The medical history of non-steroidal anti-inflammatory drugs (NSAIDs) or @Chemical$ (ASA) usage and the presence of coronary artery disease (CAD) were investigated in all patients with or without @Disease$.	0
Chronic @Chemical$ toxicity due to @Disease$ in Turkish patients.	1
"The use of @Chemical$, aspirin plus extended-release dipyridamole, or clopidogrel is recommended as initial therapy in patients with noncardioembolic ischaemic @Disease$ or TIA to reduce the risk of recurrent stroke and other cardiovascular events."	0
Genetic markers for differentiating @Chemical$-@Disease$.	1
"Aspirin desensitization can usually be achieved for those in need of the antiplatelet effects of @Chemical$, with the exception of those with aspirin-induced urticaria and baseline chronic @Disease$."	0
"METHODS AND MATERIALS: We compared the effect of NO-ASA and ASA on gastric lesions provoked by @Chemical$-immersion and restraint stress (@Disease$), ischemia-reperfusion, and 100% ethanol."	0
Possible involvement of mast-cell activation in aspirin provocation of @Chemical$-induced @Disease$.	1
"A second polymorphism study, conducted on histamine-related genes, did not find any significant associations with @Chemical$-induced @Disease$/angioedema for the genes HNMT (encoding histamine N-methyltransferase), HRH1 or HRH2 (encoding histamine receptor types 1 and 2 respectively), or the gene encoding high-affinity IgE receptor Ibeta (FcepsilonRIbeta); however, the FcepsilonRIalpha gene promoter polymorphism was significantly associated with aspirin-induced urticaria/angioedema."	1
The effect of @Chemical$ on intestinal lesions was evaluated in birds undergoing an experimental challenge with Clostridium perfringens as part of a model for inducing subclinical @Disease$ (SNE).	0
The discoveries that cyclooxygenase COX-2 is an inducible form of COX involved in @Disease$ and COX-1 is the major isoform responsible for the production of @Chemical$ have provided a reasonable basis for the development of specific COX-2 inhibitors as a new class of anti-inflammatory agents.	0
"We investigated the risks of ischemic stroke and intracranial hemorrhage (ICH) in relation to @Chemical$ at various TTRs in a real-world cohort of Chinese patients with @Disease$ receiving warfarin and compared with those on dabigatran, aspirin, and no therapy."	0
"The studies included are the Studies of @Disease$ (SOLVD) (N=6,797), the Cooperative New Scandinavian @Chemical$ Survival Study II (CONSENSUS II) (N=6,090), the Captopril and Thrombolysis Study (CATS) (N=296), and another study involving 317 subjects."	0
@Disease$ to acetylsalicylic acid (@Chemical$) limits treatment options.	1
CONCLUSIONS: Aspirin desensitization protocols represent a safe and effective option for the management of patients with a cardiovascular indication to ASA and history of @Disease$ to @Chemical$.	1
"The important factors that increase the risk of low-dose @Chemical$-related ulcer complications include a history of bleeding peptic @Disease$, prior peptic ulcer, age &gt; 70 years, H pylori infection, and concomitant drug therapy with non-steroidal anti-inflammatory drugs, other antiplatelet agents (e.g., clopidogrel) or anticoagulants."	0
Non@Chemical$ NSAID use was not associated with incident cognitive impairment or mild cognitive impairment/@Disease$ odds.	0
"When compared with the cardiac surgical patients they treat, physicians required a smaller @Disease$ risk reduction with @Chemical$ whilst accepting its known increased risk of bleeding."	0
OBJECTIVES: Discontinuation of low-dose acetylsalicylic acid (@Chemical$) therapy may increase the risk of @Disease$ events.	1
"CONCLUSION: Coupling of NO to ASA attenuates stress, @Disease$-reperfusion, and ethanol-induced damage due to mucosal hyperemia mediated by NO, which compensates for @Chemical$ deficiency induced by ASA."	0
Prevalence of @Chemical$-exacerbated @Disease$ in patients with asthma in Turkey: a cross-sectional survey.	1
"Comments in response to Analysis of risk of @Disease$ after different doses of @Chemical$ in 192,036 patients enrolled in 31 randomized controlled trials."	1
"Aspirin-exacerbated respiratory disease (AERD) refers to the combination of asthma, chronic rhinosinusitis with @Disease$, and acute upper and lower respiratory tract reactions to the ingestion of aspirin (@Chemical$, ASA) and other cyclooxygenase-1 inhibiting non-steroidal anti-inflammatory drugs."	0
@Disease$ with low-dose @Chemical$ and prasugrel mimics malignancy: a case report.	1
"However, several less frequently reported reactions were more prevalent on social media (i.e., @Chemical$-induced @Disease$ was discussed only on social media)."	1
"Particularly, we asked for the clinical approach to patients with NSAID-/@Chemical$-associated @Disease$ and prophylactic measures before the beginning of a potentially ulcerogenic medication."	1
"INTRODUCTION: @Chemical$-exacerbated respiratory disease is defined by the clinical tetrad of aspirin sensitivity, nasal polyps, asthma, and @Disease$."	0
"Prevalence of asthma, @Chemical$ sensitivity and @Disease$ in chronic rhinosinusitis: data from the UK National Chronic Rhinosinusitis Epidemiology Study."	0
"History of bleeding or non-complicated peptic @Disease$, @Chemical$ intake, concomitant treatment with NSAID or calcic inhibitors are demonstrated risk factors of bleeding ulcer associated with low-dose aspirin."	0
BACKGROUND: Manganese toxicity may lead to a @Chemical$-resistant @Disease$.	0
OBJECTIVE: To evaluate the expression of cyclooxygenase (COX) and lipoxygenase (LO) enzymes in nasal polyp specimens from @Chemical$-sensitive (AS) and aspirin-tolerant (@Disease$) patients.	0
"@Chemical$ tended to be used in higher-risk patients: composite of cardiovascular death, myocardial infarction or @Disease$ at 5.8 versus 4.2% (p = 0.056)."	0
"WHAT THE READER WILL GAIN: @Chemical$-induced @Disease$ can be reduced, and a number of strategies can be implemented to shift the risk-benefit ratio in favour of aspirin."	1
"We investigated whether aspirin with @Chemical$ (ASA++) increases headache frequency compared with aspirin alone in migraine, tension-type headache (TTH), and @Disease$ + TTH (MigTTH)."	0
"Cross sensitivity to doses of over the counter non-steroidal anti-inflammatory drugs was present in most patients with aspirin induced @Disease$: ibuprofen, 98%; @Chemical$, 100%; and diclofenac, 93%."	0
Low @Chemical$ reaction units were not associated with significant @Disease$ in these cardiac surgery patients.	0
"All 60 patients experienced oculonasal and/or @Disease$tic reactions to @Chemical$, with a mean provoking dose of 69 mg."	0
"The main models included the following predictors: demographic characteristics (age, ethnicity, and socioeconomic deprivation), clinical measurements (systolic blood pressure and ratio of total-high-@Chemical$), family history of premature CVD, medical history (smoking, diabetes, bleeding, peptic ulcer disease, cancer, @Disease$, chronic pancreatitis, or alcohol-related conditions), and medication use (nonsteroidal anti-inflammatory agents, corticosteroids, and selective serotonin reuptake inhibitors)."	0
@Chemical$ is now widely accepted as the first-line anti@Disease$ platelet therapy for at-risk individuals.	0
"DATA SYNTHESIS: In CVD primary prevention studies, very-low-dose @Chemical$ use (&lt;=100 mg daily or every other day) increased major gastrointestinal (GI) @Disease$ risk by 58% (odds ratio [OR], 1.58 [95% CI, 1.29 to 1.95]) and hemorrhagic stroke risk by 27% (OR, 1.27 [CI, 0.96 to 1.68])."	1
"In the gastric fundus, neither HP infection nor LDA was a significant factor (@Chemical$ was an aggressive factor, and HP @Disease$ a protective factor)."	0
This paper reviews recent clinical evidence that suggests that @Chemical$ prophylaxis against cardiac and @Disease$ is associated with significant gastrointestinal complications.	0
BACKGROUND: @Chemical$-intolerant asthma (AIA) is a subtype of @Disease$ induced by non-steroidal anti-inflammatory drugs and characterized by an aggressive mucosal inflammation of the lower airway (asthma) and the upper airways (rhinitis and nasal polyp).	0
"(4) When the concentrations after aspirin challenge were analysed simultaneously, a significant linear correlation was observed between urinary LTBG concentration and urinary @Chemical$ concentration in patients with @Disease$ (Spearman's rank correlation test, r = 0.817, P = 0.0003)."	0
"Objectives: To investigate the association of aspirin use with risk of all-cause, any @Disease$, gastrointestinal (GI) cancer, and colorectal cancer (CRC) mortality among older adults and to perform an exploratory analysis of the association of @Chemical$ use with mortality stratified by BMI."	0
Four patients with the Fernand @Disease$ developed bronchospasm after taking the usually recommended daily dose of @Chemical$ while all the control patients tolerated it.	0
This treatment option should be made available to all patients with @Chemical$-exacerbated @Disease$.	0
The measurements were also performed after an @Chemical$ challenge in 26 of 65 patients with @Disease$ and in 24 of 50 control subjects.	0
"For @Chemical$, the multivariate-adjusted relative risk of @Disease$ was 1.13 (95% confidence interval (CI): 1.06, 1.19) for use 2-3 days/week, 1.21 (95% CI: 1.11, 1.32) for use 4-5 days/week, and 1.24 (95% CI: 1.14, 1.35) for use &gt;=6 days/week (P-trend &lt; 0.0001), compared with use less than once per week."	0
CONCLUSION: Ethanolic extract of Cl ointment (@Chemical$Cl) containing 10% curcumin displayed remarkable healing process against wound @Disease$ by aspirin.	0
METHODS: We retrospectively reviewed all chronic @Chemical$ users (&gt;3 months) who underwent CE for suspected small @Disease$ from May 2004 to May 2008 at two medical centers.	0
Aspirin-induced @Disease$ and the preventive effect of @Chemical$.	0
Tolerance of daily low-dose aspirin does not preclude @Chemical$-exacerbated @Disease$.	0
"Conversely, acetaminophen is well tolerated, has not been shown to contribute to gastrotoxicity when taken with @Chemical$, and has not been shown to interfere with the inhibition of @Disease$ produced by aspirin."	0
"The acute clinical symptoms that develop following the oral ingestion of @Chemical$, or any other inhibitor of cyclooxygenase-1, are well established in aspirin-exacerbated respiratory disease: nasal congestion, @Disease$, and bronchospasm."	0
@Chemical$ induces @Disease$ in an acid-dependent manner.	1
"BACKGROUND: Aspirin triad disease (@Disease$) is a well-known clinical entity characterized by asthma, polyposis, and @Chemical$ intolerance."	0
"There is reasonable evidence to support the benefit of the addition of ascorbic acid, an ingredient with antioxidant properties, to moderate the @Disease$ (GI) effects of @Chemical$."	0
BACKGROUND: To improve understanding of @Chemical$ @Disease$ this study focused on adenosine as a noncyclooxygenase target molecule of aspirin.	1
METHODS: A whole-blood desktop platelet function analyzer (@Chemical$-100) with an epinephrine agonist was used to assess AR among patients with @Disease$.	0
Recently we found it necessary to use packing for persistent brisk bleeding during 'vaginal hysterectomy' in a patient on @Chemical$ therapy for @Disease$.	0
PURPOSE OF REVIEW: Aspirin-induced @Disease$/angioedema is a major @Chemical$-related hypersensitivity often associated with aspirin-intolerant asthma.	0
CONCLUSION: Contrary to prior reports our results suggest that the risk of major @Disease$ with the use VKA is higher compared to those of patients treated with @Chemical$ alone.	0
Post-PCI fatal bleeding in @Chemical$ and clopidogrel hyper responder: shifting from antiplatelet resistance to @Disease$ risk assessment?	0
BACKGROUND: @Chemical$ @Disease$ may represent a major problem in patients with ischemic coronary disease who need a stenting procedure.	1
"Average @Disease$ in ASA group 24 hours postoperatively was 1600 ml, Non @Chemical$ group had average bleeding 900 ml, while Trasylol group had average drainage of 700 ml after 24 hours."	0
The aim of this study was to evaluate the prevalence of aspirin resistance (@Chemical$) in patients undergoing hemodialysis (@Disease$) and to assess the effect of HD on the results of the Multiplate test.	0
Analysis of the mechanism for the development of @Disease$ and the application for its treatment: aspirin modulation of IgE-dependent mast cell activation: role of @Chemical$-induced exacerbation of immediate allergy.	0
"DATA SOURCES: Articles evaluating aspirin for primary prevention of CVD were gathered using a MEDLINE search with the keywords aspirin review, aspirin peripheral artery disease, aspirin stroke, @Chemical$ coronary artery disease, aspirin @Disease$, aspirin primary prophylaxis, and aspirin elderly."	0
"We report a 50-year-old man who was on @Chemical$ therapy for coronary artery disease, and presented with GI bleed after leech treatment for his knee @Disease$."	0
"Three major clinical phenotypes of NSAID-induced acute skin reactions manifesting with @Disease$, urticaria, or both have been distinguished: NSAID-exacerbated cutaneous disease, nonsteroidal anti-inflammatory drug-induced urticaria/angioedema (@Chemical$), and single NSAID-induced urticaria and angioedema."	0
"We describe the most common clinical presentations of @Chemical$ hypersensitivity, i.e. aspirin-induced @Disease$, rhinosinusitis and aspirin-induced urticaria."	0
"Despite expectations for such, few data are available on the prevalence or incidence of @Disease$ in @Chemical$ users in Japan."	1
An analgesic-induced @Disease$ can also be observed after paracetamol and @Chemical$.	1
"RESULTS: Patients taking @Chemical$ had a significantly higher cumulative incidence of haematuria and rectal @Disease$, but not of haemospermia."	1
Platelet studies showed an aspirin-like defect resulting in a lack of @Chemical$-induced @Disease$.	1
There was no clear association between @Chemical$ and risk of @Disease$ or PsA.	0
"On the other hand, the mean volume of @Disease$ and packed red blood cell transfusion was higher in the 'continuing @Chemical$' group, but this finding did not translate into higher risk of reoperation for bleeding."	0
"@Chemical$ desensitization therapy is safe and successful in many patients, but more randomized trials are needed to confirm its benefits in @Disease$ patients."	0
Network pharmacology-based identification of protective mechanism of Panax Notoginseng Saponins on @Chemical$ induced @Disease$.	1
Incidence of @Disease$ and compliance on prolonged dual antiplatelet therapy (aspirin + @Chemical$) following drug-eluting stent implantation.	0
CONCLUSION: Clopidogrel and the combination of acetylsalicylic acid and @Chemical$ were associated with similar risks for recurrent ischemic @Disease$ and bleeding; whereas acetylsalicylic acid was associated with higher risks for both ischemic stroke and bleeding.	0
"The reduction in medium number of @Disease$s or erosions was significantly greater in the @Chemical$ group (from 6.5 [range, 1-85] to 2 [range, 0-25]) than in the placebo group (from 7 [range, 1-29] to 4 [range, 0-19] (P = .005)."	0
"CONCLUSIONS: Our findings do not support that there is no difference in the risk of @Disease$ complications between enteric-coated LDA and buffered LDA, but rather may imply that the risk of GI complications associated with enteric-coated @Chemical$ is higher than that with buffered LDA."	0
"Therefore, physicians should monitor @Chemical$ users for @Disease$ and signs of ulcer, particularly if they have additional risk factors."	0
"METHODS: This prospective, placebo-controlled trial was conducted in @Disease$ patients randomized (1:1) to receive either standard @Chemical$ (aspirin and clopidogrel) vs TAPT with cilostazol for a minimum of 12 months after PCI with Endeavor zotarolimus-eluting stent (E-ZES)."	0
"An increased excretion of LTE4 and @Chemical$,11beta-prostaglandin F2 has been detected in a patient who suffered an @Disease$ attack after percutaneous administration of nonsteroidal anti-inflammatory drugs."	0
"Therefore, high risk patients for peptic ulcers should be prevented with antisecretory drugs, such as PPI or histamine H2-receptor antagonists, because @Disease$ bleedings in patients with treatment of low-dose @Chemical$ can be serious."	0
"Patients with known stable @Disease$, who were taking @Chemical$ (75 to 100 mg qd) regularly for at least 1 month, were screened for the present study."	0
"OBJECTIVES: To evaluate if esomeprazole prevents recurrent peptic ulcer in adult patients with a history of peptic @Disease$ receiving low-dose acetylsalicylic acid (@Chemical$, aspirin) for cardiovascular protection in East Asia."	0
"Considering the benefit and complications of low-dose @Chemical$ therapy, it should not be indicated to persons with a low risk of @Disease$ and should be reserved for the treatment of high risk patients."	0
"PATIENTS AND METHODS: Patients with AIA (n = 13), patients with ASA-tolerant @Disease$ (@Chemical$) (n = 12) and healthy volunteers as controls (n = 13) were included to the study."	0
"Duration of @Chemical$ use was not associated with @Disease$ (for &gt;6 years of use compared with &lt;1 year, multivariable-adjusted relative risk = 1.01, 95% confidence interval: 0.97, 1.05; P for trend = 0.35)."	0
METHODS: The Apixaban versus @Chemical$ to Prevent Stroke in @Disease$ Patients Who Have Failed or Are Unsuitable for Vitamin k Antagonist Treatment (AVERROES) trial randomized 5599 patients with atrial fibrillation and risk factors to receive either apixaban or aspirin.	0
"Patients were included if they underwent closed @Disease$, were treated regularly with @Chemical$ prior to the injury, and had radiological evidence of an intraparenchymal hemorrhage or contusion (IPHC) or an acute subdural hematoma (ASDH]."	0
"Our study also highlights that the use of aspirin for primary prevention of cancer was found to cause higher rates of bleeding (any bleeding, major bleeding, and GI bleeding) compared to placebo or no @Chemical$ at the longest follow-up period with no significant benefit in @Disease$ primary prevention."	0
CONCLUSIONS: Aspirin-precipitated @Disease$tic attacks are not associated with changes in the systemic production of @Chemical$.	0
@Chemical$ could reduce @Disease$ and yet might increase risk of bleeding.	0
A retrospective study was carried out to evaluate whether the use of warfarin/low-dose aspirin (@Chemical$) is predictive of unfavorable outcomes in geriatric patients who sustain a fall-induced @Disease$.	0
Targeted eicosanoid lipidomics of exhaled breath condensate provide a distinct pattern in the @Chemical$-intolerant @Disease$ phenotype.	0
"PARTICIPANTS: All @Chemical$ treated patients surviving 30 days after a first @Disease$ from 1997 to 2006, with follow-up for one year."	0
Drug-drug interaction between NSAIDS and low-dose @Chemical$: a focus on cardiovascular and @Disease$.	0
"Secondary prevention refers to the use of @Chemical$ to prevent cardiovascular events in patients with established CVD such as an MI, stroke, or @Disease$."	0
"The systemic effects of @Disease$, gastric pain and hives are mediated by @Chemical$."	0
OBJECTIVES: Helicobacter pylori (H. pylori) infection and NSAID/low-dose aspirin (@Chemical$) use are associated with @Disease$.	1
"Considering the association of PTGER4 in mast cells, @Disease$- and @Chemical$-related disease, we hypothesized the genetic variability of PTGER4 may be associated with aspirin-intolerant chronic urticaria (AICU)."	0
RESULTS: None of the patients on @Chemical$ suffered significant @Disease$.	0
"BACKGROUND: Aspirin triad disease (ATD) is a well-known clinical entity characterized by asthma, @Disease$, and @Chemical$ intolerance."	0
"CONCLUSIONS: In this cohort of patients with aspirin intolerance undergoing coronary stent implantation, the combination of a thienopyridine with indobufen, trapidil, or @Chemical$ was associated with a low rate of @Disease$, ST and MI."	0
"However, desensitization to aspirin is a viable option for patients with aspirin-induced respiratory reactions, especially for those who require @Chemical$ for @Disease$ prophylaxis."	0
"We describe the most common clinical presentations of @Chemical$ @Disease$, i.e. aspirin-induced asthma, rhinosinusitis and aspirin-induced urticaria."	1
"CONCLUSIONS: These results highlight the importance of aspirin therapy compliance and give an estimate of the risk associated with the discontinuation of @Chemical$ therapy in patients at risk for IS, particularly those with @Disease$."	0
"In conclusion, PPIs were superior to H2RAs for prevention of @Chemical$-related GI erosion/ulcer and @Disease$."	0
A 47-year-old woman with @Chemical$-exacerbated @Disease$ visited our hospital complaining of persistent chest pain that manifested in the evenings and early mornings.	0
"Age, male gender, Helicobacter pylori (H. pylori)infection, diabetes, @Disease$ (CKD), cirrhosis, history of uncomplicated peptic ulcer disease (PUD), and use of NSAIDs, COX-2 inhibitors, @Chemical$, and thienopyridines were independent risk factors for UGIB among aspirin users."	0
Leukotriene antagonists block the proinflammatory actions of @Chemical$s (LT) and have been introduced as new treatments for @Disease$.	0
"CONCLUSION: In our retrospective study, only pre-treatment with @Chemical$ and clopidogrel was associated with thrombolysis-related @Disease$."	1
@Chemical$-induced @Disease$ (AIA) is associated with increased production of cysteinyl leukotrienes (CysLT).	1
@Chemical$ use and outcomes in a community-based cohort of 7352 patients discharged after first hospitalization for @Disease$.	0
"RESULTS: In patients treated with @Chemical$-LTRAs, there were significant reductions in numbers of patients with ASA-induced @Disease$ and a concomitant increase in upper respiratory reactors."	0
"After cessation of @Chemical$ administration followed by conservative management, the @Disease$ completely disappeared 6 months later."	0
"RESULTS: 9225 patients were enrolled (median 1.8years) post-MI: 52% with prior ST-elevation MI, median age 67years, 24% women, 67% Caucasian, 55% had &gt;=2 additional qualifying risk factors, 14% current smokers, 67% overweight/@Disease$, 34% with blood pressure &gt;=140/90mmHg. 81% underwent percutaneous coronary intervention (PCI; 66% with drug-eluting stents) for the index MI. 75% of patients had been discharged on dual antiplatelet therapy (DAPT; @Chemical$ [ASA]+ADP receptor inhibitor [ADPri]), mainly clopidogrel (75%). 63% had discontinued antiplatelet treatment (60% ADPri) around 1year, most commonly by physician recommendation (90%)."	0
"PATIENTS: All Swedish residents &gt;= 40 years of age, without @Disease$ and receiving @Chemical$ treatment (&gt;= 80% adherence for 365 days between 2005 and 2009) were identified in the Swedish Prescription Register."	0
The mechanisms of these reactions and the characteristic course of @Chemical$-induced @Disease$ and its management are discussed.	1
"BACKGROUND: Aspirin can cause bronchoconstriction in some @Disease$tic patients through increased production of proinflammatory mediators, particularly @Chemical$."	0
Safety of meloxicam in @Chemical$-hypersensitive patients with @Disease$ and/or nasal polyps.	0
BACKGROUND: @Chemical$ has been shown to lower the incidence and the mortality of vascular disease and @Disease$ but its wider adoption appears to be seriously impeded by concerns about gastrointestinal (GI) bleeding.	0
"METHODS: We searched PubMed, EMBase, @Disease$ and Cochrane Central Register of Controlled Trials (up to June, 2013) for randomized controlled trials evaluating the efficacy and safety of clopidogrel plus aspirin versus @Chemical$ alone in high vascular risk patients."	0
"The sinus CT results showed that compared with the @Chemical$ asthma group, the @Disease$tic group had irregular turbinates and a large turbinate,as shown in Figure 1."	0
"BACKGROUND/AIMS: Many patients with @Chemical$-induced asthma have severe methacholine @Disease$ (AHR), suggesting a relationship between aspirin and methacholine in airway response."	0
"There were significantly more patients who suffered GI adverse events, principally abdominal pain, dyspepsia, @Disease$ and diarrhoea, with aspirin (18.5%) than with @Chemical$ (11.5%), but the difference between ibuprofen and paracetamol (13.1%) was not significant."	0
"Although acetylsalicylic acid is prescribed for a broad range of diseases, it can induce a wide array of clinically recognized hypersensitivity reactions, including aspirin-intolerant asthma (@Disease$) with rhinitis and @Chemical$-intolerant urticaria (AIU) with anaphylaxis."	0
METHODS: Immunohistochemical studies were performed using a peroxidase method and monoclonal antibodies on 6-microm-thick cryostat sections cut from frozen @Disease$ collected during elective surgery from 21 aspirin-sensitive and 23 @Chemical$-tolerant patients.	0
"In the non@Disease$tic patient group the mean @Chemical$(2) production was 32 +/- 33 ng/mL (35-fold of the basic production), in the ATA group it was 16 +/- 18 ng/mL (16-fold), and in the AIA group it was only 5.3 +/- 3.6 ng/mL (4-fold)."	0
"Platelet reactivity time (PRT) and whole blood aggregation (WBA) were measured in 160 healthy volunteers, before and after aspirin and in 170 participants with established @Disease$ or risk factors thereof treated with @Chemical$ +- clopidogrel."	0
"BACKGROUND AND AIM: Low-dose aspirin is effective for the prevention of cardiovascular and cerebrovascular events, but the frequency of @Disease$ among users of low-dose @Chemical$ in Japan is currently unknown."	0
BACKGROUND: @Chemical$ (ASA)-exacerbated respiratory disease (AERD) is characterized by aggressive @Disease$ of the respiratory tract and often requires topical and/or systemic corticosteroids to maintain partial control of this disease.	0
"Large-scaled, randomized clinical trials are required to confirm the clinical benefits of gastric mucoprotective drugs to low-dose @Chemical$ induced @Disease$."	1
OBJECTIVE: To determine the incidence of major gastrointestinal and intracranial bleeding episodes in individuals with and without @Disease$ taking @Chemical$.	0
"Risk factors for @Disease$ were CAD (OR:24.75, 95% CI=1.6-96.7, p=0.001), @Chemical$ usage (OR:9.76, 95% CI=2.1-37.5, p=0.021), NSAID usage (OR: 4.72, 95%CI=1.1-16.5, p=0.032), age (OR: 11.59, 95% CI= 2.7-12.1, p=0.001), and male gender (OR: 2.56, 95% CI= 0.8, 9.6, p=0.052)."	0
"Although the disease is clinically well characterized, its physiopathology is incompletely understood and noninvasive procedures, allowing an effective distinction between aspirin-induced asthma (AIA) and @Chemical$-tolerant @Disease$ (ATA) are missing."	0
Presented in the article are the results of studying antiaggregate activity of @Chemical$ and clopidogrel in a total of 36 patients suffering from various-severity chronic arterial insufficiency of lower limbs on the background of @Disease$ obliterans.	0
AIM: The use of low-dose @Chemical$ to prevent @Disease$ events is well established.	0
"Both naproxen/aspirin and celecoxib/aspirin groups demonstrated a higher incidence of @Disease$ and duodenal ulcers vs. placebo/@Chemical$ (8%; RR: 3.7, 95% CI: 1.8-7.6 and RR: 2.6, 95% CI: 1.2-5.8, respectively)."	0
"Paracetamol pack size restriction: the impact on @Chemical$ @Disease$ and the over-the-counter supply of paracetamol, aspirin and ibuprofen."	1
"In clinical trials, PPI and famotidine (40 mg/d) are proven to have the preventive effect to @Disease$ induced by low-dose @Chemical$ use."	1
Clinical study of @Disease$ associated with low-dose @Chemical$ in Japanese patients.	1
CONCLUSION: The severity of the historical aspirin/NSAID-induced @Disease$ attack was not predictive of asthma severity during @Chemical$.	0
Determining the relative impact of COX-2 selective inhibitors and nonselective NSAIDs on @Disease$ in low-dose @Chemical$ users will require further study.	0
"Gastrointestinal bleeding in patients receiving a combination of @Chemical$, clopidogrel, and enoxaparin in acute @Disease$."	0
"Key search terms included aspirin, @Disease$, @Chemical$, and treatment."	0
"On the other hand, SA alone inhibited basal @Disease$ without any effect on mucosal @Chemical$ contents, and this agent, when given together with indomethacin, prevented gastric hypermotility and lesion formation in response to indomethacin, without affecting the reduced PGE2 contents."	0
Adjusted HRs for @Chemical$ versus the combination of acetylsalicylic acid and dipyridamole were 1.48 (95% CI: 1.31-1.67) for stroke and 1.47 (95% CI: 1.18-1.82) for @Disease$.	0
Low-dose @Chemical$ prophylaxis and risk of intracranial hemorrhage in patients older than 60 years of age with mild or moderate @Disease$: a prospective study.	0
"@Chemical$ use in children younger than 19 years should be limited to diseases in which aspirin has a proven benefit, such as @Disease$ and the juvenile arthritides."	0
"Of the 46 patients previously hospitalized for aspirin/NSAID-induced @Disease$ attacks, 9 (20%) had a 20% to 29% decrease and 6 (13%) had a 30% or greater decrease in FEV(1) during @Chemical$."	0
These results support the opinion that aspirin urticaria has the different pathogenic mechanism from @Chemical$ @Disease$.	1
"OBJECTIVE: The aim of this systematic review was to provide the odds ratios (ORs) of major @Disease$, intracranial bleeding or major extra-cranial bleeding of anticoagulation with VKA compared to low doses of @Chemical$."	0
Bleeding during treatment with aspirin versus apixaban in patients with atrial fibrillation unsuitable for @Chemical$: the apixaban versus acetylsalicylic acid to prevent stroke in @Disease$ patients who have failed or are unsuitable for vitamin K antagonist treatment (AVERROES) trial.	0
Neither of the two patients with uninterrupted DO@Chemical$ had a @Disease$.	1
"In subgroup analysis, @Chemical$ use was associated with renal failure in the patients with no history of stroke (HR, 1.41; 95% CI, 1.14-1.73), and there was a borderline interaction between previous stroke and the use of aspirin on @Disease$ (interaction p=0.0565)."	0
CONCLUSIONS: High IFN-gamma levels distinguish AERD from aspirin-tolerant @Disease$ and underlie the robust constitutive and aspirin-induced secretion of @Chemical$ that characterize this disorder.	0
From the 60 patients taking NSAIDS/@Chemical$ with no histologic evidence of Hp all (100 %) were identified by the histology of the @Disease$.	0
This review concerns clinical and laboratory resistance to antiplatelet drugs (aspirin and @Chemical$) in patients with @Disease$.	0
"RESULTS: In aspirin-induced @Disease$ patients (AIA, n=10), the basal concentration of urinary LTE4, but not the other metabolites, was significantly higher than that in aspirin-tolerant asthma patients (@Chemical$, n=10)."	0
Decreased apoptosis and distinct profile of infiltrating cells in the nasal @Disease$ of patients with @Chemical$ hypersensitivity.	0
"BACKGROUND: The aim of this study was to detect cysteinyl leukotriene (Cys-LT) receptors in @Chemical$-sensitive nasal polyposis patients, and compare them with nasal polyposis and chronic @Disease$ patients without aspirin sensitivity."	0
Association analysis of ILVBL gene polymorphisms with @Chemical$-exacerbated @Disease$ in asthma.	0
"The gastrointestinal risks of aspirin are well known, but the frequency of @Disease$ in @Chemical$ users in Thailand is currently unknown."	1
METHODS: This study included 77 patients who had experienced @Disease$ induced by @Chemical$ and at least 1 other nonsteroidal anti-inflammatory drug.	1
"METHODS: A case series of three patients suffering severe @Disease$, vomiting, diarrhea, renal dysfunction and clinical decline during @Chemical$ therapy was examined."	0
"The factors associated with an increased risk of upper gastrointestinal (GI) complications in subjects taking LDA are @Chemical$ dose, history of @Disease$ or upper GI bleeding, age &gt; 70 years, concomitant use of non-aspirin NSAIDs including COX-2-selective NSAIDs, and Helicobacter pylori (H. pylori) infection."	0
@Chemical$ resistance could be defined as @Disease$ and embolic cardiovascular events despite regular aspirin therapy.	0
"RESULTS: The Aspirin-Cardio treatment reduced the mean score of GI symptom severity from the questionnaire (1.4-1.6 times, r=0.001), requirement for proton pump inhibitors (r=0.002) and endoscopy during the @Chemical$ treatment the mean score of GI symptom questionnaire &gt;3 predicted non-compliance or @Disease$ compliance with a diagnostic sensitivity of 58.9 % and specificity of 56.3 % (r=0.002), which makes this value a threshold for considering a modification of the treatment."	0
"@Chemical$ (ASA)-exacerbated respiratory disease (AERD) is characterized by upper airway congestion due to eosinophilic inflammation of the nasal and sinus membranes and @Disease$, associated with increased leukotriene production that is further accentuated by ASA or other nonsteroidal anti-inflammatory drug (NSAID) ingestion."	0
"CONCLUSION: There is a theoretical possibility that the negative interaction between ACE inhibitors and @Chemical$ may reduce the beneficial effects of ACE inhibitors in patients with @Disease$, but the information obtained from the existing databases is limited by the retrospective nature of the analyses and does not establish the association definitively."	0
"@Disease$ in patients receiving a combination of aspirin, @Chemical$, and enoxaparin in acute coronary syndrome."	0
The use of @Chemical$ in patients with @Disease$ associated with aspirin sensitivity.	0
BACKGROUND: Aspirin desensitization is an effective treatment option for @Chemical$-exacerbated @Disease$.	0
"CONCLUSION: In addition to age, male gender, H. pylori infection, and concomitant use of NSAIDs, COX-2 inhibitors, steroids, and thienopyridines, underlying co-morbidities including @Disease$, CKD, cirrhosis, history of PUD are also important risk factors for first-time occurrence of non-variceal UGIB in @Chemical$ users."	0
"In the Evaluation of Vascular Care in @Disease$ (EVA) trial (conducted in our center), 4.6% of patients in the group receiving a multicomponent treatment that included @Chemical$ had an ICH (3/65; 95% confidence interval [CI], 1.0 to 12.9) versus 0% in the control group (0/58; 95% CI, 0 to 6.2)."	0
BACKGROUND: Warfarin and @Chemical$ (acetylsalicylic acid [ASA]) are the most commonly used anticoagulant and antiplatelet drugs in the treatment of @Disease$.	0
"However, current evidence suggests that the gastrointestinal and other @Disease$ risks of @Chemical$ probably outweigh its potential benefits in primary prevention."	0
@Chemical$-rich foods and the risk of @Disease$ in men.	0
"@Chemical$ (acetyl salicylic acid) is used worldwide to treat various inflammatory conditions and prevent @Disease$, along with reducing the risk of cancer."	0
"Among individuals with BMI 25 to 29.9, @Chemical$ use 3 or more times per week was associated with reduced risk of all-cause mortality (HR, 0.82; 95% CI, 0.79-0.85; P &lt; .001), any @Disease$ mortality (HR, 0.86; 95% CI, 0.81-0.91; P &lt; .001), GI cancer mortality (HR, 0.72; 95% CI, 0.60-0.86; P &lt; .001), and CRC mortality (HR, 0.66; 95% CI, 0.51-0.85; P = .001)."	0
"In the @Chemical$ group, no bleeding events were noted after 350 biopsies [upper confidence limit (UCL) for probability of @Disease$=0.0085]."	0
"BACKGROUND: @Chemical$-exacerbated respiratory disease (AERD) is a clinical syndrome characterized by chronic rhinitis, @Disease$, asthma, and precipitation of asthma and rhinitis attacks after ingestion of aspirin (ASA) and most nonsteroidal anti-inflammatory drugs (NSAIDs)."	0
CONCLUSION: This study suggests that impaired response to both intravenous and oral @Chemical$ is frequent in @Disease$ patients resuscitated from OHCA.	0
"Overproduction of cysteinyl-leukotrienes (@Chemical$) has been implicated as major mediators of @Disease$; however, the LT receptor antagonist montelukast is only partially effective in inhibiting aspirin responses."	0
"@Chemical$ desensitization treatment, the mainstay of controlling asthma and @Disease$ in AERD patients, however, is the least understood aspect of the disease."	0
"Sudden onset of poor activity, poor appetite, lethargy, tachycardia, tachypnea, @Disease$, increased AST/ALT, coagulopathy and hyperammonemia developed 3 days after the high-dose @Chemical$ therapy."	1
Prostaglandin D2: a dominant mediator of @Chemical$-exacerbated @Disease$.	1
OBJECTIVE: To review the literature addressing the problem of @Chemical$ resistance in patients with @Disease$.	0
"It has been proposed that overproduction of cys-LTs, together with removal by aspirin/NSAIDs of the 'brake' imposed by the bronchodilator @Chemical$, may cause an @Disease$ attack in patients with AIA."	1
"BACKGROUND: Recent data from Western countries indicate that the aetiology of @Disease$ (PUD) is changing as the prevalence of Helicobacter pylori is decreasing while the use of low-dose aspirin (@Chemical$, &lt;=325 mg/day) is increasing."	0
METHODS: The 24-week clinical outcomes of the patients using low-dose aspirin for cardiovascular protection with a history of @Disease$/erosions and cotherapy of @Chemical$ or famotidine were retrospectively reviewed.	0
"METHODS AND RESULTS: Japanese patients (n=1,363) with @Disease$ undergoing percutaneous coronary intervention were randomized to either prasugrel (20/3.75 mg) or @Chemical$ (300/75 mg), both in combination with aspirin (81-330 mg for the first dose and 81-100 mg/day thereafter), for 24-48 weeks."	0
"CONCLUSIONS: In this trial, there is no evidence of an early antithrombotic effect from the addition of @Chemical$ to intravenous thrombolysis in acute @Disease$."	0
CONCLUSIONS: @Chemical$ intolerance in @Disease$tics explains the lesser association with obesity.	0
CONCLUSIONS: The addition of @Chemical$ to LDA increases @Disease$.	1
"Among the healthy subjects, the short-term administration of low-dose @Chemical$ was associated with a mild @Disease$."	1
"CONCLUSION: A high MABP at admission was found to be an independent predictor of poor prognosis for ICH patients treated with aspirin or with no drugs, but not for @Disease$ patients treated with @Chemical$."	0
In the present study was investigated the effects of @Chemical$ on upper gastrointestinal @Disease$ and potent risk factor for peptic ulcer associated with aspirin in a case-control study.	0
Aspirin and @Chemical$ were significantly associated with total @Disease$ (OR = 3.81 and 4.85 with p = 0.005 and 0.001 respectively).	0
Association between @Chemical$ therapy and the outcome in @Disease$ patients: a nested cohort study.	0
There is no evidence of general subclinical sensitivity to @Chemical$ in subjects with nasal @Disease$ and no relevant history.	0
"Persistent @Disease$ precedes development of nasal polyposis, @Chemical$ hypersensitivity, and asthma."	0
"METHODS: Systematic searches of Medline and Embase were conducted to identify observational studies published between 1946 and 4 March 2015 that reported the risks of gastrointestinal (GI) bleeding or @Disease$ (ICH) with long-term, low-dose @Chemical$ (75-325 mg/day)."	0
"BACKGROUND AND AIM: The risk for erosive @Disease$ (EE) with low-dose aspirin (@Chemical$) remains unknown, especially among Japanese patients."	0
"INTRODUCTION: Clinical features of aspirin-exacerbated @Disease$ (AERD) consist of moderate to severe asthma associated with chronic rhinosinusitis (CRS), which are derived from overproduction of @Chemical$ along with chronic type 2 mediated inflammation in the upper and lower airway mucosa."	0
"The factors associated with an increased risk of upper gastrointestinal (GI) complications in subjects taking LDA are @Chemical$ dose, history of ulcer or upper GI @Disease$, age &gt; 70 years, concomitant use of non-aspirin NSAIDs including COX-2-selective NSAIDs, and Helicobacter pylori (H. pylori) infection."	0
HYPOTHESIS: The combination of zinc-L-carnosine and vitamin E attenuates @Chemical$-induced @Disease$.	1
"Furthermore, we need to search for effective measures to detect and prevent mid and lower @Disease$ caused by @Chemical$/NSAIDs which account for about 30% of all GI bleedings."	1
"However, concomitant use of thienopyridine such as clopidogrel with @Chemical$ increased the proportion of @Disease$."	1
"@Chemical$, a synthetic analogue of prostaglandin E1 (PGE1) compensates prostagrandins of which synthesis is inhibited by aspirin and protect the @Disease$."	0
@Chemical$ is a widely used medication and has become a cornerstone for treating @Disease$.	0
Fatty acid binding protein 1 is related with development of @Chemical$-exacerbated @Disease$.	0
"Cyclooxygenase-2 (COX-2) inhibitors (e.g. @Chemical$ 400 mg/day) were associated with a significant decrease in the recurrence of both adenomas (RR, 0.66 [95% CI, 0.59-0.72]) and advanced adenomas (RR, 0.45 [95% CI, 0.33-0.57]); however, this association did not persist and there was a trend of an increased risk of recurrent @Disease$s observed 2 years after the withdrawal."	0
"OBJECTIVE: This analysis compared the efficacy of misoprostol, lansoprazole, and placebo in reducing the risk of @Disease$ or duodenal ulcer recurrence in patients taking NSAIDs and low-dose @Chemical$."	0
We aimed to identify proteins that were differentially expressed in nasal polyps between patients with @Disease$ and @Chemical$-tolerant asthma (ATA).	0
AERD was defined as @Disease$tics showing 15% or greater decreases in forced expiratory volume in one second (FEV(1)) or naso-ocular reactions by the oral acetyl salicylic acid (@Chemical$) challenge (OAC) test.	0
12-HPETE further activates the 5-lip@Chemical$ase of leukotriene B4-producing inflammatory macrophages precipitating an acute @Disease$tic attack.	0
"RECENT FINDINGS: The literature indicates that patients with coronary artery disease (@Disease$), including those with an acute coronary syndrome, may safely undergo low-dose @Chemical$ challenge and/or desensitization."	0
"Various strategies have been proposed to reduce the gastrointestinal risk of aspirin, including gastroprotection with a proton pump inhibitor (PPI), eradication of @Disease$ and replacing @Chemical$ with other anti-platelet agents."	0
"@Chemical$ exacerbated respiratory disease (@Disease$) is characterized as adult onset asthma, nasal polyps, chronic rhinosinusitis, and hypersensitivity to a cyclooxygenase-1 (COX-1) inhibitor, viz aspirin or nonsteroidal antiinflammatory drugs (NSAIDs)."	0
"In @Chemical$ users who suffered from @Disease$, the frequency of the TT genotype of rs2238631 and TT genotype of rs2243100 was higher than in those without upper gastrointestinal bleeding."	0
"The important factors that increase the risk of low-dose @Chemical$-related @Disease$ complications include a history of bleeding peptic ulcer, prior peptic ulcer, age &gt; 70 years, H pylori infection, and concomitant drug therapy with non-steroidal anti-inflammatory drugs, other antiplatelet agents (e.g., clopidogrel) or anticoagulants."	1
BACKGROUND AND AIM: The concomitant use of non-steroidal anti-inflammatory drugs is a risk factor for low-dose aspirin (@Chemical$)-associated @Disease$.	1
"The aim of this study is to report the sinonasal outcomes of endoscopic sinus surgery (ESS) in treating NP in asthmatic patients, comparing aspirin-induced asthmatic (AIA) patients with @Chemical$-tolerant @Disease$tics (ATA)."	0
To report a case of @Disease$-induced recurrent hyphema and secondary glaucoma associated with voluntary chronic @Chemical$ (ASA) use.	0
"DATA SYNTHESIS: @Chemical$ sensitivity is most often manifested as respiratory reactions (eg, bronchospasm, profuse @Disease$, conjunctival injection) or urticaria/angioedema."	1
"CONCLUSIONS: We present a patient with classic @Chemical$-exacerbated @Disease$, who despite undergoing a standard aspirin desensitization protocol was unable to maintain his desensitized state."	0
"Estimates of absolute rates of harm from @Chemical$ use, per 100,000 patient-years of follow-up, were 99-178 for non-trivial bleeds, 46-49 for major bleeds, 68-117 for GI bleeds and 8-10 for @Disease$."	0
Post-PCI fatal bleeding in aspirin and @Chemical$ @Disease$ responder: shifting from antiplatelet resistance to bleeding risk assessment?	1
"In the Evaluation of Vascular Care in Alzheimer's Disease (@Disease$) trial (conducted in our center), 4.6% of patients in the group receiving a multicomponent treatment that included @Chemical$ had an ICH (3/65; 95% confidence interval [CI], 1.0 to 12.9) versus 0% in the control group (0/58; 95% CI, 0 to 6.2)."	0
Erosive @Disease$ was noted more frequently in the @Chemical$ group than in the control group.	0
"OBJECTIVE: Despite evidence that preoperative aspirin improves outcomes in cardiac surgery, recommendations for aspirin use are inconsistent due to @Chemical$'s anti-platelet effect and concern for @Disease$."	0
"By ROC analysis the VerifyNow  @Chemical$ assay was able to distinguish between patients with and without minor @Disease$ (area under the curve [AUC] 0.66, 95 % confidence interval [CI] 0.62-0.70, P &lt; 0.0001) whereas major bleeding could not be predicted by the assay (AUC 0.54, 95 % CI 0.49-0.58, P = 0.473)."	0
"Sodium cromoglycate (@Chemical$) is used for the treatment of atopic dermatitis with food allergy, but the efficacy of SCG in ASP-exacerbated @Disease$ reactions is unclear."	0
"The Fernand Widal syndrome is a set of associations between @Disease$, nasal polyposis and @Chemical$ sensitivity."	0
"RESULTS: The final analysis included 1470 study participants: 221 controls, 553 CRS without @Disease$ (CRSsNPs), 651 CRS with nasal polyps (@Chemical$wNPs) and 45 allergic fungal rhinosinusitis (AFRS)."	0
The possible additive antiplatelet effects of aspirin and @Chemical$ have been explored in the Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) and Management of @Disease$ with Clopidogrel in High Risk Patients (MATCH) studies.	0
"Forty two percent of patients were regular @Chemical$ users, and were comparable to the non aspirin group, apart from having a significantly greater prevalence of @Disease$."	0
Attempts to address @Chemical$-induced @Disease$ through reduced dose initiation have produced variable results.	1
"HPR was defined as on-@Chemical$ P2Y12 platelet reaction units &gt;208 as measured by the VerifyNow assay; target vessel failure (TVF) was defined as the composite of all-cause death, @Disease$, or ischemia-driven target vessel revascularization."	0
"DATA SOURCES: Literature retrieval was accessed through MEDLINE (1966-March 2007) using the terms acetaminophen, aspirin, antiinflammatory agents nonsteroidal, urticaria, angioedema, @Disease$, @Chemical$ antagonists, desensitization, and tacrolimus."	0
Patients with diabetes had a high rate of @Disease$ that was not independently associated with @Chemical$ use.	0
"Of these 52 cases, there were 22 nasal polyposis cases with aspirin sensitivity, 15 @Disease$ cases without @Chemical$ sensitivity and 15 chronic rhinosinusitis cases without aspirin sensitivity."	0
Effect of inhalation aspirin challenge on exhaled nitric oxide in patients with @Chemical$-inducible @Disease$.	0
"Previous studies have examined the effect of @Chemical$ intake on the mortality in @Disease$, but the results are inconsistent."	0
"CONCLUSION: In a large genetic epidemiology study of @Chemical$-intolerant asthma in a Korean population, genetic polymorphisms of NAT2 were found to be related to a risk of aspirin @Disease$ among asthmatics."	0
"HPR was defined as on-clopidogrel P2Y12 platelet reaction units &gt;208 as measured by the VerifyNow assay; target @Disease$ (@Chemical$) was defined as the composite of all-cause death, myocardial infarction, or ischemia-driven target vessel revascularization."	0
"METHODS: To assess response to medical therapy in patients taking @Chemical$ prior to admission with an acute coronary syndrome, we reviewed outcomes data from the Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-wave Coronary Events (ESSENCE) and Platelet Receptor Inhibition in @Disease$ Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) studies."	0
"There is evidence that @Chemical$ and non-aspirin non-steroidal anti-inflammatory drug (NSAID) have anti-@Disease$ properties, but their effect on lung cancer, in particular in never-smokers, is unclear."	0
"In incomplete responders on admission, platelet aggregation with adenosine diphosphate (@Chemical$) was significantly higher compared with responders (p&lt;0.05) but there were no significant differences in collagen aggregation, platelet fibrinogen binding or P-selectin expression, plasma @Disease$ factor, fibrinogen, high-sensitivity C-reactive protein, or the urinary metabolite, 11-dehydro-TxB2."	0
"@Chemical$-induced gastropathy occurred preferentially in the antrum among H. pylori-positive @Disease$, while it affected the fundus among H. pylori-positive hyposecretors."	0
State of the Art: Medical treatment of @Chemical$ exacerbated @Disease$ (AERD).	0
"DATA SYNTHESIS: @Chemical$ sensitivity is most often manifested as @Disease$ (eg, bronchospasm, profuse rhinorrhea, conjunctival injection) or urticaria/angioedema."	1
@Chemical$ desensitization in aspirin-exacerbated @Disease$: New insights into the molecular mechanisms.	0
"@Chemical$ or nonsteroidal antinflammatory drug sensitivity can be manifested as acute urticaria, @Disease$, acute asthma, acetylsalicylic acid exacerbated respiratory disease and anaphylaxis."	1
AIM: The aim of this study was to evaluate the effects of chronic use of @Chemical$ (ASA) and vitamin K antagonists (VKA) on the incidence of age related macular degeneration (@Disease$).	0
"RESULTS: Of 8754 Chinese patients with atrial fibrillation and CHA2DS2-VASc &gt;=1 (79.5+-9.2 years; CHA2DS2-VASc, 4.1+-1.5; and Hypertension, @Disease$, Stroke, Bleeding History or Predisposition, Labile International Normalized Ratio, Elderly (&gt;65 years), Drugs/Alcohol Concomitantly [HAS-BLED], 2.2+-0.9), 16.3% received @Chemical$, 41.1% aspirin, 4.5% dabigatran, and 38.1% received no therapy."	0
"(3) The risk of @Disease$ was reduced in low-dose @Chemical$ group in the elderly (RR = 0.81, 95% CI: 0.70-0.94, P &lt; 0.05)."	0
"@Chemical$ also appears to be a key mediator of @Disease$, and this has been exploited in the development of a novel class of anti-inflammatory drugs, called NO-NSAIDs, which exhibit little if any gastrointestinal toxicity."	0
"In addition, it also suggested that the gastric acid secretion level modulates the association between H. pylori infection and @Chemical$-induced @Disease$."	1
"INTRODUCTION: Clinical features of @Chemical$-exacerbated respiratory disease (AERD) consist of moderate to severe asthma associated with @Disease$ (CRS), which are derived from overproduction of cysteinyl leukotrienes along with chronic type 2 mediated inflammation in the upper and lower airway mucosa."	0
"In 14 observational studies (n = 4485), pre-operative @Chemical$ increased post-operative @Disease$ (MD, 113.6 mL; 95% CI, 45.2-182.0; P = 0.001) and transfusion requirements (MD, 0.34; 95% CI, 0.12-0.56 units; P = 0.002), but not reoperation (OR, 1.12; 95% CI, 0.69-1.83; P = 0.647)."	1
"The cells were isolated from 3 groups of subjects: nonasthmatic patients (n = 10), patients with aspirin-tolerant @Disease$ (ATA, n = 9), and patients with aspirin-intolerant asthma (@Chemical$, n = 7)."	0
This is a case of a 60-year-old gentleman who presented with an extensive @Disease$ (leukocytoclastic) with lower gastrointestinal bleeding following a small dose of @Chemical$ (81 mg).	0
Low-dose @Chemical$ and risk of @Disease$: An observational study in UK general practice.	0
BACKGROUND: Chronic rhinosinusitis (@Chemical$) is a common disorder associated with other @Disease$ such as asthma and inhalant allergy.	1
BACKGROUND: Silent myocardial ischemia (SMI) is a relatively common complication in patients with @Disease$ (CAD) under @Chemical$ therapy presenting with upper gastrointestinal hemorrhage (UGIH).	0
"Patients with an ACS and histories of @Disease$ reactions to @Chemical$, especially following doses lower than 100 mg, should directly undergo desensitization."	1
"Change in number of small intestinal @Disease$ in the @Chemical$ group was -0.5 +- 1.6, and 0.1 +- 0.7 in the placebo group (P = 0.024)."	0
BACKGROUND: Dual antiplatelet therapy (DAPT) associating aspirin + @Chemical$ is commonly utilized in @Disease$ interventions despite unpredictable clopidogrel efficacy with 4% to 50% of patients considered nonresponders.	0
"In fact, well-managed @Chemical$ therapy (INR 2-3) has little effect on bleeding risk and is twice as effective as aspirin at preventing @Disease$."	0
"CONCLUSION: A high MABP at admission was found to be an independent predictor of poor prognosis for @Disease$ patients treated with aspirin or with no drugs, but not for ICH patients treated with @Chemical$."	0
METHODS: @Chemical$-treated patients with @Disease$ were randomly assigned to either prasugrel 10 mg or clopidogrel 75 mg daily for 7 days.	0
"Strong data also support that chronic @Chemical$ users with a recent ulcer complication should be tested for H pylori @Disease$ and, if positive, receive H pylori eradication therapy after ulcer healing, while they appear to benefit from additional long-term therapy with a proton pump inhibitor (PPI)."	0
"The results showed that patients who used aspirin after diagnosis had a RR of 0.73 (95 % CI = 0.54-0.98, P = 0.04) for @Disease$-specific mortality compared to those who did not use @Chemical$."	0
"BACKGROUND: In @Chemical$-sensitive patients with asthma, @Disease$ induced by oral aspirin may be associated with extrabronchial symptoms, suggesting the systemic character of the response."	0
CONCLUSION: SCG can prevent @Chemical$-exacerbated @Disease$ in patients with food allergy resulting from inhibition of increases in allergen absorption.	0
"Use of @Chemical$, ibuprofen or aspirin in pregnancy and risk of @Disease$ in the child."	0
"Furthermore, we should be cautious when we prescribe clopidogrel in addition to @Chemical$ because it could cause @Disease$ complications like SSEH."	1
"DESIGN, SETTING, AND PARTICIPANTS: Prospective analysis of observational data from the EINSTEIN @Disease$ and pulmonary embolism clinical trials comparing @Chemical$ with enoxaparin-VKA treatment, trials performed in hospitals and clinics in 8246 patients enrolled from 2007 to 2009."	0
The benefits of @Chemical$ usage include preserving the duration and quality of life by decreasing @Disease$ and heart attack risk.	0
BACKGROUND: We previously reported that the ILVBL gene on chromosome 19p13.1 was associated with the risk for @Chemical$-exacerbated @Disease$ (AERD) and the percent decline of forced expired volume in one second (FEV1) after an oral aspirin challenge test.	0
Which Antiplatelet Therapy in Patients With Left Ventricular Assist Device and @Chemical$ @Disease$?	1
DISCUSSION: @Chemical$-induced @Disease$ and NSAID intolerance have been well documented.	1
"Within 90 days after intervention, there were 4 patients (1.5%) with acute @Disease$, 5 patients (1.8%) with subacute thrombosis, 17 patients (6.2%) with stroke, and 2 death (0.7%) in low-dose aspirin group, compared with no patient (0%) with acute thrombosis, 2 patient (2.1%) with subacute thrombosis, 6 patients (6.2%) with stroke, and 2 death (2.1%) in high-dose @Chemical$ group, and there were no significant difference in all study endpoints between two groups."	0
"Our institutional @Disease$ registry was used to identify patients 65 years old or older after a GLF while taking @Chemical$, clopidogrel, or aspirin over a 2-year period."	0
"METHODS: Ancillary analysis of the Apixaban Versus Acetylsalicylic Acid [ASA] to Prevent Stroke in @Disease$ Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment (AVERROES) trial, comparing @Chemical$ and apixaban, focused on sex differences."	0
"It is our hypothesis that continued use of @Chemical$ for forestalling myocardial or cerebrovascular ischemic events does not increase the risk of @Disease$, compared with discontinuation of its use in patients who undergo eye procedures under peribulbar block."	0
Logistic regression models examined the association between @Chemical$ use and @Disease$ events.	0
We compared the levels of neutrophil activation and related cytokines in patients with @Chemical$-intolerant acute urticaria (AIAU) and ASA-intolerant chronic @Disease$ (AICU).	0
Mediators of @Disease$ in nasal lavage from aspirin intolerant patients after @Chemical$ challenge.	1
This results confirmed the role of @Chemical$ in pathogenesis of aspirin induced @Disease$.	0
"Also known as Samter's triad or @Chemical$-exacerbated @Disease$, aspirin triad commonly affects the adult population  and is seldom found in pediatric patients."	0
Aspirin-intolerant asthma (@Disease$) is an asthma phenotype characterized by the development of bronchoconstriction following ingestion of @Chemical$.	0
"BACKGROUND: The anti-inflammatory actions of acetylsalicylic acid (@Chemical$)/non-steroidal anti-inflammatory drugs (NSAIDs) are thought to be due to inhibition of COX-2, whereas the side effects such as @Disease$ and aspirin-induced asthma are mediated through inhibition of COX-1."	1
"In conclusion, the CysLTR1 polymorphism may contribute to develop to the AIA phenotype and be used as a genetic marker for differentiating two major @Chemical$ @Disease$ phenotypes."	1
OBJECTIVE: To determine the factors associated with continued @Chemical$ use in patients with AMI who develop @Disease$.	0
"Further research is needed to assess the benefit-risk ratio of clopidogrel plus aspirin in specific subpopulations of patients at high risk for @Disease$, and to determine the role of @Chemical$ plus aspirin in preventing cardioembolic stroke or early recurrent stroke after symptomatic large-vessel atherostenosis."	0
"@Chemical$ use 5 years (HR, 0.86 [95% CI, 0.71-1.05]; P = .13) or 10 years (HR, 0.86 [95% CI, 0.65-1.13]; P = .28) prior to retinal examination was not associated with incident early @Disease$."	0
"Sixty-three subjects without known @Chemical$ sensitivity (13 controls, 17 nasal polyps alone, 15 nasal @Disease$ and asthma and 18 asthma alone) inhaled increasing concentrations of nebulized lysine aspirin."	0
"INTRODUCTION: @Chemical$-intolerant asthma (AIA), a major clinical presentation of aspirin @Disease$ affects 10% of adult asthmatics."	0
Oral aspirin challenge (OAC) reveals @Chemical$-exacerbated respiratory disease (AERD) in approximately 50% of unselected patients with chronic rhinosinusitis with @Disease$ (CRSwNP).	0
"Coadministration of @Chemical$ and ultralow-dose aspirin increases the frequency of mild, self-limiting @Disease$ in some dogs."	0
The purpose of this work was to study the different cells involved in asthmatic inflammatory responses in allergic and @Chemical$ sensitivity patients and compared with @Disease$ patients (EAA) by BAL procedure.	0
"There was no difference in progression on RHCT (25% in ASA versus 16.6% in no-@Chemical$), change in management as a result of RHCT (1.4% versus 1.4%), RHCT as a result of neurological decline (0 versus 1.4%), discharge @Disease$ Scale (15 [14-15] versus 15 [14-15]), and mortality (0 versus 1.4%) between the two groups."	0
"Tacrolimus, a @Chemical$-derived immunosuppressant, is used for immunosuppression in organ transplantation and also for @Disease$ such as atopic dermatitis."	0
"RESULTS: The effects of @Chemical$ on @Disease$ are not apparent until at least 3 years after the start of use, and some benefits are sustained for several years after cessation in long-term users."	0
@Disease$ as a complication of @Chemical$ desensitization for aspirin-exacerbated respiratory disease.	1
"Of 509 participants (56.0% women, 42.0 +- 11.8 years [mean +- SD]), 45.2% reported aspirin intake (41.3 +- 10.9 years, 59.6% women, @Disease$ days at t0: 2.8 +- 3.1 d/mo, t2: 3.6 +- 4.1 d/mo), 11.8% @Chemical$+ intake (46.0 +- 9.8 years, 73.3%, t0: 4.8 +- 6.1 d/mo, t2: 5.3 +- 5.1 d/mo), and 43.0% no analgesics (41.6 +- 13.1 years, 47.5%, t0: 3.8 +- 6.2 d/mo, t2: 5.3 +- 6.6 d/mo)."	0
It has been proposed that aspirin (@Chemical$) and other non-steroidal anti-inflammatory drug (NSAID)-induced urticaria (UR)/@Disease$ (AE) are mediated through inhibition of cyclooxygenase-1 (COX-1) enzymes.	1
"ULDA showed prothrombotic properties in the same model of induced @Disease$ that were very similar to those described after aspirin withdrawal, but the effect was observed only 1 hour after @Chemical$ administration."	0
CONCLUSION: @Chemical$ and/or AP therapy with clopidogrel appears to increase the risk for @Disease$ following S-ICD implantation.	0
"Pre-association of aspirin with PC provides a novel therapeutic approach to significantly reduce @Chemical$-induced small @Disease$ and bleeding, as may occur with enteric-coated aspirin."	0
"The cumulative incidences of recurrent VTE in the rivaroxaban 20-mg, rivaroxaban 10-mg and @Chemical$ groups were 1.9%, 1.6%, and 5.0%, respectively, whereas the cumulative incidences of major @Disease$ were 0.7%, 0.4% and 0.5%, respectively."	0
Objective: To develop prognostic @Disease$ risk models among persons in whom @Chemical$ might be considered for the primary prevention of cardiovascular disease (CVD).	0
Use of the oral platelet inhibitors dipyridamole and @Chemical$ is associated with increased risk of @Disease$.	1
"METHODS: This rhino@Disease$ has multiple layers of pathological process, but the ultimate predicament is caused by @Chemical$ (cysLTs)."	0
@Chemical$ use and development of @Disease$: confounding or causation?	0
The mechanism of @Disease$ included free radical injury induced by @Chemical$ and decreased synthesis of vascular endothelial growth factor (VEGF) by clopidogrel.	1
Risk of upper gastrointestinal bleeding in patients taking low-dose @Chemical$ for the prevention of @Disease$.	0
"The authors prospectively examined the relation between frequency of @Chemical$, ibuprofen, and acetaminophen use and risk of @Disease$ among 62,261 women aged 31-48 years at baseline (1995) in Nurses' Health Study II."	0
"Aspirin desensitization, @Chemical$-modifying agents, biologic agents, management of asthma, chronic rhinosinusitis, and @Disease$ are recommended as treatment modalities."	0
"We investigated the risks of ischemic stroke and @Disease$ (ICH) in relation to @Chemical$ at various TTRs in a real-world cohort of Chinese patients with atrial fibrillation receiving warfarin and compared with those on dabigatran, aspirin, and no therapy."	0
"The @Disease$ index, contents of TNF, and IL-1, 2, 8 were significantly lower in all the protection groups than in the injury group (all P&lt;0.01), and contents of IL-2 and IL-8 in the compound bismuth and magnesium granules group were significantly lower than those in the @Chemical$ group ((328.17+-6.56) vs(340.23+-8.05)pg/ml, P&lt;0.01; (170.82+-7.31) vs(179.31+-7.80)pg/ml, P&lt;0.05)."	0
"Until recently, attention was mainly focused on @Chemical$-induced @Disease$ and duodenum."	1
"Although the latter is conventionally used in nasal @Chemical$-aspirin challenge, use of the former in aspirin-induced @Disease$ (AIA) has never been evaluated."	0
All patients with @Chemical$ exacerbated respiratory disease (@Disease$) can be desensitized to ASA.	0
"METHODS: 430 consecutive subjects (70+/-14 years, 55% male, 41% with coronary artery disease) released from the hospital with a primary diagnosis of @Disease$ were classified into three groups based on the use of aspirin and ACE-I at discharge: ACE-I without aspirin (group I, n=134), ACE-I with @Chemical$ (group II, n=138) and no ACE-I (group III, n=158)."	0
"According to @Disease$ standard of care, patients were treated with @Chemical$ and/or low-molecular weight heparin (LMWH) at prophylactic (pure obstetric APS) or therapeutic doses (history of thrombosis)."	0
"CONCLUSIONS: In a randomized controlled trial of users of low-dose aspirin at risk for recurrent GI @Disease$, a slightly lower proportion of patients receiving a PPI along with @Chemical$ developed recurrent bleeding or ulcer than of patients receiving an H2RA with the aspirin, although this difference was not statistically significant."	0
"In contrast, platelet activation markers in patients with @Disease$ did not change during the @Chemical$ challenge test."	0
No difference was observed in methacholine PD(20)FEV(1) and baseline @Chemical$ between ATA and @Disease$ patients.	0
"Consistent with these observations, we found that platelet activation by @Disease$ sera is also significantly reduced in patients receiving @Chemical$, an ADP receptor antagonist prodrug now in wide clinical use."	0
"CONCLUSION: Our findings suggest that long-term (&gt;=4 years) and low-frequency (1-4.5 times per week) @Chemical$ use is associated with a statistically significant, dose-dependent reduction in the risk of @Disease$."	0
"RESULTS: From fully adjusted analyses, regular @Chemical$ use was associated with a 39% and 37% reduced risk of @Disease$ in the prospective (HR = 0.61; 95% CI = 0.33-1.14) and combined cohorts (HR = 0.63; 95% CI = 0.57-0.71), respectively."	0
"The management of Hp-positive @Disease$, especially in cases with additional use of @Chemical$ or NSAIDs, was very heterogenous, including Hp-eradication only, eradication +  long-term PPI, eradication +  clopidogrel or COX-2-inhibitors/opiates."	1
Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute @Disease$ in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With @Chemical$ or Ticagrelor and Patient Outcomes).	0
Association analysis of ILVBL gene polymorphisms with @Chemical$-exacerbated respiratory disease in @Disease$.	0
"Compared with those who held or never took @Chemical$, patients continuing aspirin had similar rates of overall @Disease$ complications (27% vs 15% vs 14%, p = 0.13), hemoglobin drop &gt;3 g/dL (24% vs 15% vs 14%, p = 0.24), and postoperative blood transfusion (4% vs 3% vs 2%, p = 0.43)."	0
"Main risk factors for upper GI bleeding with low-dose aspirin are concomitant antiplatelet agents, anticoagulants, non steroidal anti-inflammatory drugs or @Chemical$ use, and recent history of complicated or non-complicated gastroduodenal @Disease$."	0
Recurrent @Disease$ due to @Chemical$.	1
Relation of @Disease$ to Response to @Chemical$ in Patients With Stable Coronary Artery Disease.	1
"Furthermore, experience with @Chemical$ desensitization in patients with @Disease$ is very limited."	0
The pathogenesis of @Disease$ is underpinned by abnormalities in @Chemical$ biosynthesis and eicosanoid receptor expression coupled with intense mast cell and eosinophilic infiltration of the entire respiratory tract.	0
"In subgroup analysis, @Chemical$ use was associated with renal failure in the patients with no history of stroke (HR, 1.41; 95% CI, 1.14-1.73), and there was a borderline interaction between previous @Disease$ and the use of aspirin on renal failure (interaction p=0.0565)."	0
Risk of @Disease$ in patients taking low-dose @Chemical$ for the prevention of cardiovascular diseases.	0
"CONCLUSIONS: Our study revealed that nasal @Disease$ of aspirin-sensitive patients were infiltrated with eosinophils and mast cells, @Chemical$-LT(1) receptor proportions in these inflammatory cells were found to be higher and Cys-LT(1) receptor immunoreactivity in eosinophils and mast cells was increased."	0
"CONCLUSION: In diabetic patients treated with E-ZES, TAPT with @Chemical$ did not add any significant benefit in terms of @Disease$ or MACE reduction."	0
"While no single genetic factor has been identified in either CRSwNP or AERD to date, differences in the metabolism of @Chemical$ as well as innate immune cell activation may uniquely contribute to @Disease$ pathogenesis."	0
"Reasons for not taking @Chemical$ included gastrointestinal intolerance (53.5%), allergy (39.4%), non-gastrointestinal @Disease$ (5.5%) and others (1.6%)."	0
METHODS: The medical records of patients with @Disease$ prescribed aspirin and @Chemical$ therapy between January 2007 and June 2011 were analyzed.	0
"BACKGROUND: In patients with aspirin-exacerbated respiratory disease (@Disease$), pretreatment with asthma controller medications (leukotriene modifiers, inhaled or systemic corticosteroids, and salmeterol) partially modifies the severity of @Chemical$-induced asthmatic reactions."	0
"The study objective was to identify the prevalence of asthma, inhalant @Disease$ and aspirin sensitivity in CRS patients referred to secondary care and establish any differences between @Chemical$ phenotypes."	0
METHODS: Nasal polyps were obtained from 16 @Chemical$-tolerant patients with asthma/rhinitis (ATAR) and 18 aspirin-intolerant patients with @Disease$/rhinitis (AIAR) undergoing nasal polypectomy.	0
BACKGROUND: Low-dose @Chemical$ is used for secondary prevention of ischemic heart disease and @Disease$.	0
"BACKGROUND: @Chemical$-exacerbated @Disease$ (AERD) is a clinical syndrome associated with chronic inflammation in the airways coincident with chronic rhinitis, sinusitis, recurrent polyposis and asthma."	1
"In addition, the effects of treatment with @Chemical$, aspirin, or both in patients with chronic kidney disease were compared with the effects in patients with no @Disease$."	0
@Chemical$ analogues may prove to be useful for preventing @Disease$ and for modulating mucosal inflammation.	0
"In subgroup analysis, @Chemical$ use was associated with renal failure in the patients with no history of @Disease$ (HR, 1.41; 95% CI, 1.14-1.73), and there was a borderline interaction between previous stroke and the use of aspirin on renal failure (interaction p=0.0565)."	0
CONCLUSION: Clopidogrel and the combination of acetylsalicylic acid and dipyridamole were associated with similar risks for recurrent ischemic @Disease$ and bleeding; whereas @Chemical$ was associated with higher risks for both ischemic stroke and bleeding.	0
"@Chemical$ is a common, chronically administered preventive treatment for @Disease$, but is often discontinued prior to invasive dental procedures because of concern for bleeding complications."	0
"Aspirin, non-steroidal anti-inflammatory drugs (NSAIDs) and @Chemical$ are the most frequent drugs used worldwide for the management of pain, @Disease$ and fever associated with many acute and chronic conditions."	0
"INTRODUCTION: Upper gastrointestinal (GI) bleeding in patients who undergo hip and knee @Disease$ tends to be associated with non-steroidal anti-inflammatory drug use, @Chemical$ intake, pre-existing peptic ulcers and smoking."	0
"The aim of our study was to verify the hypothesis if Asacard, as a form of @Chemical$, which theoretically does not block prostacycline synthesis in systematic circulation, would be well tolerated by patients with @Disease$."	0
IMPLICATIONS: Continuation of @Chemical$ until the day before coronary artery bypass grafting may increase @Disease$.	1
"Our study is novel in that it shows that gastric mucosal damage caused by @Chemical$, a commonly used NSAID, facilitates T. cruzi @Disease$ by the oral route."	0
"@Chemical$ dose, age, sex, body mass index, history of hypertension, @Disease$, intraprocedural glycoprotein IIb-IIIa or anticoagulant type, and postprocedural anticoagulant use did not have a significant effect on the risk of major bleeding."	0
"Nonaspirin NSAID use was associated with a slightly increased OR for @Disease$ (1.13; 95 % CI 1.10-1.15); however, this association was confined to localized disease and did not vary materially with amount, duration, or consistency of non@Chemical$ NSAID use."	0
"CONCLUSIONS: @Chemical$ intake overall was not associated with early AMD in this sample of Asian Indians, but in those with a history of @Disease$ the association between aspirin intake and early AMD might warrant further investigation."	0
Aspirin and non-aspirin non-@Chemical$al anti-inflammatory drug use and risk of @Disease$.	0
We report one case of Atypical Kawasaki Disease with Multiple giant @Disease$ despite early adequate treatment with IVIG and @Chemical$.	1
"Compared with the use of @Chemical$ alone, combined use of coxib and aspirin for 3 years increased the risk of a colorectal neoplasm by 80% in the fifth year (RR = 1.80, 95% CI 1.22-2.66; P = 0.003) but decreased by 79% and 30%, respectively, the risks of @Disease$ events (RR = 1.79, 95% CI 1.33-2.41; P = 0.0001) and renal impairment/hypertension (RR = 1.30, 95% CI 1.09-1.54; P = 0.003) caused by coxib use alone."	0
Whether the prostacyclin-inhibiting effects of aspirin attenuate some of the beneficial effects of ACE inhibitors mediated by @Chemical$ stimulation in @Disease$ patients is currently unknown.	0
"The risk increased when ASA was combined with clopidogrel, compared with @Chemical$ alone (OR, 1.86; 95% CI, 1.49-2.31), anticoagulants vs low doses of ASA alone (OR, 1.93; 95% CI, 1.42-2.61), or in studies that included patients with a history of GI @Disease$ or of longer duration."	0
"CONCLUSION: Histories of @Chemical$ reactions in patients with @Disease$ are uncommon, occurring in only 1.5% of our study population."	0
"Meta-analysis results showed that: (1) Compared with placebo, the incidences of total cardiovascular events (RR = 0.85, 95% CI: 0.80-0.92), @Disease$ (RR = 0.87, 95% CI: 0.77-0.98), nonfatal stroke (RR = 0.81, 95% CI: 0.70-0.95) and transient ischemic attack (RR = 0.76, 95% CI: 0.64-0.90) were significantly lower in low-dose @Chemical$ group than those in placebo control group (all P &lt; 0.05)."	0
Recurrent epistaxis following peri-interventional antiplatelet therapy (after three elective percutaneous coronary interventions) and an episode of @Disease$ required @Chemical$ withdrawal and less frequent clopidogrel use.	0
"METHOD: From July 2017 to January 2019, 901 patients including 781 (86.7%) male and 120 (13.3%) female patients underwent laparoscopic inguinal @Disease$ repair using trans-abdominal preperitoneal (@Chemical$) technique were recruited, among whom 152 (16.9%) had been taking low-dose (100 mg per day) acetylsalicylic acid which was continued during hospitalization except the operation day."	0
"The 1-year predicted risks associated with @Chemical$, the combination of acetylsalicylic acid and dipyridamole, and clopidogrel were 11.1 (95% CI: 10.2-12.2), 7.7 (95% CI: 7.3-8.3), and 8.0 (95% CI: 6.9-8.7) for ischemic @Disease$, respectively; while, the risks for bleeding were 3.4 (95% CI: 2.8-3.9), 2.4 (95% CI: 2.1-2.7), and 2.4 (95% CI: 1.9-2.9), respectively."	0
This lack of reactions found in our study supports the fact that @Chemical$ could be a safe alternative in postsurgery analgesia in NSAID-intolerant @Disease$ patients.	0
Some studies suggest that enteric-coated @Chemical$ may be more injurious to the @Disease$ mucosa than buffered aspirin.	1
"METHODS: We retrospectively compared the records of 78 and 40 @Disease$ patients receiving low-dose aspirin (LDA) and non-@Chemical$ NSAIDs, respectively."	0
"BACKGROUND: We describe three patients with Samter's triad (nasal polyps, @Chemical$ intolerance, and @Disease$) with skull base dehiscence in whom the polyps extended into the extradural space and also resulted in hypertelorism and widening of the nasal bridge."	0
Previous studies have revealed that ASA desensitization and subsequent treatment with @Chemical$ is associated with clinical improvement in @Disease$.	0
"BACKGROUND: The management of patients with traumatic brain injury (TBI), @Disease$ (pICH) and primary subarachnoid hemorrhage (@Chemical$) remains a highly demanding challenge in critical care medicine."	0
"It increased almost 6-fold following the challenge, while remained unchanged in patients without @Chemical$ @Disease$."	1
"The 1-year predicted risks associated with acetylsalicylic acid, the combination of acetylsalicylic acid and @Chemical$, and clopidogrel were 11.1 (95% CI: 10.2-12.2), 7.7 (95% CI: 7.3-8.3), and 8.0 (95% CI: 6.9-8.7) for ischemic @Disease$, respectively; while, the risks for bleeding were 3.4 (95% CI: 2.8-3.9), 2.4 (95% CI: 2.1-2.7), and 2.4 (95% CI: 1.9-2.9), respectively."	0
CONCLUSIONS: Use of @Chemical$ as add-on pretreatment to prevent reactions to aspirin in patients with @Disease$ or to achieve the goal of silent aspirin desensitization could not be accomplished.	0
[Low-dose @Chemical$ doesn't increase surgical bleeding nor transfusion rate in total knee @Disease$].	0
We therefore analyzed the effect of @Chemical$ on mortality and serious @Disease$ in diabetic patients with and without cardiovascular disease.	0
Multiple regression analysis confirmed that @Chemical$-intolerant asthma (@Disease$) was strongly associated with NFA.	0
"Urinary eicosanoids, plasma tryptase and cytokine levels, platelet-leukocyte aggregates, and granulocyte transcripts were assessed.Measurements and Main Results: Eight weeks of high-dose aspirin decreased nasal symptoms and urinary prostaglandin E metabolite (P &lt; 0.05) and increased urinary leukotriene E4 (P &lt; 0.01) levels in subjects with @Chemical$-exacerbated @Disease$, but not in those with aspirin-tolerant asthma."	0
Association of four-locus gene interaction with @Chemical$-intolerant @Disease$ in Korean asthmatics.	0
"Aspirin, non-steroidal anti-inflammatory drugs (NSAIDs) and @Chemical$ are the most frequent drugs used worldwide for the management of @Disease$, inflammation and fever associated with many acute and chronic conditions."	0
Dual antiplatelet therapy (DAT) with @Chemical$ and clopidogrel is the standard regimen to achieve rapid platelet inhibition and prevent @Disease$ events.	0
"Recent investigations have documented that @Chemical$ consumption, in place of exercise, also induces @Disease$."	1
"This permits us to discriminate asthmatic subjects from healthy subjects, as well as to distinguish the 2 @Disease$ phenotypes based on the presence or absence of @Chemical$ hypersensitivity."	0
"AIM: To investigate if the regular use of @Chemical$ is associated with the development of Crohn's disease (@Disease$) and ulcerative colitis (UC) using, for the first time, a prospective cohort study design."	0
"OBJECTIVE: To assess the consequences of switching @Chemical$ dosage from 100 mg/d to 40 mg/d on cardiovascular benefit, bleeding risk and @Disease$ in very elderly patients."	0
"QUESTION/PURPOSES: We sought to answer four questions: For the THA and TKA cohorts, respectively, (1) was the incidence of readmission resulting from VTE and bleeding complications higher with LMWH than mobile compression plus ASA; and (2) was the incidence of wound @Disease$ complications higher with @Chemical$ than mechanical compression plus ASA?"	0
"Current diagnostic and treatment strategies for aspirin-exacerbated diseases remain limited, and continued research focusing on each of the unique @Disease$ reactions to @Chemical$ is essential."	1
"However, there is cross-reactivity between the NSAIDs in patients with NSAID-exacerbated @Disease$ and @Chemical$, and thus only use of selective COX-2 inhibitors can replace the culprit drug if the chronic treatment is necessary, although aspirin desensitization will allow for chronic treatment with NSAIDs in some patients with NIUA."	0
So we suspect that the pathogenic mechanism for @Chemical$ urticaria differs from that for aspirin @Disease$.	0
"Twelve cases of Reye's syndrome are presented with different degrees of @Disease$, hyperammonemia and hypoglycemia; associated to acetyl salicylic acid (@Chemical$) ingestion."	1
Standard-dose lafutidine significantly prevents @Disease$ induced by LDA alone or @Chemical$ plus loxoprofen in H. pylori-negative volunteers.	0
"Dose-related increases in heart and ventricular weight, and @Disease$, were found more exacerbated in the @Chemical$-treated MI rat hearts than the saline-treated MI counterparts."	0
"CONCLUSION: Pre-operative aspirin increases post-operative @Disease$, but this may be avoided by the use of @Chemical$ doses &lt;325 mg/day."	0
Effective @Disease$ prevention strategies are available and should be used in at-risk patients taking low-dose @Chemical$ or clopidogrel.	0
"The cells were isolated from 3 groups of subjects: nonasthmatic patients (n = 10), patients with @Chemical$-tolerant @Disease$ (ATA, n = 9), and patients with aspirin-intolerant asthma (AIA, n = 7)."	0
"In the Coumadin and aspirin studies 100% of the randomized patients had an unprovoked @Disease$, while in the @Chemical$ studies between 73.5% and 93.2% of the VTE events were unprovoked."	0
"The independent risk factors for @Disease$ were regular @Chemical$-use at the onset of ICH (relative risks [RR], 2.5; 95% CI, 1.3 to 4.6; P=0.004), warfarin-use at the onset of ICH (RR, 3.2; 95% CI, 1.6 to 6.1; P=0.001), and ICH score higher than 2 on admission (RR, 13.8; 95% CI, 6.0 to 31.4; P&lt;0.001)."	0
This review aims to highlight the challenges of @Chemical$ @Disease$ in patients undergoing PCI and propose a treatment algorithm to address this issue in clinical practice.	1
"CONCLUSION: H2RA therapy was effective for both the prevention and treatment of low-dose @Chemical$-induced peptic ulcer, similar to the effects of PPIs, while cytoprotective anti-@Disease$ drugs were ineffective in preventing ulceration."	0
@Chemical$ resistance in @Disease$ patients.	0
METHODS: The Apixaban versus Acetylsalicylic Acid to Prevent Stroke in @Disease$ Patients Who Have Failed or Are Unsuitable for Vitamin k Antagonist Treatment (AVERROES) trial randomized 5599 patients with atrial fibrillation and risk factors to receive either @Chemical$ or aspirin.	0
OBJECTIVE: The aim of this study was to investigate the associations between proton pump inhibitor (PPI) usage patterns and risk of severe @Disease$ in patients treated with low-dose acetylsalicylic acid (@Chemical$).	0
"Patients undergoing TKA treated with LMWH had higher readmission rates within 6 weeks of surgery because of a bleeding complication, a wound @Disease$, or the development of a VTE (6.8% for @Chemical$ versus 1.5% for mobile compression; p = 0.015; OR, 4.8)."	0
BACKGROUND: Aspirin desensitization is an effective therapy for moderate-to-severe @Chemical$-exacerbated @Disease$ (AERD).	0
"CONCLUSIONS: NSAID, low-dose ASA use, and H. pylori infection are three independent risk factors for the development of PUB, but there were differences in the interaction effect between low-dose @Chemical$ (no interaction) or NSAID (addition) use and H. pylori @Disease$, which may have implications for clinical practice in prevention strategies."	0
"In case 1, premedication of misoprostol suppressed the @Disease$ and elevation of blood gliadin levels which were induced by exercise, wheat and @Chemical$ intake."	0
Functional promoter polymorphism in the TBX21 gene associated with @Chemical$-induced @Disease$.	1
"Our study also highlights that the use of aspirin for primary prevention of @Disease$ was found to cause higher rates of bleeding (any bleeding, major bleeding, and GI bleeding) compared to placebo or no @Chemical$ at the longest follow-up period with no significant benefit in cancer primary prevention."	0
"To explore the neural mechanisms underlying @Chemical$ (SS)-induced hyperexcitability and increased central gain, we examined the effects of GABA receptor agonists and antagonists on SS-induced hyperexcitability in the AC and @Disease$ reflex responses."	0
"Based on these preliminary data, the presence of an @Disease$ is not a strict contraindication to @Chemical$ use."	0
"@Chemical$ appears to be very effective in reducing both acute gastroduodenal mucosal damage and upper GI bleeding in the high-risk patient taking low-dose aspirin, but data with other anti-@Disease$ agents are lacking (misoprostol) or inconsistent (ranitidine) at present."	0
The aim of our study was to describe @Disease$ in patients on prehospital @Chemical$ (ASP) therapy undergoing emergent cholecystectomy.	0
"In haplotype analysis, the HLA-DRB1(*)1302-DQB1(*)0609-DPB1(*)0201 was significantly higher in the @Chemical$-induced urticaria (8.0%) than in the aspirin-intolerant @Disease$ (0.7%, P=0.0014) and normal controls (2.0%, P=0.0006)."	0
@Chemical$ is generally not included in a standard toxicology screen but should be considered in cases of @Disease$.	1
"CASE REPORT: A 58-year-old Caucasian male with a history of coronary heart disease and hypercholesterolemia, under treatment with acetyl-@Chemical$ for 6 years and simvastatin for 2 months, presented to the Emergency Department of our hospital with epigastric pain and @Disease$ of 24-hour duration."	0
These results support the use of PPIs as a preventive measure against @Disease$ events for patients receiving @Chemical$ and aspirin.	0
"The objective of this study was to test the effects of aspirin (1, 2.5 and 5 mg/kg), and ibuprofen (4 and 15 mg/kg), diclofenac (2.5 mg/kg), flurbiprofen (2 mg/kg), @Chemical$ (7.5 mg/kg), and rofecoxib (1 mg/kg), alone or combined on a rat model of arterial @Disease$."	0
"CONCLUSIONS: Preoperative aspirin use in all patients undergoing cardiac operations was not associated with risks of major cardiac, cerebral, or renal complications and infections and @Disease$; however, the risk of reoperation for bleeding was elevated among preoperative @Chemical$ users compared with nonusers in a subpopulation of patients undergoing valve operations only."	0
The dose and the time of oral @Chemical$ challenge test for these 18 patients were more spent than those for reported patients of aspirin @Disease$.	0
"INTRODUCTION: Upper gastrointestinal (GI) bleeding in patients who undergo hip and knee arthroplasty tends to be associated with non-steroidal anti-inflammatory drug use, @Chemical$ intake, pre-existing peptic @Disease$ and smoking."	0
"INTRODUCTION: @Chemical$ ingestion may cause serious gastrointestinal toxicity, in particular bleeding or perforated peptic @Disease$."	1
BACKGROUND AND PURPOSE: @Chemical$ reduces stroke with comparable bleeding risks when compared with aspirin in patients with @Disease$ who are unsuitable for vitamin k antagonist therapy.	0
Aspirin-induced asthma (AIA) and aspirin-induced urticaria/ @Disease$ (AIU) are two major @Chemical$-related allergies.	0
"For instance, @Chemical$ (NO) released from vascular epithelium, epithelial cells of @Disease$ and sensory nerves can influence many of the same components of mucosal defense as do prostaglandins."	0
"Aspirin plus @Chemical$ has the highest surface under the cumulative ranking curves (SUCRA) values in terms of mortality, intracranial hemorrhage, and adverse event rate among 7 drug therapies in the treatment of @Disease$."	0
"@Chemical$ results in prolonged inhibition of blood coagulation, and acetaminophen can result in @Disease$ at normal dose and liver failure at higher dose."	1
"METHODS: To estimate the numbers and rates of emergency department (ED) visits for @Disease$-related AEs (hemorrhage or evaluation for potential hemorrhage) from DAT in the United States and put them in the context of those from @Chemical$, we analyzed AEs from the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance project, 2006-2008, and outpatient prescribing from the National Ambulatory Medical Care Survey and the National Hospital Ambulatory Medical Care Survey, 2006-2007."	0
"At the 5-year follow-up, cardiovascular events were found to have developed in 11 patients (8 @Disease$ and 3 myocardial infarction) who exhibited @Chemical$ resistance (12.1%) and in 9 (4 stroke and 5 myocardial infarction) patients who did not exhibit aspirin resistance (2.4%) (P &lt; .001)."	0
"METHODS: We screened a Korean asthma cohort (581 asthmatics including 81 aspirin-intolerant @Disease$tics and 231 @Chemical$-tolerant asthmatics, and 181 normal controls) for four single nucleotide polymorphisms (SNPs; -262 A&gt;T and -115 T&gt;C in the 5'-flanking region and +5467 T&gt;C [Pro450Pro] and+11860 A&gt;G [Thr776Thr] in the coding region) and one ins/del (+21288 CT) in the ACE gene."	0
"Aspirin-induced urticaria and angioedema, but not bronchoconstriction, associated with @Chemical$ overproduction in 2 patients with @Disease$."	0
"It is our hypothesis that continued use of @Chemical$ for @Disease$ events does not increase the risk of hemorrhage, compared with discontinuation of its use in patients who undergo eye procedures under peribulbar block."	0
"The @Disease$ and symptoms precede clinical reactions to ASA or other NSAIDs, but ultimately affected subjects experience worsening of symptoms with ingestion of @Chemical$/NSAIDs."	0
"In one RCT, no statistically significant differences for @Disease$ requiring admission to hospital (p = 0.14) or blood transfusion (p = 0.29) were observed between the group receiving concomitant famotidine and ASA and the group receiving concomitant placebo and @Chemical$."	0
"In our investigation of such adverse effects, we obtained 4 important findings considered useful for physicians, as follows; 1) even when aspirin was given at a dose, the incidence rate of gastrointestinal lesions was higher than with other non-steroidal anti-inflammatory drugs (NSAIDs), 2) the odds ratios for gastrointestinal lesions induced by @Chemical$ with a histamine H2 receptor antagonist and proton pump inhibitor were 0.6 and 0.4, respectively, as compared with aspirin alone, 3) it is difficult to administer aspirin, which exerts an antiplatelet effect, without inducing gastrointestinal lesions, and 4) these @Disease$ appears early, especially within 2 years after administration."	0
Overuse of @Chemical$ powders affects cerebral glucose metabolism in chronic @Disease$ patients.	0
"INTERPRETATION: In patients receiving @Chemical$-based antiplatelet treatment without routine PPI use, the long-term risk of major @Disease$ is higher and more sustained in older patients in practice than in the younger patients in previous trials, with a substantial risk of disabling or fatal upper gastrointestinal bleeding."	0
Patterns in the use of low-dose @Chemical$ and other therapies following @Disease$.	0
CONCLUSIONS: The risk of upper GI @Disease$ is significantly higher in elderly acute vs chronic users of NSAIDs or regular-dose @Chemical$.	0
OBJECTIVE: To assess whether patients with @Disease$ and aspirin sensitivity share common eicosanoid alterations with patients who have @Chemical$-sensitive asthma.	0
"HYPOTHESES: The @Disease$ associated with @Chemical$ and ultralow-dose aspirin administration will be similar to those caused by prednisone alone, but both treatments will result in more severe lesions than placebo."	1
Epithelial folliculin enhances airway inflammation in @Chemical$-exacerbated @Disease$.	1
"BACKGROUND: Aspirin-exacerbated respiratory disease (@Disease$) is a clinical triad consisting of aspirin/@Chemical$ (ASA) sensitivity, bronchial asthma, and nasal polyposis."	0
"The full clinical picture reveals a classic triad of symptoms (Samters Triad): aspirin induced bronchial asthma (with severe acute @Disease$), @Chemical$-sensitivity and chronic rhinosinusitis with nasal polyps."	0
"Key search terms included cyclooxygenase inhibitors, @Chemical$, @Disease$, and hypersensitivity."	0
"METHODS: From 5555 patients undergoing upper gastrointestinal endoscopy from January 2005 to December 2006 at Teikyo University Hospital, Tokyo, Japan, 159 patients (76 males and 83 females, mean age: 69.3 +/- 11 years) fulfilling the following conditions were selected: (i) taking @Chemical$ (less than 100 mg/day) continuously; (ii) not taking acid suppressants; and (iii) no history of gastrointestinal tract surgery, malignancies, severe cardiac failure, or @Disease$."	0
@Chemical$-like defect of platelets does not protect against @Disease$].	0
"RESULTS: Overall, 42.2% of @Chemical$-treated subjects developed multiple erosions and/or @Disease$, whereas 22.2% treated with PL2200 developed such damage (P=0.0027)."	0
@Chemical$-exacerbated @Disease$: clinical disease and diagnosis.	1
"INTRODUCTION: @Chemical$ ingestion may cause serious @Disease$, in particular bleeding or perforated peptic ulcer."	1
"Multivariate logistic regression analysis showed that large @Disease$ size (&gt;10 mm) (OR: 6.29, 95% CI: 2.58-15.37) and past history of PUD (OR: 3.69, 95% CI: 1.24-10.97) were important predictors of unsuccessful therapy for @Chemical$-related PUD."	0
BACKGROUND: @Chemical$ @Disease$ is not a rare condition among patients with acute coronary syndrome.	1
RESULTS: NASPs showed increased @Chemical$ release from @Disease$s on increased aspirin exposure.	0
"RESULTS: A treatment with aspirin in the human bronchial epithelial cells increased the mRNA expression level of KIF3A compared to that of the untreated control (P &lt;= 0.01), and @Disease$ from aspirin-intolerant asthma (AIA) patients also showed a higher expression of KIF3A protein than @Chemical$-tolerant asthma controls."	0
CONCLUSIONS: Preoperative use of aspirin plus @Chemical$ is associated with an increased risk of @Disease$ after coronary artery bypass surgery.	0
The features described here suggest the importance of the Eosinophils and CD 4 +/- Lymphocytes in asthmatic response of allergic asthmatic patients as well as in @Chemical$ sensitivity @Disease$tic patients.	0
BACKGROUND: Aspirin desensitization (@Disease$) has been the only available modifying treatment in @Chemical$-exacerbated respiratory disease (AERD).	0
"Spirometry, skin-prick test and @Disease$ control test were documented and intracellular cytokine expression in T lymphocytes and plasma @Chemical$ levels were measured in 23 AERD patients, 17 aspirin-tolerant asthmatic (ATA) patients, and 16 healthy controls."	0
The aim was to analyze the prevalence of HLA class I phenotypes and HLA-DRB1* genotype in patients with CIU associated with @Chemical$ and NSAIDs @Disease$ (AICU).	0
@Chemical$ intolerance and @Disease$.	0
A @Disease$ in a woman on @Chemical$ has uncovered a frequently neglected toxicological parameter.	1
"Discontinuation of low-dose @Chemical$ which exposes to increased cardiovascular complications and mortality should be avoided, even in cases of peptic @Disease$ bleeding."	1
"CONCLUSIONS: Use of @Chemical$, low GCS score, opening to ventricle, older age, accompanying diabetes, and/or @Disease$ were worse prognostic factors."	0
BACKGROUND/AIMS: Low-dose @Chemical$ therapy is widely used to prevent @Disease$ events.	0
"Even if TIMI defined major bleeding favored a low dose of @Chemical$, with OR: 1.42, 95 % CI: 0.95-2.13; P = 0.09, or even if major @Disease$ was insignificantly higher with a high dose aspirin, with OR: 1.78, 95 % CI: 1.01-3.13; P = 0.05; I(2) = 94 %, higher levels of heterogeneity observed in these subgroups could not be considered significant to any extent."	0
A total of 2789 consecutive patients without significant @Disease$ who underwent @Chemical$ test between November 2004 and March 2010 were enrolled.	0
"RESULTS: @Chemical$ increased the risk of major @Disease$ (RR=1.71; 95% confidence interval [CI], 1.41-2.08), major gastrointestinal (GI) bleeding (RR=2.07; 95% CI, 1.61-2.66), and intracranial bleeding (RR=1.65; 95% CI, 1.06-5.99) versus placebo."	1
"In our investigation of such adverse effects, we obtained 4 important findings considered useful for physicians, as follows; 1) even when aspirin was given at a dose, the incidence rate of gastrointestinal lesions was higher than with other non-steroidal anti-inflammatory drugs (NSAIDs), 2) the odds ratios for @Disease$ induced by aspirin with a histamine H2 receptor antagonist and proton pump inhibitor were 0.6 and 0.4, respectively, as compared with @Chemical$ alone, 3) it is difficult to administer aspirin, which exerts an antiplatelet effect, without inducing gastrointestinal lesions, and 4) these gastrointestinal lesions appears early, especially within 2 years after administration."	0
"AREAS COVERED IN THIS REVIEW: A number of risk factors can be used to determine which patients are more likely to develop aspirin-associated GI bleeding, mainly in the upper GI tract; these include a previous GI ulcer, ulcer complications, @Disease$, and concomitant drug therapy with non-steroidal anti-inflammatory drugs (NSAIDs) or @Chemical$."	0
"INTRODUCTION: Although aspirin is the cornerstone of medication in patients with @Disease$, a minority of these patients have @Chemical$ sensitivity."	0
"@Chemical$-exacerbated respiratory disease is a clinical syndrome characterized by severe, persistent asthma, @Disease$ with nasal polyps, and reactions to aspirin and other nonsteroidal antiinflammatory drugs that preferentially inhibit cyclooxygenase 1."	0
"CONCLUSION: The use of @Chemical$, but not of LDA, might be associated with unfavorable outcomes in elderly with fall-induced @Disease$."	0
These findings indicate that gastroprotective therapy should be considered for preventing peptic @Disease$ associated with low-dose @Chemical$ in patients with hypertriglyceridemia.	1
BACKGROUND: The differences in the small intestinal @Disease$ of low-dose aspirin based on the type of @Chemical$ used remains unclear.	0
"To investigate the relationship between single-nucleotide polymorphisms (SNPs) in the RAB1A gene and @Chemical$-exacerbated respiratory disease (AERD), asthmatics (n=1197) were categorized into AERD and aspirin-tolerant @Disease$ (ATA)."	0
BACKGROUND AND PURPOSE: @Chemical$ reduces @Disease$ with comparable bleeding risks when compared with aspirin in patients with atrial fibrillation who are unsuitable for vitamin k antagonist therapy.	0
OBJECTIVE: To observe the effect of warm-needle moxibustion on the @Disease$ caused by anti-rheumatic dose of @Chemical$.	1
"OBJECTIVE: To phenotype a group of children with @Disease$ reactions to NSAIDs, including @Chemical$, and analyze the degree of agreement with the entities reported in adults and how they fit the proposed classifications."	0
"STUDY DESIGN: The OPT-BIRISK trial is a multicenter, double-blinded, placebo-controlled randomized study designed to test the superiority of extended antiplatelet therapy with clopidogrel monotherapy compared with aspirin and @Chemical$ for reduction of @Disease$ events in ACS patients with both high bleeding and high ischemic risks (bi-risk)."	0
"For @Chemical$ users, the relative risk was similar for doses up to 300 mg daily and for both @Disease$ and duodenal ulcers."	0
"CONCLUSION: For patients with inguinal @Disease$s, laparoscopic @Chemical$ repair is completely safe to be performed on those taking low-dose acetylsalicylic acid when it was only ceased on the operation day, with intravenous salvianolate given after the operation instead."	0
"We compared 1- and 3-year outcomes for cerebrovascular accident (CVA), transient ischemic attack (TIA), gastrointestinal (GI) bleeding, genitourinary (GU) bleeding, any @Disease$, and AF recurrence among patients receiving: none, @Chemical$, or warfarin as long-term therapies."	0
"PURPOSE: Among previous studies examining the associations of over-the-counter analgesics or nonsteroidal anti-inflammatory drugs (NSAIDs) and incident @Disease$, results were inconsistent for NSAIDs but suggested an increased risk with acetaminophen (@Chemical$)."	0
ISR PCI was independently associated with a higher 2-year risk of @Chemical$ (adjusted hazard ratio [HR] 1.95; 95% CI 1.68-2.27; P&lt;.001) and stent @Disease$ (adjusted HR 1.95; 95% CI 1.08-3.51; P=.027) but not bleeding (adjusted HR 0.94; 95% CI 0.73-1.21; P=.64).	0
"BACKGROUND: Increasing numbers of patients presenting for intracranial surgery are receiving concurrent medication with low-dose @Chemical$, leading to dysfunctional circulating platelets, which might increase the peri-operative risk of @Disease$."	1
"@Chemical$-exacerbated respiratory disease (@Disease$) severity and its clinical phenotypes are characterized by genetic variation within pathways for arachidonic acid metabolism, inflammation, and immune responses."	0
"BACKGROUND: Aspirin-exacerbated respiratory disease is characterized by @Disease$, chronic rhinosinusitis, nasal polyposis, and sensitivity to @Chemical$ and other nonsteroidal anti-inflammatory drugs."	0
"CONCLUSIONS: In females, @Chemical$ increased the risk of colonic mucosal lesions, suggesting that LDA may contribute to the pathogenesis of colonic ulceration or @Disease$."	0
@Chemical$ versus warfarin in patients with @Disease$.	0
Reproducibility of response to nasal lysine-aspirin challenge in patients with @Chemical$-induced @Disease$.	1
The effect of clopidogrel and @Chemical$ on blood loss in @Disease$ surgery.	0
"A 78-year-old woman visited a local clinic because of @Disease$, and was prescribed levofloxacin, carbocisteine, and cold medicine (salicylamide, @Chemical$, anhydrous caffeine, promethazine methylene disalicylate)."	0
"However, preoperative @Chemical$ use, compared with nonuse, was not associated with risks of MACE, 30-day mortality, @Disease$, blood transfusion, or postoperative infection in the entire cohort, in patients undergoing valve operations only, and in patients undergoing CABG only after PSM."	0
"Based on the AIA-specific gene expression profile of nasal polyp, candidate genes for AIA susceptibility were selected and screened by a case-control design of 219 AIA patients, 374 non-asthmatic control (CTR), and 282 @Chemical$-tolerant @Disease$tic (ATA) subjects."	0
"In view of these animal studies and in the absence of controlled studies of aspirin or NSAIDs in human myocarditis, we do not recommend indiscriminate treatment with NSAIDs or high-dose @Chemical$ in patients with @Disease$ where there is no or minimal associated pericarditis."	0
OBJECTIVES: To study whether Clopidogrel-Aspirin combined treatment for high risk transient ischaemic attack (TIA) or minor @Disease$ results in increased number of lesions associated with anti-thrombotic cerebral haemorrhage or cerebral micro-bleeds (CMB) than @Chemical$ alone treatment.	0
"METHODS: 106 consecutive adults with confirmed, physician-diagnosed difficult asthma and 100 patients with @Chemical$-induced @Disease$ underwent psychiatric interview and assessment using M.I.N.I 5.0, Beck Depression Inventory (BDI) and Panic And Agoraphobia Scale (PAS)."	1
"However, @Chemical$, even at a low dose, can induce varying degrees of @Disease$ (erosion, ulcer, ulcer bleeding)."	1
"However, it was also noted that use of PPI plays a protective role in patients with @Disease$ receiving @Chemical$ and clopidogrel therapy."	0
Lack of association between using @Chemical$ and development of @Disease$: a meta-analysis.	0
BACKGROUND: Aspirin desensitization is a useful therapy in patients with @Chemical$-exacerbated @Disease$.	0
"The other patients described adverse effects to @Chemical$, @Disease$."	1
"Despite the demonstrated benefits of @Chemical$, many patients develop secondary @Disease$ or other vascular events, an observation that has led to the concept of aspirin resistance."	1
"OBJECTIVES: To evaluate if esomeprazole prevents recurrent peptic @Disease$ in adult patients with a history of peptic ulcer receiving low-dose acetylsalicylic acid (ASA, @Chemical$) for cardiovascular protection in East Asia."	0
"OBJECTIVE: We sought to determine blood and urinary levels of @Chemical$,11beta-PGF(2), a major stable PGD(2) metabolite in 2 well-defined phenotypes of asthma, aspirin-induced @Disease$ (AIA) and aspirin-tolerant asthma (ATA), and in healthy control subjects and to study the effects of aspirin on PGD(2) release."	0
"The systemic effects of flush, @Disease$ and hives are mediated by @Chemical$."	1
"RESULTS: The final analysis included 1470 study participants: 221 controls, 553 @Chemical$ without nasal polyps (CRSsNPs), 651 CRS with nasal polyps (CRSwNPs) and 45 @Disease$ (AFRS)."	0
"CONCLUSIONS: In patients with @Disease$ taking low-dose aspirin, the use of celecoxib or naproxen plus @Chemical$ resulted in similar rates of gastroduodenal ulceration."	0
"Any (major or minor) @Disease$ occurred in 71 (8.1%) and 77 (8.9%), major bleeding in 34 (3.9%) and 49 (5.6%), and minor bleeding in 37 (4.2%) and 29 (3.3%) of placebo- and @Chemical$-treated patients, respectively; these differences were not significant."	0
"According to APS standard of care, patients were treated with @Chemical$ and/or low-molecular weight heparin (LMWH) at prophylactic (pure obstetric APS) or therapeutic doses (history of @Disease$)."	0
"@Chemical$-exacerbated respiratory disease (AERD) severity and its clinical phenotypes are characterized by genetic variation within pathways for arachidonic acid metabolism, @Disease$, and immune responses."	0
"The results of the CHARISMA trial support this recommendation; despite previous data demonstrating a favourable benefit-risk profile of @Chemical$ plus clopidogrel in patients with acute coronary syndrome, this combination should not be used in patients at high risk for @Disease$ and those with previous stroke or TIA."	0
Enzyme-linked immunosorbent assay (ELISA) was performed to identify and quantify apolipoprotein H (Apo H) in plasma from subjects with AERD and @Chemical$-@Disease$ (ATA).	0
"OBJECTIVE: Aspirin exacerbated @Disease$ (AERD) is comprised of aspirin/@Chemical$ (ASA) sensitivity, bronchial asthma, and nasal polyposis."	0
"Data Sources: We searched PubMed, Embase, CENTRAL, and ClinicalTrials.gov from inception to May 28, 2018, with the terms novel oral anticoagulants, non-vitamin K antagonist oral anticoagulants, direct oral anticoagulants, dabigatran, rivaroxaban, apixaban, edoxaban, @Chemical$, Coumadin, vitamin K antagonist, aspirin, acetylsalicylic acid, or ASA, and major bleeding, fatal bleeding, or @Disease$."	0
Altered eicosanoid metabolism is the generally accepted mechanism of aspirin intolerance; the overproduction of @Chemical$ has been suggested to play a causative role in both @Disease$ and AIU.	0
"CONCLUSION: In real life, the incidence of @Disease$ associated with the combination of @Chemical$, clopidogrel, and enoxaparin therapy was estimated to be 2.7%."	1
"Aside from patients with known @Chemical$-sensitive asthma, physicians have avoided the use of aspirin in @Disease$tic patients in general because it was believed that this agent might precipitate worsening of their condition."	0
"We evaluated changes in leukotriene and prostaglandin metabolites for @Chemical$ patients, using patients with NECD and single-NSAID-induced @Disease$/angioedema or anaphylaxis (SNIUAA) for comparison."	0
Patients who had @Disease$ with ASA ingestion or a reaction to @Chemical$ within the past year are at higher risk for reaction during the desensitization protocol.	0
"In the patients who survived at least 90 days, there was 1 @Disease$ (1%) in the ketorolac group compared with 53 (5%) in the non@Chemical$ group (p = 0.01)."	0
Urinary metabolites of histamine and leukotrienes before and after placebo-controlled challenge with @Chemical$ and food additives in chronic @Disease$ patients.	0
Five and half years male child with one day history of pain abdomen and vomiting who was on @Chemical$ for suspected @Disease$ presented initially with acute gastritis.	1
"RESULTS: We found significantly lower total symptom score (TSS) during the 7th (p = .009), 14th (p = .003), 21st (p &lt; .001) and the 28th day (p = .001), lower total endoscopic score (TES) on the 21st (p = .002) and 28th day (p = .001), lower nasal obstruction, @Disease$/pressure, headache and trouble sleeping, and lower nasal mucosal edema, nasal secretion and nasal crusting in patients treated by hypertonic sea @Chemical$."	0
"@Chemical$, but not other NSAID use, was associated with about 20% lower risk of postmenopausal breast cancer and did not vary by ER or PR status of the @Disease$, suggesting that the hypothesized protective effects of aspirin may either be through cellular pathways independent of estrogen or progesterone signaling, or on tumor microenvironment."	0
"However, as discontinuation of aspirin, unlike NSAIDs, may precipitate @Disease$ and cerebrovascular events, treatment of @Chemical$-associated ulcers should re-start aspirin as soon as possible, using proton pump inhibitor (PPI)."	0
METHODS: We compared outpatients with difficult-to-treat asthma (@Chemical$; n = 486) in a tertiary hospital for @Disease$ in central Japan with those with controlled severe asthma (n = 621) with respect to clinical factors including body mass index (BMI) and aspirin intolerance using multivariate logistic regression analysis stratified by gender and atopic phenotype.	0
"These studies indicated a deleterious effect of NSAIDs and @Chemical$ in this setting, demonstrating a 2- to 3-fold increase in inflammation, myocytes @Disease$ and even mortality when compared with placebo."	0
The association between @Chemical$ and @Disease$ in hip fracture patients.	0
Spontaneous suprachoroidal haemorrhage associated with @Disease$ and @Chemical$.	1
"CONCLUSIONS: In patients with a principal discharge diagnosis of @Disease$, the use of aspirin, in combination with ACE-I, does not worsen long-term survival compared to the use of ACE-I without @Chemical$."	0
CONCLUSION: Ethanolic extract of Cl ointment (EtOHCl) containing 10% @Chemical$ displayed remarkable healing process against wound @Disease$ by aspirin.	0
"INTRODUCTION: @Chemical$ is a popular nonsteroidal anti-inflammatory drug, but some patients suffer from @Disease$ to it."	1
Patients with peripheral @Disease$ on long-term aspirin therapy (&gt;=4 wk) were tested for aspirin responsiveness by means of the VerifyNow @Chemical$ Assay.	0
"STUDY OBJECTIVES: To characterize the safety of concomitant @Chemical$, clopidogrel, and warfarin therapy after percutaneous coronary intervention (PCI), and to identify patient characteristics that increase the risk of @Disease$."	0
"OBJECTIVES: To study the safety of etoricoxib, a specific cyclooxygenase-2 inhibitor, and to determine whether it cross-reacts with @Disease$ in patients with @Chemical$-exacerbated respiratory disease (AERD)."	0
PURPOSE: Increasing evidence suggests that @Chemical$ use may protect against @Disease$.	0
"AIM: In this study, transnasal endoscopy was used to observe the time-course changes of @Disease$ with low-dose aspirin (@Chemical$), and the preventive effect of rebamipide was compared with placebo."	0
"METHODS: Patients who reacted to 2 or more chemically unrelated NSAIDs with urticaria and @Disease$, confirmed by a double-blinded provocation test with @Chemical$, were skin tested with inhalant allergens."	0
These include pill oesophagitis from @Chemical$ and ischaemic @Disease$ relating to serotonin antagonists.	0
"High-density lipoprotein @Chemical$ was also associated with severe @Disease$ (adjusted HR=3.05; 95%CI 1.39-6.68, per 1 mmol/L increase)."	1
We therefore tested whether addition of the leukotriene receptor antagonist @Chemical$ was of therapeutic benefit in a group of aspirin-intolerant patients with @Disease$ of whom 90% already were treated with moderate to high doses of glucocorticosteroids.	0
OBJECTIVE: To determine the incidence of major gastrointestinal and intracranial @Disease$ episodes in individuals with and without diabetes taking @Chemical$.	0
"OBJECTIVE: Aspirin exacerbated respiratory disease (AERD) is comprised of aspirin/@Chemical$ (ASA) sensitivity, @Disease$, and nasal polyposis."	0
"In monocytes, we found no changes in basal or lipopolysaccharide (LPS)-stimulated PGE2 synthesis, but the response to EP4 receptor activation with respect to inhibition of LPS-induced @Disease$ factor-alpha release was reduced in AERD patients, especially in the presence of aspirin (@Chemical$)."	0
Prophylactic treatment with desmopressin does not reduce @Disease$ after coronary surgery in patients treated with @Chemical$ before surgery.	0
Difference in risk of @Disease$ between users of enteric-coated and buffered low-dose @Chemical$.	0
"CONCLUSIONS: In patients with @Disease$, all combinations of warfarin, aspirin, and @Chemical$ are associated with increased risk of nonfatal and fatal bleeding."	0
"BACKGROUND: Non-steroidal anti-inflammatory drugs (NSAIDs) and low-dose acetylsalicylic acid (@Chemical$) have several @Disease$ (GI) effects, including upper GI bleeding."	1
Co-ingestion of aspirin and @Chemical$ promoting fulminant @Disease$: A critical review of Reye syndrome in the current perspective at the dawn of the 21st century.	0
BACKGROUND AND OBJECTIVES: The relative @Disease$ risk of @Chemical$ versus vitamin K antagonists (VKA) is unclear.	0
"We retrospectively reviewed the medical records for @Disease$ complications in 182 patients, most with coronary artery disease (mean age 61 +/- 11 years, 82% men) and being treated with high-dose fish oil (mean dose 3 +/- 1.25 g), aspirin (mean dose 161 +/- 115 mg), and clopidogrel (mean dose 75 mg), and in 182 age- and gender-matched controls treated with @Chemical$ and clopidogrel alone."	0
"QUESTION/PURPOSES: We sought to answer four questions: For the @Chemical$ and TKA cohorts, respectively, (1) was the incidence of readmission resulting from @Disease$ and bleeding complications higher with LMWH than mobile compression plus ASA; and (2) was the incidence of wound bleeding complications higher with LMWH than mechanical compression plus ASA?"	0
Oral and inhalation provocation tests for the diagnosis of @Chemical$-induced @Disease$.	1
"CONCLUSIONS: Our findings do not support that there is no difference in the risk of @Disease$ complications between enteric-coated LDA and buffered LDA, but rather may imply that the risk of GI complications associated with enteric-coated LDA is higher than that with buffered @Chemical$."	0
"Based on the results of the MATCH trial, combination therapy with aspirin plus @Chemical$ is not recommended for patients with ischaemic stroke or TIA due to the increased risk of @Disease$."	0
FCERIA gene promoter polymorphisms: lack of association with @Chemical$ @Disease$ whites.	1
Rationale: Daily high-dose aspirin therapy benefits many patients with @Chemical$-exacerbated respiratory disease but provides no benefit for aspirin-tolerant patients with @Disease$.	0
"However, the TNF-alpha -857 C &gt; T polymorphism was unrelated to the induction of UGIB by enteric-coated @Chemical$ in @Disease$ patients (P &gt; 0.05)."	0
"These studies demonstrated a non-significant increase in esophageal, gastric and duodenal ulcers during treatment with low-dose @Chemical$ (Odds Ratio = 1.22, P = 0.08), but a significant increase in bleeding @Disease$ (Odds Ratio = 1.77, P = 0.04)."	0
"As a major immunomodulatory role for airway innervation has been proposed in airway inflammatory diseases, the present study assessed changes in human nasal mucosa innervation in patients with @Chemical$-sensitive @Disease$ in comparison to a control group."	0
Aspirin (@Chemical$) is the mainstay of treatment in @Disease$.	0
"OUTCOMES: Albuminuria in random urine (albumin-@Chemical$ ratio &gt;or= 30 mg/g; n = 1,088) and reduced estimated glomerular filtration rate (eGFR; &lt;60 mL/min/1.73 m(2), n = 852) using the Modification of Diet in @Disease$ Study equation and the composite of either."	0
"The association between first-year mortality and preoperative use of @Chemical$ was analyzed with Cox regression adjusting for age, sex, type of @Disease$, baseline renal dysfunction and baseline cardiovascular and/or cerebrovascular disease."	0
OBJECTIVE: The purpose of this study is to estimate urinary LTB4 @Chemical$ (LTBG) concentration in the clinically stable condition in healthy subjects and asthmatic patients and to investigate changes in urinary LTBG concentration in patients with @Disease$ after aspirin challenge.	0
Gene-expression profiles in human nasal polyp tissues and identification of genetic susceptibility in @Chemical$-intolerant @Disease$.	0
The present study evaluated the dose-response for montelukast (ML) against nasal lysine-@Chemical$ challenge in patients with @Disease$.	0
[Mucoprotective drugs and @Chemical$-induced @Disease$].	1
Clinical studies have demonstrated that decreased responsiveness to @Chemical$ therapy is associated with an increased risk of @Disease$.	1
"@Chemical$-induced @Disease$: advances in pathogenesis, diagnosis, and management."	1
"Higher CHADS2 scores are associated with increasing rates of bleeding and stroke, but the balance between risks and benefits of @Chemical$ compared with aspirin is favorable irrespective of baseline @Disease$ risk."	0
There has been particular attention looking at the role of cyclo-oxygenase enzymes 1 and 2 and their role in @Chemical$-exacerbated @Disease$.	0
OBJECTIVE(S): The aim of this paper is to describe the utility of electronic personal health records (ePHRs) to identify patients with potential risk factors for @Chemical$-induced upper @Disease$ (UGIB).	0
"Previous studies indicate that @Disease$ related to corpus atrophy, as well as taking PPIs and co-treatment with angiotensin type 1 receptor blockers (ARBs) and statins seem to reduce peptic ulcer among @Chemical$ users."	0
"For upper GI complications we assumed a baseline incidence of 1 case/1000-persons-year, a twofold increased risk with low-dose @Chemical$, and estimated a 60% GI risk reduction with proton pump inhibitors (PPI) co-therapy and a 60% risk reduction with H. pylori eradication in patients with a history of peptic @Disease$."	0
"CONCLUSIONS: Among @Chemical$ users with a history of lower GI bleeding, continuation of aspirin is associated with an increased risk of recurrent lower GI bleeding, but reduced risk of serious cardiovascular events and @Disease$."	0
"METHODS: We performed a cohort study using nationwide registries to identify all Danish patients surviving first-time hospitalization for @Disease$ between January 1, 1997, and December 31, 2006, and their posthospital therapy of warfarin, @Chemical$, clopidogrel, and combinations of these drugs."	0
"CONCLUSIONS: Urinary @Chemical$ levels, a reflection of systemic oxidative stress, did not appear to contribute to @Disease$ to aspirin, while increased platelet production may partly explain this phenomenon."	0
"@Chemical$ is known to produce severe adverse gastrointestinal effects, such as @Disease$ and perforation."	1
"The toxicity of salicylates such as @Chemical$ in this population is well known and documented, specifically in the form of @Disease$."	1
Determinations were performed at baseline and following oral aspirin and celecoxib challenges in two well-defined @Disease$ phenotypes: aspirin-sensitive and @Chemical$-tolerant patients.	0
"Sudden onset of poor activity, poor appetite, lethargy, tachycardia, @Disease$, hepatomegaly, increased AST/ALT, coagulopathy and hyperammonemia developed 3 days after the high-dose @Chemical$ therapy."	1
Isolated periorbital @Disease$ induced by @Chemical$: a case report and review of the literature.	1
"Continuous @Chemical$ therapy for patients with gastrointestinal bleeding may increase the risk of recurrent @Disease$ but potentially reduces the mortality rates, as stopping aspirin therapy is associated with higher mortality rates."	1
"Various strategies have been proposed to reduce the gastrointestinal risk of @Chemical$, including gastroprotection with a proton pump inhibitor (PPI), eradication of @Disease$ and replacing aspirin with other anti-platelet agents."	0
"DISCUSSION: Patients with @Chemical$-provoked FDEIA have been reported previously as taking ordinary doses of aspirin for reducing pain, @Disease$ and fever."	0
@Chemical$-exacerbated respiratory disease (@Disease$)].	0
@Disease$ associated with combined clopidogrel and @Chemical$ therapy.	0
NSAIDs and/or @Chemical$ use are associated with complications from both the upper and the lower @Disease$.	1
"ASA-@Chemical$ did not influence the cyclooxygenase-induced @Disease$ significantly, but the inflammatory pain was reduced as effectively as in the case of equimolar ASA doses."	0
"CONCLUSION: In this small, selected population of individuals taking low-dose @Chemical$ for secondary prevention, carriage of the a allele of the eNOS gene was associated with a decreased risk for @Disease$."	0
"The antithrombotic treatment actually ongoing at major @Disease$ was TT in 44%, DT in 50%, and @Chemical$ in 6% of cases."	0
"Antenatal intake of low dose @Chemical$ is advised for prevention of pregnancy induced hypertension, @Disease$ and pre-term labour."	0
CONCLUSION: Clopidogrel and the combination of acetylsalicylic acid and dipyridamole were associated with similar risks for recurrent ischemic stroke and @Disease$; whereas @Chemical$ was associated with higher risks for both ischemic stroke and bleeding.	0
"The relationship between @Chemical$ sensitivity, @Disease$, and nasal polyps was first reported in 1922."	0
Chronic @Chemical$ intake may cause recurrent hyphema and secondary @Disease$ even after a microtrauma.	1
"CONCLUSIONS: In this study, we found higher concentrations of @Chemical$ and LTB4 in saliva from AIA patients than in saliva from ATA patients, suggesting that the quantification of CysLT and LTB4 concentrations in saliva may be another diagnostic strategy for @Disease$."	0
"[New guideline for peptic @Disease$ treatment, attention to low-dose @Chemical$]."	0
CONCLUSION: This study did not find more @Disease$ than in previous neurointerventional reports using DAPT with aspirin + @Chemical$ or aspirin + clopidogrel.	0
This phenomenon is called @Chemical$-Dependent Pseudo@Disease$ (PTCP) defined as falsely low platelet counts reported by automated hematology analyzers due to platelet aggretgation.	0
"@Chemical$ desensitization and continuous aspirin therapy constitute an effective option in patients with nonsteroidal anti-inflammatory drug-exacerbated @Disease$ (NERD) who have suboptimally controlled asthma or rhinosinusitis, or require multiple revision polypectomies."	0
"Multivariate regression analysis showed that exposure to @Chemical$>50 g [odds ratio (OR), 2.68, 95% confidence interval (CI), 1.08-6.70], age increase by 1 year (OR, 1.05, 95% CI, 1.02-1.08), and @Disease$ (OR, 2.40, 95% CI, 1.41-4.08) had positive associations with CKD progression."	0
"There were significantly more patients who suffered GI adverse events, principally abdominal pain, @Disease$, nausea and diarrhoea, with aspirin (18.5%) than with ibuprofen (11.5%), but the difference between ibuprofen and @Chemical$ (13.1%) was not significant."	0
The incidence of @Disease$ complications was higher in the group with the combined treatment compared to the group treated with @Chemical$ antagonists (0.1 patient per a year versus 0.06 patient per a year).	0
"@Chemical$, aspirin and progression of advanced @Disease$."	0
Method: Eighty-six patients with CRS and asthma who were treated in the outpatient clinic during March 2015 to January 2018 were divided into asthma group(52 cases) and aspirin asthma group(34 cases) according to asthma and @Chemical$ @Disease$.	1
@Disease$ in low-dose @Chemical$ users.	1
"There is a well-recognized association of @Chemical$ sensitivity, aspirin-induced asthma, nasal polyposis or @Disease$, known as Samter's triad."	0
RESULTS: Twenty-one patients with @Disease$ were compared with 19 patients with @Chemical$-tolerant asthma (ATA).	0
The present study evaluated the dose-response for @Chemical$ (@Disease$) against nasal lysine-aspirin challenge in patients with AIA.	0
"Clopidrogel and @Chemical$ are antiplatelet agents widely used in the treatment of peripheral vascular, cerebrovascular, and @Disease$."	0
"RESULTS: One-year risks for ischemic @Disease$ were 1.0-1.2 % with @Chemical$, 0-0.3 % with warfarin, and 0.1-0.2 % without treatment at CHA2DS2VASc scores 0-1."	1
"Also, women had less peripheral artery disease (aspirin, 2.4% versus 3.7%; apixaban, 1.4% versus 3.0%), more heart failure, and higher mean CHADS2 (congestive @Disease$, hypertension, age of 75 years or older, diabetes [1 point each], stroke or transient ischemic attack [2 points]) scores (@Chemical$, 2.2 versus 2.0; apixaban, 2.1 versus 2.0)."	0
"The role of Helicobacter pylori is controversial in NSAID users, but there is now wide agreement that H. pylori @Disease$ and the risk of upper GI bleeding in low-dose @Chemical$ users."	0
"The median @Disease$ in the aspirin regimen was 3, while those in both aspirin + rabeprazole 10 mg and aspirin + @Chemical$ 40 mg regimens were 0."	0
Association of FANCC polymorphisms with FEV1 decline in @Chemical$ exacerbated @Disease$.	1
"There were significantly more patients who suffered GI adverse events, principally abdominal pain, @Disease$, nausea and diarrhoea, with aspirin (18.5%) than with @Chemical$ (11.5%), but the difference between ibuprofen and paracetamol (13.1%) was not significant."	0
Adjusted HRs for @Chemical$ versus the combination of acetylsalicylic acid and dipyridamole were 1.02 (95% confidence interval [CI]: 0.89-1.17) for ischemic @Disease$ and 1.06 (95% CI: 0.83-1.35) for bleeding.	0
"@Chemical$ tended to be used in higher-risk patients: composite of @Disease$, myocardial infarction or stroke at 5.8 versus 4.2% (p = 0.056)."	0
CONCLUSIONS: It seems that the @Chemical$ pack size reduction has not achieved as large an @Disease$ rate reduction as might have been expected.	0
"The 1-year predicted risks associated with @Chemical$, the combination of acetylsalicylic acid and dipyridamole, and clopidogrel were 11.1 (95% CI: 10.2-12.2), 7.7 (95% CI: 7.3-8.3), and 8.0 (95% CI: 6.9-8.7) for ischemic stroke, respectively; while, the risks for @Disease$ were 3.4 (95% CI: 2.8-3.9), 2.4 (95% CI: 2.1-2.7), and 2.4 (95% CI: 1.9-2.9), respectively."	0
Arterial blood @Chemical$ averaged 172.4+/-71.3 micromol/L and @Disease$ averaged 35.2+/-17.0 mg/dl.	0
We studied the incidence of @Disease$ in high-risk patients taking long-term low-dose @Chemical$ or non-aspirin-NSAIDs combined with omeprazole in a real-life clinical setting.	0
This study evaluated the association of BMI and asthma in patients with @Chemical$-tolerant asthma (ATA) and aspirin-intolerant @Disease$ (AIA).	0
Early effects of @Chemical$ desensitization treatment in asthmatic patients with aspirin-exacerbated @Disease$.	0
@Chemical$ use in myeloma: a note of caution regarding potential @Disease$ factor-alpha elevation.	1
Does rebamipide prevent @Disease$ in patients taking aspirin and @Chemical$?	0
"While the expression of the EP4 receptor in eosinophils was unaltered in @Disease$ patients, inhibition of eosinophil chemotaxis by @Chemical$ or the EP4 agonist CAY10598 was less pronounced in AERD patients as compared to healthy control subjects."	0
"Sixty-three subjects without known aspirin sensitivity (13 controls, 17 nasal @Disease$ alone, 15 nasal polyps and asthma and 18 asthma alone) inhaled increasing concentrations of nebulized lysine @Chemical$."	0
"Aspirin-exacerbated respiratory disease (AERD) refers to the combination of @Disease$, chronic rhinosinusitis with nasal polyposis, and acute upper and lower respiratory tract reactions to the ingestion of aspirin (@Chemical$, ASA) and other cyclooxygenase-1 inhibiting non-steroidal anti-inflammatory drugs."	0
"In a pooled analysis, major/life-threatening @Disease$ on A+C occurred in 9/241 @Chemical$-naive patients (90-day risk = 4.8%, 1.6-8.0) versus 1/204 prior-aspirin patients (p = 0.009)."	0
"In subgroup analysis, aspirin use was associated with @Disease$ in the patients with no history of stroke (HR, 1.41; 95% CI, 1.14-1.73), and there was a borderline interaction between previous stroke and the use of @Chemical$ on renal failure (interaction p=0.0565)."	0
H. pylori infection and @Chemical$ interact synergic and negative synergic with reference to @Disease$.	0
"We studied two genotypic and allelic frequencies of rs2427827 (-344C/T) and rs2251746 (-66T/C) gene polymorphisms of FcepsilonRIalpha in 20 patients with AICU, 52 subjects with airway @Disease$ without @Chemical$ intolerance, and 50 controls in a Chinese population."	0
"However, @Chemical$ treatment was associated with significantly increased risks of any bleeding (RR 1.63; 95% CI: 1.31-2.03; P &lt; 0.01), major bleeding (RR 1.41; 95% CI: 1.26-1.57; P &lt; 0.01), and GI @Disease$ (RR 1.85; 95% CI: 1.38-2.48; P &lt; 0.01) compared with placebo."	1
"The odds ratio (OR) of chronic @Disease$ (CLL/SLL) was 0.85 (95%CI: 0.75-0.97, p=0.02), The ORs of follicular lymphoma (FL) and large B-cell lymphoma (DLBCL) in individuals exposed to @Chemical$ were 1.12 (95%CI: 0.86-1.45, p=0.37) and 1.03 (95%CI: 0.9-1.19, p=0.6) respectively."	0
"RESULTS: The final analysis included 1470 study participants: 221 controls, 553 @Chemical$ without @Disease$ (CRSsNPs), 651 CRS with nasal polyps (CRSwNPs) and 45 allergic fungal rhinosinusitis (AFRS)."	0
"The patients who received ASA therapy were divided according to the results of a @Disease$ test into @Chemical$-resistant, ASA-semiresponsive, and ASA-sensitive groups."	0
"By Cox modeling, @Chemical$ use was associated with a 2.4-fold lower risk of @Disease$ (p = 0.03) in the late hazard period."	0
"Thrombolysis In Myocardial Infarction (TIMI) defined minor @Disease$ was also significantly higher with a high dose @Chemical$ with OR: 1.22, 95 % CI: 1.02-1.47; P = 0.03."	1
"This meta-analysis was aimed to assess the efficacy and safety of adding @Chemical$ to aspirin on @Disease$ prevention in high vascular risk patients, and to provide evidence for a suitable duration of dual antiplatelet therapy."	0
"Similarly, LTC4 synthase activity in platelets from AIA and aspirin-tolerant @Disease$tics (ATA) was reduced by approximately 50% after pre-treatment with @Chemical$ in vitro."	0
"Our previous studies demonstrated that aspirin blocks trafficking of STAT6 into the nucleus and thereby prevents IL-4-mediated induction of these transcripts, thereby suggesting a modality by which @Chemical$ desensitization could provide therapeutic benefit for @Disease$ patients."	0
We investigated the role of serum specific IgE to thyroid peroxidase (TPO) in patients with @Chemical$ intolerant acute urticaria (AIAU) and aspirin intolerant chronic @Disease$ (AICU).	0
"The RR of @Disease$ requiring reintervention was not significantly higher for any agent compared to control [RR 0.96 (0.76-1.22, P = 0.76) for aspirin, 1.84 (0.87-3.87, P = 0.11) for @Chemical$, and 1.51 (0.92-2.49, P = 0.1) for DAPT]."	0
"In urticaria or angioedema induced by multiple NSAIDs, patients without underlying disease develop urticaria or @Disease$ 30-90 minutes after ingestion of COX-1-inhibiting NSAIDs including @Chemical$."	0
"QUESTION/PURPOSES: We sought to answer four questions: For the THA and TKA cohorts, respectively, (1) was the incidence of readmission resulting from VTE and bleeding complications higher with LMWH than mobile compression plus @Chemical$; and (2) was the incidence of wound @Disease$ complications higher with LMWH than mechanical compression plus ASA?"	0
Is @Chemical$ associated with @Disease$?	1
"CASE REPORT: We present the case of a 56-year-old woman with a long history of headache and abuse of @Chemical$ and antiinflamatory drugs who was admitted for generalized @Disease$, right hemiparesis and coma."	0
"Those receiving apixaban/aspirin had similar @Disease$ risk compared with those receiving thienopyridine/@Chemical$ (HR 1.01, 95% CI 0.53-1.95)."	0
"The triad of bronchial asthma, nasal polyposis, and intolerance to aspirin and @Chemical$-like chemicals are designated aspirin-induced @Disease$ (AIA) or Samter's syndrome."	0
"RESULTS: The cumulative incidence of @Disease$ at 30 days was 23.1% and 16.1% in patients who were receiving dual antiplatelet therapy and @Chemical$ monotherapy, respectively (unadjusted hazard ratio [HR], 1.51; 95% confidence interval [CI], 1.09-2.08)."	0
"@Chemical$, commonly known as aspirin, can induce some hypersensitive reactions with clinical symptoms such as @Disease$, angioedema, acute bronchospasm, and rarely anaphylactic shock."	1
"Low-dose @Chemical$ dose, @Disease$ by Helicobacter pylori, NSAID intake, and absence of enteric coating, are possible risk factors for non-complicated peptic ulcer."	0
"CONCLUSION: These results indicate that it is very important to prevent @Chemical$-induced gastroduodenal @Disease$ complications, including bleeding."	1
"However, patients in the cilostazol group had less @Disease$ than did patients in the @Chemical$ group (1.5% vs 4.9%, P=0.035)."	0
"With regard to the metabolism of arachidonic acid (AA) in NSAID-intolerant @Disease$tic patients, the following changes have been observed: 1) A low production of @Chemical$, seemingly due to deficient Cox-2 regulation; 2) an increased expression of leukotriene-C4 synthase; and 3) a reduced production of metabolites (lipoxins) released through the transcellular metabolism of AA."	0
@Disease$ after lumbar puncture in a patient receiving @Chemical$ and clopidrogel.	1
"DATA SOURCES: Articles evaluating aspirin for primary prevention of CVD were gathered using a MEDLINE search with the keywords aspirin review, aspirin peripheral artery disease, @Chemical$ @Disease$, aspirin coronary artery disease, aspirin diabetes, aspirin primary prophylaxis, and aspirin elderly."	1
Clinical history and observed @Chemical$ provocation test remains gold standard for diagnosis of @Disease$.	0
@Disease$ as possible complication of @Chemical$ treatment in patient with aspirin-exacerbated respiratory disease.	1
"Trans fat, @Chemical$, and @Disease$ in postmenopausal women."	0
The effects of proton pump inhibition on patient-reported severity of @Disease$ when receiving dual anti-platelet therapy with clopidogrel and low-dose aspirin: analysis from the @Chemical$ and the Optimization of Gastrointestinal Events Trial.	0
"Thus, we investigated the effect of antioxidant enzyme cofactors-zinc and selenium-supplementation on superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), and malondialdehyde (MDA) levels (erythrocyte and liver) and @Disease$ during @Chemical$ treatment at therapeutic doses."	1
CONCLUSIONS: @Chemical$ hypersensitivity manifesting as @Disease$/angioedema remains present after 4 years in about two thirds of patients.	1
"With the increasing prevalence of obesity and conflicting data regarding the effect of aspirin in older adults, understanding the potential association of @Chemical$ use with @Disease$ mortality according to body mass index (BMI) and age is imperative."	0
"@Chemical$-exacerbated respiratory disease (AERD) is the most common phenotype characterized by an eosinophil-dominated inflammatory disease of the airways that presents clinically with @Disease$, chronic sinusitis and bronchial asthma."	0
"Sodium cromoglycate (SCG) is used for the treatment of atopic dermatitis with food allergy, but the efficacy of @Chemical$ in ASP-exacerbated @Disease$ reactions is unclear."	0
AIM: To investigate the clinical differences between small intestinal injuries in low-dose @Chemical$ (LDA) users and in non-steroidal anti-inflammatory drug (NSAID) users who were examined by capsule endoscopy (CE) for @Disease$ (OGIB).	0
"Pocket revision for @Disease$ evacuation was needed in four patients (2%), three of whom were on DAPT and only one on @Chemical$."	0
Multiple regression analysis confirmed that aspirin-intolerant asthma (@Disease$) was strongly associated with @Chemical$.	0
"Of the patients on aspirin, 20 (56%) had @Disease$, compared with 83 (59%) of those not taking @Chemical$ (difference 3%, 95% confidence interval, CI, -15 to 21)."	0
"We encountered lower gastrointestinal bleeding in 16 patients taking a low dose of @Chemical$ and examined the effect of low aspirin dose on the stool occult blood test in @Disease$ patients (mean: 76.7 +/- 9.6 years old) including 39 with cerebral infarction, 8 with ischemic heart disease and 2 with atrial fibrillation."	0
"BACKGROUND: Although it is well known that @Chemical$ causes @Disease$ and that aspirin-induced gastroduodenal mucosal injury is often asymptomatic, the prevalence and independent factors for gastroduodenal mucosal injury have not been clarified in asymptomatic patients taking low-dose aspirin and gastroprotective agents."	1
Comparison of preoperative continuation and discontinuation of @Chemical$ in patients undergoing total hip or knee @Disease$.	0
"Associations of several HLA alleles with subtypes of AI, such as aspirin-induced urticaria and aspirin-induced @Disease$, and single nucleotide polymorphisms in genes encoding enzymes involved in @Chemical$ metabolism have been shown."	0
"Data Sources: We searched PubMed, Embase, CENTRAL, and ClinicalTrials.gov from inception to May 28, 2018, with the terms novel oral anticoagulants, non-vitamin K antagonist oral anticoagulants, direct oral anticoagulants, dabigatran, rivaroxaban, apixaban, @Chemical$, warfarin, Coumadin, vitamin K antagonist, aspirin, acetylsalicylic acid, or ASA, and major bleeding, fatal bleeding, or @Disease$."	0
Aspirin exacerbated respiratory disease (AERD) is a clinical syndrome characterized by chronic rhinosinusitis with nasal polyposis and @Chemical$ @Disease$.	1
Gene expression profiling of nasal @Disease$ associated with chronic sinusitis and @Chemical$-sensitive asthma.	0
OBJECTIVES: The aim of this study was to examine the relationship of serum gliadin levels and @Disease$ induced by exercise or @Chemical$ in patients with WDEIA.	1
OBJECTIVE: This study aimed to assess sinonasal outcomes in patients with aspirin exacerbated @Disease$ (AERD) undergoing @Chemical$ desensitization following endoscopic sinus surgery (ESS).	0
"Although the disease is clinically well characterized, its physiopathology is incompletely understood and noninvasive procedures, allowing an effective distinction between aspirin-induced asthma (@Disease$) and @Chemical$-tolerant asthma (ATA) are missing."	0
"She had no symptom of @Disease$ and asthma, and had the both character of aspirin urticaria and asthma as to @Chemical$ challenge test."	0
"We collected data on the use of @Chemical$ at implantation, INR prior to device implantation, use of dual-antiplatelet therapy (DAPT), such as concomitant aspirin and clopidogrel and subsequent formation of @Disease$ in the peri-procedure period."	0
"BACKGROUND/AIMS: Many patients with aspirin-induced @Disease$ have severe methacholine airway hyperresponsiveness (AHR), suggesting a relationship between aspirin and @Chemical$ in airway response."	0
Moreover some patients with imperative cardiologic indications for combination therapy with @Chemical$ and clopidogrel (stent placement and/or acute coronary syndrome) have a history of @Disease$ to aspirin.	0
"The drugs significantly associated with @Disease$ were loxoprofen (aOR 5.0), diclofenac (aOR 3.1), diclofenac suppository (aOR 8.0), etodolac (aOR 4.9), enteric-coated aspirin (aOR 3.9), buffered aspirin (aOR 9.9), @Chemical$ (aOR 2.5), and cilostazol (aOR 7.3)."	0
"CONCLUSIONS: For the treatment of high-risk @Disease$ or minor stroke patients, the @Chemical$-aspirin treatment did not increase the number of CMB than Aspirin alone."	0
"Reye syndrome, characterized by acute encephalopathy, selective liver damages, a @Disease$ in visceral organs and miserable prognosis, is probably caused by various drugs, especially antipyretic such as @Chemical$."	1
Bleeding during treatment with aspirin versus apixaban in patients with atrial fibrillation unsuitable for warfarin: the apixaban versus @Chemical$ to prevent stroke in @Disease$ patients who have failed or are unsuitable for vitamin K antagonist treatment (AVERROES) trial.	0
"CONCLUSIONS: We observed poor short-term outcomes and increased mortality, probably attributable to rapid @Disease$, in the subjects with ICH who had been taking regularly moderate doses of @Chemical$ (median 250 mg) immediately before the onset of the stroke."	1
"In two separate series, platelet aggregation and carrageenan @Disease$-induced inflammatory pain were measured in control, ASA and @Chemical$-Tris-treated groups."	0
"However, major gastrointestinal @Disease$ occurred in significantly more @Chemical$- than placebo-treated patients (13 [1.4%] vs 3 [0.3%] [P = .011])."	0
CONTEXT: @Chemical$ is widely used for relief of @Disease$ and for cardioprotective effects.	0
"Although it is still controversial whether @Chemical$ modifiers are more effective in patients with AIA compared with other types of asthma, because LT plays an important role in the pathogenesis of AIA, leukotriene modifiers are the preferred medication for the long-term control of @Disease$."	0
Meta-analysis of major @Disease$ events on aspirin versus @Chemical$ antagonists in randomized trials.	0
Helicobacter pylori and @Chemical$ seem to be independent risk factors for peptic ulcer and @Disease$.	1
BACKGROUND: @Chemical$ desensitization (AD) is an effective and safe therapeutic option for patients with nonsteroidal anti-inflammatory drugs (NSAIDs)-exacerbated respiratory disease (@Disease$).	0
Our case is the second one in which @Disease$ from a meningioma may have been induced by @Chemical$ prophylaxis.	1
"RESULTS: Pretreatment with HRW obviously reduced @Chemical$-induced @Disease$ scores (4.04 +- 0.492 vs 2.10 +- 0.437, P &lt; 0.05)."	1
"METHODS: Preoperative computed tomography (CT), pre- and postoperative endoscopy, and two validated disease specific QOL instruments, the Rhinosinusitis Disability Index (@Chemical$) and @Disease$ (CSS), were collected."	0
Overproduction of LT by suppression of cyclooxygenase activity is involved in patients with @Chemical$-intolerant @Disease$ (AIA).	0
@Disease$ adverse effects related mainly to gastro-duodenal ulcers are more frequent in case of the regular use of @Chemical$.	0
"Using a multiple regression analysis, the administration of non-aspirin NSAIDs was identified as an independent factor for the decreased serum @Chemical$ and the decreased @Disease$ levels."	0
"DATA SOURCES: Articles evaluating aspirin for primary prevention of CVD were gathered using a MEDLINE search with the keywords aspirin review, aspirin peripheral artery disease, aspirin @Disease$, aspirin coronary artery disease, @Chemical$ diabetes, aspirin primary prophylaxis, and aspirin elderly."	0
Bleeding during treatment with aspirin versus apixaban in patients with atrial fibrillation unsuitable for warfarin: the apixaban versus @Chemical$ to prevent @Disease$ in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment (AVERROES) trial.	0
RESULT: Thirty-eight @Chemical$-response-related variants that had clinical significance had been detected in the 620 WES data.Ten (26%) of them were related with drug efficacy while 28 (74%) were related with @Disease$ or adverse drug reaction (ADR).	0
BACKGROUND: Chronic inflammation with tissue eosinophilia plays a key role in the pathogenesis of asthma and nasal @Disease$ in patients with @Chemical$ hypersensitivity.	0
"Compared with rates of patients receiving @Chemical$ alone (0.03 per patient-year), rates of @Disease$ were higher among patients receiving the antiplatelet combination (0.07 per patient-year), the anticoagulant combination (0.08 per patient-year), and the 3-drug combination (0.09 per patient-year)."	0
"Univariate analysis showed that continuous aspirin use was not significantly associated with @Disease$ complications (odds ratio, 0.933; 95% confidence interval, 0.283-3.074; P = .910 in the @Chemical$ and control groups) and that discontinuous aspirin use was not significantly associated with bleeding complications (odds ratio, 0.963; 95% confidence interval, 0.230-4.025; P = .959 in the aspirin and control groups; odds ratio, 0.969; 95% confidence interval, 0.198-4.752; P = .969 in the aspirin and discontinuous groups)."	0
Rationale: Daily high-dose @Chemical$ therapy benefits many patients with aspirin-exacerbated respiratory disease but provides no benefit for aspirin-tolerant patients with @Disease$.	1
Eosinophilic esophagitis as possible complication of aspirin treatment in patient with @Chemical$-exacerbated @Disease$.	0
Polymorphism of tandem repeat in promoter of 5-lipoxygenase in @Chemical$-intolerant asthma: a positive association with @Disease$.	0
BACKGROUND: @Chemical$ desensitization (@Disease$) treatment at doses of up to 1300 mg/day improves outcomes in aspirin-exacerbated respiratory disease (AERD).	0
PPIs were superior to H2RA in prevention of @Chemical$-associated GI ulcers (OR = 0.12; 95%CI: 0.02-0.65) and @Disease$ (OR = 0.32; 95%CI: 0.13-0.79).	0
"Within 90 days after intervention, there were 4 patients (1.5%) with acute thrombosis, 5 patients (1.8%) with subacute @Disease$, 17 patients (6.2%) with stroke, and 2 death (0.7%) in low-dose aspirin group, compared with no patient (0%) with acute thrombosis, 2 patient (2.1%) with subacute thrombosis, 6 patients (6.2%) with stroke, and 2 death (2.1%) in high-dose @Chemical$ group, and there were no significant difference in all study endpoints between two groups."	0
"OBJECTIVES AND METHODS: The cysteinyl leukotriene receptor 2 (CYSLTR2) gene on chromosome 13q14.12-q21.1 encodes a receptor for CYSLTs, potent biological mediators in the pathogenesis of @Disease$, particularly that associated with @Chemical$ intolerance (AIA)."	1
"There is a well-recognized association of @Chemical$ sensitivity, aspirin-induced asthma, @Disease$ or sinusitis, known as Samter's triad."	0
"In conclusion, @Chemical$ could be an effective therapy for secondary prevention of @Disease$ as studies are showing similar efficacy in preventing MACE with reduced GI side effects."	0
"PURPOSE OF REVIEW: @Chemical$-exacerbated respiratory disease (AERD) is a progressive inflammatory disease of the upper and lower airways characterized by marked @Disease$, asthma, and respiratory reactions to medications that inhibit the cyclooxygenase pathway."	0
Neither @Chemical$ dose nor duration of use had consistent effects on RRs for upper GI @Disease$.	0
We aimed to assess the presence of apoptotic cells in nasal polyps from @Chemical$-hypersensitive (AH) and aspirin-tolerant (AT) patients with rhinosinusitis as related to the characteristics of local @Disease$.	0
[@Chemical$ and risk of perioperative @Disease$].	0
The aim of this study was to compare the peri- and postoperative @Disease$ complication rates associated with @Chemical$ intake in patients undergoing VP shunt placement.	0
"We evaluated changes in leukotriene and prostaglandin metabolites for NIUA patients, using patients with NECD and single-NSAID-induced urticaria/@Disease$ or anaphylaxis (S@Chemical$A) for comparison."	0
Post-PCI fatal @Disease$ in aspirin and @Chemical$ hyper responder: shifting from antiplatelet resistance to bleeding risk assessment?	0
"BACKGROUND: In patients with aspirin-exacerbated @Disease$ (AERD), pretreatment with asthma controller medications (@Chemical$ modifiers, inhaled or systemic corticosteroids, and salmeterol) partially modifies the severity of aspirin-induced asthmatic reactions."	0
"Main complications in the four treatment groups (no anticoagulant treatment, aspirin, LMWH, @Chemical$ and LMWH) included @Disease$ of pregnancy (9.4%, 23.3%, 50%, 18.4%, respectively, p = 0.12) and preterm birth (16.7%, 34.3%, 75%, 36.8%, respectively, p &lt; 0.001)."	0
BACKGROUND: The blocking effect of controller medications for asthma could have an effect on the outcome of aspirin challenges in patients suspected of having @Chemical$-exacerbated respiratory disease (@Disease$).	0
An alternative treatment for many @Disease$ patients is @Chemical$ desensitization.	0
@Chemical$ @Disease$.	1
The incidence of @Chemical$-induced gastrointestinal mucosal injury and @Disease$ has increased.	1
"The main models included the following predictors: demographic characteristics (age, ethnicity, and socioeconomic deprivation), clinical measurements (systolic blood pressure and ratio of total-high-density lipoprotein cholesterol), family history of premature CVD, medical history (smoking, diabetes, bleeding, peptic @Disease$, cancer, chronic liver disease, chronic pancreatitis, or @Chemical$-related conditions), and medication use (nonsteroidal anti-inflammatory agents, corticosteroids, and selective serotonin reuptake inhibitors)."	0
"Finally, various medicamentous methods of counteracting @Chemical$-induced @Disease$ and excessive bleeding in this context are elicited, discussed and evaluated."	1
"Platelet reactivity time (PRT) and whole @Disease$ (WBA) were measured in 160 healthy volunteers, before and after aspirin and in 170 participants with established vascular disease or risk factors thereof treated with aspirin +- @Chemical$."	0
Gastrointestinal (@Disease$) complications are common side effects related to non-steroidal anti-inflammatory drugs (NSAID) and low-dose aspirin (@Chemical$) use.	0
Expression of cyclooxygenase and lipoxygenase enzymes in nasal @Disease$ of aspirin-sensitive and @Chemical$-tolerant patients.	0
"Logistic regression indicated that the frequency of the rare alleles of -262 A&gt;T and -115 T&gt;C was higher in subjects with AIA than in subjects with @Chemical$-tolerant @Disease$ (ATA) (P=0.003-0.01, P( corr)=0.015-0.05)."	0
Omalizumab for Aspirin-@Disease$ and @Chemical$ Overproduction in Aspirin-Exacerbated Respiratory Disease: A Randomized Trial.	0
"At admission, compared with @Chemical$ sensitive patients (ASP), patients with APR had more frequently diabetes, anterior infarction and @Disease$, while AHR patients had reduced values of creatine kinase, leukocytes, heart rate and systolic blood pressure."	0
AIMS: To investigate through endoscopic examination the frequency of @Disease$ associated with buffered and enteric-coated @Chemical$ (ECA).	0
"METHODS AND RESULTS: In total, 42 patients with no @Disease$, 34 with nuisance bleeding, and 14 with alarming bleeding underwent platelet reactivity testing 1 month to 1 year after PCI with light transmission aggregometry (LTA 5 and 20 muM adenosine disphosphate [@Chemical$]), vasodilator stimulated phosphoprotein phosphorylation (VASP) and VerifyNow P2Y12."	0
"Three major clinical phenotypes of NSAID-induced acute skin reactions manifesting with angioedema, urticaria, or both have been distinguished: NSAID-exacerbated cutaneous disease, nonsteroidal anti-inflammatory drug-induced urticaria/@Disease$ (@Chemical$), and single NSAID-induced urticaria and angioedema."	0
"The most significant harm associated with @Chemical$ is major @Disease$, yet there is a paucity of data on bleeding risk in suitable community populations."	1
"Animal and in vitro studies suggest that the use of @Chemical$ may be associated with reduced risk for @Disease$, but results from these studies of the association have been inconsistent."	0
"However, a history of previous UGI @Disease$ is a major risk factor for @Chemical$-associated bleeding."	0
[@Chemical$ or non-steroidal analgesics increase risk of @Disease$ in anticoagulated patients].	1
"BACKGROUND AND AIMS: Nitric oxide-releasing aspirin (NO-ASA) has been shown to inhibit cyclo-oxygenase and prostaglandin generation without causing @Disease$, but the role of @Chemical$ (ROS) and cytokines in the action of ASA and NO-ASA against acute gastric damage has been little studied."	0
"RESULTS: At baseline, patients with @Disease$ had significantly higher plasma levels of 9alpha,@Chemical$(2) than either patients with ATA or healthy subjects."	0
"Age, male gender, Helicobacter pylori (H. pylori)infection, diabetes, chronic kidney disease (@Disease$), cirrhosis, history of uncomplicated peptic ulcer disease (PUD), and use of NSAIDs, COX-2 inhibitors, steroids, and thienopyridines were independent risk factors for UGIB among @Chemical$ users."	0
"Conventionally, hypersensitivities include aspirin-exacerbated @Disease$ (AERD), @Chemical$-induced urticaria, and anaphylaxis."	0
"However, in patients achieving a good TTR, the risk of major @Disease$ with VKA or @Chemical$ is similar."	0
We aimed to assess the presence of apoptotic cells in nasal polyps from @Chemical$-hypersensitive (@Disease$) and aspirin-tolerant (AT) patients with rhinosinusitis as related to the characteristics of local inflammation.	0
"METHODS: Ninety-four aspirin-induced urticaria patients presenting urticaria/@Disease$-induced by both ASA and NSAID (50 had underlying chronic urticaria) and showing positive responses on oral @Chemical$ challenge test, 76 aspirin-intolerant asthmatics with positive responses on lysine-aspirin bronchoprovocation test, and 185 normal healthy controls were enrolled."	0
"METHODS: For 4 years, we followed up 22 patients with chronic idiopathic @Disease$ and @Chemical$ hypersensitivity who restrained from the use of aspirin and other COX-1 inhibitors."	0
"CONCLUSIONS: The patient's history and the intensity of @Disease$ are not similar in all nasal polyposis patients, that support the classification into PP, A and @Chemical$ groups."	0
"@Chemical$ has a role in the prevention of cardiovascular and cerebrovascular disease, Alzheimer's dementia and several @Disease$."	0
"Use of @Chemical$ at intermediate doses (2-5.9 standard, 325-mg tablets/wk) and frequency (4-6 days/wk) were associated with the highest risk of @Disease$ (multivariable HR, 2.32; 95% CI, 1.34-4.02, and multivariable HR, 3.13; 95% CI, 1.82-5.38, respectively)."	1
"We found that it is the fracture site, rather than @Chemical$ use pre-operatively, that is predictive of blood loss and transfusion requirements in patients presenting with @Disease$s."	0
AIM: To compare the incidence of post-@Disease$ in patients with and without prior @Chemical$ therapy.	0
CONCLUSIONS: Patients on an @Chemical$ therapy regimen have a markedly increased risk of SDH after a shunt has been implanted for the treatment of normal-pressure @Disease$.	0
This study evaluated the association of BMI and asthma in patients with aspirin-tolerant asthma (ATA) and @Chemical$-intolerant @Disease$ (AIA).	0
The crude incidence rate for @Disease$ was highest for dual @Chemical$ and warfarin therapy (13.9% per patient-year) and triple therapy (15.7% per patient-year).	0
National estimates of emergency department visits for @Disease$-related adverse events from clopidogrel plus aspirin and from @Chemical$.	0
Current Knowledge and Management of @Disease$ to @Chemical$ and NSAIDs.	1
"The study cohort included patients referred for transurethral prostatectomy, open prostatectomy and transurethral resection of @Disease$ while receiving @Chemical$ prophylaxis."	1
"Nonetheless, the fact that low-dose @Chemical$ approximately doubles risk for serious @Disease$ may impede health authorities from recommending its use by people judged to be at low cardiovascular risk."	1
Off-pump coronary bypass grafting has been proposed as an alternative technique to attenuate @Disease$ associated with @Chemical$.	1
BACKGROUND: Current @Chemical$ (ASA) dosing algorithms for the prevention of secondary @Disease$ in acute coronary syndrome (ACS) patients are inconsistent and lack sufficient data support.	0
"At about 4 years follow-up, no significant difference was observed among the aspirin and non@Chemical$ use group in major adverse cardiac events free survival estimates (95.7% versus 91.5%, P = 0.23) and freedom from cardiogenic readmission (88.5% versus 85.3%, P = 0.77) whereas the @Disease$ recurrence free survival rates was 83.7% and 73.9% in the aspirin and nonaspirin use group respectively (P = 0.02), with odd ratio for preoperative aspirin estimated at 0.71 (95% confidence interval, 0.49-1.04, P = 0.08)."	0
"Low-dose @Chemical$, one of non-steroidal anti-inflammatory drugs(NSAIDs), has been increasingly used to prevent cardiovascular and cerebrovascular disease through its antiplatelet effect, mainly in the aged population, but aspirin treatment has been associated with gastrointestinal injures, especially peptic @Disease$ bleedings."	0
OBJECTIVES: To study whether Clopidogrel-@Chemical$ combined treatment for high risk transient ischaemic attack (TIA) or minor @Disease$ results in increased number of lesions associated with anti-thrombotic cerebral haemorrhage or cerebral micro-bleeds (CMB) than aspirin alone treatment.	0
"The use of @Chemical$, as part of a dual antiplatelet therapy regimen, is an established standard following coronary stenting in patients suffering from @Disease$ (ACS)."	0
"CONCLUSION: This is the first study to report that @Chemical$ therapy is not associated with increased rates of perioperative bleeding, transfusion requirement, or major procedure related complications after elective @Disease$ surgery."	0
BACKGROUND: @Chemical$-exacerbated @Disease$ is under-diagnosed and therefore effective and inexpensive therapy with aspirin desensitization is rarely performed.	1
"We found that it is the fracture site, rather than @Chemical$ use pre-operatively, that is predictive of @Disease$ and transfusion requirements in patients presenting with hip fractures."	0
"The @Disease$ (@Chemical$, Aspirin, Ibuprofen New tolerability) study was a blinded randomised comparison of the tolerability of OTC analgesics in the treatment of common types of acute pain encountered in the community."	0
"DATA SOURCES: Articles evaluating aspirin for primary prevention of CVD were gathered using a MEDLINE search with the keywords aspirin review, aspirin peripheral artery disease, @Chemical$ stroke, aspirin coronary @Disease$, aspirin diabetes, aspirin primary prophylaxis, and aspirin elderly."	0
"Regular @Chemical$ use (i.e. 2 or more days/week) was associated with a higher risk of @Disease$ (hazard ratio=1.45; 95% confidence interval, 1.02-2.04) after adjustment for various confounding factors."	1
Thirty-one (45%) in the clopidogrel group and 25 (42%) in the @Chemical$ group had a minor @Disease$.	0
"The main models included the following predictors: demographic characteristics (age, ethnicity, and socioeconomic deprivation), clinical measurements (systolic blood pressure and ratio of total-high-@Chemical$), family history of premature CVD, medical history (smoking, diabetes, bleeding, peptic ulcer disease, cancer, chronic liver disease, @Disease$, or alcohol-related conditions), and medication use (nonsteroidal anti-inflammatory agents, corticosteroids, and selective serotonin reuptake inhibitors)."	0
"If these recommendations were followed, and if @Disease$ occurred in 3% of persons, a significant proportion of the deaths may be attributable to @Chemical$."	1
"In case 2, premedication of @Chemical$ suppressed the @Disease$ and elevation of blood gliadin levels which were induced by wheat and aspirin intake."	0
@Chemical$ desensitization as a treatment for aspirin-sensitive chronic spontaneous @Disease$.	0
Use of aspirin combinations with @Chemical$ and increasing @Disease$ frequency: a prospective population-based study.	0
Dietary modifications toward a diet that is high in omega-3 fatty acids and low in @Chemical$ can reduce the production of the inflammatory leukotriene and prostaglandin D2 lipids and help improve symptoms for patients with @Disease$.	0
"BACKGROUND: Aspirin plus clopidogrel (A+C) may be more effective than @Chemical$ only (AO) acutely after TIA and minor stroke, but the risk of @Disease$ in the acute phase is uncertain."	0
Otitis media with effusion in @Chemical$-exacerbated @Disease$ patients-A series of 22 cases.	0
"CONCLUSIONS: After correction for @Disease$ volume and location, @Chemical$ use or reduced platelet activity was associated with similar increased odds for craniotomy."	0
"The most common cause is conditioned to a genetic predisposition towards atopy (atopic asthma), although other factors can also give rise to bronchial inflammation, such as over-exposure to environmental irritants (occupational asthma), altered arachidonic acid metabolism (@Chemical$-induced @Disease$) and also exercise - in which different thermal and osmotic mechanisms are known to intervene."	1
Topical and systemic effects of @Chemical$ in the gastrointestinal mucosa are associated with @Disease$ in the upper and lower gastrointestinal tract.	1
"Patients receiving treatment for &gt;5 years showed elevated risk of CMBs in the aspirin (0.17; 0.09-0.36; P &lt; .001) and clopidogrel (0.15, 0.07-0.33; P &lt; .001) groups as well as higher odds of MB in the aspirin (0.34, 0.16-0.71; P = .004) and clopidogrel (0.37, 0.17-0.80; P = .010) groups.The WMHs and MB were associated with CMBs in patients taking aspirin or @Chemical$ for &gt;1 year, and long-term use increased the risks of CMB and @Disease$."	0
"OBJECTIVE: We sought to determine blood and urinary levels of 9alpha,@Chemical$(2), a major stable PGD(2) metabolite in 2 well-defined phenotypes of @Disease$, aspirin-induced asthma (AIA) and aspirin-tolerant asthma (ATA), and in healthy control subjects and to study the effects of aspirin on PGD(2) release."	0
"The risks of suffering ischemic stroke, @Disease$, or death with warfarin, @Chemical$, or no antithrombotic treatment during 2010 were related to CHA2DS2VASc scores, age, and complicating co-morbidities."	0
"We investigated whether aspirin with caffeine (@Chemical$+) increases headache frequency compared with aspirin alone in @Disease$, tension-type headache (TTH), and migraine + TTH (MigTTH)."	0
[Pathogenic mechanism of @Chemical$-induced @Disease$ and its characteristics].	1
"The values of @Disease$s of MPs in descending order were as follows: gefarnate, hydrotalcite &gt; teprenone &gt; @Chemical$ oral suspension &gt; L-glutamine and sodium gualenate granules &gt; rebamipide &gt; sucralfate chewable tablets."	0
"Therefore, @Chemical$ use should not influence treatment decision of the @Disease$."	0
RESULTS: The overall prevalence of gastroduodenal mucosal @Disease$ was higher in the @Chemical$ group than in the control group.	0
"A 42-year-old white woman with a history of severe asthma, @Disease$, @Chemical$ sensitivity, and chronic sinusitis was treated with aspirin desensitization."	0
"@Chemical$-exacerbated respiratory disease (AERD) is associated with severe @Disease$ and aspirin can cause asthma to worsen, often in the form of a severe and sudden attack."	0
@Disease$ associated with @Chemical$ and rofecoxib.	1
METHODS: The 24-week clinical outcomes of the patients using low-dose @Chemical$ for cardiovascular protection with a history of @Disease$/erosions and cotherapy of omeprazole or famotidine were retrospectively reviewed.	0
"On the other hand, SA alone inhibited basal @Disease$ without any effect on mucosal PGE2 contents, and this agent, when given together with @Chemical$, prevented gastric hypermotility and lesion formation in response to indomethacin, without affecting the reduced PGE2 contents."	0
Understanding the effect of @Chemical$ on @Disease$ can also alter the risk-benefit ratio in at-risk aspirin users.	0
@Chemical$ 400 mg was well tolerated by all patients except for one with aspirin-induced @Disease$.	0
"Participants completed a detailed questionnaire at baseline assessing @Chemical$ use, cardiovascular disease status, and @Disease$ risk factors."	0
"Conventionally, hypersensitivities include aspirin-exacerbated respiratory disease (AERD), @Chemical$-induced urticaria, and @Disease$."	1
Does @Chemical$ attenuate the effect of angiotensin-converting enzyme inhibitors in hypertension or @Disease$?	0
"Although precipitation of asthma attacks by ingestion of @Chemical$ and other NSAIDs is considered a hallmark of the syndrome, the @Disease$ process begins and continues in the absence of ongoing or even intermittent exposure to ASA or NSAIDs."	0
"Results: Multiple new biologics are available for the treatment of severe asthma, several of which have been specifically studied and determined to be efficacious in the subset of patients with @Disease$ who are also @Chemical$ sensitive."	1
Concurrent coxibs and anti-platelet therapy unmasks @Chemical$-exacerbated @Disease$.	1
"CONCLUSION: The increase in @Disease$ hospitalization attributable to @Chemical$ differed with the non-steroidal anti-inflammatory drug used, and seemed higher with cyclo-oxygenase-2 inhibitors than with non-selective non-steroidal anti-inflammatory drugs."	1
"CONCLUSIONS: In this cohort of patients with aspirin intolerance undergoing coronary stent implantation, the combination of a @Chemical$ with indobufen, trapidil, or triflusal was associated with a low rate of @Disease$, ST and MI."	0
Objective: Abnormalities of @Chemical$ profile were considered as risk factors of @Disease$ after ischemic stroke.	0
CONCLUSION: Cross-reactivity between @Chemical$ and celecoxib does not occur in patients with @Disease$.	0
"Thus, the lack of evidence of benefit with aspirin in patients with heart failure and @Disease$, along with growing evidence that aspirin is directly harmful in patients with heart failure and that aspirin may negate the benefits of angiotensin-converting enzyme inhibitors suggest that, unless there is an opportunity to randomize the patient into a study of antithrombotic strategies, then @Chemical$ should be withdrawn or possibly substituted with an anticoagulant or an antiplatelet agent that does not block cyclooxygenase."	0
@Chemical$ increases mortality in @Disease$ patients without cardiovascular disease: a Swedish record linkage study.	0
"We report a 50-year-old man who was on @Chemical$ therapy for coronary artery disease, and presented with @Disease$ after leech treatment for his knee pain."	1
"There remains a concern that such @Chemical$ usage may prolong bleeding after a vessel rupture in the brain, leading to larger @Disease$ that cause more damage to the surrounding tissue."	1
We aimed to assess the presence of apoptotic cells in nasal polyps from @Chemical$-@Disease$ (AH) and aspirin-tolerant (AT) patients with rhinosinusitis as related to the characteristics of local inflammation.	0
"They were compared with twenty-seven control patients with sensitivity to @Chemical$ or non-steroidal anti-inflammatories, manifesting as asthma, urticaria or @Disease$."	1
The risk of cardiovascular complications resulting from stopping @Chemical$ may exceed the risk of perioperative @Disease$ and associated complications.	0
"Compared with clopidogrel, @Chemical$ increases the risk of GI bleeding but not other @Disease$; however, 883 patients (95% CI, 357-infinity) would need to be treated with clopidogrel versus aspirin to prevent one major GI bleeding episode annually at a cost of over 1 million dollars."	0
"We aimed to evaluate the association between several widely used analgesics, including aspirin, non-@Chemical$ NSAIDs, and acetaminophen (paracetamol), and risk of psoriasis and @Disease$ (PsA) in a large cohort of US women, the Nurses' Health Study II (1991-2005)."	0
@Disease$ with ketorolac is associated with decreased mortality after isolated coronary artery bypass graft surgery in patients already receiving @Chemical$: a propensity-matched study.	0
Patients with a normal @Chemical$-100 indicating no @Disease$ but with documented aspirin and/or clopidogrel use were selected.	0
"In conclusion, high-dose fish oil is safe in combination with aspirin and clopidogrel and does not increase the risk of @Disease$ compared with that seen with aspirin and @Chemical$ alone."	0
"However, @Chemical$ efficacy may be influenced by biological characteristics, such as @Disease$ and age."	1
"We compared 1- and 3-year outcomes for cerebrovascular accident (CVA), transient ischemic attack (TIA), gastrointestinal (GI) bleeding, genitourinary (GU) bleeding, any bleeding, and @Disease$ recurrence among patients receiving: none, aspirin, or @Chemical$ as long-term therapies."	0
The relationship between @Disease$ and continuous therapy with low-dose @Chemical$ (LDA) remains controversial.	0
"This study was designed to investigate the degree of @Disease$, bleeding time (BT) and fluctuations in the serum levels of @Chemical$ (PGE2) and thromboxane A2 (TXA2) after oral administration of ASA (200 mg/kg) and IBU (50 mg/kg) either alone or in combination in rats in vivo."	0
Bleeding during treatment with aspirin versus apixaban in patients with atrial fibrillation unsuitable for @Chemical$: the apixaban versus acetylsalicylic acid to prevent @Disease$ in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment (AVERROES) trial.	0
"Based on these findings, we strongly argue for the evaluation of the risk of @Disease$ and hemorrhage if @Chemical$ therapy is required, and we stress the paramount importance of using drug combinations in individual patients."	1
"Further research is needed to assess the benefit-risk ratio of clopidogrel plus @Chemical$ in specific subpopulations of patients at high risk for atherothrombotic events, and to determine the role of clopidogrel plus aspirin in preventing cardioembolic stroke or early recurrent stroke after symptomatic large-vessel @Disease$."	0
PURPOSE OF REVIEW: Aspirin-induced urticaria/@Disease$ is a major aspirin-related hypersensitivity often associated with @Chemical$-intolerant asthma.	0
"Combination therapy with aspirin, clopidogrel and @Chemical$ following coronary stenting is associated with a significant risk of @Disease$."	0
"These symptoms, such as heartburn, may discourage more individuals from taking @Chemical$ than would the risk of @Disease$."	0
"Platelet reactivity time (PRT) and whole blood aggregation (WBA) were measured in 160 healthy volunteers, before and after @Chemical$ and in 170 participants with established @Disease$ or risk factors thereof treated with aspirin +- clopidogrel."	0
"The aim of this blinded, randomised, multicentre study was to compare the tolerability of @Chemical$, paracetamol and ibuprofen in common @Disease$ resulting from musculoskeletal conditions (MSC) in general practice with patients with other non-MSC pain conditions."	0
"METHODS AND MATERIALS: We compared the effect of NO-ASA and ASA on @Disease$ provoked by @Chemical$-immersion and restraint stress (WRS), ischemia-reperfusion, and 100% ethanol."	1
"In conclusion, spontaneous hemarthrosis is a possible complication following clopidogrel-@Chemical$ therapy and is recommended to be evaluated when appropriate clinical symptoms (e.g., @Disease$) present."	1
"The full clinical picture reveals a classic triad of symptoms (Samters Triad): @Chemical$ induced bronchial asthma (with severe acute @Disease$), aspirin-sensitivity and chronic rhinosinusitis with nasal polyps."	1
Finally one recent retrospective cohort study revealed similar @Disease$ rates between @Chemical$-treated and non-ASA-treated patients but increased cardiac complication rates in the ASA group.	0
"We used sensitivity analyses to identify the incremental benefit of longer-duration DAPT on either ST or the composite of @Disease$, myocardial infarction, and ischemic stroke (major adverse cardiovascular and cerebrovascular events [MACCEs]) required to outweigh the increased risk of bleeding associated with longer @Chemical$."	0
"Methods: Serum total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol and @Chemical$ were tested in a subgroup of 3 044 consecutive patients from Clopidogrel in High-risk patients with Acute @Disease$ (CHANCE) trial."	0
This effect of @Chemical$ is unique to aspirin-exacerbated @Disease$ and not observed in subjects with aspirin-tolerant asthma.	0
"Reye's syndrome is a serious, acute @Disease$ that has been linked with aspirin (@Chemical$) use in children and teenagers &lt;18 years of age."	0
"We compared the antithrombotic effect of clopidogrel vs ticagrelor in an @Disease$ patient with @Chemical$ allergy by using a modified protocol of the thrombin generation test, accounting selectively for the platelet contribution on thrombin generation."	0
"In conclusion, spontaneous @Disease$ is a possible complication following clopidogrel-@Chemical$ therapy and is recommended to be evaluated when appropriate clinical symptoms (e.g., intraarticular effusion) present."	1
"Based on a convincing clinical history or positive responses in challenges with the drug(s), @Disease$ to one or several drug(s) was diagnosed in 49.4% of the children (60, 76.5 and 23.2% of the children reporting reactions to ASA, @Chemical$ and paracetamol respectively)."	0
@Chemical$ use and @Disease$ risk: a meta-analysis.	0
"BACKGROUND: @Chemical$-induced chronic rhinosinusitis (@Disease$) is a severe progressive persistent disease, usually associated with nasal polyps (NPs)."	0
"CONCLUSION: @Disease$ were significantly milder in the @Chemical$ group than in the non-aspirin NSAID group, though reddened lesions were more frequent in the LDA group."	1
"@Disease$ as well as a variety of other biologic markers, for example, Th2 cytokines, peripheral blood periostin, and @Chemical$ enzymes and receptors, are associated with AERD both in the blood and in respiratory mucosa."	0
"CONCLUSIONS: Aspirin and @Chemical$ conferred similar @Disease$ risks, and both exhibited less bleeding than patients who received rivaroxaban."	0
H(1)-receptor antagonists (anti@Chemical$s) are the major class of therapeutic agents used in the management of urticaria and @Disease$.	0
Operative practice has called for the cessation of @Chemical$ 7-10 days before elective procedures because of the perceived increased risk of procedure-related @Disease$.	1
@Chemical$-exacerbated @Disease$ (AERD) are associated with the metabolism of arachidonic acid.	1
"METHODOLOGY: This review is based on an analysis of 24 randomized GI, cardiovascular and neurological studies and 8 case-control and cohort, follow-up studies evaluating GI and @Disease$ risk factors associated with the ingestion of @Chemical$ at doses of less than 500 mg/day."	1
"Although knowledge about endoscopic characteristics of L-ASA associated ulcers is limited, the ulcers have common distinctive feature that sudden gastrointestinal bleedings or latently advanced-@Disease$ are often the earliest symptom because @Chemical$-induced ulcers often exist without symptoms of dyspepsia."	0
"METHODS: From 5555 patients undergoing upper gastrointestinal endoscopy from January 2005 to December 2006 at Teikyo University Hospital, Tokyo, Japan, 159 patients (76 males and 83 females, mean age: 69.3 +/- 11 years) fulfilling the following conditions were selected: (i) taking @Chemical$ (less than 100 mg/day) continuously; (ii) not taking acid suppressants; and (iii) no history of @Disease$ surgery, malignancies, severe cardiac failure, or liver cirrhosis."	0
BACKGROUND: @Chemical$-exacerbated @Disease$ (AERD) is characterized by the development of airway obstruction in asthmatic individuals following the ingestion of aspirin or other nonsteroidal anti-inflammatory drugs.	1
"Urinary eicosanoids, plasma tryptase and cytokine levels, platelet-leukocyte aggregates, and granulocyte transcripts were assessed.Measurements and Main Results: Eight weeks of high-dose @Chemical$ decreased nasal symptoms and urinary prostaglandin E metabolite (P &lt; 0.05) and increased urinary leukotriene E4 (P &lt; 0.01) levels in subjects with aspirin-exacerbated @Disease$, but not in those with aspirin-tolerant asthma."	0
Biphasic effects of H. pylori infection on low-dose @Chemical$-induced @Disease$ depending on the gastric acid secretion level.	1
"BACKGROUND AND AIMS: Nitric oxide-releasing aspirin (NO-ASA) has been shown to inhibit cyclo-oxygenase and prostaglandin generation without causing @Disease$, but the role of reactive oxygen species (ROS) and cytokines in the action of ASA and NO-@Chemical$ against acute gastric damage has been little studied."	0
"Type 2 inflammation characterizes @Chemical$-exacerbated respiratory disease.Objectives: To determine whether high-dose aspirin therapy changes biomarkers of type 2 inflammation in aspirin-exacerbated @Disease$.Methods: Forty-two subjects with aspirin-exacerbated respiratory disease underwent an aspirin desensitization and were placed on high-dose aspirin (1,300 mg daily)."	0
Otitis media with @Disease$ in @Chemical$-exacerbated respiratory disease patients-A series of 22 cases.	1
OBJECTIVE: We sought to evaluate whether titrated initiation of ASA-@Chemical$ in patients with stroke/transient @Disease$ attack (TIA) improves tolerance and to assess the appearance of headache in those with pre-existing history of headaches.	0
"The pathogenesis of @Chemical$-exacerbated @Disease$ (AERD) is thought to be based on, mainly, overproduction of eicosanoid lipid mediators and on defective anti-inflammatory regulators."	1
METHODS: Patients taking 100 mg of @Chemical$ who were planning to undergo endoscopy for surveillance or who had history of recent upper GI @Disease$ bleeding were included.	0
"At entry to the study, incomplete response to @Chemical$, measured by arachidonic acid (AA)-stimulated @Disease$, was found in 43% of patients."	0
"OBJECTIVE: To evaluate the efficiency of @Chemical$ in patients with aspirin-induced-@Disease$ trough a measurement of VEF1, during the treatment and the symptoms daily reported."	0
"CONCLUSIONS: Adding @Chemical$ to aspirin beyond 4 weeks post PCI is not associated with a significant increase in the overall rate of major or minor bleeding, although it is associated with an increase in major gastrointestinal @Disease$ in the year after a PCI."	0
"PATIENTS: Subjects aged &gt;=18 years at risk of, or with confirmed, @Disease$, and who had been prescribed or recommended low-dose @Chemical$ (75-325 mg daily) by a physician."	0
@Chemical$ is a @Disease$ inhibitor that increases the risk of bleeding complications when combined with acetylsalicylic acid.	1
"OBJECTIVE: To investigate the effect of long-term @Chemical$ on clinical, biochemical and radiological changes in @Disease$ patients."	0
Adjusted HRs for clopidogrel versus the combination of @Chemical$ and dipyridamole were 1.02 (95% confidence interval [CI]: 0.89-1.17) for ischemic @Disease$ and 1.06 (95% CI: 0.83-1.35) for bleeding.	0
"In @Disease$tics with symptoms of hypersensitivity to non-steroidal anti-inflammatory drugs, which takes the course of clinically demonstrable @Chemical$-induced asthma, the risk of severe asthma is 30-fold higher."	0
"METHODS: Forty SD rats were equally randomized into blank group, model group, warm needling group and @Chemical$ (for relieving peptic @Disease$) group, with 10 rats in each."	0
CONCLUSION: @Chemical$ desensitization following ESS appears to be a well-tolerated and effective adjunctive therapy for long-term control of @Disease$ in patients with AERD.	0
"Type 2 inflammation characterizes aspirin-exacerbated respiratory disease.Objectives: To determine whether high-dose aspirin therapy changes biomarkers of type 2 @Disease$ in aspirin-exacerbated respiratory disease.Methods: Forty-two subjects with @Chemical$-exacerbated respiratory disease underwent an aspirin desensitization and were placed on high-dose aspirin (1,300 mg daily)."	0
CASE REPORT: A 53-year-old female with a history of @Disease$ and ischemic heart disease on anticoagulants and @Chemical$ presented with abdominal pain of a few days duration which had worsened prior to presentation.	0
"METHODS: The patients enrolled in this study were the elderly requiring a single non-impacted tooth extraction. 300 elderly outpatients used lidocaine local infiltration anesthesia, 200 patients without using aspirin before tooth extraction served as control group I, 100 patients with prolong use of @Chemical$ before tooth extraction as observation group I. 300 elderly outpatients used compound articaine local infiltration anesthesia, 200 patients without using aspirin before tooth extraction served as control group II, 100 patients with prolong use of aspirin before tooth extraction as observation group II.Bleedings at 5, 10, 30 min, 24 h after tooth extraction were observed and the relationship between postoperative @Disease$ and intake of aspirin was analyzed."	0
Baseline vascular risk factors for @Chemical$ and macroscopic @Disease$ (MB) were evaluated using univariate and multivariate analyses.The aspirin and clopidogrel groups did not differ significantly in baseline characteristics or prevalences of CMBs or MB.	0
Rapid aspirin challenge/desensitization in the @Chemical$ @Disease$ patient has been consistently shown to be both safe and successful in patients with acute coronary syndromes.	1
"CONCLUSIONS: In this subgroup analysis in patients at high risk for recurrence of gastric ulcer, use of cotherapy with @Chemical$ 200 microg QID or lansoprazole 15 or 30 mg OD significantly lowered the risk for gastric @Disease$ recurrence."	0
In vitro studies into mechanistic processes of salicylate @Disease$ propose that there is a bi-directional link and potentiation with glutathione (@Chemical$) depletion and salicylate toxicity.	0
"On the other hand, @Chemical$ may have promoted the enlargement of spontaneous @Disease$ from meningioma."	1
"Chronic users of NSAIDs or @Chemical$ co-treated with proton pump inhibitors had a lower risk of @Disease$ (OR 1.12, 95% CI 0.21-6.07) than those treated with misoprostol (OR 1.91, 95% CI 0.33-10.9) or H2 blockers (OR 2.26, 95% CI 0.81-6.36)."	0
@Chemical$ @Disease$ rate was 26.5% in patients &lt;12 years of age.	1
OBJECTIVE: To examine the effect of proton pump inhibitors on adverse cardiovascular events in @Chemical$ treated patients with first time @Disease$.	0
"Patients without AMCE-detected gastrointestinal erosions, ulceration or @Disease$ after drug-eluting stent implantation are enrolled and treated with open-label aspirin (100 mg/d) plus @Chemical$ (75 mg/d) for 6 months."	0
"OBJECTIVE: To provide further insights on the risks of gastrointestinal (@Disease$) complications in individuals using low-dose aspirin (LDA), we investigated the concomitant use of @Chemical$ and antisecretory drugs."	0
Helicobacter pylori-(@Chemical$-) induced @Disease$ were diagnosed when non-homogeneous fibrinoid necrotic material containing granulocytes and cell debris was noted.	1
"The aim of this study was to determine levels of MCP-3, RANTES, eotaxin, Il-5 and Il-3 in aspirin intolerant asthmatics (@Disease$) after nasal lysine-@Chemical$ (Lys-ASA) challenge."	0
We describe a case of esophageal mucosal lesion that was difficult to distinguish from @Disease$ in a patient with a history of ingesting LDA and @Chemical$ after implantation of a drug-eluting stent.	0
Many @Chemical$ users should receive prophylactic treatment since they often have several risk factors for upper @Disease$ complications.	1
Initial reaction to ASA involving @Disease$ and reacting to @Chemical$ within the past year increased the risk of having a reaction to desensitization.	0
"For average-risk individuals aged 50-65 years taking @Chemical$ for 10 years, there would be a relative reduction of between 7% (women) and 9% (men) in the number of cancer, @Disease$ or stroke events over a 15-year period and an overall 4% relative reduction in all deaths over a 20-year period."	0
CONCLUSIONS: Adding other antiplatelet agents to @Chemical$ did not increase the @Disease$ rate.	0
"Aspirin (@Chemical$)-exacerbated respiratory disease (AERD) is characterized by upper airway congestion due to eosinophilic inflammation of the nasal and sinus membranes and @Disease$, associated with increased leukotriene production that is further accentuated by ASA or other nonsteroidal anti-inflammatory drug (NSAID) ingestion."	0
"The median @Disease$ in the aspirin regimen was 3, while those in both aspirin + @Chemical$ 10 mg and aspirin + rabeprazole 40 mg regimens were 0."	0
There is a wealth of data that suggests an important interaction between @Chemical$ and angiotensin-converting enzyme inhibitors in patients with chronic stable @Disease$.	0
This study compared the preventive effect of histamine-2 receptor antagonists (H2RAs) and proton-pump inhibitors (PPIs) against chronic low-dose @Chemical$ (LDA)-related @Disease$ and ulcer formation.	1
"Clinically, intolerance reactions to nonsteroidal antiinflammatory drugs (NSAIDs) can lead to different clinical manifestations; five phenotypes of the @Chemical$ @Disease$ are listed in the ENDA classification."	1
"Patients on ASA 325 mg had a higher adjusted hazard ratio of 2.9 (95% confidence interval, 1.2-7.0 versus @Chemical$ 81 mg+dipyridamole; P = 0.02) and 3.4 (95% confidence interval, 1.2-9.5 versus ASA 81 mg; P = 0.02) for @Disease$ events."	0
METHODS: We performed a retrospective cohort study of 1677 patients undergoing coronary artery bypass surgery to determine the relationship of the preoperative use of aspirin plus clopidogrel vs @Chemical$ alone to the 30-day incidence of postoperative surgical site @Disease$ and bacteremia.	0
The aim of this study was to determine the incidence of upper GI bleeding and whether the use of peri-operative oral ranitidine reduces the incidence of upper @Disease$ing when @Chemical$ thromboprophylaxis is used for hip and knee arthroplasty.	1
Single-dose @Chemical$ reduces @Disease$ after coronary surgery in patients treated with aspirin until surgery.	0
CONCLUSIONS: Patients on aspirin and clopidogrel &lt;5days before CABG who had preoperative @Chemical$-induced @Disease$ &gt;=50% have bleeding risk similar to those receiving aspirin monotherapy.	1
"CONCLUSIONS: The @Chemical$ ratio was found to be high in severe CKD patients, especially haemodialysis patients, but not in mild and moderate @Disease$ patients."	0
"However, the efficacy of eradication therapy on low-dose @Chemical$-related gastroduodenal lesions in unselected H. pylori-positive lowdose aspirin users without histories of peptic @Disease$s remains to be clarified."	0
"BACKGROUND &amp; AIMS: We performed a meta-analysis of data from randomized trials to estimate the risk of all-cause mortality and bleeding (and especially gastrointestinal [GI] @Disease$) in patients treated with low doses of acetylsalicylic acid (@Chemical$) (75-325 mg/d), alone or in combination with other medications."	0
CONCLUSION: Pretreatment with @Chemical$-rich diets may prevent nonsteroidal anti-inflammatory drug-induced @Disease$.	0
"Hence, surgeons should pay careful attention to postoperative blood loss and complications related to @Disease$ in patients who have been taking low-dose @Chemical$."	0
CONCLUSION: @Chemical$ was an independent predictor of major @Disease$ after PCI in patients receiving dual antiplatelet therapy.	0
"SOCS2 (one of three SNPs) and all STAT3, STAT5A, and STAT5B SNPs significantly interacted with use of @Chemical$/NSAIDs to alter @Disease$-specific mortality."	0
"These differences include the effects on the cyclooxygenase (COX)-1 isoenzyme, local effects on the gastroduodenal mucosa specific to @Chemical$ and a reduction in @Disease$."	0
OBJECTIVE: This study aimed to assess sinonasal outcomes in patients with aspirin exacerbated @Disease$ (AERD) undergoing aspirin desensitization following endoscopic sinus surgery (@Chemical$).	0
BACKGROUND: Very few studies have examined the risk of short-term adverse @Disease$ of low-dose @Chemical$ use in primary prevention.	0
SCG ameliorated these @Chemical$-facilitated absorptions and @Disease$ in a dose-dependent manner.	1
"BACKGROUND: In sensitive patients, @Chemical$ is associated with nasal and @Disease$, eliciting local symptoms."	1
Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment: @Chemical$ modulation of IgE-dependent mast cell activation: role of aspirin-induced exacerbation of immediate @Disease$.	0
"After multivariate adjustment for age, sex, current smoking, history of @Disease$ and diabetes, and aspirin dose (aspirin-treated patients only), the hazard ratio for ICH in patients with an arterial versus a cardiac source was 0.74 (95% confidence interval, 0.30 to 1.82) for @Chemical$-treated patients and 4.34 (95% confidence interval, 0.35 to 54) for placebo-randomized patients."	0
"It has been proposed that overproduction of @Chemical$, together with removal by aspirin/NSAIDs of the 'brake' imposed by the bronchodilator prostaglandin E2, may cause an asthma attack in patients with @Disease$."	0
The upper respiratory reaction is mediated by both histamine and LTs but the @Disease$ is mediated by @Chemical$.	0
CONCLUSION: Our case describes the recurrence of spontaneous hemorrhages (perirenal and intramuscular hematoma) as a result of an underlying @Disease$ worsened by administration of @Chemical$.	1
Previous studies reported that prophylactic use of @Chemical$ reduces the risk of preeclampsia and small-for-gestational-age neonates with no significant effect on @Disease$.	0
"However, knowledge on @Chemical$ (LTB4) generation in patients with @Disease$ is insufficient."	0
"OBJECTIVE: @Chemical$ exacerbated @Disease$ (AERD) is comprised of aspirin/acetylsalicylic acid (ASA) sensitivity, bronchial asthma, and nasal polyposis."	1
"In contrast, ASA aggravated significantly @Disease$-induced lesions, and this was accompanied by a fall in the GBF, suppression of prostaglandin E(2) generation, and significant rise in @Chemical$ chemiluminescence and in plasma TNFalpha and IL-1beta levels."	0
@Chemical$ intolerance seems to be unfavourable prognostic factor in nasal @Disease$.	0
"Studies, review articles, and commentaries on @Chemical$-induced @Disease$ and aspirin- or NSAID-induced urticaria/angioedema were included in the review."	1
"@Chemical$ or nonsteroidal antinflammatory drug sensitivity can be manifested as acute urticaria, angioedema, acute @Disease$, acetylsalicylic acid exacerbated respiratory disease and anaphylaxis."	1
"Aspirin-exacerbated diseases are important examples of drug @Disease$ and include @Chemical$-exacerbated respiratory disease (AERD), aspirin- or non-steroidal anti-inflammatory drug (NSAID)-induced urticaria/angioedema, and aspirin- or NSAID-induced anaphylaxis."	0
"The objective of this study was to test the effects of aspirin (1, 2.5 and 5 mg/kg), and ibuprofen (4 and 15 mg/kg), diclofenac (2.5 mg/kg), @Chemical$ (2 mg/kg), celecoxib (7.5 mg/kg), and rofecoxib (1 mg/kg), alone or combined on a rat model of arterial @Disease$."	0
"INTRODUCTION: To study the effects of use of paracetamol, non-steroidal anti-inflammatory drugs (NSAID), acetylsalicylic acid (@Chemical$), and opioids on bone mineral density (BMD) and risk of @Disease$s."	0
"CONCLUSIONS: Taken together, this study shows an increased release of the recently discovered @Chemical$ mediator EXC4, as well as the main indicator of 15-LO activity, 15-HETE, in activated eosinophils from severe and aspirin-intolerant @Disease$tics, and also elevated EXC4 and LTC4 formation in eosinophils from AIA patients after cellular activation in the presence of lysine-aspirin."	0
BACKGROUND: There are few therapeutic options for the prevention of @Disease$ caused by low-dose @Chemical$.	1
BACKGROUND: The objective of the study was to determine the frequency of cerebral microbleeds (CMBs) by using phasesensitive imaging in patients with previous transient ischemic attack (TIA) or @Disease$ who were receiving @Chemical$ treatment.	1
"Our results indicate that apixaban, @Chemical$, rivaroxaban, idraparinux and VKAs all reduced @Disease$ recurrence when compared to placebo."	0
INTRODUCTION: The Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) study showed that patients with unstable angina pectoris (UAP) and non-ST-elevation @Disease$ (NSTEMI) benefit from combined therapy with acetylsalicylic acid (@Chemical$) and clopidogrel.	0
Plasma @Chemical$ concentrations in patients with @Disease$ and controls were not significantly different (P = 0.59).	0
Data on the role of @Chemical$ on @Disease$ risk are scanty.	0
CONCLUSIONS: The present study results suggest that hyper@Chemical$ might be one of the risk factors for peptic @Disease$ caused by aspirin.	0
"All 129 patients with high risk TIA with microbleeds or minor @Disease$ within 24 hours after the onset (average age 65.9 +- 9.3, 48.7% were male patients) were divided randomly into two groups: (1) 67 patients were given combination therapy with clopidogrel and aspirin (clopidogrel at an initial dose of 300 mg, then 75 mg per day for 90 days, plus @Chemical$ at a dose of 75 mg per day for the first 21 days);(2) the rest patients were given aspirin treatment (75 mg per day for 90 days)."	0
"BACKGROUND/AIMS: Many patients with aspirin-induced asthma have severe methacholine @Disease$ (AHR), suggesting a relationship between aspirin and @Chemical$ in airway response."	0
CONCLUSION: PPIs are effective in preventing @Chemical$-associated upper GI @Disease$s and bleeding.	0
The medical history of non-steroidal anti-inflammatory drugs (NSAIDs) or acetylsalicylic acid (@Chemical$) usage and the presence of @Disease$ (CAD) were investigated in all patients with or without hemorrhage.	0
"METHODS: Electronic databases of Pubmed, Embase and Cochrane Central Register of Controlled Trials were searched for human observations (randomised controlled trials and observational studies) comparing the long term effects of PPIs and H2RAs treatment in the prevention of GI bleeding or @Disease$ formation in patients on chronic @Chemical$ treatment listed up till September 30, 2016."	0
OBJECTIVE: We sought to investigate the role of @Chemical$-exacerbated respiratory disease (@Disease$) as a risk factor for the development of irreversible airway obstruction.	0
"METHODS: Ninety-four @Chemical$-induced urticaria patients presenting @Disease$/angioedema-induced by both ASA and NSAID (50 had underlying chronic urticaria) and showing positive responses on oral aspirin challenge test, 76 aspirin-intolerant asthmatics with positive responses on lysine-aspirin bronchoprovocation test, and 185 normal healthy controls were enrolled."	0
CONCLUSIONS: Low-dose @Chemical$ therapy is associated with an increased risk of developing @Disease$.	1
@Disease$ and @Chemical$-exacerbated respiratory disease as predictors of the olfactory outcome after endoscopic sinus surgery.	0
The objective of this study was to define '@Chemical$-@Disease$' children and adolescents in a clearly defined group of patients with CSU and to describe their clinical features.	1
"CONCLUSIONS: Our study revealed that nasal @Disease$ of @Chemical$-sensitive patients were infiltrated with eosinophils and mast cells, Cys-LT(1) receptor proportions in these inflammatory cells were found to be higher and Cys-LT(1) receptor immunoreactivity in eosinophils and mast cells was increased."	1
"Besides, @Chemical$ values demonstrated that in the 7 drug therapies, aspirin plus dipyridamole therapy was more effective than others (mortality: 80.67%; @Disease$: 76.6%; AE rate: 90.2%)."	0
"@Chemical$-induced asthma is a distinct clinical syndrome consisting of inflammation, characterized by chronic eosinophilic rhinosinusitis with asthma and often @Disease$."	0
Limited influence of aspirin intake on mast cell activation in patients with food-dependent exercise-induced @Disease$: comparison using skin prick and @Chemical$ release tests.	0
Review article: the ageing @Disease$ and intolerance to @Chemical$.	0
Our retrospective study reviewed the effectiveness of @Chemical$-100 in detecting @Disease$ caused by aspirin and clopidogrel and determined its clinical importance.	0
"@Disease$ formed in a total of seven patients (3.5%), five of whom were on DAPT consisting of @Chemical$ and clopidogrel (P &lt; 0.0001) while only two of them were on warfarin (P = 0.67)."	1
@Chemical$ Challenge in Children with @Disease$ Reactions to Nonsteroidal Anti-Inflammatory Drugs Differentiates Between Cross-Intolerant and Selective Responders.	0
"METHODS: We investigated intolerance and @Disease$ while on @Chemical$ and aspirin discontinuation using 5337 post-acute coronary syndrome patients considered appropriate for chronic antiplatelet therapy who were randomly assigned to aspirin in SYMPHONY and 2nd SYMPHONY and followed for 94 (64,157) days."	0
"OBJECTIVE: Aspirin exacerbated respiratory disease (AERD) is comprised of aspirin/acetylsalicylic acid (@Chemical$) sensitivity, bronchial asthma, and @Disease$."	0
"Urinary eicosanoids, plasma tryptase and cytokine levels, platelet-leukocyte aggregates, and granulocyte transcripts were assessed.Measurements and Main Results: Eight weeks of high-dose aspirin decreased nasal symptoms and urinary prostaglandin E metabolite (P &lt; 0.05) and increased urinary @Chemical$ (P &lt; 0.01) levels in subjects with aspirin-exacerbated @Disease$, but not in those with aspirin-tolerant asthma."	0
"The use of low-dose aspirin (@Chemical$) is well known to be associated with an increased risk of serious upper gastrointestinal complications, such as peptic ulceration and @Disease$."	1
"Although, genuine @Disease$ to @Chemical$ is encountered infrequently, it can be challenging when managing patients with concomitant CAD given the paucity of safe and effective alternatives."	1
Nasal lysine-@Chemical$ challenge appeared to be a reproducible and safe method in assessing patients with aspirin-induced @Disease$.	0
Combined anti-platelet therapy with @Chemical$ and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute @Disease$?	0
"PURPOSE: This study evaluated the benefits of and possible contraindications to @Chemical$ treatment in patients with @Disease$ (AF) prior to the introduction of new oral anticoagulants using health registry data from inpatient care, specialist ambulatory care, and primary care."	0
"With prolonged use of @Chemical$, UGIB continues to be a problem for those with risk factors and especially in patients with a history of peptic @Disease$, in which UGIB tends to occur early after aspirin therapy."	0
These findings provide evidence that EMID2 may be a susceptible genetic factor for @Chemical$ @Disease$ among asthmatics in Korean population.	1
BACKGROUND: Current @Chemical$ (ASA) dosing algorithms for the prevention of secondary thrombotic events in acute @Disease$ (ACS) patients are inconsistent and lack sufficient data support.	0
"@Chemical$-Tris did not cause bleeding, @Disease$, mucosal injury or an elevation in proinflammatory markers."	0
"Dogs receiving prednisone and prednisone/@Chemical$ had 11.1 times (95% CI, 1.7-73.6) and 31.5 times (95% CI, 3.5-288.0) higher odds, respectively, of having endoscopic @Disease$ scores &gt;=4 than dogs receiving placebo (P &lt;= .01)."	0
"Aspirin hypersensitivity is a hallmark of @Chemical$-exacerbated @Disease$ (AERD), a clinical syndrome characterized by the severe inflammation of the respiratory tract after ingestion of cyclooxygenase-1 inhibitors."	1
"Stratification to evaluate the heterogeneity found that both NANSAIDs (summary RR = 2.24, 95 % CI 1.63-3.09; 5 studies) and @Chemical$ (summary RR = 1.73; 95 % CI 1.31-2.30; 3 studies) were associated with the risk of @Disease$."	0
"@Chemical$ and other nonsteroidal anti-inflammatory drugs that inhibit COX-1 induce unique nonallergic reactions, consisting of attacks of rhinitis and @Disease$."	1
OBJECTIVE: We sought to evaluate whether titrated initiation of ASA-@Chemical$ in patients with stroke/transient ischemic attack (TIA) improves tolerance and to assess the appearance of headache in those with pre-existing history of @Disease$s.	0
"These data suggest that use of NSAIDs, either aspirin or other non-@Chemical$ NSAIDs, are associated positively with risk of NHL, and that this association is independent of @Disease$ history."	0
METHODS: A total of 991 patients with @Disease$ (CAD) on low-dose @Chemical$ were prospectively followed-up for two years for the occurrence and clinical features of first hospitalized episode of UGIB.	0
AIM: To clarify the prevalence and independent factors for gastroduodenal @Disease$/erosions in asymptomatic patients taking low-dose @Chemical$ and gastroprotective agents.	0
"CONCLUSIONS: In this subgroup analysis in patients at high risk for recurrence of gastric ulcer, use of cotherapy with misoprostol 200 microg @Disease$ or @Chemical$ 15 or 30 mg OD significantly lowered the risk for gastric ulcer recurrence."	0
CONCLUSIONS: Rebamipide is useful for the primary prevention of @Disease$ induced by LDA alone or by @Chemical$ plus clopidogrel in healthy subjects.	1
"In the remaining 17 patients, maintenance AST was required for the following main reasons: idiopathic PUD (6), @Disease$ (6), a need for @Chemical$ (5)."	0
"The reviewed studies revealed that @Chemical$ therapy, which is applied as a protection in @Disease$ in patients with early forms of AMD and geographic atrophy, should not be discontinued."	0
"DATA SOURCES: Articles evaluating aspirin for primary prevention of CVD were gathered using a MEDLINE search with the keywords aspirin review, @Chemical$ peripheral @Disease$, aspirin stroke, aspirin coronary artery disease, aspirin diabetes, aspirin primary prophylaxis, and aspirin elderly."	0
METHODS: We studied a group of 20 @Disease$ patients compared to a control group with 40 @Chemical$-tolerant patients (confirmed by oral provocation test): 10 asthmatic patients and 30 healthy subjects.	0
"A total of 16 patients with @Chemical$-exacerbated @Disease$ (AERD, 81.3% were female) with median age of 29 +- 4.3 years were included in this study."	1
Regular @Chemical$-use preceding the onset of primary intracerebral hemorrhage is an independent predictor for @Disease$.	1
"BACKGROUND AND OBJECTIVES: @Chemical$ is widely used for short-term treatment of @Disease$, fever or colds, but there are only limited data regarding the safety of this use."	0
"In the subanalysis of 25 @Chemical$-takers without severe gastropathy, gastric mucus secretion was increased and the acid/mucus ratio was decreased compared with controls, but there was no such association in the remaining 17 aspirin-takers with severe @Disease$."	0
There is evidence that @Chemical$ (Se) nutrition can influence @Disease$ but Se status in AIA patients has not received much attention.	0
"Drugs that have been tried for prevention of @Disease$ in patients taking NSAIDs including H2-receptor antagonists, proton pump inhibitors (PPIs), @Chemical$ or magnesium-containing antacids, the prostaglandin misoprostol (Cytotec, and others), and antibiotics to eradicate H. pylori."	0
"If @Chemical$ minidose therapy was administered for 1 month together with the proton pump inhibitor omeprazole, the rate of incidence of changes detected in the mucosa was statistically significantly lower, i.e. only 27.6 %, again without signs of fresh @Disease$."	0
There is now strong evidence that aspirin desensitization and daily @Chemical$ therapy is effective for treatment of the chronic inflammatory disease of the upper airway and lower airways in @Disease$.	0
OBJECTIVE: To determine whether regular @Chemical$ use is associated with a higher risk for developing age-related macular degeneration (@Disease$) by using analyzed data from a 15-year prospective cohort.	0
"A prior history of @Disease$ was predictive of LDA-related UGS (OR: 17.60; CI 95%: 11.52-26.88) whereas neither, gender nor @Chemical$ dosage (ranging from 75 and 325 mg) predicted the occurrence of UGS."	0
Platelet activation was involved in @Chemical$ overproduction and persistent airflow limitations in patients with @Disease$.	0
"At 3 years, 238 (5.9%) patients were on warfarin, 743 (18.6) on @Chemical$, and 3,013 (75.5%) on no therapy; with occurrences of CVA/TIA (1.4%, 3.0%, 3.9%, P &lt; 0.0001, respectively), GI bleeding (0.8%, 1.9%, 1.1%, P = 0.06, respectively), and GU @Disease$ (1.7%, 2.8%, 2.1%, P = 0.008, respectively) that increased with advancing CHA2 DS2 VASc score."	0
"OBJECTIVE: Aspirin-exacerbated respiratory disease (@Disease$) represents a severe form of chronic rhinosinusitis (CRS) characterized by nasal polyposis, bronchial asthma, and @Chemical$ intolerance."	0
"Lafutidine prevents low-dose @Chemical$ and loxoprofen induced @Disease$: a randomized, double-blinded, placebo controlled study."	1
This different response might indicate COX-1-dependent prostaglandin E2 control of inflammatory cells in @Chemical$-induced @Disease$.	1
A 35-year-old lady with ES taking aspirin with @Chemical$ for thrombo-prophylaxis presented with massive @Disease$.	1
Multivariable logistic regression was performed to assess the independent association between @Chemical$ administration and @Disease$ complications.	0
There is evidence that selenium (Se) nutrition can influence asthma but @Chemical$ status in @Disease$ patients has not received much attention.	0
"In patients presenting with peptic @Disease$ bleeding with low-dose aspirin, @Chemical$ should be continued in association with PPI rather than replaced with clopidogrel."	0
"OBJECTIVES: @Chemical$ may be involved in microscopic @Disease$ (MC) development, but there are no data on colon histology in asymptomatic aspirin users."	1
"Moreover, @Chemical$-LT levels in NSAID-intolerant @Disease$tics increase remarkably following NSAID provocation testing."	0
"In fact, well-managed warfarin therapy (INR 2-3) has little effect on bleeding risk and is twice as effective as @Chemical$ at preventing @Disease$."	0
CONCLUSION: The concurrent use of prednisone and ultralow-dose aspirin did not increase the severity of @Disease$ compared with @Chemical$ or placebo.	0
OBJECTIVE: We sought to evaluate the effects of nonsteroidal anti-inflammatory drugs (NSAIDs) on T-cell activation of the IL-4 pathway in @Chemical$-sensitive patients with @Disease$ and control subjects.	0
OBJECTIVE: Transnasal endoscopy was conducted to examine gastric @Disease$ in Japanese patients with ischemic heart disease who were receiving low-dose @Chemical$ for preventing the onset or recurrence of cardiovascular disease.	0
The risk of readmission resulting from bleeding and venous thromboembolism (@Disease$) has also not been determined for patients undergoing THA or TKA when treated with low-molecular-weight @Chemical$ (LMWH) alone compared with mechanical prophylaxis plus aspirin (ASA).	0
CONCLUSIONS: The addition of loxoprofen to @Chemical$ increases @Disease$.	1
"METHODS: The 267 patients who had survived a @Disease$ were randomly assigned in the Warfarin Aspirin Reinfarction Study to treatment with aspirin 160 mg/day, or @Chemical$ (INR 2.8-4.2), or aspirin 75 mg/day plus warfarin (INR 2.0-2.5)."	0
Polymorphisms in genes encoding @Chemical$ metabolizing enzymes are unrelated to @Disease$ health in cardiovascular patients on acetylsalicylic acid.	0
BACKGROUND: @Chemical$-exacerbated @Disease$ (AERD) refers to the development of bronchoconstriction in asthmatics following the ingestion of aspirin.	1
"@Chemical$ fitness grade, cardiovascular disease, previous history of angina pectoris, angioplasty, diabetes, use of vitamin K antagonists, @Disease$ and type of hepatectomy were significantly different between the groups."	0
"CONCLUSIONS: Preoperative @Chemical$ use in all patients undergoing cardiac operations was not associated with risks of major cardiac, cerebral, or renal complications and infections and death; however, the risk of reoperation for @Disease$ was elevated among preoperative aspirin users compared with nonusers in a subpopulation of patients undergoing valve operations only."	0
BACKGROUND: Aspirin desensitization (AD) has been the only available modifying treatment in @Chemical$-exacerbated @Disease$ (AERD).	0
Main Outcomes and Measures: Odds ratios (ORs) with 95% CI were used as a measure of the association of individual @Chemical$ vs aspirin with the risk of @Disease$.	0
"Compared to aspirin never users, women who regularly consumed @Chemical$ had a lower risk of @Disease$ (RR = 0.80; 95% CI: 0.71-0.90), and there was evidence for lower risk with increasing frequency of use (RR = 0.71 for aspirin use 6 or more times/week vs. never use; P trend = 0.00001)."	0
"We report a 50-year-old man who was on @Chemical$ therapy for @Disease$, and presented with GI bleed after leech treatment for his knee pain."	1
"The aging is one of the most important risk factors of upper GI injuries induced by @Chemical$, such as @Disease$."	1
A 57-year-old man who had hypertension and had been on dual antiplatelet therapy with @Chemical$ and clopidogrel for primary prevention presented with the sudden onset of @Disease$ and monoplegia of the left lower extremity.	0
Gastroprotective effects of sulforaphane and @Chemical$ against acetylsalicylic acid-induced @Disease$ in rats.	0
Recovery of platelet function after discontinuation of prasugrel or clopidogrel maintenance dosing in @Chemical$-treated patients with stable @Disease$: the recovery trial.	0
Aspirin-induced asthma (AIA) and aspirin-induced @Disease$/ angioedema (AIU) are two major @Chemical$-related allergies.	0
Sodium Cromoglycate Prevents Exacerbation of @Disease$ Induced by @Chemical$ in a Rat Model of Egg Allergy.	1
Alcohol and aspirin in combination with @Chemical$ causes @Disease$ at high altitude.	1
About 34 % of patients with @Chemical$-induced asthma and rhinosinusitis are thought to have @Disease$.	1
"This study aimed to determine, through meta-analysis, if (and by how much) infection alters the baseline risk of peptic @Disease$s during @Chemical$ therapy."	1
OBJECTIVES: Discontinuation of low-dose @Chemical$ (ASA) therapy may increase the risk of @Disease$ events.	1
We used the Multiplate analyser for rapid assessment of antiplatelet activity in a patient who developed an @Disease$ after administration of @Chemical$ and clopidogrel.	1
"Prior known oral NSAIDs @Disease$ included @Chemical$ (5), mefenamic acid (2), diclofenac (2), Synflex (2) and ibuprofen (1)."	1
"All 129 patients with high risk TIA with microbleeds or minor @Disease$ within 24 hours after the onset (average age 65.9 +- 9.3, 48.7% were male patients) were divided randomly into two groups: (1) 67 patients were given combination therapy with @Chemical$ and aspirin (clopidogrel at an initial dose of 300 mg, then 75 mg per day for 90 days, plus aspirin at a dose of 75 mg per day for the first 21 days);(2) the rest patients were given aspirin treatment (75 mg per day for 90 days)."	0
"BACKGROUND: The safety of @Chemical$ in heart failure (HF) has been called into question, particularly in those patients (1) without @Disease$, (2) with renal dysfunction, or (3) treated with low-dose angiotensin-converting enzyme (ACE) inhibitors and high-dose aspirin."	0
"CONCLUSIONS: Among aspirin users with a history of lower GI bleeding, continuation of @Chemical$ is associated with an increased risk of recurrent lower GI bleeding, but reduced risk of serious cardiovascular events and @Disease$."	0
BACKGROUND: Conflicting data exist regarding a potential deleterious association between @Chemical$ (ASA) and angiotensin-converting enzyme inhibitors (ACEIs) when used concurrently in patients with @Disease$ (HF).	0
CONCLUSIONS: @Chemical$ resistance is associated with increased clinical severity and stroke infarct volume in acute @Disease$ patients.	0
"Continuous @Chemical$ therapy for patients with gastrointestinal @Disease$ may increase the risk of recurrent bleeding but potentially reduces the mortality rates, as stopping aspirin therapy is associated with higher mortality rates."	0
"Seven months after the last dose of clopidogrel, @Disease$ recurred on @Chemical$ therapy."	1
"Of these 52 cases, there were 22 @Disease$ cases with @Chemical$ sensitivity, 15 nasal polyposis cases without aspirin sensitivity and 15 chronic rhinosinusitis cases without aspirin sensitivity."	0
The two frequent clinical presentations of aspirin hypersensitivity are: aspirin-induced bronchial asthma/rhinosinusitis (AIA/R) and @Chemical$-induced urticaria/@Disease$ (AIU).	1
"The triad of bronchial asthma, nasal polyposis, and intolerance to aspirin and @Chemical$-like chemicals are designated aspirin-induced asthma (@Disease$) or Samter's syndrome."	0
The Framingham Heart Study records of participants with @Disease$ (AF) during 1980 and 1994 were retrospectively reviewed to determine the prevalence of warfarin and @Chemical$ use in AF.	0
KEY FINDINGS: Perfusion of the stomach with acidified @Chemical$ alone led to slight @Disease$ and lesions in the stomach.	1
In the present study endoscopic examination was performed to investigate the frequency of @Disease$ associated with low-dose @Chemical$ in patients with ischemic heart disease (IHD).	1
OBJECTIVE: To examine the association of regular @Chemical$ use with incidence of @Disease$.	0
"Aspirin (@Chemical$)-induced asthma (AIA) consists of the clinical triad of asthma, chronic rhinosinusitis with @Disease$, and precipitation of asthma and rhinitis attacks in response to aspirin and other NSAIDs."	0
"For the prediction of myocardial infarction or stent @Disease$, bleeding and death, @Chemical$ score &gt;=2 had sensitivities of 57%, 41%, and 56%, respectively; specificities of 58%, 57%, and 58%, respectively; positive predictive values of 1.9%, 2.2%, and 2.1%, respectively; and negative predictive values of 99%, 98%, and 99%, respectively."	0
Co-administration of @Chemical$ and a selective COX-2 inhibitor results in substantially more severe @Disease$ than is produced with either agent alone.	0
"Therefore, several drugs have been evaluated to identify the best choice to prevent or treat @Chemical$-induced @Disease$ with different results."	1
@Chemical$ dependent anaphylaxis to carrots in a patient with @Disease$.	0
BACKGROUND: Conflicting data exist regarding a potential deleterious association between aspirin (@Chemical$) and angiotensin-converting enzyme inhibitors (ACEIs) when used concurrently in patients with @Disease$ (HF).	0
"Data Sources: We searched PubMed, Embase, CENTRAL, and ClinicalTrials.gov from inception to May 28, 2018, with the terms novel oral anticoagulants, non-vitamin K antagonist oral anticoagulants, direct oral anticoagulants, dabigatran, rivaroxaban, apixaban, edoxaban, warfarin, Coumadin, vitamin K antagonist, aspirin, acetylsalicylic acid, or @Chemical$, and major bleeding, fatal bleeding, or @Disease$."	0
"In conclusion, this meta-analysis indicated that regular use of @Chemical$ may be associated with reduced risk of @Disease$."	1
"@Chemical$-exacerbated respiratory disease is a chronic and treatment-resistant disease, characterized by the presence of eosinophilic rhinosinusitis, nasal polyposis, bronchial asthma, and nonsteroidal anti-inflammatory drugs @Disease$."	0
"Also, women had less @Disease$ (@Chemical$, 2.4% versus 3.7%; apixaban, 1.4% versus 3.0%), more heart failure, and higher mean CHADS2 (congestive heart failure, hypertension, age of 75 years or older, diabetes [1 point each], stroke or transient ischemic attack [2 points]) scores (aspirin, 2.2 versus 2.0; apixaban, 2.1 versus 2.0)."	0
@Chemical$ plus clopidogrel and risk of @Disease$ after coronary artery bypass surgery.	0
"However, the safety of low-dose @Chemical$ therapy in the @Disease$ is uncertain."	0
CONCLUSIONS: Clopidogrel and low doses of @Chemical$ cause a similar degree of @Disease$.	1
"The aim of this study was to investigate the relation between bladder @Disease$ risk and the use of selected drugs for cardiovascular disease (CVD) prevention, such as @Chemical$, statins, and calcium channel blockers (CCBs)."	0
There is a theoretical concern that treatment prior to the head injury with @Chemical$ may expand the size of @Disease$.	1
"Those receiving apixaban/@Chemical$ had similar @Disease$ risk compared with those receiving thienopyridine/aspirin (HR 1.01, 95% CI 0.53-1.95)."	1
This effect of aspirin is unique to @Chemical$-exacerbated @Disease$ and not observed in subjects with aspirin-tolerant asthma.	0
"There were four independent factors for @Disease$: age 67 years or older (odds ratio (OR) 4.7 (95 per cent confidence interval 1.8 to 12.2); P = 0.002), @Chemical$ therapy (OR 2.9 (1.4 to 6.3); P = 0.006), surgery on or around the ear (OR 2.6 (1.2 to 5.7); P = 0.012) and closure with a skin flap or graft (OR 2.7 (1.4 to 5.3); P = 0.004)."	0
"CONCLUSION: Coupling of NO to ASA attenuates stress, ischemia-reperfusion, and @Chemical$-induced damage due to @Disease$ mediated by NO, which compensates for prostaglandin deficiency induced by ASA."	1
"METHODS: Therefore, nasal polypous tissue specimens of patients suffering from @Disease$ (NP), intrinsic asthma (ATA), aspirin-intolerance (AINA), and @Chemical$-triad (TRIAD) were investigated."	0
@Chemical$ (Asasantin retard)-induced @Disease$.	1
"The proportions of patients who were free of gastric @Disease$s at the end of 12 weeks were 96% in the misoprostol group, 93% in the lansoprazole 15-mg group, 100% in the @Chemical$ 30-mg group, and 35% in the placebo group (P &lt;or= 0.008, each active treatment vs placebo)."	0
BACKGROUND: Little is known about the site and nature of @Disease$ related to low-dose @Chemical$ and other antithrombotic agents.	1
CONCLUSIONS: Dual antiplatelet therapy with combined aspirin and clopidogrel as well as clopidogrel is associated with an increased incidence of perioperative wound @Disease$ compared to @Chemical$ but on an acceptable low level of incidence.	0
"An even larger number of respondents stopped @Chemical$ therapy before surgery if the patient was taking aspirin due to an ischemic insult or due to @Disease$ with infrainguinal stenting (59-63% and 59-65%, respectively)."	0
"BACKGROUND: It remains unclear to what extent asthma in adults is linked to allergic rhinitis (AR), gastroesophageal reflux disease (@Disease$), and @Chemical$ exacerbated respiratory disease (AERD), and how these comorbidities may affect asthma outcomes in the general population."	0
"OBJECTIVES: Many elderly patients are prescribed both low-dose aspirin (@Chemical$), for cardiovascular protection and non-steroidal anti-inflammatory drugs (NSAIDs) for @Disease$ control."	0
"INTRODUCTION: Aspirin-intolerant asthma (AIA), a major clinical presentation of @Chemical$ @Disease$ affects 10% of adult asthmatics."	1
METHODS: Nasal @Disease$ were obtained from 16 @Chemical$-tolerant patients with asthma/rhinitis (ATAR) and 18 aspirin-intolerant patients with asthma/rhinitis (AIAR) undergoing nasal polypectomy.	0
"These patients were classified into three groups: Group A comprised patients with nasal polyps without @Disease$; Group B contained patients with nasal polyps and asthma; and Group C comprised patients with nasal polyps, asthma and @Chemical$ sensitivity."	0
"RESULTS: The @Chemical$-treated group was significantly older, with higher weight and poorer health state (higher incidence of ischemic heart disease, cerebral @Disease$ and diabetes)."	0
"Some studies have demonstrated that consumption of fish oil concentrate, @Chemical$ (n-3 PUFA), results in cardiovascular benefits that include reductions in mortality, @Disease$, nonfatal myocardial infarction, and thrombotic stoke, as well as improvement in graft patency."	0
"Risk of @Disease$ associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, @Chemical$ and combinations."	1
All patients had refractory @Disease$ as an indication for @Chemical$ desensitization.	0
"Although the pathogenic mechanisms of this condition are still unknown, @Disease$ may be due, at least in part, to an imbalance in @Chemical$ metabolism (increased production of cysteinyl leukotrienes (CysLTs) and reduced biosynthesis of prostaglandin (PG) E2), possibly increasing and perpetuating the process of inflammation."	0
"Thus, the lack of evidence of benefit with aspirin in patients with @Disease$ and coronary disease, along with growing evidence that aspirin is directly harmful in patients with heart failure and that aspirin may negate the benefits of angiotensin-converting enzyme inhibitors suggest that, unless there is an opportunity to randomize the patient into a study of antithrombotic strategies, then @Chemical$ should be withdrawn or possibly substituted with an anticoagulant or an antiplatelet agent that does not block cyclooxygenase."	0
"RESULTS: In the placebo arm, oral aspirin significantly decreased FEV 1 concomitant with significant increases in sputum @Disease$ protein and urinary @Chemical$(4) levels."	0
"Age, male gender, Helicobacter pylori (H. pylori)infection, @Disease$, chronic kidney disease (CKD), cirrhosis, history of uncomplicated peptic ulcer disease (PUD), and use of NSAIDs, COX-2 inhibitors, steroids, and thienopyridines were independent risk factors for UGIB among @Chemical$ users."	0
"The use of aspirin, aspirin plus extended-release @Chemical$, or clopidogrel is recommended as initial therapy in patients with noncardioembolic ischaemic @Disease$ or TIA to reduce the risk of recurrent stroke and other cardiovascular events."	0
"To assess the incremental utility of variables not included in the DAPT score, baseline high platelet reactivity was added to the @Disease$ model, and high platelet reactivity, baseline hemoglobin, and @Chemical$ use 1 year after percutaneous coronary intervention were added to the bleeding model."	0
We aimed to determine @Chemical$ levels in patients with AERD (n = 240) and aspirin-tolerant @Disease$ (ATA) (n = 226) and to assess whether its addition to urinary leukotriene E4 (uLTE4) levels and blood eosinophilia can improve the prediction of AERD diagnosis.	0
"By multivariate analysis, @Chemical$ resistance and history of @Disease$ were the only independent predictors of long-term adverse cardiovascular events."	0
"Low dose @Chemical$, &lt;em&gt;H. pylori&lt;/em&gt; infection, and the risk of @Disease$."	0
"BACKGROUND: The safety of aspirin in heart failure (HF) has been called into question, particularly in those patients (1) without @Disease$, (2) with renal dysfunction, or (3) treated with low-dose angiotensin-converting enzyme (ACE) inhibitors and high-dose @Chemical$."	0
"Results 3366 of 19,925 (16.9%) @Chemical$ treated patients experienced recurrent myocardial infarction, stroke, or @Disease$."	0
"Aside from patients with known @Chemical$-sensitive @Disease$, physicians have avoided the use of aspirin in asthmatic patients in general because it was believed that this agent might precipitate worsening of their condition."	0
"Results were adjusted for age, sex, ethnicity, study site, anti-hypertensive medication use, education, income, health insurance status, @Disease$, smoking, exercise, body mass index, blood pressure, serum @Chemical$, inflammatory markers, fasting glucose, statin medication use, and a simple diet score."	0
BACKGROUND: Proton pump inhibitors (PPIs) are the preferred agents for the prevention of @Chemical$-associated @Disease$ (UGIB).	1
"Sodium cromoglycate (@Chemical$) is used for the treatment of atopic dermatitis with @Disease$, but the efficacy of SCG in ASP-exacerbated food-allergy reactions is unclear."	0
"CONCLUSION: Our study showed that the use of @Chemical$ in @Disease$ patients was not associated with lower mortality, but rather with an increased morbidity."	0
"The similarities in the reaction between the nose and airways in @Chemical$-sensitive patients provide compelling evidence for common pathogenic mechanisms for nasal @Disease$, chronic rhinosinusitis, and bronchial asthma."	0
There is limited evidence of the use of @Chemical$ modifiers in preventing aspirin-induced @Disease$.	0
The goal of this study was to investigate a gene-gene interaction between IL-10 and TGF-beta1 polymorphisms in Korean asthmatics with @Chemical$ @Disease$.	1
"METHODS: Preoperative computed tomography (CT), pre- and postoperative endoscopy, and two validated disease specific QOL instruments, the @Disease$ Index (@Chemical$) and Chronic Sinusitis Survey (CSS), were collected."	0
"We encountered lower gastrointestinal bleeding in 16 patients taking a low dose of @Chemical$ and examined the effect of low aspirin dose on the stool occult blood test in 49 thrombotic patients (mean: 76.7 +/- 9.6 years old) including 39 with cerebral infarction, 8 with @Disease$ and 2 with atrial fibrillation."	0
Objective: To determine whether @Chemical$ therapy continued preoperatively increases @Disease$ complications in patients undergoing thyroid surgery.	0
Gastroduodenal @Disease$ were found in 19 of 101 (18.8%) low-dose @Chemical$ users compared with one of 30 (3.3%) nonaspirin users.	0
CONCLUSIONS: @Chemical$ therapy increased the risk of post-@Disease$.	1
RESULTS: The polymorphic variants of the P2RY12 and ITGB3 genes were ascertained to have no impact on the extent of @Disease$ in patients receiving clopidogrel and @Chemical$.	0
CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that discontinuation of low-dose @Chemical$ is associated with a 40% increased risk of @Disease$ within 31-180 days of discontinuation.	1
Nasal versus bronchial and nasal response to oral @Chemical$ challenge: Clinical and biochemical differences between patients with aspirin-induced @Disease$.	0
"The @Chemical$-induced percentage fall in FEV(1) was inversely correlated with BMI in @Disease$tic patients (r = -0.094, P = 0.016)."	0
"We investigated whether @Chemical$ with caffeine (ASA++) increases headache frequency compared with aspirin alone in migraine, tension-type headache (TTH), and @Disease$ + TTH (MigTTH)."	0
"Patients with AERD have high rates of recidivistic @Disease$ following sinus surgery, although the improvement in quality of life following surgery is similar to @Chemical$-tolerant patients."	0
EVIDENCE SYNTHESIS: The prevalence of @Chemical$-exacerbated respiratory tract disease is approximately 10% and for aspirin-induced @Disease$ the prevalence varies from 0.07% to 0.2% of the general population.	0
Valproic acid @Disease$ associated with low dose of aspirin and low total @Chemical$ levels: a case report.	0
@Chemical$ergic neural activity involved in salicylate-induced @Disease$ enhancement.	0
"The @Chemical$ TTR &gt;=55% episodes were associated with a 77% lower risk of @Disease$/SE (relative risk=0.23 [0.18 to 0.28]) compared to never on therapy; and the warfarin TTR &lt;55% and on-aspirin episodes were associated with a 20% lower and with a 26% lower risk of stroke/SE compared to never on therapy, respectively."	0
"The average levels of IL-5,IL-17,IFN-gamma and TNF-alpha in the @Chemical$ asthma group were significantly lower than those in the @Disease$ group(P&lt;0.05)."	0
"IMPORTANCE: Combined anticoagulant and @Chemical$ therapy is associated with increased @Disease$ risk in patients with atrial fibrillation, but the bleeding risk of combined use of anticoagulant and nonsteroidal anti-inflammatory drugs (NSAIDs) is poorly documented."	1
"A polymorphism study that examined nine single-nucleotide polymorphisms of five leukotriene-related genes [ALOX5 (encoding 5-lipoxygenase), ALOX5AP (5-lipoxygenase-activating protein), PTGS2 (cyclooxygenase 2), LTC4S (leukotriene C4 synthase), and CYSLTR1 (cysteinyl leukotriene receptor 1)] found that promoter polymorphisms of ALOX5 (-1708A&gt;G) and CYSLTR1 (-634C&gt;T) were significantly different between @Chemical$-intolerant asthma and aspirin-induced urticaria/@Disease$, suggesting different contributions to the lipoxygenase pathway."	0
"BACKGROUND: In patients with coronary or peripheral artery disease, the combination of @Chemical$ 2.5 mg twice daily and aspirin 100 mg once daily compared with aspirin 100 mg once daily reduced major adverse cardiovascular events and mortality and increased @Disease$."	0
@Disease$ induced by both aspirin and @Chemical$ in the same patient.	1
"The relationship between @Chemical$, aspirin, and clopidogrel continuation in the peri-procedural period and the incidence of @Disease$ formation after device implantation."	0
@Chemical$ use during early pregnancy and the risk of @Disease$: a population-based case-control study.	0
"A multicenter, randomized, double-blind, placebo-controlled trial of high-dose @Chemical$ treatment for low-dose aspirin-induced moderate-to-severe @Disease$."	0
"CONCLUSION: The -262 A&gt;T polymorphism in the promoter of the ACE gene is associated with AIA, and the rare allele of -262 A&gt;T may confer @Chemical$ @Disease$ via the down-regulation of ACE expression."	1
"Many of these patients present with the so-called aspirin triad of @Chemical$ sensitivity, chronic rhinosinusitis with associated nasal polyposis, and severe @Disease$."	0
Data on the chemopreventative role of these drugs on the risk of the upper aerodigestive tract @Disease$ (@Chemical$) are insufficient and mostly refer to oesophageal cancer.	0
Association of @Chemical$ use with major bleeding in patients with and without @Disease$.	0
"Older age, prior GI events, chronic renal failure, use of other injurious medicine such as NSAIDs, antithrombotic medicine, especially @Chemical$, and corticosteroids seem to be factors associated with an increased risk for upper @Disease$ ulcer and bleeding among the patients taking low dose aspirin."	0
"Therefore, a new class of drugs with COX-2 selectivity may be well tolerated by patients with @Chemical$/NSAIDs @Disease$."	0
The effects of NSAID/@Chemical$ on the @Disease$ are caused by the inhibition of this enzyme.	0
"Drugs that can lead to @Disease$ include non-steroidal anti-inflammatory drugs (NSAIDs) like diclofenac and ibuprofen, platelet inhibitors such as acetylsalicylic acid (@Chemical$), clopidogrel and prasugrel, as well as anticoagulants like vitamin-K antagonists, heparin or direct oral anticoagulants (DOAKs)."	0
"The aim of this study is to report the sinonasal outcomes of endoscopic sinus surgery (@Chemical$) in treating NP in asthmatic patients, comparing aspirin-induced asthmatic (@Disease$) patients with aspirin-tolerant asthmatics (ATA)."	0
The incidence of @Disease$ at six months in a post-stent cohort treated with aspirin and @Chemical$ is low (4.2%).	0
"Given observations of substantial increases in @Disease$ rates from many prior long-term clinical trials that have evaluated aspirin together with other oral platelet inhibitors or oral anticoagulants, the focus of contemporary research has pivoted towards tailored antithrombotic regimens that attempt to either shorten the duration of exposure to aspirin or replace @Chemical$ with an alternative antithrombotic agent."	0
"This study estimates the @Disease$ risks associated with combinations of aspirin, @Chemical$ derivatives, and warfarin in elderly patients."	0
"On multivariate analysis, @Chemical$ consumption was the only independent risk factor for upper gastrointestinal tract @Disease$."	1
"@Chemical$ had no effect on platelet-leukocyte aggregates, platelet activation markers, or plasma cytokines in either group.Conclusions: High-dose aspirin therapy for 8 weeks paradoxically increases markers of type 2 @Disease$ in subjects with aspirin-exacerbated respiratory disease, despite reducing nasal symptoms."	0
"On the other hand, @Chemical$ may have promoted the enlargement of spontaneous hemorrhage from @Disease$."	1
"Compared with @Chemical$, the rates of 30-day primary end points did not differ neither in APR group including tailored patients (MACE, adjusted OR 1.02, 95%CI 0.47-2.17; serious @Disease$, adjusted OR 1.92, 95%CI 0.79-4.63), nor in patients with AHR (MACE, adjusted OR 1.58, 95%CI 0.71-5.51; serious bleeding, adjusted OR 0.69, 95%CI 0.22-2.12)."	0
"Although the disease is clinically well characterized, its physiopathology is incompletely understood and noninvasive procedures, allowing an effective distinction between aspirin-induced @Disease$ (AIA) and @Chemical$-tolerant asthma (ATA) are missing."	0
"Among sepsis hospitalizations, @Chemical$ use was not associated with @Disease$ or hospital death."	0
"On the other hand, @Chemical$ alone inhibited basal gastric motility without any effect on mucosal PGE2 contents, and this agent, when given together with indomethacin, prevented @Disease$ and lesion formation in response to indomethacin, without affecting the reduced PGE2 contents."	0
BACKGROUND &amp; AIMS: Effervescent calcium carbasalate is a calcium-salt of acetylsalicylic acid causing less local @Disease$ than @Chemical$ at high doses in healthy controls.	0
"CONCLUSIONS: The highly sensitive eicosanoid profiling in EBC makes it possible to detect alterations in asthma, especially in its distinct phenotype characterized by @Disease$ to @Chemical$ and other nonsteroidal anti-inflammatory drugs."	1
"Recently, vitamin C releasing aspirin (ASA-VitC) has been shown to reduce gastric toxicity of @Chemical$ in animal model of @Disease$."	0
"BACKGROUND: To balance the cardiovascular benefits from low-dose @Chemical$ against the gastrointestinal harm caused, studies have considered the @Disease$ risk for each individual but not their gastrointestinal risk profile."	0
"Letter by Feng et al regarding article, Ischemic @Disease$ and intracranial hemorrhage with @Chemical$, dabigatran, and warfarin: impact of quality of anticoagulation control."	0
"The ASA-Mono and @Chemical$-Bis conjugates did not cause macroscopic @Disease$, but the inflammatory activation was apparent."	0
These results suggest that @Chemical$ has a lower incidence of gastrointestinal effects than other NSAIDs and should be useful in the management of patients with @Disease$.	0
"After propensity score matching (PSM) for identified confounders, the relationship between preoperative @Chemical$ use and 30-day all-cause mortality, postoperative renal failure, major adverse cardiocerebral events (MACE), blood transfusion, reoperation for bleeding, and @Disease$ were estimated with separate logistic regression models."	0
Effect of low-dose proton pump inhibitor on preventing @Disease$ in chronic kidney disease patients receiving @Chemical$.	1
Dramatic augmentation of wheat @Disease$ by @Chemical$ in a dose-dependent manner.	1
"We investigated the clinical features, endoscopic characteristics, and endoscopic treatment of the hemorrhagic lesion in the gastroduodenal @Disease$ patients taking @Chemical$ and compared them with those of the other groups."	0
This pro@Disease$ effect of ULDA is very similar to the effect observed after COX 2 selective inhibition with @Chemical$.	0
"@Disease$ is a serious, acute encephalopathy that has been linked with aspirin (@Chemical$) use in children and teenagers &lt;18 years of age."	1
"The triad of bronchial asthma, nasal polyposis, and intolerance to aspirin and aspirin-like chemicals are designated @Chemical$-induced asthma (@Disease$) or Samter's syndrome."	0
Effects of preoperative aspirin and @Chemical$ therapy on perioperative @Disease$ and blood transfusion requirements in patients undergoing off-pump coronary artery bypass graft surgery.	0
"An even larger number of respondents stopped aspirin therapy before surgery if the patient was taking @Chemical$ due to an @Disease$ or due to peripheral arterial disease with infrainguinal stenting (59-63% and 59-65%, respectively)."	0
Bleeding during treatment with aspirin versus apixaban in patients with atrial fibrillation unsuitable for warfarin: the @Chemical$ versus acetylsalicylic acid to prevent @Disease$ in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment (AVERROES) trial.	0
METHODS: The Apixaban versus Acetylsalicylic Acid to Prevent @Disease$ in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin k Antagonist Treatment (AVERROES) trial randomized 5599 patients with atrial fibrillation and risk factors to receive either apixaban or @Chemical$.	0
Prevention of @Chemical$-induced @Disease$: H. pylori infection eradication versus proton pump inhibitors or both.	1
"OBJECTIVES: To study the pattern of @Chemical$-induced @Disease$ (AIU) in two families, with special interest on the polymorphisms of LTC4S (AA, AC, CC) and the glutathione S-transferase M1 and P1 genes (GSTM1 and GSTP1)."	1
"CONCLUSIONS: In this cohort of patients with aspirin intolerance undergoing coronary stent implantation, the combination of a thienopyridine with @Chemical$, trapidil, or triflusal was associated with a low rate of @Disease$, ST and MI."	0
"CONCLUSIONS: @Disease$ with aspirin sensitivity is characterized by the eicosanoid alterations, which are similar to those present in @Chemical$-induced asthma."	0
It is suggested that the @Chemical$- related increase in the calcium secretion of the pancreas should be regarded as an indication of aspirin induced @Disease$.	0
"RESULTS: In total, 421 cases of upper @Disease$ were identified in the initial cohort of 784,263 NSAID users (incidence rate 54.2 per 10,000 person-years), while 1,295 cases of upper GI bleeding were identified in 235,531 @Chemical$ users (incidence rate 37.9 per 10,000 person-years)."	0
"BACKGROUND: Using data from the Reduced-Dose @Chemical$ in the Long-Term Prevention of Recurrent Symptomatic @Disease$ (EINSTEIN-CHOICE) trial, this study assessed cost impact of continued anticoagulation therapy with rivaroxaban vs aspirin."	0
The aim of this work was to determine the presence of galectin-10 in nasal lavage fluid (NLF) of patients with @Chemical$-sensitive respiratory disease (@Disease$) before and after challenge with L-ASA (aspirin) by ELISA.	0
The features described here suggest the importance of the Eosinophils and CD 4 +/- Lymphocytes in asthmatic response of allergic @Disease$tic patients as well as in @Chemical$ sensitivity asthmatic patients.	0
"In patients with left ventricular assist device support and @Chemical$ @Disease$, the choice of effective antiplatelet strategy remains a challenge."	1
"OBJECTIVE: We sought to assess a vast platform of @Chemical$s in different @Disease$ phenotypes, including aspirin-intolerant asthma, by means of a recently developed analytic approach based on mass spectrometry."	0
"It has been postulated that mediators other than histamine, such as kinins, @Chemical$ and leukotrienes, may be responsible for some of the symptoms in @Disease$ which are not controlled by antihistamines."	0
"OBJECTIVE: We investigated the roles of @Chemical$(2), COX-1 and COX-2, and PGE(2) receptors in the development of NPs and @Disease$ by measuring their expression in fibroblasts derived from nasal mucosa (NM) and NPs."	0
"Therefore, our results suggest             that CD55 polymorphisms are not genetic markers of @Chemical$-induced @Disease$,             including FEV1, in the population studied."	1
"Do zinc and selenium prevent the antioxidant, @Disease$ caused by @Chemical$ in rats?"	1
"Women were classified as regular or non-regular users of aspirin, COX-2 inhibitors, ibuprofen and other NSAIDs, and @Chemical$ (control) based on self-report at follow-up of ever using the medication for at least twice a week for &gt;=1 month prior to @Disease$ diagnosis."	0
Clinical usefulness of cellular antigen stimulation test in detection of @Chemical$ @Disease$.	1
"Clinically, these findings may support the use of a test-and-treat approach to H. pylori in @Chemical$ users, particularly those already at higher risk of developing peptic @Disease$s."	0
"Dose escalation based on @Chemical$ testing was performed in 40 of 64 patients, and significantly lower rate of @Disease$ was observed in patients who underwent dose escalation compared with those without dose escalation (0/40 vs 9/24, P &lt; .001)."	0
"DATA SYNTHESIS: @Chemical$ sensitivity is most often manifested as respiratory reactions (eg, bronchospasm, profuse rhinorrhea, conjunctival injection) or urticaria/@Disease$."	1
"Likewise, symmetry analysis was undertaken to evaluate the association between the diagnosis of @Disease$ disease and the prescription of @Chemical$ products."	0
@Chemical$ sensitivity is most often manifested as @Disease$ and asthma or urticaria/angioedema induced by cross-reacting nonsteroidal anti-inflammatory drugs that inhibit cyclooxygenase 1.	1
"Univariate analysis showed that continuous aspirin use was not significantly associated with @Disease$ complications (odds ratio, 0.933; 95% confidence interval, 0.283-3.074; P = .910 in the aspirin and control groups) and that discontinuous @Chemical$ use was not significantly associated with bleeding complications (odds ratio, 0.963; 95% confidence interval, 0.230-4.025; P = .959 in the aspirin and control groups; odds ratio, 0.969; 95% confidence interval, 0.198-4.752; P = .969 in the aspirin and discontinuous groups)."	0
"Recent interest in @Disease$ has been stirred by the finding of alterations in @Chemical$ metabolic pathways, leading to cysteinyl-leukotriene overproduction."	0
OBJECTIVE: To examine whether misoprostol (oral prostaglandin E1 analogue) use during aspirin challenge and desensitization might decrease the severity of @Chemical$-induced symptoms and make desensitization safer for patients with @Disease$.	0
"CONCLUSIONS: This study showed an important proportion (18%) of dispatched @Chemical$ users adults to digestive endoscopy, the 13.8% of them have a clear indication to use it, a substantial percent (13%) cannot inform any medical reason; the aspirin usage for more than six months in doses lower than 500 mg per day increases the mucosal gastroduodenal injury prevalence (58%)and relative risk of suffering these @Disease$ are high."	0
"The median @Disease$ in the aspirin regimen was 3, while those in both aspirin + rabeprazole 10 mg and @Chemical$ + rabeprazole 40 mg regimens were 0."	0
"CONCLUSIONS: Low-dose aspirin use could reduce the incidences of total cardiovascular events, stroke, nonfatal stroke and transient @Disease$ attack but increase the risk of bleeding, the incidence of nonfatal myocardial infarction, death from cardiovascular causes and death from any cause was not affected by low-dose @Chemical$ use."	0
"Spirometry, skin-prick test and @Disease$ control test were documented and intracellular cytokine expression in T lymphocytes and plasma lipoxin levels were measured in 23 AERD patients, 17 @Chemical$-tolerant asthmatic (ATA) patients, and 16 healthy controls."	0
"RESULTS: Fifty-four ICHs occurred in 16 625 patient-years in the @Chemical$-treated patients, and 7 @Disease$s occurred in 4317 patient-years in those on placebo."	0
CONCLUSION: Major @Disease$ risk is substantially lower on @Chemical$ than on VKA targeting current usual INR range.	1
"RESULTS: Compared with NM from control subjects, PGE(2) concentrations were significantly lower in IL-1beta-stimulated fibroblasts from patients with NPs who were tolerant to @Chemical$ and even lower in @Disease$ from patients with AIA."	0
"RESULTS: A lower incidence of gastric and duodenal @Disease$s was seen in @Chemical$/aspirin-treated subjects (19%) vs. naproxen/aspirin (27%; RR: 0.63, 95% CI: 0.44-0.92)."	0
We compared @Disease$ and all-cause mortality after dual antiplatelet therapy (DAPT) for the combination of clopidogrel and aspirin (ASA) versus @Chemical$ alone over 18 months follow-up in event-free patients at 12 months DAPT from the Health Insurance Review and Assessment (HIRA) dataset via the Korean Outcomes Registry Evaluating Antithrombotics (KOREA).	0
"This multicentre, randomized, investigator-blinded, parallel-group study compared the gastrointestinal (GI) tolerability of @Chemical$, paracetamol and aspirin at over-the-counter doses for common @Disease$ indications."	0
Polymorphisms in genes encoding acetylsalicylic acid metabolizing enzymes are unrelated to @Disease$ health in cardiovascular patients on @Chemical$.	0
"CONCLUSION: Although based on relatively few outcomes, the high risk of major @Disease$ on A+C acutely after TIA or minor stroke in @Chemical$-naive patients is a cause for concern."	0
"All 129 patients with high risk @Disease$ with microbleeds or minor stroke within 24 hours after the onset (average age 65.9 +- 9.3, 48.7% were male patients) were divided randomly into two groups: (1) 67 patients were given combination therapy with clopidogrel and aspirin (clopidogrel at an initial dose of 300 mg, then 75 mg per day for 90 days, plus aspirin at a dose of 75 mg per day for the first 21 days);(2) the rest patients were given @Chemical$ treatment (75 mg per day for 90 days)."	0
Effects of @Disease$ Risk Factors on the Association Between @Chemical$ and Colorectal Cancer.	0
"METHODS: Subjects 18 years or older with osteoarthritis, without gastroduodenal @Disease$ or erosive esophagitis at baseline endoscopy, and a cardiovascular indication for prophylaxis low-dose (81 or 325 mg) aspirin were prescribed open-label aspirin and blindly randomized to celecoxib 200 mg/day or naproxen 500 mg twice daily plus @Chemical$ 30 mg once daily."	0
"Despite reports in the literature, there does not appear to he cross-reactions between food coloring, @Chemical$ and monosodium glutamate in individuals with aspirin exacerbated @Disease$."	0
The @Chemical$ group without anti-@Disease$ drugs (A(-) group) comprised 47 patients and the non-aspirin group without anti-ulcer drugs (NA(-) group) 31 patients.	0
"After 2 months of treatment with 10 mg/day of oral prednisolone, 1600 mug/day of inhaled fluticasone propionate, @Chemical$ as a leukotriene receptor antagonist (LTRA), and long-term beta-agonist, we again challenged her with a provocation test with up to 200 mg of celecoxib; this time there were neither @Disease$ symptoms nor decrease in forced expiratory volume in 1 second."	0
"PATIENTS: Helicobacter pylori-negative patients taking daily low-dose @Chemical$ (75-325 mg), who fulfilled one or more of the following criteria: age &gt;=18 years with history of uncomplicated peptic ulcer; age &gt;=60 years with either stable @Disease$, upper gastrointestinal symptoms and five or more gastric/duodenal erosions, or low-dose ASA treatment initiated within 1 month of randomisation; or age &gt;=65 years."	0
Baseline vascular risk factors for CMBs and macroscopic @Disease$ (MB) were evaluated using univariate and multivariate analyses.The aspirin and clopidogrel groups did not differ significantly in baseline characteristics or prevalences of @Chemical$ or MB.	0
"Pre-association of aspirin with PC provides a novel therapeutic approach to significantly reduce aspirin-induced small @Disease$ and bleeding, as may occur with enteric-coated @Chemical$."	0
"Aspirin-exacerbated @Disease$ (AERD) is a clinical syndrome characterized by severe persistent asthma, hyperplastic eosinophilic sinusitis with nasal polyps, and an intolerance to @Chemical$ and other NSAIDs that preferentially inhibit COX-1."	0
CONCLUSION: The current study has observed no appreciable increase in @Disease$-related complication rates in patients with cardiac stents undergoing spine surgery while continuing to take @Chemical$ compared with patients who discontinued aspirin prior to surgery.	0
"A randomized, double-blinded, placebo-controlled, multicenter trial, healing effect of rebamipide in patients with low-dose @Chemical$ and/or non-steroidal anti-inflammatory drug induced @Disease$."	0
[Safety of reintroducing platelet-inhibitory doses of @Chemical$ in patients with urticaria or @Disease$ induced by anti-inflammatory doses].	0
"CONCLUSION: In this preliminary study of 15 patients, low-dose @Chemical$ did not lead to increased 15-epilipoxin A4 synthesis or alter inflammatory markers in patients with mild-to-moderate persistent @Disease$."	0
The @Chemical$ Response Test (ART; VerifyNow) was used to assess platelet inhibition in @Disease$ patients and guide platelet transfusion in patients with ASA-induced suppression.	0
Cases were patients with coronary artery disease (CAD) and documented history of aspirin @Disease$ who underwent rapid successful oral desensitization to @Chemical$.	1
"Effects of @Chemical$, non-steroidal anti-inflammatory drugs, acetylsalicylic acid, and opioids on bone mineral density and risk of fracture: results of the Danish @Disease$ Prevention Study (DOPS)."	0
"After 2 months of treatment with 10 mg/day of oral prednisolone, 1600 mug/day of inhaled @Chemical$, montelukast as a leukotriene receptor antagonist (LTRA), and long-term beta-agonist, we again challenged her with a provocation test with up to 200 mg of celecoxib; this time there were neither @Disease$ symptoms nor decrease in forced expiratory volume in 1 second."	0
"@Chemical$-induced @Disease$ and angioedema, but not bronchoconstriction, associated with cysteinyl leukotriene overproduction in 2 patients with asthma."	1
"RESULTS: We found significantly lower total symptom score (TSS) during the 7th (p = .009), 14th (p = .003), 21st (p &lt; .001) and the 28th day (p = .001), lower total endoscopic score (TES) on the 21st (p = .002) and 28th day (p = .001), lower @Disease$, facial pain/pressure, headache and trouble sleeping, and lower nasal mucosal edema, nasal secretion and nasal crusting in patients treated by hypertonic sea @Chemical$."	0
"Although respiratory reactions following ingestion of @Chemical$ and other nonsteroidal anti-inflammatory drugs (NSAIDs) are considered a hallmark of the condition, @Disease$ persists despite patients' avoidance of NSAIDs."	0
@Disease$ after lumbar puncture in a patient receiving aspirin and @Chemical$.	0
"Thus, functional alterations of the RAB1A gene may contribute to @Chemical$ intolerance in @Disease$tic sufferers."	0
"Aspirin-induced asthma and @Chemical$-induced @Disease$, in a substantial part of the patients, are driven by a release of mediators from activated mast cells."	1
"A 79-year-old man with @Disease$, taking @Chemical$ and aspirin, complained of purpura."	0
"CONCLUSION: Most variants that have clinical significance in aspirin response are related with drug efficacy or drug @Disease$ or ADR, indicating the urgency of variants screen in clinical practice.Significant population-specificity is detected in local 620 WES data in @Chemical$-response-related variants."	0
Our results suggest that @Chemical$-OM3 combination therapy does not affect the UGIC risk in patients with cardio- or @Disease$s.	0
"We included participants with @Disease$ at t0, @Chemical$ intake, ASA++ or no analgesics at t0 and t2, and known headache frequency."	0
@Chemical$ use is associated with gastroduodenal mucosal damage and increased risk of upper gastrointestinal (@Disease$) bleeding.	1
It is concluded that @Chemical$ may increase the risk of developing @Disease$.	1
The phenotype is recognized by the @Disease$ and worsening of symptoms acutely with @Chemical$/NSAID.	1
"Multinational, double-blind, randomised, placebo-controlled, prospective study of esomeprazole in the prevention of recurrent peptic @Disease$ in low-dose @Chemical$ users: the LAVENDER study."	0
"Objectives: To investigate the association of @Chemical$ use with risk of all-cause, any cancer, gastrointestinal (GI) cancer, and colorectal cancer (@Disease$) mortality among older adults and to perform an exploratory analysis of the association of aspirin use with mortality stratified by BMI."	0
"The authors recommend not stopping long-term @Chemical$ prior to dental extraction, and local measures for @Disease$ should be enhanced when required."	0
High on-@Chemical$ platelet reactivity predicts @Disease$ in acute coronary syndrome patients undergoing PCI.	0
"We used sensitivity analyses to identify the incremental benefit of longer-duration @Chemical$ on either ST or the composite of cardiac death, myocardial infarction, and ischemic stroke (major adverse cardiovascular and cerebrovascular events [MACCEs]) required to outweigh the increased risk of @Disease$ associated with longer DAPT."	0
"The @Disease$ index, contents of TNF, and IL-1, 2, 8 were significantly lower in all the protection groups than in the injury group (all P&lt;0.01), and contents of IL-2 and IL-8 in the compound @Chemical$ and magnesium granules group were significantly lower than those in the sucralfate group ((328.17+-6.56) vs(340.23+-8.05)pg/ml, P&lt;0.01; (170.82+-7.31) vs(179.31+-7.80)pg/ml, P&lt;0.05)."	0
"METHODS: A case series of three patients suffering severe nausea, vomiting, diarrhea, @Disease$ and clinical decline during @Chemical$ therapy was examined."	0
In vitro studies into mechanistic processes of @Chemical$ toxicity propose that there is a bi-directional link and potentiation with glutathione (GSH) depletion and salicylate @Disease$.	0
"RESULTS: The gastric acid secretion level, with an odds ratio (OR) (95% confidence interval [CI]) of 10.5 (3.0-36.9) and @Chemical$ administration, with an OR (95% CI) of 7.4 (3.0-18.3) were independently associated with gastric @Disease$, and the co-existence of both factors greatly elevated the risk of mucosal injury, with an OR (95% CI) of 77.0 (13.5-440.0)."	0
BACKGROUND: Warfarin and aspirin (acetylsalicylic acid [@Chemical$]) are the most commonly used anticoagulant and antiplatelet drugs in the treatment of @Disease$.	0
"Long-term use of @Chemical$, aspirin, and other nonsteroidal anti-inflammatory drugs and risk of @Disease$: results from the prospective Vitamins and Lifestyle (VITAL) study."	0
"Main risk factors for upper GI bleeding with low-dose @Chemical$ are concomitant antiplatelet agents, anticoagulants, non steroidal anti-inflammatory drugs or steroids use, and recent history of complicated or non-complicated gastroduodenal @Disease$."	0
Twenty @Disease$ and 10 aspirin tolerant controls (ATC) were challenged with saline or 14.4mg of Lys-@Chemical$.	0
BACKGROUND: Acetylsalicylic acid (@Chemical$) and warfarin are used to prevent @Disease$.	0
BACKGROUND: Aspirin-intolerant asthma (@Chemical$) refers to the development of bronchoconstriction in @Disease$tic individuals following the ingestion of aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs).	0
"CONCLUSIONS: NSAID, low-dose ASA use, and H. pylori @Disease$ are three independent risk factors for the development of PUB, but there were differences in the interaction effect between low-dose @Chemical$ (no interaction) or NSAID (addition) use and H. pylori infection, which may have implications for clinical practice in prevention strategies."	0
"However, many of those labeled as @Disease$ to @Chemical$ had experienced side-effects and could be safely treated with aspirin."	1
This study was performed to examine PBL cytokine expression in @Chemical$-sensitive patients who have @Disease$ before and after aspirin desensitization.	0
"RESULTS: Tacrolimus pretreatment failed to block respiratory reactions to provoking doses of aspirin in 5 of 8 patients with @Disease$, and in the other 3 patients did not block higher doses of @Chemical$."	0
"In this prospective study, we aimed to clarify the incidence of @Chemical$-induced @Disease$ in consecutive Japanese patients and identify suitable preventive measures."	1
"@Disease$ (MI), sham or normal male SD rats were injected intraperitoneally with high (300 mg/kg), low (5 mg/kg) aspirin or @Chemical$ (control) once a day for seven weeks."	0
This analysis explores patterns of @Disease$ and defines bleeding risks based on stroke risk with apixaban and @Chemical$.	0
@Chemical$ exacerbated @Disease$: the search for a biomarker.	1
"CONCLUSION: Our findings provide strong evidence that COX-2 and ITGA2 @Disease$ might increase the risk of having aspirin insensitivity, especially for @Chemical$ semi-resistance and in Chinese populations."	0
"Both naproxen/aspirin and celecoxib/@Chemical$ groups demonstrated a higher incidence of gastric and duodenal @Disease$s vs. placebo/aspirin (8%; RR: 3.7, 95% CI: 1.8-7.6 and RR: 2.6, 95% CI: 1.2-5.8, respectively)."	1
Prior exposure to @Chemical$ in acute @Disease$ patients: a cardiovascular risk marker or a predictor of adverse outcome?	0
OBJECTIVE: To evaluate frequency of ischemic and hemorrhagic events in patients treated with @Chemical$ and ticagrelor when associated with perioperative heparin bolus for @Disease$ treated with intracranial stents.	0
"Eight had a history of cutaneous sensitivity, 1 had @Disease$, 1 reported urticaria and rhinitis, while another patient showed a respiratory response in the form of an asthma attack after taking @Chemical$ in the past."	1
"BACKGROUND: We examined whether a decreased activity of nuclear factor(NF)-kappaB), a transcriptional regulator of cyclooxygenase-2 (COX-2), could account for down-regulation of COX-2 in nasal polyps of @Chemical$-sensitive @Disease$tics."	0
"DATA SOURCES: Articles evaluating aspirin for primary prevention of CVD were gathered using a MEDLINE search with the keywords aspirin review, @Chemical$ peripheral artery disease, aspirin stroke, aspirin coronary @Disease$, aspirin diabetes, aspirin primary prophylaxis, and aspirin elderly."	0
"Also, women had less peripheral artery disease (aspirin, 2.4% versus 3.7%; @Chemical$, 1.4% versus 3.0%), more heart failure, and higher mean CHADS2 (congestive @Disease$, hypertension, age of 75 years or older, diabetes [1 point each], stroke or transient ischemic attack [2 points]) scores (aspirin, 2.2 versus 2.0; apixaban, 2.1 versus 2.0)."	0
"To this end, groups of BALB/c mice were treated during 5 days with @Chemical$ (100 mg kg(-1)) before oral @Disease$ with T. cruzi metacyclic forms (4 x 10(5) or 5 x 10(7) parasites/mouse)."	0
The data suggest that regular @Chemical$ use should be measured in epidemiological work on @Disease$.	0
CONCLUSIONS: A considerable number of @Disease$tic patients with no history of @Chemical$ intolerance responded to the inhalation aspirin challenge.	0
"Comparative tolerability of paracetamol, aspirin and @Chemical$ for short-term analgesia in patients with @Disease$: results in 4291 patients."	0
CONCLUSION: The effective analgesic and anti-inflammatory doses of 1:10 aspirin complex with arabinogalactan are twice less compared to pure @Chemical$ and safer for the @Disease$.	0
"BACKGROUND: In patients with aspirin-exacerbated respiratory disease (@Disease$), pretreatment with asthma controller medications (@Chemical$ modifiers, inhaled or systemic corticosteroids, and salmeterol) partially modifies the severity of aspirin-induced asthmatic reactions."	0
AIMS: The objective of the present substudy was to examine whether @Chemical$ poor/high responsiveness (APR/AHR) is associated with increased rates of major adverse cardiovascular events (MACE) and serious @Disease$ after primary percutaneous coronary intervention (PPCI).	0
"@Chemical$-exacerbated @Disease$ (AERD) is characterized by the triad of asthma, eosinophilic nasal polyposis and a hypersensitivity to all medications that inhibit the cyclo- oxygenase (COX) -1 enzyme."	1
Association between a TGFbeta1 promoter polymorphism and the phenotype of @Chemical$-intolerant chronic @Disease$ in a Korean population.	0
Early @Disease$ signs were present among 10.9% of aspirin users and 4.9% of non-@Chemical$ users (p&lt;0.001).	0
"The aim of this study was to compare the @Disease$ risk of @Chemical$ and VKA, as indicated by the aggregate body of clinical evidence including data from the recently published WARCEF trial."	0
Minidose @Chemical$ treatment is associated with a high prevalence of @Disease$ations of the stomach and duodenum.	1
"SUMMARY: In summary, with rare exceptions, patients with a history of 'aspirin/NSAID @Disease$' who need ASA for cardiovascular issues will be able to safely take @Chemical$ either after a graded challenge or desensitization providing a central role of the allergist in the management of these patients."	0
There were 2 @Disease$s (1%) in the @Chemical$ group compared with 104 (10%) in the nonketorolac group (p &lt; 0.001).	0
"The pooled RR for the @Chemical$ use on the risk of early and late @Disease$ was 1 19 (95% CI, 0 92-1 53; I(2) , 82 6%) and 1 22 (95% CI, 0 87-1 72; I(2) , 55 7%), respectively."	0
"The impaired cardiac proteasome, enhanced by chronic @Chemical$ treatment, attenuated the removal of oxidative and ubiquitinated proteins, and chronic aspirin treatment via selective and dose-dependent inhibition of cardiac proteasome possibly constituted a potential risk to @Disease$ heart."	0
"Older age, prior GI events, chronic renal failure, use of other injurious medicine such as NSAIDs, antithrombotic medicine, especially thienopyridine, and corticosteroids seem to be factors associated with an increased risk for upper GI @Disease$ and bleeding among the patients taking low dose @Chemical$."	1
"METHODS: A comprehensive electronic database search was conducted for all RCTs that compared @Chemical$ versus placebo for the prevention of any @Disease$, and where cancer incidence or mortality was reported."	0
"We evaluated the effects of @Chemical$ on genetic/epigenetic alterations in precancerous conditions, i.e., @Disease$ (AM) and intestinal metaplasia (IM), in patients with chronic gastritis who had taken aspirin for more than 3 years."	0
Baseline vascular risk factors for CMBs and macroscopic @Disease$ (MB) were evaluated using univariate and multivariate analyses.The aspirin and @Chemical$ groups did not differ significantly in baseline characteristics or prevalences of CMBs or MB.	0
CONCLUSION: Compound bismuth and magnesium granules and its herbal components may have significant protective effect on @Chemical$-induced @Disease$.	1
"FINDINGS: The incidence of GI @Disease$ with low-dose @Chemical$ was 0.48-3.64 cases per 1000 person-years, and the overall pooled estimate of the RR with low-dose aspirin was 1.4 (95% confidence interval [CI]: 1.2-1.7)."	0
"Although acetylsalicylic acid is prescribed for a broad range of diseases, it can induce a wide array of clinically recognized @Disease$ reactions, including aspirin-intolerant asthma (AIA) with rhinitis and aspirin-intolerant urticaria (@Chemical$) with anaphylaxis."	0
"Over 10 years, no differences were present in BMD alterations except a small trend towards a higher @Disease$ in the spine in users of @Chemical$, NSAID, ASA, and opioids compared to non-exposed."	0
"Many of these patients present with the so-called @Chemical$ triad of aspirin sensitivity, chronic rhinosinusitis with associated nasal polyposis, and severe @Disease$."	0
One proposed mechanism of @Disease$ by NSAIDs is @Chemical$-dependent microvascular injury.	0
"@Chemical$ use 3 or more times per week was associated with decreased risk of mortality of all causes (HR, 0.81; 95% CI, 0.80-0.83; P &lt; .001), any cancer (HR, 0.85; 95% CI, 0.81-0.88; P &lt; .001), GI cancer (HR, 0.75; 95% CI, 0.66-0.84; P &lt; .001), and @Disease$ (HR, 0.71; 95% CI, 0.61-0.84; P &lt; .001)."	0
"Allergic conditions include @Chemical$-exacerbated respiratory disease (AERD or aspirin-induced asthma), aspirin-induced urticaria/@Disease$ (AIU), and anaphylaxis."	0
Aims: To determine antiplatelet efficacy after desensitization in patients with a history of @Chemical$ @Disease$.	1
Oxidative stress parameters after combined fluoxetine and @Chemical$ therapy in @Disease$ patients.	0
"That is, patients who had @Disease$ had significantly fewer MACEs through study end (0.49 [0.34-0.63], P &lt; 0.0001), significantly less 30-day all-cause mortality (0.33 [0.20-0.56], P &lt; 0.0001), and significantly less 30-day vascular mortality (0.35 [0.22-0.55], P &lt; 0.0001), respectively, when given high-dose (300-325 mg) @Chemical$, regardless of treatment (clopidogrel or ticagrelor) assignment."	0
Only 5 (12.5%) centers had a local policy for aspirin desensitization although 25 (64.1%) units had a clinical strategy for dealing with aspirin @Disease$; the majority (72%) giving higher doses of @Chemical$ class drugs.	0
"In saliva analysis among the three groups (AIA patients, aspirin-tolerant asthma [ATA] patients, and healthy subjects), both the concentrations of @Chemical$ and LTB4 were significantly higher in @Disease$ patients than in ATA patients and healthy subjects."	0
@Disease$ @Chemical$ can be a Cause.	1
"The effects of pranlukast on changes in sputum LTC(4)-LTD(4), eosinophil cationic protein (ECP), eosinophil count, urinary LTE(4)/creatinine, 11-dehydrothromboxane B(2) (@Chemical$(2))/creatinine, serum LTC(4)-LTD(4), ECP, and peripheral blood eosinophil count, during immediate @Disease$tic reaction (IAR) and late asthmatic reaction (LAR) in the HDM group and during IAR in the ASA group for each test, were compared in each group."	0
"At present, a history of peptic @Disease$, especially that of complicated ulcer, is the most important risk factor for low-dose @Chemical$-associated gastroduodenal adverse events."	0
"In two separate series, @Disease$ and @Chemical$ arthritis-induced inflammatory pain were measured in control, ASA and ASA-Tris-treated groups."	0
"Compared with nonusers, @Chemical$ users were no more likely to die or require HF readmission (hazard ratio [HR], 1.02 [0.91 to 1.16]), even in patients without coronary disease (HR, 0.98 [0.78 to 1.22]) or patients with @Disease$ (HR, 1.13 [0.94 to 1.36])."	0
"A conserved linkage group on chromosome 6, the 8.1 ancestral haplotype, is a predisposing factor of @Disease$ associated with nasal polyposis in @Chemical$-sensitive Hungarians."	0
"CONCLUSIONS: In a randomized controlled trial of users of low-dose @Chemical$ at risk for recurrent GI @Disease$, a slightly lower proportion of patients receiving a PPI along with aspirin developed recurrent bleeding or ulcer than of patients receiving an H2RA with the aspirin, although this difference was not statistically significant."	0
"RESULTS: Logistic regression analysis showed no relationship of hemorrhagic complications within the first 48 h to @Chemical$ pretreatment (p = 0.15), or heparin application (p = 0.38), but dependency on @Disease$ severity (NIHSS) at baseline (p = 0.01)."	0
METHODS: Patients taking 100 mg of enteric-coated @Chemical$ for @Disease$ and with a peptic ulcer or ulcer bleeding and patients who also participated in endoscopic surveillance were studied.	0
There is evidence that selenium (Se) nutrition can influence @Disease$ but @Chemical$ status in AIA patients has not received much attention.	0
We tested the hypothesis that combined pre-treatment with aspirin and @Chemical$ is a risk factor for thrombolysis-related symptomatic @Disease$ (sICH).	0
CONCLUSIONS: PNS may have protective function for @Chemical$-induced @Disease$ through increasing VEGFA expression.	1
CONCLUSIONS: The only variable that could have led to our patient's epidural @Disease$ is @Chemical$.	1
"In this study, we investigated the clinical usefulness of measuring the serum pepsinogen values for identifying a high-risk group for @Disease$ among chronic @Chemical$ users."	0
"This anti-inflammatory effect of TMG seems to be related to impairment of @Chemical$ peroxidation, neutrophil function and cytokine production in @Disease$."	0
Nasal polyp tissues were obtained from 29 patients [including nine with aspirin (@Chemical$)-hypersensitivity and 12 with bronchial asthma] undergoing polypectomy for @Disease$.	0
"Aspirin-exacerbated diseases are important examples of drug @Disease$ and include aspirin-exacerbated respiratory disease (AERD), aspirin- or non-steroidal anti-inflammatory drug (NSAID)-induced urticaria/angioedema, and @Chemical$- or NSAID-induced anaphylaxis."	0
BACKGROUND AND PURPOSE: @Chemical$ reduces stroke with comparable @Disease$ risks when compared with aspirin in patients with atrial fibrillation who are unsuitable for vitamin k antagonist therapy.	0
Specially was described the cyclooxygenase theory and genetic risk of @Chemical$ induced @Disease$ as well as tolerability of the new COX-2 inhibitors.	1
A study was undertaken to investigate the effects of aspirin on the systemic production of prostaglandin E2 and @Chemical$ in patients with @Disease$.	0
"OBJECTIVE: @Chemical$-exacerbated respiratory disease (AERD) represents a severe form of chronic rhinosinusitis (CRS) characterized by @Disease$, bronchial asthma, and aspirin intolerance."	0
"@Disease$ were found in 54 of 98 (60.7%) users of buffered aspirin (BA), whereas 38 of 101 (37.6%) users of @Chemical$ had mucosal defects."	0
"DATA SOURCES: Articles evaluating aspirin for primary prevention of CVD were gathered using a MEDLINE search with the keywords aspirin review, aspirin peripheral artery disease, aspirin stroke, aspirin coronary artery disease, aspirin @Disease$, aspirin primary prophylaxis, and @Chemical$ elderly."	0
"Low-dose @Chemical$ is associated with upper and lower @Disease$, although lower gastrointestinal effects are poorly characterized."	1
Skin and colonic @Disease$ times are prolonged for 3 and 5 days after aspirin and @Chemical$ withdrawal respectively.	0
@Chemical$ is associated with an increased risk of subdural hematoma in normal-pressure @Disease$ patients following shunt implantation.	0
@Chemical$ may reduce the risk of @Disease$ at some sites but its effect at the lung is unclear.	0
"RESULTS: We found that treatment with @Chemical$ is associated with increased overall @Disease$ risk, but not to the risk of osteoporotic fractures."	0
"The present study was designed to identify the association of SG13S114T/A polymorphism in ALOX5AP1 gene with risk of @Disease$, its subtypes and @Chemical$ resistance."	0
"@Chemical$ might represent a pharmacological treatment option for lesions causing @Disease$ that is associated with aspirin and NSAIDs, but its use should be balanced against the risk of side-effects."	0
"Exclusion criteria: @Disease$, sepsis or acute infection, active inflammatory/rheumatic disease, recent major surgery, chronic liver failure, the administration of other antiplatelet drugs, nonadherence with @Chemical$ and thrombocytopenia."	0
BACKGROUND: Cysteinyl leukotriene production seems to be dysregulated in patients with @Disease$ to @Chemical$ and other nonsteroidal anti-inflammatory drugs (NSAIDs).	1
"MATERIAL AND METHODS: This prospective, randomized study included 30 patients with @Chemical$-induced @Disease$ undergoing ESS."	1
"The genetic analysis of @Chemical$-induced urticaria/@Disease$ is limited, however."	1
"The positive-predictive-value of FOBT for advanced @Disease$ was significantly higher in the control group (30.5%) when compared to those on low-dose aspirin (20.5%; p = 0.003), NSAIDs (19.7%; p = 0.003), @Chemical$ (7.3%; p = 0.002), or warfarin (20%; p = 0.05)."	0
Sinonasal outcomes after endoscopic sinus surgery in asthmatic patients with @Disease$: a difference between @Chemical$-tolerant and aspirin-induced asthma?	0
Hemorrhagic foreign body granuloma after cutaneous surgery occurring in the setting of @Chemical$ therapy or @Disease$: a presentation of six cases.	0
Daily low-dose @Chemical$: beware of @Disease$.	1
"We included participants with headache at t0, aspirin intake, @Chemical$+ or no analgesics at t0 and t2, and known @Disease$ frequency."	0
"The authors found no significant differences on quality of life, nasal symptoms, polyp size, and CT scan scores between patients with aspirin-tolerant and @Chemical$-sensitive @Disease$."	0
"After adjusting for potential confounders, including age, smoking and previous @Disease$ surgery, @Chemical$ use was associated with early AMD (OR 1.50; 95% CI: 1.01 to 2.22)."	0
CONCLUSION: Asthmatic patients belonging to extrinsic or @Chemical$-induced @Disease$ groups irrespectively showed an improvement from zafirlukast treatment on spirometric and clinic levels.	1
"However, the prevalence and predictors of long-term @Disease$ events in patients on prolonged dual antiplatelet therapy (@Chemical$) after drug-eluting stent (DES) implantation has been poorly explored."	0
"The body weight (p = 0.0065), body mass index (p = 0.006), prevalence of hypertension (p = 0.0242), prevalence of @Disease$ (p = 0.0015), and frequency of use of low-dose @Chemical$ (p = 0.042) were significantly different between the two groups."	0
"The relationship between warfarin, aspirin, and @Chemical$ continuation in the peri-procedural period and the incidence of @Disease$ formation after device implantation."	0
"In the TBI group, 30 patients (49.2 %) were identified, while Multiplate analysis detected @Disease$ in 19 (59.4 %) subjects in the @Chemical$ group and 5 in the pSAH group (50 %)."	0
OBJECTIVE: To describe the clinical course of a man with aspirin-exacerbated @Disease$ who was unable to be desensitized to oral @Chemical$.	0
OBJECTIVE: To review data concerning combined aspirin/@Chemical$ versus aspirin alone for secondary prevention after @Disease$ (MI).	0
[New pathophysiological concepts on @Chemical$ @Disease$ (Widal syndrome); diagnostic and therapeutic consequences].	1
"For participants with OBRI scores of 0 to 1, warfarin compared with @Chemical$ reduced @Disease$ (hazard ratio [HR] 0.51, 95% CI 0.26 to 0.98, p = 0.042) without significantly increasing major bleeding (HR 1.24, 95% CI 0.66 to 2.30, p = 0.51)."	0
RESULTS: Twenty-one patients with @Disease$ and/or NP (10 males and 11 females; mean age: 38.4 +/- 2.9 years) who reacted to @Chemical$ challenges were enrolled in the study.	0
SUBJECTS AND METHODS: A retrospective review of sinonasal outcomes was conducted for 30 @Disease$ patients undergoing @Chemical$ desensitization and maintenance therapy following ESS.	0
"The risk increased when @Chemical$ was combined with clopidogrel, compared with aspirin alone (OR, 1.86; 95% CI, 1.49-2.31), anticoagulants vs low doses of ASA alone (OR, 1.93; 95% CI, 1.42-2.61), or in studies that included patients with a history of GI @Disease$ or of longer duration."	0
"Because I am @Disease$ to aspirin, it has been suggested that I take @Chemical$."	0
"Although it is still controversial whether leukotriene modifiers are more effective in patients with AIA compared with other types of asthma, because LT plays an important role in the pathogenesis of @Disease$, @Chemical$ modifiers are the preferred medication for the long-term control of AIA."	0
Our results indicate that the individuals bearing AA genotype of ALOX5AP1 SG13S114T/A polymorphism are more prone to @Disease$ and bad outcome as well as with @Chemical$ resistance than TA and TT genotypes.	0
"Sodium cromoglycate (@Chemical$) is used for the treatment of @Disease$ with food allergy, but the efficacy of SCG in ASP-exacerbated food-allergy reactions is unclear."	0
"BACKGROUND: Clopidogrel in combination with @Chemical$, given before percutaneous coronary intervention, has become the standard for stent @Disease$ prevention."	0
Multivariate analysis of the primary prevention group showed a trend towards @Disease$ (P = 0.054; HR 1.72; CI 0.99-2.97) with dual-antiplatelet therapy (@Chemical$ plus clopidogrel).	0
"@Chemical$ is cheap and effective and known to prevent cardiovascular and cerebrovascular disease, many @Disease$, and Alzheimer dementia."	0
@Chemical$CKGROUND: Low-dose aspirin is used for secondary prevention of @Disease$ and ischemic cerebrovascular disease.	0
"Main risk factors for upper @Disease$ bleeding with low-dose aspirin are concomitant antiplatelet agents, anticoagulants, non steroidal anti-inflammatory drugs or @Chemical$ use, and recent history of complicated or non-complicated gastroduodenal ulcer."	0
@Chemical$ is a platelet aggregation inhibitor that increases the risk of @Disease$ complications when combined with acetylsalicylic acid.	0
We assessed the long-term risks of recurrent lower @Disease$ and serious cardiovascular outcomes after @Chemical$-associated lower GI bleeding.	0
Daily low-dose acetylsalicylacid (@Chemical$) is prescribed to patients with @Disease$ frequently to prevent vascular complications.	0
"The values of @Disease$s of MPs in descending order were as follows: gefarnate, hydrotalcite &gt; teprenone &gt; sucralfate oral suspension &gt; L-glutamine and sodium gualenate granules &gt; rebamipide &gt; @Chemical$ chewable tablets."	0
"AIM: The goal of the present study was to investigate whether a mucosal-protective agent, rebamipide, could prevent @Disease$ induced by @Chemical$ with or without clopidogrel in healthy subjects."	1
"CONCLUSION: Switching @Chemical$ dosage from 100 mg/d to 40 mg/d reduces the bleeding events and improves upper gastrointestinal symptoms, thus inhibiting @Disease$ effectively in very elderly patients."	0
"No factors, other than female gender, reduced time to @Disease$ recurrence in addition to the effect of @Chemical$ (p&lt;0.001)."	0
"CONCLUSION: In real life, the incidence of @Disease$ associated with the combination of aspirin, clopidogrel, and @Chemical$ therapy was estimated to be 2.7%."	0
The rates of both stroke and @Disease$ increased with higher CHADS2 scores but apixaban compared with @Chemical$ was associated with a similar relative risk of bleeding (P interaction 0.21) and a reduced relative risk of stroke (P interaction 0.37) irrespective of CHADS2 category.	0
"BACKGROUND AND AIM: Low-dose @Chemical$ is effective for the prevention of cardiovascular and cerebrovascular events, but the frequency of @Disease$ among users of low-dose aspirin in Japan is currently unknown."	0
"Ischemic stroke and @Disease$ with @Chemical$, dabigatran, and warfarin: impact of quality of anticoagulation control."	1
"Tacrolimus, a @Chemical$-derived immunosuppressant, is used for immunosuppression in organ transplantation and also for allergic diseases such as @Disease$."	0
An update on the epidemiology of @Chemical$-exacerbated @Disease$.	1
"@Chemical$ healed 64% of ulcers, but despite follow-up maintenance with H2 receptor antagonists, all @Disease$ recurred rapidly, often in a new location."	0
"There were, however, significantly more subjects with one or more lesions (erosion or @Disease$) per subject in the paracetamol and @Chemical$ (16/20, 80%) treated subjects as compared to the aspirin (8/19, 42%, P &lt; 0.001) or the paracetamol (3/21, 14%, P &lt; 0.01) exposed subjects."	0
@Chemical$ exacerbated respiratory disease (AERD) is a clinical syndrome characterized by chronic rhinosinusitis with nasal polyposis and aspirin @Disease$.	0
"Letter to the Editor concerning Comparison of @Disease$ according to use of @Chemical$ in lumbar fusion patients (by Park HJ, Kwon KY, Woo JH (2014) Eur Spine J. doi:10.1007/s00586-014-3294-y)."	0
Blood @Disease$: 5.6 +/- 0.4% (PP-- 4.6 +/- 0.5; A-- 6.2 +/- 0.9; ASA-- 7.2 +/- 0.9% and PP/@Chemical$-- p = 0.019; PP/A+ASA-- p = 0.03).	0
"DATA SYNTHESIS: Despite use of low-dose @Chemical$ after an MI, risk of subsequent @Disease$ and ischemic events remains high, making strategies for secondary prevention imperative."	0
Role of @Chemical$ in mucosal gastroprotection against aspirin-induced @Disease$ in humans.	0
Baseline vascular risk factors for CMBs and macroscopic @Disease$ (MB) were evaluated using univariate and multivariate analyses.The @Chemical$ and clopidogrel groups did not differ significantly in baseline characteristics or prevalences of CMBs or MB.	0
"METHODS: Two hundred thirty-nine patients with AIU consisting of 120 patients with @Chemical$ intolerant chronic @Disease$ (AICU) and 119 with aspirin-intolerant acute urticaria (AIAU), and 524 normal controls were enrolled."	0
BACKGROUND: Chronic rhinosinusitis (@Chemical$) is a common disorder associated with other respiratory tract diseases such as @Disease$ and inhalant allergy.	0
"After a median of 8 weeks' follow-up, H2 blockers were more effective than placebo in reducing @Disease$ (2 RCTs, total of 447 patients, OR 0.07, 95% CI 0.02-0.23) and peptic ulcers (3 RCTs, total of 465 patients, OR 0.21, 95% CI 0.12-0.36) among patients taking @Chemical$ for 2 weeks or longer."	0
"To evaluate the extent of gastric mucosal injury and the protective effect of drugs, gastric mucosal lesion index, @Disease$ flow, content of gastric mucosal hexosamine, prostaglandins (@Chemical$), nitric oxide(NO), tumor necrosis factor (TNF), and interleukin (IL) -1, 2, 8 were measured in each group, and histological changes were observed by gross as well as under microscope and electron microscope."	0
"@Chemical$-exacerbated @Disease$ (AERD) is the most common phenotype characterized by an eosinophil-dominated inflammatory disease of the airways that presents clinically with nasal polyps, chronic sinusitis and bronchial asthma."	1
"AIMS: We hypothesized that patients with a history of either alarming or nuisance bleeding events, compared to those with no history of @Disease$, would have lower levels of on-treatment platelet reactivity (@Chemical$ and a thienopyridine)."	0
"The gastrointestinal risks of @Chemical$ are well known, but the frequency of @Disease$ in aspirin users in Thailand is currently unknown."	0
"The independent risk factors for death were regular aspirin-use at the onset of ICH (relative risks [RR], 2.5; 95% CI, 1.3 to 4.6; P=0.004), @Chemical$-use at the onset of ICH (RR, 3.2; 95% CI, 1.6 to 6.1; P=0.001), and @Disease$ score higher than 2 on admission (RR, 13.8; 95% CI, 6.0 to 31.4; P&lt;0.001)."	0
"PATIENTS AND METHODS: Intra-operative and perioperative @Disease$, the amount of transfused blood and surgery-related complications of 44 patients on uninterrupted clopidogrel treatment were compared with 44 matched controls not on clopidogrel (either on @Chemical$ alone or not on any anti-platelets)."	0
Various medicamentous methods of counteracting @Chemical$-induced @Disease$ and excessive bleeding in this context are discussed and evaluated.	1
"CONCLUSIONS: The combination of @Chemical$ and aspirin compared with aspirin alone increased major @Disease$, mainly from the GI tract."	0
BACKGROUND: The exact mechanism of @Chemical$-induced @Disease$ is not clear.	1
"In contrast, there is fairly robust evidence for a benefit of both @Chemical$ and angiotensin-converting enzyme inhibitors during the first 5 weeks after a @Disease$, with little evidence of an interaction."	0
"Lack of @Chemical$ responsiveness on initial testing was a significant risk factor for @Disease$ (P &lt; .001) independent of age, weight, diagnosis, and initial aspirin dose."	0
"We evaluated the effects of the probiotic Lactobacillus gasseri OLL2716 (LG) on @Chemical$-induced small intestinal lesions, such as @Disease$, erosions, reddened lesions, and bleeding."	0
"This association has also been confirmed in additional independent samples of asthma with nasal polyposis (P = 0.008), regardless of @Chemical$ @Disease$."	1
"In this study, the allelic associations of 49 single-nucleotide polymorphisms (SNPs) of the human EMID2 gene were evaluated from 163 @Disease$ patients and 429 @Chemical$-tolerant asthma (ATA) subjects as controls in a Korean population."	0
BACKGROUND: Adaptive desensitization still remains the only causative therapy for acetylsalicylic acid (@Chemical$) @Disease$ and is carried out nearly worldwide.	1
Effect of @Chemical$ desensitization on T-cell cytokines and plasma lipoxins in aspirin-exacerbated @Disease$.	0
In our study we attempted to select the most suitable procedure on the basis of characteristics and severity of @Chemical$ @Disease$.	1
Pathogenesis of @Chemical$-exacerbated @Disease$.	1
"Prior aspirin use was associated with less severe types of ACS at presentation (e.g., unstable @Disease$ &gt; non-ST-segment elevation MI &gt; ST-segment elevation MI) than their non@Chemical$ user counterparts (p &lt; 0.0001)."	0
"Patients in the study group with &gt; or = 2 chronic diseases, had lower @Chemical$ clearances than patients in the control group with &gt; or = 2 @Disease$."	0
"IMPORTANCE: Combined anticoagulant and @Chemical$ therapy is associated with increased bleeding risk in patients with atrial fibrillation, but the @Disease$ risk of combined use of anticoagulant and nonsteroidal anti-inflammatory drugs (NSAIDs) is poorly documented."	0
We examined five animal studies of NSAIDs (indomethacin and @Chemical$) and aspirin in coxsackievirus B3- and B4-induced @Disease$.	0
"We report the case of a 59-year-old female with hypertension, admitted to the coronary care unit for acute @Disease$ and treated with tissue-type plasminogen activator 100 mg in 90 min, intravenous heparin 25,000 U, @Chemical$ 100 mg, and metoprolol 50 mg orally once daily."	0
This is the first report of patients who underwent @Disease$ while on both aspirin and @Chemical$.	0
CONCLUSIONS: @Chemical$ use is associated with lower risk of @Disease$ among men and improved survival among AA.	0
The HP was positive in 63% of L-A-induced ulcer cases and in 69% of NSAIDs other than low-dose @Chemical$-induced @Disease$ cases.	1
"BACKGROUND AND OBJECTIVES: @Chemical$ is widely used for short-term treatment of pain, @Disease$ or colds, but there are only limited data regarding the safety of this use."	0
"Established risk factors for GI @Disease$ development include advanced age, history of ulcer or GI bleed, concomitant use of corticosteroids or anticoagulants, high-dose @Chemical$/NSAID therapy, and possibly concomitant Helicobacter pylori infection."	0
"There are many potential gastroprotective drugs available in Japan, and studies are needed to assess the relative effectiveness of various strategies including PPI use for the prevention of @Chemical$-related upper GI ulcer complications and whether any of these other agents also provide protection against @Disease$."	0
OBJECTIVE: To review data concerning combined @Chemical$/warfarin versus aspirin alone for secondary prevention after @Disease$ (MI).	0
"BACKGROUND: @Chemical$ triad is a subclass of chronic sinusitis characterized by @Disease$, nonallergic induced asthma, and aspirin sensitivity."	0
"HPR was defined as on-@Chemical$ P2Y12 platelet reaction units &gt;208 as measured by the VerifyNow assay; target @Disease$ (TVF) was defined as the composite of all-cause death, myocardial infarction, or ischemia-driven target vessel revascularization."	0
"Here, we evaluate the literature on the risk of @Disease$ as a complication in patients with AD treated with @Chemical$."	1
We hypothesized that the three subsets of the FCER1 gene may play a role in the development of the @Chemical$-intolerant asthma (AIA) phenotype and analyzed these genetic polymorphisms in association with clinical parameters in @Disease$ patients.	0
A 35-year-old lady with ES taking @Chemical$ with clopidogrel for thrombo-prophylaxis presented with massive @Disease$.	0
"Primary end points were pre-discharge @Disease$ necessitating the restoration of bladder irrigation or the cessation of aspirin treatment and late hematuria treated in an urgent care setting, requiring hospital admission or compelling the cessation of @Chemical$ treatment."	0
"These include rhinitis and asthma induced by NSAIDs (also known as @Chemical$-exacerbated respiratory disease), NSAID-exacerbated @Disease$ (NECD), urticaria or angioedema induced by multiple NSAIDs, single NSAID-induced reactions, and delayed NSAID reactions."	0
"At the 5-year follow-up, cardiovascular events were found to have developed in 11 patients (8 stroke and 3 @Disease$) who exhibited @Chemical$ resistance (12.1%) and in 9 (4 stroke and 5 myocardial infarction) patients who did not exhibit aspirin resistance (2.4%) (P &lt; .001)."	1
Meta-analysis on the effect of @Chemical$ use for prevention of preeclampsia on @Disease$ and antepartum hemorrhage.	0
"Aspirin exacerbated respiratory disease (@Disease$) is an adult onset condition manifested as asthma, rhinosinusitis/nasal polyps, and sensitivity to @Chemical$ and other cyclooxygenase-1 (Cox-1)-inhibitor nonsteroidal anti-inflammatory drugs (NSAIDs)."	0
Oral @Chemical$ challenge (OAC) reveals aspirin-exacerbated respiratory disease (AERD) in approximately 50% of unselected patients with @Disease$ with nasal polyposis (CRSwNP).	0
Epidemiological evidence suggests that @Chemical$ may reduce the incidence and mortality of several @Disease$.	0
We sought to assess the relation between preoperative platelet aggregation and @Disease$ in CABG patients on @Chemical$.	0
"BACKGROUND AND AIM: @Chemical$ (ASA [aspirin]) is a commonly used over-the-counter drug for the treatment of @Disease$, fever, or colds, but data on the safety of this use are very limited."	0
"AIM: We performed a prospective study to clarify NSAIDs-induced @Disease$, focusing especially on low-dose @Chemical$ (L-A)."	0
After a viral infection that was eventually treated with @Chemical$ Reye's syndrome has to be discussed after exclusion of common causes of @Disease$.	1
Risk of bleeding after endoscopic submucosal dissection for @Disease$ in patients with continued use of low-dose @Chemical$.	0
We studied the incidence of @Disease$ in high-risk patients taking long-term low-dose aspirin or non-aspirin-NSAIDs combined with @Chemical$ in a real-life clinical setting.	0
"@Chemical$, non-aspirin analgesics and the risk of @Disease$ in the SUN cohort."	0
"PATIENTS AND METHODS: Intra-operative and perioperative @Disease$, the amount of transfused blood and surgery-related complications of 44 patients on uninterrupted clopidogrel treatment were compared with 44 matched controls not on @Chemical$ (either on aspirin alone or not on any anti-platelets)."	0
The most recent data show that eradication of H. pylori infection in patients with a previous peptic @Disease$ episode who continue to take aspirin reduces the recurrence rate of this complication to levels observed in patients without a history of ulcer bleeding history who take @Chemical$ for cardiovascular disease.	0
"Dose-related increases in heart and @Disease$, and impaired cardiac functions, were found more exacerbated in the aspirin-treated MI rat hearts than the @Chemical$-treated MI counterparts."	0
"The toxicity of @Chemical$s such as aspirin in this population is well known and documented, specifically in the form of @Disease$."	0
"Considering the association of PTGER4 in mast cells, @Disease$- and aspirin-related disease, we hypothesized the genetic variability of PTGER4 may be associated with @Chemical$-intolerant chronic urticaria (AICU)."	0
For @Disease$ prevention in atrial fibrillation; @Chemical$ is rarely the right choice.	0
"DATA SYNTHESIS: @Chemical$-sensitive asthmatics experience a wide variety of symptoms, ranging from @Disease$ to life-threatening bronchospasms, after the ingestion of aspirin or nonsteroidal antiinflammatory drugs (NSAIDs)."	0
The duration of nasal @Disease$ was 10 +/- 10 years (range 0.5-30 years): PP-- 10 +/- 9; A-- 14 +/- 11; ASA-- 7 +/- 7 (A/@Chemical$-- p = 0.045).	0
"In the triple therapy group, the international normalized ratio or @Chemical$ dosage did not influence the @Disease$ risk."	0
"AREAS COVERED: In this report, we review recent findings from observational epidemiologic studies suggesting a possible adverse effect of regular @Chemical$ use in AMD, and in particular, neovascular @Disease$."	0
"Although no evidence establishes increased risk of hemorrhagic stroke from daily low-dose aspirin, one @Disease$ will occur for every 72 to 357 adults who take @Chemical$ for longer than 10 years (SOR: A, systematic reviews and meta-analyses of multiple RCTs and cohort studies)."	0
"We evaluated the effects of the probiotic Lactobacillus gasseri OLL2716 (LG) on @Chemical$-induced small intestinal lesions, such as ulcers, erosions, reddened lesions, and @Disease$."	1
"The Management of @Chemical$-induced @Disease$ (MAGIC) is the first attempt at collaboration among cardiologists, neurologists, and gastroenterologists to obtain such findings."	1
Antithrombotic therapy in @Disease$: @Chemical$ is rarely the right choice.	0
"BACKGROUND: Aspirin-exacerbated respiratory disease (AERD) is a clinical triad consisting of aspirin/acetylsalicylic acid (@Chemical$) sensitivity, bronchial asthma, and @Disease$."	0
"BACKGROUND: Aspirin-exacerbated @Disease$ (AERD) is explained in part by overexpression of 5-lipoxygenase and leukotriene C4 synthase (LTC4S), resulting in constitutive overproduction of @Chemical$ (CysLTs) and driving the surge in CysLT production that occurs with aspirin ingestion."	0
"@Chemical$-exacerbated respiratory disease (@Disease$) is characterized by the triad of asthma, eosinophilic nasal polyposis and a hypersensitivity to all medications that inhibit the cyclo- oxygenase (COX) -1 enzyme."	0
"Analyses of the genetic backgrounds of patients with @Disease$ and AIU will promote the development of early diagnostic and therapeutic interventions, which may reduce the incidence of AIA and @Chemical$."	0
"QUESTION/PURPOSES: We sought to answer four questions: For the THA and TKA cohorts, respectively, (1) was the incidence of readmission resulting from @Disease$ and bleeding complications higher with LMWH than mobile compression plus ASA; and (2) was the incidence of wound bleeding complications higher with LMWH than mechanical compression plus @Chemical$?"	0
"Our study was designed to determine the efficacy of zafirlukast, a cysteinyl @Chemical$ receptor antagonist, in nasal @Disease$."	0
"STUDY DESIGN: The OPT-BIRISK trial is a multicenter, double-blinded, placebo-controlled randomized study designed to test the superiority of extended antiplatelet therapy with clopidogrel monotherapy compared with @Chemical$ and clopidogrel for reduction of bleeding events in ACS patients with both high @Disease$ and high ischemic risks (bi-risk)."	0
BACKGROUND: Exposure to @Chemical$ (ASA) may exacerbate respiratory or @Disease$ or induce anaphylactoid reactions in apparently healthy individuals.	1
"BACKGROUND: Although administration of gastroprotective drugs may reduce the risk of peptic @Disease$s associated with the chronic use of non-steroidal anti-inflammatory drugs or @Chemical$, no consensus exists as to whether this co-therapy is effective for short-term prevention, particularly in old age."	0
"BACKGROUND: @Chemical$-exacerbated respiratory disease (AERD) is a disorder of nasal polyposis, asthma, and @Disease$ respiratory reactions when on systemic cyclooxygenase 1 blockade."	0
RESULTS: @Chemical$ and rofecoxib significantly increased the severity of aspirin-induced @Disease$.	0
"METHODS: Elderly, hospitalized @Disease$ patients on regular @Chemical$ treatment were enrolled from January 2014 to September 2016."	0
BACKGROUND &amp; AIMS: Concomitant use of nonsteroidal anti-inflammatory drugs (NSAIDs) and low-dose @Chemical$ increases the risk of @Disease$ (UGIB).	1
"CONCLUSIONS: Rapid @Chemical$ desensitisation is an effective and safe procedure for patients with aspirin allergy who are to undergo @Disease$ and stenting, allowing them to receive the optimum treatment."	0
@Chemical$ resistance in the acute stages of acute ischemic stroke is associated with the development of new @Disease$.	1
"Aspirin desensitization can usually be achieved for those in need of the antiplatelet effects of aspirin, with the exception of those with @Chemical$-induced @Disease$ and baseline chronic urticaria."	1
"Notwithstanding the consistent benefits demonstrated with aspirin for both acute and chronic @Disease$, there are a number of toxicities associated with @Chemical$ that have been showcased by recent long-term clinical trials that have included an aspirin monotherapy arm."	0
Some patients with imperative cardiologic indications for combination therapy with @Chemical$ and clopidogrel (stent placement and/or acute @Disease$) have a history of allergy to aspirin.	0
STUDY OBJECTIVES: The present study was performed to determine whether the risk of @Disease$ after transbronchial lung biopsy is increased in patients taking @Chemical$.	0
"Endoscopic characteristics of @Chemical$ associated ulcers seem to be required further investigation, including the impact of the severity of @Disease$ by Helicobacter pylori infection on the endoscopic characteristics."	0
@Chemical$ levels in @Disease$: relation with disease severity and aspirin sensitivity.	0
"BACKGROUND: Many patients requiring permanent pacemaker (PPM) or implantable @Disease$ (ICD) placement are anticoagulated with warfarin, aspirin (ASA), and @Chemical$ for a number of thromboembolic risk indications."	0
"However, @Chemical$ has also been associated with significant adverse events, such as @Disease$."	1
"RESULTS: Global mucosal expression of EP(1) and EP(2), but not EP(3) or EP(4), immunoreactivity was significantly elevated in @Chemical$-sensitive and nonaspirin-sensitive @Disease$ compared with controls (P &lt; .03)."	0
"BACKGROUND: The anti-inflammatory actions of @Chemical$ (ASA)/non-steroidal anti-inflammatory drugs (NSAIDs) are thought to be due to inhibition of COX-2, whereas the side effects such as @Disease$ and aspirin-induced asthma are mediated through inhibition of COX-1."	1
"The incidence of @Disease$ was lowest in patients on dabigatran (0.32%/y) compared with those on warfarin (0.90%/y), @Chemical$ (0.80%/y), and no therapy (0.53%/y)."	0
"Low-dose @Chemical$ also reduces the recurrence of advanced @Disease$s (RR, 0.66 [95% CI, 0.44-0.99]); however, TSA indicated lack of firm evidence for a beneficial effect."	0
"Meta-analyses of randomized, placebo-controlled trials of low-dose aspirin indicate that @Chemical$ approximately doubles the risk of major @Disease$ compared with placebo."	1
"Events occurring after PCI-definite or probable stent thrombosis (ST), @Disease$ (MI) not related to @Chemical$, and clinically relevant bleeding (CB)-were classified as early (&lt;=30 days), late (31 to 365 days), or very late (&gt;365 days)."	0
"@Chemical$ exacerbated respiratory disease is characterized by recalcitrant sinusitis/polyposis, @Disease$ and precipitation of asthma after ingestion of aspirin and most NSAIDs."	0
"DATA SYNTHESIS: In CVD primary prevention studies, very-low-dose @Chemical$ use (&lt;=100 mg daily or every other day) increased major gastrointestinal (GI) bleeding risk by 58% (odds ratio [OR], 1.58 [95% CI, 1.29 to 1.95]) and @Disease$ risk by 27% (OR, 1.27 [CI, 0.96 to 1.68])."	1
"Efficacy and safety of 1,000 mg effervescent @Chemical$: individual patient data meta-analysis of three trials in migraine headache and @Disease$ accompanying symptoms."	1
"There is evidence that aspirin and non-aspirin non-@Chemical$al anti-inflammatory drug (NSAID) have anti-carcinogenic properties, but their effect on @Disease$, in particular in never-smokers, is unclear."	0
"Multicolor immunohistofluorescence examination of bronchial cryosections from 30 treated, untreated, or bronchial antigen-provoked @Chemical$-tolerant individuals with @Disease$ and nine control subjects revealed that the dominating LTC4S-expressing cells were mast cells (&gt; 80%), and not eosinophils."	0
"The prevalence of @Chemical$ in patients undergoing HD seems higher than in most of the studied populations, and this study has shown that the AR statuses of a significant number of patients undergoing HD change after an @Disease$ session."	0
[Iatrogenic @Disease$ and extrapyramidal syndrome: rare adverse effect of @Chemical$-aspirin combination].	1
"The aim of this study is to report the sinonasal outcomes of endoscopic sinus surgery (ESS) in treating NP in asthmatic patients, comparing @Chemical$-induced @Disease$tic (AIA) patients with aspirin-tolerant asthmatics (ATA)."	1
"Perioperative @Chemical$ may decrease @Disease$ morbidity, but may also increase hemorrhagic morbidity."	0
"Anaphylaxis, immediate and accelerated reactions, atopy, older age and chronic/recurrent @Disease$ were risk factors for hypersensitivity and/or cross-reactivity between @Chemical$, ibuprofen and paracetamol."	0
"CONCLUSION: Overall, the number, size, and quality of the cardiovascular studies recommending aspirin use are far superior to the fewer, smaller and conflicting studies suggesting a possible adverse effect of @Chemical$ use in relation to @Disease$."	1
"All 129 patients with high risk TIA with microbleeds or minor @Disease$ within 24 hours after the onset (average age 65.9 +- 9.3, 48.7% were male patients) were divided randomly into two groups: (1) 67 patients were given combination therapy with clopidogrel and aspirin (@Chemical$ at an initial dose of 300 mg, then 75 mg per day for 90 days, plus aspirin at a dose of 75 mg per day for the first 21 days);(2) the rest patients were given aspirin treatment (75 mg per day for 90 days)."	0
"The absolute annual increases attributable to @Chemical$ were major bleeding: 0.13% (95% CI, 0.08-0.20); major GI bleeding: 0.12% (95% CI, 0.07-0.19), intracranial @Disease$: 0.03% (95% CI, 0.01-0.08)."	1
"Response to @Chemical$ provocation was rhinitis + @Disease$ in 13, and extrabronchial reactions in 8 (isolated rhinitis in 3) patients."	0
"A total of 12 patients with a clear-cut history of @Disease$ were randomised in double-blind cross-over fashion to receive single doses of ML 10 mg, ML 40 mg, or placebo (PL), with nasal lysine-@Chemical$ challenge performed 12 h after dosing."	0
"The key words used to search for articles about exposure to aspirin were @Chemical$, pregnancy, and pregnancy complications; key words used to search for outcome were @Disease$."	0
"At the 5-year follow-up, cardiovascular events were found to have developed in 11 patients (8 @Disease$ and 3 myocardial infarction) who exhibited aspirin resistance (12.1%) and in 9 (4 stroke and 5 myocardial infarction) patients who did not exhibit @Chemical$ resistance (2.4%) (P &lt; .001)."	0
IgE-mediated @Disease$ were evaluated by measuring changes in rectal temperature and @Chemical$ (EBD) extravasation in the intestine and liver after oral challenge with OVA.	0
"We investigated whether aspirin with caffeine (ASA++) increases @Disease$ frequency compared with @Chemical$ alone in migraine, tension-type headache (TTH), and migraine + TTH (MigTTH)."	0
"@Chemical$ therapy can also lead to an increased risk of @Disease$, upper gastrointestinal bleeding and other haemorrhagic complications."	1
"A 79-year-old man with atherosclerosis obliterans, taking @Chemical$ and aspirin, complained of @Disease$."	0
"Similarly, @Chemical$ increased the risk of clinically important @Disease$."	0
"@Chemical$-exacerbated respiratory disease (AERD), formerly known as Samter's Triad, is a syndrome of airway inflammation characterized by @Disease$, asthma, and nonsteroidal anti-inflammatory drug (NSAID) intolerance."	0
"RESULTS: @Chemical$ increased the risk of major bleeding (RR=1.71; 95% confidence interval [CI], 1.41-2.08), major gastrointestinal (GI) @Disease$ (RR=2.07; 95% CI, 1.61-2.66), and intracranial bleeding (RR=1.65; 95% CI, 1.06-5.99) versus placebo."	1
This study was performed to determine whether @Chemical$ AHR affects the response of @Disease$tics to inhaled aspirin.	0
An extremely unusual case presentation of @Chemical$-exacerbated respiratory disease (@Disease$).	0
ZnPP reversed protective and @Disease$ effect of NaHS but PAG failed to affect @Chemical$RM-2-induced gastroprotection.	0
"Age, male gender, Helicobacter pylori (H. pylori)infection, diabetes, @Disease$ (CKD), cirrhosis, history of uncomplicated peptic ulcer disease (PUD), and use of NSAIDs, COX-2 inhibitors, steroids, and thienopyridines were independent risk factors for UGIB among @Chemical$ users."	0
"@Chemical$ is known to produce severe @Disease$, such as bleeding and perforation."	1
"Events occurring after PCI-definite or probable stent thrombosis (@Chemical$), myocardial infarction (MI) not related to ST, and clinically relevant @Disease$ (CB)-were classified as early (&lt;=30 days), late (31 to 365 days), or very late (&gt;365 days)."	0
The aim of this study was to investigate prospectively the association between the regular use of aspirin and non-@Chemical$ analgesics and the incidence of @Disease$.	1
"The values of @Disease$s of MPs in descending order were as follows: gefarnate, hydrotalcite &gt; @Chemical$ &gt; sucralfate oral suspension &gt; L-glutamine and sodium gualenate granules &gt; rebamipide &gt; sucralfate chewable tablets."	0
"BACKGROUND AND AIM: Acetylsalicylic acid (ASA [@Chemical$]) is a commonly used over-the-counter drug for the treatment of pain, @Disease$, or colds, but data on the safety of this use are very limited."	0
@Chemical$ protects against nasal lysine-aspirin challenge in patients with aspirin-induced @Disease$.	0
"Over the last years, many protocols have been described about @Chemical$ desensitization in patients with ischemic heart disease, including acute @Disease$ and the need for coronary stent implantation."	1
CONCLUSIONS: Early @Chemical$ initiation after lower urinary tract surgeries does not appear to carry an increased risk of @Disease$.	0
This study investigated the association between serum albumin level and @Disease$ events in this population.Methods and Results:We enrolled 438 consecutive patients who were prescribed dual APT (DAPT; aspirin and @Chemical$) beyond 1 month after successful PCI without adverse events.	0
"A second polymorphism study, conducted on histamine-related genes, did not find any significant associations with aspirin-induced urticaria/angioedema for the genes HNMT (encoding histamine N-methyltransferase), HRH1 or HRH2 (encoding histamine receptor types 1 and 2 respectively), or the gene encoding high-affinity IgE receptor Ibeta (FcepsilonRIbeta); however, the FcepsilonRIalpha gene promoter polymorphism was significantly associated with @Chemical$-induced urticaria/@Disease$."	1
Patients receiving dual antiplatelets for &gt;= 1 year with no history of peptic @Disease$ bleeding or perforation were recruited and randomly assigned to the @Chemical$ (300 mg/day) group or the placebo group.	0
"Further research is needed to assess the benefit-risk ratio of clopidogrel plus aspirin in specific subpopulations of patients at high risk for atherothrombotic events, and to determine the role of @Chemical$ plus aspirin in preventing cardioembolic stroke or early recurrent @Disease$ after symptomatic large-vessel atherostenosis."	0
METHODS: Patients with aspirin-related non@Disease$ symptomatic ulcers were randomised to receive @Chemical$ (20 mg/day) plus aspirin (100 mg/day) or rabeprazole (20 mg/day) plus clopidogrel (75 mg/day) for 12 weeks.	0
OBJECTIVE: Low-dose @Chemical$ and diuretics are commonly co-utilized in patients with @Disease$.	0
"Among several options to provide cardiovascular protection with LDA while reducing @Disease$ risk, PPI co-therapy is considered to be preferred approach for wider populations according to recent cost-effectiveness analyses based on increasing awareness of importance on adherence of @Chemical$ together with declining cost of PPI."	0
"OBJECTIVE: @Chemical$-exacerbated respiratory disease (@Disease$) represents a severe form of chronic rhinosinusitis (CRS) characterized by nasal polyposis, bronchial asthma, and aspirin intolerance."	0
CONCLUSION: The current study has observed no appreciable increase in @Disease$-related complication rates in patients with cardiac stents undergoing spine surgery while continuing to take aspirin compared with patients who discontinued @Chemical$ prior to surgery.	0
This lack of reactions found in our study supports the fact that @Chemical$ could be a safe alternative in postsurgery @Disease$ in NSAID-intolerant asthma patients.	0
"RESULTS: During a median follow-up of 2.5 years, 7880 of 648,807 (1.2%) @Chemical$-treated patients experienced @Disease$."	0
BACKGROUND: Proton pump inhibitor and histamine-2 receptor antagonist can prevent @Chemical$-related @Disease$/erosions but few studies compare the efficacy of these two agents.	1
Gastric protection and @Disease$ with @Chemical$ thromboprophylaxis in hip and knee joint replacements.	1
"CONCLUSIONS: Continued perioperative @Disease$ with @Chemical$ in RARP is safe, feasible, and not associated with increased blood loss."	1
"Sudden onset of poor activity, poor appetite, @Disease$, tachycardia, tachypnea, hepatomegaly, increased AST/ALT, coagulopathy and hyperammonemia developed 3 days after the high-dose @Chemical$ therapy."	1
"METHODS: Subjects 18 years or older with @Disease$, without gastroduodenal ulcer or erosive esophagitis at baseline endoscopy, and a cardiovascular indication for prophylaxis low-dose (81 or 325 mg) aspirin were prescribed open-label aspirin and blindly randomized to @Chemical$ 200 mg/day or naproxen 500 mg twice daily plus lansoprazole 30 mg once daily."	0
Growing numbers of elderly people take low doses of @Chemical$ for prevention of cerebral or @Disease$.	0
No difference was observed in @Chemical$ PD(20)FEV(1) and baseline FENO between ATA and @Disease$ patients.	0
"Dogs receiving @Chemical$ and prednisone/aspirin had 11.1 times (95% CI, 1.7-73.6) and 31.5 times (95% CI, 3.5-288.0) higher odds, respectively, of having endoscopic @Disease$ scores &gt;=4 than dogs receiving placebo (P &lt;= .01)."	0
"METHODS: The subjects consisted of patients requiring continuous @Chemical$ treatment, in whom no peptic @Disease$ was found on endoscopy at enrollment."	0
We conclude that wheat @Chemical$ has a potential protective effect against aspirin induced gastro- and hepato-@Disease$ because of its free radical scavenging ability.	0
"We therefore investigated the efficacy of famotidine, a well-tolerated histamine H(2)-receptor antagonist, in the prevention of peptic @Disease$ and erosive oesophagitis in patients receiving low-dose @Chemical$ for vascular protection."	0
"We conclude that combined therapy with aspirin and @Chemical$ does not necessarily protect against clinical @Disease$, at least in patients with HIT antibodies that have strong platelet-activating characteristics."	0
Helicobacter pylori and @Chemical$ seem to be independent risk factors for peptic @Disease$ and bleeding.	1
The premature suspension of the @Disease$ Anti-inflammatory Prevention (ADAPT) and the Adenoma Prevention with @Chemical$ (APC) trials prompted intense review of the cardiovascular safety profile of selective and nonselective cyclooxygenase (COX) inhibitors.	0
"CONCLUSIONS: Among an adult cohort, @Chemical$ use 5 years prior to observed incidence was not associated with incident early or late @Disease$."	0
@Chemical$ induced @Disease$: clinical relevance of finding was not explained.	1
A recent study by Chan et al. concluded that a combination of aspirin and esomeprazole is superior to @Chemical$ in the prevention of recurrent gastrointestinal @Disease$.	0
"It has been shown that the ratios of ulcers located in the body, fundus and cardia are significantly higher in @Disease$ patients than the ratio of gastroduodenal ulcers in patients taking @Chemical$."	0
There were no associations between regular cardiac dose @Chemical$ and incident @Disease$ in either cohort.	0
"Although co-therapy with a PPI and the eradication of H. pylori substantially reduce the risk of recurrent ulcer bleeding with aspirin, the replacement of @Chemical$ by clopidogrel cannot be recommended to patients with a high @Disease$ risk."	0
The risk of no- complicated peptic @Disease$ was increased by low-dose @Chemical$ intake by a factor 2.9 in one study.	0
"Based on current references four clinical scenarios were discussed and different management strategies were compared for secondary and primary prophylaxis of @Disease$ or peptic ulcer bleeding under continuous therapy with non-steroidal antiinflammatory drugs (NSAID) or low-dose-@Chemical$, for H.pylori-positive and H.pylori-negative patients."	0
"OBJECTIVE: The aim of this study was to determine whether concomitant treatment with LTMDs was associated with a reduction of @Chemical$-provoked lower respiratory tract reactions in patients with aspirin-exacerbated @Disease$ (AERD), when compared to AERD patients who were not treated with LTMDs."	0
CONCLUSION: Patients with @Disease$ who have a history of symptoms less than 1 hour after @Chemical$ exposure can be safely desensitized with a 1-hour dose-escalation protocol that can often be completed in a single day.	1
"BACKGROUND: Although it is well known that @Chemical$ causes gastroduodenal mucosal injury and that aspirin-induced @Disease$ is often asymptomatic, the prevalence and independent factors for gastroduodenal mucosal injury have not been clarified in asymptomatic patients taking low-dose aspirin and gastroprotective agents."	0
"We describe the most common clinical presentations of aspirin hypersensitivity, i.e. @Chemical$-induced asthma, rhinosinusitis and aspirin-induced @Disease$."	0
"AREAS COVERED IN THIS REVIEW: A number of risk factors can be used to determine which patients are more likely to develop aspirin-associated GI bleeding, mainly in the upper GI tract; these include a previous @Disease$, ulcer complications, dyspepsia, and concomitant drug therapy with non-steroidal anti-inflammatory drugs (NSAIDs) or @Chemical$."	0
"BACKGROUND: The safety of aspirin in heart failure (HF) has been called into question, particularly in those patients (1) without coronary disease, (2) with @Disease$, or (3) treated with low-dose angiotensin-converting enzyme (ACE) inhibitors and high-dose @Chemical$."	0
Clinical course of patients with @Chemical$-exacerbated @Disease$: can we predict the prognosis?	0
"Neoadjuvant @Chemical$ therapy and subsequent less invasive surgery under continuation of APT is one of the preferred approaches for patients with duodenal GIST with severe @Disease$ comorbidities, as in the current case."	0
"Aspirin-exacerbated diseases are important examples of drug hypersensitivities and include @Chemical$-exacerbated respiratory disease (@Disease$), aspirin- or non-steroidal anti-inflammatory drug (NSAID)-induced urticaria/angioedema, and aspirin- or NSAID-induced anaphylaxis."	0
"METHODS AND RESULTS: Twenty-two consecutive patients with OHCA of cardiac origin were prospectively included after therapeutic @Disease$ and randomized to receive @Chemical$ 100mg per day, either intravenously (n=13) or orally via a gastric tube (n=9)."	0
@Chemical$ and other nonsteroidal anti-inflammatory drugs (NSAIDs) are common causes of peptic @Disease$.	1
Five randomised controlled trials of healthy volunteers undergoing endoscopy after a period of either enteric-coated @Chemical$ or plain aspirin administration all demonstrated a clear reduction of @Disease$.	0
"@Chemical$-exacerbated respiratory disease (@Disease$) is defined as asthma, chronic rhinosinusitis with nasal polyposis, and hypersensitivity to cyclooxygenase-1 inhibitors."	0
"METHODS: A retrospective review identified trauma patients, age 50 or greater, who had computed tomography (CT) evidence of @Disease$ and were taking ASA, @Chemical$, or a combination of both."	0
"METHODS: Using questionnaires and administrative records, we collected information on @Chemical$ and PPI utilization and risk factors for UGICs from a stratified random sample of subjects with established @Disease$."	0
Omalizumab for Aspirin-@Disease$ and Leukotriene Overproduction in @Chemical$-Exacerbated Respiratory Disease: A Randomized Trial.	0
"Proton pump inhibitors are more effective than H(2)-receptor antagonists in preventing dyspeptic symptoms, @Disease$ and bleeding ulcers in @Chemical$ users."	0
"Multivariate analysis showed that only chronic @Disease$ was the independent risk factor for @Chemical$ (P &lt; 0.001, odds ratio = 12.355), but preoperative continuation of APT or multiple APT use did not affect IBC."	0
OBJECTIVE: The aim of this study was to determine the @Disease$ risks associated with single (aspirin) and dual (@Chemical$ + clopidogrel) antiplatelet therapy (DAPT) versus placebo or no treatment in adults undergoing noncardiac surgery.	0
"The pathogenesis of aspirin (acetylsalicylic acid, @Chemical$)-intolerant @Disease$ (AIU) is still poorly understood but it has recently been suggested that it is associated with the overproduction of leukotriene (LT)."	0
Oral aspirin challenge (OAC) reveals @Chemical$-exacerbated @Disease$ (AERD) in approximately 50% of unselected patients with chronic rhinosinusitis with nasal polyposis (CRSwNP).	1
Comparison of teprenone and famotidine against @Disease$ in patients taking low-dose @Chemical$.	0
RECENT FINDINGS: A recent study on HLA genotypes has suggested that the HLA alleles DRB11302 and DQB10609 may be genetic markers for @Chemical$-induced @Disease$/angioedema.	1
"Omeprazole appears to be very effective in reducing both acute gastroduodenal mucosal damage and upper GI bleeding in the high-risk patient taking low-dose aspirin, but data with other anti-@Disease$ agents are lacking (@Chemical$) or inconsistent (ranitidine) at present."	0
"@Chemical$ exacerbated respiratory disease (AERD) is characterized as adult onset @Disease$, nasal polyps, chronic rhinosinusitis, and hypersensitivity to a cyclooxygenase-1 (COX-1) inhibitor, viz aspirin or nonsteroidal antiinflammatory drugs (NSAIDs)."	1
"Although it is difficult to solely attribute intratumoral hemorrhage to aspirin, we have to be careful when prescribing @Chemical$ for patients who have asymptomatic @Disease$."	0
High levels of nitric oxide synthase activity are associated with nasal polyp tissue from @Chemical$-sensitive @Disease$tics.	0
"Patients receiving treatment for &gt;5 years showed elevated risk of @Chemical$ in the aspirin (0.17; 0.09-0.36; P &lt; .001) and clopidogrel (0.15, 0.07-0.33; P &lt; .001) groups as well as higher odds of MB in the aspirin (0.34, 0.16-0.71; P = .004) and clopidogrel (0.37, 0.17-0.80; P = .010) groups.The WMHs and MB were associated with CMBs in patients taking aspirin or clopidogrel for &gt;1 year, and long-term use increased the risks of CMB and @Disease$."	0
"Aspirin-exacerbated @Disease$ (AERD), or aspirin-induced asthma, is characterized by asthma and rhinitis triggered by the ingestion of @Chemical$ and non-steroidal anti-inflammatory drugs."	0
"OBJECTIVE: The aim of this study was to determine whether concomitant treatment with LTMDs was associated with a reduction of ASA-provoked lower respiratory tract reactions in patients with @Chemical$-exacerbated respiratory disease (AERD), when compared to @Disease$ patients who were not treated with LTMDs."	0
Conclusion: Prognostic bleeding risk models were developed that can be used to estimate the absolute @Disease$ harms of @Chemical$ among persons in whom aspirin is being considered for the primary prevention of CVD.	0
"METHODS: Twelve patients with @Chemical$-induced @Disease$ (male:female, 3:9; mean age +/- SD, 36.7 +/- 7.2 years) received either tacrolimus (0.1 mg/kg) or placebo 2 hours before the threshold dose of oral aspirin."	1
Drug-induced @Disease$: drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome induced by @Chemical$ treatment of Kawasaki disease.	1
"Estimated excess major bleeding events were 1.39 (CI, 0.70 to 2.28) for GI @Disease$ and 0.32 (CI, -0.05 to 0.82) for hemorrhagic stroke per 1000 person-years of @Chemical$ exposure using baseline bleeding rates from a community-based observational sample."	1
"CONCLUSION: Warm-needle moxibustion can reduce the gastric lesion (@Disease$) caused by @Chemical$ in the rat, which may be closed associated with its effects in up-regulating both serum and gastric mucosal SOD activity and down-regulating both serum and gastric mucosal MDA levels."	1
"Aspirin-exacerbated respiratory disease (@Disease$) is an adult-onset condition that manifests as asthma, rhinosinusitis/nasal polyps, and sensitivity to @Chemical$ and other cyclooxygenase-1 (COX-1)-inhibitor nonsteroidal anti-inflammatory drugs (NSAIDs)."	0
"The risk of @Disease$ was also increased among patients who had non-end-stage chronic kidney disease or required renal-replacement therapy and was further increased with @Chemical$, aspirin, or both."	0
"In @Disease$, hyperammonemia and perhaps the increase of @Chemical$ are the leading factors in the mechanism of brain damage and encephalopathy."	1
METHODS: The study included 40 patients diagnosed in our clinic as @Disease$ that were desensitized and treated with @Chemical$ 300 mg/day between December 2005 and December 2012.	0
"BACKGROUND: In patients with ischemic stroke of non-cardioembolic origin, @Chemical$, clopidogrel, or a combination of acetylsalicylic acid and dipyridamole are recommended for the prevention of a recurrent @Disease$."	0
Aspirin-sensitive @Disease$ is the manifestation of @Chemical$ intolerance in the upper respiratory tract.	1
"WMH (p=0.020/0.030, 0.007/0.000) age (p=0.007/0.000) and @Disease$ (p=0.000/0.033), in patients and controls respectively, were each associated with @Chemical$."	0
A hypothesis has been suggested in which @Chemical$ is considered as @Disease$ caused by dysfunction of MT-producing cells.	1
"Older age, prior GI events, @Disease$, use of other injurious medicine such as NSAIDs, antithrombotic medicine, especially @Chemical$, and corticosteroids seem to be factors associated with an increased risk for upper GI ulcer and bleeding among the patients taking low dose aspirin."	0
RESULTS: Participants who had ever used non-@Chemical$ NSAIDs had an increased risk of @Disease$ (odds ratio 1.28 (95% CI 1.05 to 1.56) in the age matched group but not in the group also matched on confounder scores (odds ratio 1.17 (0.94 to 1.46)).	0
This study was aimed to evaluate whether genetic variants of TBXA2R may be related with development of acetyl salicylic acid (@Chemical$)-intolerant asthma (@Disease$).	0
It is generally accepted that in aspirin-induced @Disease$ (AIA) the bronchospasm is provoked by inhibition of prostaglandin synthesis with overproduction of @Chemical$.	0
"This report describes a case of @Disease$ in the setting of aspirin-induced asthma also known as Samter-Beer triad combining nasal polyps, asthma, and @Chemical$ allergy leading to vasospasm and myocardial infarction."	0
Comparative efficacy and safety of anticoagulants and @Chemical$ for extended treatment of @Disease$: A network meta-analysis.	0
The median Lewis score for the small @Disease$ inflammatory change was significantly higher in the enteric-coated aspirin group than in the buffered @Chemical$ group (P=0.035).	0
"Aspirin desensitization and continuous @Chemical$ therapy constitute an effective option in patients with nonsteroidal anti-inflammatory drug-exacerbated @Disease$ (NERD) who have suboptimally controlled asthma or rhinosinusitis, or require multiple revision polypectomies."	0
The two frequent clinical presentations of aspirin hypersensitivity are: @Chemical$-induced bronchial asthma/rhinosinusitis (AIA/R) and aspirin-induced urticaria/@Disease$ (AIU).	0
Interaction between endogenous @Chemical$ and hydrogen sulfide in the mechanism of gastroprotection against acute aspirin-induced @Disease$.	0
"Fifty patients treated with aspirin for 2 years were tested for @Chemical$ resistance using the Ultegra Rapid Platelet Function Assay (Accumetrics, San Diego, CA, USA) on admission to Royal Melbourne Hospital for ischaemic @Disease$."	0
"Although some ulcers were caused by Zollinger-Ellison syndrome (ZES), an atypical clinical course in other patients, especially with those with multiple @Disease$, suggested abuse of @Chemical$."	1
"RESULTS: Of the 105 cases of @Disease$ studied, 78 patients (74%) had been taking NSAIDs or @Chemical$ prior to or during the development of their disease."	0
Relative risks with 95% confidence intervals (CIs) of @Chemical$ use as a risk for @Disease$.	0
"@Disease$ induced by low doses of celecoxib, @Chemical$, and acetaminophen."	1
"BACKGROUND: Low-dose @Chemical$ is widely used for prevention of stroke, heart attacks, and @Disease$ in patients with atherothrombotic disease, but its use is associated with serious gastrointestinal (GI) adverse effects."	0
"These include rhinitis and asthma induced by NSAIDs (also known as @Chemical$-exacerbated respiratory disease), NSAID-exacerbated cutaneous disease (NECD), urticaria or @Disease$ induced by multiple NSAIDs, single NSAID-induced reactions, and delayed NSAID reactions."	0
"We encountered lower gastrointestinal bleeding in 16 patients taking a low dose of aspirin and examined the effect of low @Chemical$ dose on the stool occult blood test in @Disease$ patients (mean: 76.7 +/- 9.6 years old) including 39 with cerebral infarction, 8 with ischemic heart disease and 2 with atrial fibrillation."	0
The CT scans revealed evidence of @Disease$tic intracranial hemorrhage in 27 (24.5%) patients in the @Chemical$-treated group and in 31 patients (25.6%) in the control group.	0
"BACKGROUND AND AIMS: Nitric oxide-releasing aspirin (NO-ASA) has been shown to inhibit cyclo-oxygenase and prostaglandin generation without causing @Disease$, but the role of reactive oxygen species (ROS) and cytokines in the action of @Chemical$ and NO-ASA against acute gastric damage has been little studied."	0
The data are still lacking and further prospective studies are needed to identify the specific risk or protective factors for upper @Disease$ ulcer and its complications associated with @Chemical$.	0
"We refer to these patients as having @Chemical$-exacerbated @Disease$, a disease process that produces devastating eosinophilic inflammation of both the upper and lower respiratory tracts."	0
"DATA SYNTHESIS: @Chemical$-sensitive @Disease$tics experience a wide variety of symptoms, ranging from rhinitis to life-threatening bronchospasms, after the ingestion of aspirin or nonsteroidal antiinflammatory drugs (NSAIDs)."	0
"Reyes's syndrome, encephalopathy, @Disease$ and @Chemical$ ingestion in a city hospital of Buenos Aires, Argentina."	0
"@Chemical$ content of the apple extracts varied, with the EF extract having 20% w/w polyphenols and a high proportion of @Disease$ as epicatechin and procyanidin, whereas the FB extract comprised 12% w/w polyphenols, which were mostly flavonols as quercetin glycosides."	0
"In 73 patients, 23 with previous coronary stent thrombosis (ST) (ST group) and 50 without coronary ST (control group), @Disease$ was measured 3 times in monthly intervals using light transmission aggregometry (@Chemical$ [ADP] and arachidonic acid induction)."	0
"OBJECTIVE: Aspirin exacerbated respiratory disease (AERD) is comprised of @Chemical$/acetylsalicylic acid (ASA) sensitivity, bronchial asthma, and @Disease$."	0
Glutathione peroxidase (GPX) reduces semi-stable hydroperoxides to less reactive @Chemical$ and removes H(2)O(2) involved in @Disease$.	0
"H. pylori @Disease$ and low-dose aspirin (@Chemical$) are not only independent causal factors of peptic ulcer and gastrointestinal bleeding, they also have synergistic and additive effects."	0
"Compared with @Chemical$ alone, a significant @Disease$ (P = 0.01) was observed in patients receiving dual-antiplatelet therapy in the asymptomatic population."	0
"@Chemical$-exacerbated respiratory disease (AERD) is a distinct clinical condition characterized by chronic sinusitis with @Disease$, asthma, and hypersensitivity reactions to nonsteroidal anti-inflammatory drugs (NSAIDs)."	0
"Aspirin (ASA)-exacerbated respiratory disease (AERD) is characterized by upper airway congestion due to @Disease$ of the nasal and sinus membranes and nasal polyposis, associated with increased leukotriene production that is further accentuated by @Chemical$ or other nonsteroidal anti-inflammatory drug (NSAID) ingestion."	0
"The risks of suffering ischemic stroke, bleeding, or @Disease$ with @Chemical$, aspirin, or no antithrombotic treatment during 2010 were related to CHA2DS2VASc scores, age, and complicating co-morbidities."	1
"In addition, 2.5% of non-diagnosed asthmatics in this cohort reported @Disease$ symptoms following @Chemical$ ingestion."	1
Functional eicosanoid test and typing (FET) in @Chemical$ intolerant patients with @Disease$.	0
"Delayed anti@Disease$ effects of aspirin are compatible with the proposed mechanism, as continual microbleeding has a gradual cumulative effect on stored @Chemical$."	0
Dabigatran versus @Chemical$ in patients with @Disease$.	0
"METHODS: A retrospective review identified @Disease$ patients, age 50 or greater, who had computed tomography (CT) evidence of ICH and were taking @Chemical$, clopidogrel, or a combination of both."	0
"BACKGROUND: Many patients requiring permanent pacemaker (PPM) or implantable @Disease$ (ICD) placement are anticoagulated with warfarin, @Chemical$ (ASA), and clopidogrel for a number of thromboembolic risk indications."	0
"Gastric @Disease$ and mucosal damage were evaluated at 3rd, 7th, and 11th days of @Chemical$ administration by endoscopy using Lanza score."	0
Pancreatitis as a complication of aspirin desensitization for @Chemical$-exacerbated @Disease$.	0
"Helicobacter pylori infection (OR 3.07; 95 CI, 1.23-7.70; P 0.017), @Chemical$ consumption (OR 5.04; 95 CI, 1.86-13.70; P 0.001), and a history of peptic @Disease$ (OR 13.41; 95 CI, 3.78-47.64; P 0.001) were identified as risk factors for upper GI bleeding."	0
We made a comparison between treatments @Chemical$-Clopidogrel combined group and the Aspirin alone group in the numbers of CMB and subsequent @Disease$.	0
"In 73 patients, 23 with previous coronary stent @Disease$ (ST) (ST group) and 50 without coronary ST (control group), platelet aggregation was measured 3 times in monthly intervals using light transmission aggregometry (adenosine diphosphate [@Chemical$] and arachidonic acid induction)."	0
Lack of increase in MCP-3 and RANTES levels after Lys-@Chemical$ challenge suggest that those mediators are involved in chronic rather than acute phase of ASA induced @Disease$.	0
"This study aimed to analyze CMBs and white matter hyperintensities (WMHs) in patients taking aspirin or @Chemical$.This retrospective study included patients with @Disease$ administered 75 mg/day aspirin (n = 150) or clopidogrel (n = 150, matched for age and gender) for &gt;1 year (Affiliated Hospital of Inner Mongolia Medical University, China, from July, 2010 to July, 2015)."	0
"Platelet transfusion improves @Chemical$-induced, but not trauma-induced, platelet @Disease$."	0
"Acetylsalicylic acid (ASA) causes @Disease$ (GI) tract, and previous results have suggested that combination therapy with 2-amino-2-(hydroxymethyl)-1,3-propanediol (@Chemical$) could provide protection in this scenario."	0
"In the presence of sufficient amounts of gastric acid, H. pylori @Disease$ and @Chemical$ could synergistically damage gastric mucosal integrity, while in the absence of sufficient amounts of gastric acid, the synergistic effect could be completely counteracted and the infection could even suppress the aspirin-induced gastropathy."	0
"Over 10 years, no differences were present in BMD alterations except a small trend towards a higher @Disease$ in the spine in users of paracetamol, NSAID, @Chemical$, and opioids compared to non-exposed."	0
"After the @Chemical$ challenge, C3 decreased in both patients with @Disease$ and those with ATA, but the C3a concentration increased in the AIA patient group (p = 0.019)."	0
Lack of evidence for increased @Disease$ risk for dental osteotomy with continued @Chemical$ therapy.	0
BACKGROUND: Patients with @Chemical$-exacerbated respiratory disease (@Disease$) also recently known as nonsteroidal anti-inflammatory drug (NSAID) exacerbated respiratory disease (NERD) must avoid aspirin and all other oral NSAIDs.	0
"Although acetylsalicylic acid is prescribed for a broad range of diseases, it can induce a wide array of clinically recognized hypersensitivity reactions, including aspirin-intolerant asthma (AIA) with @Disease$ and aspirin-intolerant urticaria (@Chemical$) with anaphylaxis."	0
"OBJECTIVE: The aim of this study was to determine whether concomitant treatment with LTMDs was associated with a reduction of @Chemical$-provoked lower respiratory tract reactions in patients with aspirin-exacerbated respiratory disease (@Disease$), when compared to AERD patients who were not treated with LTMDs."	0
No published meta-analyses on the use of @Chemical$ for the primary prevention of @Disease$ in chronic kidney disease exist.	0
@Chemical$ plays a pivotal role in the management of patients with Coronary Artery Disease (CAD) with well-recognised benefits of reducing recurrent myocardial infarction and minimising the risk of stent @Disease$ for those undergoing Percutaneous Coronary Intervention (PCI).	0
"Of these 52 cases, there were 22 @Disease$ cases with aspirin sensitivity, 15 nasal polyposis cases without aspirin sensitivity and 15 chronic rhinosinusitis cases without @Chemical$ sensitivity."	0
"RESULTS: Nine patients (5.8%) presented symptomatic neurological complications poststenting (3 ischemic, 6 @Disease$): 8 patients received 70 U/kg of @Chemical$ (11.1%) and 1 patient received 50 U/kg (1.2%; P &lt; .009)."	0
"The commonest causes of aspirin resistance are production of @Chemical$ metabolites via the lipoxygenase pathway, poor compliance with the treatment, polymorphism of the genes encoding for cyclooxygenase and glycoprotein (GP) IIb/IIIa, @Disease$."	0
[The relationship between @Chemical$ resistance and endothelial dysfunction in patients with stable @Disease$].	0
"Allergic conditions include aspirin-exacerbated respiratory disease (AERD or aspirin-induced asthma), @Chemical$-induced @Disease$/angioedema (AIU), and anaphylaxis."	1
"In addition, in vitro experiments were performed in which @Disease$ cell line (MKN-45 cells) was incubated with @Chemical$ or ASA-VitC alone or in combination with H.pylori."	0
"OBJECTIVE: The presence of the glycoprotein IIIa allele PlA2 is associated with enhanced thrombin formation and an impaired antithrombotic action of @Chemical$, which could favor @Disease$."	0
"CONCLUSION: Although based on relatively few outcomes, the high risk of major bleeding on A+C acutely after TIA or minor @Disease$ in @Chemical$-naive patients is a cause for concern."	1
CONCLUSIONS: The MAGIC study will yield important findings with regard to the prevalence and incidence of @Disease$ and related risk factors for low-dose @Chemical$ users.	1
"In those types of surgery in which even a minor @Disease$ leads to severe complications, e.g. neurosurgery, @Chemical$ should be withdrawn 5-10 days in advance."	1
@Chemical$ in the aetiology of @Disease$ and ulcerative colitis: a European prospective cohort study.	1
"There were no statistically significant differences between the @Chemical$ and control groups in severe @Disease$ (6 5 versus 5 6 per cent respectively; odds ratio (OR) 1 18, 95 per cent c.i. 0 38 to 3 62), intraoperative transfusion (23 4 versus 23 7 per cent; OR 0 98, 0 51 to 1 87), overall haemorrhage (10 2 versus 12 0 per cent; OR 0 83, 0 35 to 1 94), CCI score (24 versus 28; P = 0 520), major complications (23 1 versus 13 9 per cent; OR 1 82, 0 92 to 3 79) and 90-day mortality (5 6 versus 4 6 per cent; OR 1 21, 0 36 to 4 09)."	0
"Aspirin (@Chemical$)-exacerbated respiratory disease (@Disease$) is characterized by upper airway congestion due to eosinophilic inflammation of the nasal and sinus membranes and nasal polyposis, associated with increased leukotriene production that is further accentuated by ASA or other nonsteroidal anti-inflammatory drug (NSAID) ingestion."	0
"OBJECTIVE: Aspirin exacerbated respiratory disease (@Disease$) is comprised of aspirin/acetylsalicylic acid (@Chemical$) sensitivity, bronchial asthma, and nasal polyposis."	0
"In our investigation of such adverse effects, we obtained 4 important findings considered useful for physicians, as follows; 1) even when aspirin was given at a dose, the incidence rate of gastrointestinal lesions was higher than with other non-steroidal anti-inflammatory drugs (NSAIDs), 2) the odds ratios for gastrointestinal lesions induced by @Chemical$ with a histamine H2 receptor antagonist and proton pump inhibitor were 0.6 and 0.4, respectively, as compared with aspirin alone, 3) it is difficult to administer aspirin, which exerts an antiplatelet effect, without inducing @Disease$, and 4) these gastrointestinal lesions appears early, especially within 2 years after administration."	0
METHODS: Forty-seven patients with @Disease$ or transient ischemic attacks and normal upper gastrointestinal endoscopy were randomized to receive either enteric-coated (n=25) or plain (n=22) @Chemical$ (150 mg/day).	0
"Events occurring after PCI-definite or probable stent @Disease$ (ST), myocardial infarction (MI) not related to @Chemical$, and clinically relevant bleeding (CB)-were classified as early (&lt;=30 days), late (31 to 365 days), or very late (&gt;365 days)."	0
Nasal polyp tissues were obtained from 29 patients [including nine with aspirin (@Chemical$)-@Disease$ and 12 with bronchial asthma] undergoing polypectomy for nasal obstruction.	0
Antiplatelet efficacy of aspirin was assessed by its effect on spontaneous and @Chemical$- induced @Disease$.	1
"However, the risk of @Disease$ is further increased by combining other anti-platelet drugs (e.g. @Chemical$) with ASA in acute coronary syndromes and coronary stent placement."	0
"CONCLUSIONS: The majority of the adverse events caused by @Chemical$ are GI @Disease$, and there appears to be no valid evidence that the overall frequency of fatal GI bleeds is increased by aspirin."	1
"INTRODUCTION: Clinical features of @Chemical$-exacerbated @Disease$ (AERD) consist of moderate to severe asthma associated with chronic rhinosinusitis (CRS), which are derived from overproduction of cysteinyl leukotrienes along with chronic type 2 mediated inflammation in the upper and lower airway mucosa."	1
"CONCLUSIONS: Although the number of cases in both trials is small, our findings suggest that @Chemical$ use in AD might pose an increased risk of @Disease$, whereas it has no effect on cognition."	1
"RESULTS: Among patients discharged after first-time ischemic @Disease$, 3043 patients were treated with @Chemical$, 12,295 with a combination of acetylsalicylic acid and dipyridamole, and 3885 with clopidogrel."	0
Acute @Disease$ of pregnancy after @Chemical$ intake.	1
"We aimed to evaluate the association between several widely used analgesics, including aspirin, non-aspirin NSAIDs, and acetaminophen (@Chemical$), and risk of psoriasis and @Disease$ (PsA) in a large cohort of US women, the Nurses' Health Study II (1991-2005)."	0
Non@Chemical$ NSAID use was not associated with incident @Disease$ or mild cognitive impairment/dementia odds.	0
"The role of gastric acid and its relationship to NSAIDs/@Chemical$ in mucosal damage, ulcer and @Disease$ complications continues to be an important concern because of the increasing worldwide use of NSAIDs and aspirin."	0
Data on the association between @Chemical$ and statin use and @Disease$ (PDAC) risk are conflicting.	0
"Among women randomized to LDA, we observed a trend favoring fewer PTBs due to spontaneous @Disease$ and preterm PPROMs, odds ratio (OR: 0.826 (0.620, 1.099)); the incidence of indicated @Chemical$ appeared unchanged, OR: 0.999 (0.787, 1.268)."	0
@Chemical$-induced @Disease$ is a special clinical syndrome existing in nearly 10 % of adult asthmatics.	1
What now for @Chemical$ and @Disease$ prevention?	0
Low-dose aspirin (@Chemical$) has been increasingly used worldwide to prevent @Disease$ events.	0
"CONCLUSIONS: Preoperatively continued @Chemical$ use was not associated with increased risk of intra- and post-operative @Disease$, blood transfusion requirements and composite outcome of in-hospital death, stroke and reoperation for bleeding in off-pump CABG."	0
"Aspirin had no effect on platelet-leukocyte aggregates, platelet activation markers, or plasma cytokines in either group.Conclusions: High-dose @Chemical$ therapy for 8 weeks paradoxically increases markers of type 2 @Disease$ in subjects with aspirin-exacerbated respiratory disease, despite reducing nasal symptoms."	1
Aspirin-induced @Disease$ (AIA) is a distinct clinical entity characterised by hypersensitivity to @Chemical$ and other non-steroidal anti-inflammatory drugs (NSAIDs) typically occurring in the form of asthma and severe rhinosinusitis.	0
BACKGROUND: @Chemical$ desensitization is an effective therapy for moderate-to-severe aspirin-exacerbated @Disease$ (AERD).	0
"CONCLUSIONS: Although in patients undergoing pacemaker implantation dual antiplatelet therapy with @Chemical$ and clopidogrel caused a significant increase of bleeding complications, the use of aspirin alone was not associated with a significant increase in @Disease$ complications."	0
"However, in patients taking aspirin for the primary prevention of cardiovascular events, it seems reasonable to stop @Chemical$ treatment, re-evaluate the indication and, if needed, reintroduce aspirin after the risk of ulcer re@Disease$ decreases, usually after hospital discharge."	0
"We speculate that in this clinical situation associated with coagulase-negative staphylococcal @Disease$, @Chemical$ resistance may play an important role."	1
The estimated @Disease$-free rate at week 12 was 99.3% (@Chemical$) and 89.0% (placebo).	0
"In monocytes, we found no changes in basal or @Chemical$ (LPS)-stimulated PGE2 synthesis, but the response to EP4 receptor activation with respect to inhibition of LPS-induced @Disease$ factor-alpha release was reduced in AERD patients, especially in the presence of aspirin (acetylsalicylic acid)."	0
"BACKGROUND: Nonsteroidal anti-inflammatory drugs (NSAIDs) cause @Disease$ in susceptible patients with asthma, often termed @Chemical$-exacerbated respiratory disease (AERD), with the risk being greatest after acute exposure."	0
"Further research is needed to assess the benefit-risk ratio of clopidogrel plus @Chemical$ in specific subpopulations of patients at high risk for atherothrombotic events, and to determine the role of clopidogrel plus aspirin in preventing cardioembolic @Disease$ or early recurrent stroke after symptomatic large-vessel atherostenosis."	0
OBJECTIVE: To review the safety of cyclooxygenase-2 (COX-2) inhibitors in asthma patients with @Chemical$ @Disease$.	1
@Disease$ recurrence in an elderly CADASIL patient on @Chemical$ discontinuation due to severe auto-immune thrombocytopenia.	1
RESULTS: Suboptimal platelet response to @Chemical$ was detected in 64 of 430 patients (15%) and @Disease$ was detected in 11 patients (2.6%).	0
The @Disease$ reaction is induced by low doses of @Chemical$ that inhibit COX-1 in platelets.	1
A 57-year-old man who had @Disease$ and had been on dual antiplatelet therapy with @Chemical$ and clopidogrel for primary prevention presented with the sudden onset of mid back pain and monoplegia of the left lower extremity.	0
"Recovery from @Disease$ due to spontaneous spinal, epidural hematoma under minimal-dose @Chemical$."	1
Stroke patients are treated with antiplatelet drugs like aspirin and @Chemical$ to prevent a secondary @Disease$.	0
"Prevalence of @Disease$, @Chemical$ sensitivity and allergy in chronic rhinosinusitis: data from the UK National Chronic Rhinosinusitis Epidemiology Study."	0
"In addition, a combination of @Chemical$ and NSAIDs or LDA and APs contributed more profoundly to the @Disease$ (OR 3.59 and 95 % CI 1.19-10.81 for LDA/NSAIDs; OR 6.70 and 95 % CI 1.83-24.50 for LDA/APs)."	1
"In addition, subjects with @Disease$ were more likely to have severe asthma by means of physician assessment (66% vs 49%, P &lt; .001), to have been intubated (20% vs 11%, P &lt; .001), to have a @Chemical$ burst in the previous 3 months (56% vs 46%, P &lt; .001), and to have required high-dose inhaled corticosteroids (34% vs 26%, P &lt; .001)."	0
Bleeding during treatment with aspirin versus apixaban in patients with @Disease$ unsuitable for warfarin: the apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment (@Chemical$) trial.	0
"CONCLUSION: Coupling of NO to ASA attenuates stress, ischemia-reperfusion, and ethanol-induced damage due to mucosal hyperemia mediated by NO, which compensates for @Chemical$ @Disease$ induced by ASA."	1
"However, there was a strong association of the ALOX5 Sp1 repeat polymorphism with airway hyperresponsiveness (AHR; PC20 @Chemical$); @Disease$ patients carrying a mutant allele (n &gt; 5 or n &lt; 5 repeats) showed increased AHR compared to AIA patients with wild-type genotype (P=0.003)."	0
The experimental oral antiplatelet agent @Chemical$ causes @Disease$ in randomized trials.	1
BACKGROUND: Dual therapy (@Chemical$ and clopidogrel) increases the risk of @Disease$ (UGIB).	1
Safety of @Chemical$ in patients with aspirin/non-steroidal anti-inflammatory drug-induced urticaria and @Disease$.	0
"Aspirin exacerbated respiratory disease (AERD) is characterized as adult onset @Disease$, nasal polyps, chronic rhinosinusitis, and hypersensitivity to a cyclooxygenase-1 (COX-1) inhibitor, viz @Chemical$ or nonsteroidal antiinflammatory drugs (NSAIDs)."	0
"OBJECTIVES: To evaluate if esomeprazole prevents recurrent peptic @Disease$ in adult patients with a history of peptic ulcer receiving low-dose acetylsalicylic acid (@Chemical$, aspirin) for cardiovascular protection in East Asia."	0
@Chemical$ is recommended during anaphylaxis but is controversial in Kounis syndrome as it may worsen @Disease$.	1
"With the increasing prevalence of @Disease$ and conflicting data regarding the effect of aspirin in older adults, understanding the potential association of @Chemical$ use with cancer mortality according to body mass index (BMI) and age is imperative."	0
"Studies, review articles, and commentaries on aspirin-induced asthma and @Chemical$- or NSAID-induced @Disease$/angioedema were included in the review."	1
"If there is an unequivocal cardiovascular indication for @Chemical$, it should not be withheld in @Disease$ patients."	0
We evaluated the prevalence of @Chemical$ resistance in a cohort of 505 patients with the diagnosis of @Disease$ taking 80-300 mg regular aspirin daily.	0
"AIM: To evaluate the effects of low-dose aspirin on @Disease$, mucosal @Chemical$(2) levels and cyclooxygenase-enzyme expression in relation to the H. pylori status."	0
"In the @Chemical$ group, there were no clinical events (UCL=0.0106) and one minor endoscopic @Disease$ event (UCL=0.0169)."	0
"@Chemical$ exacerbated respiratory disease is characterized by recalcitrant sinusitis/polyposis, asthma and precipitation of @Disease$ after ingestion of aspirin and most NSAIDs."	0
"Because low-dose ASA exerts a cardioprotective effect by irreversible inhibition of COX-1, @Disease$ patients who are at risk for coronary artery disease should be considered for @Chemical$ desensitization."	0
"Two drugs recently approved for health insurance reimbursement, celecoxib, a cyclooxygenase (COX)-2 specific inhibitor and low-dose lansoprazole for prevention of recurrent peptic @Disease$ due to @Chemical$/NSAIDs will be instrumental in mitigating the gastrointestinal injuries."	1
BACKGROUND: @Chemical$-induced @Disease$ (AIAR) is characterized by the altered metabolism of leukotrienes and proinflammatory prostaglandins.	1
"BACKGROUND: @Chemical$-induced chronic rhinosinusitis (CRS) is a severe progressive persistent disease, usually associated with @Disease$ (NPs)."	1
Accidental ingestion of @Chemical$ and nonsteroidal anti-inflammatory drugs is common in patients with aspirin-exacerbated @Disease$.	0
ASA-Tris conjugation is an effective approach through which the @Disease$ side-effects of @Chemical$ are controlled by decreasing the cytokine-mediated progression of pro-inflammatory events.	1
We previously compared expression of cysLT 1 on mucosal leukocytes in patients with aspirin-sensitive and @Chemical$-tolerant @Disease$.	0
We made a comparison between treatments Aspirin-@Chemical$ combined group and the Aspirin alone group in the numbers of CMB and subsequent @Disease$.	0
The administration of desmopressin to these patients after the neutralization of @Chemical$ with protamine sulfate does not reduce @Disease$.	0
Dual antiplatelet therapy using aspirin and a thienopyridine (e.g. @Chemical$) is known to be essential in patients in whom percutaneous coronary intervention with stent implantation has been performed in order to prevent stent @Disease$ and its fatal consequences.	0
Increased total and mite-specific immunoglobulin E in patients with @Chemical$-induced urticaria and @Disease$.	0
"There was no increase in headache frequency in participants with ASA++ intake compared with @Chemical$ (adjusted, all headache: -0.34 d/mo [95% confidence intervals: -2.50 to 1.82], migraine: -1.36 d/mo [-4.76 to 2.03], TTH: -0.57 d/mo [-4.97 to 3.84], MigTTH: 2.46 d/mo [-5.19 to 10.10]) or no analgesics (all @Disease$: -2.24 d/mo [-4.54 to 0.07], migraine: -3.77 d/mo [-9.22 to 1.68], TTH: -4.68 d/mo [-9.62 to 0.27]; MigTTH: -3.22 d/mo [-10.16 to 3.71])."	0
"Comparative tolerability of paracetamol, @Chemical$ and ibuprofen for short-term analgesia in patients with @Disease$: results in 4291 patients."	0
"CONCLUSIONS: The prevalence of @Disease$ and allergy in @Chemical$ varies by phenoytype, with CRSwNPs and AFRS having a stronger association with both."	0
The effect of @Chemical$-modifier drugs on aspirin-induced @Disease$ and rhinitis reactions.	0
Extended Anticoagulant and @Chemical$ Treatment for the Secondary Prevention of @Disease$: A Systematic Review and Meta-Analysis.	0
"BACKGROUND: Full- or lower-dose anticoagulant therapy or @Chemical$ can be used for extended therapy in patients with @Disease$ (VTE), but information on their relative benefit-risk profiles is limited."	0
Incidence and Predictors of @Disease$ in Users of Low-Dose @Chemical$.	0
"The ideal treatment for @Disease$ injury in patients taking LDA would be withdrawal of @Chemical$, however, LDA is used as an antiplatelet agent in the majority of patients, and its withdrawal could increase the risk of cardiovascular/cerebrovascular morbidity and mortality."	0
"If these recommendations were followed, and if pulmonary edema occurred in 3% of persons, a significant proportion of the @Disease$s may be attributable to @Chemical$."	1
"CONCLUSIONS: In Chinese patients with @Disease$, the benefits of @Chemical$ therapy for stroke prevention and ICH risk are closely dependent on the quality of anticoagulation, as reflected by TTR."	0
"To evaluate the extent of gastric mucosal injury and the protective effect of drugs, gastric mucosal lesion index, @Disease$ flow, content of gastric mucosal @Chemical$, prostaglandins (PG), nitric oxide(NO), tumor necrosis factor (TNF), and interleukin (IL) -1, 2, 8 were measured in each group, and histological changes were observed by gross as well as under microscope and electron microscope."	0
"DATA SOURCES: Literature retrieval was accessed through MEDLINE (1966-March 2007) using the terms acetaminophen, aspirin, antiinflammatory agents nonsteroidal, @Disease$, angioedema, asthma, @Chemical$ antagonists, desensitization, and tacrolimus."	0
The pathogenic mechanism of acetyl salicylic acid (@Chemical$)-induced @Disease$ (AIU) is not fully understood.	1
"OBJECTIVE: In order to uncover the genetic mechanism, we studied the associations of the human leucocyte antigen (HLA) genotypes in patients with aspirin-induced urticaria compared with @Chemical$-intolerant @Disease$ and normal control in a Korean population."	0
"Acetaminophen, @Chemical$, and @Disease$."	0
"Data Sources: We searched PubMed, Embase, CENTRAL, and ClinicalTrials.gov from inception to May 28, 2018, with the terms novel oral anticoagulants, non-vitamin K antagonist oral anticoagulants, direct oral anticoagulants, dabigatran, rivaroxaban, @Chemical$, edoxaban, warfarin, Coumadin, vitamin K antagonist, aspirin, acetylsalicylic acid, or ASA, and major bleeding, fatal @Disease$, or intracranial hemorrhage."	0
BACKGROUND: The association of Helicobacter pylori infection with @Chemical$-induced @Disease$ is controversial.	1
OBJECTIVES: To study whether Clopidogrel-Aspirin combined treatment for high risk transient ischaemic attack (TIA) or minor stroke results in increased number of lesions associated with anti-@Disease$ (CMB) than @Chemical$ alone treatment.	0
OBJECTIVES: To investigate the genetic contribution of adenosine A3 receptor gene (ADORA3) polymorphisms in the pathogenesis of aspirin-induced @Disease$ (@Chemical$) in a case-control association study in a Korean population.	0
"To investigate associations of FANCC polymorphisms with AERD and related phenotypes, this study genotyped 25 common single nucleotide polymorphisms (SNPs) in a total of 592 Korean asthmatics including 163 @Disease$ and 429 @Chemical$-tolerant asthma (ATA) subjects."	0
"CONCLUSIONS: The majority of the adverse events caused by @Chemical$ are GI bleeds, and there appears to be no valid evidence that the overall frequency of fatal GI @Disease$ is increased by aspirin."	0
OBJECTIVE: To evaluate the use of leukotriene modifiers in preventing @Chemical$-provoked respiratory reactions in @Disease$tics.	0
Why keep taking @Chemical$ if it caused my @Disease$?	1
"It also assesses the impact of @Chemical$ on (a) self-reported @Disease$, (b) noise-induced audiometric changes, and (c) the adverse otological effects of aminoglycoside therapy."	0
The effect of dosing interval on the efficacy of misoprostol in the prevention of @Chemical$-induced @Disease$.	1
"The strongest evidence was from a randomized controlled trial (RCT) specifically looking at elective abdominal surgery, which showed no statistically significant difference between @Chemical$ continuation and discontinuation in terms of haemorrhagic or @Disease$ events."	0
"METHODS: In a case-control study including 111 low-dose aspirin users with peptic @Disease$s and 109 controls (asymptomatic @Chemical$ users), the polymorphism (T-1676C) of the COX-1 gene promoter was genotyped, and blood type, H pylori status, and clinical factors were assessed."	0
Pathophysiology of @Disease$ is complex and extends beyond abnormalities in the @Chemical$ metabolism.	0
We compared the levels of neutrophil activation and related cytokines in patients with ASA-intolerant acute urticaria (@Disease$) and @Chemical$-intolerant chronic urticaria (AICU).	0
"Letter by Feng et al regarding article, Ischemic stroke and @Disease$ with aspirin, @Chemical$, and warfarin: impact of quality of anticoagulation control."	0
Tests for H pylori @Disease$ can be used to assign high-risk @Chemical$ users to groups that require different gastroprotective strategies.	0
The frequency of @Disease$ is similar between BA users and @Chemical$ users.	0
"The PAIN (@Chemical$, Aspirin, Ibuprofen New tolerability) study was a blinded randomised comparison of the tolerability of OTC analgesics in the treatment of common types of acute @Disease$ encountered in the community."	0
"There were significantly more patients who suffered GI adverse events, principally abdominal pain, dyspepsia, nausea and @Disease$, with @Chemical$ (18.5%) than with ibuprofen (11.5%), but the difference between ibuprofen and paracetamol (13.1%) was not significant."	1
Clopidogrel is an ADP receptor antagonist and in combination with @Chemical$ widely used in patients with atherosclerotic vascular disease to reduce the incidence of @Disease$ events.	0
Aspirin-induced asthma (AIA) and @Chemical$-induced urticaria/ @Disease$ (AIU) are two major aspirin-related allergies.	1
"In conclusion, neutrophil activation, which was associated with the levels of IL-8 and IL-18 in the @Disease$ group, may be involved in the pathogenic mechanism of @Chemical$."	0
"After ASA desensitization, patients can take daily @Chemical$ in order to treat their underlying @Disease$."	0
"@Chemical$ tended to be used in higher-risk patients: composite of cardiovascular death, @Disease$ or stroke at 5.8 versus 4.2% (p = 0.056)."	0
"Notwithstanding the consistent benefits demonstrated with aspirin for both acute and chronic @Disease$, there are a number of toxicities associated with aspirin that have been showcased by recent long-term clinical trials that have included an @Chemical$ monotherapy arm."	0
AIM: To determine the rate of endoscopic gastric/duodenal @Disease$s (GDUs) associated with use of aspirin (81 mg q.d.) alone or coadministered with celecoxib or @Chemical$.	0
"For @Chemical$ users, the relative risk was similar for doses up to 300 mg daily and for both gastric and duodenal @Disease$s."	0
"CONCLUSIONS: The highly sensitive @Chemical$ profiling in EBC makes it possible to detect alterations in @Disease$, especially in its distinct phenotype characterized by hypersensitivity to aspirin and other nonsteroidal anti-inflammatory drugs."	0
"Regarding those with duration of aspirin use, there was a tendency towards stronger risk reduction of @Disease$ for longer @Chemical$ use (10% decreased risk for 4 years, 19% for 8 years and 28% for 12 years), and no duration threshold was observed."	0
"METHODS AND MAIN RESULTS: By using a proteomics approach, six proteins were found to be differentially expressed in plasma between patients with @Disease$ and patients with ATA at baseline, and eight proteins were significantly up- or down-regulated after @Chemical$ challenge in patients with AIA."	0
Efficacy and safety of adding clopidogrel to @Chemical$ on @Disease$ prevention among high vascular risk patients: a meta-analysis of randomized controlled trials.	0
"OBJECTIVE: We sought to assess a vast platform of @Chemical$s in different asthma phenotypes, including aspirin-intolerant @Disease$, by means of a recently developed analytic approach based on mass spectrometry."	0
"The prevalence of self-reported confirmed inhalant @Disease$ was 13.1, 20.3, 31.0 and 33.3% respectively; house dust mite allergy was significantly higher in CRSwNPs (16%) compared to @Chemical$sNPs (9%, p &lt; 0.001)."	0
These figures indicate that @Chemical$ @Disease$ might be a significant community problem.	1
"DATA SOURCES: Literature retrieval was accessed through MEDLINE (1966-March 2007) using the terms @Chemical$, aspirin, antiinflammatory agents nonsteroidal, urticaria, @Disease$, asthma, leukotriene antagonists, desensitization, and tacrolimus."	0
"In the gastric fundus, neither HP @Disease$ nor @Chemical$ was a significant factor (LDA was an aggressive factor, and HP infection a protective factor)."	0
"@Chemical$ exacerbated respiratory disease (@Disease$) is an adult onset condition manifested as asthma, rhinosinusitis/nasal polyps, and sensitivity to aspirin and other cyclooxygenase-1 (Cox-1)-inhibitor nonsteroidal anti-inflammatory drugs (NSAIDs)."	0
"We recruited 139 @Disease$ patients, 171 @Chemical$-tolerant asthma patients and 160 normal controls."	0
"BACKGROUND: @Chemical$-exacerbated @Disease$ (AERD) is explained in part by overexpression of 5-lipoxygenase and leukotriene C4 synthase (LTC4S), resulting in constitutive overproduction of cysteinyl leukotrienes (CysLTs) and driving the surge in CysLT production that occurs with aspirin ingestion."	1
"The effects of pranlukast on changes in sputum LTC(4)-LTD(4), eosinophil cationic protein (ECP), eosinophil count, urinary LTE(4)/creatinine, 11-dehydrothromboxane B(2) (11-dhTXB(2))/creatinine, serum LTC(4)-LTD(4), ECP, and peripheral blood eosinophil count, during immediate @Disease$tic reaction (IAR) and late asthmatic reaction (LAR) in the HDM group and during IAR in the @Chemical$ group for each test, were compared in each group."	0
Both patients also developed @Disease$-associated clinical sequelae (acute systemic reaction postintravenous @Chemical$ bolus; thrombotic stroke) in association with their episode of HIT.	1
"Further research is needed to assess the benefit-risk ratio of clopidogrel plus @Chemical$ in specific subpopulations of patients at high risk for @Disease$, and to determine the role of clopidogrel plus aspirin in preventing cardioembolic stroke or early recurrent stroke after symptomatic large-vessel atherostenosis."	0
"CONCLUSIONS: The data from this study show that @Chemical$ intolerance, HDM allergy, and @Disease$ duration exceeding 10 years are major factors associated with severe asthma in outpatients."	0
"OBJECTIVE: The aim of this systematic review was to provide the odds ratios (ORs) of major bleeding, intracranial bleeding or major extra-cranial @Disease$ of anticoagulation with VKA compared to low doses of @Chemical$."	0
We aimed to assess the presence of apoptotic cells in nasal polyps from aspirin-@Disease$ (AH) and @Chemical$-tolerant (AT) patients with rhinosinusitis as related to the characteristics of local inflammation.	0
@Disease$ was significantly increased in those with the combination of @Chemical$ and severe hypertension (p = 0.003).	1
"Compared with patients not associated with NSAIDs and @Chemical$ medication, they are older [(41.2 +- 1.9) years vs (59.4 +- 2.2) years, P &lt; 0.001], more commonly associated with hypertension (10.4% vs 39.2%, P &lt; 0.001), @Disease$ (10.4% vs 17.6%, P &lt; 0.001), diabetes (4.2% vs 19.6%, P = 0.005); and had more severe anemia (7.3% vs 23.5%, P = 0.008)."	0
WHAT IS KNOWN AND OBJECTIVE: Premature discontinuation of @Chemical$ in patients undergoing percutaneous coronary intervention is a significant risk factor for @Disease$ adverse outcomes.	0
The use of analgesic anti-inflammatory agents in patients with asthma is clinically challenging because of the prevalence (10-20%) of @Chemical$ @Disease$.	1
"Aspirin-exacerbated diseases are important examples of drug hypersensitivities and include aspirin-exacerbated respiratory disease (@Disease$), aspirin- or non-steroidal anti-inflammatory drug (NSAID)-induced urticaria/angioedema, and @Chemical$- or NSAID-induced anaphylaxis."	0
@Chemical$ resistance associated with HbA1c and obesity in @Disease$ patients.	0
"At follow-up (a minimum of 6-24 months), only two patients had discontinued @Chemical$, both due to @Disease$, and no hypersensitivy reaction had occurred."	1
Interleukin 16 and CCL17/thymus and activation-regulated chemokine in patients with @Chemical$-exacerbated @Disease$.	0
Effect of inhalation @Chemical$ challenge on exhaled nitric oxide in patients with aspirin-inducible @Disease$.	0
"@Disease$ in patients receiving a combination of aspirin, clopidogrel, and @Chemical$ in acute coronary syndrome."	0
"When reviewing the existing literature on the effects of the coating on the incidence of gastrointestinal side effects we find that enteric-coated @Chemical$ causes significantly less minor @Disease$ compared to plain aspirin evaluated by endoscopy after short-term treatment, but there seems to be no effect of enteric-coating on the incidence of dyspepsia or gastrointestinal bleeding of clinical relevance."	1
"The main models included the following predictors: demographic characteristics (age, ethnicity, and socioeconomic deprivation), clinical measurements (systolic blood pressure and ratio of total-high-density lipoprotein cholesterol), family history of premature CVD, medical history (smoking, diabetes, bleeding, peptic ulcer disease, cancer, @Disease$, chronic pancreatitis, or @Chemical$-related conditions), and medication use (nonsteroidal anti-inflammatory agents, corticosteroids, and selective serotonin reuptake inhibitors)."	0
Randomised clinical trial: @Chemical$ plus aspirin is not inferior to rabeprazole plus clopidogrel for the healing of aspirin-related peptic @Disease$.	0
"Background: Aspirin-exacerbated respiratory disease (AERD), a syndrome that includes asthma, recurrent @Disease$, and pathognomonic reactions to @Chemical$ and other nonselective cyclooxygenase inhibitors, is still not fully understood and lacks specific disease-modifying therapeutic options."	0
These results support the opinion that aspirin @Disease$ has the different pathogenic mechanism from @Chemical$ asthma.	0
"METHODS: Therefore, nasal polypous tissue specimens of patients suffering from chronic nasal polypous sinusitis (NP), intrinsic @Disease$ (ATA), @Chemical$-intolerance (AINA), and aspirin-triad (TRIAD) were investigated."	0
"Under double-blind conditions, 80 @Chemical$-intolerant patients with @Disease$ were randomized to receive 4 wk oral treatment of either 10 mg of montelukast or placebo once daily at bedtime."	0
BACKGROUND: Patients with aspirin-exacerbated respiratory disease (@Disease$) also recently known as nonsteroidal anti-inflammatory drug (NSAID) exacerbated respiratory disease (NERD) must avoid @Chemical$ and all other oral NSAIDs.	0
OBJECTIVE: To evaluate frequency of ischemic and @Disease$ events in patients treated with @Chemical$ and ticagrelor when associated with perioperative heparin bolus for unruptured aneurysms treated with intracranial stents.	0
Autologous serum skin test (ASST) reactivity is positive in up to 60% of patients with chronic @Disease$ (@Chemical$).	0
"Primary end points were pre-discharge @Disease$ necessitating the restoration of bladder irrigation or the cessation of @Chemical$ treatment and late hematuria treated in an urgent care setting, requiring hospital admission or compelling the cessation of aspirin treatment."	0
Rebound inflammation and the risk of @Disease$ after discontinuation of @Chemical$ therapy.	1
CD4(+) IFN-gamma and CD4(+) IL-10 levels in @Disease$ patients after 1-month @Chemical$ desensitization treatment were similar to the healthy controls.	0
"@Chemical$-exacerbated respiratory disease (AERD) refers to the combination of @Disease$, chronic rhinosinusitis with nasal polyposis, and acute upper and lower respiratory tract reactions to the ingestion of aspirin (acetylsalicylic acid, ASA) and other cyclooxygenase-1 inhibiting non-steroidal anti-inflammatory drugs."	0
"Moreover, cyclooxygenase-2 is markedly downregulated in @Disease$ from @Chemical$-sensitive patients with asthma."	0
"In conclusion, PPIs were superior to H2RAs for prevention of @Chemical$-related GI erosion/@Disease$ and bleeding."	0
"[@Chemical$ (acetylsalicylic acid)-induced @Disease$, an unknown adverse effect]."	1
Clinical practitioners need to carefully assess the value of @Chemical$ in patients at low @Disease$ risk and those 80 years of age and beyond where evidence of benefit should be weighed against risk.	0
"Regular use of non-aspirin NSAID, paracetamol, @Chemical$ creams and steroid pills was uncommon and no association with @Disease$ was detected."	0
"CONCLUSION: H2RA therapy was effective for both the prevention and treatment of low-dose @Chemical$-induced peptic @Disease$, similar to the effects of PPIs, while cytoprotective anti-ulcer drugs were ineffective in preventing ulceration."	0
"Evaluation of aspirin-induced @Disease$ is relevant in various clinical situations, including during complex surgeries with high bleeding risk in individuals who have ingested @Chemical$."	0
The data supporting a moderate - without increasing the frequency of reoperation and blood transfusion - an increased risk of perioperative @Disease$ in cases where operations are conducted against a background of @Chemical$ therapy.	1
"The event sequence symmetry analysis of @Disease$, gastritis and duodenitis, and melena found significant associations with entericcoated @Chemical$ use, with adjusted sequence ratios (ASRs) of 1.58 (1.23 - 2.06), 1.30 (1.03 - 1.65), and 14.38 (2.19 - 607.95), respectively, at the 6-month interval."	0
"@Chemical$ is widely accepted as a treatment option for migraine @Disease$ relief and could provide an alternative not only for treatment of moderate migraine attacks, but also for severe migraine attacks."	0
"CONCLUSION: The rare allele of rs6962291 may play a protective role against @Chemical$ @Disease$ via a lower catalytic activity of the TBXAS1 gene, attributed to the increase of a nonfunctioning isoform of TBXAS1."	1
"Among individuals with BMI 25 to 29.9, @Chemical$ use 3 or more times per week was associated with reduced risk of all-cause mortality (HR, 0.82; 95% CI, 0.79-0.85; P &lt; .001), any cancer mortality (HR, 0.86; 95% CI, 0.81-0.91; P &lt; .001), GI @Disease$ mortality (HR, 0.72; 95% CI, 0.60-0.86; P &lt; .001), and CRC mortality (HR, 0.66; 95% CI, 0.51-0.85; P = .001)."	0
"Average bleeding in ASA group 24 hours postoperatively was 1600 ml, Non @Chemical$ group had average @Disease$ 900 ml, while Trasylol group had average drainage of 700 ml after 24 hours."	0
This is the first report of patients who underwent @Disease$ while on both @Chemical$ and clopidogrel.	1
"CONCLUSIONS: Our findings do not support the notion that entericcoated LDA products confer a lower risk for @Disease$ complications than buffered formulations, but may conversely imply that the risk of GI complications associated with buffered @Chemical$ is lower than that of enteric-coated LDA."	0
"@Chemical$ (ASA) causes adverse haemorrhagic reactions in the upper gastrointestinal (@Disease$) tract, and previous results have suggested that combination therapy with 2-amino-2-(hydroxymethyl)-1,3-propanediol (Tris) could provide protection in this scenario."	1
"CONCLUSIONS: Low-dose aspirin use could reduce the incidences of total cardiovascular events, stroke, nonfatal stroke and transient ischemic attack but increase the risk of bleeding, the incidence of @Disease$, death from cardiovascular causes and death from any cause was not affected by low-dose @Chemical$ use."	0
"Previously influenza with high temperature, headache and @Disease$ had occurred and been treated with @Chemical$ for some days."	1
Current complications and treatment of @Chemical$-exacerbated @Disease$.	1
"DESIGN, SETTING, AND PARTICIPANTS: Prospective analysis of observational data from the EINSTEIN @Disease$ and pulmonary embolism clinical trials comparing rivaroxaban with @Chemical$-VKA treatment, trials performed in hospitals and clinics in 8246 patients enrolled from 2007 to 2009."	0
"Search terms included aspirin, @Chemical$, secondary prevention, and @Disease$."	0
"However, in patients taking aspirin for the primary prevention of cardiovascular events, it seems reasonable to stop @Chemical$ treatment, re-evaluate the indication and, if needed, reintroduce aspirin after the risk of @Disease$ rebleeding decreases, usually after hospital discharge."	0
"The incidence of ischemic @Disease$ was highest in patients with no therapy (10.38%/y), followed by patients on @Chemical$ (7.95%/y)."	0
"There was no significant difference in COX-2 expression between LPS and @Chemical$ stimulation (mean 61.8%, range 26.8-89.2; p = 0.09) and @Disease$ stimulation (mean 55.5%, range 28.1-74.3) nor between aspirin stimulation alone (median 0.5%, range 0-8.6; p = 0.8) and baseline values (median 0.4%, range 0-5.4) in healthy control subjects."	0
"We investigated whether use, frequency, and duration of the anti-inflammatory drug @Chemical$ were associated with @Disease$ risk and survival, separately among AA and EA populations."	1
"Aspirin, but not other NSAID use, was associated with about 20% lower risk of postmenopausal breast cancer and did not vary by ER or PR status of the @Disease$, suggesting that the hypothesized protective effects of aspirin may either be through cellular pathways independent of estrogen or @Chemical$ signaling, or on tumor microenvironment."	0
Subgroup analysis revealed that there was a higher rate of @Disease$ expansion in the @Chemical$ cohort (p=0.034) than in the cohort of patients receiving aspirin alone.	0
"Aspirin-exacerbated respiratory disease (@Disease$) is a clinical syndrome characterized by severe persistent asthma, hyperplastic eosinophilic sinusitis with nasal polyps, and an intolerance to @Chemical$ and other NSAIDs that preferentially inhibit COX-1."	0
[Intraoperative @Disease$ during paranasal sinus surgery -- indicator of @Chemical$ intolerance syndrome?].	0
METHODS: @Disease$ were obtained from 11 aspirin-sensitive and 19 @Chemical$-tolerant patients with chronic rhinosinusitis.	0
"Patients on ASA 325 mg had a higher adjusted hazard ratio of 2.9 (95% confidence interval, 1.2-7.0 versus ASA 81 mg+@Chemical$; P = 0.02) and 3.4 (95% confidence interval, 1.2-9.5 versus ASA 81 mg; P = 0.02) for @Disease$ events."	0
@Chemical$-induced @Disease$ (AIA) is a distinct clinical entity characterised by hypersensitivity to aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) typically occurring in the form of asthma and severe rhinosinusitis.	1
"We sought to compare the risk of @Disease$ due to the low (&lt;100 mg), moderate (100 to 200 mg), and high (&gt;200 mg) doses of aspirin (acetylsalicylic acid [@Chemical$]) in 192,036 patients enrolled in 31 clinical trials."	0
"In two separate series, platelet aggregation and carrageenan @Disease$-induced inflammatory pain were measured in control, ASA and ASA-@Chemical$-treated groups."	0
"Aspirin-exacerbated diseases are important examples of drug hypersensitivities and include aspirin-exacerbated respiratory disease (AERD), @Chemical$- or non-steroidal anti-inflammatory drug (NSAID)-induced @Disease$/angioedema, and aspirin- or NSAID-induced anaphylaxis."	1
"Regarding the pathogenesis of AI, modifications of eicosanoid metabolism are supposed to underlie AI, including @Chemical$-induced asthma and aspirin-induced @Disease$."	0
OBJECTIVE: To review the safety of cyclooxygenase-2 (COX-2) inhibitors in @Disease$ patients with @Chemical$ hypersensitivity.	0
"In details, @Chemical$ decreased @Disease$ ROS level, increased CAT, GSH-Px and SOD activity, and reduced MDA concentration (P&lt;0.05)."	0
Method: Eighty-six patients with CRS and asthma who were treated in the outpatient clinic during March 2015 to January 2018 were divided into asthma group(52 cases) and @Chemical$ asthma group(34 cases) according to asthma and aspirin @Disease$.	0
Risks May Outweigh Benefits Of @Chemical$ Use in @Disease$.	0
"The impact of @Disease$ on nonadherence to, and discontinuation of, low-dose @Chemical$ in patients with cardiovascular risk."	0
Participants completed questionnaires at baseline detailing their regular @Chemical$ use and were then followed up to identify those who developed either incident @Disease$ or UC.	0
Oral aspirin challenge (@Chemical$) reveals aspirin-exacerbated @Disease$ (AERD) in approximately 50% of unselected patients with chronic rhinosinusitis with nasal polyposis (CRSwNP).	0
Review article: @Disease$ with low-dose @Chemical$ - what's the risk?	0
"STUDY DESIGN: This retrospective study assessed @Disease$ incidence for a total of 297 dental osteotomies with continued @Chemical$ therapy, compared with that of 179 similar procedures on patients who were not on any anticoagulation or anti-platelet therapy."	0
The lower @Disease$ index was only accompanied by lower gastric @Chemical$ content.	0
@Chemical$ has a central role in preventing thromboembolic complications in @Disease$.	0
A twist on @Chemical$ @Disease$: when symptoms and levels do not correlate.	1
The aim of the study was to evaluate the diagnostic utility of cellular antigen stimulation test (CAST) in the detection of @Disease$ mediated by @Chemical$.	1
Effect of misoprostol on patients with aspirin-exacerbated @Disease$ undergoing @Chemical$ challenge and desensitization.	0
"BACKGROUND: Aspirin-exacerbated @Disease$ (AERD) is a clinical triad consisting of aspirin/@Chemical$ (ASA) sensitivity, bronchial asthma, and nasal polyposis."	0
A 35-year-old lady with @Disease$ taking @Chemical$ with clopidogrel for thrombo-prophylaxis presented with massive epistaxis.	0
This study was undertaken to define the role that apoptosis may play in inducing cellular @Disease$ and death in gastric mucosa exposed to @Chemical$.	0
Non-@Chemical$ NSAID use was not associated with either @Disease$ or CAC in either cohort.	0
"To investigate the associations between CD55 single nucleotide             polymorphisms (SNPs) and the risk of @Disease$, we carried out logistic analyses with             three genetic models and further regression analysis was performed with the fall             rate of forced expiratory volume in 1 sec (FEV1) by @Chemical$ provocation."	0
"However, as discontinuation of @Chemical$, unlike NSAIDs, may precipitate @Disease$ and cerebrovascular events, treatment of aspirin-associated ulcers should re-start aspirin as soon as possible, using proton pump inhibitor (PPI)."	1
The definite condition that is necessary for the development of @Disease$ by aspirin is the direct injury with the @Chemical$ and the presence of the gastric acid.	0
"Blood type O, advanced age, history of peptic @Disease$, and concomitant use of NSAID are of independent significance in predicting peptic ulcer development during treatment with low-dose @Chemical$."	0
"Sensitivity, but not specificity, of a quantitative immunochemical fecal occult blood test for @Disease$ is slightly increased by the use of low-dose @Chemical$, NSAIDs, and anticoagulants."	1
"BACKGROUND: Aspirin-exacerbated respiratory disease (@Disease$) is a clinical triad consisting of aspirin/acetylsalicylic acid (@Chemical$) sensitivity, bronchial asthma, and nasal polyposis."	0
"BACKGROUND: Nonsteroidal anti-inflammatory drugs (NSAIDs) cause bronchospasm in susceptible patients with asthma, often termed @Chemical$-exacerbated @Disease$ (AERD), with the risk being greatest after acute exposure."	1
"The aim of this study is to report the sinonasal outcomes of endoscopic sinus surgery (@Chemical$) in treating NP in asthmatic patients, comparing aspirin-induced asthmatic (AIA) patients with aspirin-tolerant @Disease$tics (ATA)."	0
"We have previously demonstrated that @Chemical$, when injected as a single high dose (100 mg/kg), induces a pro@Disease$ state in the rat, similar to that described above, 8 and 10 days after administration."	1
"CONCLUSIONS: In ADAPT-DES, the @Chemical$ score was predictive of @Disease$ events between 1 and 2 years after drug-eluting stents."	0
Aspirin-exacerbated respiratory disease (@Disease$) is an acquired disease characterized by chronic eosinophilic airway inflammation with underlying dysregulation of @Chemical$ metabolism.	0
"Further research is needed to assess the benefit-risk ratio of clopidogrel plus aspirin in specific subpopulations of patients at high risk for atherothrombotic events, and to determine the role of @Chemical$ plus aspirin in preventing cardioembolic stroke or early recurrent stroke after symptomatic large-vessel @Disease$."	0
Association of gastric acid and mucus secretion level with low-dose @Chemical$-induced @Disease$.	1
HYPOTHESIS: Desensitization to @Chemical$ may be carried out safely and effectively in patients with reported ASA or nonsteroidal anti-inflammatory drug (NSAID) @Disease$ needing ASA for cardiac indications.	0
"According to @Chemical$ results all the patients were divided into three groups: normo-, hypo- and @Disease$."	0
"Although precipitation of @Disease$ attacks by ingestion of @Chemical$ and other NSAIDs is considered a hallmark of the syndrome, the respiratory mucosal inflammatory disease process begins and continues in the absence of ongoing or even intermittent exposure to ASA or NSAIDs."	1
BACKGROUND: Intranasal administration of aspirin-lysine has been used in Europe for the diagnosis of @Chemical$-exacerbated @Disease$.	0
"@Chemical$ desensitization treatment, the mainstay of controlling @Disease$ and rhinitis in AERD patients, however, is the least understood aspect of the disease."	0
A retrospective subgroup analysis of data from the CONSENSUS II study demonstrated that the 6-month mortality rate of patients with @Disease$ (MI) who received @Chemical$ and aspirin was higher than the combined mortality rates of patients receiving enalapril or aspirin alone.	1
"@Chemical$-induced @Disease$ and aspirin-induced urticaria, in a substantial part of the patients, are driven by a release of mediators from activated mast cells."	1
"Prior GI events, older age, and use of other injurious medicines such as NSAIDs, anticoagulants, and corticosteroids seem to be factors associated with an increased risk for upper @Disease$ among @Chemical$ users."	1
"Major advances in the molecular biology of eicosanoids, exemplified by the cloning of cysteinyl-@Chemical$ receptors and discovery of a whole family of cyclooxygenase enzymes, offer new insights into mechanisms operating in aspirin-induced @Disease$."	0
The @Chemical$ in @Disease$ was increased significantly in rats given FB apple extract.	0
"Allergic conditions include aspirin-exacerbated respiratory disease (AERD or @Chemical$-induced asthma), aspirin-induced urticaria/@Disease$ (AIU), and anaphylaxis."	0
We investigated the role of serum specific IgE to thyroid peroxidase (TPO) in patients with @Chemical$ intolerant acute urticaria (AIAU) and aspirin intolerant chronic urticaria (@Disease$).	0
"CONCLUSIONS: In Chinese patients with atrial fibrillation, the benefits of @Chemical$ therapy for @Disease$ prevention and ICH risk are closely dependent on the quality of anticoagulation, as reflected by TTR."	0
CONCLUSION: There is a significant increase in the risk of wound discharge when @Chemical$ or LMWH is used in @Disease$ patients.	0
A 64 year old woman with previous history of coronary stenting five days before was admitted in our institution for intracranial @Disease$ while receiving @Chemical$ and clopidogrel.	1
@Disease$ patients had similar characteristics to the normal albumin group except mildly higher @Chemical$ in the former.	0
@Chemical$ and Risk of @Disease$: Systematic Review and Meta-Analysis.	0
"The use of aspirin, aspirin plus extended-release dipyridamole, or @Chemical$ is recommended as initial therapy in patients with noncardioembolic ischaemic @Disease$ or TIA to reduce the risk of recurrent stroke and other cardiovascular events."	0
BACKGROUND: It is well established that long-term use of @Chemical$ can cause @Disease$.	1
"Even at the top TTR quartile, warfarin was associated with a higher stroke and @Disease$ risk than @Chemical$."	0
INTRODUCTION: @Chemical$ is used regularly for @Disease$ management and cardioprotection.	0
"For instance, nitric oxide (NO) released from vascular epithelium, epithelial cells of @Disease$ and sensory nerves can influence many of the same components of mucosal defense as do @Chemical$s."	0
"Effective strategies to prevent @Disease$ complications include initiation of a proton pump inhibitor (PPI), @Chemical$, or double dose H(2)-receptor antagonists (H(2)RAs) at the start of ASA therapy."	0
"METHODS: The label of each willow supplement and willow-containing product was assessed for the presence or absence of 3 warnings: (1) @Chemical$ @Disease$/sensitivity, (2) use of anticoagulants or blood thinners, and (3) children with flu-like symptoms or Reye's syndrome."	1
Current evidence shows that H. pylori @Disease$ increases the ulcer risk associated with NSAIDs or low-dose @Chemical$.	0
Mean PD(20) was 163.4 +/- 39.9 mg @Chemical$ among patients who reacted with @Disease$ to ASA.	0
"Over- production of cysteinyl-leukotrienes (@Chemical$) and prostaglandin D2 (PGD2) correlate with the pathogenetic features of @Disease$, suggesting the possible involvement of mast cell activation with innate type 2 immune response."	0
"Before, after 120, and 240 min of DDAVP administration the following parameters were measured: platelet aggregation (PA) and ATP release induced by ADP, collagen, @Chemical$ and thrombin; PFA-100 closure times (CT), factor VIII activity (FVIII:C), @Disease$ factor antigen (VWF:Ag), collagen binding activity (VWF:CB) and blood count."	0
Montelukast protects against nasal lysine-aspirin challenge in patients with @Chemical$-induced @Disease$.	1
"Discontinuation of low-dose @Chemical$ which exposes to increased @Disease$ and mortality should be avoided, even in cases of peptic ulcer bleeding."	1
"Dogs receiving prednisone and @Chemical$/aspirin had 11.1 times (95% CI, 1.7-73.6) and 31.5 times (95% CI, 3.5-288.0) higher odds, respectively, of having endoscopic @Disease$ scores &gt;=4 than dogs receiving placebo (P &lt;= .01)."	0
"Omeprazole appears to be very effective in reducing both acute gastroduodenal mucosal damage and upper @Disease$ bleeding in the high-risk patient taking low-dose aspirin, but data with other anti-ulcer agents are lacking (misoprostol) or inconsistent (@Chemical$) at present."	0
"@Chemical$ for the prevention of peptic ulcers and @Disease$ in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial."	0
"OBJECTIVE: Low molecular weight (LMW) heparin, with or without aspirin (@Chemical$ [ASA]), is used to prevent complications in @Disease$ in pregnancy."	0
"DATA SOURCES: Articles evaluating aspirin for primary prevention of CVD were gathered using a MEDLINE search with the keywords @Chemical$ review, aspirin peripheral artery disease, aspirin stroke, aspirin coronary artery disease, aspirin @Disease$, aspirin primary prophylaxis, and aspirin elderly."	0
"While the expression of the EP4 receptor in eosinophils was unaltered in AERD patients, inhibition of eosinophil chemotaxis by PGE2 or the EP4 agonist @Chemical$ was less pronounced in @Disease$ patients as compared to healthy control subjects."	0
"@Disease$, immediate and accelerated reactions, atopy, older age and chronic/recurrent urticaria were risk factors for hypersensitivity and/or cross-reactivity between @Chemical$, ibuprofen and paracetamol."	0
"DATA SYNTHESIS: @Chemical$ sensitivity is most often manifested as respiratory reactions (eg, bronchospasm, profuse rhinorrhea, conjunctival injection) or @Disease$/angioedema."	1
Esophageal mucosal lesion with low-dose @Chemical$ and prasugrel mimics @Disease$: a case report.	0
"CONCLUSIONS: Our findings do not support the notion that entericcoated @Chemical$ products confer a lower risk for @Disease$ complications than buffered formulations, but may conversely imply that the risk of GI complications associated with buffered LDA is lower than that of enteric-coated LDA."	0
Low-dose aspirin (@Chemical$) has emerged as one of the most important causes of peptic @Disease$ bleeding in developed countries.	0
"CONCLUSION: In real life, the incidence of @Disease$ associated with the combination of aspirin, @Chemical$, and enoxaparin therapy was estimated to be 2.7%."	0
"Patients with history of GI ulcer/bleeding were much more likely to be co-prescribed @Chemical$ than those who had no history of @Disease$ (OR, 26.5)."	0
"Also, it was found that @Chemical$ (HR, 1.28) and statin (HR, 1.55) elevated the risk of @Disease$."	1
"CONCLUSION: Our findings confirm the beneficial effect of low-dose @Chemical$ on recurrence of any @Disease$s; however, effect on advanced adenomas was inconclusive."	1
We describe a case of esophageal mucosal lesion that was difficult to distinguish from @Disease$ in a patient with a history of ingesting @Chemical$ and prasugrel after implantation of a drug-eluting stent.	0
BACKGROUND: Prophylactic @Chemical$ has been considered to be beneficial in reducing the risks of heart disease and @Disease$.	0
"CONCLUSIONS: In the UK, there appears to be no consistent approach to patients with @Chemical$ @Disease$."	1
"We compared GI hospitalization rates among elderly patients taking celecoxib, NS-NSAIDs, celecoxib and ASA or @Disease$ and @Chemical$."	0
"Comparison between the warm needling group and Omeprazole group showed that the UI, both serum and @Disease$ activity, and serum @Chemical$ level of the former group were evidently higher than those of the Omeprazole group (P&lt;0. 05), but gastric mucosal MDA level of the warm needling group was apparently lower than that of the Omeprazole group (P&lt;0.05)."	0
Association of @Chemical$ use with major @Disease$ in patients with and without diabetes.	0
The CysLTR1 mRNA levels increased significantly after @Chemical$ challenge in @Disease$ patients (P = 0.013).	0
"RESULTS: Etoricoxib was well tolerated, without any signs of immediate or delayed @Disease$ @Chemical$- and nonsteroidal anti-inflammatory drug-induced asthmatic patients."	0
"METHODS: Ninety-four aspirin-induced urticaria patients presenting urticaria/angioedema-induced by both ASA and NSAID (50 had underlying chronic urticaria) and showing positive responses on oral aspirin challenge test, 76 aspirin-intolerant @Disease$tics with positive responses on @Chemical$-aspirin bronchoprovocation test, and 185 normal healthy controls were enrolled."	0
"Type 2 inflammation characterizes aspirin-exacerbated respiratory disease.Objectives: To determine whether high-dose aspirin therapy changes biomarkers of type 2 inflammation in aspirin-exacerbated respiratory disease.Methods: Forty-two subjects with aspirin-exacerbated @Disease$ underwent an aspirin desensitization and were placed on high-dose @Chemical$ (1,300 mg daily)."	0
"CONCLUSION: Daily treatment with @Chemical$ 300 mg had beneficial effects in patients with @Disease$, especially for the control of upper airway disease."	0
CONCLUSIONS: Fewer endoscopic @Disease$s were observed in patients treated with celecoxib/aspirin vs. naproxen/@Chemical$.	0
"METHODS: The study group consisted of twenty-three individuals with @Disease$ who underwent @Chemical$, followed by ingestion of 325 mg aspirin twice daily."	0
Effects of Colorectal Cancer Risk Factors on the Association Between @Chemical$ and @Disease$.	1
@Chemical$ are involved in the physiological mechanism of @Disease$ and inflammation.	0
@Chemical$ exacerbated respiratory disease (AERD) is a clinical syndrome characterized by chronic rhinosinusitis with @Disease$ and aspirin hypersensitivity.	0
We investigated the role of serum specific IgE to thyroid peroxidase (TPO) in patients with aspirin intolerant acute @Disease$ (AIAU) and @Chemical$ intolerant chronic urticaria (AICU).	0
BACKGROUND: The mechanism of @Chemical$ sensitivity in patients with asthma and rhinosinusitis has been attributed to @Disease$.	0
"Aspirin-exacerbated respiratory disease (AERD) is a clinical syndrome characterized by severe persistent asthma, hyperplastic eosinophilic sinusitis with @Disease$, and an intolerance to @Chemical$ and other NSAIDs that preferentially inhibit COX-1."	0
"CONCLUSIONS: @Chemical$ 20/3.75 mg was associated with a low incidence of ischemic events, similar to the results of TRITON-TIMI 38, and with a low risk of clinically serious @Disease$ in Japanese ACS patients."	0
"The patients comprised three groups: LDA-interrupted group (13 patients with 13 colorectal tumors), @Chemical$-continued group (28 patients with 31 colorectal tumors), and no anticoagulant/antiplatelet group (541 patients with 565 @Disease$)."	0
Epidural @Disease$ Following Interlaminar Epidural Injection in Patient Taking @Chemical$.	0
"BACKGROUND: Aspirin-exacerbated respiratory disease (AERD) is a clinical syndrome characterized by chronic rhinitis, nasal polyps, @Disease$, and precipitation of asthma and rhinitis attacks after ingestion of @Chemical$ (ASA) and most nonsteroidal anti-inflammatory drugs (NSAIDs)."	0
"@Chemical$-exacerbated respiratory disease is a clinical entity comprising chronic rhinosinusitis with @Disease$, asthma and intolerance to COX-1 inhibiting drugs."	0
"METHODS: This Management of @Chemical$-induced Gastro-Intestinal Complications (MAGIC) study was conducted with a prospective nationwide, multicenter, real-world registry of Japanese patients at high-risk of @Disease$ who were taking regular aspirin (75-325 mg) for 1 month or more."	0
"BACKGROUND: @Chemical$ is valuable for preventing vascular events, but information about @Disease$ frequency is necessary to inform risk-benefit decisions in individual patients."	0
Lys-@Chemical$ challenge induced clinical symptoms and influx of eosinophils and basophils only in @Disease$ group.	0
The high estimated @Disease$-free rate for @Chemical$ was maintained through to week 48 (98.3% vs.	0
"@Chemical$-exacerbated respiratory disease (AERD) is the most common phenotype characterized by an eosinophil-dominated inflammatory disease of the airways that presents clinically with nasal polyps, chronic sinusitis and @Disease$."	0
Low-dose @Chemical$ therapy is not a reason for repeating head computed tomographic scans in @Disease$: a prospective study.	0
"Main complications in the four treatment groups (no anticoagulant treatment, @Chemical$, LMWH, aspirin and LMWH) included @Disease$ of pregnancy (9.4%, 23.3%, 50%, 18.4%, respectively, p = 0.12) and preterm birth (16.7%, 34.3%, 75%, 36.8%, respectively, p &lt; 0.001)."	0
"Comparison of @Disease$ Patients Receiving Rivaroxaban, @Chemical$, or Aspirin for Thromboprophylaxis."	0
"We evaluated the differences in ACS type, total mortality, and the composite end point of death, myocardial infarction (MI), recurrent ischemia, or @Disease$ between prior aspirin and nonprior @Chemical$ users."	0
"Fifteen patients were off therapy; 10 (8%) patients stopped because of headache and/or @Disease$, whereas 4 patients were switched to other antiplatelet agents by their primary care physician as a matter of choice rather than @Chemical$-dipyridamole side effects."	0
"DATA SOURCES: Literature retrieval was accessed through MEDLINE (1966-March 2007) using the terms @Chemical$, aspirin, antiinflammatory agents nonsteroidal, @Disease$, angioedema, asthma, leukotriene antagonists, desensitization, and tacrolimus."	0
"CONCLUSIONS: We not only identified @Chemical$ to be one of the major risk factors in epistaxis, but also quantified its impact on the severity of nose @Disease$."	0
"The prevalence of AR in patients undergoing HD seems higher than in most of the studied populations, and this study has shown that the @Chemical$ statuses of a significant number of patients undergoing HD change after an @Disease$ session."	0
"Type 2 inflammation characterizes aspirin-exacerbated @Disease$.Objectives: To determine whether high-dose @Chemical$ therapy changes biomarkers of type 2 inflammation in aspirin-exacerbated respiratory disease.Methods: Forty-two subjects with aspirin-exacerbated respiratory disease underwent an aspirin desensitization and were placed on high-dose aspirin (1,300 mg daily)."	0
Altered metabolism of @Chemical$ in @Disease$ patients with aspirin hypersensitivity.	0
It is generally accepted that in @Chemical$-induced asthma (@Disease$) the bronchospasm is provoked by inhibition of prostaglandin synthesis with overproduction of cysteinyl leukotrienes.	0
Comparison of incident @Disease$ between low-dose plain @Chemical$ and enteric-coated aspirin.	0
"The estimated @Disease$ was similar between the two groups, @Chemical$ versus no aspirin (median 400 mL vs 400 mL, P = .661), as was the rate of blood transfusion anytime during the index admission (29% vs 26%, P = 0.37) and the postoperative duration of hospital stay (median 7 days vs 6 days, P = .103)."	0
"Letter by Feng et al regarding article, Ischemic stroke and @Disease$ with @Chemical$, dabigatran, and warfarin: impact of quality of anticoagulation control."	1
The pooled OR for @Disease$ in patients treated with @Chemical$ vs.	1
GI bleeding adverse effects related mainly to gastro-duodenal @Disease$ are more frequent in case of the regular use of @Chemical$.	0
"We sought to assess the performance of existing bleeding risk scores, such as the Hypertension, Abnormal Renal/Liver Function, @Disease$, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly (HAS-BLED) score or the Outpatient Bleeding Risk Index (OBRI), in patients with heart failure with reduced ejection fraction (HFrEF) in sinus rhythm (SR) treated with @Chemical$ or aspirin."	0
BACKGROUND: We investigated the effect of individualised proton pump inhibitors (PPI) prescription on @Disease$ events in a cohort of patients who received combination antiplatelet therapy (aspirin and @Chemical$) after percutaneous coronary intervention (PCI).	0
"METHODS: Thirty genome-wide expression microarrays were used to compare nasal polyp tissue from patients with chronic rhinosinusitis alone (CRS, n = 10) or chronic rhino@Disease$ and a history of @Chemical$-sensitive asthma (ASA, n = 10) to normal sinonasal mucosa from patients who underwent surgery for non-sinus related conditions (controls, n = 10)."	1
"Estimates of absolute rates of harm from @Chemical$ use, per 100,000 patient-years of follow-up, were 99-178 for non-trivial bleeds, 46-49 for major @Disease$, 68-117 for GI bleeds and 8-10 for haemorrhagic stroke."	0
"This is the first study to utilize a disease-specific, validated outcomes instrument in comparing Samter's triad patients with @Chemical$-tolerant patients who have nasal polyposis and tissue @Disease$."	0
"CONCLUSIONS: Erosive oesophagitis is common in patients with upper gastrointestinal bleeding taking low-dose @Chemical$ or antithrombotic agents, and could potentially be confused with the coexisting @Disease$."	1
"CONCLUSIONS: We found that the prevalence of CMBs did not increase in the group of aspirin use, and the presence of @Chemical$ was not associated with the duration of aspirin use in asymptomatic elderly subjects without a history of stroke or transient @Disease$ attack."	0
"At all events, it is a theme for gastroenterologists to establish a mean to prevent the @Disease$ induced by @Chemical$."	1
"Patients without AMCE-detected gastrointestinal erosions, ulceration or @Disease$ after drug-eluting stent implantation are enrolled and treated with open-label @Chemical$ (100 mg/d) plus clopidogrel (75 mg/d) for 6 months."	0
@Chemical$ induced asthma accompanied with @Disease$: a case report.	1
"RESULTS: In the first study, 6 of 8 patients and 3 of 8 controls, and in the second trial 6 of 6 patients and 1 of 6 healthy subjects, developed @Disease$ on @Chemical$ (P &lt; 0.005 patients vs. healthy subjects)."	0
"We describe the most common clinical presentations of aspirin hypersensitivity, i.e. aspirin-induced asthma, rhinosinusitis and @Chemical$-induced @Disease$."	1
"In contrast, @Disease$ was seen in 50% of rats with a combination of @Chemical$ given before IBU only after 6 days of oral administration."	1
"CONCLUSIONS: In patients who had ulcer complications related to the long-term use of low-dose @Chemical$, treatment with lansoprazole in addition to the eradication of H. pylori @Disease$ significantly reduced the rate of recurrence of ulcer complications."	0
"Both naproxen/@Chemical$ and celecoxib/aspirin groups demonstrated a higher incidence of gastric and duodenal @Disease$s vs. placebo/aspirin (8%; RR: 3.7, 95% CI: 1.8-7.6 and RR: 2.6, 95% CI: 1.2-5.8, respectively)."	1
Gastroprotective effects of sulforaphane and thymoquinone against @Chemical$-induced @Disease$ in rats.	1
"CONCLUSIONS AND CLINICAL IMPORTANCE: Administration of deracoxib to healthy dogs resulted in significantly lower gastric lesion scores, and fewer days of @Disease$ compared to aspirin, indicating that deracoxib is better tolerated than @Chemical$ in some dogs."	0
"BACKGROUND: @Chemical$ (LTs) are important in @Disease$, and LT modifiers modulate antigen-induced asthma."	0
"In addition, a combination of LDA and NSAIDs or LDA and @Chemical$ contributed more profoundly to the @Disease$ (OR 3.59 and 95 % CI 1.19-10.81 for LDA/NSAIDs; OR 6.70 and 95 % CI 1.83-24.50 for LDA/APs)."	1
Our results suggest that this strategy is not beneficial as compared to @Chemical$ alone in terms of ischaemic or @Disease$ events.	0
UNLABELLED: @Chemical$ reduces @Disease$ after coronary artery bypass grafting.	0
"The lowest stroke/SE rates and major bleed rates were observed in @Chemical$ time in therapeutic range (TTR) &gt;=55% episodes (@Disease$/SE: 0.87 [0.71 to 1.04]; major bleed: 4.91 [4.53 to 5.28] per 100 person-years), which was similar to the bleed rate in aspirin episodes (4.95 [4.58 to 5.32] per 100 person-years)."	0
"We investigated the risks of ischemic @Disease$ and intracranial hemorrhage (ICH) in relation to @Chemical$ at various TTRs in a real-world cohort of Chinese patients with atrial fibrillation receiving warfarin and compared with those on dabigatran, aspirin, and no therapy."	0
CONCLUSION: The prevalence of respiratory symptoms triggered by @Chemical$/NSAID use was found to be 10-11% in patients with @Disease$ and 2.5% in non-asthmatics.	0
"RESULTS: The adjusted OR for @Disease$ associated with @Chemical$ use versus non-use was 1.45 [95% confidence interval (CI), 0.87-2.42; p = 0.152]."	1
The best therapeutic approach for reducing @Disease$ toxicity in low-dose @Chemical$ users is still ill-defined as only a few studies have focused on this problem.	0
"BACKGROUND AND PURPOSE: Little is known about the impact of quality of anticoagulation control, as reflected by time in therapeutic range (TTR), on the effectiveness and safety of @Chemical$ therapy in Chinese patients with @Disease$."	0
"Anticoagulant use increased significantly in the 393 men and women (mean ages 72.5 and 79.0 years, respectively) who developed @Disease$ over the observation period: aspirin use increased from 14% to 39% in men and from 19% to 33% in women, and @Chemical$ use increased from 10% to 39% in men and from 17% to 38% in women."	0
"The association between aspirin use and the presence of DR or VTDR was assessed using multivariable logistic regression models including age, gender, ethnicity, socioeconomic status, HbA1c, systolic blood pressure, anti-@Disease$ medicine, total cholesterol, anti-@Chemical$ medicine, BMI, current smoking status, diabetes duration, history of cardiovascular disease (CVD) and chronic kidney disease (CKD.)."	0
"RESULTS: Ten studies involving 171,729 individuals examining the association between @Chemical$ use and risk of @Disease$ were included."	0
"ASA-@Chemical$ did not influence the cyclooxygenase-induced platelet aggregation significantly, but the inflammatory @Disease$ was reduced as effectively as in the case of equimolar ASA doses."	0
"@Chemical$-Exacerbated Diseases: Advances in Asthma with @Disease$, Angioedema, and Anaphylaxis."	1
Combined clopidogrel-@Chemical$ treatment for high risk @Disease$ or minor stroke does not increase cerebral microbleeds.	0
Airway responsiveness to inhaled @Chemical$ is influenced by airway hyperresponsiveness in @Disease$tic patients.	0
We aimed to investigate whether post-ESD gastric @Disease$ is increased in patients who take @Chemical$.	0
"The acute clinical symptoms that develop following the oral ingestion of aspirin, or any other inhibitor of cyclooxygenase-1, are well established in @Chemical$-exacerbated respiratory disease: nasal congestion, rhinorrhea, and @Disease$."	0
"Based on a convincing clinical history or positive responses in challenges with the drug(s), @Disease$ to one or several drug(s) was diagnosed in 49.4% of the children (60, 76.5 and 23.2% of the children reporting reactions to ASA, ibuprofen and @Chemical$ respectively)."	0
@Chemical$-exacerbated respiratory disease (@Disease$) is a syndrome of severe asthma and rhinosinusitis with nasal polyposis with exacerbations of baseline eosinophil-driven and mast cell-driven inflammation after nonsteroidal antiinflammatory drug ingestion.	0
"The genetic analysis of @Chemical$-induced @Disease$/angioedema is limited, however."	1
INTRODUCTION: The Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) study showed that patients with @Disease$ (UAP) and non-ST-elevation myocardial infarction (NSTEMI) benefit from combined therapy with acetylsalicylic acid (@Chemical$) and clopidogrel.	0
Rationale: Daily high-dose @Chemical$ therapy benefits many patients with aspirin-exacerbated @Disease$ but provides no benefit for aspirin-tolerant patients with asthma.	0
LTMDs alone or in combination with other controllers blocked lower respiratory tract reactions during aspirin challenge in some patients with @Disease$ but did not change the overall rate of positive @Chemical$ challenge results and did not lead to false-negative challenges.	0
"After multivariate adjustment for age, sex, current smoking, history of hypertension and diabetes, and @Chemical$ dose (aspirin-treated patients only), the hazard ratio for @Disease$ in patients with an arterial versus a cardiac source was 0.74 (95% confidence interval, 0.30 to 1.82) for aspirin-treated patients and 4.34 (95% confidence interval, 0.35 to 54) for placebo-randomized patients."	0
"Three major clinical phenotypes of NSAID-induced acute skin reactions manifesting with angioedema, @Disease$, or both have been distinguished: NSAID-exacerbated cutaneous disease, nonsteroidal anti-inflammatory drug-induced urticaria/angioedema (@Chemical$), and single NSAID-induced urticaria and angioedema."	0
"CONCLUSIONS: @Disease$ with aspirin sensitivity is characterized by the @Chemical$ alterations, which are similar to those present in aspirin-induced asthma."	0
"MAIN OUTCOMES AND MEASURES: Days of NSAID or @Chemical$ use and nonuse, clinically relevant bleeding event and major @Disease$ event rates by patient-years, and hazard ratios."	0
The effects of proton pump inhibition on patient-reported severity of @Disease$ when receiving dual anti-platelet therapy with @Chemical$ and low-dose aspirin: analysis from the Clopidogrel and the Optimization of Gastrointestinal Events Trial.	0
"The risk of gastroduodenal @Disease$ is particularly high among 'at-risk' low-dose @Chemical$ patients (aged &gt;70 years, previous ulcer or upper gastrointestinal bleeding and users of antiplatelets or NSAIDs)."	0
Characterization of @Chemical$ allergies in patients with @Disease$.	0
"The commonest causes of @Chemical$ resistance are production of arachidonic acid metabolites via the lipoxygenase pathway, poor compliance with the treatment, polymorphism of the genes encoding for cyclooxygenase and glycoprotein (GP) IIb/IIIa, @Disease$."	0
"At 26 wk, the cumulative proportion of patients with erosive @Disease$ was significantly lower for @Chemical$ versus placebo (4.4% and 18.3%, respectively; P &lt; 0.0001)."	0
"Constitutively-expressed cyclooxygenase (COX-1) inhibition is likely to be responsible for the cross-reactions and side effects associated with these drugs, as well as the anaphylactoid reactions sometimes seen in @Chemical$-sensitive @Disease$."	0
"METHODS: Ninety-four aspirin-induced urticaria patients presenting @Disease$/angioedema-induced by both @Chemical$ and NSAID (50 had underlying chronic urticaria) and showing positive responses on oral aspirin challenge test, 76 aspirin-intolerant asthmatics with positive responses on lysine-aspirin bronchoprovocation test, and 185 normal healthy controls were enrolled."	1
"When conducted in accordance with current guidelines, aspirin desensitization is a safe procedure that allows patients with @Disease$ who have an indication for @Chemical$ or other NSAIDs to safely ingest these medications."	0
Rapid aspirin challenge/desensitization in the @Chemical$ allergic patient has been consistently shown to be both safe and successful in patients with @Disease$s.	0
CONCLUSION: AC and/or AP therapy with @Chemical$ appears to increase the risk for @Disease$ following S-ICD implantation.	1
"@Chemical$ was more frequently associated with CAS and @Disease$ symptoms, as well as severe and multivessel spasm, suggesting the patients who have received LDA would require more intensive medical therapies and close follow up."	1
@Chemical$-Exacerbated Respiratory Disease as an Endotype of @Disease$.	0
CONCLUSION: This study indicates that 7.5 mg of meloxicam is a safe alternative treatment for ASA-hypersensitive @Disease$ and/or NP patients with proven hypersensitivity via oral @Chemical$ challenges.	0
RESULTS: The rare C allele frequency of TBXA2R+795T&gt;C was significantly higher in @Disease$ than in ATA (P=0.03) and the TBXA2R+795T&gt;C polymorphism was also associated with extent of percent fall in forced expiratory volume in 1 s (FEV1) after the inhalation of lysine-@Chemical$ in AIA patients (P=0.009); AIA patients homozygous for the +795 C allele had a greater percent fall of FEV1 compared with individuals with TBXA2R+795 CT or TT genotypes.	0
The aim of this work was to determine the presence of galectin-10 in nasal lavage fluid (NLF) of patients with aspirin-sensitive respiratory disease (@Disease$) before and after challenge with L-ASA (@Chemical$) by ELISA.	0
"Recently, vitamin C releasing aspirin (@Chemical$-VitC) has been shown to reduce gastric toxicity of ASA in animal model of @Disease$."	0
BACKGROUND: Aspirin causes bronchospasm in patients with @Chemical$ exacerbated respiratory disease (@Disease$).	0
Acetylsalicylic acid (@Chemical$) or aspirin and nonsteroidal anti-inflammatory drug (NSAID) sensitivities encompass a diverse group of both pharmacological and @Disease$ reactions.	0
CONCLUSIONS: Co-treatment of ARB reduces peptic @Disease$ and bleeding among patients taking low dose @Chemical$.	0
BACKGROUND: This multicenter retrospective study investigated the management and outcome of patients with peptic @Disease$/erosion-related aspirin and @@Chemical$hemical$ (A + C) cotherapy.	0
Spontaneous @Disease$ in a patient on @Chemical$.	1
"BACKGROUND: Aspirin-exacerbated respiratory disease (AERD) is a clinical syndrome characterized by chronic rhinitis, nasal polyps, @Disease$, and precipitation of asthma and rhinitis attacks after ingestion of aspirin (@Chemical$) and most nonsteroidal anti-inflammatory drugs (NSAIDs)."	0
"CONCLUSIONS: In this cohort of patients with aspirin intolerance undergoing coronary stent implantation, the combination of a thienopyridine with indobufen, @Chemical$, or triflusal was associated with a low rate of @Disease$, ST and MI."	0
"TAPT and @Chemical$ were associated with similar rates of death, non-fatal MI, @Disease$ and ST, but compared with DAPT, TAPT had lower rates of target lesion revascularization (TLR) (RR 0.67, 95 % CI 0.56-0.82, P &lt; 0.0001) and target vessel revascularization (TVR) (RR 0.65, 95 % CI 0.55-0.77, P &lt; 0.00001), as well as less late loss of minimal lumen diameter (mean difference -0.14, 95 % CI -0.17--0.11, P &lt; 0.00001), and less binary angiographic restenosis (RR 0.54, 95 % CI 0.45-0.65, P &lt; 0.00001)."	1
BACKGROUND: The role of gastric acid suppression in preventing the recurrence of ulcer complications after the eradication of Helicobacter pylori @Disease$ in patients taking long-term low-dose @Chemical$ is uncertain.	0
"Spirometry, skin-prick test and asthma control test were documented and intracellular cytokine expression in T lymphocytes and plasma @Chemical$ levels were measured in 23 @Disease$ patients, 17 aspirin-tolerant asthmatic (ATA) patients, and 16 healthy controls."	0
"Since acetaminophen is a weak inhibitor of the COX-1 enzyme, patients with @Chemical$-induced @Disease$ should not take more than 1000 mg of acetaminophen in a single dose."	1
A study was undertaken to investigate the effects of @Chemical$ on the systemic production of prostaglandin E2 and cysteinyl leucotrienes in patients with @Disease$.	0
OBJECTIVES: We aimed to identify proteins that were differentially expressed in between AIA and @Chemical$-tolerant @Disease$ (ATA) plasma.	0
@Disease$ events within 30 days after initiation of @Chemical$ were recorded.	0
"@Chemical$ use was not significantly associated with increased risk of @Disease$ complication except for use of 325 mg of aspirin within 3 days of biopsy (any complication OR 3.87 [1.12, 13.4], P = .032; major complication OR 6.30 [1.27, 31.3], P = .024)."	0
Interaction between @Chemical$ and angiotensin-converting enzyme inhibitors: should they be used together in older adults with @Disease$?	0
Diagnostic Accuracy of Urinary LTE4 Measurement to Predict @Chemical$-Exacerbated @Disease$ in Patients with Asthma.	0
"BACKGROUND: Aspirin-exacerbated respiratory disease (AERD) is a clinical triad consisting of aspirin/@Chemical$ (ASA) sensitivity, bronchial asthma, and @Disease$."	0
"Although the first @Disease$ reaction was described soon after @Chemical$ had been marketed, only recently a phenomenon of cysteinyl leukotriene overproduction brought new insights on a balance between pro- and anti-inflammatory mediators derived from arachidonic acid."	1
Spontaneous spinal epidural @Disease$: an urgent complication of adding @Chemical$ to aspirin therapy.	1
@Chemical$ use in patients with significant (12.5%) or severe @Disease$ (20%) was not different from the controls (P&gt;0.05) and none of them had NSAIDs prior to sphincterotomy.	0
"The SCF/beta-actin mRNA ratios were significantly higher in ASA-hypersensitive (AH) asthmatics (median 0.97, range: 0.8-1.5) when compared with @Chemical$-tolerant (@Disease$) patients (median 0.5, range: 0.1-0.7; P &lt; 0.001)."	0
CONCLUSION: This study indicates that 7.5 mg of meloxicam is a safe alternative treatment for @Chemical$-hypersensitive asthma and/or NP patients with proven @Disease$ via oral ASA challenges.	0
@Chemical$ and metoprolol in @Disease$.	0
BACKGROUND: @Chemical$ and nonsteroidal anti-inflammatory drugs (NSAIDs) are anti-inflammatory but have been linked in some studies to Crohn disease (CD) and @Disease$ (UC).	1
"CONCLUSION: In this preliminary study of 15 patients, low-dose aspirin did not lead to increased @Chemical$ synthesis or alter inflammatory markers in patients with mild-to-moderate persistent @Disease$."	0
"BACKGROUND: In patients with ischemic @Disease$ of non-cardioembolic origin, acetylsalicylic acid, @Chemical$, or a combination of acetylsalicylic acid and dipyridamole are recommended for the prevention of a recurrent stroke."	0
Mechanisms of @Chemical$-intolerant @Disease$: identifying inflammatory pathways in the pathogenesis of asthma.	1
Low-dose @Chemical$ (&lt; 330 mg/d) is recommended for the prevention of myocardial infarction or @Disease$.	0
"CONCLUSION: Most postoperative bleeds were inconvenient but not life threatening, unlike the potential risk of @Disease$ after stopping warfarin or @Chemical$."	1
"ASA fitness grade, cardiovascular disease, previous history of angina pectoris, angioplasty, @Disease$, use of @Chemical$ antagonists, cirrhosis and type of hepatectomy were significantly different between the groups."	0
"UNLABELLED: Aspirin (ASA) and several other nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit cyclo-oxygenase (COX) enzyme both isoforms 1 and 2, and can precipitate @Disease$tic attacks in @Chemical$-induced asthmatics."	0
"RESULTS: Rofecoxib, 25 mg, was proven to be well tolerated in all 40 patients with @Chemical$-induced and NSAID-induced @Disease$."	1
[The study of 18 cases of aspirin urticaria at dermatology of Yodogawa Christian Hospital--on the difference between @Chemical$ @Disease$ and aspirin urticaria].	0
BACKGROUND: The traditional recommendation has been to stop @Chemical$ seven to 10 days prior to coronary artery bypass surgery to reduce the potential risk of @Disease$.	0
The relative risk of major @Disease$ with low-dose @Chemical$ in a meta-analysis of placebo-controlled trials of vascular protection was 2.07 (95% CI: 1.61-2.66).	1
[The study of 18 cases of aspirin @Disease$ at dermatology of Yodogawa Christian Hospital--on the difference between aspirin asthma and @Chemical$ urticaria].	0
Safety of meloxicam in patients with @Chemical$/non-steroidal anti-inflammatory drug-induced @Disease$ and angioedema.	0
"RESULTS: Compared with NM from control subjects, PGE(2) concentrations were significantly lower in IL-1beta-stimulated fibroblasts from patients with NPs who were tolerant to @Chemical$ and even lower in polyps from patients with @Disease$."	0
"METHODS: EBC from 115 adult @Disease$tic subjects (62 with @Chemical$ intolerance) and 38 healthy control subjects were assessed quantitatively for 19 eicosanoids by using complementary HPLC, gas chromatography-mass spectrometry, or both."	0
CONCLUSIONS: Failure to increase sensory thresholds during treatment with @Chemical$ is associated with the development of @Disease$.	1
@Chemical$ allergy in a patient with @Disease$ represents one of the more urgent challenges an allergist may face.	1
BACKGROUND: @Chemical$ hypersensitivity is not a rare condition among patients with @Disease$.	0
"In our investigation of such adverse effects, we obtained 4 important findings considered useful for physicians, as follows; 1) even when aspirin was given at a dose, the incidence rate of gastrointestinal lesions was higher than with other non-steroidal anti-inflammatory drugs (NSAIDs), 2) the odds ratios for gastrointestinal lesions induced by aspirin with a histamine H2 receptor antagonist and proton pump inhibitor were 0.6 and 0.4, respectively, as compared with @Chemical$ alone, 3) it is difficult to administer aspirin, which exerts an antiplatelet effect, without inducing gastrointestinal lesions, and 4) these @Disease$ appears early, especially within 2 years after administration."	0
"SUMMARY: In summary, with rare exceptions, patients with a history of 'aspirin/NSAID @Disease$' who need @Chemical$ for cardiovascular issues will be able to safely take aspirin either after a graded challenge or desensitization providing a central role of the allergist in the management of these patients."	0
"We determined the number and area of @Disease$, gastric blood flow (GBF), plasma concentration of proinflammatory cytokines IL-1beta and TNFalpha, expression of superoxide dismutase (SOD) and glutathione peroxidase (GPx), @Chemical$ generation, and the malondialdehyde (MDA) concentration as an index of lipid peroxidation."	0
"ASA-Tris did not influence the cyclooxygenase-induced platelet aggregation significantly, but the inflammatory @Disease$ was reduced as effectively as in the case of equimolar @Chemical$ doses."	0
"RESULTS: In addition to a recent history of @Disease$, all patients had at least 1 other risk factor and 112 (45.3%) had 3 or more risk factors; 78.9% were taking low-dose aspirin and the remainder non-@Chemical$ NSAIDs."	0
"CONCLUSIONS: In patients with osteoarthritis taking low-dose aspirin, the use of celecoxib or @Chemical$ plus lansoprazole resulted in similar rates of gastroduodenal @Disease$ation."	0
"CONCLUSIONS: In DES-treated patients on prolonged @Chemical$, major @Disease$ occurring at 1 year and up to 4 years following DES implantation in patients on prolonged DAPT is associated with poor long-term prognosis."	1
"SUBJECTS AND METHODS: Six polymorphisms of FCER1 (FCERIA-344C&gt;T, FCER1A-95T&gt;C, MS4A2-109T&gt;C, MS4A2 E237G, FCER1G-237A&gt;G, FCER1G-54G&gt;T) were genotyped in 126 @Disease$ patients compared to 177 patients with @Chemical$-tolerant asthma (ATA) and 222 normal health controls (NC)."	0
"A multicenter, randomized, double-blind, placebo-controlled trial of high-dose rebamipide treatment for low-dose @Chemical$-induced moderate-to-severe @Disease$."	0
"Bleeding complications associated with combinations of @Chemical$, thienopyridine derivatives, and warfarin in elderly patients following acute @Disease$."	0
"By Cox modeling, @Chemical$ use was associated with a 7-fold lower risk of @Disease$ (p = 0.02)."	0
"However, a history of previous UGI bleeding is a major risk factor for @Chemical$-associated @Disease$."	1
"Fifty-six percent of them managed @Chemical$ @Disease$ changing the therapeutic regimen (eg, clopidogrel monotherapy and indobufen)."	1
"Numerous vascular risk factors including white matter hyperintensity (WMH), duration of aspirin treatment, age, @Disease$ or diabetes mellitus were investigated for a possible association with the presence of @Chemical$ in the two groups."	0
Risk and preventive factors of low-dose @Chemical$-induced @Disease$: a comprehensive review.	1
"In this study, use of @Chemical$ or acetaminophen (but not aspirin) 2 or more days per week was associated with an increased risk of @Disease$ in women."	0
"BACKGROUND AND AIMS: @Chemical$-releasing aspirin (NO-ASA) has been shown to inhibit cyclo-oxygenase and prostaglandin generation without causing mucosal damage, but the role of reactive oxygen species (ROS) and cytokines in the action of ASA and NO-ASA against acute @Disease$ has been little studied."	0
These findings suggest that exercise and @Chemical$ facilitate allergen absorption from the @Disease$.	0
"CONCLUSIONS: In females, @Chemical$ increased the risk of @Disease$, suggesting that LDA may contribute to the pathogenesis of colonic ulceration or colitis."	1
"In trials achieving good control of anticoagulation [time in therapeutic range (TTR) &gt;65%], the risk of @Disease$ with VKA was similar to that of @Chemical$ [OR 1.16 (95% CI 0.79-1.71)]."	0
"The big idea: the coxib crisis iron, @Chemical$ and @Disease$ risk revisited."	0
@Chemical$ sensitivity and @Disease$.	0
"To clarify this issue, we conducted a systematic review of the literature concerning @Disease$, @Chemical$ and NSAIDs."	0
"CONCLUSIONS: The relative risk of UGIB in patients taking low-dose @Chemical$ is higher when used for primary than for secondary @Disease$ prevention, but this difference is more than compensated by the lower baseline risk in the primary prevention population."	0
"CONCLUSIONS: Omalizumab treatment inhibited urinary @Chemical$ E4 overproduction and upper/lower respiratory tract symptoms during oral aspirin challenge, resulting in aspirin tolerance in 62.5% of aspirin-exacerbated @Disease$ patients."	0
So we suspect that the pathogenic mechanism for aspirin urticaria differs from that for @Chemical$ @Disease$.	1
"Treatment of @Disease$ consisted of washing of the nasal cavities, @Chemical$ spray, and oral steroid administration."	0
"Although some @Disease$ were caused by Zollinger-Ellison syndrome (ZES), an atypical clinical course in other patients, especially with those with multiple ulcers, suggested abuse of @Chemical$."	1
"However, there is cross-reactivity between the NSAIDs in patients with NSAID-exacerbated @Disease$ and NIUA, and thus only use of selective COX-2 inhibitors can replace the culprit drug if the chronic treatment is necessary, although aspirin desensitization will allow for chronic treatment with NSAIDs in some patients with @Chemical$."	0
Essentials @Disease$ (ICB) are serious clinical events that have been associated with @Chemical$ use.	1
Five and half years male child with one day history of pain abdomen and vomiting who was on @Chemical$ for suspected rheumatoid arthritis presented initially with @Disease$.	1
CONCLUSIONS: The elevated numbers of nasal inflammatory leukocytes expressing the CysLT1 receptor in @Chemical$-sensitive patients with chronic @Disease$ as compared with their non-aspirin-sensitive counterparts and the down-regulation of receptor expression after desensitization to aspirin are probably fundamental in the pathogenesis of aspirin sensitivity and in the mechanism of aspirin desensitization.	0
"In addition, a combination of LDA and NSAIDs or LDA and APs contributed more profoundly to the @Disease$ (OR 3.59 and 95 % CI 1.19-10.81 for @Chemical$/NSAIDs; OR 6.70 and 95 % CI 1.83-24.50 for LDA/APs)."	0
@Chemical$ for Primary Prevention of @Disease$ in Adults 80-Years-of-Age and Older.	0
"To evaluate the extent of gastric mucosal injury and the protective effect of drugs, @Disease$ index, gastric mucosal blood flow, content of gastric mucosal hexosamine, @Chemical$ (PG), nitric oxide(NO), tumor necrosis factor (TNF), and interleukin (IL) -1, 2, 8 were measured in each group, and histological changes were observed by gross as well as under microscope and electron microscope."	0
"CONCLUSIONS: There were significant differences in the expression of COX and LO enzymes between patients with nasal @Disease$ and controls, irrespective of @Chemical$ sensitivity."	0
BACKGROUND: We have aimed to determine the sensitivity and specificity of a simpler technique with less risk than oral provocation to diagnose @Chemical$-induced @Disease$ (AIA).	1
"We retrospectively reviewed the medical records for bleeding complications in 182 patients, most with @Disease$ (mean age 61 +/- 11 years, 82% men) and being treated with high-dose fish oil (mean dose 3 +/- 1.25 g), aspirin (mean dose 161 +/- 115 mg), and clopidogrel (mean dose 75 mg), and in 182 age- and gender-matched controls treated with @Chemical$ and clopidogrel alone."	0
"Laboratory finding revealed a @Disease$, as the number of @Chemical$ and other marker related to platelet activation were increased: ADP 1 mcM lack 2 masculine wave, ADP 2 mcM lack 2 masculine wave, Adrenalina 5 mcM lack 2 masculine wave, Adrenalina 10 mcM lack 2 masculine wave."	0
"RESULTS: Altogether, 310 subjects were assessed; 217 had histories of urticaria/@Disease$, 50 of anaphylaxis, 26 of nonimmediate cutaneous eruptions, and 17 of bronchospasm related to @Chemical$/nonsteroidal anti-inflammatory drugs (NSAID) intake."	0
"RESULTS: The prevalence of EE in patients taking aspirin (9.4%) was not different from that of the controls (6.3%, odds ratio [OR]: 1.5, 95% confidence interval [CI]: 0.7-3.2), whereas peptic @Disease$ were found more frequently in the @Chemical$ group (14%) than in the control group (4%, OR: 3.6, 95% CI: 1.5-8.8)."	0
"However, in some patients, such treatment is associated with @Disease$ (GI) adverse effects, e.g. dyspeptic symptoms, peptic ulceration, and GI bleeding, that may interfere with adequate adherence to, and continuation of, low-dose @Chemical$ for CV protection."	0
"The most common adverse events were @Disease$ (ten [20%] in the @Chemical$ group vs 13 [25%] in the placebo group), nausea or vomiting (nine [18%] vs seven [13%]), and diarrhoea (11 [22%] vs six [12%])."	0
The incidences of the combined outcome of recurrent VTE and major @Disease$ were 2.8% and 3.4% lower in the rivaroxaban 20-mg and 10-mg groups than in the @Chemical$ group.	0
"Many patients with @Disease$ showed no subjective symptom, and patients receiving @Chemical$ were strongly recommended to undergo regular transnasal endoscopy, regardless of the presence or absence of symptoms."	0
"In a review of the literature describes the risks and benefits of surgical interventions, in particular, coronary artery bypass grafting in patients with @Disease$ receiving antiplatelet therapy with no cancellation or late withdrawal of @Chemical$ (ASA)."	0
"There were significantly more patients who suffered GI adverse events, principally abdominal pain, dyspepsia, nausea and @Disease$, with aspirin (18.5%) than with ibuprofen (11.5%), but the difference between ibuprofen and @Chemical$ (13.1%) was not significant."	0
"OBJECTIVES: To study the safety of @Chemical$, a specific cyclooxygenase-2 inhibitor, and to determine whether it cross-reacts with @Disease$ in patients with aspirin-exacerbated respiratory disease (AERD)."	0
@Disease$ with low-dose @Chemical$ and its prevention by rabeprazole.	1
"In the subanalysis of 25 aspirin-takers without severe gastropathy, gastric mucus secretion was increased and the acid/mucus ratio was decreased compared with controls, but there was no such association in the remaining 17 @Chemical$-takers with severe @Disease$."	0
Incidence of @Disease$ was higher in placebo group than in @Chemical$ group (40.0 vs.	0
"Dose-related increases in heart and @Disease$, and impaired cardiac functions, were found more exacerbated in the @Chemical$-treated MI rat hearts than the saline-treated MI counterparts."	0
The results indicate that @Chemical$ treatment of mice injured their @Disease$ and facilitated invasion by both CL14 and G strains of T. cruzi.	1
Reoperation due to postoperative @Disease$ was recorded in 2 cases in the @Chemical$ group as well as 2 lethal cases.	0
"PA32540, a combination pill with aspirin and @Chemical$, is a newly emerging intervention that has the potential to reinforce patient compliance with the aspirin regimen due to fewer @Disease$ effects."	0
"METHODS: In 19 patients with a history of aspirin-induced @Disease$, placebo-controlled bronchial challenges with lysine-@Chemical$ were performed."	0
This study evaluated the risk of ischemic stroke (IS) and TIA after low-dose @Chemical$ discontinuation in patients with cardiovascular disease or @Disease$.	0
CONCLUSION: @Chemical$ and the combination of acetylsalicylic acid and dipyridamole were associated with similar risks for recurrent ischemic stroke and bleeding; whereas acetylsalicylic acid was associated with higher risks for both ischemic @Disease$ and bleeding.	0
OBJECTIVE: This study aimed to assess sinonasal outcomes in patients with @Chemical$ exacerbated @Disease$ (AERD) undergoing aspirin desensitization following endoscopic sinus surgery (ESS).	0
METHODS: We obtained nasal-biopsy specimens from 22 aspirin-sensitive and 12 non-@Chemical$-sensitive patients with chronic @Disease$ and nasal polyps.	0
"To evaluate the preventive effect of lafutidine on @Disease$ caused by LDA alone and by the combination of both LDA and @Chemical$, we conducted a clinical study using healthy volunteers."	0
"@Chemical$ (acetylsalicylic acid)-induced @Disease$ (AIA) consists of the clinical triad of asthma, chronic rhinosinusitis with nasal polyps, and precipitation of asthma and rhinitis attacks in response to aspirin and other NSAIDs."	1
"RESULTS: The mean numbers of reddened lesions in the LDA group and non-@Chemical$ NSAID group were 2.49 +- 3.15 and 1.65 +- 3.04; the mean numbers of erosions/@Disease$ 1.56 +- 3.75 and 6.08 +- 10.4, and the mean CE scores 154 +- 294 and 520 +- 758, respectively."	0
"Since both are now easily measured by specialty labs, it would be reasonable to monitor these during @Disease$ treatment generally, and particularly when using @Chemical$, COX inhibitors, or any other drug with potential to increase these growth factors."	0
Predictors of high on-@Chemical$ platelet reactivity in elderly patients with @Disease$.	0
"According to APS standard of care, patients were treated with aspirin and/or low-molecular weight @Chemical$ (LMWH) at prophylactic (pure obstetric APS) or therapeutic doses (history of @Disease$)."	0
Does rebamipide prevent @Disease$ in patients taking @Chemical$ and clopidogrel?	1
AIM: To determine the rate of endoscopic gastric/duodenal @Disease$s (GDUs) associated with use of @Chemical$ (81 mg q.d.) alone or coadministered with celecoxib or naproxen.	0
"BACKGROUND: @Chemical$-exacerbated @Disease$ (AERD) is a distinct eosinophilic phenotype of severe asthma with accompanying chronic rhinosinusitis, nasal polyposis, and hypersensitivity to aspirin."	1
"In the eight studies that reported an overall risk, the risk of @Disease$ in offspring of women who were exposed to @Chemical$ was not significantly higher than that in control subjects (odds ratio, 1.33; 95% CI, 0.94-1.89)."	1
"Although the incremental cost-effectiveness of @Chemical$ in individuals with aspirin @Disease$ is marginal, if available, ambulatory desensitization remains a less-expensive option for secondary cardiovascular prophylaxis."	0
@Disease$ formation with low-dose enteric-coated @Chemical$ and the effect of COX-2 selective inhibition: a double-blind trial.	0
Protective role of hydrogen-rich @Chemical$ on aspirin-induced @Disease$ in rats.	0
BACKGROUND: @Chemical$ has a beneficial role in prevention of cardiovascular and @Disease$ events.	0
"Some studies have demonstrated that consumption of fish oil concentrate, @Chemical$ (n-3 PUFA), results in @Disease$ that include reductions in mortality, sudden death, nonfatal myocardial infarction, and thrombotic stoke, as well as improvement in graft patency."	1
"Before, after 120, and 240 min of DDAVP administration the following parameters were measured: platelet aggregation (PA) and ATP release induced by @Chemical$, collagen, ristocetin and thrombin; PFA-100 closure times (CT), factor VIII activity (FVIII:C), @Disease$ factor antigen (VWF:Ag), collagen binding activity (VWF:CB) and blood count."	0
METHODS: We retrospectively reviewed the findings in chronic low-dose @Chemical$ users (&gt;3 months) who underwent capsule endoscopy for the investigation of @Disease$.	0
"Conventionally, hypersensitivities include @Chemical$-exacerbated respiratory disease (AERD), ASA-induced urticaria, and @Disease$."	0
Sinonasal outcomes after endoscopic sinus surgery in @Disease$tic patients with nasal polyps: a difference between aspirin-tolerant and @Chemical$-induced asthma?	0
INTRODUCTION: The role of Helicobacter pylori infection on the risk of low-dose aspirin-related @Disease$ and on the efficacy of the prevention therapy in elderly chronic users of low-dose @Chemical$ is still controversial.	0
"BACKGROUND: It is debated whether in patients with chronic heart failure (@Disease$), @Chemical$ may contrast the clinical benefits of angiotensin-converting enzyme inhibitors (ACEIs)."	0
"We report here two cases of @Disease$ as a result of abuse of @Chemical$, which to our knowledge has never been reported previously."	1
"Conversely, acetaminophen is well tolerated, has not been shown to contribute to @Disease$ when taken with aspirin, and has not been shown to interfere with the inhibition of platelet aggregation produced by @Chemical$."	0
Targeted @Chemical$ lipidomics of exhaled breath condensate provide a distinct pattern in the aspirin-intolerant @Disease$ phenotype.	0
INTRODUCTION: Helicobacter pylori (HP) infection and use of nonsteroidal anti-inflammatory drugs (NSAIDs)/@Chemical$ (ASA) are risk factors for bleeding peptic @Disease$.	0
[The study of 18 cases of @Chemical$ urticaria at dermatology of Yodogawa Christian Hospital--on the difference between aspirin asthma and aspirin @Disease$].	0
There is a general consensus on @Chemical$'s effectiveness in secondary prevention of @Disease$.	0
@Chemical$ intolerance and allergy to house dust mites: important factors associated with development of severe @Disease$.	1
Increased risk of minor @Disease$ and antiplatelet therapy cessation in patients with acute coronary syndromes and low on-@Chemical$ platelet reactivity.	0
"In a recent investigation, carriage of the IL-1beta-511 T allele was significantly associated with peptic @Disease$ among low-dose @Chemical$ users."	0
CONCLUSION: This study indicates that 7.5 mg of meloxicam is a safe alternative treatment for @Chemical$-@Disease$ asthma and/or NP patients with proven hypersensitivity via oral ASA challenges.	0
"Although others may disagree, it is my belief that any objective analysis of published material in the last 20 years must conclude that there is a close link between the devastating encephalopathy @Disease$ and ingestion of @Chemical$ during the febrile prodrome."	1
A variety of protocols exist for the rapid desensitization of patients with @Chemical$ @Disease$.	1
"To confirm the diagnosis of @Disease$, provocation testing via nasal, inhalation or the oral route of @Chemical$ remains the gold standard; in vitro diagnostic methods are still not available."	0
"Two drugs recently approved for health insurance reimbursement, @Chemical$, a cyclooxygenase (COX)-2 specific inhibitor and low-dose lansoprazole for prevention of recurrent peptic ulcer due to LDA/NSAIDs will be instrumental in mitigating the @Disease$."	0
"BACKGROUND: Anticoagulants and/or antiplatelet agents such as acetylsalicylic acid (@Chemical$) are important in prevention of cardiovascular (CV) events, but may be associated with @Disease$ (UGIB)."	1
This is a distinct clinical syndrome called @Chemical$-induced asthma (@Disease$).	0
"However, patients with low-risk ulcers and those who received coronary intervention were more likely to have @Chemical$ continued during @Disease$."	1
AERD was defined as @Disease$tics showing 15% or greater decreases in forced expiratory volume in one second (FEV(1)) or naso-ocular reactions by the oral @Chemical$ (ASA) challenge (OAC) test.	0
BACKGROUND: @Chemical$ and other nonsteroidal anti-inflammatory drugs (NSAIDs) can precipitate adverse reactions in two apparently different clinical conditions: bronchial asthma and chronic idiopathic @Disease$ (CIU).	0
One clinically relevant phenotype is that of @Chemical$-sensitive respiratory disease (ASRD) which is more frequently seen in patients with difficult @Disease$.	0
"@Disease$, immediate and accelerated reactions, atopy, older age and chronic/recurrent urticaria were risk factors for hypersensitivity and/or cross-reactivity between ASA, @Chemical$ and paracetamol."	0
"@Chemical$-induced asthma and aspirin-induced @Disease$, in a substantial part of the patients, are driven by a release of mediators from activated mast cells."	0
We conducted the present study to compare the risk of EE with that of @Disease$ among Japanese patients taking @Chemical$.	0
ASA usage was more common than NSAID in patients with ulcer @Disease$ (NSAID usage n=35 (40%); @Chemical$ usage n=51 (60%); p=0.035).	0
One clinically relevant phenotype is that of @Chemical$-sensitive respiratory disease (@Disease$) which is more frequently seen in patients with difficult asthma.	0
"The meta-analysis showed that PPIs were superior to H2RAs for prevention of @Chemical$-associated GI erosion/ulcer [odds ratio (OR=0.28, 95% confidence interval (CI): 0.16-0.50] and @Disease$ (OR=0.28, 95% CI: 0.14-0.59)."	0
"OBJECTIVE: The purpose of this study was to demonstrate that rofecoxib, a specific inhibitor of COX-2, does not cause asthmatic attacks in patients with @Chemical$ and/or other NSAID-induced @Disease$."	0
"In fact, patients with blood dyscrasias have to be considered high-risk patients due to their increased propensity for uncontrolled bleeding.The aim of this article was to present and discuss the management of a case of double consecutive retrobulbar @Disease$ in a high-risk patient in treatment with @Chemical$ and warfarin."	0
H. pylori @Disease$ combined with PG I at &gt;123 ng/mL had an OR (95% CI) of 15.8 (2.4 +- 104.5) for the prediction of @Chemical$-induced gastroduodenal injury.	0
"@Chemical$ intolerance, house dust mite (HDM) @Disease$, male sex, age older than 65 years, and duration of asthma exceeding 10 years were investigated as factors potentially related to the severity of asthma."	0
"SA has a cytoprotective action against NSAID-induced gastric lesions, and this action is not mediated by endogenous @Chemical$ but may be functionally associated with inhibition of the @Disease$ response."	0
"Both aspirin and clopidogrel were associated with @Disease$, but the association was more noteworthy for @Chemical$."	0
"Aspirin exacerbated @Disease$ (AERD) is an adult onset condition manifested as asthma, rhinosinusitis/nasal polyps, and sensitivity to @Chemical$ and other cyclooxygenase-1 (Cox-1)-inhibitor nonsteroidal anti-inflammatory drugs (NSAIDs)."	0
Withholding @Chemical$ for 1 week before endoscopic sphincterotomy did not seem to decrease the risk of post-@Disease$.	0
"Gastric blood loss and @Disease$ were evaluated at 3rd, 7th, and 11th days of @Chemical$ administration by endoscopy using Lanza score."	0
"QUESTION/PURPOSES: We sought to answer four questions: For the THA and TKA cohorts, respectively, (1) was the incidence of readmission resulting from @Disease$ and bleeding complications higher with @Chemical$ than mobile compression plus ASA; and (2) was the incidence of wound bleeding complications higher with LMWH than mechanical compression plus ASA?"	0
RESULTS: @Chemical$-induced duodenal erosions occurred independently of whether H. pylori @Disease$ was present or not.	0
"We enrolled 110 @Disease$ patients, 125 @Chemical$-tolerant asthma (ATA) patients, and 125 normal controls."	0
@Chemical$ and risk of @Disease$: a case-control study from Italy.	0
[@Chemical$ and @Disease$: the problem we confront with].	0
Physiologic and pharmacologic studies support the hypothesis that aspirin-exacerbated respiratory disease (@Disease$) involves fundamental dysregulation in the production of and end-organ responsiveness to both antiinflammatory eicosanoids (prostaglandin E2) and proinflammatory effectors (@Chemical$).	0
"Factors associated with an increased risk of @Chemical$-related upper GI complications are still being elucidated but most importantly include a prior history of @Disease$ or GI bleeding, aspirin dose, and concomitant use with an NSAID, anticoagulant, or additional antiplatelet drug."	0
"These associations were stronger after more than 10 years of use (acetaminophen: odds ratio (OR) = 1.8, 95% confidence interval (CI): 1.3, 2.6; @Chemical$: OR = 1.6, 95% CI: 1.1, 2.2) and were present for indications of headache, menstrual pain, and other @Disease$."	0
"Furthermore, there is growing evidence that long-term use of @Chemical$ decreases the risk of @Disease$, even at low doses."	0
"BACKGROUND: Many patients requiring permanent pacemaker (PPM) or implantable cardiac defibrillator (@Disease$) placement are anticoagulated with @Chemical$, aspirin (ASA), and clopidogrel for a number of thromboembolic risk indications."	0
"The pooled HR for an ICH in @Disease$ patients using @Chemical$ is 7.63 (95% CI, 0.72 to 81.00; P=0.09)."	0
"This possible deleterious effect was more predominant when NSAIDs or @Chemical$ were administered during the acute and subacute phases of @Disease$; however, it was still noted when NSAIDs were administered during the late phase of the disease (the effect of aspirin was not evaluated in late phase studies)."	0
BACKGROUND: We have previously demonstrated that aspirin triggers specific generation of 15-hydroxyeicosateraenoic acid (15-HETE) from nasal polyp epithelial cells and peripheral blood leukocytes (PBL) from aspirin-sensitive (AS) but not @Chemical$-tolerant (AT) patients with @Disease$.	0
"According to @Disease$ standard of care, patients were treated with aspirin and/or low-molecular weight @Chemical$ (LMWH) at prophylactic (pure obstetric APS) or therapeutic doses (history of thrombosis)."	0
OBJECTIVE: We sought to explore the role of platelets in the pathogenesis of @Disease$ in patients under stable conditions and during an @Chemical$ challenge test.	0
RESULTS: @Chemical$ significantly inhibited @Disease$ induced by LDA alone or by LDA plus clopidogrel when compared with placebo in healthy subjects.	0
"Although knowledge about endoscopic characteristics of @Chemical$ associated ulcers is limited, the ulcers have common distinctive feature that sudden gastrointestinal bleedings or latently advanced-@Disease$ are often the earliest symptom because aspirin-induced ulcers often exist without symptoms of dyspepsia."	0
"A case is reported of very late bare metal stents @Disease$ (33 months) in two different vessels after aspirin discontinuation because of a prostatectomy in patient treated simultaneously with bare metal stents and @Chemical$ eluting stents, found patent."	0
"Multivariate analyses revealed that @Chemical$ and NSAIDs, individually, were associated with the increase in the risk of @Disease$ (OR 1.80 and 95 % CI 1.18-2.75 for LDA; 1.35 and 1.01-1.80 for NSAIDs)."	1
Low-dose @Chemical$ affects the @Disease$: results of a pilot study with a multidimensional assessment.	0
"A short cut review was carried out to establish whether pre-injury @Chemical$ increases the risk of @Disease$ following head injury. 124 papers were found using the reported searches, of which three presented the best evidence to answer the clinical question."	0
"OBJECTIVES/HYPOTHESIS: To demonstrate that quality-of-life outcomes after endoscopic sinus surgery are not compromised in patients with Samter's triad (asthma, nasal polyps, aspirin sensitivity) when compared to patients with @Disease$ with nasal polyposis (eCRSwP) who are not @Chemical$ sensitive."	0
CONCLUSIONS: Use of tacrolimus as add-on pretreatment to prevent reactions to aspirin in patients with @Disease$ or to achieve the goal of silent @Chemical$ desensitization could not be accomplished.	0
RESULTS: @Chemical$ containing 5% and 10% ethanolic extract ointment have shown significant (P &lt; 0.01) wound healing activity against an aspirin (administered 150 mg/kg body weight orally for 9 days) @Disease$ wound healing process.	0
"We determined the number and area of @Disease$, gastric blood flow (GBF), plasma concentration of proinflammatory cytokines IL-1beta and TNFalpha, expression of superoxide dismutase (SOD) and glutathione peroxidase (GPx), ROS generation, and the @Chemical$ (MDA) concentration as an index of lipid peroxidation."	0
Short Communication: Evaluation of @Disease$ by aspirin-@Chemical$ combination therapy in patients with acute coronary syndrome.	0
[Low-dose @Chemical$ (LDA)/nonsteroidal anti-inflammatory drugs(NSAIDs)-induced @Disease$ in Japan].	1
"We report the case of a 60 year old woman, suffering for 8 years from @Chemical$-induced @Disease$, having an airway infection of RSV-respiratory syncytial virus."	1
"Type 2 inflammation characterizes aspirin-exacerbated @Disease$.Objectives: To determine whether high-dose aspirin therapy changes biomarkers of type 2 inflammation in aspirin-exacerbated respiratory disease.Methods: Forty-two subjects with @Chemical$-exacerbated respiratory disease underwent an aspirin desensitization and were placed on high-dose aspirin (1,300 mg daily)."	0
Patients with @Disease$ and a further risk factor for stroke (CHA2DS2-VASc &gt;0) should therefore either receive @Chemical$ or a novel oral agent.	0
[The study of 18 cases of @Chemical$ @Disease$ at dermatology of Yodogawa Christian Hospital--on the difference between aspirin asthma and aspirin urticaria].	1
"@Chemical$, nonsteroidal anti-inflammatory drug use, and risk for @Disease$ and ulcerative colitis: a cohort study."	0
"We compared 1- and 3-year outcomes for cerebrovascular accident (CVA), transient ischemic attack (TIA), gastrointestinal (GI) @Disease$, genitourinary (GU) bleeding, any bleeding, and AF recurrence among patients receiving: none, aspirin, or @Chemical$ as long-term therapies."	0
@Chemical$ alone administered to patients taking OAC after PCI was associated with a significantly lower rate of @Disease$ complications than clopidogrel plus aspirin.	0
"Aspirin-exacerbated respiratory disease (AERD) refers to the combination of asthma, @Disease$ with nasal polyposis, and acute upper and lower respiratory tract reactions to the ingestion of @Chemical$ (acetylsalicylic acid, ASA) and other cyclooxygenase-1 inhibiting non-steroidal anti-inflammatory drugs."	0
Most @Disease$ patients are also on @Chemical$.	0
High levels of @Chemical$ synthase activity are associated with @Disease$ tissue from aspirin-sensitive asthmatics.	0
"BACKGROUND AND AIMS: We investigated the incidence of @Disease$ in the esophagus, stomach and duodenum in patients on low-dose @Chemical$ (LDA) therapy."	0
"Safety of etoricoxib, a specific cyclooxygenase-2 inhibitor, in asthmatic patients with @Chemical$-exacerbated @Disease$."	0
"Long-term introduction of the complex at doses of 250 and 500 mg/kg was safe for gastric mucosa, while @Chemical$ at the dose of 50 mg/kg showed a strong @Disease$l damage."	1
"Based on the results of the MATCH trial, combination therapy with aspirin plus @Chemical$ is not recommended for patients with ischaemic stroke or @Disease$ due to the increased risk of haemorrhage."	0
"@Disease$ to @Chemical$ and other non steroidal anti-inflammatory drugs (NSAIDs) manifesting in the airways (rhinosinusitis, polyps, asthma) or in the skin (urticaria, angioedema) is the second most frequent untoward allergic reaction to drugs."	1
"Data Sources: We searched PubMed, Embase, CENTRAL, and ClinicalTrials.gov from inception to May 28, 2018, with the terms novel oral anticoagulants, non-vitamin K antagonist oral anticoagulants, direct oral anticoagulants, dabigatran, rivaroxaban, apixaban, edoxaban, warfarin, @Chemical$, vitamin K antagonist, aspirin, acetylsalicylic acid, or ASA, and major bleeding, fatal bleeding, or @Disease$."	0
OBJECTIVE: To evaluate frequency of ischemic and hemorrhagic events in patients treated with aspirin and @Chemical$ when associated with perioperative heparin bolus for @Disease$ treated with intracranial stents.	0
"Whatever will be, will be: spontaneous chest wall @Disease$ with regular use of low-dose @Chemical$."	0
"At the 5-year follow-up, cardiovascular events were found to have developed in 11 patients (8 stroke and 3 myocardial infarction) who exhibited @Chemical$ resistance (12.1%) and in 9 (4 stroke and 5 @Disease$) patients who did not exhibit aspirin resistance (2.4%) (P &lt; .001)."	0
"The presence of salicylates in the blood or urine of @Disease$ patients has not been demonstrated, and no animal model of Reye's syndrome has been developed where @Chemical$ causes the disease."	0
"METHODS: To characterize @Chemical$ users in terms of major gastrointestinal risk factors (i.e., advanced age, male sex, prior @Disease$ history and use of non-steroidal anti-inflammatory drugs), we used The General Practice Research Database in the United Kingdom and the Base de Datos para la Investigacion Farmacoepidemiologica en Atencion Primaria in Spain."	0
"In the presence of sufficient amounts of gastric acid, H. pylori infection and @Chemical$ could synergistically damage gastric mucosal integrity, while in the absence of sufficient amounts of gastric acid, the synergistic effect could be completely counteracted and the @Disease$ could even suppress the aspirin-induced gastropathy."	0
"We describe the most common clinical presentations of aspirin hypersensitivity, i.e. @Chemical$-induced @Disease$, rhinosinusitis and aspirin-induced urticaria."	1
@Chemical$ and nonsteroidal anti-inflammatory drug @Disease$.	0
"[Aspirin induced @Disease$, urinary leukotriene E4 and @Chemical$]."	0
BACKGROUND: Evidence about the risk of bleeding and @Disease$ because of @Chemical$ mono-therapy in total knee arthroplasty (TKA) is scant.	1
"CONCLUSIONS: Our findings do not support that there is no difference in the risk of GI complications between enteric-coated @Chemical$ and buffered LDA, but rather may imply that the risk of @Disease$ complications associated with enteric-coated LDA is higher than that with buffered LDA."	0
METHODS: Nasal polyps were obtained from 16 @Chemical$-tolerant patients with @Disease$/rhinitis (ATAR) and 18 aspirin-intolerant patients with asthma/rhinitis (AIAR) undergoing nasal polypectomy.	0
"METHODS: Preoperative computed tomography (CT), pre- and postoperative endoscopy, and two validated disease specific QOL instruments, the @Disease$ Index (RSDI) and Chronic Sinusitis Survey (@Chemical$), were collected."	0
"No difference was noted in the rate of symptomatic @Disease$s between either group (for @Chemical$: 2.6% for the LMWH group versus 1.9% for the mechanical compression group; p = 1; for TKA: 1.1% versus 0%, respectively; p = 0.22)."	0
"PURPOSE: Low-dose @Chemical$ (&lt;325 mg/day), administered to those with several conditions involving @Disease$, can cause upper gastrointestinal (GI) complications."	0
Pretreatment with melatonin or @Chemical$ remarkably reduced ASA induced @Disease$ and microbleeding.	0
"PURPOSE: Among previous studies examining the associations of over-the-counter analgesics or nonsteroidal anti-inflammatory drugs (NSAIDs) and incident @Disease$, results were inconsistent for NSAIDs but suggested an increased risk with @Chemical$ (paracetamol)."	0
"AIMS: We hypothesized that patients with a history of either alarming or nuisance @Disease$ events, compared to those with no history of bleeding, would have lower levels of on-treatment platelet reactivity (@Chemical$ and a thienopyridine)."	0
Effect of @Chemical$ on airway @Disease$ and pulmonary function in patients with persistent asthma.	0
CONCLUSION: Preoperative @Chemical$ and aspirin exposure even within 2 days of surgery does not increase perioperative @Disease$ and blood transfusion requirements in patients undergoing elective off-pump coronary artery bypass grafting.	0
"Therefore, high risk patients for peptic @Disease$s should be prevented with antisecretory drugs, such as PPI or histamine H2-receptor antagonists, because ulcer bleedings in patients with treatment of low-dose @Chemical$ can be serious."	0
"DATA SOURCES: Articles evaluating aspirin for primary prevention of CVD were gathered using a MEDLINE search with the keywords aspirin review, aspirin peripheral @Disease$, @Chemical$ stroke, aspirin coronary artery disease, aspirin diabetes, aspirin primary prophylaxis, and aspirin elderly."	0
BACKGROUND: The mechanisms by which Helicobacter pylori and low-dose @Chemical$ induce @Disease$ are not completely elucidated.	1
The diagnosis of ASRD was subsequently confirmed by an inadvertent @Chemical$ challenge which led to a serious adverse @Disease$ outcome.	1
"Therefore, physicians should monitor @Chemical$ users for gastrointestinal symptoms and signs of @Disease$, particularly if they have additional risk factors."	0
Role of melatonin in mucosal gastroprotection against @Chemical$-induced @Disease$ in humans.	1
@Chemical$CKGROUND: Low-dose aspirin is used for secondary prevention of ischemic heart disease and @Disease$.	0
"Risk factors for upper gastrointestinal (@Disease$) ulcer or bleeding among @Chemical$ users include a history of prior GI events, older age, chronic renal failure, combined antithrombotic therapy and nonsteroidal anti-inflammatory drugs (NSAIDs)."	0
Dual Antiplatelet Therapy Combining Aspirin and @Chemical$ for Intracranial Stenting Procedures: A Retrospective Single Center Study of 154 Consecutive Patients With @Disease$.	0
@Chemical$ resistance in patients with @Disease$.	0
Neither heparin nor @Chemical$ alone nor combined therapy increased the risk of @Disease$.	0
BACKGROUND: We have previously shown that co-treatment of angiotensin type 1 receptor (AT1R) blocker (ARB) or angiotensin converting enzyme (ACE) inhibitor seem to reduce peptic @Disease$ among patients taking low dose @Chemical$.	0
"In one RCT, no statistically significant differences for @Disease$ requiring admission to hospital (p = 0.14) or blood transfusion (p = 0.29) were observed between the group receiving concomitant @Chemical$ and ASA and the group receiving concomitant placebo and ASA."	0
"We aimed to evaluate the association between several widely used analgesics, including aspirin, non-aspirin NSAIDs, and @Chemical$ (paracetamol), and risk of psoriasis and @Disease$ (PsA) in a large cohort of US women, the Nurses' Health Study II (1991-2005)."	0
"Adverse events considered possibly or probably related to treatment occurred in 5 (20.0%) misoprostol recipients (4 episodes of diarrhea, 1 episode of abdominal pain), 1 (14.3%) recipient of @Chemical$ 30 mg (1 episode of @Disease$), and 3 (13.6%) placebo recipients (1 episode each of abdominal pain, palpitations, and dyspepsia)."	1
"CONCLUSIONS: In this subgroup analysis in patients at high risk for recurrence of gastric @Disease$, use of cotherapy with misoprostol 200 microg QID or @Chemical$ 15 or 30 mg OD significantly lowered the risk for gastric ulcer recurrence."	0
Prevention of @Disease$ and Complications in Low-Dose @Chemical$ Users.	0
"Hypersensitivity to @Chemical$ (ASA) is characterized by the co-occurrence of symptoms so-called aspirin triad, which include bronchial asthma, chronic @Disease$ and sinusitis and the nasal mucosa polyps."	0
METHODS: The Apixaban versus Acetylsalicylic Acid to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin k Antagonist Treatment (AVERROES) trial randomized 5599 patients with @Disease$ and risk factors to receive either @Chemical$ or aspirin.	0
"The ideal treatment for @Disease$ injury in patients taking @Chemical$ would be withdrawal of aspirin, however, LDA is used as an antiplatelet agent in the majority of patients, and its withdrawal could increase the risk of cardiovascular/cerebrovascular morbidity and mortality."	0
"METHODS: Using gas chromatography/mass spectrometry, we determined plasma and urinary concentrations of 9alpha,@Chemical$(2) at baseline in 131 stable asthmatic patients, 65 of whom had @Disease$ and 66 of whom had ATA."	0
"SUMMARY: The full clinical picture of aspirin intolerance--the association of @Chemical$-induced bronchial asthma (with severe acute asthma attacks), aspirin sensitivity and nasal @Disease$--is commonly summarized as the 'Samter triad'."	0
"Estimated excess major bleeding events were 1.39 (CI, 0.70 to 2.28) for GI bleeding and 0.32 (CI, -0.05 to 0.82) for hemorrhagic stroke per 1000 person-years of @Chemical$ exposure using baseline @Disease$ rates from a community-based observational sample."	0
"CONCLUSIONS: In a real-world PCI registry, patients with DM experienced lower risk of @Disease$ risk on @Chemical$."	0
BACKGROUND: Aspirin desensitization has been associated with benefit in management of @Chemical$-exacerbated @Disease$ (AERD).	0
"Although co-therapy with a PPI and the eradication of H. pylori substantially reduce the risk of recurrent ulcer @Disease$ with @Chemical$, the replacement of aspirin by clopidogrel cannot be recommended to patients with a high gastrointestinal risk."	1
Two patients (6.7%) taking @Chemical$ and eight (27.6%) taking the placebo had peptic @Disease$s &gt;= 5 mm or &lt; 5 mm with pigmented spots (P = 0.03).	0
"CONCLUSIONS: Aspirin and enoxaparin conferred similar @Disease$ risks, and both exhibited less bleeding than patients who received @Chemical$."	0
"CONCLUSIONS: For patients taking @Chemical$ for primary or secondary prophylaxis, the American Society of Regional Anesthesia and @Disease$ Medicine antiplatelet and anticoagulation guidelines for spine and pain procedures recommend a shared assessment and risk stratification when deciding to hold the medication for intermediate-risk neuraxial procedures."	0
STUDY SELECTION: Randomized placebo-controlled trials (RCTs) that compared the risk of recurrent @Disease$ in patients with an unprovoked DVT or PE who had been treated for at least 3 months with a VKA or a @Chemical$ and were then randomized to receive an oral anti-thrombotic agent or placebo for at least 6 additional months.	0
We studied retrospectively the incidence of and risk factors for @Disease$ associated with low-dose @Chemical$ use.	0
UNLABELLED: Periorbital @Disease$ may present as an isolated manifestation of @Chemical$ intolerance and can be very alarming to the patient.	1
"Univariate analysis suggested a non-significant trend towards increased rate of previous ischaemic stroke or @Disease$ and @Chemical$ resistance (odds ratio, OR=3.88; 95% confidence interval 0.54-29.87; p=0.18)."	0
Method: Eighty-six patients with CRS and asthma who were treated in the outpatient clinic during March 2015 to January 2018 were divided into asthma group(52 cases) and aspirin asthma group(34 cases) according to @Disease$ and @Chemical$ asthma.	0
"Coadministration of prednisone and ultralow-dose @Chemical$ increases the frequency of mild, self-limiting @Disease$ in some dogs."	1
Risks for @Disease$ and bleeding with @Chemical$ or aspirin treatment in patients with atrial fibrillation at different CHA(2)DS(2)VASc scores: experience from the Stockholm region.	0
"Based on data extracted from the validation process, recent recorded drug intake showed an increased frequency of anticoagulants with colonic diverticular and angiodysplasia bleeding, whereas NSAID and low-dose @Chemical$ use were more prevalent in peptic ulcer bleeding and @Disease$ respectively."	0
Gastric acid secretion level modulates the association between Helicobacter pylori @Disease$ and low-dose @Chemical$-induced gastropathy.	0
METHODS: We performed a prospective study of 84 aspirin users with @Disease$ who required continued @Chemical$ therapy in Hong Kong and Japan.	0
Effect of @Chemical$ on patients with aspirin-exacerbated @Disease$ undergoing aspirin challenge and desensitization.	0
"To conclude, there is no more systematic indication for @Chemical$ in people with @Disease$ free of CV disease, especially when diabetes and all other CV risk factors are optimally controlled."	0
"MATERIAL AND METHODS: The study included 504 patients that were administered the primary (n=345) or secondary thromboprophylaxis after @Disease$ (n=159), by applying vitamin K antagonists, or the combination of @Chemical$ antagonists and low-dose aspirin."	0
"The cumulative occurrence rate of bleeding ulcers over 24 weeks in the @Chemical$ group was 4.6%, while bleeding @Disease$s were not observed in the 10- or 5-mg rabeprazole groups."	0
"There was no increase in headache frequency in participants with @Chemical$+ intake compared with aspirin (adjusted, all headache: -0.34 d/mo [95% confidence intervals: -2.50 to 1.82], @Disease$: -1.36 d/mo [-4.76 to 2.03], TTH: -0.57 d/mo [-4.97 to 3.84], MigTTH: 2.46 d/mo [-5.19 to 10.10]) or no analgesics (all headache: -2.24 d/mo [-4.54 to 0.07], migraine: -3.77 d/mo [-9.22 to 1.68], TTH: -4.68 d/mo [-9.62 to 0.27]; MigTTH: -3.22 d/mo [-10.16 to 3.71])."	0
Aspirin-@Disease$ (AIA) is characterized by severe asthmatic attack after ingestion of @Chemical$ and/or non-steroidal anti-inflammatory drugs.	0
CONCLUSION: Endoscopy frequently reveals low-dose @Chemical$-induced @Disease$ in patients with IHD.	1
"@Disease$ to @Chemical$ (ASA) is characterized by the co-occurrence of symptoms so-called aspirin triad, which include bronchial asthma, chronic rhinitis and sinusitis and the nasal mucosa polyps."	1
"We evaluated changes in leukotriene and @Chemical$ metabolites for NIUA patients, using patients with NECD and single-NSAID-induced @Disease$/angioedema or anaphylaxis (SNIUAA) for comparison."	0
"@Chemical$ appears to be very effective in reducing both acute gastroduodenal mucosal damage and upper @Disease$ bleeding in the high-risk patient taking low-dose aspirin, but data with other anti-ulcer agents are lacking (misoprostol) or inconsistent (ranitidine) at present."	0
"Urinary eicosanoids, plasma tryptase and cytokine levels, platelet-leukocyte aggregates, and granulocyte transcripts were assessed.Measurements and Main Results: Eight weeks of high-dose aspirin decreased nasal symptoms and urinary prostaglandin E metabolite (P &lt; 0.05) and increased urinary leukotriene E4 (P &lt; 0.01) levels in subjects with aspirin-exacerbated @Disease$, but not in those with @Chemical$-tolerant asthma."	0
"At 3 years, 238 (5.9%) patients were on @Chemical$, 743 (18.6) on aspirin, and 3,013 (75.5%) on no therapy; with occurrences of CVA/TIA (1.4%, 3.0%, 3.9%, P &lt; 0.0001, respectively), GI @Disease$ (0.8%, 1.9%, 1.1%, P = 0.06, respectively), and GU bleeding (1.7%, 2.8%, 2.1%, P = 0.008, respectively) that increased with advancing CHA2 DS2 VASc score."	0
OBJECTIVE: To estimate the @Disease$ risk of combined anticoagulant (rivaroxaban or enoxaparin-@Chemical$ antagonist [VKA]) and NSAID or aspirin therapy in patients with venous thromboembolism.	0
"MATERIAL AND METHODS: The study included 504 patients that were administered the primary (n=345) or secondary thromboprophylaxis after @Disease$ (n=159), by applying vitamin K antagonists, or the combination of vitamin K antagonists and low-dose @Chemical$."	0
Safety of @Chemical$ and aspirin for @Disease$ prevention: implications of the CHARISMA trial.	0
"The patients comprised three groups: @Chemical$-interrupted group (13 patients with 13 @Disease$), LDA-continued group (28 patients with 31 colorectal tumors), and no anticoagulant/antiplatelet group (541 patients with 565 colorectal tumors)."	0
"After oral provocation @Chemical$ challenge in 5 subjects' aspirin induced @Disease$ was confirmed, 3 persons were not qualified to test."	0
[Low-dose aspirin (@Chemical$)/nonsteroidal anti-inflammatory drugs(NSAIDs)-induced @Disease$ in Japan].	1
"In dogs with chronic @Disease$ (n=4), activated partial thromboplastin time (APTT) tended to shorten by 0.9 to 3.0 sec, and prolonged @Chemical$ was shortened in two cases for 4.2 and 1.7 min after DDAVP injection."	1
"BACKGROUND: Aspirin (acetylsalicylic acid [@Chemical$]) hypersensitivity is frequent in patients with nasal polyps (NPs) and is called aspirin exacerbated respiratory disease, previously known as @Disease$."	0
"@Chemical$, but not other NSAID use, was associated with about 20% lower risk of postmenopausal breast cancer and did not vary by ER or PR status of the tumor, suggesting that the hypothesized protective effects of aspirin may either be through cellular pathways independent of estrogen or progesterone signaling, or on @Disease$ microenvironment."	0
CONCLUSION: Low-dose @Chemical$ is not associated with an increased risk of any type of ICB and is associated with a significantly decreased risk of @Disease$ when used for &gt;=1 year.	0
CONCLUSION: Our study did not find any significant reductions in cancer-related mortality or @Disease$ incidence when compared aspirin use with placebo or no @Chemical$.	0
Limited influence of @Chemical$ intake on mast cell activation in patients with food-dependent exercise-induced @Disease$: comparison using skin prick and histamine release tests.	1
"CONCLUSION: Coupling of NO to @Chemical$ attenuates stress, ischemia-reperfusion, and ethanol-induced damage due to @Disease$ mediated by NO, which compensates for prostaglandin deficiency induced by ASA."	0
"The current report describes a Japanese boy who underwent @Chemical$ treatment for Kawasaki disease, and who subsequently presented with the manifestations of @Disease$/DRESS syndrome."	1
@Chemical$ overproduction is the major characteristic of @Disease$ (AIA).	0
OBJECTIVE: To investigate the protective effect of compound bismuth and @Chemical$ granules on aspirin-induced @Disease$ in rats and its possible mechanism.	0
"@Chemical$ (ASA)-exacerbated respiratory disease (AERD) is characterized by upper airway congestion due to @Disease$ of the nasal and sinus membranes and nasal polyposis, associated with increased leukotriene production that is further accentuated by ASA or other nonsteroidal anti-inflammatory drug (NSAID) ingestion."	0
"Adverse events considered possibly or probably related to treatment occurred in 5 (20.0%) @Chemical$ recipients (4 episodes of diarrhea, 1 episode of @Disease$), 1 (14.3%) recipient of lansoprazole 30 mg (1 episode of pharyngitis), and 3 (13.6%) placebo recipients (1 episode each of abdominal pain, palpitations, and dyspepsia)."	1
"A previous history of ulcer or GI @Disease$ are identified risk factors for GI bleeding, but few studies have been conducted on patients treated with low-dose @Chemical$ to confirm this."	0
"Independent significant predictors for @Chemical$-related @Disease$ were the preoperative prescription of aspirin (adjusted OR 1.94; 95% CI 1.10-3.44), catheter malposition (aOR 1.99; 95% CI 1.22-3.23), and use of the 2.8-mm Medtronic  catheter (aOR 4.22; 95% CI 2.39-7.41)."	1
@Disease$ after @Chemical$ treatment.	1
BACKGROUND: Silent myocardial ischemia (SMI) is a relatively common complication in patients with coronary artery disease (CAD) under @Chemical$ therapy presenting with @Disease$ (UGIH).	1
AIM: The author examined psychiatrically a group of 106 patients with difficult asthma and 100 patients with @Chemical$-induced @Disease$.	1
CONCLUSIONS: Our data suggest that continued use of @Chemical$ increased the risk of bleeding after ESD for @Disease$ compared with nonuse of anticoagulant/antiplatelets.	0
INTRODUCTION: The Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) study showed that patients with @Disease$ (UAP) and non-ST-elevation myocardial infarction (NSTEMI) benefit from combined therapy with @Chemical$ (ASA) and clopidogrel.	0
Prior @Chemical$ use in unstable @Disease$ predisposes to higher risk: the aspirin paradox.	1
The incidence of peptic @Disease$ induced by @Chemical$ was 15.8% (16/101) in authors' hospital.	1
"It has been proposed that overproduction of @Chemical$, together with removal by aspirin/NSAIDs of the 'brake' imposed by the bronchodilator prostaglandin E2, may cause an @Disease$ attack in patients with AIA."	0
The use of @Chemical$ for thromboprophylaxis is an added risk for the occurrence of @Disease$.	1
BACKGROUND: Aspirin desensitization followed by high-dose @Chemical$ therapy is routinely performed for patients with aspirin-exacerbated @Disease$ (AERD).	0
Eradication of H. pylori @Disease$ before @Chemical$ use could reduce the incidence of upper GI complications by 25-30%.	0
This pilot study aimed to determine the prevalence of @Chemical$ resistance in an Australian stroke population and to correlate aspirin resistance with an increased risk of ischaemic @Disease$.	0
"OBJECTIVE: We sought to examine whether NLRP3 polymorphisms are associated with susceptibility to food allergy, food-induced anaphylaxis, and @Chemical$-induced @Disease$ (AIA)."	1
"Identical questionnaires were sent to 210 neurosurgical facilities and proffered five main questions: (1) the adherence of any policy of stopping @Chemical$ pre-operatively, (2) the personal risk assessment for patients with spinal surgery under low-dose aspirin medication, (3) the preferred method of treatment for excessive @Disease$ in this context, (4) personal knowledge of hemorrhagic complications in this group of patients, and (5) the characteristics of the neurosurgical units concerned."	0
"Dual antiplatelet therapy (@Chemical$) with acetylsalicylic acid and a P2Y12 inhibitor (clopidogrel, ticagrelor, or prasugrel) reduces thrombotic events in patients with acute coronary syndrome (ACS), but it is also associated with an increased risk of @Disease$ complications."	0
Several genetic studies on aspirin @Disease$ have been performed to discover the genetic predisposition to @Chemical$ hypersensitivity and to gain insight into the phenotypic diversity.	0
"OBJECTIVES: To identify the reasons of using aspirin, endoscopic findings on gastropathy caused by @Chemical$ and the relative risk of developing @Disease$."	0
BACKGROUND: Patients with aspirin-exacerbated @Disease$ (AERD) are distinguished from patients with aspirin-tolerant asthma (ATA) by significantly higher baseline concentrations of urinary @Chemical$ (uLTE4).	0
"With regard to the metabolism of arachidonic acid (AA) in NSAID-intolerant @Disease$tic patients, the following changes have been observed: 1) A low production of prostaglandin E2, seemingly due to deficient Cox-2 regulation; 2) an increased expression of leukotriene-C4 synthase; and 3) a reduced production of metabolites (@Chemical$) released through the transcellular metabolism of AA."	0
To report a case of microtrauma-induced recurrent hyphema and secondary @Disease$ associated with voluntary chronic acetylsalicylic acid (@Chemical$) use.	0
"CONCLUSION: Coupling of NO to ASA attenuates stress, ischemia-reperfusion, and ethanol-induced damage due to mucosal hyperemia mediated by NO, which compensates for prostaglandin @Disease$ induced by @Chemical$."	1
"These changes disturb the pulmonary microcirculation, causing the @Disease$ even in patient who do not take @Chemical$ or other nonsteroidal anti-inflammatory drugs."	0
We address the strength of evidence between low-dose aspirin use and AMD and also discuss the risks and benefits of @Chemical$ use in primary versus secondary prevention of @Disease$ in these cases.	0
"The objective of this study was to test the effects of @Chemical$ (1, 2.5 and 5 mg/kg), and ibuprofen (4 and 15 mg/kg), diclofenac (2.5 mg/kg), flurbiprofen (2 mg/kg), celecoxib (7.5 mg/kg), and rofecoxib (1 mg/kg), alone or combined on a rat model of arterial @Disease$."	0
"Based on the results of the MATCH trial, combination therapy with @Chemical$ plus clopidogrel is not recommended for patients with ischaemic stroke or @Disease$ due to the increased risk of haemorrhage."	0
"Significant heterogeneity was present for the NSAIDs; e.g., ibuprofen was associated with an increased overall @Disease$ risk (OR = 2.09, 95% CI 2.00-2.18 for &lt;20 DDD), while @Chemical$ was not (OR = 0.76, 95% CI 0.51-1.13 for &lt;20 DDD, 2P &lt; 0.01 for comparison)."	0
Combined aspirin and @Chemical$ in cataract surgical patients: a new risk factor for @Disease$?	0
"@Chemical$ (acetylsalicylic acid) is a well-known nonsteroidal anti-inflammatory drug that can potentiate some acute allergies and causes adverse immunological reactions collectively referred to as aspirin intolerance, a disorder that induces urticaria, @Disease$, and anaphylaxis in response to oral administration of the drug."	1
"Despite reports in the literature, there does not appear to he cross-reactions between food coloring, hydrocortisone succinate and monosodium glutamate in individuals with @Chemical$ exacerbated @Disease$."	0
"METHODS: Subjects 18 years or older with @Disease$, without gastroduodenal ulcer or erosive esophagitis at baseline endoscopy, and a cardiovascular indication for prophylaxis low-dose (81 or 325 mg) aspirin were prescribed open-label aspirin and blindly randomized to celecoxib 200 mg/day or @Chemical$ 500 mg twice daily plus lansoprazole 30 mg once daily."	0
Randomised clinical trial: rabeprazole plus @Chemical$ is not inferior to rabeprazole plus clopidogrel for the healing of aspirin-related peptic @Disease$.	0
"METHODS: Gastric @Disease$s were induced by the serosal application of 100% @Chemical$, and the areas of the ulcers were measured thereafter."	0
"Compared with nonusers, @Chemical$ users were no more likely to die or require HF readmission (hazard ratio [HR], 1.02 [0.91 to 1.16]), even in patients without @Disease$ (HR, 0.98 [0.78 to 1.22]) or patients with renal dysfunction (HR, 1.13 [0.94 to 1.36])."	0
BACKGROUND: Aspirin (@Chemical$)-exacerbated @Disease$ (AERD) is characterized by aggressive inflammation of the respiratory tract and often requires topical and/or systemic corticosteroids to maintain partial control of this disease.	1
"The importance of validating @Disease$ diagnoses in The Health Improvement Network, United Kingdom: Misclassification of onset and its impact on the risk associated with low-dose @Chemical$ therapy."	0
"CONCLUSION: These results indicate that it is very important to prevent @Chemical$-induced gastroduodenal ulcer complications, including @Disease$."	1
AIM: To assess the incidence of @Disease$ in the context of the changing use of cyclo-oxygenase-2 non-steroidal anti-inflammatory drugs and low-dose @Chemical$.	0
"CONCLUSIONS: We present a case series demonstrating that in carefully selected patients, @Disease$ on @Chemical$ and clopidogrel is feasible and safe."	0
"PATIENTS AND METHODS: Using data from the Women's Health Initiative, we estimated hazard ratios for CRC in association with @Chemical$ use, with stratifications by cardiovascular disease (CVD) risk status, family history of CRC, and history of @Disease$."	0
"In order to diagnose @Disease$, oral, inhaled, nasal or intravenous @Chemical$ challenge tests are performed in facilities where experienced physicians are present and emergency treatment is available."	0
"The cumulative occurrence rate of bleeding @Disease$s over 24 weeks in the @Chemical$ group was 4.6%, while bleeding ulcers were not observed in the 10- or 5-mg rabeprazole groups."	0
"Because serum pepsinogens (PGs) and gastrin-17 (G17) can reflect gastric acid secretion, this study intended to elucidate whether serum PGs, serum G17, and H. pylori infection are associated with @Chemical$-induced @Disease$."	1
"Nonetheless, @Chemical$'s effectiveness in such disease prevention is limited by the risk of gastrointestinal (GI) complications such as ulceration, @Disease$ and perforation."	0
"Recently, vitamin C releasing @Chemical$ (ASA-VitC) has been shown to reduce gastric toxicity of ASA in animal model of @Disease$."	0
"CONCLUSIONS: In symptomatic elderly chronic users of low-dose @Chemical$, H. pylori @Disease$ may influence the prevalence of peptic ulcers and the cost-effectiveness of the proton pump inhibitor prevention therapy."	0
BACKGROUND &@Chemical$; AIMS: It is not clear whether H2-receptor antagonists (H2RAs) reduce the risk of gastrointestinal (GI) @Disease$ in aspirin users at high risk.	0
"Also, women had less peripheral artery disease (aspirin, 2.4% versus 3.7%; apixaban, 1.4% versus 3.0%), more heart failure, and higher mean CHADS2 (congestive heart failure, hypertension, age of 75 years or older, @Disease$ [1 point each], stroke or transient ischemic attack [2 points]) scores (@Chemical$, 2.2 versus 2.0; apixaban, 2.1 versus 2.0)."	0
"RESULTS AND DISCUSSION: Our results indicate the low incidence of @Disease$ (0.01 patient per a year), with a lower incidence in the vitamin K antagonists group than in the group with the combination of @Chemical$ antagonists and aspirin (0.008 patient per a year versus 0.01 patient per a year)."	0
"CONCLUSION: Among elderly patients receiving cardiovascular protection with ASA and @Disease$ control with anti-inflammatory drugs, @Chemical$ may be safer with regards to GI toxicity than NS-NSAIDs."	0
The pathogenesis of @Disease$ is underpinned by abnormalities in eicosanoid biosynthesis and @Chemical$ receptor expression coupled with intense mast cell and eosinophilic infiltration of the entire respiratory tract.	0
Montelukast protects against nasal @Chemical$-aspirin challenge in patients with aspirin-induced @Disease$.	0
"@Chemical$, nonsteroidal anti-inflammatory drug use, and risk for Crohn disease and @Disease$: a cohort study."	0
Altered @Chemical$ metabolism is the generally accepted mechanism of aspirin intolerance; the overproduction of cysteinyl leucotrienes has been suggested to play a causative role in both @Disease$ and AIU.	0
"OBJECTIVE: We sought to determine blood and urinary levels of 9alpha,11beta-PGF(2), a major stable PGD(2) metabolite in 2 well-defined phenotypes of asthma, @Chemical$-induced asthma (AIA) and aspirin-tolerant @Disease$ (ATA), and in healthy control subjects and to study the effects of aspirin on PGD(2) release."	0
"The proportions of patients who were free of gastric @Disease$s at the end of 12 weeks were 96% in the @Chemical$ group, 93% in the lansoprazole 15-mg group, 100% in the lansoprazole 30-mg group, and 35% in the placebo group (P &lt;or= 0.008, each active treatment vs placebo)."	0
OBJECTIVE: We investigated whether @Chemical$ administration would be associated with attenuation of aspirin-provoked @Disease$ in patients with AERD undergoing aspirin desensitization.	0
"In the paediatric population, there is some evidence of possible interaction, synergism, and co-@Disease$ of aspirin and @Chemical$."	0
"RESULTS: Analysis of this patient group revealed that Patient 1 experienced @Disease$, emesis, anorexia, diarrhea and significant clinical decline during treatment with @Chemical$."	1
"CONCLUSION: On the basis of the present studies, it cannot be unequivocally said whether @Chemical$ influences people's vision and if people endangered with AMD progression or who are diagnosed with @Disease$ should use this drug."	0
"History of bleeding or non-complicated peptic ulcer, @Chemical$ intake, concomitant treatment with NSAID or calcic inhibitors are demonstrated risk factors of bleeding @Disease$ associated with low-dose aspirin."	0
CONCLUSIONS: Continuous @Chemical$ use does not produce an additional @Disease$ risk in patients who undergo split-thickness skin transplantation repair of chronic wounds.	0
"CONCLUSIONS: Low-dose @Chemical$ use could reduce the incidences of total cardiovascular events, stroke, nonfatal stroke and transient ischemic attack but increase the risk of bleeding, the incidence of nonfatal myocardial infarction, @Disease$ from cardiovascular causes and death from any cause was not affected by low-dose aspirin use."	1
The @Disease$/immunology specialty is unique in the use of prolonged high-dose @Chemical$ therapy for the treatment of AERD.	1
"We compared the antithrombotic effect of @Chemical$ vs ticagrelor in an LVAD patient with aspirin @Disease$ by using a modified protocol of the thrombin generation test, accounting selectively for the platelet contribution on thrombin generation."	0
@Chemical$ sensitivity is most often manifested as rhinitis and asthma or urticaria/@Disease$ induced by cross-reacting nonsteroidal anti-inflammatory drugs that inhibit cyclooxygenase 1.	0
"OBJECTIVE: To investigate the incidence, clinical characteristics and risk factors of @Disease$ (UGIB) in patients with acute coronary syndrome (ACS) who were administrated with aspirin and @Chemical$ dual antiplatelet therapy after percutaneous coronary intervention (PCI)."	0
"Exclusion criteria: cancer, sepsis or acute infection, active inflammatory/@Disease$, recent major surgery, chronic liver failure, the administration of other antiplatelet drugs, nonadherence with @Chemical$ and thrombocytopenia."	0
"CONCLUSIONS: In a randomized, double-blind trial of healthy volunteers, we found oral Bif195 to safely reduce the risk of @Disease$ caused by @Chemical$."	1
"Data Sources: We searched PubMed, Embase, CENTRAL, and ClinicalTrials.gov from inception to May 28, 2018, with the terms novel oral anticoagulants, non-vitamin K antagonist oral anticoagulants, direct oral anticoagulants, @Chemical$, rivaroxaban, apixaban, edoxaban, warfarin, Coumadin, vitamin K antagonist, aspirin, acetylsalicylic acid, or ASA, and major bleeding, fatal bleeding, or @Disease$."	0
"OBJECTIVE: We sought to determine blood and urinary levels of 9alpha,11beta-PGF(2), a major stable PGD(2) metabolite in 2 well-defined phenotypes of asthma, aspirin-induced asthma (AIA) and aspirin-tolerant @Disease$ (ATA), and in healthy control subjects and to study the effects of @Chemical$ on PGD(2) release."	0
"In addition, patients on @Chemical$ have @Disease$ in platelet response to AA."	1
Health-care Cost Impact of Continued Anticoagulation With @Chemical$ vs Aspirin for Prevention of Recurrent Symptomatic @Disease$ in the EINSTEIN-CHOICE Trial Population.	0
BACKGROUND AND STUDY AIM: The risk of bleeding after endoscopic submucosal dissection (ESD) in patients with early @Disease$ who do not discontinue @Chemical$ for the procedure has not been established.	0
"@Chemical$ has been studied as a primary prevention method for multiple diseases, mainly cardiovascular disease and various forms of @Disease$."	0
"Treating GPBAR1(+/+) mice with two GPBAR1 agonists, ciprofloxacin and @Chemical$, rescued mice from @Disease$ caused by ASA and NSAIDs."	0
"Treated individuals with @Disease$ with more than 12% reversibility had significantly higher density of LTC4S-positive mast cells than those with less reversibility, and it correlated significantly with reduction in lung function (FEV1-predicted), both before and after @Chemical$ inhalation."	0
"Urinary eicosanoids, plasma tryptase and cytokine levels, platelet-leukocyte aggregates, and granulocyte transcripts were assessed.Measurements and Main Results: Eight weeks of high-dose aspirin decreased nasal symptoms and urinary prostaglandin E metabolite (P &lt; 0.05) and increased urinary leukotriene E4 (P &lt; 0.01) levels in subjects with @Chemical$-exacerbated respiratory disease, but not in those with aspirin-tolerant @Disease$."	0
"Although it is widely accepted that @Chemical$ will increase the risk of intra- and post-operative @Disease$, clinical studies have not consistently supported this assumption."	1
AIM: The aim of this study was to determine whether early post-operative administration of @Chemical$ influence the risk of @Disease$ in patients undergoing coronary artery bypass graft (CABG) surgery.	0
"OBJECTIVE: Our objective was to measure the risks of @Disease$ (ACS) after dispensing of ibuprofen, versus @Chemical$."	0
"Proton-pump inhibitor treatment was associated with a reduced risk of peptic @Disease$ in both acute (OR = 0.70, 95% CI: 0.24-2.04) and chronic (OR = 0.32, 95% CI: 0.15-0.67) non-steroidal anti-inflammatory drugs/@Chemical$ users."	0
"PATIENTS/METHODS: Ovid MEDLINE, Embase and the Cochrane Library, up to September 2011, were searched for RCTs comparing @Disease$ rates in adult patients randomized to @Chemical$, target International Normalized Ratio (INR) 2.0-3.5, and ASA, 50-650 mg daily, with at least 3 months of follow-up."	0
"Aspirin-exacerbated @Disease$ (AERD) is an adult-onset condition that manifests as asthma, rhinosinusitis/nasal polyps, and sensitivity to @Chemical$ and other cyclooxygenase-1 (COX-1)-inhibitor nonsteroidal anti-inflammatory drugs (NSAIDs)."	0
@Chemical$ use in @Disease$: a note of caution regarding potential tumour necrosis factor-alpha elevation.	1
Pancreatitis as a complication of @Chemical$ desensitization for aspirin-exacerbated @Disease$.	0
Omalizumab efficacy against @Chemical$-exacerbated @Disease$ has not been investigated in a randomized manner.	0
"A 42-year-old white woman with a history of severe asthma, nasal polyps, @Chemical$ sensitivity, and chronic @Disease$ was treated with aspirin desensitization."	0
The Aspirin Response Test (ART; VerifyNow) was used to assess platelet inhibition in @Disease$ patients and guide platelet transfusion in patients with @Chemical$-induced suppression.	0
"In 2013 the European Medicines Agency declared that @Chemical$ is contraindicated in patients with arterial @Disease$, based on a meta-analysis of randomised controlled trials on the adverse reactions of NSAIDs."	0
The rates of both stroke and bleeding increased with higher CHADS2 scores but @Chemical$ compared with aspirin was associated with a similar relative risk of bleeding (P interaction 0.21) and a reduced relative risk of @Disease$ (P interaction 0.37) irrespective of CHADS2 category.	0
Effect of @Chemical$ on the Intestinal Response to a @Disease$.	1
"BACKGROUND &amp; AIMS: We performed a meta-analysis of data from randomized trials to estimate the risk of all-cause mortality and @Disease$ (and especially gastrointestinal [GI] bleeding) in patients treated with low doses of @Chemical$ (ASA) (75-325 mg/d), alone or in combination with other medications."	0
"DATA SOURCES: Articles evaluating aspirin for primary prevention of CVD were gathered using a MEDLINE search with the keywords aspirin review, aspirin peripheral artery disease, aspirin @Disease$, aspirin coronary artery disease, aspirin diabetes, @Chemical$ primary prophylaxis, and aspirin elderly."	0
"CONCLUSIONS: Higher lifetime use of @Chemical$ and NSAIDs is not associated with @Disease$, but high acetaminophen use may increase the risk of loss of renal function."	0
Combined @Chemical$ and clopidogrel in @Disease$ surgical patients: a new risk factor for ocular haemorrhage?	0
"We investigated whether aspirin with caffeine (@Chemical$+) increases headache frequency compared with aspirin alone in migraine, tension-type headache (TTH), and @Disease$ + TTH (MigTTH)."	0
We address the strength of evidence between low-dose aspirin use and @Disease$ and also discuss the risks and benefits of @Chemical$ use in primary versus secondary prevention of cardiovascular diseases in these cases.	0
CONCLUSIONS: Omeprazole was superior to @Chemical$ with less @Disease$ and recurrent ulcers/erosions in patients using 24-week low-dose aspirin.	0
During dose-reduced (2-3 times a week) @Chemical$ administration ADP-induced platelet aggregation was effectively inhibited and neither important bleeding nor stent @Disease$ occurred.	0
"@Chemical$ can increase your risk of @Disease$, but medication can help."	1
"@Chemical$ is widely used for its antiplatelet activity, but it harbors a risk of severe adverse gastrointestinal effects, such as @Disease$ and perforation, especially in elderly people."	1
"CONCLUSIONS: In patients with AF, all combinations of @Chemical$, aspirin, and clopidogrel are associated with increased risk of nonfatal and fatal @Disease$."	0
CONCLUSION: Clopidogrel and the combination of @Chemical$ and dipyridamole were associated with similar risks for recurrent ischemic @Disease$ and bleeding; whereas acetylsalicylic acid was associated with higher risks for both ischemic stroke and bleeding.	1
METHODS: ASA-dipyridamole (25/200 mg) once daily together with @Chemical$ (81 mg) daily was started in 130 patients given the diagnosis of @Disease$/TIA with instructions to increase ASA-dipyridamole to twice daily after 7 days and discontinue ASA (81 mg).	0
"In addition, the effects of treatment with warfarin, @Chemical$, or both in patients with chronic kidney disease were compared with the effects in patients with no @Disease$."	0
There were significantly more @Disease$ among users of low-dose aspirin than among those using no @Chemical$ (P&lt;0.0001).	0
"Aspirin-exacerbated @Disease$ (AERD) refers to the combination of asthma, chronic rhinosinusitis with nasal polyposis, and acute upper and lower respiratory tract reactions to the ingestion of aspirin (acetylsalicylic acid, @Chemical$) and other cyclooxygenase-1 inhibiting non-steroidal anti-inflammatory drugs."	0
"In the TBI group, 30 patients (49.2 %) were identified, while Multiplate analysis detected @Disease$ in 19 (59.4 %) subjects in the pICH group and 5 in the @Chemical$ group (50 %)."	0
"METHODS: Fibroblasts were isolated from the NM of subjects without asthma who had septal deviation, turbinate hypertrophy, or both (control subjects, n = 7); NPs of aspirin-tolerant nonasthmatic patients (n = 7); and NPs of patients with @Disease$ who were intolerant of @Chemical$ (n = 7)."	0
"OBJECTIVE: @Chemical$ exacerbated respiratory disease (@Disease$) is comprised of aspirin/acetylsalicylic acid (ASA) sensitivity, bronchial asthma, and nasal polyposis."	0
"Multinational, double-blind, randomised, placebo-controlled, prospective study of @Chemical$ in the prevention of recurrent peptic @Disease$ in low-dose acetylsalicylic acid users: the LAVENDER study."	0
"When reviewing the existing literature on the effects of the coating on the incidence of gastrointestinal side effects we find that enteric-coated @Chemical$ causes significantly less minor gastrointestinal lesions compared to plain aspirin evaluated by endoscopy after short-term treatment, but there seems to be no effect of enteric-coating on the incidence of @Disease$ of clinical relevance."	0
"Although it is difficult to solely attribute intratumoral hemorrhage to @Chemical$, we have to be careful when prescribing aspirin for patients who have asymptomatic @Disease$."	0
An overproduction of @Chemical$ was observed in patients with aspirin @Disease$ at baseline and following aspirin challenge.	0
"We compared the antithrombotic effect of clopidogrel vs @Chemical$ in an LVAD patient with aspirin @Disease$ by using a modified protocol of the thrombin generation test, accounting selectively for the platelet contribution on thrombin generation."	0
"Twelve cases of @Disease$ are presented with different degrees of encephalopathy, hyperammonemia and hypoglycemia; associated to @Chemical$ (ASA) ingestion."	1
"CONCLUSIONS: Low-dose aspirin increases the risk of major bleeding by approximately 70%, but the absolute increase is modest: 769 patients (95% CI, 500-1250) need to be treated with @Chemical$ to cause one additional major @Disease$ episode annually."	1
Questions were asked regarding: (1) demographic characteristics; (2) use patterns; (3) knowledge about adverse events; (4) risk factors for experiencing @Disease$; (5) reasons for choosing an @Chemical$-containing medicine; and (6) whether their GP was informed on their use of high-dose ASA.	0
"Prolonged periods of dual antiplatelet therapy (DAT), i.e., @Chemical$ plus a thienopyridine, are currently recommended to prevent late drug-eluting stent (DES) @Disease$."	0
"Among 56 cases, 27 received @Chemical$ for @Disease$ and 29 were treated for stable CAD."	0
We assessed whether the association of aspirin and other NSAIDs with postmenopausal breast cancer risk differs by estrogen and @Chemical$ receptor (ER and PR) status of the @Disease$.	0
"Paracetamol pack size restriction: the impact on paracetamol @Disease$ and the over-the-counter supply of @Chemical$, aspirin and ibuprofen."	0
"LDA was more frequently associated with CAS and @Disease$ symptoms, as well as severe and multivessel spasm, suggesting the patients who have received @Chemical$ would require more intensive medical therapies and close follow up."	1
"However, desensitization to aspirin is a viable option for patients with @Chemical$-induced @Disease$, especially for those who require aspirin for thromboembolic prophylaxis."	1
We used the Multiplate analyser for rapid assessment of antiplatelet activity in a patient who developed an @Disease$ after administration of aspirin and @Chemical$.	1
"Statins, @Chemical$ affect @Disease$ test."	0
"The values of @Disease$s of MPs in descending order were as follows: gefarnate, hydrotalcite &gt; teprenone &gt; sucralfate oral suspension &gt; L-glutamine and sodium gualenate granules &gt; @Chemical$ &gt; sucralfate chewable tablets."	0
Enzyme up-regulation was monitored after in vitro stimulation with lipopolysaccharide (LPS) and/or aspirin in 19 @Chemical$-intolerant (AI) patients (8 aspirin-sensitive asthmatics and 11 @Disease$ patients) and 14 healthy controls.	0
Prediction of the excessive perioperative @Disease$ in patients undergoing coronary artery bypass grafting: role of @Chemical$ and platelet glycoprotein IIIa polymorphism.	0
Effects of zinc-L-carnosine and vitamin E on @Chemical$-induced @Disease$ in dogs.	1
"RESULTS: Analysis of this patient group revealed that Patient 1 experienced nausea, emesis, @Disease$, diarrhea and significant clinical decline during treatment with @Chemical$."	0
@Chemical$-induced asthma (AIA) and aspirin-induced urticaria/ @Disease$ (AIU) are two major aspirin-related allergies.	0
"@Chemical$-exacerbated respiratory disease (AERD) is the most common phenotype characterized by an eosinophil-dominated inflammatory disease of the airways that presents clinically with nasal polyps, chronic @Disease$ and bronchial asthma."	0
"BACKGROUND: Although there is increasing evidence of the importance of @Chemical$ (LT) as mediators of aspirin-induced bronchoconstriction in aspirin-sensitive @Disease$, the cellular origin of the LT is not yet clear."	0
"The pathogenesis related to inhibition of cyclooxygenase (COX)-1 includes reduced mucosal flow, reduced mucus and @Chemical$ secretion, and @Disease$."	0
BACKGROUND: Patients with @Disease$ who have aspirin sensitivity have greater cysteinyl leukotriene production and greater airway hyperresponsiveness to the effects of inhaled cysteinyl leukotrienes than their @Chemical$-tolerant counterparts.	0
"BACKGROUND: The combination of @Chemical$, clopidogrel, and enoxaparin (combination therapy) is the standard treatment for acute coronary syndrome but is associated with @Disease$."	0
"The @Chemical$-Mono and ASA-Bis conjugates did not cause macroscopic @Disease$, but the inflammatory activation was apparent."	0
"@Disease$ were found in 54 of 98 (60.7%) users of buffered aspirin (@Chemical$), whereas 38 of 101 (37.6%) users of ECA had mucosal defects."	0
Immune heparin-induced @Disease$ can occur in patients receiving clopidogrel and @Chemical$.	1
STUDY DESIGN AND SETTING: Leukotriene release from @Disease$s and leukocytes of ASPs and NASPs was measured after exposure to differing concentrations of @Chemical$.	0
The association persisted even after excluding those with conventional risks for @Chemical$-gastropathy such as @Disease$ histories.	1
The MAGIC Study and the gastrointestinal effects of low-dose aspirin : editorial to: Prospective cohort study of gastrointestinal complications and @Disease$ in patients taking @Chemical$: rationale and design of the MAGIC Study by H.	1
@Chemical$ and other inhibitors of cyclo-oxygenase precipitate acute bronchospasm in about 10% of adult @Disease$tics.	0
"BACKGROUND: The aim of this study was to evaluate whether an intraoperative @Disease$ is more frequent in sinus surgery than in non-sinus surgery, whether its appearance after application of a non-steroidal anti-inflammatory drug (NSAID) is an indicator of an aspirin intolerance syndrome, and whether its appearance can be interpreted as an @Chemical$ provocation test."	0
"Aspirin (ASA)-exacerbated respiratory disease (AERD) is characterized by upper airway congestion due to eosinophilic inflammation of the nasal and sinus membranes and @Disease$, associated with increased leukotriene production that is further accentuated by @Chemical$ or other nonsteroidal anti-inflammatory drug (NSAID) ingestion."	0
"CONCLUSIONS: Aspirin intake overall was not associated with early @Disease$ in this sample of Asian Indians, but in those with a history of cardiovascular disease the association between @Chemical$ intake and early AMD might warrant further investigation."	0
"BACKGROUND: Aspirin (@Chemical$ [ASA]) @Disease$ is frequent in patients with nasal polyps (NPs) and is called aspirin exacerbated respiratory disease, previously known as Samter's syndrome."	1
[Should Helicobacter pylori @Disease$ be tested and eradicated in patients treated or about to be treated with @Chemical$ or nonsteroidal anti-inflammatory drugs?].	0
"We used conditional logistic regression to estimate odds ratios (ORs), with 95 % confidence intervals (CIs), for @Disease$ associated with low-dose aspirin (75-150 mg) or non@Chemical$ NSAID use, adjusted for potential confounders."	0
"RESULTS: Prior @Chemical$ users (n = 17,839) were older (63 years vs. 59 years) and had more coronary risk factors and evidence of coronary artery disease (MI, @Disease$, prior intervention) than nonprior aspirin users (n = 48,604) (all p &lt; 0.0001)."	0
"@Chemical$-exacerbated respiratory disease (AERD) is a unique syndrome of airway inflammation that frequently occurs in patients with @Disease$, chronic sinusitis, and asthma."	0
Extended antiplatelet therapy with @Chemical$ alone versus clopidogrel plus aspirin after completion of 9- to 12-month dual antiplatelet therapy for @Disease$ patients with both high bleeding and ischemic risk.	0
"There were significantly more patients who suffered GI adverse events, principally abdominal pain, @Disease$, nausea and diarrhoea, with aspirin (18.5%) than with ibuprofen (11.5%), but the difference between @Chemical$ and paracetamol (13.1%) was not significant."	0
Combination of low-dose aspirin and @Chemical$ exacerbates small @Disease$.	0
@Chemical$-induced peptic @Disease$ and genetic polymorphisms.	1
"Enrolled patients continued their @Chemical$ therapy, and underwent endoscopic procedures that had a high risk of @Disease$ for treatment of lesions in the upper and lower gastrointestinal tracts."	0
This study suggests that misoprostol 3 microg/kg PO q12h is as effective as misoprostol 3 microg/kg PO q8h in preventing @Chemical$-induced @Disease$ in this model.	1
"OBJECTIVES: This study sought to explore the effects of the combination of rivaroxaban and aspirin compared with @Chemical$ on sites, timing, severity, and management of @Disease$ in the COMPASS (Cardiovascular Outcomes for People Using Anticoagulation Strategies) study."	0
We investigated the role of serum specific IgE to thyroid peroxidase (TPO) in patients with aspirin intolerant acute urticaria (@Disease$) and @Chemical$ intolerant chronic urticaria (AICU).	0
"These data closely match the frequency of @Disease$ that was observed in the CAPRIE trial, suggesting that therapy with clopidogrel, and/or @Chemical$ holds very small (if any) risk for dyspnea."	0
Or is the balance of evidence still substantially tipped towards the need for PPIs to protect against @Chemical$-induced @Disease$?	1
BACKGROUND: @Chemical$ is widely used for the secondary prevention of @Disease$ and cardiovascular disease.	0
"For average-risk individuals aged 50-65 years taking @Chemical$ for 10 years, there would be a relative reduction of between 7% (women) and 9% (men) in the number of @Disease$, myocardial infarction or stroke events over a 15-year period and an overall 4% relative reduction in all deaths over a 20-year period."	0
OBJECTIVE: The purpose of this study is to estimate urinary @Chemical$ glucuronide (LTBG) concentration in the clinically stable condition in healthy subjects and asthmatic patients and to investigate changes in urinary LTBG concentration in patients with @Disease$ after aspirin challenge.	0
"Clinical, clinicopathologic, and @Disease$ changes from @Chemical$, prednisone, or combination treatment in healthy research dogs: A double-blind randomized trial."	1
"In contrast, young mice treated with intravenous @Chemical$ had an increased @Disease$ diameter of 136 +/- 44 mum."	1
"The PAIN (Paracetamol, Aspirin, @Chemical$ New tolerability) study was a blinded randomised comparison of the tolerability of OTC analgesics in the treatment of common types of acute @Disease$ encountered in the community."	0
"@Chemical$ (acetylsalicylic acid)-induced asthma (AIA) consists of the clinical triad of @Disease$, chronic rhinosinusitis with nasal polyps, and precipitation of asthma and rhinitis attacks in response to aspirin and other NSAIDs."	0
The new highly selective cyclooxygenase 2 inhibitors are well tolerated in @Disease$ asthmatics who have not been desensitized to @Chemical$.	0
"Although H. pylori infection may be a risk factor of @Chemical$-induced @Disease$, the role of its eradication in the prevention of this outcome requires further investigation."	1
"CONCLUSIONS: Peptic ulcer history, dual anti-platelet medication, H. pylori current infection, and male gender were possible clinical risk factors for @Chemical$-induced @Disease$."	1
[Is @Chemical$ a safe alternative for the Fernand @Disease$?]	0
"CONCLUSION: Gastroduodenal ulcers/erosions were observed in about one-third of asymptomatic patients taking low-dose @Chemical$ and gastroprotective agents, and PPI use was a negative independent factor for gastroduodenal @Disease$/erosions in those patients."	0
BACKGROUND AND PURPOSE: Apixaban reduces @Disease$ with comparable bleeding risks when compared with aspirin in patients with atrial fibrillation who are unsuitable for @Chemical$ antagonist therapy.	0
"@Chemical$-exacerbated respiratory disease is a chronic and treatment-resistant disease, characterized by the presence of @Disease$, nasal polyposis, bronchial asthma, and nonsteroidal anti-inflammatory drugs hypersensitivity."	0
OBJECTIVE: We sought to establish the effect of @Chemical$ on pulmonary inflammation and function in patients with persistent @Disease$.	0
"Although the latter is conventionally used in nasal lysine-@Chemical$ challenge, use of the former in aspirin-induced @Disease$ (AIA) has never been evaluated."	0
"METHODS: Therefore, nasal polypous tissue specimens of patients suffering from @Disease$ (NP), intrinsic asthma (ATA), @Chemical$-intolerance (AINA), and aspirin-triad (TRIAD) were investigated."	0
"Among the risk factors of @Chemical$-associated ulcer @Disease$, Helicobacter pylori infection is one of the few that is treatable."	0
OBJECTIVE: This study evaluated whether there was an association between 2 polymorphisms--the platelet glycoprotein (GP) IIIa PlA1/A2 polymorphism and the 27-bp VNTR (variable number of tandem repeats) polymorphism in intron 4 of the endothelial nitric oxide synthase (eNOS) gene--and a risk for nonvariceal upper GI bleeding in Spanish patients taking low-dose @Chemical$ for secondary prophylaxis of @Disease$.	0
RESULTS: The rare C allele frequency of TBXA2R+795T&gt;C was significantly higher in AIA than in ATA (P=0.03) and the TBXA2R+795T&gt;C polymorphism was also associated with extent of percent fall in forced expiratory volume in 1 s (FEV1) after the inhalation of lysine-@Chemical$ in AIA patients (P=0.009); @Disease$ patients homozygous for the +795 C allele had a greater percent fall of FEV1 compared with individuals with TBXA2R+795 CT or TT genotypes.	0
"Patients undergoing dual antiplatelet therapy had significantly more @Disease$ complications than patients in the @Chemical$-only group [11/99: 11.1 vs. 3 %, p = 0.005, OR = 3.95 (1.43-11.16)]."	0
"The prevalence of AR in patients undergoing @Disease$ seems higher than in most of the studied populations, and this study has shown that the @Chemical$ statuses of a significant number of patients undergoing HD change after an HD session."	0
"Furthermore, chronic use of @Chemical$ results in a variety of lesions in the small bowel, including multiple petechiae, loss of villi, erosions, and round, irregular, or punched-out @Disease$."	1
"Although the incremental cost-effectiveness of clopidogrel in individuals with @Chemical$ @Disease$ is marginal, if available, ambulatory desensitization remains a less-expensive option for secondary cardiovascular prophylaxis."	1
CONCLUSION: Regular use of @Chemical$ and COX-2 inhibitors might reduce @Disease$ risk for women at familial or genetic risk.	0
Pretreatment with melatonin or tryptophan remarkably reduced @Chemical$ induced @Disease$ and microbleeding.	1
OBJECTIVE: Adverse event reports (@Chemical$) submitted to the US Food and Drug Administration (FDA) were reviewed to assess the @Disease$ complications induced by the administration of antiplatelets and to attempt to determine the rank-order of the association.	0
"@Chemical$ is widely accepted as a treatment option for migraine pain relief and could provide an alternative not only for treatment of moderate migraine attacks, but also for severe @Disease$ attacks."	0
"CONTEXT: Although @Chemical$ (aspirin) is commonly used for patients with @Disease$, a minority of patients have a sensitivity to acetylsalicylic acid and other nonsteroidal anti-inflammatory drugs."	0
"@Chemical$-exacerbated @Disease$ is a clinical syndrome characterized by severe, persistent asthma, hyperplastic eosinophilic sinusitis with nasal polyps, and reactions to aspirin and other nonsteroidal antiinflammatory drugs that preferentially inhibit cyclooxygenase 1."	1
"CONCLUSION: Coupling of NO to ASA attenuates stress, @Disease$-reperfusion, and @Chemical$-induced damage due to mucosal hyperemia mediated by NO, which compensates for prostaglandin deficiency induced by ASA."	0
The two frequent clinical presentations of aspirin hypersensitivity are: @Chemical$-induced @Disease$ (AIA/R) and aspirin-induced urticaria/angioedema (AIU).	1
Platelet Function Assay (PFA)-100 is a coagulation device that can detect @Disease$ caused by @Chemical$ and adenosine diphosphate inhibition.	1
"OBJECTIVE: To determine whether celecoxib, a selective cyclooxygenase 2 (COX-2) inhibitor, cross-reacts in patients with @Chemical$-exacerbated respiratory disease (AERD) with @Disease$."	0
Cerebral microbleeds in patients with @Disease$ taking @Chemical$ or clopidogrel.	0
"CONTEXT: Although acetylsalicylic acid (aspirin) is commonly used for patients with @Disease$, a minority of patients have a sensitivity to @Chemical$ and other nonsteroidal anti-inflammatory drugs."	0
"@Disease$, potentially associated with @Chemical$, has been observed in several patients."	1
Early effects of aspirin desensitization treatment in @Disease$tic patients with @Chemical$-exacerbated respiratory disease.	0
"PURPOSE: To determine whether the prostacyclin-inhibiting properties of @Chemical$ counteracts the bradykinin-induced prostacyclin-stimulating effects of angiotensin-converting enzyme (ACE) inhibitors, thereby attenuating the beneficial effects of ACE inhibitors in @Disease$ patients."	0
Intracerebral hemorrhage was significantly increased in those with the combination of @Chemical$ and severe @Disease$ (p = 0.003).	0
"CONCLUSIONS: In patients with stable CIHD and histories of nonsevere @Disease$ reactions to ASA/NSAIDs, an @Chemical$ challenge is advisable."	0
A 62-year-old man on prophylactic @Chemical$ presented with symptoms of acute cord compression due to spinal epidural @Disease$ that was confirmed on magnetic resonance imaging.	1
The purpose of this work was to study the different cells involved in @Disease$tic inflammatory responses in allergic and @Chemical$ sensitivity patients and compared with Extrinsic Allergic Alveolitis patients (EAA) by BAL procedure.	0
"Studies have demonstrated that, in @Disease$ patients, low-dose @Chemical$ has no adverse effect on hemodynamic, neurohumoral, or renal functions."	0
"CONCLUSIONS: In this cohort of patients with @Chemical$ intolerance undergoing coronary stent implantation, the combination of a thienopyridine with indobufen, trapidil, or triflusal was associated with a low rate of @Disease$, ST and MI."	0
Clinical approach on challenge and desensitization procedures with @Chemical$ in patients with @Disease$ and nonsteroidal anti-inflammatory drug hypersensitivity.	0
"RESULTS: The prevalence of EE in patients taking @Chemical$ (9.4%) was not different from that of the controls (6.3%, odds ratio [OR]: 1.5, 95% confidence interval [CI]: 0.7-3.2), whereas peptic @Disease$ were found more frequently in the aspirin group (14%) than in the control group (4%, OR: 3.6, 95% CI: 1.5-8.8)."	0
"The body weight (p = 0.0065), body mass index (p = 0.006), prevalence of @Disease$ (p = 0.0242), prevalence of ischemic heart disease (p = 0.0015), and frequency of use of low-dose @Chemical$ (p = 0.042) were significantly different between the two groups."	0
OBJECTIVE: To assess whether patients with CIU and @Chemical$ sensitivity share common eicosanoid alterations with patients who have aspirin-sensitive @Disease$.	0
"No patients on interrupted AC without bridging (n = 26, 13 with @Chemical$, 13 with DOAC) developed a @Disease$."	0
"Compared with placebo, @Chemical$ was not associated with significant reduction of all-cause mortality (RR 0.97; 95% CI: 0.92-1.02; P = 0.19; I2 = 13%) or @Disease$ incidence (RR: 0.98; 95% CI: 0.92-1.04; P = 0.43; I2 = 16%)."	0
In subjects with @Chemical$ @Disease$ disruption of synthesis of prostaglandin E2 (PGE2) and overproduction of cysteinyl leukotrienes (Cys-LT) seem to be crucial in the pathogenesis of bronchial symptoms.	1
"Employing two molecular biological methods, we demonstrate that galectin-10 mRNA is overexpressed in AIA, suggesting a novel candidate gene and a potentially innovative pathway for @Disease$ in @Chemical$ intolerance."	1
The crude incidence rate for @Disease$ was highest for dual clopidogrel and @Chemical$ therapy (13.9% per patient-year) and triple therapy (15.7% per patient-year).	0
"@Chemical$ dose, age, sex, body mass index, history of @Disease$, diabetes mellitus, intraprocedural glycoprotein IIb-IIIa or anticoagulant type, and postprocedural anticoagulant use did not have a significant effect on the risk of major bleeding."	0
Patients receiving apixaban plus aspirin had a similar @Disease$ risk compared with those receiving @Chemical$ plus aspirin.	0
"RESULTS: Post-@Chemical$ VCE detected 10 cases (50%) with mucosal damage not apparent in baseline studies (6 cases had petechiae, 3 had erosions, and 1 had @Disease$ in 2 ulcers)."	0
"Univariate analysis suggested a non-significant trend towards increased rate of previous ischaemic @Disease$ or TIA and @Chemical$ resistance (odds ratio, OR=3.88; 95% confidence interval 0.54-29.87; p=0.18)."	0
The incidence of @Disease$ at six months in a post-stent cohort treated with @Chemical$ and clopidogrel is low (4.2%).	0
Regular @Chemical$-use preceding the onset of ICH associated significantly with @Disease$ during the first week after ICH (P=0.006).	0
METHODS: Patients with @Chemical$-related nonbleeding symptomatic @Disease$s were randomised to receive rabeprazole (20 mg/day) plus aspirin (100 mg/day) or rabeprazole (20 mg/day) plus clopidogrel (75 mg/day) for 12 weeks.	0
BACKGROUND: @Chemical$-exacerbated @Disease$ (AERD) affects a subset of patients with asthma.	1
"@Chemical$ fitness grade, @Disease$, previous history of angina pectoris, angioplasty, diabetes, use of vitamin K antagonists, cirrhosis and type of hepatectomy were significantly different between the groups."	0
@Chemical$ desensitization achieved after omalizumab treatment in a patient with aspirin-exacerbated urticaria and @Disease$.	0
"CONCLUSIONS: Physicians should consider additional risk factors for HS, such as a history of HS or @Disease$, and the use of warfarin, before prescribing @Chemical$ for the secondary prevention of cardiovascular events."	0
The aim of the study was to assess the tolerability of @Chemical$ in patients with aspirin-exacerbated respiratory disease (@Disease$).	0
"Combining @Chemical$ 75-81 mg with warfarin to maintain the international normalized ratio at 2.0-2.5 may provide added benefit, but should be considered only for patients at high risk for @Disease$ events."	0
"The incidences of overt @Disease$ and decreased hemoglobin were 3.9% and 1.4% in @Chemical$ group, respectively, significantly higher than the control group (p &lt; 0.01; p &lt; 0.01)."	0
Our findings suggest that aspirin at cardioprophylactic doses as well as @Chemical$ at analgesic doses is associated with a reduced risk of @Disease$.	0
"During 764,247 person-years of follow-up, ibuprofen use and @Chemical$ use were independently associated with increased risk of @Disease$, but aspirin use was not."	0
"CONCLUSIONS: For the treatment of high-risk @Disease$ or minor stroke patients, the clopidogrel-@Chemical$ treatment did not increase the number of CMB than Aspirin alone."	0
The mechanism of mucosal injury included @Disease$ induced by @Chemical$ and decreased synthesis of vascular endothelial growth factor (VEGF) by clopidogrel.	1
"To evaluate the preventive effect of lafutidine on @Disease$ caused by @Chemical$ alone and by the combination of both LDA and loxoprofen, we conducted a clinical study using healthy volunteers."	1
"CONCLUSIONS: Low-dose enteric-coated aspirin frequently damages the small intestine, and misoprostol is effective in the treatment of @Chemical$-induced @Disease$."	1
@Chemical$ and @Disease$.	0
"In addition, rs1330344 was also significantly associated with the development of NSAID/@Chemical$-induced @Disease$."	1
"If no evidence of intolerance was seen, each patient was rechallenged with 60 or 90 mg of @Chemical$ once daily (according to the @Disease$) 7 days later."	0
[@Chemical$ desensitization: therapy options in patients with aspirin-exacerbated @Disease$].	0
CONCLUSIONS: Small absolute differences in the risk of ischemic events with longer @Chemical$ would be sufficient to outweigh the known @Disease$ risks.	1
"OBJECTIVE: Aspirin exacerbated @Disease$ (AERD) is comprised of aspirin/acetylsalicylic acid (@Chemical$) sensitivity, bronchial asthma, and nasal polyposis."	0
"The cumulative occurrence rate of bleeding @Disease$s over 24 weeks in the teprenone group was 4.6%, while bleeding ulcers were not observed in the 10- or 5-mg @Chemical$ groups."	0
"Aspirin (@Chemical$) is used worldwide to treat various inflammatory conditions and prevent cardiovascular disease, along with reducing the risk of @Disease$."	0
Lipoxins and @Chemical$ are important mediators of mucosal defence in the stomach (and elsewhere in the @Disease$) and represent attractive therapeutic targets for reducing the incidence of gastric ulceration.	0
"She repeated the @Chemical$ dose in the evening and, by noon the next day, 26(1/2) hours after the @Disease$ began, it was resolved."	1
"Aspirin (ASA)-exacerbated respiratory disease (@Disease$) is characterized by upper airway congestion due to eosinophilic inflammation of the nasal and sinus membranes and nasal polyposis, associated with increased @Chemical$ production that is further accentuated by ASA or other nonsteroidal anti-inflammatory drug (NSAID) ingestion."	0
"@Chemical$ showed prothrombotic properties in the same model of induced @Disease$ that were very similar to those described after aspirin withdrawal, but the effect was observed only 1 hour after aspirin administration."	0
It should be used for @Disease$ patients who do not respond to topical corticosteroids and @Chemical$ modifier drugs.	0
"Main complications in the four treatment groups (no anticoagulant treatment, aspirin, @Chemical$, aspirin and LMWH) included @Disease$ of pregnancy (9.4%, 23.3%, 50%, 18.4%, respectively, p = 0.12) and preterm birth (16.7%, 34.3%, 75%, 36.8%, respectively, p &lt; 0.001)."	0
"CONCLUSIONS: Aspirin and @Chemical$ conferred similar bleeding risks, and both exhibited less @Disease$ than patients who received rivaroxaban."	0
"However, in some patients, such treatment is associated with upper gastrointestinal (GI) adverse effects, e.g. @Disease$, peptic ulceration, and GI bleeding, that may interfere with adequate adherence to, and continuation of, low-dose @Chemical$ for CV protection."	0
"The risks of suffering ischemic @Disease$, bleeding, or death with warfarin, @Chemical$, or no antithrombotic treatment during 2010 were related to CHA2DS2VASc scores, age, and complicating co-morbidities."	0
"The most common reasons for recommending aspirin discontinuation were concern about @Disease$ after polypectomy (62%), perceived minimal downside to stopping @Chemical$ (38%), inertia to changing old policies (20%), and concern about medicolegal implications of postpolypectomy bleeding (15%)."	0
"At 30-months post-PCI, after massive (&gt;91 %) exclusions, @Disease$ risk was higher for continuous @Chemical$ [455 (4.15 %) vs 606 (4.04 %); HR=1.221; 95 %CI: 1.061-1.405; p=0.005], which remained significant by PSM (p=0.006) or IPTW (p=0.007), while all-cause mortality was similar [136 (1.24 %) vs 192 (1.28 %) HR=0.999; 95 %CI: 0.736-1.135; p=0.993]."	0
"Compared with patients not associated with NSAIDs and @Chemical$ medication, they are older [(41.2 +- 1.9) years vs (59.4 +- 2.2) years, P &lt; 0.001], more commonly associated with hypertension (10.4% vs 39.2%, P &lt; 0.001), coronary heart disease (10.4% vs 17.6%, P &lt; 0.001), @Disease$ (4.2% vs 19.6%, P = 0.005); and had more severe anemia (7.3% vs 23.5%, P = 0.008)."	0
"Preoperative @Chemical$ increased postoperative @Disease$ (mean difference 143 ml, 95% CI 39-248 ml; P = 0.007) and packed red blood cell transfusion (mean difference 142 ml, 95% CI 55-228; P = 0.001) but did not increase the risk of surgical re-exploration (risk ratio 1.316, 95% CI 0.910-1.905; P = 0.145)."	0
"Before, after 120, and 240 min of DDAVP administration the following parameters were measured: @Disease$ (PA) and @Chemical$ release induced by ADP, collagen, ristocetin and thrombin; PFA-100 closure times (CT), factor VIII activity (FVIII:C), Von Willebrand factor antigen (VWF:Ag), collagen binding activity (VWF:CB) and blood count."	0
"OBJECTIVE: Despite being a safe, effective therapy for lowering cardiovascular risk, only 20% of @Disease$ patients were using @Chemical$ in the early 1990s."	0
"Age, male gender, Helicobacter pylori (H. pylori)infection, diabetes, chronic kidney disease (CKD), cirrhosis, history of uncomplicated @Disease$ (PUD), and use of NSAIDs, COX-2 inhibitors, steroids, and thienopyridines were independent risk factors for UGIB among @Chemical$ users."	0
"In the patients who survived at least 90 days, there was 1 @Disease$ (1%) in the @Chemical$ group compared with 53 (5%) in the nonketorolac group (p = 0.01)."	0
Treatment of aspirin exacerbated @Disease$ with a low @Chemical$ diet: a pilot crossover study.	0
"Cotherapy with a PPI, @Chemical$, or double dose H(2)RAs can reduce @Disease$ complications associated with high-dose ASA therapy."	0
CONCLUSIONS: Use of tacrolimus as add-on pretreatment to prevent reactions to @Chemical$ in patients with @Disease$ or to achieve the goal of silent aspirin desensitization could not be accomplished.	0
"Dual antiplatelet therapy consisting of low-dose @Chemical$ (LDA) and other antiplatelet medications is recommended in patients with coronary heart disease, but it may increase the risk of @Disease$ and bleeding."	0
The possible additive antiplatelet effects of aspirin and @Chemical$ have been explored in the Clopidogrel in Unstable @Disease$ to Prevent Recurrent Events (CURE) and Management of Atherothrombosis with Clopidogrel in High Risk Patients (MATCH) studies.	0
The purpose of this work was to study the different cells involved in asthmatic inflammatory responses in @Disease$ and @Chemical$ sensitivity patients and compared with Extrinsic Allergic Alveolitis patients (EAA) by BAL procedure.	0
"CONCLUSIONS: Among STEMI patients treated with a fibrinolytic agent and @Chemical$, use of NSAIDs in the week preceding the incident event was associated with a higher incidence of MI, the composite of death and MI as well as the composite of death, MI, severe @Disease$ and shock at 30 days."	0
"Fracture risk associated with use of nonsteroidal anti-inflammatory drugs, acetylsalicylic acid, and @Chemical$ and the effects of @Disease$ and osteoarthritis."	0
Standard-dose lafutidine significantly prevents @Disease$ induced by LDA alone or LDA plus @Chemical$ in H. pylori-negative volunteers.	0
"CONCLUSION: @Chemical$ use was not significantly associated with DR but might be an indicator of @Disease$ (CVD, CKD) that were co-present with more severe DR type."	0
BACKGROUND: The purpose of this study was to assess the impact of continuation of @Chemical$ on @Disease$ complications following coronary artery bypass grafting (CABG) surgery operated by a single surgeon.	0
Addition of baseline high platelet reactivity to the @Chemical$ score did not improve discrimination for @Disease$ events.	0
"Also, we establish aspirin-induced @Disease$ model by the oral administration of @Chemical$ (0.5 g/kg body weight) to verify the predicted targets from network pharmacology."	0
"The factors associated with an increased risk of upper gastrointestinal (GI) complications in subjects taking @Chemical$ are aspirin dose, history of @Disease$ or upper GI bleeding, age &gt; 70 years, concomitant use of non-aspirin NSAIDs including COX-2-selective NSAIDs, and Helicobacter pylori (H. pylori) infection."	0
BACKGROUND &amp; AIMS: Effervescent calcium carbasalate is a calcium-salt of @Chemical$ causing less local @Disease$ than acetylsalicylic acid at high doses in healthy controls.	0
Balancing the Checkpoint: Managing @Disease$ Associated with Dual Checkpoint Inhibitors and High-Dose @Chemical$.	1
"In some patients, the cardiovascular benefits of low-dose aspirin might be overcome by the risk of @Disease$, but withdrawal of @Chemical$ therapy can precipitate a cardiovascular event."	0
"@Chemical$-exacerbated respiratory disease (AERD) is defined as asthma, chronic rhino@Disease$ with nasal polyposis, and hypersensitivity to cyclooxygenase-1 inhibitors."	0
It is not known if an interaction exists between aspirin and @Chemical$ in regards to @Disease$.	0
In vitro studies into mechanistic processes of salicylate toxicity propose that there is a bi-directional link and potentiation with glutathione (GSH) depletion and @Chemical$ @Disease$.	1
"RESULTS: A total of 82,854 of 118,606 patients (69.9%) surviving @Disease$ hospitalization had at least 1 prescription filled for @Chemical$, aspirin, or clopidogrel after discharge."	0
"These associations were stronger after more than 10 years of use (acetaminophen: odds ratio (OR) = 1.8, 95% confidence interval (CI): 1.3, 2.6; @Chemical$: OR = 1.6, 95% CI: 1.1, 2.2) and were present for indications of @Disease$, menstrual pain, and other pain/injury."	0
CONCLUSION: These data suggest that AR may be of special concern for @Disease$ patients with poor @Chemical$ control and obesity.	0
"However, as discontinuation of aspirin, unlike NSAIDs, may precipitate cardiovascular and cerebrovascular events, treatment of @Chemical$-associated @Disease$s should re-start aspirin as soon as possible, using proton pump inhibitor (PPI)."	1
CONCLUSIONS: The presence of the SLCO1B1*1b/*1b diplotype may be a risk factor for @Chemical$-induced @Disease$ in elderly Chinese men taking aspirin and an ACEI or ARB concomitantly.	1
About 34 % of patients with @Chemical$-induced asthma and rhino@Disease$ are thought to have AERD.	0
Clopidogrel alone administered to patients taking @Chemical$ after PCI was associated with a significantly lower rate of @Disease$ complications than clopidogrel plus aspirin.	0
The two frequent clinical presentations of aspirin @Disease$ are: aspirin-induced bronchial asthma/rhinosinusitis (AIA/R) and @Chemical$-induced urticaria/angioedema (AIU).	0
There are a few studies of the association between genetic polymorphisms and the risks of @Chemical$ (aspirin)-induced @Disease$ or its complications.	1
"Platelet adenosine diphosphate (ADP) receptors may play a role in potentiating platelet activation induced by IgG from patients with immune heparin-induced @Disease$ (HIT), as shown by previous studies using the ADP receptor antagonists @Chemical$ and ticlopidine."	0
PURPOSE OF REVIEW: Aspirin-induced urticaria/angioedema is a major @Chemical$-related @Disease$ often associated with aspirin-intolerant asthma.	1
No published meta-analyses on the use of @Chemical$ for the primary prevention of cardiovascular disease in @Disease$ exist.	0
A clinical study of Japanese patients with @Disease$ induced by low-dose @Chemical$ and other non-steroidal anti-inflammatory drugs.	1
"BACKGROUND: Although low-dose aprotinin administered after cardiopulmonary bypass has been reported to reduce mediastinal blood loss and blood product requirements in patients not taking aspirin, it is unknown whether low-dose postoperative aprotinin has any beneficial effects in patients undergoing coronary artery bypass operations who are at high risk of @Disease$ and increased transfusion requirements because of @Chemical$ use until just before the operation."	1
A meta-analysis of @Chemical$ 50-1500 mg daily reported an odds ratio for any @Disease$ of 1.68 (95% CI: 1.51-1.88) with an number-needed-to-harm at 1 year of 247.	0
"We conclude that in patients with an @Disease$ and @Chemical$ based regimen, addition of clopidogrel because of a stent placement results in a significant increase in NSH but no increase in SH."	0
CONCLUSION: Myocardial ischemia is a relatively common complication in CAD patients under @Chemical$ therapy presenting with @Disease$.	1
Comparison of @Disease$ between low-dose @Chemical$ and non-aspirin non-steroidal anti-inflammatory drugs: a capsule endoscopy study.	0
CONCLUSION: PPIs are effective in preventing @Chemical$-associated upper GI ulcers and @Disease$.	0
METHODS: Patients with aspirin-related non@Disease$ symptomatic ulcers were randomised to receive rabeprazole (20 mg/day) plus aspirin (100 mg/day) or rabeprazole (20 mg/day) plus @Chemical$ (75 mg/day) for 12 weeks.	0
The prevalence of intolerance for low-dose @Chemical$ in the secondary prevention of @Disease$.	0
Increases in risk for clinically relevant and major @Disease$ were similar for @Chemical$ and enoxaparin-VKA anticoagulation regimens.	0
"Indications for which the benefit of @Chemical$ has been shown are women with a history of preeclampsia responsible for a premature birth before 34 weeks, those having at least two history of preeclampsia, those with an antiphospholipid syndrome and those with lupus associated with positive antiphospholipid antibodies or @Disease$."	0
"OBJECTIVE: We evaluated hourly dose escalations in a subset of patients with chronic rhinosinusitis, @Disease$, and asthma who historically reacted to aspirin within 1 hour or were avoiding @Chemical$ with the goal of developing a safe and efficient desensitization protocol."	0
"Main risk factors for upper @Disease$ bleeding with low-dose @Chemical$ are concomitant antiplatelet agents, anticoagulants, non steroidal anti-inflammatory drugs or steroids use, and recent history of complicated or non-complicated gastroduodenal ulcer."	0
The aim of this study was to investigate the effect of aspirin and other NSAIDs on the risk of @Chemical$ @Disease$s.	1
"The use of aspirin, aspirin plus extended-release @Chemical$, or clopidogrel is recommended as initial therapy in patients with noncardioembolic ischaemic stroke or @Disease$ to reduce the risk of recurrent stroke and other cardiovascular events."	0
@Disease$ and angioedema (@Chemical$) represent a syndrome that is frequently encountered in children and adults.	0
"In this cohort of women, longer durations of NSAID and @Chemical$ use were associated with slightly higher risks of @Disease$, but duration of aspirin use was not."	0
"This report describes a case of Kounis-Zavras syndrome in the setting of @Chemical$-induced asthma also known as Samter-Beer triad combining nasal @Disease$, asthma, and aspirin allergy leading to vasospasm and myocardial infarction."	0
In vitro studies into mechanistic processes of salicylate toxicity propose that there is a bi-directional link and potentiation with glutathione (@Chemical$) depletion and salicylate @Disease$.	0
BACKGROUND: @Chemical$ and aspirin (acetylsalicylic acid [ASA]) are the most commonly used anticoagulant and antiplatelet drugs in the treatment of @Disease$.	0
"METHODS: A total of 11 aspirin-sensitive patients with asthma, 10 @Chemical$-tolerant patients with asthma, and 10 controls without @Disease$ were studied."	0
"CONCLUSION: Our findings confirm the beneficial effect of low-dose @Chemical$ on recurrence of any adenomas; however, effect on advanced @Disease$s was inconclusive."	0
"Recently, flowcharts regarding challenge/desensitization procedures with @Chemical$ in patients with CAD and histories of aspirin @Disease$ reactions have become available."	0
"For average-risk individuals aged 50-65 years taking @Chemical$ for 10 years, there would be a relative reduction of between 7% (women) and 9% (men) in the number of cancer, myocardial infarction or stroke events over a 15-year period and an overall 4% relative reduction in all @Disease$ over a 20-year period."	0
"We compared 1- and 3-year outcomes for cerebrovascular accident (@Disease$), transient ischemic attack (TIA), gastrointestinal (GI) bleeding, genitourinary (GU) bleeding, any bleeding, and AF recurrence among patients receiving: none, aspirin, or @Chemical$ as long-term therapies."	0
"As for bleeding complications related to the @Disease$, e.g., melaena and haematochezia, the statistical metrics suggested a stronger association for @Chemical$ than clopidogrel."	0
[Pathogenesis of @Chemical$-induced @Disease$].	1
"CONCLUSIONS: We conclude, that decreased apoptosis of inflammatory cells in nasal polyps from @Chemical$-@Disease$ patients, reflects a distinct mechanisms of local inflammation and may be related to persistence and severity of the disease in these patients."	0
CONCLUSIONS AND CLINICAL IMPORTANCE: Administration of the combination of zinc-L-carnosine and @Chemical$ at 1X or 2X dosing did not attenuate aspirin-induced @Disease$.	0
Risks for stroke and @Disease$ with warfarin or @Chemical$ treatment in patients with atrial fibrillation at different CHA(2)DS(2)VASc scores: experience from the Stockholm region.	1
"Aspirin-exacerbated respiratory disease (AERD), or @Chemical$-induced @Disease$, is characterized by asthma and rhinitis triggered by the ingestion of aspirin and non-steroidal anti-inflammatory drugs."	1
"Conclusion In @Chemical$ treated patients with first time @Disease$, treatment with proton pump inhibitors was associated with an increased risk of adverse cardiovascular events."	0
Ability of rabeprazole to prevent @Disease$ from @Chemical$ and low doses of aspirin depends on CYP2C19 genotype.	1
"@Chemical$-Tris did not cause bleeding, microcirculatory dysfunction, @Disease$ or an elevation in proinflammatory markers."	0
"METHODS: 40 subjects with @Disease$ (NP) were classified as @Chemical$-sensitive (n=13, ASNP) or aspirin-tolerant (n=27, ATNP) based on a bronchial aspirin challenge test."	0
Population studies have associated @Chemical$ use with occult gastrointestinal bleeding from the small or large @Disease$ although the magnitude of this risk is difficult to estimate but certainly small.	0
We present a case of catastrophic early drug eluting stents thrombosis in a 79-year-old Italian woman with @Chemical$ @Disease$.	1
This results confirmed the role of cysteinic leukotrienes in pathogenesis of @Chemical$ induced @Disease$.	1
"BACKGROUND: Aspirin-exacerbated respiratory disease (@Disease$) is explained in part by overexpression of 5-lipoxygenase and leukotriene C4 synthase (LTC4S), resulting in constitutive overproduction of cysteinyl leukotrienes (CysLTs) and driving the surge in CysLT production that occurs with @Chemical$ ingestion."	0
Nasal and bronchial tolerability of @Chemical$ in patients with aspirin induced @Disease$.	0
"The triad of bronchial asthma, nasal polyposis, and intolerance to @Chemical$ and aspirin-like chemicals are designated aspirin-induced @Disease$ (AIA) or Samter's syndrome."	0
"AIM: To conduct a randomised, double-blind, triple-dummy, active-controlled, multicentre trial, named the PLANETARIUM study, to assess the efficacy, dose-response relationship and safety of @Chemical$ for peptic @Disease$ recurrence in Japanese patients on long-term LDA therapy."	0
"A diagnosis of RA (RR = 1.75; 95% CI = 1.09-2.79), but not OA (RR = 1.06; 95% CI = 0.67-1.68), was associated with risk of @Disease$, but the positive association of use of @Chemical$ and other NSAIDs with NHL was independent of RA history."	0
"Incidences of poor @Disease$ control during the procedure and bleeding after the procedure were 7.7% (1/13) and 15.4% (2/13) of patients, respectively, in the @Chemical$-interrupted group, and 3.2% (1/31) and 16.1% (5/31) of patients, respectively, in the LDA-continued group."	0
From the 60 patients taking NSAIDS/ASA with no histologic evidence of @Chemical$ all (100 %) were identified by the histology of the @Disease$.	0
"IMPORTANCE OF THE FIELD: @Chemical$ reduces the risk of cardiovascular events, but it is well documented that it can also damage the @Disease$ (GI) tract."	1
"Based on data extracted from the validation process, recent recorded drug intake showed an increased frequency of anticoagulants with @Disease$, whereas NSAID and low-dose @Chemical$ use were more prevalent in peptic ulcer bleeding and colonic diverticular bleeding respectively."	0
"Drugs that can lead to @Disease$ include non-steroidal anti-inflammatory drugs (NSAIDs) like diclofenac and ibuprofen, platelet inhibitors such as @Chemical$ (ASS), clopidogrel and prasugrel, as well as anticoagulants like vitamin-K antagonists, heparin or direct oral anticoagulants (DOAKs)."	0
"METHODS: For 4 years, we followed up 22 patients with chronic idiopathic @Disease$ and aspirin hypersensitivity who restrained from the use of @Chemical$ and other COX-1 inhibitors."	0
"In Reye's syndrome, hyperammonemia and perhaps the increase of @Chemical$ are the leading factors in the mechanism of @Disease$ and encephalopathy."	0
"Because of its definitive inhibitory effect on @Disease$, @Chemical$ (more than other non-steroidal anti-inflammatory drugs exerting unselective inhibition of cyclooxygenase) is a strong factor in triggering or sustaining the bleeding disorders in these patients."	0
"CONCLUSIONS AND CLINICAL IMPORTANCE: Administration of deracoxib to healthy dogs resulted in significantly lower gastric lesion scores, and fewer days of @Disease$ compared to @Chemical$, indicating that deracoxib is better tolerated than aspirin in some dogs."	0
The rates of both stroke and @Disease$ increased with higher CHADS2 scores but @Chemical$ compared with aspirin was associated with a similar relative risk of bleeding (P interaction 0.21) and a reduced relative risk of stroke (P interaction 0.37) irrespective of CHADS2 category.	0
Oral aspirin challenge (@Chemical$) reveals aspirin-exacerbated respiratory disease (AERD) in approximately 50% of unselected patients with @Disease$ with nasal polyposis (CRSwNP).	0
"In saliva analysis among the three groups (AIA patients, aspirin-tolerant @Disease$ [ATA] patients, and healthy subjects), both the concentrations of @Chemical$ and LTB4 were significantly higher in AIA patients than in ATA patients and healthy subjects."	0
"BACKGROUND: Aspirin (acetylsalicylic acid [@Chemical$]) @Disease$ is frequent in patients with nasal polyps (NPs) and is called aspirin exacerbated respiratory disease, previously known as Samter's syndrome."	1
"@Disease$, characterized by acute encephalopathy, selective liver damages, a fatty degeneration in visceral organs and miserable prognosis, is probably caused by various drugs, especially antipyretic such as @Chemical$."	1
"METHODS AND MATERIALS: We compared the effect of NO-@Chemical$ and ASA on @Disease$ provoked by water-immersion and restraint stress (WRS), ischemia-reperfusion, and 100% ethanol."	0
"Use of NSAIDs, LDA, @Chemical$, and ACs within 2 weeks prior to the endoscopy was compared between cases and controls, and effects on ulcer @Disease$ were calculated."	0
"The main models included the following predictors: demographic characteristics (age, ethnicity, and socioeconomic deprivation), clinical measurements (systolic blood pressure and ratio of total-high-@Chemical$), family history of premature CVD, medical history (smoking, diabetes, bleeding, peptic ulcer disease, @Disease$, chronic liver disease, chronic pancreatitis, or alcohol-related conditions), and medication use (nonsteroidal anti-inflammatory agents, corticosteroids, and selective serotonin reuptake inhibitors)."	0
CONCLUSIONS: The risks of major @Disease$ with low-dose @Chemical$ in real-world settings are of a similar magnitude to those reported in randomized trials.	0
OBJECTIVES: Surgical @Disease$. transfusion rate and cardiovascular complications were analized in patients undergoing chronic treatment with low-doses @Chemical$ and scheduled to unilateral primary knee arthroplasty.	0
We present the case of a patient taking aspirin and @Chemical$ who was admitted with upper digestive @Disease$ due to duodenal ulcer.	0
"Efficacy and safety of 1,000 mg effervescent @Chemical$: individual patient data meta-analysis of three trials in @Disease$ headache and migraine accompanying symptoms."	1
This is a case of a 60-year-old gentleman who presented with an extensive cutaneous vasculitic rash (@Disease$) with lower gastrointestinal bleeding following a small dose of @Chemical$ (81 mg).	0
"BACKGROUND: During a clinical trial, we obtained 16 biopsies of skin eruptions induced by aspirin in patients with chronic @Disease$ (@Chemical$)."	0
"In conclusion, @Chemical$ use might has, if any, only a small effect on the survival of @Disease$ patients based on current evidence."	0
"There was no significant difference in COX-2 expression between @Disease$ and aspirin stimulation (mean 61.8%, range 26.8-89.2; p = 0.09) and LPS stimulation (mean 55.5%, range 28.1-74.3) nor between @Chemical$ stimulation alone (median 0.5%, range 0-8.6; p = 0.8) and baseline values (median 0.4%, range 0-5.4) in healthy control subjects."	0
The good clinical outcomes of @Disease$ in our study are supported by overall changes observed in the @Chemical$ metabolites (decreased PGD2 over a constant LTC4/PGE2).	0
"Aspirin exacerbated respiratory disease (AERD) is an adult onset condition manifested as asthma, @Disease$, and sensitivity to @Chemical$ and other cyclooxygenase-1 (Cox-1)-inhibitor nonsteroidal anti-inflammatory drugs (NSAIDs)."	0
"Herein, we focus on the role of proton pump inhibitor (PPI) in the strategy to prevent and to treat @Chemical$-induced peptic @Disease$ations and their complications, based on the scientific evidence."	0
"BACKGROUND: Although it is well known that aspirin causes gastroduodenal mucosal injury and that @Chemical$-induced @Disease$ is often asymptomatic, the prevalence and independent factors for gastroduodenal mucosal injury have not been clarified in asymptomatic patients taking low-dose aspirin and gastroprotective agents."	1
Antral @Chemical$(2)-basal levels appear to be critical for development of aspirin-induced gastric damage in subjects without H. pylori @Disease$.	0
"CONCLUSION: The chronic periodontitis and @Disease$ patients with long-term oral administration of low dose of @Chemical$ can be safely treated with periodontal mechanical treatment, and the effect of local hemostasis is positive without stopping the drug."	0
"The investigated compounds provide equivalent @Disease$ to ligand structures for GABA, @Chemical$, NMDA and nicotinic receptors."	0
"Factors independently associated with @Chemical$ use were prior aortic or peripheral intervention, drug-eluting stent implantation, stroke, carotid endarterectomy and time since @Disease$ diagnosis."	0
"In those who took @Chemical$ and smoked there was no detectable increased risk of @Disease$ (OR=0.30, 95% CI=0.03-3.08)."	0
Oral aspirin challenge (@Chemical$) test was performed to identify aspirin @Disease$.	0
H(1)-receptor antagonists (anti@Chemical$s) are the major class of therapeutic agents used in the management of @Disease$ and angioedema.	0
@Chemical$-induced @Disease$ was diagnosed in 11 patients (14.7%) with clinical manifestations of hypersensitivity responses.	1
The @Chemical$ component may in all probability be the cause of the @Disease$.	1
BACKGROUND: Use of low-dose @Chemical$ increases the risk for peptic @Disease$ (PUB) by approximately 60%.	1
"After 3 months, the patient is free from adverse events.@Disease$ is commonly considered a contraindication to aspirin intake; however, this case shows that @Chemical$ at low, antiplatelet dosage is well tolerated and should not be denied to patients with ischaemic heart disease and complex coronary anatomy."	0
"METHODS: This Management of Aspirin-induced Gastro-Intestinal Complications (MAGIC) study was conducted with a prospective nationwide, multicenter, real-world registry of Japanese patients at high-risk of @Disease$ who were taking regular @Chemical$ (75-325 mg) for 1 month or more."	0
CONCLUSIONS: This case shows that SEH occurs under a minimal dose of @Chemical$ and that such patients rapidly recover upon immediate surgical decompression and evacuation of the @Disease$.	0
"Risk of bleeding with single, dual, or triple therapy with @Chemical$, aspirin, and clopidogrel in patients with @Disease$."	0
Reproducibility of response to nasal @Chemical$-aspirin challenge in patients with aspirin-induced @Disease$.	0
@Chemical$ is a well-known trigger for @Disease$ in patients with FDEIA.	1
"BACKGROUND: In @Chemical$-sensitive patients with @Disease$, bronchial obstruction induced by oral aspirin may be associated with extrabronchial symptoms, suggesting the systemic character of the response."	0
"Less frequent NSAID use was not clearly associated with risk for @Disease$ or UC, and there was no clear association between @Chemical$ use and disease."	0
This cohort's clinical experience adds significant support for low-dose @Chemical$ use to optimize neurodevelopmental outcome in @Disease$ with minimal side effects.	0
@Chemical$ plays a pivotal role in the management of patients with Coronary Artery Disease (@Disease$) with well-recognised benefits of reducing recurrent myocardial infarction and minimising the risk of stent thrombosis for those undergoing Percutaneous Coronary Intervention (PCI).	0
BACKGROUND: Acetylsalicylic acid (@Chemical$) is used in the treatment of @Disease$ (AMI) but is also a risk factor for peptic ulcer disease (PUD) bleeding.	0
@Chemical$ users had higher @Disease$ rates (hazard ratio 1.35; 95% CI: 1.22-1.49) but this association was attenuated following adjustment for potential confounders (adjusted HR 0.99; 95% CI: 0.88-1.12).	1
@Chemical$-induced @Disease$ (AIA) and aspirin-induced urticaria/ angioedema (AIU) are two major aspirin-related allergies.	1
We aimed to assess the differential occurrence of @Disease$ between the two phases and the cardiovascular mortality of patients whether on @Chemical$ or not.	0
"@Chemical$ intolerance, house dust mite (HDM) allergy, male sex, age older than 65 years, and duration of asthma exceeding 10 years were investigated as factors potentially related to the severity of @Disease$."	1
"CONCLUSIONS: In this subgroup analysis in patients at high risk for recurrence of @Disease$ ulcer, use of cotherapy with @Chemical$ 200 microg QID or lansoprazole 15 or 30 mg OD significantly lowered the risk for gastric ulcer recurrence."	0
@Chemical$-sensitive @Disease$ is associated with reduced E-prostanoid 2 receptor expression on nasal mucosal inflammatory cells.	0
"Within 90 days after intervention, there were 4 patients (1.5%) with acute thrombosis, 5 patients (1.8%) with subacute @Disease$, 17 patients (6.2%) with stroke, and 2 death (0.7%) in low-dose @Chemical$ group, compared with no patient (0%) with acute thrombosis, 2 patient (2.1%) with subacute thrombosis, 6 patients (6.2%) with stroke, and 2 death (2.1%) in high-dose aspirin group, and there were no significant difference in all study endpoints between two groups."	0
"In addition, standard-dose PPI therapy might be more effective in the prevention of @Chemical$-induced @Disease$ than low-dose PPI therapy."	1
"Further research is needed to assess the benefit-risk ratio of clopidogrel plus aspirin in specific subpopulations of patients at high risk for atherothrombotic events, and to determine the role of clopidogrel plus @Chemical$ in preventing cardioembolic @Disease$ or early recurrent stroke after symptomatic large-vessel atherostenosis."	0
"The cells were isolated from 3 groups of subjects: nonasthmatic patients (n = 10), patients with aspirin-tolerant asthma (ATA, n = 9), and patients with @Chemical$-intolerant @Disease$ (AIA, n = 7)."	0
Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With @Chemical$ After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (@Disease$ or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes).	0
"Proton-pump inhibitor treatment resulted in an absolute risk reduction of peptic ulcer by 36.6% in acute and 34.6% in chronic non-steroidal anti-inflammatory drugs/@Chemical$ users; indeed, the number needed to treat to avoid one peptic @Disease$ in elderly non-steroidal anti-inflammatory drugs/aspirin users was three both in acute and chronic users."	0
"CONCLUSIONS: Higher lifetime use of aspirin and NSAIDs is not associated with @Disease$, but high @Chemical$ use may increase the risk of loss of renal function."	0
"Aspirin-exacerbated respiratory disease (AERD) is associated with severe asthma and @Chemical$ can cause @Disease$ to worsen, often in the form of a severe and sudden attack."	1
"CONCLUSIONS: Low-dose aspirin use could reduce the incidences of total cardiovascular events, stroke, nonfatal stroke and transient ischemic attack but increase the risk of bleeding, the incidence of nonfatal myocardial infarction, death from cardiovascular causes and @Disease$ from any cause was not affected by low-dose @Chemical$ use."	0
ASA usage was more common than NSAID in patients with @Disease$ hemorrhage (NSAID usage n=35 (40%); @Chemical$ usage n=51 (60%); p=0.035).	0
"@Chemical$ (ASA)-exacerbated @Disease$ (AERD) is characterized by upper airway congestion due to eosinophilic inflammation of the nasal and sinus membranes and nasal polyposis, associated with increased leukotriene production that is further accentuated by ASA or other nonsteroidal anti-inflammatory drug (NSAID) ingestion."	1
Does concomitant use of @Chemical$ potentiate the @Disease$ associated with aspirin?	0
"Of these, 38 (54.3%) had a history of @Chemical$-induced @Disease$ and/or angioedema, including three laryngeal oedemas (7.9%)."	1
"@Chemical$-exacerbated respiratory disease (AERD) is characterized by chronic rhinosinusitis with @Disease$, asthma, and reactions to cyclooxygenase-1-inhibiting drugs."	0
CONCLUSION: The effective analgesic and anti-inflammatory doses of 1:10 @Chemical$ complex with arabinogalactan are twice less compared to pure aspirin and safer for the @Disease$.	0
"METHODS: The effect of @Chemical$ for site-specific @Disease$ incidence and mortality, cardiovascular events was collated from the most recent systematic reviews."	0
OBJECTIVE: Patients who present with a spectrum of @Disease$ and pseudoallergic reactions to @Chemical$ pose a special challenge for the physician.	1
"Risk factors for upper gastrointestinal (GI) @Disease$ or bleeding among @Chemical$ users include a history of prior GI events, older age, chronic renal failure, combined antithrombotic therapy and nonsteroidal anti-inflammatory drugs (NSAIDs)."	0
Panax Notoginseng @Chemical$(PNS) which is also used to prevent @Disease$ may alleviate this side effect according to previous clinical evidences.	0
"CONCLUSIONS: We conclude, that decreased apoptosis of inflammatory cells in nasal @Disease$ from @Chemical$-hypersensitive patients, reflects a distinct mechanisms of local inflammation and may be related to persistence and severity of the disease in these patients."	1
Natural history and clinical features of @Chemical$-exacerbated @Disease$.	1
Aspirin-induced loss of stored @Chemical$ from chronic @Disease$ is proposed as a mechanism underlying this beneficial effect.	0
"BACKGROUND: This study compares clinical outcomes in patients with @Disease$, taking preinjury antiplatelet drugs (aspirin, clopidogrel) and anticoagulants (@Chemical$)."	0
"BACKGROUND: Aspirin-exacerbated respiratory disease (AERD) is characterized by progressive sinusitis, @Disease$, and asthma that begins and continues in the absence of exposure to @Chemical$ and nonsteroidal anti-inflammatory drugs (NSAIDs)."	0
"Thus, the lack of evidence of benefit with aspirin in patients with heart failure and @Disease$, along with growing evidence that aspirin is directly harmful in patients with heart failure and that @Chemical$ may negate the benefits of angiotensin-converting enzyme inhibitors suggest that, unless there is an opportunity to randomize the patient into a study of antithrombotic strategies, then aspirin should be withdrawn or possibly substituted with an anticoagulant or an antiplatelet agent that does not block cyclooxygenase."	0
"CONCLUSIONS: Urinary 8-iso-PGF2alpha levels, a reflection of systemic oxidative stress, did not appear to contribute to @Disease$ to @Chemical$, while increased platelet production may partly explain this phenomenon."	1
"@Disease$ after @Chemical$ treatment, and Kounis syndrome."	1
Aspirin-exacerbated @Disease$ (AERD) are associated with the metabolism of @Chemical$.	0
"@Chemical$, Reye syndrome, Kawasaki disease, and @Disease$; a reconsideration of the links."	1
"Arachidonic acid (AA, 0.5 mg/mL) and adenosine diphosphate (ADP, 5 micromol/L) induced @Disease$ were measured via light transmission assay (LTA) to evaluate antiplatelet responses, referred as LTA-AA and LTA-@Chemical$."	0
"@Disease$ formed in a total of seven patients (3.5%), five of whom were on DAPT consisting of ASA and clopidogrel (P &lt; 0.0001) while only two of them were on @Chemical$ (P = 0.67)."	0
@Chemical$ @Disease$ and resistance.	1
"Background: Many prognostic models for cardiovascular risk can be used to estimate @Chemical$'s absolute benefits, but few @Disease$ risk models are available to estimate its likely harms."	0
"CONCLUSIONS: Higher lifetime use of aspirin and NSAIDs is not associated with renal function decline, but high @Chemical$ use may increase the risk of @Disease$."	0
"However, @Chemical$, even at a low dose, can induce varying degrees of gastroduodenal mucosal injury (erosion, ulcer, @Disease$ bleeding)."	0
There is limited evidence of the use of leukotriene modifiers in preventing @Chemical$-induced @Disease$.	1
The safety and efficacy of aspirin and @Chemical$ as a combination treatment in patients with @Disease$.	0
"Using an in vivo model of laser-induced @Disease$, @Chemical$ injected in 1 single dose of 100 mg/kg body weight has also shown a prothrombotic activity in the rat 8 to 10 days after injection in the normal rat."	0
"Among the @Chemical$-treated patients with CHA2DS2VASc scores &gt;=2, half had possible contraindications and high risks for ischemic @Disease$ (5.2 %), bleeding (5.0 %), and death (19.3 %)."	0
Prehospital low-dose @Chemical$ therapy as a sole criterion should not warrant a routine repeat head CT in @Disease$.	0
The @Chemical$-induced @Disease$ is mediated by mast cell and eosinophilic inflammation.	1
"SUMMARY: The full clinical picture of @Chemical$ intolerance--the association of aspirin-induced @Disease$ (with severe acute asthma attacks), aspirin sensitivity and nasal polyps--is commonly summarized as the 'Samter triad'."	0
Flow cytometry was performed in another cohort of patients with known @Disease$ (n = 30) to determine the effect of @Chemical$ on platelet surface receptors.	0
The trend towards increased bleeding with @Chemical$ appears to be explained by an excess of intracranial @Disease$ in warfarin patients.	0
"For @Chemical$, no increase in overall @Disease$ risk was present with recent use."	0
"@Chemical$ was associated with increased @Disease$ risks when combined with non-steroidal anti-inflammatory drugs, clopidogrel and selective serotonin reuptake inhibitors compared with monotherapy."	1
"Both naproxen/aspirin and celecoxib/aspirin groups demonstrated a higher incidence of gastric and duodenal @Disease$s vs. placebo/@Chemical$ (8%; RR: 3.7, 95% CI: 1.8-7.6 and RR: 2.6, 95% CI: 1.2-5.8, respectively)."	0
"PURPOSE OF REVIEW: The pathophysiology of @Chemical$-exacerbated @Disease$ (AERD) is not fully understood and diagnostic methods and so far, treatments for AERD have not been standardized."	0
OBJECTIVE: To investigate the protective effect of compound bismuth and magnesium granules on @Chemical$-induced @Disease$ in rats and its possible mechanism.	1
AIM: To evaluate in symptomatic elderly chronic users of low-dose @Chemical$: (1) the association between H. pylori infection and the prevalence of upper gastrointestinal lesions; and (2) the effect of H. pylori @Disease$ on the efficacy of proton pump inhibitors in the prevention of aspirin-related gastroduodenal lesions.	0
"We present a case of @Disease$ associated with concomitant ingestion of @Chemical$, aspirin and grapefruit juice."	0
"Medical management of rhinosinusitis comorbidities-asthma, @Chemical$ sensitivity, gastroesophageal reflux, @Disease$."	0
"BACKGROUND: Clinical features of aspirin-exacerbated @Disease$ (AERD) are characterized by overproduction of @Chemical$ (LT) and eosinophil activation, in which epithelial cells contribute to eosinophilic airway inflammation."	0
"Recently, flowcharts regarding challenge/desensitization procedures with aspirin in patients with @Disease$ and histories of @Chemical$ hypersensitivity reactions have become available."	0
@Disease$ with low-dose aspirin and @Chemical$ mimics malignancy: a case report.	1
"This report describes a case of Kounis-Zavras syndrome in the setting of aspirin-induced asthma also known as Samter-Beer triad combining nasal polyps, @Disease$, and @Chemical$ allergy leading to vasospasm and myocardial infarction."	0
"This report describes a case of Kounis-Zavras syndrome in the setting of aspirin-induced @Disease$ also known as Samter-Beer triad combining nasal polyps, asthma, and @Chemical$ allergy leading to vasospasm and myocardial infarction."	0
The hypotheses were to investigate if use of @Chemical$ or phosphodiesterase inhibitors were associated with increased risk of @Disease$s after adjustment for potential confounders.	0
"An increased excretion of @Chemical$ and 9alpha,11beta-prostaglandin F2 has been detected in a patient who suffered an @Disease$ attack after percutaneous administration of nonsteroidal anti-inflammatory drugs."	0
CONCLUSIONS: Continuous @Chemical$ use increases the risk of @Disease$ after gastric ESD.	1
OBJECTIVE: To determine whether high-dose @Chemical$ cross-reacts in patients with AERD and @Disease$.	0
@Chemical$ usage was more common than NSAID in patients with @Disease$ hemorrhage (NSAID usage n=35 (40%); ASA usage n=51 (60%); p=0.035).	0
@Chemical$ sensitivity is most often manifested as rhinitis and asthma or @Disease$/angioedema induced by cross-reacting nonsteroidal anti-inflammatory drugs that inhibit cyclooxygenase 1.	0
Several ASA desensitization protocols exist and have been proven to successfully treat @Chemical$ @Disease$ and allow for ASA therapy to be safely initiated.	1
"BACKGROUND: Low-dose @Chemical$ has proven effectiveness in secondary and primary prevention of cardiovascular events, but is also associated with an increased risk of major @Disease$ events."	1
CONCLUSIONS: High-dose ASA in Heart Mate II patients treated concomitantly with @Chemical$ is associated with an increased hazard of bleeding but does not reduce @Disease$ events.	0
METHODS: Data from the EINSTEIN-CHOICE trial were used to compare the benefit-risk profiles of extended treatment with @Chemical$ (20 or 10 mg once daily) and aspirin (100 mg once daily) in @Disease$ patients who had completed 6 to 12 months of anticoagulation therapy.	0
"The warfarin TTR &gt;=55% episodes were associated with a 77% lower risk of @Disease$/SE (relative risk=0.23 [0.18 to 0.28]) compared to never on therapy; and the @Chemical$ TTR &lt;55% and on-aspirin episodes were associated with a 20% lower and with a 26% lower risk of stroke/SE compared to never on therapy, respectively."	0
"OBJECTIVE: The purpose of this study was to demonstrate that @Chemical$, a specific inhibitor of COX-2, does not cause asthmatic attacks in patients with ASA and/or other NSAID-induced @Disease$."	0
"CONCLUSIONS: Low-dose @Chemical$ use could reduce the incidences of total cardiovascular events, stroke, nonfatal @Disease$ and transient ischemic attack but increase the risk of bleeding, the incidence of nonfatal myocardial infarction, death from cardiovascular causes and death from any cause was not affected by low-dose aspirin use."	0
"Our study also highlights that the use of @Chemical$ for primary prevention of cancer was found to cause higher rates of bleeding (any bleeding, major bleeding, and GI @Disease$) compared to placebo or no aspirin at the longest follow-up period with no significant benefit in cancer primary prevention."	1
This study suggests that the combined antiplatelet treatment with clopidogrel and @Chemical$ could be a good option in ACS patients with @Disease$ to aspirin undergoing coronary stenting.	0
"Because platelet adherence to leukocytes allows for both firm adhesion to endothelial cells and augmented transcellular conversion of @Chemical$s, a disturbance in platelet-leukocyte interactions may be partly responsible for the respiratory tissue @Disease$ and the overproduction of cysLTs that characterize AERD."	0
[Safety of reintroducing platelet-inhibitory doses of @Chemical$ in patients with @Disease$ or angioedema induced by anti-inflammatory doses].	0
Complement C3a and C4a increased in plasma of patients with @Chemical$-induced @Disease$.	1
"QUESTION/PURPOSES: We sought to answer four questions: For the THA and TKA cohorts, respectively, (1) was the incidence of readmission resulting from @Disease$ and bleeding complications higher with LMWH than mobile compression plus @Chemical$; and (2) was the incidence of wound bleeding complications higher with LMWH than mechanical compression plus ASA?"	0
RESULTS: Celecoxib 200 mg was proven to be well tolerated in all 30 three @Chemical$- and NSAID-induced @Disease$ patients.	1
"METHODS: This retrospective cohort study assessed overt @Disease$, decreased hemoglobin levels suspecting small bowel blood loss, and CV death in patients taking @Chemical$ for more than 1 year (LDA group) and in patients not taking LDA (control group)."	0
RESULTS: Rebamipide significantly inhibited @Disease$ induced by @Chemical$ alone or by LDA plus clopidogrel when compared with placebo in healthy subjects.	1
"It has been proposed that overproduction of cys-LTs, together with removal by @Chemical$/NSAIDs of the 'brake' imposed by the bronchodilator prostaglandin E2, may cause an asthma attack in patients with @Disease$."	0
"RESULTS: The final analysis included 1470 study participants: 221 controls, 553 CRS without @Disease$ (@Chemical$sNPs), 651 CRS with nasal polyps (CRSwNPs) and 45 allergic fungal rhinosinusitis (AFRS)."	0
"The five genes identified in this study likely play roles in the pathogenesis of polyps associated with @Disease$ and @Chemical$, and are therefore attractive targets for novel medical therapies for these common debilitating diseases."	0
"RESULTS: Buffered acetylsalicylic acid plus @Chemical$ yielded the lowest Lanza score, the lowest increase in the number of @Disease$ and the lowest increase in the amount of gastric microbleeding."	0
@Chemical$-induced asthma (@Disease$) is associated with increased production of cysteinyl leukotrienes (CysLT).	0
"BACKGROUND: Although the mechanism that underlies aspirin hypersensitivity is not completely understood, an IgE-mediated response was reported for a patient with @Chemical$-intolerant chronic @Disease$ (AICU)."	0
"Although @Chemical$ increases the risk for @Disease$, the effect on esophageal mucosa is unclear."	1
"@Chemical$, Reye syndrome, @Disease$, and allergies; a reconsideration of the links."	1
A risk score to predict silent myocardial ischemia in patients with @Disease$ under @Chemical$ therapy presenting with upper gastrointestinal hemorrhage.	0
This effect of aspirin is unique to @Chemical$-exacerbated respiratory disease and not observed in subjects with aspirin-tolerant @Disease$.	0
"To evaluate the @Disease$ risk in patients requiring chronic warfarin therapy and undergoing stent implantation, we compared 107 consecutive patients on chronic warfarin therapy who underwent coronary stenting and were discharged on aspirin, @Chemical$ and warfarin to 107 contemporary patients who were treated with aspirin and clopidogrel."	0
"@Chemical$ concentrations are reduced in @Disease$, and our published studies confirm that this reflects diminished expression of cyclooxygenase (COX)-2."	0
"However, @Chemical$/aspirin was associated with a significantly higher incidence of @Disease$ and duodenal ulcers than aspirin alone."	0
@Chemical$-exacerbated @Disease$ (AERD) is an asthma phenotype with a prevalence that ranges from 2% to 25% of the asthma population.	1
"AIMS: We hypothesized that patients with a history of either alarming or nuisance bleeding events, compared to those with no history of @Disease$, would have lower levels of on-treatment platelet reactivity (aspirin and a @Chemical$)."	0
"Hypersensitivity to acetylsalicylic acid (ASA) is characterized by the co-occurrence of symptoms so-called @Chemical$ triad, which include @Disease$, chronic rhinitis and sinusitis and the nasal mucosa polyps."	1
"@Chemical$ intolerance, house dust mite (HDM) allergy, male sex, age older than 65 years, and duration of @Disease$ exceeding 10 years were investigated as factors potentially related to the severity of asthma."	0
"@Chemical$-exacerbated diseases are important examples of drug hypersensitivities and include aspirin-exacerbated respiratory disease (AERD), aspirin- or non-steroidal anti-inflammatory drug (NSAID)-induced @Disease$/angioedema, and aspirin- or NSAID-induced anaphylaxis."	0
Four of 12 patients with @Chemical$ and bridging AC (33%) and two of 13 patients with uninterrupted warfarin (15%) developed a @Disease$.	0
MAIN OUTCOME MEASURES: Odds of having been exposed to prior non-@Chemical$ NSAID or aspirin use by participants with @Disease$ and by their controls in each case-control set.	0
"However, in glucose-6-phosphate dehydrogenase (G6PD) deficient patients, precaution is always taken with @Chemical$ use, due to the risk of @Disease$."	1
"CONCLUSIONS: Combination of low-dose aspirin therapy and @Chemical$ may exacerbate small @Disease$, and the preventive strategies should be established."	1
"Even if TIMI defined major bleeding favored a low dose of aspirin, with OR: 1.42, 95 % CI: 0.95-2.13; P = 0.09, or even if major @Disease$ was insignificantly higher with a high dose @Chemical$, with OR: 1.78, 95 % CI: 1.01-3.13; P = 0.05; I(2) = 94 %, higher levels of heterogeneity observed in these subgroups could not be considered significant to any extent."	0
"Three weeks later, he had acute renal failure, which was initially thought to be secondary to systemic vasculitis, but proved to be @Disease$ as a delayed reaction to @Chemical$."	1
Rapid Aspirin Challenge in Patients with @Chemical$ @Disease$ and Acute Coronary Syndromes.	1
"To evaluate the @Disease$ risk in patients requiring chronic warfarin therapy and undergoing stent implantation, we compared 107 consecutive patients on chronic @Chemical$ therapy who underwent coronary stenting and were discharged on aspirin, clopidogrel and warfarin to 107 contemporary patients who were treated with aspirin and clopidogrel."	0
"RESULTS: The rate of a @Disease$ event was 3.8%/year with @Chemical$ and 4.5%/year with apixaban (hazard ratio with apixaban, 1.18; 95% CI, 0.92-1.51; P=0.19)."	0
